PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Quint, P; Ruan, M; Pederson, L; Kassem, M; Westendorf, JJ; Khosla, S; Oursler, MJ				Quint, Patrick; Ruan, Ming; Pederson, Larry; Kassem, Moustapha; Westendorf, Jennifer J.; Khosla, Sundeep; Oursler, Merry Jo			Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; THERAPEUTIC TARGETS; BONE-RESORPTION; TNF-ALPHA; JAK-STAT; CANCER; GROWTH; SPHINGOSINE-1-PHOSPHATE; PROLIFERATION; CARCINOMA	Normal bone turnover requires tight coupling of bone resorption and bone formation to preserve bone quantity and structure. With aging and during several pathological conditions, this coupling breaks down, leading to either net bone loss or excess bone formation. To preserve or restore normal bone metabolism, it is crucial to determine the mechanisms by which osteoclasts and osteoblast precursors interact and contribute to coupling. We showed that osteoclasts produce the chemokine sphingosine 1-phosphate (S1P), which stimulates osteoblast migration. Thus, osteoclast-derived S1P may recruit osteoblasts to sites of bone resorption as an initial step in replacing lost bone. In this study we investigated the mechanisms by which S1P stimulates mesenchymal (skeletal) cell chemotaxis. S1P treatment of mesenchymal (skeletal) cells activated RhoA GTPase, but this small G protein did not contribute to migration. Rather, two S1P receptors, S1PR1 and S1PR2, coordinately promoted migration through activation of the JAK/STAT3 and FAK/PI3K/AKT signaling pathways, respectively. These data demonstrate that the chemokine S1P couples bone formation to bone resorption through activation of kinase signaling pathways.	[Quint, Patrick; Ruan, Ming; Pederson, Larry; Khosla, Sundeep; Oursler, Merry Jo] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA; [Quint, Patrick; Ruan, Ming; Pederson, Larry; Khosla, Sundeep; Oursler, Merry Jo] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Div Orthoped Res, Rochester, MN 55905 USA; [Westendorf, Jennifer J.; Oursler, Merry Jo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11451, Saudi Arabia	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern Denmark; Odense University Hospital; King Saud University	Quint, P (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	quint.patrick@mayo.edu	Kassem, Moustapha/O-3819-2019; Kassem, Moustapha/J-7688-2013; Khosla, Sundeep/AAE-6170-2020	Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Khosla, Sundeep/0000-0002-2936-4372	National Institutes of Health [P01 AG004875]; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AG004875 through the NIA.	Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Baumruker T, 2007, EXPERT OPIN INV DRUG, V16, P283, DOI 10.1517/13543784.16.3.283; Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Brown S, 2006, DEV DYNAM, V235, P958, DOI 10.1002/dvdy.20709; Cuvillier O, 2007, ANTI-CANCER DRUG, V18, P105, DOI 10.1097/CAD.0b013e328011334d; Delehedde M, 2001, EUR J BIOCHEM, V268, P4423, DOI 10.1046/j.1432-1327.2001.02363.x; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Garcia-Bernal D, 2013, J PATHOL, V229, P36, DOI 10.1002/path.4066; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Harvey KA, 2010, MOL CELL BIOCHEM, V342, P7, DOI 10.1007/s11010-010-0461-2; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jin ZQ, 2007, CARDIOVASC RES, V76, P41, DOI 10.1016/j.cardiores.2007.05.029; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lai WQ, 2012, FUTURE MED CHEM, V4, P727, DOI [10.4155/FMC.12.28, 10.4155/fmc.12.28]; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; Lee SH, 2012, J CLIN ENDOCR METAB, V97, pE1421, DOI 10.1210/jc.2012-1044; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lynch Kevin R, 2012, Biochem J, V444, pe1, DOI 10.1042/BJ20120567; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Schwalm S, 2010, BRIT J PHARMACOL, V160, P1641, DOI 10.1111/j.1476-5381.2010.00818.x; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamada O, 2012, MOL CANCER THER, V11, P1112, DOI 10.1158/1535-7163.MCT-11-0850; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	66	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5398	5406		10.1074/jbc.M112.413583	http://dx.doi.org/10.1074/jbc.M112.413583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300082	hybrid, Green Published			2022-12-25	WOS:000315342500015
J	Ucero, AC; Berzal, S; Ocana-Salceda, C; Sancho, M; Orzaez, M; Messeguer, A; Ruiz-Ortega, M; Egido, J; Vicent, MJ; Ortiz, A; Ramos, AM				Ucero, Alvaro C.; Berzal, Sergio; Ocana-Salceda, Carlos; Sancho, Monica; Orzaez, Mar; Messeguer, Angel; Ruiz-Ortega, Marta; Egido, Jesus; Vicent, Maria J.; Ortiz, Alberto; Ramos, Adrian M.			A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATING FACTOR-1 APAF-1; ACUTE KIDNEY INJURY; CYTOCHROME-C; APOPTOSIS; INHIBITORS; EXPRESSION; RECRUITMENT; COMPLEX; ALPHA	The polyglutamic acid/peptoid 1 (QM56) nanoconjugate inhibits apoptosis by interfering with Apaf-1 binding to procaspase-9. We now describe anti-inflammatory properties of QM56 in mouse kidney and renal cell models. In cultured murine tubular cells, QM56 inhibited the inflammatory response to Tweak, a non-apoptotic stimulus. Tweak induced MCP-1 and Rantes synthesis through JAK2 kinase and NF-kappa B activation. Similar to JAK2 kinase inhibitors, QM56 inhibited Tweak-induced NF-kappa B transcriptional activity and chemokine expression, despite failing to inhibit NF-kappa B-p65 nuclear translocation and NF-kappa B DNA binding. QM56 prevented JAK2 activation and NF-kappa B-p65(Ser536) phosphorylation. The anti-inflammatory effect and JAK2 inhibition by QM56 were observed in Apaf-1(-/-) cells. In murine acute kidney injury, QM56 decreased tubular cell apoptosis and kidney inflammation as measured by down-modulations of MCP-1 and Rantes mRNA expression, immune cell infiltration and activation of the JAK2-dependent inflammatory pathway. In conclusion, QM56 has an anti-inflammatory activity which is independent from its role as inhibitor of Apaf-1 and apoptosis and may have potential therapeutic relevance.	[Ucero, Alvaro C.; Berzal, Sergio; Ocana-Salceda, Carlos; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto; Ramos, Adrian M.] IIS FJD, Lab Nephrol & Vasc Pathol, Madrid, Spain; [Sancho, Monica; Orzaez, Mar; Vicent, Maria J.] Ctr Invest Principe Felipe, Dept Med Chem, Valencia, Spain; [Messeguer, Angel] Inst Quim Avancada Catalunya, Dept Chem & Biomol Nanotechnol, Barcelona, Spain; [Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Egido, Jesus; Ortiz, Alberto] FRIAT, Madrid, Spain	Fundacion Jimenez Diaz; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Madrid	Ramos, AM (corresponding author), IIS FJD, Lab Nephrol & Vasc Pathol, Madrid, Spain.	amramos@fjd.es	Orzaez, Mar/B-4992-2014; Ruiz-Ortega, Marta/D-3584-2012; Ucero, Alvaro Conrado/AGQ-2114-2022; Ortega, Marta Ruiz/AAN-2136-2020; Ramos, Adrián Mario/W-6860-2018; Ucero, Alvaro C/C-8437-2013; ortiz, alberto/Y-7582-2018; Vicent, Maria J./O-3664-2019; Medina, Mónica Sancho/L-4660-2014; Vicent, Maria J. J/A-9690-2014; ruiz-ortega, marta/D-3584-2012	Orzaez, Mar/0000-0003-3231-5835; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ucero, Alvaro Conrado/0000-0002-5575-0808; Ortega, Marta Ruiz/0000-0002-1495-6535; Ucero, Alvaro C/0000-0002-5575-0808; ortiz, alberto/0000-0002-9805-9523; Vicent, Maria J./0000-0001-7771-3373; Medina, Mónica Sancho/0000-0003-3707-062X; Vicent, Maria J. J/0000-0001-7771-3373; Messeguer, Angel/0000-0002-8358-9425; ruiz-ortega, marta/0000-0002-1403-2690; Ocana-Salceda, Carlos/0000-0002-3949-0014	Instituto de Salud Carlos III [PI07/0020, CP08/1083, PS09/00447, ISCIII-RETICS REDINREN RD 06/0016]; Sociedad Espanola de Nefrologia; Fundacion Conchita Rabago; Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III; Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO [0283/2006]; FIS (Programa Miguel Servet)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Espanola de Nefrologia; Fundacion Conchita Rabago; Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III; Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO; FIS (Programa Miguel Servet)	This work was supported by grants from the Instituto de Salud Carlos III (www.isciii.es), FIS: PI07/0020, CP08/1083, PS09/00447 and ISCIII-RETICS REDINREN RD 06/0016; Sociedad Espanola de Nefrologia (www.senefro.org). Alvaro Ucero, Sergio Berzal and Carlos Ocana supported by Fundacion Conchita Rabago (www.fundacionconchitarabago.net), Alberto Ortiz by the Programa de Intensificacion de la Actividad Investigadora in the Sistema Nacional de Salud of the Instituto de Salud Carlos III and the Agencia "Pedro Lain Entralgo'' of the Comunidad de Madrid and CIFRA S-BIO 0283/2006 www.madrid.org/lainentralgo) and Adrian Ramos, by FIS (Programa Miguel Servet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fritzenwanger M, 2006, CYTOKINE, V33, P46, DOI 10.1016/j.cyto.2005.11.016; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Goncalves S, 2010, CURR MED CHEM, V17, P974, DOI 10.2174/092986710790820642; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Neria F, 2009, KIDNEY INT, V75, P227, DOI 10.1038/ki.2008.487; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sattler M, 2009, CANCER CELL, V16, P365, DOI 10.1016/j.ccr.2009.10.009; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Strassheim D, 2009, J IMMUNOL, V183, P6981, DOI 10.4049/jimmunol.0901045; Tanimoto A, 2008, J BIOL CHEM, V283, P4643, DOI 10.1074/jbc.M708853200; Grande MT, 2008, CURR MED CHEM, V15, P2054, DOI 10.2174/092986708785132889; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Wang S, 2010, LUPUS, V19, P1171, DOI 10.1177/0961203310367660; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	44	28	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51992	10.1371/journal.pone.0051992	http://dx.doi.org/10.1371/journal.pone.0051992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300960	Green Published, gold			2022-12-25	WOS:000313320900016
J	Hollingsworth, K; Callaway, L; Duhig, M; Matheson, S; Scott, J				Hollingsworth, Katharine; Callaway, Leonie; Duhig, Michael; Matheson, Sally; Scott, James			The Association between Maltreatment in Childhood and Pre-Pregnancy Obesity in Women Attending an Antenatal Clinic in Australia	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; PREGNANCY; HEALTH; WEIGHT; LIFE; ABUSE; RISK; TERM; CONSEQUENCES	Introduction: Obesity in pregnancy is associated with increased risk of complications and adverse outcomes in mother and child. Childhood adverse experiences are known to have numerous negative physical and emotional sequelae. We aimed to examine if exposure to abuse and/or neglect in childhood increased the likelihood of pre-pregnancy obesity. Methods: Demographic and clinical data including weight, height, mental health as measured by the General Health Questionnaire and exposure to childhood trauma as measured by the childhood trauma questionnaire was collected from 239 women attending antenatal care at an Australian tertiary hospital. Results: More than one quarter of women were obese prior to pregnancy and approximately 20% of women self reported experiencing moderate to severe physical, sexual or emotional abuse. Almost 60% of women scored in the clinical range on the GHQ. Pre-pregnancy obesity in women attending antenatal care was associated with a self-reported history of emotional or physical abuse with those exposed to moderate or severe emotional or physical abuse having increased odds of being obese prior to pregnancy (O.R. and 95% CI: 2.40; 1.19-4.84 and 2.38; 1.18-4.79 respectively). There was no significant association between other forms of childhood maltreatment, demographic or current mental health status and pre-pregnancy obesity. Conclusions: The high rates of obesity, mental health problems and self reported childhood maltreatment in the Australian antenatal population are serious public health concerns due to the extra health risks conferred on mother and offspring. Exposure to physical or emotional abuse during childhood increases the likelihood of obesity in women attending antenatal care. Further research is required to determine reasons for this association.	[Callaway, Leonie; Scott, James] Royal Brisbane & Womens Hosp Herston, Dept Med, Herston, Qld, Australia; [Callaway, Leonie] Univ Queensland, Sch Med, Herston, Qld, Australia; [Duhig, Michael; Scott, James] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia; [Scott, James] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Scott, J (corresponding author), Royal Brisbane & Womens Hosp Herston, Dept Med, Herston, Qld, Australia.	James_g_scott@health.qld.gov.au	Scott, James G/D-5900-2012	Scott, James G/0000-0002-0744-0688; Duhig, Michael/0000-0003-3880-4760; Callaway, Leonie/0000-0002-0137-9935	Royal Brisbane and Women's Hospital Foundation; Royal Brisbane and Women's Hospital; RBWH Foundation	Royal Brisbane and Women's Hospital Foundation; Royal Brisbane and Women's Hospital; RBWH Foundation	The study was undertaken by the first author (KH) whilst doing her honours degree during her medical studies. The publication fee was paid by The Royal Brisbane and Women's Hospital Foundation. There was no external funding for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the women who participated in this study, the staff of the Royal Brisbane and Women's Hospital and the RBWH Foundation who supported the publication of this manuscript.	ABS, 2011, OV OB AD AUSTR SNAPS; ABS, 2005, PERS SAF SURV; Austin MP, 2000, AUST NZ J OBSTET GYN, V40, P331, DOI 10.1111/j.1479-828X.2000.tb03344.x; Bardone-Cone AM, 2008, INT J EAT DISORDER, V41, P697, DOI 10.1002/eat.20567; Barlow J, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002020.PUB2; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; Baxter S, 2011, HEALTH EDUC RES, V26, P265, DOI 10.1093/her/cyq092; Begum KS, 2011, CLIN EXP OBSTET GYN, V38, P14; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Burton NW, 2010, AUST NZ J PUBL HEAL, V34, P620, DOI 10.1111/j.1753-6405.2010.00618.x; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Ching HL, 2007, CLIN ENDOCRINOL, V66, P373, DOI 10.1111/j.1365-2265.2007.02742.x; Cohen RA, 2006, INT J PSYCHIAT MED, V36, P35, DOI 10.2190/5R62-9PQY-0NEL-TLPA; Coverdale JH, 1996, AUST NZ J OBSTET GYN, V36, P424, DOI 10.1111/j.1479-828X.1996.tb02185.x; D'Argenio A, 2009, PHYSIOL BEHAV, V98, P543, DOI 10.1016/j.physbeh.2009.08.010; DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227; Ehrenberg HM, 2002, AM J OBSTET GYNECOL, V187, P1189, DOI 10.1067/mob.2002.127125; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008; Fraser JA, 2000, CHILD ABUSE NEGLECT, V24, P1399, DOI 10.1016/S0145-2134(00)00193-9; Gao Fei, 2004, Health Qual Life Outcomes, V2, P63, DOI 10.1186/1477-7525-2-63; Gartland D, 2010, AUST NZ J OBSTET GYN, V50, P413, DOI 10.1111/j.1479-828X.2010.01204.x; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goodwin A, 2000, AUST NZ J OBSTET GYN, V40, P442, DOI 10.1111/j.1479-828X.2000.tb01178.x; Gunstad J, 2006, PSYCHIAT RES, V142, P31, DOI 10.1016/j.psychres.2005.11.007; Gustafson T B, 2004, Obes Rev, V5, P129, DOI 10.1111/j.1467-789X.2004.00145.x; Hinkle SN, 2011, MATERNAL CHILD HLTH; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Johnson DB, 2006, J AM DIET ASSOC, V106, P97, DOI 10.1016/j.jada.2005.09.048; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lois K, 2011, OCCUPATIONAL MED; Maughan B, 1997, J PERS DISORD, V11, P19, DOI 10.1521/pedi.1997.11.1.19; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Melhuish E, 2010, ARCH DIS CHILD, V95, P159, DOI 10.1136/adc.2009.161018; Nemeroff CB Charles B, 2004, Psychopharmacol Bull, V38, P14; Price-Robertson R, FAMILY MATT IN PRESS; Rooney K, 2011, INT J OBESITY, V35, P883, DOI 10.1038/ijo.2011.96; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Taylor AW, 2000, AUST NZ J PUBL HEAL, V24, P29, DOI 10.1111/j.1467-842X.2000.tb00719.x; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Tsoi E, 2010, POSTGRAD MED J, V86, P617, DOI 10.1136/pgmj.2010.098186; Van Eerden P, 2011, S DAKOTA MED J S DAK; Wane S, 2010, J WOMENS HEALTH, V19, P1327, DOI 10.1089/jwh.2009.1738; WHITWELL D, 1990, BRIT J HOSP MED, V43, P346; Wiederman MW, 1999, WOMEN HEALTH, V29, P89, DOI 10.1300/J013v29n01_07; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	53	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51868	10.1371/journal.pone.0051868	http://dx.doi.org/10.1371/journal.pone.0051868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300572	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600010
J	Caballero, JM; Garzon, A; Gonzalez-Cintado, L; Kowalczyk, W; Torres, IJ; Calderita, G; Rodriguez, M; Gondar, V; Bernal, JJ; Ardavin, C; Andreu, D; Zurcher, T; von Kobbe, C				Martin Caballero, Juan; Garzon, Ana; Gonzalez-Cintado, Leticia; Kowalczyk, Wioleta; Jimenez Torres, Ignacio; Calderita, Gloria; Rodriguez, Margarita; Gondar, Virginia; Jose Bernal, Juan; Ardavin, Carlos; Andreu, David; Zuercher, Thomas; von Kobbe, Cayetano			Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7-Dependent Tumors	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; DENDRITIC CELLS; CERVICAL-CANCER; DNA VACCINES; CTL EPITOPES; E7; VACCINATION; PROTECTION; COMBINATION; IMMUNITY	Cervical cancer is caused by persistent high-risk human papillomavirus (HR-HPV) infection and represents the second most frequent gynecological malignancy in the world. The HPV-16 type accounts for up to 55% of all cervical cancers. The HPV-16 oncoproteins E6 and E7 are necessary for induction and maintenance of malignant transformation and represent tumor-specific antigens for targeted cytotoxic T lymphocyte-mediated immunotherapy. Therapeutic cancer vaccines have become a challenging area of oncology research in recent decades. Among current cancer immunotherapy strategies, virus-like particle (VLP)-based vaccines have emerged as a potent and safe approach. We generated a vaccine (VLP-E7) incorporating a long C-terminal fragment of HPV-16 E7 protein into the infectious bursal disease virus VLP and tested its therapeutic potential in HLA-A2 humanized transgenic mice grafted with TC1/A2 tumor cells. We performed a series of tumor challenge experiments demonstrating a strong immune response against already-formed tumors (complete eradication). Remarkably, therapeutic efficacy was obtained with a single dose without adjuvant and against two injections of tumor cells, indicating a potent and long-lasting immune response.	[Martin Caballero, Juan] Barcelona Biomed Res Pk, Lab Anim Unit, Barcelona, Spain; [Garzon, Ana; Jimenez Torres, Ignacio; Calderita, Gloria; Rodriguez, Margarita; Gondar, Virginia; Jose Bernal, Juan; Zuercher, Thomas; von Kobbe, Cayetano] Chimera Pharma SLU, Canc Vaccines Unit, R&D Dept, Madrid, Spain; [Gonzalez-Cintado, Leticia; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Pompeu Fabra University	von Kobbe, C (corresponding author), Chimera Pharma SLU, Canc Vaccines Unit, R&D Dept, Madrid, Spain.	cvonkobbe@cbm.uam.es	Kowalczyk, Wioleta/F-5904-2014; bernal, juan jose/AAA-6474-2020; Andreu, David/I-4359-2014	Andreu, David/0000-0002-6317-6666; Kowalczyk, Wioleta/0000-0001-5180-594X; bernal, juan jose/0000-0001-6825-4590; von Kobbe, Cayetano/0000-0003-3895-3790	Instituto Marileno de Desarrollo [PIE/473/2009, PIE/506/2008]; Comunidad Autonoma de Madrid [25/2008]; Ministerio de Educacion [CIT-010000-2008-18]; Ministerio de Industria, Turismo y Comercio [FIT-010000-2007-68]; Ministerio de Ciencia e Innovacion (PROFIT) [CIT-010000-2007-34]; Consorci Parc de Recerca Biomedica de Barcelona	Instituto Marileno de Desarrollo; Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion; Ministerio de Industria, Turismo y Comercio(Spanish Government); Ministerio de Ciencia e Innovacion (PROFIT); Consorci Parc de Recerca Biomedica de Barcelona	This work was supported in part by grants PIE/473/2009 and PIE/506/2008 from Instituto Marileno de Desarrollo, 25/2008 from Comunidad Autonoma de Madrid, CIT-010000-2008-18 from Ministerio de Educacion, FIT-010000-2007-68 from Ministerio de Industria, Turismo y Comercio, and CIT-010000-2007-34 from Ministerio de Ciencia e Innovacion (PROFIT). Additional support was provided by Consorci Parc de Recerca Biomedica de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman JA, 2007, VACCINE, V25, P3437, DOI 10.1016/j.vaccine.2006.12.045; Cid-Arregui Angel, 2009, Open Virol J, V3, P67, DOI 10.2174/1874357900903010067; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Daftarian PM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-26; Delgui L, 2009, VIROLOGY, V386, P360, DOI 10.1016/j.virol.2008.12.036; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Dybing JK, 1998, AVIAN DIS, V42, P80, DOI 10.2307/1592579; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Haigh O, 2010, CANCER GENE THER, V17, P708, DOI 10.1038/cgt.2010.27; Herbert Jennifer, 2008, J Am Osteopath Assoc, V108, P65; Hirohashi Y, 2009, CANCER SCI, V100, P798, DOI 10.1111/j.1349-7006.2009.01137.x; Hoory T, 2008, J FORMOS MED ASSOC, V107, P198, DOI 10.1016/S0929-6646(08)60138-2; Hung CF, 2007, EXP MOL MED, V39, P679, DOI 10.1038/emm.2007.74; International Agency for Research on Cancer (IARC), 2005, IARC HANDBOOKS OF CA, V10; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Keller SA, 2009, J IMMUNOL, V182, P6261, DOI 10.4049/jimmunol.0804035; Khatri M, 2007, CYTOGENET GENOME RES, V117, P388, DOI 10.1159/000103202; Kowalczyk W, 2011, J PEPT SCI, V17, P247, DOI 10.1002/psc.1310; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Ma B, 2010, CURR CANCER THER REV, V6, P81, DOI 10.2174/157339410791202583; Peng S, 2006, GENE THER, V13, P257, DOI 10.1038/sj.gt.3302646; Peng SW, 1998, VIROLOGY, V240, P147, DOI 10.1006/viro.1997.8912; Qin Y, 2007, GYNECOL ONCOL, V104, P199, DOI 10.1016/j.ygyno.2006.07.044; RESSING ME, 1995, J IMMUNOL, V154, P5934; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Schreiber TH, 2010, SEMIN IMMUNOL, V22, P105, DOI 10.1016/j.smim.2010.02.001; Sheng WY, 2011, PHARM RES-DORDR, V28, P200, DOI 10.1007/s11095-010-0258-8; Smith KA, 2009, CLIN CANCER RES, V15, P6167, DOI 10.1158/1078-0432.CCR-09-0645; Toubaji A, 2007, VACCINE, V25, P5882, DOI 10.1016/j.vaccine.2007.05.040; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vergati M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/596432; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Yamaguchi T, 1996, ARCH VIROL, V141, P1493, DOI 10.1007/BF01718250; Zhou LQ, 2010, HUM GENE THER, V21, P109, DOI 10.1089/hum.2009.139	37	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52976	10.1371/journal.pone.0052976	http://dx.doi.org/10.1371/journal.pone.0052976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300838	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600042
J	Mesnil, C; Sabatel, CM; Marichal, T; Toussaint, M; Cataldo, D; Drion, PV; Lekeux, P; Bureau, F; Desmet, CJ				Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Cataldo, Didier; Drion, Pierre-Vincent; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.			Resident CD11b(+)Ly6C(-) Lung Dendritic Cells Are Responsible for Allergic Airway Sensitization to House Dust Mite in Mice	PLOS ONE			English	Article							TH2 RESPONSES; T-CELLS; GM-CSF; IMMUNE-RESPONSES; IN-VIVO; INFLAMMATION; ANTIGEN; ASTHMA; DIFFERENTIATION; HOMEOSTASIS	Conventional dendritic cells (DCs) are considered to be the prime initiators of airway allergy. Yet, it remains unclear whether specific DC subsets are preferentially involved in allergic airway sensitization. Here, we systematically assessed the respective pro-allergic potential of individually sorted lung DC subsets isolated from house dust mite antigen (HDM)-treated donor mice, following transfer to naive recipients. Transfer of lung CD11c(+)CD11b(+) DCs, but not CD11c(+)CD11b(-)CD103(+) DCs, was sufficient to prime airway allergy. The CD11c(+)CD11b(+) DC subpopulation was composed of CD11c(+)CD11b(+)Ly6C(+) inflammatory monocyte-derived cells, whose numbers increase in the lungs following HDM exposure, and of CD11c(+)CD11b(+)Ly6C(-) DCs, which remain stable. Counterintuitively, only CD11c(+)CD11b(+)Ly6C(-) DCs, and not CD11c(+)CD11b(+)Ly6C(+) DCs, were able to convey antigen to the lymph nodes and induce adaptive T cell responses and subsequent airway allergy. Our results thus support that lung resident non-inflammatory CD11c(+)CD11b(+)Ly6C(-) DCs are the essential inducers of allergic airway sensitization to the common aeroallergen HDM in mice.	[Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Lab Cellular & Mol Immunol, GIGA Res, Liege, Belgium; [Mesnil, Claire; Sabatel, Catherine M.; Marichal, Thomas; Toussaint, Marie; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Fac Vet Med, Liege, Belgium; [Cataldo, Didier] Univ Liege, Lab Tumours & Dev Biol, GIGA Res, Liege, Belgium; [Drion, Pierre-Vincent] Univ Liege, Lab Preclin & Biomed Sci, Univ Hosp Ctr, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Bureau, F (corresponding author), Univ Liege, Lab Cellular & Mol Immunol, GIGA Res, Liege, Belgium.	fabrice.bureau@ulg.ac.be; christophe.desmet@ulg.ac.be	Cataldo, Didier/GPG-3453-2022	Cataldo, Didier/0000-0002-3079-7941	"Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium); "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE); Belgian State (Belgian Science Policy)	"Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium)(Fonds de la Recherche Scientifique - FNRS); "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE)(Belgian Federal Science Policy Office); Belgian State (Belgian Science Policy)(Belgian Federal Science Policy Office)	The Laboratory of Cellular and Molecular Immunology is supported by grants of the "Fonds National de la Recherche Scientifique" (FRS-FNRS; Belgium), the "Fonds de la Recherche Scientifique Medicale" (FRSM; Belgium), and the Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE) initiated by the Belgian State (Belgian Science Policy). C. M., C. S. and T. M. are research fellows, and C.J.D. is a post-doctoral researcher of the FRS-FNRS. M. T. is a research fellow of the "Fonds de la Formation a la Recherche dans l'Industrie et l'Agriculture" (FRIA; Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Ortiz-Stern A, 2011, MUCOSAL IMMUNOL, V4, P343, DOI 10.1038/mi.2010.73; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Plantinga M, 2010, EUR J IMMUNOL, V40, P2112, DOI 10.1002/eji.201040562; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	40	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53242	10.1371/journal.pone.0053242	http://dx.doi.org/10.1371/journal.pone.0053242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300898	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600073
J	Yang, XW; Yang, J; Li, L; Man, XB; Zhang, BH; Shen, F; Wu, MC				Yang, Xin-wei; Yang, Jue; Li, Liang; Man, Xiao-bo; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao			Analysis of the Relationships between Clinicopathologic Factors and Survival in Gallbladder Cancer following Surgical Resection with Curative Intent	PLOS ONE			English	Article							GALL-BLADDER CANCER; RADICAL RESECTION; BILE-DUCT; CARCINOMA; JAUNDICE; MORTALITY; HEPATECTOMY; PREDICTOR; OUTCOMES; T2	Background: This study elucidated the relationships between various clinicopathologic factors and the outcome of patients with gallbladder cancer (GBC) treated by surgical resection with curative intent. Methods: Between January 2003 and January 2011, 76 patients with GBC underwent surgical resection with curative intent at our department. We then conducted a retrospective analysis of clinicopathologic data. Fourteen clinicopathological variables were selected for univariate and multivariate analysis to evaluate their influence on the outcome. Results: The actuarial 1-, 3-, and 5-year survival rates in the 76 resected cases were 56.6%, 32.7%, and 23.8%, respectively. The univariate analysis revealed that curative resection (P<0.001), lymph node metastasis (P<0.001), AJCC stage (P = 0.030), tumor location (P = 0.008), histologic differentiation (P = 0.028), intraoperative blood loss (P = 0.011), and preoperative jaundice (P = 0.012) were significant risk factors for survival. Multivariate analysis revealed that noncurative resection and tumor location on gallbladder neck were significant risk factors for poor outcome. Among jaundiced patients, we discovered that gallbladder carcinoma with tumor thrombus in common bile duct (CBD) was very rare but with relatively special clinical manifestation and characteristic radiography manifestation. The prognosis of gallbladder carcinoma with tumor thrombus in CBD after surgical procedure was apparently better than gallbladder carcinoma with invasion of hilar tissues. Conclusions: Curative surgical resection remains the only effective approach to the treatment of GBC. This series confirm that jaundice is a poor prognostic factor. However, the presence of jaundice does not preclude resection, especially in highly selected patients (when R0 resection is achievable). Gallbladder carcinoma with tumor thrombus in CBD has special clinical characteristics, which need to be awared by radiologists and clinicians.	[Yang, Xin-wei; Yang, Jue; Li, Liang; Man, Xiao-bo; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University	Zhang, BH (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	weicelia@163.com; shenfengdfgd@yahoo.com.cn	Li, Liang/AAY-9298-2020; Shen, Feng/GSD-2508-2022	Li, Liang/0000-0002-9410-6513; 				Agarwal AK, 2007, ANN SURG ONCOL, V14, P2831, DOI 10.1245/s10434-007-9456-y; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Choi SB, 2010, J GASTROINTEST SURG, V14, P668, DOI 10.1007/s11605-009-1132-z; D'Angelica M, 2009, ANN SURG ONCOL, V16, P806, DOI 10.1245/s10434-008-0189-3; Dixon E, 2005, ANN SURG, V241, P385, DOI 10.1097/01.sla.0000154118.07704.ef; Dutta U, 2012, J GASTROEN HEPATOL, V27, P642, DOI 10.1111/j.1440-1746.2011.07048.x; Goetze TO, 2008, ANN SURG, V247, P104, DOI 10.1097/SLA.0b013e318154bf5d; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Jayaraman S, 2010, GASTROENTEROL CLIN N, V39, P331, DOI 10.1016/j.gtc.2010.02.006; Kim WS, 2010, J GASTROINTEST SURG, V14, P679, DOI 10.1007/s11605-009-1140-z; Kobayashi A, 2012, WORLD J SURG, V36, P645, DOI 10.1007/s00268-011-1413-z; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Kondo S, 2003, WORLD J SURG, V27, P272, DOI 10.1007/s00268-002-6654-4; Kondo S, DIG SURG, V28, P148; Midorikawa Y, 2000, SURGERY, V127, P473, DOI 10.1067/msy.2000.102421; Miura F, 2010, SURGERY, V148, P271, DOI 10.1016/j.surg.2010.04.022; Nishio H, 2000, BRIT J SURG, V87, P1656, DOI 10.1046/j.1365-2168.2000.01590.x; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Pilgrim C, 2009, EJSO-EUR J SURG ONC, V35, P903, DOI 10.1016/j.ejso.2009.02.005; Pilgrim CHC, 2009, EJSO-EUR J SURG ONC, V35, P1131, DOI 10.1016/j.ejso.2009.02.006; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Shih SP, 2007, ANN SURG, V245, P893, DOI 10.1097/SLA.0b013e31806beec2; Shimada K, 2011, BRIT J SURG, V98, P117, DOI 10.1002/bjs.7262; Varma V, 2009, DIGEST SURG, V26, P306, DOI 10.1159/000231880; Wakai T, 2008, WORLD J SURG, V32, P1067, DOI 10.1007/s00268-007-9393-8; Wakai T, 2010, AM J SURG PATHOL, V34, P65, DOI 10.1097/PAS.0b013e3181c467d4; Yagi H, 2006, J HEPATO-BILIARY-PAN, V13, P530, DOI 10.1007/s00534-006-1104-6	29	23	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51513	10.1371/journal.pone.0051513	http://dx.doi.org/10.1371/journal.pone.0051513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300551	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600006
J	Elhanati, Y; Brenner, N				Elhanati, Yuval; Brenner, Naama			Metabolic Variability in Micro-Populations	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; CELL; GROWTH; DIVERSITY; SURVIVAL; CHANCE; NOISE; YIELD	Biological cells in a population are variable in practically every property. Much is known about how variability of single cells is reflected in the statistical properties of infinitely large populations; however, many biologically relevant situations entail finite times and intermediate-sized populations. The statistical properties of an ensemble of finite populations then come into focus, raising questions concerning inter-population variability and dependence on initial conditions. Recent technologies of microfluidic and microdroplet-based population growth realize these situations and make them immediately relevant for experiments and biotechnological application. We here study the statistical properties, arising from metabolic variability of single cells, in an ensemble of micro-populations grown to saturation in a finite environment such as a micro-droplet. We develop a discrete stochastic model for this growth process, describing the possible histories as a random walk in a phenotypic space with an absorbing boundary. Using a mapping to Polya's Urn, a classic problem of probability theory, we find that distributions approach a limiting inoculum-dependent form after a large number of divisions. Thus, population size and structure are random variables whose mean, variance and in general their distribution can reflect initial conditions after many generations of growth. Implications of our results to experiments and to biotechnology are discussed.	[Brenner, Naama] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Elhanati, Yuval] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Elhanati, Yuval; Brenner, Naama] Technion Israel Inst Technol, Network Biol Res Lab, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Brenner, N (corresponding author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.	nbrenner@technion.ac.il	Elhanati, Yuval/AAF-8601-2021	Elhanati, Yuval/0000-0002-4354-8864	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	Funding provided by Israeli Science Foundation personal grant 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8; BOYCE MS, 1984, ANNU REV ECOL SYST, V15, P427, DOI 10.1146/annurev.es.15.110184.002235; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Elhanati Y, 2011, THEOR POPUL BIOL, V80, P49, DOI 10.1016/j.tpb.2011.03.005; Feller W., 1971, WILEY SERIES PROBABI; Filiba E, 2012, THEOR POPUL BIOL, V82, P187, DOI 10.1016/j.tpb.2012.06.004; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; Friedlander T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018104; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Janson S, 2006, PROBAB THEORY REL, V134, P417, DOI 10.1007/s00440-005-0442-7; Johnson N., 1977, URN MODELS THEIR APP; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lu T, 2007, P NATL ACAD SCI USA, V104, P18982, DOI 10.1073/pnas.0706115104; MAC ARTHUR ROBERT H., 1967; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Mahmoud H, 2008, TEXTS STAT SCI, V76; Marcoux PR, 2011, COLLOID SURFACE A, V377, P54, DOI 10.1016/j.colsurfa.2010.12.013; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Schauble S, 2011, METHOD ENZYMOL, V500, P437, DOI 10.1016/B978-0-12-385118-5.00022-0; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Um E, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3500980; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002	42	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52105	10.1371/journal.pone.0052105	http://dx.doi.org/10.1371/journal.pone.0052105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300596	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100020
J	Fujiwara, K; Ohuchida, K; Mizumoto, K; Shindo, K; Eguchi, D; Kozono, S; Ikenaga, N; Ohtsuka, T; Takahata, S; Aishima, S; Tanaka, M				Fujiwara, Kenji; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Shindo, Koji; Eguchi, Daiki; Kozono, Shingo; Ikenaga, Naoki; Ohtsuka, Takao; Takahata, Shunichi; Aishima, Shinichi; Tanaka, Masao			CD271(+) Subpopulation of Pancreatic Stellate Cells Correlates with Prognosis of Pancreatic Cancer and Is Regulated by Interaction with Cancer Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; STROMAL FIBROBLASTS; STIMULATING PROLIFERATION; MATRIX SYNTHESIS; TUMOR-STROMA; IDENTIFICATION; EXPRESSION; FIBROSIS; ENHANCE	Pancreatic stellate cells (PSCs) play a crucial role in the aggressive behavior of pancreatic cancer. Although heterogeneity of PSCs has been identified, the functional differences remain unclear. We characterized CD271(+) PSCs in human pancreatic cancer. Immunohistochemistry for CD271 was performed for 31 normal pancreatic tissues and 105 pancreatic ductal adenocarcinomas (PDACs). We performed flow cytometry and quantitative RT-PCR, and assessed CD271 expression in PSCs isolated from pancreatic tissues and the changes in CD271 expression in PSCs cocultured with cancer cells. We also investigated the pattern of CD271 expression in a SCID mouse xenograft model. In the immunohistochemical analyses, the CD271-high staining rates in pancreatic stroma in normal pancreatic tissues and PDACs were 2/31 (6.5%) and 29/105 (27.6%), respectively (p = 0.0069). In PDACs, CD271(+) stromal cells were frequently observed on the edge rather than the center of the tumors. Stromal CD271 high expression was associated with a good prognosis (p = 0.0040). Flow cytometric analyses demonstrated CD271-positive rates in PSCs were 0-2.1%. Quantitative RT-PCR analyses revealed that CD271 mRNA expression was increased in PSCs after coculture with pancreatic cancer cells. However, the level of CD271 mRNA expression subsequently decreased after the transient increase. Furthermore, CD271 mRNA expression was decreased in PSCs migrating toward pancreatic cancer cells through Matrigel. In the xenograft model, CD271(+) PSCs were present at tumor margins/periphery and were absent in the tumor core. In conclusion, CD271 was expressed in PSCs around pancreatic tumors, but not in the center of the tumors, and expression decreased after long coculture with pancreatic cancer cells or after movement toward pancreatic cancer cells. These findings suggest that CD271(+) PSCs appear at the early stage of pancreatic carcinogenesis and that CD271 expression is significantly correlated with a better prognosis in patients with PDAC.	[Fujiwara, Kenji; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Shindo, Koji; Eguchi, Daiki; Kozono, Shingo; Ikenaga, Naoki; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Adv Med Initiat, Fukuoka 812, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan; [Shindo, Koji; Aishima, Shinichi] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Ohuchida, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382; Ohuchida, Kenoki/0000-0003-4792-1168	JSPS KAKENHI [24-1237, 23390327, 24659613, 23659654, 24390319, 22591524, 23-11109, 23659655, 24390318]; Grants-in-Aid for Scientific Research [24791430] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 24-1237, 23390327, 24659613, 23659654, 24390319, 22591524, 23-11109, 23659655, 24390318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Cook KL, 2010, CANCER RES, V70, P8319, DOI 10.1158/0008-5472.CAN-10-1136; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Haas SL, 2009, GROWTH FACTORS, V27, P289, DOI 10.1080/08977190903132273; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Polisetty N, 2008, MOL VIS, V14, P431; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Strakova Z, 2008, CELL TISSUE RES, V332, P479, DOI 10.1007/s00441-008-0604-x; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang W, 2009, EJSO-EUR J SURG ONC, V35, P826, DOI 10.1016/j.ejso.2008.10.013	28	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52682	10.1371/journal.pone.0052682	http://dx.doi.org/10.1371/journal.pone.0052682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300742	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100073
J	Almeida, ARM; Arroz-Madeira, S; Fonseca-Pereira, D; Ribeiro, H; Lasrado, R; Pachnis, V; Veiga-Fernandes, H				Martins Almeida, Afonso Rocha; Arroz-Madeira, Silvia; Fonseca-Pereira, Diogo; Ribeiro, Helder; Lasrado, Reena; Pachnis, Vassilis; Veiga-Fernandes, Henrique			RET/GFR alpha Signals Are Dispensable for Thymic T Cell Development In Vivo	PLOS ONE			English	Article							MEDULLARY-THYROID CANCER; C-RET PROTOONCOGENE; KINASE RECEPTOR RET; NEUROTROPHIC FACTOR; TYROSINE KINASE; NERVOUS-SYSTEM; GDNF FAMILY; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; MICE LACKING	Identification of thymocyte regulators is a central issue in T cell biology. Interestingly, growing evidence indicates that common key molecules control neuronal and immune cell functions. The neurotrophic factor receptor RET mediates critical functions in foetal hematopoietic subsets, thus raising the possibility that RET-related molecules may also control T cell development. We show that Ret, Gfra1 and Gfra2 are abundantly expressed by foetal and adult immature DN thymocytes. Despite the developmentally regulated expression of these genes, analysis of foetal thymi from Gfra1, Gfra2 or Ret deficient embryos revealed that these molecules are dispensable for foetal T cell development. Furthermore, analysis of RET gain of function and Ret conditional knockout mice showed that RET is also unnecessary for adult thymopoiesis. Finally, competitive thymic reconstitution assays indicated that Ret deficient thymocytes maintained their differentiation fitness even in stringent developmental conditions. Thus, our data demonstrate that RET/GFR alpha signals are dispensable for thymic T cell development in vivo, indicating that pharmacological targeting of RET signalling in tumours is not likely to result in T cell production failure.	[Martins Almeida, Afonso Rocha; Arroz-Madeira, Silvia; Fonseca-Pereira, Diogo; Ribeiro, Helder; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Lasrado, Reena; Pachnis, Vassilis] Natl Inst Med Res, Div Mol Neurobiol, MRC, London NW7 1AA, England	Universidade de Lisboa; MRC National Institute for Medical Research	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	jhfernandes@fm.ul.pt	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/D-9857-2013; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Fonseca-Pereira, Diogo/0000-0002-7400-9804; Ribeiro, Helder/0000-0002-7090-9274; Almeida, Afonso/0000-0002-4292-8558; Pachnis, Vassilis/0000-0001-9733-7686; Veiga-Fernandes, Henrique/0000-0001-6216-1836	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/44426/2008, SFRH/BD/44960/2008, PTDC/SAU-MII/104931/2008]; European Molecular Biology Organization [1648]; European Research Council [207057]; Medical Research Council [G0800973, MC_U117537087] Funding Source: researchfish; MRC [G0800973, MC_U117537087] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ARMA and DF-P were supported by scholarships from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/44426/2008 and SFRH/BD/44960/2008). Work in this article was funded by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-MII/104931/2008), Portugal; European Molecular Biology Organization (Project 1648) and European Research Council (Project 207057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Anderson G, 2008, J IMMUNOL, V181, P7435, DOI 10.4049/jimmunol.181.11.7435; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carlomagno F, 1998, ENDOCRINOLOGY, V139, P3613, DOI 10.1210/en.139.8.3613; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Gattei V, 1997, BLOOD, V89, P2925; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Houvras Y, 2012, J CLIN ONCOL, V30, P200, DOI 10.1200/JCO.2011.38.7639; Kondo S, 2003, EUR J IMMUNOL, V33, P2233, DOI 10.1002/eji.200323458; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakayama S, 1999, BRIT J HAEMATOL, V105, P50, DOI 10.1046/j.1365-2141.1999.01311.x; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52949	10.1371/journal.pone.0052949	http://dx.doi.org/10.1371/journal.pone.0052949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300832	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100104
J	Schmidt, CS; Bultmann, S; Meilinger, D; Zacher, B; Tresch, A; Maier, KC; Peter, C; Martin, DE; Leonhardt, H; Spada, F				Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Peter, Christian; Martin, Dietmar E.; Leonhardt, Heinrich; Spada, Fabio			Global DNA Hypomethylation Prevents Consolidation of Differentiation Programs and Allows Reversion to the Embryonic Stem Cell State	PLOS ONE			English	Article							SELF-RENEWAL; MAMMALIAN DEVELOPMENT; METHYLATION PATTERNS; GENE-REGULATION; ES CELLS; MOUSE; PLURIPOTENCY; METHYLTRANSFERASE; MAINTENANCE; TRANSCRIPTION	DNA methylation patterns change dynamically during mammalian development and lineage specification, yet scarce information is available about how DNA methylation affects gene expression profiles upon differentiation. Here we determine genome-wide transcription profiles during undirected differentiation of severely hypomethylated (Dnmt1(-/-)) embryonic stem cells (ESCs) as well as ESCs completely devoid of DNA methylation (Dnmt1(-/-); Dnmt3a(-/-); Dnmt3b(-/-) or TKO) and assay their potential to transit in and out of the ESC state. We find that the expression of only few genes mainly associated with germ line function and the X chromosome is affected in undifferentiated TKO ESCs. Upon initial differentiation as embryoid bodies (EBs) wild type, Dnmt1(-/-) and TKO cells downregulate pluripotency associated genes and upregulate lineage specific genes, but their transcription profiles progressively diverge upon prolonged EB culture. While Oct4 protein levels are completely and homogeneously suppressed, transcription of Oct4 and Nanog is not completely silenced even at late stages in both Dnmt1(-/-) and TKO EBs. Despite late wild type and Dnmt1(-/-) EBs showing a much higher degree of concordant expression, after EB dissociation and replating under pluripotency promoting conditions both Dnmt1(-/-) and TKO cells, but not wild type cells rapidly revert to expression profiles typical of undifferentiated ESCs. Thus, while DNA methylation seems not to be critical for initial activation of differentiation programs, it is crucial for permanent restriction of developmental fate during differentiation.	[Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Leonhardt, Heinrich; Spada, Fabio] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Martin, Dietmar E.] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany; [Schmidt, Christine S.; Bultmann, Sebastian; Meilinger, Daniela; Zacher, Benedikt; Tresch, Achim; Maier, Kerstin C.; Martin, Dietmar E.; Leonhardt, Heinrich; Spada, Fabio] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Tresch, Achim] Univ Cologne, Inst Genet, Inst Bot, Cologne, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Dept Computat Biol, Cologne, Germany; [Peter, Christian] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Munich; University of Munich; University of Munich; University of Cologne; Max Planck Society; University of Oxford	Spada, F (corresponding author), Univ Munich, Dept Chem, Munich, Germany.	Fabio.Spada@cup.uni-muenchen.de	Spada, Fabio/J-4354-2013; Bultmann, Sebastian/AAC-7729-2020; Leonhardt, Heinrich/B-2791-2014	Spada, Fabio/0000-0002-7148-9013; 	Deutsche Forschungsgemeinschaft [SPP1356, SFB TR5, SFB 646]; International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School Life Science Munich (LSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School Life Science Munich (LSM)	This work was supported by grants from the Deutsche Forschungsgemeinschaft to HL (SPP1356, SFB TR5, SFB 646; www.dfg.de) and AT (SFB 646; www.dfg.de). CSS gratefully acknowledges the support by the International Doctorate Program NanoBioTechnology (IDK-NBT; www.cens.de/doctorate-program) and the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, www.imprs-ls.de). SB was supported by the Graduate School Life Science Munich (LSM, www.lsm.bio.lmu.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Hata K, 2002, DEVELOPMENT, V129, P1983; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isagawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026052; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Leeb M, 2012, CHROMOSOMA, V121, P251, DOI 10.1007/s00412-012-0365-x; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2012, EPIGENETICS, P7; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	79	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52629	10.1371/journal.pone.0052629	http://dx.doi.org/10.1371/journal.pone.0052629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300728	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100069
J	Okiro, EA; Ngama, M; Bett, A; Nokes, DJ				Okiro, Emelda A.; Ngama, Mwanajuma; Bett, Ann; Nokes, D. James			The Incidence and Clinical Burden of Respiratory Syncytial Virus Disease Identified through Hospital Outpatient Presentations in Kenyan Children	PLOS ONE			English	Article							KILIFI DISTRICT; YOUNG-CHILDREN; INFECTION; EPIDEMIOLOGY; INFANTS; PNEUMONIA; TRACT; DURATION; VACCINES; BIRTH	Background: There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods: We studied a systematic sample of children aged,5 years presenting to a rural district hospital in Kenya with acute respiratory infection (ARI) between May 2002 and April 2004. We collected clinical data and screened nasal wash samples for RSV antigen by immunofluorescence. We used a linked demographic surveillance system to estimate disease incidence. Results: Among 2143 children tested, 166 (8%) were RSV positive (6% among children with upper respiratory tract infection and 12% among children with lower respiratory tract infection (LRTI). RSV was more likely in LRTI than URTI (p<0.001). 51% of RSV cases were aged 1 year or over. RSV cases represented 3.4% of hospital outpatient presentations. Relative to RSV negative cases, RSV positive cases were more likely to have crackles (RR = 1.63; 95% CI 1.34-1.97), nasal flaring (RR = 2.66; 95% CI 1.40-5.04), in-drawing (RR = 2.24; 95% CI 1.47-3.40), fast breathing for age (RR = 1.34; 95% CI 1.03-1.75) and fever (RR = 1.54; 95% CI 1.33-1.80). The estimated incidence of RSV-ARI and RSV-LRTI, per 100,000 child years, among those aged,5 years was 767 and 283, respectively. Conclusion: The burden of childhood RSV-associated URTI and LRTI presenting to outpatients in this setting is considerable. The clinical features of cases associated with an RSV infection were more severe than cases without an RSV diagnosis.	[Okiro, Emelda A.] KEMRI Wellcome Trust Collaborat Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya; [Okiro, Emelda A.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Ngama, Mwanajuma; Bett, Ann; Nokes, D. James] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Nokes, D. James] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Oxford; Kenya Medical Research Institute; University of Warwick	Okiro, EA (corresponding author), KEMRI Wellcome Trust Collaborat Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya.	eokiro@nairobi.kemri-wellcome.org		Okiro, Emelda/0000-0001-9543-8360	Wellcome Trust [061584]; Wellcome Trust under their Research Training Fellowship programme [086166]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust under their Research Training Fellowship programme(Wellcome Trust)	Financial support was provided by the Wellcome Trust(061584). EAO is supported by the Wellcome Trust under their Research Training Fellowship programme (#086166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Central Bureau of Statistics Ministry of finance and planning, 2002, KEN 1999 POP HOUS CE; Collins PL, 2007, RESP SYNCYTIAL VIRUS, P233; Fisher RG, 1997, PEDIATRICS, V99, pE71, DOI 10.1542/peds.99.2.e7; Freymuth F, 1997, CLIN DIAGN VIROL, V8, P31, DOI 10.1016/S0928-0197(97)00060-3; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Government of Kenya, 2002, DEV MOPAN, P1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Moura FEA, 2003, MEM I OSWALDO CRUZ, V98, P739, DOI 10.1590/S0074-02762003000600005; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Okiro EA, 2007, TRANSMISSION DYNAMIC; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Okiro EA, 2008, J CLIN MICROBIOL, V46, P1659, DOI 10.1128/JCM.02190-07; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2009, LANCET, V374, P854, DOI 10.1016/S0140-6736(09)61608-1; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1998, PEDIATR INFECT DIS J, V17, P224, DOI 10.1097/00006454-199803000-00010; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52520	10.1371/journal.pone.0052520	http://dx.doi.org/10.1371/journal.pone.0052520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300695	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800099
J	Shodai, A; Ido, A; Fujiwara, N; Ayaki, T; Morimura, T; Oono, M; Uchida, T; Takahashi, R; Ito, H; Urushitani, M				Shodai, Akemi; Ido, Akemi; Fujiwara, Noriko; Ayaki, Takashi; Morimura, Toshifumi; Oono, Miki; Uchida, Tsukasa; Takahashi, Ryosuke; Ito, Hidefumi; Urushitani, Makoto			Conserved Acidic Amino Acid Residues in a Second RNA Recognition Motif Regulate Assembly and Function of TDP-43	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; CYTOPLASMIC INCLUSIONS; MUTATIONS; AGGREGATION; ALS; FRAGMENT; NUCLEAR; SOD1	Accumulating evidence suggests that pathogenic TAR DNA-binding protein (TDP)-43 fragments contain a partial RNA-recognition motif domain 2 (RRM2) in amyotrophic lateral sclerosis (ALS)/frontotemporal lobar degeneration. However, the molecular basis for how this domain links to the conformation and function of TDP-43 is unclear. Previous crystal analyses have documented that the RRM2-DNA complex dimerizes under acidic and high salt conditions, mediated by the intermolecular hydrogen bonds of Glu246-Ile249 and Asp247-Asp247. The aims of this study were to investigate the roles of Glu246 and Asp247 in the molecular assembly of RRM2 under physiological conditions, and to evaluate their potential use as markers for TDP-43 misfolding due to the aberrantly exposed dimer interface. Unexpectedly, gel filtration analyses showed that, regardless of DNA interaction, the RRM2 domain remained as a stable monomer in phosphate-buffered saline. Studies using substitution mutants revealed that Glu246 and, especially, Asp247 played a crucial role in preserving the functional RRM2 monomers. Substitution to glycine at Glu246 or Asp247 induced the formation of fibrillar oligomers of RRM2 accompanied by the loss of DNA-binding affinity, which also affected the conformation and the RNA splicing function of full-length TDP-43. A novel monoclonal antibody against peptides containing Asp247 was found to react with TDP-43 inclusions of ALS patients and mislocalized cytosolic TDP-43 in cultured cells, but not with nuclear wild-type TDP-43. Our findings indicate that Glu246 and Asp247 play pivotal roles in the proper conformation and function of TDP-43. In particular, Asp247 should be studied as a molecular target with an aberrant conformation related to TDP-43 proteinopathy.	[Shodai, Akemi; Ido, Akemi; Morimura, Toshifumi; Oono, Miki; Uchida, Tsukasa; Urushitani, Makoto] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Fujiwara, Noriko] Hyogo Coll Med, Dept Biochem, Hyogo, Japan; [Ayaki, Takashi; Oono, Miki; Uchida, Tsukasa; Takahashi, Ryosuke; Ito, Hidefumi] Kyoto Univ, Dept Neurol, Kyoto, Japan; [Ito, Hidefumi] Wakayama Med Univ, Grad Sch Med, Dept Neurol, Wakayama, Japan	Shiga University of Medical Science; Hyogo College of Medicine; Kyoto University; Wakayama Medical University	Urushitani, M (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan.	uru@belle.shiga-med.ac.jp		Urushitani, Makoto/0000-0003-2773-9836	KEKENHI from the Ministry of Education, Culture, Sports, Science & Technology (MEXT) [23300131, 22659171, 23111002]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [22-4]; Grants-in-Aid for Scientific Research [23580417, 23300131] Funding Source: KAKEN	KEKENHI from the Ministry of Education, Culture, Sports, Science & Technology (MEXT); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by KEKENHI 23300131 for Scientific Research (B), 22659171 for Challenging Exploratory Research, and a Grant-in Aid 23111002 for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science & Technology (MEXT), a Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan, and an Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of NCNP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu C-H, 2012, NATURE; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52776	10.1371/journal.pone.0052776	http://dx.doi.org/10.1371/journal.pone.0052776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300771	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800145
J	Yu, MA; Kiang, A; Wang-Rodriguez, J; Rahimy, E; Haas, M; Yu, V; Ellies, LG; Chen, J; Fan, JB; Brumund, KT; Weisman, RA; Ongkeko, WM				Yu, Michael Andrew; Kiang, Alan; Wang-Rodriguez, Jessica; Rahimy, Elham; Haas, Martin; Yu, Vicky; Ellies, Lesley G.; Chen, Jing; Fan, Jian-Bing; Brumund, Kevin T.; Weisman, Robert A.; Ongkeko, Weg M.			Nicotine Promotes Acquisition of Stem Cell and Epithelial-to-Mesenchymal Properties in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; CANCER METASTASIS; DNA METHYLATION; TUMOR PROMOTION; IN-VIVO; TRANSITION; EXPRESSION; IDENTIFICATION; PROLIFERATION; TUMORIGENESIS	The ability of nicotine to enhance the malignancy of cancer cells is known; however, the possibility that nicotine could regulate a cancer stem cell phenotype remains to be well-established. In this study we sought to determine whether long-term exposure to nicotine could promote cancer stem cell-like properties in two head and neck squamous cell carcinoma cell lines, UMSCC-10B and HN-1. Nicotine treatment induced epithelial-to-mesenchymal transition (EMT) in both cell lines by repressing E-cadherin expression, and led to the induction of stem cell markers Oct-4, Nanog, CD44 and BMI-1, which was reversed upon ectopic re-expression of E-cadherin. Nicotine-treated cells formed spheres at a higher efficiency than non-treated cells, formed larger tumors when injected into mice, and formed tumors with 4-fold greater efficiency compared to control cells when injected at limiting doses. Consistent with previous literature, nicotine-treated cells demonstrated a greater capacity for survival and also a higher tendency to invade. Comparison of microRNA profiles between nicotine and control cells revealed the upregulation of miR-9, a repressor of E-cadherin, and the downregulation of miR-101, a repressor of EZH2. Taken together, these results suggest that nicotine may play a critical role in the development of tobacco-induced cancers by regulating cancer stem cell characteristics, and that these effects are likely mediated through EMT-promoting, microRNA-mediated pathways. Further characterization of such pathways remains a promising avenue for the understanding and treatment of tobacco-related cancers.	[Yu, Michael Andrew; Kiang, Alan; Rahimy, Elham; Yu, Vicky; Brumund, Kevin T.; Weisman, Robert A.; Ongkeko, Weg M.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Ellies, Lesley G.] Univ Calif San Diego, Vet Adm Med Ctr, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Haas, Martin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Chen, Jing; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego; Illumina	Ongkeko, WM (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996	American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award; Department of Defense/CDMRP [ARMY/41482]	American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award; Department of Defense/CDMRP(United States Department of Defense)	This work was supported by the American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award (to WMO); ARMY/41482, Department of Defense/CDMRP (to WMO). The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Besancon R, 2009, CURR MED CHEM, V16, P394, DOI 10.2174/092986709787315531; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hombach-Klonisch S, 2008, ARCH IMMUNOL THER EX, V56, P165, DOI 10.1007/s00005-008-0023-4; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin JW, 2009, EXP DERMATOL, V18, P497, DOI 10.1111/j.1600-0625.2009.00854.x; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nakao S, 2009, ARCH ORAL BIOL, V54, P251, DOI 10.1016/j.archoralbio.2008.11.006; Okamoto A, 2008, ORAL ONCOL; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; SCHWACHOFER JHM, 1990, ANTICANCER RES, V10, P805; Shen TJ, 2010, AM J RHINOL ALLERGY, V24, pE73, DOI 10.2500/ajra.2010.24.3456; Shieh YS, 2005, CANCER-AM CANCER SOC, V104, P1013, DOI 10.1002/cncr.21278; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; WRIGHT SC, 1993, FASEB J, V7, P1045, DOI 10.1096/fasebj.7.11.8370474; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Zhou XD, 2009, J INT MED RES, V37, P503, DOI 10.1177/147323000903700226; Zhu JH, 2009, CYTOTHERAPY, V11, P485, DOI 10.1080/14653240902887267	44	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51967	10.1371/journal.pone.0051967	http://dx.doi.org/10.1371/journal.pone.0051967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300583	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800041
J	Huson, MG; Church, JS; Poole, JM; Weisman, S; Sriskantha, A; Warden, AC; Campbell, PM; Ramshaw, JAM; Sutherland, TD				Huson, Mickey G.; Church, Jeffrey S.; Poole, Jacinta M.; Weisman, Sarah; Sriskantha, Alagacone; Warden, Andrew C.; Campbell, Peter M.; Ramshaw, John A. M.; Sutherland, Tara D.			Controlling the Molecular Structure and Physical Properties of Artificial Honeybee Silk by Heating or by Immersion in Solvents	PLOS ONE			English	Article							CROSS-LINKING; PROTEINS; FIBROIN; CONFORMATION; COLLAGEN; FIBERS; QUANTIFICATION; IDENTIFICATION; SPECTROSCOPY; SAMPLES	Honeybee larvae produce silken cocoons that provide mechanical stability to the hive. The silk proteins are small and non-repetitive and therefore can be produced at large scale by fermentation in E. coli. The recombinant proteins can be fabricated into a range of forms; however the resultant material is soluble in water and requires a post production stabilizing treatment. In this study, we describe the structural and mechanical properties of sponges fabricated from artificial honeybee silk proteins that have been stabilized in aqueous methanol baths or by dry heating. Aqueous methanol treatment induces formation of beta-sheets, with the amount of beta-sheet dictated by methanol concentration. Formation of beta-sheets renders sponges insoluble in water and generates a reversibly compressible material. Dry heat treatments at 190 degrees C produce a water insoluble material, that is stiffer than the methanol treated equivalent but without significant secondary structural changes. Honeybee silk proteins are particularly high in Lys, Ser, Thr, Glu and Asp. The properties of the heat treated material are attributed to generation of lysinoalanine, amide (isopeptide) and/or ester covalent cross-links. The unique ability to stabilize material by controlling secondary structure rearrangement and covalent cross-linking allows us to design recombinant silk materials with a wide range of properties.	[Huson, Mickey G.; Church, Jeffrey S.] CSIRO, Mat Sci & Engn, Geelong, Vic, Australia; [Poole, Jacinta M.; Ramshaw, John A. M.] CSIRO, Mat Sci & Engn, Melbourne, Vic, Australia; [Weisman, Sarah; Sriskantha, Alagacone; Warden, Andrew C.; Campbell, Peter M.; Sutherland, Tara D.] CSIRO, Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Huson, MG (corresponding author), CSIRO, Mat Sci & Engn, Geelong, Vic, Australia.	Mickey.Huson@csiro.au	Campbell, Peter M/B-7232-2008; Sriskantha, Alagacone/M-5989-2017; Warden, Andrew C/C-1484-2008; Sutherland, Tara/B-5635-2009; Weisman, Sarah/B-5091-2009	Warden, Andrew C/0000-0003-2683-9798; Sutherland, Tara/0000-0001-5211-4593; Ramshaw, John A.M./0000-0002-2131-3685	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); AFOSR (Air Force Office of Scientific Research) [FA9550-09-1-0332]; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); AFOSR (Air Force Office of Scientific Research)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	This material is based upon work supported by CSIRO (The Commonwealth Scientific and Industrial Research Organisation) and the AFOSR (Air Force Office of Scientific Research) (Award No. FA9550-09-1-0332). This study was facilitated by access to the Australian Proteome Analysis Facility supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JF, 1990, US Patent, Patent No. 4980403; Church JS, 1998, J MOL STRUCT, V440, P15, DOI 10.1016/S0022-2860(97)00227-5; CHURCH JS, 1994, APPL SPECTROSC, V48, P813, DOI 10.1366/0003702944029938; Dollish F. R., 1974, CHARACTERISTIC RAMAN; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Friedman M, 1999, Adv Exp Med Biol, V459, P145; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9; Huson MG, 2006, POLYM TEST, V25, P2, DOI 10.1016/j.polymertesting.2005.09.014; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a; Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f; Kweon H, 2001, J APPL POLYM SCI, V81, P2271, DOI 10.1002/app.1667; Lefevre T, 2012, BIOPOLYMERS, V97, P322, DOI 10.1002/bip.21712; MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915; MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P765; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Mohammed ZH, 2000, J FOOD SCI, V65, P221, DOI 10.1111/j.1365-2621.2000.tb15983.x; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; RAMSHAW JAM, 1984, ANAL BIOCHEM, V141, P361, DOI 10.1016/0003-2697(84)90056-3; Rudall K.M., 1962, COMP BIOCHEM PHYSIOL, V4, P397; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer C, 2005, J AGR FOOD CHEM, V53, P2830, DOI 10.1021/jf048190a; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; SUSI H, 1988, APPL SPECTROSC, V42, P819, DOI 10.1366/0003702884428905; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016489; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108; WEDER JKP, 1981, Z LEBENSM UNTERS FOR, V172, P9, DOI 10.1007/BF01255454; Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021; Wittmer CR, 2011, ACTA BIOMATER, V7, P3789, DOI 10.1016/j.actbio.2011.06.001; YANNAS AV, 1967, NATURE, V215, P509, DOI 10.1038/215509b0	34	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52308	10.1371/journal.pone.0052308	http://dx.doi.org/10.1371/journal.pone.0052308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300639	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800044
J	Izawa, T; Kondo, T; Kurosawa, M; Oura, R; Matsumoto, K; Tanaka, E; Yamada, A; Arakaki, R; Kudo, Y; Hayashi, Y; Ishimaru, N				Izawa, Takashi; Kondo, Tomoyuki; Kurosawa, Mie; Oura, Ritsuko; Matsumoto, Kazuma; Tanaka, Eiji; Yamada, Akiko; Arakaki, Rieko; Kudo, Yasusei; Hayashi, Yoshio; Ishimaru, Naozumi			Fas-Independent T-Cell Apoptosis by Dendritic Cells Controls Autoimmune Arthritis in MRL/lpr Mice	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRAIL-INDUCED APOPTOSIS; RHEUMATOID-ARTHRITIS; OSTEOPROTEGERIN-LIGAND; DECOY RECEPTOR; INTERLEUKIN-10; ACTIVATION; DISEASE; EXPRESSION	Background: Although autoimmunity in MRL/lpr mice occurs due to a defect in Fas-mediated cell death of T cells, the role of Fas-independent apoptosis in pathogenesis has rarely been investigated. We have recently reported that receptor activator of nuclear factor (NF)-kappa B ligand (RANKL)-activated dendritic cells (DCs) play a key role in the pathogenesis of rheumatoid arthritis (RA) in MRL/lpr mice. We here attempted to establish a new therapeutic strategy with RANKL-activated DCs in RA by controlling apoptosis of peripheral T cells. Repeated transfer of RANKL-activated DCs into MRL/lpr mice was tested to determine whether this had a therapeutic effect on autoimmunity. Methods and Finding: Cellular and molecular mechanisms of Fas-independent apoptosis of T cells induced by the DCs were investigated by in vitro and in vivo analyses. We demonstrated that repeated transfers of RANKL-activated DCs into MRL/lpr mice resulted in therapeutic effects on RA lesions and lymphoproliferation due to declines of CD4(+) T, B, and CD4(-)CD8(-) double negative (DN) T cells. We also found that the Fas-independent T-cell apoptosis was induced by a direct interaction between tumor necrosis factor (TNF)-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) on T cells and TRAIL on Fas-deficient DCs in MRL/lpr mice. Conclusion: These results strongly suggest that a novel Fas-independent apoptosis pathway in T cells maintains peripheral tolerance and thus controls autoimmunity in MRL/lpr mice.	[Izawa, Takashi; Kondo, Tomoyuki; Kurosawa, Mie; Oura, Ritsuko; Yamada, Akiko; Arakaki, Rieko; Kudo, Yasusei; Hayashi, Yoshio; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 770, Japan; [Izawa, Takashi; Matsumoto, Kazuma; Tanaka, Eiji] Univ Tokushima, Grad Sch, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University; Tokushima University	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 770, Japan.	ishimaru@dent.tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015	Tanaka, Eiji/0000-0002-2707-1613; Kudo, Yasusei/0000-0002-0392-7720	Funding Program for Next Generation World-Leading Researchers in Japan [LS090]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21249090, 23390429, 23659879]; Grants-in-Aid for Scientific Research [23390429, 23659966] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers in Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Funding Program for Next Generation World-Leading Researchers in Japan (LS090) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 21249090, no. 23390429, no. 23659879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bonardelle D, 2001, J RHEUMATOL, V28, P956; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Edwards CK, 1996, J IMMUNOL, V157, P1758; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; HANG L, 1982, J EXP MED, V155, P1690, DOI 10.1084/jem.155.6.1690; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Izawa T, 2007, BLOOD, V110, P242, DOI 10.1182/blood-2006-11-059980; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Liu ZG, 2003, J CLIN INVEST, V112, P1332, DOI 10.1172/JCI200319209; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Lopatin U, 2001, BLOOD, V97, P3161, DOI 10.1182/blood.V97.10.3161; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; MORSE HC, 1982, J IMMUNOL, V129, P2612; OSULLIVAN FX, 1985, ARTHRITIS RHEUM, V28, P529, DOI 10.1002/art.1780280511; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Plows D, 1999, J IMMUNOL, V162, P1018; PRUDHOMME GJ, 1995, MOL IMMUNOL, V32, P495, DOI 10.1016/0161-5890(95)00024-9; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sarkar S, 2005, FRONT BIOSCI-LANDMRK, V10, P656, DOI 10.2741/1560; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Sheikh MS, 1999, ONCOGENE, V18, P4153, DOI 10.1038/sj.onc.1202763; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; TARKOWSKI A, 1987, ARTHRITIS RHEUM-US, V30, P75, DOI 10.1002/art.1780300110; van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014; VanGool SW, 1996, IMMUNOL REV, V153, P47; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wenink M H, 2009, Handb Exp Pharmacol, P81, DOI 10.1007/978-3-540-71029-5_4; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wu XJ, 2005, J BONE MINER RES, V20, P107, DOI 10.1359/JBMR.041022; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	53	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48798	10.1371/journal.pone.0048798	http://dx.doi.org/10.1371/journal.pone.0048798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23300516	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200009
J	van de Kooij, B; Verbrugge, I; de Vries, E; Gijsen, M; Montserrat, V; Maas, C; Neefjes, J; Borst, J				van de Kooij, Bert; Verbrugge, Inge; de Vries, Evert; Gijsen, Merel; Montserrat, Veronica; Maas, Chiel; Neefjes, Jacques; Borst, Jannie			Ubiquitination by the Membrane-associated RING-CH-8 (MARCH-8) Ligase Controls Steady-state Cell Surface Expression of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; DOWN-REGULATION; PROTEASOMAL ACTIVITY; E3 LIGASES; C-MIR; DEGRADATION; ENDOCYTOSIS; ACTIVATION; PROTEINS	The eleven members of the membrane-associated RING-CH (MARCH) ubiquitin ligase family are relatively unexplored. Upon exogenous (over) expression, a number of these ligases can affect the trafficking of membrane molecules. However, only for MARCH-1 endogenous functions have been demonstrated. For the other endogenous MARCH proteins, no functions or substrates are known. We report here that TRAIL-R1 is a physiological substrate of the endogenous MARCH-8 ligase. Human TRAIL-R1 and R2 play a role in immunosurveillance and are targets for cancer therapy, because they selectively induce apoptosis in tumor cells. We demonstrate that TRAIL-R1 is down-regulated from the cell surface, with great preference over TRAIL-R2, by exogenous expression of MARCH ligases that are implicated in endosomal trafficking, such as MARCH-1 and -8. MARCH-8 attenuated TRAIL-R1 cell surface expression and apoptosis signaling by virtue of its ligase activity. This suggested that ubiquitination of TRAIL-R1 was instrumental in its down-regulation by MARCH-8. Indeed, in cells with endogenous MARCH expression, TRAIL-R1 was ubiquitinated at steady-state, with the conserved membrane proximal lysine 273 as one of the potential acceptor sites. This residue was also essential for the interaction of TRAIL-R1 with MARCH-1 and MARCH-8 and its down-regulation by these ligases. Gene silencing identified MARCH-8 as the endogenous ligase that ubiquitinates TRAIL-R1 and attenuates its cell surface expression. These findings reveal that endogenous MARCH-8 regulates the steady-state cell surface expression of TRAIL-R1.	[van de Kooij, Bert; Verbrugge, Inge; de Vries, Evert; Gijsen, Merel; Maas, Chiel; Borst, Jannie] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Montserrat, Veronica; Neefjes, Jacques] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst Antoni van Leeuwenhoek, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Borst, Jannie/0000-0002-8043-5009	Dutch Cancer Society [NKI 2004-3079, NKI 2008-4110]; Netherlands Organization for Scientific Research [ECHO 700.57.008]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grants NKI 2004-3079 and NKI 2008-4110 from the Dutch Cancer Society and Grant ECHO 700.57.008 from the Netherlands Organization for Scientific Research (to J. B.).	Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Maas C, 2010, CELL DEATH DIFFER, V17, P1613, DOI 10.1038/cdd.2010.39; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Verbrugge I, 2008, ONCOGENE, V27, P574, DOI 10.1038/sj.onc.1210696; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002	51	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6617	6628		10.1074/jbc.M112.448209	http://dx.doi.org/10.1074/jbc.M112.448209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300075	Green Published, hybrid			2022-12-25	WOS:000315820700061
J	McGee-Lawrence, ME; Li, XD; Bledsoe, KL; Wu, H; Hawse, JR; Subramaniam, M; Razidlo, DF; Stensgard, BA; Stein, GS; van Wijnen, AJ; Lian, JB; Hsu, W; Westendorf, JJ				McGee-Lawrence, Meghan E.; Li, Xiaodong; Bledsoe, Krista L.; Wu, Hai; Hawse, John R.; Subramaniam, Malayannan; Razidlo, David F.; Stensgard, Bridget A.; Stein, Gary S.; van Wijnen, Andre J.; Lian, Jane B.; Hsu, Wei; Westendorf, Jennifer J.			Runx2 Protein Represses Axin2 Expression in Osteoblasts and Is Required for Craniosynostosis in Axin2-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEIDOCRANIAL DYSPLASIA; BETA-CATENIN; SUTURE CRANIOSYNOSTOSIS; CALVARIAL MORPHOGENESIS; COLORECTAL-CANCER; PREMATURE FUSION; BONE-FORMATION; DNA-BINDING; DIFFERENTIATION; TRANSCRIPTION	Runx2 and Axin2 regulate craniofacial development and skeletal maintenance. Runx2 is essential for calvarial bone development, as Runx2 haploinsufficiency causes cleidocranial dysplasia. In contrast, Axin2-deficient mice develop craniosynostosis because of high beta-catenin activity. Axin2 levels are elevated in Runx2(-/-) calvarial cells, and Runx2 represses transcription of Axin2 mRNA, suggesting a direct relationship between these factors in vivo. Here we demonstrate that Runx2 binds several regions of the Axin2 promoter and that Runx2-mediated repression of Axin2 transcription depends on Hdac3. To determine whether Runx2 contributes to the etiology of Axin2 deficiency-induced craniosynostosis, we generated Axin2(-/-):Runx2(-/-) mice. These double mutant mice had longer skulls than Axin2(-/-) mice, indicating that Runx2 haploinsufficiency rescued the craniosynostosis phenotype of Axin2(-/-) mice. Together, these studies identify a key mechanistic pathway for regulating intramembranous bone development within the skull that involves Runx2- and Hdac3-mediated suppression of Axin2 to prevent the untimely closure of the calvarial sutures.	[McGee-Lawrence, Meghan E.; Li, Xiaodong; Bledsoe, Krista L.; Hawse, John R.; Subramaniam, Malayannan; Razidlo, David F.; Stensgard, Bridget A.; van Wijnen, Andre J.; Westendorf, Jennifer J.] Mayo Clin, Rochester, MN 55905 USA; [Wu, Hai; Stein, Gary S.; Lian, Jane B.] Univ Vermont, Burlington, VT 05405 USA; [Hsu, Wei] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Mayo Clinic; University of Vermont; University of Rochester	Westendorf, JJ (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; Hsu, Wei/ABG-6856-2021	van Wijnen, Andre J./0000-0002-4458-0946; Hsu, Wei/0000-0001-6738-6030; McGee-Lawrence, Meghan/0000-0002-2728-5849	National Institutes of Health [R01 AR48147, R01 DE020194, T32 AR056950, T32 CA148073, F32 AR60140]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR056950, F32AR060140, R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528, R01DE020194, R01DE015654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR48147, R01 DE020194, T32 AR056950, T32 CA148073, and F32 AR60140.	Behr B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00037; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Bradley JP, 1996, PLAST RECONSTR SURG, V98, P1039, DOI 10.1097/00006534-199611000-00018; Carver EA, 2002, ANAT REC, V268, P90, DOI 10.1002/ar.10124; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Godman CA, 2008, CANCER BIOL THER, V7, P1570, DOI 10.4161/cbt.7.10.6561; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Li X, 2009, J CELL BIOCHEM, V108, P378, DOI 10.1002/jcb.22263; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Maeno T, 2011, BONE, V49, P673, DOI 10.1016/j.bone.2011.07.023; Martinez-Abadias N, 2010, DEV DYNAM, V239, P3058, DOI 10.1002/dvdy.22414; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Mirando AJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-116; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park J, 2012, J CELL BIOCHEM, V113, P457, DOI 10.1002/jcb.23368; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shevde NK, 2001, CLEFT PALATE-CRAN J, V38, P606, DOI 10.1597/1545-1569(2001)038<0606:EAOODF>2.0.CO;2; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tanimoto Y, 2012, J BIOL CHEM, V287, P21429, DOI 10.1074/jbc.M112.362145; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wu R, 2001, CANCER RES, V61, P8247; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	58	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5291	5302		10.1074/jbc.M112.414995	http://dx.doi.org/10.1074/jbc.M112.414995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300083	hybrid, Green Published			2022-12-25	WOS:000315342500004
J	Kim, S; Dubrovska, A; Salamone, RJ; Walker, JR; Grandinetti, KB; Bonamy, GMC; Orth, AP; Elliott, J; Porta, DG; Garcia-Echeverria, C; Reddy, VA				Kim, Sungeun; Dubrovska, Anna; Salamone, Richard J.; Walker, John R.; Grandinetti, Kathryn B.; Bonamy, Ghislain M. C.; Orth, Anthony P.; Elliott, Jimmy; Porta, Diana Graus; Garcia-Echeverria, Carlos; Reddy, Venkateshwar A.			FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; GROWTH-FACTOR RECEPTOR-2; TYROSINE KINASE INHIBITOR; MAMMARY-GLAND DEVELOPMENT; GENOME-WIDE ASSOCIATION; ACUTE MYELOID-LEUKEMIA; ADULT HUMAN BREAST; MOUSE MODEL; HEMATOPOIETIC PROGENITORS; MULTIPLE-MYELOMA	Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiating cells) and eliminating TICs may offer a new strategy to develop successful anti-cancer therapies. As molecular mechanisms underlying the maintenance of the TIC pool are poorly understood, the development of TIC-specific therapeutics remains a major challenge. We first identified and characterized TICs and non-TICs isolated from a mouse breast cancer model. TICs displayed increased tumorigenic potential, self-renewal, heterogeneous differentiation, and bipotency. Gene expression analysis and immunostaining of TICs and non-TICs revealed that FGFR2 was preferentially expressed in TICs. Loss of FGFR2 impaired self-renewal of TICs, thus resulting in marked decreases in the TIC population and tumorigenic potential. Restoration of FGFR2 rescued the defects in TIC pool maintenance, bipotency, and breast tumor growth driven by FGFR2 knockdown. In addition, pharmacological inhibition of FGFR2 kinase activity led to a decrease in the TIC population which resulted in suppression of breast tumor growth. Moreover, human breast TICs isolated from patient tumor samples were found enriched in a FGFR2+ population that was sufficient to initiate tumor growth. Our data suggest that FGFR2 is essential in sustaining the breast TIC pool through promotion of self-renewal and maintenance of bipotent TICs, and raise the possibility of FGFR2 inhibition as a strategy for anti-cancer therapy by eradicating breast TICs.	[Kim, Sungeun; Salamone, Richard J.; Walker, John R.; Grandinetti, Kathryn B.; Bonamy, Ghislain M. C.; Orth, Anthony P.; Elliott, Jimmy; Reddy, Venkateshwar A.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Dubrovska, Anna] Scripps Res Inst, La Jolla, CA 92037 USA; [Porta, Diana Graus; Garcia-Echeverria, Carlos] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland	Novartis; Scripps Research Institute; Novartis	Kim, S (corresponding author), Amgen Inc, San Francisco, CA USA.	sungeunk@amgen.com; venkateshwar.reddy@sanofi.com	Dubrovska, Anna/AAE-8514-2019	Dubrovska, Anna/0000-0002-3375-1500; Bonamy, Ghislain/0000-0002-2826-5225	Genomics Institute of the Novartis Research Foundation	Genomics Institute of the Novartis Research Foundation	This work was supported by Genomics Institute of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNANE J, 1991, ONCOGENE, V6, P659; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chase A, 2007, BLOOD, V110, P3729, DOI 10.1182/blood-2007-02-074286; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iseki S, 1999, DEVELOPMENT, V126, P5611; Jang JH, 2001, CANCER RES, V61, P3541; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Moffa AB, 2004, MOL CANCER RES, V2, P643; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pedchenko VK, 2000, MOL REPROD DEV, V56, P441, DOI 10.1002/1098-2795(200008)56:4&lt;441::AID-MRD1&gt;3.0.CO;2-C; PIERCE GB, 1974, AM J PATHOL, V77, P103; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Turner N, 2010, ONCOGENE; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Xin XH, 2006, CLIN CANCER RES, V12, P4908, DOI 10.1158/1078-0432.CCR-06-0957; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	66	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51671	10.1371/journal.pone.0051671	http://dx.doi.org/10.1371/journal.pone.0051671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300950	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900008
J	Gadelha, A; Ota, VK; Cano, JP; Melaragno, MI; Smith, MAC; Mari, JD; Bressan, RA; Belangero, SI; Breen, G				Gadelha, Ary; Ota, Vanessa Kiyomi; Cano, Jose Paya; Melaragno, Maria Isabel; Smith, Marilia A. C.; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole; Breen, Gerome			Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families	PLOS ONE			English	Article							GENOME-WIDE LINKAGE; BIPOLAR DISORDER; PSYCHOTIC DISORDERS; METAANALYSIS; ASSOCIATION; VALIDITY; ALLELE; LOCUS; MOOD	We report analyses of a Brazilian study of early onset schizophrenia (BEOS) families. We genotyped 22 members of 4 families on a linkage SNP array and report here non-parametric linkage analyses using MERLIN (R) software. We found suggestive evidence for linkage on two chromosomal regions, 13q32 and 11p15.4. A LOD score of 2.71 was observed at 13q32 with a one LOD interval extending from 60.63-92.35 cM. From simulations, this LOD score gave a genome-wide empirical corrected p = 0.33, after accounting for all markers tested. Similarly 11p15.4 showed the same maximum LOD of 2.71 and a narrower one LOD interval of 4-14 cM. Of these, 13q32 has been reported to be linked to schizophrenia by multiple different studies. Thus, our study provides additional supporting evidence for an aetiological role of variants at 13q32 in schizophrenia.	[Gadelha, Ary; Ota, Vanessa Kiyomi; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil; [Gadelha, Ary; Ota, Vanessa Kiyomi; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Schizophrenia Program PROESQ, Sao Paulo, Brazil; [Ota, Vanessa Kiyomi; Melaragno, Maria Isabel; Smith, Marilia A. C.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Morphol & Genet Dept, Sao Paulo, Brazil; [Cano, Jose Paya; Breen, Gerome] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Breen, Gerome] Kings Coll London, Inst Psychiat, Natl Inst Hlth Res Biomed Res, Ctr Mental Hlth, London WC2R 2LS, England	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London; University of London; King's College London	Gadelha, A (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil.	aryararipe@yahoo.com.br	de A. C. Smith, Marilia/C-4397-2012; de Jesus Mari, Jair/A-7309-2008; Ota, Vanessa/J-6442-2012; Belangero, Sintia I/A-6818-2009; Melaragno, Maria I/F-9013-2012; Melaragno, Maria Isabel/W-8714-2019; Psiquiatria, Inct/I-1060-2013; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; Bressan, Rodrigo A/E-9178-2010	de A. C. Smith, Marilia/0000-0002-1441-1033; de Jesus Mari, Jair/0000-0002-5403-0112; Ota, Vanessa/0000-0003-0129-6360; Belangero, Sintia I/0000-0002-2419-4351; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Bressan, Rodrigo A/0000-0002-0868-4449; Gadelha de Alencar Araripe Neto, Ary/0000-0002-0993-8017	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/00030-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant number 2011/00030-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brasil HHA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-83; Bressan RA, 1998, SCHIZOPHR RES, V32, P41; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Craddock N, 1999, AM J MED GENET, V88, P244, DOI 10.1002/(SICI)1096-8628(19990618)88:3<244::AID-AJMG7>3.0.CO;2-1; Cui YH, 2010, METHODS MOL BIOL, V620, P219, DOI 10.1007/978-1-60761-580-4_6; de Lima MS, 2007, REV BRAS PSIQUIATR, V29, P246, DOI 10.1590/S1516-44462007000300010; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Faraone SV, 2002, AM J MED GENET, V114, P598, DOI 10.1002/ajmg.10601; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; Gornick MC, 2007, AM J MED GENET B, V144B, P379, DOI 10.1002/ajmg.b.30460; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Liu XQ, 2008, BIOL PSYCHIAT, V64, P561, DOI 10.1016/j.biopsych.2008.05.023; Maziade M, 2009, EUR J HUM GENET, V17, P1034, DOI 10.1038/ejhg.2008.268; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; Mulle JG, 2005, MOL PSYCHIATR, V10, P429, DOI 10.1038/sj.mp.4001639; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	35	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52262	10.1371/journal.pone.0052262	http://dx.doi.org/10.1371/journal.pone.0052262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300629	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600012
J	Jenkinson, WE; Nakamura, K; White, AJ; Jenkinson, EJ; Anderson, G				Jenkinson, William E.; Nakamura, Kyoko; White, Andrea J.; Jenkinson, Eric J.; Anderson, Graham			Normal T Cell Selection Occurs in CD205-Deficient Thymic Microenvironments	PLOS ONE			English	Article							CORTICAL EPITHELIAL-CELLS; DENDRITIC CELLS; POSITIVE SELECTION; IN-VIVO; ANTIGEN PRESENTATION; RECEPTOR DEC-205; SELF-TOLERANCE; BETA-CHAIN; THYMOCYTES; EXPRESSION	The thymus imparts a developmental imprint upon T cells, screening beneficial and self-tolerant T cell receptor (TCR) specificities. Cortical thymic epithelial cells (CTEC) present self-peptide self-MHC complexes to thymocytes, positively selecting those with functional TCRs. Importantly, CTEC generate diverse self-peptides through highly specific peptide processing. The array of peptides utilized for positive selection appears to play a key role in shaping TCR repertoire and influencing T cell functionality. Whilst self-peptide diversity influences T cell development, the precise source of proteins generating such self-peptide arrays remains unknown, the abundance of apoptotic thymocytes failing thymic selection may provide such a pool of self-proteins. In relation to this notion, whilst it has been previously demonstrated that CTEC expression of the endocytic receptor CD205 facilitates binding and uptake of apoptotic thymocytes, the possible role of CD205 during intrathymic T cell development has not been studied. Here, we directly address the role of CD205 in normal thymocyte development and selection. Through analysis of both polyclonal and monoclonal transgenic TCR T-cell development in the context of CD205 deficiency, we demonstrate that CD205 does not play an overt role in T cell development or selection.	[Jenkinson, William E.; Nakamura, Kyoko; White, Andrea J.; Jenkinson, Eric J.; Anderson, Graham] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England	University of Birmingham	Jenkinson, WE (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England.	w.e.jenkinson@bham.ac.uk; g.anderson@bham.ac.uk	Nakamura, Kyoko/B-4184-2013	anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372	MRC; Medical Research Council [G1000213, G0401620, G1001055] Funding Source: researchfish; MRC [G1001055, G1000213, G0401620] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an MRC New Investigator Award to WEJ, an MRC Program Grant to GA and EJ and core facilities of the MRC Centre for Immune Regulation, University of Birmingham, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Fiorini E, 2008, J IMMUNOL, V181, P8199, DOI 10.4049/jimmunol.181.12.8199; Fukui Y, 1998, J EXP MED, V188, P897, DOI 10.1084/jem.188.5.897; Gaszewska-Mastalarz A, 2000, J IMMUNOL, V165, P6099, DOI 10.4049/jimmunol.165.11.6099; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nitta T, 2011, CURR OPIN IMMUNOL, V23, P190, DOI 10.1016/j.coi.2010.12.002; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Small M, 2003, INT IMMUNOL, V15, P197, DOI 10.1093/intimm/dxg024; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; VANVLIET E, 1984, EUR J IMMUNOL, V14, P524, DOI 10.1002/eji.1830140608; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53416	10.1371/journal.pone.0053416	http://dx.doi.org/10.1371/journal.pone.0053416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300927	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600098
J	Lee, LA; Yu, JF; Lo, YL; Chen, YS; Wang, DL; Cho, CM; Ni, YL; Chen, NH; Fang, TJ; Huang, CG; Li, HY				Lee, Li-Ang; Yu, Jen-Fang; Lo, Yu-Lun; Chen, Yen-Sheng; Wang, Ding-Li; Cho, Chih-Ming; Ni, Yung-Lun; Chen, Ning-Hung; Fang, Tuan-Jen; Huang, Chung-Guei; Li, Hsueh-Yu			Energy Types of Snoring Sounds in Patients with Obstructive Sleep Apnea Syndrome: A Preliminary Observation	PLOS ONE			English	Article							OUTCOMES SURVEY; HYPOPNEA INDEX; SEVERITY; VALIDATION; SNORERS; ANATOMY; SIGNALS; SITE	Background: Annoying snore is the principle symptom and problem in obstructive sleep apnea syndrome (OSAS). However, investigation has been hampered by the complex snoring sound analyses. Objective: This study was aimed to investigate the energy types of the full-night snoring sounds in patients with OSAS. Patients and Method: Twenty male OSAS patients underwent snoring sound recording throughout 6 hours of in-lab overnight polysomnogragphy. Snoring sounds were processed and analyzed by a new sound analytic program, named as Snore Map (R). We transformed the 6-hour snoring sound power spectra into the energy spectrum and classified it as snore map type 1 (monosyllabic low-frequency snore), type 2 (duplex low-& mid-frequency snore), type 3 (duplex low-& high-frequency snore), and type 4 (triplex low-, mid-, & high-frequency snore). The interrator and test-retest reliabilities of snore map typing were assessed. The snore map types and their associations among demographic data, subjective snoring questionnaires, and polysomnographic parameters were explored. Results: The interrator reliability of snore map typing were almost perfect (kappa = 0.87) and the test-retest reliability was high (r = 0.71). The snore map type was proportional to the body mass index (r = 0.63, P = 0.003) and neck circumference (r = 0.52, P = 0.018). Snore map types were unrelated to subjective snoring questionnaire scores (All P > 0.05). After adjustment for body mass index and neck circumference, snore map type 3-4 was significantly associated with severity of OSAS (r = 0.52, P = 0.026). Conclusions: Snore map typing of a full-night energy spectrum is feasible and reliable. The presence of a higher snore map type is a warning sign of severe OSAS and indicated priority OSAS management. Future studies are warranted to evaluate whether snore map type can be used to discriminate OSAS from primary snoring and whether it is affected by OSAS management.	[Lee, Li-Ang; Fang, Tuan-Jen; Li, Hsueh-Yu] Chang Gung Univ, Dept Otolaryngol, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Yu, Jen-Fang; Chen, Yen-Sheng; Wang, Ding-Li; Cho, Chih-Ming] Chang Gung Univ, Grad Inst Med Mechatron, Taiouan Interdisciplinary Otolaryngol Lab, Tao Yuan, Taiwan; [Lo, Yu-Lun; Ni, Yung-Lun; Chen, Ning-Hung] Chang Gung Univ, Dept Thorac Med, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Huang, Chung-Guei] Chang Gung Univ, Dept Pathol, Chang Gung Mem Hosp, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Li, HY (corresponding author), Chang Gung Univ, Dept Otolaryngol, Sleep Ctr, Chang Gung Mem Hosp, Taipei, Taiwan.	hyli38@adm.cgmh.org.tw	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; Fang, TuanJen/0000-0002-7805-3458; YU, JEN-FANG/0000-0002-3202-8433	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG390301, CMRPG390302]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG390301 and CMRPG390302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2002, CLIN OTOLARYNGOL, V27, P162, DOI 10.1046/j.1365-2273.2002.00554.x; Fiz JA, 2010, LARYNGOSCOPE, V120, P854, DOI 10.1002/lary.20815; Beck R, 1995, EUR RESPIR J, V8, P2120, DOI 10.1183/09031936.95.08122120; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; Cathcart RA, 2010, CLIN OTOLARYNGOL, V35, P198, DOI 10.1111/j.1749-4486.2010.02127.x; Chen NH, 2002, QUAL LIFE RES, V11, P601, DOI 10.1023/A:1016337008763; Chuang Li-Pang, 2008, Chang Gung Med J, V31, P175; Douglas SA, 2006, OTOLARYNG HEAD NECK, V134, P56, DOI 10.1016/j.otohns.2005.09.006; Emoto T., 2011, Journal of Medical Engineering & Technology, V35, P425, DOI 10.3109/03091902.2011.626838; Friedman M, 2004, LARYNGOSCOPE, V114, P454, DOI 10.1097/00005537-200403000-00013; Gliklich RE, 2002, ARCH OTOLARYNGOL, V128, P819, DOI 10.1001/archotol.128.7.819; Hoffstein V, 1996, SLEEP, V19, P783; Iber C., 2007, AASM MANUAL SCORING; Jury E., 1961, P IRE, V49, P1947; Li HY, 2008, LARYNGOSCOPE, V118, P354, DOI 10.1097/MLG.0b013e318158f73f; Li HY, 2006, SLEEP, V29, P1537, DOI 10.1093/sleep/29.12.1537; Lim PVH, 1999, J LARYNGOL OTOL, V113, P336, DOI 10.1017/S0022215100143919; Mesquita J, 2012, MED BIOL ENG COMPUT, V50, P373, DOI 10.1007/s11517-012-0885-9; Michael H, 2008, EUR ARCH OTO-RHINO-L, V265, P105, DOI 10.1007/s00405-007-0408-8; Miyazaki S, 1998, ACTA OTO-LARYNGOL, P47; PEREZPADILLA JR, 1993, AM REV RESPIR DIS, V147, P635, DOI 10.1164/ajrccm/147.3.635; Sola-Soler J, 2003, P ANN INT IEEE EMBS, V25, P2527, DOI 10.1109/IEMBS.2003.1280430; WHITE JES, 1994, CLIN OTOLARYNGOL, V19, P218, DOI 10.1111/j.1365-2273.1994.tb01218.x; Wilson K, 1999, CHEST, V115, P762, DOI 10.1378/chest.115.3.762; Xu HJ, 2010, ACTA OTO-LARYNGOL, V130, P1175, DOI 10.3109/00016481003694774; Yu JF, 2012, J MECH, V28, P91, DOI 10.1017/jmech.2012.9	26	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53481	10.1371/journal.pone.0053481	http://dx.doi.org/10.1371/journal.pone.0053481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300931	Green Published, gold			2022-12-25	WOS:000313872600102
J	Zhang, YX; Barry, JG; Moore, DR; Amitay, S				Zhang, Yu-Xuan; Barry, Johanna G.; Moore, David R.; Amitay, Sygal			A New Test of Attention in Listening (TAIL) Predicts Auditory Performance	PLOS ONE			English	Article							SELECTIVE ATTENTION; WORKING-MEMORY; HUMAN BRAIN; SYSTEM; DISCRIMINATION; INHIBITION; INTERFERENCE; MODULATION; JUDGMENTS; CORTEX	Attention modulates auditory perception, but there are currently no simple tests that specifically quantify this modulation. To fill the gap, we developed a new, easy-to-use test of attention in listening (TAIL) based on reaction time. On each trial, two clearly audible tones were presented sequentially, either at the same or different ears. The frequency of the tones was also either the same or different (by at least two critical bands). When the task required same/different frequency judgments, presentation at the same ear significantly speeded responses and reduced errors. A same/different ear (location) judgment was likewise facilitated by keeping tone frequency constant. Perception was thus influenced by involuntary orienting of attention along the task-irrelevant dimension. When information in the two stimulus dimensions were congruent (same-frequency same-ear, or different-frequency different-ear), response was faster and more accurate than when they were incongruent (same-frequency different-ear, or different-frequency same-ear), suggesting the involvement of executive control to resolve conflicts. In total, the TAIL yielded five independent outcome measures: (1) baseline reaction time, indicating information processing efficiency, (2) involuntary orienting of attention to frequency and (3) location, and (4) conflict resolution for frequency and (5) location. Processing efficiency and conflict resolution accounted for up to 45% of individual variances in the low-and high-threshold variants of three psychoacoustic tasks assessing temporal and spectral processing. Involuntary orientation of attention to the irrelevant dimension did not correlate with perceptual performance on these tasks. Given that TAIL measures are unlikely to be limited by perceptual sensitivity, we suggest that the correlations reflect modulation of perceptual performance by attention. The TAIL thus has the power to identify and separate contributions of different components of attention to auditory perception.	[Zhang, Yu-Xuan; Barry, Johanna G.; Moore, David R.; Amitay, Sygal] MRC, Inst Hearing Res, Nottingham, England; [Zhang, Yu-Xuan] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, YX (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	yuxuan.zhang@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435; Barry, Johanna/0000-0002-3733-8721	Medical Research Council (MRC), United Kingdom; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council (MRC), United Kingdom, through intramural funding to the MRC Institute of Hearing Research. All authors were MRC employees at the time the research was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Armony J.L., 2010, OXFORD HDB AUDITORY, VVol. 2, P479, DOI [10.1093/oxfordhb/9780199233281.013.0019, DOI 10.1093/OXFORDHB/9780199233281.013.0019]; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barry J. G., 2010, JOVE-J VIS EXP, V44, P2139, DOI [10.3791/2139, DOI 10.3791/2139]; Botvinick M, 2004, COGNITIVE NEUROSCIEN; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brancucci A, 1999, NEUROPSYCHOLOGIA, V37, P1445, DOI 10.1016/S0028-3932(99)00065-2; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cherry EC, 1952, AM SCI, V40, P640; Cohen J. D., 2004, COGNITIVE NEUROSCIEN, P71; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fossella J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1255; Houston DM, 2012, J AM ACAD AUDIOL, V23, P446, DOI 10.3766/jaaa.23.6.7; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; James W., 1890, PRINCIPLES PSYCHOL; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leigh-Paffenroth ED, 2011, J AM ACAD AUDIOL, V22, P393, DOI 10.3766/jaaa.22.7.2; Lupianez J, 1997, PERCEPT PSYCHOPHYS, V59, P1241, DOI 10.3758/BF03214211; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Martin-Arevalo E, 2013, Q J EXP PSYCHOL, V66, P347, DOI 10.1080/17470218.2012.711844; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McKinnon MC, 1997, CAN J EXP PSYCHOL, V51, P171, DOI 10.1037/1196-1961.51.2.171; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mondor TA, 1998, PERCEPT PSYCHOPHYS, V60, P296, DOI 10.3758/BF03206038; Moore B., 2003, INTRO PSYCHOL HEARIN; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Moore DR, 2012, INT J AUDIO IN PRESS; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; PENDSE SG, 1977, PERCEPT MOTOR SKILL, V44, P923, DOI 10.2466/pms.1977.44.3.923; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Posner M., 1975, INFORM PROCESSING CO; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Roberts KL, 2006, J INT NEUROPSYCH SOC, V12, P485, DOI 10.1017/S1355617706060620; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; Schneider BA, 2010, SPRINGER HANDB AUDIT, V34, P167, DOI 10.1007/978-1-4419-0993-0_7; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Dijk P, 2003, HEARING RES, V181, P8, DOI 10.1016/S0378-5955(03)00130-8; Vernon P. A., 1987, SPEED INFORM PROCESS; Weinberger N. M., 2010, AUDITORY BRAIN, P441; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53502	10.1371/journal.pone.0053502	http://dx.doi.org/10.1371/journal.pone.0053502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300934	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872600104
J	Novoa, A; Gonzalez, L; Moravcova, L; Pysek, P				Novoa, Ana; Gonzalez, Luis; Moravcova, Lenka; Pysek, Petr			Effects of Soil Characteristics, Allelopathy and Frugivory on Establishment of the Invasive Plant Carpobrotus edulis and a Co-Occuring Native, Malcolmia littorea	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SPECIES INVASIVENESS; BIOLOGICAL INVASION; SPP. AIZOACEAE; ALIEN PLANTS; GERMINATION; LITTER; IMPACT; COMMUNITIES; CALIFORNIA	Background: The species Carpobrotus edulis, native to South Africa, is one of the major plant invaders of Mediterranean coastal ecosystems around the world. Invasion by C. edulis exerts a great impact on coastal habitats. The low number of native species in invaded communities points to the possible existence of mechanisms suppressing their germination. In this study we assessed whether soil factors, endozoochory, competition and allelopathic effects of the invader affect its own early establishment and that of the native species Malcolmia littorea. We used laboratory solutions representing different chemical composition and moisture of the soil, herbivore feeding assays to simulate seed scarification and rainwater solutions to account for the effect of differently aged C. edulis litter. Principal Findings: We show that unlike that of the native species, germination and early growth of C. edulis was not constrained by low moisture. The establishment of C. edulis, in terms of germination and early growth, was increased by scarification of seeds following passage through the European rabbit intestines; the rabbits therefore may have potential implications for plant establishment. There was no competition between C. edulis and M. littorea. The litter of the invasive C. edulis, which remains on the soil surface for several years, releases allelopathic substances that suppress the native plant germination process and early root growth. Conclusions: The invasive species exhibits features that likely make it a better colonizer of sand dunes than the co-occurring native species. Allelopathic effects, ability to establish in drier microsites and efficient scarification by rabbits are among the mechanisms allowing C. edulis to invade. The results help to explain the failure of removal projects that have been carried out in order to restore dunes invaded by C. edulis, and the long-lasting effects of C. edulis litter need to be taken into account in future restoration projects.	[Novoa, Ana; Gonzalez, Luis] Univ Vigo, Dept Bioloxia Vexetal & Ciencia Solo, Vigo 36310, Spain; [Novoa, Ana; Moravcova, Lenka; Pysek, Petr] Acad Sci Czech Republ, Dept Invas Ecol, Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	Universidade de Vigo; Czech Academy of Sciences; Charles University Prague	Novoa, A (corresponding author), Univ Vigo, Dept Bioloxia Vexetal & Ciencia Solo, Vigo 36310, Spain.	ananovoa@uvigo.es	Moravcová, Lenka/H-1613-2014; González, Luís/M-2582-2019; Novoa, Ana/F-9034-2016; Pysek, Petr/B-1957-2012; González, Luís/F-6408-2010	González, Luís/0000-0001-8091-9364; Novoa, Ana/0000-0001-7092-3917; González, Luís/0000-0001-8091-9364	Ministry of Education of Spain; Academy of Sciences of the Czech Republic [GA206/09/0563, RVO 67985939]; Praemium Academiae award from the Academy of Sciences of the Czech Republic	Ministry of Education of Spain(Spanish Government); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Praemium Academiae award from the Academy of Sciences of the Czech Republic	AN was supported by the "grant to encourage mobility of visiting professors and students under institutional strategies of doctoral training in universities and consolidation of doctoral programs with mention to Excellence" of the Ministry of Education of Spain. PP and LM were supported by grant no. GA206/09/0563 and long-term research development project no. RVO 67985939 (both from the Academy of Sciences of the Czech Republic). PP was also supported by institutional resources of the Ministry of Education, Youth and Sports of the Czech Republic, and acknowledges support by the Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ME, 1995, PORTRAIT INVADER; Allen SE, 1989, CHEM ANAL ECOLOGICAL; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 1992, OFFICIAL J EUROPEAN, P7; Balestri E, 2004, J COASTAL RES, V20, P761, DOI 10.2112/1551-5036(2004)20[761:GAEECO]2.0.CO;2; Bartomeus I, 2008, ANN BOT-LONDON, V102, P417, DOI 10.1093/aob/mcn109; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bourgeois K, 2005, ECOSCIENCE, V12, P248, DOI 10.2980/i1195-6860-12-2-248.1; Bradbeer J.W., 1998, SEED DORMANCY GERMIN, Vfirst; Bubel N., 1988, NEW SEED STARTERS HD; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Carranza ML, 2011, PRESLIA, V83, P529; Castroviejo S, 1991, N E BR FLORA IBERICA, V2, P84; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cervan Carmona Maria, 1997, Donana Acta Vertebrata, V24, P143; Chiapusio G, 1997, J CHEM ECOL, V23, P2445, DOI 10.1023/B:JOEC.0000006658.27633.15; Cogoni A, 2011, NOVA HEDWIGIA, V92, P159, DOI 10.1127/0029-5035/2011/0092-0159; Conser C, 2009, BIOL INVASIONS, V11, P349, DOI 10.1007/s10530-008-9252-z; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; D'Antonio CM, 2006, GLOBAL INVASIVE SPEC; DANTONIO CM, 1991, AM J BOT, V78, P885, DOI 10.2307/2445167; DANTONIO CM, 1990, J APPL ECOL, V27, P693, DOI 10.2307/2404312; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; de la Pena E, 2010, BIOL INVASIONS, V12, P3637, DOI 10.1007/s10530-010-9756-1; Del Vecchio S, J NATURE CO IN PRESS; Dias LS, 2001, J CHEM ECOL, V27, P411, DOI 10.1023/A:1005644808956; Diaz Gonzalez TE, 2005, ESPECIES PROTEGIDAS, P1; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gallagher KG, 1997, AM J BOT, V84, P905, DOI 10.2307/2446280; Gioria M, 2012, PRESLIA, V84, P327; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hejda M, 2009, GLOBAL ECOL BIOGEOGR, V18, P372, DOI 10.1111/j.1466-8238.2009.00445.x; HESP PA, 1991, J ARID ENVIRON, V21, P165, DOI 10.1016/S0140-1963(18)30681-5; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Hulme P, 2004, ECOLOGIA INSULAR ASO, P359; Hussain MI, 2008, ALLELOPATHY J, V22, P101; Khurana E, 2004, J TROP ECOL, V20, P385, DOI 10.1017/S026646740400135X; Lorenzo P, 2010, AUST J BOT, V58, P546, DOI 10.1071/BT10094; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchante E, 2009, BIOL INVASIONS, V11, P813, DOI 10.1007/s10530-008-9295-1; Marques C, 2001, MAMMALIA, V65, P437, DOI 10.1515/mamm.2001.65.4.437; Martina JP, 2012, ENVIRON EXP BOT, V82, P43, DOI 10.1016/j.envexpbot.2012.03.010; Maun MA, 2009, BIOL COASTAL SAND DU; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Moravcova L., 2011, NeoBiota, P31, DOI 10.3897/neobiota.9.1266; Moravcova L, 2010, PRESLIA, V82, P365; Okay Y, 2011, AFR J BIOTECHNOL, V10, P1545; Phillips ML, 2010, PRESLIA, V82, P465; Pignatti, 1982, FLORA ITALY; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodgers JC, 2003, DIVERS DISTRIB, V9, P385, DOI 10.1046/j.1472-4642.2003.00036.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; SENECA ED, 1972, ECOLOGY, V53, P465, DOI 10.2307/1934234; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Suehs CM, 2004, HEREDITY, V92, P31, DOI 10.1038/sj.hdy.6800374; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Traveset A, 2008, BIOL INVASIONS, V10, P847, DOI 10.1007/s10530-008-9245-y; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Tutin TG, 1993, FLORA EUROPAEA, V1; Viard-Cretat F, 2010, PRESLIA, V82, P483; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vila M, 1998, ECOLOGY, V79, P1053, DOI 10.1890/0012-9658(1998)079[1053:FCASDO]2.0.CO;2; Violle C, 2006, J ECOL, V94, P196, DOI 10.1111/j.1365-2745.2005.01061.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; Wardle DA, 1996, J CHEM ECOL, V22, P933, DOI 10.1007/BF02029946; Weber E, 1999, CAN J BOT, V77, P1411, DOI 10.1139/cjb-77-10-1411; Weber E., 2003, INVASIVE PLANT SPECI; Wisura W., 1993, CONTRIB BOLUS HERB, V15, P76; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	81	49	50	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53166	10.1371/journal.pone.0053166	http://dx.doi.org/10.1371/journal.pone.0053166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300885	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500114
J	Beckmann, S; Quack, T; Dissous, C; Cailliau, K; Lang, G; Grevelding, CG				Beckmann, Svenja; Quack, Thomas; Dissous, Colette; Cailliau, Katia; Lang, Gabriele; Grevelding, Christoph G.			Discovery of Platyhelminth-Specific alpha/beta-Integrin Families and Evidence for Their Role in Reproduction in Schistosoma mansoni	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MALE-FEMALE INTERACTION; MOLECULAR EVOLUTION; BETA-2 INTEGRINS; SRC; SYK; ACTIVATION; GENOME; ADHESION; BINDING	In all metazoa, the response of cells to molecular stimuli from their environment represents a fundamental principle of regulatory processes controlling cell growth and differentiation. Among the membrane-linked receptors mediating extracellular communication processes are integrin receptors. Besides managing adhesion to the extracellular matrix or to other cells, they arrange information flow into the cells by activating intracellular signaling pathways often acting synergistically through cooperation with growth factor receptors. Although a wealth of information exists on integrins in different model organisms, there is a big gap of knowledge for platyhelminths. Here we report on the in silico detection and reconstruction of alpha and beta integrins from free-living and parasitic platyhelminths, which according to structural and phylogenetic analyses form specific clades separate from each other and from further metazoan integrins. As representative orthologs of parasitic platyhelminths we have cloned one beta-integrin (Sm beta-Int1) and four alpha-integrins (Sm alpha-Int1 - Sm alpha-Int4) from Schistosoma mansoni; they were characterized by molecular and biochemical analyses. Evidence is provided that Sm beta-Int1 interacts and co-localizes in the reproductive organs with known schistosome cellular tyrosine kinases (CTKs), of which the Syk kinase SmTK4 appeared to be the strongest interaction partner as shown by yeast two-hybrid analyses and coimmunoprecipitation experiments. By a novel RNAi approach with adult schistosomes in vitro we demonstrate for the first time multinucleated oocytes in treated females, indicating a decisive role Sm beta-Int1 during oogenesis as phenotypically analyzed by confocal laser scanning microscopy (CLSM). Our findings provide a first comprehensive overview about platyhelminth integrins, of which the parasite group exhibits unique features allowing a clear distinction from the free-living groups. Furthermore, we shed first lights on the functions of integrins in a trematode model parasite, revealing the complexity of molecular processes involved in its reproductive biology, which may be representative for other platyhelminths.	[Beckmann, Svenja; Quack, Thomas; Lang, Gabriele; Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, Giessen, Germany; [Dissous, Colette] Univ Lille, CIIL, Inserm U1019, Lille, France; [Cailliau, Katia] Univ Lille 1, Lab Regulat Signaux Div, Lille, France	Justus Liebig University Giessen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Grevelding, CG (corresponding author), Univ Giessen, Inst Parasitol, Giessen, Germany.	Christoph.Grevelding@vetmed.uni-giessen.de		Cailliau, Katia/0000-0001-7993-8437; Dissous, Colette/0000-0002-5003-8205; cailliau, katia/0000-0003-1772-1034	Deutsche Forschungsgemeinschaft [GR1549/8-2]; Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2	This work was supported by the Deutsche Forschungsgemeinschaft, Grant GR1549/8-2, and by the Institut de la Sante et de la Recherche Medicale, Centre national de la Recherche Scientifique, Universite de Lille 1- Lille 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Beckmann S, 2010, INT J PARASITOL, V40, P521, DOI 10.1016/j.ijpara.2010.01.007; Beckmann S, 2010, PARASITOLOGY, V139, P651; Beckmann S, 2011, J BIOL CHEM, V286, P42325, DOI 10.1074/jbc.M110.210336; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; ERASMUS DA, 1973, PARASITOLOGY, V67, P165, DOI 10.1017/S0031182000046394; Ewan R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-31; FINKEN M, 1994, MOL BIOCHEM PARASIT, V64, P135, DOI 10.1016/0166-6851(94)90141-4; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006; GREVELDING CG, 1995, MOL BIOCHEM PARASIT, V71, P269, DOI 10.1016/0166-6851(94)00058-U; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Knobloch J, 2002, GENE, V294, P87, DOI 10.1016/S0378-1119(02)00760-6; Knobloch J, 2002, DEV GROWTH DIFFER, V44, P559; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Leutner S, 2011, AN ACAD BRAS CIENC, V83, P637, DOI 10.1590/S0001-37652011000200023; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MUSIAL J, 1990, CIRCULATION, V82, P261, DOI 10.1161/01.CIR.82.1.261; Ndegwa D, 2007, EXP PARASITOL, V117, P284, DOI 10.1016/j.exppara.2007.07.012; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Oliveira KC, 2011, AN ACAD BRAS CIENC, V83, P673, DOI 10.1590/S0001-37652011000200026; Piccardoni P, 2004, BIOCHEM J, V380, P57, DOI 10.1042/BJ20040151; POPIEL I, 1986, J CHEM ECOL, V12, P1745, DOI 10.1007/BF01022380; Quack T, 2006, BERL MUNCH TIERARZTL, V119, P365; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; SATO M, 1990, J CELL BIOL, V111, P1713, DOI 10.1083/jcb.111.4.1713; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wimmer W, 1999, EUR J BIOCHEM, V260, P156, DOI 10.1046/j.1432-1327.1999.00146.x; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	78	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52519	10.1371/journal.pone.0052519	http://dx.doi.org/10.1371/journal.pone.0052519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300694	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100059
J	Edwards, DB				Edwards, Darryl B.			Immune Investment Is Explained by Sexual Selection and Pace-of-Life, but Not Longevity in Parrots (Psittaciformes)	PLOS ONE			English	Article							TRADE-OFFS; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL IMMUNOLOGY; NATURAL-POPULATIONS; MOLECULAR PHYLOGENY; MATING SYSTEMS; DISEASE RISK; EVOLUTION; PARASITES; HISTORY	Investment in current reproduction should come at the expense of traits promoting future reproduction, such as immunity and longevity. To date, comparative studies of pace-of-life traits have provided some support for this, with slower paced species having greater immune function. Another means of investment in current reproduction is through secondary sexual characters (SSC). Investment in SSC's is considered costly, both in terms of immunity and longevity, with greater costs being borne by species with more elaborate traits. Yet within species, females prefer more ornate males and those males are typically immunologically superior. Because of this, predictions about the relationship between immunity and SSC's across species are not clear. If traits are costly, brighter species should have reduced immune function, but the opposite is true if SSC's arise from selection for more immunocompetent individuals. My approach was to investigate immune investment in relation to SSC's, pace-of-life and longevity while considering potentially confounding ecological factors. To do so I assessed leukocyte counts from in a novel group, the Psittaciformes. Investment in SSC's best explained investment in immunity: species with brighter plumage had higher leukocyte counts and those with a greater degree of sexual dichromatism had fewer. Ecological variables and pace-of-life models tended to be poor predictors of immune investment. However, shorter incubation periods were associated with lower leukocyte counts supporting the notion that species with a fast pace-of-life invest less in immunity. These results suggest that investment in reproduction in terms of fast pace-of-life and sexual dichromatism results in reduced immunity; however, investment in plumage colour per se does not impose a cost on immunity across species.	Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	Laurentian University	Edwards, DB (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	db_edwards@laurentian.ca			Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship	Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada: PGLS D Scholarship. The NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2009, P ROY SOC B-BIOL SCI, V276, P3979, DOI 10.1098/rspb.2009.1296; Alderton D, 2000, ULTIMATE ENCY CAGED; Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Astuti D, 2006, ZOOL SCI, V23, P191, DOI 10.2108/zsj.23.191; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Catoni C, 2008, FUNCT ECOL, V22, P649, DOI 10.1111/j.1365-2435.2008.01400.x; CHRISTIDIS L, 1991, CONDOR, V93, P302, DOI 10.2307/1368946; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Del Hoyo, 1997, HDB BIRDS WORLD SAND; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE, DOI [10.1093/acprof:oso/9780199208784.001.0001, DOI 10.1093/ACPR0F:0S0/9780199208784.001.0001]; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forshaw J. M., 1973, PARROTS WORLD; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; HOLMES DJ, 1995, AM ZOOL, V35, P307; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Juniper T, 1998, PARROTS GUIDE PARROT; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Low R, 1998, ENCY LORIES; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Masello JF, 2008, J AVIAN BIOL, V39, P653, DOI 10.1111/j.1600-048X.2008.04417.x; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P2267, DOI 10.1098/rspb.2006.3590; Mayr G, 2010, EMU, V110, P348, DOI 10.1071/MU10035; McGraw KJ, 2005, BIOL LETTERS, V1, P38, DOI 10.1098/rsbl.2004.0269; McNaught MK, 2002, J EVOLUTION BIOL, V15, P505, DOI 10.1046/j.1420-9101.2002.00431.x; Moller AP, 1997, P ROY SOC B-BIOL SCI, V264, P561, DOI 10.1098/rspb.1997.0080; Moller AP, 1998, J EVOLUTION BIOL, V11, P703, DOI 10.1007/s000360050114; Moller AP, 2001, AM NAT, V158, P136, DOI 10.1086/321308; Moller AP, 1998, OIKOS, V82, P265, DOI 10.2307/3546966; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Moller AP, 1999, Q REV BIOL, V74, P3, DOI 10.1086/392949; Monaghan P, 2001, TRENDS GENET, V17, P568, DOI 10.1016/S0168-9525(01)02415-5; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morelli R, 2003, DRUG EXP CLIN RES, V29, P95; Munshi-South J, 2006, AUK, V123, P108, DOI 10.1642/0004-8038(2006)123[0108:DILSIP]2.0.CO;2; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Nunn CL, 2002, EVOLUTION, V56, P177; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palacios MG, 2006, OECOLOGIA, V146, P505, DOI 10.1007/s00442-005-0220-3; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peach WJ, 2001, OIKOS, V93, P235, DOI 10.1034/j.1600-0706.2001.930207.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pini E, 2004, DRUG EXP CLIN RES, V30, P203; PROMISLOW D, 1994, EVOLUTION, V48, P2045, DOI 10.1111/j.1558-5646.1994.tb02232.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; R Core Team, 2022, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; READ AF, 1989, NATURE, V339, P618, DOI 10.1038/339618a0; READ AF, 1987, NATURE, V328, P68, DOI 10.1038/328068a0; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricklefs RE, 2000, J AVIAN BIOL, V31, P103, DOI 10.1034/j.1600-048X.2000.210201.x; Roitt I, 1993, IMMUNOLOGY; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Schweizer M, 2010, MOL PHYLOGENET EVOL, V54, P984, DOI 10.1016/j.ympev.2009.08.021; SCOTT DK, 1990, BEHAV ECOL SOCIOBIOL, V26, P261, DOI 10.1007/BF00178319; Semple S, 2002, P ROY SOC B-BIOL SCI, V269, P1031, DOI 10.1098/rspb.2001.1950; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Stearns S.C., 1992, pi; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Valkiunas G, 2004, AVIAN MALARIA PARASI; WATVE MG, 1995, P NATL ACAD SCI USA, V92, P8945, DOI 10.1073/pnas.92.19.8945; Watve MG, 1997, J THEOR BIOL, V184, P167, DOI 10.1006/jtbi.1996.0267; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	92	3	3	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53066	10.1371/journal.pone.0053066	http://dx.doi.org/10.1371/journal.pone.0053066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300862	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100115
J	Ndungu, FM; Mwacharo, J; Kimani, D; Kai, O; Moris, P; Jongert, E; Vekemans, J; Olotu, A; Bejon, P				Ndungu, Francis M.; Mwacharo, Jedidah; Kimani, Domtila; Kai, Oscar; Moris, Philippe; Jongert, Erik; Vekemans, Johan; Olotu, Ally; Bejon, Philip			A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; VACCINIA VIRUS ANKARA; AFRICAN CHILDREN; ADJUVANT SYSTEMS; IMMUNE-RESPONSE; DOUBLE-BLIND; EFFICACY; TRIAL; PROTECTION; INDUCTION	The candidate malaria vaccine RTS,S/AS01(E) provides significant but partial protection from clinical malaria. On in vitro circumsporozoite protein (CSP) peptide stimulation and intra-cellular cytokine staining of whole blood taken from 407 5-17 month-old children in a phase IIb trial of RTS,S/AS01(E), we identified significantly increased frequencies of two CSP-specific CD4+ T cells phenotypes among RTS,S/AS01(E) vaccinees (IFN gamma IL2+TNF- and IFN gamma IL2+TNF+ CD4+ T cells), and increased frequency of IFN gamma-IL2-TNF+ CD4+ T cells after natural exposure. All these T cells phenotypes were individually associated with reductions in the risk of clinical malaria, but IFN gamma-IL2-TNF+ CD4+ T cells independently predicted reduced risk of clinical malaria on multi-variable analysis (HR = 0.29, 95% confidence intervals 0.15-0.54, p<0.0005). Furthermore, there was a strongly significant synergistic interaction between CSP-specific IFN gamma-IL2-TNF+ CD4+ T cells and anti-CSP antibodies in determining protection against clinical malaria (p = 0.002). Vaccination strategies that combine potent cellular and antibody responses may enhance protection against malaria.	[Ndungu, Francis M.; Mwacharo, Jedidah; Kimani, Domtila; Kai, Oscar; Olotu, Ally; Bejon, Philip] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Ndungu, Francis M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Moris, Philippe; Jongert, Erik; Vekemans, Johan] GlaxoSmithKline Biol, Wavre, Belgium; [Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	Kenya Medical Research Institute; University of Oxford; GlaxoSmithKline; University of Oxford	Ndungu, FM (corresponding author), Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya.	fndungu@kilifi.kemri-wellcome.org	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030	PATH Malaria Vaccine Initiative (MVI); European and Developing Countries Clinical Trials Partnership (EDCTP); Biomedical Research Centre in Oxford; MRC - UK; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	PATH Malaria Vaccine Initiative (MVI); European and Developing Countries Clinical Trials Partnership (EDCTP); Biomedical Research Centre in Oxford; MRC - UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project has been funded by PATH Malaria Vaccine Initiative (MVI). Francis Ndungu is a post-doctoral fellow under the Malaria Vectored Vaccines Consortium (MVVC), funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). Philip Bejon is supported by the Biomedical Research Centre in Oxford, and the MRC - UK. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MVI had no other role in data collection or analysis, and the decision to publish was covered by a pre-study agreement.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Ansong D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018891; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Depinay N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017464; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-168; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Horowitz A, 2012, J IMMUNOL, V188, P5054, DOI 10.4049/jimmunol.1102710; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; TAPCHAISRI P, 1983, AM J TROP MED HYG, V32, P1203, DOI 10.4269/ajtmh.1983.32.1203; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Wang RB, 1996, J IMMUNOL, V157, P4061; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	38	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52870	10.1371/journal.pone.0052870	http://dx.doi.org/10.1371/journal.pone.0052870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300801	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100088
J	Sahana, N; Kaur, H; Basavaraj; Tena, F; Jain, RK; Palukaitis, P; Canto, T; Praveen, S				Sahana, Nandita; Kaur, Harpreet; Basavaraj; Tena, Fatima; Jain, Rakesh Kumar; Palukaitis, Peter; Canto, Tomas; Praveen, Shelly			Inhibition of the Host Proteasome Facilitates Papaya Ringspot Virus Accumulation and Proteosomal Catalytic Activity Is Modulated by Viral Factor HcPro	PLOS ONE			English	Article							HELPER COMPONENT-PROTEINASE; LONG-DISTANCE MOVEMENT; SMALL RNA-BINDING; 20S PROTEASOME; HC-PRO; TAT PROTEIN; SUPPRESSOR; POTYVIRUS; GENE; DEGRADATION	The ubiquitin/26S proteasome system plays an essential role not only in maintaining protein turnover, but also in regulating many other plant responses, including plant-pathogen interactions. Previous studies highlighted different roles of the 20S proteasome in plant defense during virus infection, either indirectly through viral suppressor-mediated degradation of Argonaute proteins, affecting the RNA interference pathway, or directly through modulation of the proteolytic and RNase activity of the 20S proteasome, a component of the 20S proteasome, by viral proteins, affecting the levels of viral proteins and RNAs. Here we show that MG132, a cell permeable proteasomal inhibitor, caused an increase in papaya ringspot virus (PRSV) accumulation in its natural host papaya (Carica papaya). We also show that the PRSV HcPro interacts with the papaya homologue of the Arabidopsis PAA (alpha 1 subunit of the 20S proteasome), but not with the papaya homologue of Arabidopsis PAE (alpha 5 subunit of the 20S proteasome), associated with the RNase activity, although the two 20S proteasome subunits interacted with each other. Mutated forms of PRSV HcPro showed that the conserved KITC54 motif in the N-terminal domain of HcPro was necessary for its binding to PAA. Co-agroinfiltration assays demonstrated that HcPro expression mimicked the action of MG132, and facilitated the accumulation of bothtotal ubiquitinated proteins and viral/non-viral exogenous RNA in Nicotiana benthamiana leaves. These effects were not observed by using an HcPro mutant (KITS54), which impaired the HcPro - PAA interaction. Thus, the PRSV HcPro interacts with a proteasomal subunit, inhibiting the action of the 20S proteasome, suggesting that HcPro might be crucial for modulating its catalytic activities in support of virus accumulation.	[Tena, Fatima; Canto, Tomas] CSIC, Ctr Invest Biol, Madrid, Spain; [Sahana, Nandita] Indian Agr Res Inst, Div Biochem, New Delhi 110012, India; [Kaur, Harpreet; Basavaraj; Jain, Rakesh Kumar; Praveen, Shelly] Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India; [Palukaitis, Peter] Seoul Womens Univ, Dept Hort Sci, Seoul, South Korea	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Seoul Women's University	Canto, T (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	tomas.canto@cib.csic.es; shellypraveen@iari.res.in	Praveen, Shelly/D-3691-2014	Praveen, Shelly/0000-0002-6330-4592; sahana, nandita/0000-0003-4959-173X	Department of Science and Technology, Govt. of India [DST/INT/SPAIN/P-9/2009]; Ministerio de Ciencia e Innovacion, Govt. of Spain [ACI/2009-0855]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [MOEHRD-KRF-2012-0007187]; Indian Agricultural Research Institute, New Delhi;  [PJ007450]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Ministerio de Ciencia e Innovacion, Govt. of Spain; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); 	This work was supported in part by grants from Department of Science and Technology, Govt. of India to SP (Grant DST/INT/SPAIN/P-9/2009), from Ministerio de Ciencia e Innovacion, Govt. of Spain (Grant ACI/2009-0855) to TC, and from a Research Professorship Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MOEHRD-KRF-2012-0007187) and Agenda grants (PJ007450) of RDA to PP. The authors are also thankful to Indian Agricultural Research Institute, New Delhi, for providing fellowship to NS and B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; ATREYA CD, 1993, P NATL ACAD SCI USA, V90, P11919, DOI 10.1073/pnas.90.24.11919; Ballut L, 2005, J GEN VIROL, V86, P2595, DOI 10.1099/vir.0.81107-0; Ballut L, 2003, BBA-PROTEINS PROTEOM, V1645, P30, DOI 10.1016/S1570-9639(02)00500-9; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Blanc S, 1998, J GEN VIROL, V79, P3119, DOI 10.1099/0022-1317-79-12-3119; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Dhanam S., 2011, Archives of Phytopathology and Plant Protection, V44, P925, DOI 10.1080/03235400903395393; Dielen AS, 2011, MOL PLANT PATHOL, V12, P137, DOI 10.1111/j.1364-3703.2010.00654.x; Gautier-Bert K, 2003, MOL BIOL REP, V30, P1, DOI 10.1023/A:1022261925117; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; GOVIER DA, 1977, VIROLOGY, V78, P306, DOI 10.1016/0042-6822(77)90101-5; GRZIWA A, 1991, FEBS LETT, V290, P186, DOI 10.1016/0014-5793(91)81256-8; Guo DY, 1999, J GEN VIROL, V80, P1127, DOI 10.1099/0022-1317-80-5-1127; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; HUET H, 1994, J GEN VIROL, V75, P1407, DOI 10.1099/0022-1317-75-6-1407; Jin YS, 2007, J VIROL, V81, P12881, DOI 10.1128/JVI.00913-07; Kasschau KD, 1997, VIROLOGY, V228, P251, DOI 10.1006/viro.1996.8368; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Mangrauthia SK, 2008, J PLANT BIOCHEM BIOT, V17, P201, DOI 10.1007/BF03263287; Mangrauthia SK, 2010, MOL BIOTECHNOL, V44, P22, DOI 10.1007/s12033-009-9205-5; Mangrauthia SK, 2009, VIRUS GENES, V38, P429, DOI 10.1007/s11262-009-0336-3; Marx J, 2002, SCIENCE, V297, P1792, DOI 10.1126/science.297.5588.1792; Parameswari B, 2007, ARCH VIROL, V152, P843, DOI 10.1007/s00705-006-0890-0; Plisson C, 2003, J BIOL CHEM, V278, P23753, DOI 10.1074/jbc.M302512200; Qiu QS, 2007, PLANT PHYSIOL, V144, P468, DOI 10.1104/pp.106.095182; Rakitina DV, 2006, FEBS LETT, V580, P5077, DOI 10.1016/j.febslet.2006.08.032; Reichel C, 2000, J VIROL, V74, P3330, DOI 10.1128/JVI.74.7.3330-3337.2000; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; THORNBURY DW, 1985, VIROLOGY, V144, P260, DOI 10.1016/0042-6822(85)90322-8; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Urcuqui-Inchima S, 1999, VIROLOGY, V258, P95, DOI 10.1006/viro.1999.9725; Varrelmann M, 2007, J GEN VIROL, V88, P1005, DOI 10.1099/vir.0.82200-0; Wang RY, 1999, PHYTOPATHOLOGY, V89, P564, DOI 10.1094/PHYTO.1999.89.7.564; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053	47	40	41	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52546	10.1371/journal.pone.0052546	http://dx.doi.org/10.1371/journal.pone.0052546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300704	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100062
J	Schultz, A; Koch, S; Fuss, M; Mazzotta, AS; Sarzotti-Kelsoe, M; Ozaki, DA; Montefiori, DC; von Briesen, H; Zimmermann, H; Meyerhans, A				Schultz, Anke; Koch, Stefanie; Fuss, Martina; Mazzotta, Angela S.; Sarzotti-Kelsoe, Marcella; Ozaki, Daniel A.; Montefiori, David C.; von Briesen, Hagen; Zimmermann, Heiko; Meyerhans, Andreas			An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials	PLOS ONE			English	Article							FUSION INHIBITOR T-20; NEUTRALIZING ANTIBODIES; V3 LOOP; TYPE-1; CULTURE; CLONES; INFECTIONS; LINEAGE; PROTEIN; DESIGN	Background: Infections with HIV still represent a major human health problem worldwide and a vaccine is the only long-term option to fight efficiently against this virus. Standardized assessments of HIV-specific immune responses in vaccine trials are essential for prioritizing vaccine candidates in preclinical and clinical stages of development. With respect to neutralizing antibodies, assays with HIV-1 Env-pseudotyped viruses are a high priority. To cover the increasing demands of HIV pseudoviruses, a complete cell culture and transfection automation system has been developed. Methodology/Principal Findings: The automation system for HIV pseudovirus production comprises a modified Tecan-based Cellerity system. It covers an area of 5x3 meters and includes a robot platform, a cell counting machine, a CO2 incubator for cell cultivation and a media refrigerator. The processes for cell handling, transfection and pseudovirus production have been implemented according to manual standard operating procedures and are controlled and scheduled autonomously by the system. The system is housed in a biosafety level II cabinet that guarantees protection of personnel, environment and the product. HIV pseudovirus stocks in a scale from 140 ml to 1000 ml have been produced on the automated system. Parallel manual production of HIV pseudoviruses and comparisons (bridging assays) confirmed that the automated produced pseudoviruses were of equivalent quality as those produced manually. In addition, the automated method was fully validated according to Good Clinical Laboratory Practice (GCLP) guidelines, including the validation parameters accuracy, precision, robustness and specificity. Conclusions: An automated HIV pseudovirus production system has been successfully established. It allows the high quality production of HIV pseudoviruses under GCLP conditions. In its present form, the installed module enables the production of 1000 ml of virus-containing cell culture supernatant per week. Thus, this novel automation facilitates standardized large-scale productions of HIV pseudoviruses for ongoing and upcoming HIV vaccine trials.	[Koch, Stefanie; Fuss, Martina; Meyerhans, Andreas] Univ Saarland, Dept Virol, D-6650 Homburg, Germany; [Schultz, Anke; Mazzotta, Angela S.; von Briesen, Hagen; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn, St Ingbert, Germany; [Sarzotti-Kelsoe, Marcella; Ozaki, Daniel A.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, ICREA Infect Biol Lab, Barcelona, Spain	Saarland University; Fraunhofer Gesellschaft; Duke University; ICREA; Pompeu Fabra University	Meyerhans, A (corresponding author), Univ Saarland, Dept Virol, D-6650 Homburg, Germany.	andreas.meyerhans@upf.edu	Meyerhans, Andreas/D-3382-2014; Meyerhans, Andreas/S-2559-2019	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317; Zimmermann, Heiko/0000-0001-8595-1304	Bill and Melinda Gates Foundation [OPP38580_01]; Fraunhofer Society, Germany; ICREA Funding Source: Custom	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fraunhofer Society, Germany; ICREA(ICREA)	This article derived from a collaboration of the Fraunhofer Institute for Biomedical Engineering, the "Global HIV Vaccine Research Cryorepository Consortium" (principal investigator: HVB) and the "Comprehensive Antibody Vaccine Immune Monitoring Consortium" (principal investigator: DM) within the "Collaboration for AIDS Vaccine Discovery", funded by the Bill and Melinda Gates Foundation (#OPP38580_01). Automation of cell culture and HIV pseudovirus production was established in exclusive cooperation with TECAN funded as a strategic investment by the Fraunhofer Society, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beuselinck K, 2005, J CLIN MICROBIOL, V43, P5541, DOI 10.1128/JCM.43.11.5541-5546.2005; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang LC, 2010, BIOLOGICALS, V38, P393, DOI 10.1016/j.biologicals.2010.01.009; Johnson V.A., 1990, TECHNIQUES HIV RES, P71; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI [10.1089/ten.tec.2009.0305, 10.1089/ten.TEC.2009.0305]; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kowalski MP, 2012, J BIOMOL SCREEN; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liu Y, 2010, J TISSUE ENG REGEN M, V4, P45, DOI 10.1002/term.217; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Ozaki DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030963; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shi SP, 2011, JOVE-J VIS EXP, DOI 10.3791/3010; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stevens W, 2003, Qual Assur, V10, P83; STILES T, 2003, GOOD CLIN LAB PRACTI, P1; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Thomas R, 2012, METHODS MOL BIOL, V806, P393, DOI 10.1007/978-1-61779-367-7_26; Todd CA, 2012, J IMMUNOL METHODS, V375, P57, DOI 10.1016/j.jim.2011.09.007; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017	44	11	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51715	10.1371/journal.pone.0051715	http://dx.doi.org/10.1371/journal.pone.0051715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300558	gold, Green Published			2022-12-25	WOS:000312829100012
J	Ng, SK; Tessa, RMT; Wang, Y; Ng, D; Goh, LT; Bardor, M; Victor, VTW; Lam, KP				Say Kong Ng; Tessa Rui Min Tan; Wang, Yang; Daniel Ng; Goh, Lin-Tang; Bardor, Muriel; Victor Vai Tak Wong; Kong Peng Lam			Production of Functional Soluble Dectin-1 Glycoprotein Using an IRES-Linked Destabilized-Dihydrofolate Reductase Expression Vector	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; MAMMALIAN-CELL LINES; CHO-CELLS; PNEUMOCYSTIS-CARINII; RECOMBINANT PROTEINS; BICISTRONIC VECTOR; STABLE EXPRESSION; TYROSINE KINASE; RECOGNITION; SEQUENCE	Dectin-1 (CLEC7A) is a C-type lectin receptor that binds to beta-glucans found in fungal cell walls to act as a major pattern recognition receptor (PRR). Since beta-glucans epitope is not present in human cells, we are of the opinion that Dectin-1 can have therapeutic functions against fungal infections. We thus set out to produce a soluble extracellular domain of murine Dectin-1 (called sDectin-1) in sufficient titers to facilitate such studies in mouse models. Since sDectin-1 has previously been shown to be glycosylated, we chose to produce this protein using Chinese Hamster Ovary (CHO) cells, a mammalian host cell line suitable for the high-titer production of recombinant glycoproteins. To ensure a high titer production of sDectin-1 and minimize the effects of gene fragmentation, we constructed a mammalian expression vector with a PEST-destabilized dhfr amplifiable marker downstream of an attenuated IRES element, which was in turn downstream of the sDectin-1 gene and a CMV IE promoter. Stably transfected and MTX-amplified cell pools were generated using this vector, and maximum sDectin-1 titers of 246 mg/l and 598 mg/l were obtained in shake flask batch culture and bioreactor fed-batch culture respectively. The purified recombinant sDectin-1 was shown to be glycosylated. Protein functionality was also demonstrated by its ability to bind to zymosan particles and to the cell wall of Saccharomyces cerevisiae. We describe for the first time the use of an attenuated IRES-linked PEST-destabilized dhfr amplifiable marker for the production of recombinant proteins with stably amplified cell pools. With our process, we reached the highest reported titer for producing recombinant proteins smaller than 50 kDa in cell pools. sDectin-1 protein produced is glycosylated and functional. This vector design can thus be used efficiently for the high-titer production of functional recombinant proteins.	[Say Kong Ng; Tessa Rui Min Tan; Wang, Yang; Daniel Ng; Goh, Lin-Tang; Bardor, Muriel; Victor Vai Tak Wong; Kong Peng Lam] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Say Kong Ng] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Ng, SK (corresponding author), Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore.	ng_say_kong@bti.a-star.edu.sg	victor, victor/Q-4843-2019	Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TL, 2003, BIOTECHNOL PROGR, V19, P1433, DOI 10.1021/bp034056j; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; AUCOUTURIER P, 1992, BIOCHEM J, V285, P149, DOI 10.1042/bj2850149; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Campbell M, 2010, MOL BIOTECHNOL, V45, P199, DOI 10.1007/s12033-010-9266-5; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Goulart HR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/405872; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; HOFFMAN MA, 1995, J VIROL, V69, P4399, DOI 10.1128/JVI.69.7.4399-4406.1995; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jiang Z, 2008, BIOTECHNOL BIOENG, V100, P189, DOI 10.1002/bit.21726; Kato Y, 2006, BIOL PHARM BULL, V29, P1580, DOI 10.1248/bpb.29.1580; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Lu SB, 2005, PROCESS BIOCHEM, V40, P1917, DOI 10.1016/j.procbio.2004.07.004; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; MILBRANDT JD, 1981, P NATL ACAD SCI-BIOL, V78, P6043, DOI 10.1073/pnas.78.10.6043; Ng SK, 2007, METAB ENG, V9, P304, DOI 10.1016/j.ymben.2007.01.001; Ng SK, 2010, BIOTECHNOL PROGR, V26, P11, DOI 10.1002/btpr.281; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Plantinga TS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2933; Rajendra Y, 2012, BIOTECHNOL LETT, V34, P619, DOI 10.1007/s10529-011-0809-z; Rees S, 1996, BIOTECHNIQUES, V20, P102; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Schatz SM, 2003, BIOTECHNOL BIOENG, V84, P433, DOI 10.1002/bit.10793; Schilling J, 1982, GENE AMPLIFICATION, P149; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Ujita M, 2009, BIOSCI BIOTECH BIOCH, V73, P237, DOI 10.1271/bbb.80503; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Viriyakosol S, 2005, INFECT IMMUN, V73, P1553, DOI 10.1128/IAI.73.3.1553-1560.2005; Westwood AD, 2010, BIOTECHNOL PROGR, V26, P1558, DOI 10.1002/btpr.491; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Ye JX, 2010, BIOTECHNOL PROGR, V26, P1431, DOI 10.1002/btpr.469; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Yung CW, 2009, LAB CHIP, V9, P1171, DOI 10.1039/b816986a; Zhang Z, 2011, J BIOSCI BIOENG, V111, P1, DOI 10.1016/j.jbiosc.2010.08.012; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	61	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52785	10.1371/journal.pone.0052785	http://dx.doi.org/10.1371/journal.pone.0052785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300776	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800147
J	Schramm, RD; Li, S; Harris, BS; Rounds, RP; Burgess, RW; Ytreberg, FM; Fuerst, PG				Schramm, R. Dee; Li, Shuai; Harris, Belinda S.; Rounds, Ryan P.; Burgess, Robert W.; Ytreberg, F. Marty; Fuerst, Peter G.			A Novel Mouse Dscam Mutation Inhibits Localization and Shedding of DSCAM	PLOS ONE			English	Article							DENDRITIC SELF-AVOIDANCE; NETRIN RECEPTOR; NEUROMUSCULAR-JUNCTION; MOLECULAR DIVERSITY; REQUIRE DSCAM; RETINA; DROSOPHILA; CONNECTIONS; SPECIFICITY; LAMINATION	The differential adhesion hypothesis of development states that patterning of organisms, organs and tissues is mediated in large part by expression of cell adhesion molecules. The cues provided by cell adhesion molecules are also hypothesized to facilitate specific connectivity within the nervous system. In this study we characterize a novel mouse mutation in the gene Dscam (Down Syndrome Cell Adhesion Molecule). Vertebrate DSCAM is required for normal development of the central nervous system and has been best characterized in the visual system. In the visual system DSCAM is required for regulation of cell number, mosaic formation, laminar specificity, and refinement of retinal-tectal projections. We have identified a novel mutation in Dscam that results in a single amino acid substitution, R1018P, in the extracellular domain of the DSCAM protein. Mice homozygous for the R1018P mutation develop a subset of defects observed in Dscam null mice. In vitro analysis identified defects in DSCAM R1018P localization to filopodia. We also find that wild type DSCAM protein is constitutively cleaved and shed from transfected cells. This secretion is inhibited by the R1018P mutation. We also characterized a novel splice isoform of Dscam and identified defects in lamination of type 2 and type 6 cone bipolar cells in Dscam mutant mice. The identification and characterization of partial loss of function mutations in genes such as Dscam will be helpful in predicting signs and symptoms that may be observed in human patients with partial loss of DSCAM function.	[Schramm, R. Dee; Li, Shuai; Rounds, Ryan P.; Fuerst, Peter G.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Harris, Belinda S.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Fuerst, Peter G.] Univ Idaho, WWAMI Med Educ Program, Univ Washington, Moscow, ID 83843 USA	Idaho; University of Idaho; Jackson Laboratory; Idaho; University of Idaho; Idaho; University of Idaho	Fuerst, PG (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	Fuerst@uidaho.edu		Li, Shuai/0000-0001-5889-3655; Burgess, Robert/0000-0002-9229-3407	National Eye Institute [EY020857, EY018605]; National Center for Research Resources [RR01183, CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018605, R01EY020857] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Eye Institute EY020857 to Peter G. Fuerst; National Eye Institute EY018605 to Robert W. Burgess; and National Center for Research Resources RR01183 and CA34196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blank M, 2011, J NEUROSCI, V31, P5764, DOI 10.1523/JNEUROSCI.6015-10.2011; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2007, DEV BIOL, V303, P165, DOI 10.1016/j.ydbio.2006.11.033; Fuerst PG, 2012, DEV BIOL, V361, P326, DOI 10.1016/j.ydbio.2011.10.028; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Fuerst PG, 2009, CURR OPIN NEUROBIOL, V19, P389, DOI 10.1016/j.conb.2009.07.013; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Keeley PW, 2011, J COMP NEUROL; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Matthews BJ, 2011, CURR BIOL, V21, P1480, DOI 10.1016/j.cub.2011.07.040; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Qin FH X.-R., RIKEN STRUCTUR UNPUB; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Xiao T, 2011, CELL, V146, P164, DOI 10.1016/j.cell.2011.06.016; Xu YL, 2011, PROTEIN CELL, V2, P647, DOI 10.1007/s13238-011-1072-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52652	10.1371/journal.pone.0052652	http://dx.doi.org/10.1371/journal.pone.0052652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300735	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800121
J	Siebert, AP; Ma, ZM; Grevet, JD; Demuro, A; Parker, I; Foskett, JK				Siebert, Adam P.; Ma, Zhongming; Grevet, Jeremy D.; Demuro, Angelo; Parker, Ian; Foskett, J. Kevin			Structural and Functional Similarities of Calcium Homeostasis Modulator 1 (CALHM1) Ion Channel with Connexins, Pannexins, and Innexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; ORGANIC CATIONS; TOPOLOGY PREDICTION; MOLECULAR-BASIS; SODIUM-CHANNEL; ORAI3 CHANNELS; PERMEABILITY; FAMILY	CALHM1 (calcium homeostasis modulator 1) forms a plasma membrane ion channel that mediates neuronal excitability in response to changes in extracellular Ca2+ concentration. Six human CALHM homologs exist with no homology to other proteins, although CALHM1 is conserved across >20 species. Here we demonstrate that CALHM1 shares functional and quaternary and secondary structural similarities with connexins and evolutionarily distinct innexins and their vertebrate pannexin homologs. A CALHM1 channel is a hexamer, comprised of six monomers, each of which possesses four transmembrane domains, cytoplasmic amino and carboxyl termini, an aminoterminal helix, and conserved extracellular cysteines. The estimated pore diameter of the CALHM1 channel is similar to 14 angstrom, enabling permeation of large charged molecules. Thus, CALHMs, connexins, and pannexins and innexins are structurally related protein families with shared and distinct functional properties.	[Siebert, Adam P.; Ma, Zhongming; Grevet, Jeremy D.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Irvine	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, 726 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [MH059937, GM056328, GM048071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM048071, R01GM056328, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH059937 and GM056328 (to J. K. F.) and GM048071 (to I. P.).	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; BALASUBRAMANIAN S, 1995, J MEMBRANE BIOL, V146, P177; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; BARNES TM, 1994, TRENDS GENET, V10, P303, DOI 10.1016/0168-9525(94)90023-X; Beblo DA, 1997, J GEN PHYSIOL, V109, P509, DOI 10.1085/jgp.109.4.509; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; DANI JA, 1989, J NEUROSCI, V9, P884; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Ebihara L, 2003, NEWS PHYSIOL SCI, V18, P100, DOI 10.1152/nips.01431.2002; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fushiki D, 2010, BIOMED RES-TOKYO, V31, P133, DOI 10.2220/biomedres.31.133; Gallego-Sandin S, 2011, BIOCHEM J, V437, P469, DOI 10.1042/BJ20110479; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hamer W. J., 1972, J PHYS CHEM REF DATA, V1, P1047, DOI DOI 10.1063/1.3253108; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hua VB, 2003, J MEMBRANE BIOL, V194, P59, DOI 10.1007/s00232-003-2026-8; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Landesman Y, 1999, J CELL SCI, V112, P2391; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez-Wittinghan FJ, 2006, J MEMBRANE BIOL, V211, P163, DOI 10.1007/s00232-006-0021-6; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Moreno-Ortega AJ, 2010, BIOCHEM BIOPH RES CO, V391, P722, DOI 10.1016/j.bbrc.2009.11.127; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sitaram A, 2009, MOL BIOL CELL, V20, P1464, DOI 10.1091/mbc.E08-07-0710; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; VEENSTRA RD, 1994, BIOPHYS J, V66, P1915, DOI 10.1016/S0006-3495(94)80985-3; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; White TW, 1999, EUR J NEUROSCI, V11, P1883, DOI 10.1046/j.1460-9568.1999.00607.x; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; ZAREI MM, 1995, J NEUROSCI, V15, P1446	90	82	83	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6140	6153		10.1074/jbc.M112.409789	http://dx.doi.org/10.1074/jbc.M112.409789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300080	Green Published, hybrid			2022-12-25	WOS:000315820700011
J	Goebl, W; Palmer, C				Goebl, Werner; Palmer, Caroline			Temporal Control and Hand Movement Efficiency in Skilled Music Performance	PLOS ONE			English	Article							FINGER MOVEMENTS; PIANO; ACCURACY; FEEDBACK; MODEL	Skilled piano performance requires considerable movement control to accomplish the high levels of timing and force precision common among professional musicians, who acquire piano technique over decades of practice. Finger movement efficiency in particular is an important factor when pianists perform at very fast tempi. We document the finger movement kinematics of highly skilled pianists as they performed a five-finger melody at very fast tempi. A three-dimensional motion-capture system tracked the movements of finger joints, the hand, and the forearm of twelve pianists who performed on a digital piano at successively faster tempi (7-16 tones/s) until they decided to stop. Joint angle trajectories computed for all adjacent finger phalanges, the hand, and the forearm (wrist angle) indicated that the metacarpophalangeal joint contributed most to the vertical fingertip motion while the proximal and distal interphalangeal joints moved slightly opposite to the movement goal (finger extension). An efficiency measure of the combined finger joint angles corresponded to the temporal accuracy and precision of the pianists' performances: Pianists with more efficient keystroke movements showed higher precision in timing and force measures. Keystroke efficiency and individual joint contributions remained stable across tempo conditions. Individual differences among pianists supported the view that keystroke efficiency is required for successful fast performance.	[Goebl, Werner] Univ Mus & Performing Arts Vienna, Inst Mus Acoust, Vienna, Austria; [Palmer, Caroline] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Palmer, C (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	caroline.palmer@mcgill.ca		Goebl, Werner/0000-0002-1722-0718; Palmer, Caroline/0000-0003-4816-8067	Austrian Science Fund [FWF J 2526, P 23248]; NSERC Grant [298173]; Canada Research Chair	Austrian Science Fund(Austrian Science Fund (FWF)); NSERC Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by the Austrian Science Fund (FWF J 2526 and P 23248 to the first author) and by NSERC Grant 298173 and a Canada Research Chair to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp R, 1997, CLASSICAL PIANO  MAR; Beauchamp R, 2003, CURVED FINGERS TENSI; Bernstein NA, 1930, P PIAN METH SECT STA, P5; Della Bella S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015029; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Furuya S, 2008, NEUROSCIENCE, V156, P390, DOI 10.1016/j.neuroscience.2008.07.028; Furuya S, 2011, FRONT HUM NEUROSCI, V5, P1; Furuya S, 2012, J NEUROPHYSIOL, V108, P2060, DOI 10.1152/jn.00378.2012; Furuya S, 2011, J NEUROPHYSIOL, V106, P2849, DOI 10.1152/jn.00378.2011; Gat J, 1988, TECHNIQUE PIANO PLAY; Gerig Reginald R., 1974, FAMOUS PIANISTS THEI; Goebl W., 2009, P INT S PERF SCI 200, P65; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hildebrandt Dieter, 1988, PIANOFORTE SOCIAL HI; Huron D, 2001, MUSIC PERCEPT, V19, P1, DOI 10.1525/mp.2001.19.1.1; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Kay BA, 2003, MOTOR CONTROL, V7, P1; Kopiez Reinhard, 2004, MUSIKALISCHE VIRTUOS, P205; Leijnse JNAL, 1997, J BIOMECH, V30, P1107, DOI 10.1016/S0021-9290(97)00091-2; Lhevinne, 1972, BASIC PRINCIPLES PIA; Loehr JD, 2009, J MOTOR BEHAV, V41, P128, DOI 10.3200/JMBR.41.2.128-136; Mark T., 2003, WHAT EVERY PIANIST N; Neuhaus H., 1973, ART PIANO PLAYING; Ortmann O, 1962, PHYSL MECH PIANO TEC; Ortmann Otto, 1929, PHYSL MECH PIANO TEC; Palmer C, 2009, MUSIC PERCEPT, V26, P439, DOI 10.1525/MP.2009.26.5.439; Parncutt R., 2002, SCI PSYCHOL MUSIC PE, P285, DOI DOI 10.1093/ACPR0F:0S0/9780195138108.001.0001; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Slobounov S, 2002, BRAIN RES, V954, P212, DOI 10.1016/S0006-8993(02)03288-2; TUBIANA R, 1988, MED PROBL PERFORM AR, V3, P83; TUBIANA R, 1988, MED PROBL PERFORM AR, V3, P123; Watson AHD, 2006, J ANAT, V208, P527, DOI 10.1111/j.1469-7580.2006.00545.x; Watson AHD, 2009, BIOL MUSICAL PERFORM; Wolters K, 1985, HDB KLAVIERLITERATUR	37	56	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e50901	10.1371/journal.pone.0050901	http://dx.doi.org/10.1371/journal.pone.0050901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23300946	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000002
J	Lech, PJ; Tobin, GJ; Bushnell, R; Gutschenritter, E; Pham, LD; Nace, R; Verhoeyen, E; Cosset, FL; Muller, CP; Russell, SJ; Nara, PL				Lech, Patrycja J.; Tobin, Gregory J.; Bushnell, Ruth; Gutschenritter, Emily; Pham, Linh D.; Nace, Rebecca; Verhoeyen, Els; Cosset, Francois-Loic; Muller, Claude P.; Russell, Stephen J.; Nara, Peter L.			Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies	PLOS ONE			English	Article							CURRENT WILD-TYPE; CELLULAR RECEPTOR; IMMUNE-RESPONSES; VACCINE FAILURE; CD46; SITES; GLYCOSYLATION; ATTACHMENT; STRAINS; RESCUE	The measles virus (MV) is serologically monotypic. Life-long immunity is conferred by a single attack of measles or following vaccination with the MV vaccine. This is contrary to viruses such as influenza, which readily develop resistance to the immune system and recur. A better understanding of factors that restrain MV to one serotype may allow us to predict if MV will remain monotypic in the future and influence the design of novel MV vaccines and therapeutics. MV hemagglutinin (H) glycoprotein, binds to cellular receptors and subsequently triggers the fusion (F) glycoprotein to fuse the virus into the cell. H is also the major target for neutralizing antibodies. To explore if MV remains monotypic due to a lack of plasticity of the H glycoprotein, we used the technology of Immune Dampening to generate viruses with rationally designed N-linked glycosylation sites and mutations in different epitopes and screened for viruses that escaped monoclonal antibodies (mAbs). We then combined rationally designed mutations with naturally selected mutations to generate a virus resistant to a cocktail of neutralizing mAbs targeting four different epitopes simultaneously. Two epitopes were protected by engineered N-linked glycosylations and two epitopes acquired escape mutations via two consecutive rounds of artificial selection in the presence of mAbs. Three of these epitopes were targeted by mAbs known to interfere with receptor binding. Results demonstrate that, within the epitopes analyzed, H can tolerate mutations in different residues and additional N-linked glycosylations to escape mAbs. Understanding the degree of change that H can tolerate is important as we follow its evolution in a host whose immunity is vaccine induced by genotype A strains instead of multiple genetically distinct wild-type MVs.	[Lech, Patrycja J.; Gutschenritter, Emily; Pham, Linh D.; Nace, Rebecca; Russell, Stephen J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Tobin, Gregory J.; Bushnell, Ruth; Nara, Peter L.] Biol Mimet Inc, Frederick, MD USA; [Verhoeyen, Els; Cosset, Francois-Loic] INSERM, EVIR Team, Human Virol Lab, U758, Lyon, France; [Verhoeyen, Els; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Verhoeyen, Els; Cosset, Francois-Loic] Univ Lyon, UCB Lyon1, Lyon, France; [Muller, Claude P.] WHO Collaborating Ctr Reference & Res Measles Inf, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg; [Muller, Claude P.] Dept Immunol, Luxembourg, Luxembourg; [Nara, Peter L.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Mayo Clinic; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Luxembourg Institute of Health; Iowa State University	Lech, PJ (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	Lech.patrycja@mayo.edu	Verhoeyen, Els/AAW-4853-2021; Verhoeyen, Els/H-6360-2016; Dr. Peter L. Nara, M.Sc./I-7432-2019; Cosset, François-Loïc/M-5862-2019	Verhoeyen, Els/0000-0001-9224-5491; Cosset, François-Loïc/0000-0001-8842-3726; Tobin, Gregory/0000-0002-8396-0466; Russell, Stephen/0000-0002-0799-6432	Mayo Clinic, NIH/NCI [R01 CA129966]; Richard M. Schulze Family Foundation; BMI; NATIONAL CANCER INSTITUTE [R01CA129966] Funding Source: NIH RePORTER	Mayo Clinic, NIH/NCI; Richard M. Schulze Family Foundation; BMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from Mayo Clinic, NIH/NCI (R01 CA129966), and the Richard M. Schulze Family Foundation. The funders for the design and constructions of the mutant measles viruses used in the study were done so using BMI R&D funds. The co-authors Dr. Peter L. Nara and Greg Tobin are employed by BMI and were involved in part in the study design, some data collection, decision to publish and preparation of the manuscript.; There are no financial, personal, or professional interest that could be construed to have influenced the paper. There were no identified intellectual property developed in the course of the funded work by BMI. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials. Gregory J. Tobin, Peter L. Nara, and Ruth V. Bushnell are employees of Biological Mimetics, Inc. BMI does not currently have any products or patents in development related to the materials produced in this study. BMI confirms its adherence to all PLOS ONE policies on sharing data and materials.	Bankamp B, 2011, J INFECT DIS, V204, pS533, DOI 10.1093/infdis/jir097; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; de Swart RL, 2009, J GEN VIROL, V90, P2982, DOI 10.1099/vir.0.014944-0; de Swart RL, 2005, J VIROL, V79, P11547, DOI 10.1128/JVI.79.17.11547-11551.2005; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; EDMONSON MB, 1990, JAMA-J AM MED ASSOC, V263, P2467, DOI 10.1001/jama.263.18.2467; Erlenhofer C, 2002, J GEN VIROL, V83, P1431, DOI 10.1099/0022-1317-83-6-1431; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Gans HA, 2004, J INFECT DIS, V190, P83, DOI 10.1086/421032; Gans HA, 2004, VIRAL IMMUNOL, V17, P298, DOI 10.1089/0882824041310522; Garrity RR, 1997, J IMMUNOL, V159, P279; GIRAUDON P, 1985, VIROLOGY, V144, P46, DOI 10.1016/0042-6822(85)90303-4; GIRAUDON P, 1981, J GEN VIROL, V54, P325, DOI 10.1099/0022-1317-54-2-325; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; GRIFFIN DE, 2007, FIELDS VIROLOGY; Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00247; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Hashiguchi Takao, 2008, Virus (Nagoya), V58, P1; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; HU AH, 1994, J GEN VIROL, V75, P1043, DOI 10.1099/0022-1317-75-5-1043; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Klingele M, 2000, J MED VIROL, V62, P91, DOI 10.1002/1096-9071(200009)62:1&lt;91::AID-JMV14&gt;3.0.CO;2-B; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Lancz G., 1992, NEUTRALIZATION; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Manchester M, 2000, VIROLOGY, V274, P5, DOI 10.1006/viro.2000.0469; Manchester M, 2000, J VIROL, V74, P3967, DOI 10.1128/JVI.74.9.3967-3974.2000; MARKOWITZ LE, 1990, PEDIATR CLIN N AM, V37, P603; MATHIAS RG, 1989, AM J PUBLIC HEALTH, V79, P475, DOI 10.2105/AJPH.79.4.475; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; Mossong J, 1999, AM J EPIDEMIOL, V150, P1238, DOI 10.1093/oxfordjournals.aje.a009951; Msaouel P, 2009, PROSTATE, V69, P82, DOI 10.1002/pros.20857; Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Nakamura T, 2004, NAT BIOTECHNOL, V22, P331, DOI 10.1038/nbt942; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Nicacio CD, 2002, J VIROL, V76, P251, DOI 10.1128/JVI.76.1.251-258.2002; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Pabst HF, 1999, VACCINE, V17, P1910, DOI 10.1016/S0264-410X(98)00472-1; Pham L, 2009, J GENE MED, V11, P197, DOI 10.1002/jgm.1289; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; RICHARDSON CD, 1983, VIROLOGY, V131, P518, DOI 10.1016/0042-6822(83)90517-2; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Santiago C, 2002, J BIOL CHEM, V277, P32294, DOI 10.1074/jbc.M202973200; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0; Schierup MH, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-52; Schrag SJ, 1999, J VIROL, V73, P51, DOI 10.1128/JVI.73.1.51-54.1999; SHESHBERADARAN H, 1986, VIROLOGY, V152, P58, DOI 10.1016/0042-6822(86)90371-5; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; WARD BJ, 1995, J INFECT DIS, V172, P1591, DOI 10.1093/infdis/172.6.1591; Whittle H, 1999, PEDIATR INFECT DIS J, V18, P53, DOI 10.1097/00006454-199901000-00013; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; World Health Organization, 2012, MEASL FACT SHEET 286; XIANG JZ, 1983, REV INFECT DIS, V5, P506; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	80	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52306	10.1371/journal.pone.0052306	http://dx.doi.org/10.1371/journal.pone.0052306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300970	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000008
J	Watanabe, Y; Tatebe, H; Taguchi, K; Endo, Y; Tokuda, T; Mizuno, T; Nakagawa, M; Tanaka, M				Watanabe, Yoshihisa; Tatebe, Harutsugu; Taguchi, Katsutoshi; Endo, Yasuhisa; Tokuda, Takahiko; Mizuno, Toshiki; Nakagawa, Masanori; Tanaka, Masaki			p62/SQSTM1-Dependent Autophagy of Lewy Body-Like alpha-Synuclein Inclusions	PLOS ONE			English	Article							PARKINSONS-DISEASE; DEGRADATION; PROTEINS; PATHWAY; MACROAUTOPHAGY; MITOCHONDRIA; MECHANISMS; CLEARANCE; MODELS; P62	alpha-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson's disease. Although alpha-synuclein accumulation is caused by inhibition of proteasome and autophagy-lysosome, the degradation of alpha-synuclein inclusions is still unknown. Formation of Lewy body-like inclusions can be replicated in cultured cells by introducing alpha-synuclein fibrils generated in vitro. We used this cell culture model to investigate the autophagy of alpha-synuclein inclusions and impaired mitochondria. The intracellular alpha-synuclein inclusions immediately underwent phosphorylation and ubiquitination. Simultaneously they were encircled by an adaptor protein p62/SQSTM1 and directed to the autophagy-lysosome pathway in HEK293 cell line. Most phospho-alpha-synuclein-positive inclusions were degraded in 24 h, however, lysosomal dysfunction with bafilomycin A1 significantly affected their clearance. Moreover, inhibition of autophagy by Atg-5 siRNA treatment reduced the incorporation of alpha-synuclein inclusions into LC3-positive autophagosomes. Knockdown experiments demonstrated the requirement of p62 for alpha-synuclein autophagy. These results demonstrate that alpha-synuclein inclusions are preferred targets for p62-dependent autophagy. Next, we investigated the autophagic clearance of impaired mitochondria in alpha-synuclein inclusion-containing cells. Impaired mitochondria were almost completely eliminated after mitochondrial uncoupling even in the presence of alpha-synuclein inclusions, suggesting that mitochondrial clearance is not prevented by alpha-synuclein inclusions in HEK293 cells.	[Watanabe, Yoshihisa; Taguchi, Katsutoshi; Tanaka, Masaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan; [Tatebe, Harutsugu; Tokuda, Takahiko; Mizuno, Toshiki; Nakagawa, Masanori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamikyo Ku, Kyoto, Japan; [Endo, Yasuhisa] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Institute of Technology	Tanaka, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan.	mtanaka@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020		Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591272, 23591252, 22591595, 21500329]; NICHD, National Institutes of Health; Grants-in-Aid for Scientific Research [23591252] Funding Source: KAKEN	Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan to M.N., and from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, to Y.W. (No. 24591272), T. T. (No. 23591252), T. M. (No. 22591595), and M. T. (No. 21500329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The anti-LAMP-1 antibody, developed by J. Thomas August and James E. K. Hildreth, was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of NICHD, National Institutes of Health, and maintained by the Department of Biology, University of Iowa.	Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsui H, 2010, J NEUROCHEM, V115, P1150, DOI 10.1111/j.1471-4159.2010.07012.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Olanow CW, 2011, MOVEMENT DISORD, V26, P1056, DOI 10.1002/mds.23767; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Tanji K, 2011, NEUROBIOL DIS, V43, P690, DOI 10.1016/j.nbd.2011.05.022; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yamaguchi T, 2008, J NEUROSCI RES, V86, P610, DOI 10.1002/jnr.21517; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	37	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52868	10.1371/journal.pone.0052868	http://dx.doi.org/10.1371/journal.pone.0052868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300799	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600032
J	Candelario, J; Tavakoli, H; Chachisvilis, M				Candelario, Jose; Tavakoli, Hesam; Chachisvilis, Mirianas			PTH1 Receptor Is Involved in Mediating Cellular Response to Long-Chain Polyunsaturated Fatty Acids	PLOS ONE			English	Article							PARATHYROID-HORMONE RECEPTOR; BONE-MINERAL DENSITY; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; SUPPLEMENTATION; DIFFERENTIATION; MECHANISMS; MOUSE; OMEGA-3-FATTY-ACIDS; PROLIFERATION	The molecular pathways by which long chain polyunsaturated fatty acids (LCPUFA) influence skeletal health remain elusive. Both LCPUFA and parathyroid hormone type 1 receptor (PTH1R) are known to be involved in bone metabolism while any direct link between the two is yet to be established. Here we report that LCPUFA are capable of direct, PTH1R dependent activation of extracellular ligand-regulated kinases (ERK). From a wide range of fatty acids studied, varying in chain length, saturation, and position of double bonds, eicosapentaenoic (EPA) and docosahexaenoic fatty acids (DHA) caused the highest ERK phosphorylation. Moreover, EPA potentiated the effect of parathyroid hormone (PTH(1-34)) in a superagonistic manner. EPA or DHA dependent ERK phosphorylation was inhibited by the PTH1R antagonist and by knockdown of PTH1R. Inhibition of PTH1R downstream signaling molecules, protein kinases A (PKA) and C (PKC), reduced EPA and DHA dependent ERK phosphorylation indicating that fatty acids predominantly activate G-protein pathway and not the beta-arrestin pathway. Using picosecond time-resolved fluorescence microscopy and a genetically engineered PTH1R sensor (PTH-CC), we detected conformational responses to EPA similar to those caused by PTH(1-34). PTH1R antagonist blocked the EPA induced conformational response of the PTH-CC. Competitive binding studies using fluorescence anisotropy technique showed that EPA and DHA competitively bind to and alter the affinity of PTH1 receptor to PTH(1-34) leading to a superagonistic response. Finally, we showed that EPA stimulates protein kinase B (Akt) phosphorylation in a PTH1R-dependent manner and affects the osteoblast survival pathway, by inhibiting glucocorticoid-induced cell death. Our findings demonstrate for the first time that LCPUFAs, EPA and DHA, can activate PTH1R receptor at nanomolar concentrations and consequently provide a putative molecular mechanism for the action of fatty acids in bone.	[Candelario, Jose; Tavakoli, Hesam; Chachisvilis, Mirianas] La Jolla Bioengn Inst, San Diego, CA USA	La Jolla Bioengineering Institute	Chachisvilis, M (corresponding author), La Jolla Bioengn Inst, San Diego, CA USA.	mirianas@ljbi.org		Tavakoli, Hesam/0000-0003-3787-007X	NIH [HL86943, HL86943-S1]; NSF [MCB 0721396]; TeraGrid [TG-MCB090202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); TeraGrid; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL86943 and HL86943-S1, NSF grant MCB 0721396, and TeraGrid resources (TG-MCB090202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; ANDERSON WB, 1977, ARCH BIOCHEM BIOPHYS, V180, P374, DOI 10.1016/0003-9861(77)90051-0; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bonnet N, 2011, J NUTR BIOCHEM, V22, P665, DOI 10.1016/j.jnutbio.2010.05.006; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Coetzee M, 2007, PROSTAG LEUKOTR ESS, V76, P35, DOI 10.1016/j.plefa.2006.10.001; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; Fernandes G, 2008, FRONT BIOSCI-LANDMRK, V13, P4015, DOI 10.2741/2989; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; HOAK JC, 1970, NATURE, V228, P1330, DOI 10.1038/2281330a0; Hogstrom M, 2007, AM J CLIN NUTR, V85, P803; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Juppner H, 2001, ENDOCRINOLOGY, P969; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; KRUGER MC, 1995, NUTR RES, V15, P211, DOI 10.1016/0271-5317(95)92587-A; Kruger MC, 1998, AGING-CLIN EXP RES, V10, P385, DOI 10.1007/BF03339885; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li Y, 2010, BRIT J NUTR, V104, P674, DOI 10.1017/S0007114510001133; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; McCarthy ID, 1997, CLIN ORTHOP RELAT R, P24; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; NUTT RF, 1990, ENDOCRINOLOGY, V127, P491, DOI 10.1210/endo-127-1-491; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; OTTO JC, 1994, J BIOL CHEM, V269, P19868; OWEN M, 1976, J PHYSIOL-LONDON, V257, P293, DOI 10.1113/jphysiol.1976.sp011369; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; ROBINSON DR, 1993, J LIPID RES, V34, P1423; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rossignol M, 2002, INT J TECHNOL ASSESS, V18, P597; Saito J, 1997, ATHEROSCLEROSIS, V131, P219, DOI 10.1016/S0021-9150(97)00048-8; SAKAGUCHI K, 1994, PROSTAG LEUKOTR ESS, V50, P81, DOI 10.1016/0952-3278(94)90151-1; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Schlemmer CK, 1999, PROSTAG LEUKOTR ESS, V61, P381, DOI 10.1054/plef.1999.0116; Shichikawa K, 1981, Ryumachi, V21 Suppl, P35; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Sneddon WB, 2007, AM J PHYSIOL-RENAL, V292, pF1028, DOI 10.1152/ajprenal.00288.2006; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Strewler GJ, 2000, NEW ENGL J MED, V342, P177, DOI 10.1056/NEJM200001203420306; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; van Kan GA, 2008, J NUTR HEALTH AGING, V12, P355, DOI 10.1007/BF02982667; VANMETER AR, 1994, MECH AGEING DEV, V75, P95, DOI 10.1016/0047-6374(94)90079-5; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Watkins BA, 2001, PROG LIPID RES, V40, P125, DOI 10.1016/S0163-7827(00)00016-3; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weiss LA, 2005, AM J CLIN NUTR, V81, P934, DOI 10.1093/ajcn/81.4.934; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008; Zwart SR, 2010, J BONE MINER RES, V25, P1049, DOI 10.1359/jbmr.091041	72	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52583	10.1371/journal.pone.0052583	http://dx.doi.org/10.1371/journal.pone.0052583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300710	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100065
J	Keller, KK; Thomsen, JS; Stengaard-Pedersen, K; Dagnaes-Hansen, F; Nyengaard, JR; Hauge, EM				Keller, Kresten Krarup; Thomsen, Jesper Skovhus; Stengaard-Pedersen, Kristian; Dagnaes-Hansen, Frederik; Nyengaard, Jens Randel; Hauge, Ellen-Margrethe			Bone Formation and Resorption Are Both Increased in Experimental Autoimmune Arthritis	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ARBITRARY PARTICLES; NUMBER; CELLS; SIZE; OSTEOPROTEGERIN; REGULATOR; CYTOKINE	Introduction: Arthritic bone loss in the joints of patients with rheumatoid arthritis is the result of a combination of osteoclastic bone resorption and osteoblastic bone formation. This process is not completely understood, and especially the importance of local inflammation needs further investigation. We evaluated how bone formation and bone resorption are altered in experimental autoimmune arthritis. Methods: Twenty-one female SKG mice were randomized to either an arthritis group or a control group. Tetracycline was used to identify mineralizing surfaces. After six weeks the right hind paws were embedded undecalcified in methylmethacrylate. The paws were cut exhaustively according to the principles of vertical sectioning and systematic sampling. 3D design-based methods were used to estimate the total number of osteoclasts, mineralizing surfaces, eroded surfaces, and osteoclast-covered bone surfaces. In addition the presence of adjacent inflammation was ascertained. Results: The total number of osteoclasts, mineralizing surfaces, eroded surfaces, and osteoclast covered surfaces were elevated in arthritic paws compared to normal paws. Mineralizing surfaces were elevated adjacent to as well as not adjacent to inflammation in arthritic mice compared to normal mice. In arthritic mice, eroded surfaces and osteoclast covered surfaces were larger on bone surfaces adjacent to inflammation than on bone surfaces without adjacent inflammation. However, we found no difference between mineralizing surfaces at bone surfaces with or without inflammation in arthritic mice. Conclusions: Inflammation induced an increase in resorptive bone surfaces as well as formative bone surfaces. The bone formative response may be more general, since formative bone surfaces were also increased when not associated with inflammation. Thus, the bone loss may be the result of a substantial local bone resorption, which cannot be compensated by the increased local bone formation. These findings may be valuable for the development of new osteoblast targeting drugs in RA.	[Keller, Kresten Krarup; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Thomsen, Jesper Skovhus; Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Nyengaard, Jens Randel] Aarhus Univ Hosp, Stereol & Electron Microscopy Lab, Ctr Stochast Geometry & Adv Bioimaging, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Keller, KK (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	kresten@ana.au.dk	Keller, Kresten Krarup/S-2067-2019	Keller, Kresten Krarup/0000-0003-2474-3389; Thomsen, Jesper Skovhus/0000-0001-9386-6679; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Danish Rheumatism Association; A. P. Moller Foundation for the Advancement of Medical Science; Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant; Hede Nielsens Family Foundation; Aase and Ejnar Danielsens Foundation; Villum Foundation	Danish Rheumatism Association; A. P. Moller Foundation for the Advancement of Medical Science; Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant; Hede Nielsens Family Foundation; Aase and Ejnar Danielsens Foundation; Villum Foundation(Villum Fonden)	This work was supported by grants from the Danish Rheumatism Association, The A. P. Moller Foundation for the Advancement of Medical Science, the Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant, the Hede Nielsens Family Foundation, and Aase and Ejnar Danielsens Foundation. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Ferguson SJ, 1999, MED ENG PHYS, V21, P111, DOI 10.1016/S1350-4533(99)00032-6; Gortz B, 2004, J BONE MINER RES, V19, P990, DOI 10.1359/JBMR.040205; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hyde DM, 2007, TOXICOL PATHOL, V35, P41, DOI 10.1080/01926230601059977; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jimi E, 1999, J IMMUNOL, V163, P434; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Keller KK, 2011, CLIN EXP RHEUMATOL, V29, P536; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; McQueen FM, 2003, ARTHRITIS RHEUM, V48, P1814, DOI 10.1002/art.11162; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P1126, DOI 10.1007/BF00401056; Rau R, 2006, CLIN EXP RHEUMATOL, V24, pS41; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; Romas E, 2000, ARTHRITIS RHEUM, V43, P821, DOI 10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53034	10.1371/journal.pone.0053034	http://dx.doi.org/10.1371/journal.pone.0053034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300855	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100111
J	Loutfy, MR; Logie, CH; Zhang, YM; Blitz, SL; Margolese, SL; Tharao, WE; Rourke, SB; Rueda, S; Raboud, JM				Loutfy, Mona R.; Logie, Carmen H.; Zhang, Yimeng; Blitz, Sandra L.; Margolese, Shari L.; Tharao, Wangari E.; Rourke, Sean B.; Rueda, Sergio; Raboud, Janet M.			Gender and Ethnicity Differences in HIV-related Stigma Experienced by People Living with HIV in Ontario, Canada	PLOS ONE			English	Article							AIDS-RELATED STIGMA; HIV/AIDS STIGMA; POSITIVE MEN; MEDICATION ADHERENCE; YOUNGER ADULTS; UNITED-STATES; BLACK-WOMEN; CAPE-TOWN; HEALTH; DISCRIMINATION	This study aimed to understand gender and ethnicity differences in HIV-related stigma experienced by 1026 HIV-positive individuals living in Ontario, Canada that were enrolled in the OHTN Cohort Study. Total and subscale HIV-related stigma scores were measured using the revised HIV-related Stigma Scale. Correlates of total stigma scores were assessed in univariate and multivariate linear regression. Women had significantly higher total and subscale stigma scores than men (total, median = 56.0 vs. 48.0, p<0.0001). Among men and women, Black individuals had the highest, Aboriginal and Asian/Latin-American/Unspecified people intermediate, and White individuals the lowest total stigma scores. The gender-ethnicity interaction term was significant in multivariate analysis: Black women and Asian/Latin-American/Unspecified men reported the highest HIV-related stigma scores. Gender and ethnicity differences in HIV-related stigma were identified in our cohort. Findings suggest differing approaches may be required to address HIV-related stigma based on gender and ethnicity; and such strategies should challenge racist and sexist stereotypes.	[Loutfy, Mona R.; Logie, Carmen H.; Margolese, Shari L.] Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON M5S 1B2, Canada; [Loutfy, Mona R.; Zhang, Yimeng] Univ Toronto, Fac Med, Toronto, ON, Canada; [Blitz, Sandra L.; Raboud, Janet M.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Tharao, Wangari E.] Womens Hands Community Hlth Ctr, Womens Hlth, Toronto, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Dept Psychiat, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Loutfy, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON M5S 1B2, Canada.	mona.loutfy@wchospital.ca			AIDS Bureau - Ontario Ministry of Health and Long-Term Care; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Ontario HIV Treatment Network	AIDS Bureau - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	We gratefully acknowledge all of the people living with HIV who volunteered to participate in the OHTN Cohort Study and the work and support of the past and present members of the OCS Governance Committee: Darien Taylor, Dr. Evan Collins, Dr. Greg Robinson, Shari Margolese, Patrick Cupido, Tony Di Pede, Rick Kennedy, Michael Hamilton, Ken King, Brian Finch, Lori Stoltz, Dr. Ahmed Bayoumi, Dr. Clemon George, Dr. Curtis Cooper, Dr. Troy Grennan, Adrian Betts, Tracey Conway, and Colleen Price. We thank all the interviewers, data collectors, research associates and coordinators, nurses and physicians who provide support for data collection and extraction. The authors wish to thank the OHTN staff and their teams for data management and IT support ( Mark Fisher, Director, IT), and OCS project coordination (Samantha Robinson, Project Coordinator). The OHTN Cohort Study is supported by the Ontario Ministry of Health and Long-Term Care.; The OHTN Cohort Study is supported by the AIDS Bureau - Ontario Ministry of Health and Long-Term Care. Three investigators are also the recipients of salary support from the Canadian Institutes of Health Research (MRL, CHL) and the Ontario HIV Treatment Network (JMR).	Abell N, 2007, AIDS CARE, V19, P242, DOI 10.1080/09540120600774297; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Brondolo E, 2009, J BEHAV MED, V32, P1, DOI 10.1007/s10865-008-9190-3; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Buseh AG, 2006, WOMEN HEALTH, V44, P1, DOI 10.1300/J013v44n03_01; Campbell C, 2006, J COMMUNITY APPL SOC, V16, P411, DOI 10.1002/casp.901; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Collins P. H., 1991, BLACK FEMINIST THOUG; Collins P.H., 2000, BLACK FEMINIST THOUG; Collins PY, 2008, SOC SCI MED, V67, P389, DOI 10.1016/j.socscimed.2008.03.013; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Crandall CS, 1997, J APPL SOC PSYCHOL, V27, P95, DOI 10.1111/j.1559-1816.1997.tb00625.x; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1989, P139; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Doyal L, 2009, CULT HEALTH SEX, V11, P173, DOI 10.1080/13691050802560336; Emlet C, 2005, RES SOCIAL WORK PRAC, V15, P291, DOI 10.1177/1049731504273250; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Farmer P.E, 2001, INFECT INEQUALITIES; Gibson K, 2009, SOCIOBEHAVIOURAL VAR; Gilman Sander, 1988, DIS REPRESENTATION I; Goffman E., 1963, BEHAV PUBLIC PLACES; GREEN G, 1996, SOC AS AIDS, P46; Heckman TG, 2004, HEALTH PSYCHOL, V23, P94, DOI 10.1037/0278-6133.23.1.94; HEREK GM, 1988, AM PSYCHOL, V43, P886, DOI 10.1037/0003-066X.43.11.886; Herek GM, 2003, HEALTH PSYCHOL, V22, P533, DOI 10.1037/0278-6133.22.5.533; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Herek GM, 1999, AM BEHAV SCI, V42, P1130, DOI 10.1177/0002764299042007006; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Herek GM, 2007, ANNU REV CLIN PSYCHO, V3, P353, DOI 10.1146/annurev.clinpsy.3.022806.091510; Ingram D, 2000, QUAL HEALTH RES, V10, P117, DOI 10.1177/104973200129118282; [Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2007, AIDS EP UPD 2007; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Katz S, 2005, AIDS PATIENT CARE ST, V19, P110, DOI 10.1089/apc.2005.19.110; Konkle-Parker DJ, 2008, J ASSOC NURSE AIDS C, V19, P98, DOI 10.1016/j.jana.2007.09.005; Kylma J, 2005, J ADV NURS, V52, P620, DOI 10.1111/j.1365-2648.2005.03633.x; Lawless S, 1996, SOC SCI MED, V43, P1371, DOI 10.1016/0277-9536(96)00017-2; Lee RS, 2002, AIDS BEHAV, V6, P309, DOI DOI 10.1023/A:1021144511957; Lekas HM, 2006, QUAL HEALTH RES, V16, P1165, DOI 10.1177/1049732306292284; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015; Margulies Peter, 1994, Georget Immgr Law J, V8, P521; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P87, DOI 10.1080/17441692.2010.549139; Newman PA, 2008, J HEALTH CARE POOR U, V19, P829, DOI 10.1353/hpu.0.0043; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patton Cindy, 2002, GLOBALIZING AIDS; Public Health Agency of Canada (PHAC), 2009, HIV AIDS CAN; Purdie-Vaughns V, 2008, SEX ROLES, V59, P377, DOI 10.1007/s11199-008-9424-4; Raboud J, 2010, P OHTN RES C TOR ONT; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Reidpath DD, 2005, AIDS CARE, V17, P425, DOI 10.1080/09540120412331319769; Reif S, 2005, AIDS CARE, V17, P558, DOI 10.1080/09540120412331319750; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Rourke SB, 2012, INT J EPIDEMIOL; Rueda S, 2011, AIDS BEHAV, V16, P660; Sandelowski M, 2004, J NURS SCHOLARSHIP, V36, P122, DOI 10.1111/j.1547-5069.2004.04024.x; Schuster MA, 2005, J GEN INTERN MED, V20, P807, DOI 10.1111/j.1525-1497.2005.05049.x; Schwartz JP, 2009, J PRIM PREV, V30, P27, DOI 10.1007/s10935-008-0162-8; Scott-Sheldon LAJ, 2008, HEALTH PSYCHOL, V27, P129, DOI 10.1037/0278-6133.27.2.129; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sowell RL, 1997, PUBLIC HEALTH NURS, V14, P302, DOI 10.1111/j.1525-1446.1997.tb00379.x; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P167, DOI 10.1001/jama.284.2.167; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Swendeman D, 2006, HEALTH PSYCHOL, V25, P501, DOI 10.1037/0278-6133.25.4.501; Tharao E, 2006, SILENT VOICES HIV AI; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2005, HIV REL STIGM DISCR; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; White RC, 2005, CULT HEALTH SEX, V7, P347, DOI 10.1080/13691050500100799; Williams CC, 2009, SOC SCI MED, V68, P12, DOI 10.1016/j.socscimed.2008.09.043; Wolffers I, 2000, B WORLD HEALTH ORGAN, V78, P267; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	86	73	80	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e48168	10.1371/journal.pone.0048168	http://dx.doi.org/10.1371/journal.pone.0048168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300514	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100002
J	Qin, J; He, XJ; Wang, D; Qi, P; Guo, L; Huang, SH; Cai, X; Li, HP; Wang, R				Qin, Jie; He, Xijing; Wang, Dong; Qi, Peng; Guo, Lei; Huang, Sihua; Cai, Xuan; Li, Haopeng; Wang, Rui			Artificial Cervical Vertebra and Intervertebral Complex Replacement through the Anterior Approach in Animal Model: A Biomechanical and In Vivo Evaluation of a Successful Goat Model	PLOS ONE			English	Article							TOTAL DISC REPLACEMENT; SPINE; FUSION; BONE; ADJACENT; ANATOMY; KINEMATICS; DISKECTOMY; SCREWS	This was an in vitro and in vivo study to develop a novel artificial cervical vertebra and intervertebral complex (ACVC) joint in a goat model to provide a new method for treating degenerative disc disease in the cervical spine. The objectives of this study were to test the safety, validity, and effectiveness of ACVC by goat model and to provide preclinical data for a clinical trial in humans in future. We designed the ACVC based on the radiological and anatomical data on goat and human cervical spines, established an animal model by implanting the ACVC into goat cervical spines in vitro prior to in vivo implantation through the anterior approach, and evaluated clinical, radiological, biomechanical parameters after implantation. The X-ray radiological data revealed similarities between goat and human intervertebral angles at the levels of C2-3, C3-4, and C4-5, and between goat and human lordosis angles at the levels of C3-4 and C4-5. In the in vivo implantation, the goats successfully endured the entire experimental procedure and recovered well after the surgery. The radiological results showed that there was no dislocation of the ACVC and that the ACVC successfully restored the intervertebral disc height after the surgery. The biomechanical data showed that there was no significant difference in range of motion (ROM) or neural zone (NZ) between the control group and the ACVC group in flexion-extension and lateral bending before or after the fatigue test. The ROM and NZ of the ACVC group were greater than those of the control group for rotation. In conclusion, the goat provides an excellent animal model for the biomechanical study of the cervical spine. The ACVC is able to provide instant stability after surgery and to preserve normal motion in the cervical spine.	[Qin, Jie; He, Xijing; Wang, Dong; Qi, Peng; Guo, Lei; Huang, Sihua; Cai, Xuan; Li, Haopeng; Wang, Rui] Xi An Jiao Tong Univ, Dept Orthoped, Hosp 2, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	He, XJ (corresponding author), Xi An Jiao Tong Univ, Dept Orthoped, Hosp 2, Xian 710049, Shaanxi Provinc, Peoples R China.	xijing_h@vip.tom.com	He, Xijing/AAE-7424-2021; Li, Hao/GPS-9834-2022	He, Xijing/0000-0002-0465-5376; 	"13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province [2011KTCL03-17]; China Scholarship Council; Ministry of Education of China	"13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province; China Scholarship Council(China Scholarship Council); Ministry of Education of China(Ministry of Education, China)	This study was sponsored by "13115" Key Projects of Scientific and Technical Innovation of Shaanxi Province (Program title: Study of design and application of artificial cervical vertebra and intervertebral complex (ACVC). Program number: 2011KTCL03-17. http://www.sninfo.gov.cn/). No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript. Jie Qin was supported in part by a fellowship from the China Scholarship Council (http://www.csc.edu.cn/) and a fellowship of academic talent of doctorial candidates from Ministry of Education of China (http://www.moe.edu.cn/). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231; Auerbach JD, 2008, SPINE J, V8, P711, DOI 10.1016/j.spinee.2007.06.018; Auerbach JD, 2007, SPINE, V32, P527, DOI 10.1097/01.brs.0000256915.90236.17; Cakir B, 2009, SPINE, V34, P1287, DOI 10.1097/BRS.0b013e3181a136ab; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e; Galbusera F, 2008, MED ENG PHYS, V30, P1127, DOI 10.1016/j.medengphy.2008.02.002; Gore DR, 1998, SPINE, V23, P2047, DOI 10.1097/00007632-199810010-00002; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348; Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5; Lu B, 2009, SPINE, V34, P1893, DOI 10.1097/BRS.0b013e3181ae25dc; Lu B, 2009, EUR SPINE J, V18, P109, DOI 10.1007/s00586-008-0835-2; Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x; Pait TG, 1996, NEUROSURGERY, V39, P769, DOI 10.1097/00006123-199610000-00026; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; PANJABI MM, 1991, SPINE, V16, P861, DOI 10.1097/00007632-199108000-00001; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Rocca M, 1998, INT J ARTIF ORGANS, V21, P553, DOI 10.1177/039139889802100911; SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023; TOMINAGA T, 1995, SPINE, V20, P131, DOI 10.1097/00007632-199501150-00001; van der Donk S, 2001, COMPARATIVE MED, V51, P336; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; ZDEBLICK TA, 1992, SPINE, V17, pS418, DOI 10.1097/00007632-199210001-00013; Zhang J, 2006, SPINE, V31, P2195, DOI 10.1097/01.brs.0000232798.97075.73; Zhu QG, 2007, SPINE, V32, P55, DOI 10.1097/01.brs.0000250983.91339.9f	28	19	21	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52910	10.1371/journal.pone.0052910	http://dx.doi.org/10.1371/journal.pone.0052910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300816	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100096
J	Chen, G; Li, SC; Dong, XX; Bai, Y; Chen, AL; Yang, SM; Fang, MY; Zamaratskaia, G; Doran, O				Chen, Gang; Li, Sicong; Dong, Xinxing; Bai, Ying; Chen, Ailiang; Yang, Shuming; Fang, Meiying; Zamaratskaia, Galia; Doran, Olena			Investigation of Testosterone, Androstenone, and Estradiol Metabolism in HepG2 Cells and Primary Culture Pig Hepatocytes and Their Effects on 17 beta HSD7 Gene Expression	PLOS ONE			English	Article							3-BETA-HYDROXYSTEROID DEHYDROGENASE; 17-BETA-HYDROXYSTEROID DEHYDROGENASES; MASS-SPECTROMETRY; BOAR; SULFOCONJUGATION; LOCALIZATION; TAINT; FAT	Steroid metabolism is important in various species. The accumulation of androgen metabolite, androstenone, in pig adipose tissue is negatively associated with pork flavor, odour and makes the meat unfit for human consumption. The 17 beta-hydroxysteroid dehydrogenase type 7 (17 beta HSD7) expressed abundantly in porcine liver, and it was previously suggested to be associated with androstenone levels. Understanding the enzymes and metabolic pathways responsible for androstenone as well as other steroids metabolism is important for improving the meat quality. At the same time, metabolism of steroids is known to be species- and tissue-specific. Therefore it is important to investigate between-species variations in the hepatic steroid metabolism and to elucidate the role of 17 beta HSD7 in this process. Here we used an effective methodological approach, liquid chromatography coupled with mass spectrometry, to investigate species- specific metabolism of androstenone, testosterone and beta-estradiol in HepG2 cell line, and pig cultured hepatocytes. Species- and concentration-depended effect of steroids on 17 beta HSD7 gene expression was also investigated. It was demonstrated that the investigated steroids can regulate the 17 beta HSD7 gene expression in HepG2 and primary cultured porcine hepatocytes in a concentration-dependent and species- dependent pattern. Investigation of steroid metabolites demonstrated that androstenone formed a 3'-hydroxy compound 3 beta-hydroxy-5 alpha-androst-16-ene. Testosterone was metabolized to 4-and-rostene-3,17-dione. Estrone was found as the metabolite for beta-estradiol. Inhibition study with 17 beta HSD inhibitor apigenin showed that apigenin didn't affect androstenone metabolism. Apigenin at high concentration (50 mu M) tends to inhibit testosterone metabolism but this inhibition effect was negligible. Beta-estradiol metabolism was notably inhibited with apigenin at high concentration. The study also established that the level of testosterone and b-estradiol metabolites was markedly increased after Co-incubation with high concentration of apigenin. This study established that 17bHSD7 is not the key enzyme responsible for androstenone and testosterone metabolism in porcine liver cells.	[Chen, Gang; Li, Sicong; Chen, Ailiang; Yang, Shuming] Chinese Acad Agr Sci, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China; [Dong, Xinxing; Bai, Ying; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Zamaratskaia, Galia] Swedish Univ Agr Sci SLU, Dept Food Sci, Uppsala, Sweden; [Doran, Olena] Univ W England, Ctr Res Biosci, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; China Agricultural University; Swedish University of Agricultural Sciences; University of West England	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	meiying@cau.edu.cn	Zamaratskaia, Galia/I-6155-2016; Chen, Ailiang/AAA-6470-2022	Zamaratskaia, Galia/0000-0003-0926-4849; 	Natural Science Foundation of China (NSFC) [31171691, 31072002]; Special Fund for Agro-Scientific Research in the Public Interest [201203046]; International Science & Technology Cooperation Program of China [2012DFA31140]; National High Technology and Science Development Plan of China [2011AA100302]; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award [BB/H531435/1]; BBSRC [BB/H531435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506072/1, BB/H531435/1] Funding Source: researchfish	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest; International Science & Technology Cooperation Program of China; National High Technology and Science Development Plan of China(National High Technology Research and Development Program of China); Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Science Foundation of China (NSFC, Grant Nos. 31171691, and 31072002), Special Fund for Agro-Scientific Research in the Public Interest (201203046), International Science & Technology Cooperation Program of China (2012DFA31140), National High Technology and Science Development Plan of China (2011AA100302), and Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award (BB/H531435/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ME, 2001, MOL CELL ENDOCRINOL, V171, P211, DOI 10.1016/S0303-7207(00)00414-7; BOOTH WD, 1988, J ENDOCRINOL, V118, P47, DOI 10.1677/joe.0.1180047; Brittany D, 2010, J LIPID RES, V51, P262; BROOKS RI, 1986, J ANIM SCI, V62, P632, DOI 10.2527/jas1986.623632x; Chen G, 2007, J ANIM SCI, V85, P2457, DOI 10.2527/jas.2007-0087; CLAUS R, 1994, MEAT SCI, V38, P289, DOI 10.1016/0309-1740(94)90118-X; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; De Brabander HF, 2007, J MASS SPECTROM, V42, P983, DOI 10.1002/jms.1272; Dong XX, 2012, GENE, V499, P186, DOI 10.1016/j.gene.2012.02.039; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GOLDSTEIN JA, 1993, ENVIRON HEALTH PERSP, V100, P169, DOI 10.2307/3431523; Hansen LL, 2006, ANIM SCI, V82, P359, DOI 10.1079/ASC200648; Krazeisen A, 1999, FEBS LETT, V460, P373, DOI 10.1016/S0014-5793(99)01366-6; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Mareck U, 2008, J MASS SPECTROM, V43, P877, DOI 10.1002/jms.1457; Nicolau-Solano SI, 2006, J ANIM SCI, V84, P2809, DOI 10.2527/jas.2005-595; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Rauh M, 2006, STEROIDS, V71, P450, DOI 10.1016/j.steroids.2006.01.015; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sinclair PA, 2006, J MOL ENDOCRINOL, V36, P301, DOI 10.1677/jme.1.01847; Sinclair PA, 2005, J ANIM SCI, V83, P358; Valsamakis G, 2004, J CLIN ENDOCR METAB, V89, P4755, DOI 10.1210/jc.2003-032240	27	9	10	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52255	10.1371/journal.pone.0052255	http://dx.doi.org/10.1371/journal.pone.0052255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300627	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800061
J	Francois, A; Grauso, M; Demondion, E; Bozzolan, F; Debernard, S; Lucas, P				Francois, Adrien; Grauso, Marta; Demondion, Elodie; Bozzolan, Francoise; Debernard, Stephane; Lucas, Philippe			Bestrophin-Encoded Ca2+-Activated Cl- Channels Underlie a Current with Properties Similar to the Native Current in the Moth Spodoptera littoralis Olfactory Receptor Neurons	PLOS ONE			English	Article							ACTIVATED CHLORIDE CONDUCTANCE; FUNCTIONAL-PROPERTIES; MOUSE BESTROPHIN-2; RT-PCR; CALCIUM; FAMILY; DROSOPHILA; PROTEIN; GENE; CA2+	Responses of insect olfactory receptor neurons (ORNs) involve an entry of Ca2+ through olfactory heterodimeric receptor complexes. In moths, the termination of ORN responses was found to strongly depend on the external Ca2+ concentration through the activation of unknown Ca2+-dependent Cl- channels. We thus investigated the molecular identity of these Cl- channels. There is compelling evidence that bestrophins form Cl- channels when expressed in heterologous systems. Here we provide evidence that antennae of the moth Spodoptera littoralis express three transcripts encoding proteins with hallmarks of bestrophins. One of these transcripts, SlitBest1b, is expressed in ORNs. The heterologous expression of SlitBest1b protein in CHO-K1 cells yielded a Ca2+-activated Cl- current that shares electrophysiological properties with the native Ca2+-activated Cl- current of ORNs. Both currents are anionic, present similar dependence on the intracellular Ca2+ concentration, partly inactivate over time, have the same anion permeability sequence, the same sequence of inhibitory efficiency of blockers, the same almost linear I-V relationships and finally both currents do not depend on the cell volume. Therefore, our data suggest that SlitBest1b is a good candidate for being a molecular component of the olfactory Ca2+-activated Cl- channel and is likely to constitute part of the insect olfactory transduction pathway. A different function (e. g. regulation of other proteins, maintenance of the anionic homeostasis in the sensillar lymph) and a different role (e. g. involvement in the olfactory system development) cannot be excluded however.	[Francois, Adrien; Grauso, Marta; Demondion, Elodie; Lucas, Philippe] INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France; [Francois, Adrien; Bozzolan, Francoise; Debernard, Stephane] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Lucas, P (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France.	philippe.lucas@versailles.inra.fr	Lucas, Philippe/I-6020-2016	Grauso, Marta/0000-0003-0413-9950; Lucas, Philippe/0000-0003-2166-8248	state program "Investissements d'avenir'' [ANR-10-BINF-05]	state program "Investissements d'avenir''(French National Research Agency (ANR))	This work was funded by the state program "Investissements d'avenir'' managed by ANR (grant ANR-10-BINF-05 "Pherotaxis''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audinat E, 1996, NEUROCHEM INT, V28, P119, DOI 10.1016/0197-0186(95)00075-5; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; BAKER TC, 1987, PHYSIOL ENTOMOL, V12, P263, DOI 10.1111/j.1365-3032.1987.tb00751.x; Barro-Soria R, 2009, PFLUGERS ARCH; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Britton FC, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P233; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jacquin-Joly E., 2005, CURR TOP NEUROCHEM, V4, P75; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling KE, 1997, EXS, V84, P343; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keil T.A., 1984, P477; Kleene SJ, 2002, CURR TOP MEMBR, V53, P119, DOI 10.1016/S1063-5823(02)53031-3; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Klimmeck D, 2009, J COMP NEUROL, V515, P585, DOI 10.1002/cne.22075; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Lucas P, 1997, CELL TISSUE RES, V289, P375, DOI 10.1007/s004410050884; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Matchkov VV, 2008, CIRC RES, V103, P864, DOI 10.1161/CIRCRESAHA.108.178517; Milenkovic VM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-72; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nakagawa-Inoue A, 1998, ZOOL SCI, V15, P661, DOI 10.2108/zsj.15.661; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; O'Driscoll KE, 2008, AM J PHYSIOL-CELL PH, V295, pC1610, DOI 10.1152/ajpcell.00461.2008; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Pezier A, 2010, J NEUROSCI, V30, P6323, DOI 10.1523/JNEUROSCI.0261-10.2010; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2010, J CARDIOVASC PHARM, V55, P110, DOI 10.1097/FJC.0b013e3181c87c85; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WILLIS MA, 1984, PHYSIOL ENTOMOL, V9, P341, DOI 10.1111/j.1365-3032.1984.tb00715.x; Yang C, 2010, J GEN PHYSIOL, V135, P3, DOI 10.1085/jgp.200910265; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583	70	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52691	10.1371/journal.pone.0052691	http://dx.doi.org/10.1371/journal.pone.0052691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300744	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800127
J	Hansen, U; Allen, JM; White, R; Moscibrocki, C; Bruckner, P; Bateman, JF; Fitzgerald, J				Hansen, Uwe; Allen, Justin M.; White, Rachel; Moscibrocki, Cathleen; Bruckner, Peter; Bateman, John F.; Fitzgerald, Jamie			WARP Interacts with Collagen VI-Containing Microfibrils in the Pericellular Matrix of Human Chondrocytes	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; BEADED MICROFIBRILS; BASEMENT-MEMBRANES; ALPHA-2(VI) CHAINS; GLOBULAR DOMAINS; TERMINAL REGION; PROTEIN WARP; CARTILAGE; FIBRILS; PROTEOGLYCAN	Collagen VI and WARP are extracellular structural macromolecules present in cartilage and associated with BM suprastructures in non-skeletal tissues. We have previously shown that in WARP-deficient mice, collagen VI is specifically reduced in regions of the peripheral nerve ECM where WARP is expressed, suggesting that both macromolecules are part of the same suprastructure. The object of this study was to conduct a detailed analysis of WARP-collagen VI interactions in vitro in cartilage, a tissue rich in WARP and collagen VI. Immunohistochemical analysis of mouse and human articular cartilage showed that WARP and collagen VI co-localize in the pericellular matrix of superficial zone articular chondrocytes. EM analysis on extracts of human articular cartilage showed that WARP associates closely with collagen VI-containing suprastructures. Additional evidence of an interaction is provided by immunogold EM and immunoblot analysis showing that WARP was present in collagen VI-containing networks isolated from cartilage. Further characterization were done by solid phase binding studies and reconstitution experiments using purified recombinant WARP and isolated collagen VI. Collagen VI binds to WARP with an apparent K-d of approximately 22 nM and the binding site(s) for WARP resides within the triple helical domain since WARP binds to both intact collagen VI tetramers and pepsinized collagen VI. Together, these data confirm and extend our previous findings by demonstrating that WARP and collagen VI form high affinity associations in vivo in cartilage. We conclude that WARP is ideally placed to function as an adapter protein in the cartilage pericellular matrix.	[Hansen, Uwe; Bruckner, Peter] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Allen, Justin M.; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Justin M.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [White, Rachel; Moscibrocki, Cathleen; Fitzgerald, Jamie] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA	University of Munster; Murdoch Children's Research Institute; University of Melbourne; Oregon Health & Science University	Fitzgerald, J (corresponding author), Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA.	fitzgerj@ohsu.edu	Bruckner, Peter/F-4817-2019	Bruckner, Peter/0000-0002-5566-5611; Bateman, John/0000-0001-8542-0730	National Health and Medical Research grant [284524]; National Institutes of Health [R01AR055957]; Deutsche Forschungsgemeinschaft Grant [SFB, A2]; Victorian Government's Operational Infrastructure Support Program; National Center for Research Resources [S10-RR023432]; Arthritis Research Campaign Travel Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055957] Funding Source: NIH RePORTER	National Health and Medical Research grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Victorian Government's Operational Infrastructure Support Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arthritis Research Campaign Travel Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Health and Medical Research grant 284524 (to JF and JB), an Arthritis Research Campaign Travel Award (to RW) and by the National Institutes of Health (to JF, R01AR055957), the Deutsche Forschungsgemeinschaft Grant SFB, A2 (to PB), the Victorian Government's Operational Infrastructure Support Program and by the National Center for Research Resources (S10-RR023432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Allen JM, 2009, J BIOL CHEM, V284, P12020, DOI 10.1074/jbc.M806968200; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Niiyama T, 2002, ACTA NEUROPATHOL, V104, P67, DOI 10.1007/s00401-002-0522-z; POOLE CA, 1988, J CELL SCI, V90, P635; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Wilusz RE, 2012, J R SOC INTERFACE; Wilusz RE, 2012, MATRIX BIOL	29	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52793	10.1371/journal.pone.0052793	http://dx.doi.org/10.1371/journal.pone.0052793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300779	Green Published, gold			2022-12-25	WOS:000313618800148
J	Hu, W; Li, LN; Sharma, S; Wang, J; McHardy, I; Lux, R; Yang, Z; He, XS; Gimzewski, JK; Li, YZ; Shi, WY				Hu, Wei; Li, Lina; Sharma, Shivani; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Gimzewski, James K.; Li, Yuezhong; Shi, Wenyuan			DNA Builds and Strengthens the Extracellular Matrix in Myxococcus xanthus Biofilms by Interacting with Exopolysaccharides	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; STAPHYLOCOCCUS-EPIDERMIDIS; MULTICELLULAR STRUCTURES; COLOCALIZATION ANALYSIS; NEISSERIA-GONORRHOEAE; CHEMOTAXIS HOMOLOGS; MEMBRANE-VESICLES; CHROMOSOMAL DNA; SOCIAL MOTILITY; POLYSACCHARIDE	One intriguing discovery in modern microbiology is the extensive presence of extracellular DNA (eDNA) within biofilms of various bacterial species. Although several biological functions have been suggested for eDNA, including involvement in biofilm formation, the detailed mechanism of eDNA integration into biofilm architecture is still poorly understood. In the biofilms formed by Myxococcus xanthus, a Gram-negative soil bacterium with complex morphogenesis and social behaviors, DNA was found within both extracted and native extracellular matrices (ECM). Further examination revealed that these eDNA molecules formed well organized structures that were similar in appearance to the organization of exopolysaccharides (EPS) in ECM. Biochemical and image analyses confirmed that eDNA bound to and colocalized with EPS within the ECM of starvation biofilms and fruiting bodies. In addition, ECM containing eDNA exhibited greater physical strength and biological stress resistance compared to DNase I treated ECM. Taken together, these findings demonstrate that DNA interacts with EPS and strengthens biofilm structures in M. xanthus.	[Hu, Wei; Wang, Jing; Li, Yuezhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Hu, Wei; Li, Lina; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hu, Wei; Li, Lina; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Shi, Wenyuan] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Sharma, Shivani; Gimzewski, James K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shivani; Gimzewski, James K.] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90024 USA; [Gimzewski, James K.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton Satellite MANA, Tsukuba, Ibaraki, Japan	Shandong University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science	Shi, WY (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	wenyuan@ucla.edu	He, Xuesong/GXN-2297-2022; SHI, wen/GPW-9531-2022; Li, Yuezhong/ACN-5179-2022	gimzewski, james/0000-0003-4333-6957; McHardy, Ian/0000-0002-2121-5460; Li, Yuezhong/0000-0001-8336-6638	United States National Institutes of Health Grant [GM54666]; Chinese Natural Science Foundation Grant [30870020]; Shandong Natural Science Foundation Grant [ZR2012CM003]; SDU Innovation Grant [2012TS007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054666] Funding Source: NIH RePORTER	United States National Institutes of Health Grant; Chinese Natural Science Foundation Grant; Shandong Natural Science Foundation Grant; SDU Innovation Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grant GM54666 (to W.S.), Chinese Natural Science Foundation Grant 30870020 (to W.H.), Shandong Natural Science Foundation Grant ZR2012CM003 (to W.H.) and SDU Innovation Grant 2012TS007 (to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Andersson S, 2009, APPL MICROBIOL BIOT, V82, P535, DOI 10.1007/s00253-008-1817-3; AVERY L, 1983, MOL GEN GENET, V191, P110, DOI 10.1007/BF00330897; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BEHMLANDER RM, 1994, J BACTERIOL, V176, P6295, DOI 10.1128/jb.176.20.6295-6303.1994; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Bhinu VS, 2005, J MOL MICROB BIOTECH, V10, P15, DOI 10.1159/000090344; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Cao WD, 2006, ANAL CHEM, V78, P7222, DOI 10.1021/ac060391l; CHANG BY, 1994, J BACTERIOL, V176, P7190, DOI 10.1128/JB.176.23.7190-7196.1994; COHEN GH, 1964, J BACTERIOL, V88, P329, DOI 10.1128/JB.88.2.329-338.1964; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Diodati ME, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P43; Dworkin M, 1993, MYXOBACTERIA, P63; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; HARA T, 1981, AGR BIOL CHEM TOKYO, V45, P2457, DOI 10.1080/00021369.1981.10864927; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Kolenbrander PE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P453; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lux R., 2004, BIOFILMS, V1, P293; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mayer C, 1999, INT J BIOL MACROMOL, V26, P3, DOI 10.1016/S0141-8130(99)00057-4; Merroun ML, 2003, CHEMOSPHERE, V52, P113, DOI 10.1016/S0045-6535(03)00220-0; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OCONNOR KA, 1988, J BACTERIOL, V170, P4103, DOI 10.1128/jb.170.9.4103-4112.1988; PALMEN R, 1995, CURR MICROBIOL, V30, P7, DOI 10.1007/BF00294516; Pelling AE, 2005, P NATL ACAD SCI USA, V102, P6484, DOI 10.1073/pnas.0501207102; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rasband W., 2006, IMAGEJ; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; ROSENBLUH A, 1993, MYXOBACTERIA, V2, P213; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; SHIMKETS LJ, 1986, J BACTERIOL, V166, P842, DOI 10.1128/jb.166.3.842-848.1986; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Vlassov VV, 2007, BIOESSAYS, V29, P654, DOI 10.1002/bies.20604; Wang J, 2011, J BACTERIOL, V193, P2122, DOI 10.1128/JB.00041-11; Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	61	40	44	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51905	10.1371/journal.pone.0051905	http://dx.doi.org/10.1371/journal.pone.0051905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300576	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800035
J	Jellyman, JK; Martin-Gronert, MS; Cripps, RL; Giussani, DA; Ozanne, SE; Shen, QWW; Du, M; Fowden, AL; Forhead, AJ				Jellyman, Juanita K.; Martin-Gronert, Malgorzata S.; Cripps, Roselle L.; Giussani, Dino A.; Ozanne, Susan E.; Shen, Qingwu W.; Du, Min; Fowden, Abigail L.; Forhead, Alison J.			Effects of Cortisol and Dexamethasone on Insulin Signalling Pathways in Skeletal Muscle of the Ovine Fetus during Late Gestation	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; ANTENATAL CORTICOSTEROIDS; DEVELOPMENTAL CONTROL; MAMMALIAN TARGET; FETAL; GROWTH; SHEEP; GLUCOCORTICOIDS; EXPRESSION; RESTRICTION	Before birth, glucocorticoids retard growth, although the extent to which this is mediated by changes in insulin signalling pathways in the skeletal muscle of the fetus is unknown. The current study determined the effects of endogenous and synthetic glucocorticoid exposure on insulin signalling proteins in skeletal muscle of fetal sheep during late gestation. Experimental manipulation of fetal plasma glucocorticoid concentration was achieved by fetal cortisol infusion and maternal dexamethasone treatment. Cortisol infusion significantly increased muscle protein levels of Akt2 and phosphorylated Akt at Ser473, and decreased protein levels of phosphorylated forms of mTOR at Ser2448 and S6K at Thr389. Muscle GLUT4 protein expression was significantly higher in fetuses whose mothers were treated with dexamethasone compared to those treated with saline. There were no significant effects of glucocorticoid exposure on muscle protein abundance of IR-beta, IGF-1R, PKC zeta, Akt1, calpastatin or muscle glycogen content. The present study demonstrated that components of the insulin signalling pathway in skeletal muscle of the ovine fetus are influenced differentially by naturally occurring and synthetic glucocorticoids. These findings may provide a mechanism by which elevated concentrations of endogenous glucocorticoids retard fetal growth.	[Jellyman, Juanita K.; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Martin-Gronert, Malgorzata S.; Cripps, Roselle L.; Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Shen, Qingwu W.; Du, Min] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA	University of Cambridge; University of Cambridge; University of Wyoming	Forhead, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ajf1005@cam.ac.uk	Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X; Forhead, Alison/0000-0003-2125-4811; Ozanne, Susan/0000-0001-8753-5144; Jellyman, Juanita/0000-0002-8455-7652; Giussani, Dino/0000-0002-1308-1204	Biotechnology and Biological Sciences Research Council; Tommy's the Baby Charity, UK; Biotechnology and Biological Sciences Research Council [BB/E002668/1, S18103, BB/I011773/1] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; BBSRC [BB/E002668/1, BB/I011773/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommy's the Baby Charity, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council and Tommy's the Baby Charity, UK. SEO is a British Heart Foundation Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1256, DOI 10.1152/ajpregu.2001.281.4.R1256; Blanco CL, 2010, ENDOCRINOLOGY, V151, P1990, DOI 10.1210/en.2009-0777; Brown LD, 2009, AM J PHYSIOL-ENDOC M, V296, pE56, DOI 10.1152/ajpendo.90310.2008; Challis JRG, 2001, MOL CELL ENDOCRINOL, V185, P135, DOI 10.1016/S0303-7207(01)00624-4; Coderre L, 1996, AM J PHYSIOL-ENDOC M, V271, pE643, DOI 10.1152/ajpendo.1996.271.4.E643; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; Ewart HS, 1998, FEBS LETT, V425, P178; Forhead AJ, 2008, J PHYSIOL-LONDON, V586, P2393, DOI 10.1113/jphysiol.2007.149237; Forhead AJ, 2007, ENDOCRINOLOGY, V148, P800, DOI 10.1210/en.2006-1194; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Fowden AL, 1996, J ENDOCRINOL, V151, P97, DOI 10.1677/joe.0.1510097; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; Gray S, 2006, J ENDOCRINOL, V189, P219, DOI 10.1677/joe.1.06589; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Jellyman JK, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.012; Kelly BA, 2012, PEDIATRICS, V129, pE1282, DOI 10.1542/peds.2011-3175; LI J, 1993, ENDOCRINOLOGY, V132, P2083, DOI 10.1210/en.132.5.2083; Li J, 2002, J PHYSIOL-LONDON, V541, P581, DOI 10.1113/jphysiol.2002.016402; MOLINA RD, 1993, PEDIATR RES, V34, P654, DOI 10.1203/00006450-199311000-00018; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROBINSON PM, 1983, Q J EXP PHYSIOL CMS, V68, P15, DOI 10.1113/expphysiol.1983.sp002697; Royal College of Obstetricians and Gynaecologists, 2010, GREEN TOP GUID; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shen WH, 2003, AM J PHYSIOL-ENDOC M, V284, pE748, DOI 10.1152/ajpendo.00399.2002; Sloboda DM, 2005, AM J PHYSIOL-ENDOC M, V289, pE721, DOI 10.1152/ajpendo.00040.2005; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wu M, 2010, J CELL PHYSL, V226, P29; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	43	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52363	10.1371/journal.pone.0052363	http://dx.doi.org/10.1371/journal.pone.0052363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300651	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800072
J	Keyes, LR; Hargett, D; Soland, M; Bego, MG; Rossetto, CC; Almeida-Porada, G; St Jeor, S				Keyes, Lisa R.; Hargett, Danna; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen			HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14(+) Cells	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; HEMATOPOIETIC PROGENITOR CELLS; GENE-EXPRESSION; IN-VITRO; MODEL; MONOCYTES; TRANSCRIPT; DAXX	Human cytomegalovirus (HCMV) is a member of the Herpesviridae family that infects individuals throughout the world. Following an initial lytic stage, HCMV can persist in the individual for life in a non-active (or latent) form. During latency, the virus resides within cells of the myeloid lineage. The mechanisms controlling HCMV latency are not completely understood. A latency associated transcript, UL81-82ast, encoding the protein LUNA (Latency Unique Natural Antigen) was identified from latently infected donors in vivo. To address the role of the UL81-82ast protein product LUNA, in the context of the viral genome, we developed a recombinant HCMV bacterial artificial chromosome (BAC) that does not express LUNA. This construct, LUNA knockout FIX virus (FIX-Delta LUNA), was used to evaluate LUNA's role in HCMV latency. The FIX-Delta LUNA virus was able to lytically infect Human Fibroblast (HF) cells, showing that LUNA is not required to establish a lytic infection. Interestingly, we observed significantly higher viral copy numbers in HF cells infected with FIX-Delta LUNA when compared to FIX-WT virus. Furthermore, FIX-WT and FIX- Delta LUNA genomic DNA and transcription of UL81-82ast persisted over time in primary monocytes. In contrast, the levels of UL138 transcript expression in FIX-Delta LUNA infected HF and CD14(+) cells was 100 and 1000 fold lower (respectively) when compared to the levels observed for FIX-WT infection. Moreover, FIX-Delta LUNA virus failed to reactivate from infected CD14(+) cells following differentiation. This lack of viral reactivation was accompanied by a lack of lytic gene expression, increase in viral copy numbers, and lack of the production of infectious units following differentiation of the cells. Our study suggests that the LUNA protein is involved in regulating HCMV reactivation, and that in the absence of LUNA, HCMV may not be able to enter a proper latent state and therefore cannot be rescued from the established persistent infection in CD14(+) cells.	[Keyes, Lisa R.; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen] Univ Nevada, Dept Microbiol, Reno, NV 89557 USA; [Keyes, Lisa R.; Soland, Melisa; Bego, Mariana G.; Rossetto, Cyprian C.; Almeida-Porada, Graca; St Jeor, Stephen] Univ Nevada, Grad Program Cell & Mol Biol, Reno, NV 89557 USA; [Hargett, Danna] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Princeton University	St Jeor, S (corresponding author), Univ Nevada, Dept Microbiol, Reno, NV 89557 USA.	stjeor@gmail.com		soland, Melisa/0000-0001-8217-9734; Rossetto, Cyprian/0000-0002-4415-0196; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	NIH [HL63470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063470] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by NIH grant HL63470. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Bego M, 2005, J VIROL, V79, P11022, DOI 10.1128/JVI.79.17.11022-11034.2005; Bego MG, 2006, EXP HEMATOL, V34, P555, DOI 10.1016/j.exphem.2005.11.012; Bego MG, 2011, ARCH VIROL, V156, P1847, DOI 10.1007/s00705-011-1027-7; Bego MG, 2011, ARCH VIROL; Beisser PS, 2001, J VIROL, V75, P5949, DOI 10.1128/JVI.75.13.5949-5957.2001; Cheung AKL, 2009, BLOOD, V114, P4128, DOI 10.1182/blood-2008-12-197111; CHUA CC, 1981, J GEN VIROL, V56, P1, DOI 10.1099/0022-1317-56-1-1; Goodrum F, 2004, BLOOD, V104, P687, DOI 10.1182/blood-2003-12-4344; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; GREFTE A, 1994, J GEN VIROL, V75, P1989, DOI 10.1099/0022-1317-75-8-1989; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Hwang JW, 2007, VIROLOGY, V367, P334, DOI 10.1016/j.virol.2007.05.037; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Kondo K, 1995, SCAND J INFECT DIS, P63; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; LaMarca HL, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-8; Landini MP, 2000, BIOL BLOOD MARROW TR, V6, P100, DOI 10.1016/S1083-8791(00)70072-3; MACIEJEWSKI JP, 1992, BLOOD, V80, P170; Maciejewski JP, 1999, LEUKEMIA LYMPHOMA, V33, P1; Patrone M, 2005, J VIROL, V79, P8361, DOI 10.1128/JVI.79.13.8361-8373.2005; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; Reeves MB, 2010, J GEN VIROL, V91, P599, DOI 10.1099/vir.0.015602-0; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Saffert RT, 2010, J VIROL, V84, P5594, DOI 10.1128/JVI.00348-10; Slobedman B, 2010, FUTURE MICROBIOL, V5, P883, DOI 10.2217/FMB.10.58; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Sorg G, 1998, J GEN VIROL, V79, P3039, DOI 10.1099/0022-1317-79-12-3039; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhuravskaya T, 1997, BLOOD, V90, P2482, DOI 10.1182/blood.V90.6.2482.2482_2482_2491	39	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52827	10.1371/journal.pone.0052827	http://dx.doi.org/10.1371/journal.pone.0052827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300789	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800154
J	Mercer, SE; Cheng, CH; Atkinson, DL; Krcmery, J; Guzman, CE; Kent, DT; Zukor, K; Marx, KA; Odelberg, SJ; Simon, HG				Mercer, Sarah E.; Cheng, Chia-Ho; Atkinson, Donald L.; Krcmery, Jennifer; Guzman, Claudia E.; Kent, David T.; Zukor, Katherine; Marx, Kenneth A.; Odelberg, Shannon J.; Simon, Hans-Georg			Multi-Tissue Microarray Analysis Identifies a Molecular Signature of Regeneration	PLOS ONE			English	Article							AMPHIBIAN LIMB REGENERATION; FIBROBLAST-GROWTH-FACTOR; ZEBRAFISH HEART REGENERATION; SPINAL-CORD REGENERATION; DIGIT TIP REGENERATION; LARGE GENE LISTS; INTERMEDIATE-FILAMENTS; LENS REGENERATION; NEWT LIMB; FIN REGENERATION	The inability to functionally repair tissues that are lost as a consequence of disease or injury remains a significant challenge for regenerative medicine. The molecular and cellular processes involved in complete restoration of tissue architecture and function are expected to be complex and remain largely unknown. Unlike humans, certain salamanders can completely regenerate injured tissues and lost appendages without scar formation. A parsimonious hypothesis would predict that all of these regenerative activities are regulated, at least in part, by a common set of genes. To test this hypothesis and identify genes that might control conserved regenerative processes, we performed a comprehensive microarray analysis of the early regenerative response in five regeneration-competent tissues from the newt Notophthalmus viridescens. Consistent with this hypothesis, we established a molecular signature for regeneration that consists of common genes or gene family members that exhibit dynamic differential regulation during regeneration in multiple tissue types. These genes include members of the matrix metalloproteinase family and its regulators, extracellular matrix components, genes involved in controlling cytoskeleton dynamics, and a variety of immune response factors. Gene Ontology term enrichment analysis validated and supported their functional activities in conserved regenerative processes. Surprisingly, dendrogram clustering and RadViz classification also revealed that each regenerative tissue had its own unique temporal expression profile, pointing to an inherent tissue-specific regenerative gene program. These new findings demand a reconsideration of how we conceptualize regenerative processes and how we devise new strategies for regenerative medicine.	[Mercer, Sarah E.; Krcmery, Jennifer; Guzman, Claudia E.; Simon, Hans-Georg] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Mercer, Sarah E.; Krcmery, Jennifer; Guzman, Claudia E.; Simon, Hans-Georg] Childrens Mem Res Ctr, Chicago, IL USA; [Cheng, Chia-Ho; Marx, Kenneth A.] Univ Massachusetts Lowell, Dept Chem, Lowell, MA USA; [Atkinson, Donald L.; Kent, David T.; Zukor, Katherine; Odelberg, Shannon J.] Univ Utah, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84112 USA	Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Lowell; Utah System of Higher Education; University of Utah	Simon, HG (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	hgsimon@northwestern.edu			DARPA; Restorative Injury Repair [BAA04-12]; Chicago Community Trust; Craig H. Neilsen Foundation; American Heart Association [11PRE5570021]; National Institutes of Health (NIH) [T-32 GM008061-27]; NIH [5T32 HL07576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Restorative Injury Repair; Chicago Community Trust; Craig H. Neilsen Foundation; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DARPA, Restorative Injury Repair BAA04-12 Addendum B (H.-G. Simon and S. Odelberg), Searle Funds at the Chicago Community Trust (H.-G. Simon), the Craig H. Neilsen Foundation (S. Odelberg), American Heart Association predoctoral fellowship 11PRE5570021 (S. Mercer), National Institutes of Health (NIH) Cellular and Molecular Basis of Disease training program T-32 GM008061-27 (S. Mercer), and NIH Cardiology Fellowship Training Grant 5T32 HL07576 (D. Kent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHEMIN M, 1994, INT J DEV BIOL, V38, P641; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bicknell KA, 2004, BIOCHEM J, V382, P411, DOI 10.1042/BJ20031481; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calve S, 2012, FASEB J; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Cameron DA, 2005, MOL VIS, V11, P775; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; CHERNOFF EAG, 1995, DEV GROWTH DIFFER, V37, P133; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; COMERA C, 1995, BRIT J PHARMACOL, V115, P1043, DOI 10.1111/j.1476-5381.1995.tb15916.x; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIS BM, 1990, EXP NEUROL, V108, P198, DOI 10.1016/0014-4886(90)90124-B; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; DelRioTsonis K, 1997, P NATL ACAD SCI USA, V94, P13701, DOI 10.1073/pnas.94.25.13701; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; Ferretti P, 2004, CURR NEUROVASC RES, V1, P215, DOI 10.2174/1567202043362397; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084952102000903; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grow M, 2006, DEV DYNAM, V235, P2667, DOI 10.1002/dvdy.20897; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Han MJ, 2001, DEV DYNAM, V220, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1085>3.0.CO;2-8; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Hoffman P, 1997, VISUALIZATION '97 - PROCEEDINGS, P437, DOI 10.1109/VISUAL.1997.663916; Holten-Andersen MN, 2004, EUR J CANCER, V40, P2159, DOI 10.1016/j.ejca.2004.06.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imokawa Y, 2004, PHILOS T R SOC B, V359, P765, DOI 10.1098/rstb.2004.1467; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; KIRCHHEIMER JC, 1987, THROMB RES, V48, P291, DOI 10.1016/0049-3848(87)90441-5; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Liu NK, 2007, J NEUROPATH EXP NEUR, V66, P932, DOI 10.1097/nen.0b013e3181567d59; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Marx KA, 2003, J CHEM INF COMP SCI, V43, P1652, DOI 10.1021/ci034050+; Marx KA, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P131; McCarthy JF, 2004, ANN NY ACAD SCI, V1020, P239, DOI 10.1196/annals.1310.020; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; Murciano C, 2002, DEV BIOL, V252, P214, DOI 10.1006/dbio.2002.0848; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012058; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip JG, 1998, REGUL PEPTIDES, V73, P133, DOI 10.1016/S0167-0115(97)01077-X; Pizette S, 2001, DEVELOPMENT, V128, P4463; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; POULIN ML, 1993, DEVELOPMENT, V119, P353; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; RAMAEKERS FCS, 1983, P NATL ACAD SCI-BIOL, V80, P2618, DOI 10.1073/pnas.80.9.2618; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shimazaki Y, 2001, DEV COMP IMMUNOL, V25, P467, DOI 10.1016/S0145-305X(01)00007-6; SIMON HG, 1993, DEVELOPMENT, V117, P1397; SIMON HG, 1995, DEV DYNAM, V202, P1, DOI 10.1002/aja.1002020102; Simon HG, 2002, CELL MOL LIFE SCI, V59, P1264, DOI 10.1007/s00018-002-8505-8; Simon HG, 1996, GENE, V172, P175, DOI 10.1016/0378-1119(96)00015-7; Singh BN, 2010, J CARDIOVASC TRANSL; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Stevenson TJ, 2006, DEV DYNAM, V235, P606, DOI 10.1002/dvdy.20654; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Tanaka EM, 1999, CURR BIOL, V9, P792, DOI 10.1016/S0960-9822(99)80362-5; Tazaki A, 2005, DEV DYNAM, V233, P1394, DOI 10.1002/dvdy.20472; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; TSONIS PA, 1982, DEV GROWTH DIFFER, V24, P183; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Tsonis PA, 2008, CURR STEM CELL RES T, V3, P53, DOI 10.2174/157488808783489408; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walder S, 2003, DEV GENES EVOL, V213, P625, DOI 10.1007/s00427-003-0364-2; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang F, 2000, DEV BIOL, V225, P381, DOI 10.1006/dbio.2000.9843; ZILAKOS NP, 1992, CANCER RES, V52, P4858; Zukor KA, 2010, DEV DYNAM, V239, P3048, DOI 10.1002/dvdy.22441	129	29	29	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52375	10.1371/journal.pone.0052375	http://dx.doi.org/10.1371/journal.pone.0052375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300656	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800076
J	Miller, HD; Clark, BW; Hinton, DE; Whitehead, A; Martin, S; Kwok, KW; Kullman, SW				Miller, Hilary D.; Clark, Bryan W.; Hinton, David E.; Whitehead, Andrew; Martin, Stan; Kwok, Kevin W.; Kullman, Seth W.			Anchoring Ethinylestradiol Induced Gene Expression Changes with Testicular Morphology and Reproductive Function in the Medaka	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; FROG RANA-ESCULENTA; MALE GERM-CELLS; ORYZIAS-LATIPES; ESTROGEN-RECEPTOR; C-MYC; GONADAL DEVELOPMENT; FERTILIZATION SUCCESS	Environmental estrogens are ubiquitous in the environment and can cause detrimental effects on male reproduction. In fish, a multitude of effects from environmental estrogens have been observed including altered courting behavior and fertility, sex reversal, and gonadal histopathology. However, few studies in fish assess the impacts of estrogenic exposure on a physiological endpoint, such as reproduction, as well as the associated morphologic response and underlying global gene expression changes. This study assessed the implications of a 14 day sub-chronic exposure of ethinylestradiol (EE2; 1.0 or 10.0 mu g/L EE2) on male medaka fertility, testicular histology and testicular gene expression. The findings demonstrate that a 14 day exposure to EE2 induced impaired male reproductive capacity and time- and dose-dependent alterations in testicular morphology and gene expression. The average fertilization rate/day following the exposure for control, 1.0 and 10.0 mu g/L EE2 was 91.3% (+/- 4.4), 62.8% (+/- 8.3) and 28.8% (+/- 5.8), respectively. The testicular morphologic alterations included increased germ cell apoptosis, decreased germinal epithelium and thickening of the interstitium. These changes were highly associated with testicular gene expression changes using a medaka-specific microarray. A pathway analysis of the differentially expressed genes emphasized genes and pathways associated with apoptosis, cell cycle and proliferation, collagen production/extracellular matrix organization, hormone signaling, male reproduction and protein ubiquitination among others. These findings highlight the importance of anchoring global gonadal gene expression changes with morphology and ultimately with tissue/organ function.	[Miller, Hilary D.; Clark, Bryan W.] Duke Univ, Nicholas Sch Environm, Integrated Toxicol & Environm Hlth Program, Durham, NC 27708 USA; [Whitehead, Andrew] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Martin, Stan] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Kullman, Seth W.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	Duke University; University of California System; University of California Davis; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kullman, SW (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	swkullma@ncsu.edu	Whitehead, Andrew/G-2122-2012	Kullmam, Seth/0000-0002-6029-2266; Kwok, Kevin Wing Hin/0000-0003-3264-134X	National Institute of Environmental Health Sciences (NIEHS) [T3207031, P42ES010356]; Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS) [NIEHS P30ES03828]; National Institutes of Health (NIH) National Center for Research Resources (NCRR) [NCRR 1R01RR018583]; NIH National Cancer Institute (NCI) [NCI R21CA106084-01A1]; Water Environment Research Foundation (WERF) [01-HHE-22-T]; North Carolina Biotechnology Center [ARG0030]; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE [R21CA106084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, P30ES003828] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS); National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Water Environment Research Foundation (WERF); North Carolina Biotechnology Center; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in-part by National Institute of Environmental Health Sciences Institutional Training Grant funded Duke University Integrated Toxicology and Environmental Health Program (NIEHS T3207031), Duke University Superfund Basic Research Program (NIEHS P42ES010356), and Mount Desert Island Biological Laboratory Center for Membrane Toxicity Studies (NIEHS P30ES03828), National Institutes of Health (NIH) National Center for Research Resources (NCRR 1R01RR018583) and NIH National Cancer Institute (NCI R21CA106084-01A1), Water Environment Research Foundation (WERF) (01-HHE-22-T), and North Carolina Biotechnology Center (ARG0030), as well as Fred and Alice Stanback. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Y, 1999, ENVIRON TOXICOL CHEM, V18, P1791, DOI 10.1002/etc.5620180827; Almog T, 2008, MOL CELL ENDOCRINOL, V282, P39, DOI 10.1016/j.mce.2007.11.011; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Aoki J, 2010, SCI TOTAL ENVIRON, V408, P660, DOI 10.1016/j.scitotenv.2009.08.009; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; Balch GC, 2004, ENVIRON TOXICOL CHEM, V23, P782, DOI 10.1897/02-539; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bouskine A, 2008, ENDOCRINOLOGY, V149, P565, DOI 10.1210/en.2007-1318; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Carreau S, 2010, PHILOS T R SOC B, V365, P1517, DOI 10.1098/rstb.2009.0235; Chieffi P, 2002, MOL REPROD DEV, V61, P218, DOI 10.1002/mrd.1151; CHIEFFI P, 1995, GEN COMP ENDOCR, V99, P127, DOI 10.1006/gcen.1995.1093; Chieffi P, 2000, J ENDOCRINOL, V167, P77, DOI 10.1677/joe.0.1670077; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Dolci S, 2001, J BIOL CHEM, V276, P40225, DOI 10.1074/jbc.M105143200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ewen K, 2010, BIOL REPROD, V83, P1005, DOI 10.1095/biolreprod.110.086801; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Foran CM, 2002, TOXICOL SCI, V68, P389, DOI 10.1093/toxsci/68.2.389; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; GRIER HJ, 1981, AM ZOOL, V21, P345; GRIER HJ, 1976, CELL TISSUE RES, V168, P419, DOI 10.1007/BF00215993; Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/reprod/122.6.857; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Harshbarger JC, 2000, MAR ENVIRON RES, V50, P247, DOI 10.1016/S0141-1136(00)00055-6; Hashimoto S, 2009, ARCH ENVIRON CON TOX, V56, P253, DOI 10.1007/s00244-008-9183-9; Hinck JE, 2009, AQUAT TOXICOL, V95, P60, DOI 10.1016/j.aquatox.2009.08.001; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Islinger M, 2003, AQUAT TOXICOL, V62, P85, DOI 10.1016/S0166-445X(02)00049-8; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Johnson R., 2009, OECD GUIDANCE DCUMEN; Kang IJ, 2002, CHEMOSPHERE, V47, P71, DOI 10.1016/S0045-6535(01)00205-3; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kieffer E, 2010, M S-MED SCI, V26, P848, DOI 10.1051/medsci/20102610848; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kirchen R. V, 1976, JAPANESE MEDAKA ITS; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Koulish S, 2002, J MORPHOL, V254, P292, DOI 10.1002/jmor.10037; Kuch HM, 2000, FRESEN J ANAL CHEM, V366, P392, DOI 10.1007/s002160050080; Kullman SW, 2003, ENV SCI, V10, P223; Lange A, 2009, ENVIRON SCI TECHNOL, V43, P1219, DOI 10.1021/es802661p; Lange A, 2011, ENVIRON SCI TECHNOL, V45, P1673, DOI 10.1021/es103232q; Larsson DGJ, 1999, AQUAT TOXICOL, V45, P91, DOI 10.1016/S0166-445X(98)00112-X; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Levens D, 2002, P NATL ACAD SCI USA, V99, P5757, DOI 10.1073/pnas.102173199; Lo Nostro FL, 2004, TISSUE CELL, V36, P221, DOI 10.1016/j.tice.2004.03.001; LOIR M, 1995, MICROSC RES TECHNIQ, V32, P533, DOI 10.1002/jemt.1070320606; Lu CX, 2005, PEDIATR RES, V57, p70R, DOI 10.1203/01.PDR.0000159573.55187.CA; Luconi M, 2002, J STEROID BIOCHEM, V80, P369, DOI 10.1016/S0960-0760(02)00041-9; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Matsui Y, 1998, APMIS, V106, P142, DOI 10.1111/j.1699-0463.1998.tb01329.x; McCabe ERB, 2007, MOL CELL ENDOCRINOL, V265, P179, DOI 10.1016/j.mce.2006.12.017; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; Niakan KK, 2005, MOL GENET METAB, V86, P70, DOI 10.1016/j.ymgme.2005.07.019; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Palace VP, 2006, ENVIRON TOXICOL CHEM, V25, P1114, DOI 10.1897/04-557R1.1; Parenti LR, 2004, INTEGR COMP BIOL, V44, P333, DOI 10.1093/icb/44.5.333; Parrott JL, 2005, ENVIRON TOXICOL, V20, P131, DOI 10.1002/tox.20087; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI 10.1897/1551-5028(2002)021&lt;1692:EOEOTR&gt;2.0.CO;2; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Stabile V, 2006, REPRODUCTION, V132, P477, DOI 10.1530/rep.1.01107; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; TABAK HH, 1981, DEV IND MICROBIOL, V22, P497; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Tilton SC, 2005, ENVIRON TOXICOL CHEM, V24, P352, DOI 10.1897/04-016R.1; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; Van der Ven LTM, 2003, ENVIRON TOXICOL CHEM, V22, P908, DOI [10.1897/1551-5028(2003)022&lt;0908:HAATFT&gt;2.0.CO;2, 10.1002/etc.5620220431]; Vicini E, 2006, J CELL PHYSIOL, V206, P238, DOI 10.1002/jcp.20454; Vigano L, 2001, SCI TOTAL ENVIRON, V269, P189, DOI 10.1016/S0048-9697(00)00821-4; Volz DC, 2006, TOXICOL SCI, V89, P524, DOI 10.1093/toxsci/kfj033; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Weber LP, 2004, ENVIRON TOXICOL CHEM, V23, P792, DOI 10.1897/02-570; Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xu H, 2008, AQUAT TOXICOL, V88, P1, DOI 10.1016/j.aquatox.2008.01.020; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	92	22	24	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52479	10.1371/journal.pone.0052479	http://dx.doi.org/10.1371/journal.pone.0052479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300682	gold, Green Published			2022-12-25	WOS:000313618800094
J	Ose, D; Rochon, J; Campbell, SM; Wensing, M; van Lieshout, J; Uhlmann, L; Freund, T; Szecsenyi, J; Ludt, S				Ose, Dominik; Rochon, Justine; Campbell, Stephen M.; Wensing, Michel; van Lieshout, Jan; Uhlmann, Lorenz; Freund, Tobias; Szecsenyi, Joachim; Ludt, Sabine			Secondary Prevention in Patients with Coronary Heart Diseases: What Factors Are Associated with Health Status in Usual Primary Care?	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; STRUCTURAL CAPABILITIES; CLINICAL-PRACTICE; GUIDED CARE; MANAGEMENT; RISK; BURDEN; TRIAL; INDICATORS	Background: For patients with coronary heart diseases a substantial part of secondary prevention is delivered in primary care. Along with the growing importance of prevention, health-related quality of life (HRQoL) is an indicator of patient-centered care that has gained increased attention. Different approaches for reorganization in primary care have been associated with improvements in HRQoL. However, these are often results of complex interventions. Evidence on aspects concerning usual primary care that actually have an impact on HRQoL remains scarce. Therefore, this observational study aimed to identify factors which are associated with HRQoL in usual primary care at practice and patient-level. Methods: This observational study was conducted in eight European countries. We were able to match data from survey instruments for 3505 patients with coronary heart disease (CHD) in 228 practices. A multilevel analysis was performed to identify associations of EQ-5D scores at patient and practice-level. Results: After dropping patients with missing information, our cohort consisted of 2656 patients. In this sample, 30.5% were female and the mean age was 67.5 years (SD 10.1). The final model included a total set of 14 potential explanatory variables. At practice-level no variable was associated with EQ-5D. At patient-level, lower education (r = -0.0381, p < 0.0001), female gender (r = -0.0543, p < 0.0001) and a higher number of other conditions (r = -0.0340, p < 0.0001), had a strong negative effect on HRQoL. Strong positive associations with HRQoL were found for a good medication adherence (Morisky) (r = 0.0195, p < 0.0001) and more positive evaluations of physicians' clinical behavior (r = 0.0282, p = 0.002). In terms of HRQoL no differences between single-handed and group practices exist. Conclusion: The results of our study suggest that a better patient-physician relationship rather than organization of CHD care is associated with higher HRQOL in the primary care setting. The results may imply that interventions to improve HRQoL require a strong patient-centered approach.	[Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Freund, Tobias; Szecsenyi, Joachim; Ludt, Sabine] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv, Heidelberg, Germany; [Wensing, Michel; van Lieshout, Jan] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Rochon, Justine; Uhlmann, Lorenz] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Campbell, Stephen M.] Univ Manchester, Hlth Sci Primary Care Grp, Manchester, Lancs, England	Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Manchester	Ose, D (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv, Heidelberg, Germany.	dominik.ose@med.uni-heidelberg.de	Uhlmann, Lorenz/AAL-9839-2020; Ose, Dominik J/F-7691-2013; Wensing, Michel/H-8113-2014; Ose, Dominik/L-4250-2019; Van Lieshout, J./L-4490-2015	Ose, Dominik J/0000-0002-5079-2152; Wensing, Michel/0000-0001-6569-8137; Ose, Dominik/0000-0002-5079-2152; Campbell, Stephen/0000-0002-2328-4136	Bertelsmann Foundation (Gutersloh, Germany); IQ Healthcare of the Radboud University Nijmegen (The Netherlands)	Bertelsmann Foundation (Gutersloh, Germany); IQ Healthcare of the Radboud University Nijmegen (The Netherlands)	The Bertelsmann Foundation (Gutersloh, Germany) initiated, coordinated, and funded the EPA Cardio project, in collaboration with IQ Healthcare of the Radboud University Nijmegen (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RJ, 2007, CLIN ENDOCRINOL, V66, P548, DOI 10.1111/j.1365-2265.2007.02771.x; Bielaszka-DuVernay C, 2011, HEALTH AFFAIR, V30, P431, DOI 10.1377/hlthaff.2011.0043; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boyd CM, 2007, GERONTOLOGIST, V47, P697, DOI 10.1093/geront/47.5.697; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Brown JR, 2010, NEW ENGL J MED, V362, P2150, DOI 10.1056/NEJMp1003880; Byrne M, 2005, J PSYCHOSOM RES, V58, P403, DOI 10.1016/j.jpsychores.2004.11.010; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Davis PD, 1995, SURV METHODOL, V21, P99; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Engels Y, 2006, FAM PRACT, V23, P137, DOI 10.1093/fampra/cmi091; Eriksson MK, 2010, ARCH INTERN MED, V170, P1470, DOI 10.1001/archinternmed.2010.301; Ford ES, 2008, J WOMENS HEALTH, V17, P757, DOI 10.1089/jwh.2007.0468; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Friedman SM, 2005, GERONTOLOGIST, V45, P157, DOI 10.1093/geront/45.2.157; Garster NC, 2009, QUAL LIFE RES, V18, P1239, DOI 10.1007/s11136-009-9533-8; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Koertge J, 2003, AM J CARDIOL, V91, P1316, DOI 10.1016/S0002-9149(03)00320-5; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Nadash P, 2004, GERONTOLOGIST, V44, P644, DOI 10.1093/geront/44.5.644; Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Rasbash J, 2011, MLWIN VERSION 2 24; Raudenbusch S. W., 2002, HIERARCHICAL LINEAR; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rumsfeld JS, 2002, CIRCULATION, V106, P5, DOI 10.1161/01.CIR.0000020805.31531.48; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Takach M, 2010, STRENGTHENING PRIMAR; Tsai AC, 2005, AM J MANAG CARE, V11, P478; van Dam RM, 2009, CIRCULATION, V120, P1171, DOI 10.1161/CIRCULATIONAHA.109.891507; van Lieshout J, 2009, AM J MANAG CARE, V15, P255; Vargas RB, 2007, J GEN INTERN MED, V22, P215, DOI 10.1007/s11606-006-0072-5; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wang WR, 2012, HEART LUNG, V41, P15, DOI 10.1016/j.hrtlng.2011.05.005; Wensing M, 2000, EUROPEAN J GEN PRACT, V6, P82, DOI DOI 10.3109/13814780009069953; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wroth TH, 2006, J AM BOARD FAM MED, V19, P478, DOI 10.3122/jabfm.19.5.478; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	50	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51726	10.1371/journal.pone.0051726	http://dx.doi.org/10.1371/journal.pone.0051726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300560	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800024
J	Schuepp, C; Rittiner, S; Entling, MH				Schueepp, Christof; Rittiner, Sarah; Entling, Martin H.			High Bee and Wasp Diversity in a Heterogeneous Tropical Farming System Compared to Protected Forest	PLOS ONE			English	Article							FLOWER-VISITING INSECTS; BETA-DIVERSITY; SPECIES RICHNESS; HABITAT FRAGMENTATION; HUMAN DISTURBANCE; CROP POLLINATION; RAIN-FORESTS; BIODIVERSITY; CONSERVATION; COMMUNITIES	It is a globally important challenge to meet increasing demands for resources and, at the same time, protect biodiversity and ecosystem services. Farming is usually regarded as a major threat to biodiversity due to its expansion into natural areas. We compared biodiversity of bees and wasps between heterogeneous small-scale farming areas and protected forest in northern coastal Belize, Central America. Malaise traps operated for three months during the transition from wet to dry season. Farming areas consisted of a mosaic of mixed crop types, open habitat, secondary forest, and agroforestry. Mean species richness per site (alpha diversity), as well as spatial and temporal community variation (beta diversity) of bees and wasps were equal or higher in farming areas compared to protected forest. The higher species richness and community variation in farmland was due to additional species that did not occur in the forest, whereas most species trapped in forest were also found in farming areas. The overall regional species richness (gamma diversity) increased by 70% with the inclusion of farming areas. Our results suggest that small-scale farming systems adjacent to protected forest may not only conserve, but even favour, biodiversity of some taxonomic groups. We can, however, not exclude possible declines of bee and wasp diversity in more intensified farmland or in landscapes completely covered by heterogeneous farming systems.	[Schueepp, Christof; Rittiner, Sarah] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Schueepp, Christof; Entling, Martin H.] Univ Koblenz Landau, Landau, Germany	University of Bern; University of Koblenz & Landau	Schuepp, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	christof.schueepp@iee.unibe.ch	Entling, Martin H/C-6953-2008		International Tropical Conservation Foundation ITCF, Kerzers, Switzerland; Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern)	International Tropical Conservation Foundation ITCF, Kerzers, Switzerland; Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern)	This research project was funded by the International Tropical Conservation Foundation ITCF, Kerzers, Switzerland (www.shipstern.org) and the Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern, www.nmbe.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except for the requirement of ITCF that at least a part of the research project takes place at Shipstern Nature Reserve.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Axmacher JC, 2011, BIOL CONSERV, V144, P2362, DOI 10.1016/j.biocon.2011.06.016; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bijleveld CFA, 1998, VEGETATION SHIPSTERN; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruggisser OT, 2010, BIOL CONSERV, V143, P1521, DOI 10.1016/j.biocon.2010.03.034; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Campbell JW, 2007, J INSECT CONSERV, V11, P399, DOI 10.1007/s10841-006-9055-4; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Coad L., 2009, ECOLOGICAL REPRESENT; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; EHRLICH PR, 1992, AMBIO, V21, P219; Eltz T, 2002, OECOLOGIA, V131, P27, DOI 10.1007/s00442-001-0848-6; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Godfray HCJ, 2011, SCIENCE, V333, P1231, DOI 10.1126/science.1211815; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Google, 2011, GOOGL EARTH 6 1 0 50; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; Hoehn P, 2010, BIODIVERS CONSERV, V19, P2189, DOI 10.1007/s10531-010-9831-z; Jha S, 2010, BIOL CONSERV, V143, P1423, DOI 10.1016/j.biocon.2010.03.017; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C., 2008, BEE POLLINATION AGR; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Magurran AE, 2007, MEASURING BIOL DIVER, V5; Meerman J. C., 2010, BIODIVERSITY ENV RES; Calvillo LM, 2010, J INSECT CONSERV, V14, P323, DOI 10.1007/s10841-010-9262-x; Michener C.D., 2007, BEES WORLD, Vsecond; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roubik D. W., 2004, ORCHID BEES TROPICAL; Samejima H, 2004, BIOL CONSERV, V120, P577, DOI 10.1016/j.biocon.2004.03.030; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schleuning M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027785; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; Vulliamy B, 2006, OIKOS, V114, P529, DOI 10.1111/j.2006.0030-1299.14004.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Zuur Alain F., 2009, P1	81	22	23	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52109	10.1371/journal.pone.0052109	http://dx.doi.org/10.1371/journal.pone.0052109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300598	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800049
J	Kurata, HT; Akrouh, A; Li, JBW; Marton, LJ; Nichols, CG				Kurata, Harley T.; Akrouh, Alejandro; Li, Jenny B. W.; Marton, Laurence J.; Nichols, Colin G.			Scanning the Topography of Polyamine Blocker Binding in an Inwardly Rectifying Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; CYTOPLASMIC POLYAMINES; VOLTAGE SENSITIVITY; SPERMINE BINDING; KIR2.1 CHANNELS; MOLECULAR-BASIS; RECTIFICATION; PORE; MECHANISM	Steeply voltage-dependent inward rectification of Kir (inwardly rectifying potassium) channels arises from blockade by cytoplasmic polyamines. These polycationic blockers traverse a long (> 70 angstrom) pore, displacing multiple permeant ions, en route to a high affinity binding site that remains loosely defined. We have scanned the effects of cysteine modification at multiple pore-lining positions on the blocking properties of a library of polyamine analogs, demonstrating that the effects of cysteine modification are position-and blocker-dependent. Specifically, introduction of positively charged adducts results in two distinct phenotypes: either disruption of blocker binding or generation of a barrier to blocker migration, in a consistent pattern that depends on both the length of the polyamine blocker and the position of the modified cysteine. These findings reveal important details about the chemical basis and specific location of high affinity polyamine binding.	[Kurata, Harley T.; Li, Jenny B. W.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Akrouh, Alejandro; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Akrouh, Alejandro; Nichols, Colin G.] Washington Univ, Sch Med, CIMED, St Louis, MO 63110 USA; [Marton, Laurence J.] Univ Calif San Francisco, Dept Lab Med, Palo Alto, CA 94306 USA	University of British Columbia; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	National Institutes of Health [HL54171, HL53268]; Canadian Institutes for Health Research (CIHR) [MOP-97998]; Natural Sciences and Engineering Research Council (NSERC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171 (to C. G. N.) and HL53268 (to H. T. K.). This work was also supported by Canadian Institutes for Health Research (CIHR) Operating Grant MOP-97998 (to H. T. K.) and a Natural Sciences and Engineering Research Council (NSERC) Discovery grant (to H. T. K.).	Bushman JD, 2010, J BIOL CHEM, V285, P6012, DOI 10.1074/jbc.M109.085860; Cerrone M, 2006, J INTERN MED, V259, P24, DOI 10.1111/j.1365-2796.2005.01582.x; Chang HK, 2003, J PHYSIOL-LONDON, V553, P101, DOI 10.1113/jphysiol.2003.052845; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2008, BIOPHYS J, V95, P3827, DOI 10.1529/biophysj.108.133256; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lopatin AN, 1996, J GEN PHYSIOL, V108, P105, DOI 10.1085/jgp.108.2.105; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; MAVRI J, 1994, PROTEINS, V18, P381, DOI 10.1002/prot.340180408; Mitchell JLA, 2002, BIOCHEM J, V366, P663, DOI 10.1042/BJ20011612; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Shin HG, 2005, J GEN PHYSIOL, V125, P413, DOI 10.1085/jgp.200409242; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Valasinas A, 2001, J MED CHEM, V44, P390, DOI 10.1021/jm000309t; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	38	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6591	6601		10.1074/jbc.M112.383794	http://dx.doi.org/10.1074/jbc.M112.383794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300089	hybrid, Green Published			2022-12-25	WOS:000315820700059
J	Grimes, ML; Lee, WJ; Van der Maaten, L; Shannon, P				Grimes, Mark L.; Lee, Wan-Jui; Van der Maaten, Laurens; Shannon, Paul			Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways	PLOS ONE			English	Article							SRC FAMILY KINASES; LUNG-CANCER; NETWORKS; RECEPTOR; GENE; CYTOSCAPE; BIOINFORMATICS; VISUALIZATION; COMBINATION; SOFTWARE	The interpretation of biological data sets is essential for generating hypotheses that guide research, yet modern methods of global analysis challenge our ability to discern meaningful patterns and then convey results in a way that can be easily appreciated. Proteomic data is especially challenging because mass spectrometry detectors often miss peptides in complex samples, resulting in sparsely populated data sets. Using the R programming language and techniques from the field of pattern recognition, we have devised methods to resolve and evaluate clusters of proteins related by their pattern of expression in different samples in proteomic data sets. We examined tyrosine phosphoproteomic data from lung cancer samples. We calculated dissimilarities between the proteins based on Pearson or Spearman correlations and on Euclidean distances, whilst dealing with large amounts of missing data. The dissimilarities were then used as feature vectors in clustering and visualization algorithms. The quality of the clusterings and visualizations were evaluated internally based on the primary data and externally based on gene ontology and protein interaction networks. The results show that t-distributed stochastic neighbor embedding (t-SNE) followed by minimum spanning tree methods groups sparse proteomic data into meaningful clusters more effectively than other methods such as k-means and classical multidimensional scaling. Furthermore, our results show that using a combination of Spearman correlation and Euclidean distance as a dissimilarity representation increases the resolution of clusters. Our analyses show that many clusters contain one or more tyrosine kinases and include known effectors as well as proteins with no known interactions. Visualizing these clusters as networks elucidated previously unknown tyrosine kinase signal transduction pathways that drive cancer. Our approach can be applied to other data types, and can be easily adopted because open source software packages are employed.	[Grimes, Mark L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lee, Wan-Jui; Van der Maaten, Laurens] Delft Univ Technol, Pattern Recognit & Bioinformat Grp, Cd Delft, Netherlands; [Shannon, Paul] Fred Hutchison Canc Res Inst, Seattle, WA USA	University of Montana System; University of Montana; Delft University of Technology; Fred Hutchinson Cancer Center	Grimes, ML (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	Mark.Grimes@mso.umt.edu			National Institutes of Health (NIH) [NS070746-01, NS061303-01]; COBRE NCRR [P20 RR015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070746, R15NS061303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG was supported by National Institutes of Health (NIH) NS070746-01, NS061303-01, and COBRE NCRR grant P20 RR015583. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044982; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belani CP, 2012, CANCER TREAT REV, V38, P173, DOI 10.1016/j.ctrv.2011.05.009; Bennetzen MV, 2012, J PROTEOME RES, V11, P3480, DOI 10.1021/pr300016e; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bot JJ, 2011, BIOINFORMATICS, V27, P2451, DOI 10.1093/bioinformatics/btr388; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Celton M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-15; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Clery D, 2011, SCIENCE, V333, P173, DOI 10.1126/science.333.6039.173; Cuesta-Albertos JA, 1997, ANN STAT, V25, P553; Duin RPW, 2012, PATTERN RECOGN LETT, V33, P826, DOI 10.1016/j.patrec.2011.04.019; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Engholm-Keller K, 2012, J PROTEOMICS, V75, P5749, DOI 10.1016/j.jprot.2012.08.007; Gabow H. N., 1977, SIAM Journal on Computing, V6, P139, DOI 10.1137/0206011; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Gilmore JM, 2012, ANAL BIOANAL CHEM, V402, P711, DOI 10.1007/s00216-011-5466-5; Goh WWB, 2012, PROTEOMICS, V12, P550, DOI 10.1002/pmic.201100321; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Ibba A., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3360, DOI 10.1109/ICPR.2010.820; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jianu R, 2010, IEEE T VIS COMPUT GR, V16, P609, DOI 10.1109/TVCG.2009.106; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; Lopez Elena, 2011, J Clin Bioinforma, V1, P26, DOI 10.1186/2043-9113-1-26; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Naegle KM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002119; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pekalska E, 2006, PATTERN RECOGN, V39, P189, DOI 10.1016/j.patcog.2005.06.012; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Salakhutdinov R., 2007, P 24 INT C MACHINE L, P791, DOI 10.1145/1273496.1273596; Sasaki H, 2012, ONCOL LETT, V4, P33, DOI 10.3892/ol.2012.684; SCHAAB C, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.014068; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Srebro N., 2003, P 20 INT C MACHINE L, P720; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tufte ER, 2001, GRAPHICS PR, P1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Wu XD, 2012, CANCER TREAT REV, V38, P580, DOI 10.1016/j.ctrv.2012.02.013; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	64	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52884	10.1371/journal.pone.0052884	http://dx.doi.org/10.1371/journal.pone.0052884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300999	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000020
J	Hamilton, ST; Scott, G; Naing, Z; Iwasenko, J; Hall, B; Graf, N; Arbuckle, S; Craig, ME; Rawlinson, WD				Hamilton, Stuart T.; Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Hall, Beverley; Graf, Nicole; Arbuckle, Susan; Craig, Maria E.; Rawlinson, William D.			Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy Outcomes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; TERM PLACENTAE; IN-VITRO; INFECTION; EXPRESSION; INDUCTION; TRANSMISSION; PROTEIN-1; APOPTOSIS	Human cytomegalovirus (CMV) infection of the developing fetus can result in adverse pregnancy outcomes including death in utero. Fetal injury results from direct viral cytopathic damage to the CMV-infected fetus, although evidence suggests CMV placental infection may indirectly cause injury to the fetus, possibly via immune dysregulation with placental dysfunction. This study investigated the effects of CMV infection on expression of the chemokine MCP-1 (CCL2) and cytokine TNF-alpha in placentae from naturally infected stillborn babies, and compared these changes with those found in placental villous explant histocultures acutely infected with CMV ex vivo. Tissue cytokine protein levels were assessed using quantitative immunohistochemistry. CMV-infected placentae from stillborn babies had significantly elevated MCP-1 and TNF-alpha levels compared with uninfected placentae (p = 0.001 and p = 0.007), which was not observed in placentae infected with other microorganisms (p = 0.62 and p = 0.71) (n = 7 per group). Modelling acute clinical infection using ex vivo placental explant histocultures showed infection with CMV laboratory strain AD169 (0.2 pfu/ml) caused significantly elevated expression of MCP-1 and TNF-alpha compared with uninfected explants (p = 0.0003 and p<0.0001) (n = 25 per group). Explant infection with wild-type Merlin at a tenfold lower multiplicity of infection (0.02 pfu/ml), caused a significant positive correlation between increased explant infection and upregulation of MCP-1 and TNF-alpha expression (p = 0.0001 and p = 0.017). Cytokine dysregulation has been associated with adverse outcomes of pregnancy, and can negatively affect placental development and function. These novel findings demonstrate CMV infection modulates the placental immune environment in vivo and in a multicellular ex vivo model, suggesting CMV-induced cytokine modulation as a potential initiator and/or exacerbator of placental and fetal injury.	[Hamilton, Stuart T.; Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Hall, Beverley; Craig, Maria E.; Rawlinson, William D.] Prince Wales Hosp, Div Virol, SEALS Microbiol, Sydney, NSW, Australia; [Hamilton, Stuart T.; Scott, Gillian; Rawlinson, William D.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Scott, Gillian; Naing, Zin; Iwasenko, Jenna; Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Graf, Nicole; Arbuckle, Susan] Childrens Hosp Westmead, Dept Histopathol, Sydney, NSW, Australia; [Craig, Maria E.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Craig, Maria E.] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney	Rawlinson, WD (corresponding author), Prince Wales Hosp, Div Virol, SEALS Microbiol, Sydney, NSW, Australia.	w.rawlinson@unsw.edu.au		Rawlinson, William/0000-0003-0988-7827; Craig, Maria E/0000-0001-6004-576X; Hamilton, Stuart/0000-0002-2170-4889	Stillbirth Foundation Australia	Stillbirth Foundation Australia	This work was supported by charitable grants from the Stillbirth Foundation Australia, www.stillbirthfoundation.org.au. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Briana DD, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65032; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P159, DOI 10.1080/713605644; Chan G, 2006, J PATHOL, V210, P111, DOI 10.1002/path.2025; Chan G, 2004, BIOL REPROD, V71, P797, DOI 10.1095/biolreprod.104.028118; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Esplin MS, 2005, PLACENTA, V26, P661, DOI 10.1016/j.placenta.2004.09.012; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026; Garcia-Lloret MI, 2000, J LEUKOCYTE BIOL, V68, P903; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; GENDRON RL, 1990, J REPROD FERTIL, V90, P395, DOI 10.1530/jrf.0.0900395; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P253, DOI 10.1007/s00795-003-0223-2; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325; Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x; Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Lopez H, 2011, PLACENTA, V32, P522, DOI 10.1016/j.placenta.2011.04.016; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06; Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210; McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004; Nigro G, 2011, CURR OPIN OBSTET GYN, V23, P123, DOI 10.1097/GCO.0b013e328342f1f6; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Scott GM, 2012, J INFECT DIS, V205, P1305, DOI 10.1093/infdis/jis186; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Steinborn A, 1998, OBSTET GYNECOL, V91, P329, DOI 10.1016/S0029-7844(97)00680-7; Tabata T, 2012, AM J PATHOL; Toder V, 2003, J ASSIST REPROD GEN, V20, P73, DOI 10.1023/A:1021740108284; Trincado DE, 2005, J INFECT DIS, V192, P650, DOI 10.1086/431999; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; VINCE G, 1992, CLIN EXP IMMUNOL, V88, P174; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004	51	58	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52899	10.1371/journal.pone.0052899	http://dx.doi.org/10.1371/journal.pone.0052899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300810	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872600034
J	Kazi, JU; Ronnstrand, L				Kazi, Julhash U.; Roennstrand, Lars			Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling	PLOS ONE			English	Article							CBL-DEPENDENT MANNER; C-CBL; NEGATIVE REGULATOR; FAMILY KINASES; LEUKEMIA; EXPRESSION; AUTOPHOSPHORYLATION; SUBTYPES; SYK; AML	Fms-like tyrosine kinase 3 (Flt3) is an important growth factor receptor in hematopoiesis. Gain-of-function mutations of the receptor contribute to the transformation of acute myeloid leukemia (AML). Src-like adaptor protein (SLAP) is an interaction partner of the E3 ubiquitin ligase Cbl that can regulate receptor tyrosine kinases-mediated signal transduction. In this study, we analyzed the role of SLAP in signal transduction downstream of the type III receptor tyrosine kinase Flt3. The results show that upon ligand stimulation SLAP stably associates with Flt3 through multiple phosphotyrosine residues in Flt3. SLAP constitutively interacts with oncogenic Flt3-ITD and co-localizes with Flt3 near the cell membrane. This association initiates Cbl-dependent receptor ubiquitination and degradation. Depletion of SLAP expression by shRNA in Flt3-transfected Ba/F3 cells resulted in a weaker activation of FL-induced PI3K-Akt and MAPK signaling. Meta-analysis of microarray data from patient samples suggests that SLAP mRNA is differentially expressed in different cancers and its expression was significantly increased in patients carrying the Flt3-ITD mutation. Thus, our data suggest a novel role of SLAP in different cancers and in modulation of receptor tyrosine kinase signaling apart from its conventional role in regulation of receptor stability.	[Kazi, Julhash U.; Roennstrand, Lars] Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Kazi, Julhash U./D-9190-2011	Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Cancer Society; Swedish Children's Cancer Organization; Swedish Research Council; ALF governmental clinical grant; Wenner Foundation; Gren Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Organization; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF governmental clinical grant; Wenner Foundation; Gren Foundation	This research was funded by the Swedish Cancer Society, the Swedish Children's Cancer Organization, the Swedish Research Council, and an ALF governmental clinical grant. J.U. Kazi was supported by Wenner-Gren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asyali MH, 2005, BIOINFORMATICS, V21, P644, DOI 10.1093/bioinformatics/bti036; Dragone LL, 2006, P NATL ACAD SCI USA, V103, P18202, DOI 10.1073/pnas.0608965103; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Hiragun T, 2006, J IMMUNOL, V177, P2047, DOI 10.4049/jimmunol.177.4.2047; Kazi JU, 2012, J BIOL CHEM, V287, P36509, DOI 10.1074/jbc.M112.376111; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Liontos LM, 2011, J IMMUNOL, V186, P1923, DOI 10.4049/jimmunol.0903292; Marasca R, 2006, LEUKEMIA, V20, P103, DOI 10.1038/sj.leu.2404000; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Roche S, 1998, CURR BIOL, V8, P975, DOI 10.1016/S0960-9822(98)70400-2; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Sirvent A, 2008, ONCOGENE, V27, P3494, DOI 10.1038/sj.onc.1211011; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Tang J, 1999, P NATL ACAD SCI USA, V96, P9775, DOI 10.1073/pnas.96.17.9775; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421	28	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53509	10.1371/journal.pone.0053509	http://dx.doi.org/10.1371/journal.pone.0053509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300935	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600105
J	Koutsoudakis, G; Perez-del-Pulgar, S; Gonzalez, P; Crespo, G; Navasa, M; Forns, X				Koutsoudakis, George; Perez-del-Pulgar, Sofia; Gonzalez, Patricia; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier			A Gaussia Luciferase Cell-Based System to Assess the Infection of Cell Culture- and Serum-Derived Hepatitis C Virus	PLOS ONE			English	Article							B TYPE-I; REPLICATION; EPIDEMIOLOGY; RECEPTOR	Robust replication of hepatitis C virus (HCV) in cell culture occurs only with the JFH-1 (genotype 2a) recombinant genome. The aim of this study was to develop a system for HCV infection quantification analysis and apply it for the selection of patient sera that may contain cell culture infectious viruses, particularly of the most clinically important genotype 1. Initially, a hepatoma cell line (designated Huh-7.5/EG(4A/4B)GLuc) was generated that stably expressed the enhanced green fluorescent protein (EGFP) fused in-frame to the secreted Gaussia luciferase via a recognition sequence of the viral NS3/4A protease. Upon HCV infection, NS3/4A cleaved at its signal and the Gaussia was secreted to the culture medium, thus facilitating the infection quantification. The Huh-7.5/EG(4A/4B)GLuc cell line provided a rapid and highly sensitive quantification of HCV infection in cell culture using JFH-1-derived viruses. Furthermore, the Huh-7.5/EG(4A/4B)GLuc cells were also shown to be a suitable host for the discovery of anti-HCV inhibitors by using known compounds that target distinct stages of the HCV life cycle; the Z-factor of this assay ranged from 0.72 to 0.75. Additionally, eighty-six sera derived from HCV genotype 1b infected liver transplant recipients were screened for their in vitro infection and replication potential. Approximately 12% of the sera contained in vitro replication-competent viruses, as deduced by the Gaussia signal, real time quantitative PCR, immunofluorescence and capsid protein secretion. We conclude that the Huh-7.5/EG(4A/4B)GLuc cell line is an excellent system not only for the screening of in vitro replication-competent serum-derived viruses, but also for the subsequent cloning of recombinant isolates. Additionally, it can be utilized for high-throughput screening of antiviral compounds.	[Koutsoudakis, George; Perez-del-Pulgar, Sofia; Gonzalez, Patricia; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Koutsoudakis, G (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	gkoutsou@clinic.ub.es	Navasa, Miquel/G-7958-2016	Navasa, Miquel/0000-0002-3130-9604; Forns, Xavier/0000-0002-8188-1764; Perez-del-Pulgar, Sofia/0000-0002-9890-300X; Crespo, Gonzalo/0000-0002-1178-4897	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad [PI11/01907]; Fondo Europeo de Desarrollo Regional (FEDER); Union Europea; Una manera de hacer Europa; Roche Organ Transplantation Research Foundation (ROTRF) [CI: 442035057]	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Union Europea; Una manera de hacer Europa; Roche Organ Transplantation Research Foundation (ROTRF)	X. Forns received a grant from Instituto de Salud Carlos III, Ministerio de Economia y Competitividad (PI11/01907), co-funded by Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa; and from the Roche Organ Transplantation Research Foundation (ROTRF, CI: 442035057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dragun J, 2011, AM J TRANSPLANT, V11, P767, DOI 10.1111/j.1600-6143.2011.03440.x; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kato N, 2000, CURR TOP MICROBIOL, V242, P261; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JC, 2005, ASSAY DRUG DEV TECHN, V3, P385, DOI 10.1089/adt.2005.3.385; Lee JW, 2003, CHEM COMMUN, P1852, DOI 10.1039/b303960a; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pan KL, 2009, ANTIMICROB AGENTS CH, V53, P4825, DOI 10.1128/AAC.00601-09; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	40	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53254	10.1371/journal.pone.0053254	http://dx.doi.org/10.1371/journal.pone.0053254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300900	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600075
J	Leung, L; Andrews-Zwilling, Y; Yoon, SY; Jain, S; Ring, K; Dai, J; Wang, MM; Tong, L; Walker, D; Huang, YD				Leung, Laura; Andrews-Zwilling, Yaisa; Yoon, Seo Yeon; Jain, Sachi; Ring, Karen; Dai, Jessica; Wang, Max Mu; Tong, Leslie; Walker, David; Huang, Yadong			Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; MESSENGER-RIBONUCLEIC-ACID; ALZHEIMERS-DISEASE; DENTATE GYRUS; TARGETED REPLACEMENT; ULTRASTRUCTURAL EVIDENCE; STEREOLOGICAL METHODS; REDUCED INHIBITION; ANDROGEN RECEPTORS	Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease (AD). ApoE4 has sex-dependent effects, whereby the risk of developing AD is higher in apoE4-expressing females than males. However, the mechanism underlying the sex difference, in relation to apoE4, is unknown. Previous findings indicate that apoE4 causes age-dependent impairments of hilar GABAergic interneurons in female mice, leading to learning and memory deficits. Here, we investigate whether the detrimental effects of apoE4 on hilar GABAergic interneurons are sex-dependent using apoE knock-in (KI) mice across different ages. We found that in female apoE-KI mice, there was an age-dependent depletion of hilar GABAergic interneurons, whereby GAD67- or somatostatin-positive-but not NPY-or parvalbumin-positive-interneuron loss was exacerbated by apoE4. Loss of these neuronal populations was correlated with the severity of spatial learning deficits at 16 months of age in female apoE4-KI mice; however, this effect was not observed in female apoE3-KI mice. In contrast, we found an increase in the numbers of hilar GABAergic interneurons with advancing age in male apoE-KI mice, regardless of apoE genotype. Moreover, male apoE-KI mice showed a consistent ratio of hilar inhibitory GABAergic interneurons to excitatory mossy cells approximating 1.5 that is independent of apoE genotype and age, whereas female apoE-KI mice exhibited an age-dependent decrease in this ratio, which was exacerbated by apoE4. Interestingly, there are no apoE genotype effects on GABAergic interneurons in the CA1 and CA3 subregions of the hippocampus as well as the entorhinal and auditory cortexes. These findings suggest that the sex-dependent effects of apoE4 on developing AD is in part attributable to inherent sex-based differences in the numbers of hilar GABAergic interneurons, which is further modulated by apoE genotype.	[Leung, Laura; Andrews-Zwilling, Yaisa; Yoon, Seo Yeon; Jain, Sachi; Ring, Karen; Dai, Jessica; Wang, Max Mu; Tong, Leslie; Walker, David; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Walker, David; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Leung, Laura; Andrews-Zwilling, Yaisa; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Jain, Sachi; Ring, Karen; Tong, Leslie; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu		Wang, Max/0000-0002-2810-8561	J. David Gladstone Institutes; National Institutes of Health [P01 AG022074, P30 NS065780, C06RR18928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes, National Institutes of Health grants P01 AG022074, P30 NS065780, and C06RR18928, and a gift from the S.D. Bechtel Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo S, 2008, LETT DRUG DES DISCOV, V5, P271, DOI 10.2174/157018008784619898; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; BAREGGI SR, 1982, ARCH NEUROL-CHICAGO, V39, P709, DOI 10.1001/archneur.1982.00510230035010; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; BEATTY WW, 1979, HORM BEHAV, V12, P112, DOI 10.1016/0018-506X(79)90017-5; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; CASTELLANO C, 1993, BEHAV NEURAL BIOL, V60, P123, DOI 10.1016/0163-1047(93)90215-4; CLANCY AN, 1992, LIFE SCI, V50, P409, DOI 10.1016/0024-3205(92)90375-Y; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Collinson N, 2002, J NEUROSCI, V22, P5572; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Fillit H, 1997, MATURITAS, V26, P159, DOI 10.1016/S0378-5122(97)01101-8; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Fukuda T, 1998, J COMP NEUROL, V395, P177, DOI 10.1002/(SICI)1096-9861(19980601)395:2<177::AID-CNE3>3.0.CO;2-#; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gill DA, 2010, BRAIN RES, V1331, P114, DOI 10.1016/j.brainres.2010.03.054; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; Grouselle D, 1998, NEUROSCI LETT, V255, P21, DOI 10.1016/S0304-3940(98)00698-3; Hajszan T, 2007, PROG BRAIN RES, V163, P399, DOI 10.1016/S0079-6123(07)63023-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1987, NEUROSCI LETT, V73, P192, DOI 10.1016/0304-3940(87)90016-4; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476; Hilke S, 2009, NEUROPEPTIDES, V43, P327, DOI 10.1016/j.npep.2009.04.005; Hu JH, 2004, NEUROREPORT, V15, P9, DOI 10.1097/00001756-200401190-00003; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Hunter JM, 2012, BRAIN RES, V1467, P120, DOI 10.1016/j.brainres.2012.05.048; Jinno S, 2009, HIPPOCAMPUS, V19, P1130, DOI 10.1002/hipo.20576; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Lloyd K G, 1986, Adv Neurol, V44, P1033; LOY R, 1988, DEV BRAIN RES, V39, P245, DOI 10.1016/0165-3806(88)90028-4; Luine, 1997, Stress, V2, P21; McAbee MD, 1998, ENDOCRINOLOGY, V139, P1738, DOI 10.1210/en.139.4.1738; McEwen BS, 1997, ACTA PAEDIATR, V86, P41; MCKINNEY TD, 1972, J MAMMAL, V53, P391, DOI 10.2307/1379187; Medina AE, 2001, PHARMACOL BIOCHEM BE, V68, P591, DOI 10.1016/S0091-3057(01)00466-X; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Milner TA, 2001, J COMP NEUROL, V429, P355; Mortensen EL, 2001, NEUROLOGY, V57, P89, DOI 10.1212/WNL.57.1.89; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Naftolin F, 1975, Adv Biosci, V15, P105; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Payami H, 1996, NEUROLOGY, V46, P126, DOI 10.1212/WNL.46.1.126; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pfankuch T, 2005, BRAIN RES, V1053, P88, DOI 10.1016/j.brainres.2005.06.028; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Seidl R, 2001, N-S ARCH PHARMACOL, V363, P139, DOI 10.1007/s002100000346; Shi J, 2012, ACTA BIOCH BIOPHYS S; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; Stoffel-Wagner B, 1998, BIOCHEM BIOPH RES CO, V244, P768, DOI 10.1006/bbrc.1998.8337; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tabori NE, 2005, NEUROSCIENCE, V130, P151, DOI 10.1016/j.neuroscience.2004.08.048; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Tokita K, 2005, EUR J PHARMACOL, V527, P111, DOI 10.1016/j.ejphar.2005.10.022; Vas CJ, 2001, INT PSYCHOGERIATR, V13, P439, DOI 10.1017/S1041610201007852; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Vepsalainen S, 2007, J NEUROL, V254, P1504, DOI 10.1007/s00415-007-0539-2; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Wang WZ, 2000, NEUROEPIDEMIOLOGY, V19, P194, DOI 10.1159/000026255; WEILAND NG, 1992, ENDOCRINOLOGY, V131, P2697, DOI 10.1210/en.131.6.2697; Weiland NG, 1997, J COMP NEUROL, V388, P603, DOI 10.1002/(SICI)1096-9861(19971201)388:4<603::AID-CNE8>3.0.CO;2-6; West M J, 2001, Folia Morphol (Warsz), V60, P11; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Xue SF, 2009, NEUROSCI LETT, V465, P181, DOI 10.1016/j.neulet.2009.09.002; Zappone CA, 2004, J NEUROSCI, V24, P853, DOI 10.1523/JNEUROSCI.1619-03.2004; ZIMMER R, 1984, ARCH NEUROL-CHICAGO, V41, P602, DOI 10.1001/archneur.1984.04210080010005	94	61	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53569	10.1371/journal.pone.0053569	http://dx.doi.org/10.1371/journal.pone.0053569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300939	Green Published, gold			2022-12-25	WOS:000313872600109
J	Tsai, YC; Hung, CC; Kuo, MC; Tsai, JC; Yeh, SM; Hwang, SJ; Chiu, YW; Kuo, HT; Chang, JM; Chen, HC				Tsai, Yi-Chun; Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Yeh, Shih-Meng; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun			Association of hsCRP, White Blood Cell Count and Ferritin with Renal Outcome in Chronic Kidney Disease Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACUTE-PHASE PROTEINS; CARDIOVASCULAR-DISEASE; SERUM FERRITIN; ALL-CAUSE; INFLAMMATION; DIALYSIS; MORTALITY; PROGRESSION; MARKERS	Inflammation is a pathogenic factor in renal injury, but whether inflammation is related to renal outcome in chronic kidney disease (CKD) patients is little known. We thus assess the association of inflammation and renal outcome in an advanced CKD cohort. This study analyzed the association between inflammatory markers, such as C-reactive protein (hsCRP), white blood cell (WBC) count and ferritin, renal replacement therapy (RRT) and rapid renal progression (estimated GFR slope<-6 ml/min/1.73 m(2)/y) in 3303 patients with stage 3-5 CKD. In all subjects, the mean hsCRP, WBC count, and ferritin levels were 1.2 (0.4, 5.4) mg/L, 7.2 +/- 2.3x10(3) cells/mu L, and 200 (107,349) ng/mL, respectively. During a mean 3.2-year follow-up, there were 1080 (32.7%) subjects commencing RRT, and 841(25.5%) subjects presenting rapid renal progression. Both hsCRP and ferritin were associated with increased risk for RRT with the adjusted HR (tertile 3 versus tertile 1:1.17 (1.01-1.36) and 1.20 (1.03-1.40), respectively). Both hsCRP and ferritin were associated with increased odds for rapid renal progression with the adjusted OR (tertile 3 versus tertile 1:1.40 (1.13-1.77) and 1.32 (1.06-1.67), respectively). hsCRP and ferritin stratified by albumin were also associated with RRT and rapid renal progression. Instead, WBC count was not associated with renal outcome. In conclusion, elevated levels of hsCRP and ferritin are risk factors associated with RRT and rapid renal progression in advanced CKD patients.	[Tsai, Yi-Chun; Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Yeh, Shih-Meng; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Hung, Chi-Chih; Kuo, Mei-Chuan; Tsai, Jer-Chia; Hwang, Shang-Jyh; Chiu, Yi-Wen; Kuo, Hung-Tien; Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Chang, JM (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan.	jemich@kmu.edu.tw		Kuo, Hung-Tien/0000-0002-9931-4354				Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Ates K, 2005, PERITON DIALYSIS INT, V25, P256; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; Boos CJ, 2006, CURR PHARM DESIGN, V12, P1623, DOI 10.2174/138161206776843313; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Erlinger TP, 2003, AM J KIDNEY DIS, V42, P256, DOI 10.1016/S0272-6386(03)00650-4; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Fox ER, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-1; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Johnson DW, 2005, KIDNEY INT, V67, P738, DOI 10.1111/j.1523-1755.2005.67135.x; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P141, DOI 10.1093/ndt/gfg493; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V37, P564, DOI 10.1053/ajkd.2001.22433; Kalender B, 2002, INT J CLIN PRACT, V56, P505; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim Y, 2012, INT UROL NEPHROL, DOI [10.1007/j.int urol nephrol.2012.04.015, DOI 10.1007/J.INTUROLNEPHROL.2012.04.015]; Koeda Y, 2011, INT HEART J, V52, P180, DOI 10.1536/ihj.52.180; Kovesdy CP, 2009, CLIN J AM SOC NEPHRO, V4, P435, DOI 10.2215/CJN.03980808; Kovesdy CP, 2009, AM J CLIN NUTR, V90, P407, DOI 10.3945/ajcn.2008.27390; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Navarro JF, 2006, AM J NEPHROL, V26, P562, DOI 10.1159/000098004; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rijkin DE, 2009, AM J KIDNEY DIS, V53, P572, DOI 10.1053/j.ajkd.2009.01.001; ROGERS JT, 1990, J BIOL CHEM, V265, P14572; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Streja E, 2011, AM J KIDNEY DIS, V57, P883, DOI 10.1053/j.ajkd.2010.10.050; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Tatli MM, 2000, PEDIATR INT, V42, P289, DOI 10.1046/j.1442-200x.2000.01217.x; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wang AYM, 2003, J AM SOC NEPHROL, V14, P1871, DOI 10.1097/01.ASN.0000070071.57901.B3; Wanner C, 2002, KIDNEY INT, V61, pS99, DOI 10.1046/j.1523-1755.61.s80.18.x; Westhuyzen J, 2000, ANN CLIN LAB SCI, V30, P133; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417	48	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52775	10.1371/journal.pone.0052775	http://dx.doi.org/10.1371/journal.pone.0052775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300770	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600025
J	Zhu, J; Siclari, VA; Liu, F; Spatz, JM; Chandra, A; Pajevic, PD; Qin, L				Zhu, Ji; Siclari, Valerie A.; Liu, Fei; Spatz, Jordan M.; Chandra, Abhishek; Pajevic, Paola Divieti; Qin, Ling			Amphiregulin-EGFR Signaling Mediates the Migration of Bone Marrow Mesenchymal Progenitors toward PTH-Stimulated Osteoblasts and Osteocytes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INTERMITTENT PARATHYROID-HORMONE; IN-VIVO; OSTEOPROGENITOR CELLS; PTH/PTHRP RECEPTOR; ANABOLIC ACTIONS; EXPRESSION; DIFFERENTIATION; MECHANISMS; MICROARRAY	Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass and currently is one of the most effective treatments for osteoporosis. However, the detailed mechanisms are still largely unknown. Here we demonstrate that conditioned media from PTH-treated osteoblastic and osteocytic cells contain soluble chemotactic factors for bone marrow mesenchymal progenitors, which express a low amount of PTH receptor (PTH1R) and do not respond to PTH stimulation by increasing cAMP production or migrating toward PTH alone. Conditioned media from PTH-treated osteoblasts elevated phosphorylated Akt and p38MAPK amounts in mesenchymal progenitors and inhibition of these pathways blocked the migration of these progenitors toward conditioned media. Our previous and current studies revealed that PTH stimulates the expression of amphiregulin, an epidermal growth factor (EGF)-like ligand that signals through the EGF receptor (EGFR), in both osteoblasts and osteocytes. Interestingly, conditioned media from PTH-treated osteoblasts increased EGFR phosphorylation in mesenchymal progenitors. Using several different approaches, including inhibitor, neutralizing antibody, and siRNA, we demonstrate that PTH increases the release of amphiregulin from osteoblastic cells, which acts on the EGFRs expressed on mesenchymal progenitors to stimulate the Akt and p38MAPK pathways and subsequently promote their migration in vitro. Furthermore, inactivation of EGFR signaling specifically in osteoprogenitors/osteoblasts attenuated the anabolic actions of PTH on bone formation. Taken together, these results suggest a novel mechanism for the therapeutic effect of PTH on osteoporosis and an important role of EGFR signaling in mediating PTH's anabolic actions on bone.	[Zhu, Ji; Siclari, Valerie A.; Liu, Fei; Chandra, Abhishek; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Liu, Fei] Shanghai Ninth Peoples Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Spatz, Jordan M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Pajevic, Paola Divieti/M-3236-2019; Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669; Divieti Pajevic, Paola/0000-0001-9853-9837; Spatz, Jordan/0000-0002-6732-7353	National Institutes of Health [K01-DK071988, UH2-AR059655]; New Jersey Stem Cell Research Grant; National Osteoporosis Foundation; National Cancer Institute [R25 CA101871-07]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Stem Cell Research Grant; National Osteoporosis Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was made possible by support from the National Institutes of Health K01 grants K01-DK071988 (to LQ), UH2-AR059655 (to PDP), New Jersey Stem Cell Research Grant (to LQ), National Osteoporosis Foundation (to LQ), and grant R25 CA101871-07 from the National Cancer Institute (to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bianco P, 2011, J CELL BIOCHEM, V112, P1713, DOI 10.1002/jcb.23103; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Compston JE, 2007, BONE, V40, P1447, DOI 10.1016/j.bone.2006.09.008; Davies J, 2004, J ENDOCRINOL, V180, P505, DOI 10.1677/joe.0.1800505; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu Y, 2007, MOL MEMBR BIOL, V24, P91, DOI 10.1080/10929080600990500; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Prisby R, 2011, J BONE MINER RES, V26, P2583, DOI 10.1002/jbmr.459; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; ROULEAU MF, 1988, ENDOCRINOLOGY, V123, P187, DOI 10.1210/endo-123-1-187; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Sakai A, 1999, J BONE MINER RES, V14, P1691, DOI 10.1359/jbmr.1999.14.10.1691; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schipani E, 2009, ADULT MESENCHYMAL ST; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; Schneider MR, 2012, BONE, V50, P237, DOI 10.1016/j.bone.2011.10.019; Schneider MR, 2009, J BONE MINER RES, V24, P455, DOI 10.1359/JBMR.081202; Shinoda Y, 2010, J CELL BIOCHEM, V109, P755, DOI 10.1002/jcb.22454; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Wang YM, 2007, J BONE MINER RES, V22, P1329, DOI 10.1359/JBMR.070517; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012; Yamaoka T, 2011, AM J PHYSIOL-GASTR L, V301, pG368, DOI 10.1152/ajpgi.00327.2010; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	50	47	51	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50099	10.1371/journal.pone.0050099	http://dx.doi.org/10.1371/journal.pone.0050099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300521	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600001
J	Bhat, KH; Ahmed, A; Kumar, S; Sharma, P; Mukhopadhyay, S				Bhat, Khalid Hussain; Ahmed, Asma; Kumar, Santosh; Sharma, Pawan; Mukhopadhyay, Sangita			Role of PPE18 Protein in Intracellular Survival and Pathogenicity of Mycobacterium tuberculosis in Mice	PLOS ONE			English	Article							GRANULOMA-FORMATION; INFECTIOUS-DISEASE; HUMAN MACROPHAGES; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; IL-10; VIRULENCE; APOPTOSIS; CYTOKINES	Background: Ever since its discovery the mycobacterial proline-proline-glutamic acid (PPE) family of proteins has generated a huge amount of interest. Understanding the role of these proteins in the pathogenesis of Mycobacterium tuberculosis (Mtb) is important. We have demonstrated earlier that the PPE18 protein of Mtb induces IL-10 production in macrophages with subsequent downregulation of pro-inflammatory cytokines like IL-12 and TNF-alpha and favors a T-helper (Th) 2-type of immune response. Methodology/Principal Findings: Using a ppe18 genetic knock-out Mtb strain, we have now carried out infection studies in mice to understand the role of PPE18 in Mtb virulence. The studies reveal that lack of PPE18 leads to attenuation of Mtb in vivo. Mice infected with the ppe18 deleted strain have reduced infection burden in lung, liver and spleen and have better survival rates compared to mice infected with the wild-type Mtb strain. Conclusions/Significance: Taken together our data suggest that PPE18 could be a crucial virulence factor for intracellular survival of Mtb.	[Bhat, Khalid Hussain; Ahmed, Asma; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, Andhra Pradesh, India; [Kumar, Santosh; Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Sharma, Pawan] NE Reg Biotechnol Programme Management Cell NER B, New Delhi, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, Andhra Pradesh, India.	sangita@cdfd.org.in	Sharma, Pawan/F-7806-2010	Sharma, Pawan/0000-0002-2525-5451; Bhat, Dr. Khalid Hussain/0000-0002-0952-7496; Mukhopadhyay, Sangita/0000-0002-5511-3315; Ahmed, Asma/0000-0001-7735-1202	Department of Biotechnology (DBT), Government of India [BT/PR/7890/MED/14/1171/2006, BT/01/COE/07/02]; DBT; Council of Scientific and Industrial Research (CSIR), India; DBT Research Associateship in Biotechnology and Life Sciences from Department of Biotechnology (DBT), Government of India; National Institutes of Health-NIAID	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT Research Associateship in Biotechnology and Life Sciences from Department of Biotechnology (DBT), Government of India; National Institutes of Health-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants (BT/PR/7890/MED/14/1171/2006 and BT/01/COE/07/02) from Department of Biotechnology (DBT), Government of India and a core grant to Centre for DNA Fingerprinting and Diagnostics (CDFD), India by DBT. This work was also supported by research fellowship to KHB from the Council of Scientific and Industrial Research (CSIR), India and by DBT Research Associateship in Biotechnology and Life Sciences to AA from the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the gift of mutant strain (JHU ID 1440, MT1234) and the WT strain (CDC1551) of M. tuberculosis from Dr. Karen Dobos of the Colorado State University, Ft. Collins, CO through the National Institutes of Health-NIAID Contract entitled "Tuberculosis Vaccine Testing & Research Materials". We thank Dr. J. Gowrishankar, CDFD, India and Prof. V.S. Chauhan, ICGEB, India for kind help and support. The animal infection studies and determination of CFU counts were carried out at the Department of Biotechnology (DBT), Govt. of India-funded National Facility for Tuberculosis Research at ICGEB, New Delhi.	Abdul-Majid KB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-151; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Baliko Z, 1998, FEMS IMMUNOL MED MIC, V22, P199, DOI 10.1016/S0928-8244(98)00089-3; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; FALCONE V, 1994, FEMS IMMUNOL MED MIC, V8, P225, DOI 10.1016/0928-8244(94)90054-X; Feng CG, 2002, INFECT IMMUN, V70, P6672, DOI 10.1128/IAI.70.12.6672-6679.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Goldstone RM, 2009, INFECT IMMUN, V77, P4654, DOI 10.1128/IAI.01495-08; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Karls RK, 2006, MICROBIOL-SGM, V152, P1591, DOI 10.1099/mic.0.28591-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Li W, 2012, VACCINE, V30, P3223, DOI 10.1016/j.vaccine.2012.02.014; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Mukhopadhyay S, 2012, FEMS MICROBIOL REV, V36, P463, DOI 10.1111/j.1574-6976.2011.00302.x; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Rook G, 2001, TRENDS IMMUNOL, V22, P481, DOI 10.1016/S1471-4906(01)01980-9; Rook GAW, 2001, EUR RESPIR J, V17, P537, DOI 10.1183/09031936.01.17305370; Rosas-Taraco AG, 2009, AM J RESP CELL MOL, V41, P136, DOI 10.1165/rcmb.2008-0363OC; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Senaldi G, 1996, J IMMUNOL, V157, P5022; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Wilsher M. L., 1999, Tubercle and Lung Disease, V79, P371, DOI 10.1054/tuld.1999.0223	81	37	40	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52601	10.1371/journal.pone.0052601	http://dx.doi.org/10.1371/journal.pone.0052601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300718	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500038
J	Glas, J; Seiderer, J; Czamara, D; Pasciuto, G; Diegelmann, J; Wetzke, M; Olszak, T; Wolf, C; Muller-Myhsok, B; Balschun, T; Achkar, JP; Kamboh, MI; Franke, A; Duerr, RH; Brand, S				Glas, Juergen; Seiderer, Julia; Czamara, Darina; Pasciuto, Giulia; Diegelmann, Julia; Wetzke, Martin; Olszak, Torsten; Wolf, Christiane; Mueller-Myhsok, Bertram; Balschun, Tobias; Achkar, Jean-Paul; Kamboh, M. Ilyas; Franke, Andre; Duerr, Richard H.; Brand, Stephan			PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-kappa B and XBP1 Binding Sites	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; CELL-DIFFERENTIATION; FRAMESHIFT MUTATION; GERMAN POPULATION; RECEPTOR SUBTYPE; SULFONIC-ACID; GENETIC RISK	Background: Genome-wide association studies identified a PTGER4 expression-modulating region on chromosome 5p13.1 as Crohn's disease (CD) susceptibility region. The study aim was to test this association in a large cohort of patients with inflammatory bowel disease (IBD) and to elucidate genotypic and phenotypic interactions with other IBD genes. Methodology/Principal Findings: A total of 7073 patients and controls were genotyped: 844 CD and 471 patients with ulcerative colitis and 1488 controls were analyzed for the single nucleotide polymorphisms (SNPs) rs4495224 and rs7720838 on chromosome 5p13.1. The study included two replication cohorts of North American (CD: n = 684; controls: n = 1440) and of German origin (CD: n = 1098; controls: n = 1048). Genotype-phenotype, epistasis and transcription factor binding analyses were performed. In the discovery cohort, an association of rs4495224 (p = 4.10x10(-5); 0.76 [0.67-0.87]) and of rs7720838 (p = 6.91x10(-4); 0.81 [0.71-0.91]) with susceptibility to CD was demonstrated. These associations were confirmed in both replication cohorts. In silico analysis predicted rs4495224 and rs7720838 as essential parts of binding sites for the transcription factors NF-kappa B and XBP1 with higher binding scores for carriers of the CD risk alleles, providing an explanation of how these SNPs might contribute to increased PTGER4 expression. There was no association of the PTGER4 SNPs with IBD phenotypes. Epistasis detected between 5p13.1 and ATG16L1 for CD susceptibility in the discovery cohort (p = 5.99x10(-7) for rs7720838 and rs2241880) could not be replicated in both replication cohorts arguing against a major role of this gene-gene interaction in the susceptibility to CD. Conclusions/Significance: We confirmed 5p13.1 as a major CD susceptibility locus and demonstrate by in silico analysis rs4495224 and rs7720838 as part of binding sites for NF-kappa B and XBP1. Further functional studies are necessary to confirm the results of our in silico analysis and to analyze if changes in PTGER4 expression modulate CD susceptibility.	[Glas, Juergen; Seiderer, Julia; Pasciuto, Giulia; Diegelmann, Julia; Olszak, Torsten; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Czamara, Darina; Wolf, Christiane; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-8000 Munich, Germany; [Wetzke, Martin] Hannover Med Sch, Ctr Pediat, D-3000 Hannover, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med, Boston, MA 02115 USA; [Balschun, Tobias; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Achkar, Jean-Paul] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Achkar, Jean-Paul] Cleveland Clin, Dept Gastroenterol & Hepatol, Inst Digest Dis, Cleveland, OH 44106 USA; [Kamboh, M. Ilyas; Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA	University of Munich; University of Munich; RWTH Aachen University; Max Planck Society; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	Stephan.Brand@med.uni-muenchen.de	Franke, Andre/B-2151-2010; Wetzke, Martin/HDM-2614-2022; Duerr, Richard H/B-4188-2009	Franke, Andre/0000-0003-1530-5811; Duerr, Richard H/0000-0001-6586-3905; Kamboh, M. Ilyas/0000-0002-3453-1438	Deutsche Forschungsgemeinschaft [BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Demling Grant from DCCV e.V.; Excellence Initiative of the Ludwig-Maximilians-University Munich; University of Munich (FoFoLe) [422]; Robert-Bosch-Foundation; Else-Kroner-Fresenius-Stiftung; Broad Medical Foundation [IBD-0126R2]; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'; National Institutes of Health (NIH)/NIDDK [DK062420]; NIH [AG030653, HL092397, AG041718, DK068112]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068112, U01DK062420, R01DK076025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030653, R01AG041718] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Demling Grant from DCCV e.V.; Excellence Initiative of the Ludwig-Maximilians-University Munich; University of Munich (FoFoLe); Robert-Bosch-Foundation; Else-Kroner-Fresenius-Stiftung; Broad Medical Foundation; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); National Institutes of Health (NIH)/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SB was supported by grants from Deutsche Forschungsgemeinschaft (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), by the Ludwig-Demling Grant 2007 from DCCV e.V. and by a grant from the Excellence Initiative of the Ludwig-Maximilians-University Munich (Investment Funds 2008). JS and JD were supported by grants from the University of Munich (FoFoLe Nr. 422; Habilitationsstipendium to JS and Promotionsstipendium to JD); JS also was supported by the Robert-Bosch-Foundation and the Else-Kroner-Fresenius-Stiftung. JG was supported by a grant from the Broad Medical Foundation (IBD-0126R2). TB and AF were supported by the German Ministry of Education and Research through the National Genome Research Network and infrastructure support through the Deutsche Forschungsgemeinschaft cluster of excellence 'Inflammation at Interfaces'. RHD is supported by National Institutes of Health (NIH)/NIDDK grant DK062420. MIK was supported by NIH grants AG030653, HL092397 and AG041718. JPA was supported by NIH grant DK068112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chen Q, 2010, BRIT J PHARMACOL, V160, P292, DOI 10.1111/j.1476-5381.2010.00647.x; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clark P, 2008, J PHARMACOL EXP THER, V325, P425, DOI 10.1124/jpet.107.134510; Cox DG, 2005, WORLD J GASTROENTERO, V11, P6003, DOI 10.3748/wjg.v11.i38.6003; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Gookin JL, 2003, AM J PHYSIOL-GASTR L, V285, pG967, DOI 10.1152/ajpgi.00532.2002; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Morteau Olivier, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P473; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nitta M, 2002, SCAND J IMMUNOL, V56, P66, DOI 10.1046/j.1365-3083.2002.01096.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okamoto T, 2012, J PHARMACOL EXP THER, V341, P340, DOI 10.1124/jpet.111.190447; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Thalmaier D, 2006, ALIMENT PHARM THERAP, V24, P1105, DOI 10.1111/j.1365-2036.2006.03093.x; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	57	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52873	10.1371/journal.pone.0052873	http://dx.doi.org/10.1371/journal.pone.0052873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300802	Green Published, gold			2022-12-25	WOS:000312829100089
J	Jung, C; Colombel, JF; Lemann, M; Beaugerie, L; Allez, M; Cosnes, J; Vernier-Massouille, G; Gornet, JM; Gendre, JP; Cezard, JP; Ruemmele, FM; Turck, D; Merlin, F; Zouali, H; Libersa, C; Dieude, P; Soufir, N; Thomas, G; Hugot, JP				Jung, Camille; Colombel, Jean-Frederic; Lemann, Marc; Beaugerie, Laurent; Allez, Matthieu; Cosnes, Jacques; Vernier-Massouille, Gwenola; Gornet, Jean-Marc; Gendre, Jean-Pierre; Cezard, Jean-Pierre; Ruemmele, Frank M.; Turck, Dominique; Merlin, Francoise; Zouali, Habib; Libersa, Christian; Dieude, Philippe; Soufir, Nadem; Thomas, Gilles; Hugot, Jean-Pierre			Genotype/Phenotype Analyses for 53 Crohn's Disease Associated Genetic Polymorphisms	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DELETION POLYMORPHISM; ATG16L1 T300A; VARIANTS; IL23R; POPULATION; ONSET; RISK	Background & Aims: Recent studies reported a role for more than 70 genes or loci in the susceptibility to Crohn's disease (CD). However, the impact of these associations in clinical practice remains to be defined. The aim of the study was to analyse the relationship between genotypes and phenotypes for the main 53 CD-associated polymorphisms. Method: A cohort of 798 CD patients with a median follow up of 7 years was recruited by tertiary adult and paediatric gastroenterological centres. A detailed phenotypic description of the disease was recorded, including clinical presentation, response to treatments and complications. The participants were genotyped for 53 CD-associated variants previously reported in the literature and correlations with clinical sub-phenotypes were searched for. A replication cohort consisting of 722 CD patients was used to further explore the putative associations. Results: The NOD2 rare variants were associated with an earlier age at diagnosis (p = 0.0001) and an ileal involvement (OR = 2.25[1.49-3.41] and 2.77 [1.71-4.50] for rs2066844 and rs2066847, respectively). Colonic lesions were positively associated with the risk alleles of IL23R rs11209026 (OR = 2.25 [1.13-4.51]) and 6q21 rs7746082 (OR = 1.60 [1.10-2.34] and negatively associated with the risk alleles of IRGM rs13361189 (OR = 0.29 [0.11-0.74]) and DEFB1 rs11362 (OR = 0.50 [0.30-0.80]). The ATG16L1 and IRGM variants were associated with a non-inflammatory behaviour (OR = 1.75 [1.22-2.53] and OR = 1.50 [1.04-2.16] respectively). However, these associations lost significance after multiple testing corrections. The protective effect of the IRGM risk allele on colonic lesions was the only association replicated in the second cohort (p = 0.03). Conclusions: It is not recommended to genotype the studied polymorphisms in routine practice.	[Jung, Camille; Merlin, Francoise; Hugot, Jean-Pierre] Univ Paris Diderot, UMR843, Paris, France; [Jung, Camille; Merlin, Francoise; Hugot, Jean-Pierre] INSERM, UMR843, Paris, France; [Jung, Camille; Cezard, Jean-Pierre; Hugot, Jean-Pierre] Hop Robert Debre, APHP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Colombel, Jean-Frederic; Vernier-Massouille, Gwenola] Univ Lille, Hop Claude Huriez, Serv Gastroenterol, Lille, France; [Lemann, Marc; Allez, Matthieu; Gornet, Jean-Marc] Univ Paris Diderot, Hop St Louis, AP HP, Serv Gastroenterol, Paris, France; [Beaugerie, Laurent; Cosnes, Jacques; Gendre, Jean-Pierre] Univ Paris 06, Paris, France; [Beaugerie, Laurent; Cosnes, Jacques; Gendre, Jean-Pierre] Hop St Antoine, AP HP, Dept Gastroenterol, F-75571 Paris, France; [Ruemmele, Frank M.] Univ Paris 05, Serv Gastroenterol Pediat, Hop Necker Enfants Malad, APHP, Paris, France; [Turck, Dominique] Univ Lille 2, Hop Jean de Flandre, Serv Gastroenterol Pediat, Lille, France; [Zouali, Habib; Thomas, Gilles] CEPH Fdn Jean Dausset, Paris, France; [Libersa, Christian] Hop Cardiol, INSERM, Ctr Invest Clin 9301, F-59037 Lille, France; [Dieude, Philippe] Hop Bichat Claude Bernard, Serv Rhumatol, F-75877 Paris, France; [Soufir, Nadem] Hop Bichat Claude Bernard, Serv Biochim Genet, F-75877 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Hugot, JP (corresponding author), Univ Paris Diderot, UMR843, Paris, France.	jean-pierre.hugot@rdb.aphp.fr	Turck, Dominique/S-2382-2018	Turck, Dominique/0000-0003-1370-4667; Allez, Matthieu/0000-0002-2012-7522; Hugot, Jean-Pierre/0000-0002-8446-6056; JUNG, Camille/0000-0001-8486-8939; Dieude, Philippe/0000-0002-4814-0307	Ministere de la Sante (PHRC) [P010904]; Assistance-Publique Hopitaux de Paris APHP; Institut National de la Recherche Scientifique (INSERM); Universites Paris Denis-Diderot; Paris Pierre et Marie-Curie; Paris Rene-Descartes and Lille 2 droit et sante; Agence Nationale de la Recherche (ANR); fondation Jean Dausset/CEPH; Centre National de Genotypage (CNG); Societe Nationale Francaise de Gastroenterologie; Fondation pour la Recherche Medicale; Association Francois Aupetit	Ministere de la Sante (PHRC); Assistance-Publique Hopitaux de Paris APHP; Institut National de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universites Paris Denis-Diderot; Paris Pierre et Marie-Curie; Paris Rene-Descartes and Lille 2 droit et sante; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); fondation Jean Dausset/CEPH; Centre National de Genotypage (CNG); Societe Nationale Francaise de Gastroenterologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francois Aupetit	This work was financially supported by the Ministere de la Sante (PHRC noP010904), Assistance-Publique Hopitaux de Paris APHP, Institut National de la Recherche Scientifique (INSERM), Universites Paris Denis-Diderot, Paris Pierre et Marie-Curie, Paris Rene-Descartes and Lille 2 droit et sante, Agence Nationale de la Recherche (ANR), fondation Jean Dausset/CEPH, the Centre National de Genotypage (CNG), Societe Nationale Francaise de Gastroenterologie, Fondation pour la Recherche Medicale and the Association Francois Aupetit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Baldassano RN, 2007, GUT, V56, P1171, DOI 10.1136/gut.2007.122747; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Cooney R, 2009, INFLAMM BOWEL DIS, V15, P1014, DOI 10.1002/ibd.20885; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duraes C, 2012, INFLAMM BOWEL DIS; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marquez A, 2008, INFLAMM BOWEL DIS, V14, P1192, DOI 10.1002/ibd.20463; Mascheretti S, 2005, AM J PHARMACOGENOMIC, V5, P213, DOI 10.2165/00129785-200505040-00002; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P75, DOI 10.1002/ibd.20611; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Peyrin-Biroulet Laurent, 2008, Gastroenterology, V135, P1420, DOI 10.1053/j.gastro.2008.08.017; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Radford-Smith G, 2006, WORLD J GASTROENTERO, V12, P7097, DOI 10.3748/wjg.v12.i44.7097; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Van Limbergen J, 2008, INFLAMM BOWEL DIS, V14, P338, DOI 10.1002/ibd.20340; Limbergen J, 2007, GUT, V56, P1173, DOI 10.1136/gut.2007.122069; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x	53	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52223	10.1371/journal.pone.0052223	http://dx.doi.org/10.1371/journal.pone.0052223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300620	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100031
J	Korkut, A; Hendrickson, WA				Korkut, Anil; Hendrickson, Wayne A.			Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN SECONDARY STRUCTURE; ATOM MOLECULAR-MECHANICS; RECEPTOR-BINDING; FORCE-FIELD; NORMAL-MODE; FLUCTUATION DYNAMICS; CD4-BOUND STATE; CD4 RECEPTOR; CCR5 BINDING	HIV envelope glycoproteins undergo large-scale conformational changes as they interact with cellular receptors to cause the fusion of viral and cellular membranes that permits viral entry to infect targeted cells. Conformational dynamics in HIV gp120 are also important in masking conserved receptor epitopes from being detected for effective neutralization by the human immune system. Crystal structures of HIV gp120 and its complexes with receptors and antibody fragments provide high-resolution pictures of selected conformational states accessible to gp120. Here we describe systematic computational analyses of HIV gp120 plasticity in such complexes with CD4 binding fragments, CD4 mimetic proteins, and various antibody fragments. We used three computational approaches: an isotropic elastic network analysis of conformational plasticity, a full atomic normal mode analysis, and simulation of conformational transitions with our coarse-grained virtual atom molecular mechanics (VAMM) potential function. We observe collective sub-domain motions about hinge points that coordinate those motions, correlated local fluctuations at the interfacial cavity formed when gp120 binds to CD4, and concerted changes in structural elements that form at the CD4 interface during large-scale conformational transitions to the CD4-bound state from the deformed states of gp120 in certain antibody complexes.	[Korkut, Anil; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	wayne@xtl.cumc.columbia.edu			National Institutes of Health [GM56550]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM56550 (to WAH) and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Berkower I, 2008, VIROLOGY, V377, P330, DOI 10.1016/j.virol.2008.03.040; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haliloglu T, 1999, PROTEINS, V37, P654, DOI 10.1002/(SICI)1097-0134(19991201)37:4<654::AID-PROT15>3.0.CO;2-J; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15673, DOI 10.1073/pnas.0907684106; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15667, DOI 10.1073/pnas.0907674106; Krol M, 2004, J COMPUT AID MOL DES, V18, P41, DOI 10.1023/B:JCAM.0000022562.76762.f0; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Madani N, 2004, J VIROL, V78, P3742, DOI 10.1128/JVI.78.7.3742-3752.2004; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mechulam A, 2005, J MOL MED, V83, P542, DOI 10.1007/s00109-005-0673-1; Miller DW, 1999, J MOL BIOL, V286, P267, DOI 10.1006/jmbi.1998.2445; MOUAWAD L, 1993, BIOPOLYMERS, V33, P599, DOI 10.1002/bip.360330409; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pan YP, 2005, J MOL BIOL, V350, P514, DOI 10.1016/j.jmb.2005.05.009; Pan YP, 2004, J BIOL CHEM, V279, P30523, DOI 10.1074/jbc.M404364200; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sanchez R, 2000, METH MOL B, V143, P97; Shrivastava I, 2011, BIOCHEMISTRY-US, V50, P4173, DOI 10.1021/bi2002218; Shrivastava I, 2010, PROTEINS, V78, P2935, DOI 10.1002/prot.22816; Tan HP, 2009, PROTEINS, V74, P881, DOI 10.1002/prot.22196; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yuan W, 2006, J VIROL, V80, P6725, DOI 10.1128/JVI.00118-06; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	54	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52170	10.1371/journal.pone.0052170	http://dx.doi.org/10.1371/journal.pone.0052170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300605	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100025
J	Huby, AC; Kavvadas, P; Alfieri, C; Abed, A; Toubas, J; Rastaldi, MP; Dussaule, JC; Chatziantoniou, C; Chadjichristos, CE				Huby, Anne-Cecile; Kavvadas, Panagiotis; Alfieri, Carlo; Abed, Ahmed; Toubas, Julie; Rastaldi, Maria-Pia; Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.			The RenTg Mice: A Powerful Tool to Study Renin-Dependent Chronic Kidney Disease	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; NITRIC-OXIDE SYNTHESIS; KAPPA-B ACTIVATION; ANGIOTENSIN-II; TRANSGENIC MICE; ADHESION MOLECULE-1; RENAL FIBROSIS; TGF-BETA; COLLAGEN; INJURY	Background: Several studies have shown that activation of the renin-angiotensin system may lead to hypertension, a major risk factor for the development of chronic kidney disease (CKD). The existing hypertension-induced CDK mouse models are quite fast and consequently away from the human pathology. Thus, there is an urgent need for a mouse model that can be used to delineate the pathogenic process leading to progressive renal disease. The objective of this study was dual: to investigate whether mice overexpressing renin could mimic the kinetics and the physiopathological characteristics of hypertension-induced renal disease and to identify cellular and/or molecular events characterizing the different steps of the progression of CKD. Methodology/Principal Findings: We used a novel transgenic strain, the RenTg mice harboring a genetically clamped renin transgene. At 3 months, heterozygous mice are hypertensive and slightly albuminuric. The expression of adhesion markers such as vascular cell adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 are increased in the renal vasculature indicating initiation of endothelial dysfunction. At 5 months, perivascular and periglomerular infiltrations of macrophages are observed. These early renal vascular events are followed at 8 months by leukocyte invasion, decreased expression of nephrin, increased expression of KIM-1, a typical protein of tubular cell stress, and of several pro-fibrotic agents of the TGFb family. At 12 months, mice display characteristic structural alterations of hypertensive renal disease such as glomerular ischemia, glomerulo- and nephroangio-sclerosis, mesangial expansion and tubular dilation. Conclusions/Significance: The RenTg strain develops CKD progressively. In this model, endothelial dysfunction is an early event preceding the structural and fibrotic alterations which ultimately lead to the development of CKD. This model can provide new insights into the mechanisms of chronic renal failure and help to identify new targets for arresting and/or reversing the development of the disease.	[Huby, Anne-Cecile; Kavvadas, Panagiotis; Alfieri, Carlo; Abed, Ahmed; Toubas, Julie; Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.] Tenon Hosp, Inst Natl Sante & Rech Med Joint Res Unit S 702, Paris, France; [Rastaldi, Maria-Pia] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Rastaldi, Maria-Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Dussaule, Jean-Claude] Hosp St Antoine, AP HP, Dept Physiol, Paris, France; [Dussaule, Jean-Claude; Chatziantoniou, Christos; Chadjichristos, Christos E.] Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; IRCCS Ca Granda Ospedale Maggiore Policlinico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Chatziantoniou, C (corresponding author), Tenon Hosp, Inst Natl Sante & Rech Med Joint Res Unit S 702, Batiment Rech, Paris, France.	christos.chatziantoniou@upmc.fr	Chadjichristos, Christos E/J-4871-2016; Chatziantoniou, Christos/L-2501-2016; Alfieri, Carlo/Q-8959-2016	Chadjichristos, Christos E/0000-0001-6657-7900; Alfieri, Carlo/0000-0003-3860-5219	European Union [PIEF-GA-2008-221415]; European Renal Association; European Dialysis and Transplant Association [ERALTF25-2007]; Institut National de la Sante et de la Recherche Medicale; University Pierre et Marie Curie; ERA-EDTA; University of Milano	European Union(European Commission); European Renal Association; European Dialysis and Transplant Association; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre et Marie Curie; ERA-EDTA; University of Milano	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the European Union (PIEF-GA-2008-221415 to CEC and JCD), the European Renal Association and European Dialysis and Transplant Association (ERALTF25-2007 to CEC), the Institut National de la Sante et de la Recherche Medicale (CC) and the University Pierre et Marie Curie (CC and JCD). ACH, AA and JT are doctoral fellows of the French Ministry of National Education (Ecole Doctorale de Physiologie & Physiopathologie, ED 394). PK and CA were financially supported by fellowships from ERA-EDTA and the University of Milano, respectively.	Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; DIAMOND JR, 1990, AM J PATHOL, V137, P1323; Dirks J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P695; Dussaule JC, 2007, CELL DEATH DIFFER, V14, P1343, DOI 10.1038/sj.cdd.4402143; Eliahou H, 2001, AM J NEPHROL, V21, P78, DOI 10.1159/000046225; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Macconi D, 2010, HISTOL HISTOPATHOL, V25, P655, DOI 10.14670/HH-25.655; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; NavarroCid J, 1996, AM J HYPERTENS, V9, P1077, DOI 10.1016/0895-7061(96)00195-1; Pastore L, 1999, CIRCULATION, V100, P1646, DOI 10.1161/01.CIR.100.15.1646; Placier S, 2006, NEPHROL DIAL TRANSPL, V21, P881, DOI 10.1093/ndt/gfk004; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Sata M, 2010, J MED INVESTIG, V57, P12, DOI 10.2152/jmi.57.12; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Ying L, 2003, HYPERTENSION, V42, P937, DOI 10.1161/01.HYP.0000099240.89890.94; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	25	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52362	10.1371/journal.pone.0052362	http://dx.doi.org/10.1371/journal.pone.0052362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300650	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800071
J	Wei, Q; Zhang, DJ; Yao, AN; Mai, LY; Zhang, ZW; Zhou, QB				Wei, Qiong; Zhang, Dejun; Yao, Anna; Mai, Liyi; Zhang, Zhiwei; Zhou, Qibing			Design, Synthesis, and In Vitro and In Vivo Biological Studies of a 3 '-Deoxythymidine Conjugate that Potentially Kills Cancer Cells Selectively	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; THYMIDINE KINASE 1; NUCLEOSIDE ANALOGS; HEPATITIS-B; MECHANISM; TOXICITY; 3'-AZIDO-3'-DEOXYTHYMIDINE; 5-FLUOROURACIL; CYTOTOXICITY; DOXORUBICIN	Thymidine kinases (TKs) have been considered one of the potential targets for anticancer therapeutic because of their elevated expressions in cancer cells. However, nucleobase analogs targeting TKs have shown poor selective cytotoxicity in cancer cells despite effective antiviral activity. 3'-Deoxythymidine phenylquinoxaline conjugate (dT-QX) was designed as a novel nucleobase analog to target TKs in cancer cells and block cell replication via conjugated DNA intercalating quinoxaline moiety. In vitro cell screening showed that dT-QX selectively kills a variety of cancer cells including liver carcinoma, breast adenocarcinoma and brain glioma cells; whereas it had a low cytotoxicity in normal cells such as normal human liver cells. The anticancer activity of dT-QX was attributed to its selective inhibition of DNA synthesis resulting in extensive mitochondrial superoxide stress in cancer cells. We demonstrate that covalent linkage with 3'-deoxythymidine uniquely directed cytotoxic phenylquinoxaline moiety more toward cancer cells than normal cells. Preliminary mouse study with subcutaneous liver tumor model showed that dT-QX effectively inhibited the growth of tumors. dT-QX is the first molecule of its kind with highly amendable constituents that exhibits this selective cytotoxicity in cancer cells.	[Wei, Qiong; Zhang, Dejun; Yao, Anna; Mai, Liyi; Zhou, Qibing] Huazhong Univ Sci & Technol, Inst Mat Med, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Zhiwei] Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Zhou, Qibing] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Virginia Commonwealth University	Zhou, QB (corresponding author), Huazhong Univ Sci & Technol, Inst Mat Med, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	qibingzhou@hust.edu.cn			National Basic Research Program of China [2011CB933100]; Fundamental Research Funds for the Central Universities [HUST: 2010ZD023]; Important National Science & Technology Specific Projects [2009ZX09301-014]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Important National Science & Technology Specific Projects	This work is supported by National Basic Research Program of China (2011CB933100), the Fundamental Research Funds for the Central Universities (HUST: 2010ZD023), and the Important National Science & Technology Specific Projects (2009ZX09301-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barth RF, 2008, P NATL ACAD SCI USA, V105, P17493, DOI 10.1073/pnas.0809569105; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; ELION GB, 1982, AM J MED, V73, P7, DOI 10.1016/0002-9343(82)90055-9; Feng YX, 2010, HEPATOLOGY, V51, P535, DOI 10.1002/hep.23313; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; He QM, 2004, INT J ONCOL, V25, P945; HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Li XQ, 2011, CANCER LETT, V301, P212, DOI 10.1016/j.canlet.2010.12.004; Lin J, 2010, BIOORGAN MED CHEM, V18, P3261, DOI 10.1016/j.bmc.2010.03.023; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lund KC, 2007, ANTIMICROB AGENTS CH, V51, P2531, DOI 10.1128/AAC.00039-07; Miltenburger H G, 1987, Dev Biol Stand, V66, P91; Morgenroth A, 2008, CLIN CANCER RES, V14, P7311, DOI 10.1158/1078-0432.CCR-08-0907; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; PATT YZ, 1994, J CLIN ONCOL, V12, P1204, DOI 10.1200/JCO.1994.12.6.1204; Perez MJ, 2002, FREE RADICAL BIO MED, V33, P111, DOI 10.1016/S0891-5849(02)00865-1; Sangro B, 2010, CANCER GENE THER, V17, P837, DOI 10.1038/cgt.2010.40; Shen YC, 2010, J GASTROENTEROL, V45, P794, DOI 10.1007/s00535-010-0270-0; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Slamenova D, 2006, MUTAT RES-FUND MOL M, V593, P97, DOI 10.1016/j.mrfmmm.2005.06.029; Van Poecke S, 2010, J MED CHEM, V53, P2902, DOI 10.1021/jm901532h; Yuan JN, 2008, MED ONCOL, V25, P201, DOI 10.1007/s12032-007-9013-3; YUSA T, 1988, CANCER RES, V48, P5001; Zhou Q, 2008, CHEM RES TOXICOL, V21, P732, DOI 10.1021/tx700363s	29	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52199	10.1371/journal.pone.0052199	http://dx.doi.org/10.1371/journal.pone.0052199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300611	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800054
J	Zhang, YD; Baker, SS; Baker, RD; Zhu, RX; Zhu, LX				Zhang, Yida; Baker, Susan S.; Baker, Robert D.; Zhu, Ruixin; Zhu, Lixin			Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE; ETHANOL-PRODUCTION; ACID-METABOLISM; FOLLOW-UP; DISEASE; ASSOCIATION; VALIDATION; SIMILARITY; DIFFERENCE; DIAGNOSIS	Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD). The molecular pathological mechanism of NASH is poorly understood. Recently, high throughput data such as microarray data together with bioinformatics methods have become a powerful way to identify biomarkers and to investigate pathogenesis of diseases. Taking advantage of well characterized microarray datasets of NASH livers, we performed a systematic analysis of potential biomarkers and possible pathological mechanism of NASH from a bioinformatics perspective. CodeLink Human Whole Genome Bioarrays were analyzed to find differentially expressed genes (DEGs) between controls and NASH patients. Four methods were used to identify DEGs and the intersection of DEGs identified by these methods was subsequently used for both biomarker prediction and molecular pathological mechanism analysis. For biomarker prediction, rank aggregation was used to rank DEGs identified by all these methods according to their significance of different expression. Alcohol dehydrogenase 4 (ADH4) exhibited the highest rank suggesting the most significant differential expression between normal and disease condition. Together with the previous report demonstrating the association between ADH4 and the pathogenesis of NASH, our data suggest that ADH4 could be a potential biomarker for NASH. For molecular pathological mechanism analysis, two clusters of highly correlated annotation terms and genes in these terms were identified based on the intersection of DEGs. Then, pathways enriched with these genes were identified to construct the network. Using this network, both for the first time, amino acid catabolism is implicated to play a pivotal role and urea cycle is implicated to be involved in the development of NASH. The results of our study identified potential biomarkers and suggested possible molecular pathological mechanism of NASH. These findings provide a comprehensive and systematic understanding of the pathogenesis of NASH and may facilitate the diagnosis, prevention and treatment of NASH.	[Zhang, Yida; Zhu, Ruixin] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Baker, Susan S.; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA	Tongji University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhu, RX (corresponding author), Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China.	rxzhu@tongji.edu.cn; lixinzhu@buffalo.edu	, 金石为开/AFU-9737-2022; Zhang, Yida/ABB-6924-2021	Zhu, Lixin/0000-0001-7904-1769; Zhu, Ruixin/0000-0002-5070-6453	Peter and Tommy Fund, Inc., Buffalo, NY; National Natural Science Foundation of China [31200986, 30976611]; Research Fund for the Doctoral Program of Higher Education of China [20100072120050]	Peter and Tommy Fund, Inc., Buffalo, NY; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY, http://thepeterandtommyfund.org (to SSB), a departmental start-up fund (to LZ), National Natural Science Foundation of China 31200986, 30976611(to RZ), and Research Fund for the Doctoral Program of Higher Education of China 20100072120050 (to RZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Banasch M, 2011, EUR J MED RES, V16, P258, DOI 10.1186/2047-783X-16-6-258; Baranova A, 2008, HEPATOLOGY, V47, P373, DOI 10.1002/hep.22140; BARAONA E, 1986, GASTROENTEROLOGY, V90, P103, DOI 10.1016/0016-5085(86)90081-8; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Chitturi S, 2001, ETIOPATHOGENESIS NON, P23; Chu G., 2002, SAM SIGNIFICANCE ANA; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Hashimoto E, 2009, J GASTROEN HEPATOL, V24, P501, DOI 10.1111/j.1440-1746.2009.05806.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadota K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-227; Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kang H, 2012, J CHEM INF MODEL, V52, P834, DOI 10.1021/ci200481c; Kaur I, 2012, PROTEOMICS, V12, P2036, DOI 10.1002/pmic.201100105; Kojima H, 2005, ALCOHOL CLIN EXP RES, V29, p259S, DOI 10.1097/01.alc.0000191776.37626.30; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Ma Xiong, 2006, Chin J Dig Dis, V7, P7, DOI 10.1111/j.1443-9573.2006.00237.x; Ma Y, 2005, INT J IMMUNOPATH PH, V18, P173, DOI 10.1177/039463200501800118; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; Masotti A, 2012, J GASTROEN HEPATOL, V27, P187, DOI 10.1111/j.1440-1746.2011.07032.x; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Medicinenet, ALC NUTR; Miller MH, 2011, LIVER INT, V31, P461, DOI 10.1111/j.1478-3231.2011.02451.x; Nosova T, 1996, ALCOHOL ALCOHOLISM, V31, P555; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Valdecantos MP, 2011, BIOMARKERS, V16, P670, DOI 10.3109/1354750X.2011.625504; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; Raychaudhuri S, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P286; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; SARIN SK, 1988, DIGEST DIS SCI, V33, P443, DOI 10.1007/BF01536029; SOFER W, 1987, ANNU REV GENET, V21, P203, DOI 10.1146/annurev.genet.21.1.203; Stokkeland K, 2010, ALCOHOL CLIN EXP RES, V34, P1993, DOI 10.1111/j.1530-0277.2010.01289.x; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Tsodikov A, 2002, BIOINFORMATICS, V18, P251, DOI 10.1093/bioinformatics/18.2.251; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4387, DOI 10.3748/wjg.15.4387; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	70	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51131	10.1371/journal.pone.0051131	http://dx.doi.org/10.1371/journal.pone.0051131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300535	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800011
J	Nguyen, HM; Galea, CA; Schmunk, G; Smith, BJ; Edwards, RA; Norton, RS; Chandy, KG				Nguyen, Hai M.; Galea, Charles A.; Schmunk, Galina; Smith, Brian J.; Edwards, Robert A.; Norton, Raymond S.; Chandy, K. George			Intracellular Trafficking of the K(V)1.3 Potassium Channel Is Regulated by the Prodomain of a Matrix Metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILE; GATED K+ CHANNELS; CYSTEINE ARRAY; FORCE-FIELD; PROTEIN; IDENTIFICATION; SUBUNIT; TISSUE; TOXIN; KV1.3	Matrix metalloproteases (MMPs) are endopeptidases that regulate diverse biological processes. Synthesized as zymogens, MMPs become active after removal of their prodomains. Much is known about the metalloprotease activity of these enzymes, but noncanonical functions are poorly defined, and functions of the prodomains have been largely ignored. Here we report a novel metalloprotease-independent, channel-modulating function for the prodomain of MMP23 (MMP23-PD). Whole-cell patch clamping and confocal microscopy, coupled with deletion analysis, demonstrate that MMP23-PD suppresses the voltage-gated potassium channel K(V)1.3, but not the closely related K(V)1.2 channel, by trapping the channel intracellularly. Studies with K(V)1.2-1.3 chimeras suggest that MMP23-PD requires the presence of the K(V)1.3 region from the S5 trans-membrane segment to the C terminus to modulate K(V)1.3 channel function. NMR studies of MMP23-PD reveal a single, kinked trans-membrane alpha-helix, joined by a short linker to a juxtamembrane alpha-helix, which is associated with the surface of the membrane and protected from exchange with the solvent. The topological similarity of MMP23-PD to KCNE1, KCNE2, and KCNE4 proteins that trap K(V)1.3, K(V)1.4, K(V)3.3, and K(V)3.4 channels early in the secretory pathway suggests a shared mechanism of channel regulation. MMP23 and K(V)1.3 expression is enhanced and overlap-ping in colorectal cancers where the interaction of the two proteins could affect cell function.	[Nguyen, Hai M.; Schmunk, Galina; Chandy, K. George] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92697 USA; [Edwards, Robert A.] Univ Calif Irvine, Dept Pathol, Sch Med, Irvine, CA 92697 USA; [Galea, Charles A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Program Med Chem, Parkville, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, Dept Chem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia	University of California System; University of California Irvine; University of California System; University of California Irvine; Monash University; La Trobe University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Program Med Chem, Parkville, Vic 3052, Australia.	ray.norton@monash.edu; gchandy@uci.edu	Galea, Charles/O-8800-2014; Smith, Brian J/F-8282-2011	Galea, Charles/0000-0003-2730-1105; Smith, Brian J/0000-0003-0498-1910; Norton, Raymond/0000-0001-8893-0584	National Institutes of Health [NS48252]; Australian Research Council [DP1093909]; National Institutes of Health through the NCI [P30CA062203]; Australian National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS48252 (to K. G. C.). This work was also supported by the Australian Research Council (Grant DP1093909 to R. S. N., B. J. S., and K. G. C.). Colorectal cancer tissue procurement was supported by Award Number P30CA062203 from the National Institutes of Health through the NCI.; Recipient of fellowship support from the Australian National Health and Medical Research Council.	Abdul M, 2002, ONCOL REP, V9, P961; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beswick V, 1998, BIOCHIMIE, V80, P451, DOI 10.1016/S0300-9084(00)80012-7; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Clancy BM, 2003, BONE, V33, P46, DOI 10.1016/S8756-3282(03)00116-9; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golubkov VS, 2011, J BIOL CHEM, V286, P34215, DOI 10.1074/jbc.M111.264036; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grunnet M, 2003, BBA-BIOMEMBRANES, V1616, P85, DOI 10.1016/S0005-2736(03)00198-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kanda VA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00231; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Klammt C, 2012, NAT METHODS, V9, P834, DOI [10.1038/NMETH.2033, 10.1038/nmeth.2033]; Krogsgaard M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8541; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohnishi J, 2001, MOL ENDOCRINOL, V15, P747, DOI 10.1210/me.15.5.747; Okada Aiko, 2009, Clin Calcium, V19, P1593, DOI CliCa091115931601; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pei DQ, 1999, FEBS LETT, V457, P262, DOI 10.1016/S0014-5793(99)01046-7; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Rangaraju S, 2010, J BIOL CHEM, V285, P9124, DOI 10.1074/jbc.M109.071266; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Van Horn WD, 2011, CURR OPIN STRUC BIOL, V21, P283, DOI 10.1016/j.sbi.2011.01.001; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	56	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6451	6464		10.1074/jbc.M112.421495	http://dx.doi.org/10.1074/jbc.M112.421495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300077	Green Published, hybrid			2022-12-25	WOS:000315820700039
J	Zhu, TT; Chappel, JC; Hsu, FF; Turk, J; Aurora, R; Hyrc, K; De Camilli, P; Broekelmann, TJ; Mecham, RP; Teitelbaum, SL; Zou, W				Zhu, Tingting; Chappel, Jean C.; Hsu, Fong-Fu; Turk, John; Aurora, Rajeev; Hyrc, Krzysztof; De Camilli, Pietro; Broekelmann, Thomas J.; Mecham, Robert P.; Teitelbaum, Steven L.; Zou, Wei			Type I Phosphotidylinosotol 4-Phosphate 5-Kinase gamma Regulates Osteoclasts in a Bifunctional Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTDINS(4,5)P-2 SYNTHESIS; PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; ACTIN CYTOSKELETON; BONE-RESORPTION; KINASE; INTEGRIN; ALPHA-V-BETA-3; LOCALIZATION; PHAGOCYTOSIS; PLC-GAMMA-2	Type 1 phosphotidylinosotol-4 phosphate 5 kinase gamma (PIP5KI gamma) is central to generation of phosphotidylinosotol (4,5)P-2 (PI(4,5)P-2). PIP5KI gamma also participates in cytoskeletal organization by delivering talin to integrins, thereby enhancing their ligand binding capacity. As the cytoskeleton is pivotal to osteoclast function, we hypothesized that absence of PIP5KI gamma would compromise their resorptive capacity. Absence of the kinase diminishes PI(4,5) abundance and desensitizes pre-cursors to RANK ligand-stimulated differentiation. Thus, PIP5KI gamma(-/-) osteoclasts are reduced in number in vitro and confirm physiological relevance in vivo. Despite reduced numbers, PIP5KI gamma(-/-) osteoclasts surprisingly have normal cytoskeletons and effectively resorb bone. PIP5KI gamma overexpression, which increases PI(4,5)P-2, also delays osteoclast differentiation and reduces cell number but in contrast to cells lacking the kinase, its excess disrupts the cytoskeleton. The cytoskeleton-disruptive effects of excess PIP5KI gamma reflect its kinase activity and are independent of talin recognition. The combined arrested differentiation and disorganized cytoskeleton of PIP5KI gamma-transduced osteoclasts compromises bone resorption. Thus, optimal PIP5KI gamma and PI(4,5)P-2 expression, by osteoclasts, are essential for skeletal homeostasis.	[Zhu, Tingting; Chappel, Jean C.; Teitelbaum, Steven L.; Zou, Wei] Washington Univ, St Louis Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hsu, Fong-Fu; Turk, John; Teitelbaum, Steven L.] Washington Univ, St Louis Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, St Louis Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Hyrc, Krzysztof] Washington Univ, St Louis Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [De Camilli, Pietro] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [De Camilli, Pietro] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Yale University; Howard Hughes Medical Institute; Yale University	Teitelbaum, SL (corresponding author), Washington Univ, St Louis Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu; weizou@wustl.edu		Zou, Wei/0000-0001-8081-268X; Hsu, Fong-Fu/0000-0001-5368-0183; Aurora, Rajeev/0000-0002-6609-6055; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [AR032788, AR046523, AR054618, AR057037, AR057235, HL53325, HL74138, NS036251, P41-RR-00954, P60-DK-20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053325, R01HL074138, R01HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057037, P30AR057235, R01AR046523, R37AR046523, R01AR054618, R01AR032788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR032788, AR046523, AR054618, AR057037, and AR057235 (to S. L. T.), HL53325 and HL74138 (to R. P. M.), and NS036251 (to P. D. C.). This work was also supported by NIH Grants P41-RR-00954, P60-DK-20579, and P30-DK56341.	Biswas RS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-19; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Weinkove D, 2008, DEV BIOL, V313, P384, DOI 10.1016/j.ydbio.2007.10.029; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777; Zou W., 2012, MOL CELL BIOL; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	29	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5268	5277		10.1074/jbc.M112.446054	http://dx.doi.org/10.1074/jbc.M112.446054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300084	Green Published, hybrid			2022-12-25	WOS:000315342500002
J	Zhao, Y; Xing, B; Dang, YH; Qu, CL; Zhu, F; Yan, CX				Zhao, Yan; Xing, Bo; Dang, Yong-hui; Qu, Chao-ling; Zhu, Feng; Yan, Chun-xia			Microinjection of Valproic Acid into the Ventrolateral Orbital Cortex Enhances Stress-Related Memory Formation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; GYRUS GRANULE NEURONS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; DENTATE GYRUS; EPIGENETIC MECHANISMS; HISTONE MODIFICATIONS; PSYCHOLOGICAL STRESS; DOPAMINE-RECEPTORS; CONDITIONED FEAR	There is collecting evidence suggesting that the process of chromatin remodeling such as changes in histone acetylation contribute to the formation of stress-related memory. Recently, the ventrolateral orbital cortex (VLO), a major subdivision of orbitofrontal cortex (OFC), was shown to be involved in antidepressant-like actions through epigenetic mechanisms. Here, we further investigated the effects of the histone deacetylase inhibitor (HDACi) valproic acid (VPA) on stress-related memory formation and the underlying molecular mechanisms by using the traditional two-day forced swimming test (FST). The results showed that VPA significantly increased the immobility time on day 2 when infused into the VLO before the initial forced swim stress on day 1. The learned immobility response to the stress was associated with increased phosphorylation of extracellular signal-regulated kinase (ERK) in VLO and hippocampus on the first day. The levels of phosphorylated ERK (phospho-ERK) in VLO and hippocampus were significantly decreased when retested 24 h later. The pretreatment with intra-VLO VPA infusion further reduced the activation of ERK on day 2 and day 7 compared with the saline controls. Moreover, the VPA infusion pretreatment also induced a significantly decreased BDNF level in the VLO on day 2, whereas no change was detected in the hippocampus. These findings suggest that VPA enhance the memories of emotionally stressful events and the ERK activity is implicated in stimulating adaptive and mnemonic processes in case the event would recur.	[Zhao, Yan; Dang, Yong-hui; Zhu, Feng; Yan, Chun-xia] Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Forens Med,Key Lab Environm & Genes Related, Xian 710049, Shaanxi, Peoples R China; [Xing, Bo] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Qu, Chao-ling] Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Physiol & Pathophysiol,Key Lab Environm & Ge, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Dang, YH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Minist Educ, Dept Forens Med,Key Lab Environm & Genes Related, Xian 710049, Shaanxi, Peoples R China.	psydyh@mail.xjtu.edu.cn; yanchx@mail.xjtu.edu.cn	Qu, Chaoling/J-5841-2013		National Science Foundation of China [NSFC 81171262, NSFC 81172903]; scientific and technological research and development projects in Shaanxi Province [2011K15-01-03, 2012K16-03-02]; scientific research project of Shaanxi Provincial Health Department [2012E4]; Fundamental Research Funds for the Central Universities in China [2011JDHZ59]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological research and development projects in Shaanxi Province; scientific research project of Shaanxi Provincial Health Department; Fundamental Research Funds for the Central Universities in China	This work was supported by the National Science Foundation of China (NSFC 81171262 for Yong-hui Dang and NSFC 81172903 for Chun-xia Yan), the scientific and technological research and development projects in Shaanxi Province (2011K15-01-03 and 2012K16-03-02), the scientific research project of Shaanxi Provincial Health Department (2012E4) and the Fundamental Research Funds for the Central Universities in China (2011JDHZ59). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betensky JD, 2008, PSYCHIAT RES, V160, P38, DOI 10.1016/j.psychres.2007.06.001; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Bohn I, 2003, CEREB CORTEX, V13, P968, DOI 10.1093/cercor/13.9.968; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Calzavara MB, 2009, SCHIZOPHRENIA BULL, V35, P748, DOI 10.1093/schbul/sbn006; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chen YC, 2012, NEUROSCI LETT, V506, P327, DOI 10.1016/j.neulet.2011.11.038; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P79, DOI 10.1016/0166-4328(94)90010-8; Dang YH, 2010, NEUROSCIENCE, V169, P1872, DOI 10.1016/j.neuroscience.2010.06.050; Dang YH, 2011, EUR J PHARMACOL, V657, P97, DOI 10.1016/j.ejphar.2011.01.064; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Foley AG, 2004, NEUROBIOL AGING, V25, P539, DOI 10.1016/j.neurobiolaging.2003.07.006; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Lin HL, 2012, BRAIN RES, V1447, P119, DOI 10.1016/j.brainres.2012.01.053; Loring DW, 2004, NEUROLOGY, V62, P872, DOI 10.1212/01.WNL.0000115653.82763.07; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; Michaelis M, 2006, CELL DEATH DIFFER, V13, P446, DOI 10.1038/sj.cdd.4401759; Nemeroff CB, 2009, HDB STRESS SCI BIOL; Padovan CM, 2004, PHARMACOL BIOCHEM BE, V77, P15, DOI 10.1016/j.pbb.2003.09.015; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Whittle N, 2013, NEUROPHARMACOLOGY, V64, P414, DOI 10.1016/j.neuropharm.2012.06.001; Xing B, 2011, BRAIN RES BULL, V85, P153, DOI 10.1016/j.brainresbull.2011.03.007; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011	40	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52698	10.1371/journal.pone.0052698	http://dx.doi.org/10.1371/journal.pone.0052698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070BE	23300985	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000013
J	Albouy, G; Fogel, S; Pottiez, H; Nguyen, VA; Ray, L; Lungu, O; Carrier, J; Robertson, E; Doyon, J				Albouy, Genevieve; Fogel, Stuart; Pottiez, Hugo; Vo An Nguyen; Ray, Laura; Lungu, Ovidiu; Carrier, Julie; Robertson, Edwin; Doyon, Julien			Daytime Sleep Enhances Consolidation of the Spatial but Not Motoric Representation of Motor Sequence Memory	PLOS ONE			English	Article							EFFECTOR-SPECIFIC REPRESENTATIONS; TIME-COURSE; INTERMANUAL TRANSFER; BASAL GANGLIA; IMPLICIT; ACQUISITION; MECHANISMS; SPINDLES; DISSOCIATION; PERFORMANCE	Motor sequence learning is known to rely on more than a single process. As the skill develops with practice, two different representations of the sequence are formed: a goal representation built under spatial allocentric coordinates and a movement representation mediated through egocentric motor coordinates. This study aimed to explore the influence of daytime sleep (nap) on consolidation of these two representations. Through the manipulation of an explicit finger sequence learning task and a transfer protocol, we show that both allocentric (spatial) and egocentric (motor) representations of the sequence can be isolated after initial training. Our results also demonstrate that nap favors the emergence of offline gains in performance for the allocentric, but not the egocentric representation, even after accounting for fatigue effects. Furthermore, sleep-dependent gains in performance observed for the allocentric representation are correlated with spindle density during non-rapid eye movement (NREM) sleep of the post-training nap. In contrast, performance on the egocentric representation is only maintained, but not improved, regardless of the sleep/wake condition. These results suggest that motor sequence memory acquisition and consolidation involve distinct mechanisms that rely on sleep (and specifically, spindle) or simple passage of time, depending respectively on whether the sequence is performed under allocentric or egocentric coordinates.	[Albouy, Genevieve; Fogel, Stuart; Pottiez, Hugo; Vo An Nguyen; Ray, Laura; Lungu, Ovidiu; Carrier, Julie; Doyon, Julien] CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Albouy, Genevieve; Fogel, Stuart; Carrier, Julie; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Donald Berman Maimonides Geriatr Ctr, Dept Res, Montreal, PQ, Canada; [Carrier, Julie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Robertson, Edwin] Harvard Univ, Sch Med, Harvard Ctr Noninvas Brain Stimulat, Boston, MA USA; [Robertson, Edwin] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Doyon, J (corresponding author), CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada.	julien.doyon@umontreal.ca	Fogel, Stuart/F-7179-2017; ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019	Fogel, Stuart/0000-0002-3227-5370; ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Lungu, Ovidiu/0000-0001-6608-5818; Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health and Research (CIHR); Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE); postdoctoral grant from the Fyssen Foundation; CIHR postdoctoral grant	Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE); postdoctoral grant from the Fyssen Foundation; CIHR postdoctoral grant(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health and Research (CIHR) as well as the Ministry of Economic Development, Innovation and Exportation of Quebec (MDEIE). GA was first supported by a postdoctoral grant from the Fyssen Foundation and is now supported through a CIHR postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Bapi RS, 2006, NEUROIMAGE, V32, P714, DOI 10.1016/j.neuroimage.2006.04.205; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Barakat M, 2012, HUM BRAIN M IN PRESS; Bischoff-Grethe A, 2004, J COGNITIVE NEUROSCI, V16, P127, DOI 10.1162/089892904322755610; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; ELLIS BW, 1981, SLEEP, V4, P93, DOI 10.1093/sleep/4.1.93; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, SLEEP SPINDLES UNPUB; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gheysen F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00137; Grafton ST, 1998, J NEUROSCI, V18, P9420; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Hallgato E, 2012, CORTEX; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; Keisler A, 2007, LEARN MEMORY, V14, P669, DOI 10.1101/lm.751807; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Leclercq Y, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/598206; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Morin A, 2008, SLEEP, V31, P1149; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer C, 2000, PSYCHOL SCI, V11, P63, DOI 10.1111/1467-9280.00216; Perez MA, 2007, CURR BIOL, V17, P1896, DOI 10.1016/j.cub.2007.09.058; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Press DZ, 2005, BRAIN RES COGN BRAIN; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Romei V, 2009, CORTEX, V45, P1058, DOI 10.1016/j.cortex.2009.01.003; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Shea CH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00052; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Verwey WB, 2005, PSYCHOL RES-PSYCH FO, V69, P242, DOI 10.1007/s00426-004-0181-x; Verwey WB, 2004, PSYCHOL RES-PSYCH FO, V68, P64, DOI 10.1007/s00426-003-0144-7; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062	64	81	81	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52805	10.1371/journal.pone.0052805	http://dx.doi.org/10.1371/journal.pone.0052805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300993	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900040
J	Elmazar, MM; El-Abhar, HS; Schaalan, MF; Farag, NA				Elmazar, Mohamed M.; El-Abhar, Hanan S.; Schaalan, Mona F.; Farag, Nahla A.			Phytol/Phytanic Acid and Insulin Resistance: Potential Role of Phytanic Acid Proven by Docking Simulation and Modulation of Biochemical Alterations	PLOS ONE			English	Article							ACTIVATED RECEPTOR PPAR; PLASMA-CONCENTRATIONS; PIOGLITAZONE; ADIPONECTIN; PHYTOL; ALPHA; SENSITIVITY; DIET; GAMMA; METABOLISM	Since activation of PPAR gamma is the main target for the antidiabetic effect of TZDs, especially when it heterodimerizes with RXR, we aimed to test the potential antidiabetic effect of phytol (250 mg/ kg), the natural precursor of phytanic acid, a RXR ligand and/or pioglitazone (5 mg/kg) to diabetic insulin-resistant rats. Regarding the molecular docking simulation on PPAR gamma, phytanic acid, rather than phytol, showed a binding mode that mimics the crystal orientation of rosiglitazone and pioglitazone, forming H bonds with the same amino acids (S289, H 323, H 449 and Y 473), and the least energy level, which emphasizes their importance for PPAR gamma molecular recognition, activation, hence antidiabetic activity. In addition, docking on the RXR alpha/PPAR gamma heterodimer, revealed that phytanic acid has higher binding affinity and lesser energy score on RXR alpha, compared to the original ligand, retinoic acid. Phytanic acid binds by 3H bonds and shares retinoic acid in arginine (R 316). These results were further supported biochemically, where oral phytol and/or pioglitazone (5 mg/ kg) improved significantly glucose homeostasis, lipid panel, raised serum adiponectin level and lowered TNF- a, reaching in most cases the effect of the 10 mg/ kg pioglitazone. The study concluded that the insulin sensitizing/ anti- diabetic effect of phytol is mediated by partly from activation of nuclear receptors and heterodimerization of RXR with PPAR gamma by phytanic acid.	[Elmazar, Mohamed M.] British Univ Cairo BUE, Cairo, Egypt; [El-Abhar, Hanan S.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Schaalan, Mona F.] Misr Int Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Farag, Nahla A.] Misr Int Univ, Fac Pharm, Dept Pharmaceut Med Chem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology; Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology	El-Abhar, HS (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanabhar@yahoo.com	Farag, Nahla/AAJ-6846-2020; El-Abhar, Hanan/L-2289-2019; Elmazar, M M/D-9325-2013	Farag, Nahla/0000-0003-0978-7973; El-Abhar, Hanan/0000-0001-8819-9891; Schaalan, Mona/0000-0002-8569-689X; Elmazar, M M/0000-0002-5076-9817				Allen NE, 2008, BRIT J NUTR, V99, P653, DOI 10.1017/S000711450782407X; Anderson A, 1999, J MOL GRAPH MODEL, V17, P180, DOI 10.1016/S1093-3263(99)00029-7; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Ding SY, 2005, ACTA PHARMACOL SIN, V26, P575, DOI 10.1111/j.1745-7254.2005.00090.x; Elmazar MMA, 2004, ARCH TOXICOL, V78, P660, DOI 10.1007/s00204-004-0586-8; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gloerich J, 2007, J LIPID RES, V48, P77, DOI 10.1194/jlr.M600050-JLR200; Gloerich J, 2005, J LIPID RES, V46, P716, DOI 10.1194/jlr.M400337-JLR200; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HANSEN RP, 1966, NATURE, V210, P841, DOI 10.1038/210841a0; Hashimoto T, 2006, J NUTR, V136, P882, DOI 10.1093/jn/136.4.882; Heim M, 2002, FASEB J, V16, P718, DOI 10.1096/fj.01-0816fje; HOFMANN C, 1991, ENDOCRINOLOGY, V129, P1915, DOI 10.1210/endo-129-4-1915; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Koch SSC, 1999, J MED CHEM, V42, P742, DOI 10.1021/jm980621r; LEVY J, 1984, DIABETES, V33, P901, DOI 10.2337/diabetes.33.9.901; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarty MF, 2005, MED HYPOTHESES, V64, P399, DOI 10.1016/j.mehy.2004.03.034; McCarty MF, 2001, MED HYPOTHESES, V56, P217, DOI 10.1054/mehy.2000.1153; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Murcko M. A., 1997, PRACTICAL APPL COMPU, P355; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Sakamoto J, 2000, BIOCHEM BIOPH RES CO, V278, P704, DOI 10.1006/bbrc.2000.3868; Schaalan M, 2009, J DIABETES COMPLICAT, V23, P199, DOI 10.1016/j.jdiacomp.2008.02.003; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van den Brink DM, 2005, J BIOL CHEM, V280, P26838, DOI 10.1074/jbc.M501861200; VANDENBRANDEN C, 1986, PEDIATR RES, V20, P411, DOI 10.1203/00006450-198605000-00007; Vijay SK, 2009, ACTA DIABETOL, V46, P27, DOI 10.1007/s00592-008-0054-7; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	47	70	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e45638	10.1371/journal.pone.0045638	http://dx.doi.org/10.1371/journal.pone.0045638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300941	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900001
J	Moll, K; Roces, F; Federle, W				Moll, Karin; Roces, Flavio; Federle, Walter			How Load-Carrying Ants Avoid Falling Over: Mechanical Stability during Foraging in Atta vollenweideri Grass-Cutting Ants	PLOS ONE			English	Article							LEAF-CUTTER ANTS; SIZE DETERMINATION; STEPPING PATTERNS; TISSUE TRANSPORT; LOCOMOTION; DISTANCE; FORMICIDAE; STRATEGIES; CEPHALOTES; SELECTION	Background: Foraging workers of grass-cutting ants (Atta vollenweideri) regularly carry grass fragments larger than their Fragment length has been shown to influence the ants' running speed and thereby the colony's food intake rate. We investigated whether and how grass-cutting ants maintain stability when carrying fragments of two different lengths but identical mass. Principal Findings: Ants carried all fragments in an upright, backwards-tilted position, but held long fragments more vertically than short ones. All carrying ants used an alternating tripod gait, where mechanical stability was increased by overlapping stance phases of consecutive steps. The overlap was greatest for ants carrying long fragments, resulting in more legs contacting the ground simultaneously. For all ants, the projection of the total centre of mass (ant and fragment) was often outside the supporting tripod, i.e. the three feet that would be in stance for a non-overlapping tripod gait. Stability was only achieved through additional legs in ground contact. Tripod stability (quantified as the minimum distance of the centre of mass to the edge of the supporting tripod) was significantly smaller for ants with long fragments. Here, tripod stability was lowest at the beginning of each step, when the center of mass was near the posterior margin of the supporting tripod. By contrast, tripod stability was lowest at the end of each step for ants carrying short fragments. Consistently, ants with long fragments mainly fell backwards, whereas ants carrying short fragments mainly fell forwards or to the side. Assuming that transporting ants adjust neither the fragment angle nor the gait, they would be less stable and more likely to fall over. Conclusions: In grass-cutting ants, the need to maintain static stability when carrying long grass fragments has led to multiple kinematic adjustments at the expense of a reduced material transport rate.	[Moll, Karin; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Moll, Karin] Univ Freiburg, Univ Coll Freiburg, D-79106 Freiburg, Germany; [Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, D-97070 Wurzburg, Germany	University of Cambridge; University of Freiburg; University of Wurzburg	Moll, K (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	moll.karin.home@gmail.com	Federle, Walter/K-8263-2014	Federle, Walter/0000-0002-6375-3005; Roces, Flavio/0000-0001-9258-3079	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D526129/1]; German Academic Exchange Service (DAAD); Cambridge European Trust; Balfour Fund of the Department of Zoology (University of Cambridge); German Research Foundation (DFG) [Sonderforschungsbereich SFB 554]; Biotechnology and Biological Sciences Research Council [BB/E004156/1] Funding Source: researchfish; BBSRC [BB/E004156/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Cambridge European Trust; Balfour Fund of the Department of Zoology (University of Cambridge)(University of Cambridge); German Research Foundation (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by a Dissertation Grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/D526129/1, http://www.bbsrc.ac.uk/), by the German Academic Exchange Service (DAAD, http://www.daad.de/en/), by the Cambridge European Trust, by the Balfour Fund of the Department of Zoology (University of Cambridge, http://www.zoo.cam.ac.uk/), and by the German Research Foundation (DFG, Sonderforschungsbereich SFB 554, http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; BALDERRAMA NM, 1992, J COMP PHYSIOL B, V162, P440, DOI 10.1007/BF00258967; Bollazzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017667; Burd M, 2001, ECOL ENTOMOL, V26, P551, DOI 10.1046/j.1365-2311.2001.00334.x; Cartmill M, 1985, FUNCTIONAL VERTEBRAT; Dussutour A, 2009, ANIM COGN, V12, P21, DOI 10.1007/s10071-008-0165-0; FOWLER HG, 1979, ECOL ENTOMOL, V4, P239, DOI 10.1111/j.1365-2311.1979.tb00581.x; FULL RJ, 1991, J EXP BIOL, V156, P215; GRAHAM D, 1981, J EXP BIOL, V92, P229; Gunther M, 2012, J THEOR BIOL, V293, P82, DOI 10.1016/j.jtbi.2011.10.011; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Heran H, 1962, VERHANDLUNGEN DTSCH, P346; Holt NC, 2012, J EXP BIOL, V215, P2545, DOI 10.1242/jeb.057695; HUBBELL SP, 1980, BIOTROPICA, V12, P210, DOI 10.2307/2387973; HUGHES GM, 1952, J EXP BIOL, V29, P267; JONKMAN JCM, 1979, Z ANGEW ENTOMOL, V88, P27; JONKMAN JCM, 1976, Z ANGEW ENTOMOL, V81, P140; Lewis OT, 2008, BEHAV ECOL, V19, P805, DOI 10.1093/beheco/arn032; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Lutz FE, 1929, AM MUS NOVIT, V388, P1, DOI DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Moll K, 2012, J EXP BIOL, V215, P161, DOI 10.1242/jeb.063594; Moll K, 2010, J COMP PHYSIOL A, V196, P471, DOI 10.1007/s00359-010-0535-3; RISSING SW, 1982, ENVIRON ENTOMOL, V11, P905, DOI 10.1093/ee/11.4.905; ROBINSON SW, 1982, Z ANGEW ENTOMOL, V93, P42; ROCES F, 1993, BEHAV ECOL SOCIOBIOL, V33, P183, DOI 10.1007/BF00216599; ROCES F, 1995, NATURE, V373, P392, DOI 10.1038/373392a0; ROCES F, 1990, ANIM BEHAV, V40, P1181, DOI 10.1016/S0003-3472(05)80185-X; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; Roschard J, 2002, THESIS U WURZBURG; Roschard J, 2011, PSYCHE, V2011; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; TING LH, 1994, J EXP BIOL, V197, P251; Torres-Contreras H, 2004, INSECT SOC, V51, P265, DOI 10.1007/s00040-004-0737-1; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; Wetterer JK, 1990, BEHAV ECOL, V1, P95, DOI 10.1093/beheco/1.2.95; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P119; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P95	40	23	23	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52816	10.1371/journal.pone.0052816	http://dx.doi.org/10.1371/journal.pone.0052816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300994	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900041
J	Reigada, R				Reigada, Ramon			Atomistic Study of Lipid Membranes Containing Chloroform: Looking for a Lipid-Mediated Mechanism of Anesthesia	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LATERAL PRESSURE PROFILES; GENERAL-ANESTHETICS; FATTY-ACIDS; CHOLESTEROL; BILAYER; CHANNEL; CONFORMATION; PROTEINS; ALCOHOLS	The molecular mechanism of general anesthesia is still a controversial issue. Direct effect by linking of anesthetics to proteins and indirect action on the lipid membrane properties are the two hypotheses in conflict. Atomistic simulations of different lipid membranes subjected to the effect of small volatile organohalogen compounds are used to explore plausible lipid-mediated mechanisms. Simulations of homogeneous membranes reveal that electrostatic potential and lateral pressure transversal profiles are affected differently by chloroform (anesthetic) and carbon tetrachloride (non-anesthetic). Simulations of structured membranes that combine ordered and disordered regions show that chloroform molecules accumulate preferentially in highly disordered lipid domains, suggesting that the combination of both lateral and transversal partitioning of chloroform in the cell membrane could be responsible of its anesthetic action.	[Reigada, Ramon] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain; [Reigada, Ramon] Univ Barcelona, Inst Quim Teor & Computac IQTCUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Reigada, R (corresponding author), Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain.	reigada@ub.edu		Reigada, Ramon/0000-0003-2177-7014	Secretaria de Estado de Investigacion y Desarrollo [BFU2010-21847-C02-02]; Departament d'Universitats, Recerca i Sistemes de la Informacio [2009-SGR-1055]	Secretaria de Estado de Investigacion y Desarrollo; Departament d'Universitats, Recerca i Sistemes de la Informacio	Financial support is provided by Secretaria de Estado de Investigacion y Desarrollo through project BFU2010-21847-C02-02 and by Departament d'Universitats, Recerca i Sistemes de la Informacio through project 2009-SGR-1055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Bachar M, 2004, J PHYS CHEM B, V108, P7170, DOI 10.1021/jp036981u; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bondarenko V, 2008, BIOPHYS J, V94, P1681, DOI 10.1529/biophysj.107.116772; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1997, NAT MED, V3, P377, DOI 10.1038/nm0497-377; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gurtovenko AA, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148885; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Hu MY, 2012, BIOPHYS J, V102, P1403, DOI 10.1016/j.bpj.2012.02.013; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; Koubi L, 2001, BIOPHYS J, V81, P3339, DOI 10.1016/S0006-3495(01)75967-X; LIEB WR, 1982, BIOCHIM BIOPHYS ACTA, V688, P388, DOI 10.1016/0005-2736(82)90350-9; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123; Martinez-Seara H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011162; Martinez-Seara H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976443; MILLER KW, 1989, P NATL ACAD SCI USA, V86, P1084, DOI 10.1073/pnas.86.3.1084; MILLER KW, 1976, NATURE, V263, P253, DOI 10.1038/263253a0; Nishizawa M, 2008, BIOPHYS J, V95, P1729, DOI 10.1529/biophysj.108.130658; Ollila OHS, 2007, J STRUCT BIOL, V159, P311, DOI 10.1016/j.jsb.2007.01.012; Ollila OHS, 2010, RSC BIOMOL SCI, P26, DOI 10.1039/9781849732154-00026; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pandit SA, 2004, BIOPHYS J, V87, P1092, DOI 10.1529/biophysj.104.041939; PANG KYY, 1978, BIOCHIM BIOPHYS ACTA, V511, P1, DOI 10.1016/0005-2736(78)90060-3; Patra M, 2005, EUR BIOPHYS J BIOPHY, V35, P79, DOI 10.1007/s00249-005-0011-0; Reigada R, 2011, J PHYS CHEM B, V115, P2527, DOI 10.1021/jp110699h; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tang P, 2002, P NATL ACAD SCI USA, V99, P16035, DOI 10.1073/pnas.252522299; Turkyilmaz S, 2010, LANGMUIR, V26, P5309, DOI 10.1021/la100712y; Turkyilmaz S, 2009, J AM CHEM SOC, V131, P5068, DOI 10.1021/ja9011468; Ueda I, 1998, BIOPHYS J, V75, P1052, DOI 10.1016/S0006-3495(98)77594-0; Ueda Issaku, 2001, Keio Journal of Medicine, V50, P20; Watts P, 2004, 58 WHO IPCS; Xu Y, 1997, BBA-BIOMEMBRANES, V1323, P154, DOI 10.1016/S0005-2736(96)00184-8	49	19	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52631	10.1371/journal.pone.0052631	http://dx.doi.org/10.1371/journal.pone.0052631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300982	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900034
J	Tan, JZ; Hare, B				Tan, Jingzhi; Hare, Brian			Bonobos Share with Strangers	PLOS ONE			English	Article							BEHAVIORAL-EXPERIMENTS; SOCIAL RELATIONSHIPS; CHIMPANZEES HELP; FOOD; COOPERATION; EVOLUTION; PREFERENCES; NONHUMAN; PRIMATE; RECIPROCITY	Humans are thought to possess a unique proclivity to share with others - including strangers. This puzzling phenomenon has led many to suggest that sharing with strangers originates from human-unique language, social norms, warfare and/or cooperative breeding. However, bonobos, our closest living relative, are highly tolerant and, in the wild, are capable of having affiliative interactions with strangers. In four experiments, we therefore examined whether bonobos will voluntarily donate food to strangers. We show that bonobos will forego their own food for the benefit of interacting with a stranger. Their prosociality is in part driven by unselfish motivation, because bonobos will even help strangers acquire out-of-reach food when no desirable social interaction is possible. However, this prosociality has its limitations because bonobos will not donate food in their possession when a social interaction is not possible. These results indicate that other-regarding preferences toward strangers are not uniquely human. Moreover, language, social norms, warfare and cooperative breeding are unnecessary for the evolution of xenophilic sharing. Instead, we propose that prosociality toward strangers initially evolves due to selection for social tolerance, allowing the expansion of individual social networks. Human social norms and language may subsequently extend this ape-like social preference to the most costly contexts.	[Tan, Jingzhi; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University	Tan, JZ (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA.	jingzhi.tan@duke.edu			ERC [233297, NSF-BCS-27552, NSF-BCS-25172]	ERC(European Research Council (ERC)European Commission)	This work was supported by the ERC #233297 (http://erc.europa.eu/) and NSF-BCS-27552; NSF-BCS-25172 (http://www.nsf.gov/div/index.jsp?div=BCS) to Brian Hare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Brent L., 2001, CARE MANAGEMENT CAPT; Bullinger AE, ANIMAL BEHA IN PRESS; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Cheney DL, 2011, P NATL ACAD SCI USA, V108, P10902, DOI 10.1073/pnas.1100291108; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Crofoot MC, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P171, DOI 10.1007/978-3-642-02725-3_8; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Engh AL, 2006, P ROY SOC B-BIOL SCI, V273, P707, DOI 10.1098/rspb.2005.3378; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Feistner A.T.C., 1989, P21; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Ganem G, 2004, PHYSIOL BEHAV, V82, P555, DOI 10.1016/j.physbeh.2004.05.002; Gold Kenneth C., 2001, P90; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Hare B, 2007, CURR DIR PSYCHOL SCI, V16, P60, DOI 10.1111/j.1467-8721.2007.00476.x; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann E, 2011, DEVELOPMENTAL SCI, V14, P1393, DOI 10.1111/j.1467-7687.2011.01082.x; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hohmann G, 2001, PRIMATES, V42, P91, DOI 10.1007/BF02640692; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; House BR, 2012, EVOL HUM BEHAV, V33, P291, DOI 10.1016/j.evolhumbehav.2011.10.007; IDANI G, 1991, FOLIA PRIMATOL, V57, P83, DOI 10.1159/000156568; Jaeggi AV, 2011, BEHAV ECOL SOCIOBIOL, V65, P2125, DOI 10.1007/s00265-011-1221-3; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; Rosati AG, 2012, ANIM BEHAV, V84, P869, DOI 10.1016/j.anbehav.2012.07.010; Seabright P, 2004, CO STRANGERS; Seres M, 2001, ZOO BIOL, V20, P501, DOI 10.1002/zoo.10003; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; Stumpf R, 2011, PRIMATES PERSPECTIVE, P340; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tomasello M, 2009, WHY WE COOPERATE, P1; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Vaish A, 2012, SO NEUROSCI SER, P131; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wobber V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017147; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Woods V, 2011, PRIMATES, V52, P111, DOI 10.1007/s10329-010-0229-z; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; Yamamoto S, 2012, P NATL ACAD SCI USA; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416	68	156	159	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51922	10.1371/journal.pone.0051922	http://dx.doi.org/10.1371/journal.pone.0051922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300956	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900012
J	Isin, B; Estiu, G; Wiest, O; Oltvai, ZN				Isin, Basak; Estiu, Guillermina; Wiest, Olaf; Oltvai, Zoltan N.			Identifying Ligand Binding Conformations of the beta 2-Adrenergic Receptor by Using Its Agonists as Computational Probes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CONSERVED NPXXY MOTIF; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ACTIVE STATE; ACTIVATION; RHODOPSIN; IDENTIFICATION	Recently available G-protein coupled receptor (GPCR) structures and biophysical studies suggest that the difference between the effects of various agonists and antagonists cannot be explained by single structures alone, but rather that the conformational ensembles of the proteins need to be considered. Here we use an elastic network model-guided molecular dynamics simulation protocol to generate an ensemble of conformers of a prototypical GPCR, beta(2)-adrenergic receptor (beta(2)AR). The resulting conformers are clustered into groups based on the conformations of the ligand binding site, and distinct conformers from each group are assessed for their binding to known agonists of beta(2)AR. We show that the select ligands bind preferentially to different predicted conformers of beta(2)AR, and identify a role of beta(2)AR extracellular region as an allosteric binding site for larger drugs such as salmeterol. Thus, drugs and ligands can be used as "computational probes" to systematically identify protein conformers with likely biological significance.	[Isin, Basak; Oltvai, Zoltan N.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Estiu, Guillermina; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Estiu, Guillermina; Wiest, Olaf] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Wiest, Olaf] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Notre Dame; University of Notre Dame; Peking University; University Town of Shenzhen	Isin, B (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	bai2@pitt.edu; oltvai@pitt.edu			NIAID [U01-0700499]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID U01-0700499 to OW and ZNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Arakawa M, 2010, PROTEIN SCI, V19, P85, DOI 10.1002/pro.285; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gales C, 2000, J BIOL CHEM, V275, P17321, DOI 10.1074/jbc.M909801199; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Han DS, 2008, BIOCHEMISTRY-US, V47, P7317, DOI 10.1021/bi800442g; Isin B, 2002, BIOPHYS J, V82, P569, DOI 10.1016/S0006-3495(02)75422-2; Isin B, 2008, BIOPHYS J, V95, P789, DOI 10.1529/biophysj.107.120691; Isin B, 2006, PROTEINS, V65, P970, DOI 10.1002/prot.21158; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Johnson MS, 2006, CELL SIGNAL, V18, P1793, DOI 10.1016/j.cellsig.2006.02.002; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reynolds KA, 2009, J COMPUT AIDED MOL D; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shenkin PS, 1994, CLUSTER ANAL MOL CON, V15, P899; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1989, J BIOL CHEM, V264, P16470; Strange PG, 1999, BIOCHEM PHARMACOL, V58, P1081; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p	62	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50186	10.1371/journal.pone.0050186	http://dx.doi.org/10.1371/journal.pone.0050186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300522	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000313872600002
J	Schon, C; Hoffmann, NA; Ochs, SM; Burgold, S; Filser, S; Steinbach, S; Seeliger, MW; Arzberger, T; Goedert, M; Kretzschmar, HA; Schmidt, B; Herms, J				Schoen, Christian; Hoffmann, Nadine A.; Ochs, Simon M.; Burgold, Steffen; Filser, Severin; Steinbach, Sonja; Seeliger, Mathias W.; Arzberger, Thomas; Goedert, Michel; Kretzschmar, Hans A.; Schmidt, Boris; Herms, Jochen			Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice	PLOS ONE			English	Article							AMYLOID DEPOSITION; MOUSE MODEL; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PROTEIN; ABNORMALITIES; DEGENERATION; MUTATIONS; PATHOLOGY; PRECEDES	Tauopathies are widespread neurodegenerative disorders characterised by the intracellular accumulation of hyperphosphorylated tau. Especially in Alzheimer's disease, pathological alterations in the retina are discussed as potential biomarkers to improve early diagnosis of the disease. Using mice expressing human mutant P301S tau, we demonstrate for the first time a straightforward optical approach for the in vivo detection of fibrillar tau in the retina. Longitudinal examinations of individual animals revealed the fate of single cells containing fibrillar tau and the progression of tau pathology over several months. This technique is most suitable to monitor therapeutic interventions aimed at reducing the accumulation of fibrillar tau. In order to evaluate if this approach can be translated to human diagnosis, we tried to detect fibrillar protein aggregates in the post-mortem retinas of patients that had suffered from Alzheimer's disease or Progressive Supranuclear Palsy. Even though we could detect hyperphosphorylated tau, we did not observe any fibrillar tau or Ass aggregates. In contradiction to previous studies, our observations do not support the notion that Ab or tau in the retina are of diagnostic value in Alzheimer's disease.	[Schoen, Christian; Hoffmann, Nadine A.; Ochs, Simon M.; Burgold, Steffen; Filser, Severin; Steinbach, Sonja; Herms, Jochen] DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany; [Schoen, Christian; Hoffmann, Nadine A.; Burgold, Steffen; Arzberger, Thomas; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol, Munich, Germany; [Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, Darmstadt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; MRC Laboratory Molecular Biology; Technical University of Darmstadt	Herms, J (corresponding author), DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany.	Jochen.Herms@med.uni-muenchen.de	Schmidt, Boris/D-3293-2009; Herms, Jochen/D-3518-2011; Schmidt, Boris/M-7886-2019	Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392	German Federal Ministry for Education and Research (BMBF) [13N10636]; UK Medical Research Council [U105184291]; Medical Research Council [MC_U105184291] Funding Source: researchfish; MRC [MC_U105184291] Funding Source: UKRI	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the German Federal Ministry for Education and Research (BMBF - 13N10636)( http://www.bmbf.de) and the UK Medical Research Council (U105184291) (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Bolander A, 2012, J MED CHEM; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bull ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034724; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Leger F, 2011, J NEUROPATH EXP NEUR, V70, P63, DOI 10.1097/NEN.0b013e31820376cc; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Maurage CA, 2003, ANN NEUROL, V54, P542, DOI 10.1002/ana.10730; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021405; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Walsh MK, 2008, J NEUROSCI METH, V169, P214, DOI 10.1016/j.jneumeth.2007.11.029; Wostyn P, 2009, BRIT J OPHTHALMOL, V93, P1557, DOI 10.1136/bjo.2008.148064; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x	46	116	119	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53547	10.1371/journal.pone.0053547	http://dx.doi.org/10.1371/journal.pone.0053547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300938	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600108
J	Tahvanainen, P; Alpermann, TJ; Figueroa, RI; John, U; Hakanen, P; Nagai, S; Blomster, J; Kremp, A				Tahvanainen, Pia; Alpermann, Tilman J.; Figueroa, Rosa Isabel; John, Uwe; Hakanen, Paivi; Nagai, Satoshi; Blomster, Jaanika; Kremp, Anke			Patterns of Post-Glacial Genetic Differentiation in Marginal Populations of a Marine Microalga	PLOS ONE			English	Article							ALEXANDRIUM-OSTENFELDII DINOPHYCEAE; FUCUS-VESICULOSUS; COMPUTER-PROGRAM; ZOSTERA-MARINA; RIBOSOMAL DNA; DIVERSITY; DINOFLAGELLATE; ATLANTIC; AFLP; LIFE	This study investigates the genetic structure of an eukaryotic microorganism, the toxic dinoflagellate Alexandrium ostenfeldii, from the Baltic Sea, a geologically young and ecologically marginal brackish water estuary which is predicted to support evolution of distinct, genetically impoverished lineages of marine macroorganisms. Analyses of the internal transcribed spacer (ITS) sequences and Amplified Fragment Length Polymorphism (AFLP) of 84 A. ostenfeldii isolates from five different Baltic locations and multiple external sites revealed that Baltic A. ostenfeldii is phylogenetically differentiated from other lineages of the species and micro-geographically fragmented within the Baltic Sea. Significant genetic differentiation (FST) between northern and southern locations was correlated to geographical distance. However, instead of discrete genetic units or continuous genetic differentiation, the analysis of population structure suggests a complex and partially hierarchic pattern of genetic differentiation. The observed pattern suggests that initial colonization was followed by local differentiation and varying degrees of dispersal, most likely depending on local habitat conditions and prevailing current systems separating the Baltic Sea populations. Local subpopulations generally exhibited low levels of overall gene diversity. Association analysis suggests predominately asexual reproduction most likely accompanied by frequency shifts of clonal lineages during planktonic growth. Our results indicate that the general pattern of genetic differentiation and reduced genetic diversity of Baltic populations found in large organisms also applies to microscopic eukaryotic organisms.	[Tahvanainen, Pia; Hakanen, Paivi; Kremp, Anke] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Tahvanainen, Pia; Blomster, Jaanika] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Alpermann, Tilman J.] LOEWE Biodivers & Climate Res Ctr, Frankfurt, Germany; [Alpermann, Tilman J.] Senckenberg Res Inst, Frankfurt, Germany; [Alpermann, Tilman J.] Natl Museum, Frankfurt, Germany; [Figueroa, Rosa Isabel] Lund Univ, Lund, Sweden; [Figueroa, Rosa Isabel] Inst Espanol Oceanog, Vigo, Spain; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Nagai, Satoshi] Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan	Finnish Environment Institute; University of Helsinki; Senckenberg Gesellschaft fur Naturforschung (SGN); Lund University; Spanish Institute of Oceanography; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Japan Fisheries Research & Education Agency (FRA)	Tahvanainen, P (corresponding author), Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland.	pia.tahvanainen@helsinki.fi	john, uwe/S-3009-2016; Kremp, Anke/I-8139-2013; Figueroa, Rosa Isabel/M-7598-2015	john, uwe/0000-0002-1297-4086; Figueroa, Rosa Isabel/0000-0001-9944-7993; Blomster, Jaanika/0000-0003-1347-7919	Academy of Finland [128833]; Maj and Thor Nessling foundation; Walter ja Andree de Nottbeck foundation; Hesse's Ministry of Higher Education, Research, and the Arts; Alfred Wegener Institute	Academy of Finland(Academy of Finland); Maj and Thor Nessling foundation; Walter ja Andree de Nottbeck foundation; Hesse's Ministry of Higher Education, Research, and the Arts; Alfred Wegener Institute	This paper was supported by grants from the Academy of Finland (# 128833), the Maj and Thor Nessling as well as the Walter ja Andree de Nottbeck foundations. Additional financial support was obtained by the research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; and the PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADACHI M, 1994, J PHYCOL, V30, P857, DOI 10.1111/j.0022-3646.1994.00857.x; Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Bolch CJS, 1999, J PHYCOL, V35, P339, DOI 10.1046/j.1529-8817.1999.3520339.x; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Brosnahan ML, 2010, DEEP-SEA RES PT II, V57, P175, DOI 10.1016/j.dsr2.2009.09.005; Casali Sandro, 2011, P1; Cembella AD, 2001, J PLANKTON RES, V23, P1413, DOI 10.1093/plankt/23.12.1413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Elken Jueri, 2008, P379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Figueroa RI, 2008, PROTIST, V159, P563, DOI 10.1016/j.protis.2008.05.003; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu HF, 2011, J SYST EVOL, V49, P606, DOI 10.1111/j.1759-6831.2011.00160.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakanen P, 2012, HARMFUL ALGAE, V15, P91, DOI 10.1016/j.hal.2011.12.002; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Haubold B, 1998, GENETICS, V150, P1341; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Figueroa RI, 2010, DEEP-SEA RES PT II, V57, P190, DOI 10.1016/j.dsr2.2009.09.016; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, J PHYCOL, V47, P990, DOI 10.1111/j.1529-8817.2011.01032.x; John U, 2004, PROTIST, V155, P169, DOI 10.1078/143446104774199574; John U, 2003, MOL BIOL EVOL, V20, P1015, DOI 10.1093/molbev/msg105; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kremp A, 2006, J PHYCOL, V42, P400, DOI 10.1111/j.1529-8817.2006.00205.x; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kremp A, 2009, HARMFUL ALGAE, V8, P318, DOI 10.1016/j.hal.2008.07.004; Laamanen MJ, 2002, APPL ENVIRON MICROB, V68, P5296, DOI 10.1128/AEM.68.11.5296-5303.2002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Logares R, 2007, MICROB ECOL, V53, P549, DOI 10.1007/s00248-006-9088-y; Logares R, 2009, PROTIST, V160, P301, DOI 10.1016/j.protis.2008.10.004; MOESTRUP O, 1988, OPHELIA, V28, P195, DOI 10.1080/00785326.1988.10430813; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Olsson J, 2011, J FISH BIOL, V79, P122, DOI 10.1111/j.1095-8649.2011.02998.x; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rambaut A., 2007, TRACER V1 4; Reusch TBH, 1999, MAR ECOL PROG SER, V183, P301, DOI 10.3354/meps183301; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Tatarenkov A, 2007, J PHYCOL, V43, P675, DOI 10.1111/j.1529-8817.2007.00369.x; ten Lohuis MR, 1998, J PHYCOL, V34, P152; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Xu J, 2010, MICROBIAL POPULATION GENETICS, P1; Xu J., 2005, EVOL GENET, P87	75	45	45	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53602	10.1371/journal.pone.0053602	http://dx.doi.org/10.1371/journal.pone.0053602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300940	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600110
J	Cetinkol, OP; Smith-Moritz, AM; Cheng, G; Lao, J; George, A; Hong, KL; Henry, R; Simmons, BA; Heazlewood, JL; Holmes, BM				Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Cheng, Gang; Lao, Jeemeng; George, Anthe; Hong, Kunlun; Henry, Robert; Simmons, Blake A.; Heazlewood, Joshua L.; Holmes, Bradley M.			Structural and Chemical Characterization of Hardwood from Tree Species with Applications as Bioenergy Feedstocks	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; ENZYMATIC-HYDROLYSIS; CELL-WALL; LIGNIN MODIFICATION; PULP PRODUCTION; OPPOSITE WOOD; CELLULOSE; BIOMASS; NMR; SPECTROSCOPY	Eucalypt species are a group of flowering trees widely used in pulp production for paper manufacture. For several decades, the wood pulp industry has focused research and development efforts on improving yields, growth rates and pulp quality through breeding and the genetic improvement of key tree species. Recently, this focus has shifted from the production of high quality pulps to the investigation of the use of eucalypts as feedstocks for biofuel production. Here the structure and chemical composition of the heartwood and sapwood of Eucalyptus dunnii, E. globulus, E. pillularis, E. urophylla, an E. urophylla-E. grandis cross, Corymbia citriodora ssp. variegata, and Acacia mangium were compared using nuclear magnetic resonance spectroscopy (NMR), X-ray diffraction (XRD) and biochemical composition analysis. Some trends relating to these compositions were also identified by Fourier transform near infrared (FT-NIR) spectroscopy. These results will serve as a foundation for a more comprehensive database of wood properties that will help develop criteria for the selection of tree species for use as biorefinery feedstocks.	[Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Cheng, Gang; Lao, Jeemeng; George, Anthe; Simmons, Blake A.; Heazlewood, Joshua L.; Holmes, Bradley M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Cetinkol, Oezguel Persil; Smith-Moritz, Andreia M.; Lao, Jeemeng; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cheng, Gang; George, Anthe; Simmons, Blake A.; Holmes, Bradley M.] Sandia Natl Labs, Joint BioEnergy Inst, Livermore, CA USA; [Hong, Kunlun] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Henry, Robert; Simmons, Blake A.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Queensland	Heazlewood, JL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA.	jlheazlewood@lbl.gov	Heazlewood, Joshua L/A-2554-2008; Cetinkol, Ozgul Persil/AAZ-6526-2020; Hong, Kunlun/E-9787-2015; Simmons, Blake/N-6022-2016; Henry, Robert J/B-5824-2008	Heazlewood, Joshua L/0000-0002-2080-3826; Hong, Kunlun/0000-0002-2852-5111; Simmons, Blake/0000-0002-1332-1810; Henry, Robert J/0000-0002-4060-0292; PERSIL CETINKOL, OZGUL/0000-0002-6632-6981; Lao, Jeemeng/0000-0002-6576-1260	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Basic Energy Sciences, United States Department of Energy	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE))	This work was part of the Department of Energy (DOE) Joint BioEnergy Institute (http://www.jbei.org) supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the United States Department of Energy. The XRD experiments were conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo MG, 2010, MADERAS-CIENC TECNOL, V12, P241, DOI 10.4067/S0718-221X2010000300008; Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; Alves EF, 2010, CARBOHYD POLYM, V82, P1097, DOI 10.1016/j.carbpol.2010.06.038; Antal MJ, 1996, ENERG FUEL, V10, P652, DOI 10.1021/ef9501859; BORRALHO NMG, 1993, CAN J FOREST RES, V23, P648, DOI 10.1139/x93-085; Bunzel M, 2006, J AGR FOOD CHEM, V54, P8352, DOI 10.1021/jf061525z; Cao Y, 2004, J MOL STRUCT, V693, P87, DOI 10.1016/j.molstruc.2004.02.017; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z; Coates JP, 1996, APPL SPECTROSC REV, V31, P179, DOI 10.1080/05704929608000568; Del Lungo A., 2006, 38 FAO UN; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Evtuguin DV, 2003, CARBOHYD RES, V338, P597, DOI 10.1016/S0008-6215(02)00529-3; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Garrote G, 2003, BIORESOURCE TECHNOL, V88, P61, DOI 10.1016/S0960-8524(02)00256-0; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hames B, 2003, APPL BIOCHEM BIOTECH, V105, P14; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Ibarra D, 2007, HOLZFORSCHUNG, V61, P634, DOI 10.1515/HF.2007.096; Ibarra D, 2007, J AGR FOOD CHEM, V55, P3477, DOI 10.1021/jf063728t; Inoue H, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-2; Kaida R, 2009, J WOOD SCI, V55, P381, DOI 10.1007/s10086-009-1038-0; Kim H, 2008, BIOENERG RES, V1, P56, DOI 10.1007/s12155-008-9004-z; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; KUMAR M, 1992, BIOMASS BIOENERG, V3, P411, DOI 10.1016/0961-9534(92)90037-Q; Lisboa SA, 2007, HOLZFORSCHUNG, V61, P478, DOI 10.1515/HF.2007.110; MAEKAWA E, 1989, J WOOD CHEM TECHNOL, V9, P549, DOI 10.1080/02773818908050315; Magalhaes W., 2011, BMC P, V5, P116, DOI [10.1186/1753-6561-5-S7-P116, DOI 10.1186/1753-6561-5-S7-P116]; Munoz C, 2011, J IND MICROBIOL BIOT, V38, P1861, DOI 10.1007/s10295-011-0975-y; Norgate T, 2009, ISIJ INT, V49, P587, DOI 10.2355/isijinternational.49.587; NORRIS KH, 1984, CEREAL CHEM, V61, P158; Piketty MG, 2009, BIOMASS BIOENERG, V33, P180, DOI 10.1016/j.biombioe.2008.06.002; Pinto PC, 2005, J AGR FOOD CHEM, V53, P7856, DOI 10.1021/jf058081b; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Raymond C. A., 2001, Forest Genetics, V8, P213; Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096; Rencoret J, 2009, HOLZFORSCHUNG, V63, P691, DOI 10.1515/HF.2009.070; Romani A, 2011, BIORESOURCE TECHNOL, V102, P5896, DOI 10.1016/j.biortech.2011.02.070; Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/BFS.11.136, 10.4155/bfs.11.136]; Sierra R, 2008, CHEM ENG PROG, V104, pS10; Sluiter A, 2008, TECHNICAL REPORT; Smith-Moritz AM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-26; SUEHARA KI, 2004, ADV BIOCHEM ENG BIOT, V90, P173; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Wada M, 2003, POLYM J, V35, P155, DOI 10.1295/polymj.35.155; Watson C, 1977, ANAL CHEM, V49, P835; Watt DK, 1999, CARBOHYD POLYM, V39, P165, DOI 10.1016/S0144-8617(99)00002-8; WETZEL DL, 1983, ANAL CHEM, V55, P1165, DOI 10.1021/ac00262a001; Willfor S, 2005, WOOD SCI TECHNOL, V39, P601, DOI 10.1007/s00226-005-0039-4; Wyman CE, 1999, ANNU REV ENERG ENV, V24, P189, DOI 10.1146/annurev.energy.24.1.189; Yelle DJ, 2008, MAGN RESON CHEM, V46, P508, DOI 10.1002/mrc.2201; Yu Q, 2010, BIORESOURCE TECHNOL, V101, P4895, DOI 10.1016/j.biortech.2009.11.051	55	25	25	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52820	10.1371/journal.pone.0052820	http://dx.doi.org/10.1371/journal.pone.0052820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300786	Green Published, gold			2022-12-25	WOS:000313051500066
J	Liebler, SS; Feldner, A; Adam, MG; Korff, T; Augustin, HG; Fischer, A				Liebler, Sven S.; Feldner, Anja; Adam, M. Gordian; Korff, Thomas; Augustin, Hellmut G.; Fischer, Andreas			No Evidence for a Functional Role of Bi-Directional Notch Signaling during Angiogenesis	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; LIGAND DELTA1; VASCULAR MORPHOGENESIS; SPROUTING ANGIOGENESIS; PRIMARY NEUROGENESIS; CYTOPLASMIC DOMAIN; GAMMA-SECRETASE; ADAM PROTEASES; BINDING; REGION	The Delta-Notch pathway is a signal exchanger between adjacent cells to regulate numerous differentiation steps during embryonic development. Blood vessel formation by sprouting angiogenesis requires high expression of the Notch ligand DLL4 in the leading tip cell, while Notch receptors in the trailing stalk cells are activated by DLL4 to achieve strong Notch signaling activity. Upon ligand binding, Notch receptors are cleaved by ADAM proteases and gamma-secretase. This releases the intracellular Notch domain that acts as a transcription factor. There is evidence that also Notch ligands (DLL1, DLL4, JAG1, JAG2) are processed upon receptor binding to influence transcription in the ligand-expressing cell. Thus, the existence of bi-directional Delta-Notch signaling has been proposed. We report here that the Notch ligands DLL1 and JAG1 are processed in endothelial cells in a gamma-secretase-dependent manner and that the intracellular ligand domains accumulate in the cell nucleus. Overexpression of JAG1 intracellular domain (ICD) as well as DLL1-ICD, DLL4-ICD and NOTCH1-ICD inhibited endothelial proliferation. Whereas NOTCH1-ICD strongly repressed endothelial migration and sprouting angiogenesis, JAG1-ICD, DLL1-ICD and DLL4-ICD had no significant effects. Consistently, global gene expression patterns were only marginally affected by the processed Notch ligands. In addition to its effects as a transcription factor, NOTCH1-ICD promotes cell adhesion to the extracellular matrix in a transcription-independent manner. However, JAG1-ICD, DLL1-ICD and DLL4-ICD did not influence endothelial cell adhesion. In summary, reverse signaling of Notch ligands appears to be dispensable for angiogenesis in cellular systems.	[Liebler, Sven S.; Feldner, Anja; Adam, M. Gordian; Fischer, Andreas] DKFZ ZMBH Alliance, German Canc Res Ctr Heidelberg, Heidelberg, Germany; [Liebler, Sven S.; Adam, M. Gordian; Augustin, Hellmut G.; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis CBTM, D-6800 Mannheim, Germany; [Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis A190, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, A (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr Heidelberg, Heidelberg, Germany.	a.fischer@dkfz.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242	Deutsche Forschungsgemeinschaft [DFG-SFB/TR23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft DFG-SFB/TR23 to T.K., H.G.A., and A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Carey MF, 2009, COLD SPRING HARB PRO, V2009; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kiyota T, 2004, MECH DEVELOP, V121, P573, DOI 10.1016/j.mod.2004.03.034; Klueg KM, 1998, MOL BIOL CELL, V9, P1709, DOI 10.1091/mbc.9.7.1709; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Meloty-Kapella L, 2012, DEV CELL; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfister S, 2003, J MOL BIOL, V333, P229, DOI 10.1016/j.jmb.2003.08.043; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Popovic M, 2007, FEBS J, V274, P5325, DOI 10.1111/j.1742-4658.2007.06053.x; Popovic M, 2006, PROTEIN EXPRES PURIF, V47, P398, DOI 10.1016/j.pep.2005.11.027; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	36	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53074	10.1371/journal.pone.0053074	http://dx.doi.org/10.1371/journal.pone.0053074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300864	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500106
J	Chan, KH; Lam, KSL; Cheng, OY; Kwan, JSC; Ho, PWL; Cheng, KKY; Chung, SK; Ho, JWM; Guo, VY; Xu, A				Chan, Koon-Ho; Lam, Karen Siu-Ling; Cheng, On-Yin; Kwan, Jason Shing-Cheong; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Chung, Sookja Kim; Ho, Jessica Wing-Man; Guo, Vivian Yawei; Xu, Almin			Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NEUROBLASTOMA SH-SY5Y CELLS; GROWTH-FACTOR EXPRESSION; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; METABOLIC SYNDROME; PRECURSOR PROTEIN; GENE-EXPRESSION; MOUSE MODEL	Beta-amyloid (A beta) neurotoxicity is important in Alzheimer's disease (AD) pathogenesis. Ab neurotoxicity causes oxidative stress, inflammation and mitochondrial damage resulting in neuronal degeneration and death. Oxidative stress, inflammation and mitochondrial failure are also pathophysiological mechanisms of type 2 diabetes (T2DM) which is characterized by insulin resistance. Interestingly, T2DM increases risk to develop AD which is associated with reduced neuronal insulin sensitivity (central insulin resistance). We studied the potential protective effect of adiponectin (an adipokine with insulin-sensitizing, anti-inflammatory and anti-oxidant properties) against A beta neurotoxicity in human neuroblastoma cells (SH-SY5Y) transfected with the Swedish amyloid precursor protein (Sw-APP) mutant, which overproduced A beta with abnormal intracellular A beta accumulation. Cytotoxicity was measured by assay for lactate dehydrogenase (LDH) released upon cell death and lysis. Our results revealed that Sw-APP transfected SH-SY5Y cells expressed both adiponectin receptor 1 and 2, and had increased AMP-activated protein kinase (AMPK) activation and enhanced nuclear factor-kappa B (NF-kappa B) activation compared to control empty-vector transfected SH-SY5Y cells. Importantly, adiponectin at physiological concentration of 10 mu g/ml protected Sw-APP transfected SH-SY5Y cells against cytotoxicity under oxidative stress induced by hydrogen peroxide. This neuroprotective action of adiponectin against A beta neurotoxicity-induced cytotoxicity under oxidative stress involved 1) AMPK activation mediated via the endosomal adaptor protein APPL1 (adaptor protein with phosphotyrosine binding, pleckstrin homology domains and leucine zipper motif) and possibly 2) suppression of NF-kappa B activation. This raises the possibility of novel therapies for AD such as adiponectin receptor agonists.	[Chan, Koon-Ho; Lam, Karen Siu-Ling; Cheng, On-Yin; Kwan, Jason Shing-Cheong; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Ho, Jessica Wing-Man; Guo, Vivian Yawei; Xu, Almin] Univ Hong Kong, LKS Fac Med, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Lam, Karen Siu-Ling; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Xu, Almin] Univ Hong Kong, LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Lam, Karen Siu-Ling; Chung, Sookja Kim] Univ Hong Kong, LKS Fac Med, Hong Kong Univ Alzheimers Dis Res Network, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Cheng, On-Yin; Kwan, Jason Shing-Cheong] Univ Hong Kong, LKS Fac Med, Neuroimmunol & Neuroinflammat Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KH (corresponding author), Univ Hong Kong, LKS Fac Med, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China.	koonho@hkucc.hku.hk	Guo, Vivian/ABB-5803-2022; Xu, Aimin/D-3291-2013; Ho, Philip Wing-Lok/K-5814-2013; /C-4315-2009	Xu, Aimin/0000-0002-0668-033X; Ho, Philip Wing-Lok/0000-0001-7794-0146; /0000-0003-4665-2576; Guo, Vivian Yawei/0000-0001-9399-1808; Cheng, Kenneth King Yip/0000-0002-7274-0839; /0000-0001-5757-541X	Hong Kong University Alzheimer's Disease Research Network; LKS Faculty of Medicine of the University of Hong Kong	Hong Kong University Alzheimer's Disease Research Network; LKS Faculty of Medicine of the University of Hong Kong	This study is supported by funding from the Hong Kong University Alzheimer's Disease Research Network and Seed Funding for Basic Research from the LKS Faculty of Medicine of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bossu P, 2008, BRAIN BEHAV IMMUN, V22, P487, DOI 10.1016/j.bbi.2007.10.001; Britschgi M, 2007, NAT MED, V13, P408, DOI 10.1038/nm0407-408; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jeon BT, 2009, BRAIN RES REV, V61, P81, DOI 10.1016/j.brainresrev.2009.05.002; Jones A, 2009, J ALZHEIMERS DIS, V16, P787, DOI 10.3233/JAD-2009-0973; Jung TW, 2006, BIOCHEM PHARMACOL, V72, P616, DOI 10.1016/j.bcp.2006.05.013; Jung TW, 2006, BIOCHEM BIOPH RES CO, V343, P564, DOI 10.1016/j.bbrc.2006.02.186; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Marques CA, 2003, J BIOL CHEM, V278, P28294, DOI 10.1074/jbc.M212265200; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Ojala J, 2007, NEUROBIOL AGING, V30, P198; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Terai K, 1996, BRAIN RES, V735, P159; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x; van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xu AM, 2004, ENDOCRINOLOGY, V145, P487, DOI 10.1210/en.2003-1140; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yaffe K, 2007, J AM GERIATR SOC, V55, P758, DOI 10.1111/j.1532-5415.2007.01139.x; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; ZHONG ZY, 1994, J BIOL CHEM, V269, P12179; Zhou L, 2012, BIOCHEM BIOPH RES CO, V423, P697, DOI 10.1016/j.bbrc.2012.06.017	85	98	105	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52354	10.1371/journal.pone.0052354	http://dx.doi.org/10.1371/journal.pone.0052354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300647	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100044
J	He, CF; Li, YX; Zhang, GX; Gu, ZG; Yang, R; Li, J; Lu, ZJ; Zhou, ZH; Zhang, CY; Wang, J				He, Chenfeng; Li, Ying-Xin; Zhang, Guangxin; Gu, Zuguang; Yang, Rong; Li, Jie; Lu, Zhi John; Zhou, Zhi-Hua; Zhang, Chenyu; Wang, Jin			MiRmat: Mature microRNA Sequence Prediction	PLOS ONE			English	Article							NUCLEAR EXPORT; REGULATORY MOTIFS; RNA INTERFERENCE; DROSHA; IDENTIFICATION; BIOGENESIS; PRECURSORS	Background: MicroRNAs are known to be generated from primary transcripts mainly through the sequential cleavages by two enzymes, Drosha and Dicer. The sequence of a mature microRNA, especially the 'seeding sequence', largely determines its binding ability and specificity to target mRNAs. Therefore, methods that predict mature microRNA sequences with high accuracy will benefit the identification and characterization of novel microRNAs and their targets, and contribute to inferring the post-transcriptional regulation network at a genome scale. Methodology/Principal Findings: We have developed a method, MiRmat, to predict the mature microRNA sequence. MiRmat is essentially composed of two parts: the prediction of Drosha processing site and the identification of Dicer processing site. Based on the analysis of microRNAs from 12 species, we found that the patterns of free energy profiles are conserved among vertebrate microRNA hairpins. Therefore, we introduced in our method the free energy distribution pattern of the downstream part of pri-microRNA secondary structure and Random Forest algorithm to predict the mature microRNA sequence. Based on the evaluation on an independent test dataset from 10 vertebrates, MiRmat was shown to identify 77.8% of the Drosha processing sites and 92.8% of the Dicer sites within a deviation of 2 nt. In a more stringent evaluation by excluding the microRNAs sharing the same family between the training set and test set, MiRmat kept a rather well performance of 71.9% and 87.2% of the identification rate on the Drosha and Dicer site respectively, which represents the ability to deal with the novel microRNA family. MiRmat outperforms other state-of-the-art methods and has a high degree of efficacy for the prediction of mature microRNA sequences of vertebrates. Conclusion: MiRmat was developed for identifying microRNA mature sequence(s) by introducing the free energy distribution of RNA stem-loop structure and the Random Forest algorithm. We prove that MiRmat has better performance than the existing tools and is applicable among vertebrates. MiRmat is freely available at http://mcube.nju.edu.cn/jwang/lab/soft/MiRmat/.	[Li, Ying-Xin; Zhou, Zhi-Hua] Nanjing Univ, Natl Key Lab Novel Software Technol, Nanjing, Jiangsu, Peoples R China; [He, Chenfeng; Zhang, Guangxin; Gu, Zuguang; Li, Jie; Zhang, Chenyu; Wang, Jin] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [He, Chenfeng; Zhang, Guangxin; Gu, Zuguang; Li, Jie; Zhang, Chenyu; Wang, Jin] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Ying-Xin] Beijing Jingwei Text Machinery New Technol Co Ltd, Inst Machine Vis & Machine Intelligence, Beijing, Peoples R China; [Yang, Rong] Nanjing Univ, Sch Phys, Inst Biophys, Nanjing, Jiangsu, Peoples R China; [Lu, Zhi John] Tsinghua Univ, Minist Educ, Key Lab Bioinformat & Syst Biol, Sch Life Sci, Beijing 100084, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Tsinghua University	Zhou, ZH (corresponding author), Nanjing Univ, Natl Key Lab Novel Software Technol, Nanjing, Jiangsu, Peoples R China.	zhouzh@nju.edu.cn; cyzhang@nju.edu.cn; jwang@nju.edu.cn	Gu, Zuguang/C-5914-2009; He, Chenfeng/W-9330-2019	He, Chenfeng/0000-0002-9171-3879; Gu, Zuguang/0000-0002-7395-8709	National Natural Science Foundation of China [30890044, 31071232, 61021062, 61173068]; National Basic Research Program [2007CB814806, 2010CB327903]; Postdoctoral Science Foundation of China [20090461086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (30890044, 31071232, 61021062, 61173068), the National Basic Research Program (2007CB814806, 2010CB327903) and the Postdoctoral Science Foundation of China (20090461086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathews David H, 2006, Curr Protoc Bioinformatics, VChapter 12, DOI [10.1002/0471250953.bi1206s46, 10.1002/0471250953.bi1206s13]; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sinha S, 2009, J PROTEOM BIOINFORM, V2, P336; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zhou Z.H., 2009, ENCY BIOMETRICS, P270, DOI [10.1007/978-0-387-73003-5_293, DOI 10.1007/978-0-387-73003-5_293]; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	52	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51673	10.1371/journal.pone.0051673	http://dx.doi.org/10.1371/journal.pone.0051673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300555	Green Published, gold			2022-12-25	WOS:000312829100011
J	Kientz, B; Ducret, A; Luke, S; Vukusic, P; Mignot, T; Rosenfeld, E				Kientz, Betty; Ducret, Adrien; Luke, Stephen; Vukusic, Peter; Mignot, Tam; Rosenfeld, Eric			Glitter-Like Iridescence within the Bacteroidetes Especially Cellulophaga spp.: Optical Properties and Correlation with Gliding Motility	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SP NOV.; FLAVOBACTERIUM-JOHNSONIAE; STRUCTURAL COLORS; BACTERIA; MECHANISMS; RECLASSIFICATION; IRIDOPHORES; SURFACES; LYTICA	Iridescence results from structures that generate color. Iridescence of bacterial colonies has recently been described and illustrated. The glitter-like iridescence class, created especially for a few strains of Cellulophaga lytica, exhibits an intense iridescence under direct illumination. Such color appearance effects were previously associated with other bacteria from the Bacteroidetes phylum, but without clear elucidation and illustration. To this end, we compared various bacterial strains to which the iridescent trait was attributed. All Cellulophaga species and additional Bacteroidetes strains from marine and terrestrial environments were investigated. A selection of bacteria, mostly marine in origin, were found to be iridescent. Although a common pattern of reflected wavelengths was recorded for the species investigated, optical spectroscopy and physical measurements revealed a range of different glitter-like iridescence intensity and color profiles. Importantly, gliding motility was found to be a common feature of all iridescent colonies. Dynamic analyses of "glitter" formation at the edges of C. lytica colonies showed that iridescence was correlated with layer superposition. Both gliding motility, and unknown cell-to-cell communication processes, may be required for the establishment, in time and space, of the necessary periodic structures responsible for the iridescent appearance of Bacteroidetes.	[Kientz, Betty; Rosenfeld, Eric] Univ La Rochelle, UMR Littoral Environm & Soc 7266, CNRS, La Rochelle, France; [Ducret, Adrien; Mignot, Tam] Univ Aix Marseille, UMR 7283, CNRS, Lab Chim Bacterienne,Inst Microbiol Mediterranee, Marseille, France; [Luke, Stephen; Vukusic, Peter] Univ Exeter, Sch Phys, Exeter, Devon, England	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Exeter	Rosenfeld, E (corresponding author), Univ La Rochelle, UMR Littoral Environm & Soc 7266, CNRS, La Rochelle, France.	eric.rosenfeld@univ-lr.fr		Mignot, Tam/0000-0003-4338-9063; ERIC, ROSENFELD/0000-0003-1196-5265	AFOSR [FA9550-10-1-0020]; Ministere de la recherche et de l'enseignement superieur; CNRS [AIR75515]; Biotechnology and Biological Sciences Research Council [BB/E000177/1, JF16983] Funding Source: researchfish; BBSRC [BB/E000177/1] Funding Source: UKRI	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ministere de la recherche et de l'enseignement superieur; CNRS(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	PV acknowledges the support of AFOSR grant FA9550-10-1-0020. BK was a PhD student with a grant from the Ministere de la recherche et de l'enseignement superieur. ER acknowledges the support of CNRS grant AIR75515 ("Bacteridescence" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2011, STAND GENOMIC SCI, V4, P72, DOI 10.4056/sigs.1543845; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J-F, 2006, PROKARYOTES HDB BIOL, V7, P455, DOI [DOI 10.1007/0-387-30747-8_16, DOI 10.1007/0-387-30747-8]; Bowman JP, 2000, INT J SYST EVOL MICR, V50, P1861, DOI 10.1099/00207713-50-5-1861; Bowman JP, 2011, BERGEYS MANUAL SYSTE, V4, P176; Braun TF, 2005, J BACTERIOL, V187, P6943, DOI 10.1128/JB.187.20.6943-6952.2005; DOBSON SJ, 1991, ARCH MICROBIOL, V156, P56, DOI 10.1007/BF00418188; Doucet SM, 2006, J EXP BIOL, V209, P380, DOI 10.1242/jeb.01988; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; ENGBOEK HC, 1950, ACTA PATHOL MIC SC, V27, P388; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Greenewalt CH, 1960, P AM PHILOS SOC, V104, P249, DOI DOI 10.1364/JOSA.50; Guillot M, 1941, CR HEBD ACAD SCI, P1100; Jensen PR, 1996, MAR BIOL, V126, P1, DOI 10.1007/BF00571371; Johansen JE, 1999, INT J SYST BACTERIOL, V49, P1231, DOI 10.1099/00207713-49-3-1231; Kahng HY, 2009, INT J SYST EVOL MICR, V59, P654, DOI 10.1099/ijs.0.003210-0; Kientz B, 2012, FEMS MICROBIOL LETT, V333, P101, DOI 10.1111/j.1574-6968.2012.02614.x; Kientz B, 2012, APPL ENVIRON MICROB, V78, P2092, DOI 10.1128/AEM.07339-11; KOBELT F, 1992, J COMP PHYSIOL B, V162, P314; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; LEWIN RA, 1969, J GEN MICROBIOL, V58, P145, DOI 10.1099/00221287-58-2-145; Lewin RA, 1969, MICROBIOLOGY, V58, P189; LYTHGOE JN, 1989, J EXP BIOL, V141, P313; McBride MJ, 2004, J MOL MICROB BIOTECH, V7, P63, DOI 10.1159/000077870; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Meadows MG, 2009, J R SOC INTERFACE, V6, pS107, DOI 10.1098/rsif.2009.0013.focus; Nedashkovskaya OI, 2004, INT J SYST EVOL MICR, V54, P609, DOI 10.1099/ijs.0.02737-0; NOGRADY G, 1964, Rev Can Biol, V23, P367; Noyes J, 2008, J MATER RES, V23, P3229, DOI 10.1557/JMR.2008.0381; Park S, 2012, INT J SYST EVOL MICR, V62, P1354, DOI 10.1099/ijs.0.033340-0; Pati A, 2011, STAND GENOMIC SCI, V4, P221, DOI 10.4056/sigs.1774329; Pijper A, 1923, S AFR MED REC, V17, P243; Pijper A, 1918, MED J S AFRICA, V14, P211; Ponder E, 1934, J EXP BIOL, V11, P54; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Reichenbach H, 1981, PROKARYOTES, V1, P356; Reichenbach H, 1989, BERGEYS MANUAL SYSTE, V3, P2015; Rhodes RG, 2011, J BACTERIOL, V193, P2418, DOI 10.1128/JB.00117-11; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; STANIER RY, 1947, J BACTERIOL, V53, P297, DOI 10.1128/JB.53.3.297-315.1947; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P85, DOI 10.1099/ijs.0.02857-0; VANDERMEULEN HJ, 1974, A VAN LEEUW J MICROB, V40, P329, DOI 10.1007/BF00399345; VOZNYAKOVSKAYA Y M, 1969, Mikrobiologiya, V38, P135; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Vukusic P, 2001, NATURE, V410, P36, DOI 10.1038/35065161; WEEKS OWEN B., 1955, JOUR BACT, V69, P649; Welch V, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041916; WILLIAMS RC, 1958, BIOCHIM BIOPHYS ACTA, V28, P464, DOI 10.1016/0006-3002(58)90507-9; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P2051, DOI 10.1099/ijs.0.63777-0	52	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52900	10.1371/journal.pone.0052900	http://dx.doi.org/10.1371/journal.pone.0052900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300811	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100092
J	Tamura, Y; Nakajima, Y; Ozeki, Y; Ono, T; Takei, M; Yamamoto, T; Fukuda, K				Tamura, Yuichi; Nakajima, Yasuo; Ozeki, Yasushi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Fukuda, Keiichi			Temperature Variations around Medication Cassette and Carry Bag in Routine Use of Epoprostenol Administration in Healthy Volunteers	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PROSTACYCLIN; DIAGNOSIS; THERAPY; TIME	Background: According to several treatment guidelines, epoprostenol is an important treatment option for pulmonary arterial hypertension. However, the pharmacokinetic characteristics and poor stability of epoprostenol at room temperature make its administration challenging. We therefore studied temperature fluctuations between the drug administration cassette and atmosphere to promote the safe use of epoprostenol. Methods and Findings: Five healthy volunteers carried a portable intravenous infusion pump attached to a medication cassette containing saline in a bag during their ordinary activities over 16 days during which the mean atmospheric temperature was 29.6 +/- 1.5 degrees C. The temperature around the medication cassette was not less than 25 degrees C on any occasion, and the mean period over 24 h during which the temperature around the cassette exceeded 35 degrees C and 40 degrees C was 96.9 +/- 156.4 min and 24.4 +/- 77.3 min, respectively. Significant correlations were observed between the temperatures outside the bag and around the cassette, as well as between temperatures around the cassette and of the saline solution in the cassette (r = 0.9258 and 0.8276, respectively). There were no differences in the temperatures outside the bag or around the cassette with respect to the bag material. Conclusions: Temperatures around a medication cassette and outside the bag containing the medication increase with sunlight exposure. The temperature around cassettes used for administering epoprostenol must therefore be kept low for as long as possible during hot summer conditions to maintain the drug stability.	[Tamura, Yuichi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Nakajima, Yasuo; Ozeki, Yasushi] GlaxoSmithKline KK, Dev & Med Affairs Div, Shibuya Ku, Tokyo, Japan	Keio University; GlaxoSmithKline	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013; Yamamoto, Tsunehisa/O-2014-2013; Tamura, Yuichi/B-5991-2014	Tamura, Yuichi/0000-0002-4437-8019; Yamamoto, Tsunehisa/0000-0002-5241-9482	GlaxoSmithKline KK	GlaxoSmithKline KK(GlaxoSmithKline)	This study was sponsored by GlaxoSmithKline KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2010, CIRC J, V74, P2200, DOI 10.1253/circj.CJ-10-0190; Al-Qudah AA, 2007, J DENT, V35, P238, DOI 10.1016/j.jdent.2006.07.012; Barst RJ, 1986, NEW ENGL J MED, V334, P296; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Flolan [package insert], 2011, FLOL PACK INS; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Marty W, 2001, AM J FOREN MED PATH, V22, P215, DOI 10.1097/00000433-200109000-00001; RUBIN LJ, 1982, CIRCULATION, V66, P334, DOI 10.1161/01.CIR.66.2.334	8	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52216	10.1371/journal.pone.0052216	http://dx.doi.org/10.1371/journal.pone.0052216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300618	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100030
J	Bevacqua, D; Genard, M; Lescourret, F				Bevacqua, Daniele; Genard, Michel; Lescourret, Francoise			A Simple Model to Predict the Probability of a Peach (Prunus persicae) Tree Bud to Develop as a Long or Short Shoot as a Consequence of Winter Pruning Intensity and Previous Year Growth	PLOS ONE			English	Article							RESPONSES; HERBIVORY; LOAD	In many woody plants, shoots emerging from buds can develop as short or long shoots. The probability of a bud to develop as a long or short shoot relies upon genetic, environmental and management factors and controlling it is an important issue in commercial orchard. We use peach (Prunus persicae) trees, subjected to different winter pruning levels and monitored for two years, to develop and calibrate a model linking the probability of a bud to develop as a long shoot to winter pruning intensity and previous year vegetative growth. Eventually we show how our model can be used to adjust pruning intensity to obtain a desired proportion of long and short shoots.	[Bevacqua, Daniele; Genard, Michel; Lescourret, Francoise] INRA, PSH UR1115, Avignon, France	INRAE	Bevacqua, D (corresponding author), INRA, PSH UR1115, Avignon, France.	daniele.bevacqua@avignon.inra.fr	Bevacqua, Daniele/ABA-7173-2021; Bevacqua, Daniele/D-9421-2012	Bevacqua, Daniele/0000-0002-3341-1696; Lescourret, Francoise/0000-0002-6576-8067				BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bussi C, 2011, SCI HORTIC-AMSTERDAM, V130, P725, DOI 10.1016/j.scienta.2011.08.026; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELFVING DC, 1976, J AM SOC HORTIC SCI, V101, P290; Faust M., 1989, PHYSL TEMPERATE ZONE; Fournier D, 1998, ACTA HORTIC, P557, DOI 10.17660/ActaHortic.1998.465.69; GIAUQUE P, 2003, CONDUITE VERGER PECH; Gordon D, 2007, ANN BOT-LONDON, V99, P323, DOI 10.1093/aob/mcl262; Grechi I, 2008, ENTOMOL EXP APPL, V128, P369, DOI 10.1111/j.1570-7458.2008.00720.x; Grechi I, 2010, ECOL MODEL, V221, P2363, DOI 10.1016/j.ecolmodel.2010.06.015; Greenwood MS, 2010, TREE PHYSIOL, V30, P459, DOI 10.1093/treephys/tpq004; Lakso A, 1984, GRAT LAKES FRUIT GRO, V23, P50; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; ROM CR, 1985, J AM SOC HORTIC SCI, V110, P455; Stephan J, 2007, ANN BOT-LONDON, V99, P1055, DOI 10.1093/aob/mcm049; Thornley J. H. M., 2000, PLANT CROP MODELING; WEBSTER AD, 1984, J HORTIC SCI, V59, P175, DOI 10.1080/00221589.1984.11515185; Wilson B. F., 1966, DEV SHOOT SYSTEM ACE; Zimmermann M.H., 1971, TREES-STRUCT FUNCT, P307, DOI 10.1007/978-3-642-88528-0_7	21	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52185	10.1371/journal.pone.0052185	http://dx.doi.org/10.1371/journal.pone.0052185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300609	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800053
J	Eiro, N; Pidal, I; Fernandez-Garcia, B; Junquera, S; Lamelas, ML; del Casar, JM; Gonzalez, LO; Lopez-Muniz, A; Vizoso, FJ				Eiro, Noemi; Pidal, Ivan; Fernandez-Garcia, Belen; Junquera, Sara; Lamelas, Maria L.; del Casar, Jose M.; Gonzalez, Luis O.; Lopez-Muniz, Alfonso; Vizoso, Francisco J.			Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast Cancer	PLOS ONE			English	Article							MONONUCLEAR INFLAMMATORY CELLS; ANTIGEN-PRESENTING CELLS; MATRIX METALLOPROTEINASES; B-CELLS; CLINICAL-VALUE; T-CELLS; MACROPHAGES; INHIBITORS; EXPRESSION; ANGIOGENESIS	Tumors are infiltrated by macrophages, T and B-lymphocytes, which may favor tumor development by promoting angiogenesis, growth and invasion. The aim of this study was to investigate the clinical relevance of the relative amount of macrophages (CD68(+)), T-cells (CD3(+)) and B-cells (CD20(+)) at the invasive front of breast carcinomas, and the expression of matrix metalloproteases (MMPs) and their inhibitors (TIMPs) either at the invasive front or at the tumor center. We performed an immunohistochemical study counting CD3, CD20 and CD68 positive cells at the invasive front, in 102 breast carcinomas. Also, tissue sections were stained with MMP-2, -9, -11, -14 and TIMP-2 antibodies, and immunoreactivity location, percentage of reactive area and intensity were determined at the invasive front and at the tumor center. The results showed that an increased CD68 count and CD68/(CD3+CD20) ratio were directly associated with both MMP-11 and TIMP-2 expression by mononuclear inflammatory cells at the tumor center (p = 0.041 and p = 0.025 for CD68 count and p = 0.001 and p = 0.045 for ratio, respectively for MMP-11 and TIMP-2). In addition, a high CD68/(CD3+CD20) ratio (>0.05) was directly associated with a higher probability of shortened relapse-free survival. Multivariate analysis revealed that CD68/(CD3+CD20) ratio was an independent factor associated with distant relapse- free survival (RR: 2.54, CI: (1.23-5.24), p<0.01). Therefore, CD68/(CD3+ CD20) ratio at the invasive front could be used as an important prognostic marker.	[Eiro, Noemi; Pidal, Ivan; Fernandez-Garcia, Belen; Junquera, Sara; Lamelas, Maria L.; del Casar, Jose M.; Gonzalez, Luis O.; Vizoso, Francisco J.] Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain; [Lamelas, Maria L.] Fdn Hosp Jove, Serv Ginecol, Gijon, Asturias, Spain; [del Casar, Jose M.; Vizoso, Francisco J.] Fdn Hosp Jove, Serv Cirugia Gen, Gijon, Asturias, Spain; [Gonzalez, Luis O.] Fdn Hosp Jove, Serv Anat Patol, Gijon, Asturias, Spain; [Lopez-Muniz, Alfonso] Univ Oviedo, Dept Morfol & Biol Celular, Fac Med, E-33006 Oviedo, Asturias, Spain	University of Oviedo	Vizoso, FJ (corresponding author), Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain.	investigacion@hospitaldejove.com	; Eiro, Noemi/C-9510-2018	Fernandez-Garcia, Belen/0000-0002-9950-2494; Eiro, Noemi/0000-0001-5840-4807	Fondo de Inversion Sanitaria-Instituto Carlos III [FIS-PI07/0306, FIS-PI10/02106]; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia [FICYT IB08-170]; Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU)	Fondo de Inversion Sanitaria-Instituto Carlos III; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia(Principality of Asturias); Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU)	This work was supported by grants from Fondo de Inversion Sanitaria-Instituto Carlos III (FIS-PI07/0306, FIS-PI10/02106), from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT IB08-170), and Fundacion para la Investigacion con Celulas Madre Uterinas (FICEMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel D, 2005, CANCER RES, V65, P2018, DOI 10.1158/0008-5472.CAN-04-3444; Del Casar J, 2009, BREAST CANCER RES TR, V116, P39, DOI 10.1007/s10549-009-0351-z; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eiro N, 2012, PLOS ONE IN PRESS; Eiro N, 2012, EUR J CANC IN PRESS; Ellis I.O., 2006, HISTOLOGIC GRADE BRE, P225; Giatromanolaki A, 2004, APMIS, V112, P431, DOI 10.1111/j.1600-0463.2004.apm11207-0804.x; Gonzalez LO, 2007, BRIT J CANCER, V97, P957, DOI 10.1038/sj.bjc.6603963; Gonzalez LO, 2010, HISTOPATHOLOGY, V57, P862, DOI 10.1111/j.1365-2559.2010.03723.x; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Griffiths L, 2000, GENE THER, V7, P255, DOI 10.1038/sj.gt.3301058; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; JOHNSON JP, 1989, IMMUNOL TODAY, V10, pS35; KELLY PMA, 1988, BRIT J CANCER, V57, P174, DOI 10.1038/bjc.1988.36; Lapointe R, 2003, CANCER RES, V63, P2836; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Lin Elaine Y, 2004, Novartis Found Symp, V256, P158; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Lofdahl B, 2012, ACTA ONCOL; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; NAUKKARINEN A, 1990, J PATHOL, V160, P217, DOI 10.1002/path.1711600307; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Volodko N, 1998, BREAST, V7, P99, DOI 10.1016/S0960-9776(98)90065-0	46	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52796	10.1371/journal.pone.0052796	http://dx.doi.org/10.1371/journal.pone.0052796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300781	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800149
J	Farid, WO; Lawrence, AJ; Krstew, EV; Tait, RJ; Hulse, GK; Dunlop, SA				Farid, Waleed O.; Lawrence, Andrew J.; Krstew, Elena V.; Tait, Robert J.; Hulse, Gary K.; Dunlop, Sarah A.			Maternally Administered Sustained-Release Naltrexone in Rats Affects Offspring Neurochemistry and Behaviour in Adulthood	PLOS ONE			English	Article							ENDOGENOUS OPIOID SYSTEMS; LOW-DOSE NALTREXONE; MESSENGER-RNA EXPRESSION; LONG-LASTING CHANGES; BLOOD NALTREXONE; ETHANOL-CONSUMPTION; INCREASED VULNERABILITY; ANTAGONIST NALTREXONE; MAINTENANCE TREATMENT; ALCOHOL DEPENDENCE	Naltrexone is not recommended during pregnancy. However, sustained-release naltrexone implant use in humans has resulted in cases of inadvertent foetal exposure. Here, we used clinically relevant dosing to examine the effects of maternally administered sustained-release naltrexone on the rat brain by examining offspring at birth and in adulthood. Maternal treatment (naltrexone or placebo implant) started before conception and ceased during gestation, birth or weaning. Morphometry was assessed in offspring at birth and adulthood. Adult offspring were evaluated for differences in locomotor behaviour (basal and morphine-induced, 10 mg/kg, s.c.) and opioid neurochemistry, propensity to self-administer morphine and cue-induced drug-seeking after abstinence. Blood analysis confirmed offspring exposure to naltrexone during gestation, birth and weaning. Naltrexone exposure increased litter size and reduced offspring birth-weight but did not alter brain morphometry. Compared to placebo, basal motor activity of naltrexone- exposed adult offspring was lower, yet they showed enhanced development of psychomotor sensitization to morphine. Developmental naltrexone exposure was associated with resistance to morphine-induced down-regulation of striatal preproenkephalin mRNA expression in adulthood. Adult offspring also exhibited greater operant responding for morphine and, in addition, cue-induced drug-seeking was enhanced. Collectively, these data show pronounced effects of developmental naltrexone exposure, some of which persist into adulthood, highlighting the need for follow up of humans that were exposed to naltrexone in utero.	[Farid, Waleed O.; Dunlop, Sarah A.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Dunlop, Sarah A.] Western Australian Inst Med Res, Perth, WA, Australia; [Farid, Waleed O.; Tait, Robert J.; Hulse, Gary K.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Unit Res & Educ Drugs & Alcohol, Perth, WA 6009, Australia; [Lawrence, Andrew J.; Krstew, Elena V.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [Lawrence, Andrew J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Tait, Robert J.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Australian National University	Dunlop, SA (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	sarah.dunlop@uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Tait, Robert/B-8693-2009	Dunlop, Sarah/0000-0002-1306-3962; Tait, Robert/0000-0003-0648-3093	Australian Children's Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC [APP1002347, PRF1020737]; Woodside Neurotrauma Award	Australian Children's Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Woodside Neurotrauma Award	The research was supported by the Australian Children's Trust and a Woodside Neurotrauma Award. AJL is supported by the Victorian Government's Operational Infrastructure Support Program. SAD (Grant number: APP1002347) and AJL (Grant number: PRF1020737) are NHMRC Principal Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal YP, 2005, MED HYPOTHESES, V64, P721, DOI 10.1016/j.mehy.2004.09.024; Arnold JM, 1997, PHARMACOL BIOCHEM BE, V57, P441, DOI 10.1016/S0091-3057(96)00445-5; BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Bertolotti M, 1997, J HEPATOL, V27, P505, DOI 10.1016/S0168-8278(97)80355-8; BHARGAVA HN, 1993, PHARMACOLOGY, V46, P66, DOI 10.1159/000139030; Bickel WK, 2000, PSYCHOPHARMACOLOGY, V153, P44, DOI 10.1007/s002130000589; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; Bugge CJL, 1996, DETERMINATION NALTRE; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Carroll ME, 2001, EXP CLIN PSYCHOPHARM, V9, P307, DOI 10.1037//1064-1297.9.3.307; CARROLL ME, 1981, PSYCHOPHARMACOLOGY, V74, P197, DOI 10.1007/BF00427092; Caswell A, 2005, MIMS BIMONTHLY; Chen F, 2004, J PHARMACOL EXP THER, V310, P1020, DOI 10.1124/jpet.104.068692; Chen F, 2000, J PHARMACOL EXP THER, V293, P159; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cowen MS, 1999, ALCOHOL CLIN EXP RES, V23, P1008, DOI 10.1097/00000374-199906000-00007; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; Cree BAC, 2010, ANN NEUROL, V68, P145, DOI 10.1002/ana.22006; DAMATO FR, 1988, DEV PSYCHOBIOL, V21, P283, DOI 10.1002/dev.420210309; Dannon PN, 2005, J CLIN PSYCHOPHARM, V25, P593, DOI 10.1097/01.jcp.0000186867.90289.ed; Darlington RB, 1999, J COMP NEUROL, V411, P359; DELAVEGA CD, 1995, PHARMACOL BIOCHEM BE, V50, P277, DOI 10.1016/0091-3057(94)00314-9; DIRESTA GR, 1991, J NEUROSCI METH, V39, P245, DOI 10.1016/0165-0270(91)90103-7; Djouma E, 2002, J PHARMACOL EXP THER, V302, P551, DOI 10.1124/jpet.102.035915; Farid WO, 2009, J BIOMED MATER RES A, V91A, P964, DOI 10.1002/jbm.a.32283; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FRANK P, 1991, J PHARMACOL METHOD, V26, P233, DOI 10.1016/0160-5402(91)90047-9; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Georges F, 1999, EUR J NEUROSCI, V11, P481, DOI 10.1046/j.1460-9568.1999.00462.x; Gironi M, 2008, MULT SCLER J, V14, P1076, DOI 10.1177/1352458508095828; Grasing K, 2003, PSYCHOPHARMACOLOGY, V168, P387, DOI 10.1007/s00213-003-1442-x; GROTA LJ, 1973, ANIM BEHAV, V21, P78, DOI 10.1016/S0003-3472(73)80042-9; HARRY GJ, 1979, PHARMACOL BIOCHEM BE, V11, P19; HAUSER KF, 1989, J COMP NEUROL, V281, P13, DOI 10.1002/cne.902810103; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Hulse G, 2002, AUST NZ J OBSTET GYN, V42, P569, DOI 10.1111/j.0004-8666.2002.548_14.x; Hulse GK, 2004, INT J GYNECOL OBSTET, V85, P170, DOI 10.1016/j.ijgo.2003.10.001; Hulse GK, 2004, ADDICT BIOL, V9, P67, DOI 10.1080/13556210410001674112; Hulse GK, 2004, ADDICT BIOL, V9, P59, DOI 10.1080/13556210410001674103; Hulse GK, 2003, AUST NZ J OBSTET GYN, V43, P386, DOI 10.1046/j.0004-8666.2003.00121.x; Hulse GK, 2002, AUST NZ J OBSTET GYN, V42, P93; Hulse GK, 2001, AUST NZ J OBSTET GYN, V41, P424, DOI 10.1111/j.1479-828X.2001.tb01322.x; JACOBSON B, 1990, BRIT MED J, V301, P1067, DOI 10.1136/bmj.301.6760.1067; Johansson BA, 2006, ADDICTION, V101, P491, DOI 10.1111/j.1360-0443.2006.01369.x; Kalinichev M, 2004, PSYCHOPHARMACOLOGY, V177, P61, DOI 10.1007/s00213-004-1990-8; Kalinichev M, 2003, NEUROPSYCHOPHARMACOL, V28, P317, DOI 10.1038/sj.npp.1300068; Kalinichev M, 2002, NEUROPSYCHOPHARMACOL, V27, P518; Kim SW, 2001, BIOL PSYCHIAT, V49, P914, DOI 10.1016/S0006-3223(01)01079-4; Kim SW, 1998, J CLIN PSYCHIAT, V59, P159; Kirchmayer U, 2002, ADDICTION, V97, P1241, DOI 10.1046/j.1360-0443.2002.00217.x; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kranzler HR, 2004, ALCOHOL CLIN EXP RES, V28, P1051, DOI 10.1097/01.ALC.0000130804.08397.29; Lahti T, 2010, PSYCHOPHARMACOL BULL, V43, P35; LANG WJ, 1977, PHARMACOL BIOCHEM BE, V7, P65, DOI 10.1016/0091-3057(77)90012-0; Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959; Lee SC, 2000, PHARMACOL BIOCHEM BE, V66, P347, DOI 10.1016/S0091-3057(00)00170-2; Lesscher HMB, 2003, EUR J NEUROSCI, V17, P1006, DOI 10.1046/j.1460-9568.2003.02502.x; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Liu YD, 2006, DRUG DEV IND PHARM, V32, P85, DOI 10.1080/03639040500388466; LUDDEN TM, 1976, J PHARM SCI, V65, P712, DOI 10.1002/jps.2600650521; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; McLaughlin PJ, 1997, PHARMACOL BIOCHEM BE, V58, P1075, DOI 10.1016/S0091-3057(97)00307-9; McLaughlin PJ, 1997, PHYSIOL BEHAV, V62, P501, DOI 10.1016/S0031-9384(97)00007-3; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; MEYER MC, 1984, J CLIN PSYCHIAT, V45, P15; MEYERSON BJ, 1988, PHARMACOL BIOCHEM BE, V31, P63, DOI 10.1016/0091-3057(88)90312-7; MISRA AL, 1976, DRUG METAB DISPOS, V4, P276; Narita M, 2006, NEUROSCI LETT, V402, P249, DOI 10.1016/j.neulet.2006.04.014; Ngo HTT, 2008, PROG NEURO-PSYCHOPH, V32, P23, DOI 10.1016/j.pnpbp.2007.06.007; NOWOSIELSKISLE.BJA, 1974, ACTA MORPHOL NEER SC, V12, P299; Nyberg K, 2000, EPIDEMIOLOGY, V11, P715, DOI 10.1097/00001648-200011000-00018; NYBERG K, 1992, BRIT J ADDICT, V87, P1669; O'Brien CP, 2011, AM J ADDICTION, V20, P106, DOI 10.1111/j.1521-0391.2010.00107.x; Olive MF, 1998, J PHARMACOL EXP THER, V285, P1310; Owoeye O, 2011, ROM J MORPHOL EMBRYO, V52, P81; PAUL L, 1978, NEUROPHARMACOLOGY, V17, P655, DOI 10.1016/0028-3908(78)90163-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plodkowski RA, 2009, EXPERT OPIN PHARMACO, V10, P1069, DOI [10.1517/14656560902775750 , 10.1517/14656560902775750]; Riley MA, 2006, NEUROPHARMACOLOGY, V51, P295, DOI 10.1016/j.neuropharm.2006.03.022; Roberts D.C.S., 1992, ANIMAL MODELS DRUG A, P233, DOI [10.1385/0-89603-217-5:233, DOI 10.1385/0-89603-217-5:233]; ROBINSON SR, 1990, BRAIN BEHAV EVOLUT, V36, P177, DOI 10.1159/000115306; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 1998, NEUROSCI BIOBEHAV R, V22, P347, DOI 10.1016/S0149-7634(97)00020-1; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Shabat-Simon M, 2008, J NEUROSCI, V28, P8406, DOI 10.1523/JNEUROSCI.1958-08.2008; SINGER G, 1978, PHARMACOL BIOCHEM BE, V9, P387, DOI 10.1016/0091-3057(78)90302-7; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; TEMPEL A, 1992, ANN NY ACAD SCI, V654, P529, DOI 10.1111/j.1749-6632.1992.tb26021.x; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WALL ME, 1984, DRUG METAB DISPOS, V12, P677; WALL ME, 1981, DRUG METAB DISPOS, V9, P369; Wang HF, 2008, BIORESOURCES, V3, P3; Wassum KM, 2009, NEUROSCIENCE, V163, P770, DOI 10.1016/j.neuroscience.2009.06.071; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WILLIG F, 1987, NEUROBIOL AGING, V8, P393, DOI 10.1016/0197-4580(87)90033-9; Witkamp RF, 2011, PHARM RES-DORDR, V28, P1792, DOI 10.1007/s11095-010-0341-1; YOBURN BC, 1988, LIFE SCI, V43, P1319, DOI 10.1016/0024-3205(88)90587-5; YOBURN BC, 1985, LIFE SCI, V36, P2325, DOI 10.1016/0024-3205(85)90322-4; YOBURN BC, 1986, J PHARMACOL EXP THER, V237, P126; ZAGON IS, 1987, BRAIN RES, V412, P68, DOI 10.1016/0006-8993(87)91440-5; ZAGON IS, 1986, J NEUROSCI, V6, P1424; ZAGON IS, 1985, PHYSIOL BEHAV, V34, P507, DOI 10.1016/0031-9384(85)90041-1; ZAGON IS, 1985, PHARMACOL BIOCHEM BE, V22, P441, DOI 10.1016/0091-3057(85)90046-2; ZAGON IS, 1986, DEV BRAIN RES, V28, P233, DOI 10.1016/0165-3806(86)90025-8; ZAGON IS, 1983, LIFE SCI, V33, P2449, DOI 10.1016/0024-3205(83)90639-2; Zagon IS, 1997, LIFE SCI, V61, P1261, DOI 10.1016/S0024-3205(97)00671-1; Zagon IS, 1999, BRAIN RES, V839, P313, DOI 10.1016/S0006-8993(99)01753-9; Zagon IS, 1997, LIFE SCI, V62, P221, DOI 10.1016/S0024-3205(97)01090-4; ZAGON IS, 1984, LIFE SCI, V35, P2057, DOI 10.1016/0024-3205(84)90563-0; Zagon IS, 1998, PHARMACOL BIOCHEM BE, V59, P201, DOI 10.1016/S0091-3057(97)00419-X	112	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52812	10.1371/journal.pone.0052812	http://dx.doi.org/10.1371/journal.pone.0052812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300784	Green Published, gold			2022-12-25	WOS:000313618800151
J	Figueroa-Romero, C; Hur, J; Bender, DE; Delaney, CE; Cataldo, MD; Smith, AL; Yung, R; Ruden, DM; Callaghan, BC; Feldman, EL				Figueroa-Romero, Claudia; Hur, Junguk; Bender, Diane E.; Delaney, Colin E.; Cataldo, Michael D.; Smith, Andrea L.; Yung, Raymond; Ruden, Douglas M.; Callaghan, Brian C.; Feldman, Eva L.			Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; DNA METHYLATION; SUPEROXIDE-DISMUTASE; GENECHIP DATA; MOUSE MODEL; 5-HYDROXYMETHYLCYTOSINE; PATHWAYS; TRANSCRIPTION; MECHANISM; SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a terminal disease involving the progressive degeneration of motor neurons within the motor cortex, brainstem and spinal cord. Most cases are sporadic (sALS) with unknown causes suggesting that the etiology of sALS may not be limited to the genotype of patients, but may be influenced by exposure to environmental factors. Alterations in epigenetic modifications are likely to play a role in disease onset and progression in ALS, as aberrant epigenetic patterns may be acquired throughout life. The aim of this study was to identify epigenetic marks associated with sALS. We hypothesize that epigenetic modifications may alter the expression of pathogenesis-related genes leading to the onset and progression of sALS. Using ELISA assays, we observed alterations in global methylation (5 mC) and hydroxymethylation (5 HmC) in postmortem sALS spinal cord but not in whole blood. Loci-specific differentially methylated and expressed genes in sALS spinal cord were identified by genome-wide 5mC and expression profiling using high-throughput microarrays. Concordant direction, hyper- or hypo-5mC with parallel changes in gene expression (under-or over-expression), was observed in 112 genes highly associated with biological functions related to immune and inflammation response. Furthermore, literature-based analysis identified potential associations among the epigenes. Integration of methylomics and transcriptomics data successfully revealed methylation changes in sALS spinal cord. This study represents an initial identification of epigenetic regulatory mechanisms in sALS which may improve our understanding of sALS pathogenesis for the identification of biomarkers and new therapeutic targets.	[Figueroa-Romero, Claudia; Hur, Junguk; Bender, Diane E.; Cataldo, Michael D.; Smith, Andrea L.; Callaghan, Brian C.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Delaney, Colin E.; Yung, Raymond] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ruden, Douglas M.] Wayne State Univ, Inst Environm Hlth Sci, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA; [Feldman, Eva L.] Univ Michigan, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu	Hur, Junguk/J-6229-2019; Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Hur, Junguk/0000-0002-0736-2149; Ruden, Douglas/0000-0002-0070-437X; Figueroa-Romero, Claudia/0000-0001-7546-4190; Delaney, Colin E/0000-0001-6880-6973; Bender, Diane/0000-0002-8311-4390; Feldman, Eva/0000-0002-9162-2694	University of Michigan A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; National Institutes of Health (NIH) [R01-ES012933, AG020628, AG028268, ES017885]; National Institutes of Health (NIH) Michigan Institute for Clinical & Health Research [UL1RR024986]; American Diabetes Association; Juvenile Diabetes Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021983, R01ES012933, P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028268, R56AG020628, R01AG020628] Funding Source: NIH RePORTER	University of Michigan A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) Michigan Institute for Clinical & Health Research; American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the University of Michigan A. Alfred Taubman Medical Research Institute (http://www.taubmaninstitute.org); the Program for Neurology Research and Discovery (to E. L. F.); the National Institutes of Health (NIH) (R01-ES012933 to D. M. R.; AG020628, AG028268, and ES017885 to R.Y.; the Michigan Institute for Clinical & Health Research (UL1RR024986)); the American Diabetes Association Junior Faculty Award to B. C. C.; and the Juvenile Diabetes Research Foundation Postdoctoral Fellowship to J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, NEUROL CLIN, V29, P689, DOI 10.1016/j.ncl.2011.06.001; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Calvo A, 2010, CNS NEUROL DISORD-DR, V9, P325, DOI 10.2174/187152710791292657; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Connolly R, 2012, J MAMMARY GLAND BIOL; Coppede F, 2011, THESCIENTIFICWORLDJO, V11, P1679, DOI 10.1100/2011/853474; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Crispi S, 2004, FEBS LETT, V562, P27, DOI 10.1016/S0014-5793(04)00166-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Deforges S, 2009, J PHYSIOL-LONDON, V587, P3561, DOI 10.1113/jphysiol.2009.169748; Eklow C, 2008, ANN RHEUM DIS, V67, P1742, DOI 10.1136/ard.2007.076976; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Hashioka S, 2009, NEUROBIOL AGING, V30, P1924, DOI 10.1016/j.neurobiolaging.2008.02.019; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur J, 2011, BRAIN, V134, P3222, DOI 10.1093/brain/awr228; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Illumina I, 2008, GENOMESTUDIO GEN EXP, P97; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Irier HA, 2012, DNA CELL BIOL, V31, pS42, DOI 10.1089/dna.2011.1565; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishigaki S, 2002, FEBS LETT, V531, P354, DOI 10.1016/S0014-5793(02)03546-9; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kim JH, 2011, INT J ONCOL, V39, P955, DOI 10.3892/ijo.2011.1075; Kirby J, 2011, BRAIN, V134, P506, DOI 10.1093/brain/awq345; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lee YM, 2011, J CELL BIOCHEM, V112, P394, DOI 10.1002/jcb.22969; Lokk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039813; Makrantonaki E, 2007, EXP GERONTOL, V42, P879, DOI 10.1016/j.exger.2007.07.002; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Miah SMS, 2008, J IMMUNOL, V180, P2922; Morahan JM, 2007, TOXICOL LETT, V168, P83, DOI 10.1016/j.toxlet.2006.11.003; Morahan JM, 2009, AMYOTROPH LATERAL SC, V10, P418, DOI 10.3109/17482960802635397; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Oates N, 2007, AMYOTROPH LATERAL SC, V8, P83, DOI 10.1080/17482960601149160; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Qureshi IA, 2011, CURR NEUROL NEUROSCI, V11, P464, DOI 10.1007/s11910-011-0210-2; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Siddique T, 2011, Acta Myol, V30, P117; SMITH SA, 1994, J NEUROL SCI, V124, P84, DOI 10.1016/0022-510X(94)90188-0; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; Valente T, 2012, NEUROBIOL AGING, V33, P2186, DOI 10.1016/j.neurobiolaging.2011.09.019; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van Blitterswijk M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.004; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; van den Hove DLA, 2012, CURR ALZHEIMER RES, V9, P545; Wang Q, 2011, NEUROSCI BULL, V27, P15, DOI 10.1007/s12264-011-1042-4; Wang XS, 2006, AMYOTROPH LATERAL SC, V7, P201, DOI 10.1080/17482960600947689; WERDELIN L, 1990, ACTA NEUROL SCAND, V82, P132; Xu J, 2009, J NEUROSCI, V29, P2022, DOI 10.1523/JNEUROSCI.2621-08.2009; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zheng S, 2002, DEV BRAIN RES, V136, P101, DOI 10.1016/S0165-3806(02)00348-6	92	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52672	10.1371/journal.pone.0052672	http://dx.doi.org/10.1371/journal.pone.0052672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300739	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800124
J	Formoso, G; Taraborrelli, M; Guagnano, MT; D'Adamo, M; Di Pietro, N; Tartaro, A; Consoli, A				Formoso, Gloria; Taraborrelli, Merilda; Guagnano, Maria T.; D'Adamo, Monica; Di Pietro, Natalia; Tartaro, Armando; Consoli, Agostino			Magnetic Resonance Imaging Determined Visceral Fat Reduction Associates with Enhanced IL-10 Plasma Levels in Calorie Restricted Obese Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; WEIGHT-LOSS; GLUCOSE-INTOLERANCE; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; INFLAMMATION; INTERLEUKIN-10; MARKERS; HUMANS	Background: Obesity is characterized by a low grade chronic inflammation state. Indeed circulating pro-inflammatory cytokines, such as TNF-alpha and IL-6, are elevated in obese subjects, while anti-inflammatory cytokines, such as IL-10, appear to be reduced. Cytokines profile improves after weight loss, but how visceral or subcutaneous fat loss respectively affect pro- or anti-inflammatory cytokines plasma levels has not been precisely assessed. Therefore in the present study we correlated changes in circulating cytokine profile with quantitative changes in visceral and subcutaneous adipose tissue depots measured by an ad hoc Magnetic Resonance Imaging (MRI) protocol before and after weight loss. Materials and Methods: In 14 obese subjects, MRI determination of visceral and subcutaneous fat and plasma glucose, insulin, TNF-alpha IL-6, and IL-10 measurements were performed before and after a caloric restriction induced weight loss of at least 5% of the original body weight. Results: Weight loss improved insulin sensitivity (QUICKI Index: 0.35 +/- 0.03 vs 0.37 +/- 0.04; P<0.05), increased IL-10 (3.4 +/- 1.9 vs 4.6 +/- 1.0 pg/mL; P<0.03), and reduced TNF-alpha and IL-6 plasma levels (2.5 +/- 1.3 vs 1.6 +/- 1.5 pg/mL, P<0.0015, 2.3 +/- 0.4 vs 1.6 +/- 0.6 pg/mL, P<0.02 respectively). A significant correlation was observed between the amount of visceral fat loss and the percentage reduction in both TNF-alpha (r = 0.56, p<0.05) and IL-6 (r = 0.19 p<0.05) plasma levels. In a multiple regression analysis, the amount of visceral fat loss independently correlated with the increase in IL-10 plasma levels. Conclusion: The reduction in visceral adipose tissue is the main driver of the improved inflammatory profile induced by weight loss.	[Formoso, Gloria; Taraborrelli, Merilda; Guagnano, Maria T.; Consoli, Agostino] Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy; [Formoso, Gloria; Consoli, Agostino] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Formoso, Gloria; Di Pietro, Natalia; Consoli, Agostino] Univ G DAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Formoso, Gloria; Di Pietro, Natalia; Tartaro, Armando; Consoli, Agostino] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Formoso, Gloria; Di Pietro, Natalia; Consoli, Agostino] Univ G dAnnunzio, CeSI, Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Consoli, A (corresponding author), Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy.	consoli@unich.it	Di Pietro, Natalia/K-1604-2016; tartaro, armando at/K-2184-2016; D'Adamo, Monica/AAL-4676-2020; Consoli, Agostino/J-8027-2018; Guagnano, Maria Teresa/AAT-1701-2021	Di Pietro, Natalia/0000-0001-9720-2116; tartaro, armando at/0000-0003-0095-2792; D'Adamo, Monica/0000-0002-1673-1591; Consoli, Agostino/0000-0002-1885-451X; 	Government Italian Research Grant [2009FATXW3]	Government Italian Research Grant	A Government Italian Research Grant, Protocol #2009FATXW3, supported the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busetto L, 2000, INT J OBESITY, V24, P60, DOI 10.1038/sj.ijo.0801086; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fisher G, 2012, OBESITY, V20, P715, DOI 10.1038/oby.2011.85; Fisman EZ, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-11; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Organization WH, 1997, WHONUTNCD981; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zhang HR, 2011, ARTERIOSCL THROM VAS, V31, P2063, DOI 10.1161/ATVBAHA.111.225870	26	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52774	10.1371/journal.pone.0052774	http://dx.doi.org/10.1371/journal.pone.0052774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300769	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800144
J	Hernandez-Baltazar, D; Martinez-Fong, D; Trudeau, LE				Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel; Trudeau, Louis-Eric			Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons	PLOS ONE			English	Article							RAT SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; NEUROTENSIN POLYPLEX; NEUROTROPHIC FACTOR; NONVIRAL VECTOR; GROWTH-FACTOR; DELIVERY; EXPRESSION; THERAPY; LOCALIZATION	The study of signal transduction in dopamine (DA)-containing neurons as well as the development of new therapeutic approaches for Parkinson's disease requires the selective expression of transgenes in such neurons. Here we describe optimization of the use of the NTS-polyplex, a gene carrier system taking advantage of neurotensin receptor internalization, to transfect mouse DA neurons in primary culture. The plasmids DsRed2 (4.7 kbp) and VGLUT2-Venus (11 kbp) were used to compare the ability of this carrier system to transfect plasmids of different sizes. We examined the impact of age of the neurons (1, 3, 5 and 8 days after seeding), of culture media used during the transfection (Neurobasal with B27 vs. conditioned medium) and of three molar ratios of plasmid DNA to carrier. While the NTS-polyplex successfully transfected both plasmids in a control N1E-115 cell line, only the pDsRed2 plasmid could be transfected in primary cultured DA neurons. We achieved 20% transfection efficiency of pDsRed2 in DA neurons, with 80% cell viability. The transfection was demonstrated pharmacologically to be dependent on activation of neurotensin receptors and to be selective for DA neurons. The presence of conditioned medium for transfection was found to be required to insure cell viability. Highest transfection efficiency was achieved in the most mature neurons. In contrast, transfection with the VGLUT2-Venus plasmid produced cell damage, most likely due to the high molar ratios required, as evidenced by a 15% cell viability of DA neurons at the three molar ratios tested (1: 36, 1: 39 and 1: 42). We conclude that, when used at molar ratios lower than 1: 33, the NTS-polyplex can selectively transfect mature cultured DA neurons with only low levels of toxicity. Our results provide evidence that the NTS-polyplex has good potential for targeted gene delivery in cultured DA neurons, an in vitro system of great use for the screening of new therapeutic approaches for Parkinson's disease.	[Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel] Ctr Invest & Estudios Avanzados Inst Politecn Nac, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	BALTAZAR, DANIEL HERNANDEZ/S-9655-2019; Trudeau, Louis-Eric/AAE-4782-2020	BALTAZAR, DANIEL HERNANDEZ/0000-0002-3658-4808; Trudeau, Louis-Eric/0000-0003-4684-1377	Quebec Ministry of International Relations - CONACTY Mexico [B330.521]; Canadian Institutes of Health Research [MOP-106556]; Brain Canada Foundation; Krembil Foundation; CONACYT [206727/203652]	Quebec Ministry of International Relations - CONACTY Mexico; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation; Krembil Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a Quebec-Mexico bilateral cooperation grant # B330.521 (Quebec Ministry of International Relations - CONACTY Mexico) to L.-E.T. and D.-M.F., and in part by research grants from the Canadian Institutes of Health Research (MOP-106556) and from the Brain Canada Foundation and Krembil Foundation (to L.-E.T). D. H.-B. was the recipient of scholarship from CONACYT (206727/203652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Bauer M, 2000, HUM GENE THER, V11, P1529, DOI 10.1089/10430340050083261; BECK KD, 1993, NEUROSCIENCE, V52, P855, DOI 10.1016/0306-4522(93)90534-M; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Burke RE, 1998, J NEUROCHEM, V71, P517; CARDOZO DL, 1993, NEUROSCIENCE, V56, P409, DOI 10.1016/0306-4522(93)90342-D; CUSACK B, 1991, EUR J PHARM-MOLEC PH, V206, P339, DOI 10.1016/0922-4106(91)90119-3; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Imaoka T, 1998, HUM GENE THER, V9, P1093, DOI 10.1089/hum.1998.9.7-1093; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Lim KI, 2012, BMB REP, V45, P207, DOI 10.5483/BMBRep.2012.45.4.207; Mandel RJ, 2008, EXP NEUROL, V209, P58, DOI 10.1016/j.expneurol.2007.08.008; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Martinez-Fong D, 1999, MOL BRAIN RES, V69, P249, DOI 10.1016/S0169-328X(99)00114-X; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; Martres MP, 1998, EUR J NEUROSCI, V10, P3607, DOI 10.1046/j.1460-9568.1998.00366.x; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Nihira T, 2011, J NEUROSCI METH, V201, P55, DOI 10.1016/j.jneumeth.2011.07.010; Orozco-Barrios CE, 2009, PLOS ONE, V4, pe8268; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; SZIGETHY E, 1989, J COMP NEUROL, V279, P128, DOI 10.1002/cne.902790111; TAKESHIMA T, 1994, J NEUROSCI, V14, P4769; Takeshima T, 1996, J NEUROSCI METH, V67, P27, DOI 10.1016/S0165-0270(96)00002-7; Toulorge D, 2011, FASEB J, V25, P2563, DOI 10.1096/fj.11-182824; Toy-Miou-Leong M, 2004, J HISTOCHEM CYTOCHEM, V52, P335, DOI 10.1177/002215540405200304; Ulusoy A, 2011, THER DELIV, V2, P37, DOI 10.4155/TDE.10.95; Yu LY, 2008, J NEUROSCI METH, V169, P8, DOI 10.1016/j.jneumeth.2007.11.018; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51341	10.1371/journal.pone.0051341	http://dx.doi.org/10.1371/journal.pone.0051341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300540	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800014
J	Hinterwirth, AJ; Medina, B; Lockey, J; Otten, D; Voldman, J; Lang, JH; Hildebrand, JG; Daniel, TL				Hinterwirth, Armin J.; Medina, Billie; Lockey, Jacob; Otten, David; Voldman, Joel; Lang, Jeffrey H.; Hildebrand, John G.; Daniel, Thomas L.			Wireless Stimulation of Antennal Muscles in Freely Flying Hawkmoths Leads to Flight Path Changes	PLOS ONE			English	Article							URTICAE L-LEPIDOPTERA; STABILIZATION; MOTHS	Insect antennae are sensory organs involved in a variety of behaviors, sensing many different stimulus modalities. As mechanosensors, they are crucial for flight control in the hawkmoth Manduca sexta. One of their roles is to mediate compensatory reflexes of the abdomen in response to rotations of the body in the pitch axis. Abdominal motions, in turn, are a component of the steering mechanism for flying insects. Using a radio controlled, programmable, miniature stimulator, we show that ultra-low-current electrical stimulation of antennal muscles in freely-flying hawkmoths leads to repeatable, transient changes in the animals' pitch angle, as well as less predictable changes in flight speed and flight altitude. We postulate that by deflecting the antennae we indirectly stimulate mechanoreceptors at the base, which drive compensatory reflexes leading to changes in pitch attitude.	[Hinterwirth, Armin J.; Medina, Billie; Lockey, Jacob; Daniel, Thomas L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Otten, David; Voldman, Joel; Lang, Jeffrey H.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ USA	University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); University of Arizona	Hinterwirth, AJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ahinterw@uw.edu			Defense Advanced Research Projects Agency (DARPA); University of Washington (UW) Komen Endowed Chair	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Washington (UW) Komen Endowed Chair	This work was supported by a Defense Advanced Research Projects Agency (DARPA) grant to JV, JGH and TLD, and funds from the University of Washington (UW) Komen Endowed Chair to TLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GEWECKE M, 1970, NATURE, V225, P1263, DOI 10.1038/2251263a0; GEWECKE M, 1981, J COMP PHYSIOL, V145, P249, DOI 10.1007/BF00605037; GEWECKE M, 1974, NATURE, V249, P584, DOI 10.1038/249584a0; Gewecke M, 1967, J COMP PHYSL A; Gullan PA, 2014, INSECTS OUTLINE ENTO; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heran H, 1959, J COMP PHYSIOL A, V42, P103; Hinterwirth AJ, 2010, J COMP PHYSIOL A, V196, P947, DOI 10.1007/s00359-010-0578-5; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767; Krishnan A, 2012, J EXP BIOL, V215, P3096, DOI 10.1242/jeb.071704; NIEHAUS M, 1981, J COMP PHYSIOL, V145, P257, DOI 10.1007/BF00605038; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Sun M, 2007, J EXP BIOL, V210, P2714, DOI 10.1242/jeb.004507; Taylor GK, 2003, J EXP BIOL, V206, P2803, DOI 10.1242/jeb.00501; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8	16	29	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52725	10.1371/journal.pone.0052725	http://dx.doi.org/10.1371/journal.pone.0052725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300751	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800131
J	Jeckel, KM; Veeramachaneni, DNR; Chicco, AJ; Chapman, PL; Mulligan, CM; Hegarty, JR; Pagliassotti, MJ; Ferguson, LA; Bouma, GJ; Frye, MA				Jeckel, Kimberly M.; Veeramachaneni, D. N. Rao; Chicco, Adam J.; Chapman, Phillip L.; Mulligan, Christopher M.; Hegarty, Jennifer R.; Pagliassotti, Michael J.; Ferguson, Lindsay A.; Bouma, Gerrit J.; Frye, Melinda A.			Docosahexaenoic Acid Supplementation Does Not Improve Western Diet-Induced Cardiomyopathy in Rats	PLOS ONE			English	Article							HIGH-FAT DIET; LEFT-VENTRICULAR MASS; CARDIAC-HYPERTROPHY; HEART-FAILURE; CONTRACTILE DYSFUNCTION; LIPID-ACCUMULATION; INSULIN-RESISTANCE; SYSTOLIC FUNCTION; GENE-EXPRESSION; OBESITY	Obesity increases risk for cardiomyopathy in the absence of hypertension, diabetes or ischemia. The fatty acid milieu, modulated by diet, may modify myocardial structure and function, lending partial explanation for the array of cardiomyopathic phenotypy. We sought to identify gross, cellular and ultrastructural myocardial changes associated with Western diet intake, and subsequent modification with docosahexaenoic acid (DHA) supplementation. Wistar and Sprague-Dawley (SD) rats received 1 of 3 diets: control (CON); Western (WES); Western + DHA (WES+DHA). After 12 weeks of treatment, echocardiography was performed and myocardial adiponectin, fatty acids, collagen, area occupied by lipid and myocytes, and ultrastructure were determined. Strain effects included higher serum adiponectin in Wistar rats, and differences in myocardial fatty acid composition. Diet effects were evident in that both WES and WES+DHA feeding were associated with similarly increased left ventricular (LV) diastolic cranial wall thickness (LVWcr/d) and decreased diastolic internal diameter (LVIDd), compared to CON. Unexpectedly, WES+DHA feeding was associated additionally with increased thickness of the LV cranial wall during systole (LVWcr/s) and the caudal wall during diastole (LVWca/d) compared to CON; this was observed concomitantly with increased serum and myocardial adiponectin. Diastolic dysfunction was present in WES+DHA rats compared to both WES and CON. Myocyte cross sectional area (CSA) was greater in WES compared to CON rats. In both fat-fed groups, transmission electron microscopy (TEM) revealed myofibril degeneration, disorganized mitochondrial cristae, lipid inclusions and vacuolation. In the absence of hypertension and whole body insulin resistance, WES+DHA intake was associated with more global LV thickening and with diastolic dysfunction, compared to WES feeding alone. Myocyte hypertrophy, possibly related to subcellular injury, is an early change that may contribute to gross hypertrophy. Strain differences in adipokines and myocardial fatty acid accretion may underlie heterogeneous data from rodent studies.	[Jeckel, Kimberly M.; Veeramachaneni, D. N. Rao; Chicco, Adam J.; Bouma, Gerrit J.; Frye, Melinda A.] Colorado State Univ, Dept Biomed Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Chicco, Adam J.] Colorado State Univ, Dept Hlth & Exercise Sci, Coll Appl Human Sci, Ft Collins, CO 80523 USA; [Chapman, Phillip L.] Colorado State Univ, Coll Nat Sci, Dept Stat, Ft Collins, CO 80523 USA; [Chicco, Adam J.; Mulligan, Christopher M.; Pagliassotti, Michael J.] Colorado State Univ, Coll Appl Human Sci, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA; [Hegarty, Jennifer R.] Colorado State Univ, Coll Engn, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Ferguson, Lindsay A.] Creighton Univ, Sch Med, Omaha, NE USA; [Frye, Melinda A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; Colorado State University; Creighton University; Colorado State University	Frye, MA (corresponding author), Colorado State Univ, Dept Biomed Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA.	melinda.frye@colostate.edu	Bouma, Gerrit/AAT-4644-2020; Pagliassotti, Michael/AAV-8238-2021	Bouma, Gerrit/0000-0003-2433-5086; 	National Institutes of Health, National Center for Research Resources [SERCA K01]; Colorado State University College Research Council; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010971] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Colorado State University College Research Council; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this project was contributed by the National Institutes of Health, National Center for Research Resources (SERCA K01) and the Colorado State University College Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2009, CARDIOVASC RES, V81, P610, DOI 10.1093/cvr/cvn316; AMAD KH, 1965, CIRCULATION, V32, P740, DOI 10.1161/01.CIR.32.5.740; Amin RH, 2010, AM J PHYSIOL-HEART C, V299, pH690, DOI 10.1152/ajpheart.01032.2009; Arterburn LM, 2000, FOOD CHEM TOXICOL, V38, P35, DOI 10.1016/S0278-6915(99)00119-2; Ayalew-Pervanchon A, 2007, AM J PHYSIOL-HEART C, V293, pH2296, DOI 10.1152/ajpheart.00194.2007; Bartels ED, 2010, ENDOCRINOLOGY, V151, P5218, DOI 10.1210/en.2010-0355; Berkalp B, 1995, INT J CARDIOL, V52, P23, DOI 10.1016/0167-5273(95)02431-U; Bordoni A, 2007, FEBS LETT, V581, P923, DOI 10.1016/j.febslet.2007.01.070; Chicco AJ, 2008, HYPERTENSION, V52, P549, DOI 10.1161/HYPERTENSIONAHA.108.114264; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Drazner MH, 2004, J AM COLL CARDIOL, V43, P2207, DOI 10.1016/j.jacc.2003.11.064; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang Y, 2011, FUND CLIN PHARMACOL, V25, P323, DOI 10.1111/j.1472-8206.2010.00839.x; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Fujita M, 2011, BIOL PHARM BULL, V34, P87, DOI 10.1248/bpb.34.87; GALAN X, 1994, LIPIDS, V29, P333, DOI 10.1007/BF02537186; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Ge F, 2012, J OBES, V2012, DOI 10.1155/2012/205648; Glenn DJ, 2011, HYPERTENSION, V57, P216, DOI 10.1161/HYPERTENSIONAHA.110.160655; Gruber C, 2012, CARDIOVASC PATHOL, V21, P346, DOI 10.1016/j.carpath.2011.11.003; Guo ZX, 2012, EUR J PHARMACOL, V685, P116, DOI 10.1016/j.ejphar.2012.04.010; Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012; Higashino H., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS292, DOI 10.1111/j.1440-1681.1995.tb02923.x; Iyer A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep090; Jalili T, 2003, J NUTR, V133, P358, DOI 10.1093/jn/133.2.358; Jeckel KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-92; Jude S, 2007, BRIT J NUTR, V98, P1143, DOI 10.1017/S0007114507798914; Kardys I, 2009, INT J CARDIOL, V133, P198, DOI 10.1016/j.ijcard.2007.12.031; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Kortelainen ML, 2011, AM J FOREN MED PATH, V32, P372, DOI 10.1097/PAF.0b013e318219cd89; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; KUWAHARA M, 1991, EXP ANIM TOKYO, V40, P331, DOI 10.1538/expanim1978.40.3_331; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li YQ, 2009, J MOL CELL CARDIOL, V47, P536, DOI 10.1016/j.yjmcc.2009.07.001; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Lind L, 2011, ARTERIOSCL THROM VAS, V31, pE27, DOI 10.1161/ATVBAHA.110.221572; Loh MY, 1998, P SOC EXP BIOL MED, V218, P38, DOI 10.3181/00379727-218-44265; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McLennan PL, 2012, BRIT J NUTR, V108, P645, DOI 10.1017/S0007114511005915; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Oliveira SA, 2010, MED SCI MONITOR, V16, pBR367; Oliveira SA, 2009, ARQ BRAS CARDIOL, V93, P487, DOI 10.1590/S0066-782X2009001100014; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; Park J, 2011, J HYPERTENS, V29, P1765, DOI 10.1097/HJH.0b013e32834a50f3; Perona JS, 2005, AM J HYPERTENS, V18, P72, DOI 10.1016/j.amjhyper.2004.11.012; Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; Powell BD, 2006, AM J CARDIOL, V98, P116, DOI 10.1016/j.amjcard.2006.01.063; Pulakat L, 2011, AM J PHYSIOL-REG I, V301, pR885, DOI 10.1152/ajpregu.00316.2011; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Rider OJ, 2011, HEART, V97, P203, DOI 10.1136/hrt.2009.185009; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; RUSTAN AC, 1992, BIOCHEM J, V283, P333, DOI 10.1042/bj2830333; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; SCHEMMEL R, 1970, J NUTR, V100, P1041; Sergiel JP, 1998, CAN J PHYSIOL PHARM, V76, P728, DOI 10.1139/cjpp-76-7-8-728; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Slee EL, 2010, J LIPID RES, V51, P1841, DOI 10.1194/jlr.M004069; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Tumuklu MM, 2007, ECHOCARDIOGR-J CARD, V24, P802, DOI 10.1111/j.1540-8175.2007.00484.x; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Xu FP, 2004, CIRCULATION, V110, P1269, DOI 10.1161/01.CIR.0000140766.52771.6D; Yi W, 2011, ANTIOXID REDOX SIGN, V15, P1779, DOI 10.1089/ars.2010.3722	77	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51994	10.1371/journal.pone.0051994	http://dx.doi.org/10.1371/journal.pone.0051994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300587	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800043
J	Ligasova, A; Strunin, D; Liboska, R; Rosenberg, I; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Liboska, Radek; Rosenberg, Ivan; Koberna, Karel			Atomic Scissors: A New Method of Tracking the 5-Bromo-2 '-Deoxyuridine-Labeled DNA In Situ	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; REPLICATION SITES; STRAND SCISSION; DAMAGE; ION; COPPER(II); ASCORBATE; CLUSTERS	A new method of the light microscopy detection of BrdU-labeled DNA in situ is described. It is based on the oxidative attack at the deoxyribose moiety by copper(I) in the presence of oxygen, which leads to the abstraction of hydrogen atom from deoxyribose culminating in the elimination of the nucleobase, scission of the nucleic-acid strand and formation of frequent gaps. The gaps allow the reaction of the antibodies with the commonly used markers of replication (e.g. 5-bromo-2'-deoxyuridine), which are otherwise masked. The method developed makes it possible to detect nuclear and mitochondrial DNA replication efficiently. In most cases, it does not inhibit effective protein detections and in addition enables simultaneous localization of newly-synthesized RNA. The alternative presently-used methods result in protein denaturation and/or extensive DNA cleavage followed by the DNA-bound proteins peeling off.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Acad Sci Czech Republic, Inst Biophys, Dept Mol Cytol & Cytometry, CS-61265 Brno, Czech Republic; [Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Acad Sci Czech Republic, Inst Mol Genet, Dept RNA Biol, Prague, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Oligonucleotide Grp, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Ligasova, A (corresponding author), Acad Sci Czech Republic, Inst Biophys, Dept Mol Cytol & Cytometry, Kralovopolska 135, CS-61265 Brno, Czech Republic.	ligasova@gmail.com	Ligasová, Anna/P-5460-2015; Liboska, Radek/I-5715-2014; Rosenberg, Ivan/G-5602-2014; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Czech Science Foundation [204/09/0973, P302/12/G157]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514, AV0Z50040702]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work has been supported by the Czech Science Foundation [204/09/0973, P302/12/G157] and the Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514 and AV0Z50040702]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Drouin R, 1996, FREE RADICAL BIO MED, V21, P261, DOI 10.1016/0891-5849(96)00037-8; Haines KM, J VIS EXP; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JOHNSON GRA, 1988, J CHEM SOC FARAD T 1, V84, P501, DOI 10.1039/f19888400501; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; MASARWA M, 1988, J AM CHEM SOC, V110, P4293, DOI 10.1021/ja00221a031; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; REED CJ, 1989, BIOCHEM BIOPH RES CO, V162, P1111, DOI 10.1016/0006-291X(89)90788-2; RUSH JD, 1988, J AM CHEM SOC, V110, P4957, DOI 10.1021/ja00223a013; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SAWYER DT, 1993, J AM CHEM SOC, V115, P5817, DOI 10.1021/ja00066a057; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; STOEWE R, 1987, FREE RADICAL BIO MED, V3, P97, DOI 10.1016/S0891-5849(87)80003-5; Tkatchenko AV, 2006, BIOTECHNIQUES, V40, P29, DOI 10.2144/000112094; YAMAMOTO K, 1989, J BIOL CHEM, V264, P15435; YAMAZAKI I, 1991, J AM CHEM SOC, V113, P7588, DOI 10.1021/ja00020a021	31	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52584	10.1371/journal.pone.0052584	http://dx.doi.org/10.1371/journal.pone.0052584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300711	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800107
J	Lou, CJ; Zhang, FY; Yang, M; Zhao, J; Zeng, WF; Fang, XC; Zhang, YQ; Zhang, CL; Liang, W				Lou, Changjie; Zhang, Fayun; Yang, Ming; Zhao, Juan; Zeng, Wenfeng; Fang, Xiaocui; Zhang, Yanqiao; Zhang, Chunling; Liang, Wei			Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-beta-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RECEPTOR KINASE; GROWTH; EXPRESSION; TGF-BETA-1; TRANSDIFFERENTIATION; PROLIFERATION; RESISTANCE	Epithelial to mesenchymal transition (EMT) promotes cellular motility, invasiveness and metastasis during embryonic development and tumorigenesis. Transforming growth factor-beta (TGF-beta) signaling pathway is a key regulator of EMT. A lot of evidences suggest that this process is Smad3-dependent. Herein we showed that exposure of aspc-1 and panc-1 pancreatic cancer cells to TGF-beta 1 resulted in characteristic morphological alterations of EMT, and enhancement of cell motility and gemcitabine (Gem) resistance along with an up-regulation of EMT markers genes such as vimentin, N-cadherin, MMP2 and MMP9. Naringenin (Nar) down-regulated EMT markers expression in both mRNA and protein levels by inhibiting TGF-beta 1/Smad3 signal pathway in the pancreatic cancer cells. Consequently, Nar suppressed the cells migration and invasion and reversed their resistance to Gem.	[Lou, Changjie; Yang, Ming; Zhao, Juan; Zhang, Yanqiao] Harbin Med Univ, Inst Prevent & Treatment Canc Heilongjiang Prov, Dept Gastrointestinal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China; [Lou, Changjie; Zhang, Fayun; Zeng, Wenfeng; Fang, Xiaocui; Zhang, Chunling; Liang, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Prot & Peptide Pharmaceut Lab, Beijing 100080, Peoples R China	Harbin Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, YQ (corresponding author), Harbin Med Univ, Inst Prevent & Treatment Canc Heilongjiang Prov, Dept Gastrointestinal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China.	yanqiaozhang@126.com; zhangcl@moon.ibp.ac.cn			National Nature Sciences Foundation of China [81173633]; State Key Development Plan Project [2011CB707705]; Research Foundation of Department of Health of Heilongjiang Province [2010-107]; startup Fund of The Affiliated Third Hospital of Harbin Medical University [JJ2010-15]	National Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Plan Project; Research Foundation of Department of Health of Heilongjiang Province; startup Fund of The Affiliated Third Hospital of Harbin Medical University	This work was supported by the National Nature Sciences Foundation of China (81173633), grants from State Key Development Plan Project (2011CB707705), the Research Foundation of Department of Health of Heilongjiang Province(2010-107) and the startup Fund of The Affiliated Third Hospital of Harbin Medical University (JJ2010-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Banerjee S, 2011, INT J CANCER, V128, P1240, DOI 10.1002/ijc.25658; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Du GJ, 2009, CANCER RES, V69, P3205, DOI 10.1158/0008-5472.CAN-08-3393; Duarte N, 2010, PLANTA MED, V76, P975, DOI 10.1055/s-0029-1240892; Ellenrieder V, 2001, INT J CANCER, V93, P204, DOI 10.1002/ijc.1330; Ellenrieder V, 2001, CANCER RES, V61, P4222; Fakhrai H, 2006, CANCER GENE THER, V13, P1052, DOI 10.1038/sj.cgt.7700975; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Furukawa H, 1996, CANCER, V78, P986, DOI 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong JH, 2009, J CELL BIOCHEM, V106, P73, DOI 10.1002/jcb.21977; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lim H, 2011, J PHARMACOL SCI, V116, P221, DOI 10.1254/jphs.11014FP; Liu XJ, 2006, PHARM RES-DORDR, V23, P82, DOI 10.1007/s11095-005-9043-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Qin L, 2011, PROTEIN CELL, V2, P507, DOI 10.1007/s13238-011-1056-8; Shin JA, 2011, J CELL BIOCHEM, V112, P179, DOI 10.1002/jcb.22929; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas Hilary, 2003, Cancer Control, V10, P159; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Yang Y, 2011, CHEM COMMUN, V47, P5440, DOI 10.1039/c1cc10778j; Yin Tao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P700, DOI 10.1007/s11596-006-0619-z; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y	37	86	92	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50956	10.1371/journal.pone.0050956	http://dx.doi.org/10.1371/journal.pone.0050956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300530	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800008
J	Qin, SM; Verkasalo, H; Mohtaschemi, M; Hartonen, T; Alava, M				Qin, Shao-Meng; Verkasalo, Hannu; Mohtaschemi, Mikael; Hartonen, Tuomo; Alava, Mikko			Patterns, Entropy, and Predictability of Human Mobility and Life	PLOS ONE			English	Article								Cellular phones are now offering an ubiquitous means for scientists to observe life: how people act, move and respond to external influences. They can be utilized as measurement devices of individual persons and for groups of people of the social context and the related interactions. The picture of human life that emerges shows complexity, which is manifested in such data in properties of the spatiotemporal tracks of individuals. We extract from smartphone-based data for a set of persons important locations such as "home", "work" and so forth over fixed length time-slots covering the days in the dataset (see also [1,2]). This set of typical places is heavy-tailed, a power-law distribution with an exponent close to -1.7. To analyze the regularities and stochastic features present, the days are classified for each person into regular, personal patterns. To this are superimposed fluctuations for each day. This randomness is measured by "life" entropy, computed both before and after finding the clustering so as to subtract the contribution of a number of patterns. The main issue that we then address is how predictable individuals are in their mobility. The patterns and entropy are reflected in the predictability of the mobility of the life both individually and on average. We explore the simple approaches to guess the location from the typical behavior, and of exploiting the transition probabilities with time from location or activity A to B. The patterns allow an enhanced predictability, at least up to a few hours into the future from the current location. Such fixed habits are most clearly visible in the working-day length.	[Qin, Shao-Meng; Mohtaschemi, Mikael; Hartonen, Tuomo; Alava, Mikko] Aalto Univ, Dept Appl Phys, Espoo, Finland; [Verkasalo, Hannu] WR WIRELESS Res Ltd, Espoo, Finland; [Verkasalo, Hannu] Zokem Ltd, Espoo, Finland	Aalto University	Alava, M (corresponding author), Aalto Univ, Dept Appl Phys, Espoo, Finland.	mikko.alava@aalto.fi	Alava, Mikko/G-2202-2013	Alava, Mikko/0000-0001-9249-5079	Finnish Funding Agency for Technology and Innovation; National Agency for Technology; Academy of Finland's Center of Excellence program	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); National Agency for Technology; Academy of Finland's Center of Excellence program	The study has been financed by the Finnish Funding Agency for Technology and Innovation, the National Agency for Technology and the Academy of Finland's Center of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad U, 2007, P 6 INT C MOB UB MUL, P55; [Anonymous], 2007, STAT PHYS PARTICLES; Blondel V. D., 2012, ARXIV12100137; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chon Y, 2012, INT CONF PERVAS COMP, P206, DOI 10.1109/PerCom.2012.6199868; De Domenico M, 2012, NOK MOB DAT CHALL 20; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eagle N, 2009, BEHAV ECOL SOCIOBIOL, V63, P1057, DOI 10.1007/s00265-009-0739-0; Etter V, 2012, NOK MOB DAT CHALL 20; Farrahi K, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1889681.1889684; Farrahi K, 2008, TWELFTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P29, DOI 10.1109/ISWC.2008.4911580; Gambs S, 2012, 1 WORKSH MEAS PRIV M; Gambs S, 2011, 1 INT WORKSH DYN OPO; Gao H., 2012, P NOK MOB DAT CHALL, V41, P1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Huang CM, 2012, NOK MOB DAT CHALL 20; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Kim DH, 2009, UBICOMP'09: PROCEEDINGS OF THE 11TH ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P21; Kirmse A., 2011, P 19 ACM SIGSPATIAL, P397, DOI DOI 10.1145/2093973.2094032; Kiukkonen N., 2010, P ICPS, V68, P1; Laasonen K, 2009, THESIS U HELSINKI; Lu Z, 2012, NOK MOB DAT CHALL 20; McGrath R, 2012, NOK MOB DAT CHALL 20; McInerney J, 2012, NOK MOB DAT CHALL 20; Mitchell TM, 2009, SCIENCE, V326, P1644, DOI 10.1126/science.1174459; Montoliu R., 2012, P NOK MOB DAT CHALL, V1, P1; Nguyen L, 2012, NOK MOB DAT CHALL 20; Nurmi P., 2009, THESIS U HELSINKI; Raento M, 2005, IEEE PERVAS COMPUT, V4, P51, DOI 10.1109/MPRV.2005.29; Raento M, 2009, SOCIOL METHOD RES, V37, P426, DOI 10.1177/0049124108330005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang J, 2012, NOK MOB DAT CHALL 20; Zhu Y, 2012, NOK MOB DAT CHALL 20	41	34	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51353	10.1371/journal.pone.0051353	http://dx.doi.org/10.1371/journal.pone.0051353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300542	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000313618800015
J	Titmarsh, DM; Hudson, JE; Hidalgo, A; Elefanty, AG; Stanley, EG; Wolvetang, EJ; Cooper-White, JJ				Titmarsh, Drew M.; Hudson, James E.; Hidalgo, Alejandro; Elefanty, Andrew G.; Stanley, Edouard G.; Wolvetang, Ernst J.; Cooper-White, Justin J.			Microbioreactor Arrays for Full Factorial Screening of Exogenous and Paracrine Factors in Human Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							WNT; MOUSE; GENE; EMBRYOGENESIS; OPTIMIZATION; INDUCTION; CANCER; LINES; AXIS	Timed exposure of pluripotent stem cell cultures to exogenous molecules is widely used to drive differentiation towards desired cell lineages. However, screening differentiation conditions in conventional static cultures can become impractical in large parameter spaces, and is intrinsically limited by poor spatiotemporal control of the microenvironment that also makes it impossible to determine whether exogenous factors act directly or through paracrine-dependent mechanisms. We detail here the development of a continuous flow microbioreactor array platform that combines full-factorial multiplexing of input factors with progressive accumulation of paracrine factors through serially-connected culture chambers, and further, the use of this system to explore the combinatorial parameter space of both exogenous and paracrine factors involved in human embryonic stem cell (hESC) differentiation to a MIXL1-GFP(+) primitive streak-like population. We show that well known inducers of primitive streak (BMP, Activin and Wnt signals) do not simply act directly on hESC to induce MIXL1 expression, but that this requires accumulation of surplus, endogenous factors; and, that conditioned medium or FGF-2 supplementation is able to offset this. Our approach further reveals the presence of a paracrine, negative feedback loop to the MIXL1-GFP(+) population, which can be overcome with GSK-3 beta inhibitors (BIO or CHIR99021), implicating secreted Wnt inhibitory signals such as DKKs and sFRPs as candidate effectors. Importantly, modulating paracrine effects identified in microbioreactor arrays by supplementing FGF-2 and CHIR in conventional static culture vessels resulted in improved differentiation outcomes. We therefore demonstrate that this microbioreactor array platform uniquely enables the identification and decoding of complex soluble factor signalling hierarchies, and that this not only challenges prevailing strategies for extrinsic control of hESC differentiation, but also is translatable to conventional culture systems.	[Titmarsh, Drew M.; Hudson, James E.; Hidalgo, Alejandro; Wolvetang, Ernst J.; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia	University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; University of Queensland	Cooper-White, JJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	j.cooperwhite@uq.edu.au	Hudson, James/AAE-1605-2019; Titmarsh, Drew M/F-9546-2011; Hudson, James E/O-1775-2013; Elefanty, Andrew G/A-6066-2008; Wolvetang, Ernst J/J-7602-2013; Stanley, Ed G/A-2985-2013; Wolvetang, Ernst jurgen/D-6644-2017	Titmarsh, Drew M/0000-0001-8379-6136; Hudson, James E/0000-0003-0832-9356; Stanley, Ed G/0000-0002-6389-3665; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Cooper-White, Justin/0000-0002-1920-8229; Elefanty, Andrew/0000-0001-6448-8314; Hidalgo, Alejandro/0000-0002-8395-7179	Australian Stem Cell Centre	Australian Stem Cell Centre	The Australian Stem Cell Centre (www.stemcellcentre.edu.au) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Box GEP, 1978, STAT EXPT INTRO DESI, pxviii; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Moledina F, 2012, P NATL ACAD SCI US; Monahan J, 2001, ANAL CHEM, V73, P3193, DOI 10.1021/ac001426z; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Przybyla L, 2012, ANNU REV ANAL CHEM, V5, P293, DOI 10.1146/annurev-anchem-062011-143122; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sachlos E, 2008, BIOMATERIALS, V29, P4471, DOI 10.1016/j.biomaterials.2008.08.012; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Titmarsh DM, 2012, BIOTECHNOL IN PRESS; Titmarsh D, 2011, BIOTECHNOL BIOENG, V108, P2894, DOI 10.1002/bit.23260; Titmarsh D, 2009, BIOTECHNOL BIOENG, V104, P1240, DOI 10.1002/bit.22504; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	34	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52405	10.1371/journal.pone.0052405	http://dx.doi.org/10.1371/journal.pone.0052405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300662	Green Published, gold			2022-12-25	WOS:000313618800081
J	Vannier, J				Vannier, Jean			Gut Contents as Direct Indicators for Trophic Relationships in the Cambrian Marine Ecosystem	PLOS ONE			English	Article							PHYLLOPOD BED COMMUNITY; BURGESS SHALE; PRIAPULUS-CAUDATUS; ANOMALOCARIS; WORMS; ARTHROPOD; ORIGIN; LAGERSTATTE; PREDATORS; BEHAVIOR	Present-day ecosystems host a huge variety of organisms that interact and transfer mass and energy via a cascade of trophic levels. When and how this complex machinery was established remains largely unknown. Although exceptionally preserved biotas clearly show that Early Cambrian animals had already acquired functionalities that enabled them to exploit a wide range of food resources, there is scant direct evidence concerning their diet and exact trophic relationships. Here I describe the gut contents of Ottoia prolifica, an abundant priapulid worm from the middle Cambrian (Stage 5) Burgess Shale biota. I identify the undigested exoskeletal remains of a wide range of small invertebrates that lived at or near the water sediment interface such as hyolithids, brachiopods, different types of arthropods, polychaetes and wiwaxiids. This set of direct fossil evidence allows the first detailed reconstruction of the diet of a 505-million-year-old animal. Ottoia was a dietary generalist and had no strict feeding regime. It fed on both living individuals and decaying organic matter present in its habitat. The feeding behavior of Ottoia was remarkably simple, reduced to the transit of food through an eversible pharynx and a tubular gut with limited physical breakdown and no storage. The recognition of generalist feeding strategies, exemplified by Ottoia, reveals key-aspects of modern-style trophic complexity in the immediate aftermath of the Cambrian explosion. It also shows that the middle Cambrian ecosystem was already too complex to be understood in terms of simple linear dynamics and unique pathways.	Univ Lyon 1, Lab Geol Lyon Terre, F-69622 Villeurbanne, France	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vannier, J (corresponding author), Univ Lyon 1, Lab Geol Lyon Terre, F-69622 Villeurbanne, France.	jean.vannier@univ-lyon1.fr			ANR (Agence Nationale de la Recherche) grant (ORECO); European Assemble Project (Sven Loven Centre for Marine Sciences at Kristineberg, Sweden); ANR (Agence Nationale de la Recherche) grant (RALI)	ANR (Agence Nationale de la Recherche) grant (ORECO)(French National Research Agency (ANR)); European Assemble Project (Sven Loven Centre for Marine Sciences at Kristineberg, Sweden); ANR (Agence Nationale de la Recherche) grant (RALI)(French National Research Agency (ANR))	The author's research is supported by ANR (Agence Nationale de la Recherche) grants (ORECO and RALI) and by the European Assemble Project (2010, Sven Loven Centre for Marine Sciences at Kristineberg, Sweden). ANR website at: www.agence-nationale-recherche.fr, ASSEMBLE (Association of European Marine Biological Laboratories): www.assemblemarine.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKAR S, 1981, OPHELIA, V20, P45, DOI 10.1080/00785236.1981.10426561; BABCOCK L E, 1988, University of Kansas Paleontological Contributions Paper, P1; Babcock LE, 2002, PREDATOR PREY INTERA, P317; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Brusca RC, 2003, INVERTEBRATES; BRUTON DL, 1983, PHILOS T R SOC B, V300, P553, DOI 10.1098/rstb.1983.0020; Bruton DL, 2001, LETHAIA, V34, P163, DOI 10.1080/00241160152418456; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Butterfield N.J., 2001, P40, DOI 10.1002/9780470999295.ch7; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Caron J-B, 2009, ICCE 2009; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Conway Morris S., 1977, SPEC PAP PALAEONTOL, V20, P1; Cutler E. B, 1994, SIPUNCULA THEIR SYST; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Fletcher TP, 2003, CAN J EARTH SCI, V40, P1823, DOI 10.1139/E03-057; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Hagadorn JW, 2009, GEOLOGICAL SOC AM AB, V41, P162; Hagadorn JW, 2009, WALC 2009 INT C CAMB, P33; Harvey THP, 2008, NATURE, V452, P868, DOI 10.1038/nature06724; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2008, SCIENCE, V322, P224, DOI 10.1126/science.1162794; Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044; Huang DY, 2004, P ROY SOC B-BIOL SCI, V271, P1671, DOI 10.1098/rspb.2004.2774; JENSEN S, 1990, LETHAIA, V23, P29, DOI 10.1111/j.1502-3931.1990.tb01779.x; Laflamme M, 2009, P NATL ACAD SCI USA, V106, P14438, DOI 10.1073/pnas.0904836106; Land J. van der, 1970, ZOOL VERHANDL, V112, P1; LANG KARL, 1948, ARKIV ZOOL, V41B, P1; Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097; Leighton LR, 2003, PREDATOR PREY INTERA, P317; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Minter NJ, 2012, P ROY SOC B-BIOL SCI, V279, P1613, DOI 10.1098/rspb.2011.1986; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; MORRIS SC, 1979, PHILOS T R SOC B, V285, P227, DOI 10.1098/rstb.1979.0006; MORRIS SC, 1987, NATURE, V326, P181, DOI 10.1038/326181a0; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Nedin C, 1999, GEOLOGY, V27, P987, DOI 10.1130/0091-7613(1999)027<0987:APONAM>2.3.CO;2; O'Brien LL, 2012, PLOS ONE, V7, pe2923; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Peng SC, 2011, B GEOSCI, V86, P391, DOI 10.3140/bull.geosci.1273; RASETTI FRANCO, 1951, SMITHSONIAN MISC COLL, V116, P1; Rigby J.K., 1986, PALAEONTOGR CAN, V2, P1; Rigby J.K., 2004, ROYAL ONTARIO MUSEUM, V1, P1; Siveter David J., 1997, Special Papers in Palaeontology, V57, P1; Smith MR, 2010, NATURE, V465, P469, DOI 10.1038/nature09068; Stein M, 2010, LETHAIA, V43, P258, DOI 10.1111/j.1502-3931.2009.00189.x; STORCH V, 1994, J MORPHOL, V220, P281, DOI 10.1002/jmor.1052200307; Storch V, 1991, MICROSCOPIC ANATOMY, V4; Trott TJ, 1998, MAR FRESHW BEHAV PHY, V31, P251, DOI 10.1080/10236249809387076; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; Vannier J, 2010, GEOLOGY, V38, P711, DOI 10.1130/G30829.1; Vannier J, 2009, CR PALEVOL, V8, P133, DOI 10.1016/j.crpv.2008.10.006; Walcott C. D., 1924, Smithsonian Miscellaneous Collections, V67, P477; Walcott C.D, 1912, GEOL SURV US MONOGR, V2, P1; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wilson LA, 2006, THESIS CAMBRIDGE; Zhang XL, 2007, J PALEONTOL, V81, P1, DOI 10.1666/06-082.1; Zhao FC, 2012, PALAEOGEOGR PALAEOCL, V346, P54, DOI 10.1016/j.palaeo.2012.05.021; Zhao FC, 2009, PALAIOS, V24, P826, DOI 10.2110/palo.2009.p09-004r; Zhu MY, 2004, P ROY SOC B-BIOL SCI, V271, pS277, DOI 10.1098/rsbl.2004.0194	73	74	76	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52200	10.1371/journal.pone.0052200	http://dx.doi.org/10.1371/journal.pone.0052200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300612	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800055
J	Wu, J; Liu, DJ; Xie, Q; Wang, JY				Wu, Jing; Liu, Duojian; Xie, Qing; Wang, Jingyu			Biological Fractionation of Lead Isotopes in Sprague-Dawley Rats Lead Poisoned via the Respiratory Tract	PLOS ONE			English	Article							EXPOSURE; TOXICITY; CHILDREN; RATIOS; BLOOD; REDUCTION; POLLUTION; CADMIUM; ZINC	Objectives: It was considered that lead isotope ratios did not change during physical, chemical, or biological processes. Thus, lead isotope ratios have been used as fingerprints to identify possible lead sources. However, recent evidence has shown that the lead isotope ratios among different biological samples in human are not always identical from its lead origins in vitro. An animal experiment was conducted to explore the biological fractionation of lead isotopes in biological systems. Methods: 24 male Sprague-Dawley (SD) rats were divided into groups that received acute lead exposure (0, 0.02, 0.2, or 2 mg/kg body weight of lead acetate) via the respiratory route every day for 5 days. Biological samples (i.e., blood, urine, and feces) were collected for comparison with the lead acetate (test substance) and the low-lead animal feed (diet) administered to the rats. The lead isotope ratios were determined by inductively coupled plasma mass spectrometry (ICP-MS). Results: There are significant differences (p<0.05) in lead isotope ratios between blood, urine, and feces. Moreover, a nonlinear relationship between the blood lead concentration and the blood lead isotope ratios was observed. There is also a threshold effect to the fractionation function. Only the blood isotope ratio of Pb-204/Pb-206 matches the test substance well. As for feces, when Pb-204/Pb-206 ratio is considered, there is no significant difference between feces-test substance pairs in medium and high dose group. Conclusions: The biological fractionation of lead isotopes in SD rats was observed. Moreover, there might be a threshold for the biological fractionation of lead isotopes which is depending on whole blood lead level. It is considered to be more reliable that we compared the isotope ratios of potential lead hazards with both blood and feces lead fingerprints especially for Pb-204/Pb-206 ratio under high-dose exposure.	[Wu, Jing; Liu, Duojian; Xie, Qing; Wang, Jingyu] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Xie, Qing; Wang, Jingyu] Peking Univ, Ctr Med & Hlth Anal, Beijing 100871, Peoples R China; [Wu, Jing] Hebei Univ Technol, Sch Chem Engn & Technol, Tianjin, Peoples R China	Peking University; Peking University; Hebei University of Technology	Wang, JY (corresponding author), Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China.	wjy@bjmu.edu.cn			Natural Science Foundation of China [30972434]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Natural Science Foundation of China (No. 30972434, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton H, 2000, MICROCHEM J, V67, P21, DOI 10.1016/S0026-265X(00)00089-8; BERMAN E, 1966, CLIN PEDIATR, V5, P287, DOI 10.1177/000992286600500508; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Budge SM, 2011, J EXP BIOL, V214, P3790, DOI 10.1242/jeb.057596; Cheng HF, 2010, ENVIRON POLLUT, V158, P1134, DOI 10.1016/j.envpol.2009.12.028; Chiaradia M, 2000, ATMOS ENVIRON, V34, P959, DOI 10.1016/S1352-2310(99)00213-7; Cloquet C, 2008, ANAL BIOANAL CHEM, V390, P451, DOI 10.1007/s00216-007-1635-y; Cui JF, 2011, ARCHAEOMETRY, V53, P205, DOI 10.1111/j.1475-4754.2010.00548.x; Glorennec P, 2006, ENVIRON RES, V100, P150, DOI 10.1016/j.envres.2005.03.007; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; Gwiazda RH, 2000, ENVIRON HEALTH PERSP, V108, P1091, DOI 10.2307/3434964; Hoefs J., 2009, STABLE ISOTOPE GEOCH, P1, DOI [DOI 10.1007/978-3-540-70708-0, 10.1007/978-3-540-70708-0]; Jouvin D, 2012, ENVIRON SCI TECHNOL, V46, P2652, DOI 10.1021/es202587m; Landrigan PJ, 2000, PUBLIC HEALTH REP, V115, P530, DOI 10.1093/phr/115.6.530; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu J, 2007, CHINESE J FOOD HYGIE, V19, P297; Liu Jingxiu, 2009, Wei Sheng Yan Jiu, V38, P375; Morton-Bermea O, 2011, CHEM ERDE-GEOCHEM, V71, P189, DOI 10.1016/j.chemer.2011.03.003; NEATHERY MW, 1975, J DAIRY SCI, V58, P1767, DOI 10.3168/jds.S0022-0302(75)84785-0; Patel MM, 2008, INT J CIRCUMPOL HEAL, V67, P261, DOI 10.3402/ijch.v67i2-3.18283; PIOMELLI S, 1982, P NATL ACAD SCI-BIOL, V79, P3335, DOI 10.1073/pnas.79.10.3335; RADER JI, 1981, ENVIRON HEALTH PERSP, V42, P187, DOI 10.2307/3429208; Rankin CW, 2005, ENVIRON HEALTH PERSP, V113, P1344, DOI 10.1289/ehp.8009; Reitsema LJ, 2011, AM J PHYS ANTHROPOL, V145, P495, DOI 10.1002/ajpa.21513; SCHWARTZ J, 1990, AM J PUBLIC HEALTH, V80, P165, DOI 10.2105/AJPH.80.2.165; Shiel AE, 2010, SCI TOTAL ENVIRON, V408, P2357, DOI 10.1016/j.scitotenv.2010.02.016; SINGH B, 1994, BIOL TRACE ELEM RES, V40, P21, DOI 10.1007/BF02916817; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; STURGES WT, 1987, NATURE, V329, P144, DOI 10.1038/329144a0; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Wu J, 2011, The enrichment and separation of trace lead in complex matrix, Patent No. 201110001498; Wu J, 2012, SPECTROSC SPECT ANAL, V32, P765, DOI 10.3964/j.issn.1000-0593(2012)03-0765-05	35	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52462	10.1371/journal.pone.0052462	http://dx.doi.org/10.1371/journal.pone.0052462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300678	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800092
J	Xia, CH; Chang, B; DeRosa, AM; Cheng, C; White, TW; Gong, XH				Xia, Chun-hong; Chang, Bo; DeRosa, Adam M.; Cheng, Catherine; White, Thomas W.; Gong, Xiaohua			Cataracts and Microphthalmia Caused by a Gja8 Mutation in Extracellular Loop 2	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; LENS DEVELOPMENT; ALPHA(3) CONNEXIN; DOMINANT CATARACTS; POINT MUTATION; MOUSE MODELS; MICE; CATARACTOGENESIS; PROTEIN; CX50	The mouse semi-dominant Nm2249 mutation displays variable cataracts in heterozygous mice and smaller lenses with severe cataracts in homozygous mice. This mutation is caused by a Gja8(R205G) point mutation in the second extracellular loop of the Cx50 (or alpha 8 connexin) protein. Immunohistological data reveal that Cx50-R205G mutant proteins and endogenous wild-type Cx46 (or alpha 3 connexin) proteins form diffuse tiny spots rather than typical punctate signals of normal gap junctions in the lens. The level of phosphorylated Cx46 proteins is decreased in Gja8(R205G/R205G) mutant lenses. Genetic analysis reveals that the Cx50-R205G mutation needs the presence of wild-type Cx46 to disrupt lens peripheral fibers and epithelial cells. Electrophysiological data in Xenopus oocytes reveal that Cx50-R205G mutant proteins block channel function of gap junctions composed of wild-type Cx50, but only affect the gating of wild-type Cx46 channels. Both genetic and electrophysiological results suggest that Cx50-R205G mutant proteins alone are unable to form functional channels. These findings imply that the Gja8(R205G) mutation differentially impairs the functions of Cx50 and Cx46 to cause cataracts, small lenses and microphthalmia. The Gja8(R205G) mutation occurs at the same conserved residue as the human GJA8(R198W) mutation. This work provides molecular insights to understand the cataract and microphthalmia/microcornea phenotype caused by Gja8 mutations in mice and humans.	[Xia, Chun-hong; Cheng, Catherine; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Xia, Chun-hong; Cheng, Catherine; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [DeRosa, Adam M.; White, Thomas W.] SUNY Stony Brook, Stony Brook, NY 11794 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Jackson Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gong, XH (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	xgong@berkeley.edu	White, Thomas/GPG-4026-2022; White, Thomas W./R-3605-2019	White, Thomas/0000-0002-3285-7434; Chang, Bo/0000-0001-8259-7290	National Institutes of Health [EY13849, EY13163, EY019943]; NATIONAL EYE INSTITUTE [R01EY013849, R01EY013163, R01EY019943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (EY13849 to XG and EY13163 to TW, and EY019943 to BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chang B, 2002, HUM MOL GENET, V11, P507, DOI 10.1093/hmg/11.5.507; Cheng C, 2008, EXP EYE RES, V86, P966, DOI 10.1016/j.exer.2008.03.015; DeRosa AM, 2007, J CELL SCI, V120, P4107, DOI 10.1242/jcs.012237; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hu SS, 2010, MOL VIS, V16, P1585; Huang Guo-Ying, 2011, J Cardiovasc Dis Res, V2, P206, DOI 10.4103/0975-3583.89804; JIANG JX, 1993, INVEST OPHTH VIS SCI, V34, P3558; Jiang JX, 1996, P NATL ACAD SCI USA, V93, P1287, DOI 10.1073/pnas.93.3.1287; Kar R, 2012, ARCH BIOCH BIOPHYSIC; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z; Magnotti LM, 2011, GLIA, V59, P26, DOI 10.1002/glia.21073; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Rong P, 2002, DEVELOPMENT, V129, P167; RUNGE PE, 1992, INVEST OPHTH VIS SCI, V33, P3202; Schutz M, 2011, HUM MOL GENET, V20, P28, DOI 10.1093/hmg/ddq429; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shiels A, 2010, MOL VIS, V16, P2007; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Xia CH, 2006, DEVELOPMENT, V133, P2033, DOI 10.1242/dev.02361; Xia CH, 2006, EXP EYE RES, V83, P688, DOI 10.1016/j.exer.2006.03.013; Xia CH, 2006, J CELL SCI, V119, P2138, DOI 10.1242/jcs.02940	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52894	10.1371/journal.pone.0052894	http://dx.doi.org/10.1371/journal.pone.0052894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300808	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800160
J	Miwa, S; Nishida, H; Tanzawa, Y; Takata, M; Takeuchi, A; Yamamoto, N; Shirai, T; Hayashi, K; Kimura, H; Igarashi, K; Mizukoshi, E; Nakamoto, Y; Kaneko, S; Tsuchiya, H				Miwa, Shinji; Nishida, Hideji; Tanzawa, Yoshikazu; Takata, Munetomo; Takeuchi, Akihiko; Yamamoto, Norio; Shirai, Toshiharu; Hayashi, Katsuhiro; Kimura, Hiroaki; Igarashi, Kentaro; Mizukoshi, Eishiro; Nakamoto, Yasunari; Kaneko, Shuichi; Tsuchiya, Hiroyuki			TNF-alpha and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors	PLOS ONE			English	Article							CANCER; THERAPY; LYMPHOCYTES; MELANOMA; IMMUNITY; BLOOD; OSTEOSARCOMA; VACCINATION; ANTICANCER; ACTIVATION	Background: Dendritic cells (DCs) play a pivotal role in the immune system. There are many reports concerning DC-based immunotherapy. The differentiation and maturation of DCs is a critical part of DC-based immunotherapy. We investigated the differentiation and maturation of DCs in response to various stimuli. Methods: Thirty-one patients with malignant bone and soft tissue tumors were enrolled in this study. All the patients had metastatic tumors and/or recurrent tumors. Peripheral blood mononuclear cells (PBMCs) were suspended in media containing interleukin-4 (IL-4) and granulocyte-macrophage colony stimulating factor (GM-CSF). These cells were then treated with or without 1) tumor lysate (TL), 2) TL + TNF-alpha, 3) OK-432. The generated DCs were mixed and injected in the inguinal or axillary region. Treatment courses were performed every week and repeated 6 times. A portion of the cells were analyzed by flow cytometry to determine the degree of differentiation and maturation of the DCs. Serum IFN-gamma and serum IL-12 were measured in order to determine the immune response following the DC-based immunotherapy. Results: Approximately 50% of PBMCs differentiated into DCs. Maturation of the lysate-pulsed DCs was slightly increased. Maturation of the TL/TNF-alpha-pulsed DCs was increased, commensurate with OK-432-pulsed DCs. Serum IFN-gamma and serum IL-12 showed significant elevation at one and three months after DC-based immunotherapy. Conclusions: Although TL-pulsed DCs exhibit tumor specific immunity, TL-pulsed cells showed low levels of maturation. Conversely, the TL/TNF-alpha-pulsed DCs showed remarkable maturation. The combination of IL-4/GM-CSF/TL/TNF-alpha resulted in the greatest differentiation and maturation for DC-based immunotherapy for patients with bone and soft tissue tumors.	[Miwa, Shinji; Nishida, Hideji; Tanzawa, Yoshikazu; Takata, Munetomo; Takeuchi, Akihiko; Yamamoto, Norio; Shirai, Toshiharu; Hayashi, Katsuhiro; Kimura, Hiroaki; Igarashi, Kentaro; Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan; [Mizukoshi, Eishiro; Nakamoto, Yasunari; Kaneko, Shuichi] Kanazawa Univ, Sch Med, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 920, Japan	Kanazawa University; Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan.	tsuchi@med.kanazawa-u.ac.jp	Miwa, Shinji/AAI-9309-2020; Takeuchi, Akihiko/AAJ-1563-2020; Hayashi, K/C-4685-2015	Miwa, Shinji/0000-0002-5962-8287; Takeuchi, Akihiko/0000-0002-4071-5620; Hayashi, K/0000-0001-8665-2154; Igarashi, Kentaro/0000-0003-2278-1736	Grants-in-Aid for Scientific Research [23791630] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agarwal A, 2010, IMMUNOPHARM IMMUNOT, V32, P348, DOI 10.3109/08923970903300151; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15; Crittenden MR, 2005, IMMUNOLOGY, V114, P11, DOI 10.1111/j.1365-2567.2004.02001.x; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Gregoire M, 2003, VACCINE, V21, P791, DOI 10.1016/S0264-410X(02)00600-X; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hovden AO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-2; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Joyama S, 2006, CLIN ORTHOP RELAT R, P318, DOI 10.1097/01.blo.0000229347.02834.5e; Kawano M, 2010, CLIN ORTHOP RELAT R, V468, P1373, DOI 10.1007/s11999-010-1302-z; Ladanyi A, 2007, CANCER IMMUNOL IMMUN, V56, P1459, DOI 10.1007/s00262-007-0286-3; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Matsumoto M, 2001, INT IMMUNOPHARMACOL, V1, P1559, DOI 10.1016/S1567-5769(01)00071-6; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Moretti S, 2001, MELANOMA RES, V11, P395, DOI 10.1097/00008390-200108000-00010; Nakamoto Y, 2007, CLIN EXP IMMUNOL, V147, P296, DOI 10.1111/j.1365-2249.2006.03290.x; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Okada H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-67; OKAMOTO H, 1967, JPN J MICROBIOL, V11, P323, DOI 10.1111/j.1348-0421.1967.tb00350.x; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Reddy A, 1997, BLOOD, V90, P3640, DOI 10.1182/blood.V90.9.3640; Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tsuboi K, 2004, CANCER LETT, V205, P207, DOI 10.1016/j.canlet.2003.10.010; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wertel I, 2008, CYTOM PART B-CLIN CY, V74B, P251, DOI 10.1002/cyto.b.20410	38	12	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52926	10.1371/journal.pone.0052926	http://dx.doi.org/10.1371/journal.pone.0052926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300824	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800108
J	Jayakar, SS; Dailey, WP; Eckenhoff, RG; Cohen, JB				Jayakar, Selwyn S.; Dailey, William P.; Eckenhoff, Roderic G.; Cohen, Jonathan B.			Identification of Propofol Binding Sites in a Nicotinic Acetylcholine Receptor with a Photoreactive Propofol Analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NONCOMPETITIVE ANTAGONIST; GENERAL-ANESTHETICS; GABA(A) RECEPTOR; ETOMIDATE; POTENTIATION; DESENSITIZATION; SUBUNIT; STATE	Propofol, a widely used intravenous general anesthetic, acts at anesthetic concentrations as a positive allosteric modulator of gamma-aminobutyric acid type A receptors and at higher concentration as an inhibitor of nicotinic acetylcholine receptors (nAChRs). Here, we characterize propofol binding sites in a muscle-type nAChR by use of a photoreactive analog of propofol, 2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol (AziPm). Based upon radioligand binding assays, AziPm stabilized the Torpedo nAChR in the resting state, whereas propofol stabilized the desensitized state. nAChR-rich membranes were photolabeled with [H-3] AziPm, and labeled amino acids were identified by Edman degradation. [H-3] AziPm binds at three sites within the nAChR transmembrane domain: (i) an intrasubunit site in the delta subunit helix bundle, photolabeling in the nAChR desensitized state (+agonist) delta M2-18' and two residues in delta M1 (delta Phe-232 and delta Cys-236); (ii) in the ion channel, photolabeling in the nAChR resting, closed channel state (-agonist) amino acids in the M2 helices (alpha M2-6', beta M2-6' and -13', and delta M2-13') that line the channel lumen (with photolabeling reduced by >90% in the desensitized state); and (iii) at the gamma-alpha interface, photolabeling alpha M2-10'. Propofol enhanced [H-3] AziPm photolabeling at alpha M2-10'. Propofol inhibited [H-3]AziPm photolabeling within the delta subunit helix bundle at lower concentrations (IC50 = 40 mu M) than it inhibited ion channel photolabeling (IC50 = 125 mu M). These results identify for the first time a single intrasubunit propofol binding site in the nAChR transmembrane domain and suggest that this is the functionally relevant inhibitory binding site.	[Jayakar, Selwyn S.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Dailey, William P.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health from the United States Public Health Service [GM-58448, GM-55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58448 (to J. B. C. and K. W. M.) and GM-55876 (to R. G. E.) from the United States Public Health Service.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Bertaccini EJ, 2010, J CHEM INF MODEL, V50, P2248, DOI 10.1021/ci100266c; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; NEUBIG RR, 1982, BIOCHEMISTRY-US, V21, P3460, DOI 10.1021/bi00257a032; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; TAYLOR P, 1983, CURR TOP MEMBR TRANS, V18, P407; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	42	61	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6178	6189		10.1074/jbc.M112.435909	http://dx.doi.org/10.1074/jbc.M112.435909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300078	Green Published, hybrid			2022-12-25	WOS:000315820700014
J	Abrahams, KA; Cox, JAG; Spivey, VL; Loman, NJ; Pallen, MJ; Constantinidou, C; Fernandez, R; Alemparte, C; Remuinan, MJ; Barros, D; Ballell, L; Besra, GS				Abrahams, Katherine A.; Cox, Jonathan A. G.; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Fernandez, Raquel; Alemparte, Carlos; Remuinan, Modesto J.; Barros, David; Ballell, Lluis; Besra, Gurdyal S.			Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; DRUG-RESISTANT TUBERCULOSIS; ANTITUBERCULAR DRUG; RESPIRATORY-CHAIN; QUINOL OXIDATION; ATP HOMEOSTASIS; DISCOVERY; MUCIDIN; LIBRARY; GENES	Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. Through the use of high throughput whole cell screening of an extensive compound library a number of imidazo[1,2-a]pyridine (IP) compounds were obtained as potent lead molecules active against M. tuberculosis and Mycobacterium bovis BCG. The IP inhibitors (1-4) demonstrated minimum inhibitory concentrations (MICs) in the range of 0.03 to 5 mu M against a panel of M. tuberculosis strains. M. bovis BCG spontaneous resistant mutants were generated against IP 1, 3, and 4 at 56 MIC and subsequent whole genome sequencing identified a single nucleotide polymorphism (937)ACC>(937)GCC (T313A) in qcrB, which encodes the b subunit of the electron transport ubiquinol cytochrome C reductase. This mutation also conferred cross-resistance against IP 1, 3 and 4 demonstrating a common target. Gene dosage experiments confirmed M. bovis BCG QcrB as the target where over-expression in M. bovis BCG led to an increase in MIC from 0.5 to >8 mu M for IP 3. An acute murine model of TB infection established bacteriostatic activity of the IP series, which await further detailed characterization.	[Abrahams, Katherine A.; Cox, Jonathan A. G.; Spivey, Vickey L.; Loman, Nicholas J.; Pallen, Mark J.; Constantinidou, Chrystala; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Fernandez, Raquel; Alemparte, Carlos; Remuinan, Modesto J.; Barros, David; Ballell, Lluis] GlaxoSmithKline, Dis Dev World, Madrid, Spain	University of Birmingham; GlaxoSmithKline	Ballell, L (corresponding author), GlaxoSmithKline, Dis Dev World, Madrid, Spain.	Lluis.p.ballell@gsk.com; g.besra@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Abrahams, Katherine/0000-0002-0769-3423; Alemparte, Carlos/0000-0001-5521-8304; Besra, Gurdyal/0000-0002-5605-0395; Rowlands, Vicky/0000-0002-1352-938X; Cox, Jonathan/0000-0001-5208-4056; Ballell, Lluis/0000-0002-3029-1860	Royal Society Wolfson Research Merit Award; European Union's 7th Framework Programme [261378]; Biotechnology and Biological Sciences Research Council [1112080] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); European Union's 7th Framework Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GSB acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick and a Royal Society Wolfson Research Merit Award. The research leading to these results has received funding from the European Union's 7th Framework Programme (FP7-2007-2013) under grant agreement no 261378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAFLOUS A, 2004, LETT DRUG DES DISCOV, V1, P35; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CLOUGH JM, 1993, NAT PROD REP, V10, P565, DOI 10.1039/np9931000565; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; DALDAL F, 1989, EMBO J, V8, P3951, DOI 10.1002/j.1460-2075.1989.tb08578.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Kasimogullari BO, 2004, MOLECULES, V9, P894, DOI 10.3390/91000894; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kraiczy P, 1996, EUR J BIOCHEM, V235, P54, DOI 10.1111/j.1432-1033.1996.00054.x; KUCERA I, 1988, BIOCHEM J, V252, P905, DOI 10.1042/bj2520905; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lee RE, 2003, J COMB CHEM, V5, P172, DOI 10.1021/cc020071p; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Matteelli A, 2010, FUTURE MICROBIOL, V5, P849, DOI [10.2217/fmb.10.50, 10.2217/FMB.10.50]; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Sacksteder KA, 2012, FUTURE MICROBIOL, V7, P823, DOI [10.2217/FMB.12.56, 10.2217/fmb.12.56]; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Scherman MS, 2012, BIOORGAN MED CHEM, V20, P3255, DOI 10.1016/j.bmc.2012.03.058; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; SUBIK J, 1974, BIOCHEM BIOPH RES CO, V57, P17, DOI 10.1016/S0006-291X(74)80351-7; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; TOKITO MK, 1993, MOL MICROBIOL, V9, P965, DOI 10.1111/j.1365-2958.1993.tb01226.x; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; VONJAGOW G, 1986, BIOCHEMISTRY-US, V25, P775, DOI 10.1021/bi00352a006; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP	51	148	152	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52951	10.1371/journal.pone.0052951	http://dx.doi.org/10.1371/journal.pone.0052951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300833	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000313872600041
J	Guo, EE; He, QY; Liu, SM; Tian, L; Sheng, ZT; Peng, Q; Guan, JM; Shi, MA; Li, K; Gilbert, LI; Wang, J; Cao, Y; Li, S				Guo, Enen; He, Qianyu; Liu, Shumin; Tian, Ling; Sheng, Zhentao; Peng, Qin; Guan, Jingmin; Shi, Mingan; Li, Kang; Gilbert, Lawrence I.; Wang, Jian; Cao, Yang; Li, Sheng			MET Is Required for the Maximal Action of 20-Hydroxyecdysone during Bombyx Metamorphosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BHLH-PAS FAMILY; JUVENILE-HORMONE RECEPTOR; FTZ-F1 NUCLEAR RECEPTOR; DROSOPHILA FAT-BODY; METHOPRENE-TOLERANT; ECDYSONE RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATORS; SILKWORM	Little is known about how the putative juvenile hormone (JH) receptor, the bHLH-PAS transcription factor MET, is involved in 20-hydroxyecdysone (20E; the molting hormone) action. Here we report that two MET proteins found in the silkworm, Bombyx mori, participate in 20E signal transduction. Met is 20E responsive and its expression peaks during molting and pupation, when the 20E titer is high. As found with results from RNAi knockdown of EcR-USP (the ecdysone receptor genes), RNAi knockdown of Met at the early wandering stage disrupts the 20E-triggered transcriptional cascade, preventing tissue remodeling (including autophagy, apoptosis and destruction of larval tissues and generation of adult structures) and causing lethality during the larval-pupal transition. MET physically interacts with EcR-USP. Moreover, MET, EcR-USP and the 20E-response element (EcRE) form a protein-DNA complex, implying that MET might modulate 20E-induced gene transcription by interacting with EcR-USP. In conclusion, the 20E induction of MET is required for the maximal action of 20E during Bombyx metamorphosis.	[Guo, Enen; Li, Kang; Cao, Yang] S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Guo, Enen; He, Qianyu; Liu, Shumin; Tian, Ling; Sheng, Zhentao; Peng, Qin; Guan, Jingmin; Shi, Mingan; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland College Park	Cao, Y (corresponding author), S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou, Guangdong, Peoples R China.	caoyang@scau.edu.cn; shengli@sippe.ac.cn	sheng, Zhentao Sheng/E-8962-2017		973 program [2012CB114605, 2012CB114602]; National Science Foundation of China [31125025, 31101670]; Science and Technology Commission of Shanghai Municipality [10JC1416700]	973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the 973 program (2012CB114605), the National Science Foundation of China (31125025) and the Science and Technology Commission of Shanghai Municipality (10JC1416700) to S. Li (corresponding author), the National Science Foundation of China (31101670) to LT, and the 973 program (2012CB114602) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Chan HM, 2001, J CELL SCI, V114, P2363; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Imamura M, 2003, GENETICS, V165, P1329; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Khurad AM, 2009, IN VITRO CELL DEV-AN, V45, P414, DOI 10.1007/s11626-009-9197-2; Kimura S, 2008, BIOCHEM BIOPH RES CO, V371, P889, DOI 10.1016/j.bbrc.2008.05.003; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu Y, 2010, J INSECT PHYSIOL, V56, P1436, DOI 10.1016/j.jinsphys.2010.02.011; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou S, 2010, INSECT MOL BIOL, V19, P727, DOI 10.1111/j.1365-2583.2010.01026.x; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	48	37	43	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53256	10.1371/journal.pone.0053256	http://dx.doi.org/10.1371/journal.pone.0053256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300902	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100130
J	Horvat, N; Koder, M; Kos, M				Horvat, Nejc; Koder, Marko; Kos, Mitja			Using the Simulated Patient Methodology to Assess Paracetamol-Related Counselling for Headache	PLOS ONE			English	Article							COMMUNITY PHARMACIES; IMPLEMENTATION; ANALGESICS; MEDICINES; BEHAVIOR; QUALITY; CARE	Objectives: Firstly, to assess paracetamol-related counselling. Secondly, to evaluate the patient's approach as a determinant of counselling and to test the acceptability of the simulated patient method in Slovenian pharmacies. Methods: The simulated patient methodology was used in 17 community pharmacies. Three scenarios related to self-medication for headaches were developed and used in all participating pharmacies. Two scenarios were direct product requests: scenario 1: a patient with an uncomplicated short-term headache; scenario 2: a patient with a severe, long-duration headache who takes paracetamol for too long and concurrently drinks alcohol. Scenario 3 was a symptom-based request: a patient asking for medicine for a headache. Pharmacy visits were audio recorded and scored according to predetermined criteria arranged in two categories: counselling content and manner of counselling. The acceptability of the methodology used was evaluated by surveying the participating pharmacists. Results: The symptom-based request was scored significantly better (a mean 2.17 out of a possible 4 points) than the direct product requests (means of 1.64 and 0.67 out of a possible 4 points for scenario 1 and 2, respectively). The most common information provided was dosage and adverse effects. Only the symptom-based request stimulated spontaneous counselling. No statistically significant differences in the duration of the consultation between the scenarios were found. There were also no significant differences in the quality of counselling between the Masters of Pharmacy and Pharmacy Technicians. The acceptability of the SP method was not as high as in other countries. Conclusion: The assessment of paracetamol-related counselling demonstrates room for practice improvement.	[Horvat, Nejc; Koder, Marko; Kos, Mitja] Univ Ljubljana, Fac Pharm, Chair Social Pharm, Ljubljana, Slovenia	University of Ljubljana	Kos, M (corresponding author), Univ Ljubljana, Fac Pharm, Chair Social Pharm, Ljubljana, Slovenia.	mitja.kos@ffa.uni-lj.si	Kos, Mitja/C-7440-2019; Horvat, Nejc/I-4746-2012	Kos, Mitja/0000-0002-6801-6450; Horvat, Nejc/0000-0001-8460-276X	University of Ljubljana - Faculty of Pharmacy	University of Ljubljana - Faculty of Pharmacy	No separate funding was obtained for this study. The authors are researchers at the University of Ljubljana - Faculty of Pharmacy, which has contributed to financing the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alte D, 2007, ANN PHARMACOTHER, V41, P1023, DOI 10.1345/aph.1H565; Benrimoj SI, 2008, PHARM WORLD SCI, V30, P147, DOI 10.1007/s11096-007-9162-7; Berger K, 2005, J CLIN PHARM THER, V30, P45, DOI 10.1111/j.1365-2710.2004.00611.x; Brvar M, 2008, ZDR VESTN, V77, P39; Cufar A, 2006, FARM VESTN, V57, P55; Dargan PI, 2002, DRUG SAFETY, V25, P625, DOI 10.2165/00002018-200225090-00002; Deschamps M, 2003, CAN PHARM J, V136, P42; French DP, 2008, PHARM WORLD SCI, V30, P79, DOI 10.1007/s11096-007-9146-7; IBM SPSS Inc, 2008, IBM SPSS STAT VERS 1; Kaniecki R, 2003, JAMA-J AM MED ASSOC, V289, P1430, DOI 10.1001/jama.289.11.1430; Kelly FS, 2009, ANN PHARMACOTHER, V43, P1877, DOI 10.1345/aph.1L121; Lowe N K, 1999, Nurse Pract, V24, P34; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Mlinaric A, 2007, FARMAKON, V26, P1; Moynihan R, 2002, BRIT MED J, V325, P678, DOI 10.1136/bmj.325.7366.678; O'Rourke M, 2002, IRISH J MED SCI, V171, P148, DOI 10.1007/BF03170503; Orizio G, 2010, PHARMACOEPIDEM DR S, V19, P970, DOI 10.1002/pds.2007; ORTIZ M, 1989, J SOC ADMIN PHARM, V6, P39; Puspitasari HP, 2009, RES SOC ADMIN PHARM, V5, P197, DOI 10.1016/j.sapharm.2008.08.006; Puumalainen I, 2005, THESIS U KUOPIO KUOP; Puumalainen II, 2005, INT J PHARM PRACT, V13, P149, DOI 10.1211/0022357056307; QSR International Pty Ltd, 2008, NVIVO QUAL DAT AN SO; Roumie CL, 2004, DRUG AGING, V21, P485, DOI 10.2165/00002512-200421080-00001; Schommer JC, 1997, PHARM RES-DORDR, V14, P145, DOI 10.1023/A:1012084207399; Sheen CL, 2002, QJM-INT J MED, V95, P609, DOI 10.1093/qjmed/95.9.609; Trsinar M, 2007, FARM VESTN, V58, P45; Tully MP, 2011, PATIENT EDUC COUNS, V83, P3, DOI 10.1016/j.pec.2010.04.029; van Mil JWF, 2004, PHARM WORLD SCI, V26, P303; Watson MC, 2009, FAM PRACT, V26, P532, DOI 10.1093/fampra/cmp061; Watson MC, 2004, PHARM WORLD SCI, V26, P32, DOI 10.1023/B:PHAR.0000013467.61875.ce; Werner JB, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7206136	31	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52510	10.1371/journal.pone.0052510	http://dx.doi.org/10.1371/journal.pone.0052510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300691	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100058
J	Nguyen, TM; Ravindra, D; Kwong, B; Waheed, S; Ferguson, R; Tarlton, N; Wu, V; Sequeira, CS; Bremer, M; Abramson, T				Nguyen, Tuan M.; Ravindra, Dipti; Kwong, Brian; Waheed, Sana; Ferguson, Ryan; Tarlton, Nicole; Wu, Victoria; Sequeira, Christopher S.; Bremer, Martina; Abramson, Tzvia			Differential Expression of Alpha 4 Integrins on Effector Memory T Helper Cells during Bordetella Infections. Delayed Responses in Bordetella pertussis	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; ADENYLATE-CYCLASE TOXIN; ISLET-ACTIVATING PROTEIN; DENDRITIC CELLS; CHEMOKINE RECEPTORS; LUNG; LYMPHOCYTES; MOLECULES; PULMONARY; IMMUNITY	Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, a respiratory disease that is reemerging worldwide. Mechanisms of selective lymphocyte trafficking to the airways are likely to be critical in the immune response to this pathogen. We compared murine infection by B. pertussis, B. parapertussis, and a pertussis toxin-deleted B. pertussis mutant (Bp Delta PTX) to test the hypothesis that effector memory T-helper cells (emTh) display an altered pattern of trafficking receptor expression in B. pertussis infection due to a defect in imprinting. Increased cell recruitment to the lungs at 5 days post infection (p.i.) with B. parapertussis, and to a lesser extent with Bp Delta PTX, coincided with an increased frequency of circulating emTh cells expressing the mucosal-associated trafficking receptors alpha 4 beta 7 and alpha 4 beta 1 while a reduced population of these cells was observed in B. pertussis infection. These cells were highly evident in the blood and lungs in B. pertussis infection only at 25 days p.i. when B. parapertussis and BpDPTX infections were resolved. Although at 5 days p.i., an equally high percentage of lung dendritic cells (DCs) from all infections expressed maturation markers, this expression persisted only in B. pertussis infection at 25 days p.i. Furthermore, at 5 days p.i with B. pertussis, lung DCs migration to draining lymph nodes may be compromised as evidenced by decreased frequency of CCR7(+) DCs, inhibited CCR7-mediated in vitro migration, and fewer DCs in lung draining lymph nodes. Lastly, a reduced frequency of allogeneic CD4(+) cells expressing alpha 4 beta 1 was detected following co-culture with lung DCs from B. pertussis-infected mice, suggesting a defect in DC imprinting in comparison to the other infection groups. The findings in this study suggest that B. pertussis may interfere with imprinting of lung-associated trafficking receptors on T lymphocytes leading to extended survival in the host and a prolonged course of disease.	[Nguyen, Tuan M.; Ravindra, Dipti; Kwong, Brian; Waheed, Sana; Ferguson, Ryan; Tarlton, Nicole; Wu, Victoria; Sequeira, Christopher S.; Abramson, Tzvia] San Jose State Univ, Dept Biol, San Jose, CA 95192 USA; [Bremer, Martina] San Jose State Univ, Dept Math, San Jose, CA 95192 USA	California State University System; San Jose State University; California State University System; San Jose State University	Abramson, T (corresponding author), San Jose State Univ, Dept Biol, San Jose, CA 95192 USA.	tzvia.abramson@sjsu.edu	Nguyen, Tony Minh/AAH-1121-2019	Nguyen, Tony Minh/0000-0003-4879-3962	CSU startup 538 funds; National Institutes of Health (NIH) [SC3 GM100854-01]; NIH [AI047822, AI072618, DK084647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072618, R21AI047822, R37AI047822, R01AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM100854] Funding Source: NIH RePORTER	CSU startup 538 funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CSU startup 538 funds and National Institutes of Health (NIH) grant SC3 GM100854-01 awarded to Dr. Tzvia Abramson, and in part by NIH grants AI047822, AI072618, and DK084647 awarded to Dr. Eugene Butcher (Stanford University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitorabi MA, 1996, J IMMUNOL, V156, P3111; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Anis MM, 2008, INFECT IMMUN, V76, P671, DOI 10.1128/IAI.01079-07; ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Bergfors E, 1999, Int J Infect Dis, V3, P140, DOI 10.1016/S1201-9712(99)90035-8; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Garcia A, 1996, J CLIN MICROBIOL, V34, P182; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kang SG, 2011, MUCOSAL IMMUNOL, V4, P66, DOI 10.1038/mi.2010.42; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; MUNOZ JJ, 1981, INFECT IMMUN, V33, P820, DOI 10.1128/IAI.33.3.820-826.1981; NENCIONI L, 1991, INFECT IMMUN, V59, P4732, DOI 10.1128/IAI.59.12.4732-4734.1991; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; PICKER LJ, 1990, AM J PATHOL, V136, P1053; PICKER LJ, 1994, EUR J IMMUNOL, V24, P1269, DOI 10.1002/eji.1830240605; PITTMAN M, 1980, J INFECT DIS, V142, P56, DOI 10.1093/infdis/142.1.56; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693; Schneider OD, 2009, J IMMUNOL, V182, P5730, DOI 10.4049/jimmunol.0803114; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Thatte J, 2003, BLOOD, V101, P4916, DOI 10.1182/blood-2002-10-3159; UI M, 1988, ADV SEC MESS PHOSPH, V21, P39; Vaya A, 2012, CLIN HEMORHEOL MICRO, V51, P51, DOI 10.3233/CH-2011-1508; Verma A, 2008, J BACTERIOL, V190, P7285, DOI 10.1128/JB.01106-08; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Wolber FM, 1998, J IMMUNOL, V161, P4396; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	60	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52903	10.1371/journal.pone.0052903	http://dx.doi.org/10.1371/journal.pone.0052903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300813	Green Published, gold			2022-12-25	WOS:000312829100094
J	Tseng, CH				Tseng, Chin-Hsiao			Thyroid Cancer Risk Is Not Increased in Diabetic Patients	PLOS ONE			English	Article							METABOLIC SYNDROME; POOLED ANALYSIS; UNITED-STATES; INSULIN; TAIWAN; POPULATION; EXPRESSION; COHORT; CELLS	Objective: This study evaluated thyroid cancer risk with regards to diabetes status and diabetes duration, and with the use of anti-diabetic drugs including sulfonylurea, metformin, insulin, acarbose, pioglitazone and rosiglitazone, by using a population-based reimbursement database in Taiwan. Methods: A random sample of 1,000,000 subjects covered by the National Health Insurance was recruited. After excluding patients with type 1 diabetes, 999730 subjects (495673 men and 504057 women) were recruited into the analyses. Logistic regression estimated the odds ratios (OR) and their 95% confidence intervals (Cl) for independent variables including age, sex, diabetes status/duration, anti-diabetic drugs, other medications, comorbidities, living regions, occupation and examinations that might potentially lead to the diagnosis of thyroid cancer in various models. Results: The diabetic patients had a significantly higher probability of receiving potential detection examinations (6.38% vs. 5.83%, P<0.0001). After multivariable-adjustment, the OR (95% Cl) for diabetes status was 0.816 (0.652-1.021); and for diabetes duration <1 year, 1-3 years, 3-5 years and >= 5 years vs. non-diabetes was 0.071 (0.010-0.507), 0.450 (0.250-0.813), 0.374 (0.203-0.689) and 1.159 (0.914-1.470), respectively. Among the anti-diabetic agents, only sulfonylurea was significantly associated with thyroid cancer, OR (95% Cl): 1.882 (1.202-2.947). The OR (95% Cl) for insulin, metformin, acarbose, pioglitazone and rosiglitazone was 1.701 (0.860-3.364), 0.696 (0.419-1.155), 0.581 (0.202-1.674), 0.522 (0.069-3.926) and 0.669 (0.230-1.948), respectively. Furthermore, patients with benign thyroid disease or other cancer, living in Kao-Ping/Eastern regions, or receiving potential detection examinations might have a significantly higher risk; and male sex, hypertension, dyslipidemia, chronic obstructive pulmonary disease, vascular complications or use of statin, aspirin or non-steroidal anti-inflammatory drugs might be associated with a significantly lower risk. Conclusions: There is a lack an overall association between diabetes and thyroid cancer, but patients with diabetes duration <5 years have a significantly lower risk. Sulfonylurea may increase the risk of thyroid cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123				Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Aschebrook-Kilfoy B, 2011, THYROID, V21, P957, DOI 10.1089/thy.2010.0396; Bureau of Health Promotion, 2010, CANC REG ANN REP 200; Cappelli C, 2012, OBES SURG, V22, P460, DOI 10.1007/s11695-011-0410-5; Chen GG, 2008, CURR CANCER DRUG TAR, V8, P367, DOI 10.2174/156800908785133150; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chiou WK, 2011, ASIAN PAC J CANCER P, V12, P1577; Cho NL, 2010, THYROID, V20, P615, DOI 10.1089/thy.2009.0415; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Farasat T, 2011, PAK J ZOOL, V43, P379; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guney E, 1999, TURKISH J ENDOCRINOL, V4, P173; Hegedus L, 2008, CLIN ENDOCRINOL, V68, P2, DOI 10.1111/j.1365-2265.2007.02983.x; HERSHMAN JM, 1968, ENDOCRINOLOGY, V83, P74, DOI 10.1210/endo-83-1-74; HU RM, 1994, MOL CELL ENDOCRINOL, V103, P65; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kadiyala R, 2010, INT J CLIN PRACT, V64, P1130, DOI 10.1111/j.1742-1241.2010.02376.x; Kim HK, 2013, CLIN ENDOCRINOL, V78, P472, DOI 10.1111/cen.12027; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P1615, DOI 10.1007/s10552-012-0039-2; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P463, DOI 10.1007/s10552-012-9896-y; McNally RJQ, 2012, EUR J EPIDEMIOL, V27, P615, DOI 10.1007/s10654-012-9710-x; NIKKILA EA, 1960, ACTA ENDOCRINOL-COP, V33, P623; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Roche LM, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/850105; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; Shih SR, 2012, EXP DIABETES RES, DOI 10.1155/2012/578285; Tarcin O, 2012, METAB SYNDR RELAT D, V10, P137, DOI 10.1089/met.2011.0098; Tseng CH, 2012, EUR J ENDOCRINOL, V167, P409, DOI 10.1530/EJE-12-0369; Wang CY, 2012, ENDOCR J, V59, P911, DOI 10.1507/endocrj.EJ12-0076; Zhan YS, 2010, MED ONCOL, V27, P177, DOI 10.1007/s12032-009-9189-9	31	76	78	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53096	10.1371/journal.pone.0053096	http://dx.doi.org/10.1371/journal.pone.0053096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300866	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100117
J	You, QS; Wu, LJ; Duan, JL; Luo, YX; Liu, LJ; Li, X; Gao, Q; Wang, W; Xu, L; Jonas, JB; Guo, XH				You, Qi Sheng; Wu, Li Juan; Duan, Jia Li; Luo, Yan Xia; Liu, Li Juan; Li, Xia; Gao, Qi; Wang, Wei; Xu, Liang; Jonas, Jost B.; Guo, Xiu Hua			Factors Associated with Myopia in School Children in China: The Beijing Childhood Eye Study	PLOS ONE			English	Article							RISK-FACTORS; REFRACTIVE ERRORS; OUTDOOR ACTIVITY; ADULT CHINESE; OCULAR PARAMETERS; PARENTAL MYOPIA; FOLLOW-UP; SINGAPORE; WORK; PREVALENCE	Purpose: To assess factors associated with myopia in school children in rural and urban parts of Greater Beijing. Methods: The Beijing Pedriatic Eye Study was a population-based cross-sectional study, in which one school of each level (primary, junior high, senior high) was randomly selected from nine randomly selected districts out of 18 districts of Greater Beijing. The children underwent non-cylcoplegic refractometry and their parents an interview. Results: Of 16,771 eligible students, 15,066 (89.8%) children (7,769 (51.6%) girls) participated, with 8,860 (58.8%) participants living in the rural region. Mean age was 13.2 +/- 3.4 years (range: 7-18 years). In multivariate analysis, prevalence of myopia (defined as <=-1.00 diopters) was associated with higher age (Odds ratio(OR): 1.37; 95% confidence interval(CI): 1.35,1.39), female gender (OR: 1.35; 95% CI: 1.25,1.47), key school type (OR: 0.77; 95% CI: 0.70,0.85), higher family income (OR: 1.04; 95% CI: 1.01,1.07), parental myopia (OR: 1.46; 95% CI: 1.40,1.53), dim reading illumination (OR: 0.93; 95% CI: 0.88,0.98), longer daily studying duration (OR: 1.10; 95% CI: 1.06,1.15), shorter duration of watching television (or computer) (OR: 0.93; 95% CI: 0.89,0.97), higher self-reported protein intake (OR: 0.94; 95% CI: 0.90,0.99), feeling well about life and status (OR: 0.93; 95% CI: 0.89,0.98), and feeling tired or dizzy (OR: 0.94; 95% CI: 0.91,0.97). Prevalence of high myopia (defined as <=-6.00 diopters) was associated with higher age (OR: 1.43; 95% CI: 1.38, 1.48), key school type (OR: 0.61; 95% CI: 0.49,0.74), family income (OR: 1.07; 95% CI: 1.02,1.13), parental myopia (OR: 1.65; 95% CI: 1.54,1.76), dim reading illumination (OR: 0.86; 95% CI: 0.77,0.96), less rest during studying (OR: 1.18; 95% CI: 1.10,1.27), feeling well about life and studying (OR: 0.88; 95% CI: 0.81,0.96) and feeling dizzy or tired (OR: 0.93; 95% CI: 0.87,0.99). Prevalence of high myopia (defined as <=-8.00 diopters) was significantly associated with higher age (OR: 1.39; 95% CI: 1.31,1.48;), key school type (OR: 0.61; 95% CI: 0.42,0.88) and parental myopia (OR: 1.87; 95% CI: 1.66,2.12). Conclusions: Myopia in school children in Greater Beijing was associated with higher age, female gender, school type, parental myopia, higher socioeconomic background, dim reading illumination, longer daily studying duration, less rest during study, shorter duration of watching television (or computer), higher self-reported protein intake, feeling well about life and status, and feeling tired and dizzy.	[You, Qi Sheng; Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Beijing Key Lab Epidemiol, Beijing, Peoples R China; [Duan, Jia Li] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Joondalup, Australia; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Edith Cowan University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com; jost.jonas@umm.de; guoxiuh@ccmu.edu.cn	Gao, Qi/N-8721-2019; You, Qisheng/AAG-7153-2020; liu, li/HGC-0900-2022; You, Qisheng/A-3619-2014	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Gao, Qi/0000-0002-5370-5536; wang, wei/0000-0002-1430-1360	Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]; Natural Science Fund of China [30972550]; Beijing Nova Program [2010B032]	Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Supported by the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); the program of Natural Science Fund of China (Serial Number: 30972550), and the Beijing Nova Program (No. 2010B032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Dong F, 2011, MOL VIS, V17, P2824; French AN, 2012, INVEST OPHTHALMOL VI; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P3858, DOI 10.1167/iovs.07-1451; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P2520, DOI 10.1167/iovs.06-0716; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Khader Y. S., 2006, Eastern Mediterranean Health Journal, V12, P434; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim LS, 2010, OPHTHALMOLOGY, V117, P993, DOI 10.1016/j.ophtha.2009.10.003; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Loman J, 2002, OPHTHALMOLOGY, V109, P1032, DOI 10.1016/S0161-6420(02)01012-6; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P1230, DOI 10.1136/bjo.2006.093450; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Sharma A, 2010, AM J OPHTHALMOL, V149, P347, DOI 10.1016/j.ajo.2009.08.015; Williams C, 2008, BRIT J OPHTHALMOL, V92, P1117, DOI 10.1136/bjo.2007.128256; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2011, ACTA OPHTHALMOL, V89, P442, DOI 10.1111/j.1755-3768.2009.01734.x; Zhang MZ, 2010, INVEST OPHTH VIS SCI, V51, P4969, DOI 10.1167/iovs.10-5424; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	42	72	83	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52668	10.1371/journal.pone.0052668	http://dx.doi.org/10.1371/journal.pone.0052668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300738	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100071
J	Gao, XG; Liu, D; Fan, YY; Li, XZ; Xue, HT; Ma, YY; Zhou, YF; Tai, GH				Gao, Xiaoge; Liu, Dan; Fan, Yuying; Li, Xinzhi; Xue, Huiting; Ma, Yingyun; Zhou, Yifa; Tai, Guihua			The Two Endocytic Pathways Mediated by the Carbohydrate Recognition Domain and Regulated by the Collagen-like Domain of Galectin-3 in Vascular Endothelial Cells	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; EXTRACELLULAR FUNCTIONS; CIRCULATING GALECTIN-3; HOMOTYPIC AGGREGATION; ANGIOGENESIS; METASTASIS; INHIBITION; ACTIVATION; SECRETION; CLEAVAGE	Galectin-3 plays an important role in endothelial morphogenesis and angiogenesis. We investigated the endocytosis of galectin-3 in human vascular endothelial cells and showed that galectin-3 could associate with and internalized into the cells in a carbohydrate-dependent manner. Our work also revealed that galectin-3 was transported to the early/recycling endosomes and then partitioned into two routes - recycling back to the plasma membrane or targeting to the late endosomes/lysosomes. Various N- and C-terminal truncated forms of galectin-3 were constructed and compared with the full-length protein. These comparisons showed that the carbohydrate-recognition domain of galectin-3 was required for galectin-3 binding and endocytosis. The N- terminal half of the protein, which comprises the N- terminal leader domain and the collagen-like internal repeating domain, could not mediate binding and endocytosis alone. The collagen-like domain, although it was largely irrelevant to galectin-3 trafficking to the early/recycling endosomes, was required for targeting galectin-3 to the late endosomes/lysosomes. In contrast, the leader domain was irrelevant to both binding and intracellular trafficking. The data presented in this study correlate well with different cellular behaviors induced by the full-length and the truncated galectin-3 and provide an alternative way of understanding its angiogenic mechanisms.	[Gao, Xiaoge; Liu, Dan; Fan, Yuying; Li, Xinzhi; Xue, Huiting; Ma, Yingyun; Zhou, Yifa; Tai, Guihua] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China	Northeast Normal University - China	Tai, GH (corresponding author), NE Normal Univ, Sch Life Sci, Changchun, Peoples R China.	taigh477@nenu.edu.cn			National Natural Science Foundation of China [81173605, 30670478]; Fundamental Research Funds for the Central Universities [11SSXT154, 12SSXM005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Nos: 81173605 & 30670478; http://www.nsfc.gov.cn/Portal0/default152.htm) and the Fundamental Research Funds for the Central Universities (11SSXT154 & 12SSXM005; http://www.nenu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Glinsky VV, 2003, CANCER RES, V63, P3805; Gong HC, 1999, CANCER RES, V59, P6239; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; LEVI G, 1981, J BIOL CHEM, V256, P5735; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233; Mirandola L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021811; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rapoport EM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P393, DOI 10.1134/S0006297908040032; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Yang E, 2007, BIOCHEM BIOPH RES CO, V363, P336, DOI 10.1016/j.bbrc.2007.08.179; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096; Zhu WQ, 2001, CANCER RES, V61, P1869	39	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52430	10.1371/journal.pone.0052430	http://dx.doi.org/10.1371/journal.pone.0052430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300668	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800085
J	Karp, NA; Melvin, D; Mott, RF				Karp, Natasha A.; Melvin, David; Mott, Richard F.		Sanger Mouse Genetics Project	Robust and Sensitive Analysis of Mouse Knockout Phenotypes	PLOS ONE			English	Article							EXPERIMENTAL-DESIGN; REFERENCE VALUES; COMPLEX TRAITS; GENOME-WIDE; GENE; ASSOCIATION; ENVIRONMENT; BEHAVIOR; QUALITY; MODEL	A significant challenge of in-vivo studies is the identification of phenotypes with a method that is robust and reliable. The challenge arises from practical issues that lead to experimental designs which are not ideal. Breeding issues, particularly in the presence of fertility or fecundity problems, frequently lead to data being collected in multiple batches. This problem is acute in high throughput phenotyping programs. In addition, in a high throughput environment operational issues lead to controls not being measured on the same day as knockouts. We highlight how application of traditional methods, such as a Student's t-Test or a 2-way ANOVA, in these situations give flawed results and should not be used. We explore the use of mixed models using worked examples from Sanger Mouse Genome Project focusing on Dual-Energy X-Ray Absorptiometry data for the analysis of mouse knockout data and compare to a reference range approach. We show that mixed model analysis is more sensitive and less prone to artefacts allowing the discovery of subtle quantitative phenotypes essential for correlating a gene's function to human disease. We demonstrate how a mixed model approach has the additional advantage of being able to include covariates, such as body weight, to separate effect of genotype from these covariates. This is a particular issue in knockout studies, where body weight is a common phenotype and will enhance the precision of assigning phenotypes and the subsequent selection of lines for secondary phenotyping. The use of mixed models with in-vivo studies has value not only in improving the quality and sensitivity of the data analysis but also ethically as a method suitable for small batches which reduces the breeding burden of a colony. This will reduce the use of animals, increase throughput, and decrease cost whilst improving the quality and depth of knowledge gained.	[Karp, Natasha A.; Melvin, David; Sanger Mouse Genetics Project] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England; [Mott, Richard F.] Wellcome Trust Ctr Human Genet, Oxford, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics	Karp, NA (corresponding author), Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England.	nk3@sanger.ac.uk		Mott, Richard/0000-0002-1022-9330; Karp, Natasha/0000-0002-8404-2907	Wellcome Trust [WT098051]; National Institutes of Health [1 U54 HG006370-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Wellcome Trust (grant number WT098051) and the National Institutes of Health (grant number 1 U54 HG006370-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Chen CK, 2012, HUM MUTAT, V33, P858, DOI 10.1002/humu.22051; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley MJ., 2007, R BOOK; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; Goncalves P, 2005, STAT MODELLING CARDI; Hu Donglei, 2008, V448, P31, DOI 10.1007/978-1-59745-205-2_3; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kafkafi N, 2005, P NATL ACAD SCI USA, V102, P4619, DOI 10.1073/pnas.0409554102; Karp NA, 2012, LAB ANIM IN PRESS; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Mansergh FC, 2007, PHYSIOL GENOMICS, V32, P64, DOI 10.1152/physiolgenomics.00151.2007; Meyer CW, 2007, NATURWISSENSCHAFTEN, V94, P401, DOI 10.1007/s00114-006-0203-1; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pinkert CA., 2002, TRANSGENIC ANIMAL TE; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Richter S, 2010, CHLOE, V41, P7; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Sabrautzki S, 2012, MAMM GENOME; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; SOLBERG HE, 1983, J CLIN CHEM CLIN BIO, V21, P749; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; West B. T., 2007, LINEAR MIXED MODELS; Wurbel H., 2007, NC3RS, V9, P1, DOI DOI 10.1016/S1353-8020(08)70759-4; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	37	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52410	10.1371/journal.pone.0052410	http://dx.doi.org/10.1371/journal.pone.0052410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300663	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800082
J	Yang, SZ; Wen, X; Jin, HJ; Wu, QB				Yang, Sizhong; Wen, Xi; Jin, Huijun; Wu, Qingbai			Pyrosequencing Investigation into the Bacterial Community in Permafrost Soils along the China-Russia Crude Oil Pipeline (CRCOP)	PLOS ONE			English	Article							MICROBIAL DIVERSITY; TUNDRA SOILS; BIOREMEDIATION; DEGRADATION; HYDROCARBONS; PENTACHLOROPHENOL; BIODEGRADATION; WETLANDS; REMOVAL; ECOLOGY	The China-Russia Crude Oil Pipeline (CRCOP) goes through 441 km permafrost soils in northeastern China. The bioremediation in case of oil spills is a major concern. So far, little is known about the indigenous bacteria inhabiting in the permafrost soils along the pipeline. A pilot 454 pyrosequencing analysis on the communities from four selected sites which possess high environment risk along the CRCOP is herein presented. The results reveal an immense bacterial diversity than previously anticipated. A total of 14448 OTUs with 84834 reads are identified, which could be assigned into 39 different phyla, and 223 families or 386 genera. Only five phyla sustain a mean OTU abundance more than 5% in all the samples, but they altogether account for 85.08% of total reads. Proteobacteria accounts for 41.65% of the total OTUs or 45% of the reads across all samples, and its proportion generally increases with soil depth, but OTUs numerically decline. Among Proteobacteria, the abundance of Beta-, Alpha-, Delta- and Gamma- subdivisions average to 38.7% (2331 OTUs), 37.5% (2257 OTUs), 10.35% (616 OTUs), and 6.21% (374 OTUs), respectively. Acidobacteria (esp. Acidobacteriaceae), Actinobacteria (esp. Intrasporangiaceae), Bacteroidetes (esp. Sphingobacteria and Flavobacteria) and Chloroflexi (esp. Anaerolineaceae) are also very common, accounting for 8.56% (1237 OTUs), 7.86% (1136 OTUs); 7.35% (1063 OTUs) and 8.27% (1195 OTUs) of total libraries, respectively. The ordination analysis indicates that bacteria communities in the upper active layer cluster together (similar), while bacterial consortia from the lower active layer and permafrost table scatter (less similar). The abundance of Rhodococcus (12 OTUs), Pseudomonas (71 OTUs) and Sphingomonas (87 OTUs) is even less (<0.01%). This effort to profile the background diversity may set the first stage for better evaluating the bacterial dynamics in response to accidental oil spills.	[Yang, Sizhong; Jin, Huijun; Wu, Qingbai] Chinese Acad Sci, State Key Lab Frozen Soil Engn SKLFSE, Cold & Arid Reg Environm & Engn Res Inst CAREERI, Lanzhou, Peoples R China; [Wen, Xi] NW Univ Nationalities, Coll Elect Engn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Yang, SZ (corresponding author), Chinese Acad Sci, State Key Lab Frozen Soil Engn SKLFSE, Cold & Arid Reg Environm & Engn Res Inst CAREERI, Lanzhou, Peoples R China.	yangsz@lzb.ac.cn		Yang, Sizhong/0000-0001-8417-593X	National Natural Science Foundation of China (NSFC) [20091044]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (NSFC) (Grant No. 20091044) (http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeckersberg F, 1998, ARCH MICROBIOL, V170, P361, DOI 10.1007/s002030050654; Aislabie J, 2001, POLAR BIOL, V24, P308, DOI 10.1007/s003000000210; Al Ming-qiang, 2010, Yingyong Shengtai Xuebao, V21, P1014; [Anonymous], BIOREMEDIATION PETRO; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Chakraborty R, 2004, APPL MICROBIOL BIOT, V64, P437, DOI 10.1007/s00253-003-1526-x; Chen H., 2012, VENNDIAGRAM GENERATE; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Det Norske Veritas (DNV), 2003, RUSS PIP OIL SPILL S; Gerdes B, 2005, FEMS MICROBIOL ECOL, V53, P129, DOI 10.1016/j.femsec.2004.11.010; Gilichinsky David, 2008, P83, DOI 10.1007/978-3-540-74335-4_6; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He ZG, 2003, PETROL SCI TECHNOL, V21, P201, DOI 10.1081/LFT-120016942; Huang LC, 2007, BIOMED ENVIRON SCI, V20, P414; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jin HJ, 2007, PERMAFROST PERIGLAC, V18, P245, DOI 10.1002/ppp.589; Jin HJ, 2010, COLD REG SCI TECHNOL, V64, P213, DOI 10.1016/j.coldregions.2009.12.003; Kolde R., 2013, PHEATMAP PRETTY HEAT; Li G, 2000, WATER RES, V34, P3845, DOI 10.1016/S0043-1354(00)00134-2; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li PJ, 2002, ENVIRON ENG SCI, V19, P277, DOI 10.1089/10928750260418926; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Liu YJ, 2009, ANAEROBE, V15, P214, DOI 10.1016/j.anaerobe.2009.03.007; Lo KV, 1998, ENVIRON TECHNOL, V19, P91, DOI 10.1080/09593331908616659; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Mohn WW, 2001, APPL MICROBIOL BIOT, V57, P242; Niu H.G., 1995, SWAMPS CHINA, P143; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Rike A. G., 2001, Polar Record, V37, P239; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Saul DJ, 2005, FEMS MICROBIOL ECOL, V53, P141, DOI 10.1016/j.femsec.2004.11.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Snape Ian, 2003, Polar Record, V39, P291, DOI 10.1017/S003224740300322X; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spormann AM, 2000, BIODEGRADATION, V11, P85, DOI 10.1023/A:1011122631799; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Tyagi M, 2011, BIODEGRADATION, V22, P231, DOI 10.1007/s10532-010-9394-4; Vishnivetskaya TA, 2006, ASTROBIOLOGY, V6, P400, DOI 10.1089/ast.2006.6.400; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang J, 2007, PETROL SCI, V4, P68, DOI 10.1007/s12182-007-0012-y; Jun W, 2008, WORLD J MICROB BIOT, V24, P1981, DOI 10.1007/s11274-008-9694-6; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/W11-004, 10.1139/w11-004]; Williams Peter A., 2008, P99; XUN LY, 1992, J BACTERIOL, V174, P2898, DOI 10.1128/JB.174.9.2898-2902.1992; Yang SZ, 2010, COLD REG SCI TECHNOL, V64, P271, DOI 10.1016/j.coldregions.2009.11.004; Ye SH, 2006, APPL MICROBIOL BIOT, V71, P543, DOI 10.1007/s00253-005-0165-9; Yu SL, 2011, J ENVIRON SCI, V23, P1533, DOI 10.1016/S1001-0742(10)60585-2; Zhang F, 2010, APPL MICROBIOL BIOT, V88, P1413, DOI 10.1007/s00253-010-2841-7; Zheng CG, 2011, BIORESOURCE TECHNOL, V102, P9155, DOI 10.1016/j.biortech.2011.06.074	52	27	35	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52730	10.1371/journal.pone.0052730	http://dx.doi.org/10.1371/journal.pone.0052730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300754	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800134
J	Volz, MS; Suarez-Contreras, V; Mendonca, ME; Pinheiro, FS; Merabet, LB; Fregni, F				Volz, Magdalena Sarah; Suarez-Contreras, Vanessa; Mendonca, Mariana E.; Pinheiro, Fernando Santos; Merabet, Lotfi B.; Fregni, Felipe			Effects of Sensory Behavioral Tasks on Pain Threshold and Cortical Excitability	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; ELECTRICAL NERVE-STIMULATION; PRIMARY SOMATOSENSORY CORTEX; MOTOR CORTEX; NEUROPATHIC PAIN; MACAQUE MONKEY; MEDIAL PAIN; SYSTEM; PLASTICITY	Background/Objective: Transcutaneous electrical stimulation has been proven to modulate nervous system activity, leading to changes in pain perception, via the peripheral sensory system, in a bottom up approach. We tested whether different sensory behavioral tasks induce significant effects in pain processing and whether these changes correlate with cortical plasticity. Methodology/Principal Findings: This randomized parallel designed experiment included forty healthy right-handed males. Three different somatosensory tasks, including learning tasks with and without visual feedback and simple somatosensory input, were tested on pressure pain threshold and motor cortex excitability using transcranial magnetic stimulation (TMS). Sensory tasks induced hand-specific pain modulation effects. They increased pain thresholds of the left hand ( which was the target to the sensory tasks) and decreased them in the right hand. TMS showed that somatosensory input decreased cortical excitability, as indexed by reduced MEP amplitudes and increased SICI. Although somatosensory tasks similarly altered pain thresholds and cortical excitability, there was no significant correlation between these variables and only the visual feedback task showed significant somatosensory learning. Conclusions/Significance: Lack of correlation between cortical excitability and pain thresholds and lack of differential effects across tasks, but significant changes in pain thresholds suggest that analgesic effects of somatosensory tasks are not primarily associated with motor cortical neural mechanisms, thus, suggesting that subcortical neural circuits and/or spinal cord are involved with the observed effects. Identifying the neural mechanisms of somatosensory stimulation on pain may open novel possibilities for combining different targeted therapies for pain control.	[Volz, Magdalena Sarah; Suarez-Contreras, Vanessa; Mendonca, Mariana E.; Pinheiro, Fernando Santos; Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat,Dept Phys Med & Rehabil, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Volz, Magdalena Sarah] Charite Univ Med Berlin, Charite Ctr Neurol Neurosurg & Psychiat, Berlin, Germany; [Merabet, Lotfi B.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Fregni, F (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat,Dept Phys Med & Rehabil, Boston, MA 02115 USA.	fregni.felipe@mgh.harvard.edu	Merabet, Lotfi B./V-2735-2017; merabet, lotfi/AAU-8259-2020	Merabet, Lotfi B./0000-0002-8094-9536; merabet, lotfi/0000-0002-8094-9536; Pruss, Magdalena Sarah/0000-0002-4522-7482; Fregni, Felipe/0000-0001-9359-8643	National Institutes of Health (NIH) grant [R21 DK081773-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081773] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health (NIH) grant (R21 DK081773-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Chesterton LS, 2002, PAIN, V99, P253, DOI 10.1016/S0304-3959(02)00118-5; DARIANSMITH C, 1993, J COMP NEUROL, V335, P200, DOI 10.1002/cne.903350205; DARIANSMITH C, 1993, J COMP NEUROL, V335, P173, DOI 10.1002/cne.903350204; Dietrich C, 2011, NEUROSCI LETT; Dionne JK, 2010, HUM BRAIN MAPP, V31, P14, DOI 10.1002/hbm.20841; Fischer AA, 1987, CLIN J PAIN, V2, P207; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Freitas C, 2011, FRONT AGING NEUROSCI, V3, DOI [10.3389/fnagi.2011.00005, 10.3389/fnagi.2011.00006]; Heed T, 2011, J EXP PSYCHOL HUM PE; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Johnson MI, 2011, EXPERT REV NEUROTHER, V11, P735, DOI [10.1586/ern.11.48, 10.1586/ERN.11.48]; Knudsen L, 2011, J PAIN, V12, P451, DOI 10.1016/j.jpain.2010.10.008; Lane JW, 2010, J NEUROSCI METH, V185, P221, DOI 10.1016/j.jneumeth.2009.09.025; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lefaucheur JP, 2008, CLIN NEUROPHYSIOL, V119, P2179, DOI 10.1016/j.clinph.2008.07.007; Lefaucheur JP, 2008, BRAIN STIMUL, V1, P337, DOI 10.1016/j.brs.2008.07.003; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Mulvey MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007264.pub2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reed JL, 2011, J NEUROSCI, V31, P3589, DOI 10.1523/JNEUROSCI.4310-10.2011; REEVES JL, 1986, PAIN, V24, P313, DOI 10.1016/0304-3959(86)90117-X; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sewards TV, 2002, BRAIN RES BULL, V58, P243, DOI 10.1016/S0361-9230(02)00783-9; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; van Vliet PM, 2006, MANUAL THER, V11, P208, DOI 10.1016/j.math.2006.03.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Volz MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034273; Wang L, 2006, CLIN NEUROPHYSIOL, V117, P1075, DOI 10.1016/j.clinph.2006.01.007; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14	42	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52968	10.1371/journal.pone.0052968	http://dx.doi.org/10.1371/journal.pone.0052968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301010	gold, Green Submitted, Green Published			2022-12-25	WOS:000313480000022
J	Lu, YN; Bhushan, S; Tchatalbachev, S; Marconi, M; Bergmann, M; Weidner, W; Chakraborty, T; Meinhardt, A				Lu, Yongning; Bhushan, Sudhanshu; Tchatalbachev, Svetlin; Marconi, Marcelo; Bergmann, Martin; Weidner, Wolfgang; Chakraborty, Trinad; Meinhardt, Andreas			Necrosis Is the Dominant Cell Death Pathway in Uropathogenic Escherichia coli Elicited Epididymo-Orchitis and Is Responsible for Damage of Rat Testis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; TOLL-LIKE RECEPTORS; REPRODUCTIVE-TRACT; MALE-INFERTILITY; MALE-FERTILITY; INFLAMMATION; HMGB1; APOPTOSIS; MEN; ACTIVATION	Male infertility is a frequent medical condition, compromising approximately one in twenty men, with infections of the reproductive tract constituting a major etiological factor. Bacterial epididymo-orchitis results in acute inflammation most often caused by ascending canalicular infections from the urethra via the continuous male excurrent ductal system. Uropathogenic Escherichia coli (UPEC) represent a relevant pathogen in urogenital tract infections. To explore how bacteria can cause damage and cell loss and thus impair fertility, an in vivo epididymo-orchitis model was employed in rats by injecting UPEC strain CFT073 into the vas deference in close proximity to the epididymis. Seven days post infection bacteria were found predominantly in the testicular interstitial space. UPEC infection resulted in severe impairment of spermatogenesis by germ cell loss, damage of testicular somatic cells, a decrease in sperm numbers and a significant increase in TUNEL (+) cells. Activation of caspase-8 (extrinsic apoptotic pathway), caspase-3/-6 (intrinsic apoptotic pathway), caspase-1 (pyroptosis pathway) and the presence of 180 bp DNA fragments, all of which serve as indicators of the classical apoptotic pathway, were not observed in infected testis. Notably, electron microscopical examination revealed degenerative features of Sertoli cells (SC) in UPEC infected testis. Furthermore, the passive release of high mobility group protein B1 (HMGB1), as an indication of necrosis, was observed in vivo in infected testis. Thus, necrosis appears to be the dominant cell death pathway in UPEC infected testis. Substantial necrotic changes seen in Sertoli cells will contribute to impaired spermatogenesis by loss of function in supporting the dependent germ cells.	[Lu, Yongning; Bhushan, Sudhanshu; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35390 Giessen, Germany; [Tchatalbachev, Svetlin; Chakraborty, Trinad] Univ Giessen, Dept Med Microbiol, D-35390 Giessen, Germany; [Marconi, Marcelo; Weidner, Wolfgang] Univ Giessen, Clin & Policlin Urol Pediat Urol & Androl, D-35390 Giessen, Germany; [Bergmann, Martin] Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35390 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	chakraborty, trinad/D-1812-2014		Deutsche Forschungsgemeinschaft [KFO 181/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 181/2) to AM and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bryniarski K, 2004, AM J REPROD IMMUNOL, V52, P27, DOI 10.1111/j.1600-0897.2004.00178.x; CHAPIN RE, 1983, EXP MOL PATHOL, V38, P149, DOI 10.1016/0014-4800(83)90082-5; Chassin C, 2008, J AM SOC NEPHROL, V19, P2364, DOI 10.1681/ASN.2007121273; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen M, 2004, J INFECT DIS, V190, P127, DOI 10.1086/421243; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Girling JE, 2007, IMMUNOL CELL BIOL, V85, P481, DOI 10.1038/sj.icb.7100086; Hedger MP, 2011, J REPROD IMMUNOL, V88, P130, DOI 10.1016/j.jri.2011.01.010; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Huyghe S, 2006, ENDOCRINOLOGY, V147, P2228, DOI 10.1210/en.2005-1571; Johnson JR, 2005, CLIN INFECT DIS, V40, P813, DOI 10.1086/428048; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Krieger JN, 2011, UROLOGY, V77, P1420, DOI 10.1016/j.urology.2010.12.059; Lamkanfi M, CELL HOST MICROBE, V8, P44; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Lipsky BA, 1999, AM J MED, V106, P327, DOI 10.1016/S0002-9343(99)00017-0; Ludwig M, 2002, BJU INT, V90, P933, DOI 10.1046/j.1464-410X.2002.03029.x; MERINO G, 1995, ARCH ANDROLOGY, V35, P43, DOI 10.3109/01485019508987852; Metukuri MR, 2010, INFLAMMATION, V33, P235, DOI 10.1007/s10753-009-9177-4; Nieschlag E, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P1, DOI 10.1007/978-3-540-78355-8; Palladino MA, 2007, BIOL REPROD, V76, P958, DOI 10.1095/biolreprod.106.059410; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perry SW, 1997, BIOTECHNIQUES, V22, P1102, DOI 10.2144/97226st01; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; Schuppe HC, 2008, BIOL MALE GERM CELLS; Wu C-X, 2011, J SURG RES; Wu CX, 2012, J SURG RES, V175, P88, DOI 10.1016/j.jss.2011.02.026; Zetterstrom CK, 2006, HUM REPROD, V21, P2801, DOI 10.1093/humrep/del256	38	40	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52919	10.1371/journal.pone.0052919	http://dx.doi.org/10.1371/journal.pone.0052919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301002	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900045
J	Martinez-Argudo, I; Veenendaal, AKJ; Liu, X; Roehrich, AD; Ronessen, MC; Franzoni, G; van Rietschoten, KN; Morimoto, YV; Saijo-Hamano, Y; Avison, MB; Studholme, DJ; Namba, K; Minamino, T; Blocker, AJ				Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Morimoto, Yusuke V.; Saijo-Hamano, Yumiko; Avison, Matthew B.; Studholme, David J.; Namba, Keiichi; Minamino, Tohru; Blocker, Ariel J.			Isolation of Salmonella Mutants Resistant to the Inhibitory Effect of Salicylidene acylhydrazides on Flagella-Mediated Motility	PLOS ONE			English	Article							III SECRETION SYSTEM; SMALL-MOLECULE INHIBITORS; TERMINAL CYTOPLASMIC DOMAIN; PROTEIN EXPORT APPARATUS; VIRULENCE FACTORS; ESCHERICHIA-COLI; BACTERIAL VIRULENCE; GENETIC-ANALYSIS; ATP SYNTHASE; FLII	Salicylidene acylhydrazides identified as inhibitors of virulence-mediating type III secretion systems (T3SSs) potentially target their inner membrane export apparatus. They also lead to inhibition of flagellar T3SS-mediated swimming motility in Salmonella enterica serovar. Typhimurium. We show that INP0404 and INP0405 act by reducing the number of flagella/cell. These molecules still inhibit motility of a Salmonella Delta fliH-fliI-fliJ/flhB((P28T)) strain, which lacks three soluble components of the flagellar T3S apparatus, suggesting that they are not the target of this drug family. We implemented a genetic screen to search for the inhibitors' molecular target(s) using motility assays in the Delta fliH-fliI/flhB((P28T)) background. Both mutants identified were more motile than the background strain in the absence of the drugs, although HM18 was considerably more so. HM18 was more motile than its parent strain in the presence of both drugs while DI15 was only insensitive to INP0405. HM18 was hypermotile due to hyperflagellation, whereas DI15 was not hyperflagellated. HM18 was also resistant to a growth defect induced by high concentrations of the drugs. Whole-genome resequencing of HM18 indicated two alterations within protein coding regions, including one within atpB, which encodes the inner membrane a-subunit of the FOF1-ATP synthase. Reverse genetics indicated that the alteration in atpB was responsible for all of HM18' s phenotypes. Genome sequencing of DI15 uncovered a single A562P mutation within a gene encoding the flagellar inner membrane protein FlhA, the direct role of which in mediating drug insensitivity could not be confirmed. We discuss the implications of these findings in terms of T3SS export apparatus function and drug target identification.	[Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Avison, Matthew B.; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Martinez-Argudo, Isabel; Veenendaal, Andreas K. J.; Liu, Xia; Roehrich, A. Dorothea; Ronessen, Maria C.; Franzoni, Giulia; van Rietschoten, Katerine N.; Avison, Matthew B.; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Veenendaal, Andreas K. J.; Blocker, Ariel J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Morimoto, Yusuke V.; Saijo-Hamano, Yumiko; Namba, Keiichi; Minamino, Tohru] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Studholme, David J.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Minamino, Tohru] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	University of Bristol; University of Bristol; University of Oxford; Osaka University; University of Exeter; Japan Science & Technology Agency (JST)	Blocker, AJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	ariel.blocker@bristol.ac.uk	Morimoto, Yusuke V./M-4022-2015; Blocker, Ariel/Q-6617-2016; Studholme, David/H-6790-2019; Namba, Keiichi/A-9406-2016; Martinez, Isabel/R-4803-2019; Franzoni, Giulia/AAY-1088-2020	Morimoto, Yusuke V./0000-0003-1573-8967; Studholme, David/0000-0002-3010-6637; Martinez, Isabel/0000-0001-5067-1791; Franzoni, Giulia/0000-0003-0987-3863; Avison, Matthew/0000-0003-1454-8440	Wellcome Trust [088266, 088231]; E.C. Marie Curie postdoctoral fellowship [MEIF-CT-2005-023694]; EMBO short-term fellowship [244-2007]; University of Bristol Centenary Postgraduate Studentship; MRC [G0701243, MR-J002097-1]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22570161, 23121516, 21227006]; Takeda Science Foundation; MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [G0701243, MR/J002097/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); E.C. Marie Curie postdoctoral fellowship; EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); University of Bristol Centenary Postgraduate Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	IMA and XL were supported by Wellcome Trust Project Grant 088266 to IMA and AJB. AKJV was funded by an E.C. Marie Curie postdoctoral fellowship (MEIF-CT-2005-023694) and an EMBO short-term fellowship (244-2007). XL was supported additionally by Wellcome Trust Project Grant 088231 to AJB and KN. DR was supported by a University of Bristol Centenary Postgraduate Studentship. This work was also supported in part by MRC project grants G0701243 and MR-J002097-1 to AJB and AJB and KN, respectively, and by Grants-in-Aid for Scientific Research (22570161 and 23121516 to TM, and 21227006 to KN) and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Takeda Science Foundation (to TM). YVM is a Research Fellow of the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Erhardt M, 2010, MOL MICROBIOL, V75, P376, DOI 10.1111/j.1365-2958.2009.06973.x; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Grier MC, 2010, BIOORG MED CHEM LETT, V20, P3380, DOI 10.1016/j.bmcl.2010.04.014; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Iwatsuki M, 2008, J ANTIBIOT, V61, P230, DOI 10.1038/ja.2008.33; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Kimura K, 2011, J ANTIBIOT, V64, P197, DOI 10.1038/ja.2010.155; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; KUTSUKAKE K, 1985, MOL GEN GENET, V199, P406, DOI 10.1007/BF00330750; Layton AN, 2010, FEMS MICROBIOL LETT, V302, P114, DOI 10.1111/j.1574-6968.2009.01847.x; Le Gall S, 2009, VET MICROBIOL, V137, P306, DOI 10.1016/j.vetmic.2009.01.023; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linington RG, 2006, J NAT PROD, V69, P173, DOI 10.1021/np050192h; Linington RG, 2002, ORG LETT, V4, P4089, DOI 10.1021/ol0268337; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Noda S, 2006, J BACTERIOL, V188, P6869, DOI 10.1128/JB.00452-06; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pan N, 2007, ADV EXP MED BIOL, V603, P367; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Wang D, 2011, J BIOL CHEM; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	69	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52179	10.1371/journal.pone.0052179	http://dx.doi.org/10.1371/journal.pone.0052179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300965	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900021
J	Schaefer, M; Konczak, F; Heinze, HJ; Rotte, M				Schaefer, Michael; Konczak, Franziska; Heinze, Hans-Jochen; Rotte, Michael			Referral of Touch and Ownership between the Hands and the Role of the Somatosensory Cortices	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; CORTEX; REPRESENTATION; REORGANIZATION; ACTIVATION; SENSATIONS; ILLUSION	Recent studies have shown that the feeling of body ownership can be fooled by simple visuo-tactile manipulations. Perceptual illusions have been reported in which participants sense phantom touch seen on a rubber hand (rubber hand illusion). While previous studies used homologous limbs for those experiments, we here examined an illusion where people feel phantom touch on a left rubber hand when they see it brushed simultaneously with brushes applied to their right hand. Thus, we investigated a referral of touch from the right to the left hand (across the body midline). Since it is known from animal studies that tactile illusions may alter early sensory processing, we expected a modulation of the primary somatosensory cortex (SI) corresponding to this illusion. Neuromagnetic source imaging of the functional topographic organization in SI showed a shift in left SI, associated with the strength of the referral of touch. Hence, we argue that SI seems to be closely associated with this perceptual illusion. The results suggest that the transfer of tactile information across the body midline could be mediated by neurons with bilateral tactile receptive fields (most likely BA2).	[Schaefer, Michael; Konczak, Franziska; Heinze, Hans-Jochen; Rotte, Michael] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany	Otto von Guericke University	Schaefer, M (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.	mischa@neuro2.med.uni-magdeburg.de			Deutsche Forschungsgemeinschaft [Scha105/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MS was supported by the Deutsche Forschungsgemeinschaft (Scha105/4-1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Braun C, 2002, NEUROIMAGE, V17, P1451, DOI 10.1006/nimg.2002.1277; Braun C, 2000, J NEUROSCI, V20, P446, DOI 10.1523/JNEUROSCI.20-01-00446.2000; Braun C, 2001, BRAIN, V124, P2259, DOI 10.1093/brain/124.11.2259; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Ebisch SJ, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI DOI 10.1162/J0CN.2008.20111; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Flor H, 2000, NEUROREPORT, V11, P1407, DOI 10.1097/00001756-200005150-00011; GALLEN CC, 1994, ELECTROEN CLIN NEURO, V90, P145, DOI 10.1016/0013-4694(94)90006-X; Grusser SM, 2004, EXP BRAIN RES, V154, P97, DOI 10.1007/s00221-003-1649-4; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Schaefer M, 2006, NEUROIMAGE, V29, P67, DOI 10.1016/j.neuroimage.2005.07.001; Schaefer M, 2004, BRAIN TOPOGR, V17, P47, DOI 10.1023/B:BRAT.0000047336.15770.86; Tastevin J, 1937, ENCEPHALE, V1, P57; YUMIYA H, 1984, EXP BRAIN RES, V53, P259	30	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52768	10.1371/journal.pone.0052768	http://dx.doi.org/10.1371/journal.pone.0052768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300992	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900039
J	Bin, Y; Ye, WH; Muller-Landau, HC; Wu, LF; Lian, JY; Cao, HL				Bin, Yue; Ye, Wanhui; Muller-Landau, Helene C.; Wu, Linfang; Lian, Juyu; Cao, Honglin			Unimodal Tree Size Distributions Possibly Result from Relatively Strong Conservatism in Intermediate Size Classes	PLOS ONE			English	Article							RAIN-FOREST TREES; SUBTROPICAL FOREST; METABOLIC ECOLOGY; TROPICAL FORESTS; POPULATION-LEVEL; SHADE TOLERANCE; GROWTH; MORTALITY; COMMUNITY; PLOT	Tree size distributions have long been of interest to ecologists and foresters because they reflect fundamental demographic processes. Previous studies have assumed that size distributions are often associated with population trends or with the degree of shade tolerance. We tested these associations for 31 tree species in a 20 ha plot in a Dinghushan south subtropical forest in China. These species varied widely in growth form and shade-tolerance. We used 2005 and 2010 census data from that plot. We found that 23 species had reversed J shaped size distributions, and eight species had unimodal size distributions in 2005. On average, modal species had lower recruitment rates than reversed J species, while showing no significant difference in mortality rates, per capita population growth rates or shade-tolerance. We compared the observed size distributions with the equilibrium distributions projected from observed size-dependent growth and mortality. We found that observed distributions generally had the same shape as predicted equilibrium distributions in both unimodal and reversed J species, but there were statistically significant, important quantitative differences between observed and projected equilibrium size distributions in most species, suggesting that these populations are not at equilibrium and that this forest is changing over time. Almost all modal species had U-shaped size-dependent mortality and/or growth functions, with turning points of both mortality and growth at intermediate size classes close to the peak in the size distribution. These results show that modal size distributions do not necessarily indicate either population decline or shade-intolerance. Instead, the modal species in our study were characterized by a life history strategy of relatively strong conservatism in an intermediate size class, leading to very low growth and mortality in that size class, and thus to a peak in the size distribution at intermediate sizes.	[Bin, Yue; Ye, Wanhui; Wu, Linfang; Lian, Juyu; Cao, Honglin] Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Muller-Landau, Helene C.] Smithsonian Trop Res Inst, Panama City, Panama	Chinese Academy of Sciences; South China Botanical Garden, CAS; Smithsonian Institution; Smithsonian Tropical Research Institute	Lian, JY (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	lianjy@scbg.ac.cn		Muller-Landau, Helene C./0000-0002-3526-9021	Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-EW-Z]; National Natural Science Foundation of China [31100312, 31011120470]; Chinese Forest Biodiversity Monitoring Network; US National Science Foundation [DEB-1046113]; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Forest Biodiversity Monitoring Network; US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-EW-Z), the National Natural Science Foundation of China (31100312) and Chinese Forest Biodiversity Monitoring Network. This manuscript is a product of the 2011 analytical workshop of the Center for Tropical Forest Science (CTFS) in Changbaishan, China, jointly funded by the US National Science Foundation (DEB-1046113) and the National Natural Science Foundation of China (31011120470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Y, 2012, EUR J FOREST RES, V131, P453, DOI 10.1007/s10342-011-0519-z; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; CONDIT R, 1993, FOREST ECOL MANAG, V62, P123, DOI 10.1016/0378-1127(93)90046-P; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Deb P, 2008, FOREST ECOL MANAG, V255, P3995, DOI 10.1016/j.foreco.2008.03.046; Doak DF, 1999, ECOLOGY, V80, P1537, DOI 10.2307/176545; Franklin J, 2003, NEW ZEAL J BOT, V41, P669, DOI 10.1080/0028825X.2003.9512877; George AK, 2005, RIVER RES APPL, V21, P271, DOI 10.1002/rra.846; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kohira M, 2003, FOREST ECOL MANAG, V174, P423, DOI 10.1016/S0378-1127(02)00076-2; KOHYAMA T, 1992, FUNCT ECOL, V6, P206, DOI 10.2307/2389756; KOHYAMA T, 1991, ANN BOT-LONDON, V68, P173, DOI 10.1093/oxfordjournals.aob.a088236; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; KOHYAMA T, 1994, J PLANT RES, V107, P107, DOI 10.1007/BF02344537; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; LEAK WB, 1975, ECOLOGY, V56, P1451, DOI 10.2307/1934714; Lin J, 2001, CAN J FOREST RES, V31, P345, DOI 10.1139/cjfr-31-2-345; McCarthy JW, 2006, SILVA FENN, V40, P209, DOI 10.14214/sf.339; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; North M, 2004, FOREST SCI, V50, P299; Peng S., 1998, ACTA PHYTOECOLOGICA, V22, P245; Poorter L, 1996, FOREST ECOL MANAG, V84, P61, DOI 10.1016/0378-1127(96)03736-X; Primack RB., 1995, PRIMER CONSERVATION; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; Wei P., 1998, CHINESE BIODIVERSITY, V6, P116; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005	38	23	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52596	10.1371/journal.pone.0052596	http://dx.doi.org/10.1371/journal.pone.0052596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300714	Green Published, gold			2022-12-25	WOS:000313872600020
J	Braun, N; Alscher, MD; Fritz, P; Latus, J; Edenhofer, I; Reimold, F; Alper, SL; Kimmel, M; Biegger, D; Lindenmeyer, M; Cohen, CD; Wuthrich, RP; Segerer, S				Braun, Niko; Alscher, M. Dominik; Fritz, Peter; Latus, Joerg; Edenhofer, Ilka; Reimold, Fabian; Alper, Seth L.; Kimmel, Martin; Biegger, Dagmar; Lindenmeyer, Maja; Cohen, Clemens D.; Wuethrich, Rudolf P.; Segerer, Stephan			The Spectrum of Podoplanin Expression in Encapsulating Peritoneal Sclerosis	PLOS ONE			English	Article							CELLS; INFLAMMATION	Encapsulating peritoneal sclerosis (EPS) is a life threatening complication of peritoneal dialysis (PD). Podoplanin is a glycoprotein expressed by mesothelial cells, lymphatic endothelial cells, and myofibroblasts in peritoneal biopsies from patients with EPS. To evaluate podoplanin as a marker of EPS we measured podoplanin mRNA and described the morphological patterns of podoplanin-positive cells in EPS. Included were 20 peritoneal biopsies from patients with the diagnosis of EPS (n = 5), patients on PD without signs of EPS (n = 5), and control patients (uremic patients not on PD, n = 5, non-uremic patients n = 5). EPS patient biopsies revealed significantly elevated levels of podoplanin mRNA (p < 0.05). In 24 peritoneal biopsies from patients with EPS, podoplanin and smooth muscle actin (SMA) were localized by immunohistochemistry. Four patterns of podoplanin distribution were distinguishable. The most common pattern (8 of 24) consisted of organized, longitudinal layers of podoplanin-positive cells and vessels in the fibrotic zone ("organized'' pattern). 7 of 24 biopsies demonstrated a diffuse distribution of podoplanin-positive cells, accompanied by occasional, dense clusters of podoplanin-positive cells. Five biopsies exhibited a mixed pattern, with some diffuse areas and some organized areas ("mixed"). These contained cuboidal podoplanin-positive cells within SMA-negative epithelial structures embedded in extracellular matrix. Less frequently observed was the complete absence of, or only focal accumulations of podoplanin-positive fibroblasts outside of lymphatic vessels (podoplanin "low'', 4 of 24 biopsies). Patients in this group exhibited a lower index of systemic inflammation and a longer symptomatic period than in EPS patients with biopsies of the "mixed" type (p < 0.05). In summary we confirm the increased expression of podoplanin in EPS, and distinguish EPS biopsies according to different podoplanin expression patterns which are associated with clinical parameters. Podoplanin might serve as a useful adjunct to the morphological workup of peritoneal biopsies.	[Braun, Niko; Alscher, M. Dominik; Latus, Joerg; Reimold, Fabian; Kimmel, Martin] Robert Bosch Krankenhaus, Dept Internal Med, Div Gen Internal Med & Nephrol, Stuttgart, Germany; [Alscher, M. Dominik; Fritz, Peter] Inst Digital Med, Stuttgart, Germany; [Fritz, Peter] Robert Bosch Krankenhaus, Div Pathol, Dept Diagnost Med, Stuttgart, Germany; [Edenhofer, Ilka; Lindenmeyer, Maja; Cohen, Clemens D.; Wuethrich, Rudolf P.; Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Edenhofer, Ilka; Segerer, Stephan] Univ Zurich, Inst Anat, Zurich, Switzerland; [Reimold, Fabian; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Nephrol,Dept Med, Boston, MA 02215 USA; [Biegger, Dagmar] Univ Tubingen, Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Lindenmeyer, Maja; Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich, Switzerland	Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus; University of Zurich; University Zurich Hospital; University of Zurich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eberhard Karls University of Tubingen; University of Zurich	Segerer, S (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	Stephan.segerer@usz.ch	Kimmel, Martin/AAM-2514-2021	Segerer, Stephan/0000-0002-1936-9719; Latus, Joerg/0000-0003-0584-4870; Alscher, Mark Dominik/0000-0002-9658-1211; Lindenmeyer, Maja/0000-0003-4162-9107	Baxter; Swiss National Science Foundation [SNF 32003B_129710]; Robert-Bosch Foundation; SNF [32-122439/1]; Harvard Digestive Diseases Center [DK34854]	Baxter; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Robert-Bosch Foundation; SNF; Harvard Digestive Diseases Center	SS is supported by a grant by Baxter and a grant by the Swiss National Science Foundation (SNF 32003B_129710); NB by the Robert-Bosch Foundation and a grant by Baxter, FR by the Robert-Bosch Foundation; CDC by SNF (32-122439/1); SLA by the Harvard Digestive Diseases Center (DK34854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher DM, 2007, AM J KIDNEY DIS, V49, P452, DOI 10.1053/j.ajkd.2006.11.040; Augustine T, 2009, NEPHRON CLIN PRACT, V111, pC149, DOI 10.1159/000191214; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown MC, 2009, CLIN J AM SOC NEPHRO; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Garosi G, 2001, J NEPHROL, V14, pS30; Heller F, 2007, AM J PATHOL, V170, P457, DOI 10.2353/ajpath.2007.060554; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Hou TZ, 2010, FEBS LETT, V584, P3955, DOI 10.1016/j.febslet.2010.07.053; Kalof AN, 2009, ADV ANAT PATHOL, V16, P62, DOI 10.1097/PAP.0b013e3181915e94; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Raica M, 2008, ANTICANCER RES, V28, P2997; Vlijm A, 2009, PERITON DIALYSIS INT, V29, P517; Yaginuma T, 2012, PERIT DIAL INT	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53382	10.1371/journal.pone.0053382	http://dx.doi.org/10.1371/journal.pone.0053382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300922	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000313872600093
J	Dai, LB; Zhou, SH; Ruan, LX; Zheng, ZJ				Dai, Li-Bo; Zhou, Shui-Hong; Ruan, Ling-Xiang; Zheng, Zhou-Jun			Correlation of Computed Tomography with Pathological Features in Angiomatous Nasal Polyps	PLOS ONE			English	Article							ANGIOFIBROMA; VARIANT; MRI; CT	Background: Angiomatous nasal polyps (ANPs), also known as angiectatic polyps, have rarely been reported in the literature. ANPs are characterized by extensive vascular proliferation and ectasia. ANPs can grow rapidly and exhibit aggressive clinical behavior that could simulate malignancy preoperatively, and they are easily confused with other diseases. In the present study, we analyzed the correlation between the computed tomography (CT) findings of nasal angiomatous polyps and their pathological features. Methods: We evaluated CT findings and pathological features of 31 surgically proven ANPs. Results: The study population included 16 males and 15 females aged between 27 and 81 years (mean age, 53.5 years). On CT, the masses were heterogeneous; they had a soft tissue density and filled the maxillary and/or nasal cavities. Calcifications were found in 2 of the 31 cases. The lesions showed a clear boundary (15/31). The low-density shading on CT was related to the inflammatory, necrotic, and cystic changes, and the high-density shading on CT was related to hemorrhagic areas of the mass. On contrast-enhanced CT, the center of the lesions was non-enhanced with peripheral intensification due to occlusion or compression of feeder vessels of the polyp center, and the inflammatory cells and neovascularization around the edge of the mass. The most common site of maxillary wall erosion was the medial wall (21/31), followed by the posterior lateral wall (3/31), upper wall (2/31), and septum (3/31). Of these, the nasal cavity and/or maxillary sinus were enlarged in 28 cases. These findings were associated with the chronic progress of nasal angiomatous changes. Conclusions: CT of ANPs may demonstrate benign bone changes associated with the lesions and may also reflect the fact that ANPs do not invade peripheral soft tissue. CT demonstrated these lesions consistently and provided information useful for surgical planning.	[Dai, Li-Bo; Zhou, Shui-Hong] Zhejiang Univ, Dept Otolaryngol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ruan, Ling-Xiang] Zhejiang Univ, Dept Radiol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Zhou-Jun] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, SH (corresponding author), Zhejiang Univ, Dept Otolaryngol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zhouyunzhoush@163.com						BATSAKIS JG, 1992, ANN OTO RHINOL LARYN, V101, P623, DOI 10.1177/000348949210100716; Ceylan A, 2007, B-ENT, V3, P145; De Vuysere S, 2001, EUR RADIOL, V11, P55, DOI 10.1007/s003300000565; Iwata N, 2002, AURIS NASUS LARYNX, V29, P335, DOI 10.1016/S0385-8146(02)00028-7; Lee DK, 2007, AM J NEURORADIOL, V28, P618; Lloyd G, 2000, J LARYNGOL OTOL, V114, P727; Mafee MF, 2006, CLIN REV ALLERG IMMU, V30, P165, DOI 10.1385/CRIAI:30:3:165; Onerci M, 2006, RHINOLOGY, V44, P39; Rudralingam M, 2002, BRIT J ORAL MAX SURG, V40, P504, DOI 10.1016/S0266-4356(02)00225-5; Ryan WR, 2011, LARYNGOSCOPE, V121, P674, DOI 10.1002/lary.21394; Sheahan P, 2005, EUR ARCH OTO-RHINO-L, V262, P225, DOI 10.1007/s00405-004-0779-z; SOM PM, 1982, RADIOLOGY, V144, P329, DOI 10.1148/radiology.144.2.6283593; Wang YZ, 2012, AM J NEURORADIOL, V33, P767, DOI 10.3174/ajnr.A2856; Yfantis HG, 2000, ARCH PATHOL LAB MED, V124, P406	14	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53306	10.1371/journal.pone.0053306	http://dx.doi.org/10.1371/journal.pone.0053306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300910	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600082
J	Evans, J; Hannan, NJ; Hincks, C; Rombauts, LJF; Salamonsen, LA				Evans, Jemma; Hannan, Natalie J.; Hincks, Cassandra; Rombauts, Luk J. F.; Salamonsen, Lois A.			Defective Soil for a Fertile Seed? Altered Endometrial Development Is Detrimental to Pregnancy Success	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; IN-VITRO FERTILIZATION; LOW-INTENSITY IVF; HUMAN CHORIONIC-GONADOTROPIN; OVARIAN STIMULATION; EMBRYO IMPLANTATION; OOCYTE RETRIEVAL; LUTEAL-PHASE; REPRODUCTIVE-BIOLOGY; PROGESTERONE RISE	Background: Synchronous development of the endometrium (to achieve a receptive state) and of the embryo is essential for successful implantation and ongoing pregnancy. Endometrial receptivity exists only for a finite time in a menstrual cycle and the endometrium is refractory to embryo implantation outside of this window. Administration of hormones to stimulate multifollicular development within the ovary, integral to the majority of assisted reproduction (ART) protocols, dramatically alters the hormonal milieu to which the endometrium is exposed versus normal menstrual cycles. Endometrial maturation may be profoundly affected by this altered endocrine environment. Aim: Compare endometrial histology in fertile women, fertile women undergoing hormonal stimulation for oocyte donation and infertile women undergoing fresh embryo transfers in an ART cycle with further comparisons between women who did or did not become pregnant. Examine the presence of leukocytes and markers of endometrial maturation. Methods: Endometrial histology was examined by hematoxylin and eosin staining with a semi quantitative scoring method developed to compare histological appearance of tissues. The presence of leukocytes and developmental markers was examined by immunohistochemistry and scored. Results: Endometrial histology was dramatically altered upon stimulation for ART. However, those women who became pregnant presented with significantly less alterations in histological endometrial maturation. Numbers and activation status of leukocyte populations were also altered within the endometria stimulated for ART, with neutrophils undergoing degranulation, usually observed only pre-menstrually. Conclusion: We propose that such developmental changes render the endometrium hostile to the embryo and that modifications to ART protocols should be considered to take account of the requirement for endometrial receptivity and hence increase pregnancy rates.	[Evans, Jemma; Hannan, Natalie J.; Hincks, Cassandra; Salamonsen, Lois A.] Univ Melbourne, Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Hannan, Natalie J.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Rombauts, Luk J. F.] Monash Univ, Melbourne, Vic 3004, Australia; [Rombauts, Luk J. F.] Monash IVF, Melbourne, Vic, Australia	Prince Henry's Institute of Medical Research; University of Melbourne; University of Melbourne; Monash University	Evans, J (corresponding author), Univ Melbourne, Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	jemma.evans@princehenrys.org	Salamonsen, Lois/J-9822-2019	evans, jemma/0000-0002-3300-8127; Salamonsen, Lois/0000-0003-0558-7325; Rombauts, Luk/0000-0003-2656-2792; Hannan, Natalie/0000-0001-8446-2250	Monash IVF; National Health and Medical Research Council (NHMRC) (Australia) [494802]; Victorian Government's Operational Infrastructure Support Program; NHMRC Postdoctoral Training Fellowship [628927]; NHMRC Fellowship [388901]	Monash IVF; National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Postdoctoral Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Monash IVF and National Health and Medical Research Council (NHMRC) (Australia): Project/Program Grant #494802 and by the Victorian Government's Operational Infrastructure Support Program. NJH was supported by NHMRC Postdoctoral Training Fellowship #628927, and LAS by NHMRC Fellowship #388901. Monash IVF partially funded this research and Luk JF Rombauts is a minority shareholder and company board member of Monash IVF. Luk JF Rombauts conducted human tissue collections and aided manuscript editing.	Boomsma CM, 2009, REPROD BIOMED ONLINE, V18, P85, DOI 10.1016/S1472-6483(10)60429-4; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; [CDC Prevention CfDCa], 2011, ASS REPR TECHN; Coutifaris C, 2004, FERTIL STERIL, V82, P1264, DOI 10.1016/j.fertnstert.2004.03.069; Deligdisch L, 2000, MODERN PATHOLOGY, V13, P10; DeLoia JA, 2002, FERTIL STERIL, V77, P548, DOI 10.1016/S0015-0282(01)03062-X; Devoto L, 1997, HUM REPROD, V12, P708, DOI 10.1093/humrep/12.4.708; Devroey P, 2004, TRENDS ENDOCRIN MET, V15, P84, DOI 10.1016/j.tem.2004.01.009; Fatemi HM, 2011, CURR PHARM BIOTECHNO; Fatemi HM, 2010, FERTIL STERIL, V94, P2054, DOI 10.1016/j.fertnstert.2009.11.036; Gleicher N, 2012, REPROD BIOMED ONLINE, V24, P396, DOI 10.1016/j.rbmo.2011.12.011; Gleicher N, 2011, REPROD BIOMED ONLINE, V23, P274, DOI 10.1016/j.rbmo.2011.05.018; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2011, EXPERT REV CLIN IMMU, V7, P789, DOI [10.1586/ECI.11.65, 10.1586/eci.11.65]; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Kolibianakis E, 2002, FERTIL STERIL, V78, P1025, DOI 10.1016/S0015-0282(02)03323-X; Kolibianakis Efstratios M, 2002, Reprod Biomed Online, V5 Suppl 1, P26; Kolibianakis EM, 2003, FERTIL STERIL, V80, P464, DOI 10.1016/S0015-0282(03)00663-0; Kolibianakis EM, 2005, HUM REPROD, V20, P2453, DOI 10.1093/humrep/dei069; Kolibianakis EM, 2011, CURR PHARM BIOTECHNO; Lessey BA, 2011, FERTIL STERIL, V96, P522, DOI 10.1016/j.fertnstert.2011.07.1095; Lukassen HGM, 2004, MOL HUM REPROD, V10, P513, DOI 10.1093/molehr/gah067; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; Murray MJ, 2004, FERTIL STERIL, V81, P1333, DOI 10.1016/j.fertnstert.2003.11.030; Navot D., 1991, ANN NY ACAD SCI, V622, P212, DOI 10.1111/j.1749-6632.1991.tb37864.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Paiva P, 2011, HUM REPROD, V26, P1153, DOI 10.1093/humrep/der027; Papanikolaou EG, 2005, HUM REPROD, V20, P1541, DOI 10.1093/humrep/deh793; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Pollard JW, 2008, J CLIN INVEST, V118, P3832, DOI 10.1172/JCI37733; Rackow BW, 2008, FERTIL STERIL, V89, P1234, DOI [10.1016/j.fertnstert.2007.04.060, 10.1016/j.fertnstert.2007.12.030]; Reshkin SJ, 1997, INT J ONCOL, V11, P603; Robertson SA, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.01039.x; Robker RL, 2011, J REPROD IMMUNOL, V88, P142, DOI 10.1016/j.jri.2011.01.008; Russell P, 2011, J REPROD IMMUNOL, V91, P90, DOI 10.1016/j.jri.2011.03.013; Salamonsen LA, 2000, HUM REPROD UPDATE, V6, P16, DOI 10.1093/humupd/6.1.16; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Scherjon S, 2011, PLACENTA, V32, pS291, DOI 10.1016/j.placenta.2011.03.014; Schulke L, 2008, HUM REPROD, V23, P1574, DOI 10.1093/humrep/den030; Seow KM, 2010, GYNECOL OBSTET INVES, V70, P64, DOI 10.1159/000290062; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; SIMS JA, 1994, HUM REPROD, V9, P235, DOI 10.1093/oxfordjournals.humrep.a138488; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Tavaniotou A, 2001, ANN NY ACAD SCI, V943, P55, DOI 10.1111/j.1749-6632.2001.tb03790.x; Ubaldi F, 1997, FERTIL STERIL, V67, P521, DOI 10.1016/S0015-0282(97)80080-5; URBANCSEK J, 1990, HUM REPROD, V5, P675, DOI 10.1093/oxfordjournals.humrep.a137166; van der Gaast MH, 2008, REPROD BIOMED ONLINE, V17, P553, DOI 10.1016/S1472-6483(10)60244-1; Van Vaerenbergh I, 2009, HUM REPROD, V24, P1085, DOI 10.1093/humrep/den501; Verberg MFG, 2009, HUM REPROD UPDATE, V15, P13, DOI 10.1093/humupd/dmn056; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wynn RM, 1989, BIOL UTERUS, P289; Zhang J, 2012, REPROD BIOMED ONLINE, V24, P254, DOI 10.1016/j.rbmo.2011.11.009	59	47	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53098	10.1371/journal.pone.0053098	http://dx.doi.org/10.1371/journal.pone.0053098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300868	gold, Green Published			2022-12-25	WOS:000313872600056
J	Orsomando, G; Cialabrini, L; Amici, A; Mazzola, F; Ruggieri, S; Conforti, L; Janeckova, L; Coleman, MP; Magni, G				Orsomando, Giuseppe; Cialabrini, Lucia; Amici, Adolfo; Mazzola, Francesca; Ruggieri, Silverio; Conforti, Laura; Janeckova, Lucie; Coleman, Michael P.; Magni, Giulio			Simultaneous Single-Sample Determination of NMNAT Isozyme Activities in Mouse Tissues	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; WALLERIAN DEGENERATION; NAD BIOSYNTHESIS; SUBCELLULAR COMPARTMENTATION; NMN/NAMN ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; AXON DEGENERATION; EXPRESSION; ENZYME; METABOLISM	A novel assay procedure has been developed to allow simultaneous activity discrimination in crude tissue extracts of the three known mammalian nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1) isozymes. These enzymes catalyse the same key reaction for NAD biosynthesis in different cellular compartments. The present method has been optimized for NMNAT isozymes derived from Mus musculus, a species often used as a model for NAD-biosynthesis-related physiology and disorders, such as peripheral neuropathies. Suitable assay conditions were initially assessed by exploiting the metal-ion dependence of each isozyme recombinantly expressed in bacteria, and further tested after mixing them in vitro. The variable contributions of the three individual isozymes to total NAD synthesis in the complex mixture was calculated by measuring reaction rates under three selected assay conditions, generating three linear simultaneous equations that can be solved by a substitution matrix calculation. Final assay validation was achieved in a tissue extract by comparing the activity and expression levels of individual isozymes, considering their distinctive catalytic efficiencies. Furthermore, considering the key role played by NMNAT activity in preserving axon integrity and physiological function, this assay procedure was applied to both liver and brain extracts from wild-type and Wallerian degeneration slow (Wld(S)) mouse. Wld(S) is a spontaneous mutation causing overexpression of NMNAT1 as a fusion protein, which protects injured axons through a gain-of-function. The results validate our method as a reliable determination of the contributions of the three isozymes to cellular NAD synthesis in different organelles and tissues, and in mutant animals such as Wld(S).	[Orsomando, Giuseppe; Cialabrini, Lucia; Amici, Adolfo; Mazzola, Francesca] Polytech Univ Marche, Dept Clin Sci DISCO, Biochem Sect, Ancona, Italy; [Ruggieri, Silverio] Polytech Univ Marche, Dept Agr Food & Environm Sci D3A, Ancona, Italy; [Conforti, Laura] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham, England; [Janeckova, Lucie; Coleman, Michael P.] Babraham Inst, Cambridge, England; [Magni, Giulio] Univ Camerino, Sch Biol & Biotechnol, I-62032 Camerino, MC, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Camerino	Orsomando, G (corresponding author), Polytech Univ Marche, Dept Clin Sci DISCO, Biochem Sect, Ancona, Italy.	g.orsomando@univpm.it; giulio.magni@unicam.it	Amici, Adolfo/C-5342-2012; Orsomando, Giuseppe/L-2120-2015; Mazzola, Francesca/ADC-1197-2022	Amici, Adolfo/0000-0002-1081-7749; Orsomando, Giuseppe/0000-0001-6640-097X; Mazzola, Francesca/0000-0001-9140-012X	Ricerca Scientifica di Ateneo - RSA; Medical Research Council [G10000702]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C200] Funding Source: researchfish	Ricerca Scientifica di Ateneo - RSA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by "Ricerca Scientifica di Ateneo - RSA 2009-2010'' (GO, AA and SR), the Medical Research Council grant G10000702 (MPC and GM), and a Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant (LC, MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Brunetti L, 2010, PROTEIN SCI, V19, P2440, DOI 10.1002/pro.526; Chen L, 2008, CURR MED CHEM, V15, P650; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 2005, J NEUROL SCI, V233, P133, DOI 10.1016/j.jns.2005.03.028; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hasmann M, 2003, CANCER RES, V63, P7436; HUGHES KT, 1983, J BACTERIOL, V155, P213, DOI 10.1128/JB.155.1.213-221.1983; Imai S, 2009, BBA-GEN SUBJECTS, V1790, P997, DOI 10.1016/j.bbagen.2009.03.005; Jayaram HN, 2011, CURR MED CHEM, V18, P1962; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; KORNBERG A, 1948, J BIOL CHEM, V176, P1475; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raches DW, 2011, MED CHEM, V7, P718; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Trench WF, 1972, MULTIVARIABLE CALCUL, P82; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang J, 2009, CELL ADHES MIGR, V3, P77, DOI 10.4161/cam.3.1.7483; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	44	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53271	10.1371/journal.pone.0053271	http://dx.doi.org/10.1371/journal.pone.0053271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300904	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600077
J	Liu, M; Lin, LS; Gao, TX; Yanagimoto, T; Sakurai, Y; Grant, WS				Liu, Ming; Lin, Longshan; Gao, Tianxiang; Yanagimoto, Takashi; Sakurai, Yasunori; Grant, W. Stewart			What Maintains the Central North Pacific Genetic Discontinuity in Pacific Herring?	PLOS ONE			English	Article							POPULATION-STRUCTURE; CLUPEA-PALLASII; MITOCHONDRIAL-DNA; CONTROL REGION; PLEISTOCENE; DIVERSITY; DIVERGENCE; SOFTWARE; SEA; DISPERSAL	Pacific herring show an abrupt genetic discontinuity in the central North Pacific that represents secondary contact between refuge populations previously isolated during Pleistocene glaciations. Paradoxically, high levels of gene flow produce genetic homogeneity among ocean-type populations within each group. Here, we surveyed variability in mtDNA control-region sequences (463 bp) and nine microsatellite loci in Pacific herring from sites across the North Pacific to further explore the nature of the genetic discontinuity around the Alaska Peninsula. Consistent with previous studies, little divergence (Phi(ST) = 0.011) was detected between ocean-type populations of Pacific herring in the North West Pacific, except for a population in the Yellow Sea (Phi(ST) = 0.065). A moderate reduction in genetic diversity for both mtDNA and microsatellites in the Yellow Sea likely reflects founder effects during the last colonization of this sea. Reciprocal monophyly between divergent mtDNA lineages (Phi(ST) = 0.391) across the Alaska Peninsula defines the discontinuity across the North Pacific. However, microsatellites did not show a strong break, as eastern Bering Sea (EBS) herring were more closely related to NE Pacific than to NW Pacific herring. This discordance between mtDNA and microsatellites may be due to microsatellite allelic convergence or to sex-biased dispersal across the secondary contact zone. The sharp discontinuity between Pacific herring populations may be maintained by high-density blocking, competitive exclusion or hybrid inferiority.	[Liu, Ming; Lin, Longshan; Gao, Tianxiang] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China; [Yanagimoto, Takashi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Sakurai, Yasunori] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Grant, W. Stewart] Alaska Dept Fish & Game, Anchorage, AK 99518 USA	Ocean University of China; Japan Fisheries Research & Education Agency (FRA); Hokkaido University; Alaska Department of Fish & Game	Gao, TX (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China.	gaozhang@ouc.edu.cn	Liu, Ming/ABC-8369-2020	Liu, Ming/0000-0002-6454-7297	Special Fund for Agro-scientific Research in the Public Interest [200903005]; National Natural Science Foundation of China [31061160187]; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 200903005), the National Natural Science Foundation of China (31061160187), and the Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike Shoichi, 2010, Scientific Reports of Hokkaido Fisheries Experimental Station, V77, P29; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beacham TD, 2008, T AM FISH SOC, V137, P1795, DOI 10.1577/T08-033.1; Binks RM, 2012, EVOLUTION, V66, P3545, DOI 10.1111/j.1558-5646.2012.01700.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gorbarenko SA, 2000, PALAEOGEOGR PALAEOCL, V156, P177, DOI 10.1016/S0031-0182(99)00137-6; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; GRANT WS, 1984, CAN J FISH AQUAT SCI, V41, P856, DOI 10.1139/f84-102; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; Hay DE, 2008, PROG OCEANOGR, V77, P233, DOI 10.1016/j.pocean.2008.03.015; HAY DE, 1985, CAN J FISH AQUAT SCI, V42, P111; Hotta T, 1999, NIPPON SUISAN GAKK, V65, P655; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiang X, 2008, J APPL ICHTHYOL, V24, P180, DOI 10.1111/j.1439-0426.2007.01016.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kanno Y., 1989, Bulletin of the Japanese Society of Scientific Fisheries, V55, P431; Kobayashi Tokimasa, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P1; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; Liu M, 2011, CHIN J OCEANOL LIMN, V29, P317, DOI 10.1007/s00343-011-0008-8; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; MANN DH, 1995, QUATERNARY SCI REV, V14, P449, DOI 10.1016/0277-3791(95)00016-I; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Nagasawa K, 2001, PROG OCEANOGR, V49, P551, DOI 10.1016/S0079-6611(01)00040-4; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; O'Connell M, 1998, J FISH BIOL, V53, P150; Olsen JB, 2002, MOL ECOL NOTES, V2, P101, DOI 10.1046/j.1471-8286.2002.00160.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; REEB CA, 1990, GENETICS, V124, P397; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANCETTA C, 1983, DEEP-SEA RES, V30, P851, DOI 10.1016/0198-0149(83)90004-3; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Small MP, 2005, T AM FISH SOC, V134, P1329, DOI 10.1577/T05-050.1; Springer SA, 2007, EVOLUTION, V61, P772, DOI 10.1111/j.1558-5646.2007.00073.x; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tojo N, 2007, DEEP-SEA RES PT II, V54, P2832, DOI 10.1016/j.dsr2.2007.07.032; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wildes SL, 2011, FISH B-NOAA, V109, P382; Yamane K, 2010, AQUAT BIOL, V10, P283, DOI 10.3354/ab00291; Yeh F.C., 1999, POPGENE VERSION 1 32; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zebdi Abdelkrim, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P277	63	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50340	10.1371/journal.pone.0050340	http://dx.doi.org/10.1371/journal.pone.0050340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300525	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500003
J	Blouin, Y; Hauck, Y; Soler, C; Fabre, M; Vong, R; Dehan, C; Cazajous, G; Massoure, PL; Kraemer, P; Jenkins, A; Garnotel, E; Pourcel, C; Vergnaud, G				Blouin, Yann; Hauck, Yolande; Soler, Charles; Fabre, Michel; Vong, Rithy; Dehan, Celine; Cazajous, Geraldine; Massoure, Pierre-Laurent; Kraemer, Philippe; Jenkins, Akinbowale; Garnotel, Eric; Pourcel, Christine; Vergnaud, Gilles			Significance of the Identification in the Horn of Africa of an Exceptionally Deep Branching Mycobacterium tuberculosis Clade	PLOS ONE			English	Article							LARGE SEQUENCE POLYMORPHISMS; DRUG SUSCEPTIBILITY PATTERN; GENETIC DIVERSITY; VARIABLE-NUMBER; POPULATION-STRUCTURE; COMPLEX; STRAINS; GENOME; DNA; EVOLUTION	Molecular and phylogeographic studies have led to the definition within the Mycobacterium tuberculosis complex (MTBC) of a number of geotypes and ecotypes showing a preferential geographic location or host preference. The MTBC is thought to have emerged in Africa, most likely the Horn of Africa, and to have spread worldwide with human migrations. Under this assumption, there is a possibility that unknown deep branching lineages are present in this region. We genotyped by spoligotyping and multiple locus variable number of tandem repeats (VNTR) analysis (MLVA) 435 MTBC isolates recovered from patients. Four hundred and eleven isolates were collected in the Republic of Djibouti over a 12 year period, with the other 24 isolates originating from neighbouring countries. All major M. tuberculosis lineages were identified, with only two M. africanum and one M. bovis isolates. Upon comparison with typing data of worldwide origin we observed that several isolates showed clustering characteristics compatible with new deep branching. Whole genome sequencing (WGS) of seven isolates and comparison with available WGS data from 38 genomes distributed in the different lineages confirms the identification of ancestral nodes for several clades and most importantly of one new lineage, here referred to as lineage 7. Investigation of specific deletions confirms the novelty of this lineage, and analysis of its precise phylogenetic position indicates that the other three superlineages constituting the MTBC emerged independently but within a relatively short timeframe from the Horn of Africa. The availability of such strains compared to the predominant lineages and sharing very ancient ancestry will open new avenues for identifying some of the genetic factors responsible for the success of the modern lineages. Additional deep branching lineages may be readily and efficiently identified by large-scale MLVA screening of isolates from sub-Saharan African countries followed by WGS analysis of a few selected isolates.	[Blouin, Yann; Hauck, Yolande; Pourcel, Christine; Vergnaud, Gilles] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Blouin, Yann; Hauck, Yolande; Pourcel, Christine; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Soler, Charles; Fabre, Michel; Vong, Rithy] Hop Instruct Armees Percy, Lab Biol Clin, Clamart, France; [Dehan, Celine; Cazajous, Geraldine] Hop Mil Bouffard, Djibouti, Djibouti; [Massoure, Pierre-Laurent; Kraemer, Philippe; Garnotel, Eric] Hop Instruct Armees Alphonse Laveran, Marseille, France; [Jenkins, Akinbowale] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Pretoria	Vergnaud, G (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	gilles.vergnaud@u-psud.fr	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Jenkins, Akinbowale/0000-0001-8107-3321	CNRS; Paris-Sud University; french military health services; french Direction Generale de l'Armement (DGA)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Paris-Sud University; french military health services; french Direction Generale de l'Armement (DGA)	The study was funded by CNRS, Paris-Sud University, the french military health services, and the french Direction Generale de l'Armement (DGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Asiimwe BB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-101; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Deshayes C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-78; Eldholm V, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-76; Eldin GSS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-219; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Ferdinand Severine, 2005, Infection Genetics and Evolution, V5, P340, DOI 10.1016/j.meegid.2004.10.002; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Godreuil S, 2009, CLIN MICROBIOL INFEC; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KAPUR V, 1994, J INFECT DIS, V170, P1348, DOI 10.1093/infdis/170.5.1348; Kibiki GS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-51; Koeck JL, 2010, CLIN MICROBIOL INFEC; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Ledru S, 1996, TUBERCLE LUNG DIS, V77, P429, DOI 10.1016/S0962-8479(96)90116-1; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Mays S, 2001, AM J PHYS ANTHROPOL, V114, P298, DOI 10.1002/ajpa.1042; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mulenga C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-177; Namouchi A, 2012, GENOME RES; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; Rothschild BM, 2001, CLIN INFECT DIS, V33, P305, DOI 10.1086/321886; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2011, INFECT GENET EVOL; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stavrum R, 2009, J CLIN MICROBIOL, V47, P1848, DOI 10.1128/JCM.02167-08; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taylor GM, 1999, MICROBIOL-UK, V145, P899, DOI 10.1099/13500872-145-4-899; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Veyrier FJ, 2011, TRENDS MICROBIOL, V19, P156, DOI 10.1016/j.tim.2010.12.008; Viana-Niero C, 2001, J CLIN MICROBIOL, V39, P57, DOI 10.1128/JCM.39.1.57-65.2001; Viegas SO, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-195; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038; Wilbur AK, 2009, J ARCHAEOL SCI, V36, P1990, DOI 10.1016/j.jas.2009.05.020; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003; Zumarraga M, 1999, MICROBIOL-SGM, V145, P893, DOI 10.1099/13500872-145-4-893	71	69	71	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52841	10.1371/journal.pone.0052841	http://dx.doi.org/10.1371/journal.pone.0052841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300794	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100085
J	Deogan, C; Ferguson, J; Stenberg, K				Deogan, Charlotte; Ferguson, Jane; Stenberg, Karin			Resource Needs for Adolescent Friendly Health Services: Estimates for 74 Low- and Middle-Income Countries	PLOS ONE			English	Article							YOUNG-PEOPLE; INJECT DRUGS; MORTALITY; DISEASE; HIV	Background: In order to achieve Millennium Development Goals 4, 5 and 6, it is essential to address adolescents' health. Objective: To estimate the additional resources required to scale up adolescent friendly health service interventions with the objective to reduce mortality and morbidity among individuals aged 10 to 19 years in 74 low-and middle-income countries. Methods: A costing model was developed to estimate the financial resources needed to scale-up delivery of a set of interventions including contraception, maternity care, management of sexually transmitted infections, HIV testing and counseling, safe abortion services, HIV harm reduction, HIV care and treatment and care of injuries due to intimate partner physical and sexual violence. Financial costs were estimated for each intervention, country and year using a bottom-up ingredients approach, defining costs at different levels of delivery (i.e., community, health centre, and hospital level). Programme activity costs to improve quality of care were also estimated, including activities undertaken at national-, district-and facility level in order to improve adolescents' use of health services (i.e., to render health services adolescent friendly). Results: Costs of achieving universal coverage are estimated at an additional US$ 15.41 billion for the period 2011-2015, increasing from US$ 1.86 billion in 2011 to US$ 4,31 billion in 2015. This corresponds to approximately US$ 1.02 per adolescent in 2011, increasing to 4.70 in 2015. On average, for all 74 countries, an annual additional expenditure per capita ranging from of US$ 0.38 in 2011 to US$ 0.82 in 2015, would be required to support the scale-up of key adolescent friendly health services. Conclusion: The estimated costs show a substantial investment gap and are indicative of the additional investments required to scale up health service delivery to adolescents towards universal coverage by 2015.	[Deogan, Charlotte] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ferguson, Jane] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Stenberg, Karin] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland	Karolinska Institutet; World Health Organization; World Health Organization	Deogan, C (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	charlotte.deogan@ki.se						Brown C., 2002, COST EFFECTIVENESS E, P139; Dumitru A., 2022, CONNECTING NATURE GU; Ebbeler J, 2009, FINANCIAL REQUIREMEN; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Haller DM, 2012, J ADOLESCENT HEALTH, V51, P422, DOI 10.1016/j.jadohealth.2012.01.019; Inst Med, 2009, ADOLESCENT HEALTH SERVICES: MISSING OPPORTUNITIES, P1; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Management Sciences for Health, 2004, INT DRUG PRIC GUID; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Ross D. A., 2006, WHO Technical Report Series; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Stenberg K, 2012, GLOB HEART, V7, P52, DOI 10.1016/j.gheart.2012.02.001; Taskforce-on-Innovative-International-Financing-for-Health-Systems, 2009, HIGH LEV TASKF INT I; Temin M., 2009, START GIRL NEW AGEND; UN Millennium Project, 2005, INV DEV PRACT PLAN A; UN Population Division, 2009, WORLD POP PROSP 2008; UNAIDS, 2007, FIN RES REQ ACH UN A; UNICEF, 2011, OPP CRIS PREV HIV EA; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; USAID UNAIDS WHO UNICEF, 2004, COV SEL SERV HIV AID; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; WHO, 2012, PREL RES MNCAH SURV; WHO, 2012, WHO ESTIMATES UNSAFE; WHO, 2008, OP GUID MAN OP DEP S; WHO, 2012, COUNTR SPEC EST OUTP; WHO, 2012, EST COSTS SCAL UP AD; WHO, 2012, MAK HLTH SERV AD FRI; WHO, 2011, GUID PREV PREGN POOR; WHO, 2004, SCAL ANT THER RES LI; WHO, 2011, YOUTH HLTH RISKS WHO; WHO, 2009, STRENGTHENING HLTH S; WHO, 2005, EST COST SCAL UP MAT; WHO Department of Child and Adolescent Health and Development, 2002, WHOFCHCAH0218 DEP CH; WHO UNICEF, 2010, COUNTD 2015 MAT NEWB; World Health Organization, 2010, ANT THER HIV INF AD; World Health Organization, 2006, CONS GUID US ANT DRU; World Health Organization, 2009, TECHN GUID COUNTR SE; World Health Organization, 2011, PREV INC SEL SEX TRA; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, WHO CHOICE	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51420	10.1371/journal.pone.0051420	http://dx.doi.org/10.1371/journal.pone.0051420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300548	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100008
J	Fitzpatrick, KE; Sellers, S; Spark, P; Kurinczuk, JJ; Brocklehurst, P; Knight, M				Fitzpatrick, Kathryn E.; Sellers, Susan; Spark, Patsy; Kurinczuk, Jennifer J.; Brocklehurst, Peter; Knight, Marian			Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study	PLOS ONE			English	Article							PREVIA-ACCRETA; PATHOLOGY; PREGNANCY; MORBIDITY	Background: Placenta accreta/increta/percreta is associated with major pregnancy complications and is thought to be becoming more common. The aims of this study were to estimate the incidence of placenta accreta/increta/percreta in the UK and to investigate and quantify the associated risk factors. Methods: A national case-control study using the UK Obstetric Surveillance System was undertaken, including 134 women diagnosed with placenta accreta/increta/percreta between May 2010 and April 2011 and 256 control women. Results: The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall; 577 per 10,000 in women with both a previous caesarean delivery and placenta praevia. Women who had a previous caesarean delivery (adjusted odds ratio (aOR) 14.41, 95%CI 5.63-36.85), other previous uterine surgery (aOR 3.40, 95%CI 1.30-8.91), an IVF pregnancy (aOR 32.13, 95%CI 2.03-509.23) and placenta praevia diagnosed antepartum (aOR 65.02, 95%CI 16.58-254.96) had raised odds of having placenta accreta/increta/percreta. There was also a raised odds of placenta accreta/increta/ percreta associated with older maternal age in women without a previous caesarean delivery (aOR 1.30, 95%CI 1.13-1.50 for every one year increase in age). Conclusions: Women with both a prior caesarean delivery and placenta praevia have a high incidence of placenta accreta/increta/percreta. There is a need to maintain a high index of suspicion of abnormal placental invasion in such women and preparations for delivery should be made accordingly.	[Fitzpatrick, Kathryn E.; Spark, Patsy; Kurinczuk, Jennifer J.; Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Sellers, Susan] Univ Hosp Bristol NHS Trust, Bristol, Avon, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London, England	University of Oxford; University of London; University College London	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.	kate.fitzpatrick@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575	National Institute for Health Research (NIHR) [RP-PG-0608-10038]; National Institute for Health Research [RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the "Beyond maternal death: Improving the quality of maternity care through national studies of "near-miss" maternal morbidity" programme (Programme Grant RP-PG-0608-10038). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Serehi A, 2008, J ULTRAS MED, V27, P1623, DOI 10.7863/jum.2008.27.11.1623; CLARK SL, 1985, OBSTET GYNECOL, V66, P89; Cook J, 2012, BJOG INT J OBSTET GY; Esh-Broder E, 2011, BJOG-INT J OBSTET GY, V118, P1084, DOI 10.1111/j.1471-0528.2011.02976.x; Garmi G, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/873929; General Register Office for Scotland, 2011, VIT EV REF TABL 2010; Gielchinsky Y, 2002, PLACENTA, V23, P210, DOI 10.1053/plac.2001.0764; Guise JM, 2010, VAGINAL BIRTH CESARE, P1; Hung TH, 1999, OBSTET GYNECOL, V93, P545, DOI 10.1016/S0029-7844(98)00460-8; Jacques SM, 1996, INT J GYNECOL PATHOL, V15, P28, DOI 10.1097/00004347-199601000-00005; JAMES WH, 1995, HUM REPROD, V10, P1403, DOI 10.1093/HUMREP/10.6.1403; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; Northern Ireland Statistics and Research Agency, 2011, REG GEN ANN REP 2010; Office for National Statistics, 2007, BRIT STAT REV REG GE; Office for National Statistics (ONS), 2021, BIRTH SUMM TABL ENGL; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; RCOG Clinical Effectiveness Support Unit, 2001, NAT SENT CAES SECT A; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Usta IM, 2005, AM J OBSTET GYNECOL, V193, P1045, DOI 10.1016/j.ajog.2005.06.037; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074; Zaki ZMS, 1998, ACTA OBSTET GYN SCAN, V77, P391, DOI 10.1034/j.1600-0412.1998.00015.x	25	216	231	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52893	10.1371/journal.pone.0052893	http://dx.doi.org/10.1371/journal.pone.0052893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300807	Green Published, gold			2022-12-25	WOS:000312829100091
J	Kuban-Jankowska, A; Tuszynski, JA; Winter, P; Gorska, M; Knap, N; Wozniak, M				Kuban-Jankowska, Alicja; Tuszynski, Jack A.; Winter, Philip; Gorska, Magdalena; Knap, Narcyz; Wozniak, Michal			Activation of Hydrogen Peroxide to Peroxytetradecanoic Acid Is Responsible for Potent Inhibition of Protein Tyrosine Phosphatase CD45	PLOS ONE			English	Article								Hydrogen peroxide induces oxidation and consequently inactivation of many protein tyrosine phosphatases. It was found that hydrogen peroxide, in the presence of carboxylic acids, was efficiently activated to form even more potent oxidant - peroxy acid. We have found that peroxytetradecanoic acid decreases the enzymatic activity of CD45 phosphatase significantly more than hydrogen peroxide. Our molecular docking computational analysis suggests that peroxytetradecanoic acid has a higher binding affinity to the catalytic center of CD45 than hydrogen peroxide.	[Kuban-Jankowska, Alicja; Gorska, Magdalena; Knap, Narcyz; Wozniak, Michal] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland; [Tuszynski, Jack A.; Winter, Philip] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Wozniak, Michal] Fac Gdynia, Coll Hlth Beauty Care & Educ Poznan, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk; University of Alberta	Kuban-Jankowska, A (corresponding author), Med Univ Gdansk, Dept Med Chem, Gdansk, Poland.	alicjakuban@gumed.edu.pl; mwozniak@gumed.edu.pl	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; gorska-ponikowska, magdalena/0000-0002-7366-8429; Wozniak, Michal/0000-0001-7083-6792; Knap, Narcyz/0000-0002-6162-3987	Polish National Science Center [N N401 029537]; NSERC (Canada); Allard Foundation; Canadian Breast Cancer Foundation	Polish National Science Center; NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Allard Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by Grant No. N N401 029537 from the Polish National Science Center. JAT acknowledges support from NSERC (Canada), the Allard Foundation, and the Canadian Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernhardt P, 2005, ANGEW CHEM INT EDIT, V44, P2742, DOI 10.1002/anie.200463006; Bhattacharya S, 2008, BIOORG MED CHEM LETT, V18, P5856, DOI 10.1016/j.bmcl.2008.06.029; BJORKLING F, 1992, TETRAHEDRON, V48, P4587, DOI 10.1016/S0040-4020(01)81232-1; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; de Dios I, 2006, J PATHOL, V210, P234, DOI 10.1002/path.2037; De Dios I, 2005, FEBS LETT, V579, P6355, DOI 10.1016/j.febslet.2005.10.017; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Klenk H., 2000, ULLMANNS ENCY IND CH, DOI [DOI 10.1002/14356007.A19_199, 10.1002/14356007.a19_199]; Kuban-Jankowska A, 2011, BIOCHEM BIOPH RES CO, V415, P270, DOI 10.1016/j.bbrc.2011.10.033; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; PARKER WE, 1955, J AM CHEM SOC, V77, P4037, DOI 10.1021/ja01620a023; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Rubio M, 2005, J MOL STRUC-THEOCHEM, V726, P261, DOI 10.1016/j.theochem.2005.02.076; Soulsby M, 2009, PHYSIOLOGY, V24, P281, DOI 10.1152/physiol.00017.2009; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52495	10.1371/journal.pone.0052495	http://dx.doi.org/10.1371/journal.pone.0052495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300686	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100054
J	Malisi, C; Schumann, M; Toussaint, NC; Kageyama, J; Kohlbacher, O; Hocker, B				Malisi, Christoph; Schumann, Marcel; Toussaint, Nora C.; Kageyama, Jorge; Kohlbacher, Oliver; Hoecker, Birte			Binding Pocket Optimization by Computational Protein Design	PLOS ONE			English	Article							LIGAND-BINDING; DOCKING; ALGORITHMS; PREDICTION; ACCURACY; REDESIGN; PROGRAMS; DATABASE	Engineering specific interactions between proteins and small molecules is extremely useful for biological studies, as these interactions are essential for molecular recognition. Furthermore, many biotechnological applications are made possible by such an engineering approach, ranging from biosensors to the design of custom enzyme catalysts. Here, we present a novel method for the computational design of protein-small ligand binding named POCKETOPTIMIZER. The program can be used to modify protein binding pocket residues to improve or establish binding of a small molecule. It is a modular pipeline based on a number of customizable molecular modeling tools to predict mutations that alter the affinity of a target protein to its ligand. At its heart it uses a receptor-ligand scoring function to estimate the binding free energy between protein and ligand. We compiled a benchmark set that we used to systematically assess the performance of our method. It consists of proteins for which mutational variants with different binding affinities for their ligands and experimentally determined structures exist. Within this test set POCKETOPTIMIZER correctly predicts the mutant with the higher affinity in about 69% of the cases. A detailed analysis of the results reveals that the strengths of POCKETOPTIMIZER lie in the correct introduction of stabilizing hydrogen bonds to the ligand, as well as in the improved geometric complemetarity between ligand and binding pocket. Apart from the novel method for binding pocket design we also introduce a much needed benchmark data set for the comparison of affinities of mutant binding pockets, and that we use to asses programs for in silico design of ligand binding.	[Malisi, Christoph; Kageyama, Jorge; Hoecker, Birte] Max Planck Inst Dev Biol, Tubingen, Germany; [Schumann, Marcel; Toussaint, Nora C.; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, Quantitat Biol Ctr, Tubingen, Germany; [Schumann, Marcel; Toussaint, Nora C.; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hocker, B (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	birte.hoecker@tuebingen.mpg.de	Kohlbacher, Oliver/B-7310-2008; Kohlbacher, Oliver/AAF-3297-2021	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Schumann, Marcel/0000-0002-9473-0156; Hocker, Birte/0000-0002-8250-9462; Toussaint, Nora/0000-0001-7911-7647	Deutsche Forschungsgemeinschaft [HO 4022/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 4022/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Benson DE, 2000, P NATL ACAD SCI USA, V97, P6292, DOI 10.1073/pnas.97.12.6292; Boas FE, 2008, J MOL BIOL, V380, P415, DOI 10.1016/j.jmb.2008.04.001; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; Frey KM, 2010, P NATL ACAD SCI USA, V107, P13707, DOI 10.1073/pnas.1002162107; Georgiev I, 2008, BIOINFORMATICS, V24, pI196, DOI 10.1093/bioinformatics/btn169; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hildebrandt A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-531; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; Morin A, 2011, PROTEIN ENG DES SEL, V24, P503, DOI 10.1093/protein/gzr006; Morin A, 2011, TRENDS BIOTECHNOL, V29, P159, DOI 10.1016/j.tibtech.2011.01.002; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Murphy PM, 2009, P NATL ACAD SCI US, V0, P00; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Schumann M, 2012, CADDSUITE 1 0; Shetty RP, 2003, PROTEIN ENG, V16, P963, DOI 10.1093/protein/gzg143; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vallee-Belisle A, 2010, CURR OPIN STRUC BIOL, V20, P518, DOI 10.1016/j.sbi.2010.05.001; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Weiss Y., 2008, P UAI, P503; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zavodszky MI, 2009, J MOL RECOGNIT, V22, P280, DOI 10.1002/jmr.942	46	29	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52505	10.1371/journal.pone.0052505	http://dx.doi.org/10.1371/journal.pone.0052505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300688	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100056
J	Mencacci, A; Leli, C; Cardaccia, A; Meucci, M; Moretti, A; D'Alo, F; Farinelli, S; Pagliochini, R; Barcaccia, M; Bistoni, F				Mencacci, Antonella; Leli, Christian; Cardaccia, Angela; Meucci, Marta; Moretti, Amedeo; D'Alo, Francesco; Farinelli, Senia; Pagliochini, Rita; Barcaccia, Mariella; Bistoni, Francesco			Procalcitonin Predicts Real-Time PCR Results in Blood Samples from Patients with Suspected Sepsis	PLOS ONE			English	Article							LIGHTCYCLER SEPTIFAST; STREAM INFECTION; RAPID DETECTION; DIAGNOSIS; MANAGEMENT; BACTERIAL; BACTEREMIA; CONTAMINATION; BIOMARKERS; PATHOGENS	Background: Early diagnosis and rapid bacterial identification are of primary importance for outcome of septic patients. SeptiFast (R) (SF) real-time PCR assay is of potential utility in the etiological diagnosis of sepsis, but it cannot replace blood culture (BC) for routine use in clinical laboratory. Procalcitonin (PCT) is a marker of sepsis and can predict bacteremia in septic patients. The aim of the present study was to investigate whether PCT serum levels could predict SF results, and could help screening febrile patients in which a SF assay can improve the etiological diagnosis of sepsis. Methods: From 1009 febrile patients with suspected sepsis, 1009 samples for BC, SF real-time PCR, and PCT determination were obtained simultaneously, and results were compared and statistically analysed. Receiver operating characteristic (ROC) curves were generated to determine the area under the curve and to identify which cut-off of PCT value produced the best sensitivity to detect SF results. Results: Mean PCT values of sera drawn simultaneously with samples SF positive (35.42 +/- 61.03 ng/ml) or BC positive (23.14 +/- 51.56 ng/ml) for a pathogen were statistically higher than those drawn simultaneously with SF negative (0.84 +/- 1.67 ng/ml) or BC negative (2.79 +/- 16.64 ng/ml) samples (p<0.0001). For SF, ROC analysis showed an area under the curve of 0.927 (95% confidence interval: 0.899-0.955, p<0.0001). The PCT cut-off value of 0.37 ng/ml showed a negative predictive value of 99%, reducing the number of SF assays of 53.9%, still identifying the 96.4% of the pathogens. Conclusion: PCT can be used in febrile patients with suspected sepsis to predict SF positive or negative results. A cut-off value of 0.37 ng/ml can be considered for optimal sensitivity, so that, in the routine laboratory activity, SF assay should not be used for diagnosis of sepsis in an unselected patient population with a PCT value <0.37 ng/ml.	[Mencacci, Antonella; Leli, Christian; Cardaccia, Angela; Meucci, Marta; Moretti, Amedeo; D'Alo, Francesco; Farinelli, Senia; Pagliochini, Rita; Barcaccia, Mariella; Bistoni, Francesco] Univ Perugia, Microbiol Sect, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Perugia	Mencacci, A (corresponding author), Univ Perugia, Microbiol Sect, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	mencacci@unipg.it	Leli, Christian/AAP-9337-2020	Leli, Christian/0000-0002-8689-7028; MENCACCI, ANTONELLA/0000-0001-9221-6172				Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bravo D, 2011, INT J INFECT DIS, V15, pE326, DOI 10.1016/j.ijid.2011.01.003; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Emonet S, 2011, EXPERT REV ANTI-INFE, V9, P707, DOI [10.1586/eri.11.84, 10.1586/ERI.11.84]; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hausfater P, 2010, CLIN CHEM LAB MED, V48, P501, DOI 10.1515/CCLM.2010.091; Kim MH, 2011, YONSEI MED J, V52, P276, DOI 10.3349/ymj.2011.52.2.276; Knudsen JB, 2010, AM J MED, V123, P1121, DOI 10.1016/j.amjmed.2010.07.018; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mencacci A, 2012, J MED MICROBIOL, V61, P881, DOI 10.1099/jmm.0.040113-0; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Muller B, 2001, SWISS MED WKLY, V131, P595; Obara H, 2011, J INFECT CHEMOTHER, V17, P327, DOI 10.1007/s10156-010-0168-z; Pasqualini L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; PLORDE JJ, 1985, J CLIN MICROBIOL, V22, P292, DOI 10.1128/JCM.22.2.292-295.1985; Riedel S, 2012, DIAGN MICR INFEC DIS, V73, P221, DOI 10.1016/j.diagmicrobio.2012.05.002; Sakr Y, 2008, INFECTION, V36, P396, DOI 10.1007/s15010-008-7374-Y; Schuetz P, 2007, INFECTION, V35, P352, DOI 10.1007/s15010-007-7065-0; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; Tromp M, 2012, J INFECTION, V65, P292, DOI 10.1016/j.jinf.2012.06.004; Vincent JL, 2008, LANGENBECK ARCH SURG, V393, P817, DOI 10.1007/s00423-008-0343-1; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003	35	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53279	10.1371/journal.pone.0053279	http://dx.doi.org/10.1371/journal.pone.0053279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300907	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100132
J	Brulle, L; Vandamme, M; Ries, D; Martel, E; Robert, E; Lerondel, S; Trichet, V; Richard, S; Pouvesle, JM; Le Pape, A				Brulle, Laura; Vandamme, Marc; Ries, Delphine; Martel, Eric; Robert, Eric; Lerondel, Stephanie; Trichet, Valerie; Richard, Serge; Pouvesle, Jean-Michel; Le Pape, Alain			Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model	PLOS ONE			English	Article							GROWTH-INHIBITION; CANCER; CELLS; RADIOSENSITIZATION; TOMOGRAPHY; EXPRESSION; HYPOXIA; TUMORS	Pancreatic tumors are the gastrointestinal cancer with the worst prognosis in humans and with a survival rate of 5% at 5 years. Nowadays, no chemotherapy has demonstrated efficacy in terms of survival for this cancer. Previous study focused on the development of a new therapy by non thermal plasma showed significant effects on tumor growth for colorectal carcinoma and glioblastoma. To allow targeted treatment, a fibered plasma (Plasma Gun) was developed and its evaluation was performed on an orthotopic mouse model of human pancreatic carcinoma using a MIA PaCa2-luc bioluminescent cell line. The aim of this study was to characterize this pancreatic carcinoma model and to determine the effects of Plasma Gun alone or in combination with gemcitabine. During a 36 days period, quantitative BLI could be used to follow the tumor progression and we demonstrated that plasma gun induced an inhibition of MIA PaCa2-luc cells proliferation in vitro and in vivo and that this effect could be improved by association with gemcitabine possibly thanks to its radiosensitizing properties.	[Brulle, Laura; Vandamme, Marc; Lerondel, Stephanie; Le Pape, Alain] UPS44 CNRS, Ctr Imagerie Petit Anim CIPA TAAM, Orleans, France; [Brulle, Laura; Martel, Eric; Richard, Serge] Ctr Rech Biol CERB, Baugy, France; [Vandamme, Marc; Ries, Delphine; Robert, Eric; Pouvesle, Jean-Michel] Univ Orleans, GREMI UMR CNRS 7344, Orleans, France; [Le Pape, Alain] Univ Tours, INSERM UMR1100 EA6305, CEPR, Tours, France; [Trichet, Valerie] Univ Nantes, Fac Med, INSERM, UMR957, Nantes, France; [Vandamme, Marc] GERMITEC SAS, Clichy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Brulle, L (corresponding author), UPS44 CNRS, Ctr Imagerie Petit Anim CIPA TAAM, Orleans, France.	laura.brulle@cnrs-orleans.fr	Trichet, Valérie/L-1553-2015; POUVESLE, Jean-Michel/L-2087-2018; robert, eric/E-7992-2019	Trichet, Valérie/0000-0003-4183-9032; POUVESLE, Jean-Michel/0000-0002-3236-0102; robert, eric/0000-0002-7894-7080	Region Centre (APR "PlasMed''); Germitec; Conseil Regional du Centre; CNRS; French 'Agence Nationale de la Recherche' [ANR 2010 BLAN 0930 01]	Region Centre (APR "PlasMed'')(Region Centre-Val de Loire); Germitec; Conseil Regional du Centre(Region Centre-Val de Loire); CNRS(Centre National de la Recherche Scientifique (CNRS)); French 'Agence Nationale de la Recherche'(French National Research Agency (ANR))	This work is supported by the Region Centre (APR "PlasMed''), Germitec, Conseil Regional du Centre, CNRS and also by French 'Agence Nationale de la Recherche' (program ANR 2010 BLAN 0930 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bornmann C, 2008, CANCER CHEMOTH PHARM, V61, P395, DOI 10.1007/s00280-007-0482-z; Bouvet M, 2009, MINERVA CHIR, V64, P521; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Buchs NC, 2011, J GASTROEN HEPATOL, V26, P657, DOI 10.1111/j.1440-1746.2010.06525.x; Cardillo TM, 2002, INT J CANCER, V97, P386, DOI 10.1002/ijc.1613; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Hessenius C, 2000, EUR J NUCL MED, V27, P1684, DOI 10.1007/s002590000325; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, APPL PHYS LETT, V96; Kim CH, 2010, J BIOTECHNOL; Kim JY, 2011, SMALL, V7, P2291, DOI 10.1002/smll.201100456; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Latz D, 1998, INT J RADIAT ONCOL, V41, P875, DOI 10.1016/S0360-3016(98)00105-9; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; Mees G, 2009, EUR J NUCL MED MOL I, V36, P1674, DOI 10.1007/s00259-009-1195-9; Milas L, 1999, CANCER RES, V59, P107; Okano K, 2011, WORLD J GASTROENTERO, V17, P231, DOI 10.3748/wjg.v17.i2.231; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Robert E, 2009, PLASMA PROCESS POLYM, V6, P795, DOI 10.1002/ppap.200900078; Rousseau J, 2010, CANCER GENE THER, V17, P387, DOI 10.1038/cgt.2009.89; Saif MW, 2011, J PANCREAS, V12, P306; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Vandamme M, 2011, PLASMA MED, V1, P27, DOI DOI 10.1615/PlasmaMed.v1.i1.30; Vandamme M, 2011, INT J CANC; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Varvarigou A, 2004, CANCER BIOTHER RADIO, V19, P219, DOI 10.1089/108497804323072002; Wescott MP, 2008, CANCER PREV RES, V1, P503, DOI 10.1158/1940-6207.CAPR-08-0195; Wilson KD, 2009, METHODS MOL BIOL, V574, P87, DOI 10.1007/978-1-60327-321-3_8; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; Yip-Schneider MT, 2001, J PHARMACOL EXP THER, V298, P976; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118; Zagon IS, 2005, CANCER CHEMOTH PHARM, V56, P510, DOI 10.1007/s00280-005-1028-x; Zhao H, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-15	44	176	179	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52653	10.1371/journal.pone.0052653	http://dx.doi.org/10.1371/journal.pone.0052653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300736	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800122
J	Gardill, BR; Vogl, MR; Lin, HY; Hammond, GL; Muller, YA				Gardill, Bernd R.; Vogl, Michael R.; Lin, Hai-Yan; Hammond, Geoffrey L.; Muller, Yves A.			Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences	PLOS ONE			English	Article							SERPIN CONFORMATIONAL-CHANGE; CORTISOL-BINDING; MECHANISM; VARIANT; SERUM; MUTATIONS; OVALBUMIN; TRANSPORT; SITE	Corticosteroid-binding globulin (CBG) transports glucocorticoids and progesterone in the blood and thereby modulates the tissue availability of these hormones. As a member of the serine protease inhibitor (SERPIN) family, CBG displays a reactive center loop (RCL) that is targeted by proteinases. Cleavage of the RCL is thought to trigger a SERPIN-typical stressed-to-relaxed (S-to-R) transition that leads to marked structural rearrangements and a reduced steroid-binding affinity. To characterize structure-function relationships in CBG we studied various conformational states of E. coli-produced rat and human CBG. In the 2.5 angstrom crystal structure of human CBG in complex with progesterone, the RCL is cleaved at a novel site that differs from the known human neutrophil elastase recognition site. Although the cleaved RCL segment is five residues longer than anticipated, it becomes an integral part of beta-sheet A as a result of the S-to-R transition. The atomic interactions observed between progesterone and CBG explain the lower affinity of progesterone in comparison to corticosteroids. Surprisingly, CD measurements in combination with thermal unfolding experiments show that rat CBG fails to undergo an S-to-R transition upon proteolytic cleavage of the RCL hinting that the S-to-R transition observed in human CBG is not a prerequisite for CBG function in rat. This observation cautions against drawing general conclusions about molecular mechanisms by comparing and merging structural data from different species.	[Gardill, Bernd R.; Vogl, Michael R.; Muller, Yves A.] Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, D-91054 Erlangen, Germany; [Lin, Hai-Yan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Hammond, Geoffrey L.] Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of Erlangen Nuremberg; Chinese Academy of Sciences; Institute of Zoology, CAS; Child & Family Research Institute; University of British Columbia	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, D-91054 Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016	Muller, Yves A/0000-0003-0519-8928; Hammond, Geoffrey/0000-0002-4639-7336	DFG [MU 1477/5]; BIGSS; BMBF [05-ES3XBA/5]	DFG(German Research Foundation (DFG)); BIGSS; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the DFG (MU 1477/5) and BIGSS. Synchrotron data collection was supported by a grant from the BMBF (05-ES3XBA/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier J, 1998, CRIT CARE MED, V26, P452, DOI 10.1097/00003246-199803000-00014; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; Delano WL., 2002, PYMOL MOL GRAPHICS S; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin HY, 2012, J CLIN ENDOCR METAB, V97, pE678, DOI 10.1210/jc.2011-3141; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LOMAS DA, 1995, J BIOL CHEM, V270, P5282, DOI 10.1074/jbc.270.10.5282; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICKELSON KE, 1981, BIOCHEMISTRY-US, V20, P6211, DOI 10.1021/bi00524a047; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2010, J CLIN ENDOCR METAB, V95, pE142, DOI 10.1210/jc.2010-0746; PUGEAT M, 1989, CLIN CHEM, V35, P1675; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumer-Bayraktar Z, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009100; Torpy DJ, 2012, J CLIN ENDOCR METAB, V97, pE151, DOI 10.1210/jc.2011-2022; Torpy DJ, 2001, J CLIN ENDOCR METAB, V86, P3692, DOI 10.1210/jc.86.8.3692; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; VANBAELEN H, 1982, J BIOL CHEM, V257, P3397; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; ZOUAGHI H, 1985, EUR J CLIN INVEST, V15, P365, DOI 10.1111/j.1365-2362.1985.tb00286.x	50	39	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52759	10.1371/journal.pone.0052759	http://dx.doi.org/10.1371/journal.pone.0052759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300763	Green Published, gold			2022-12-25	WOS:000313618800139
J	Guo, YF; Fan, Y; Qiu, JX; Liu, Y; Gao, JW; Guo, F				Guo, Yifeng; Fan, Yu; Qiu, Jianxin; Liu, Yong; Gao, Junwei; Guo, Fang			Polymorphisms in CTLA4 Influence Incidence of Drug-Induced Liver Injury after Renal Transplantation in Chinese Recipients	PLOS ONE			English	Article							ACUTE REJECTION; KIDNEY-TRANSPLANTATION; ANTIGEN-4 INFLUENCE; GENE POLYMORPHISMS; PROMOTER REGION; ASSOCIATION; DISEASE; SUSCEPTIBILITY; DETERMINANT; GENOTYPE	Genetic polymorphisms in cytotoxic T lymphocyte-associated antigen 4 (CTLA4) play an influential role in graft rejection and the long-term clinical outcome of organ transplantation. We investigated the association of 5 CTLA4 single-nucleotide polymorphisms (SNPs) (rs733618 C/T, rs4553808 A/G, rs5742909 C/T, rs231775 A/G, and rs3087243 G/A) with drug-induced liver injury (DILI) in Chinese renal transplantation (RT) recipients. Each recipient underwent a 24-month follow-up observation for drug-induced liver damage. The CTLA4 SNPs were genotyped in 864 renal transplantation recipients. A significant association was found between the rs231775 genotype and an early onset of DILI in the recipients. Multivariate analyses revealed that a risk factor, recipient rs231775 genotype (p = 0.040), was associated with DILI. Five haplotypes were estimated for 4 SNPs (excluding rs733618); the frequency of haplotype ACGG was significantly higher in the DILI group (68.9%) than in the non-DILI group (61.1%) (p = 0.041). In conclusion, CTLA4 haplotype ACGG was partially associated with the development of DILI in Chinese kidney transplant recipients. The rs231775 GG genotype may be a risk factor for immunosuppressive drug-induced liver damage.	[Guo, Yifeng; Fan, Yu; Qiu, Jianxin; Liu, Yong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China; [Gao, Junwei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Pharm, Shanghai 200030, Peoples R China; [Guo, Fang] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Nanomed & Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Guo, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China.	gyfslm@gmail.com; guof@sari.ac.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	National Natural Science Foundation of China [30971137, 31171308]; Chinese Postdoctoral Science Foundation [2003033271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The project was supported by the National Natural Science Foundation of China (30971137 and 31171308) and grants from the Chinese Postdoctoral Science Foundation (2003033271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouqbis L, 2003, GENES IMMUN, V4, P132, DOI 10.1038/sj.gene.6363933; Daly AK, 2009, SEMIN LIVER DIS, V29, P400, DOI 10.1055/s-0029-1240009; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; de Reuver P, 2003, AM J TRANSPLANT, V3, P1587, DOI 10.1046/j.1600-6135.2003.00261.x; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Gao JW, 2012, TRANSPL IMMUNOL, V26, P207, DOI 10.1016/j.trim.2012.02.005; Gorgi Y, 2006, TRANSPLANT P, V38, P2303, DOI 10.1016/j.transproceed.2006.06.132; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Hurst FP, 2011, TRANSPLANTATION, V92, P36, DOI 10.1097/TP.0b013e31821c1e70; Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895; Kanno Yukiko, 2006, Fukushima J Med Sci, V52, P79; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kulak CA, 2012, OSTEOPOROSIS TRANSPL, V10, P48; Kupeli E, 2011, TRANSPL P, V43, P551, DOI 10.1016/j.transproceed.2011.01.063; Kusztal M, 2010, TRANSPL IMMUNOL, V23, P121, DOI 10.1016/j.trim.2010.05.002; Lee CS, 2003, CLIN RHEUMATOL, V22, P221, DOI 10.1007/s10067-003-0720-7; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e; Maria VAJ, 1997, HEPATOLOGY, V26, P664, DOI 10.1053/jhep.1997.v26.pm0009303497; Navarro V, 2010, HEPATIC ADVERSE EVEN; Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Rezzani R, 2004, PROG HISTOCHEM CYTO, V39, P85, DOI 10.1016/j.proghi.2004.04.001; Tapirdamaz O, 2006, GUT, V55, P863, DOI 10.1136/gut.2005.080937; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valenti L, 2004, ALCOHOL ALCOHOLISM, V39, P276, DOI 10.1093/alcalc/agh047; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu J, 2009, CLIN CHIM ACTA, V403, P229, DOI 10.1016/j.cca.2009.03.037	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51723	10.1371/journal.pone.0051723	http://dx.doi.org/10.1371/journal.pone.0051723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300559	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800014
J	Price, ME; Pound, N; Dunn, J; Hopkins, S; Kang, JS				Price, Michael E.; Pound, Nicholas; Dunn, James; Hopkins, Sian; Kang, Jinsheng			Body Shape Preferences: Associations with Rater Body Shape and Sociosexuality	PLOS ONE			English	Article							FEMALE PHYSICAL ATTRACTIVENESS; PREDICTS WOMENS PREFERENCES; WAIST-HIP RATIO; SEXUAL-DIMORPHISM; EVOLUTIONARY PSYCHOLOGY; VISUAL-PERCEPTION; MATE CHOICE; MALE FACES; STRATEGIES; CONTEXT	There is accumulating evidence of condition-dependent mate choice in many species, that is, individual preferences varying in strength according to the condition of the chooser. In humans, for example, people with more attractive faces/bodies, and who are higher in sociosexuality, exhibit stronger preferences for attractive traits in opposite-sex faces/bodies. However, previous studies have tended to use only relatively simple, isolated measures of rater attractiveness. Here we use 3D body scanning technology to examine associations between strength of rater preferences for attractive traits in opposite-sex bodies, and raters' body shape, self-perceived attractiveness, and sociosexuality. For 118 raters and 80 stimuli models, we used a 3D scanner to extract body measurements associated with attractiveness (male waist-chest ratio [WCR], female waist-hip ratio [WHR], and volume-height index [VHI] in both sexes) and also measured rater self-perceived attractiveness and sociosexuality. As expected, WHR and VHI were important predictors of female body attractiveness, while WCR and VHI were important predictors of male body attractiveness. Results indicated that male rater sociosexuality scores were positively associated with strength of preference for attractive (low) VHI and attractive (low) WHR in female bodies. Moreover, male rater self-perceived attractiveness was positively associated with strength of preference for low VHI in female bodies. The only evidence of condition-dependent preferences in females was a positive association between attractive VHI in female raters and preferences for attractive (low) WCR in male bodies. No other significant associations were observed in either sex between aspects of rater body shape and strength of preferences for attractive opposite-sex body traits. These results suggest that among male raters, rater self-perceived attractiveness and sociosexuality are important predictors of preference strength for attractive opposite-sex body shapes, and that rater body traits -with the exception of VHI in female raters-may not be good predictors of these preferences in either sex.	[Price, Michael E.; Pound, Nicholas; Dunn, James; Hopkins, Sian] Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Kang, Jinsheng] Brunel Univ, Sch Engn & Design, Uxbridge UB8 3PH, Middx, England	Brunel University; Brunel University	Price, ME (corresponding author), Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England.	michael.price@brunel.ac.uk	Pound, Nicholas/B-5453-2008	Pound, Nicholas/0000-0003-2170-9943; Kang, Jinsheng/0000-0002-0050-1062; Price, Michael/0000-0002-2572-4326	Brunel University School of Social Sciences	Brunel University School of Social Sciences	Funding was provided by the Brunel University School of Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; BURLEY N, 1983, ETHOL SOCIOBIOL, V4, P191, DOI 10.1016/0162-3095(83)90009-2; Burriss RP, 2011, PERS INDIV DIFFER, V50, P542, DOI 10.1016/j.paid.2010.11.022; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buunk BP, 2005, PERS INDIV DIFFER, V39, P379, DOI 10.1016/j.paid.2005.01.020; Cicchetti DV, 1981, AM J MENTAL DEFICIEN, V86; Confer JC, 2010, EVOL HUM BEHAV, V31, P348, DOI 10.1016/j.evolhumbehav.2010.04.002; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; Darwin G., 1871, P423; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Fan JT, 2007, PERCEPT MOTOR SKILL, V105, P117, DOI 10.2466/PMS.105.1.117-132; Fan JT, 2005, P ROY SOC B-BIOL SCI, V272, P219, DOI 10.1098/rspb.2004.2922; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; Fawcett TW, 2003, BEHAV ECOL, V14, P771, DOI 10.1093/beheco/arg075; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Fink B, 2002, CURR DIR PSYCHOL SCI, V11, P154, DOI 10.1111/1467-8721.00190; Furnham A, 2006, PERS INDIV DIFFER, V41, P443, DOI 10.1016/j.paid.2006.02.007; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; HORVATH T, 1979, SOC BEHAV PERSONAL, V7, P145, DOI 10.2224/sbp.1979.7.2.145; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jones BC, 2005, EVOL HUM BEHAV, V26, P451, DOI 10.1016/j.evolhumbehav.2005.05.001; KALICK SM, 1986, J PERS SOC PSYCHOL, V51, P673, DOI 10.1037/0022-3514.51.4.673; Lassek WD, 2008, EVOL HUM BEHAV, V29, P26, DOI 10.1016/j.evolhumbehav.2007.07.005; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lee L, 2008, PSYCHOL SCI, V19, P669, DOI 10.1111/j.1467-9280.2008.02141.x; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2008, EVOL HUM BEHAV, V29, P140, DOI 10.1016/j.evolhumbehav.2007.11.007; Little AC, 2011, BEHAV ECOL, V22, P862, DOI 10.1093/beheco/arr061; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Norman P. Li, 2007, [心理学报, Acta Psychologica Sinica], V39, P528; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; POMIANKOWSKI A, 1987, J THEOR BIOL, V128, P195, DOI 10.1016/S0022-5193(87)80169-8; Provost MP, 2006, ARCH SEX BEHAV, V35, P305, DOI 10.1007/s10508-006-9029-3; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Riebel Katharina, 2010, Communicative & Integrative Biology, V3, P271; Sacco DF, 2009, PERS INDIV DIFFER, V47, P777, DOI 10.1016/j.paid.2009.06.021; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; Smith FG, 2009, PERS INDIV DIFFER, V47, P476, DOI 10.1016/j.paid.2009.04.022; Swami V, 2007, J SOC PSYCHOL, V147, P15, DOI 10.3200/SOCP.147.1.15-26; Swami V, 2008, PERS INDIV DIFFER, V44, P98, DOI 10.1016/j.paid.2007.07.017; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; TC2 - Textile/Clothing Technology Corporation, 2010, 3D BOD SCANN SPEC; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; Waynforth D, 2005, EVOL HUM BEHAV, V26, P409, DOI 10.1016/j.evolhumbehav.2005.03.003; Welling LLM, 2008, HORM BEHAV, V54, P703, DOI 10.1016/j.yhbeh.2008.07.012	64	23	24	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52532	10.1371/journal.pone.0052532	http://dx.doi.org/10.1371/journal.pone.0052532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23300976	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900028
J	Alves, GS; O'Dwyer, L; Jurcoane, A; Oertel-Knochel, V; Knochel, C; Prvulovic, D; Sudo, F; Alves, CE; Valente, L; Moreira, D; Fusser, F; Karakaya, T; Pantel, J; Engelhardt, E; Laks, J				Alves, Gilberto Sousa; O'Dwyer, Laurence; Jurcoane, Alina; Oertel-Knoechel, Viola; Knoechel, Christian; Prvulovic, David; Sudo, Felipe; Alves, Carlos Eduardo; Valente, Letice; Moreira, Denise; Fusser, Fabian; Karakaya, Tarik; Pantel, Johannes; Engelhardt, Eliasz; Laks, Jerson			Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients	PLOS ONE			English	Article							RAT SPINAL-CORD; SPATIAL STATISTICS; CORPUS-CALLOSUM; TENSOR TRACTOGRAPHY; UNCINATE FASCICULUS; WALLERIAN DEGENERATION; VOXELWISE ANALYSIS; AXONAL DAMAGE; BRAIN IMAGES; DISEASE	Alzheimers disease (AD) represents the most prevalent neurodegenerative disorder that causes cognitive decline in old age. In its early stages, AD is associated with microstructural abnormalities in white matter (WM). In the current study, multiple indices of diffusion tensor imaging (DTI) and brain volumetric measurements were employed to comprehensively investigate the landscape of AD pathology. The sample comprised 58 individuals including cognitively normal subjects (controls), amnestic mild cognitive impairment (MCI) and AD patients. Relative to controls, both MCI and AD subjects showed widespread changes of anisotropic fraction (FA) in the corpus callosum, cingulate and uncinate fasciculus. Mean diffusivity and radial changes were also observed in AD patients in comparison with controls. After controlling for the gray matter atrophy the number of regions of significantly lower FA in AD patients relative to controls was decreased; nonetheless, unique areas of microstructural damage remained, e. g., the corpus callosum and uncinate fasciculus. Despite sample size limitations, the current results suggest that a combination of secondary and primary degeneration occurrs in MCI and AD, although the secondary degeneration appears to have a more critical role during the stages of disease involving dementia.	[Alves, Gilberto Sousa; Sudo, Felipe; Alves, Carlos Eduardo; Valente, Letice; Engelhardt, Eliasz; Laks, Jerson] Univ Fed Rio de Janeiro, Inst Psychiat, Alzheimers Dis Ctr, BR-21941 Rio De Janeiro, Brazil; [Engelhardt, Eliasz] Univ Fed Rio de Janeiro, Inst Neurol, Cognit & Behav Neurol Unit, BR-21941 Rio De Janeiro, Brazil; [Moreira, Denise] Univ Fed Rio de Janeiro, Procardiaco Hosp, Inst Neurol Deolindo Couto, Serv Radiol, BR-21941 Rio De Janeiro, Brazil; [Alves, Gilberto Sousa; O'Dwyer, Laurence; Oertel-Knoechel, Viola; Knoechel, Christian; Prvulovic, David; Fusser, Fabian; Karakaya, Tarik] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany; [Moreira, Denise] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany; [Pantel, Johannes] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Alves, GS (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Alzheimers Dis Ctr, BR-21941 Rio De Janeiro, Brazil.	gsalves123@hotmail.com	Sudo, Felipe Kenji/P-3090-2016; Alves, Gilberto S./J-9515-2012; Pantel, Johannes/ABC-6341-2020; Jurcoane, Alina/E-7982-2010	Sudo, Felipe Kenji/0000-0003-4738-1368; Alves, Gilberto S./0000-0002-0463-6183; Jurcoane, Alina/0000-0001-5571-9635	Fundacao Universitaria Jose Bonifacio [11112-4]; Brazilian National Council of Research (CNPq); CNPq in exchange cooperation program [290012/2009-0]; Deutscher Akademischer Austauschdienst (DAAD)	Fundacao Universitaria Jose Bonifacio; Brazilian National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq in exchange cooperation program(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Fundacao Universitaria Jose Bonifacio (Nr. 11112-4). Dr. Jerson Laks received funding as a researcher 2 from the Brazilian National Council of Research (CNPq). Dr. Gilberto Sousa Alves was also supported from the CNPq in exchange cooperation program (Nr. 290012/2009-0) with the Deutscher Akademischer Austauschdienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Berlow YA, 2010, INT J GERIATR PSYCH, V25, P780, DOI 10.1002/gps.2418; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Chavez S, 2009, MAGN RESON MED, V62, P510, DOI 10.1002/mrm.22019; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Cole M, 1964, ARCH NEUROL-CHICAGO, V11, DOI [10.1001/archneur.1964.00460240114017, DOI 10.1001/ARCHNEUR.1964.00460240114017]; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frisoni GB, 2007, NAT CLIN PRACT NEURO, V3, P620, DOI 10.1038/ncpneuro0638; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Moreira IDH, 2009, CAD SAUDE PUBLICA, V25, P1774, DOI 10.1590/S0102-311X2009000800013; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Ito S, 2008, CURR MED IMAGING REV, V4, P226, DOI 10.2174/157340508786404116; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; O'Dwyer L, 2011, PLOS ONE, V6, DOI [10.1371/journal.-pone.0021745, DOI 10.1371/JOURNAL.-PONE.0021745]; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reisberg B, 1999, EUR ARCH PSY CLIN N, V249, P28; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shim YS, 2008, CLIN NEUROL NEUROSUR, V110, P552, DOI 10.1016/j.clineuro.2008.02.021; Shu N, 2011, J ALZHEIMERS DIS, V26, P275, DOI 10.3233/JAD-2011-0024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weintraub S., 1978, BOSTON NAMING TEST E; Xie S, 2005, NEUROREPORT, V16, P1275, DOI 10.1097/01.wnr.0000174061.41897.ee; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zarei M, 2009, STROKE, V40, P773, DOI 10.1161/STROKEAHA.108.530832; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	91	52	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52859	10.1371/journal.pone.0052859	http://dx.doi.org/10.1371/journal.pone.0052859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300797	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600030
J	Chappell, JM; Iqbal, A; Iannella, N; Abbott, D				Chappell, James M.; Iqbal, Azhar; Iannella, Nicolangelo; Abbott, Derek			Revisiting Special Relativity: A Natural Algebraic Alternative to Minkowski Spacetime	PLOS ONE			English	Article							ELECTRON-STRUCTURE; PHYSICS; ZITTERBEWEGUNG; LIGHT; MODEL; TIME	Minkowski famously introduced the concept of a space-time continuum in 1908, merging the three dimensions of space with an imaginary time dimension ict, with the unit imaginary producing the correct spacetime distance x(2) - c(2)t(2), and the results of Einstein's then recently developed theory of special relativity, thus providing an explanation for Einstein's theory in terms of the structure of space and time. As an alternative to a planar Minkowski space-time of two space dimensions and one time dimension, we replace the unit imaginary i =root 1,with the Clifford bivector i=e(1)e(2) for the plane that also squares to minus one, but which can be included without the addition of an extra dimension, as it is an integral part of the real Cartesian plane with the orthonormal basis e(1) and e(2). We find that with this model of planar spacetime, using a two-dimensional Clifford multivector, the spacetime metric and the Lorentz transformations follow immediately as properties of the algebra. This also leads to momentum and energy being represented as components of a multivector and we give a new efficient derivation of Compton's scattering formula, and a simple formulation of Dirac's and Maxwell's equations. Based on the mathematical structure of the multivector, we produce a semi-classical model of massive particles, which can then be viewed as the origin of the Minkowski spacetime structure and thus a deeper explanation for relativistic effects. We also find a new perspective on the nature of time, which is now given a precise mathematical definition as the bivector of the plane.	[Chappell, James M.; Iqbal, Azhar; Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Iannella, Nicolangelo/A-1026-2009; Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Iannella, Nicolangelo/0000-0002-1983-9071; Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674				Augustine, 1972, CITY GOD; Baylis WE, 2004, CAN J PHYS, V82, P853, DOI 10.1139/P04-058; Boudet R, 2009, SPRINGER SER ATOM OP, V52; Catillon P, 2008, FOUND PHYS, V38, P659, DOI 10.1007/s10701-008-9225-1; COLE EAB, 1980, PHYS LETT A, V76, P371, DOI 10.1016/0375-9601(80)90734-3; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Eckle P, 2008, NAT PHYS, V4, P565, DOI 10.1038/nphys982; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Einstein A., 1952, PRINCIPLE RELATIVITY; Einstein A., 1934, PHILOS SCI, V2, P163, DOI DOI 10.1086/286316; Einstein Albert, 1921, RELATIVITY SPECIAL G; Ernst A, 2001, CHINESE J PHYS, V39, P211; French A P, 1987, SPECIAL RELATIVITY; Gerritsma R, 2010, NATURE, V463, P68, DOI 10.1038/nature08688; Goenner H., 1999, EXPANDING WORLDS GEN; GOLDBERG S, 1967, AM J PHYS, V35, P934, DOI 10.1119/1.1973643; Goldstein H., 2001, CLASSICAL MECH; Hestenes D, 2003, AM J PHYS, V71, P691, DOI 10.1119/1.1571836; Hestenes D., 2003, Annales de la Fondation Louis de Broglie, V28, P367; HESTENES D, 1990, FOUND PHYS, V20, P1213, DOI 10.1007/BF01889466; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Lehto A., 1990, Chinese Journal of Physics, V28, P215; Leveugle J, 2004, RELATIVE POINCARE EI; Logunov AA, 2004, PHYSICS0408077 ARXIV; Lorentz HA, 1904, P K AKAD WET-AMSTERD, V6, P809; Matolcsi T, 1984, MODELS SPACE TIME CO; Minkowski H, 1909, RAUM ZEIT VORTR GEH; Misner C. W., 1973, GRAVITATION; Murguia G, 2011, PLANAR DIRAC FERMION; Newton I, 1686, PRINCIPIA; PAVSIC M, 1993, PHYS LETT B, V318, P481, DOI 10.1016/0370-2693(93)91543-V; Pavsic M, 2004, HEPTH0411053 ARXIV; Pfeiffer AN, 2011, NAT PHYS, V7, P428, DOI [10.1038/nphys1946, 10.1038/NPHYS1946]; Poincare M, 1906, RENDICONTI CIRCOLO M, V21, P129, DOI DOI 10.1007/BF03013466;; Poincare M, 1905, CR HEBD ACAD SCI, V140, P1504; Rodrigues Jr W.A., 2007, MANY FACES MAXWELL D, V722; RODRIGUES WA, 1993, PHYS LETT B, V318, P623, DOI 10.1016/0370-2693(93)90464-S; Rowe DE, 2009, MATH INTELL, V31, P27, DOI 10.1007/s00283-009-9027-0; Schrodinger Erwin, 1930, SITZ PREUSS AKAD WIS, V24, P418; Sexl RU., 2001, RELATIVITY GROUPS PA, DOI [10.1007/978-3-7091-6234-7, DOI 10.1007/978-3-7091-6234-7]; Taylor EF., 1966, SPACETIME PHYS; Tifft WG, 1996, ASTROPHYS SPACE SCI, V244, P187, DOI 10.1007/BF00642291; Ueda K, 2011, NAT PHYS, V7, P371, DOI 10.1038/nphys1985; VAZ J, 1995, PHYS LETT B, V345, P448, DOI 10.1016/0370-2693(94)01630-U; VAZ J, 1995, PHYS LETT B, V344, P149, DOI 10.1016/0370-2693(94)01548-Q; VAZ J, 1993, PHYS LETT B, V319, P203, DOI 10.1016/0370-2693(93)90803-P; Voigt W, 1887, NACHR GES WISS, P41; WEINBERG NN, 1980, PHYS LETT A, V80, P102, DOI 10.1016/0375-9601(80)90195-4; Wunderlich C, 2010, NATURE, V463, P37, DOI 10.1038/463037a; Zawadzki W, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/14/143201; ZEEMAN EC, 1964, J MATH PHYS, V5, P490, DOI 10.1063/1.1704140; ZENI JR, 1992, INT J MOD PHYS A, V7, P1793, DOI 10.1142/S0217751X92000776	55	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51756	10.1371/journal.pone.0051756	http://dx.doi.org/10.1371/journal.pone.0051756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300566	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600008
J	Hoh, RA; Stowe, TR; Turk, E; Stearns, T				Hoh, Ramona A.; Stowe, Timothy R.; Turk, Erin; Stearns, Tim			Transcriptional Program of Ciliated Epithelial Cells Reveals New Cilium and Centrosome Components and Links to Human Disease	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; PROTEOMIC ANALYSIS; MOLECULAR CHARACTERIZATION; CENTRIOLE BIOGENESIS; FUNCTIONAL GENOMICS; EXPRESSION; DIFFERENTIATION; CILIOGENESIS; FLAGELLAR; PROTEINS	Defects in the centrosome and cilium are associated with a set of human diseases having diverse phenotypes. To further characterize the components that define the function of these organelles we determined the transcriptional profile of multiciliated tracheal epithelial cells. Cultures of mouse tracheal epithelial cells undergoing differentiation in vitro were derived from mice expressing GFP from the ciliated-cell specific FOXJ1 promoter (FOXJ1: GFP). The transcriptional profile of ciliating GFP+ cells from these cultures was defined at an early and a late time point during differentiation and was refined by subtraction of the profile of the non-ciliated GFP-cells. We identified 649 genes upregulated early, when most cells were forming basal bodies, and 73 genes genes upregulated late, when most cells were fully ciliated. Most, but not all, of known centrosome proteins are transcriptionally upregulated early, particularly Plk4, a master regulator of centriole formation. We found that three genes associated with human disease states, Mdm1, Mlf1, and Dyx1c1, are upregulated during ciliogenesis and localize to centrioles and cilia. This transcriptome for mammalian multiciliated epithelial cells identifies new candidate centrosome and cilia proteins, highlights similarities between components of motile and primary cilia, and identifies new links between cilia proteins and human disease.	[Hoh, Ramona A.; Stowe, Timothy R.; Turk, Erin; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Piazza, Erin/0000-0002-3263-5946; Stearns, Tim/0000-0002-0671-6582	NSF; Gabilan Stanford Graduate Fellowship; United States National Institutes of Health [GM52022]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Gabilan Stanford Graduate Fellowship; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF graduate research fellowship to T. R. S., the Gabilan Stanford Graduate Fellowship to E. T., and United States National Institutes of Health grant GM52022 to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Anitha A, 2009, AM J MED GENET B, V150B, P967, DOI 10.1002/ajmg.b.30926; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bettencourt-Dias M, 2009, CELL, V136, P188, DOI 10.1016/j.cell.2008.12.035; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; BLOODGOOD RA, 1990, J CELL SCI, V96, P27; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chen NS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r126; Christensen ST, 2003, CURR BIOL, V13, pR50, DOI 10.1016/S0960-9822(02)01425-2; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Ma L, 2011, J CELL SCI, V124, P2622, DOI 10.1242/jcs.084798; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Martin-Lanneree S, 2006, GENES CELLS, V11, P1317, DOI 10.1111/j.1365-2443.2006.01023.x; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Matsumoto N, 2000, LEUKEMIA, V14, P1757, DOI 10.1038/sj.leu.2401897; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pan JM, 2000, J BIOL CHEM, V275, P24106, DOI 10.1074/jbc.M002686200; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Poelmans G, 2009, AM J MED GENET B, V150B, P140, DOI 10.1002/ajmg.b.30787; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schulz Irene, 2006, V346, P479; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shah AS, 2009, SCIENCE; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Staples CJ, 2012, J CELL SCI; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2012, BIOL PSYCHIAT; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yoneda-Kato N, 2008, MOL CELL BIOL, V28, P422, DOI 10.1128/MCB.02335-06; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	108	86	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52166	10.1371/journal.pone.0052166	http://dx.doi.org/10.1371/journal.pone.0052166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300604	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600011
J	Luhken, G; Fleck, K; Pauciullo, A; Huisinga, M; Erhardt, G				Luehken, Gesine; Fleck, Katharina; Pauciullo, Alfredo; Huisinga, Maike; Erhardt, Georg			Familiar Hypopigmentation Syndrome in Sheep Associated with Homozygous Deletion of the Entire Endothelin Type-B Receptor Gene	PLOS ONE			English	Article							WHITE FOAL SYNDROME; OVERO SPOTTED HORSES; HIRSCHSPRUNG-DISEASE; WAARDENBURG-SYNDROME; LETHAL WHITE; INTERSTITIAL DELETION; INTESTINAL AGANGLIONOSIS; RIVER BUFFALO; FRAGILE SITES; 13Q DELETION	In humans, rodents and horses, pigmentary anomalies in combination with other disorders, notably intestinal aganglionosis, are associated with variants of the endothelin type-B receptor gene (EDNRB). In an inbred Cameroon sheep flock, five white lambs with light blue eyes were sired from the same ram and died within a few hours up to a few days after birth, some of them with signs of intestinal obstruction. The aim of this study was to investigate if the observed hypopigmentation and a possible lethal condition were associated with a molecular change at the ovine EDNRB locus, and to check if such a genetic alteration also occurs in other Cameroon sheep flocks. Sequence analysis revealed a deletion of about 110 kb on sheep chromosome 10, comprising the entire EDNRB gene, on both chromosomes in the two available hypopigmented lambs and on a single chromosome in the two dams and three other unaffected relatives. This micro-chromosomal deletion was also confirmed by quantitative real-time PCR and by fluorescence in situ hybridization. Genotyping of a total of 127 Cameroon sheep in 7 other flocks by duplex PCR did not identify additional carriers of the deletion. Although both hypopigmented lambs available for post-mortem examination had a considerably dilated cecum and remaining meconium, histopathological examination of intestinal samples showed morphologically normal ganglion cells in appropriate number and distribution. This is to our knowledge the first description of an ENDRB gene deletion and associated clinical signs in a mammalian species different from humans and rodents. In humans and rats it is postulated that the variable presence and severity of intestinal aganglionosis and other features in individuals with EDNRB deletion is due to a variable genetic background and multiple gene interactions. Therefore the here analyzed sheep are a valuable animal model to test these hypotheses in another species.	[Luehken, Gesine; Fleck, Katharina; Pauciullo, Alfredo; Erhardt, Georg] Univ Giessen, Dept Anim Breeding & Genet, D-35390 Giessen, Germany; [Huisinga, Maike] Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Luhken, G (corresponding author), Univ Giessen, Dept Anim Breeding & Genet, D-35390 Giessen, Germany.	Gesine.Luehken@agrar.uni-giessen.de	Pauciullo, Alfredo/AAF-7713-2020	Pauciullo, Alfredo/0000-0002-3140-9373				Ali A, 2008, J GENET, V87, P219, DOI 10.1007/s12041-008-0035-1; ARAI H, 1993, J BIOL CHEM, V268, P3463; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; Bonnet JP, 1996, EUR J PEDIATR SURG, V6, P245, DOI 10.1055/s-2008-1066521; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Hilbe M, 2005, J COMP PATHOL, V132, P223, DOI 10.1016/j.jcpa.2004.07.002; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Huisinga M, 2008, VET PATHOL, V45, P63, DOI 10.1354/vp.45-1-63; HULTGREN BD, 1982, J AM VET MED ASSOC, V180, P289; Iannuzzi L, 2001, CYTOGENET CELL GENET, V94, P43, DOI 10.1159/000048781; Iannuzzi L, 2008, J APPL GENET, V49, P357, DOI 10.1007/BF03195634; Jimenez A, 2007, J VET MED A, V54, P103, DOI 10.1111/j.1439-0442.2007.00871.x; Karaki H, 1996, BIOCHEM BIOPH RES CO, V222, P139, DOI 10.1006/bbrc.1996.0711; Kutzbach B, 2007, J AAPOS, V11, P513, DOI 10.1016/j.jaapos.2007.04.012; LAMONT MA, 1989, J MED GENET, V26, P100, DOI 10.1136/jmg.26.2.100; MCCABE L, 1990, AM J MED GENET, V36, P336, DOI 10.1002/ajmg.1320360319; McCallion AS, 2001, PIGM CELL RES, V14, P161, DOI 10.1034/j.1600-0749.2001.140305.x; Meier-Ruge WA, 2004, EUR J PEDIATR SURG, V14, P392, DOI 10.1055/s-2004-830354; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; MONTGOMERY GW, 1990, NEW ZEAL J AGR RES, V33, P437, DOI 10.1080/00288233.1990.10428440; Nicodemo D, 2008, CYTOGENET GENOME RES, V120, P178, DOI 10.1159/000118760; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Santschi EM, 1998, MAMM GENOME, V9, P306, DOI 10.1007/s003359900754; Schlapfer J, 1997, MAMM GENOME, V8, P380, DOI 10.1007/s003359900447; SCHNEIDER JE, 1978, J EQUINE MED SURG, V2, P479; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Shanske A, 2001, AM J MED GENET, V102, P231, DOI 10.1002/ajmg.1451; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; TROMMERSHAUSENSMITH A, 1977, THERIOGENOLOGY, V8, P303, DOI 10.1016/0093-691X(77)90237-0; Tuysuz B, 2009, AM J MED GENET A, V149A, P2290, DOI 10.1002/ajmg.a.33031; VANCAMP G, 1995, J MED GENET, V32, P531, DOI 10.1136/jmg.32.7.531; VONDERFECHT SL, 1983, VET PATHOL, V20, P65, DOI 10.1177/030098588302000107; Weigel BJ, 1998, AM J MED GENET, V77, P285, DOI 10.1002/(SICI)1096-8628(19980526)77:4<285::AID-AJMG7>3.0.CO;2-M; Yang GC, 1998, HUM MOL GENET, V7, P1047, DOI 10.1093/hmg/7.6.1047	39	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53020	10.1371/journal.pone.0053020	http://dx.doi.org/10.1371/journal.pone.0053020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300849	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600047
J	Ye, SD; Xiao, Y; Jin, CR; Cassell, H; Blevins, M; Sun, JP; Vermund, SH; Qian, HZ				Ye, Shaodong; Xiao, Yan; Jin, Canrui; Cassell, Holly; Blevins, Meridith; Sun, Jiangping; Vermund, Sten H.; Qian, Han-Zhu			Effectiveness of Integrated HIV Prevention Interventions among Chinese Men Who Have Sex with Men: Evaluation of a 16-City Public Health Program	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAM; SYPHILIS INFECTIONS; PREVALENCE; MUNICIPALITY; SURVEILLANCE	To examine the impacts of a multi-city HIV prevention public health program (China Global Fund Round 5 Project) on condom use and HIV infection, we analyzed four yearly cross-sectional surveys from 2006 through 2009 among 20,843 men who have sex with men (MSM) in 16 Chinese cities. Self-reported condom use at last sex with a male partner increased from 58% in 2006 to 81% in 2009 (trend test, P<0.001). HIV prevalence increased from 2.3% in 2006 to 5.3% in 2009 (P<0.001). Multivariable logistic regression analysis showed that self-reported receipt of interventions was an independent predictor of increased condom use at last sex with a male partner over time (adjusted odds ratio [aOR], 1.63 in 2006 to 2.33 in 2009; P<0.001), and lower HIV prevalence (aOR, 1.08 in 2006 to 0.45 in 2009; P<0.001). HIV prevalence increased from 2006-2009 for participants with no self-reported receipt of interventions (2.1% in 2006 to 10.3% in 2009) and less so for those with interventions (2.4% to 4.7%). This Chinese public health program had positive impacts on both behaviors and disease rate among MSM population. Escalation of the coverage and intensity of effective interventions is needed for further increasing condom use and for reversing the rising trend of HIV epidemic.	[Ye, Shaodong; Cassell, Holly; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Ye, Shaodong; Xiao, Yan; Jin, Canrui; Sun, Jiangping] China Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Blevins, Meridith] Vanderbilt Univ, Dept Biostat, Nashville, TN USA	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Vanderbilt University	Qian, HZ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	han-zhu.qian@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Cassell, Holly/0000-0003-3754-7328; Blevins, Meridith/0000-0002-3861-9859	China Global Fund Round Five Project [CHN-506-G06-H]; US NIH [5 D43 TW001035-12]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER	China Global Fund Round Five Project; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	China Global Fund Round Five Project (Grant # CHN-506-G06-H) and US NIH grant (Grant # 5 D43 TW001035-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HIV US; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Lai L, 2009, LEGAL SYSTEM SOC, V22, P198; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Liu B, 2007, AIDS, V21, pS123, DOI 10.1097/01.aids.0000304707.56670.cf; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministry of Health of the People's Republic of China UNAIDS and WHO, 2011, NAT REP HIV AIDS EST; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; Qian HZ, 2012, J AIDS CLIN RES S, VS4, pe001, DOI [10.4172/2155-6113.S4-e001, DOI 10.4172/2155-6113.S4-E001]; Rogowska-Szadkowska Dorota, 2011, Przegl Epidemiol, V65, P515; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Fund, 2012, HIV PREV NOW PROGR B; World Health Organization Regional Office for Europe, 2010, HIV AIDS SURV EUR; World Health Organization Regional Office for South-East Asia, 2009, HIV AIDS SE AS REG 2; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	25	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50873	10.1371/journal.pone.0050873	http://dx.doi.org/10.1371/journal.pone.0050873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300528	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600003
J	Vegfors, J; Petersson, S; Kovacs, A; Polyak, K; Enerback, C				Vegfors, Jenny; Petersson, Stina; Kovacs, Aniko; Polyak, Kornelia; Enerback, Charlotta			The Expression of Psoriasin (S100A7) and CD24 Is Linked and Related to the Differentiation of Mammary Epithelial Cells	PLOS ONE			English	Article							CARCINOMA IN-SITU; HUMAN BREAST-CARCINOMA; DUCTAL CARCINOMA; CANCER DEVELOPMENT; CALGRANULIN-B; PROGRESSION; GROWTH; PROTEINS; RECEPTOR; CULTURE	Psoriasin (S100A7), a member of the S100 family of calcium-binding proteins, is highly expressed in high-grade ductal carcinoma in situ (DCIS) and in the benign hyperproliferative skin disorder psoriasis. The gene that encodes psoriasin and many other S100 genes are located within a gene cluster on chromosome region 1q21, known as the epidermal differentiation complex. This cluster contains genes for several differentiation markers that play important roles in the terminal differentiation of the epidermis. The purpose of the present study was to evaluate the role of psoriasin in the differentiation process of mammary epithelial cells. Normal mammary epithelial cells (MCF10A) cultured in confluence and suspension, conditions known to induce psoriasin expression, demonstrated a shift towards a more differentiated phenotype indicated by an increase in the expression of the luminal differentiation markers CD24 and MUC1 and the reduced expression of the breast stem cell marker CD44. The expression of psoriasin and MUC1 was most pronounced in the CD24(+)-enriched fraction of confluent MCF10A cells. The shift towards a more differentiated phenotype was abolished upon the downregulation of psoriasin using short hairpin RNA (shRNA) and small interfering RNA (siRNA). Using specific inhibitors, we showed that psoriasin and CD24 expression was regulated by reactive oxygen species (ROS) and the nuclear factor (NF)-kappa B signaling pathways. While immunohistochemical analyses of DCIS showed heterogeneity, the expression of psoriasin and CD24 showed a similar staining pattern. Our findings suggest that the expression of psoriasin is linked to the luminal differentiation marker CD24 in mammary epithelial cells. Psoriasin demonstrated an essential role in the shift towards a more differentiated CD24(+) phenotype, supporting the hypothesis that psoriasin plays a role in the differentiation of luminal mammary epithelial cells.	[Vegfors, Jenny; Petersson, Stina; Enerback, Charlotta] Linkoping Univ, Ingrid Asp Psoriasis Res Ctr, Dept Clin & Expt Med, Linkoping, Sweden; [Kovacs, Aniko] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Linkoping University; Sahlgrenska University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Enerback, C (corresponding author), Linkoping Univ, Ingrid Asp Psoriasis Res Ctr, Dept Clin & Expt Med, Linkoping, Sweden.	charlotta.enerback@liu.se			Ingrid Asp Foundation; Swedish Cancer Society; Swedish Psoriasis Association; Welander Foundation	Ingrid Asp Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Psoriasis Association; Welander Foundation	This study was supported by grants from the Ingrid Asp Foundation, the Swedish Cancer Society, the Swedish Psoriasis Association and the Welander Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; BORGLUM AD, 1995, HUM GENET, V96, P592; Cabezon T, 2009, MOL ONCOL; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Carlsson H, 2005, INT J ONCOL, V27, P1473; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; Fogel M, 1999, CANCER LETT, V143, P87, DOI 10.1016/S0304-3835(99)00195-0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Lee JH, 2009, ONCOL REP, V22, P1149, DOI 10.3892/or_00000548; Leygue E, 1996, CANCER RES, V56, P4606; Martinsson H, 2005, EXP DERMATOL, V14, P161, DOI 10.1111/j.0906-6705.2005.00239.x; Martinsson H, 2004, EXP DERMATO IN PRESS; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Petersson S, 2011, BREAST CANCER RES TR, V125, P13, DOI 10.1007/s10549-010-0820-4; Petersson S, 2010, BREAST CANC RES TREA; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Porter D, 2003, MOL CANCER RES, V1, P362; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Shubbar E, 2011, BREAST CANC RES TREA; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53119	10.1371/journal.pone.0053119	http://dx.doi.org/10.1371/journal.pone.0053119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300877	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100122
J	Villa-Galaviz, E; Boege, K; del-Val, E				Villa-Galaviz, Edith; Boege, Karina; del-Val, Ek			Resilience in Plant-Herbivore Networks during Secondary Succession	PLOS ONE			English	Article							TROPICAL FOREST; COMMUNITIES; NESTEDNESS; DIVERSITY; HABITAT; ASSEMBLAGES; RICHNESS; UPLAND	Extensive land-use change in the tropics has produced a mosaic of successional forests within an agricultural and cattle-pasture matrix. Post-disturbance biodiversity assessments have found that regeneration speed depends upon propagule availability and the intensity and duration of disturbance. However, reestablishment of species interactions is still poorly understood and this limits our understanding of the anthropogenic impacts upon ecosystem resilience. This is the first investigation that evaluates plant-herbivore interaction networks during secondary succession. In particular we investigated succession in a Mexican tropical dry forest using data of caterpillar associations with plants during 2007-2010. Plant-herbivore networks showed high resilience. We found no differences in most network descriptors between secondary and mature forest and only recently abandoned fields were found to be different. No significant nestedness or modularity network structure was found. Plant-herbivore network properties appear to quickly reestablish after perturbation, despite differences in species richness and composition. This study provides some valuable guidelines for the implement of restoration efforts that can enhance ecological processes such as the interaction between plants and their herbivores.	[Villa-Galaviz, Edith; del-Val, Ek] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Boege, Karina] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	del-Val, E (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	ekdelval@oikos.unam.mx	Paré, Karina Boege/AAP-9596-2021; del val, Ek/AAB-8343-2019; Villa-Galaviz, Edith/ABB-9896-2020	del-val, ek/0000-0003-3862-1024; Villa-Galaviz, Edith/0000-0002-2783-7877	Conacyt;  [PAPIIT-UNAM- IN208610]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This study was supported by PAPIIT-UNAM- IN208610 and PAPIIT-UNAM- IN208610, EVG received a grant from Conacyt for graduate studies and acknowledges the academic support provided by the Posgrado en Ciencias Biologicas-UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Chazdon Robin L., 2011, P195; Crawley M. J, 2002, STAT COMPUTING INTRO; Avila-Cabadilla LD, 2009, FOREST ECOL MANAG, V258, P986, DOI 10.1016/j.foreco.2008.12.011; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Dormann C.F., 2008, R NEWS, V8, P8, DOI DOI 10.1159/000265935; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Food and Agriculture Organization of the United Nations [FAO], 2020, GLOBAL FOREST RESOUR; Godinez MC, 2011, PLANTAS UTILES POTEN; Guariguata MR, 2002, ECOLOGIA CONSERVACIO, P591; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; Kitching RL, 2000, J APPL ECOL, V37, P284, DOI 10.1046/j.1365-2664.2000.00490.x; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lebrija-Trejos E, 2008, PERSPECT PLANT ECOL, V12, P267; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lopez-Carretero A, 2010, COMPOSICION DIVERSID; LOTT EJ, 1987, BIOTROPICA, V19, P228, DOI 10.2307/2388340; Martinez-Garza C, 2003, J APPL ECOL, V40, P423, DOI 10.1046/j.1365-2664.2003.00819.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Newman M. E. J., 2004, PHYS REV, V69; Noguera F, 2002, HIST NATURAL CHAMELA; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Nylin S, 1999, HERBIVORES PLANTS PR, P175; Passmore HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040803; Pescador-Rubio A, 2002, HIST NATURAL CHAMELA, P183; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; R Core Team, 2021, R LANG ENV STAT COMP; Sanchez-Azofeifa GA, 2009, FOREST ECOL MANAG, V258, P907, DOI 10.1016/j.foreco.2008.10.030; Sanchez-Azofeifa GA, 2005, CONSERV BIOL, V19, P285, DOI 10.1111/j.1523-1739.2005.s01_1.x; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; WRIGHT SJ, 1992, TRENDS ECOL EVOL, V7, P260, DOI 10.1016/0169-5347(92)90171-7	49	46	46	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53009	10.1371/journal.pone.0053009	http://dx.doi.org/10.1371/journal.pone.0053009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300846	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100107
J	Contreras, V; Urien, C; Jouneau, L; Bourge, M; Bouet-Cararo, C; Bonneau, M; Zientara, S; Klonjkowski, B; Schwartz-Cornil, I				Contreras, Vanessa; Urien, Celine; Jouneau, Luc; Bourge, Mickael; Bouet-Cararo, Coraline; Bonneau, Michel; Zientara, Stephan; Klonjkowski, Bernard; Schwartz-Cornil, Isabelle			Canine Recombinant Adenovirus Vector Induces an Immunogenicity-Related Gene Expression Profile in Skin-Migrated CD11b(+)-Type DCs	PLOS ONE			English	Article							LYMPH DENDRITIC CELLS; RECEPTOR PATHWAY; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; TYPE-35 VECTORS; IN-VITRO; VACCINE; EFFICACY; SUBSETS; VIRUS	Gene expression profiling of the blood cell response induced early after vaccination has previously been demonstrated to predict the immunogenicity of vaccines. In this study, we evaluated whether the analysis of the gene expression profile of skin-migrated dendritic cells (DCs) could be informative for the in vitro prediction of immunogenicity of vaccine, using canine adenovirus serotype 2 (CAV2) as vaccine vector. CAV2 has been shown to induce immunity to transgenes in several species including sheep and is an interesting alternative to human adenovirus-based vectors, based on the safety records of the parental strain in dogs and the lack of pre-existing immunity in non-host species. Skin-migrated DCs were collected from pseudo-afferent lymph in sheep. Both the CD11b(+)-type and CD103(+)-type skin-migrated DCs were transduced by CAV2. An analysis of the global gene response to CAV2 in the two skin DC subsets showed that the gene response in CD11b+-type DCs was far higher and broader than in the CD103(+)-type DCs. A newly released integrative analytic tool from Ingenuity systems revealed that the CAV2-modulated genes in the CD11b(+)-type DCs clustered in several activated immunogenicity-related functions, such as immune response, immune cell trafficking and inflammation. Thus gene profiling in skin-migrated DC in vitro indicates that the CD11b(+) DC type is more responsive to CAV2 than the CD103(+) DC type, and provides valuable information to help in evaluating and possibly improving viral vector vaccine effectiveness.	[Bonneau, Michel; Schwartz-Cornil, Isabelle] INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France; [Bourge, Mickael] CNRS, IMAGIF, Gif Sur Yvette, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] INRA, UMR Virol, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Univ Paris Est, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Ecole Natl Vet Alfort, Maisons Alfort, France; [Bouet-Cararo, Coraline; Zientara, Stephan; Klonjkowski, Bernard] Agence Natl Securite Sanit Alimentat Environm & T, Maisons Alfort, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Schwartz-Cornil, I (corresponding author), INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr	schwartz-cornil, isabelle/D-8547-2011; Klonjkowski, Bernard/N-7785-2019; Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021; Jouneau, Luc/AAC-4711-2020	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503; Contreras, Vanessa/0000-0003-4072-9819; Bourge, Mickael/0000-0002-4111-6208; Klonjkowski, Bernard/0000-0003-3372-0656	Agence Nationale pour la Recherche [ANR 06 GANI 015-03, ANR 09 BLAN 0073]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale pour la Recherche (VacGenDC ANR 06 GANI 015-03; PhylogenDC, ANR 09 BLAN 0073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WC, 2009, J GEN VIROL, V90, P1600, DOI 10.1099/vir.0.008342-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bouet-Cararo C, 2011, VACCINE, V29, P1304, DOI 10.1016/j.vaccine.2010.11.068; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Buschow SI, 2010, IMMUNITY, V32, P149, DOI 10.1016/j.immuni.2010.02.006; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Combadiere B, 2008, COMP IMMUNOL MICROB, V31, P293, DOI 10.1016/j.cimid.2007.07.015; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Cubillos-Zapata C, 2011, J VIROL, V85, P9385, DOI 10.1128/JVI.05127-11; de Gruijl TD, 2006, J IMMUNOL, V177, P2208, DOI 10.4049/jimmunol.177.4.2208; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Hangalapura BN, 2011, VACCINE, V29, P2313, DOI 10.1016/j.vaccine.2011.01.022; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Henning P, 2011, EUR J IMMUNOL, V41, P2185, DOI 10.1002/eji.201041009; Hu RL, 2007, VACCINE, V25, P5301, DOI 10.1016/j.vaccine.2007.05.024; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; Keriel A, 2006, J VIROL, V80, P1487, DOI 10.1128/JVI.80.3.1487-1496.2006; Kremer EJ, 2004, J GENE MED, V6, pS139, DOI 10.1002/jgm.497; Kushwah R, 2011, IMMUNOLOGY, V133, P409, DOI 10.1111/j.1365-2567.2011.03457.x; Lindsay RWB, 2010, J IMMUNOL, V185, P1513, DOI 10.4049/jimmunol.1000338; Liu Y, 2008, VACCINE, V26, P5368, DOI 10.1016/j.vaccine.2008.08.001; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016320; Miller G, 2003, CANCER IMMUNOL IMMUN, V52, P347, DOI 10.1007/s00262-003-0379-6; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nalubarnba KS, 2007, VET IMMUNOL IMMUNOP, V118, P252, DOI 10.1016/j.vetimm.2007.05.018; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Perreau M, 2006, MOL BIOTECHNOL, V34, P247, DOI 10.1385/MB:34:2:247; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Schwartz-Cornil I, 2006, NAT PROTOC, V1, P874, DOI 10.1038/nprot.2006.147; Smyth GK, 2004, STAT APPL GENETICS M; Soudais C, 2000, J VIROL, V74, P10639, DOI 10.1128/JVI.74.22.10639-10649.2000; Top S, 2011, J VIROL, V85, P12982, DOI 10.1128/JVI.00128-11; Verhaagh S, 2006, J GEN VIROL, V87, P255, DOI 10.1099/vir.0.81293-0; Yuan ZG, 2009, VACCINE, V27, P5247, DOI 10.1016/j.vaccine.2009.06.062; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52513	10.1371/journal.pone.0052513	http://dx.doi.org/10.1371/journal.pone.0052513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300693	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800098
J	Fleischman, D; Berdahl, JP; Zaydlarova, J; Stinnett, S; Fautsch, MP; Allingham, RR				Fleischman, David; Berdahl, John P.; Zaydlarova, Jana; Stinnett, Sandra; Fautsch, Michael P.; Allingham, R. Rand			Cerebrospinal Fluid Pressure Decreases with Older Age	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; OCULAR HYPERTENSION; CHOROID-PLEXUS; CSF PRESSURE; RISK-FACTORS; PREVALENCE; POPULATION	Purpose: Clinical studies implicate low cerebrospinal fluid pressure (CSFP) or a high translaminar pressure difference in the pathogenesis of primary open angle glaucoma (POAG) and normal tension glaucoma (NTG). This study was performed to examine the effect of age, sex, race and body mass index (BMI) on CSFP. Methods: Electronic medical records from all patients who had a lumbar puncture (LP) performed at the Mayo Clinic from 1996-2009 were reviewed. Information including age, sex, race, height and weight, ocular and medical diagnoses, intraocular pressure (IOP) and LP opening pressure was obtained. Patients using medications or with medical diagnoses known to affect CSFP, and those who underwent neurosurgical procedures or where more than one LP was performed were excluded from analysis. Results: Electronic medical records of 33,922 patients with a history of having an LP during a 13-year period (1996-2009) were extracted. Of these, 12,118 patients met all entry criteria. Relative to mean CSFP at age group 20-49 (mean 11.5 +/- 2.8 mmHg), mean CSFP declined steadily after age 50, with percent reduction of 2.5% for the 50-54 age group (mean 11.2 +/- 2.7 mmHg, p<0.002) to 26.9% for the 90-95 group (mean 8.4 +/- 2.4 mmHg, p<0.001). Females had lower CSFP than males throughout all age groups. BMI was positively and independently associated with CSFP within all age groups. Conclusion: There is a sustained and significant reduction of CSFP with age that begins in the 6th decade. CSFP is consistently lower in females. BMI is positively and independently associated with CSFP in all age groups. The age where CSFP begins to decline coincides with the age where the prevalence of POAG increases. These data support the hypothesis that reduced CSFP may be a risk factor for POAG and may provide an explanation for the mechanism that underlies the age-related increase in the prevalence of POAG and NTG.	[Fleischman, David] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA; [Berdahl, John P.] Univ S Dakota, Med Ctr, Sioux Falls, SD USA; [Zaydlarova, Jana; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Stinnett, Sandra; Allingham, R. Rand] Duke Univ, Ctr Eye, Durham, NC 27706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of South Dakota; Mayo Clinic; Duke University	Allingham, RR (corresponding author), Duke Univ, Ctr Eye, Durham, NC 27706 USA.	rand.allingham@duke.edu		Stinnett, Sandra/0000-0001-7192-0195	National Institutes of Health [EY 15736, EY 07065]; Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY; Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE [R01EY015736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health research grants EY 15736 (MPF), EY 07065 (MPF); Mayo Foundation, Rochester, MN (MPF); and Research to Prevent Blindness, New York, NY (MPF is a recipient of a Lew R. Wasserman Merit Award and the Department of Ophthalmology, Mayo Clinic; Department of Ophthalmology, University of North Carolina Hospitals, and Duke University Eye Center are recipients of unrestricted grants). The funding agencies had no role in the design or conduct of this research.	Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; [Anonymous], 1995, PHYS STAT US INT ANT; Anton A, 2004, J GLAUCOMA, V13, P371; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; FARACI FM, 1990, AM J PHYSIOL, V258, pR94, DOI 10.1152/ajpregu.1990.258.1.R94; Fishman RA, 1992, CEREBROSPINAL FLUID, P71; Fleischman D, 2011, OPHTHALMOLOGY, V118, P1225, DOI 10.1016/j.ophtha.2011.01.025; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Francis BA, 2011, INVEST OPHTH VIS SCI, V52, P6257, DOI 10.1167/iovs.09-5126; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Frolkis VV, 1999, ARCH GERONTOL GERIAT, V29, P193; GILLAND O, 1974, J NEUROSURG, V40, P587, DOI 10.3171/jns.1974.40.5.0587; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Herndon LW, 2004, ARCH OPHTHALMOL-CHIC, V122, P17, DOI 10.1001/archopht.122.1.17; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Karahalios DG, 1996, NEUROLOGY, V46, P198, DOI 10.1212/WNL.46.1.198; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Malm J, 2011, NEUROLOGY, V76, P903, DOI 10.1212/WNL.0b013e31820f2dd0; Masserman JH, 1935, ARCH NEURO PSYCHIATR, V34, P564, DOI 10.1001/archneurpsyc.1935.02250210085006; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; McComb J, 1990, PATHOPHYSIOLOGY BLOO, P421; McComb JG., 1984, HYDROCEPHALUS, P83; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Nagra G, 2007, NEUROPATH APPL NEURO, V33, P684, DOI 10.1111/j.1365-2990.2007.00857.x; Nizankowska Maria Hanna, 2004, Klin Oczna, V106, P147; Nizankowska MH, 2005, OPHTHAL EPIDEMIOL, V12, P363, DOI 10.1080/09286580500212904; Papaiconomou C, 2004, CHILD NERV SYST, V20, P29, DOI 10.1007/s00381-003-0840-z; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Saenz-Frances F, 2011, INVEST OPHTH VIS SCI, V52, P3683, DOI 10.1167/iovs.10-6660; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Sugerman HJ, 1997, NEUROLOGY, V49, P507, DOI 10.1212/WNL.49.2.507; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wu RY, 2011, INVEST OPHTH VIS SCI, V52, P1320, DOI 10.1167/iovs.10-6038; Yoshida M, 2001, J CLIN EPIDEMIOL, V54, P1151, DOI 10.1016/S0895-4356(01)00388-2; Zakharov A, 2004, MICROVASC RES, V67, P96, DOI 10.1016/j.mvr.2003.08.004	64	89	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52664	10.1371/journal.pone.0052664	http://dx.doi.org/10.1371/journal.pone.0052664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300737	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800123
J	Ge, SQ; Wipfler, B; Pohl, H; Hua, Y; Slipinski, A; Yang, XK; Beutel, RG				Ge, Si-Qin; Wipfler, Benjamin; Pohl, Hans; Hua, Yi; Slipinski, Adam; Yang, Xing-Ke; Beutel, Rolf Georg			The First Complete 3D Reconstruction of a Spanish Fly Primary Larva (Lytta vesicatoria, Meloidae, Coleoptera)	PLOS ONE			English	Article							BLISTER BEETLE GENUS; INSTAR LARVAE; PHYLOGENETIC IMPLICATIONS; SYSTEMATIC POSITION; HEAD MORPHOLOGY; WORLD GENERA; MINIATURIZATION; TENEBRIONOIDEA; KEY; CYANEOLYTTA	The first detailed anatomical study of a primary larva of Meloidae is presented. Thereby techniques such as three-dimensional reconstructions, microtome sections, SEM (scanning electronic microscopy) and CLSM (confocal laser scanning microscopy) are applied. The structural features are discussed in the context of phylogeny, but also possible correlations with parasitism, phoresy and miniaturisation. The triungulin first instar larva is likely an apomorphy of Meloidae excl. Eleticinae and linked with a specialisation on acridoid eggs or larvae and provisions of bees. The campodeid body shape of Lytta and Meloinae is a groundplan feature of Meloidae, whereas a navicular body is an autapomorphy of the generally phoretic larvae of Nemognathinae. Head structures of Lytta and features of the postcephalic body are largely plesiomorphic. The musculature of the head is only moderately simplified while the one of the postcephalic body is well developed. Its thorax is largely characterised by plesiomorphies. The characteristics of the legs suggest phoretic habits, even though this does not apply to larvae of Lytta. It is conceivable that a phoretic behaviour is secondarily lost, together with some but not all morphological modifications related to it. Derived features of the abdomen of Meloidae are the complete loss of the fixed urogomphi (also missing in Rhipiphoridae and other related groups) and the presence of one or two conspicuous caudal bristles. Only few features of Lytta are shared with the parasitic larvae of Rhipiphoridae and Strepsiptera. These characteristics, which are possibly linked with specialised life habits, have obviously evolved independently. Miniaturisation effects are minimal in the larvae of Lytta.	[Ge, Si-Qin; Wipfler, Benjamin; Hua, Yi; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ge, Si-Qin; Wipfler, Benjamin; Pohl, Hans; Beutel, Rolf Georg] Univ Jena, Entomol Grp, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum, Jena, Germany; [Slipinski, Adam] Australian Natl Insect Collect, CSIRO Ecosyst Sci, Canberra, ACT, Australia	Chinese Academy of Sciences; Institute of Zoology, CAS; Friedrich Schiller University of Jena; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yang, XK (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn	Pohl, Hans/M-6873-2019; Slipinski, Stanislaw Adam/B-4293-2009; Wipfler, Benjamin/M-2926-2015; Slipinski, Adam/AAZ-2485-2020	Slipinski, Adam/0000-0002-1216-8068; Pohl, Hans/0000-0002-7090-6612; Beutel, Rolf Georg/0000-0002-0433-7626	National Science Foundation of China [31010103913, 30970390]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX3-IOZ-1004]; National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy) [NSFC-J0630964/J0109, J0930004]; DFG [BE1789/61]; Chinese Academy of Sciences Fellowship for Young International Scientist [2011Y2SB05]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy); DFG(German Research Foundation (DFG)); Chinese Academy of Sciences Fellowship for Young International Scientist	The project partly supported by grants from the National Science Foundation of China (Grant Nos. 31010103913 and 30970390), the Knowledge Innovation Program of Chinese Academy of Sciences (No. KSCX3-IOZ-1004), the National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0630964/J0109, J0930004). BW is supported by the DFG (grant number BE1789/61) and the Chinese Academy of Sciences Fellowship for Young International Scientist (grant number 2011Y2SB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi, 1994, EOS, V69, P45; Beutel R. G., 1999, Tijdschrift voor Entomologie, V142, P9; Beutel R.G., 1994, Koleopterologische Rundschau, V64, P103; Beutel RG, 1998, ZOOMORPHOLOGY, V118, P103, DOI 10.1007/s004350050061; Beutel RG, 2005, EUR J ENTOMOL, V102, P241, DOI 10.14411/eje.2005.037; BEUTEL RG, 1993, SYST ENTOMOL, V18, P127, DOI 10.1111/j.1365-3113.1993.tb00658.x; Beutel RG, 2002, SYST ENTOMOL, V27, P169, DOI 10.1046/j.1365-3113.2002.00172.x; Beutel RG, 2002, EUR J ENTOMOL, V99, P53, DOI 10.14411/eje.2002.011; Beutel RG, 1995, J ZOOL SYST EVOL RES, V33, P145; Beutel RG, 2001, EUR J ENTOMOL, V98, P219, DOI 10.14411/eje.2001.039; Beutel RG, 2000, INVERTEBR TAXON, V14, P825, DOI 10.1071/IT00030; BOLOGNA M A, 1992, Tropical Zoology, V5, P55; Bologna MA, 2003, ANN SOC ENTOMOL FR, V39, P139, DOI 10.1080/00379271.2003.10697369; Bologna MA, 2002, J NAT HIST, V36, P2013, DOI 10.1080/00222930110062318; Bologna MA, 2001, AFR ENTOMOL, V9, P105; Bologna MA, 1998, TROP ZOOL, V11, P19, DOI 10.1080/03946975.1998.10539352; Bologna MA, 1995, B ZOOL, V62, P383, DOI 10.1080/11250009509356093; Bologna MA, 2001, SYST ENTOMOL, V26, P33, DOI 10.1046/j.1365-3113.2001.00132.x; Bologna MA, 2010, HDB ZOOLOGY, V2, P681; Bologna MA, 2008, CONTRIB ZOOL, V77, P227, DOI 10.1163/18759866-07704003; Bouchard P, 2005, ANN ZOOL, V55, P499; Crowson RA, 1981, BIOL COLEOPTERA; Di Giulio A, 2003, TROP ZOOL, V16, P165, DOI 10.1080/03946975.2003.10531193; DYBAS H S, 1976, Fieldiana Zoology, V70, P29; Grebennikov VV, 2002, ARTHROPOD STRUCT DEV, V31, P157, DOI 10.1016/S1467-8039(02)00022-1; Josting E. A., 1942, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V67, P381; KINZELBACH R K, 1971, Zoologica (Stuttgart), V41, P1; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; Niehuis O, 2012, CURRENT BIOL; PINTO J D, 1970, P222; Pinto JD, 1999, J NAT HIST, V33, P569, DOI 10.1080/002229399300254; Pinto JD, 1996, SYST ENTOMOL, V21, P63, DOI 10.1111/j.1365-3113.1996.tb00599.x; Pohl H, 2010, MICROSC RES TECHNIQ, V73, P1073, DOI 10.1002/jemt.20835; Pohl Hans, 2000, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V10, P1; Polilov AA, 2010, ARTHROPOD STRUCT DEV, V39, P52, DOI 10.1016/j.asd.2009.08.005; Polilov AA, 2009, ARTHROPOD STRUCT DEV, V38, P247, DOI 10.1016/j.asd.2008.11.003; Selander R.B., 1991, Insecta Mundi, V5, P65; SELANDER RB, 1987, DEUT ENTOMOL Z, V34, P341; SELANDER RB, 1982, J KANSAS ENTOMOL SOC, V55, P427; SELANDER RB, 1987, J KANSAS ENTOMOL SOC, V60, P288; SELANDER RICHARD B., 1960, ILLINOIS BIOL MONOGR, V28, P1; Tagwireyi D, 2000, TOXICON, V38, P1865, DOI 10.1016/S0041-0101(00)00093-3; Turco F, 2006, DEUT ENTOMOL Z, V53, P213, DOI 10.1002/mmnd.200600017; von Keler S., 1963, ENTOMOLOGISCHES WORT; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; YOUNG DK, 1991, CAN J ZOOL, V69, P2234, DOI 10.1139/z91-312	46	14	17	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52511	10.1371/journal.pone.0052511	http://dx.doi.org/10.1371/journal.pone.0052511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300692	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800097
J	Kahan, J; Mancini, L; Urner, M; Friston, KJ; Hariz, M; Holl, E; White, M; Ruge, D; Jahanshahi, M; Boertien, T; Yousry, T; Thornton, JS; Limousin, P; Zrinzo, L; Foltynie, T				Kahan, Josh; Mancini, Laura; Urner, Maren; Friston, Karl J.; Hariz, Marwan; Holl, Etienne; White, Mark; Ruge, Diane; Jahanshahi, Marjan; Boertien, Tessel; Yousry, Tarek; Thornton, John S.; Limousin, Patricia; Zrinzo, Ludvic; Foltynie, Tom			Therapeutic Subthalamic Nucleus Deep Brain Stimulation Reverses Cortico-Thalamic Coupling during Voluntary Movements in Parkinson's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; EFFECTIVE CONNECTIVITY; FUNCTIONAL MRI; ACTIVATION; MOTOR; ASSOCIATION; MODELS; DISORDERS; PATTERN; SAFETY	Deep brain stimulation of the subthalamic nucleus (STN DBS) has become an accepted treatment for patients experiencing the motor complications of Parkinson's disease (PD). While its successes are becoming increasingly apparent, the mechanisms underlying its action remain unclear. Multiple studies using radiotracer-based imaging have investigated DBS-induced regional changes in neural activity. However, little is known about the effect of DBS on connectivity within neural networks; in other words, whether DBS impacts upon functional integration of specialized regions of cortex. In this work, we report the first findings of fMRI in 10 subjects with PD and fully implanted DBS hardware receiving efficacious stimulation. Despite the technical demands associated with the safe acquisition of fMRI data from patients with implanted hardware, robust activation changes were identified in the insula cortex and thalamus in response to therapeutic STN DBS. We then quantified the neuromodulatory effects of DBS and compared sixteen dynamic causal models of effective connectivity between the two identified nodes. Using Bayesian model comparison, we found unequivocal evidence for the modulation of extrinsic (between region), i.e. cortico-thalamic and thalamo-cortical connections. Using Bayesian model parameter averaging we found that during voluntary movements, DBS reversed the effective connectivity between regions of the cortex and thalamus. This casts the therapeutic effects of DBS in a fundamentally new light, emphasising a role in changing distributed cortico-subcortical interactions. We conclude that STN DBS does impact upon the effective connectivity between the cortex and thalamus by changing their sensitivities to extrinsic afferents. Furthermore, we confirm that fMRI is both feasible and is tolerated well by these patients provided strict safety measures are adhered to.	[Kahan, Josh; Hariz, Marwan; Ruge, Diane; Jahanshahi, Marjan; Boertien, Tessel; Limousin, Patricia; Zrinzo, Ludvic; Foltynie, Tom] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Mancini, Laura; White, Mark; Yousry, Tarek; Thornton, John S.] Natl Hosp Neurol & Neurosurg UCLH NHS Fdn Trust, Lysholm Dept Neuroradiol, London, England; [Mancini, Laura; White, Mark; Thornton, John S.] UCL Inst Neurol, Neuroradiol Acad Unit, Dept Brain Repair & Rehabil, London, England; [Zrinzo, Ludvic] Natl Hosp Neurol & Neurosurg UCLH NHS Fdn Trust, Victor Horsley Dept Neurosurg, London, England; [Urner, Maren; Friston, Karl J.] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Urner, Maren] UCL, UCL Inst Cognit Neurosci, London, England; [Holl, Etienne] Med Univ Graz, Dept Neurosurg, Graz, Austria	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Medical University of Graz	Kahan, J (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	joshua.kahan@ucl.ac.uk	Kahan, Joshua/AAO-2239-2020; Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909; Zrinzo, Ludvic/0000-0002-6013-4946; Kahan, Joshua/0000-0002-1443-9837; Thornton, John/0000-0003-3248-8437	Brain Research trust; Astor Foundation; Rosetrees Trust; MHMS General Charitable Trust; Wellcome Trust; Parkinson's Appeal; Monument trust; UK Department of Health's NIHR Biomedical Research Centres funding scheme	Brain Research trust; Astor Foundation; Rosetrees Trust(Rosetrees Trust); MHMS General Charitable Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Parkinson's Appeal(Parkinson's UK); Monument trust; UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This study was funded by the Brain Research trust (www.brt.org.uk). Josh Kahan receives funding from The Astor Foundation, The Rosetrees Trust, and the MHMS General Charitable Trust. Karl Friston receives funding from the Wellcome Trust. The Unit of Functional Neurosurgery is funded by the Parkinson's Appeal and the Monument trust. The work was undertaken by UCL/UCLH, who receive a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Allen P, 2010, NEUROIMAGE, V49, P947, DOI 10.1016/j.neuroimage.2009.08.038; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Ballanger B, 2009, J CEREBR BLOOD F MET, V29, P1743, DOI 10.1038/jcbfm.2009.111; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Boertien T, 2011, MOVEMENT DISORDERS O; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dima D, 2011, J NEUROSCI, V31, P14378, DOI 10.1523/JNEUROSCI.2400-11.2011; Dorval AD, 2008, J NEUROPHYSIOL, V100, P2807, DOI 10.1152/jn.90763.2008; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etgen T, 2003, J NEUROL, V250, P226, DOI 10.1007/s00415-003-0984-5; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Foltynie T, 2011, J NEUROL NEUROSUR PS, V82, P358, DOI 10.1136/jnnp.2010.205542; Foltynie T, 2010, EXPERT REV NEUROTHER, V10, P903, DOI 10.1586/ERN.10.68; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Guo YX, 2008, J NEUROPHYSIOL, V99, P1477, DOI 10.1152/jn.01080.2007; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Hesselmann V, 2004, EUR RADIOL, V14, P686, DOI 10.1007/s00330-003-2051-0; Holl EM, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7422a; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lambert C, 2011, NEUROIMAGE; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Phillips MD, 2006, RADIOLOGY, V239, P209, DOI 10.1148/radiol.2391041990; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Rowe JB, 2010, NEUROIMAGE, V52, P1015, DOI 10.1016/j.neuroimage.2009.12.080; Seghier ML, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.001422007, 10.3389/fnsys.2010.00142]; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Strafella AP, 2003, NEUROLOGY, V60, P1039, DOI 10.1212/01.WNL.0000052691.48076.92; Thobois S, 2002, J NEUROL, V249, P1689, DOI 10.1007/s00415-002-0906-y; Vulliemoz S, 2011, NEUROIMAGE, V54, P182, DOI 10.1016/j.neuroimage.2010.08.004; Xu WD, 2008, J NEUROSCI, V28, P11916, DOI 10.1523/JNEUROSCI.2027-08.2008; Zrinzo L, 2011, WORLD NEUROSURG, V76, P164, DOI 10.1016/j.wneu.2011.02.029	56	52	53	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50270	10.1371/journal.pone.0050270	http://dx.doi.org/10.1371/journal.pone.0050270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300524	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800006
J	MacLeod, AK; Davies, G; Payton, A; Tenesa, A; Harris, SE; Liewald, D; Ke, XY; Luciano, M; Lopez, LM; Gow, AJ; Corley, J; Redmond, P; McNeill, G; Pickles, A; Ollier, W; Horan, M; Starr, JM; Pendleton, N; Thomson, PA; Porteous, DJ; Deary, IJ				MacLeod, Andrew K.; Davies, Gail; Payton, Antony; Tenesa, Albert; Harris, Sarah E.; Liewald, David; Ke, Xiayi; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul; McNeill, Geraldine; Pickles, Andrew; Ollier, William; Horan, Michael; Starr, John M.; Pendleton, Neil; Thomson, Pippa A.; Porteous, David J.; Deary, Ian J.			Genetic Copy Number Variation and General Cognitive Ability	PLOS ONE			English	Article							RARE CHROMOSOMAL DELETIONS; HIDDEN-MARKOV MODEL; GENOME-WIDE; MISSING HERITABILITY; STRUCTURAL VARIATION; MENTAL-RETARDATION; HUMAN INTELLIGENCE; INCREASE RISK; COMMON SNPS; AUTISM	Differences in genomic structure between individuals are ubiquitous features of human genetic variation. Specific copy number variants (CNVs) have been associated with susceptibility to numerous complex psychiatric disorders, including attention-deficit-hyperactivity disorder, autism-spectrum disorders and schizophrenia. These disorders often display comorbidity with low intelligence. Rare chromosomal deletions and duplications are associated with these disorders, so it has been suggested that these deletions or duplications may be associated with differences in intelligence. Here we investigate associations between large (>= 500kb), rare (< 1% population frequency) CNVs and both fluid and crystallized intelligence in community-dwelling older people. We observe no significant associations between intelligence and total CNV load. Examining individual CNV regions previously implicated in neuropsychological disorders, we find suggestive evidence that CNV regions around SHANK3 are associated with fluid intelligence as derived from a battery of cognitive tests. This is the first study to examine the effects of rare CNVs as called by multiple algorithms on cognition in a large non-clinical sample, and finds no effects of such variants on general cognitive ability.	[MacLeod, Andrew K.; Harris, Sarah E.; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Starr, John M.; Thomson, Pippa A.; Porteous, David J.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [MacLeod, Andrew K.; Harris, Sarah E.; Thomson, Pippa A.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Med Genet Sect, Ctr Mol Med, Edinburgh, Midlothian, Scotland; [Davies, Gail; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Payton, Antony; Ollier, William] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Ke, Xiayi] UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England; [McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Pickles, Andrew] Univ Manchester, Dept Med, Sch Epidemiol & Hlth Sci, Manchester M13 9PL, Lancs, England; [Horan, Michael; Pendleton, Neil] Univ Manchester, Neurodegenerat Res Grp, Sch Community Based Med, Manchester, Lancs, England; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of London; University College London; University of Aberdeen; University of Manchester; University of Manchester; University of Edinburgh	MacLeod, AK (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	andrew.macleod@ed.ac.uk; i.deary@ed.ac.uk	Porteous, David J/C-7289-2013; Deary, Ian J/C-6297-2009; Pickles, Andrew/A-9625-2011; Lopez, Lorna/AAR-4912-2020; Pendleton, Neil/F-2333-2015; Gow, Alan J/A-6070-2009; Luciano, Michelle/F-7277-2010; Porteous, David/AAA-3446-2021; MacLeod, Andrew/Q-8655-2016	Porteous, David J/0000-0003-1249-6106; Deary, Ian J/0000-0002-1733-263X; Pickles, Andrew/0000-0003-1283-0346; Lopez, Lorna/0000-0002-0241-9783; Pendleton, Neil/0000-0003-0794-2386; Gow, Alan J/0000-0002-3320-4531; Luciano, Michelle/0000-0003-0935-7682; Porteous, David/0000-0003-1249-6106; MacLeod, Andrew/0000-0003-3298-5193; Tenesa, Albert/0000-0003-4884-4475; McNeill, Geraldine/0000-0003-0373-650X; Payton, Antony/0000-0003-0335-152X	UK's Biotechnology and Biological Sciences Research Council (BBSRC); RCUK Fellowship; AXA research fund; BBSRC [BB/F022441/1, BB/F019394/1] Funding Source: UKRI; MRC [G1001375, G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1, BB/F022441/1] Funding Source: researchfish; Medical Research Council [G0700704, G1001375] Funding Source: researchfish	UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RCUK Fellowship(UK Research & Innovation (UKRI)); AXA research fund(AXA Research Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Genotyping and analyses of the cohorts conducted here were supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). ML is a Royal Society of Edinburgh/Lloyds TSB Foundation for Scotland Personal Research Fellow. PAT is partially funded by an RCUK Fellowship. LML is funded by the AXA research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Blauw HM, 2010, HUM MOL GENET, V19, P4091, DOI 10.1093/hmg/ddq323; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2007, BMC GERIATRICS, V7; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Edelmann L, 2009, ANN NY ACAD SCI, V1151, P157, DOI 10.1111/j.1749-6632.2008.03610.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frank B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-83; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hill SK, 2004, AM J PSYCHIAT, V161, P996, DOI 10.1176/appi.ajp.161.6.996; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Houlihan LM, 2009, GENES BRAIN BEHAV, V8, P238, DOI 10.1111/j.1601-183X.2008.00470.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ingason A, 2009, MOL PSYCHIAT; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; McMullan DJ, 2009, HUM MUTAT, V30, P1082, DOI 10.1002/humu.21015; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Mitchell KJ, 2010, SCHIZOPHR RES, V117, P222, DOI 10.1016/j.schres.2010.02.318; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Nelson H., 1991, NATL ADULT READING T; Payton A, 2009, NEUROPSYCHOL REV, V19, P451, DOI 10.1007/s11065-009-9116-z; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Raven JC, 1977, MANUAL RAVENS PROGR; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wechsler D, 1998, WAIS 3 UK ADM SCORIN; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang Y, 2007, MOL IMMUNOL, V44, P261, DOI 10.1016/j.molimm.2006.07.268; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339; Zhang D, 2011, PLOS ONE	83	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e37385	10.1371/journal.pone.0037385	http://dx.doi.org/10.1371/journal.pone.0037385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300510	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800001
J	Cao, CK; Zakharian, E; Borbiro, I; Rohacs, T				Cao, Chike; Zakharian, Eleonora; Borbiro, Istvan; Rohacs, Tibor			Interplay between Calmodulin and Phosphatidylinositol 4,5-Bisphosphate in Ca2(+)-induced Inactivation of Transient Receptor Potential Vanilloid 6 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CA2+ CHANNELS; K+ CHANNEL; TRPV6; PIP2; ACTIVATION; PROTEINS; BINDING	The epithelial Ca2(+) channel transient receptor potential vanilloid 6 (TRPV6) undergoes Ca2(+)-induced inactivation that protects the cell from toxic Ca2(+) overload and may also limit intestinal Ca2(+) transport. To dissect the roles of individual signaling pathways in this phenomenon, we studied the effects of Ca2(+), calmodulin (CaM), and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in excised inside-out patches. The activity of TRPV6 strictly depended on the presence of PI(4,5) P2, and Ca2(+)-CaM inhibited the channel at physiologically relevant concentrations. Ca2(+) alone also inhibited TRPV6 at high concentrations (IC50 = similar to 20 mu M). A double mutation in the distal C-terminal CaM-binding site of TRPV6 (W695A/R699E) essentially eliminated inhibition by CaM in excised patches. In whole cell patch clamp experiments, this mutation reduced but did not eliminate Ca2(+)-induced inactivation. Providing excess PI(4,5)P-2 reduced the inhibition by CaM in excised patches and in planar lipid bilayers, but PI(4,5)P-2 did not inhibit binding of CaM to the C terminus of the channel. Overall, our data show a complex interplay between CaM and PI(4,5)P-2 and show that Ca2(+), CaM, and the depletion of PI(4,5)P-2 all contribute to inactivation of TRPV6.	[Cao, Chike; Zakharian, Eleonora; Borbiro, Istvan; Rohacs, Tibor] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			National Institutes of Health [NS055159, GM093290, GM098052]; University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290, R01GM098052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055159 and GM093290 (to T. R.) and GM098052 (to E. Z.). This work was also supported by a grant from the University of Medicine and Dentistry of New Jersey Foundation (to T. R.).	Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; Kovalevskaya Nadezda V., 2012, Journal of Structural and Functional Genomics, V13, P91, DOI 10.1007/s10969-012-9128-4; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Park EJ, 2009, BIOL PHARM BULL, V32, P1790, DOI 10.1248/bpb.32.1790; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Thyagarajan B, 2009, MOL PHARMACOL, V75, P608, DOI 10.1124/mol.108.052449; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	39	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5278	5290		10.1074/jbc.M112.409482	http://dx.doi.org/10.1074/jbc.M112.409482			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300090	hybrid, Green Published			2022-12-25	WOS:000315342500003
J	Kleinschmit, A; Takemura, M; Dejima, K; Choi, PY; Nakato, H				Kleinschmit, Adam; Takemura, Masahiko; Dejima, Katsufumi; Choi, Pui Yee; Nakato, Hiroshi			Drosophila Heparan Sulfate 6-O-Endosulfatase Sulf1 Facilitates Wingless (Wg) Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGEN GRADIENT FORMATION; ENDOCYTIC PATHWAY; BINDING-SITES; PROTEOGLYCAN; GLYPICAN; QSULF1; IDENTIFICATION; ENDOSULFATASE; SYSTEM; GROWTH	Heparan sulfate proteoglycans regulate various physiological and developmental processes through interactions with a number of protein ligands. Heparan sulfate (HS)-ligand binding depends on the amount and patterns of sulfate groups on HS, which are controlled by various HS sulfotransferases in the Golgi apparatus as well as extracellular 6-O-endosulfatases called "Sulfs." Sulfs are a family of secreted molecules that specifically remove 6-O-sulfate groups within the highly sulfated regions on HS. Vertebrate Sulfs promote Wnt signaling, whereas the only Drosophila homologue of Sulfs, Sulf1, negatively regulates Wingless (Wg) signaling. To understand the molecular mechanism for the negative regulation of Wg signaling by Sulf1, we studied the effects of Sulf1 on HS-Wg interaction and Wg stability. Sulf1 overexpression strongly inhibited the binding of Wg to Dally, a potential target heparan sulfate proteoglycan of Sulf1. This effect of Drosophila Sulf1 on the HS-Wg interaction is similar to that of vertebrate Sulfs. Using in vitro, in vivo, and ex vivo systems, we show that Sulf1 reduces extracellular Wg protein levels, at least partly by facilitating Wg degradation. In addition, expression of human Sulf1 in the Drosophila wing disc lowers the levels of extracellular Wg protein, as observed for Drosophila Sulf1. Our study demonstrates that vertebrate and Drosophila Sulfs have an intrinsically similar activity and that the function of Sulfs in the fate of Wnt/Wg ligands is context-dependent.	[Kleinschmit, Adam; Takemura, Masahiko; Dejima, Katsufumi; Choi, Pui Yee; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H.N.). This work was also supported by a grant from the American Heart Association (to A. K. and H.N.).	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bengali Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017248; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Hirst M, 2001, P NATL ACAD SCI USA, V98, P8726, DOI 10.1073/pnas.141413598; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wojcinski A, 2011, DEV BIOL, V358, P168, DOI 10.1016/j.ydbio.2011.07.027; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562	49	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5081	5089		10.1074/jbc.M112.447029	http://dx.doi.org/10.1074/jbc.M112.447029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23300081	Green Published, hybrid			2022-12-25	WOS:000315340400056
J	Lopez-Acosta, JF; Moreno-Amador, JL; Jimenez-Palomares, M; Diaz-Marrero, AR; Cueto, M; Perdomo, G; Cozar-Castellano, I				Francisco Lopez-Acosta, Jose; Luis Moreno-Amador, Jose; Jimenez-Palomares, Margarita; Diaz-Marrero, Ana R.; Cueto, Mercedes; Perdomo, German; Cozar-Castellano, Irene			Epoxypukalide Induces Proliferation and Protects against Cytokine-Mediated Apoptosis in Primary Cultures of Pancreatic beta-Cells	PLOS ONE			English	Article							CYCLIN D2; REPLICATION; MOLECULE; GROWTH; INFLAMMATION; EXPRESSION; EXPANSION; HUMANS; MICE; MASS	There is an urgency to find new treatments for the devastating epidemic of diabetes. Pancreatic beta-cells viability and function are impaired in the two most common forms of diabetes, type 1 and type 2. Regeneration of pancreatic beta-cells has been proposed as a potential therapy for diabetes. In a preliminary study, we screened a collection of marine products for beta-cell proliferation. One unique compound (epoxypukalide) showed capability to induce beta-cell replication in the cell line INS1 832/13 and in primary rat cell cultures. Epoxypukalide was used to study beta-cell proliferation by [H-3] thymidine incorporation and BrdU incorporation followed by BrdU/insulin staining in primary cultures of rat islets. AKT and ERK1/2 signalling pathways were analyzed. Cell cycle activators, cyclin D2 and cyclin E, were detected by western-blot. Apoptosis was studied by TUNEL and cleaved caspase 3. beta-cell function was measured by glucose-stimulated insulin secretion. Epoxypukalide induced 2.5-fold increase in beta-cell proliferation; this effect was mediated by activation of ERK1/2 signalling pathway and upregulation of the cell cycle activators, cyclin D2 and cyclin E. Interestingly, epoxypukalide showed protection from basal (40% lower versus control) and cytokine-induced apoptosis (80% lower versus control). Finally, epoxypukalide did not impair beta-cell function when measured by glucose-stimulated insulin secretion. In conclusion, epoxypukalide induces beta-cell proliferation and protects against basal and cytokine-mediated beta-cell death in primary cultures of rat islets. These findings may be translated into new treatments for diabetes.	[Francisco Lopez-Acosta, Jose; Cozar-Castellano, Irene] Univ Valladolid, IBGM, Valladolid, Spain; [Francisco Lopez-Acosta, Jose; Luis Moreno-Amador, Jose; Jimenez-Palomares, Margarita; Perdomo, German; Cozar-Castellano, Irene] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Diaz-Marrero, Ana R.; Cueto, Mercedes] CSIC, Inst Prod Nat & Agrobiol, Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Cozar-Castellano, I (corresponding author), Univ Valladolid, IBGM, Valladolid, Spain.	cozarirene@gmail.com	Perdomo, German/K-6703-2014; Jimenez-Palomares, Margarita/ABG-8855-2020; Cozar-Castellano, Irene/B-5625-2015; Cueto, MERCEDES/L-3185-2014; Marrero, Ana R. Díaz/L-2899-2014	Perdomo, German/0000-0002-2301-0012; Cozar-Castellano, Irene/0000-0002-6065-5362; Cueto, MERCEDES/0000-0002-9112-6877; Marrero, Ana R. Díaz/0000-0002-8886-7519; Jimenez-Palomares, Margarita/0000-0002-3051-194X; Moreno Amador, Jose Luis/0000-0002-8028-2735	ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain [PS09/00671, CP08/00094]; Europe-FP7 Marie Curie grant [IRG-247835]; Servicio Andaluz de Salud [PI-0256/2009]	ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain; Europe-FP7 Marie Curie grant; Servicio Andaluz de Salud	This work was supported by ISCIII-Subdireccion Geeneral de Evaluacion y Fomento de la nvestigacion, Spain (PS09/00671 and CP08/00094), Europe-FP7 Marie Curie grant (IRG-247835) and Servicio Andaluz de Salud (PI-0256/2009) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorta E, 2007, TETRAHEDRON, V63, P9057, DOI 10.1016/j.tet.2007.06.080; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Grote D, 2008, CHEM BIODIVERS, V5, P2449, DOI 10.1002/cbdv.200890210; Guthalu Kondegowda Nagesha, 2010, Diabetes, V59, P3131, DOI 10.2337/db09-1796; KSEBATI MB, 1984, J NAT PROD, V47, P1009, DOI 10.1021/np50036a018; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Salpeter SJ, 2011, ENDOCRINOLOGY, V152, P2589, DOI 10.1210/en.2010-1372; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	23	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52862	10.1371/journal.pone.0052862	http://dx.doi.org/10.1371/journal.pone.0052862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300997	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900042
J	Adamcic, U; Yurkiewich, A; Coomber, BL				Adamcic, Una; Yurkiewich, Alexander; Coomber, Brenda L.			Differential Expression of Tie2 Receptor and VEGFR2 by Endothelial Clones Derived from Isolated Bovine Mononuclear Cells	PLOS ONE			English	Article							BONE-MARROW CELLS; PROGENITOR CELLS; THERAPEUTIC NEOVASCULARIZATION; TIP CELLS; PHENOTYPIC HETEROGENEITY; IN-VITRO; TRANSPLANTATION; ANGIOGENESIS; MECHANISMS; ISCHEMIA	The purpose of these experiments was to evaluate the expression of endothelial markers, such as Tie2 and VEGFR2 in endothelial cells derived from blood mononuclear endothelial progenitor cells. Bovine mononuclear cells were isolated using separation by centrifugation and were grown in endothelial specific media supplemented with growth factors. Isolation of the whole cell population of mononuclear cells (MNC) from bovine peripheral blood gave rise to progenitor-like cells (CD45(-)) that, although morphologically similar, have different phenotypes revealed by expression of endothelial specific markers Tie2 and VEGFR2. Plating of MNCs on collagen and fibronectin gave rise to more colonies than non-coated dishes. Occasional colonies from MNC isolations had a mural cell phenotype, negative for Tie2 and VEGFR2 but positive for smooth muscle actin and PDGFR beta. Although cells expressing high levels of VEGFR2 and low levels of Tie2, and vice versa were both able to form cords on Matrigel, cells with higher expression of Tie2 migrate faster in a scratch assay than ones with lower expression of Tie2. When these different clones of cells were introduced in mice through tail vein injections, they retained an ability to home to angiogenesis occurring in a subcutaneous Matrigel plug, regardless of their Tie2/VEGFR2 receptor expression patterns, but cells with high VEGFR2/low Tie2 were more likely to be CD31 positive. Therefore, we suggest that active sites of angiogenesis (such as wounds, tumors, etc.) can attract a variety of endothelial cell precursors that may differentially express Tie2 and VEGFR2 receptors, and thus affect our interpretation of EPCs as biomarkers or therapies for vascular disease.	[Adamcic, Una; Yurkiewich, Alexander; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Coomber, BL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	bcoomber@uoguelph.ca			Canadian Institutes of Health Research [81213]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by an Operating Grant (MOP # 81213) to BLC from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; COOMBER BL, 1995, J CELL BIOCHEM, V58, P199, DOI 10.1002/jcb.240580209; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Deshpande H, 2011, VASC CELL, V3, P16; Fathers KE, 2005, AM J PATHOL, V167, P1753, DOI 10.1016/S0002-9440(10)61256-4; Gehling UM, 2007, BLOOD, V110, P1073, DOI 10.1182/blood-2007-03-081638; Gerhardt H, 2005, EXP SUPPL, V94, P3; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P45, DOI 10.1160/TH06-04-0185; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hsu JY, 2009, BIODRUGS, V23, P289, DOI 10.2165/11317600-000000000-00000; Ii M, 2010, METHODS MOL BIOL, V660, P9, DOI 10.1007/978-1-60761-705-1_2; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kuczynski EA, 2011, CANCER-AM CANCER SOC, V117, P5601, DOI 10.1002/cncr.26247; Kuczynski EA, 2011, ONCOLOGY-BASEL, V81, P126, DOI 10.1159/000332849; Lyon CA, 2010, J VASC SURG, V52, P1301, DOI 10.1016/j.jvs.2010.05.096; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mross K, 2011, CLIN MED INSIGHTS ON, V5, P213; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Smadja DM, 2007, CELL BIOL TOXICOL, V23, P223, DOI 10.1007/s10565-007-0177-6; Takahashi M, 2009, CURR PHARM DESIGN, V15, P2778, DOI 10.2174/138161209788923813; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Weber A, 2004, EUR J CARDIO-THORAC, V26, P137, DOI 10.1016/j.ejcts.2004.03.024; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	49	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53385	10.1371/journal.pone.0053385	http://dx.doi.org/10.1371/journal.pone.0053385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300924	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600095
J	Amorosi, CA; Myskova, H; Monti, MR; Argarana, CE; Morita, M; Kemp, S; de Kremer, RD; Dvorakova, L; de Ramirez, AMO				Anabel Amorosi, Cyntia; Myskova, Helena; Roxana Monti, Mariela; Enrique Argarana, Carlos; Morita, Masashi; Kemp, Stephan; Dodelson de Kremer, Raquel; Dvorakova, Lenka; Oller de Ramirez, Ana Maria			X-Linked Adrenoleukodystrophy: Molecular and Functional Analysis of the ABCD1 Gene in Argentinean Patients	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SKIN FIBROBLASTS; PROTEIN; PLASMA; MUTATIONS; OXIDATION; SEQUENCE; PMP70; ALDP	X-linked adrenoleukodystrophy (X-ALD) is an inherited metabolic disease associated with mutations in the ABCD1 gene that encodes an ATP-binding cassette transporter protein, ALDP. The disease is characterized by increased concentrations of very long-chain fatty acids (VLCFAs) in plasma and in adrenal, testicular and nervous tissues, due to a defect in peroxisomal VLCFA beta-oxidation. In the present study, we analyzed 10 male patients and 17 female carriers from 10 unrelated pedigrees with X-ALD from Argentina. By sequencing the ABCD1 we detected 9 different mutations, 8 of which were novel. These new mutations were verified by a combination of methods that included both functional (western blot and peroxisomal VLCFA beta-oxidation) and bioinformatics analysis. The spectrum of novel mutations consists of 3 frameshift (p.Ser284fs*16, p.Glu380Argfs*21 and p.Thr254Argfs*82); a deletion (p.Ser572_Asp575del); a splicing mutation (c.1081+5G>C) and 3 missense mutations (p.Ala341Asp, p.His420Pro and p.Tyr547Cys). In one patient 2 changes were found: a known missense (p.His669Arg) and an unpublished amino acid substitution (p.Ala19Ser). In vitro studies suggest that p.Ala19Ser is a polymorphism. Moreover, we identified two novel intronic polymorphisms and two amino acid polymorphisms. In conclusion, this study extends the spectrum of mutation in X-ALD and facilitates the identification of heterozygous females.	[Anabel Amorosi, Cyntia; Dodelson de Kremer, Raquel; Oller de Ramirez, Ana Maria] Univ Nacl Cordoba, Fac Med, Hosp Ninos, Ctr Estudio Metabolopatias Congenitas CEMECO,Cate, RA-5000 Cordoba, Argentina; [Myskova, Helena; Dvorakova, Lenka] First Fac Med, Inst Inherited Metab Disorders, Prague, Czech Republic; [Myskova, Helena; Dvorakova, Lenka] Gen Fac Hosp, Prague, Czech Republic; [Roxana Monti, Mariela; Enrique Argarana, Carlos] Natl Univ Cordoba, Sch Chem, Dept Biol Chem, CIQUIBIC, Cordoba, Argentina; [Morita, Masashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 930, Japan; [Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Pediatr,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands	National University of Cordoba; Charles University Prague; General University Hospital Prague; National University of Cordoba; University of Toyama; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Amorosi, CA (corresponding author), Univ Nacl Cordoba, Fac Med, Hosp Ninos, Ctr Estudio Metabolopatias Congenitas CEMECO,Cate, RA-5000 Cordoba, Argentina.	cytiam@hotmail.com	Kemp, Stephan/A-3935-2008; Dvorakova, Lenka/F-5011-2017	Kemp, Stephan/0000-0003-2023-064X; Dvorakova, Lenka/0000-0002-1620-3211	Fundacion Florencio Fiorini; Universidad Nacional de Cordoba (SECyT-UNC); Grant for Secretaria de Ciencia y Tecnologia;  [1116 PREST. BID 2437/OC-AR];  [VZ MSM CR 0021620806];  [PRVOUK-P24/LF1/3];  [RVO-VFN64165/2012]	Fundacion Florencio Fiorini; Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Grant for Secretaria de Ciencia y Tecnologia; ; ; ; 	This research was supported by a Grant for PICT 2010-FONCYT No1116 PREST. BID 2437/OC-AR, Fundacion Florencio Fiorini, Grant for Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SECyT-UNC), Grant support: VZ MSM CR 0021620806, PRVOUK-P24/LF1/3, RVO-VFN64165/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi CA, 2010, HUM GENET, V127, P463; Aveldano MI, 1996, CLIN CHEM, V42, P454; Bezman L, 1998, AM J MED GENET, V76, P415, DOI 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Dvorakova L, 2001, HUM MUTAT, V18, P52, DOI 10.1002/humu.1149; Echeverri PO, 2005, ACTA NEUROL COLOMB, V21, P299; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 2000, CELL BIOCHEM BIOPHYS, V32, P131, DOI 10.1385/CBB:32:1-3:131; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; Moser HW, 1991, MEASUREMENT SATURATE, P177; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pereira FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034195; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; SARDE CO, 1994, MAMM GENOME, V5, P810, DOI 10.1007/BF00292021; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; Soardi FC, 2010, ARQ BRAS ENDOCRINOL, V54, P738, DOI 10.1590/S0004-27302010000800013; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takahashi N, 2007, J NEUROCHEM, V101, P1632, DOI 10.1111/j.1471-4159.2007.04457.x; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Vargas CR, 2004, BBA-MOL BASIS DIS, V1688, P26, DOI 10.1016/j.bbadis.2003.10.004; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	33	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52635	10.1371/journal.pone.0052635	http://dx.doi.org/10.1371/journal.pone.0052635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300730	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600021
J	Della Gaspera, B; Armand, AS; Lecolle, S; Charbonnier, F; Chanoine, C				Della Gaspera, Bruno; Armand, Anne-Sophie; Lecolle, Sylvie; Charbonnier, Frederic; Chanoine, Christophe			Mef2d Acts Upstream of Muscle Identity Genes and Couples Lateral Myogenesis to Dermomyotome Formation in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2C; NEURAL-TUBE CLOSURE; CONVERGENT EXTENSION; MOUSE EMBRYOGENESIS; PARAXIAL MESODERM; SOMITE FORMATION; EXPRESSION; DIFFERENTIATION; MYOD; CELLS	Xenopus myotome is formed by a first medial and lateral myogenesis directly arising from the presomitic mesoderm followed by a second myogenic wave emanating from the dermomyotome. Here, by a series of gain and loss of function experiments, we showed that Mef2d, a member of the Mef2 family of MADS-box transcription factors, appeared as an upstream regulator of lateral myogenesis, and as an inducer of dermomyotome formation at the beginning of neurulation. In the lateral presomitic cells, we showed that Mef2d transactivates Myod expression which is necessary for lateral myogenesis. In the most lateral cells of the presomitic mesoderm, we showed that Mef2d and Paraxis (Tcf15), a member of the Twist family of transcription factors, were co-localized and activate directly the expression of Meox2, which acts upstream of Pax3 expression during dermomyotome formation. Cell tracing experiments confirm that the most lateral Meox2 expressing cells of the presomitic mesoderm correspond to the dermomyotome progenitors since they give rise to the most dorsal cells of the somitic mesoderm. Thus, Xenopus Mef2d couples lateral myogenesis to dermomyotome formation before somite segmentation. These results together with our previous works reveal striking similarities between dermomyotome and tendon formation in Xenopus: both develop in association with myogenic cells and both involve a gene transactivation pathway where one member of the Mef2 family, Mef2d or Mef2c, cooperates with a bHLH protein of the Twist family, Paraxis or Scx (Scleraxis) respectively. We propose that these shared characteristics in Xenopus laevis reflect the existence of a vertebrate ancestral mechanism which has coupled the development of the myogenic cells to the formation of associated tissues during somite compartmentalization.	[Della Gaspera, Bruno; Armand, Anne-Sophie; Lecolle, Sylvie; Charbonnier, Frederic; Chanoine, Christophe] Univ Paris 05, Ctr Univ St Peres, Ctr Etud Sensori Motricite, UMR 8194,CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Della Gaspera, B (corresponding author), Univ Paris 05, Ctr Univ St Peres, Ctr Etud Sensori Motricite, UMR 8194,CNRS, Paris, France.	bruno.della-gaspera@parisdescartes.fr		chanoine, christophe/0000-0001-8155-2357; Armand, Anne-Sophie/0000-0002-0291-6421; Charbonnier, Frederic/0000-0003-4341-3246; della gaspera, bruno/0000-0002-0652-1822	CNRS; AFM (Association Francaise contre les Myopathies)	CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies)	This work was supported by grants from CNRS and AFM (Association Francaise contre les Myopathies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES V, 1995, MOL CELL BIOL, V15, P4272; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Becker C, 2003, DEV DYNAM, V227, P445, DOI 10.1002/dvdy.10318; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; CANDIA AF, 1995, MECH DEVELOP, V52, P27, DOI 10.1016/0925-4773(95)00384-D; Carpio R, 2004, DEV DYNAM, V231, P609, DOI 10.1002/dvdy.20147; Charbonnier F, 2002, J BIOL CHEM, V277, P1139, DOI 10.1074/jbc.M107018200; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Colas A, 2008, DEV BIOL, V320, P351, DOI 10.1016/j.ydbio.2008.05.547; Daughters RS, 2011, DEVELOPMENT, V138, P821, DOI 10.1242/dev.056481; Davidson LA, 1999, DEVELOPMENT, V126, P4547; Della Gaspera B, 2006, DEV DYNAM, V235, P524, DOI 10.1002/dvdy.20628; Della Gaspera B, 2012, DEV DYNAM, V241, P995, DOI 10.1002/dvdy.23780; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; FRANK D, 1991, DEVELOPMENT, V113, P1387; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; HARVEY RP, 1990, DEVELOPMENT, V108, P669; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; JENNINGS CGB, 1992, DEV BIOL, V150, P121, DOI 10.1016/0012-1606(92)90012-6; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Keren A, 2005, DEV BIOL, V288, P73, DOI 10.1016/j.ydbio.2005.09.020; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kusakabe R, 2007, DEV DYNAM, V236, P2410, DOI 10.1002/dvdy.21177; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; Leise WF, 2004, DEVELOPMENT, V131, P1703, DOI 10.1242/dev.01054; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Mariani FV, 2001, DEV CELL, V1, P115, DOI 10.1016/S1534-5807(01)00018-1; Martin BL, 2001, DEV BIOL, V239, P270, DOI 10.1006/dbio.2001.0434; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; SCALES JB, 1990, MOL CELL BIOL, V10, P1516, DOI 10.1128/MCB.10.4.1516; Steinbach OC, 1998, DEV BIOL, V202, P280, DOI 10.1006/dbio.1998.8993; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; WONG MW, 1994, DEV BIOL, V166, P683, DOI 10.1006/dbio.1994.1347; Yusuf F, 2006, ANAT EMBRYOL, V211, pS21, DOI 10.1007/s00429-006-0119-8	76	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52359	10.1371/journal.pone.0052359	http://dx.doi.org/10.1371/journal.pone.0052359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300648	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600015
J	Hua, XD; Yang, JF; Wang, LM; Fang, QK; Zhang, GP; Liu, FQ				Hua, Xiude; Yang, Jifei; Wang, Limin; Fang, Qingkui; Zhang, Gaiping; Liu, Fengquan			Development of an Enzyme Linked Immunosorbent Assay and an Immunochromatographic Assay for Detection of Organophosphorus Pesticides in Different Agricultural Products	PLOS ONE			English	Article							RAPID DETECTION; MONOCLONAL-ANTIBODIES; LIQUID-CHROMATOGRAPHY; CHLORPYRIFOS-METHYL; GAS-CHROMATOGRAPHY; HAPTEN HETEROLOGY; IMMUNOASSAY; PARATHION; WATER; MICROEXTRACTION	Objective: Organophosphorus (OP) pesticides are considered hazardous substances because of their high toxicity to nontarget species and their persistence in the environment and agricultural products. Therefore, it is important to develop a rapid, sensitive, and economical method for detecting OP pesticides and their residues in food and the environment. Methods: A broad, selective monoclonal antibody (MAb) for organophosphorus pesticides was produced. Based on the MAb, an enzyme linked immunosorbent assay (ELISA) and an immunochromatography assay (ICA) for detecting OP pesticides in different agricultural products were developed using a binding inhibition format on microtiter plates and a membrane strip, respectively. Results: Under the optimized conditions, the IC50 values of the ELISA ranged from 3.7 to 162.2 ng mL(-1) for the 8 OP pesticides. The matrix interferences of Apple, Chinese cabbage, and greengrocery were removed by 40-fold dilution, the recoveries from spiked samples ranged from 79.1% to 118.1%. The IC50 values of ICA for the 8 OP pesticides ranged from 11.8 to 470.4 ng mL(-1). The matrix interference was removed from the Chinese cabbage and Apple samples with 5-fold dilution, and the interference was removed from the greengrocery samples with 20-fold dilution. The recoveries from the spiked samples ranged between 70.6 and 131.9%. The established ELISA and ICA were specific selectivity for the 8 OP pesticides. Conclusions: The established ELISA is a sensitive screening method for the detection of OP pesticides, but the ELISA detection method depends on a laboratory platform and requires a relative long assay time and several steps operation. The established ICA is very useful as a screening method for the quantitative, semi-quantitative or qualitative detection of OP pesticides in agricultural products, and it has advantages over ELISA methods with regard to factors such as the testing procedure, testing time, and matrix interferences, among others.	[Hua, Xiude; Wang, Limin; Fang, Qingkui; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Hua, Xiude; Wang, Limin; Fang, Qingkui; Liu, Fengquan] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Yang, Jifei; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Nanjing Agricultural University; Henan Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com			National High Technology Research and Development Program of China [2012AA101401-1]; Key Projects in the National Science & Technology Pillar Program [2009BADB9B03]; China Agriculture Research System [nycytx-29]; Natural Science Foundation of Jiangsu Province [BK2010445]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Projects in the National Science & Technology Pillar Program; China Agriculture Research System; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National High Technology Research and Development Program of China (2012AA101401-1), the Key Projects in the National Science & Technology Pillar Program (2009BADB9B03), the earmarked fund for the China Agriculture Research System (nycytx-29) and the Natural Science Foundation of Jiangsu Province (BK2010445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandler J, 2000, IVD TECHNOL, V6, P37, DOI DOI 10.1111/jfd.13302; Farran A, 1996, J CHROMATOGR A, V737, P109, DOI 10.1016/0021-9673(96)00145-8; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gandhi S, 2009, BIOSENS BIOELECTRON, V25, P502, DOI 10.1016/j.bios.2009.07.018; Gas F, 2010, BIOSENS BIOELECTRON, V25, P1235, DOI 10.1016/j.bios.2009.09.033; Gui WJ, 2008, ANAL BIOCHEM, V377, P202, DOI 10.1016/j.ab.2008.03.013; Gui WJ, 2009, ANAL BIOCHEM, V393, P88, DOI 10.1016/j.ab.2009.06.014; Hua XD, 2010, BIOSENS BIOELECTRON, V26, P189, DOI 10.1016/j.bios.2010.06.005; Jang MS, 2002, B KOR CHEM SOC, V23, P1116; Johnson JC, 1998, J AGR FOOD CHEM, V46, P3116, DOI 10.1021/jf970191y; Kim MJ, 2003, ANAL CHIM ACTA, V493, P47, DOI 10.1016/S0003-2670(03)00793-1; Kim YJ, 2003, ANAL CHIM ACTA, V494, P29, DOI 10.1016/j.aca.2003.07.003; Kim YJ, 2007, ANAL CHIM ACTA, V591, P183, DOI 10.1016/j.aca.2007.03.072; Kim YA, 2011, ANAL CHIM ACTA, V693, P106, DOI 10.1016/j.aca.2011.03.011; Kolosova AY, 2004, ANAL CHIM ACTA, V511, P323, DOI 10.1016/j.aca.2004.01.047; Krotzky AJ, 1995, PURE APPL CHEM, V67, P2065, DOI 10.1351/pac199567122065; LANGONE JJ, 1982, METHOD ENZYMOL, V84, P628; Li DW, 2009, BIOSENS BIOELECTRON, V24, P2277, DOI 10.1016/j.bios.2008.11.004; Liu Y, 2009, MICROCHEM J, V93, P36, DOI 10.1016/j.microc.2009.04.004; Liu YH, 2007, ANAL CHIM ACTA, V591, P173, DOI 10.1016/j.aca.2007.03.071; Morozova VS, 2005, J ANAL CHEM+, V60, P202, DOI 10.1007/s10809-005-0075-0; NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0; Padron-Sanz C, 2005, J CHROMATOGR A, V1078, P13, DOI 10.1016/j.chroma.2005.05.005; Pastor-Navarro N, 2007, TALANTA, V71, P923, DOI 10.1016/j.talanta.2006.05.073; Piao YZ, 2009, J AGR FOOD CHEM, V57, P10004, DOI 10.1021/jf901998y; Qian GL, 2009, FOOD CHEM, V117, P364, DOI 10.1016/j.foodchem.2009.03.097; Reder S, 2003, BIOSENS BIOELECTRON, V19, P447, DOI 10.1016/S0956-5663(03)00202-1; Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07; Roex EWM, 2003, AQUAT TOXICOL, V64, P451, DOI 10.1016/S0166-445X(03)00100-0; ROTH J, 1983, TECHNIQUES IMMUNOCYT, V2, P217; Sun JW, 2010, ANAL CHIM ACTA, V666, P76, DOI 10.1016/j.aca.2010.03.051; Wang CM, 2010, J AGR FOOD CHEM, V58, P5658, DOI 10.1021/jf904575k; Wang CM, 2009, FOOD CHEM, V115, P365, DOI 10.1016/j.foodchem.2008.11.091; Xiao Q, 2006, TALANTA, V69, P848, DOI 10.1016/j.talanta.2005.11.024; Xu Y, 2010, FOOD CHEM, V119, P834, DOI 10.1016/j.foodchem.2009.08.049; Xu ZL, 2009, ANAL CHIM ACTA, V647, P90, DOI 10.1016/j.aca.2009.05.025; Yao ZW, 2001, TALANTA, V55, P807, DOI 10.1016/S0039-9140(01)00504-5; Zhang GP, 2006, J IMMUNOL METHODS, V312, P27, DOI 10.1016/j.jim.2006.02.017; Zhang Q, 2007, ANAL CHIM ACTA, V596, P303, DOI 10.1016/j.aca.2007.06.009; Zhou P, 2004, J AGR FOOD CHEM, V52, P4355, DOI 10.1021/jf0499121; Zhou Y, 2009, BIOSENS BIOELECTRON, V24, P2744, DOI 10.1016/j.bios.2009.01.034; Zhu J, 2008, ENVIRON POLLUT, V156, P136, DOI 10.1016/j.envpol.2007.12.020	42	31	33	2	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53099	10.1371/journal.pone.0053099	http://dx.doi.org/10.1371/journal.pone.0053099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300869	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600057
J	Morgan, RML; Hernandez-Ramirez, LC; Trivellin, G; Zhou, LH; Roe, SM; Korbonits, M; Prodromou, C				Morgan, Rhodri M. L.; Hernandez-Ramirez, Laura C.; Trivellin, Giampaolo; Zhou, Lihong; Roe, S. Mark; Korbonits, Marta; Prodromou, Chrisostomos			Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal alpha-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition	PLOS ONE			English	Article							ARYL-HYDROCARBON-RECEPTOR; CELL-CYCLE ARREST; AH RECEPTOR; EVOLUTIONARY CONSERVATION; ATPASE ACTIVITY; NUCLEIC-ACIDS; BREAST-CANCER; HSP90; GENE; ESTROGEN	Mutations of the aryl hydrocarbon receptor interacting protein (AIP) have been associated with familial isolated pituitary adenomas predisposing to young-onset acromegaly and gigantism. The precise tumorigenic mechanism is not well understood as AIP interacts with a large number of independent proteins as well as three chaperone systems, HSP90, HSP70 and TOMM20. We have determined the structure of the TPR domain of AIP at high resolution, which has allowed a detailed analysis of how disease-associated mutations impact on the structural integrity of the TPR domain. A subset of C-terminal alpha-7 helix (C alpha-7h) mutations, R304* (nonsense mutation), R304Q, Q307* and R325Q, a known site for AhR and PDE4A5 client-protein interaction, occur beyond those that interact with the conserved MEEVD and EDDVE sequences of HSP90 and TOMM20. These C-terminal AIP mutations appear to only disrupt client-protein binding to the C alpha-7h, while chaperone binding remains unaffected, suggesting that failure of client-protein interaction with the C alpha-7h is sufficient to predispose to pituitary adenoma. We have also identified a molecular switch in the AIP TPR-domain that allows recognition of both the conserved HSP90 motif, MEEVD, and the equivalent sequence (EDDVE) of TOMM20.	[Morgan, Rhodri M. L.; Zhou, Lihong; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Hernandez-Ramirez, Laura C.; Trivellin, Giampaolo; Korbonits, Marta] Queen Mary Univ London, Dept Endocrinol, Barts & London Sch Med, London, England	University of Sussex; University of London; Queen Mary University London	Prodromou, C (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	chris.prodromou@sussex.ac.uk	Trivellin, Giampaolo/J-6583-2016; Prodromou, Chrisostomos/ABA-9133-2021; Hernández-Ramírez, Laura C./F-7983-2017	Trivellin, Giampaolo/0000-0003-2384-4153; Prodromou, Chrisostomos/0000-0003-4320-1147; Hernández-Ramírez, Laura C./0000-0002-6599-6406; Korbonits, Marta/0000-0002-4101-9432; Roe, Mark/0000-0002-7371-9855	Diamond Light Source; Wellcome Trust [095605/Z11/Z]; National Council of Science and Technology of Mexico; Barts and The London Charity	Diamond Light Source; Wellcome Trust(Wellcome TrustEuropean Commission); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Barts and The London Charity	The authors acknowledge support from the Diamond Light Source and the Wellcome Trust senior investigator award (LHP), 095605/Z11/Z. LCH-R is supported by the National Council of Science and Technology of Mexico and by the Barts and The London Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025201; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chahal HS, 2011, NEW ENGL J MED, V364, P43, DOI 10.1056/NEJMoa1008020; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cook C, 2012, J ALZHEIMERS DIS JAD; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Oliveira SK, 2007, J BIOL CHEM, V282, P13656, DOI 10.1074/jbc.M610942200; de Oliveira SK, 2009, BIOCHEM PHARMACOL, V77, P723, DOI 10.1016/j.bcp.2008.08.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Hollingshead BD, 2004, J BIOL CHEM, V279, P45652, DOI 10.1074/jbc.M407840200; Huang GM, 2005, MOL PHARMACOL, V67, P88, DOI 10.1124/mol.104.002410; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Jackson SE, 2012, HSP90 STRUCTURE FUNC; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Linnert M, 2012, BIOMOL NMR ASSIGN, V6, P209, DOI 10.1007/s12104-012-9359-0; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Muller P., 2012, ONCOGENE; Ozfirat Z, 2010, MOL CELL ENDOCRINOL, V326, P71, DOI 10.1016/j.mce.2010.05.001; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Persson I, 1999, CANCER CAUSE CONTROL, V10, P253, DOI 10.1023/A:1008909128110; Pocar P, 2005, REPRODUCTION, V129, P379, DOI 10.1530/rep.1.00294; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Safe S, 2000, J MAMMARY GLAND BIOL, V5, P295, DOI 10.1023/A:1009550912337; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Zeng Q, 2008, J PATHOL, V214, P425, DOI 10.1002/path.2297; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	58	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53339	10.1371/journal.pone.0053339	http://dx.doi.org/10.1371/journal.pone.0053339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300914	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000313872600085
J	Oka, O; Waters, LC; Strong, SL; Dosanjh, NS; Veverka, V; Muskett, FW; Renshaw, PS; Klempnauer, KH; Carr, MD				Oka, Ojore; Waters, Lorna C.; Strong, Sarah L.; Dosanjh, Nuvjeevan S.; Veverka, Vaclav; Muskett, Frederick W.; Renshaw, Philip S.; Klempnauer, Karl-Heinz; Carr, Mark D.			Interaction of the Transactivation Domain of B-Myb with the TAZ2 Domain of the Coactivator p300: Molecular Features and Properties of the Complex	PLOS ONE			English	Article							HUMAN HSP70 PROMOTER; N-TERMINAL DOMAIN; STRUCTURAL BASIS; TRANSCRIPTION FACTOR; SECONDARY STRUCTURE; CHEMICAL-SHIFT; CYCLIN D1; UNSTRUCTURED PROTEINS; UNFOLDED PROTEINS; ACTIVATION DOMAIN	The transcription factor B-Myb is a key regulator of the cell cycle in vertebrates, with activation of transcription involving the recognition of specific DNA target sites and the recruitment of functional partner proteins, including the coactivators p300 and CBP. Here we report the results of detailed studies of the interaction between the transactivation domain of B-Myb (B-Myb TAD) and the TAZ2 domain of p300. The B-Myb TAD was characterized using circular dichroism, fluorescence and NMR spectroscopy, which revealed that the isolated domain exists as a random coil polypeptide. Pull-down and spectroscopic experiments clearly showed that the B-Myb TAD binds to p300 TAZ2 to form a moderately tight (K-d, similar to 1.0-10 mu M) complex, which results in at least partial folding of the B-Myb TAD. Significant changes in NMR spectra of p300 TAZ2 suggest that the B-Myb TAD binds to a relatively large patch on the surface of the domain (similar to 1200 angstrom(2)). The apparent B-Myb TAD binding site on p300 TAZ2 shows striking similarity to the surface of CBP TAZ2 involved in binding to the transactivation domain of the transcription factor signal transducer and activator of transcription 1 (STAT1), which suggests that the structure of the B-Myb TAD-p300 TAZ2 complex may share many features with that reported for STAT1 TAD-p300 TAZ2.	[Oka, Ojore; Waters, Lorna C.; Strong, Sarah L.; Dosanjh, Nuvjeevan S.; Veverka, Vaclav; Muskett, Frederick W.; Renshaw, Philip S.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Leicester; University of Munster	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 7RH, Leics, England.	lw83@le.ac.uk; mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Oka, Ojore/H-4456-2013; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	Wellcome Trust [083629/Z/07/Z]; UCB Celltech Ltd; UK Biotechnology and Biological Sciences Research Council; University of Leicester	Wellcome Trust(Wellcome TrustEuropean Commission); UCB Celltech Ltd(UCB Pharma SA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leicester	The work reported here was funded by equipment and project grants from the Wellcome Trust (083629/Z/07/Z: http://www.wellcome.ac.uk/). Vaclav Veverka is supported by a collaborative grant from UCB Celltech Ltd (http://www.ucb.com/) and Nuvjeevan Dosanjh was supported by a Ph.D studentship from UK Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx). Ojore Oka was awarded a Ph.D scholarship by the University of Leicester (www.le.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bartusel T, 2005, GENE, V351, P171, DOI 10.1016/j.gene.2005.03.035; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; FOOS G, 1993, ONCOGENE, V8, P1775; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Garner E., 1998, GEN INF SER WORKSH G, V9, P201; Goodman RH, 2000, GENE DEV, V14, P1553; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; He J, 2011, NUCLEIC ACIDS RES, V39, P4464, DOI 10.1093/nar/gkr030; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; IYER KS, 1973, J BIOL CHEM, V248, P707; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; LEE MS, 1992, J BIOMOL NMR, V2, P307, DOI 10.1007/BF01874810; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Miller M, 2009, ACTA CRYSTALLOGR D, V65, P1301, DOI 10.1107/S0907444909040153; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; NAKAGOSHI H, 1993, J BIOL CHEM, V268, P14161; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; O'Connor MJ, 1999, J VIROL, V73, P3574; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Sala A, 1999, ONCOGENE, V18, P1333, DOI 10.1038/sj.onc.1202421; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Sala A, 1999, J CELL PHYSIOL, V179, P245; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Toribio F, 1996, J CHROMATOGR B, V684, P77, DOI 10.1016/0378-4347(95)00504-8; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; WATSON RJ, 1993, NUCLEIC ACIDS RES, V21, P267, DOI 10.1093/nar/21.2.267; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52906	10.1371/journal.pone.0052906	http://dx.doi.org/10.1371/journal.pone.0052906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300815	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600035
J	Reid, CN; Stevenson, M; Abogunrin, F; Ruddock, MW; Emmert-Streib, F; Lamont, JV; Williamson, KE				Reid, Cherith N.; Stevenson, Michael; Abogunrin, Funso; Ruddock, Mark W.; Emmert-Streib, Frank; Lamont, John V.; Williamson, Kate E.			Standardization of Diagnostic Biomarker Concentrations in Urine: The Hematuria Caveat	PLOS ONE			English	Article							BLADDER-CANCER; CREATININE; PROTEOMICS; PROTEINS; VALIDATION; DISCOVERY; ACCURACY; MARKERS	Sensitive and specific urinary biomarkers can improve patient outcomes in many diseases through informing early diagnosis. Unfortunately, to date, the accuracy and translation of diagnostic urinary biomarkers into clinical practice has been disappointing. We believe this may be due to inappropriate standardization of diagnostic urinary biomarkers. Our objective was therefore to characterize the effects of standardizing urinary levels of IL-6, IL-8, and VEGF using the commonly applied standards namely urinary creatinine, osmolarity and protein. First, we report results based on the biomarker levels measured in 120 hematuric patients, 80 with pathologically confirmed bladder cancer, 27 with confounding pathologies and 13 in whom no underlying cause for their hematuria was identified, designated "no diagnosis''. Protein levels were related to final diagnostic categories (p = 0.022, ANOVA). Osmolarity (mean = 529 mOsm; median = 528 mOsm) was normally distributed, while creatinine (mean = 10163 mu mol/l, median = 9350 mu mol/l) and protein (0.3297, 0.1155 mg/ml) distributions were not. When we compared AUROCs for IL-6, IL-8 and VEGF levels, we found that protein standardized levels consistently resulted in the lowest AUROCs. The latter suggests that protein standardization attenuates the "true'' differences in biomarker levels across controls and bladder cancer samples. Second, in 72 hematuric patients; 48 bladder cancer and 24 controls, in whom urine samples had been collected on recruitment and at follow-up (median = 11 (1 to 20 months)), we demonstrate that protein levels were approximately 24% lower at follow-up (Bland Altman plots). There was an association between differences in individual biomarkers and differences in protein levels over time, particularly in control patients. Collectively, our findings identify caveats intrinsic to the common practice of protein standardization in biomarker discovery studies conducted on urine, particularly in patients with hematuria.	[Reid, Cherith N.; Ruddock, Mark W.; Lamont, John V.] Randox Labs, Crumlin, North Ireland; [Stevenson, Michael] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland; [Abogunrin, Funso; Emmert-Streib, Frank; Williamson, Kate E.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Randox Laboratories; Queens University Belfast; Queens University Belfast	Williamson, KE (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	k.williamson@qub.ac.uk	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020; Abogunrin, Funso/L-5108-2015	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; Abogunrin, Funso/0000-0002-5931-6072	Randox Laboratories Ltd.	Randox Laboratories Ltd.	Randox Laboratories undertook laboratory analyses on anonymised patient samples. Randox played no role in data analyses which were undertaken by MS, FES and KW (Queen's University Belfast). Randox employees contributed to the preparation of the manuscript but were not involved in the decision to publish which was taken by Queen's University Belfast. The funders, Randox Laboratories Ltd., played no role in the design of the case control study and were not involved in collection of patient data and samples.	Abogunrin F, 2011, CANCER, V18, P2641; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Bazari H., 2007, CECIL MED; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Chen YT, 2010, J PROTEOME RES, V9, P5803, DOI 10.1021/pr100576x; Eissa Sanaa, 2007, Cancer Biomarkers, V3, P275; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Garde AH, 2004, ANN OCCUP HYG, V48, P171, DOI 10.1093/annhyg/meh019; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Henry T.J., 1974, CLIN CHEM, V2nd; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Julian BA, 2009, PROTEOM CLIN APPL, V3, P1029, DOI 10.1002/prca.200800243; Kashif W, 2003, CLEV CLIN J MED, V70, P535, DOI 10.3949/ccjm.70.6.535; Lee JW, 2009, BIOANALYSIS, V1, P1461, DOI 10.4155/BIO.09.130; Leibovici D, 2005, J CLIN ONCOL, V23, P5746, DOI 10.1200/JCO.2005.01.598; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Margel D, 2011, EUR UROL, V59, P113, DOI 10.1016/j.eururo.2010.10.008; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; Pesic I, 2011, J PROTEOMICS, V74, P1994, DOI 10.1016/j.jprot.2011.05.020; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Sanchez-Carbayo M, 2000, UROLOGY, V55, P526, DOI 10.1016/S0090-4295(99)00557-9; Seegmiller JC, 2009, CLIN CHEM, V55, P1991, DOI 10.1373/clinchem.2009.129833; Sertic J, 2007, CLIN CHEM LAB MED, V45, P1347, DOI 10.1515/CCLM.2007.321; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Svatek RS, 2006, CANCER-AM CANCER SOC, V106, P1701, DOI 10.1002/cncr.21795; Urquidi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037797	33	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53354	10.1371/journal.pone.0053354	http://dx.doi.org/10.1371/journal.pone.0053354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300915	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600086
J	Uno, Y; Nishida, C; Tarui, H; Ishishita, S; Takagi, C; Nishimura, O; Ishijima, J; Ota, H; Kosaka, A; Matsubara, K; Murakami, Y; Kuratani, S; Ueno, N; Agata, K; Matsuda, Y				Uno, Yoshinobu; Nishida, Chizuko; Tarui, Hiroshi; Ishishita, Satoshi; Takagi, Chiyo; Nishimura, Osamu; Ishijima, Junko; Ota, Hidetoshi; Kosaka, Ayumi; Matsubara, Kazumi; Murakami, Yasunori; Kuratani, Shigeru; Ueno, Naoto; Agata, Kiyokazu; Matsuda, Yoichi			Inference of the Protokaryotypes of Amniotes and Tetrapods and the Evolutionary Processes of Microchromosomes from Comparative Gene Mapping	PLOS ONE			English	Article							SEX-CHROMOSOMES; GENOME ANALYSIS; BIRD; INSIGHTS; REVEALS; TURTLE; ORIGIN; DIFFERENTIATION; RECONSTRUCTION; SALAMANDER	Comparative genome analysis of non-avian reptiles and amphibians provides important clues about the process of genome evolution in tetrapods. However, there is still only limited information available on the genome structures of these organisms. Consequently, the protokaryotypes of amniotes and tetrapods and the evolutionary processes of microchromosomes in tetrapods remain poorly understood. We constructed chromosome maps of functional genes for the Chinese soft-shelled turtle (Pelodiscus sinensis), the Siamese crocodile (Crocodylus siamensis), and the Western clawed frog (Xenopus tropicalis) and compared them with genome and/or chromosome maps of other tetrapod species (salamander, lizard, snake, chicken, and human). This is the first report on the protokaryotypes of amniotes and tetrapods and the evolutionary processes of microchromosomes inferred from comparative genomic analysis of vertebrates, which cover all major non-avian reptilian taxa (Squamata, Crocodilia, Testudines). The eight largest macrochromosomes of the turtle and chicken were equivalent, and 11 linkage groups had also remained intact in the crocodile. Linkage groups of the chicken macrochromosomes were also highly conserved in X. tropicalis, two squamates, and the salamander, but not in human. Chicken microchromosomal linkages were conserved in the squamates, which have fewer microchromosomes than chicken, and also in Xenopus and the salamander, which both lack microchromosomes; in the latter, the chicken microchromosomal segments have been integrated into macrochromosomes. Our present findings open up the possibility that the ancestral amniotes and tetrapods had at least 10 large genetic linkage groups and many microchromosomes, which corresponded to the chicken macro-and microchromosomes, respectively. The turtle and chicken might retain the microchromosomes of the amniote protokaryotype almost intact. The decrease in number and/or disappearance of microchromosomes by repeated chromosomal fusions probably occurred independently in the amphibian, squamate, crocodilian, and mammalian lineages.	[Uno, Yoshinobu; Ishishita, Satoshi; Matsuda, Yoichi] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nishida, Chizuko; Ishijima, Junko; Kosaka, Ayumi; Matsubara, Kazumi] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido, Japan; [Tarui, Hiroshi; Nishimura, Osamu] RIKEN Ctr Dev Biol, Genome Resource & Anal Subunit, Kobe, Hyogo, Japan; [Takagi, Chiyo; Ueno, Naoto] Natl Inst Basic Biol, Div Morphogenesis, Okazaki, Aichi 444, Japan; [Nishimura, Osamu; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Nishimura, Osamu] Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Kyoto, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Kobe, Hyogo 6500044, Japan; [Ota, Hidetoshi] Univ Hyogo, Museum Nat & Human Act, Kobe, Hyogo 6500044, Japan; [Murakami, Yasunori; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo, Japan; [Ueno, Naoto] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	Nagoya University; Hokkaido University; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; Kyoto University; University of Hyogo; University of Hyogo; RIKEN; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Matsuda, Y (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	yoimatsu@agr.nagoya-u.ac.jp	Ueno, Naoto/B-3307-2015; Kuratani, Shigeru/J-4146-2014; Nishimura, Osamu/AAC-1236-2020	Kuratani, Shigeru/0000-0001-9717-7221; Nishimura, Osamu/0000-0003-1969-2580; Matsubara, Kazumi/0000-0002-6680-1084; Ueno, Naoto/0000-0002-8375-2317; Uno, Yoshinobu/0000-0001-9609-1186; Agata, Kiyokazu/0000-0002-5195-2576	Ministry of Education, Culture, Sports, Science and Technology in Japan [23113004, 22370081]; Kyoto University Global COE Program [A06]; Grants-in-Aid for Scientific Research [24770226] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (no. 23113004) and Grant-in-Aid for Scientific Research (no. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology in Japan, and the Kyoto University Global COE Program (A06) for Evolution and Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Arai R, 2011, FISH KARYOTYPES CHEC, P26; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Castoe TA, 2011, STAND GENOMIC SCI, V4, P257, DOI 10.4056/sigs.1664145; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Kawagoshi T, 2008, CHROMOSOME RES, V16, P1119, DOI 10.1007/s10577-008-1263-1; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kuraku S, 2006, CHROMOSOME RES, V14, P187, DOI 10.1007/s10577-006-1035-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; Morescalchi A., 1973, P233; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Rock J, 1996, CYTOGENET CELL GENET, V73, P187, DOI 10.1159/000134336; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Signorino G., 2005, CHROMOREP REPTILE CH; Smith JJ, 2007, GENETICS, V177, P607, DOI 10.1534/genetics.107.072033; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2005, GENETICS, V171, P1161, DOI 10.1534/genetics.105.046433; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Uno Y, 2008, CHROMOSOME RES, V16, P999, DOI 10.1007/s10577-008-1257-z; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang F, 2003, P NATL ACAD SCI USA, V100, P1062, DOI 10.1073/pnas.0335540100	49	69	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53027	10.1371/journal.pone.0053027	http://dx.doi.org/10.1371/journal.pone.0053027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300852	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600050
J	Semlali, A; Witoled, C; Alanazi, M; Rouabhia, M				Semlali, Abdelhabib; Witoled, Chmielewski; Alanazi, Mohammed; Rouabhia, Mahmoud			Whole Cigarette Smoke Increased the Expression of TLRs, HBDs, and Proinflammory Cytokines by Human Gingival Epithelial Cells through Different Signaling Pathways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; BETA-CAROTENE; ORAL-CANCER; INFLAMMATION; ACTIVATION; RECEPTORS; MOLECULES	The gingival epithelium is becoming known as a regulator of the oral innate immune responses to a variety of insults such as bacteria and chemicals, including those chemicals found in cigarette smoke. We investigated the effects of whole cigarette smoke on cell-surface-expressed Toll-like receptors (TLR)-2, -4 and -6, human beta-defensin (HBD) and proinflammatory cytokine expression and production in primary human gingival epithelial cells. Whole cigarette smoke was shown to increase TLR2, TLR4 and TLR6 expression. Cigarette smoke led to ERK1/2, p38 and JNK phosphorylation in conjunction with nuclear factor-kappa B (NF kappa B) translocation into the nucleus. TLR expression following cigarette smoke exposure was down regulated by the use of ERK1/2, p38, JNK MAP kinases, and NF kappa B inhibitors, suggesting the involvement of these signaling pathways in the cellular response against cigarette smoke. Cigarette smoke also promoted HBD2, HBD3, IL-1 beta, and IL-6 expression through the ERK1/2 and NF kappa B pathways. Interestingly, the modulation of TLR, HBD, and cytokine expression was maintained long after the gingival epithelial cells were exposed to smoke. By promoting TLR, HBDs, and proinflammatory cytokine expression and production, cigarette smoke may contribute to innate immunity dysregulation, which may have a negative effect on human health.	[Semlali, Abdelhabib; Witoled, Chmielewski; Rouabhia, Mahmoud] Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Semlali, Abdelhabib; Alanazi, Mohammed] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia	Laval University; King Saud University	Rouabhia, M (corresponding author), Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.	mahmoud.rouabhia@fmd.ulaval.ca	Semlali, Abdelhabib/AAP-7043-2020	Semlali, Abdelhabib/0000-0002-1643-0377; Rouabhia, Mahmoud/0000-0003-2205-8281	Natural Sciences and Engineering Research Council of Canada (NSERC); "Fonds Emile-Beaulieu", Laval University Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds Emile-Beaulieu", Laval University Foundation	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Program (MR), and "Fonds Emile-Beaulieu", Laval University Foundation (MR and WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balansky R, 2012, ARCH TOXICOL, V86, P509, DOI 10.1007/s00204-011-0765-3; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BLUHM AL, 1971, NATURE, V229, P500, DOI 10.1038/229500a0; BROWN GP, 1989, AM J PHYSIOL, V256, pC260, DOI 10.1152/ajpcell.1989.256.2.C260; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen L, 2010, EUR RESPIR J, V36, P638, DOI 10.1183/09031936.00029409; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; De Nardo D, 2009, J IMMUNOL, V183, P8110, DOI 10.4049/jimmunol.0901031; Decanis N, 2009, CYTOKINE, V45, P132, DOI 10.1016/j.cyto.2008.11.011; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Eckmann L, 2006, CURR OPIN GASTROEN, V22, P95, DOI 10.1097/01.mog.0000208458.38772.2a; Fooladi Abbas Ali Imani, 2011, Inflammation & Allergy Drug Targets, V10, P198; Gao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009351; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Gorr SU, 2012, FRONT ORAL BIOL, V15, P84, DOI 10.1159/000329673; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Herfs M, 2012, AM J RESP CELL MOL B; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Janardhanam SB, 2011, ARCH ORAL BIOL; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kashiwagi Y, 2011, ARCH ORAL BIOL; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khorram O, 2010, FERTIL STERIL, V93, P257, DOI 10.1016/j.fertnstert.2008.09.074; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SY, 2006, AM J PHYSIOL-LUNG C, V291, pL84, DOI 10.1152/ajplung.00388.2005; Lee WK, 2007, AM J RHINOL, V21, P658, DOI 10.2500/ajr.2007.21.3094; Li Q, 2010, TRANSL RES, V156, P326, DOI 10.1016/j.trsl.2010.09.001; Lim DM, 2009, AM J PHYSIOL-GASTR L, V297, pG1172, DOI 10.1152/ajpgi.00065.2009; Liu XD, 2007, BIOCHEM BIOPH RES CO, V353, P121, DOI 10.1016/j.bbrc.2006.11.147; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Malemud CJ, 2007, CURR OPIN PHARMACOL, V7, P339, DOI 10.1016/j.coph.2006.11.012; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Muscat JE, 2011, CANCER-AM CANCER SOC, V117, P5377, DOI 10.1002/cncr.26235; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Nagler R, 2010, BBA-MOL BASIS DIS, V1802, P454, DOI 10.1016/j.bbadis.2010.01.008; Nihon-Yanagi Y, 2012, CANCER IMMUNOL IMMUN, V61, P71, DOI 10.1007/s00262-011-1085-4; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Palozza P, 2004, CARCINOGENESIS, V25, P1315, DOI 10.1093/carcin/bgh142; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pelaia G, 2004, J CELL BIOCHEM, V93, P142, DOI 10.1002/jcb.20124; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Proctor I, 2012, J CLIN PATHOL, V65, P129, DOI 10.1136/jclinpath-2011-200299; Profita M, 2011, LIFE SCI, V89, P36, DOI 10.1016/j.lfs.2011.04.025; Proia NK, 2006, CANCER EPIDEM BIOMAR, V15, P1061, DOI 10.1158/1055-9965.EPI-05-0983; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Rouabhia M, 2011, MED MYCOL, V49, P458, DOI 10.3109/13693786.2010.535031; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Semlali A, 2011, J PERIODONTAL RES, V46, P533, DOI 10.1111/j.1600-0765.2011.01370.x; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Shibata Y, 2008, RESPIROLOGY, V13, P1061, DOI 10.1111/j.1440-1843.2008.01362.x; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh RK, 2012, MICROBIOL RES; Starrett W, 2011, J IMMUNOTOXICOL, V8, P150, DOI 10.3109/1547691X.2011.558529; Taybos G, 2003, AM J MED SCI, V326, P179, DOI 10.1097/00000441-200310000-00005; Tsoumakidou M, 2011, CURR DRUG TARGETS, V12, P450, DOI 10.2174/138945011794751546; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201; Witschi H, 2005, TOXICOL SCI, V84, P81, DOI 10.1093/toxsci/kfi043; Yu HM, 2011, BASIC CLIN PHARMACOL, V109, P63, DOI 10.1111/j.1742-7843.2011.00686.x	73	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52614	10.1371/journal.pone.0052614	http://dx.doi.org/10.1371/journal.pone.0052614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300722	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500040
J	Cha, S; Yu, H; Kim, JY				Cha, Seongwon; Yu, Hyunjoo; Kim, Jong Yeol			Bone Mineral Density-Associated Polymorphisms Are Associated with Obesity-Related Traits in Korean Adults in a Sex-Dependent Manner	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; AORTIC CALCIFICATION; RISK-FACTOR; OSTEOPOROSIS; FRACTURE; MEN; PROGRESSION; PHENOTYPES; MENOPAUSE	Obesity and osteoporosis share common physiological factors, including the presence of atherosclerosis, a risk factor for cardiometabolic disease, as well as a common progenitor that differentiates into both adipocytes and osteoblasts. Among the 23 polymorphisms associated with bone mineral density (BMD) in recent genome-wide association studies (GWASs), an Osterix polymorphism has been identified and associated with childhood obesity in girls. Therefore, we focused on elucidating polymorphisms associated with adulthood obesity in a sex-dependent manner among the previously published BMD-associated polymorphisms from GWASs. We performed 2 screenings of 18 BMD-associated polymorphisms for obesity-related traits in 2,362 adults aged > 20 years. We excluded 13 polymorphisms showing deviations from Hardy-Weinberg equilibrium or no association with obesity-related traits (body mass index, waist circumference (WC), and waist-to-hip ratio). Among 5 selected polymorphisms (rs9594738 of RANKL, rs17066364 of NUFIP1, rs7227401 of OSBPL1A, and rs1856057 and rs2982573 of ESR1) analyzed, 2 polymorphisms (rs9594738 and rs17066364) were associated with obesity-related traits. We found sex-dependent associations such that the 4 polymorphisms (excluding rs9594738 of RANKL) were associated with abdominal traits such as WC and waist-to-hip ratio only in men. In addition, when the combined genetic risk score (GRS) for WC increase was calculated with 4 SNPs (rs9594738, rs17066364, rs7227401, and rs1856057) exhibiting similar trends for both sexes, the magnitude of the GRS effect for the WC increase was larger in men than in women (effect size = 0.856 cm, P = 0.0000452 for men; effect size = 0.598 cm, P = 0.00228 for women). In summary, we found 4 polymorphisms, previously related to osteoporosis, to be associated to obesity-related traits in a sex-dependent manner in Korean adults, particularly in men.	[Cha, Seongwon; Yu, Hyunjoo] KIOM, Constitut Med & Diag Res Grp, Div Med Res, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Cha, S (corresponding author), KIOM, Constitut Med & Diag Res Grp, Div Med Res, Taejon, South Korea.	scha@kiom.re.kr	Yeol, Kim Jong/AAP-5998-2020; Cha, Seongwon/A-2377-2012	Cha, Seongwon/0000-0001-9012-8718	Korea Science and Engineering Foundation (KOSEF) grant; Korea government (MEST) [20120009001, 2006-2005173]	Korea Science and Engineering Foundation (KOSEF) grant(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 20120009001 (2006-2005173)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CG, 2000, OSTEOPOROSIS INT, V11, P714, DOI 10.1007/s001980070071; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blum M, 2003, CALCIFIED TISSUE INT, V73, P27, DOI 10.1007/s00223-002-1019-4; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Farhat GN, 2007, OSTEOPOROSIS INT, V18, P999, DOI 10.1007/s00198-007-0338-8; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Gerber Y, 2011, AM J MED, V124, P418, DOI 10.1016/j.amjmed.2010.11.029; Gu JM, 2009, ACTA PHARMACOL SIN, V30, P1634, DOI 10.1038/aps.2009.169; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027312; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Imamov O, 2005, BIOL REPROD, V73, P866, DOI 10.1095/biolreprod.105.043497; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Jeong S, 2011, J BIOTECHNOL, V154, P321, DOI 10.1016/j.jbiotec.2011.05.017; Jorgensen L, 2001, STROKE, V32, P47, DOI 10.1161/01.STR.32.1.47; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim BY, 2012, J ALTERN COMPLEM MED, V18, P262, DOI 10.1089/acm.2010.0764; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim KC, 2010, YONSEI MED J, V51, P857, DOI 10.3349/ymj.2010.51.6.857; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210/jc.86.5.1884; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Premaor MO, 2011, J CLIN ENDOCR METAB, V96, P2414, DOI 10.1210/jc.2011-0076; Raspa M, 2010, AJIDD-AM J INTELLECT, V115, P482, DOI 10.1352/1944-7558-115.6.482; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; von der Recke P, 1999, AM J MED, V106, P273, DOI 10.1016/S0002-9343(99)00028-5; Xie H, 2011, CARDIOVASC RES, V92, P296, DOI 10.1093/cvr/cvr200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zhao JH, 2011, OBESITY, V19, P1311, DOI 10.1038/oby.2010.324; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	48	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53013	10.1371/journal.pone.0053013	http://dx.doi.org/10.1371/journal.pone.0053013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300848	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100109
J	D'Angelo, A; De Angelis, A; Avallone, B; Piscopo, I; Tammaro, R; Studer, M; Franco, B				D'Angelo, Anna; De Angelis, Amalia; Avallone, Bice; Piscopo, Immacolata; Tammaro, Roberta; Studer, Michele; Franco, Brunella			Ofd1 Controls Dorso-Ventral Patterning and Axoneme Elongation during Embryonic Brain Development	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; PRIMARY CILIA FORMATION; DEVELOPING NEOCORTEX; GENE-EXPRESSION; TELENCEPHALON DEVELOPMENT; TRANSCRIPTION FACTORS; DORSAL TELENCEPHALON; POSTMITOTIC NEURONS; MOUSE TELENCEPHALON; REPRESSOR FUNCTIONS	Oral-facial-digital type I syndrome (OFDI) is a human X-linked dominant-male-lethal developmental disorder caused by mutations in the OFD1 gene. Similar to other inherited disorders associated to ciliary dysfunction OFD type I patients display neurological abnormalities. We characterized the neuronal phenotype that results from Ofd1 inactivation in early phases of mouse embryonic development and at post-natal stages. We determined that Ofd1 plays a crucial role in forebrain development, and in particular, in the control of dorso-ventral patterning and early corticogenesis. We observed abnormal activation of Sonic hedgehog (Shh), a major pathway modulating brain development. Ultrastructural studies demonstrated that early Ofd1 inactivation results in the absence of ciliary axonemes despite the presence of mature basal bodies that are correctly orientated and docked. Ofd1 inducible-mediated inactivation at birth does not affect ciliogenesis in the cortex, suggesting a developmental stage-dependent role for a basal body protein in ciliogenesis. Moreover, we showed defects in cytoskeletal organization and apical-basal polarity in Ofd1 mutant embryos, most likely due to lack of ciliary axonemes. Thus, the present study identifies Ofd1 as a developmental disease gene that is critical for forebrain development and ciliogenesis in embryonic life, and indicates that Ofd1 functions after docking and before elaboration of the axoneme in vivo.	[D'Angelo, Anna; De Angelis, Amalia; Piscopo, Immacolata; Tammaro, Roberta; Studer, Michele; Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Avallone, Bice] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Franco, Brunella] Univ Naples Federico II, Dept Pediat, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II	Franco, B (corresponding author), Telethon Inst Genet & Med TIGEM, Via Pietro Castellino 111, Naples, Italy.	franco@tigem.it	Avallone, Bice/ABB-3425-2020; Studer, Michele/P-4580-2016; FRANCO, Brunella/S-2882-2018	Avallone, Bice/0000-0002-5355-1557; Studer, Michele/0000-0001-7105-2957; FRANCO, Brunella/0000-0001-5588-4569	Fondazione Telethon; European Community [201804, 241955]	Fondazione Telethon(Fondazione TelethonEuropean Commission); European Community(European Commission)	This work was supported by Fondazione Telethon (http://www.telethon.it/en) and the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreements 201804 and 241955. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Besse L, 2011, DEVELOPMENT, V138, P2079, DOI 10.1242/dev.059808; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Blotta S, 2009, BLOOD, V114, P3276, DOI 10.1182/blood-2009-04-219436; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BULFONE A, 1993, J NEUROSCI, V13, P3155; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Fode C, 2000, GENE DEV, V14, P67; Fotaki V, 2006, J NEUROSCI, V26, P9282, DOI 10.1523/JNEUROSCI.2673-06.2006; Fotaki V, 2010, DEV DYNAM, V239, P284, DOI 10.1002/dvdy.22137; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Grove EA, 1998, DEVELOPMENT, V125, P2315; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Howard PW, 2010, TRANSGENIC RES, V19, P121, DOI 10.1007/s11248-009-9292-x; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hunkapiller J, 2011, STEM CELLS DEV, V20, P831, DOI 10.1089/scd.2010.0362; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Juric-Sekhar G, 2012, ACTA NEUROPATHOL, V123, P695, DOI 10.1007/s00401-012-0951-2; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Prattichizzo C, 2008, HUM MUTAT, V29, P1237, DOI 10.1002/humu.20792; Qin J, 2011, P NATL ACAD SCI US; Richardson M, 1999, MAMM GENOME, V10, P923, DOI 10.1007/s003359901115; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Ruat M, 2012, DIFFERENTIATION, V83, pS97, DOI 10.1016/j.diff.2011.11.011; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Sussel L, 1999, DEVELOPMENT, V126, P3359; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Vogel TW, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12222; Waclaw RR, 2004, DEVELOPMENT, V131, P4013, DOI 10.1242/dev.01272; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Willaredt MA, 2012, MECH DEV; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Winterbottom EF, 2010, DEVELOPMENT, V137, P2623, DOI 10.1242/dev.047159	93	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52937	10.1371/journal.pone.0052937	http://dx.doi.org/10.1371/journal.pone.0052937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300826	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100101
J	Hertzog, M; Monteiro, P; Le Dez, G; Chavrier, P				Hertzog, Maud; Monteiro, Pedro; Le Dez, Gaelle; Chavrier, Philippe			Exo70 Subunit of the Exocyst Complex Is Involved in Adhesion-Dependent Trafficking of Caveolin-1	PLOS ONE			English	Article							PLASMA-MEMBRANE; CELL-MIGRATION; DOMAINS; PROTEIN; INTERNALIZATION; INTEGRINS; INTERACTS; DYNAMICS; RAC	Caveolae are specialized domains of the plasma membrane, which play key roles in signaling, endocytosis and mechanosensing. Using total internal reflection fluorescent microscopy (TIRF-M), we observe that the exocyst subunit Exo70 forms punctuate structures at the plasma membrane and partially localizes with caveolin-1, the main component of caveolae. Upon cell detachment, we found that Exo70 accumulates with caveolin-1-positive vesicular structures. Upon cell re-adhesion, caveolin-1 traffics back to the plasma membrane in a multistep process involving microtubules and actin cytoskeleton. In addition, silencing of Exo70 redirects caveolin-1 to focal adhesions identified by markers such as alpha 5 integrin or vinculin. Based on these findings, we conclude that Exo70 is involved in caveolin-1 recycling to the plasma membrane during re-adhesion of the cells to the substratum.	[Hertzog, Maud; Monteiro, Pedro; Le Dez, Gaelle; Chavrier, Philippe] Inst Curie, CNRS, UMR144, Res Ctr, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Hertzog, M (corresponding author), Univ Toulouse 3, CNRS, LMGM, UMR 5100, F-31062 Toulouse, France.	maud.hertzog@ibcg.biotoul.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X; Le Dez, Gaelle/0000-0002-9247-9666; Monteiro, Pedro/0000-0002-1690-0252	Association pour la Recherche sur le Cancer [SL220100601356]; Agence Nationale pour la Recherche [ANR-08-BLAN-0111]; Institut Curie; Centre National de la Recherche Scientifique (National Center for Scientific Research, France)	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut Curie; Centre National de la Recherche Scientifique (National Center for Scientific Research, France)	Support was provided to PC by Association pour la Recherche sur le Cancer.(grant #SL220100601356) and Agence Nationale pour la Recherche (grant #ANR-08-BLAN-0111). Core funding for this work was provided by Institut Curie and Centre National de la Recherche Scientifique (National Center for Scientific Research, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hertzog M, 2011, BIOCHEM J, V433, P403, DOI 10.1042/BJ20101214; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mundy DI, 2012, MOL BIOL CELL, V23, P864, DOI 10.1091/mbc.E11-07-0598; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	28	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52627	10.1371/journal.pone.0052627	http://dx.doi.org/10.1371/journal.pone.0052627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300727	Green Submitted, gold, Green Published			2022-12-25	WOS:000312829100068
J	Kelly, DJ; Robertson, A; Murphy, D; Fitzsimons, T; Costello, E; Gormley, E; Corner, LAL; Marples, NM				Kelly, David J.; Robertson, Andrew; Murphy, Denise; Fitzsimons, Tara; Costello, Eamon; Gormley, Eamonn; Corner, Leigh A. L.; Marples, Nicola M.			Trophic Enrichment Factors for Blood Serum in the European Badger (Meles meles)	PLOS ONE			English	Article							MULTIPLE STABLE ISOTOPES; OTTERS ENHYDRA-LUTRIS; BOVINE TUBERCULOSIS; STOMACH CONTENTS; MIXING MODELS; DIET; NITROGEN; CARBON; FRACTIONATION; ECOLOGY	Ecologists undertaking stable isotopic analyses of animal diets require trophic enrichment factors (TEFs) for the specific animal tissues that they are studying. Such basic data are available for a small number of species, so values from trophically or phylogenetically similar species are often substituted for missing values. By feeding a controlled diet to captive European badgers (Meles meles) we determined TEFs for carbon and nitrogen in blood serum. TEFs for nitrogen and carbon in blood serum were +3.0 +/- 0.4 parts per thousand and +0.4 +/- 0.1 parts per thousand respectively. The TEFs for serum in badgers are notably different from those published for the red fox (Vulpes vulpes). There is currently no data for TEFs in the serum of other mustelid species. Our data show that species sharing similar niches (red fox) do not provide adequate proxy values for TEFs of badgers. Our findings emphasise the importance of having species-specific data when undertaking trophic studies using stable isotope analysis.	[Kelly, David J.; Marples, Nicola M.] Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland; [Robertson, Andrew] Univ Exeter, Ctr Ecol & Conservat, Tremough, Cornwall, England; [Murphy, Denise; Fitzsimons, Tara; Gormley, Eamonn; Corner, Leigh A. L.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Costello, Eamon] Dept Agr Food & Marine, Cent Vet Res Lab, Celbridge, Kildare, Ireland	Trinity College Dublin; University of Exeter; University College Dublin	Kelly, DJ (corresponding author), Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland.	djkelly@tcd.ie	Gormley, Eamonn/AAU-6678-2020; Kelly, David/AAE-8278-2019; Marples, Nicola/D-8753-2014; Robertson, Andrew/A-4944-2016	Gormley, Eamonn/0000-0003-3900-0393; Robertson, Andrew/0000-0003-3720-6670; Kelly, David/0000-0002-5880-4162; Marples, Nicola/0000-0003-4693-2607	Irish Department of Agriculture, Fisheries and Food; FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis)	Irish Department of Agriculture, Fisheries and Food; FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis)	DJK was supported by a grant from the Irish Department of Agriculture, Fisheries and Food. The contributions of EG, LALC and DM were funded by FP7 TB-Step (Strategies for the Eradication of Bovine Tuberculosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker BH, 2007, CONDOR, V109, P451, DOI 10.1650/0010-5422(2007)109[451:DSINAC]2.0.CO;2; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Ben-David M, 1996, THESIS U ALASKA FAIR; Bodey TW, 2010, J APPL ECOL, V47, P114, DOI 10.1111/j.1365-2664.2009.01739.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Chang SSR., 2004, HDB STABLE ISOTOPE A; Christie KS, 2008, CAN J ZOOL, V86, P1317, DOI 10.1139/Z08-110; Cleary GP, 2011, MAMM BIOL, V76, P470, DOI 10.1016/j.mambio.2010.10.012; Cleary GP, 2009, MAMM BIOL, V74, P438, DOI 10.1016/j.mambio.2009.07.003; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Criss RE, 2008, REV MINERAL GEOCHEM, V68, P15, DOI 10.2138/rmg.2008.68.3; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Dalerum Fredrik, 2009, Current Zoology, V55, P188; Del Cerro I, 2010, ZOOL SCR, V39, P415, DOI 10.1111/j.1463-6409.2010.00436.x; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Flindt R, 2006, AMAZING NUMBERS BIOL; Gormley E, 2003, J APPL MICROBIOL, V94, p80S; Goszczynski J, 2000, J ZOOL, V250, P495, DOI 10.1111/j.1469-7998.2000.tb00792.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hinwood BG, 1997, TXB SCI HLTH PROFESS; Kaneko Y, 2006, J ZOOL, V270, P78, DOI 10.1111/j.1469-7998.2006.00063.x; KRUUK H, 1979, J APPL ECOL, V16, P453, DOI 10.2307/2402521; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; KRUUK H, 1983, Z SAUGETIERKD, V48, P45; Kruuk H., 1989, SOCIAL BADGER; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Lake JL, 2007, ENVIRON TOXICOL CHEM, V26, P2611, DOI 10.1897/06-607.1; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; LUPS P, 1987, MAMMALIA, V51, P559, DOI 10.1515/mamm.1987.51.4.559; MacDonald DW, 2005, CANIDS FOXES WOLVES, P129; Mathews F, 2009, ADV PARASIT, V68, P185, DOI 10.1016/S0065-308X(08)00608-8; McNett K, 2010, INSECT SOC, V57, P67, DOI 10.1007/s00040-009-0051-z; Meckstroth AM, 2007, J WILDLIFE MANAGE, V71, P2387, DOI 10.2193/2005-527; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; MIZUTANI H, 1992, ECOLOGY, V73, P1391, DOI 10.2307/1940684; Muldowney J, 2003, PEDOBIOLOGIA, V47, P913, DOI 10.1016/S0031-4056(04)70289-9; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; NEAL E, 1988, J ZOOL, V215, P367, DOI 10.1111/j.1469-7998.1988.tb04904.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Roper T, 2010, BADGER; Rosalino LM, 2005, MAMM BIOL, V70, P12, DOI 10.1078/1616-5047-00172; Rosalino LM, 2009, MAMMAL REV, V39, P67, DOI 10.1111/j.1365-2907.2008.00134.x; Rosalino LM, 2006, EUR J WILDLIFE RES, V52, P202, DOI 10.1007/s10344-006-0033-7; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Seminoff JA, 2009, J EXP MAR BIOL ECOL, V381, P33, DOI 10.1016/j.jembe.2009.08.018; Szpak P, 2012, J ARCHAEOL SCI, V39, P1553, DOI 10.1016/j.jas.2011.12.006; Tibbets TM, 2006, INTEGR COMP BIOL, V46, pE141; Todd SK, 2010, MAR MAMMAL SCI, V26, P176, DOI 10.1111/j.1748-7692.2009.00345.x; VACHA J, 1981, COMP BIOCHEM PHYS A, V69, P357, DOI 10.1016/0300-9629(81)92990-X; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Ward AI, 2006, ANIM SCI, V82, P767, DOI 10.1017/ASC2006102; White PCL, 2008, TRENDS MICROBIOL, V16, P420, DOI 10.1016/j.tim.2008.06.005	63	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53071	10.1371/journal.pone.0053071	http://dx.doi.org/10.1371/journal.pone.0053071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300863	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100116
J	Krause, G; Kreuchwig, A; Kleinau, G				Krause, Gerd; Kreuchwig, Annika; Kleinau, Gunnar			Extended and Structurally Supported Insights into Extracellular Hormone Binding, Signal Transduction and Organization of the Thyrotropin Receptor	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LEUCINE-RICH REPEATS; CHORIONIC-GONADOTROPIN RECEPTOR; SITE-DIRECTED MUTAGENESIS; HUMAN TSH RECEPTOR; HINGE REGION; CONSTITUTIVE ACTIVITY; LIGAND-BINDING; NEGATIVE COOPERATIVITY; GLYCOPROTEIN HORMONES	The hormone thyrotropin (TSH) and its receptor (TSHR) are crucial for the growth and function of the thyroid gland. The TSHR is evolutionary linked with the receptors of follitropin (FSHR) and lutropin/choriogonadotropin (LHR) and their sequences and structures are similar. The extracellular region of TSHR contains more than 350 amino acids and binds hormone and antibodies. Several important questions related to functions and mechanisms of TSHR are still not comprehensively understood. One major reason for these open questions is the lack of any structural information about the extracellular segment of TSHR that connects the N-terminal leucine-rich repeat domain (LRRD) with the transmembrane helix (TMH) 1, the hinge region. It has been shown experimentally that this segment is important for fine tuning of signaling and ligand interactions. A new crystal structure containing most of the extracellular hFSHR region in complex with hFSH has recently been published. Now, we have applied these new structural insights to the homologous TSHR and have generated a structural model of the TSHR LRRD/hinge-region/TSH complex. This structural model is combined and evaluated with experimental data including hormone binding (bTSH, hTSH, thyrostimulin), super-agonistic effects, antibody interactions and signaling regulation. These studies and consideration of significant and non-significant amino acids have led to a new description of mechanisms at the TSHR, including ligand-induced displacements of specific hinge region fragments. This event triggers conformational changes at a convergent center of the LRRD and the hinge region, activating an "intramolecular agonistic unit" close to the transmembrane domain.	[Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Krause, Gerd; Kreuchwig, Annika] Leibniz Inst Mol Pharmacol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Kleinau, G (corresponding author), Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	Gunnar.Kleinau@charite.de	Kleinau, Gunnar/GPX-6330-2022		Deutsche Forschungsgemeinschaft [KL2334/2-2, KR1273/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, projects KL2334/2-2 and KR1273/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Alvarez E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-90; Angelova K, 2010, J BIOL CHEM, V285, P34813, DOI 10.1074/jbc.M110.148221; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; BOLONKIN D, 1975, J BIOL CHEM, V250, P6516; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chen CR, 2012, ENDOCRINOLOGY, V153, P5058, DOI 10.1210/en.2012-1376; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2003, ENDOCRINOLOGY, V144, P3821, DOI 10.1210/en.2003-0430; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Galet C, 2005, MOL ENDOCRINOL, V19, P1263, DOI 10.1210/me.2004-0410; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Hai MTV, 2009, J CELL MOL MED, V13, P2253, DOI 10.1111/j.1582-4934.2008.00422.x; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Ho SC, 2005, MOL CELL ENDOCRINOL, V245, P158, DOI 10.1016/j.mce.2005.11.008; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jaquette J, 2002, MOL CELL ENDOCRINOL, V194, P211, DOI 10.1016/S0303-7207(02)00220-4; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Kreuchwig A, 2011, MOL ENDOCRINOL, V25, P707, DOI 10.1210/me.2010-0510; Miguel RN, 2004, THYROID, V14, P991, DOI 10.1089/thy.2004.14.991; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Mueller S, 2011, ENDOCRINOLOGY, V152, P3268, DOI 10.1210/en.2011-0153; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nishihara E, 2012, J ENDOCRINOL INVEST, V35, P49, DOI 10.3275/7738; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Sellami A, 2011, GEN COMP ENDOCR, V170, P582, DOI 10.1016/j.ygcen.2010.11.015; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Szkudlinski MW, 1996, TRENDS ENDOCRIN MET, V7, P277, DOI 10.1016/S1043-2760(96)00129-4; TATE RL, 1975, J BIOL CHEM, V250, P6509; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	81	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52920	10.1371/journal.pone.0052920	http://dx.doi.org/10.1371/journal.pone.0052920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300822	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100099
J	Liu, T; Zhou, Y; Chen, L; Chen, W; Liu, L; Shen, X; Zhang, WQ; Zhang, JZ; Yang, Q				Liu, Tian; Zhou, Yong; Chen, Lei; Chen, Wei; Liu, Lin; Shen, Xu; Zhang, Wenqing; Zhang, Jianzhen; Yang, Qing			Structural Insights into Cellulolytic and Chitinolytic Enzymes Revealing Crucial Residues of Insect beta-N-acetyl-D-hexosaminidase	PLOS ONE			English	Article							CATALYTIC MECHANISM; OSTRINIA-FURNACALIS; D-GLUCOSIDASE; PURIFICATION; SEQUENCE; CHITOBIASE; BINDING; GENOME	The chemical similarity of cellulose and chitin supports the idea that their corresponding hydrolytic enzymes would bind beta-1,4-linked glucose residues in a similar manner. A structural and mutational analysis was performed for the plant cellulolytic enzyme BGlu1 from Oryza sativa and the insect chitinolytic enzyme OfHex1 from Ostrinia furnacalis. Although BGlu1 shows little amino-acid sequence or topological similarity with OfHex1, three residues (Trp(490), Glu(328), Val(327) in OfHex1, and Trp(358), Tyr(131) and Ile(179) in BGlu1) were identified as being conserved in the +1 sugar binding site. OfHex1 Glu(328) together with Trp(490) was confirmed to be necessary for substrate binding. The mutant E328A exhibited a 8-fold increment in K-m for (GlcNAc) 2 and a 42-fold increment in K-i for TMG-chitotriomycin. A crystal structure of E328A in complex with TMG-chitotriomycin was resolved at 2.5 angstrom, revealing the obvious conformational changes of the catalytic residues (Glu(368) and Asp(367)) and the absence of the hydrogen bond between E328A and the C3-OH of the +1 sugar. V327G exhibited the same activity as the wild-type, but acquired the ability to efficiently hydrolyse beta-1,2-linked GlcNAc in contrast to the wild-type. Thus, Glu(328) and Val(327) were identified as important for substrate-binding and as glycosidic-bond determinants. A structure-based sequence alignment confirmed the spatial conservation of these three residues in most plant cellulolytic, insect and bacterial chitinolytic enzymes.	[Liu, Tian; Chen, Lei; Chen, Wei; Liu, Lin; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Zhou, Yong] Dalian Univ Technol, Sch Software Technol, Dalian, Peoples R China; [Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Zhang, Wenqing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Sun Yat Sen University; Shanxi University	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	qingyang@dlut.edu.cn	zhang, wenqing/GYA-0786-2022; Liu, Tian/E-2481-2012; Yang, Qing/GZK-2526-2022	Liu, Tian/0000-0001-9768-5496; Yang, Qing/0000-0001-8623-7532; liu, lin/0000-0002-4248-7377	National Key Project for Basic Research [2010CB126100]; National Natural Science Foundation of China [31070715, 31101671]; National High Technology Research and Development Program of China [2011AA10A204]; National Key Technology RD Program [2011BAE06B05]; Fundamental Research Funds for the Central Universities [DUT11ZD113, DUT11RC(3)73]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors acknowledge the financial support provided by the National Key Project for Basic Research (2010CB126100), the National Natural Science Foundation of China (31070715, 31101671), the National High Technology Research and Development Program of China (2011AA10A204), the National Key Technology R&D Program (2011BAE06B05), and the Fundamental Research Funds for the Central Universities (DUT11ZD113, DUT11RC(3)73). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGUIN P, 1990, ANNU REV MICROBIOL, V44, P219, DOI 10.1146/annurev.mi.44.100190.001251; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Chuenchor W, 2011, J STRUCT BIOL, V173, P169, DOI 10.1016/j.jsb.2010.09.021; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 1996, J BIOL CHEM, V271, P5277, DOI 10.1074/jbc.271.9.5277; Hrmova M, 1998, J BIOL CHEM, V273, P11134, DOI 10.1074/jbc.273.18.11134; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; Liu JL, 2012, INT J MOL SCI, V13, P4545, DOI 10.3390/ijms13044545; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Opassiri R, 2004, BIOCHEM J, V379, P125, DOI 10.1042/BJ20031485; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Tews I, 1996, GENE, V170, P63, DOI 10.1016/0378-1119(95)00848-9; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Usuki H, 2011, ORG BIOMOL CHEM, V9, P2943, DOI 10.1039/c0ob01090a; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang YL, 2012, CHEM BIOL DRUG DES, V79, P572, DOI 10.1111/j.1747-0285.2011.01301.x; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561	37	14	16	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52225	10.1371/journal.pone.0052225	http://dx.doi.org/10.1371/journal.pone.0052225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300622	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100032
J	Phillips, BL; Puschendorf, R; VanDerWal, J; Alford, RA				Phillips, Ben L.; Puschendorf, Robert; VanDerWal, Jeremy; Alford, Ross A.			There Is No Evidence for a Temporal Link between Pathogen Arrival and Frog Extinctions in North-Eastern Australia	PLOS ONE			English	Article							AMPHIBIAN EXTINCTIONS; EPIDEMIC DISEASE; FUNGAL PATHOGEN; POPULATION; DECLINES; MORTALITY; GENOTYPES; DYNAMICS; CLIMATE	Pathogen spread can cause population declines and even species extinctions. Nonetheless, in the absence of tailored monitoring schemes, documenting pathogen spread can be difficult. In the case of worldwide amphibian declines the best present understanding is that the chytrid fungus Batrachochytrium dendrobatidis (Bd) has recently spread, causing amphibian declines and extinction in the process. However, good evidence demonstrating pathogen arrival followed by amphibian decline is rare, and analysis of putative evidence is often inadequate. Here we attempt to examine the relationship between Bd arrival and amphibian decline across north-eastern Australia, using sites where a wave-like pattern of amphibian decline was first noticed and at which intensive research has since been conducted. We develop an analytical framework that allows rigorous estimation of pathogen arrival date, which can then be used to test for a correlation between the time of pathogen arrival and amphibian decline across sites. Our results show that, with the current dataset, the earliest possible arrival date of Bd in north-eastern Australia is completely unresolved; Bd could have arrived immediately before sampling commenced or may have arrived thousands of years earlier, the present data simply cannot say. The currently available data are thus insufficient to assess the link between timing of pathogen arrival and population decline in this part of the world. This data insufficiency is surprising given that there have been decades of research on chytridiomycosis in Australia and that there is a general belief that the link between Bd arrival and population decline is well resolved in this region. The lack of data on Bd arrival currently acts as a major impediment to determining the role of environmental factors in driving the global amphibian declines, and should be a major focus of future research.	[Phillips, Ben L.; Puschendorf, Robert; VanDerWal, Jeremy; Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	James Cook University	Phillips, BL (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	ben.phillips1@jcu.edu.au	Phillips, Ben/C-7957-2009; Puschendorf, Robert/B-6280-2011; Alford, Ross A/H-1577-2011; VanDerWal, Jeremy/C-7457-2009	Phillips, Ben/0000-0003-2580-2336; Puschendorf, Robert/0000-0002-8105-171X; Alford, Ross A/0000-0002-3010-6768; 	Australian Research Council; Centre for Tropical Biodiversity and Climate Change	Australian Research Council(Australian Research Council); Centre for Tropical Biodiversity and Climate Change	BLP and RP thank the Australian Research Council for support through its fellowships program. JV was supported by The Centre for Tropical Biodiversity and Climate Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A.A., 2002, CONSERVATION MED ECO; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Collins J.P., 2009, EXTINCTION OUR TIMES; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; GINSBERG JR, 1995, P ROY SOC B-BIOL SCI, V262, P221, DOI 10.1098/rspb.1995.0199; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P1, DOI 10.1111/j.1442-9993.2007.01812.x; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; MCDONALD KR, 1999, DECLINES DISAPPEARAN; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; PLOWRIGHT W, 1962, ANN NY ACAD SCI, V101, P548, DOI 10.1111/j.1749-6632.1962.tb18896.x; Plowright W., 1982, Symposia of the Zoological Society of London, V50, P1; Plummer R, 2011, RJAGS BAYESIAN GRAPH; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; R Development Core Team, 2009, R FDN STAT COMP; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860	37	7	7	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52502	10.1371/journal.pone.0052502	http://dx.doi.org/10.1371/journal.pone.0052502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300687	gold, Green Published, Green Accepted			2022-12-25	WOS:000312829100055
J	Mongraw-Chaffin, ML; Matsushita, K; Brancati, FL; Astor, BC; Coresh, J; Crawford, SO; Schmidt, MI; Hoogeveen, RC; Ballantyne, CM; Young, JH				Mongraw-Chaffin, Morgana L.; Matsushita, Kunihiro; Brancati, Frederick L.; Astor, Brad C.; Coresh, Josef; Crawford, Stephen O.; Schmidt, Maria Ines; Hoogeveen, Ron C.; Ballantyne, Christie M.; Young, Jeffery Hunter			Diabetes Medication Use and Blood Lactate Level among Participants with Type 2 Diabetes: The Atherosclerosis Risk in Communities Carotid MRI Study	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; HYPOXIA	Background: The objective of this study is to compare lactate levels between users and non-users of diabetes medications under the hypothesis that the level of lactate is a marker of oxidative capacity. Methods: The cross-sectional data of 493 participants aged 61-84 with type 2 diabetes who participated in the Atherosclerosis Risk in Communities Carotid MRI study were analyzed using survey weighted linear regression. Results: Median plasma lactate level was 8.58 (95% CI: 8.23, 8.87) mg/dl. Comparing users of diabetic medications with non-users, thiazolidinedione use was significantly associated with lower lactate level (7.57 (6.95-8.25) mg/dL vs. 8.78 (8.43-9.14) mg/dL), metformin use with a slightly higher lactate level (9.02 (8.51-9.58) mg/dL vs. 8.36 (7.96-8.77) mg/dL), and sulfonylurea and insulin use were not associated with lactate level. After adjustment for demographic and lifestyle factors, the plasma lactate level for thiazolidinedione users was 15.78% lower than that for non-users (p < 0.001). Considering use of each medication separately and in combination did not change the results. Conclusion: In conclusion, thiazolidinedione use was associated with lower plasma lactate level compared to non-use and metformin use was only marginally associated with a slightly higher lactate level. These results are consistent with the previously demonstrated effects of diabetes medications on oxidative metabolism. Further investigation of the role that diabetes medications play in improvement of oxidative metabolism is warranted.	[Mongraw-Chaffin, Morgana L.; Matsushita, Kunihiro; Brancati, Frederick L.; Astor, Brad C.; Coresh, Josef; Crawford, Stephen O.; Young, Jeffery Hunter] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Brancati, Frederick L.; Coresh, Josef; Young, Jeffery Hunter] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Astor, Brad C.] Univ Wisconsin Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Crawford, Stephen O.] Davita Clin Res Inc, Minneapolis, MN USA; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Schmidt, Maria Ines] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth Chapel Hill, Chapel Hill, NC USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; DaVita; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Mongraw-Chaffin, ML (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	mmongraw@jhsph.edu	Schmidt, Maria/V-3196-2019; Iats, Inct/K-2300-2013; Matsushita, Kunihiro/AAJ-5817-2020; Matsushita, Kunihiro/B-1021-2018; Schmidt, Maria Inês/AGP-6441-2022; Ballantyne, Christie/A-6599-2008; Schmidt, Maria Inês/AGT-5691-2022	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Schmidt, Maria Inês/0000-0002-3837-0731; Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730; Mongraw-Chaffin, Morgana/0000-0001-6541-7198	National Heart, Lung, and Blood Institute [5T32HL007024, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK 085458]; ARIC [U01HL075572-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075572, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085458, P30DK079637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARIC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Heart, Lung, and Blood Institute grant 5T32HL007024 to MMC. The measurement of lactate were supported by National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK 085458 to JHY. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C] with the ARIC carotid MRI examination funded by U01HL075572-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bakerman S., 1984, ABCS INTERPRETIVE LA; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; DiGirolamo M, 1989, INT J OBESITY, V13, P394; Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Jansen TC, 2009, CRIT CARE MED, V37, P2827, DOI 10.1097/CCM.0b013e3181a98899; JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Martens FMAC, 2002, DRUGS, V62, P1463, DOI 10.2165/00003495-200262100-00004; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Regensteiner JG, 2005, DIABETES CARE, V28, P2877, DOI 10.2337/diacare.28.12.2877; Reusch JEB, 2003, AM J MED, V115, P69, DOI 10.1016/j.amjmed.2003.09.012; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Salpeter SR, 2010, COCHRANE DATABASE SY, DOI 10.1002/14651858.00002967.pub4; StataCorp, 2009, STAT STAT SOFTW REL; Stolar MW, 2008, J MANAGE CARE PHARM, V14, pS2; Wasserman BA, 2010, J MAGN RESON IMAGING, V31, P406, DOI 10.1002/jmri.22043; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	24	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51237	10.1371/journal.pone.0051237	http://dx.doi.org/10.1371/journal.pone.0051237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300538	Green Published, gold			2022-12-25	WOS:000313618800013
J	Naim, F; Nakasugi, K; Crowhurst, RN; Hilario, E; Zwart, AB; Hellens, RP; Taylor, JM; Waterhouse, PM; Wood, CC				Naim, Fatima; Nakasugi, Kenlee; Crowhurst, Ross N.; Hilario, Elena; Zwart, Alexander B.; Hellens, Roger P.; Taylor, Jennifer M.; Waterhouse, Peter M.; Wood, Craig C.			Advanced Engineering of Lipid Metabolism in Nicotiana benthamiana Using a Draft Genome and the V2 Viral Silencing-Suppressor Protein	PLOS ONE			English	Article							RNA; EFFICIENT; PLANTS; SGS3; P19	The transient leaf assay in Nicotiana benthamiana is widely used in plant sciences, with one application being the rapid assembly of complex multigene pathways that produce new fatty acid profiles. This rapid and facile assay would be further improved if it were possible to simultaneously overexpress transgenes while accurately silencing endogenes. Here, we report a draft genome resource for N. benthamiana spanning over 75% of the 3.1 Gb haploid genome. This resource revealed a two-member NbFAD2 family, NbFAD2.1 and NbFAD2.2, and quantitative RT-PCR (qRT-PCR) confirmed their expression in leaves. FAD2 activities were silenced using hairpin RNAi as monitored by qRT-PCR and biochemical assays. Silencing of endogenous FAD2 activities was combined with overexpression of transgenes via the use of the alternative viral silencing-suppressor protein, V2, from Tomato yellow leaf curl virus. We show that V2 permits maximal overexpression of transgenes but, crucially, also allows hairpin RNAi to operate unimpeded. To illustrate the efficacy of the V2-based leaf assay system, endogenous lipids were shunted from the desaturation of 18: 1 to elongation reactions beginning with 18: 1 as substrate. These V2-based leaf assays produced similar to 50% more elongated fatty acid products than p19-based assays. Analyses of small RNA populations generated from hairpin RNAi against NbFAD2 confirm that the siRNA population is dominated by 21 and 22 nt species derived from the hairpin. Collectively, these new tools expand the range of uses and possibilities for metabolic engineering in transient leaf assays.	[Naim, Fatima; Taylor, Jennifer M.; Waterhouse, Peter M.; Wood, Craig C.] Commonwealth Sci & Ind Res Org, Plant Ind, Canberra, ACT, Australia; [Crowhurst, Ross N.; Hilario, Elena; Hellens, Roger P.] New Zealand Inst Plant & Food Res Ltd, Breeding & Genom, Auckland, New Zealand; [Zwart, Alexander B.] Commonwealth Sci & Ind Res Org, Math Informat & Stat, Canberra, ACT, Australia; [Waterhouse, Peter M.] Univ Sydney, Sch Biol Sci, Sch Mol Biosci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); New Zealand Institute for Plant & Food Research Ltd; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Wood, CC (corresponding author), Commonwealth Sci & Ind Res Org, Plant Ind, Canberra, ACT, Australia.	Craig.Wood@csiro.au	Crowhurst, Ross N/N-8892-2017; Wood, Craig C/B-5792-2009; Taylor, Jennifer M/A-1686-2010; Hilario, Elena/ABB-8574-2021; Zwart, Alexander B/A-4822-2009	Crowhurst, Ross N/0000-0003-0608-2134; Taylor, Jennifer M/0000-0003-4231-0181; Hilario, Elena/0000-0001-8124-8881; Zwart, Alexander B/0000-0002-9158-3795; , Pepe/0000-0002-8794-9985; Waterhouse, Peter/0000-0002-2812-3753; Naim, Fatima/0000-0001-8451-1104; Hellens, Roger/0000-0003-2094-0887	CSIRO OCE PhD Scholarship; CSIRO; University of Sydney; New Zealand Institute for Plant and Food Research; ARC Federation [FF0776510]	CSIRO OCE PhD Scholarship; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Sydney(University of Sydney); New Zealand Institute for Plant and Food Research; ARC Federation(Australian Research Council)	FN is a CSIRO OCE PhD Scholarship recipient. This work was funded collaboratively by CSIRO, University of Sydney and The New Zealand Institute for Plant and Food Research. PMW is funded by the ARC Federation Fellowship FF0776510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baulcombe DC, 2004, TRENDS BIOCHEM SCI, V29, P279, DOI 10.1016/j.tibs.2004.04.007; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bombarely A, 2012, MOL PLANT MICROBE IN; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Coutu C, 2007, TRANSGENIC RES, V16, P771, DOI 10.1007/s11248-007-9066-2; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Fusaro AF, 2012, VIROLOGY, V426, P178, DOI 10.1016/j.virol.2012.01.026; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hilario E, 2004, ANTON LEEUW INT J G, V86, P51, DOI 10.1023/B:ANTO.0000024910.57117.16; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440, DOI 10.21273/HORTSCI.27.5.440; Mikkelsen MD, 2010, MOL PLANT, V3, P751, DOI 10.1093/mp/ssq020; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Petrie JR, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-8; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2011, PLOS PATHOGENS, V7; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zrachya A, 2007, VIROLOGY, V358, P159, DOI 10.1016/j.virol.2006.08.016	33	61	66	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52717	10.1371/journal.pone.0052717	http://dx.doi.org/10.1371/journal.pone.0052717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300750	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800130
J	Ozawa, T; Piao, XH; Kobayashi, E; Zhou, Y; Sakurai, H; Andoh, T; Jin, AS; Kishi, H; Muraguchi, A				Ozawa, Tatsuhiko; Piao, Xiuhong; Kobayashi, Eiji; Zhou, Yue; Sakurai, Hiroaki; Andoh, Tsugunobu; Jin, Aishun; Kishi, Hiroyuki; Muraguchi, Atsushi			A Novel Rabbit Immunospot Array Assay on a Chip Allows for the Rapid Generation of Rabbit Monoclonal Antibodies with High Affinity	PLOS ONE			English	Article							SINGLE-CELL; B-CELLS; MOUSE HYBRIDOMAS; SECRETING CELLS; ANTIGEN; GROWTH; TAK1; TAB1; HETEROHYBRIDOMAS; PHOSPHORYLATION	Antigen-specific rabbit monoclonal antibodies (RaMoAbs) are useful due to their high specificity and high affinity, and the establishment of a comprehensive and rapid RaMoAb generation system has been highly anticipated. Here, we present a novel system using immunospot array assay on a chip (ISAAC) technology in which we detect and retrieve antigen-specific antibody-secreting cells from the peripheral blood lymphocytes of antigen-immunized rabbits and produce antigen-specific RaMoAbs with 10(-12) M affinity within a time period of only 7 days. We have used this system to efficiently generate RaMoAbs that are specific to a phosphorylated signal-transducing molecule. Our system provides a new method for the comprehensive and rapid production of RaMoAbs, which may contribute to laboratory research and clinical applications.	[Ozawa, Tatsuhiko; Piao, Xiuhong; Kobayashi, Eiji; Jin, Aishun; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan; [Zhou, Yue; Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 930, Japan; [Andoh, Tsugunobu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 930, Japan; [Jin, Aishun] Harbin Med Univ, Coll Basic Med Sci, Dept Immunol, Harbin, Peoples R China	University of Toyama; University of Toyama; University of Toyama; Harbin Medical University	Kishi, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan.	immkishi@med.u-toyama.ac.jp	Sakurai, Hiroaki/AAE-4294-2019	Ozawa, Tatsuhiko/0000-0002-3112-452X; Kobayashi, Eiji/0000-0002-7303-2797; Zhou, Yue/0000-0002-1335-5703; Sakurai, Hiroaki/0000-0003-0657-9570	Vivalis; Vivalis (Nantes, France.)	Vivalis; Vivalis (Nantes, France.)	Vivalis; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AM was supported by a research fund from Vivalis (Nantes, France.) The ISAAC method is covered by patents that have been exclusively licensed to Vivalis (Nantes, France.) Patent details: Pub. No.: WO/2009/017226, International Application No.: PCT/JP2008/063874, Title: CELL SCREENING METHOD; HK is one of Scientific Advisory Board Members of Vivalis. Microwell array chips are now provided to us by Vivalis. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams GP, 2001, CANCER RES, V61, P4750; Bao YP, 2006, ANAL CHEM, V78, P2055, DOI 10.1021/ac051798d; BYSTRYN JC, 1982, HYBRIDOMA, V1, P465, DOI 10.1089/hyb.1.1982.1.465; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Djavadi-Ohaniance L., 1996, ANTIBODY ENG PRACTIC, P77; Feng LF, 2011, AM J TRANSL RES, V3, P269; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Huang ZD, 2006, APPL IMMUNOHISTO M M, V14, P229, DOI 10.1097/01.pai.0000157906.38495.31; Jin A, 2011, NAT PROTOC, V6, P668, DOI 10.1038/nprot.2011.322; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kinoshita K, 2009, CYTOM PART A, V75A, P682, DOI 10.1002/cyto.a.20758; Krause R M, 1970, Adv Immunol, V12, P1, DOI 10.1016/S0065-2776(08)60167-4; KUO MC, 1985, MOL IMMUNOL, V22, P351; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; NORRBY E, 1987, P NATL ACAD SCI USA, V84, P6572, DOI 10.1073/pnas.84.18.6572; Ozawa T, 2006, BIOTECHNIQUES, V40, P469, DOI 10.2144/000112123; Ozawa T, 2009, LAB CHIP, V9, P158, DOI 10.1039/b810438g; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; RAMAN C, 1994, J IMMUNOL, V152, P3935; RAYBOULD TJG, 1988, SCIENCE, V240, P1788, DOI 10.1126/science.3289119; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHAR IN PRESS; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Tajiri K, 2007, CYTOM PART A, V71A, P961, DOI 10.1002/cyto.a.20471; Tao GZ, 2006, EXP CELL RES, V312, P411, DOI 10.1016/j.yexcr.2005.11.010; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; VERBANAC KM, 1993, TRANSPLANT P, V25, P837; VERBANAC KM, 1993, HYBRIDOMA, V12, P285, DOI 10.1089/hyb.1993.12.285; WELLER A, 1987, DEVELOPMENT, V100, P351; Winstead CR, 1999, J IMMUNOL, V162, P6602; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009072; Zhu W, 2009, THERAPEUTIC MONOCLON; Zhu Z, 2003, LEUKEMIA, V17, P604, DOI 10.1038/sj.leu.2402831	41	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52383	10.1371/journal.pone.0052383	http://dx.doi.org/10.1371/journal.pone.0052383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300658	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800077
J	Hasson, D; Theorell, T; Bergquist, J; Canlon, B				Hasson, Dan; Theorell, Tores; Bergquist, Jonas; Canlon, Barbara			Acute Stress Induces Hyperacusis in Women with High Levels of Emotional Exhaustion	PLOS ONE			English	Article							COLD-PRESSOR TEST; SUBJECTIVE HEALTH COMPLAINTS; CHRONIC-FATIGUE-SYNDROME; HEARING-LOSS; GLUCOCORTICOID-RECEPTORS; CLINICAL CONDITIONS; BLOOD-PRESSURE; PREVALENCE; NOISE; PAIN	Background: Hearing problems is one of the top ten public health disorders in the general population and there is a well-established relationship between stress and hearing problems. The aim of the present study was to explore if an acute stress will increase auditory sensitivity (hyperacusis) in individuals with high levels of emotional exhaustion (EE). Methods: Hyperacusis was assessed using uncomfortable loudness levels (ULL) in 348 individuals (140 men; 208 women; age 23-71 years). Multivariate analyses (ordered logistic regression), were used to calculate odds ratios, including interacting or confounding effects of age, gender, ear wax and hearing loss (PTA). Two-way ANCOVAs were used to assess possible differences in mean ULLs between EE groups pre- and post-acute stress task (a combination of cold pressor, emotional Stroop and Social stress/video recording). Results: There were no baseline differences in mean ULLs between the three EE groups (one-way ANOVA). However, after the acute stress exposure there were significant differences in ULL means between the EE-groups in women. Post-hoc analyses showed that the differences in mean ULLs were between those with high vs. low EE (range 5.5-6.5 dB). Similar results were found for frequencies 0.5 and 1 kHz. The results demonstrate that women with high EE-levels display hyperacusis after an acute stress task. The odds of having hyperacusis were 2.5 (2 kHz, right ear; left ns) and 2.2 (4 kHz, right ear; left ns) times higher among those with high EE compared to those with low levels. All these results are adjusted for age, hearing loss and ear wax. Conclusion: Women with high levels of emotional exhaustion become more sensitive to sound after an acute stress task. This novel finding highlights the importance of including emotional exhaustion in the diagnosis and treatment of hearing problems.	[Hasson, Dan; Canlon, Barbara] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hasson, Dan; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Karolinska Institutet; Stockholm University; Uppsala University	Hasson, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	dan.hasson@ki.se	Hasson, Dan/T-9262-2019; Bergquist, Jonas/C-5894-2015	Canlon, Barbara/0000-0002-4377-5266; Bergquist, Jonas/0000-0002-4597-041X; Theorell, Tores/0000-0003-1956-7931	Swedish Research Council [2008-4122, K2010-62X-09476-20-3, 621-2011-4423]; Swedish Council for Working Life and Social Research; Stiftelsen Tysta Skolan; AFA Forsakring; Bliwastiftelsen; Karolinska Institutet Funds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stiftelsen Tysta Skolan; AFA Forsakring; Bliwastiftelsen; Karolinska Institutet Funds	The authors express deepest gratitude for the kind and invaluable financial support from the following funding bodies that made this study and analyses possible: The Swedish Research Council (project numbers: 2008-4122 (TT), K2010-62X-09476-20-3 (BC), 621-2011-4423 (JB)), The Swedish Council for Working Life and Social Research (BC, DH), Stiftelsen Tysta Skolan (BC, DH), AFA Forsakring (DH) and Bliwastiftelsen (DH), and Karolinska Institutet Funds (BC, DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare they received funding from The Swedish Research Council, AFA Forsakring, The Swedish Council for Working Life and Social Research, Stiftelsen Tysta Skolan, Bliwastiftelsen and Karolinska Institutet Funds. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aaron LA, 2003, BEST PRACT RES CL RH, V17, P563, DOI 10.1016/S1521-6942(03)00033-0; Aaron LA, 2001, J GEN INTERN MED, V16, P24, DOI 10.1046/j.1525-1497.2001.03419.x; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Ciccone DS, 2003, PSYCHOSOM MED, V65, P268, DOI 10.1097/01.PSY.0000033125.08272.A9; Clauw DJ, 2002, AM J IND MED, V41, P370, DOI 10.1002/ajim.10068; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; De Nicola AF, 2009, EXP GERONTOL, V44, P34, DOI 10.1016/j.exger.2008.03.005; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; EASTWOOD MR, 1985, BRIT J PSYCHIAT, V147, P552, DOI 10.1192/bjp.147.5.552; Eriksen HR, 2004, J PSYCHOSOM RES, V56, P445, DOI 10.1016/S0022-3999(03)00629-9; Fasano ML, 1996, CLIN AUTON RES, V6, P249, DOI 10.1007/BF02556295; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; HAGERMAN B, 1995, SCAND AUDIOL, V24, P71, DOI 10.3109/01050399509042213; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Hallberg UE, 2004, EUR J PSYCHOL ASSESS, V20, P320, DOI 10.1027/1015-5759.20.4.320; Hannula S, 2011, J AM ACAD AUDIOL, V22, P550, DOI 10.3766/jaaa.22.8.7; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Hebert S, 2012, PSYCHOTHER IN PRESS; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hines EA, 1936, AM HEART J, V11, P1, DOI 10.1016/S0002-8703(36)90370-8; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Lawrence H P, 2001, Spec Care Dentist, V21, P129, DOI 10.1111/j.1754-4505.2001.tb00242.x; LINDQVIST M, 1993, CLIN SCI, V85, P401, DOI 10.1042/cs0850401; Lusk SL, 2002, ARCH ENVIRON HEALTH, V57, P273, DOI 10.1080/00039890209601410; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maslach C., 1996, MASLACH BURNOUT INVE; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 2002, METABOLISM, V51, P2, DOI 10.1053/meta.2002.33183; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 2000, PROG BRAIN RES, V122, P25; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Tahera Y, 2006, NEUROREPORT, V17, P879, DOI 10.1097/01.wnr.0000220131.24468.e7; Ursin H, 2001, ANN NY ACAD SCI, V933, P119; Velasco M, 1997, Am J Ther, V4, P34, DOI 10.1097/00045391-199701000-00008; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	48	34	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52945	10.1371/journal.pone.0052945	http://dx.doi.org/10.1371/journal.pone.0052945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23301005	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900048
J	Yu, PC; Sewell, MA; Matson, PG; Rivest, EB; Kapsenberg, L; Hofmann, GE				Yu, Pauline C.; Sewell, Mary A.; Matson, Paul G.; Rivest, Emily B.; Kapsenberg, Lydia; Hofmann, Gretchen E.			Growth Attenuation with Developmental Schedule Progression in Embryos and Early Larvae of Sterechinus neumayeri Raised under Elevated CO2	PLOS ONE			English	Article							REDUCED SEAWATER PH; OCEAN ACIDIFICATION; CLIMATE-CHANGE; ECHINODERM LARVAE; HATCHING ENZYME; MCMURDO SOUND; IMPACT; PLASTICITY; INVERTEBRATES; ECHINOIDEA	The Southern Ocean, a region that will be an ocean acidification hotspot in the near future, is home to a uniquely adapted fauna that includes a diversity of lightly-calcified invertebrates. We exposed the larvae of the echinoid Sterechinus neumayeri to environmental levels of CO2 in McMurdo Sound (control: 410 mu atm, Omega = 1.35) and mildly elevated pCO(2) levels, both near the level of the aragonite saturation horizon (510 matm pCO(2), Omega = 1.12), and to under-saturating conditions (730 matm, Omega = 0.82). Early embryological development was normal under these conditions with the exception of the hatching process, which was slightly delayed. Appearance of the initial calcium carbonate (CaCO3) spicule nuclei among the primary mesenchyme cells of the gastrulae was synchronous between control and elevated pCO(2) treatments. However, by prism (7 days after the initial appearance of the spicule nucleus), elongating arm rod spicules were already significantly shorter in the highest CO2 treatment. Unfed larvae in the 730 matm pCO(2) treatment remained significantly smaller than unfed control larvae at days 15-30, and larvae in the 510 mu atm treatment were significantly smaller at day 20. At day 30, the arm lengths were more differentiated between 730 mu atm and control CO2 treatments than were body lengths as components of total length. Arm length is the most plastic morphological aspect of the echinopluteus, and appears to exhibit the greatest response to high pCO(2)/low pH/low carbonate, even in the absence of food. Thus, while the effects of elevated pCO(2) representative of near future climate scenarios are proportionally minor on these early developmental stages, the longer term effects on these long-lived invertebrates is still unknown.	[Yu, Pauline C.; Matson, Paul G.; Rivest, Emily B.; Kapsenberg, Lydia; Hofmann, Gretchen E.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Sewell, Mary A.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of California System; University of California Santa Barbara; University of Auckland	Yu, PC (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	pauline.yu@lifesci.ucsb.edu	Sewell, Mary A/C-9017-2009; Matson, Paul/AAB-9767-2019	Sewell, Mary A/0000-0002-1595-7951; Matson, Paul/0000-0003-2105-7308; Kapsenberg, Lydia/0000-0002-7361-9061	U.S. Office of Polar Programs, Antarctic Division (NSF) [ANT-0944201]; U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP) [1019340]; NSF Graduate Student Research Fellowships; Royal Society of New Zealand Marsden Fund; Directorate For Geosciences [0944201] Funding Source: National Science Foundation	U.S. Office of Polar Programs, Antarctic Division (NSF); U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP)(National Science Foundation (NSF)); NSF Graduate Student Research Fellowships; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by the U.S. Office of Polar Programs, Antarctic Division (NSF grant ANT-0944201 to GEH) (http:/www.nsf.gov). PCY was supported by a U.S. National Science Foundation (NSF) Polar Programs Postdoctoral Fellowship (NSF-OPP Award 1019340); EBR and LK were supported by NSF Graduate Student Research Fellowships. MS was supported by the Royal Society of New Zealand Marsden Fund (http://www.royalsociety.org.nz/programmes/funds/marsden/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1603; Adomako-Ankomah A, 2011, DEV BIOL, V353, P81, DOI 10.1016/j.ydbio.2011.02.021; Anderson D, 2010, J EXP MAR BIOL ECOL, V384, P68, DOI 10.1016/j.jembe.2009.12.005; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Armstrong AF, 2012, AM NAT IN PRESS; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; BOSCH I, 1987, BIOL BULL, V173, P126, DOI 10.2307/1541867; BOUGIS P, 1967, HELGOLAND WISS MEER, V15, P59, DOI 10.1007/BF01618609; BREY T, 1991, POLAR BIOL, V11, P227; Brey T, 1995, MAR BIOL, V124, P279, DOI 10.1007/BF00347132; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Catarino AI, 2012, POLAR BIOL, V35, P455, DOI 10.1007/s00300-011-1074-2; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clarke A, 2007, PHILOS T R SOC B, V362, P5, DOI 10.1098/rstb.2006.1943; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Ericson JA, 2012, POLAR BIOL, V35, P1027, DOI 10.1007/s00300-011-1150-7; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; Hammond LM, 2012, J EXP BIOL, V215, P2445, DOI 10.1242/jeb.058008; Hammond LM, 2010, PHYSL RESPONSE ENV V; HART MW, 1994, BIOL BULL, V186, P291, DOI 10.2307/1542275; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Horstadius S, 1939, BIOL REV CAMB PHILOS, V14, P132, DOI 10.1111/j.1469-185X.1939.tb00929.x; Jimmy RA, 2003, AQUACULTURE, V220, P261, DOI 10.1016/S0044-8486(02)00193-X; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lamare M, 2010, 9 INT LARV BIOL S WE; Lebrato M, 2010, ECOL MONOGR, V80, P441, DOI 10.1890/09-0553.1; Leong PKK, 1999, J EXP BIOL, V202, P2051; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; Marsh AG, 1999, J EXP BIOL, V202, P2041; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Matson PG, 2011, ANTARCT SCI, V23, P607, DOI 10.1017/S0954102011000551; Matson PG, 2012, BIOL B IN PRESS; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McEdward LR, 1996, AM ZOOL, V36, P169; McNeil B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044597; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Miner BG, 2007, J EXP MAR BIOL ECOL, V343, P158, DOI 10.1016/j.jembe.2006.11.001; Miner BG, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P221; Morgan Steven G., 1995, P279; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pace DA, 2007, BIOL BULL-US, V212, P115, DOI 10.2307/25066589; Padilla-Gamino J, 2012, 10 INT LARV BIOL S B; PEARSE JS, 1991, AM ZOOL, V31, P65; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peled-Kamar M, 2002, EXP CELL RES, V272, P56, DOI 10.1006/excr.2001.5398; Place SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034068; Portner HO, 2010, GUIDE BEST PRACTICES; Reitzel AM, 2004, J PLANKTON RES, V26, P901, DOI 10.1093/plankt/fbh077; RIVKIN RB, 1991, AM ZOOL, V31, P5; Robbins L., 2010, US GEOLOGICAL SURVEY, P1, DOI DOI 10.3133/OFR20101280; ROE JL, 1990, J BIOL CHEM, V265, P8704; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Sabine CL, 2012, CARBON DIOXIDE HYDRO; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Sewell MA, 2011, 6 N AM ECH C AN WA; Sewell MA, 2011, GLOBAL CHANGE BIOL, V17, P734, DOI 10.1111/j.1365-2486.2010.02288.x; SHILLING FM, 1995, AM ZOOL, V35, P399; Shingleton AW, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P43; Smith CR, 2012, P ROY SOC B-BIOL SCI, V279, P1017, DOI 10.1098/rspb.2011.1496; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Sweet H, 2004, METHOD CELL BIOL, V74, P243; TAKEUCHI K, 1979, EUR J BIOCHEM, V100, P257, DOI 10.1111/j.1432-1033.1979.tb02056.x; Thatje S, 2008, POLAR BIOL, V31, P1143, DOI 10.1007/s00300-008-0457-5; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WOLPERT L, 1992, DEVELOPMENT, P7; Wray GA, 2004, METHOD CELL BIOL, V74, P75; Yoshikawa-Inoue H, 2005, TELLUS B, V57, P58, DOI 10.1111/j.1600-0889.2005.00130.x; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016	89	34	34	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52448	10.1371/journal.pone.0052448	http://dx.doi.org/10.1371/journal.pone.0052448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300974	gold, Green Submitted, Green Published			2022-12-25	WOS:000313320900026
J	Bertke, AS; Apakupakul, K; Ma, A; Imai, Y; Gussow, AM; Wang, KN; Cohen, JI; Bloom, DC; Margolis, TP				Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Gussow, Anne M.; Wang, Kening; Cohen, Jeffrey I.; Bloom, David C.; Margolis, Todd P.			LAT Region Factors Mediating Differential Neuronal Tropism of HSV-1 and HSV-2 Do Not Act in Trans	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; LATENCY-ASSOCIATED TRANSCRIPT; PRIMARY SENSORY NEURONS; IMMUNOHISTOCHEMICAL ANALYSIS; PRODUCTIVE INFECTION; VIRAL REPLICATION; GENE-EXPRESSION; TYPE-1; REACTIVATION; INTRON	After HSV infection, some trigeminal ganglion neurons support productive cycle gene expression, while in other neurons the virus establishes a latent infection. We previously demonstrated that HSV-1 and HSV-2 preferentially establish latent infection in A5+ and KH10+ sensory neurons, respectively, and that exchanging the latency-associated transcript (LAT) between HSV-1 and HSV-2 also exchanges the neuronal preference. Since many viral genes besides the LAT are functionally interchangeable between HSV-1 and HSV-2, we co-infected HSV-1 and HSV-2, both in vivo and in vitro, to determine if transacting viral factors regulate whether HSV infection follows a productive or latent pattern of gene expression in sensory neurons. The pattern of HSV-1 and HSV-2 latent infection in trigeminal neurons was no different following co-infection than with either virus alone, consistent with the hypothesis that a trans-acting viral factor is not responsible for the different patterns of latent infection of HSV-1 and HSV-2 in A5+ and KH10+ neurons. Since exchanging the LAT regions between the viruses also exchanges neuronal preferences, we infected transgenic mice that constitutively express 2.8 kb of the LAT region with the heterologous viral serotype. Endogenous expression of LAT did not alter the pattern of latent infection after inoculation with the heterologous serotype virus, demonstrating that the LAT region does not act in trans to direct preferential establishment of latency of HSV-1 and HSV-2. Using HSV1-RFP and HSV2-GFP in adult trigeminal ganglion neurons in vitro, we determined that HSV-1 and HSV-2 do not exert trans-acting effects during acute infection to regulate neuron specificity. Although some neurons were productively infected with both HSV-1 and HSV-2, no A5+ or KH10+ neurons were productively infected with both viruses. Thus, trans-acting viral factors do not regulate preferential permissiveness of A5+ and KH10+ neurons for productive HSV infection and preferential establishment of latent infection.	[Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Margolis, Todd P.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Bertke, Andrea S.; Apakupakul, Kathleen; Ma, AyeAye; Imai, Yumi; Margolis, Todd P.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Gussow, Anne M.; Bloom, David C.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Wang, Kening; Cohen, Jeffrey I.] NIAID, Med Virol Sect, Infect Dis Lab, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margolis, TP (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	todd.margolis@ucsf.edu		Bertke, Andrea/0000-0002-8941-8010	That Man May See (San Francisco, CA); National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [AI048633]; NICHD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000058, R01AI048633] Funding Source: NIH RePORTER	That Man May See (San Francisco, CA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by That Man May See (San Francisco, CA), and the intramural research program of the National Institute of Allergy and Infectious Diseases and National Institutes of Health (NIH) grant AI048633. Monoclonal antibodies FE-A5 developed by B. Fenderson and KH10 developed by T. M. Jessell and J. Dodd were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa, IA 52242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; FAREED MU, 1994, J VIROL, V68, P8071, DOI 10.1128/JVI.68.12.8071-8081.1994; Garber DA, 1997, J VIROL, V71, P5885, DOI 10.1128/JVI.71.8.5885-5893.1997; Gussow AM, 2006, J VIROL, V80, P9414, DOI 10.1128/JVI.00530-06; Imai Y, 2009, J VIROL, V83, P7873, DOI 10.1128/JVI.00043-09; Jarman RG, 2002, VIROLOGY, V292, P59, DOI 10.1006/viro.2001.1265; Mador N, 1998, J VIROL, V72, P5067, DOI 10.1128/JVI.72.6.5067-5075.1998; Margolis TP, 2007, J VIROL, V81, P1872, DOI 10.1128/JVI.02110-06; MARGOLIS TP, 1992, INVEST OPHTH VIS SCI, V33, P259; Ng AK, 2004, J VIROL, V78, P12097, DOI 10.1128/JVI.78.22.12097-12106.2004; Shen WW, 2009, J VIROL, V83, P9131, DOI 10.1128/JVI.00871-09; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Tang S, 2011, J VIROL, V85, P4501, DOI 10.1128/JVI.01997-10; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang KN, 2001, J VIROL, V75, P8166, DOI 10.1128/JVI.75.17.8166-8172.2001; Yang L, 2000, J VIROL, V74, P209, DOI 10.1128/JVI.74.1.209-217.2000	21	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53281	10.1371/journal.pone.0053281	http://dx.doi.org/10.1371/journal.pone.0053281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300908	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600080
J	Casalta, JP; Thuny, F; Fournier, PE; Lepidi, H; Habib, G; Grisoli, D; Raoult, D				Casalta, Jean-Paul; Thuny, Franck; Fournier, Pierre-Edouard; Lepidi, Hubert; Habib, Gilbert; Grisoli, Dominique; Raoult, Didier			DNA Persistence and Relapses Questions on the Treatment Strategies of Enterococcus Infections of Prosthetic Valves	PLOS ONE			English	Article							TERM-FOLLOW-UP; BIOPROSTHESIS DYSFUNCTION; DIAGNOSTIC METHODS; ENDOCARDITIS; GUIDELINES; RISK; PCR; REOPERATION; REINFECTION; BACTERIA	We used amplification of the 16S rRNA gene followed by sequencing to evaluate the persistence of bacterial DNA in explanted heart valve tissue as part of the routine work of a clinical microbiology laboratory, and we analyzed the role of this persistence in the relapses observed in our center. We enrolled 286 patients treated for infective endocarditis (IE) who had valve replacement surgery and were diagnosed according to the modified Duke's criteria described by Li et al. from a total of 579 IE cases treated in our center. The patients were grouped based on the infecting bacteria, and we considered the 4 most common bacterial genus associated with IE separately (144 were caused by Streptococcus spp., 52 by Enterococcus spp., 58 by Staphylococcus aureus and 32 by coagulase-negative Staphylococcus). Based on our cohort, the risk of relapse in patients with enterococcal prosthetic valve infections treated with antibiotics alone was 11%. Bacterial DNA is cleared over time, but this might be a very slow process, especially with Enterococcus spp. Based on a comprehensive review of the literature performed on Medline, most reports still advise combined treatment with penicillin and an aminoglycoside for as long as 4-6 weeks, but there has been no consensus for the treatment of enterococcal infection of prostheses in IE patients.	[Casalta, Jean-Paul; Fournier, Pierre-Edouard; Lepidi, Hubert; Raoult, Didier] Aix Marseille Univ, URMITE, UMR CNRS 7278, Fac Med,IRD 198,INSERM 1095, Marseille, France; [Thuny, Franck; Habib, Gilbert] Hop Enfants La Timone, Serv Cardiol, Marseille, France; [Grisoli, Dominique] Hop Enfants La Timone, Serv Chirurg Cardiaque, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Raoult, D (corresponding author), Aix Marseille Univ, URMITE, UMR CNRS 7278, Fac Med,IRD 198,INSERM 1095, Marseille, France.	didier.raoult@gmail.com	Fournier, Pierre-Edouard/AAC-6155-2021; Thuny, Franck/ABB-2408-2021; Thuny, Franck/ABC-7157-2020; RAOULT, Didier/A-8434-2008; Thuny, Franck/GSD-2668-2022	Fournier, Pierre-Edouard/0000-0001-8463-8885; Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154				Casalta JP, 2009, ANTIBIOTIQUES, V11, P81, DOI 10.1016/j.antib.2009.01.004; Cenciarini-Borde C, 2009, FUTURE MICROBIOL, V4, P45, DOI 10.2217/17460913.4.1.45; Chu VH, 2005, CLIN INFECT DIS, V41, P406, DOI 10.1086/431590; Fournier, 1999, Curr Infect Dis Rep, V1, P136, DOI 10.1007/s11908-996-0020-x; Fournier PE, 1996, AM J MED, V100, P629, DOI 10.1016/S0002-9343(96)00040-X; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Habib G, 2005, HEART, V91, P954, DOI 10.1136/hrt.2004.046177; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Ho Hee-Hwa, 2010, Asian Cardiovasc Thorac Ann, V18, P430, DOI 10.1177/0218492310379457; Houpikian P, 2002, INFECT DIS CLIN N AM, V16, P377, DOI 10.1016/S0891-5520(01)00010-1; HUNTER TH, 1947, AM J MED, V2, P436, DOI 10.1016/0002-9343(47)90088-0; Jaussaud N, 2012, J HEART VALVE DIS, V21, P56; Jaussaud N, 2009, J HEART VALVE DIS, V18, P256; Jovanovic M, 2010, J HEART VALVE DIS, V19, P540; Lang S, 2004, J INFECTION, V48, P269, DOI 10.1016/S0163-4453(03)00102-6; Lepidi H, 2002, INFECT DIS CLIN N AM, V16, P339, DOI 10.1016/S0891-5520(02)00005-3; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mandell GL, 2000, ENTEROCOCCUS SPECIES, V2, P2147; Mansur AJ, 2001, AM HEART J, V141, P78, DOI 10.1067/mhj.2001.111952; MOELLERING RC, 1991, J ANTIMICROB CHEMOTH, V28, P1, DOI 10.1093/jac/28.1.1; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Olaison L, 2002, CLIN INFECT DIS, V34, P159, DOI 10.1086/338233; Potron A, 2010, J MED MICROBIOL, V59, P1524, DOI 10.1099/jmm.0.024380-0; Rovery C, 2005, J CLIN MICROBIOL, V43, P163, DOI 10.1128/JCM.43.1.163-167.2005; Talarmin JP, 2011, J CLIN MICROBIOL, V49, P1182, DOI 10.1128/JCM.02049-10; TORNOS MP, 1992, ANN INTERN MED, V117, P567, DOI 10.7326/0003-4819-117-7-567; Truninger K, 1999, HEART, V82, P714, DOI 10.1136/hrt.82.6.714; VERHEUL HA, 1993, AM J CARDIOL, V72, P682, DOI 10.1016/0002-9149(93)90885-G; Voldstedlund M, 2008, APMIS, V116, P190, DOI 10.1111/j.1600-0463.2008.00942.x; Vollmer T, 2010, EUR HEART J, V31, P1105, DOI 10.1093/eurheartj/ehp600; YU VL, 1994, ANN THORAC SURG, V58, P1073, DOI 10.1016/0003-4975(94)90458-8	32	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53335	10.1371/journal.pone.0053335	http://dx.doi.org/10.1371/journal.pone.0053335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300913	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600084
J	Manabe, Y; Miyatake, S; Takagi, M; Nakamura, M; Okeda, A; Nakano, T; Hirshman, MF; Goodyear, LJ; Fujii, NL				Manabe, Yasuko; Miyatake, Shouta; Takagi, Mayumi; Nakamura, Mio; Okeda, Ai; Nakano, Taemi; Hirshman, Michael F.; Goodyear, Laurie J.; Fujii, Nobuharu L.			Characterization of an Acute Muscle Contraction Model Using Cultured C2C12 Myotubes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; EXERCISE; STIMULATION; EXPRESSION; INSULIN; AKT	A cultured C2C12 myotube contraction system was examined for application as a model for acute contraction-induced phenotypes of skeletal muscle. C2C12 myotubes seeded into 4-well rectangular plates were placed in a contraction system equipped with a carbon electrode at each end. The myotubes were stimulated with electric pulses of 50 V at 1 Hz for 3 ms at 997-ms intervals. Approximately 80% of the myotubes were observed to contract microscopically, and the contractions lasted for at least 3 h with electrical stimulation. Calcium ion (Ca2+) transient evoked by the electric pulses was detected fluorescently with Fluo-8. Phosphorylation of protein kinase B/Akt (Akt), 5' AMP-activated protein kinase (AMPK), p38 mitogen-activated protein kinase (p38), and c-Jun NH2-terminal kinase (JNK)1/2, which are intracellular signaling proteins typically activated in exercised/contracted skeletal muscle, was observed in the electrically stimulated C2C12 myotubes. The contractions induced by the electric pulses increased glucose uptake and depleted glycogen in the C2C12 myotubes. C2C12 myotubes that differentiated after exogenous gene transfection by a lipofection or an electroporation method retained their normal contractile ability by electrical stimulation. These findings show that our C2C12 cell contraction system reproduces the muscle phenotypes that arise in vivo (exercise), in situ (hindlimb muscles in an anesthetized animal), and in vitro (dissected muscle tissues in incubation buffer) by acute muscle contraction, demonstrating that the system is applicable for the analysis of intracellular events evoked by acute muscle contraction.	[Manabe, Yasuko; Miyatake, Shouta; Takagi, Mayumi; Nakamura, Mio; Okeda, Ai; Nakano, Taemi; Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo 158, Japan; [Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Tokyo Metropolitan University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Fujii, NL (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo 158, Japan.	fujiin@tmu.ac.jp	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033	Japan Society for the Promotion of Science Kakenhi [21240063]; Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy [LS102]; National Institutes of Health [AR45670, AR42238];  [21700657]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR042238, R01AR042238, R01AR045670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Grant-in-Aid for Young Scientists B 21700657 (to Y.M.), the Japan Society for the Promotion of Science Kakenhi 21240063 (to N.L.F.), Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy LS102 (to N.L.F.), and National Institutes of Health Grants AR45670 and AR42238 (to L.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; De Deyne PG, 2000, AM J PHYSIOL-CELL PH, V279, pC1801, DOI 10.1152/ajpcell.2000.279.6.C1801; Deshmukh AS, 2008, INT J OBESITY, V32, pS18, DOI 10.1038/ijo.2008.118; Fujii N, 2004, P NUTR SOC, V63, P205, DOI 10.1079/PNS2004340; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Fujita H, 2011, BIOMED MICRODEVICES, V13, P123, DOI 10.1007/s10544-010-9477-3; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Ho RC, 2004, AM J PHYSIOL-REG I, V286, pR342, DOI 10.1152/ajpregu.00563.2003; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; Ito Y, 2006, PFLUG ARCH EUR J PHY, V451, P803, DOI 10.1007/s00424-005-1512-5; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Nagamine K, 2010, BIOTECHNOL BIOENG, V105, P1161, DOI 10.1002/bit.22636; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; PRICE TB, 1994, MED SCI SPORT EXER, V26, P983; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Wilson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011042; Wojtaszewski JFP, 2002, J APPL PHYSIOL, V93, P384, DOI 10.1152/japplphysiol.00043.2002	21	71	74	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52592	10.1371/journal.pone.0052592	http://dx.doi.org/10.1371/journal.pone.0052592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300713	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600019
J	Irla, M; Guerri, L; Guenot, J; Serge, A; Lantz, O; Liston, A; Imhof, BA; Palmer, E; Reith, W				Irla, Magali; Guerri, Lucia; Guenot, Jeanne; Serge, Arnauld; Lantz, Olivier; Liston, Adrian; Imhof, Beat A.; Palmer, Ed; Reith, Walter			Antigen Recognition by Autoreactive CD4(+) Thymocytes Drives Homeostasis of the Thymic Medulla	PLOS ONE			English	Article							T-CELL RECEPTOR; EPITHELIAL-CELLS; CENTRAL TOLERANCE; NEGATIVE SELECTION; POSITIVE SELECTION; GENE-EXPRESSION; PROMOTER-IV; IN-VIVO; MICE; SELF	The thymic medulla is dedicated for purging the T-cell receptor (TCR) repertoire of self-reactive specificities. Medullary thymic epithelial cells (mTECs) play a pivotal role in this process because they express numerous peripheral tissue-restricted self-antigens. Although it is well known that medulla formation depends on the development of single-positive (SP) thymocytes, the mechanisms underlying this requirement are incompletely understood. We demonstrate here that conventional SP CD4(+) thymocytes bearing autoreactive TCRs drive a homeostatic process that fine-tunes medullary plasticity in adult mice by governing the expansion and patterning of the medulla. This process exhibits strict dependence on TCR-reactivity with self-antigens expressed by mTECs, as well as engagement of the CD28-CD80/CD86 costimulatory axis. These interactions induce the expression of lymphotoxin alpha in autoreactive CD4(+) thymocytes and RANK in mTECs. Lymphotoxin in turn drives mTEC development in synergy with RANKL and CD40L. Our results show that Ag-dependent interactions between autoreactive CD4(+) thymocytes and mTECs fine-tune homeostasis of the medulla by completing the signaling axes implicated in mTEC expansion and medullary organization.	[Irla, Magali; Guenot, Jeanne; Serge, Arnauld; Imhof, Beat A.; Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Guerri, Lucia; Lantz, Olivier] Inst Curie, Dept Biol Tumeurs, Paris, France; [Guerri, Lucia; Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Liston, Adrian] VIB, Autoimmune Genet Lab, Louvain, Belgium; [Liston, Adrian] Katholieke Univ Leuven, Louvain, Belgium; [Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	University of Geneva; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Basel	Irla, M (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France.	Magali.Irla@unige.ch; Walter.Reith@unige.ch	Liston, Adrian/G-8606-2013; Sergé, Arnauld/N-4828-2019; Serge, Arnauld/AAP-1525-2020; IRLA, Magali/AAH-7941-2019; Guerri, Lucia/AAZ-4011-2020	Liston, Adrian/0000-0002-6272-4085; Sergé, Arnauld/0000-0003-4271-3706; Serge, Arnauld/0000-0002-1280-6277; IRLA, Magali/0000-0001-8803-9708; Guerri, Lucia/0000-0002-0878-0529; Lantz, olivier/0000-0003-3161-7719	Swiss National Science Foundation [PZ00P3-131945, 31003A-127255]; Jules Thorn foundation; Association de la Recherche sur le Cancer; ANR; Ligue Contre le Cancer; Inserm; Institut Curie	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Jules Thorn foundation; Association de la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	MI was supported by grants from the Swiss National Science Foundation (PZ00P3-131945, www.snf.ch) and the Jules Thorn foundation (www.julesthorntrust.org.uk). Work in the laboratory of WR was supported by the Swiss National Science Foundation (grant 31003A-127255, www.snf.ch). LG was supported by fellowships from the Association de la Recherche sur le Cancer (www.arc-cancer.net) and the ANR (www.agence-nationale-recherche.fr). The laboratory of OL was funded by the Ligue Contre le Cancer (www.liguecancer.ch/fr), Inserm (www.inserm.fr) and Institut Curie (curie.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Heikenwalder M, 2008, AM J PATHOL, V172, P1555, DOI 10.2353/ajpath.2008.070572; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2011, TRENDS IMMUNOL, V32, P188, DOI 10.1016/j.it.2011.03.002; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mouri Y, 2011, J IMMUNOL; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Zhu MZ, 2008, IMMUNITY, V29, P386, DOI 10.1016/j.immuni.2008.09.001; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	47	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52591	10.1371/journal.pone.0052591	http://dx.doi.org/10.1371/journal.pone.0052591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300712	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100066
J	Lee, SL; Nekouzadeh, A; Butler, B; Pryse, KM; McConnaughey, WB; Nathan, AC; Legant, WR; Schaefer, PM; Pless, RB; Elliot, LE; Genin, GM				Lee, Sheng-Lin; Nekouzadeh, Ali; Butler, Boyd; Pryse, Kenneth M.; McConnaughey, William B.; Nathan, Adam C.; Legant, Wesley R.; Schaefer, Pascal M.; Pless, Robert B.; Elson, Elliot L.; Genin, Guy M.			Physically-Induced Cytoskeleton Remodeling of Cells in Three-Dimensional Culture	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; AIRWAY HYPERRESPONSIVENESS; CONTRACTILE FIBROBLASTS; BIOPHYSICAL BASIS; FOCAL ADHESIONS; STRESS FIBERS; SMOOTH-MUSCLE; LIVING CELL; STRETCH; ACTIN	Characterizing how cells in three-dimensional (3D) environments or natural tissues respond to biophysical stimuli is a longstanding challenge in biology and tissue engineering. We demonstrate a strategy to monitor morphological and mechanical responses of contractile fibroblasts in a 3D environment. Cells responded to stretch through specific, cell-wide mechanisms involving staged retraction and reinforcement. Retraction responses occurred for all orientations of stress fibers and cellular protrusions relative to the stretch direction, while reinforcement responses, including extension of cellular processes and stress fiber formation, occurred predominantly in the stretch direction. A previously unreported role of F-actin clumps was observed, with clumps possibly acting as F-actin reservoirs for retraction and reinforcement responses during stretch. Responses were consistent with a model of cellular sensitivity to local physical cues. These findings suggest mechanisms for global actin cytoskeleton remodeling in non-muscle cells and provide insight into cellular responses important in pathologies such as fibrosis and hypertension.	[Lee, Sheng-Lin; Nathan, Adam C.; Genin, Guy M.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Nekouzadeh, Ali; Legant, Wesley R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Butler, Boyd] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Pryse, Kenneth M.; McConnaughey, William B.; Elson, Elliot L.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Schaefer, Pascal M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Pless, Robert B.] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Texas Tech University System; Texas Tech University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Genin, GM (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.	genin@wustl.edu	Pless, Robert B/I-4698-2013	Lee, Sheng-Lin/0000-0001-5180-682X	NIH [K25-HL079165, R01-HL109505]; Johanna D. Bemis Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL079165, R01HL109505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johanna D. Bemis Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NIH through grants K25-HL079165 and R01-HL109505, and by the Johanna D. Bemis Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, CAN J PHYSIOL PHARM, V85, P700, DOI 10.1139/Y07-059; BYERS HR, 1982, J CELL BIOL, V93, P804, DOI 10.1083/jcb.93.3.804; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; De RM, 2010, METHOD CELL BIOL, V98, P143, DOI 10.1016/S0091-679X(10)98007-2; De R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031923; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Fabry Ben, 2007, Drug Discov Today Dis Models, V4, P131, DOI 10.1016/j.ddmod.2007.12.003; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; Fredberg JJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1179, DOI 10.1152/ajplung.00190.2002; Friedrich BM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002544; Friedrich BM, 2011, BIOPHYS J, V100, P2706, DOI 10.1016/j.bpj.2011.04.050; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Haviv L, 2008, EUR BIOPHYS J BIOPHY, V37, P447, DOI 10.1007/s00249-007-0236-1; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Krishnan R, 2012, AM J PHYSL CELL PHYS; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Lee S-L, 2011, THESIS WASH U; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Lenormand G, 2006, BIORHEOLOGY, V43, P1; Marquez JP, 2010, PHILOS T R SOC A, V368, P635, DOI 10.1098/rsta.2009.0240; McGarry JP, 2009, ANN BIOMED ENG, V37, P2317, DOI 10.1007/s10439-009-9772-4; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; Nekouzadeh A, 2011, P ROY SOC A-MATH PHY, V467, P2310, DOI 10.1098/rspa.2010.0623; Nguyen Trang T B, 2008, Proc Am Thorac Soc, V5, P58, DOI 10.1513/pats.200705-055VS; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P925, DOI 10.1016/j.jaci.2005.01.064; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Taber LA, 2009, PHILOS T R SOC A, V367, P3555, DOI 10.1098/rsta.2009.0100; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Waters CM, 2002, AM J PHYSIOL-LUNG C, V283, pL503, DOI 10.1152/ajplung.00141.2002; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110; Zemel A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021905	52	82	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e45512	10.1371/journal.pone.0045512	http://dx.doi.org/10.1371/journal.pone.0045512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300512	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100001
J	Williams, C; Rauch, MF; Michaud, M; Robinson, R; Xu, H; Madri, J; Lavik, E				Williams, Cicely; Rauch, Millicent Ford; Michaud, Michael; Robinson, Rebecca; Xu, Hao; Madri, Joseph; Lavik, Erin			Short Term Interactions with Long Term Consequences: Modulation of Chimeric Vessels by Neural Progenitors	PLOS ONE			English	Article							OUTGROWTH ENDOTHELIAL-CELLS; HUMAN PERIPHERAL-BLOOD; SPINAL-CORD-INJURY; NETWORKS IN-VIVO; GROWTH-FACTOR; GENE-THERAPY; STEM-CELLS; VASCULAR NETWORKS; NEUROTROPHIC FACTOR; ANGIOGENESIS	Vessels are a critical and necessary component of most tissues, and there has been substantial research investigating vessel formation and stabilization. Several groups have investigated coculturing endothelial cells with a second cell type to promote formation and stabilization of vessels. Some have noted that long-term vessels derived from implanted cocultures are often chimeric consisting of both host and donor cells. The questions arise as to whether the coculture cell might impact the chimeric nature of the microvessels and can modulate the density of donor cells over time. If long-term engineered microvessels are primarily of host origin, any impairment of the host's angiogenic ability has significant implications for the long-term success of the implant. If one can modulate the host versus donor response, one may be able to overcome a host's angiogenic impairment. Furthermore, if one can modulate the donor contribution, one may be able to engineer microvascular networks to deliver molecules a patient lacks systemically for long times. To investigate the impact of the cocultured cell on the host versus donor contributions of endothelial cells in engineered microvascular networks, we varied the ratio of the neural progenitors to endothelial cells in subcutaneously implanted poly(ethylene glycol)/poly-L-lysine hydrogels. We found that the coculture of neural progenitors with endothelial cells led to the formation of chimeric host-donor vessels, and the ratio of neural progenitors has a significant impact on the long term residence of donor endothelial cells in engineered microvascular networks in vivo even though the neural progenitors are only present transiently in the system. We attribute this to the short term paracrine signaling between the two cell types. This suggests that one can modulate the host versus donor contributions using short-term paracrine signaling which has broad implications for the application of engineered microvascular networks and cellular therapy more broadly.	[Lavik, Erin] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Williams, Cicely] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Rauch, Millicent Ford; Robinson, Rebecca] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Michaud, Michael; Madri, Joseph] Yale Univ, Dept Pathol, New Haven, CT USA; [Xu, Hao] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Case Western Reserve University; Yale University; Yale University; Yale University; Washington University (WUSTL)	Lavik, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	erin.lavik@case.edu		Michaud, Michael/0000-0001-7332-4987; Lavik, Erin/0000-0002-0644-744X	NIH MSTP Training Grant [5T32GM07205]; NIH Neuroengineering Training Grant [T90-DK070068]; NIH Director's New Innovator Award [DP2OD007338]; NIH [PO1-NS00344738, RO1-HL51018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007338] Funding Source: NIH RePORTER	NIH MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroengineering Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by generous gifts from Richard and Gail Siegal and Carol Sirot. CAW acknowledges NIH MSTP Training Grant 5T32GM07205. MFR and RR acknowledge NIH Neuroengineering Training Grant T90-DK070068. This work was also funded by an NIH Director's New Innovator Award, DP2OD007338 to EL and NIH PO1-NS00344738 and RO1-HL51018 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chamberlain MD, 2011, TISSUE ENG A; Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI [10.1089/ten.tea.2010.0293, 10.1089/ten.TEA.2010.0293]; Cheng G, 2011, BLOOD; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Debatin KM, 2008, GENE THER, V15, P780, DOI 10.1038/gt.2008.36; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Dellian M, 1996, AM J PATHOL, V149, P59; Dudek AZ, 2007, BRIT J CANCER, V97, P513, DOI 10.1038/sj.bjc.6603883; Dudek AZ, 2010, TRANSL RES, V156, P136, DOI 10.1016/j.trsl.2010.07.003; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GOLDEN MA, 1991, J CLIN INVEST, V87, P406, DOI 10.1172/JCI115011; Gosain A, 2006, J SURG RES, V135, P218, DOI 10.1016/j.jss.2006.04.006; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Kolbe M, 2011, TISSUE ENG A; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; Laschke MW, 2009, TISSUE ENG PART B-RE, V15, P455, DOI 10.1089/ten.TEB.2009.0252; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Milbauer LC, 2009, TRANSL RES, V153, P179, DOI 10.1016/j.trsl.2008.12.009; Mondrinos MJ, 2008, TISSUE ENG PT A, V14, P361, DOI 10.1089/tea.2007.0041; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pap-Szekeres J, 2005, DIS ESOPHAGUS, V18, P274, DOI 10.1111/j.1442-2050.2005.00483.x; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134; PILI R, 1994, JNCI-J NATL CANCER I, V86, P1303, DOI 10.1093/jnci/86.17.1303; Pinter E, 1999, AM J PATHOL, V154, P1367, DOI 10.1016/S0002-9440(10)65391-6; Potter MJ, 2006, PLAST RECONSTR SURG, V117, P1876, DOI 10.1097/01.prs.0000218843.86011.f8; Rauch MF, 2008, J BIOMAT SCI-POLYM E, V19, P1469, DOI 10.1163/156856208786140409; Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x; Reed MJ, 2000, J CELL BIOCHEM, V77, P116, DOI 10.1002/(SICI)1097-4644(20000401)77:1<116::AID-JCB12>3.3.CO;2-Z; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Somani A, 2007, TRANSL RES, V150, P30, DOI 10.1016/j.trsl.2007.02.002; Squinto S P, 1994, In Vivo, V8, P771; Swift ME, 1999, LAB INVEST, V79, P1479; Thiele J, 2004, TRANSPLANTATION, V77, P1902, DOI 10.1097/01.TP.0000127591.34203.8E; Thiele J, 2004, HISTOL HISTOPATHOL, V19, P201, DOI 10.14670/HH-19.201; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	72	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53208	10.1371/journal.pone.0053208	http://dx.doi.org/10.1371/journal.pone.0053208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300890	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100127
J	El Harchi, A; Melgari, D; Zhang, YH; Zhang, HG; Hancox, JC				El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Zhang, Henggui; Hancox, Jules C.			Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K+ Channel	PLOS ONE			English	Article							POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; DOFETILIDE BLOCK; CLASS-I; MUTATION; INHIBITION; RECTIFIER; DISOPYRAMIDE; DEPENDENCE; QUINIDINE	Background: The familial Short QT Syndrome (SQTS) is associated with an increased risk of cardiac arrhythmia and sudden death. Gain-of-function mutations in the hERG K+ channel protein have been linked to variant 1 of the SQTS. A hERG channel pore (T618I) mutation has recently been identified in families with heritable SQTS. This study aimed to determine effects of the T618I-hERG mutation on (i) hERG current (I-hERG) elicited by ventricular action potentials; (ii) the sensitivity of I-hERG to inhibition by four clinically used antiarrhythmic drugs. Methods: Electrophysiological recordings of I-hERG were made at 37 degrees C from HEK 293 cells expressing wild-type (WT) or T618I hERG. Whole-cell patch clamp recording was performed using both conventional voltage clamp and ventricular action potential (AP) clamp methods. Results: Under conventional voltage-clamp, WT I-hERG peaked at 0-+10 mV, whilst for T618I I-hERG maximal current was rightward shifted to similar to +40 mV. Voltage-dependent activation and inactivation of T618I I-hERG were positively shifted (respectively by +15 and similar to +25 mV) compared to WT I-hERG. The I-hERG 'window' was increased for T618I compared to WT hERG. Under ventricular AP clamp, maximal repolarising WT I-hERG occurred at similar to -30 mV, whilst for T618I hERG peak I-hERG occurred earlier during AP repolarisation, at similar to +5 mV. Under conventional voltage clamp, half-maximal inhibitory concentrations (IC50) for inhibition of I-hERG tails by quinidine, disopyramide, D-sotalol and flecainide for T618I hERG ranged between 1.4 and 3.2 fold that for WT hERG. Under action potential voltage clamp, T618I IC(50)s ranged from 1.2 to 2.0 fold the corresponding IC50 values for WT hERG. Conclusions: The T618I mutation produces a more modest effect on repolarising I-hERG than reported previously for the N588K-hERG variant 1 SQTS mutation. All drugs studied here appear substantially to retain their ability to inhibit I-hERG in the setting of the SQTS-linked T618I mutation.	[El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Hancox, Jules C.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [El Harchi, Aziza; Melgari, Dario; Zhang, Yi Hong; Hancox, Jules C.] Univ Bristol, Cardiovasc Res Labs, Bristol, Avon, England; [Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England	University of Bristol; University of Bristol; University of Manchester	Hancox, JC (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	Jules.hancox@bristol.ac.uk	Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011; Hancox, Jules C./Z-1550-2019	EL HARCHI, Aziza/0000-0003-3329-6234	British Heart Foundation [PG/10/96, FS/11/59, PG/10/17]; British Heart Foundation [PG/10/017/28239, PG/10/96/28661, FS/11/59/28938] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The authors thank the British Heart Foundation for funding (AEH: PG/10/96; DM: FS/11/59; YZ: PG/10/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002313; Breindahl T, 2000, J CHROMATOGR B, V746, P249, DOI 10.1016/S0378-4347(00)00343-1; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Du CY, 2010, J CARDIOVASC ELECTR, V21, P1160, DOI 10.1111/j.1540-8167.2010.01772.x; El Harchi A, 2009, J MOL CELL CARDIOL, V137, P83; El Harchi A, 2012, J MOL CELL CARDIOL, V52, P185, DOI 10.1016/j.yjmcc.2011.09.021; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gaita F, 2004, J AM COLL CARDIOL, V43, P1494, DOI 10.1016/j.jacc.2004.02.034; Giustetto C, 2006, EUR HEART J, V27, P2440, DOI 10.1093/eurheartj/ehl185; Giustetto C, 2011, J AM COLL CARDIOL, V58, P587, DOI 10.1016/j.jacc.2011.03.038; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; Kirsch Glenn E., 2004, Journal of Pharmacological and Toxicological Methods, V50, P93, DOI 10.1016/j.vascn.2004.06.003; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Levi AJ, 1996, PFLUG ARCH EUR J PHY, V432, P930, DOI 10.1007/s004240050217; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Maury P, 2008, ARCH CARDIOVASC DIS, V101, P779, DOI 10.1016/j.acvd.2008.08.009; McPate MJ, 2008, BRIT J PHARMACOL, V155, P957, DOI 10.1038/bjp.2008.325; McPate MJ, 2009, J PHYSIOL PHARMACOL, V60, P23; McPate MJ, 2006, J MOL CELL CARDIOL, V41, P563, DOI 10.1016/j.yjmcc.2006.05.021; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Milnes JT, 2010, J PHARMACOL TOX MET, V61, P178, DOI 10.1016/j.vascn.2010.02.007; Modell SM, 2006, GENET MED, V8, P143, DOI 10.1097/01.gim.0000204468.85308.86; Numaguchi H, 2000, CIRC RES, V87, P1012, DOI 10.1161/01.RES.87.11.1012; Paul AA, 2002, BRIT J PHARMACOL, V136, P717, DOI 10.1038/sj.bjp.0704784; Paul AA, 2001, BIOCHEM BIOPH RES CO, V280, P1243, DOI 10.1006/bbrc.2001.4269; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1995, POTASSIUM CHANNELS N, P151; Schimpf R, 2005, CARDIOVASC RES, V67, P357, DOI 10.1016/j.cardiores.2005.03.026; Schimpf R, 2003, J CARDIOVASC ELECTR, V14, P1273, DOI 10.1046/j.1540-8167.2003.03278.x; Schimpf R, 2007, J CARDIOVASC ELECTR, V18, P1157, DOI 10.1111/j.1540-8167.2007.00925.x; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Sun YX, 2011, J MOL CELL CARDIOL, V50, P433, DOI 10.1016/j.yjmcc.2010.11.017; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viskin S, 2007, EUROPACE, V9, P1105, DOI 10.1093/europace/eum181; Weerapura M, 2002, PFLUG ARCH EUR J PHY, V443, P520, DOI 10.1007/s004240100720; Weirich J, 1998, BASIC RES CARDIOL, V93, P125; Witchel HJ, 2000, CLIN EXP PHARMACOL P, V27, P753, DOI 10.1046/j.1440-1681.2000.03337.x; Wolpert C, 2005, J CARDIOVASC ELECTR, V16, P54, DOI 10.1046/j.1540-8167.2005.04470.x; Yao Jian-An, 2005, Journal of Pharmacological and Toxicological Methods, V52, P146, DOI 10.1016/j.vascn.2005.04.008; ZEMA MJ, 1984, THER DRUG MONIT, V6, P192, DOI 10.1097/00007691-198406000-00011; Zhang YH, 2011, BBA-BIOMEMBRANES, V1808, P2477, DOI 10.1016/j.bbamem.2011.07.001; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52451	10.1371/journal.pone.0052451	http://dx.doi.org/10.1371/journal.pone.0052451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300672	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800088
J	Hua, K; Schindler, MK; McQuail, JA; Forbes, ME; Riddle, DR				Hua, Kun; Schindler, Matthew K.; McQuail, Joseph A.; Forbes, M. Elizabeth; Riddle, David R.			Regionally Distinct Responses of Microglia and Glial Progenitor Cells to Whole Brain Irradiation in Adult and Aging Rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; WHITE-MATTER; SPINAL-CORD; STEM-CELL; RADIATION; RADIOTHERAPY; AGE; INJURY	Radiation therapy has proven efficacy for treating brain tumors and metastases. Higher doses and larger treatment fields increase the probability of eliminating neoplasms and preventing reoccurrence, but dose and field are limited by damage to normal tissues. Normal tissue injury is greatest during development and in populations of proliferating cells but also occurs in adults and older individuals and in non-proliferative cell populations. To better understand radiation-induced normal tissue injury and how it may be affected by aging, we exposed young adult, middle-aged, and old rats to 10 Gy of whole brain irradiation and assessed in gray- and white matter the responses of microglia, the primary cellular mediators of radiation-induced neuroinflammation, and oligodendrocyte precursor cells, the largest population of proliferating cells in the adult brain. We found that aging and/or irradiation caused only a few microglia to transition to the classically ``activated'' phenotype, e. g., enlarged cell body, few processes, and markers of phagocytosis, that is seen following more damaging neural insults. Microglial changes in response to aging and irradiation were relatively modest and three markers of reactivity - morphology, proliferation, and expression of the lysosomal marker CD68- were regulated largely independently within individual cells. Proliferation of oligodendrocyte precursors did not appear to be altered during normal aging but increased following irradiation. The impacts of irradiation and aging on both microglia and oligodendrocyte precursors were heterogeneous between white-and gray matter and among regions of gray matter, indicating that there are regional regulators of the neural response to brain irradiation. By several measures, the CA3 region of the hippocampus appeared to be differentially sensitive to effects of aging and irradiation. The changes assessed here likely contribute to injury following inflammatory challenges like brain irradiation and represent important end-points for analysis in studies of therapeutic strategies to protect patients from neural dysfunction.	[Hua, Kun; Forbes, M. Elizabeth; Riddle, David R.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [McQuail, Joseph A.; Riddle, David R.] Wake Forest Sch Med, Program Neurosci, Winston Salem, NC USA; [Schindler, Matthew K.] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA	Wake Forest University; Wake Forest University; University of Pennsylvania	Riddle, DR (corresponding author), Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA.	driddle@wakehealth.edu	Schindler, Matthew/ABG-6790-2020	Schindler, Matthew/0000-0003-0157-5669; McQuail, Joseph/0000-0003-4431-8582; Forbes, Elizabeth/0000-0003-3300-5476	National Institutes of Health [AG11370, CA133483]; NATIONAL CANCER INSTITUTE [R01CA133483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG11370 and CA133483 (DRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2011, CANCER RES, V71, P4834, DOI 10.1158/0008-5472.CAN-11-0027; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Atkinson SL, 2005, INT J RADIAT ONCOL, V62, P535, DOI 10.1016/j.ijrobp.2005.01.061; Barani IJ, 2007, INT J RADIAT ONCOL, V68, P324, DOI 10.1016/j.ijrobp.2007.01.033; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bodles AM, 2004, TRENDS NEUROSCI, V27, P621, DOI 10.1016/j.tins.2004.07.011; Brandes AA, 2000, EUR J CANCER, V36, P447, DOI 10.1016/S0959-8049(99)00322-6; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Byrne TN, 2005, CURR OPIN NEUROL, V18, P662, DOI 10.1097/01.wco.0000191511.52745.99; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Conner KR, 2010, RADIAT RES, V173, P49, DOI 10.1667/RR1821.1; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Fox Sherry W, 2006, Clin J Oncol Nurs, V10, P169, DOI 10.1188/06.CJON.169-176; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gutierrez AN, 2007, INT J RADIAT ONCOL, V69, P589, DOI 10.1016/j.ijrobp.2007.05.038; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayakawa K, 1997, Radiat Med, V15, P405; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kanaan NM, 2008, GLIA, V56, P1199, DOI 10.1002/glia.20690; Kempermann G, 1998, J NEUROSCI, V18, P3206; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; LEE PWH, 1989, J NEUROL NEUROSUR PS, V52, P488, DOI 10.1136/jnnp.52.4.488; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; Li YQ, 1996, CANCER RES, V56, P5417; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Maher FO, 2004, NEUROBIOL AGING, V25, P795, DOI 10.1016/j.neurobiolaging.2003.08.007; Marsh JC, 2010, INT J RADIAT ONCOL, V78, P946, DOI 10.1016/j.ijrobp.2009.12.012; Miller KR, 2007, NEURON GLIA BIOL, V3, P245, DOI 10.1017/S1740925X08000136; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakagawa M, 1996, INT J RADIAT ONCOL, V36, P113, DOI 10.1016/S0360-3016(96)00239-8; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Peiffer AM, 2010, BRAIN RES, V1351, P23, DOI 10.1016/j.brainres.2010.06.049; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Ramanan S, 2009, INT J RADIAT ONCOL, V75, P870, DOI 10.1016/j.ijrobp.2009.06.059; Reinacher PC, 1999, EXP NEUROL, V160, P117, DOI 10.1006/exnr.1999.7177; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Sasaki R, 2000, NEUROSCI LETT, V279, P57, DOI 10.1016/S0304-3940(99)00910-6; Schindler MK, 2008, INT J RADIAT ONCOL, V70, P826, DOI 10.1016/j.ijrobp.2007.10.054; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Shi L, 2009, J NEUROL SCI, V285, P178, DOI 10.1016/j.jns.2009.06.031; Siegal T, 1996, INT J RADIAT ONCOL, V36, P649, DOI 10.1016/S0360-3016(96)00357-4; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Swennen MHJ, 2004, J NEURO-ONCOL, V66, P333, DOI 10.1023/B:NEON.0000014518.16481.7e; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; Wen P.Y., 2001, CANC PRINCIPLES PRAC, P2655; Wu KL, 2010, INT J RADIAT ONCOL, V76, P220, DOI 10.1016/j.ijrobp.2009.08.017; Xu YZ, 2010, BRAIN BEHAV IMMUN, V24, P138, DOI 10.1016/j.bbi.2009.09.006; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	78	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52728	10.1371/journal.pone.0052728	http://dx.doi.org/10.1371/journal.pone.0052728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300752	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800132
J	Liang, JW; Gao, P; Wang, ZN; Song, YX; Xu, YY; Wang, MX; Dong, YL; Xu, HM				Liang, Ji-wang; Gao, Peng; Wang, Zhen-ning; Song, Yong-xi; Xu, Ying-ying; Wang, Mei-xian; Dong, Yu-lan; Xu, Hui-mian			The Integration of Macroscopic Tumor Invasion of Adjacent Organs into TNM Staging System for Colorectal Cancer	PLOS ONE			English	Article							SURVIVAL; ADENOCARCINOMAS; DEPOSITS; NUMBER; COLON	Objective: In addition to pathological TNM (pTNM) staging, the macroscopic staging (surgical TNM, sTNM) is another method used to stage and assess tumors, and it also potentially influences patient treatment guidelines. However, for the same patient, surgeons and pathologists might assess tumor depth differently. We aimed to evaluate the prognosis of patients who exhibit unconformity of intraoperative and postoperative results and propose a revised pT category (r-pT category) to predict survival in colorectal cancer. Methods and Results: In our study, 948 colorectal cancer patients were reviewed. We proposed a novel r-pT category in which surgical macroscopic T4b (sT4b) is incorporated into the pT category, namely, patients in the pT3 category with sT4b cancers are reclassified as being in the r-pT4a category; patients in the pT4a category with sT4b cancers are reclassified as being in the r-pT4b category. Cancer-specific survival according to the r-pT category was analyzed using Kaplan-Meier survival curves. A two-step multivariate analysis was used to determine correlations between the r-pT category and the prognosis. Harrell's C statistic was utilized to test the predictive capacity. There were significant prognostic differences among the r-pT subcategories. We substituted the r-pT category for the pT category in current TNM staging in a 2-step multivariate analysis. The Harrell's C statistical analysis results demonstrated that the r-pT category had superior predictive capacity compared to the pT category (Harrell' C: 0.668 vs. 0.636; P = 0.002). Conclusions: Patients in the pT3 category with sT4b cancers, and patients in the pT4a category with sT4b cancers, are potentially under-staged, reclassification into higher categories could potentially benefit these patients. The results indicate that the r-pT category we proposed is potentially superior to the pT category in the assessment of prognosis for colorectal cancer.	[Liang, Ji-wang; Gao, Peng; Wang, Zhen-ning; Song, Yong-xi; Xu, Ying-ying; Xu, Hui-mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang, Peoples R China; [Wang, Mei-xian; Dong, Yu-lan] China Med Univ, Dept Tumor Pathol & Surg Oncol, Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; wang, zhen ning/E-1878-2011; Gao, Peng/B-8031-2013	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; 	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Program of Education Department of Liaoning Province [L2011137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Program of Education Department of Liaoning Province	This work was supported by National Science Foundation of China (30972879 and 81172370), the Program of Scientific and Technological Department of Liaoning Province (2010225032) and the Program of Education Department of Liaoning Province (L2011137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN J, 1986, Journal of Fujian Agricultural College, V15, P347; Chen YG, 2011, CELL BIOCHEM BIOPHYS, V59, P1, DOI 10.1007/s12013-010-9106-z; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Gajra A, 2003, J CLIN ONCOL, V21, P1029, DOI 10.1200/JCO.2003.07.010; Goldstein NS, 2000, CANCER-AM CANCER SOC, V88, P2228, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1; Greene FL, 2009, J SURG ONCOL, V99, P269, DOI 10.1002/jso.21237; Harisi R, 2008, HEPATO-GASTROENTEROL, V55, P66; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hemminki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-688; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; MADDEN MV, 1987, BRIT J SURG, V74, P119, DOI 10.1002/bjs.1800740217; Markman Maurie, 2003, Curr Oncol Rep, V5, P437, DOI 10.1007/s11912-003-0001-2; Nagtegaal ID, 2007, HISTOPATHOLOGY, V51, P141, DOI 10.1111/j.1365-2559.2007.02720.x; Ostadi MA, 2007, SURG ENDOSC, V21, P2142, DOI 10.1007/s00464-007-9414-6; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Sun Z, 2009, ANN SURG, V249, P768, DOI 10.1097/SLA.0b013e3181a3df77; Tong LL, 2012, ANN SURG, V255, P208, DOI 10.1097/SLA.0b013e31821ad8a2; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Tong LL, 2011, ANN SURG ONCOL, V18, P1389, DOI 10.1245/s10434-010-1440-2; Xu HM, 1995, J CHINA MED U, V24, P352	22	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52269	10.1371/journal.pone.0052269	http://dx.doi.org/10.1371/journal.pone.0052269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300631	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800064
J	Tomoda, A; Polcari, A; Anderson, CM; Teicher, MH				Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.			Reduced Visual Cortex Gray Matter Volume and Thickness in Young Adults Who Witnessed Domestic Violence during Childhood	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; CEREBRAL-BLOOD-FLOW; HIPPOCAMPAL VOLUME; CORPUS-CALLOSUM; MALTREATED CHILDREN; SENSITIVE PERIODS; HURTFUL WORDS; VERBAL ABUSE	Exposure to interparental violence is associated with negative outcomes, such as depression, post-traumatic stress disorder and reduced cognitive abilities. However, little is known about the potential effects of witnessing domestic violence during childhood on gray matter volume (GMV) or cortical thickness. High-resolution 3.0 T volumetric scans (Siemens Trio Scanner) were obtained on 52 subjects (18-25 years) including 22 (6 males/16 females) with a history of visually witnessing episodes of domestic violence, and 30 (8 males/22 females) unexposed control subjects, with neither a current nor past DSM-IV Axis I or II disorder. Potential confounding effects of age, gender, level of parental verbal aggression, parental education, financial stress, full scale IQ, and total GMV, or average thickness were modeled using voxel based morphometry and FreeSurfer. Witnessing domestic violence subjects had a 6.1% GMV reduction in the right lingual gyrus (BA18) (P = 0.029, False Discovery Rate corrected peak level). Thickness in this region was also reduced, as was thickness in V2 bilaterally and left occipital pole. Theses regions were maximally sensitive to exposure to witnessing domestic violence between 11-13 years of age. Regional reductions in GMV and thickness were observed in both susceptible and resilient witnessing domestic violence subjects. Results in subjects witnessing domestic violence were similar to previously reported results in subjects with childhood sexual abuse, as the primary region affected was visual cortex. Brain regions that process and convey the adverse sensory input of the abuse may be specifically modified by this experience, particularly in subjects exposed to a single type of maltreatment. Exposure to multiple types of maltreatment is more commonly associated with morphological alterations in corticolimbic regions. These findings fit with preclinical studies showing that visual cortex is a highly plastic structure.	[Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Tomoda, Akemi; Polcari, Ann; Anderson, Carl M.; Teicher, Martin H.] McLean Hosp, Dev Biopsychiat Res Program, Belmont, MA 02178 USA; [Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Polcari, Ann] Northeastern Univ, Sch Nursing, Boston, MA 02115 USA; [Anderson, Carl M.] McLean Hosp, Brain Imaging Ctr, Belmont, MA 02178 USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Fukui; Northeastern University; Harvard University; McLean Hospital	Tomoda, A (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	atomoda@u-fukui.ac.jp	Teicher, Martin H/P-3906-2017	Teicher, Martin H/0000-0002-6036-0177	United States of America National Institute of Mental Health [MH-066222, MH-091391]; National Institute of Drug Abuse [DA-016934, DA-017846]; Japan-United States Brain Research Cooperation Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091391, R01MH066222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017846, R01DA016934] Funding Source: NIH RePORTER	United States of America National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Japan-United States Brain Research Cooperation Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by RO1 awards from the United States of America National Institute of Mental Health (MH-066222, MH-091391) http://www.nimh.nih.gov/index.shtml and National Institute of Drug Abuse (DA-016934, DA-017846) http://www.drugabuse.gov/to MHT, and Grant-in-Aid for Scientific Research to AT from Japan-United States Brain Research Cooperation Program http://www.nips.ac.jp/jusnou/eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Casiano H, 2009, J NERV MENT DIS, V197, P856, DOI 10.1097/NMD.0b013e3181be9c55; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Fantuzzo J, 1997, J AM ACAD CHILD PSY, V36, P116, DOI 10.1097/00004583-199701000-00025; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; First M.B, 1997, STRUCTURED CLIN INTE; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gold, 1980, INTRO BIVARIATE MULT, DOI DOI 10.2307/2287559; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Hamby S, 2010, CHILD ABUSE NEGLECT, V34, P734, DOI 10.1016/j.chiabu.2010.03.001; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HERMAN JL, 1989, TRAUMATIC ANTECEDENT; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Joo EY, 2008, SLEEP, V31, P868, DOI 10.1093/sleep/31.6.868; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; KELLNER R, 1987, J CLIN PSYCHIAT, V48, P268; Kiyosawa M, 1996, GRAEF ARCH CLIN EXP, V234, P110, DOI 10.1007/BF00695250; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Luthra R, 2009, J INTERPERS VIOLENCE, V24, P1919, DOI 10.1177/0886260508325494; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; McCrory EJ, 2011, CURR BIOL, V21, pR947, DOI 10.1016/j.cub.2011.10.015; McDonald R, 2006, J FAM PSYCHOL, V20, P137, DOI 10.1037/0893-3200.20.1.137; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Nicodimos Semret, 2009, East Afr J Public Health, V6, P184; R Core Team, 2021, R LANG ENV STAT COMP; Richert KA, 2006, DEPRESS ANXIETY, V23, P17, DOI 10.1002/da.20131; Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa; Russo R, 2003, STAT BEHAV SCI INTRO, P192; Salminen-Vaparanta N, 2012, NEUROPSYCHOLOGIA, V50, P1621, DOI 10.1016/j.neuropsychologia.2012.03.015; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Silva RR, 2000, AM J PSYCHIAT, V157, P1229, DOI 10.1176/appi.ajp.157.8.1229; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Teicher MH, 2010, AM J PSYCHIAT, V167, P1464, DOI 10.1176/appi.ajp.2010.10010030; Teicher MH, 2004, BIOL PSYCHIAT, V56, P80, DOI 10.1016/j.biopsych.2004.03.016; TEICHER MH, 1993, J NEUROPSYCH CLIN N, V5, P301; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; van Harmelen AL, 2012, SOC COGN AFFECT NEUR; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	71	85	87	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52528	10.1371/journal.pone.0052528	http://dx.doi.org/10.1371/journal.pone.0052528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300699	Green Published, gold			2022-12-25	WOS:000313618800101
J	White, EJ; Genesee, F; Steinhauer, K				White, Erin Jacquelyn; Genesee, Fred; Steinhauer, Karsten			Brain Responses before and after Intensive Second Language Learning: Proficiency Based Changes and First Language Background Effects in Adult Learners	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; ACQUISITION; ERP; ACTIVATION; EXPLICIT; IMPLICIT; CHINESE; AGE; MORPHOLOGY	This longitudinal study tracked the neuro-cognitive changes associated with second language (L2) grammar learning in adults in order to investigate how L2 processing is shaped by a learner's first language (L1) background and L2 proficiency. Previous studies using event-related potentials (ERPs) have argued that late L2 learners cannot elicit a P600 in response to L2 grammatical structures that do not exist in the L1 or that are different in the L1 and L2. We tested whether the neuro-cognitive processes underlying this component become available after intensive L2 instruction. Korean- and Chinese late-L2- learners of English were tested at the beginning and end of a 9-week intensive English-L2 course. ERPs were recorded while participants read English sentences containing violations of regular past tense (a grammatical structure that operates differently in Korean and does not exist in Chinese). Whereas no P600 effects were present at the start of instruction, by the end of instruction, significant P600s were observed for both L1 groups. Latency differences in the P600 exhibited by Chinese and Korean speakers may be attributed to differences in L1-L2 reading strategies. Across all participants, larger P600 effects at session 2 were associated with: 1) higher levels of behavioural performance on an online grammaticality judgment task; and 2) with correct, rather than incorrect, behavioural responses. These findings suggest that the neuro-cognitive processes underlying the P600 (e.g., "grammaticalization'') are modulated by individual levels of L2 behavioural performance and learning.	[White, Erin Jacquelyn; Genesee, Fred; Steinhauer, Karsten] Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [White, Erin Jacquelyn; Genesee, Fred] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Steinhauer, Karsten] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada	McGill University; McGill University	White, EJ (corresponding author), Ctr Res Brain Language & Mus, Montreal, PQ, Canada.	erin.white@mail.mcgill.ca; karsten.steinhauer@mcgill.ca	Steinhauer, Karsten/B-2863-2008		Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS) [PGS D3 - 347964 - 2007]; Canada Research Chair program; Canada Foundation for Innovation (CRC/CFI) [201876]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPGP 312835]; Center for Research on Brain, Language and Music [CRLMB 214404]; Social Sciences and Humanities Research Council of Canada SSHRC [232345]; Fonds de Recherche Societe et Culture FQRSC [2010-SE-103727]	Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Canada Foundation for Innovation (CRC/CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Center for Research on Brain, Language and Music; Social Sciences and Humanities Research Council of Canada SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Fonds de Recherche Societe et Culture FQRSC	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS), Application No: PGS D3 - 347964 - 2007 (http://www.nserc-crsng.gc.ca/index_eng.asp); Canada Research Chair program; Canada Foundation for Innovation (CRC/CFI; project # 201876, http://www.chairs.gc.ca/); Natural Sciences and Engineering Research Council of Canada (NSERC; #RGPGP 312835, http://www.nserc-crsng.gc.ca/index_eng.asp); Center for Research on Brain, Language and Music (CRLMB 214404, http://www.crblm.ca/); Social Sciences and Humanities Research Council of Canada SSHRC (grant no: 232345, http://www.sshrc-crsh.gc.ca/Default.aspx); Fonds de Recherche Societe et Culture FQRSC (#2010-SE-103727, http://www.fqrsc.gouv.qc.ca/fr/accueil.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsong D, 2006, LANG LEARN, V56, P9, DOI 10.1111/j.1467-9922.2006.00353.x; Chen L, 2007, BILING-LANG COGN, V10, P161, DOI 10.1017/S136672890700291X; Drury J, 2007, J COGNITIVE NEUROS S, P249; Ellis R., 1994, STUDY 2 LANGUAGE ACQ; Franceschina F., 2005, FOSSILIZED 2 LANGUAG; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Dowens MG, 2011, NEUROPSYCHOLOGIA, V49, P1651, DOI 10.1016/j.neuropsychologia.2011.02.034; Dowens MG, 2010, J COGNITIVE NEUROSCI, V22, P1870, DOI 10.1162/jocn.2009.21304; Goad H, 2008, LINGUA, V118, P577, DOI 10.1016/j.lingua.2007.01.008; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 2006, J COGNITIVE NEUROSCI, V18, P121, DOI 10.1162/089892906775250067; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hahne A, 2001, J PSYCHOLINGUIST RES, V30, P251, DOI 10.1023/A:1010490917575; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Inoue K., BILINGUALIS IN PRESS; Jia G, 2007, J SPEECH LANG HEAR R, V50, P1280, DOI 10.1044/1092-4388(2007/090); Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, J COGNITIVE NEUROSCI, V15, P272, DOI 10.1162/089892903321208204; Li P, 2007, BILING-LANG COGN, V10, P117, DOI 10.1017/S1366728907002878; Macmillan N. A., 2005, DETECTION THEORY USE; MacWhinney B., 2005, HDB BILINGUALISM PSY, P49, DOI DOI 10.1075/TILAR.22.15MAC; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; McLaughlin J, 2004, NAT NEUROSCI, V7, P703, DOI 10.1038/nn1264; McLaughlin J, 2010, LANG LEARN, V60, P123, DOI 10.1111/j.1467-9922.2010.00604.x; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Ojima S, 2005, J COGNITIVE NEUROSCI, V17, P1212, DOI 10.1162/0898929055002436; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P271; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 2006, LANG LEARN, V56, P199, DOI 10.1111/j.1467-9922.2006.00361.x; Osterhout L, 2008, J NEUROLINGUIST, V21, P509, DOI 10.1016/j.jneuroling.2008.01.001; Pakulak E, 2011, J COGNITIVE NEUROSCI, V23, P2752, DOI 10.1162/jocn.2010.21586; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Perfetti CA, 2010, NEURAL BASIS READING, P147; Rossi S, 2006, J COGNITIVE NEUROSCI, V18, P2030, DOI 10.1162/jocn.2006.18.12.2030; Sabourin L, 2006, SECOND LANG RES, V22, P1, DOI 10.1191/0267658306sr259oa; Sabourin L, 2008, SECOND LANG RES, V24, P397, DOI 10.1177/0267658308090186; Steinhauer K, 2006, J COGNITIVE NEUROS S, P99; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Steinhauer K, 2009, SECOND LANG RES, V25, P13, DOI 10.1177/0267658308098995; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Tan LH, 2005, HONG KONG J PAEDIATR, V10, P131; Tanner D, 2009, PROC ANN BUCLD, P528; Tokowicz N, 2005, STUD SECOND LANG ACQ, V27, P173, DOI 10.1017/S0272263105050102; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Wang M, 2003, COGNITION, V87, P129, DOI 10.1016/S0010-0277(02)00232-9; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; White L., 2003, 2 LANGUAGE ACQUISITI	58	44	44	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52318	10.1371/journal.pone.0052318	http://dx.doi.org/10.1371/journal.pone.0052318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300641	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800068
J	Della Vecchia, MC; Rued, AC; Carattino, MD				Della Vecchia, Margaret C.; Rued, Anna C.; Carattino, Marcelo D.			Gating Transitions in the Palm Domain of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EXTRACELLULAR DOMAIN; SODIUM-CHANNEL; DESENSITIZATION; PLASTICITY	Acid-sensing ion channels (ASICs) are trimeric cation-selective proton-gated ion channels expressed in the central and peripheral nervous systems. The pore-forming transmembrane helices in these channels are linked by short loops to the palm domain in the extracellular region. Here, we explore the contribution to proton gating and desensitization of Glu-79 and Glu-416 in the palm domain of ASIC1a. Engineered Cys, Lys, and Gln substitutions at these positions shifted apparent proton affinity toward more acidic values. Double mutant cycle analysis indicated that Glu-79 and Glu-416 cooperatively facilitated pore opening in response to extracellular acidification. Channels bearing Cys at position 79 or 416 were irreversibly modified by thiol-reactive reagents in a state-dependent manner. Glu-79 and Glu-416 are located in beta-strands 1 and 12, respectively. The covalent modification by (2-(trimethylammonium)ethyl) methanethiosulfonate bromide of Cys at position 79 impacted conformational changes associated with pore closing during desensitization, whereas the modification of Cys at position 416 affected conformational changes associated with proton gating. These results suggest that beta-strands 1 and 12 contribute antagonistically to activation and desensitization of ASIC1a. Site-directed mutagenesis experiments indicated that the lower palm domain contracts in response to extracellular acidification. Taken together, our studies suggest that the lower palm domain mediates conformational movements that drive pore opening and closing events.	Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Dept Med, Renal Electrolyte Div, S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health Grant [R01 DK084060]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084060.	Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	29	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5487	5495		10.1074/jbc.M112.441964	http://dx.doi.org/10.1074/jbc.M112.441964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300086	Green Published, hybrid			2022-12-25	WOS:000315342500023
J	Wang, JM; Du, J; Wu, ZQ; Jin, Q				Wang, Jianmin; Du, Jiang; Wu, Zhiqiang; Jin, Qi			Quinacrine Impairs Enterovirus 71 RNA Replication by Preventing Binding of Polypyrimidine-Tract Binding Protein with Internal Ribosome Entry Sites	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS VIRUS-RNA; CAP-INDEPENDENT TRANSLATION; REPUBLIC-OF-CHINA; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; WESTERN-AUSTRALIA; PICORNAVIRUS RNA; POLIOVIRUS RNA; IN-VITRO; INITIATION	Since the 1980s, epidemics of enterovirus 71 (EV71) and other enteroviruses have occurred in Asian countries and regions, causing a wide range of human diseases. No effective therapy is available for the treatment of these infections. Internal ribosome entry sites (IRESs) are indispensable for the initiation of translation in enteroviruses. Several cellular factors, as well as the ribosome, are recruited to the conserved IRES during this process. Quinacrine intercalates into the RNA architecture and inhibits RNA transcription and protein synthesis, and a recent study showed that quinacrine inhibited encephalomyocarditis virus and poliovirus IRES-mediated translation in vitro without disrupting internal cellular IRES. Here, we report that quinacrine was highly active against EV71, protecting cells from EV71 infection. Replication of viral RNA, expression of viral capsid protein, and production of virus were all strongly inhibited by quinacrine. Interaction of the polypyrimidine tract-binding protein (PTB) with the conserved IRES was prevented by quinacrine. Coxsackieviruses and echovirus were also inhibited by quinacrine in cultured cells. These results indicate that quinacrine may serve as a potential protective agent for use in the treatment of patients with chronic enterovirus infection.	[Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Basic Research Program from the Ministry of Science and Technology of China [2011CB504902, 2005CB522905]	National Basic Research Program from the Ministry of Science and Technology of China	The work was supported by the National Basic Research Program (grant no. 2011CB504902 and no. 2005CB522905) (http://www.973.gov.cn/AreaAppl.aspx) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; BASNUEVO J G, 1950, Rev Kuba Med Trop Parasitol, V6, P121; BASNUEVO J G, 1952, Rev Kuba Med Trop Parasitol, V8, P67; BORMAN A, 1993, J GEN VIROL, V74, P1775, DOI 10.1099/0022-1317-74-9-1775; BROWN EA, 1991, J VIROL, V65, P5828, DOI 10.1128/JVI.65.11.5828-5838.1991; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Craig ME, 1999, J PAEDIATR CHILD H, V35, P107, DOI 10.1046/j.1440-1754.1999.t01-1-00348.x; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Friedman J, 2007, CLIN CANCER RES, V13, P6568, DOI 10.1158/1078-0432.CCR-07-1591; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gasparian AV, 2010, J VIROL, V84, P9390, DOI 10.1128/JVI.02569-09; Gorbachev AV, 2007, EUR J IMMUNOL, V37, P2257, DOI 10.1002/eji.200636708; Gosert R, 2000, MOL CELL BIOL, V20, P1583, DOI 10.1128/MCB.20.5.1583-1595.2000; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hellen CUT, 1995, CURR TOP MICROBIOL, V203, P31; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Honda M, 1996, RNA, V2, P955; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; JONSSON F, 1953, Sven Lakartidn, V50, P239; Kaminski A, 1995, RNA, V1, P924; Kobayashi Yuka, 2003, Rinsho Shinkeigaku, V43, P403; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Malina A, 2005, FEBS LETT, V579, P79, DOI 10.1016/j.febslet.2004.06.103; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; OBRIEN RL, 1966, P NATL ACAD SCI USA, V55, P1511, DOI 10.1073/pnas.55.6.1511; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRITCHAR.NJ, 1966, NATURE, V212, P1360, DOI 10.1038/2121360a0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Toubi E, 2006, SCAND J IMMUNOL, V63, P299, DOI 10.1111/j.1365-3083.2006.01737.x; WALLACE DJ, 1989, SEMIN ARTHRITIS RHEU, V18, P282, DOI 10.1016/0049-0172(89)90050-4; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; WHITEHOU.MW, 1965, BIOCHEM PHARMACOL, V14, P1173, DOI 10.1016/0006-2952(65)90295-9; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zipper J, 1980, Int J Gynaecol Obstet, V18, P275	53	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52954	10.1371/journal.pone.0052954	http://dx.doi.org/10.1371/journal.pone.0052954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23301007	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000021
J	Du, YH; Yan, L; Wang, J; Zhan, WZ; Song, K; Han, X; Li, X; Cao, JM; Liu, HR				Du, Yunhui; Yan, Li; Wang, Jin; Zhan, Wenzhang; Song, Kai; Han, Xue; Li, Xiao; Cao, Jimin; Liu, Huirong			beta(1)-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the beta(1)-AR/cAMP/PKA and p38 MAPK Pathways	PLOS ONE			English	Article							PROTEIN-KINASE-A; DILATED CARDIOMYOPATHY; CARDIAC BETA(1)-ADRENOCEPTORS; BETA-1-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTORS; SERUM AUTOANTIBODIES; EXPRESSION; ANTIBODIES; AUTOIMMUNITY; PHOSPHORYLATION	Background: Autoantibodies against the second extracellular loop of the beta(1)-adrenergic receptor (beta(1)-AA) not only contribute to increased susceptibility to heart failure, but also play a causative role in myocardial remodeling through their sympathomimetic-like effects that are induced upon binding to the beta(1)-adrenergic receptor. However, their role in the function of T lymphocytes has never been previously investigated. Our present study was designed to determine whether beta(1)-AA isolated from the sera of dilated cardiomyopathy (DCM) patients caused the proliferation of T cells and the secretion of cytokines. Methods: Blood samples were collected from 95 DCM patients as well as 95 healthy subjects, and beta(1)-AA was detected using ELISA. The CD3(+)T lymphocytes were selected separately through flow cytometry and the effect of beta(1)-AA on T lymphocyte proliferation was examined by CCK-8 kits and CFSE assay. Western blotting was used to analyze the expressions of phospho-VASP and phospho-p38 MAPK. Results: beta(1)-AA enhanced the proliferation of T lymphocytes. This effect could be blocked by the selective beta(1)-adrenergic receptor antagonist metoprolol, PKA inhibitor H89, and p38 MAPK inhibitor SB203580. Furthermore, the expression of the phosphorylated forms of phospho-VASP and phospho-p38 MAPK were markedly increased in the presence of beta(1)-AA. beta(1)-AA also inhibited the secretion of interferon-gamma (IFN-gamma) while promoting an increase in interleukin-4 (IL-4) levels. Conclusions: These results demonstrate that beta(1)-AA isolated from DCM patients binds to beta(1)-AR on the surface of T cells, causing changes in T-cell proliferation and secretion through the beta(1)-AR/cAMP/PKA and p38 MAPK pathways.	[Du, Yunhui; Han, Xue; Li, Xiao; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Du, Yunhui] Shandong Univ, Dept Marine Bioengn, Marine Coll, Weihai, Shandong, Peoples R China; [Yan, Li; Cao, Jimin] Peking Union Med Coll, Inst Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100021, Peoples R China; [Wang, Jin] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Zhan, Wenzhang] Tonghua Min Grp CO LTD, Gen Hosp, Dept Internal Med, Baishan, Jilin, Peoples R China; [Song, Kai] Changzhi Med Coll, Peace Hosp, Dept Internal Med, Changzhi, Shanxi, Peoples R China; [Liu, Huirong] Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shanxi Medical University; Changzhi Medical College; Capital Medical University	Liu, HR (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	liuhr2000@126.com			National Natural Science Foundation of China [81070263]; General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China [KZ201110025023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81070263) and the General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (Grant No. KZ201110025023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; Bonney KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014571; Caforio ALP, 1997, HEART, V77, P62, DOI 10.1136/hrt.77.1.62; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; CHIALE PA, 1995, J AM COLL CARDIOL, V26, P864, DOI 10.1016/0735-1097(95)00262-2; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Dobreva ZG, 2009, IMMUNOPHARM IMMUNOT, V31, P195, DOI 10.1080/08923970802626276; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748; Ganapathy V, 2000, INT IMMUNOL, V12, P851, DOI 10.1093/intimm/12.6.851; Hsu SC, 2003, BLOOD, V101, P970, DOI 10.1182/blood-2002-03-0744; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Jahns R, 2006, INT J CARDIOL, V112, P7, DOI 10.1016/j.ijcard.2006.05.008; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lindberg E, 2010, CELL IMMUNOL, V263, P224, DOI 10.1016/j.cellimm.2010.04.003; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V119, P235, DOI 10.1016/j.jaci.2006.09.019; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; Magnusson Y, 1996, INT J CARDIOL, V54, P137, DOI 10.1016/0167-5273(96)02590-9; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Miao GB, 2006, EUR J CLIN INVEST, V36, P614, DOI 10.1111/j.1365-2362.2006.01705.x; Nagatomo Y, 2009, J CARD FAIL, V15, P224, DOI 10.1016/j.cardfail.2008.10.027; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Ramgolam VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014450; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Robinet A, 2005, CARDIOVASC RES, V66, P530, DOI 10.1016/j.cardiores.2005.02.010; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Tutor AS, 2007, CARDIOVASC RES, V76, P51, DOI 10.1016/j.cardiores.2007.05.022; Wallukat G, 1999, AM J CARDIOL, V83, p75H; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; WALLUKAT G, 1987, BIOMED BIOCHIM ACTA, V46, pS634; Yu XY, 2007, CLIN PHARMACOL THER, V81, P654, DOI 10.1038/sj.clpt.6100154; Zhang W G, 1996, Blood Press Suppl, V3, P45; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	40	24	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52911	10.1371/journal.pone.0052911	http://dx.doi.org/10.1371/journal.pone.0052911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300817	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600036
J	Raudies, F; Neumann, H				Raudies, Florian; Neumann, Heiko			A Bio-Inspired, Motion-Based Analysis of Crowd Behavior Attributes Relevance to Motion Transparency, Velocity Gradients, and Motion Patterns	PLOS ONE			English	Article							OPTIC FLOW STIMULI; MST NEURONS; AREA MT; MODEL; SELECTIVITY; PERCEPTION; ATTENTION; FEATURES; SIGNALS	The analysis of motion crowds is concerned with the detection of potential hazards for individuals of the crowd. Existing methods analyze the statistics of pixel motion to classify non-dangerous or dangerous behavior, to detect outlier motions, or to estimate the mean throughput of people for an image region. We suggest a biologically inspired model for the analysis of motion crowds that extracts motion features indicative for potential dangers in crowd behavior. Our model consists of stages for motion detection, integration, and pattern detection that model functions of the primate primary visual cortex area (V1), the middle temporal area (MT), and the medial superior temporal area (MST), respectively. This model allows for the processing of motion transparency, the appearance of multiple motions in the same visual region, in addition to processing opaque motion. We suggest that motion transparency helps to identify "danger zones" in motion crowds. For instance, motion transparency occurs in small exit passages during evacuation. However, motion transparency occurs also for non-dangerous crowd behavior when people move in opposite directions organized into separate lanes. Our analysis suggests: The combination of motion transparency and a slow motion speed can be used for labeling of candidate regions that contain dangerous behavior. In addition, locally detected decelerations or negative speed gradients of motions are a precursor of danger in crowd behavior as are globally detected motion patterns that show a contraction toward a single point. In sum, motion transparency, image speeds, motion patterns, and speed gradients extracted from visual motion in videos are important features to describe the behavioral state of a motion crowd.	[Raudies, Florian] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA; [Raudies, Florian; Neumann, Heiko] Boston Univ, Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany	Boston University; Boston University; Ulm University	Raudies, F (corresponding author), Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA.	fraudies@bu.edu			Office of Naval Research [ONR N00014-11-1-0535]; German Research Foundation (DFG) [SFB/TRR 62]	Office of Naval Research(Office of Naval Research); German Research Foundation (DFG)(German Research Foundation (DFG))	FR is supported in part by the Office of Naval Research (ONR N00014-11-1-0535) and HN in part by the Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Ali S, 2008, P EUR C COMP VIS ECC; Ali S., 2007, P IEEE C COMP VIS PA, DOI [10.1109/CVPR.2007.382977, DOI 10.1109/CVPR.2007.382977]; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Andrade EL, 2006, P IEEE INT C PATT RE; Angelucci A, 2002, J NEUROSCI, V22, P8633; Batty M, 1997, NATURE, V388, P19, DOI 10.1038/40266; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Bayerl P, 2007, BIOSYSTEMS, V89, P208, DOI 10.1016/j.biosystems.2006.04.018; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Braddick O, 2001, MOTION VISION, P85; Braddick OJ, 2002, VISION RES, V42, P1237, DOI 10.1016/S0042-6989(02)00018-4; Burr D, 2006, VISION RES, V46, P932, DOI 10.1016/j.visres.2005.09.025; Cao T, 2009, P IEEE INT C ROB BIO; Cohen CJ, 2008, 2008 IEEE CONFERENCE ON TECHNOLOGIES FOR HOMELAND SECURITY, VOLS 1 AND 2, P559, DOI 10.1109/THS.2008.4534514; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Duffy CJ, 1997, J NEUROSCI, V17, P2839; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Durant S, 2006, BIOL LETTERS, V2, P101, DOI 10.1098/rsbl.2005.0379; ENDRES D., 2011, 4 INT C IM CRIM DET, P1; Felisberti FM, 2005, VISION RES, V45, P2587, DOI 10.1016/j.visres.2005.03.004; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HEEGER DJ, 1987, INT J COMPUT VISION, V1, P279, DOI 10.1007/BF00133568; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2010, ENCY COMPLEXITY SYST, P6476, DOI DOI 10.1007/978-0-387-30440-3_382; HENDERSON LF, 1974, TRANSPORT RES, V8, P509, DOI 10.1016/0041-1647(74)90027-6; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ihaddadene N, 2008, P IEEE INT C PATT RE; Jiang F, 2009, P IEEE INT C IM PROC; Johansson A, 2008, ADV COMPLEX SYST, V11, P497, DOI 10.1142/S0219525908001854; Krausz B, 2012, COMPUT VIS IMAGE UND, V116, P307, DOI 10.1016/j.cviu.2011.08.006; Lucas Bruce, 1981, P 7 INT JOINT C ART, V81; Mechler F, 2002, J NEUROSCI, V22, P6129; Mehran R, 2011, VIDEOS NORMAL ABNORM; Mehran R, 2009, P IEEE INT C COMP VI; Mehran R, 2010, LECT NOTES COMPUT SC, V6313, P439; Moussaid M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002442; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Narain R, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618468; Nyquist H, 2002, P IEEE, V90, P280, DOI 10.1109/5.989875; Papenberg N, 2006, INT J COMPUT VISION, V67, P141, DOI 10.1007/s11263-005-3960-y; POLUS A, 1983, J TRANSP ENG-ASCE, V109, P46, DOI 10.1061/(ASCE)0733-947X(1983)109:1(46); QIAN N, 1994, J NEUROSCI, V14, P7381; Raudies F, 2012, DEV APPL BIOL INSPIR; Raudies F, VELOCITY GRADIENTS O; Raudies F, 2011, NEURAL COMPUT, V23, P2868, DOI 10.1162/NECO_a_00193; Raudies F, 2010, NEURAL NETWORKS, V23, P160, DOI 10.1016/j.neunet.2009.10.005; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Rodriguez M, 2009, IEEE I CONF COMP VIS, P1389, DOI 10.1109/ICCV.2009.5459301; Siebel NT, 2004, P ECCV 2004 WORKSH A, P103; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Stafstrom CE, 2000, J NEUROPHYSIOL, V2, P254; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; Xiong T, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/10/108901; Yu H, 2011, P IEEE 4 INT C IM SI; Zach C, 2007, LECT NOTES COMPUT SC, V4713, P214, DOI 10.1007/978-3-540-74936-3_22; Zanker JM, 2005, SPATIAL VISION, V18, P431, DOI 10.1163/1568568054389615; Zhan BB, 2008, MACH VISION APPL, V19, P345, DOI 10.1007/s00138-008-0132-4	67	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53456	10.1371/journal.pone.0053456	http://dx.doi.org/10.1371/journal.pone.0053456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300930	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600101
J	Mudrak, OS; Nazarov, IB; Jones, EL; Zalensky, AO				Mudrak, Olga S.; Nazarov, Igor B.; Jones, Estella L.; Zalensky, Andrei O.			Positioning of Chromosomes in Human Spermatozoa Is Determined by Ordered Centromere Arrangement	PLOS ONE			English	Article							HUMAN SPERM NUCLEUS; GENOME ORGANIZATION; NONHOMOLOGOUS CENTROMERES; SEX-CHROMOSOMES; EARLY G1; CHROMATIN; ARCHITECTURE; MOUSE; DNA; MITOSIS	The intranuclear positioning of chromosomes (CHRs) is a well-documented fact; however, mechanisms directing such ordering remain unclear. Unlike somatic cells, human spermatozoa contain distinct spatial markers and have asymmetric nuclei which make them a unique model for localizing CHR territories and matching peri-centromere domains. In this study, we established statistically preferential longitudinal and lateral positioning for eight CHRs. Both parameters demonstrated a correlation with the CHR gene densities but not with their sizes. Intranuclear non-random positioning of the CHRs was found to be driven by a specific linear order of centromeres physically interconnected in continuous arrays. In diploid spermatozoa, linear order of peri-centromeres was identical in two genome sets and essentially matched the arrangement established for haploid cells. We propose that the non-random longitudinal order of CHRs in human spermatozoa is generated during meiotic stages of spermatogenesis. The specific arrangement of sperm CHRs may serve as an epigenetic basis for differential transcription/replication and direct spatial CHR organization during early embryogenesis.	[Mudrak, Olga S.; Nazarov, Igor B.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Mudrak, Olga S.; Nazarov, Igor B.; Jones, Estella L.; Zalensky, Andrei O.] Eastern Virginia Med Sch, Jones Inst Reprod Med, Norfolk, VA 23501 USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Eastern Virginia Medical School	Mudrak, OS (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	olgamudrak2010@gmail.com	Nazarov, Igor/AAE-9319-2021	Nazarov, Igor/0000-0003-4525-6694	National Institutes of Health [HD-042748]; Jones Foundation; Russian Foundation for Basic Research [12-04-01489-a]; MCB RAS Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jones Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); MCB RAS Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant HD-042748, the Jones Foundation grant to A.O.Z., the Russian Foundation for Basic Research grant # 12-04-01489-a and the grant from MCB RAS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bardhan A, 2010, MOL BIOL CELL, V21, P1799, DOI 10.1091/mbc.E09-05-0392; Bickmore WA, 2003, CURR BIOL, V13, pR357, DOI 10.1016/S0960-9822(03)00276-8; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bojanowski K, 1998, J CELL BIOCHEM, V69, P127, DOI 10.1002/(SICI)1097-4644(19980501)69:2<127::AID-JCB4>3.0.CO;2-U; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2004, BIOL CELL, V96, P555, DOI 10.1016/j.biolcel.2004.07.002; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dozortsev D, 2000, FERTIL STERIL, V73, P366, DOI 10.1016/S0015-0282(99)00491-4; Egozcue S, 2002, HUM REPROD, V17, P5, DOI 10.1093/humrep/17.1.5; Elcock LS, 2010, BIOCHEM SOC T, V38, P263, DOI 10.1042/BST0380263; Essers J, 2005, MOL BIOL CELL, V16, P769, DOI 10.1091/mbc.e04-10-0876; Finch KA, 2008, HUM REPROD, V23, P1263, DOI 10.1093/humrep/den112; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Greaves IK, 2003, CHROMOSOME RES, V11, P503, DOI 10.1023/A:1024982929452; Gurevitch M, 2001, MOL REPROD DEV, V60, P507, DOI 10.1002/mrd.1116; HAAF T, 1990, EXP CELL RES, V187, P157, DOI 10.1016/0014-4827(90)90130-3; HAAF T, 1995, EXP CELL RES, V219, P604, DOI 10.1006/excr.1995.1270; Hartl TA, 2008, PLOS GENET, V4; Hazzouri M, 2000, MOL REPROD DEV, V55, P307, DOI 10.1002/(SICI)1098-2795(200003)55:3<307::AID-MRD9>3.0.CO;2-P; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; KORF BR, 1977, CYTOGENET CELL GENET, V19, P335, DOI 10.1159/000130827; Lanctot C, 2007, EXP CELL RES, V313, P1449, DOI 10.1016/j.yexcr.2007.01.027; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114; Manvelyan M, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-25; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Sbracia M, 2002, HUM REPROD, V17, P320, DOI 10.1093/humrep/17.2.320; Sengupta K, 2008, CHROMOSOMA, V117, P499, DOI 10.1007/s00412-008-0171-7; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Stewart MN, 2008, TRENDS GENET, V24, P564, DOI 10.1016/j.tig.2008.08.006; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Verschure PJ, 2004, BIOL CELL, V96, P569, DOI 10.1016/j.biolcel.2004.07.001; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Ward WS, 1996, CRIT REV EUKAR GENE, V6, P139, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.30; Weierich C, 2003, CHROMOSOME RES, V11, P485, DOI 10.1023/A:1025016828544; Wiland E, 2008, CHROMOSOME RES, V16, P291, DOI 10.1007/s10577-007-1194-2; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zalensky A, 2007, BIOCHEM SOC T, V35, P609, DOI 10.1042/BST0350609; ZALENSKY AO, 1995, CHROMOSOMA, V103, P577; ZALENSKY AO, 1993, CHROMOSOMA, V102, P509, DOI 10.1007/BF00368344	54	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52944	10.1371/journal.pone.0052944	http://dx.doi.org/10.1371/journal.pone.0052944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300830	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100102
J	Takano, M; Hikishima, K; Fujiyoshi, K; Shibata, S; Yasuda, A; Konomi, T; Hayashi, A; Baba, H; Honke, K; Toyama, Y; Okano, H; Nakamura, M				Takano, Morito; Hikishima, Keigo; Fujiyoshi, Kanehiro; Shibata, Shinsuke; Yasuda, Akimasa; Konomi, Tsunehiko; Hayashi, Akiko; Baba, Hiroko; Honke, Koichi; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			MRI Characterization of Paranodal Junction Failure and Related Spinal Cord Changes in Mice	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; PERIPHERAL NERVOUS-SYSTEM; MOUSE-BRAIN; IN-VIVO; SULFATIDE; MYELIN; DEGENERATION; AXON; GALACTOCEREBROSIDE; SULFOGLYCOLIPIDS	The paranodal junction is a specialized axon-glia contact zone that is important for normal neuronal activity and behavioral locomotor function in the central nervous system (CNS). Histological examination has been the only method for detecting pathological paranodal junction conditions. Recently, diffusion tensor MRI (DTI) has been used to detect microstructural changes in various CNS diseases. This study was conducted to determine whether MRI and DTI could detect structural changes in the paranodal junctions of the spinal cord in cerebroside sulfotransferase knock-out (CST-KO) mice. Here, we showed that high-resolution MRI and DTI characteristics can reflect paranodal junction failure in CST-KO mice. We found significantly lower T1 times and significantly higher T2 times in the spinal cord MRIs of CST-KO mice as compared to wildtype (WT) mice. Spinal cord DTI showed significantly lower axial diffusivity and significantly higher radial diffusivity in CST-KO mice as compared to WT mice. In contrast, the histological differences in the paranodal junctions of WT and CST-KO mice were so subtle that electron microscopy or immunohistological analyses were necessary to detect them. We also measured gait disturbance in the CST-KO mice, and determined the conduction latency by electrophysiology. These findings demonstrate the potential of using MRI and DTI to evaluate white matter disorders that involve paranodal junction failure.	[Takano, Morito; Yasuda, Akimasa; Konomi, Tsunehiko; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takano, Morito; Hikishima, Keigo; Shibata, Shinsuke; Konomi, Tsunehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Fujiyoshi, Kanehiro] Natl Hosp Org, Murayama Med Ctr, Tokyo, Japan; [Hayashi, Akiko; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, Tokyo, Japan; [Honke, Koichi] Kochi Univ, Dept Biochem, Sch Med, Nanko Ku, Kochi 780, Japan	Keio University; Keio University; Tokyo University of Pharmacy & Life Sciences; Kochi University	Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	masa@a8.keio.jp	Toyama, Yoshiaki/K-5743-2013; Konomi, Tsunehiko/AAY-6082-2020; Nakamura, Masaya/K-4111-2013; Konomi, Tsunehiko/ABB-1765-2020; Okano, Hideyuki/I-7584-2019; Hikishima, Keigo/AAP-9586-2020; Shibata, Shinsuke/AAM-6620-2020; Hikishima, Keigo/L-1202-2013	Konomi, Tsunehiko/0000-0001-6704-7573; Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); General Insurance Association of Japan; JST-CIRM Collaborative Research Program; Strategic Research Program for Brain Sciences; Leading Project for Realization of Regenerative Medicine; MEXT; Funding Program for World-leading Innovative R&D on Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); General Insurance Association of Japan; JST-CIRM Collaborative Research Program; Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); by a grant from the General Insurance Association of Japan, by the JST-CIRM Collaborative Research Program, to YO and MN; by a grant from the Strategic Research Program for Brain Sciences and the Leading Project for Realization of Regenerative Medicine, support for the Core Institutes for iPS cell research from MEXT and the Funding Program for World-leading Innovative R&D on Science and Technology to HO, and by a Grant-in-aid for the Global COE program from MEXT to the Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bonny JM, 2004, NEUROBIOL DIS, V15, P474, DOI 10.1016/j.nbd.2003.11.026; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Bosshard SC, 2010, PAIN, V151, P655, DOI 10.1016/j.pain.2010.08.025; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cowin GJ, 2011, NEUROIMAGE, V58, P69, DOI 10.1016/j.neuroimage.2011.06.003; Dyakin VV, 2010, NEUROIMAGE, V51, P1098, DOI 10.1016/j.neuroimage.2010.03.013; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; Eckhardt M, 2007, J NEUROSCI, V27, P9009, DOI 10.1523/JNEUROSCI.2329-07.2007; Ellingson BM, 2010, MAGN RESON IMAGING, V28, P1353, DOI 10.1016/j.mri.2010.06.006; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Hassen WB, 2009, NEUROIMAGE, V46, P1, DOI 10.1016/j.neuroimage.2009.01.022; Honke K, 2004, GLYCOCONJUGATE J, V21, P59, DOI 10.1023/B:GLYC.0000043749.06556.3d; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogura H, 2001, BEHAV BRAIN RES, V122, P215, DOI 10.1016/S0166-4328(01)00187-5; Patay Z, 2005, EUR RADIOL, V15, P2284, DOI 10.1007/s00330-005-2846-2; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; UZMAN BG, 1957, J BIOPHYS BIOCHEM CY, V3, P589, DOI 10.1083/jcb.3.4.589; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767	34	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52904	10.1371/journal.pone.0052904	http://dx.doi.org/10.1371/journal.pone.0052904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300814	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100095
J	Bepari, AK; Sano, H; Tamamaki, N; Nambu, A; Tanaka, KF; Takebayashi, H				Bepari, Asim K.; Sano, Hiromi; Tamamaki, Nobuaki; Nambu, Atsushi; Tanaka, Kenji F.; Takebayashi, Hirohide			Identification of Optogenetically Activated Striatal Medium Spiny Neurons by Npas4 Expression	PLOS ONE			English	Article							BASAL GANGLIA; C-FOS; GENE-EXPRESSION; MOTOR CORTEX; RAT STRIATUM; ORGANIZATION; STIMULATION; CONNECTIONS; PLASTICITY; INDUCTION	Optogenetics is a powerful neuromodulatory tool with many unique advantages to explore functions of neuronal circuits in physiology and diseases. Yet, interpretation of cellular and behavioral responses following in vivo optogenetic manipulation of brain activities in experimental animals often necessitates identification of photoactivated neurons with high spatial resolution. Although tracing expression of immediate early genes (IEGs) provides a convenient approach, neuronal activation is not always followed by specific induction of widely used neuronal activity markers like c-fos, Egr1 and Arc. In this study we performed unilateral optogenetic stimulation of the striatum in freely moving transgenic mice that expressed a channelrhodopsin-2 (ChR2) variant ChR2(C128S) in striatal medium spiny neurons (MSNs). We found that in vivo blue light stimulation significantly altered electrophysiological activity of striatal neurons and animal behaviors. To identify photoactivated neurons we then analyzed IEG expression patterns using in situ hybridization. Upon light illumination an induction of c-fos was not apparent whereas another neuronal IEG Npas4 was robustly induced in MSNs ipsilaterally. Our results demonstrate that tracing Npas4 mRNA expression following in vivo optogenetic modulation can be an effective tool for reliable and sensitive identification of activated MSNs in the mouse striatum.	[Bepari, Asim K.; Tamamaki, Nobuaki] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto, Japan; [Bepari, Asim K.; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Sano, Hiromi; Nambu, Atsushi] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 444, Japan; [Nambu, Atsushi] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi, Japan; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Takebayashi, Hirohide] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Kumamoto University; Niigata University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Keio University; Japan Science & Technology Agency (JST)	Tanaka, KF (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	kftanaka@a8.jp; takebaya@med.niigata-u.ac.jp	Bepari, Asim/D-4001-2013; Bepari, Asim Kumar/GQI-3155-2022; Bepari, Asim Kumar/ABC-1166-2021; Takebayashi, Hirohide/AAO-1693-2020	Bepari, Asim/0000-0001-5656-1833; Bepari, Asim Kumar/0000-0001-5656-1833; Bepari, Asim Kumar/0000-0001-5656-1833; Tanaka, Kenji/0000-0003-2511-0057; Nambu, Atsushi/0000-0003-2153-5445	JST PRESTO; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT [23680042, 24111551, 20700353, 23700479]; Takeda Science Foundation; Japanese Government (Monbukagakusho: MEXT) Scholarship	JST PRESTO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Government (Monbukagakusho: MEXT) Scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from JST PRESTO, the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to HT), a Grant-in-Aid for Young Scientists (A) from MEXT [23680042](to KFT), a Grant-in-Aid for Scientific Research on Innovative Areas "Brain Environment'' from MEXT [24111551](to KFT), Grants-in-Aid for Young Scientists (B) from MEXT [20700353, 23700479](to HS) and a grant from Takeda Science Foundation (to KFT and AN). AKB is a recipient of the Japanese Government (Monbukagakusho: MEXT) Scholarship. A part of this study is the result of the "Highly creative animal model development for brain sciences'' carried out under the Strategic Research Program for Brain Sciences by the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Gross NB, 2009, NEUROSCIENCE, V161, P1114, DOI 10.1016/j.neuroscience.2009.04.023; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; LaHoste GJ, 1996, BRAIN RES, V728, P97; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Mena-Segovia J, 2003, BRAIN RES, V986, P30, DOI 10.1016/S0006-8993(03)03167-6; Nakano K, 2000, J NEUROL, V247, P1; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; PISA M, 1988, BEHAV BRAIN RES, V27, P21, DOI 10.1016/0166-4328(88)90106-4; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Sano H, 2007, J NEUROSCI, V27, P6948, DOI 10.1523/JNEUROSCI.0514-07.2007; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Sullivan AM, 1996, NEUROREPORT, V8, P211, DOI 10.1097/00001756-199612200-00043; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Usui N, 2012, DEVELOPMENT, V139, P1125, DOI 10.1242/dev.069997; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x	48	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52783	10.1371/journal.pone.0052783	http://dx.doi.org/10.1371/journal.pone.0052783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300775	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800146
J	Boehme, L; Thompson, D; Fedak, M; Bowen, D; Hammill, MO; Stenson, GB				Boehme, Lars; Thompson, Dave; Fedak, Mike; Bowen, Don; Hammill, Mike O.; Stenson, Garry B.			How Many Seals Were There? The Global Shelf Loss during the Last Glacial Maximum and Its Effect on the Size and Distribution of Grey Seal Populations	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; GRAY SEALS; MAMMOTH STEPPE; CLIMATE-CHANGE; PHOCA-HISPIDA; NORTH-SEA; MOVEMENT; BEHAVIOR; HABITAT; PALEOECOLOGY	Predicting how marine mammal populations respond to habitat changes will be essential for developing conservation management strategies in the 21st century. Responses to previous environmental change may be informative in the development of predictive models. Here we describe the likely effects of the last ice age on grey seal population size and distribution. We use satellite telemetry data to define grey seal foraging habitat in terms of the temperature and depth ranges exploited by the contemporary populations. We estimate the available extent of such habitat in the North Atlantic at present (between 1.42.10(6) km(2) and 2.07.10(6) km(2)) and at the last glacial maximum (between 4.74.10(4) km(2) and 2.11.10(5) km(2)); taking account of glacial and seasonal sea-ice coverage, estimated reductions of sea-level (123 m) and sea surface temperature hind-casts. Most of the extensive continental shelf waters (North Sea, Baltic Sea and Scotian Shelf), currently supporting >95% of grey seals, were unavailable during the last glacial maximum. A combination of lower sea-level and extensive ice-sheets, massively increased seasonal sea-ice coverage and southerly extent of cold water would have pushed grey seals into areas with no significant shelf waters. The habitat during the last glacial maximum might have been as small as 3% of today's extent and grey seal populations may have fallen to similarly low numbers. An alternative scenario involving a major change to a pelagic or bathy-pelagic foraging niche cannot be discounted. However, hooded seals currently dominate that niche and may have excluded grey seals from such habitat. If as seems likely, the grey seal population fell to very low levels it would have remained low for several thousand years before expanding into current habitats over the past 12,000 years or so.	[Boehme, Lars; Thompson, Dave; Fedak, Mike] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Bowen, Don] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Hammill, Mike O.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Dept Fisheries & Oceans, Mont Joli, PQ G5H 3Z4, Canada; [Stenson, Garry B.] Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF, Canada	University of St Andrews; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Boehme, L (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	lb284@st-andrews.ac.uk	Fedak, Michael A/B-3987-2009; Boehme, Lars/B-6567-2009	Fedak, Michael A/0000-0002-9569-1128; Boehme, Lars/0000-0003-3513-6816; Thompson, David/0000-0003-1546-2876	Natural Environment Research Council, UK; Atlantic seal research program, Department of Fisheries and Oceans, Canada; NSERCD Discovery grants, Canada; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Atlantic seal research program, Department of Fisheries and Oceans, Canada; NSERCD Discovery grants, Canada; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The tagging studies were funded by the Natural Environment Research Council, UK; the Atlantic seal research program, Department of Fisheries and Oceans, Canada and NSERCD Discovery grants, Canada. This work also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Amante C., 2009, NGDC24 NOAA NESDIS, P19, DOI DOI 10.7289/V5C8276M.AVAILABLE0NLINEAT:HTTPS://WWW.NGDC.N0AA.G0V/MGG/GL0BAL/RELIEF/ET0P01/D0CS/ET0P01.PDF; [Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; [Anonymous], 2006, NATL ICE CTR ARCTIC; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Bigg GR, 2008, P ROY SOC B-BIOL SCI, V275, P163, DOI 10.1098/rspb.2007.1153; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bowen W. Don, 2010, P283; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2011, MAR ECOL PROG SER, V431, P267, DOI 10.3354/meps09134; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Collecte Localisation Satellites, 2016, ARG US MAN WORLDW TR; Darwin C., 1859, ORIGIN SPECIES MEANS; Duck C.D., 2007, NAMMCO Scientific Publications, V6, P69; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Freitas C, 2008, ECOL MODEL, V217, P19, DOI 10.1016/j.ecolmodel.2008.05.014; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Gerondeau M, 2007, J MAR BIOL ASSOC UK, V87, P365, DOI 10.1017/S0025315407054586; Grist JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048204; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; Hanebuth TJJ, 2009, GLOBAL PLANET CHANGE, V66, P76, DOI 10.1016/j.gloplacha.2008.03.011; Harding KC, 1999, AMBIO, V28, P619; Harington CR, 2008, ECOL APPL, V18, pS23, DOI 10.1890/06-0624.1; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; HAUG T, 1994, BIOL CONSERV, V70, P59, DOI 10.1016/0006-3207(94)90299-2; Hauksson Erlingur, 2007, NAMMCO Scientific Publications, V6, P85; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Jahnke RA, 2010, GLOB CHANGE IGBP SER, P597, DOI 10.1007/978-3-540-92735-8_16; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; Mansfield AW, 1965, GREY SEAL HALICHOERU; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Meland MY, 2005, QUATERNARY SCI REV, V24, P835, DOI 10.1016/j.quascirev.2004.05.011; Members CP, 1981, SEASONAL RECONSTRUCT; Mikkelsen Bjarni, 2007, NAMMCO Scientific Publications, V6, P79; Moore SE, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P137; Nilssen Kjell Tormod, 2007, NAMMCO Scientific Publications, V6, P23; OSPAR Commission, 2000, ASS CLIM CHANG MIT A; Overpeck JT, 2005, EOS, V86; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pflaumann U, 2003, PALEOCEANOGRAPHY, V18; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Rivals F, 2010, PALAEOGEOGR PALAEOCL, V286, P42, DOI 10.1016/j.palaeo.2009.12.002; Rosvig-Asvid A, 2010, SEALS GREENLAND ILIN; Row LW, 1995, NGDC KEY GEOPHYS REC; SARNTHEIN M, 2003, PALEOCEANOGRAPHY, V18; SCOS, 2011, SCI ADV MATT REL MAN; SMRU Instrumentation Group, 2012, ARG GPS ARG SRDL TAG, P4; Stirling I., 1983, Special Publication American Society of Mammalogists, P489; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; THOMPSON D, 1993, J EXP BIOL, V174, P139; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Vibe C., 1967, Meddelelser om Gronland, V170, P1; Vie J-C, 2009, WILDLIFE CHANGING WO; Vincent C, 2005, BIOL CONSERV, V126, P62, DOI 10.1016/j.biocon.2005.04.022; Vincent C, 2003, MARQUAGE ELECTRONIQUE ET SUIVI TELEMETRIQUE DES GRANDS VERTEBRES MARINS MIGRATEURS, P101; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Waters JM, 2008, DIVERS DISTRIB, V14, P692, DOI 10.1111/j.1472-4642.2008.00481.x; Winton M, 2006, GEOPHYS RES LETT, V33; Wood SA, 2011, CAN J ZOOL, V89, P490, DOI 10.1139/Z11-012; Wood Stephanie A., 2007, NAMMCO Scientific Publications, V6, P117	75	10	10	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e53000	10.1371/journal.pone.0053000	http://dx.doi.org/10.1371/journal.pone.0053000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300843	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800166
J	Dyer, GA; Matthews, R; Meyfroidt, P				Dyer, George A.; Matthews, Robin; Meyfroidt, Patrick			Is There an Ideal REDD plus Program? An Analysis of Policy Trade-Offs at the Local Level	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES HELP; ECOSYSTEM SERVICES; DESIGNING PAYMENTS; DEFORESTATION; EMISSIONS; POVERTY; LESSONS; FORESTS; ISSUES	We use economy-wide simulation methods to analyze the outcome of a simple REDD+ program in a mixed subsistence/commercial-agriculture economy. Alternative scenarios help trace REDD+'s causal chain, revealing how trade-offs between the program's public and private costs and benefits determine its effectiveness, efficiency and equity (the 3Es). Scenarios reveal a complex relationship between the 3Es not evident in more aggregate analyses. Setting aside land as a carbon sink always influences the productivity of agriculture and its supply of non-market goods and services; but the overall returns to land and labor-which ultimately determine the opportunity cost of enrollment, the price of carbon and the distribution of gains and losses-depend on local conditions. In the study area, market-oriented landowners could enroll 30% of local land into a cost-effective program, but local subsistence demands would raise their opportunity costs as REDD+ unfurls, increasing the marginal cost of carbon. A combination of rent and wage changes would create net costs for most private stakeholders, including program participants. Increasing carbon prices undermines the program's efficiency without solving its inequities; expanding the program reduces inefficiencies but increases private costs with only minor improvements in equity. A program that prevents job losses could be the best option, but its efficiency compared to direct compensation could depend on program scale. Overall, neither the cost nor the 3Es of alternative REDD+ programs can be assessed without accounting for local demand for subsistence goods and services. In the context of Mexico's tropical highlands, a moderate-sized REDD+ program could at best have no net impact on rural households. REDD+ mechanisms should avoid general formulas by giving local authorities the necessary flexibility to address the trade-offs involved. National programs themselves should remain flexible enough to adjust for spatially and temporally changing contexts.	[Dyer, George A.; Matthews, Robin] Craigiebuckler, James Hutton Inst, Aberdeen, Scotland; [Meyfroidt, Patrick] FRS FNRS, Louvain, Belgium; [Meyfroidt, Patrick] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate, Earth & Life Inst, B-1348 Louvain, Belgium	James Hutton Institute; Fonds de la Recherche Scientifique - FNRS; Universite Catholique Louvain	Dyer, GA (corresponding author), Craigiebuckler, James Hutton Inst, Aberdeen, Scotland.	georgie.dyer@gmail.com	Matthews, Robin B/E-7975-2013; Meyfroidt, Patrick/G-7768-2012	Meyfroidt, Patrick/0000-0002-1047-9794	European Union [226310]	European Union(European Commission)	Financial support for this work was provided by the European Union under the REDD-ALERT (Reducing Emissions from Deforestation and Degradation from Alternative Land Uses in Rainforests of the Tropics) project, Grant Agreement number 226310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A., 2009, REALISING REDD NATL; Alix-Garcia J., LAND EC IN PRESS; ANGELSEN A., 2008, MOVING AHEAD REDD IS, P11, DOI [10.17528/cifor/002601, DOI 10.17528/CIFOR/002601]; Appendini K, 2010, GRANDES PROBLEMAS ME; Bell RG, 2011, MORE MEETS EYE SOCIA; Bond I M, 2009, NATURAL RESOURCE ISS, V16; Bulte EH, 2008, ENVIRON DEV ECON, V13, P245, DOI 10.1017/S1355770X08004348; Busch J, 2012, P NATL ACAD SCI USA, V109, P1062, DOI 10.1073/pnas.1109034109; Busch J, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044006; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chomitz KM, 2007, ENVIRON DEV ECON, V10, P293; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; Dyer G, 2005, VALUING CROP BIODIVE; Dyer G, 2008, 1774958V1MET1014 IDB; Dyer GA, 2006, AM J AGR ECON, V88, P279, DOI 10.1111/j.1467-8276.2006.00858.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Groom B, 2010, ENVIRON DEV ECON, V15, P219, DOI 10.1017/S1355770X09990167; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jagger P, 2010, 56 CIFOR; Key N, 2000, AM J AGR ECON, V82, P245, DOI 10.1111/0002-9092.00022; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Matthews R, 2011, CARBON MANAG, V2, P517, DOI 10.4155/CMT.11.52; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Sadoulet E, 2001, WORLD DEV, V29, P1043, DOI 10.1016/S0305-750X(01)00018-3; Seymour F., 2009, REALISING REDD NATL; Singh I., 1986, Agricultural household models. Extensions, applications, and policy, P17; Sloan S, 2012, GLOBAL ENVIRON CHANG, V22, P440, DOI 10.1016/j.gloenvcha.2012.02.001; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Southgate D, 2010, ENVIRON DEV ECON, V15, P21, DOI 10.1017/S1355770X09005361; Springate-Baginski O, 2010, REDD FOREST GOVERNAN; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; Taylor JE, 1999, J POLICY MODEL, V21, P453, DOI 10.1016/S0161-8938(97)00069-0; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Zilberman D, 2008, ENVIRON DEV ECON, V13, P255, DOI 10.1017/S1355770X08004294	40	11	11	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52478	10.1371/journal.pone.0052478	http://dx.doi.org/10.1371/journal.pone.0052478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300681	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800093
J	Griesser, M; Schneider, NA; Collis, MA; Overs, A; Guppy, M; Guppy, S; Takeuchi, N; Collins, P; Peters, A; Hall, ML				Griesser, Michael; Schneider, Nicole A.; Collis, Mary-Anne; Overs, Anthony; Guppy, Michael; Guppy, Sarah; Takeuchi, Naoko; Collins, Pete; Peters, Anne; Hall, Michelle L.			Causes of Ring-Related Leg Injuries in Birds - Evidence and Recommendations from Four Field Studies	PLOS ONE			English	Article							AUSTRALIAN PASSERINE; SIBERIAN JAY; FOOT LOSS; BANDS; FLYCATCHERS; MORTALITY; PREDATION; BEHAVIOR; PLOVERS; HISTORY	One of the main techniques for recognizing individuals in avian field research is marking birds with plastic and metal leg rings. However, in some species individuals may react negatively to rings, causing leg injuries and, in extreme cases, the loss of a foot or limb. Here, we report problems that arise from ringing and illustrate solutions based on field data from Brown Thornbills (Acanthiza pusilla) (2 populations), Siberian Jays (Perisoreus infaustus) and Purple-crowned Fairy-wrens (Malurus coronatus). We encountered three problems caused by plastic rings: inflammations triggered by material accumulating under the ring (Purple-crowned Fairy-wrens), contact inflammations as a consequence of plastic rings touching the foot or tibio-tarsal joint (Brown Thornbills), and toes or the foot getting trapped in partly unwrapped flat-band colour rings (Siberian Jays). Metal rings caused two problems: the edges of aluminium rings bent inwards if mounted on top of each other (Brown Thornbills), and too small a ring size led to inflammation (Purple-crowned Fairy-wrens). We overcame these problems by changing the ringing technique (using different ring types or larger rings), or using different adhesive. Additionally, we developed and tested a novel, simple technique of gluing plastic rings onto metal rings in Brown Thornbills. A review of studies reporting ring injuries (N = 23) showed that small birds (<55 g body weight) are more prone to leg infections while larger birds (>35 g) tend to get rings stuck over their feet. We give methodological advice on how these problems can be avoided, and suggest a ringing hazard index to compare the impact of ringing in terms of injury on different bird species. Finally, to facilitate improvements in ringing techniques, we encourage online deposition of information regarding ringing injuries of birds at a website hosted by the European Union for Bird Ringing (EURING).	[Griesser, Michael] Univ Bern, Dept Biol, Inst Ecol & Evolut, Bern, Switzerland; [Griesser, Michael; Schneider, Nicole A.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Griesser, Michael] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Schneider, Nicole A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Peters, Anne] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Hall, Michelle L.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Bern; Swedish University of Agricultural Sciences; University of Zurich; University of Tasmania; Monash University; University of Melbourne	Griesser, M (corresponding author), Univ Bern, Dept Biol, Inst Ecol & Evolut, Bern, Switzerland.	michael.griesser@uzh.ch	Hall, Michelle L/A-1904-2010; Griesser, Michael/J-4542-2012; Peters, Anne/A-1821-2010	Hall, Michelle L/0000-0002-1263-8314; Griesser, Michael/0000-0002-2220-2637; Peters, Anne/0000-0001-8071-0560	Swedish Research Council [621-2008-5349]; Swiss National Science Foundation [PPOOP3-123520]; Stiftelsen Lars Hiertas Minne [FO2010-0041]; Max Planck Society (Minerva Program)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftelsen Lars Hiertas Minne; Max Planck Society (Minerva Program)	The different project were made possible from funding from the Swedish Research Council (621-2008-5349; to MGR), the Swiss National Science Foundation (PPOOP3-123520; to MGR), Stiftelsen Lars Hiertas Minne (FO2010-0041; to NAS), and the Max Planck Society (Minerva Program; to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 1999, J FIELD ORNITHOL, V70, P555; Amirault DL, 2006, J FIELD ORNITHOL, V77, P18, DOI 10.1111/j.1557-9263.2006.00002.x; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; Berggren A, 2004, WILDLIFE RES, V31, P535, DOI 10.1071/WR03058; Blake C. H., 1954, Bird-Banding, V25, P11; Boland CRJ, 2002, EMU, V102, P9, DOI 10.1071/MU01039; Brown J.L., 1987, HELPING COMMUNAL BRE; Calvo B., 1992, Ringing and Migration, V13, P129; Cresswell W, 2007, J AVIAN BIOL, V38, P309, DOI 10.1111/j.0908-8857.2007.03925.x; Dettmann B, 1999, FLIGHTLINES, P3; Eggers S, 2005, OIKOS, V111, P150, DOI 10.1111/j.0030-1299.2005.13802.x; Ekman J, 2001, J ANIM ECOL, V70, P317, DOI 10.1046/j.1365-2656.2001.00490.x; GRATTOTREVOR CL, 1994, J FIELD ORNITHOL, V65, P133; Green DJ, 2001, J ANIM ECOL, V70, P505, DOI 10.1046/j.1365-2656.2001.00503.x; Green DJ, 1999, AUST J ZOOL, V47, P633, DOI 10.1071/ZO99052; Griesser M, 2012, FOREST ECOL MANAG, V271, P58, DOI 10.1016/j.foreco.2012.01.037; Griesser M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023438; Guppy M, AUSTR ZOOLO IN PRESS; Gustafson M. E., 1997, N AM BIRD BANDING MA; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Hartley I, 2011, RINGING NEWS, V12, P8; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; KEAST A, 1970, Biotropica, V2, P61, DOI 10.2307/2989764; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Koronkiewicz TJ, 2005, J FIELD ORNITHOL, V76, P94, DOI 10.1648/0273-8570-76.1.94; Marchant S, 1992, EUROBODALLA NATURAL, V1, P1; Newton I., 1998, POPULATION LIMITATIO; Nice M.M., 1937, T LINNAEAN SOC NEW Y, V4, P1; NISBET ICT, 1991, N AM BIRD BANDER, V16, P61; Nystrand M, 2010, J ANIM ECOL, V79, P266, DOI 10.1111/j.1365-2656.2009.01627.x; Pekins CE, 2002, GOLDEN CHEEKED WARBL; Pierce Andrew J., 2007, Ringing & Migration, V23, P205; REED JM, 1993, J FIELD ORNITHOL, V64, P145; Reed P. C., 1953, Bird-Banding, V24, P65; Roff Derek A., 1992; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schneider NA, 2012, GETTING INFORM RISKY; Schneider NA, 2013, BEHAV ECOL, V24, P47, DOI 10.1093/beheco/ars134; Sedgwick JA, 1997, J FIELD ORNITHOL, V68, P622; Splittgerber K, 2006, J FIELD ORNITHOL, V77, P195, DOI 10.1111/j.1557-9263.2006.00041.x; Stacey P.B., 1990, COOPERATIVE BREEDING; SWEENEY TM, 1985, J FIELD ORNITHOL, V56, P251	42	19	22	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51891	10.1371/journal.pone.0051891	http://dx.doi.org/10.1371/journal.pone.0051891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300574	Green Published, gold, Green Accepted			2022-12-25	WOS:000313618800033
J	Haden, V; Niles, MT; Lubell, M; Perlman, J; Jackson, LE				Haden, Van R.; Niles, Meredith T.; Lubell, Mark; Perlman, Joshua; Jackson, Louise E.			Global and Local Concerns: What Attitudes and Beliefs Motivate Farmers to Mitigate and Adapt to Climate Change?	PLOS ONE			English	Article							MEDIATION ANALYSIS; RISK PERCEPTION; POLICY; STRATEGIES; PSYCHOLOGY; EXPERIENCE; RESPONSES; OPTIONS; BARON	In response to agriculture's vulnerability and contribution to climate change, many governments are developing initiatives that promote the adoption of mitigation and adaptation practices among farmers. Since most climate policies affecting agriculture rely on voluntary efforts by individual farmers, success requires a sound understanding of the factors that motivate farmers to change practices. Recent evidence suggests that past experience with the effects of climate change and the psychological distance associated with people's concern for global and local impacts can influence environmental behavior. Here we surveyed farmers in a representative rural county in California's Central Valley to examine how their intention to adopt mitigation and adaptation practices is influenced by previous climate experiences and their global and local concerns about climate change. Perceived changes in water availability had significant effects on farmers' intention to adopt mitigation and adaptation strategies, which were mediated through global and local concerns respectively. This suggests that mitigation is largely motivated by psychologically distant concerns and beliefs about climate change, while adaptation is driven by psychologically proximate concerns for local impacts. This match between attitudes and behaviors according to the psychological distance at which they are cognitively construed indicates that policy and outreach initiatives may benefit by framing climate impacts and behavioral goals concordantly; either in a global context for mitigation or a local context for adaptation.	[Haden, Van R.] Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA; [Niles, Meredith T.; Lubell, Mark; Perlman, Joshua] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haden, V (corresponding author), Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA.	vrhaden@ucdavis.edu; mtniles@ucdavis.edu		Lubell, Mark/0000-0001-5757-7116; Niles, Meredith/0000-0002-8323-1351	California Energy Commission [CEC-500-2012-032]	California Energy Commission	The source of funding for this study was the California Energy Commission (grant # CEC-500-2012-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Antle JM, 2010, APPL ECON PERSPECT P, V32, P386, DOI 10.1093/aepp/ppq015; Bryan E, 2009, ENVIRON SCI POLICY, V12, P413, DOI 10.1016/j.envsci.2008.11.002; California Air Resources Board, 2008, CLIMATE CHANGE SCOPI; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005; Haden VR, 2012, J ENVIRON PLANNING M; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Jackson LE, 2011, CLIMATIC CHANGE, V109, P407, DOI 10.1007/s10584-011-0306-3; Kerr S., 2008, FARM POLICY J, V4, P19; Krosnick JA, 2006, CLIMATIC CHANGE, V77, P7, DOI 10.1007/s10584-006-9068-8; Leary N, 2006, INTERNATIONAL START, P1; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Loewenstein G., 1992, CHOICE TIME; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lubell M, 2007, POLIT BEHAV, V29, P391, DOI 10.1007/s11109-006-9025-2; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Metz ORDB, 2007, CLIMATE CHANGE 2007; Niemeier D, 2009, CALIF AGR, V63, P96, DOI 10.3733/ca.v063n02p96; Niles MT, 2012, POLICY STUD J, V40, P41, DOI 10.1111/j.1541-0072.2012.00445.x; Ostrom E, 2010, ENVIRON CONSERV, V37, P451, DOI 10.1017/S0376892910000834; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rabinovich A, 2009, J ENVIRON PSYCHOL, V29, P391, DOI 10.1016/j.jenvp.2009.09.004; Reganold JP, 2011, SCIENCE, V332, P670, DOI 10.1126/science.1202462; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Sanna LJ, 2010, J EXP SOC PSYCHOL, V46, P1126, DOI 10.1016/j.jesp.2010.05.018; Sanna LJ, 2009, PSYCHOL SCI, V20, P1319, DOI 10.1111/j.1467-9280.2009.02458.x; Smith P, 2007, CLIMATE CHANGE 2007; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Valdivia C, 2010, ANN ASSOC AM GEOGR, V100, P818, DOI 10.1080/00045608.2010.500198; Victor DG, 2005, SCIENCE, V309, P1820, DOI 10.1126/science.1113180; Weber E. U., 1997, PSYCHOL PERSPECTIVES, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	40	145	148	2	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52882	10.1371/journal.pone.0052882	http://dx.doi.org/10.1371/journal.pone.0052882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300805	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800158
J	Kotecki, N; Penel, N; Adenis, A; Ferte, C; Clisant, S				Kotecki, Nuria; Penel, Nicolas; Adenis, Antoine; Ferte, Charles; Clisant, Stephanie			Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials	PLOS ONE			English	Article							RESPONSE EVALUATION; CRITERIA; RECIST; DESIGN	Background: The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging. Purpose: In this study, we intend to analyze the value of the PD based on clinical judgment and the risk of overestimating the occurrence of PD by clinical judgment. Methods: We have conducted a single-centre retrospective study to analyse the diagnostic accuracy of this clinical judgment compared to planned imaging including all patients enrolled in our institution in phase II trials investigating systemic treatments for advanced solid tumours between January 2008 and November 2010. Results: The positive predictive value (PPV) and the specificity of clinical judgment of PD was very high (>90%). Conclusions: According to this study, the clinical judgment of PD is highly predictive of radiological PD as assessed, for example, by RECIST. Physicians do not overestimate PD occurence. Clinical judgment of PD could be taken into account in the definition of PD.	[Kotecki, Nuria; Penel, Nicolas; Adenis, Antoine; Ferte, Charles; Clisant, Stephanie] Ctr Oscar Lambret, F-59020 Lille, France; [Penel, Nicolas] Lille Nord De France Univ, EA 2694, Lille, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Penel, N (corresponding author), Ctr Oscar Lambret, F-59020 Lille, France.	n-penel@o-lambret.fr	adenis, antoine/N-1536-2014	adenis, antoine/0000-0003-0585-5078; PENEL, Nicolas/0000-0001-5243-1548				Cousin S, 2012, CURR OPIN ONCOL, V24, P338, DOI 10.1097/CCO.0b013e3283528b73; Dodd LE, 2008, J CLIN ONCOL, V26, P3791, DOI 10.1200/JCO.2008.16.1711; Dudeck O, 2011, ANN ONCOL, V22, P1828, DOI 10.1093/annonc/mdq696; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Mick R, 2000, CONTROL CLIN TRIALS, V21, P343, DOI 10.1016/S0197-2456(00)00058-1; Penel N, 2011, ANN ONCOL, V22, P1266, DOI 10.1093/annonc/mdq608; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	7	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52638	10.1371/journal.pone.0052638	http://dx.doi.org/10.1371/journal.pone.0052638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300731	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800118
J	Roescher, N; Vosters, JL; Lai, ZA; Uede, T; Tak, PP; Chiorini, JA				Roescher, Nienke; Vosters, Jelle L.; Lai, Zhenan; Uede, Toshimitsu; Tak, Paul P.; Chiorini, John A.			Local Administration of Soluble CD40:Fc to the Salivary Glands of Non-Obese Diabetic Mice Does Not Ameliorate Autoimmune Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; SJOGRENS-SYNDROME; PATHWAYS; THERAPY; CD40IG; LACTOFERRIN; ACTIVATION; INDUCTION; BACTERIA	Objective: CD40-CD154 (CD40 ligand) interaction in the co-stimulatory pathway is involved in many (auto) immune processes and both molecules are upregulated in salivary glands of Sjogren's syndrome (SS) patients. Interference within the CD40 pathway has ameliorated (auto) inflammation in a number of disease models. To test the potential role of the CD40 pathway in loss of gland function and inflammation in SS, an inhibitor of CD40-CD154 interaction was overexpressed in the salivary glands (SGs) of a spontaneous murine model of SS; the Non-Obese Diabetic (NOD) mouse. Materials and Methods: At different disease stages an adeno associated viral vector encoding CD40 coupled to a human Fc domain (CD40: Fc) was injected locally into the SGs of NOD mice. Delivery was confirmed by PCR. The overall effect on local inflammation was determined by assessment of the focus score (FS), quantification of infiltrating cell types, immunoglobulin levels, and microarray analysis. The effect on SG function was determined by measuring stimulated salivary flow. Results: CD40: Fc was stably expressed in the SG of NOD mice, and the protein was secreted into the blood stream. Microarray analysis revealed that expression of CD40: Fc affected the expression of many genes involved in regulation of the immune response. However, FS, infiltrating cell types, immunoglobulin levels, and salivary gland output were similar for treated and control mice. Discussion: Although endogenous CD40 is expressed in SG inflammatory foci in the SG of NOD mice, the expression of soluble CD40: Fc did not lead to reduced overall inflammation and/or improved salivary gland function. These data indicate possible redundancy of the CD40 pathway in the SG and suggests that targeting CD40 alone may not be sufficient to alter the disease phenotype.	[Roescher, Nienke; Vosters, Jelle L.; Lai, Zhenan; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Roescher, Nienke; Vosters, Jelle L.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] GlaxoSmithKline, London, England; [Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; Hokkaido University	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov			United States National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was funded by a United States National Institutes of Health intramural grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Balasa B, 1997, J IMMUNOL, V159, P4620; Cha S, 2002, CRIT REV ORAL BIOL M, V13, P5, DOI 10.1177/154411130201300103; Chang GJ, 2002, SURGERY, V132, P149, DOI 10.1067/msy.2002.125169; Curran CS, 2006, CELL IMMUNOL, V242, P23, DOI 10.1016/j.cellimm.2006.08.006; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Dimitriou ID, 2002, CLIN EXP IMMUNOL, V127, P386, DOI 10.1046/j.1365-2249.2002.01752.x; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Girvin AM, 2002, J AUTOIMMUN, V18, P83, DOI 10.1006/jaut.2001.0573; GREENSPAN JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; HU YF, 1992, AM J PHYSIOL, V263, pE607, DOI 10.1152/ajpendo.1992.263.4.E607; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kanaya K, 2003, TRANSPLANTATION, V75, P275, DOI 10.1097/01.TP.0000046966.35399.75; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kelly JA, 2011, ACR 2011; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kok MR, 2005, J GENE MED, V7, P432, DOI 10.1002/jgm.678; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; MAIA AL, 1995, MOL ENDOCRINOL, V9, P969, DOI 10.1210/me.9.8.969; Mauri C, 2000, NAT MED, V6, P673, DOI 10.1038/76251; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Najafian N, 2003, EXPERT OPIN BIOL TH, V3, P227, DOI 10.1517/14712598.3.2.227; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Nomura M, 2002, TRANSPLANTATION, V73, P1403, DOI 10.1097/00007890-200205150-00008; Ohlsson M, 2002, SCAND J IMMUNOL, V56, P561, DOI 10.1046/j.1365-3083.2002.01168.x; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Roescher N, 2011, ORAL DIS; Roescher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019962; Saito Miwako, 2007, Mod Rheumatol, V17, P45, DOI 10.1007/s10165-006-0538-7; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Sidiropoulos PI, 2004, LUPUS, V13, P391, DOI 10.1191/0961203304lu1032oa; Van Kooten Cees, 1997, Frontiers in Bioscience (online), V2, pD1; VANHAASTEREN GAC, 1994, ENDOCRINOLOGY, V135, P1336, DOI 10.1210/en.135.4.1336; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51375	10.1371/journal.pone.0051375	http://dx.doi.org/10.1371/journal.pone.0051375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300544	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800016
J	Sartori, M; Reggiani, M; Farina, D; Lloyd, DG				Sartori, Massimo; Reggiani, Monica; Farina, Dario; Lloyd, David G.			EMG-Driven Forward-Dynamic Estimation of Muscle Force and Joint Moment about Multiple Degrees of Freedom in the Human Lower Extremity	PLOS ONE			English	Article							HUMAN KNEE; MUSCULOSKELETAL MODELS; BICEPS-BRACHII; TASKS; GAIT; OPTIMIZATION; SIMULATIONS; ACTIVATION; STRATEGIES; SUPPORT	This work examined if currently available electromyography (EMG) driven models, that are calibrated to satisfy joint moments about one single degree of freedom (DOF), could provide the same musculotendon unit (MTU) force solution, when driven by the same input data, but calibrated about a different DOF. We then developed a novel and comprehensive EMG-driven model of the human lower extremity that used EMG signals from 16 muscle groups to drive 34 MTUs and satisfy the resulting joint moments simultaneously produced about four DOFs during different motor tasks. This also led to the development of a calibration procedure that allowed identifying a set of subject-specific parameters that ensured physiological behavior for the 34 MTUs. Results showed that currently available single-DOF models did not provide the same unique MTU force solution for the same input data. On the other hand, the MTU force solution predicted by our proposed multi-DOF model satisfied joint moments about multiple DOFs without loss of accuracy compared to single-DOF models corresponding to each of the four DOFs. The predicted MTU force solution was (1) a function of experimentally measured EMGs, (2) the result of physiological MTU excitation, (3) reflected different MTU contraction strategies associated to different motor tasks, (4) coordinated a greater number of MTUs with respect to currently available single-DOF models, and (5) was not specific to an individual DOF dynamics. Therefore, our proposed methodology has the potential of producing a more dynamically consistent and generalizable MTU force solution than was possible using single-DOF EMG-driven models. This will help better address the important scientific questions previously approached using single-DOF EMG-driven modeling. Furthermore, it might have applications in the development of human-machine interfaces for assistive devices.	[Sartori, Massimo; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Sartori, Massimo] CNR, Inst Biomed Engn, Padua, Italy; [Reggiani, Monica] Univ Padua, Dept Management & Engn, Vicenza, Italy; [Lloyd, David G.] Griffith Univ, Griffith Hlth Inst, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia	University of Gottingen; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Griffith University; Menzies Health Institute Queensland	Sartori, M (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany.	massimo.srt@gmail.com	Reggiani, Monica/AAC-4776-2022; sartori, massimo/N-1220-2016; Farina, Dario/AAB-2648-2019; Lloyd, David/AAH-6066-2020	Reggiani, Monica/0000-0002-5029-1892; sartori, massimo/0000-0003-0930-6535; Lloyd, David/0000-0002-0824-9682	National Institutes of Health in the USA [R01 EB009351-01A2]; National Health and Medical Research Council in Australia [628850, 334151]; Western Australian Medical and Health Research Infrastructure Council; European Research Council Advanced Grant DEMOVE; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009351] Funding Source: NIH RePORTER	National Institutes of Health in the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia); Western Australian Medical and Health Research Infrastructure Council; European Research Council Advanced Grant DEMOVE; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by the National Institutes of Health in the USA [R01 EB009351-01A2]; the National Health and Medical Research Council in Australia [628850 and 334151]; the Western Australian Medical and Health Research Infrastructure Council; and the European Research Council Advanced Grant DEMOVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Barrett RS, 2007, SIMUL MODEL PRACT TH, V15, P1146, DOI 10.1016/j.simpat.2007.07.005; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Besier TF, 2009, J BIOMECH, V42, P898, DOI 10.1016/j.jbiomech.2009.01.032; Blemker SS, 2007, J MAGN RESON IMAGING, V25, P441, DOI 10.1002/jmri.20805; BOBET J, 1990, J BIOMECH, V23, P1275, DOI 10.1016/0021-9290(90)90386-H; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; BUCHANAN TS, 1995, NEUROSCI LETT, V194, P61, DOI 10.1016/0304-3940(95)11727-E; Buchanan TS, 1997, J ORTHOPAED RES, V15, P11, DOI 10.1002/jor.1100150103; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Cheng EJ, 2008, J NEURAL ENG, V5, P232, DOI 10.1088/1741-2560/5/2/014; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Farina D, 2012, REV BIOMEDI IN PRESS; Fleischer C, 2008, IEEE T ROBOT, V24, P872, DOI 10.1109/TRO.2008.926860; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Kahle W, 2002, COLOR ATLAS TXB HUMA, V3; Ko J, 2009, AUTON ROBOT, V27, P75, DOI 10.1007/s10514-009-9119-x; Lanovaz J L, 2001, Equine Vet J Suppl, P27; Lloyd D.G., 2008, HDB BIOMECHANICS HUM, P3; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Lloyd DG, 1996, J BIOMECH ENG-T ASME, V118, P367, DOI 10.1115/1.2796019; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Manal K, 2012, MULTIBODY SYST DYN, V28, P169, DOI 10.1007/s11044-011-9285-4; Martelli S, 2011, J BIOMECH, V44, P1716, DOI 10.1016/j.jbiomech.2011.03.039; Menegaldo LL, 2012, MULTIBODY SYST DYN, V28, P21, DOI 10.1007/s11044-011-9273-8; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; Pfeifer S, 2011, INT C REHAB ROBOT, DOI 10.1109/ICORR.2011.5975474; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Rao G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001383; Sartori M, 2012, CONVERGING CLIN ENG, P427; Sartori M, 2012, IEEE T BIO-MED ENG, V59, P2642, DOI 10.1109/TBME.2012.2208746; Sartori M, 2012, J BIOMECH, V45, P595, DOI 10.1016/j.jbiomech.2011.10.040; Shao Q, 2008, J BIOMECH, V41, P3097, DOI 10.1016/j.jbiomech.2008.07.015; Shao Q, 2011, ANN BIOMED ENG, V39, P110, DOI 10.1007/s10439-010-0131-2; Shao Q, 2009, COMPUT BIOL MED, V39, P1083, DOI 10.1016/j.compbiomed.2009.09.002; TAX AAM, 1990, EXP BRAIN RES, V79, P138, DOI 10.1007/BF00228882; TAX AAM, 1990, EXP BRAIN RES, V81, P567, DOI 10.1007/BF02423505; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Winby CR, 2008, J BIOMECH, V41, P1682, DOI 10.1016/j.jbiomech.2008.03.008; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Winter D.A., 2004, BIOMECHANICS MOTOR C, V4, DOI [10.1002/9780470549148, DOI 10.1002/9780470549148]; Yamaguchi G, 1990, MULTIPLE MUSCLE SYST; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	47	172	179	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52618	10.1371/journal.pone.0052618	http://dx.doi.org/10.1371/journal.pone.0052618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300725	Green Published, gold			2022-12-25	WOS:000313618800115
J	Badin, RA; Spinnewyn, B; Gaillard, MC; Jan, C; Malgorn, C; Van Camp, N; Dolle, F; Guillermier, M; Boulet, S; Bertrand, A; Savasta, M; Auguet, M; Brouillet, E; Chabrier, PE; Hantraye, P				Badin, Romina Aron; Spinnewyn, Brigitte; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Dolle, Frederic; Guillermier, Martine; Boulet, Sabrina; Bertrand, Anne; Savasta, Marc; Auguet, Michel; Brouillet, Emmanuel; Chabrier, Pierre-Etienne; Hantraye, Philippe			IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; MOTOR COMPLICATIONS; DOPAMINERGIC-NEURONS; MESSENGER-RNA; DOUBLE-BLIND; DISEASE; MODEL; AMANTADINE; MONKEYS; MECHANISMS	The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem in the long-term treatment of Parkinson's disease. This study aimed at evaluating the effect of IRC-082451 (base of BN82451), a novel multitargeting hybrid molecule, on L-DOPA-induced dyskinesias (LIDs) and hypolocomotor activity in a non-human primate model of PD. IRC-082451 displays multiple properties: it inhibits neuronal excitotoxicity (sodium channel blocker), oxidative stress (antioxidant) and neuroinflammation (cyclooxygenase inhibitor) and is endowed with mitochondrial protective properties. Animals received daily MPTP injections until stably parkinsonian. A daily treatment with increasing doses of L-DOPA was administered to parkinsonian primates until the appearance of dyskinesias. Then, different treatment regimens and doses of IRC-082451 were tested and compared to the benchmark molecule amantadine. Primates were regularly filmed and videos were analyzed with specialized software. A novel approach combining the analysis of dyskinesias and locomotor activity was used to determine efficacy. This analysis yielded the quantification of the total distance travelled and the incidence of dyskinesias in 7 different body parts. A dose-dependent efficacy of IRC-082451 against dyskinesias was observed. The 5 mg/kg dose was best at attenuating the severity of fully established LIDs. Its effect was significantly different from that of amantadine since it increased spontaneous locomotor activity while reducing LIDs. This dose was effective both acutely and in a 5-day sub-chronic treatment. Moreover, positron emission tomography scans using radiolabelled dopamine demonstrated that there was no direct interference between treatment with IRC-082451 and dopamine metabolism in the brain. Finally, post-mortem analysis indicated that this reduction in dyskinesias was associated with changes in cFOS, FosB and ARC mRNA expression levels in the putamen. The data demonstrates the antidyskinetic efficacy of IRC-082451 in a primate model of PD with motor complications and opens the way to the clinical application of this treatment for the management of LIDs.	[Badin, Romina Aron; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Guillermier, Martine; Brouillet, Emmanuel; Hantraye, Philippe] Commissariat Energie Atom, Mol Imaging Res Ctr, Fontenay Aux Roses, France; [Badin, Romina Aron; Gaillard, Marie-Claude; Jan, Caroline; Malgorn, Carole; Van Camp, Nadja; Guillermier, Martine; Brouillet, Emmanuel; Hantraye, Philippe] Commissariat Energie Atom, URA CEA CNRS 2210, Fontenay Aux Roses, France; [Spinnewyn, Brigitte; Auguet, Michel; Chabrier, Pierre-Etienne] IPSEN Innovat, Les Ulis, France; [Dolle, Frederic] Commissariat Energie Atom, Inst Imagerie BioMed, Serv Hosp Frederic Joliot, Orsay, France; [Boulet, Sabrina; Bertrand, Anne; Savasta, Marc] INSERM, Grenoble Inst, Neurosci Team 1, U836, Grenoble, France; [Boulet, Sabrina; Savasta, Marc] Univ Grenoble 1, Grenoble, France; [Savasta, Marc] Ctr Hosp Univ, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Ipsen; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Badin, RA (corresponding author), Commissariat Energie Atom, Mol Imaging Res Ctr, Fontenay Aux Roses, France.	romina.aron-badin@cea.fr	Van Camp, Nadja/H-5141-2017; Brouillet, Emmanuel/B-4784-2014; Savasta, Marc/M-4939-2017; Van Camp, Nadja/AAC-4357-2019; Dollé, Frédéric/R-5756-2017	Van Camp, Nadja/0000-0002-2261-7314; Brouillet, Emmanuel/0000-0001-6322-7403; Van Camp, Nadja/0000-0002-2261-7314; 	MIRCen; IPSEN Innovation	MIRCen; IPSEN Innovation(Ipsen)	The research reported in this manuscript has been funded by MIRCen and IPSEN Innovation (http://www.ipsen.com/fr). The funders had no role in study design, data collection or decision to publish. Their support was requested for data analysis and their advice for preparation and critical evaluation of the manuscript.	Bedard PJ, 1999, MOVEMENT DISORD, V14, P4; Bezard E, 1998, REV NEUROSCIENCE, V9, P71; Bezard E, 1997, NEUROSCI LETT, V234, P47, DOI 10.1016/S0304-3940(97)00663-0; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Blanchet PJ, 1998, MOVEMENT DISORD, V13, P798, DOI 10.1002/mds.870130507; Blanchet PJ, 2004, PARKINSONISM RELAT D, V10, P297, DOI 10.1016/j.parkreldis.2004.02.011; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Calabresi P, 2000, ANN NEUROL, V47, pS60; Castillo PE, 2008, NEURON, V59, P1, DOI 10.1016/j.neuron.2008.06.016; Chabrier PE, 2007, CNS DRUG REV, V13, P317, DOI 10.1111/j.1527-3458.2007.00018.x; Chase Thomas N., 1998, Neurology, V50, pS17; Chase TN, 2000, ANN NEUROL, V47, pS122; Church JS, 2006, BEHAV RES METHODS, V38, P434, DOI 10.3758/BF03192797; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; da Silva-Junior FP, 2005, PARKINSONISM RELAT D, V11, P449, DOI 10.1016/j.parkreldis.2005.05.008; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; HANTRAYE P, 1993, NEUROSCIENCE, V53, P169, DOI 10.1016/0306-4522(93)90295-Q; Hill MP, 2004, J PHARMACOL EXP THER, V310, P386, DOI 10.1124/jpet.104.066191; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Iravani MM, 2003, J NEUROSCI, V23, P9107; Jarraya B, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000130; Kobylecki C, 2001, MOVEMENT DISORD, V26, P2354; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Koprich JB, 2011, MOVEMENT DISORD, V26, P1225, DOI 10.1002/mds.23631; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Rascol O, 2001, CLIN NEUROPHARMACOL, V24, P313, DOI 10.1097/00002826-200111000-00002; Sawada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015298; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; Schneider JS, 1998, MOVEMENT DISORD, V13, P637, DOI 10.1002/mds.870130405; Sgambato-Faure V, 2005, J NEUROPATH EXP NEUR, V64, P936, DOI 10.1097/01.jnen.0000186922.42592.b7; Sgambato-Faure V, 2012, PROG NEUROBIOL, V96, P69, DOI 10.1016/j.pneurobio.2011.10.005; Shin M, 2011, NEUROBIOL AGING, V32, P2100, DOI 10.1016/j.neurobiolaging.2009.11.015; Spinnewyn B, 2011, NEUROPHARMACOLOGY, V60, P692, DOI 10.1016/j.neuropharm.2010.11.019; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tahar AH, 2003, ADV NEUROL, V91, P51; VARASTET M, 1994, NEUROSCIENCE, V63, P47, DOI 10.1016/0306-4522(94)90006-X; Walton A, 2006, NEUROBIOL AGING, V27, P1477, DOI 10.1016/j.neurobiolaging.2005.08.003; Wolf E, 2010, MOVEMENT DISORD, V25, P1357, DOI 10.1002/mds.23034	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52680	10.1371/journal.pone.0052680	http://dx.doi.org/10.1371/journal.pone.0052680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300984	Green Published, gold			2022-12-25	WOS:000313480000012
J	Donega, V; van Velthoven, CTJ; Nijboer, CH; van Bel, F; Kas, MJH; Kavelaars, A; Heijnen, CJ				Donega, Vanessa; van Velthoven, Cindy T. J.; Nijboer, Cora H.; van Bel, Frank; Kas, Martien J. H.; Kavelaars, Annemieke; Heijnen, Cobi J.			Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement	PLOS ONE			English	Article							HYPOXIA-ISCHEMIA; PROGENITOR CELLS; THERAPY; INJURY; ENCEPHALOPATHY; ASPHYXIA; GRAFTS	Mesenchymal stem cell (MSC) administration via the intranasal route could become an effective therapy to treat neonatal hypoxic-ischemic (HI) brain damage. We analyzed long-term effects of intranasal MSC treatment on lesion size, sensorimotor and cognitive behavior, and determined the therapeutic window and dose response relationships. Furthermore, the appearance of MSCs at the lesion site in relation to the therapeutic window was examined. Nine-day-old mice were subjected to unilateral carotid artery occlusion and hypoxia. MSCs were administered intranasally at 3, 10 or 17 days after hypoxia-ischemia (HI). Motor, cognitive and histological outcome was investigated. PKH-26 labeled cells were used to localize MSCs in the brain. We identified 0.5 x 10(6) MSCs as the minimal effective dose with a therapeutic window of at least 10 days but less than 17 days post-HI. A single dose was sufficient for a marked beneficial effect. MSCs reach the lesion site within 24 h when given 3 or 10 days after injury. However, no MSCs were detected in the lesion when administered 17 days following HI. We also show for the first time that intranasal MSC treatment after HI improves cognitive function. Improvement of sensorimotor function and histological outcome was maintained until at least 9 weeks post-HI. The capacity of MSCs to reach the lesion site within 24 h after intranasal administration at 10 days but not at 17 days post-HI indicates a therapeutic window of at least 10 days. Our data strongly indicate that intranasal MSC treatment may become a promising non-invasive therapeutic tool to effectively reduce neonatal encephalopathy.	[Donega, Vanessa; van Velthoven, Cindy T. J.; Nijboer, Cora H.; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [van Bel, Frank] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Kas, Martien J. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	CJHeijnen@mdanderson.org	Donega, Vanessa/M-8058-2014; Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618; van Velthoven, Cindy/0000-0001-5120-4546; Donega, Vanessa/0000-0002-3152-2675	EU-7 Neurobid from the European Union [HEALTH-F2-2009-241778]; Zon-MW Project [116002003]	EU-7 Neurobid from the European Union; Zon-MW Project	This study was supported by EU-7 Neurobid (HEALTH-F2-2009-241778) from the European Union and Zon-MW Project (no 116002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY DM, 1993, LEUKEMIA RES, V17, P873, DOI 10.1016/0145-2126(93)90153-C; Auger CJ, 2006, J NEUROENDOCRINOL, V18, P187, DOI 10.1111/j.1365-2826.2005.01400.x; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64; van Velthoven CTJ, 2010, PEDIATR RES, V68, P419, DOI 10.1203/PDR.0b013e3181f1c289; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2006, CELL TRANSPLANT, V15, P231, DOI 10.3727/000000006783982034	24	125	132	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e51253	10.1371/journal.pone.0051253	http://dx.doi.org/10.1371/journal.pone.0051253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300948	Green Submitted, gold, Green Published			2022-12-25	WOS:000313480000003
J	Choi, Y; Kim, HS; Cho, KW; Lee, KM; Yi, YJ; Eun, SJ; Kim, HJ; Woo, J; Choi, SH; Whangbo, TK; Choi, C; Noh, DY; Moon, WK				Choi, YoonSeok; Kim, Hoe Suk; Cho, Kyoung-Won; Lee, Kyung-Min; Yi, Yoon Jung; Eun, Sung-Jong; Kim, Hyun Jin; Woo, Jisu; Choi, Seung Hong; Whangbo, Taeg-Keun; Choi, ChulSoo; Noh, Dong-Young; Moon, Woo Kyung			Noninvasive Identification of Viable Cell Populations in Docetaxel-Treated Breast Tumors Using Ferritin-Based Magnetic Resonance Imaging	PLOS ONE			English	Article							CANCER STEM-CELLS; IRON-OXIDE NANOPARTICLES; MRI REPORTER; CHEMOTHERAPY; TRACKING; QUANTIFICATION; RESISTANCE; RECEPTOR	Background: Cancer stem cells (CSCs) are highly tumorigenic and are responsible for tumor progression and chemoresistance. Noninvasive imaging methods for the visualization of CSC populations within tumors in vivo will have a considerable impact on the development of new CSC-targeting therapeutics. Methodology/Principal Findings: In this study, human breast cancer stem cells (BCSCs) transduced with dual reporter genes (human ferritin heavy chain [FTH] and enhanced green fluorescence protein [EGFP]) were transplanted into NOD/SCID mice to allow noninvasive tracking of BCSC-derived populations. No changes in the properties of the BCSCs were observed due to ferritin overexpression. Magnetic resonance imaging (MRI) revealed significantly different signal intensities (R-2* values) between BCSCs and FTH-BCSCs in vitro and in vivo. In addition, distinct populations of pixels with high R-2* values were detected in docetaxel-treated FTH-BCSC tumors compared with control tumors, even before the tumor sizes changed. Histological analysis revealed that areas showing high R-2* values in docetaxel-treated FTH-BCSC tumors by MRI contained EGFP+/FTH+ viable cell populations with high percentages of CD44+/CD24- cells. Conclusions/Significance: These findings suggest that ferritin-based MRI, which provides high spatial resolution and tissue contrast, can be used as a reliable method to identify viable cell populations derived from BCSCs after chemotherapy and may serve as a new tool to monitor the efficacy of CSC-targeting therapies in vivo.	[Choi, YoonSeok; Kim, Hoe Suk; Cho, Kyoung-Won; Yi, Yoon Jung; Kim, Hyun Jin; Woo, Jisu; Choi, Seung Hong; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Choi, YoonSeok; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Hoe Suk; Woo, Jisu] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Lee, Kyung-Min; Noh, Dong-Young] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Choi, ChulSoo] Gachon Univ Med Sci, Inst LeeGilYeo Canc & Diabet Ctr, Inchon, South Korea; [Eun, Sung-Jong; Whangbo, Taeg-Keun] Gachon Univ, Dept Comp Sci, Songnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Gachon University; Gachon University	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.	moonwk@snu.ac.kr	Noh, Dong-Young/G-5531-2011; Moon, Woo Kyung/J-2755-2012	Choi, Seung Hong/0000-0002-0412-2270	National Research Foundation of Korea (NRF); Korea government (MEST) [2012-01010846]; Second Stage of Brain Korea 21 program	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Second Stage of Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NO. 2012-01010846) and the Second Stage of Brain Korea 21 program in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406; Bair S, 2009, BLOOD, V113, P1841, DOI 10.1182/blood-2008-09-178517; Choi SH, 2012, NMR BIOMED, V25, P737, DOI 10.1002/nbm.1788; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elliott R.L., 2012, J CANC THER, V03, P278; Flegel T, 2012, J VET INTERN MED; Foster P, 2011, STEM CELLS BIOL REG, P297, DOI 10.1007/978-1-61779-246-5_17; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Gilad AA, 2008, J NUCL MED, V49, P1905, DOI 10.2967/jnumed.108.053520; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Kim HS, 2010, CANCER RES, V70, P7315, DOI 10.1158/0008-5472.CAN-10-0241; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim EK, 2011, BIOMATERIALS, V32, P7941, DOI 10.1016/j.biomaterials.2011.06.077; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; McLaughlin R, 2011, NMR BIOMED, V24, P712, DOI 10.1002/nbm.1739; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Naumova AV, 2010, MOL IMAGING, V9, P201, DOI 10.2310/7290.2010.00020; Penet MF, 2010, FUTURE MED CHEM, V2, P975, DOI 10.4155/FMC.10.25; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Shigdar S, 2012, THER DELIV, V3, P227, DOI 10.4155/TDE.11.148; Snyder EL, 2009, LAB INVEST, V89, P857, DOI 10.1038/labinvest.2009.54; Townson JL, 2009, CANCER RES, V69, P8326, DOI 10.1158/0008-5472.CAN-09-1496; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Xia T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/420364; Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	41	11	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52931	10.1371/journal.pone.0052931	http://dx.doi.org/10.1371/journal.pone.0052931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301003	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900046
J	Allam, AB; Brown, MB; Reyes, L				Allam, Ayman B.; Brown, Mary B.; Reyes, Leticia			Disruption of the S41 Peptidase Gene in Mycoplasma mycoides capri Impacts Proteome Profile, H2O2 Production, and Sensitivity to Heat Shock	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; CARBOXYL-TERMINAL PROTEASE; LARGE-COLONY TYPE; SUBSP-MYCOIDES; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; SERINE PROTEASES; HYDROGEN-PEROXIDE; MOLLICUTES; VIRULENCE	Members of the Mycoplasma mycoides cluster are among the most virulent of the mycoplasmas, causing worldwide economically significant diseases of cattle and goats. A distinguishing phenotype among the members of the cluster is the ability to degrade casein. The MMCAP2_0241 gene, an S41 peptidase, confers the proteolytic phenotype in Mycoplasma mycoides subsp. capri GM12. In order to determine the impact of disruption of the gene, we used differential proteome profiling to compare the M. mycoides subsp. capri wild type with a mutant lacking the proteolytic phenotype. Disruption of MMCAP2_0241 resulted in altered phenotypes reminiscent of M. mycoides subsp. mycoides SC and had significant impacts on the proteome profile of the microbe. The mutant exhibited increased production of hydrogen peroxide, decreased lactate dehydrogenase activity, and increased sensitivity to heat shock.	[Allam, Ayman B.; Brown, Mary B.; Reyes, Leticia] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32603 USA	State University System of Florida; University of Florida	Brown, MB (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32603 USA.	mbbrown@ufl.edu	Reyes, Leticia/H-7338-2019; Allam, Ayman/AAJ-7852-2020	Allam, Ayman/0000-0002-6726-089X	USDA CSREES grant [99-35204-8367]; University of South Florida Center for Biological Defense [6415-100607, W911SR-06-C-0023]; Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases [5K08DK07651]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007651] Funding Source: NIH RePORTER	USDA CSREES grant(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of South Florida Center for Biological Defense; Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The majority of the work was funded by USDA CSREES grant 99-35204-8367 to M. B. B. and subcontract 6415-100607 to M. B. B. from the University of South Florida Center for Biological Defense (contract W911SR-06-C-0023). L. R. was supported by Public Health Service grant 5K08DK07651 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGROUN EAM, 1994, MICROBIOL-UK, V140, P2033, DOI 10.1099/13500872-140-8-2033; Allam AB, 2010, APPL ENVIRON MICROB, V76, P6951, DOI 10.1128/AEM.00056-10; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bandara AB, 2005, J BACTERIOL, V187, P5767, DOI 10.1128/JB.187.16.5767-5775.2005; Bandara AB, 2008, MICROB PATHOGENESIS, V45, P207, DOI 10.1016/j.micpath.2008.05.005; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; BenMenachem G, 1997, MICROBIOL-SGM, V143, P1933, DOI 10.1099/00221287-143-6-1933; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; COTTEW GS, 1978, AUST VET J, V54, P293, DOI 10.1111/j.1751-0813.1978.tb02462.x; COTTEW GS, 1987, ISRAEL J MED SCI, V23, P632; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DINER BA, 1988, J BIOL CHEM, V263, P8972; Djordjevic SP, 2003, MICROBIOL-SGM, V149, P195, DOI 10.1099/mic.0.25742-0; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gilbert KB, 2007, FEMS MICROBIOL LETT, V272, P65, DOI 10.1111/j.1574-6968.2007.00735.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Kannan TR, 2000, INFECT IMMUN, V68, P6419, DOI 10.1128/IAI.68.11.6419-6422.2000; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan LA, 2005, VET RES COMMUN, V29, P181, DOI 10.1023/B:VERC.0000047506.04096.06; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Madsen ML, 2006, INFECT IMMUN, V74, P160, DOI 10.1128/IAI.74.1.160-166.2006; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; MILES RJ, 1992, J GEN MICROBIOL, V138, P1773, DOI 10.1099/00221287-138-9-1773; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; NAGASAWA H, 1989, J BACTERIOL, V171, P5890, DOI 10.1128/jb.171.11.5890-5893.1989; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niang M, 1998, J VET MED A, V45, P29, DOI 10.1111/j.1439-0442.1998.tb00798.x; Ostberg Y, 2004, J BACTERIOL, V186, P2074, DOI 10.1128/JB.186.7.2074-2084.2004; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; POLLACK JD, 1981, J BACTERIOL, V146, P907, DOI 10.1128/JB.146.3.907-913.1981; Reyes L, 2009, INFECT IMMUN, V77, P4265, DOI 10.1128/IAI.00458-09; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Rodriguez JL, 1995, J VET MED B, V42, P587, DOI 10.1111/j.1439-0450.1995.tb00752.x; Schmidl SR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002263; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SILBER KR, 1994, MOL GEN GENET, V242, P237, DOI 10.1007/BF00391018; Thiaucourt F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-114; Thon JN, 2008, TRANSFUSION, V48, P425, DOI 10.1111/j.1537-2995.2007.01546.x; Vilei EM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-31; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Weiner J, 2003, NUCLEIC ACIDS RES, V31, P6306, DOI 10.1093/nar/gkg841; Zhang Q, 2012, CURR MICROBIOL, V64, P294, DOI 10.1007/s00284-011-0060-9; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	59	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51345	10.1371/journal.pone.0051345	http://dx.doi.org/10.1371/journal.pone.0051345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300541	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600005
J	Hummel, E; Guttmann, P; Werner, S; Tarek, B; Schneider, G; Kunz, M; Frangakis, AS; Westermann, B				Hummel, Eric; Guttmann, Peter; Werner, Stephan; Tarek, Basel; Schneider, Gerd; Kunz, Michael; Frangakis, Achilleas S.; Westermann, Benedikt			3D Ultrastructural Organization of Whole Chlamydomonas reinhardtii Cells Studied by Nanoscale Soft X-Ray Tomography	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; ELECTRON TOMOGRAPHY; MICROSCOPE; RECONSTRUCTION; PURIFICATION; PROJECTIONS; VOLVOCALES	The complex architecture of their structural elements and compartments is a hallmark of eukaryotic cells. The creation of high resolution models of whole cells has been limited by the relatively low resolution of conventional light microscopes and the requirement for ultrathin sections in transmission electron microscopy. We used soft x-ray tomography to study the 3D ultrastructural organization of whole cells of the unicellular green alga Chlamydomonas reinhardtii at unprecedented spatial resolution. Intact frozen hydrated cells were imaged using the natural x-ray absorption contrast of the sample without any staining. We applied different fiducial-based and fiducial-less alignment procedures for the 3D reconstructions. The reconstructed 3D volumes of the cells show features down to 30 nm in size. The whole cell tomograms reveal ultrastructural details such as nuclear envelope membranes, thylakoids, basal apparatus, and flagellar microtubule doublets. In addition, the x-ray tomograms provide quantitative data from the cell architecture. Therefore, nanoscale soft x-ray tomography is a new valuable tool for numerous qualitative and quantitative applications in plant cell biology.	[Hummel, Eric; Westermann, Benedikt] Univ Bayreuth, Inst Zellbiol, Bayreuth, Germany; [Guttmann, Peter; Werner, Stephan; Tarek, Basel; Schneider, Gerd] Helmholtz Zent Mat & Energie GmbH, Inst Soft Matter & Funct Mat, Berlin, Germany; [Kunz, Michael; Frangakis, Achilleas S.] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Kunz, Michael; Frangakis, Achilleas S.] Goethe Univ Frankfurt, Inst Biophys, D-60054 Frankfurt, Germany	University of Bayreuth; Goethe University Frankfurt; Goethe University Frankfurt	Hummel, E (corresponding author), Univ Bayreuth, Inst Zellbiol, Bayreuth, Germany.	eric.hummel@uni-bayreuth.de	Westermann, Benedikt/H-7766-2013; Guttmann, Peter/H-9869-2015	Westermann, Benedikt/0000-0002-2991-1604; Guttmann, Peter/0000-0002-0534-238X; Frangakis, Achilleas/0000-0002-8067-6611; Schneider, Gerd/0000-0001-9448-0524	German Research Foundation (DFG); University of Bayreuth	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	The authors thank the Helmholtz center for beam time allocation. This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional founding was required to publish this study.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bui KH, 2011, J SYNCHROTRON RADIAT, V18, P2, DOI 10.1107/S0909049510036812; Cardone G, 2005, J STRUCT BIOL, V151, P117, DOI 10.1016/j.jsb.2005.04.006; Carrascosa JL, 2009, J STRUCT BIOL, V168, P234, DOI 10.1016/j.jsb.2009.07.009; Castano-Diez D, 2010, J STRUCT BIOL, V170, P117, DOI 10.1016/j.jsb.2010.01.014; Colon-Ramos DA, 2003, DEV CELL, V4, P941, DOI 10.1016/S1534-5807(03)00163-1; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; DAVIES DR, 1972, MOL GEN GENET, V115, P334; ETTL H, 1976, PROTOPLASMA, V88, P75, DOI 10.1007/BF01280361; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Geimer S, 1997, CELL MOTIL CYTOSKEL, V37, P72; GILBERT PFC, 1972, PROC R SOC SER B-BIO, V182, P89, DOI 10.1098/rspb.1972.0068; GORMAN DS, 1966, PLANT PHYSIOL, V41, P1643, DOI 10.1104/pp.41.10.1643; Guttmann P, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012064; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Harris EH, 2009, CHLAMYDOMONAS SOURCE, V1; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hummel E, 2007, PLANT BIOLOGY, V9, P489, DOI 10.1055/s-2006-924759; Hummel E, 2010, J EXP BOT, V61, P2603, DOI 10.1093/jxb/erq091; Hurbain I, 2011, BIOL CELL, V103, P405, DOI 10.1042/BC20110015; Chichon FJ, 2012, J STRUCT BIOL, V177, P202, DOI 10.1016/j.jsb.2011.12.001; KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Morita E, 1998, PLANTA, V204, P269, DOI 10.1007/s004250050256; Muller WG, 2012, J STRUCT BIOL, V177, P179, DOI 10.1016/j.jsb.2011.11.025; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; OSAFUNE T, 1975, J ELECTRON MICROSC, V24, P247; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rehbein S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110801; Rehbein S, 2012, OPT EXPRESS, V20, P5830, DOI 10.1364/OE.20.005830; SAGER R, 1954, EXP CELL RES, V7, P584, DOI 10.1016/S0014-4827(54)80107-8; SAGER R, 1955, GENETICS, V40, P476; Schmahl G, 1996, NATURWISSENSCHAFTEN, V83, P61, DOI 10.1007/BF01141872; Schneider G, 2003, ANAL BIOANAL CHEM, V376, P558, DOI 10.1007/s00216-003-2007-x; Schneider G, 2012, J STRUCT BIOL, V177, P212, DOI 10.1016/j.jsb.2011.12.023; Schneider G, 2010, NAT METHODS, V7, P985, DOI 10.1038/NMETH.1533; Uchida M, 2010, YEAST; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Weiss D, 2000, ULTRAMICROSCOPY, V84, P185, DOI 10.1016/S0304-3991(00)00034-6; Zeng XH, 2008, APPL OPTICS, V47, P2376, DOI 10.1364/AO.47.002376	49	23	23	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53293	10.1371/journal.pone.0053293	http://dx.doi.org/10.1371/journal.pone.0053293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300909	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600081
J	Issa, F; Hester, J; Milward, K; Wood, KJ				Issa, Fadi; Hester, Joanna; Milward, Kate; Wood, Kathryn J.			Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model	PLOS ONE			English	Article							IMMUNE-RESPONSE; INTERLEUKIN 22; REJECTION; TREG; IDENTIFICATION; ALLOGRAFTS; EFFECTOR; MAJORITY; EXPRESS	Regulatory T cell (Treg) therapy for immune modulation is a promising therapeutic strategy for the treatment and prevention of autoimmune disease and graft-versus-host disease (GvHD) after bone marrow transplantation. However, Treg are heterogeneous and express a variety of chemokine receptor molecules. The optimal subpopulation of Treg for therapeutic use may vary according to the pathological target. Indeed, clinical trials of Treg for the prevention of GvHD where the skin is a major target of the anti-host response have employed Treg derived from a variety of different sources. We postulated that for the effective treatment of GvHD-related skin pathology, Treg must be able to migrate to skin in order to regulate local alloimmune responses efficiently. To test the hypothesis that different populations of Treg display distinct efficacy in vivo based on their expression of tissue-specific homing molecules, we evaluated the activity of human Treg derived from two disparate sources in a model of human skin transplantation. Treg were derived from adult blood or cord blood and expanded in vitro. While Treg from both sources displayed similar in vitro suppressive efficacy, they exhibited marked differences in the expression of skin homing molecules. Importantly, only adult-derived Treg were able to prevent alloimmune-mediated human skin destruction in vivo, by virtue of their improved migration to skin. The presence of Treg within the skin was sufficient to prevent its alloimmune-mediated destruction. Additionally, Treg expressing the skin homing cutaneous lymphocyte antigen (CLA) were more efficient at preventing skin destruction than their CLA-deficient counterparts. Our findings highlight the importance of the careful selection of an effective subpopulation of Treg for clinical use according to the pathology of interest.	[Issa, Fadi; Hester, Joanna; Milward, Kate; Wood, Kathryn J.] Univ Oxford, Transplantat Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX1 2JD, England	University of Oxford	Wood, KJ (corresponding author), Univ Oxford, Transplantat Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX1 2JD, England.	kathryn.wood@nds.ox.ac.uk	Issa, Fadi/HDM-8760-2022	Issa, Fadi/0000-0002-8279-7732; Milward, Kate/0000-0003-3019-4443; Hester, Joanna/0000-0002-7466-3849	Wellcome Trust; European Union; Medical Research Council UK; Royal College of Surgeons of England; Oxfordshire Health Services Research Committee Charitable Trust; MRC [G0800842] Funding Source: UKRI; Medical Research Council [G0800842] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Surgeons of England; Oxfordshire Health Services Research Committee Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from The Wellcome Trust, the European Union Integrated Projects, Reprogramming the Immune System for Establishment of Tolerance (RISET) and the One Study, Medical Research Council UK, the Royal College of Surgeons of England and the Oxfordshire Health Services Research Committee Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Duhen T, 2012, BLOOD; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; McMurchy AN, 2011, SEMIN IMMUNOL; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048; Oliveira V, 2008, EUR J IMMUNOL, V38, P1677, DOI 10.1002/eji.200737562; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Wood KJ, 2011, IMMUNOL REV, V241, P119, DOI 10.1111/j.1600-065X.2011.01013.x	26	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53331	10.1371/journal.pone.0053331	http://dx.doi.org/10.1371/journal.pone.0053331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300911	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000313872600083
J	Ridley, AW; Magabe, S; Schlipalius, DI; Rafter, MA; Collins, PJ				Ridley, Andrew W.; Magabe, Seymour; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.			Sublethal Exposure to Phosphine Decreases Offspring Production in Strongly Phosphine Resistant Female Red Flour Beetles, Tribolium castaneum (Herbst)	PLOS ONE			English	Article							RHYZOPERTHA-DOMINICA F; DROSOPHILA-MELANOGASTER; STARVATION RESISTANCE; IMMATURE STAGES; COLEOPTERA; GRAIN; TENEBRIONIDAE; REPRODUCTION; RESPIRATION; EVOLUTION	The red flour beetle is a cosmopolitan pest of stored grain and stored grain products. The pest has developed resistance to phosphine, the primary chemical used for its control. The reproductive output of survivors from a phosphine treatment is an important element of resistance development but experimental data are lacking. We exposed mated resistant female beetles to 0.135 mg/L of phosphine for 48 h at 25 degrees C. Following one week of recovery we provided two non-exposed males to half of the phosphine exposed females and to half of the non-exposed control females. Females that had been exposed produced significantly fewer offspring than non-exposed females. Females that remained isolated produced significantly fewer offspring than both exposed females with access to males and non-exposed controls (P < 0.05). Some females were permanently damaged from exposure to phosphine and did not reproduce even when given access to males. We also examined the additional effects of starvation prior to phosphine exposure on offspring production. Non-exposed starved females experienced a small reduction in mean offspring production in the week following starvation, followed by a recovery in the second week. Females that were starved and exposed to phosphine demonstrated a very significant reduction in offspring production in the first week following exposure which remained significantly lower than that of starved non-exposed females (P < 0.05). These results demonstrate a clear sublethal effect of phosphine acting on the female reproductive system and in some individuals this can lead to permanent reproductive damage. Pest population rebound after a fumigation may be slower than expected which may reduce the rate of phosphine resistance development. The results presented strongly suggest that phosphine resistance models should include sublethal effects.	[Ridley, Andrew W.; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.] Agrisci Queensland, Dept Agr Fisheries & Forestry, EcoSci Precinct, Brisbane, Qld, Australia; [Ridley, Andrew W.; Schlipalius, David I.; Rafter, Michelle A.; Collins, Patrick J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Magabe, Seymour] Perum BULOG, Jakarta, Indonesia; [Magabe, Seymour] La Trobe Univ, Dept Agr Sci, Bundoora, Vic, Australia	Queensland Department of Agriculture & Fisheries; La Trobe University	Ridley, AW (corresponding author), Agrisci Queensland, Dept Agr Fisheries & Forestry, EcoSci Precinct, Brisbane, Qld, Australia.	andrew.ridley@daff.qld.gov.au	Rafter, Michelle/AAD-6045-2019; Rafter, Michelle/GRE-8544-2022; Rafter, Michelle A/D-9790-2011; Schlipalius, David/B-8155-2011	Rafter, Michelle/0000-0002-5180-0062; Rafter, Michelle A/0000-0002-5180-0062; Schlipalius, David/0000-0002-8102-7031	Australian Government's Cooperative Research Centres Program	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	AR, DS, MR and PC would like to acknowledge the support the Australian Government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur FH, 2006, J STORED PROD RES, V42, P226, DOI 10.1016/j.jspr.2005.02.003; Baldal EA, 2006, EVOLUTION, V60, P1435, DOI 10.1111/j.0014-3820.2006.tb01222.x; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bloch MC, 1996, ANN ENTOMOL SOC AM, V89, P892, DOI 10.1093/aesa/89.6.892; BOND EJ, 1969, J STORED PROD RES, V5, P289, DOI 10.1016/0022-474X(69)90002-2; BOND EJ, 1973, J STORED PROD RES, V8, P307, DOI 10.1016/0022-474X(73)90047-7; Campbell JF, 2010, J ECON ENTOMOL, V103, P991, DOI 10.1603/EC09347; Daglish GJ, 2006, J STORED PROD RES, V42, P328, DOI 10.1016/j.jspr.2005.04.003; Emekci M, 2004, J STORED PROD RES, V40, P27, DOI 10.1016/S0022-474X(02)00076-0; Espejo M, 1966, TRIBOLIUM INFORM B, V9, P90; FAO, 1975, FAO PLANT PROTECTION, P105; GenStat 14 Committee, 2011, GENSTAT WINDOWS; Good NE, 1933, J AGRIC RES, V46, P0327; Harshman LG, 1998, EVOLUTION, V52, P1679, DOI [10.2307/2411340, 10.1111/j.1558-5646.1998.tb02247.x]; Hinton HE, 1942, NATURE, V149, P500, DOI 10.1038/149500b0; HOBBS SK, 1989, J STORED PROD RES, V25, P137, DOI 10.1016/0022-474X(89)90035-0; HOWE R. W., 1962, BULL ENTOMOL RES, V53, P301, DOI 10.1017/S0007485300048148; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Kaur R, 2012, J STORED PROD RES, V51, P74, DOI 10.1016/j.jspr.2012.08.002; KHAN MA, 1983, Z ANGEW ENTOMOL, V95, P217; Koura A., 1971, RES B OBIHIRO U, V51, P35; Lilford K., 2009, 18 WORLD IMACS C MOD; Opit GP, 2012, J ECON ENTOMOL, V105, P1107, DOI 10.1603/EC12064; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; PRICE LA, 1988, J STORED PROD RES, V24, P51, DOI 10.1016/0022-474X(88)90008-2; Ridley AW, 2011, MOL ECOL, V20, P1635, DOI 10.1111/j.1365-294X.2011.05049.x; Ridley AW, 2012, J STORED PROD RES, V48, P106, DOI 10.1016/j.jspr.2011.10.005; SAXENA J D, 1980, Indian Journal of Entomology, V42, P796; Shi MR, 2012, J STORED PROD RES, V51, P23, DOI 10.1016/j.jspr.2012.06.003; Simwat G. S., 1975, Bulletin of Grain Technology, V13, P23; TAHER M, 1983, J STORED PROD RES, V19, P43, DOI 10.1016/0022-474X(83)90023-1; Taylor R. W. D., 1986, 1986 British Crop Protection Conference. Pests and diseases. Volume 2. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986., P607; Trauner J, 2007, DEV GENES EVOL, V217, P13, DOI 10.1007/s00427-006-0114-3; WHITE GG, 1982, J STORED PROD RES, V18, P115, DOI 10.1016/0022-474X(82)90010-8; Wijayaratne LKW, 2012, PEST MANAG SCI, V68, P217, DOI 10.1002/ps.2247	35	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53356	10.1371/journal.pone.0053356	http://dx.doi.org/10.1371/journal.pone.0053356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300916	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600087
J	Allen, GE; Brown, SGA; Buckley, NA; O'Leary, MA; Page, CB; Currie, BJ; White, J; Isbister, GK				Allen, George E.; Brown, Simon G. A.; Buckley, Nicholas A.; O'Leary, Margaret A.; Page, Colin B.; Currie, Bart J.; White, Julian; Isbister, Geoffrey K.		Asp Investigators	Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming - Australian Snakebite Project (ASP-14)	PLOS ONE			English	Article							IN-VITRO; VENOM; EFFICACY; TEXTILIS; COAGULOPATHY; ANAPHYLAXIS; DEATHS; BITE	Background: Snakebite is a global health issue and treatment with antivenom continues to be problematic. Brown snakes (genus Pseudonaja) are the most medically important group of Australian snakes and there is controversy over the dose of brown snake antivenom. We aimed to investigate the clinical and laboratory features of definite brown snake (Pseudonaja spp.) envenoming, and determine the dose of antivenom required. Methods and Finding: This was a prospective observational study of definite brown snake envenoming from the Australian Snakebite Project (ASP) based on snake identification or specific enzyme immunoassay for Pseudonaja venom. From January 2004 to January 2012 there were 149 definite brown snake bites [median age 42y (2-81y); 100 males]. Systemic envenoming occurred in 136 (88%) cases. All envenomed patients developed venom induced consumption coagulopathy (VICC), with complete VICC in 109 (80%) and partial VICC in 27 (20%). Systemic symptoms occurred in 61 (45%) and mild neurotoxicity in 2 (1%). Myotoxicity did not occur. Severe envenoming occurred in 51 patients (38%) and was characterised by collapse or hypotension (37), thrombotic microangiopathy (15), major haemorrhage (5), cardiac arrest (7) and death (6). The median peak venom concentration in 118 envenomed patients was 1.6 ng/mL (Range: 0.15-210 ng/mL). The median initial antivenom dose was 2 vials (Range: 1-40) in 128 patients receiving antivenom. There was no difference in INR recovery or clinical outcome between patients receiving one or more than one vial of antivenom. Free venom was not detected in 112/115 patients post-antivenom with only low concentrations (0.4 to 0.9 ng/ml) in three patients. Conclusions: Envenoming by brown snakes causes VICC and over a third of patients had serious complications including major haemorrhage, collapse and microangiopathy. The results of this study support accumulating evidence that giving more than one vial of antivenom is unnecessary in brown snake envenoming.	[Buckley, Nicholas A.; Page, Colin B.; Isbister, Geoffrey K.] Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia; [Allen, George E.] Queen Elizabeth II Jubilee Hosp, Emergency Dept, Brisbane, Qld, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Western Australian Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Brown, Simon G. A.] Univ Western Australia, Perth, WA 6009, Australia; [Buckley, Nicholas A.] Univ New S Wales, Sch Med, Prince Wales Hosp, Med Professorial Unit, Sydney, NSW, Australia; [O'Leary, Margaret A.; Isbister, Geoffrey K.] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia; [O'Leary, Margaret A.; Page, Colin B.; Isbister, Geoffrey K.] Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Newcastle, NSW, Australia; [Page, Colin B.] Princess Alexandra Hosp, Emergency Dept, Brisbane, Qld 4102, Australia; [Currie, Bart J.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Currie, Bart J.] No Terr Clin Sch, Darwin, NT, Australia; [White, Julian] Womens & Childrens Hosp, Dept Toxinol, Adelaide, SA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of New South Wales Sydney; University of Newcastle; Calvary Mater Newcastle Hospital; Charles Darwin University; Menzies School of Health Research; Northern Territory Government; Womens & Childrens Hospital Australia	Isbister, GK (corresponding author), Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia.	geoff.isbister@gmail.com	; Buckley, Nicholas/D-4030-2012	O'Leary, Margaret/0000-0003-2579-2334; Buckley, Nicholas/0000-0002-6326-4711; Brown, Simon/0000-0002-9961-0890	NHMRC Project Grant [ID490305]; NHMRC Clinical Career Development Award [ID605817]; NHMRC Career Development Fellowship Award [ID1023265]	NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported in part by NHMRC Project Grant ID490305. GKI is supported by an NHMRC Clinical Career Development Award ID605817. SGAB is supported by NHMRC Career Development Fellowship Award ID1023265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CM, 2012, TOXICOL LETT, V210, P318, DOI 10.1016/j.toxlet.2012.02.001; Birrell GW, 2006, MOL CELL PROTEOMICS, V5, P379, DOI 10.1074/mcp.M500270-MCP200; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Chaisakul J, 2012, TOXICOL LETT; Currie B. J., 2000, EMERGEN MED, V12, P285; Currie BJ, 2004, MED J AUSTRALIA, V181, P693, DOI 10.5694/j.1326-5377.2004.tb06526.x; Gan M, 2009, MED J AUSTRALIA, V191, P183, DOI 10.5694/j.1326-5377.2009.tb02736.x; Health, 2007, SNAK SPID CLIN MAN G; HENDERSON A, 1993, MED J AUSTRALIA, V158, P709, DOI 10.5694/j.1326-5377.1993.tb121923.x; Isbister GK, 2011, TOXICON, V58, P634, DOI 10.1016/j.toxicon.2011.09.013; Isbister GK, 2008, MED J AUSTRALIA, V188, P473, DOI 10.5694/j.1326-5377.2008.tb01721.x; Isbister GK, 2007, TOXICON, V49, P57, DOI 10.1016/j.toxicon.2006.09.007; Isbister GK, 2010, SEMIN THROMB HEMOST, V36, P444, DOI 10.1055/s-0030-1254053; Isbister GK, 2010, TOXICON, V56, P75, DOI 10.1016/j.toxicon.2010.03.013; Isbister GK, 2010, TOXICOLOGY, V268, P148, DOI 10.1016/j.tox.2009.09.013; JELINEK GA, 1990, MED J AUSTRALIA, V153, P658, DOI 10.5694/j.1326-5377.1990.tb126315.x; JELINEK GA, 1991, MED J AUSTRALIA, V155, P761, DOI 10.5694/j.1326-5377.1991.tb94030.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kulawickrama S, 2010, TOXICON, V55, P1510, DOI 10.1016/j.toxicon.2010.03.003; Kuruppu S, 2008, CRIT REV TOXICOL, V38, P73, DOI 10.1080/10408440701703964; Mirtschin PJ, 2006, ECOTOXICOLOGY, V15, P531, DOI 10.1007/s10646-006-0089-x; O'Leary MA, 2009, TOXICON, V54, P192, DOI 10.1016/j.toxicon.2009.04.004; Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611, DOI 10.1055/s-0037-1613264; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Skinner A, 2005, MOL PHYLOGENET EVOL, V37, P558, DOI 10.1016/j.ympev.2005.06.020; Sprivulis P, 1996, ANAESTH INTENS CARE, V24, P379, DOI 10.1177/0310057X9602400314; Sutherland SK, 1995, MED J AUSTRALIA, V163, P616, DOI 10.5694/j.1326-5377.1995.tb124770.x; TIBBALLS J, 1991, ANAESTH INTENS CARE, V19, P530, DOI 10.1177/0310057X9101900407; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; White J, 2001, CSL ANTIVENOM HDB; White J, 2003, TOXIC PLANTS ANIMALS; Yeung JM, 2004, MED J AUSTRALIA, V181, P703, DOI 10.5694/j.1326-5377.2004.tb06528.x	32	59	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53188	10.1371/journal.pone.0053188	http://dx.doi.org/10.1371/journal.pone.0053188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300888	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500119
J	Campos, JC; Queliconi, BB; Dourado, PMM; Cunha, TF; Zambelli, VO; Bechara, LRG; Kowaltowski, AJ; Brum, PC; Mochly-Rosen, D; Ferreira, JCB				Campos, Juliane C.; Queliconi, Bruno B.; Dourado, Paulo M. M.; Cunha, Telma F.; Zambelli, Vanessa O.; Bechara, Luiz R. G.; Kowaltowski, Alicia J.; Brum, Patricia C.; Mochly-Rosen, Daria; Ferreira, Julio C. B.			Exercise Training Restores Cardiac Protein Quality Control in Heart Failure	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 20S PROTEASOME; MICE; DYSFUNCTION; MITOCHONDRIA; DEGRADATION; PROGRESSION; ACTIVATION; DEHYDROGENASE; INACTIVATION	Exercise training is a well-known coadjuvant in heart failure treatment; however, the molecular mechanisms underlying its beneficial effects remain elusive. Despite the primary cause, heart failure is often preceded by two distinct phenomena: mitochondria dysfunction and cytosolic protein quality control disruption. The objective of the study was to determine the contribution of exercise training in regulating cardiac mitochondria metabolism and cytosolic protein quality control in a post-myocardial infarction-induced heart failure (MI-HF) animal model. Our data demonstrated that isolated cardiac mitochondria from MI-HF rats displayed decreased oxygen consumption, reduced maximum calcium uptake and elevated H2O2 release. These changes were accompanied by exacerbated cardiac oxidative stress and proteasomal insufficiency. Declined proteasomal activity contributes to cardiac protein quality control disruption in our MI-HF model. Using cultured neonatal cardiomyocytes, we showed that either antimycin A or H2O2 resulted in inactivation of proteasomal peptidase activity, accumulation of oxidized proteins and cell death, recapitulating our in vivo model. Of interest, eight weeks of exercise training improved cardiac function, peak oxygen uptake and exercise tolerance in MI-HF rats. Moreover, exercise training restored mitochondrial oxygen consumption, increased Ca2+-induced permeability transition and reduced H2O2 release in MI-HF rats. These changes were followed by reduced oxidative stress and better cardiac protein quality control. Taken together, our findings uncover the potential contribution of mitochondrial dysfunction and cytosolic protein quality control disruption to heart failure and highlight the positive effects of exercise training in re-establishing cardiac mitochondrial physiology and protein quality control, reinforcing the importance of this intervention as a nonpharmacological tool for heart failure therapy.	[Campos, Juliane C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Queliconi, Bruno B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Dourado, Paulo M. M.] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil; [Cunha, Telma F.; Bechara, Luiz R. G.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Zambelli, Vanessa O.] Butantan Inst, Sao Paulo, Brazil; [Mochly-Rosen, Daria; Ferreira, Julio C. B.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Stanford University	Ferreira, JCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	jcesarbf@usp.br	Kowaltowski, Alicia J/H-8698-2012; Ferreira, Julio Cesar Batista/I-3177-2012; Bechara, Luiz R G/K-4095-2012; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/AEU-0494-2022; Zambelli, Vanessa O/C-2716-2013; Cunha, Telma F/I-5222-2016; Campos, Juliane/G-5997-2014; Brum, Patricia C/E-6605-2011	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Campos, Juliane/0000-0003-0075-7209; Brum, Patricia C/0000-0002-4750-6506; Zambelli, Vanessa/0000-0003-0890-9561; Queliconi, Bruno Barros/0000-0001-7361-5573; Mochly-Rosen, Daria/0000-0002-6691-8733; Bechara, Luiz/0000-0002-1642-1008	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP) [2009/18546-4, 2010/00028-4, 2012/05765-2]; Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq) [479407/2010-0]; Instituto Nacional de Ciencia e Tecnologia; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/12349-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011147] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo - SP (FAPESP #2009/18546-4, #2010/00028-4 and #2012/05765-2), Conselho Nacional de Pesquisa e Desenvolvimento - Brasil (CNPq, 479407/2010-0), Instituto Nacional de Ciencia e Tecnologia and Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina. JCC held a master's fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2009/12349-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; da Cunha FM, 2011, FREE RADICAL BIO MED, V51, P664, DOI 10.1016/j.freeradbiomed.2011.05.035; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Emter CA, 2005, AM J PHYSIOL-HEART C, V289, pH2030, DOI 10.1152/ajpheart.00526.2005; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Ferrington DA, 2004, FEBS LETT, V578, P217, DOI 10.1016/j.febslet.2004.11.003; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Grune Tilman, 2003, Molecular Aspects of Medicine, V24, P195, DOI 10.1016/S0098-2997(03)00014-1; Guyatt GH, 2004, MT SINAI J MED, V71, P47; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Jonsdottir S, 2006, EUR J HEART FAIL, V8, P97, DOI 10.1016/j.ejheart.2005.05.002; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Maki CG, 1996, CANCER RES, V56, P2649; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Oliveira RSF, 2009, J PHYSIOL-LONDON, V587, P3899, DOI 10.1113/jphysiol.2009.173948; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Powers SK, 2002, CURR OPIN CARDIOL, V17, P495, DOI 10.1097/00001573-200209000-00009; Qi ZT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021140; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141; Shin JH, 2009, NEUROSCI RES; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tsukamoto O, 2006, BIOCHEM BIOPH RES CO, V340, P1125, DOI 10.1016/j.bbrc.2005.12.120; Vallentin A, 2007, J BIOL CHEM, V282, P1650, DOI 10.1074/jbc.M601710200; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041	50	56	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52764	10.1371/journal.pone.0052764	http://dx.doi.org/10.1371/journal.pone.0052764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300764	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100078
J	Ahlering, MA; Eggert, LS; Western, D; Estes, A; Munishi, L; Fleischer, R; Roberts, M; Maldonado, JE				Ahlering, Marissa A.; Eggert, Lori S.; Western, David; Estes, Anna; Munishi, Linus; Fleischer, Robert; Roberts, Melissa; Maldonado, Jesus E.			Identifying Source Populations and Genetic Structure for Savannah Elephants in Human-Dominated Landscapes and Protected Areas in the Kenya-Tanzania Borderlands	PLOS ONE			English	Article							CYTONUCLEAR GENOMIC DISSOCIATION; AFRICAN ELEPHANT; MICROSATELLITE LOCI; LOXODONTA-AFRICANA; PATERNITY SUCCESS; DNA; PHYLOGEOGRAPHY; MITOCHONDRIAL; SOFTWARE; CONSERVATION	We investigated the genetic metapopulation structure of elephants across the trans Rift Valley region of Kenya and Tanzania, one of the remaining strongholds for savannah elephants (Loxodonata africana) in East Africa, using microsatellite and mitochondrial DNA (mtDNA) markers. We then examined this population structure to determine the source population for a recent colonization event of savannah elephants on community-owned land within the trans rift valley region. Four of the five sampled populations showed significant genetic differentiation (p<0.05) as measured with both mtDNA haplotypes and microsatellites. Only the samples from the adjacent Maasai Mara and Serengeti ecosystems showed no significant differentiation. A phylogenetic neighbour-joining tree constructed from mtDNA haplotypes detected four clades. Clade four corresponds to the F clade of previous mtDNA studies that reported to have originated in forest elephants (Loxodonta cyclotis) but to also be present in some savannah elephant populations. The split between clade four and the other three clades corresponded strongly to the geographic distribution of mtDNA haplotypes across the rift valley in the study area. Clade four was the dominant clade detected on the west side of the rift valley with rare occurrences on the east side. Finally, the strong patterns of population differentiation clearly indicated that the recent colonists to the community-owned land in Kenya came from the west side of the rift valley. Our results indicate strong female philopatry within the isolated populations of the trans rift valley region, with gene flow primarily mediated via male movements. The recent colonization event from Maasai Mara or Serengeti suggests there is hope for maintaining connectivity and population viability outside formal protected areas in the region.	[Ahlering, Marissa A.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Ahlering, Marissa A.; Fleischer, Robert; Roberts, Melissa; Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC USA; [Ahlering, Marissa A.; Western, David] African Conservat Ctr, Nairobi, Kenya; [Estes, Anna] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Munishi, Linus] Wildlife Conservat Soc, Tarangire Elephant Project, Arusha, Tanzania; [Roberts, Melissa; Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	University of Missouri System; University of Missouri Columbia; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Virginia; Smithsonian Institution; Smithsonian National Museum of Natural History	Ahlering, MA (corresponding author), Nature Conservancy, Grand Forks, ND USA.	mahlering@tnc.org	Maldonado, Jesus/AIE-8664-2022	Maldonado, Jesus/0000-0002-4282-1072	University of Missouri Research Board; Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute; Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo; American Philosophical Society; Liz Claiborne and Art Ortenberg Foundation	University of Missouri Research Board; Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute; Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo; American Philosophical Society; Liz Claiborne and Art Ortenberg Foundation	This study was supported by the University of Missouri Research Board, the Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute, the Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo, the American Philosophical Society and the Liz Claiborne and Art Ortenberg Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2012, DIVERS DISTRIB, V18, P952, DOI 10.1111/j.1472-4642.2012.00896.x; Ahlering MA, 2011, MOL ECOL RESOUR, V11, P831, DOI 10.1111/j.1755-0998.2011.03030.x; AMOS W, 1992, MAR MAMMAL SCI, V8, P275, DOI 10.1111/j.1748-7692.1992.tb00409.x; Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; Barnes R., 1999, AFRICAN ELEPHANT DAT; Blanc J. J., 2007, OCCASIONAL PAPER SER, V33; Brandt AL, 2012, MOL ECOL, V21, P1175, DOI 10.1111/j.1365-294X.2012.05461.x; Comstock KE, 2000, MOL ECOL, V9, P1004, DOI 10.1046/j.1365-294x.2000.00939-8.x; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Douglas-Hamilton I., 1987, Oryx, V6, P11; Drummond A., 2011, GENEIOUS V 5 5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Eggert LS, 2000, MOL ECOL, V9, P2223, DOI 10.1046/j.1365-294X.2000.105336.x; EGGERT LS, 2007, P 2007 INT EL CONS R, P157; Enk J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r51; Estes AB, 2012, BIOL CONSERV, V147, P255, DOI 10.1016/j.biocon.2012.01.010; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Guajardo JCR, 2010, MOL ECOL, V19, P5126, DOI 10.1111/j.1365-294X.2010.04833.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heller R, 2010, MOL ECOL, V19, P1324, DOI 10.1111/j.1365-294X.2010.04589.x; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ishida Y, 2012, EVOLUTIONARY APPL ON; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Lei R, 2012, J ZOOL, V286, P38, DOI 10.1111/j.1469-7998.2011.00851.x; Lei RH, 2009, J HERED, V100, P675, DOI 10.1093/jhered/esp069; Miller CR, 2002, GENETICS, V160, P357; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Nyakaana S, 1999, MOL ECOL, V8, P1105, DOI 10.1046/j.1365-294x.1999.00661.x; Nyakaana S, 1998, MOL ECOL, V7, P1436; Okello JBA, 2008, J HERED, V99, P443, DOI 10.1093/jhered/esn028; Park SDE, 2001, THESIS U DUBLIN; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scribner KT, 2005, J WILDLIFE MANAGE, V69, P1434, DOI 10.2193/0022-541X(2005)69[1434:GGCFAE]2.0.CO;2; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101	57	18	18	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52288	10.1371/journal.pone.0052288	http://dx.doi.org/10.1371/journal.pone.0052288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300634	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800065
J	Chou, CY; Dong, Y; Hung, YK; Kao, YJ; Wang, WC; Kao, CM; Chen, CT				Chou, Cheng-Ying; Dong, Yun; Hung, Yukai; Kao, Yu-Jiun; Wang, Weichung; Kao, Chien-Min; Chen, Chin-Tu			Accelerating Image Reconstruction in Dual-Head PET System by GPU and Symmetry Properties	PLOS ONE			English	Article							SMALL-ANIMAL PET; ITERATIVE RECONSTRUCTION; DETECTOR; DEPTH; PERFORMANCE; RESOLUTION; DESIGN; SCANNER; MATRIX	Positron emission tomography (PET) is an important imaging modality in both clinical usage and research studies. We have developed a compact high-sensitivity PET system that consisted of two large-area panel PET detector heads, which produce more than 224 million lines of response and thus request dramatic computational demands. In this work, we employed a state-of-the-art graphics processing unit (GPU), NVIDIA Tesla C2070, to yield an efficient reconstruction process. Our approaches ingeniously integrate the distinguished features of the symmetry properties of the imaging system and GPU architectures, including block/warp/thread assignments and effective memory usage, to accelerate the computations for ordered subset expectation maximization (OSEM) image reconstruction. The OSEM reconstruction algorithms were implemented employing both CPU-based and GPU-based codes, and their computational performance was quantitatively analyzed and compared. The results showed that the GPU-accelerated scheme can drastically reduce the reconstruction time and thus can largely expand the applicability of the dual-head PET system.	[Chou, Cheng-Ying; Kao, Yu-Jiun] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Dong, Yun] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Hung, Yukai; Wang, Weichung] Natl Taiwan Univ, Dept Math, Taipei 10764, Taiwan; [Kao, Chien-Min; Chen, Chin-Tu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	National Taiwan University; Illinois Institute of Technology; National Taiwan University; University of Chicago	Wang, WC (corresponding author), Natl Taiwan Univ, Dept Math, Taipei 10764, Taiwan.	wwang@ntu.edu.tw	Kao, Chien-Min/CAI-0648-2022; Chen, Chin-Tu/K-3393-2014	Kao, Chien-Min/0000-0002-8785-5225; CHOU, CHENG-YING/0000-0002-5737-6960; Wang, Weichung/0000-0002-6154-7750	National Science Council [NSC 99-2221-E-002-043-MY3, NSC 100-2628-M-002-011-MY4]; Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences; National Center for Theoretical Sciences (Taipei Office)	National Science Council(Ministry of Science and Technology, Taiwan); Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences; National Center for Theoretical Sciences (Taipei Office)	This work was supported in part by the National Science Council under grant No. NSC 99-2221-E-002-043-MY3 and NSC 100-2628-M-002-011-MY4, the Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences, and the National Center for Theoretical Sciences (Taipei Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexoff DL, 2011, NUCL MED BIOL, V38, P191, DOI 10.1016/j.nucmedbio.2010.08.004; Astakhov V, 2003, IEEE T NUCL SCI, V50, P1373, DOI 10.1109/TNS.2003.817944; BARTZAKOS P, 1991, PHYS MED BIOL, V36, P735, DOI 10.1088/0031-9155/36/6/003; Boning G, 2001, IEEE T NUCL SCI, V48, P805, DOI 10.1109/23.940167; Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3; Chou CY, 2011, MED PHYS, V38, P4052, DOI 10.1118/1.3591994; de Jong HWAM, 2007, PHYS MED BIOL, V52, P1505, DOI 10.1088/0031-9155/52/5/019; Dong Y, 2006, IEEE NUCL SCI CONF R, P2864; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Herraiz JL, 2006, PHYS MED BIOL, V51, P4547, DOI 10.1088/0031-9155/51/18/007; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hwu W.W., 2011, GPU COMPUTING GEMS E; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kao C, 2002, NUCL SCI IEEE T, V47, P1551; Kao CM, 2007, IEEE NUCL SCI CONF R, P3046, DOI 10.1109/NSSMIC.2007.4436773; Kao CM, 2005, IEEE NUCL SCI CONF R, P2081; Kao CM, 2009, IEEE T NUCL SCI, V56, P2678, DOI 10.1109/TNS.2009.2026647; Kao CM, 2002, IEEE T NUCL SCI, V49, P208, DOI 10.1109/TNS.2002.998753; Kao CN, 2004, IEEE NUCL SCI CONF R, P2072; Kawachi N, 2011, IEEE T NUCL SCI, V58, P395, DOI 10.1109/TNS.2011.2113192; Kwon SI, 2011, J NUCL MED, V52, P572, DOI 10.2967/jnumed.110.079707; Lecomte R, 2004, NUCL INSTRUM METH A, V527, P157, DOI 10.1016/j.nima.2004.03.113; Miyaoka RS, 1998, IEEE T NUCL SCI, V45, P1069, DOI 10.1109/23.681980; Moehrs S, 2006, PHYS MED BIOL, V51, P1113, DOI 10.1088/0031-9155/51/5/004; Moisan C, 1996, IEEE T NUCL SCI, V43, P1926, DOI 10.1109/23.507248; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; MOSES WW, 1994, IEEE T NUCL SCI, V41, P1441, DOI 10.1109/23.322929; Mumcuoglu E, 2002, NUCL SCI S 1996 C RE, V3, P1569; Murayama H, 1998, IEEE T NUCL SCI, V45, P1152, DOI 10.1109/23.681994; Murphy M, 2010, P ISMRM SCI M EXH, P4854; Nestle U, 2009, PHYS MED BIOL, V54, pR1, DOI 10.1088/0031-9155/54/1/R01; Nvidia C, 2007, COMP UN DEV ARCH PRO; NVIDIA Corporation, 2008, NVIDIA CUDA CUBLAS L; Okitsu Y, 2010, PARALLEL COMPUT, V36, P129, DOI 10.1016/j.parco.2010.01.004; Pratx G, 2011, PHYS MED BIOL, V56, P4023, DOI 10.1088/0031-9155/56/13/018; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rafecas M, 2004, IEEE T NUCL SCI, V51, P2597, DOI 10.1109/TNS.2004.834827; Rogers JG, 1996, IEEE T NUCL SCI, V43, P3240, DOI 10.1109/23.552726; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Sanders J., 2010, CUDA EXAMPLE; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Uchida H, 2004, NUCL INSTRUM METH A, V516, P564, DOI 10.1016/j.nima.2003.08.165; Wang ZG, 2005, IEEE T NUCL SCI, V52, P1274, DOI 10.1109/TNS.2005.858231; Weisenberger AG, 2009, IEEE NUCL SCI CONF R, P2323, DOI 10.1109/NSSMIC.2009.5402259; Wuest F, 2005, AMINO ACIDS, V29, P323, DOI 10.1007/s00726-005-0201-1; Yamamoto S, 1998, IEEE T NUCL SCI, V45, P1078, DOI 10.1109/23.681982; Zhou J, 2011, PHYS MED BIOL, V56, P6739, DOI 10.1088/0031-9155/56/20/015	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50540	10.1371/journal.pone.0050540	http://dx.doi.org/10.1371/journal.pone.0050540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300527	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800007
J	Korman, TP; Bowie, JU				Korman, Tyler P.; Bowie, James U.			Crystal Structure of Proteus mirabilis Lipase, a Novel Lipase from the Proteus/Psychrophilic Subfamily of Lipase Family I.1	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA LIPASE; OPEN CONFORMATION; TRIACYLGLYCEROL LIPASE; BACTERIAL LIPASES; DISULFIDE BOND; CLASSIFICATION; EXPRESSION; FEATURES; REVEALS; GENE	Bacterial lipases from family I.1 and I.2 catalyze the hydrolysis of triacylglycerol between 25-45 degrees C and are used extensively as biocatalysts. The lipase from Proteus mirabilis belongs to the Proteus/psychrophilic subfamily of lipase family I.1 and is a promising catalyst for biodiesel production because it can tolerate high amounts of water in the reaction. Here we present the crystal structure of the Proteus mirabilis lipase, a member of the Proteus/psychrophilic subfamily of I.1lipases. The structure of the Proteus mirabilis lipase was solved in the absence and presence of a bound phosphonate inhibitor. Unexpectedly, both the apo and inhibitor bound forms of P. mirabilis lipase were found to be in a closed conformation. The structure reveals a unique oxyanion hole and a wide active site that is solvent accessible even in the closed conformation. A distinct mechanism for Ca2+ coordination may explain how these lipases can fold without specific chaperones.	[Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA; [Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	bowie@mbi.ucla.edu			Department of Energy [DE-FC02-02ER63421]	Department of Energy(United States Department of Energy (DOE))	This work was supported by grant number DE-FC02-02ER63421 from the Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alquati C, 2002, EUR J BIOCHEM, V269, P3321, DOI 10.1046/j.1432-1033.2002.03012.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; El Khattabi M, 2003, J MOL CATAL B-ENZYM, V22, P329, DOI 10.1016/S1381-1177(03)00047-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao B, 2009, J BIOTECHNOL, V139, P169, DOI 10.1016/j.jbiotec.2008.10.004; Gao B, 2011, J MOL CATAL B-ENZYM, V68, P286, DOI 10.1016/j.molcatb.2010.12.001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Invernizzi G, 2009, J STRUCT BIOL, V168, P562, DOI 10.1016/j.jsb.2009.07.021; Invernizzi G, 2009, J BIOTECHNOL, V141, P42, DOI 10.1016/j.jbiotec.2009.02.020; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Joshi GK, 2007, RES J BIOTECHNOL, V2, P50; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Krishna SH, 2002, CATAL REV, V44, P499, DOI 10.1081/CR-120015481; Lang D, 1996, J MOL BIOL, V259, P704, DOI 10.1006/jmbi.1996.0352; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HW, 2000, BIOTECHNOL LETT, V22, P1543, DOI 10.1023/A:1005621532280; Liebeton K, 2001, J BACTERIOL, V183, P597, DOI 10.1128/JB.183.2.597-603.2001; Lu Yaping, 2010, Weishengwu Xuebao, V50, P755; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pauwels K, 2006, NAT STRUCT MOL BIOL, V13, P374, DOI 10.1038/nsmb1065; Pauwels K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036999; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Whangsuk W, 2012, MOL BIOTECHNOLOGY; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu T, 2010, BBA-PROTEINS PROTEOM, V1804, P2183, DOI 10.1016/j.bbapap.2010.08.012; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	38	17	19	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52890	10.1371/journal.pone.0052890	http://dx.doi.org/10.1371/journal.pone.0052890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300806	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800159
J	Lin, CC; Zhou, JP; Liu, YP; Liu, JJ; Yang, XN; Jazag, A; Zhang, ZP; Guleng, B; Ren, JL				Lin, Chan-Chan; Zhou, Jing-Ping; Liu, Yun-Peng; Liu, Jing-Jing; Yang, Xiao-Ning; Jazag, Amarsanaa; Zhang, Zhi-Ping; Guleng, Bayasi; Ren, Jian-Lin			The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway	PLOS ONE			English	Article							REPRESSES TRANSCRIPTION; NUCLEAR-LOCALIZATION; POOR-PROGNOSIS; FBI-1; ACTIVATION; GENE; EXPRESSION; GROWTH; ERK; MIGRATION	Pokemon (POK erythroid myeloid ontogenic factor), which belongs to the POK protein family, is also called LRF, OCZF and FBI-1. As a transcriptional repressor, Pokemon assumes a critical function in cellular differentiation and oncogenesis. Our study identified an oncogenic role for Pokemon in human hepatocellular carcinoma (HCC). We successfully established human HepG2 and Huh-7 cell lines in which Pokemon was stably knocked down. We demonstrated that Pokemon silencing inhibited cell proliferation and migration. Pokemon knockdown inhibited the PI3K/Akt and c-Raf/MEK/ERK pathways and modulated the expression of various cell cycle regulators in HepG2 and Huh-7 cells. Therefore, Pokemon may also be involved in cell cycle progression in these cells. We confirmed that Pokemon silencing suppresses hepatocellular carcinoma growth in tumor xenograft mice. These results suggest that Pokemon promotes cell proliferation and migration in hepatocellular carcinoma and accelerates tumor development in an Akt- and ERK-signaling-dependent manner.	[Lin, Chan-Chan; Zhou, Jing-Ping; Liu, Yun-Peng; Liu, Jing-Jing; Yang, Xiao-Ning; Zhang, Zhi-Ping; Guleng, Bayasi; Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China; [Guleng, Bayasi] Xiamen Univ, Coll Med, Fac Clin Med, Xiamen, Peoples R China; [Jazag, Amarsanaa] 3rd Gen Hosp, Natl Inst Med Res, Ulaanbaatar, Mongolia	Xiamen University; Xiamen University	Guleng, B (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China.	bayasi8@gmail.com; renjianl@xmu.edu.cn		zhou, jingping/0000-0002-3703-2204	Youth Innovation Fund of Fujian Province [2006F3127]; National Natural Science Foundation of China [30971362, 81072013]; Fundamental Research Funds for the Central Universities in China [2010111082]	Youth Innovation Fund of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work was supported by Youth Innovation Fund of Fujian Province (2006F3127), National Natural Science Foundation of China (No. 30971362 & 81072013) and Fundamental Research Funds for the Central Universities in China (No. 2010111082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2010, EXP MOL PATHOL, V89, P140, DOI 10.1016/j.yexmp.2010.05.002; Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Horn S, 2004, LEUKEMIA, V18, P1839, DOI 10.1038/sj.leu.2403529; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Merle P, 2009, VIRUSES-BASEL, V1, P852, DOI 10.3390/v1030852; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Suzuki A, 2000, HEPATOLOGY, V32, P796, DOI 10.1053/jhep.2000.17738; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wiesenauer CA, 2004, J AM COLL SURGEONS, V198, P410, DOI 10.1016/j.jamcollsurg.2003.10.004; Zhang QL, 2011, ONKOLOGIE, V34, P526, DOI 10.1159/000332141	26	29	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51916	10.1371/journal.pone.0051916	http://dx.doi.org/10.1371/journal.pone.0051916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300578	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800037
J	Shimada, Y; Hirano, M; Nishimura, Y; Tanaka, T				Shimada, Yasuhito; Hirano, Minoru; Nishimura, Yuhei; Tanaka, Toshio			A High-Throughput Fluorescence-Based Assay System for Appetite-Regulating Gene and Drug Screening	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; FOOD-INTAKE; LARVAL ZEBRAFISH; NEUROPEPTIDE-Y; RECEPTOR; FLUOXETINE; BRAIN; SIBUTRAMINE; INSULIN; OBESITY	The increasing number of people suffering from metabolic syndrome and obesity is becoming a serious problem not only in developed countries, but also in developing countries. However, there are few agents currently approved for the treatment of obesity. Those that are available are mainly appetite suppressants and gastrointestinal fat blockers. We have developed a simple and rapid method for the measurement of the feeding volume of Danio rerio (zebrafish). This assay can be used to screen appetite suppressants and enhancers. In this study, zebrafish were fed viable paramecia that were fluorescently-labeled, and feeding volume was measured using a 96-well microplate reader. Gene expression analysis of brain-derived neurotrophic factor (bdnf), knockdown of appetite-regulating genes (neuropeptide Y, preproinsulin, melanocortin 4 receptor, agouti related protein, and cannabinoid receptor 1), and the administration of clinical appetite suppressants (fluoxetine, sibutramine, mazindol, phentermine, and rimonabant) revealed the similarity among mechanisms regulating appetite in zebrafish and mammals. In combination with behavioral analysis, we were able to evaluate adverse effects on locomotor activities from gene knockdown and chemical treatments. In conclusion, we have developed an assay that uses zebrafish, which can be applied to high-throughput screening and target gene discovery for appetite suppressants and enhancers.	[Shimada, Yasuhito; Hirano, Minoru; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Ind Technol Innovat Inst, Dept Om Med, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Nishimura, Yuhei/0000-0003-1901-8799; Hirano, Minoru/0000-0002-4546-3864	KAKENHI from Japan Society for the Promotion of Science [24590318]; New Energy and Industrial Technology Development Organization; Japan Chemical Industry Association; Grants-in-Aid for Scientific Research [24590318] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Chemical Industry Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (Grant-in-Aid for Scientific Research, 24590318) from Japan Society for the Promotion of Science, the New Energy and Industrial Technology Development Organization, and the Japan Chemical Industry Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FAKM, 2001, INT J DEV NEUROSCI, V19, P209, DOI 10.1016/S0736-5748(00)00073-3; Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; Ampatzis K, 2008, J COMP NEUROL, V508, P72, DOI 10.1002/cne.21663; Aronne LJ, 2007, CLIN PHARMACOL THER, V81, P748, DOI 10.1038/sj.clpt.6100163; Benkimoun P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e996; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101; Brotchie JM, 2003, CURR OPIN PHARMACOL, V3, P54, DOI 10.1016/S1471-4892(02)00011-5; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Butler AA, 2003, ANN NY ACAD SCI, V994, P240, DOI 10.1111/j.1749-6632.2003.tb03186.x; Casado A, 2003, NUTR NEUROSCI, V6, P103, DOI 10.1080/1028415031000094264; Clements S, 2002, GEN COMP ENDOCR, V125, P319, DOI 10.1006/gcen.2001.7707; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Currie PJ, 2004, PSYCHOPHARMACOLOGY, V172, P359, DOI 10.1007/s00213-003-1681-x; Dakin CL, 2001, ENDOCRINOLOGY, V142, P4244, DOI 10.1210/en.142.10.4244; DEBONS AF, 1970, AM J PHYSIOL, V219, P938, DOI 10.1152/ajplegacy.1970.219.4.938; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Gadde KM, 2006, CIRCULATION, V114, P974, DOI 10.1161/CIRCULATIONAHA.105.596130; Gerozissis K, 2004, EUR J PHARMACOL, V490, P59, DOI 10.1016/j.ejphar.2004.02.044; Heal DJ, 1998, INT J OBESITY, V22, pS18; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; INUI A, 1991, AM J PHYSIOL, V261, pR588, DOI 10.1152/ajpregu.1991.261.3.R588; Janhunen SK, 2011, OBESITY, V19, P1979, DOI 10.1038/oby.2011.51; Johansson K, 2009, OBES REV, V10, P564, DOI 10.1111/j.1467-789X.2009.00581.x; Kanarek R B, 1988, Curr Concepts Nutr, V16, P1; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Lauzurica N, 2012, J PHYSL BIO IN PRESS, V23; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; Cerda-Reverter JM, 2011, EUR J PHARMACOL, V660, P53, DOI 10.1016/j.ejphar.2010.10.108; Mortensen OV, 2001, J NEUROCHEM, V79, P237, DOI 10.1046/j.1471-4159.2001.00587.x; Myung CS, 2005, ARCH PHARM RES, V28, P716, DOI 10.1007/BF02969363; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Papasani MR, 2006, PHYSIOL GENOMICS, V27, P79, DOI 10.1152/physiolgenomics.00012.2006; Piccinetti CC, 2010, HORM BEHAV, V58, P780, DOI 10.1016/j.yhbeh.2010.07.013; Rico EP, 2011, NEUROTOXICOL TERATOL, V33, P608, DOI 10.1016/j.ntt.2011.07.007; Rosenzweig S, 2010, GRAEF ARCH CLIN EXP, V248, P1423, DOI 10.1007/s00417-010-1377-y; Rowland NE, 1996, NUTRITION, V12, P626, DOI 10.1016/S0899-9007(96)00227-4; SCHANZER MC, 1978, NEUROENDOCRINOLOGY, V25, P329, DOI 10.1159/000122754; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schwartz MW, 1997, J AM DIET ASSOC, V97, P54, DOI 10.1016/S0002-8223(97)00018-7; Shishkina GT, 2012, CELL MOL NEUROBIOL, V32, P787, DOI 10.1007/s10571-012-9828-0; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Tanaka T, 2008, J PHARMACOL SCI, V107, P8, DOI 10.1254/jphs.08R03FM; Usenko CY, 2011, ENVIRON TOXICOL CHEM, V30, P1865, DOI 10.1002/etc.570; VANROSSUM JM, 1969, PSYCHOPHARMACOLOGIA, V14, P248, DOI 10.1007/BF00404223; Varga ZM, 2011, METHOD CELL BIOL, V104, P453, DOI 10.1016/B978-0-12-374814-0.00024-0; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang YH, 2006, TOHOKU J EXP MED, V208, P267, DOI 10.1620/tjem.208.267; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; ZAMBOTTI F, 1976, EUR J PHARMACOL, V36, P405, DOI 10.1016/0014-2999(76)90094-7; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	70	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52549	10.1371/journal.pone.0052549	http://dx.doi.org/10.1371/journal.pone.0052549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300705	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800105
J	Wu, H; Xie, JS; Pan, QR; Wang, BB; Hu, DQ; Hu, X				Wu, Hao; Xie, Jiansheng; Pan, Qiangrong; Wang, Beibei; Hu, Danqing; Hu, Xun			Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance	PLOS ONE			English	Article							ANTI-TUMOR ACTIVITY; CELL-DEATH; TOPOISOMERASE-I; CARCINOMA CELLS; P-GLYCOPROTEIN; BETA-HYDROXYISOVALERYLSHIKONIN; MULTIDRUG-RESISTANCE; ANTITUMOR-ACTIVITY; BREAST-CANCER; APOPTOSIS	Purpose: Cancer drug resistance is a major obstacle for the success of chemotherapy. Since most clinical anticancer drugs could induce drug resistance, it is desired to develop candidate drugs that are highly efficacious but incompetent to induce drug resistance. Numerous previous studies have proven that shikonin and its analogs not only are highly tumoricidal but also can bypass drug-transporter and apoptotic defect mediated drug resistance. The purpose of this study is to investigate if or not shikonin is a weak inducer of cancer drug resistance. Experimental Design: Different cell lines (K562, MCF-7, and a MDR cell line K562/Adr), after repeatedly treated with shikonin for 18 months, were assayed for drug resistance and gene expression profiling. Results: After 18-month treatment, cells only developed a mere 2-fold resistance to shikonin and a marginal resistance to cisplatin and paclitaxel, without cross resistance to shikonin analogs and other anticancer agents. Gene expression profiles demonstrated that cancer cells did strongly respond to shikonin treatment but failed to effectively mobilize drug resistant machineries. Shikonin-induced weak resistance was associated with the up-regulation of beta II-tubulin, which physically interacted with shikonin. Conclusion: Taken together, apart from potent anticancer activity, shikonin and its analogs are weak inducers of cancer drug resistance and can circumvent cancer drug resistance. These merits make shikonin and its analogs potential candidates for cancer therapy with advantages of avoiding induction of drug resistance and bypassing existing drug resistance.	[Wu, Hao; Xie, Jiansheng; Pan, Qiangrong; Wang, Beibei; Hu, Danqing; Hu, Xun] Zhejiang Univ, Sch Med, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn	hu, dq/K-9722-2016		National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by National 863 project (2007AA02Z143), China Natural Sciences Foundation projects (30772544, 81071802) and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to X. Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; AHN BZ, 1995, J MED CHEM, V38, P1044, DOI 10.1021/jm00006a025; Allen JD, 1999, CANCER RES, V59, P4237; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; BEKETICORESKOVIC L, 1995, J NATL CANCER I, V87, P1593, DOI 10.1093/jnci/87.21.1593; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen J, 2011, ONCOGENE; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Floreani M, 2000, BIOCHEM PHARMACOL, V60, P601, DOI 10.1016/S0006-2952(00)00350-6; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo X P, 1991, Zhong Xi Yi Jie He Za Zhi, V11, P598; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Hayashi M, 1977, Nihon Yakurigaku Zasshi, V73, P193; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Hsu PC, 2004, J AGR FOOD CHEM, V52, P6330, DOI 10.1021/jf0495993; HU X, 1995, CHEMOTHERAPY, V41, P296, DOI 10.1159/000239359; Hu X, 2008, CANCER LETT, V259, P127, DOI 10.1016/j.canlet.2007.11.007; Hu X, 2007, AUTOPHAGY, V3, P490, DOI 10.4161/auto.4592; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim SH, 2001, CANCER LETT, V172, P171, DOI 10.1016/S0304-3835(01)00665-6; LAU DHM, 1991, CANCER RES, V51, P5181; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Li L, 2007, LIFE SCI, V80, P741, DOI 10.1016/j.lfs.2006.11.002; Ling CQ, 2005, ANN ONCOL, V16, P109, DOI 10.1093/annonc/mdi019; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Masuda Y, 2003, ONCOGENE, V22, P1012, DOI 10.1038/sj.onc.1206200; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nakaya K, 2003, ANTI-CANCER DRUG, V14, P683, DOI 10.1097/01.cad.0000092781.37568.df; Pan QR, 2006, CANCER CHEMOTH PHARM, V58, P99, DOI 10.1007/s00280-005-0133-1; Pan QR, 2005, BIOCHEM BIOPH RES CO, V335, P406, DOI 10.1016/j.bbrc.2005.07.097; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Plyta ZF, 1998, BIOORG MED CHEM LETT, V8, P3385, DOI 10.1016/S0960-894X(98)00600-3; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; SANKAWA U, 1981, CHEM PHARM BULL, V29, P116; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xu D, 2006, CANCER LETT, V243, P274, DOI 10.1016/j.canlet.2005.11.031; Xuan YY, 2009, CANCER LETT, V274, P233, DOI 10.1016/j.canlet.2008.09.029; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Yeh PY, 2003, BIOCHEM PHARMACOL, V66, P25, DOI 10.1016/S0006-2952(03)00250-8; Yoon Y, 1999, PLANTA MED, V65, P532, DOI 10.1055/s-1999-14010	54	40	42	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52706	10.1371/journal.pone.0052706	http://dx.doi.org/10.1371/journal.pone.0052706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300986	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000014
J	Chen, ZG; Zhang, TT; Li, HT; Chen, FH; Zou, XL; Ji, JZ; Chen, H				Chen, Zhuang-Gui; Zhang, Tian-Tuo; Li, Hong-Tao; Chen, Fen-Hua; Zou, Xiao-Ling; Ji, Jing-Zhi; Chen, Hong			Neutralization of TSLP Inhibits Airway Remodeling in a Murine Model of Allergic Asthma Induced by Chronic Exposure to House Dust Mite	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; DENDRITIC CELLS; T-BET; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IFN-GAMMA; INFLAMMATION; BLOCKADE	Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function. However, the initiating factor that links airway inflammation to remodeling is unknown. Thymic stromal lymphopoietin (TSLP), an epithelium-derived cytokine, can strongly activate lung dendritic cells (DCs) through the TSLP-TSLPR and OX40L-OX40 signaling pathways to promote Th2 differentiation. To determine whether TSLP is the underlying trigger of airway remodeling in chronic allergen-induced asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite (HDM) extracts for up to 5 consecutive weeks. We showed that repeated respiratory exposure to HDM caused significant airway eosinophilic inflammation, peribronchial collagen deposition, goblet cell hyperplasia, and airway hyperreactivity (AHR) to methacholine. These effects were accompanied with a salient Th2 response that was characterized by the upregulation of Th2-typed cytokines, such as IL-4 and IL-13, as well as the transcription factor GATA-3. Moreover, the levels of TSLP and transforming growth factor beta 1 (TGF-beta 1) were also increased in the airway. We further demonstrated, using the chronic HDM-induced asthma model, that the inhibition of Th2 responses via neutralization of TSLP with an anti-TSLP mAb reversed airway inflammation, prevented structural alterations, and decreased AHR to methacholine and TGF-beta 1 level. These results suggest that TSLP plays a pivotal role in the initiation and persistence of airway inflammation and remodeling in the context of chronic allergic asthma.	[Chen, Zhuang-Gui; Zhang, Tian-Tuo; Li, Hong-Tao; Zou, Xiao-Ling] Sun Yat Sen Univ, Inst Resp Dis, Affiliated Hosp 3, Dept Pulm Dis, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhuang-Gui; Chen, Fen-Hua; Ji, Jing-Zhi; Chen, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, TT (corresponding author), Sun Yat Sen Univ, Inst Resp Dis, Affiliated Hosp 3, Dept Pulm Dis, Guangzhou 510275, Guangdong, Peoples R China.	zhtituli@163.com			Guangdong Natural Science Foundation [10151008901000008]; Science and Technology Planning Project of Guangdong Province, China [2008B030301040]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	Tian-Tuo Zhang was supported by Guangdong Natural Science Foundation (grant number: 10151008901000008; URL of funder's website: http://gdsf.gdstc.gov.cn/). Zhuang-Gui Chen was supported by Science and Technology Planning Project of Guangdong Province, China (grant number: 2008B030301040; URL of funder's website: http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Chen ZG, 2009, CHINESE MED J-PEKING, V122, P1157, DOI 10.3760/cma.j.issn.0366-6999.2009.10.008; Fahy JV, 2001, AM J RESP CRIT CARE, V164, pS46, DOI 10.1164/ajrccm.164.supplement_2.2106066; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kiwamoto T, 2006, AM J RESP CRIT CARE, V174, P142, DOI 10.1164/rccm.200601-079OC; Kolb M, 2002, AM J RESP CELL MOL, V27, P141, DOI 10.1165/ajrcmb.27.2.4674; Komai M, 2003, BRIT J PHARMACOL, V138, P912, DOI 10.1038/sj.bjp.0705105; Labonte I, 2009, AM J PHYSIOL-LUNG C, V297, pL698, DOI 10.1152/ajplung.00142.2009; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Li Hong-tao, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P497; Li YL, 2010, J ASTHMA, V47, P117, DOI 10.3109/02770900903483816; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pascual RM, 2009, J ALLERGY CLIN IMMUN, V124, P883, DOI 10.1016/j.jaci.2009.09.047; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shi LY, 2008, CLIN IMMUNOL, V129, P202, DOI 10.1016/j.clim.2008.07.015; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	51	76	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51268	10.1371/journal.pone.0051268	http://dx.doi.org/10.1371/journal.pone.0051268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300949	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900007
J	Jin, R; Zhao, PX; Ma, XM; Ma, JM; Wu, YN; Yang, XJ; Zhang, JX; Zhong, RG; Zeng, Y				Jin, Rui; Zhao, Pengxiang; Ma, Xuemei; Ma, Jianmin; Wu, Yanan; Yang, Xinji; Zhang, Jingxue; Zhong, Rugang; Zeng, Yi			Quantification of Epstein-Barr Virus DNA in Patients with Idiopathic Orbital Inflammatory Pseudotumor	PLOS ONE			English	Article							MYOFIBROBLASTIC TUMOR; CHILDREN; PLASMA	Inflammatory pseudotumors (IPT) are soft tissue tumors that include a diverse group of lesions characterized by inflammatory cell infiltration and variable fibrotic responses. Idiopathic orbital inflammatory pseudotumors (IOIP) are IPTs of unknown etiology that develop in the orbit. Due to the lack of well-defined pathogenic mechanisms, diagnosis and treatment of this disease remain a significant challenge. Epstein-Barr virus (EBV) infection, which causes significant lymphocyte infiltration, has been proposed to be involved in IOIP. This study tries to validate the relationship between EBV infection and the development of IOIP. Sixteen IOIP tissue samples were obtained from patients during surgical resection of the lesion. One Graves' ophthalmopathy tissue sample and 20 normal donors' plasma serves as controls. The plasma level of five EBV antibodies, including VCA-IgG, VCA-IgA, VCA-IgM, EA-IgG and EBNA1-IgG were examined. All plasma samples were EB-VCA-IgG positive and EB-VCA-IgM negative, suggesting that all people tested had been infected with EBV but not in the acute infection stage. EBV-DNA was detected in 15/16 (94%) of IOIP tissue samples despite different levels of lymphocyte infiltration and 5/16 plasma samples (31%) were detected EBV DNA positive which is higher than the normal controls (10%). Percent of positive plus suspected positive samples with one or more of the three important risk markers (VCA-IgA, EA-IgG, EBV-DNA) is 50% of the patients (8/16) which is much higher compare with the normal controls (20%). The results further reveal the relationship between IOIP and EBV infection.	[Jin, Rui; Zhao, Pengxiang; Ma, Xuemei; Wu, Yanan; Zhong, Rugang; Zeng, Yi] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Ma, Jianmin; Zhang, Jingxue] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Vis Sci Key Lab, Beijing, Peoples R China; [Yang, Xinji] Chinese Armed Police Gen Hosp, Inst Orbital Dis, Beijing, Peoples R China; [Zeng, Yi] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Beijing University of Technology; Capital Medical University; Chinese Center for Disease Control & Prevention	Ma, XM (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China.	xmma@bjut.edu.cn; leslieziyi@163.com	Zhao, Peng/HDO-7507-2022		Beijing Science Nova Program [2004B051/4CE2004A26]	Beijing Science Nova Program	This work was supported by the Beijing Science Nova Program (2004B051/4CE2004A26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Garcia Jesus, 2004, Ann Hepatol, V3, P34; Arber DA, 1998, SEMIN DIAGN PATHOL, V15, P155; ARBER DA, 1995, HUM PATHOL, V26, P1093, DOI 10.1016/0046-8177(95)90271-6; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Bousnina S, 2004, Rev Pneumol Clin, V60, P55, DOI 10.1016/S0761-8417(04)72085-4; Fan HX, 2004, INT J CANCER, V112, P1036, DOI 10.1002/ijc.20520; Gulley ML, 2008, J MOL DIAGN, V10, P279, DOI 10.2353/jmoldx.2008.080023; Henderson JW, 1994, ORBITAL TUMORS, P317; Ishikawa T, 2004, INT J UROL, V11, P337, DOI 10.1111/j.1442-2042.2004.00790.x; Janik JS, 2003, J PEDIATR SURG, V38, P1491, DOI 10.1016/S0022-3468(03)00501-3; Jin Rui, 2010, INT C BIOM ENG COMP, P432; Karnak I, 2001, J PEDIATR SURG, V36, P908, DOI 10.1053/jpsu.2001.23970; Lin Huai-xue, 1988, CHINESE J PRACTICAL, V6, P46; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lo YMD, 1999, CANCER RES, V59, P1188; Martin C J, 1997, J Am Optom Assoc, V68, P775; MAVES CK, 1989, RADIOLOGY, V173, P381, DOI 10.1148/radiology.173.2.2678252; Mergan F, 2005, J PEDIATR SURG, V40, P1581, DOI 10.1016/j.jpedsurg.2005.06.021; Mertens, 2002, PATHOLOGY GENETICS T, P91; Morotti RA, 2005, PEDIATR DEVEL PATHOL, V8, P224, DOI 10.1007/s10024-004-8088-5; Puyan FO, 2004, EUR J HAEMATOL, V72, P285, DOI 10.1111/j.0902-4441.2003.00208.x; Rehmani Jamshed A, 2004, J Coll Physicians Surg Pak, V14, P53; Sanders BM, 2001, J PEDIATR SURG, V36, P169, DOI 10.1053/jpsu.2001.20045; STARK P, 1992, CHEST, V102, P1884, DOI 10.1378/chest.102.6.1884; Sun Hongxia, 2005, OPHTHALMOLOGY CHINA, V6, P369; Trevenzoli M, 2003, ANN MED INTERNE, V154, P557	26	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50812	10.1371/journal.pone.0050812	http://dx.doi.org/10.1371/journal.pone.0050812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300945	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900004
J	Lee, WY; Sun, LM; Lin, MC; Liang, JA; Chang, SN; Sung, FC; Muo, CH; Kao, CH				Lee, Wen-Yuan; Sun, Li-Min; Lin, Ming-Chia; Liang, Ji-An; Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin; Kao, Chia-Hung			A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study	PLOS ONE			English	Article							ESOPHAGEAL CANCER; BISPHOSPHONATES; DISEASE; TRENDS	Background: Controversy still exists regarding whether alendronate (ALN) use increases the risk of esophageal cancer or breast cancer. Methods: This paper explores the possible association between the use of oral ALN in osteoporosis patients and subsequent cancer risk using the National Health Insurance (NHI) system database of Taiwan with a Cox proportional-hazard regression analysis. The exposure cohort contained 5,624 osteoporosis patients used ALN and randomly frequency-matched by age and gender of 3 osteoporosis patients without any kind of anti-osteoporosis drugs in the same period. Results: For a dose >= 1.0 g/year, the risk of developing overall cancer was significantly higher (hazard ratio: 1.69, 95% confidence ratio: 1.39-2.04) than in osteoporosis patients without any anti-osteoporosis drugs. The risks for developing liver, lung, and prostate cancers and lymphoma were also significantly higher than in the control group. Conclusions: This population-based retrospective cohort study did not find a relationship between ALN use and either esophageal or breast cancer, but unexpectedly discovered that use of ALN with dose >= 1.0 g/year significantly increased risks of overall cancer incidence, as well as liver, lung, and prostate cancers and lymphoma. Further large population-based unbiased studies to enforce our findings are required before any confirmatory conclusion can be made.	[Lee, Wen-Yuan] China Med Univ Hosp, Taipei Branch, Taichung, Taiwan; [Lee, Wen-Yuan; Liang, Ji-An; Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Wen-Yuan; Liang, Ji-An; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Sun, Li-Min] Zuoying Armed Forces Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Lin, Ming-Chia] E DA Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Shih-Ni] China Med Univ, Ph D Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chang, Shih-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Inst Environm Hlth, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; E-Da Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Muo, CH (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	A17776@mail.cmuh.org; d10040@mail.cmuh.org.tw			Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH101-TD-C-111-005];  [DMR-101-061];  [DMR-100-076]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; ; 	The study was supported in part by the study projects (DMR-101-061 and DMR-100-076) in the authors' hospital and the Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH101-TD-B-111-004), and the Taiwan Department of Health Cancer Research Center for Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; [Anonymous], CANC STAT ANN REP; [Anonymous], BROWS AL SOD SID EFF; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Cossentino Mark J, 2003, Semin Gastrointest Dis, V14, P128; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Dreyfuss John Henry, 2010, CA Cancer J Clin, V60, P343, DOI 10.3322/caac.20091; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555; Peter C, 1999, INT J CLIN PRACT, P3; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Ryan JM, 1998, RADIOLOGY, V206, P389, DOI 10.1148/radiology.206.2.9457190; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Vestergaard P, 2011, CALCIFIED TISSUE INT, V88, P255, DOI 10.1007/s00223-011-9463-7; Wang Y, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-34; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	27	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53032	10.1371/journal.pone.0053032	http://dx.doi.org/10.1371/journal.pone.0053032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300854	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600051
J	Ringpis, GEE; Shimizu, S; Arokium, H; Camba-Colon, J; Carroll, MV; Cortado, R; Xie, YM; Kim, PY; Sahakyan, A; Lowe, EL; Narukawa, M; Kandarian, FN; Burke, BP; Symonds, GP; An, DS; Chen, ISY; Kamata, M				Ringpis, Gene-Errol E.; Shimizu, Saki; Arokium, Hubert; Camba-Colon, Joanna; Carroll, Maria V.; Cortado, Ruth; Xie, Yiming; Kim, Patrick Y.; Sahakyan, Anna; Lowe, Emily L.; Narukawa, Munetoshi; Kandarian, Fadi N.; Burke, Bryan P.; Symonds, Geoff P.; An, Dong Sung; Chen, Irvin S. Y.; Kamata, Masakazu			Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem/Progenitor Cells in Humanized BLT Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUPPRESSES HIV-1 INFECTION; GENE-THERAPY; LENTIVIRAL VECTOR; TAR DECOY; MONONUCLEAR PHAGOCYTES; DISEASE PROGRESSION; CCR5; INHIBITION; INTERFERENCE	Down-regulation of the HIV-1 coreceptor CCR5 holds significant potential for long-term protection against HIV-1 in patients. Using the humanized bone marrow/liver/thymus (hu-BLT) mouse model which allows investigation of human hematopoietic stem/progenitor cell (HSPC) transplant and immune system reconstitution as well as HIV-1 infection, we previously demonstrated stable inhibition of CCR5 expression in systemic lymphoid tissues via transplantation of HSPCs genetically modified by lentiviral vector transduction to express short hairpin RNA (shRNA). However, CCR5 down-regulation will not be effective against existing CXCR4-tropic HIV-1 and emergence of resistant viral strains. As such, combination approaches targeting additional steps in the virus lifecycle are required. We screened a panel of previously published shRNAs targeting highly conserved regions and identified a potent shRNA targeting the R-region of the HIV-1 long terminal repeat (LTR). Here, we report that human CD4(+) T-cells derived from transplanted HSPC engineered to co-express shRNAs targeting CCR5 and HIV-1 LTR are resistant to CCR5- and CXCR4-tropic HIV-1-mediated depletion in vivo. Transduction with the combination vector suppressed CXCR4- and CCR5-tropic viral replication in cell lines and peripheral blood mononuclear cells in vitro. No obvious cytotoxicity or interferon response was observed. Transplantation of combination vector-transduced HSPC into hu-BLT mice resulted in efficient engraftment and subsequent stable gene marking and CCR5 down-regulation in human CD4(+) T-cells within peripheral blood and systemic lymphoid tissues, including gut-associated lymphoid tissue, a major site of robust viral replication, for over twelve weeks. CXCR4- and CCR5-tropic HIV-1 infection was effectively inhibited in hu-BLT mouse spleen-derived human CD4(+) T-cells ex vivo. Furthermore, levels of gene-marked CD4(+) T-cells in peripheral blood increased despite systemic infection with either CXCR4- or CCR5-tropic HIV-1 in vivo. These results demonstrate that transplantation of HSPCs engineered with our combination shRNA vector may be a potential therapy against HIV disease.	[Ringpis, Gene-Errol E.; Arokium, Hubert; Xie, Yiming; Kim, Patrick Y.; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ringpis, Gene-Errol E.; Shimizu, Saki; Arokium, Hubert; Xie, Yiming; Kim, Patrick Y.; An, Dong Sung; Chen, Irvin S. Y.; Kamata, Masakazu] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Shimizu, Saki; An, Dong Sung; Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Camba-Colon, Joanna; Carroll, Maria V.; Burke, Bryan P.; Symonds, Geoff P.] Calimmune Inc, Los Angeles, CA USA; [Cortado, Ruth; Sahakyan, Anna; Lowe, Emily L.; Narukawa, Munetoshi; An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Kandarian, Fadi N.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Kandarian, Fadi N.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Sahakyan, Anna/0000-0002-8840-9171; Kamata, Masakazu/0000-0003-0323-3742; Chen, Irvin/0000-0003-1199-2415	California Institute for Regenerative Medicine [DR1-01431]; National Institutes of Health [1RO1HL086409, 3RO1HL086409-03S1, 5T32AI060567]; University of California Los Angeles AIDS Institute/Center for AIDS Research [5P30AI028697]; CIRM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, P30AI028697, T32AI060567] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles AIDS Institute/Center for AIDS Research; CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM grant DR1-01431 to ISYC), the National Institutes of Health (1RO1HL086409 and 3RO1HL086409-03S1 to DSA and 5T32AI060567), and the University of California Los Angeles AIDS Institute/Center for AIDS Research (5P30AI028697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ISYC and DSA have a financial interest in Calimmune, Inc. Calimmune is a subcontractor of the grant from CIRM. GER, ISYC, and MK are co-inventors of a provisional application for patent titled SHRNA VECTORS FOR THE TREATMENT OF HIV, #US 61/647,201 (UCLA Case 2012-623-1). All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Anderson J, 2007, MOL THER, V15, P1182, DOI 10.1038/sj.mt.6300157; Anderson JS, 2009, MOL THER, V17, P2103, DOI 10.1038/mt.2009.187; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Baba M, 2000, AIDS RES HUM RETROV, V16, P935, DOI 10.1089/08892220050058344; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kiem HP, 2012, CELL STEM CELL, V10, P137, DOI 10.1016/j.stem.2011.12.015; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; Klasens BIF, 1999, NUCLEIC ACIDS RES, V27, P446, DOI 10.1093/nar/27.2.446; Koper-Emde D, 2004, BIOL CHEM, V385, P791, DOI 10.1515/BC.2004.103; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Liang M, 2010, J GENE MED, V12, P255, DOI 10.1002/jgm.1440; Mcintyre GJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-55; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Morner A, 1999, J VIROL, V73, P2343; Neff CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020209; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Poon B, 2005, J VIROL, V79, P10210, DOI 10.1128/JVI.79.16.10210-10217.2005; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Symonds GP, 2010, IMMUNOL RES, V48, P84, DOI 10.1007/s12026-010-8169-7; Tamhane Mayur, 2008, AIDS Res Ther, V5, P16, DOI 10.1186/1742-6405-5-16; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; Ter Brake O, 2007, J GENE MED, V9, P743, DOI 10.1002/jgm.1078; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; UNAIDS, 2011, 2011 WORLD AIDS DAY; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	64	48	48	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53492	10.1371/journal.pone.0053492	http://dx.doi.org/10.1371/journal.pone.0053492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300932	gold, Green Published			2022-12-25	WOS:000313872600103
J	Downes, JC; Birsoy, B; Chipman, KC; Rothman, JH				Downes, Joanna C.; Birsoy, Bilge; Chipman, Kyle C.; Rothman, Joel H.			Handedness of a Motor Program in C. elegans Is Independent of Left-Right Body Asymmetry	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY NEURON FATES; MATING-BEHAVIOR; EMBRYONIC-DEVELOPMENT; ISOGENIC POPULATIONS; CELL LINEAGES; CHEMOTAXIS; EVOLUTION; GENETICS; PROTEIN	Complex animals display bilaterally asymmetric motor behavior, or "motor handedness," often revealed by preferential use of limbs on one side. For example, use of right limbs is dominant in a strong majority of humans. While the mechanisms that establish bilateral asymmetry in motor function are unknown in humans, they appear to be distinct from those for other handedness asymmetries, including bilateral visceral organ asymmetry, brain laterality, and ocular dominance. We report here that a simple, genetically homogeneous animal comprised of only similar to 1000 somatic cells, the nematode C. elegans, also shows a distinct motor handedness preference: on a population basis, males show a pronounced right-hand turning bias during mating. The handedness bias persists through much of adult lifespan, suggesting that, as in more complex animals, it is an intrinsic trait of each individual, which can differ from the population mean. Our observations imply that the laterality of motor handedness preference in C. elegans is driven by epigenetic factors rather than by genetic variation. The preference for right-hand turns is also seen in animals with mirror-reversed anatomical handedness and is not attributable to stochastic asymmetric loss of male sensory rays that occurs by programmed cell death. As with C. elegans, we also observed a substantial handedness bias, though not necessarily the same preference in direction, in several gonochoristic Caenorhabditis species. These findings indicate that the independence of bilaterally asymmetric motor dominance from overall anatomical asymmetry, and a population-level tendency away from ambidexterity, occur even in simple invertebrates, suggesting that these may be common features of bilaterian metazoans.	[Rothman, Joel H.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Rothman, JH (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	joel.rothman@lifesci.ucsb.edu		Bairzin, Joanna/0000-0001-7628-0684; Birsoy, Bilge/0000-0003-4337-4582	National Institutes of Health (NIH) [GM87137, HD062922]; University of California Santa Barbara CCS Summer Undergraduate Research Fellowship; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Santa Barbara CCS Summer Undergraduate Research Fellowship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM87137 and HD062922 from the National Institutes of Health (NIH) to JHR. BB was supported by an NIH Ruth Kirschstein Fellowship and a Harvey Karp Discovery Award. JCD was supported in part by a University of California Santa Barbara CCS Summer Undergraduate Research Fellowship. The Caenorhabditis Genetics Center is funded by the NIH National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; BRENNER S, 1974, GENETICS, V77, P71; Byrne RA, 2002, ANIM BEHAV, V64, P461, DOI 10.1006/anbe.2002.3089; Chen J, 2001, EXP GERONTOL, V36, P431, DOI 10.1016/S0531-5565(00)00225-4; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Croll N. A., 1977, Biology of nematodes.; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; GENDREAU SB, 1994, DEV BIOL, V166, P770, DOI 10.1006/dbio.1994.1355; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; Hermann GJ, 2000, DEVELOPMENT, V127, P3429; HODGKIN J, 1983, GENETICS, V103, P43; HUTTER H, 1995, DEVELOPMENT, V121, P3417; HUTTER H, 1994, DEVELOPMENT, V120, P2051; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kight SL, 2008, BEHAV PROCESS, V79, P66, DOI 10.1016/j.beproc.2008.04.001; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; MCCULLAGH P, 1989, GEN LINEAR MODELS, pR19; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; Mevorach C, 2005, NAT NEUROSCI, V8, P276, DOI 10.1038/nn1400; MOSKOWITZ IPG, 1994, DEVELOPMENT, V120, P3325; Nance J, 1999, GENETICS, V152, P209; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pohl Christian, 2011, Commun Integr Biol, V4, P34, DOI 10.4161/cib.4.1.14144; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1983, COLD SPRING HARB SYM, V48, P443, DOI 10.1101/SQB.1983.048.01.049; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0	39	8	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52138	10.1371/journal.pone.0052138	http://dx.doi.org/10.1371/journal.pone.0052138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300601	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100023
J	Migrenne, S; Moreau, E; Pakarinen, P; Dierich, A; Merlet, J; Habert, R; Racine, C				Migrenne, Stephanie; Moreau, Evelyne; Pakarinen, Pirjo; Dierich, Andree; Merlet, Jorge; Habert, Rene; Racine, Chrystele			Mouse Testis Development and Function Are Differently Regulated by Follicle-Stimulating Hormone Receptors Signaling During Fetal and Prepubertal Life	PLOS ONE			English	Article							LEYDIG-CELL DEVELOPMENT; ANTI-MULLERIAN HORMONE; TRANSCRIPTION FACTORS GATA-4; SERTOLI-CELLS; RAT TESTIS; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; MICE; STEROIDOGENESIS; PROLIFERATION	It is currently admitted that Follicle-Stimulating Hormone (FSH) is physiologically involved in the development and function of fetal/neonatal Sertoli cells in the rat but not the mouse. However, FSH is produced by both species from late fetal life onwards. We thus reinvestigated the role of FSH in mouse testis development at day 0 (birth) 6, 8 and 10 post-partum (dpp) by using mice that lack functional FSH receptors (FSH-R-/-). At birth, the number and proliferative index of Sertoli cells were significantly lower in FSH-R-/- mice than in wild type neonates. Claudin 11 mRNA expression also was significantly reduced in FSH-R-/- testes at 0 and 8 dpp, whereas the mRNA levels of other Sertoli cell markers (Transferrin and Desert hedgehog) were comparable in FSH-R-/- and wild type testes. Conversely, AMH mRNA and protein levels were higher at birth, comparable at 6 dpp and then significantly lower in FSH-R-/- testes at 8-10 dpp in FSH-R-/- mice than in controls. Although the plasma concentration of LH and the number of Leydig cells were similar in FSH-R-/- and control (wild type), testosterone concentration and P450c17 mRNA expression were significantly increased in FSH-R-/- testes at birth. Conversely, at 10 dpp when adult Leydig cells appear, expression of the steroidogenic genes P450scc, P450c17 and StAR was lower in FSH-R-/- testes than in controls. In conclusion, our results show that 1) like in the rat, signaling via FSH- R controls Sertoli cell development and function during late fetal life in the mouse as well; 2) paracrine factors produced by Sertoli cells are involved in the FSH-R-dependent regulation of the functions of fetal Leydig cells in late fetal life; and 3) the role of FSH-R signaling changes during the prepubertal period.	[Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France; [Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] CEA, DSV, iRCM, SCSR,LDG, Fontenay Aux Roses, France; [Migrenne, Stephanie; Moreau, Evelyne; Merlet, Jorge; Habert, Rene; Racine, Chrystele] INSERM, U967, Fontenay Aux Roses, France; [Pakarinen, Pirjo] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Dierich, Andree] CNRS 7104, IGBMC, Illkirch Graffenstaden, France; [Dierich, Andree] INSERM, U964, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Habert, R (corresponding author), Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France.	rene.habert@cea.fr		Racine, Chrystele/0000-0003-0250-5355; Habert, Rene/0000-0002-6045-0324	Universite Paris Diderot; INSERM; CEA; Ministere de l'Education Nationale et de la Recherche; Fondation pour la Recherche Medicale	Universite Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Ministere de l'Education Nationale et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Universite Paris Diderot, INSERM and CEA. Stephanie Migrenne holds PhD studentships from the Ministere de l'Education Nationale et de la Recherche and from the Fondation pour la Recherche Medicale. Jorge Merlet holds a PhD studentship from the Ministere de l'Education Nationale et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Barakat B, 2012, MOL CELL ENDOCRINOL, V359, P66, DOI 10.1016/j.mce.2012.02.018; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Delbes R, 2004, ENDOCRINOLOGY, V145, P3395, DOI 10.1210/en.2003-1479; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; HABERT R, 1982, ACTA ENDOCRINOL-COP, V99, P466, DOI 10.1530/acta.0.0990466; Habert R, 2009, FOLIA HISTOCHEM CYTO, V47, pS67, DOI 10.2478/v10042-009-0056-5; Heikinheimo M, 1997, ENDOCRINOLOGY, V138, P3505, DOI 10.1210/en.138.8.3505; HUHTANIEMI I, 1989, International Journal of Developmental Biology, V33, P117; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; KERR JB, 1988, DEVELOPMENT, V103, P535; KERR JB, 1985, CELL TISSUE RES, V239, P405, DOI 10.1007/BF00218021; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Krishnamurthy H, 2001, BIOL REPROD, V65, P1201, DOI 10.1095/biolreprod65.4.1201; KURODA T, 1990, ENDOCRINOLOGY, V127, P1825, DOI 10.1210/endo-127-4-1825; LECERF L, 1993, ENDOCRINOLOGY, V133, P2313, DOI 10.1210/en.133.5.2313; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; MAGRE S, 1991, J ELECTRON MICR TECH, V19, P172, DOI 10.1002/jemt.1060190205; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Migrenne S, 2003, ENDOCRINOLOGY, V144, P2617, DOI 10.1210/en.2002-0011; Migrenne S, 2001, MOL CELL ENDOCRINOL, V172, P193, DOI 10.1016/S0303-7207(00)00339-7; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; NORTON JN, 1989, ENDOCRINOLOGY, V124, P2711, DOI 10.1210/endo-124-6-2711; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 2011, REPRODUCTION, V141, P37, DOI 10.1530/REP-10-0365; ORTH JM, 1984, ENDOCRINOLOGY, V115, P1248, DOI 10.1210/endo-115-4-1248; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Park SY, 2007, ENDOCRINOLOGY, V148, P3704, DOI 10.1210/en.2006-1731; PICON R, 1981, ACTA ENDOCRINOL-COP, V97, P176, DOI 10.1530/acta.0.0970176; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; RANNIKKI AS, 1995, MOL CELL ENDOCRINOL, V107, P199, DOI 10.1016/0303-7207(94)03444-X; Rouiller-Fabre V, 1998, ENDOCRINOLOGY, V139, P1213, DOI 10.1210/en.139.3.1213; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; SKINNER MK, 1980, J BIOL CHEM, V255, P9523; Svechnikov K, 2008, BEST PRACT RES CL EN, V22, P95, DOI 10.1016/j.beem.2007.09.002; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; TEERDS KJ, 1989, J ENDOCRINOL, V120, P97, DOI 10.1677/joe.0.1200097; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VERGOUWEN RPFA, 1993, J REPROD FERTIL, V99, P479, DOI 10.1530/jrf.0.0990479; WARREN DW, 1973, BIOL REPROD, V8, P560, DOI 10.1093/biolreprod/8.5.560; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202	55	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53257	10.1371/journal.pone.0053257	http://dx.doi.org/10.1371/journal.pone.0053257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300903	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100131
J	Almlof, JC; Lundmark, P; Lundmark, A; Ge, B; Maouche, S; Goring, HHH; Liljedahl, U; Enstrom, C; Brocheton, J; Proust, C; Godefroy, T; Sambrook, JG; Jolley, J; Crisp-Hihn, A; Foad, N; Lloyd-Jones, H; Stephens, J; Gwilliam, R; Rice, CM; Hengstenberg, C; Samani, NJ; Erdmann, J; Schunkert, H; Pastinen, T; Deloukas, P; Goodall, AH; Ouwehand, WH; Cambien, F; Syvanen, AC				Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Ge, Bing; Maouche, Seraya; Goering, Harald H. H.; Liljedahl, Ulrika; Enstrom, Camilla; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Sambrook, Jennifer G.; Jolley, Jennifer; Crisp-Hihn, Abigail; Foad, Nicola; Lloyd-Jones, Heather; Stephens, Jonathan; Gwilliam, Rhian; Rice, Catherine M.; Hengstenberg, Christian; Samani, Nilesh J.; Erdmann, Jeanette; Schunkert, Heribert; Pastinen, Tomi; Deloukas, Panos; Goodall, Alison H.; Ouwehand, Willem H.; Cambien, Francois; Syvanen, Ann-Christine		CARDIOGENICS Consortium; CARDIOGENICS Consortium; CARDIOGENICS Consortium; CARDIOGENICS Consortium	Powerful Identification of Cis-regulatory SNPs in Human Primary Monocytes Using Allele-Specific Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISCOVERY	A large number of genome-wide association studies have been performed during the past five years to identify associations between SNPs and human complex diseases and traits. The assignment of a functional role for the identified disease-associated SNP is not straight-forward. Genome-wide expression quantitative trait locus (eQTL) analysis is frequently used as the initial step to define a function while allele-specific gene expression (ASE) analysis has not yet gained a wide-spread use in disease mapping studies. We compared the power to identify cis-acting regulatory SNPs (cis-rSNPs) by genome-wide allele-specific gene expression (ASE) analysis with that of traditional expression quantitative trait locus (eQTL) mapping. Our study included 395 healthy blood donors for whom global gene expression profiles in circulating monocytes were determined by Illumina BeadArrays. ASE was assessed in a subset of these monocytes from 188 donors by quantitative genotyping of mRNA using a genome-wide panel of SNP markers. The performance of the two methods for detecting cis-rSNPs was evaluated by comparing associations between SNP genotypes and gene expression levels in sample sets of varying size. We found that up to 8-fold more samples are required for eQTL mapping to reach the same statistical power as that obtained by ASE analysis for the same rSNPs. The performance of ASE is insensitive to SNPs with low minor allele frequencies and detects a larger number of significantly associated rSNPs using the same sample size as eQTL mapping. An unequivocal conclusion from our comparison is that ASE analysis is more sensitive for detecting cis-rSNPs than standard eQTL mapping. Our study shows the potential of ASE mapping in tissue samples and primary cells which are difficult to obtain in large numbers.	[Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Liljedahl, Ulrika; Enstrom, Camilla; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Ge, Bing; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Maouche, Seraya; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Maouche, Seraya; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Cambien, Francois] Sch Med, Paris, France; [Goering, Harald H. H.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Sambrook, Jennifer G.; Lloyd-Jones, Heather; Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Sambrook, Jennifer G.; Jolley, Jennifer; Crisp-Hihn, Abigail; Foad, Nicola; Lloyd-Jones, Heather; Stephens, Jonathan; Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Gwilliam, Rhian; Rice, Catherine M.; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany	Uppsala University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Texas Biomedical Research Institute; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of Regensburg; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; Almlöf, Jonas/E-1608-2017	Erdmann, Jeanette/0000-0002-4486-6231; Almlöf, Jonas/0000-0002-1211-9821; Stephens, Jonathan/0000-0003-2020-9330; Goodall, Alison/0000-0002-7883-9645; Maouche, Seraya/0000-0001-8186-1635; Ouwehand, Willem/0000-0002-7744-1790	Cardiogenics EU FP6 project [LSHM-CT-2006-037593]; European Sequencing and Genotyping Infrastructure (ESGI) EU FP7 [262055]; GEUVADIS EU FP7 project [261123]; Swedish Research Council for Science and Technology [90559401]; Knut and Alice Wallenberg Foundation [KAW 2011.0073]; National Institute for Health Research (NIHR) [RP-PG-0310-1002]; National Institute of Health (NIH) [RR017515]; Canadian Institutes of Health Research; Swedish Research Council; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515] Funding Source: NIH RePORTER	Cardiogenics EU FP6 project; European Sequencing and Genotyping Infrastructure (ESGI) EU FP7; GEUVADIS EU FP7 project; Swedish Research Council for Science and Technology(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cardiogenics EU FP6 project (grant number LSHM-CT-2006-037593); the European Sequencing and Genotyping Infrastructure (ESGI) EU FP7 (grant number 262055); the GEUVADIS EU FP7 project (grant number 261123); the Swedish Research Council for Science and Technology (grant number 90559401 to ACS); the Knut and Alice Wallenberg Foundation (KAW 2011.0073 to ACS); the National Institute for Health Research (NIHR) (RP-PG-0310-1002 to HG); and the National Institute of Health (NIH) (RR017515 to HG). TP holds a Canada Research Chair and his work is supported by the Canadian Institutes of Health Research. Funding for open access charge was granted by the Swedish Research Council. The project made use of volunteers from the Cambridge BioResource.(http://www.cambridgebioresource.org.uk/). This local resource for genotype-phenotype association studies is supported by a grant from the National Institute for Health Research (NIHR) to the Cambridge Biomedical Research Centre (to JS and JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	18	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52260	10.1371/journal.pone.0052260	http://dx.doi.org/10.1371/journal.pone.0052260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300628	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800062
J	Dayyani, F; Parikh, NU; Varkaris, AS; Song, JH; Moorthy, S; Chatterji, T; Maity, SN; Wolfe, AR; Carboni, JM; Gottardis, MM; Logothetis, CJ; Gallick, GE				Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Carboni, Joan M.; Gottardis, Marco M.; Logothetis, Christopher J.; Gallick, Gary E.			Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASES; POTENT INHIBITOR; TUMOR-GROWTH; DASATINIB; EXPRESSION; CELLS; BONE; PROGRESSION; ANTIBODY	Background: Treatment of metastatic prostate cancer (PCa) with single agents has shown only modest efficacy. We hypothesized dual inhibition of different pathways in PCa results in improved tumor inhibition. The Src family kinases (SFK) and insulin-like growth factor-1 (IGF-1) signaling axes are aberrantly activated in both primary PCa and bone metastases and regulate distinct and overlapping functions in PCa progression. We examined the antitumor effects of combined inhibition of these pathways. Materials and Methods: Src andIGF-1 receptor (IGF-1R) inhibition was achieved in vitro by short hairpin (sh) RNA and in vitro and in vivo by small molecule inhibitors (dasatinib and BMS-754807, against SFK and IGF-1R/Insulin Receptor(IR), respectively). Results: In vitro, inhibition of IGF-1 signaling affected cell survival and proliferation. SFK blockade alone had modest effects on proliferation, but significantly enhanced the IGF-1R blockade. These findings correlated with a robust inhibition of IGF-1-induced Akt1 phophorylation by dasatinib, whereas Akt2 phosphorylation was SFK independent and only inhibited by BMS-754807. Thus, complete inhibition of both Akt genes, not seen by either drug alone, is likely a major mechanism for the decreased survival of PCa cells. Furthermore, dasatinib and BMS-754807 inhibited in vivo growth of the primary human xenograft MDA PCa 133, with corresponding inhibition of Akt in tumors. Also, both orthotopic and intratibial tumor growth of PC-3 cells were more potently inhibited by dual SFK and IGF-1R/IR blockade compared to either pathway alone, with a corresponding decrease in bone turnover markers. Conclusions: Dual IGF-1R/IR and SFK inhibition may be a rational therapeutic approach in PCa by blocking both independent and complementary processes critical to tumor growth.	[Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Logothetis, Christopher J.; Gallick, Gary E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Logothetis, Christopher J.; Gallick, Gary E.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA; [Chatterji, Tanushree; Gallick, Gary E.] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Metastasis, Houston, TX USA; [Carboni, Joan M.; Gottardis, Marco M.] Bristol Myers Squibb Co, Dept Pharmaceut Candidate Org, Princeton, NJ USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Bristol-Myers Squibb	Gallick, GE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	ggallick@mdanderson.org	varkaris, andreas/AAS-4833-2020; Varkaris, Andreas/AAU-3262-2020; Dayyani, Farshid/CAF-8867-2022; Wolfe, Adam/AAF-1213-2019	Dayyani, Farshid/0000-0002-4970-5189; Wolfe, Adam/0000-0002-0123-7371; Maity, Sankar/0000-0002-2387-6545; Moorthy, Shhyam/0000-0003-3169-2719	United States National Institutes of Health [T32 CA009666, 1 P50 CA140388-01]; Prostate Cancer Foundation; NIH through MD Anderson's Cancer Center Support Grant [5 P30 CA016672-35]; Prostate Cancer Research Program grant at UTMDACC; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672, T32CA009666] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NIH through MD Anderson's Cancer Center Support Grant; Prostate Cancer Research Program grant at UTMDACC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	F.D. was supported by United States National Institutes of Health grant T32 CA009666; F.D., G.E.G., J.C.A., and C.J.L. were supported by 1 P50 CA140388-01; F.D., G.E.G., and C.J.L. were also supported from a grant by the Prostate Cancer Foundation. This work was also supported by the NIH through MD Anderson's Cancer Center Support Grant, 5 P30 CA016672-35. S.N.M. was supported by a Prostate Cancer Research Program grant at UTMDACC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JC, 2012, CANCER-AM CANCER SOC, V118, P63, DOI 10.1002/cncr.26204; Brownlow N, 2009, LEUKEMIA, V23, P590, DOI 10.1038/leu.2008.237; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Davies MA, 2002, CLIN CANCER RES, V8, P1904; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Desai J, 2010, J CLIN ONCOL S, V28, p15s, DOI DOI 10.1200/jco.2010.28.15_suppl.3104; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kim SJ, 2006, JNCI-J NATL CANCER I, V98, P783, DOI 10.1093/jnci/djj211; Kimura T, 2010, CLIN CANCER RES, V16, P121, DOI 10.1158/1078-0432.CCR-09-0982; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Maloney EK, 2003, CANCER RES, V63, P5073; Miyake H, 2000, ENDOCRINOLOGY, V141, P2257, DOI 10.1210/en.141.6.2257; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Paccez JD, 2013, ONCOGENE, V32, P689, DOI 10.1038/onc.2012.89; Papageorgiou E, 2008, MOL MED, V14, P403, DOI 10.2119/2008-00021.Papageorgiou; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rabbani SA, MOL CANC THER, V9, P1147; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Su AI, 2001, CANCER RES, V61, P7388; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yap TA, 2011, EXPERT OPIN INV DRUG, V20, P1293, DOI 10.1517/13543784.2011.602630; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	54	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51189	10.1371/journal.pone.0051189	http://dx.doi.org/10.1371/journal.pone.0051189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300537	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800012
J	Ren, J; Sun, JH; Zhang, YP; Liu, T; Ren, QZ; Li, Y; Guo, AK				Ren, Jing; Sun, Jinghan; Zhang, Yunpeng; Liu, Tong; Ren, Qingzhong; Li, Yan; Guo, Aike			Down-Regulation of Decapping Protein 2 Mediates Chronic Nicotine Exposure-Induced Locomotor Hyperactivity in Drosophila	PLOS ONE			English	Article							MESSENGER-RNA TURNOVER; LONG-TERM CHANGES; ADULT DROSOPHILA; MELANOGASTER; GENE; RECEPTORS; MODEL; BEHAVIOR; PATHWAY; ETHANOL	Long-term tobacco use causes nicotine dependence via the regulation of a wide range of genes and is accompanied by various health problems. Studies in mammalian systems have revealed some key factors involved in the effects of nicotine, including nicotinic acetylcholine receptors (nAChRs), dopamine and other neurotransmitters. Nevertheless, the signaling pathways that link nicotine-induced molecular and behavioral modifications remain elusive. Utilizing a chronic nicotine administration paradigm, we found that adult male fruit flies exhibited locomotor hyperactivity after three consecutive days of nicotine exposure, while nicotine-naive flies did not. Strikingly, this chronic nicotine-induced locomotor hyperactivity (cNILH) was abolished in Decapping Protein 2 or 1 (Dcp2 or Dcp1) -deficient flies, while only Dcp2-deficient flies exhibited higher basal levels of locomotor activity than controls. These results indicate that Dcp2 plays a critical role in the response to chronic nicotine exposure. Moreover, the messenger RNA (mRNA) level of Dcp2 in the fly head was suppressed by chronic nicotine treatment, and up-regulation of Dcp2 expression in the nervous system blocked cNILH. These results indicate that down-regulation of Dcp2 mediates chronic nicotine-exposure-induced locomotor hyperactivity in Drosophila. The decapping proteins play a major role in mRNA degradation; however, their function in the nervous system has rarely been investigated. Our findings reveal a significant role for the mRNA decapping pathway in developing locomotor hyperactivity in response to chronic nicotine exposure and identify Dcp2 as a potential candidate for future research on nicotine dependence.	[Ren, Jing; Liu, Tong; Ren, Qingzhong; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [Sun, Jinghan; Zhang, Yunpeng; Li, Yan; Guo, Aike] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	liyan@ibp.ac.cn; akguo@ion.ac.cn	Ren, Qingzhong/U-6833-2017; Zhang, Yunpeng/AAT-5139-2021	Ren, Qingzhong/0000-0001-9633-1477; Zhang, Yunpeng/0000-0001-6014-0193	973 Program [2011CBA00400]; National Science Foundation of China [30921064, 90820008, 31130027, 31070956, 91132709]; One Hundred Talents Project of the CAS [KSCX2-YW-R-156]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB02040100]	973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Project of the CAS; "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a 973 Program (Grant 2011CBA00400 to A.G.), the National Science Foundation of China (Grants 30921064, 90820008, and 31130027 to A.G., 31070956 and 91132709 to Y.L.), the One Hundred Talents Project of the CAS (KSCX2-YW-R-156 to Y.L.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences, grant No.XDB02040100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JL, 1993, J PHYSIOL-LONDON, V463, P605, DOI 10.1113/jphysiol.1993.sp019613; Asherson P, 2007, BRIT J PSYCHIAT, V190, P4, DOI 10.1192/bjp.bp.106.026484; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barik Jacques, 2009, Handb Exp Pharmacol, P173, DOI 10.1007/978-3-540-69248-5_7; Cavalieri C, 2010, FOOD ADDIT CONTAM A, V27, P473, DOI 10.1080/19440040903479768; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Cohen LS, 2005, MOL CELL BIOL, V25, P8779, DOI 10.1128/MCB.25.20.8779-8791.2005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Dwoskin LP, 1999, PSYCHOPHARMACOLOGY, V145, P442, DOI 10.1007/s002130051079; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Ferrari R, 2002, EUR J NEUROSCI, V15, P1810, DOI 10.1046/j.1460-9568.2001.02009.x; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hillebrand J, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00121; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; Huang WH, 2009, INT J NEUROPSYCHOPH, V12, P537, DOI 10.1017/S1461145708009528; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; KLEIN E, 1992, BIOL PSYCHIAT, V31, P279, DOI 10.1016/0006-3223(92)90051-Z; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Li MD, 2002, MOL NEUROBIOL, V25, P265, DOI 10.1385/MN:25:3:265; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; McCarthy MJ, 2012, PSYCHOPHARMACOLOGY, V221, P143, DOI 10.1007/s00213-011-2559-y; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpot RM, 2012, BEHAV BRAIN RES, V230, P62, DOI 10.1016/j.bbr.2012.01.036; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Sellier MJ, 2011, CHEM SENSES, V36, P323, DOI 10.1093/chemse/bjq133; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trauth JA, 2001, BRAIN RES, V892, P269, DOI 10.1016/S0006-8993(00)03227-3; Trimarchi JR, 1997, J NEUROSCI, V17, P4700; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Wang Ju, 2011, Front Psychiatry, V2, P5, DOI 10.3389/fpsyt.2011.00005; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhu HW, 2005, BIOL PSYCHIAT, V58, P981, DOI 10.1016/j.biopsych.2005.05.026	55	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52521	10.1371/journal.pone.0052521	http://dx.doi.org/10.1371/journal.pone.0052521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300696	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800100
J	Roopin, M; Levy, O				Roopin, Modi; Levy, Oren			Melatonin Distribution Reveals Clues to Its Biological Significance in Basal Metazoans	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PINEAL MELATONIN; OXIDATIVE STRESS; PHYLUM CNIDARIA; NERVOUS-SYSTEM; HORMONE; IDENTIFICATION; CHROMATOGRAPHY; NEUROPEPTIDES; ANTIOXIDANT	Although nearly ubiquitous in nature, the precise biological significance of endogenous melatonin is poorly understood in phylogenetically basal taxa. In the present work, we describe insights into the functional role of melatonin at the most "basal" level of metazoan evolution. Hitherto unknown morphological determinants of melatonin distribution were evaluated in Nematostella vectensis by detecting melatonin immunoreactivity and examining the spatial gene expression patterns of putative melatonin biosynthetic and receptor elements that are located at opposing ends of the melatonin signaling pathway. Immuno-melatonin profiling indicated an elaborate interaction with reproductive tissues, reinforcing previous conjectures of a melatonin-responsive component in anthozoan reproduction. In situ hybridization (ISH) to putative melatonin receptor elements highlighted the possibility that the bioregulatory effects of melatonin in anthozoan reproduction may be mediated by interactions with membrane receptors, as in higher vertebrates. Another intriguing finding of the present study pertains to the prevalence of melatonin in centralized nervous structures. This pattern may be of great significance given that it 1) identifies an ancestral association between melatonin and key neuronal components and 2) potentially implies that certain effects of melatonin in basal species may be spread widely by regionalized nerve centers.	[Roopin, Modi; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Roopin, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	modiroopin@gmail.com			PADI Foundation [159]; Israeli Science Foundation [243/10]	PADI Foundation; Israeli Science Foundation(Israel Science Foundation)	This study was funded by a PADI Foundation grant to MR, Req No. 159 (2009), and an Israeli Science Foundation (No. 243/10) grant to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Antolin I, 1997, J PINEAL RES, V23, P182, DOI 10.1111/j.1600-079X.1997.tb00353.x; BRAINARD GC, 1982, NEUROENDOCRINOLOGY, V35, P342, DOI 10.1159/000123405; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Cary GA, 2012, COMP BIOCHEM PHYS A, V161, P355, DOI 10.1016/j.cbpa.2011.12.005; Collin F, 2009, J MASS SPECTROM, V44, P318, DOI 10.1002/jms.1508; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7; GRIMMELIKHUIJZEN CJP, 1983, HISTOCHEMISTRY, V78, P361, DOI 10.1007/BF00496623; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; GRIMMELIKHUIJZEN CJP, 1991, HYDROBIOLOGIA, V216, P555, DOI 10.1007/BF00026513; Hardeland R, 1999, REPROD NUTR DEV, V39, P399, DOI 10.1051/rnd:19990311; Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x; Hardeland R, 2008, CELL MOL LIFE SCI, V65, P2001, DOI 10.1007/s00018-008-8001-x; Hardeland R, 1996, TREND COMPAR BIOCHEM, V2, P25; Hardeland R., 2008, OPEN PHYSL J, V1, P1, DOI DOI 10.2174/1874360900901010001; Hardeland R., 2007, FUNCT PLANT SCI BIOT, V1, P32; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; LEROITH D, 1986, RECENT PROG HORM RES, V42, P549; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Mechawar N, 1997, J COMP NEUROL, V387, P243; Odorico DM, 1997, P ROY SOC B-BIOL SCI, V264, P77, DOI 10.1098/rspb.1997.0011; PANTIN CFA, 1952, PROC R SOC SER B-BIO, V140, P147, DOI 10.1098/rspb.1952.0052; Pape C, 1999, STUDIES ANTIOXIDANTS, P28; Parker GH, 1919, ELEMENTARY NERVOUS S, P1; Pernet V, 2004, J COMP NEUROL, V472, P208, DOI 10.1002/cne.20108; Pevet P, 2006, CHRONOBIOL INT, V23, P39, DOI 10.1080/07420520500482074; Reiter RJ, 2007, ADV MED SCI-POLAND, V52, P11; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; REITER RJ, 1974, CHRONOBIOLOGIA, V1, P365; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; ROLLAG MD, 1980, P SOC EXP BIOL MED, V165, P330, DOI 10.3181/00379727-165-40981; Roopin M, 2012, J PINEAL RES, V53, P259, DOI 10.1111/j.1600-079X.2012.00994.x; Sato S, 2008, J PHYSIOL SCI, V58, P317, DOI 10.2170/physiolsci.RP006208; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; Tan DX, 2003, J PINEAL RES, V34, P75, DOI 10.1034/j.1600-079X.2003.02111.x; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; VIVIENROELS B, 1993, EXPERIENTIA, V49, P642, DOI 10.1007/BF01923945; VIVIENROELS B, 1984, NEUROSCI LETT, V49, P153, DOI 10.1016/0304-3940(84)90152-6; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Wurtman R J, 1968, Adv Pharmacol, V6, P141; Yang SM, 2002, J PHARMACEUT BIOMED, V30, P781, DOI 10.1016/S0731-7085(02)00387-4; Yasuo S, 2009, INTEGR COMP BIOL, V49, P507, DOI 10.1093/icb/icp011	54	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52266	10.1371/journal.pone.0052266	http://dx.doi.org/10.1371/journal.pone.0052266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300630	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800063
J	Wei, PL; Liu, SP; Keller, JJ; Lin, HC				Wei, Po-Li; Liu, Shih-Ping; Keller, Joseph J.; Lin, Herng-Ching			Volume-Outcome Relation for Acute Appendicitis: Evidence from a Nationwide Population-Based Study	PLOS ONE			English	Article							HOSPITAL VOLUME; PERFORATED APPENDICITIS; NEGATIVE APPENDECTOMY; SURGICAL MORTALITY; UNITED-STATES; ASIAN COUNTRY; IMPACT; RATES; RISK; ASSOCIATION	Background: Although procedures like appendectomy have been studied extensively, the relative importance of each surgeon's surgical volume-to-ruptured appendicitis has not been explored. The purpose of this study was to investigate the rate of ruptured appendicitis by surgeon-volume groups as a measure of quality of care for appendicitis by using a nationwide population-based dataset. Methods: We identified 65,339 first-time hospitalizations with a discharge diagnosis of acute appendicitis (International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes 540, 540.0, 540.1 and 540.9) between January 2007 and December 2009. We used "whether or not a patient had a perforated appendicitis'' as the outcome measure. A conditional (fixed-effect) logistic regression model was performed to explore the odds of perforated appendicitis among surgeon case volume groups. Results: Patients treated by low-volume surgeons had significantly higher morbidity rates than those treated by high-volume (28.1% vs. 26.15, p < 0.001) and very-high-volume surgeons (28.1% vs. 21.4%, p < 0.001). After adjusting for surgeon practice location, and teaching status of practice hospital, and patient age, gender, and Charlson Comorbidity Index, and hospital acute appendicitis volume, patients treated by low-volume surgeons had significantly higher rates of perforated appendicitis than those treated by medium-volume surgeons (OR = 1.09, p < 0.001), high-volume surgeons (OR = 1.16, p < 0.001), or very-high-volume surgeons (OR = 1.54, p < 0.001). Conclusion: Our study suggested that surgeon volume is an important factor with regard to the rate of ruptured appendicitis.	[Wei, Po-Li] Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Dept Surg, Sch Med, Coll Med, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Keller, Joseph J.] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Al-Omran M, 2003, CAN J SURG, V46, P263; Andersson RE, 2007, WORLD J SURG, V31, P86, DOI 10.1007/s00268-006-0056-y; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Camp M, 2010, ARCH SURG-CHICAGO, V145, P1139, DOI 10.1001/archsurg.2010.271; Ditillo MF, 2006, ANN SURG, V244, P656, DOI 10.1097/01.sla.0000231726.53487.dd; Fuchs JR, 2002, J SURG RES, V106, P131, DOI 10.1006/jsre.2002.6441; Hale DA, 1997, ANN SURG, V225, P252, DOI 10.1097/00000658-199703000-00003; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Lien WC, 2011, WORLD J SURG, V35, P1636, DOI 10.1007/s00268-011-1132-5; Lien YC, 2007, ANN THORAC SURG, V83, P1837, DOI 10.1016/j.athoracsur.2006.12.008; Lin HC, 2006, ANN SURG ONCOL, V13, P1182, DOI 10.1245/s10434-006-9005-0; Nallamothu BK, 2005, ARCH INTERN MED, V165, P333, DOI 10.1001/archinte.165.3.333; NITECKI S, 1990, SURG GYNECOL OBSTET, V171, P185; Paquette IM, 2011, ANN SURG, V253, P534, DOI 10.1097/SLA.0b013e3182096d68; Pittman-Waller VA, 2000, AM SURGEON, V66, P548; Ponsky TA, 2004, JAMA-J AM MED ASSOC, V292, P1977, DOI 10.1001/jama.292.16.1977; Smink DS, 2005, PEDIATRICS, V115, P920, DOI 10.1542/peds.2004-1363; Welke KF, 2009, ANN THORAC SURG, V87, P216, DOI 10.1016/j.athoracsur.2008.10.032; Wen HC, 2006, ANN THORAC SURG, V81, P835, DOI 10.1016/j.athoracsur.2005.09.031; WILLIAMS GR, 1983, ANN SURG, V197, P495, DOI 10.1097/00000658-198305000-00001; Williams NMA, 1998, ANN ROY COLL SURG, V80, P122	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52539	10.1371/journal.pone.0052539	http://dx.doi.org/10.1371/journal.pone.0052539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300703	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800104
J	Xu, B; Sathitsuksanoh, N; Tang, YH; Udvardi, MK; Zhang, JY; Shen, ZX; Balota, M; Harich, K; Zhang, PYH; Zhao, BY				Xu, Bin; Sathitsuksanoh, Noppadon; Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi; Shen, Zhengxing; Balota, Maria; Harich, Kim; Zhang, Percival Y-H; Zhao, Bingyu			Overexpression of AtLOV1 in Switchgrass Alters Plant Architecture, Lignin Content, and Flowering Time	PLOS ONE			English	Article							FERMENTABLE SUGAR YIELDS; ZINC-FINGER PROTEIN; TRANSCRIPTION-FACTOR; TRANSLATIONAL GENOMICS; PANICUM-VIRGATUM; GENE ENCODES; BIOENERGY PRODUCTION; BIOMASS YIELD; ARABIDOPSIS; BIOSYNTHESIS	Background: Switchgrass (Panicum virgatum L.) is a prime candidate crop for biofuel feedstock production in the United States. As it is a self-incompatible polyploid perennial species, breeding elite and stable switchgrass cultivars with traditional breeding methods is very challenging. Translational genomics may contribute significantly to the genetic improvement of switchgrass, especially for the incorporation of elite traits that are absent in natural switchgrass populations. Methodology/Principal Findings: In this study, we constitutively expressed an Arabidopsis NAC transcriptional factor gene, LONG VEGETATIVE PHASE ONE (AtLOV1), in switchgrass. Overexpression of AtLOV1 in switchgrass caused the plants to have a smaller leaf angle by changing the morphology and organization of epidermal cells in the leaf collar region. Also, overexpression of AtLOV1 altered the lignin content and the monolignol composition of cell walls, and caused delayed flowering time. Global gene-expression analysis of the transgenic plants revealed an array of responding genes with predicted functions in plant development, cell wall biosynthesis, and flowering. Conclusions/Significance: To our knowledge, this is the first report of a single ectopically expressed transcription factor altering the leaf angle, cell wall composition, and flowering time of switchgrass, therefore demonstrating the potential advantage of translational genomics for the genetic improvement of this crop.	[Xu, Bin; Shen, Zhengxing; Zhao, Bingyu] Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA; [Sathitsuksanoh, Noppadon; Zhang, Percival Y-H] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA; [Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Balota, Maria] Virginia Tech, Dept Plant Pathol Plant Physiol & Weed Sci, Blacksburg, VA USA; [Harich, Kim] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi] US DOE, BESC BioEnergy Sci Ctr, Ardmore, OK USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Noble Research Institute; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Zhao, BY (corresponding author), Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA.	bzhao07@vt.edu	sathitsuksanoh, noppadon/O-6305-2014; Udvardi, Michael/GPX-4653-2022	sathitsuksanoh, noppadon/0000-0003-1521-9155; Udvardi, Michael/0000-0001-9850-0828; Tang, Yuhong/0000-0003-2967-778X	Department of Energy [DE-FG02-08ER64629]; Institute for Critical Technology and Applied Science at Virginia Tech; Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech; Virginia Agricultural Experimental Station [VA135872]; College of Agriculture and Life Sciences at Virginia Tech; Department of Energy through the BioEnergy Science Center	Department of Energy(United States Department of Energy (DOE)); Institute for Critical Technology and Applied Science at Virginia Tech; Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech; Virginia Agricultural Experimental Station; College of Agriculture and Life Sciences at Virginia Tech; Department of Energy through the BioEnergy Science Center(United States Department of Energy (DOE))	This work was supported by grants from the Department of Energy (DE-FG02-08ER64629), the Institute for Critical Technology and Applied Science at Virginia Tech, the Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech, the Virginia Agricultural Experimental Station (VA135872). This activity was funded, in part, with an integrated, internal competitive grant from the College of Agriculture and Life Sciences at Virginia Tech. It was also supported by Department of Energy through the BioEnergy Science Center to M. Udvardi, Y. Tang and J.-Y. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Boateng AA, 2008, IND ENG CHEM RES, V47, P4115, DOI 10.1021/ie800096g; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Bush DR, 2007, PLANT CELL, V19, P2971, DOI 10.1105/tpc.107.191040; Candela H, 2008, PLANT CELL, V20, P2073, DOI 10.1105/tpc.108.059709; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Century K, 2008, PLANT PHYSIOL, V147, P20, DOI 10.1104/pp.108.117887; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chiang VL, 2006, ENVIRON CHEM LETT, V4, P143, DOI 10.1007/s10311-006-0067-9; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Eckardt NA, 2010, PLANT CELL, V22, P2103, DOI 10.1105/tpc.110.220710; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jensen MK, 2010, PLANT SIGNAL BEHAV, V5, P907, DOI 10.4161/psb.5.7.12099; Kang Y, 2011, PLANT J; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Lawrence CJ, 2007, PLANT CELL, V19, P2091, DOI 10.1105/tpc.107.053660; Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9; Madakadze IC, 1998, BIOMASS BIOENERG, V15, P475, DOI 10.1016/S0961-9534(98)00060-9; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Mosesson Y, 2009, DEV CELL, V16, P687, DOI 10.1016/j.devcel.2009.03.015; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Rastogi S, 2008, PLANT SCI, V174, P264, DOI 10.1016/j.plantsci.2007.11.014; Reguera M, 2011, BIOCH BIOPHYS ACTA; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Salentijn EMJ, 2007, MOL BREEDING, V20, P1, DOI 10.1007/s11032-006-9069-3; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Sinclair TR, 1999, SCIENCE, V283, P1456; Sluiter A, 2004, DETERMINATION STRUCT; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tesso T, 2011, FIELD CROP RES, V120, P271, DOI 10.1016/j.fcr.2010.10.015; Tobias CM, 2005, THEOR APPL GENET, V111, P956, DOI 10.1007/s00122-005-0030-3; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Van Esbroeck GA, 1998, CROP SCI, V38, P342, DOI 10.2135/cropsci1998.0011183X003800020010x; VanEsbroeck GA, 1997, CROP SCI, V37, P864, DOI 10.2135/cropsci1997.0011183X003700030028x; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Wang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003521; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu B, 2011, SCI HORTIC-AMSTERDAM, V129, P854, DOI 10.1016/j.scienta.2011.05.016; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	70	35	36	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e47399	10.1371/journal.pone.0047399	http://dx.doi.org/10.1371/journal.pone.0047399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300513	Green Published, gold			2022-12-25	WOS:000313618800002
J	Yin, J; Shine, L; Raycroft, F; Deeti, S; Reynolds, A; Ackerman, KM; Glaviano, A; O'Farrell, S; O'Leary, O; Kilty, C; Kennedy, C; McLoughlin, S; Rice, M; Russell, E; Higgins, DG; Hyde, DR; Kennedy, BN				Yin, Jun; Shine, Lisa; Raycroft, Francis; Deeti, Sudhakar; Reynolds, Alison; Ackerman, Kristin M.; Glaviano, Antonino; O'Farrell, Sean; O'Leary, Olivia; Kilty, Claire; Kennedy, Ciaran; McLoughlin, Sarah; Rice, Megan; Russell, Eileen; Higgins, Desmond G.; Hyde, David R.; Kennedy, Breandan N.			Inhibition of the Pim1 Oncogene Results in Diminished Visual Function	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; GENE-EXPRESSION; PROTOONCOGENE PIM-1; JAK/STAT PATHWAY; SWISS-MODEL; C-MYC; ZEBRAFISH; MUTATIONS; KINASE; ROLES	Our objective was to profile genetic pathways whose differential expression correlates with maturation of visual function in zebrafish. Bioinformatic analysis of transcriptomic data revealed Jak-Stat signalling as the pathway most enriched in the eye, as visual function develops. Real-time PCR, western blotting, immunohistochemistry and in situ hybridization data confirm that multiple Jak-Stat pathway genes are up-regulated in the zebrafish eye between 3-5 days post-fertilisation, times associated with significant maturation of vision. One of the most up-regulated Jak-Stat genes is the proto-oncogene Pim1 kinase, previously associated with haematological malignancies and cancer. Loss of function experiments using Pim1 morpholinos or Pim1 inhibitors result in significant diminishment of visual behaviour and function. In summary, we have identified that enhanced expression of Jak-Stat pathway genes correlates with maturation of visual function and that the Pim1 oncogene is required for normal visual function.	[Yin, Jun; Higgins, Desmond G.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland; [Shine, Lisa; Deeti, Sudhakar; Reynolds, Alison; Glaviano, Antonino; O'Farrell, Sean; O'Leary, Olivia; Kilty, Claire; Kennedy, Ciaran; McLoughlin, Sarah; Rice, Megan; Russell, Eileen; Kennedy, Breandan N.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin 4, Ireland; [Raycroft, Francis; Ackerman, Kristin M.; Hyde, David R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raycroft, Francis; Ackerman, Kristin M.; Hyde, David R.] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA	University College Dublin; University College Dublin; University of Notre Dame; University of Notre Dame	Kennedy, BN (corresponding author), Natl Univ Ireland Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019; Yin, Jun/A-7502-2010	kennedy, Breandan/0000-0001-7991-4689; Yin, Jun/0000-0003-4543-1229; Kennedy, Ciaran/0000-0003-1967-8754; wang, jun/0000-0002-0926-4761; Reynolds, Alison/0000-0002-3147-0094; Higgins, Des/0000-0002-3952-3285	Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP); Science Foundation Ireland (SFI) [SFI 04/IN3/B559, SFI 06/RFP/BIM052]	Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors thank the Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP), and Science Foundation Ireland (SFI) SFI 04/IN3/B559 (BK), and SFI 06/RFP/BIM052 (BK) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KM, 2009, DEV DYNAM, V238, P980, DOI 10.1002/dvdy.21912; Adachi M, 1998, LEUKEMIA LYMPHOMA, V30, P483, DOI 10.3109/10428199809057561; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; Blanco-Aparicio C, 2010, CANC LETT; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chiang WF, 2006, INT J ORAL MAX SURG, V35, P740, DOI 10.1016/j.ijom.2006.01.027; Daiger S., 1998, INVESTIG OPHTHALMOL, V39; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ding C, 2011, MOL MICROBIOL; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Ebong S, 2004, MOL VIS, V10, P122; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; EMRAN F, 2008, J VIS EXP; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffith AJ, 2000, ARCH OTOLARYNGOL, V126, P891, DOI 10.1001/archotol.126.7.891; Grosdidier A, 2011, NUCL ACIDS RES; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Houlden H, 2003, NEUROLOGY, V61, P1423, DOI 10.1212/01.WNL.0000094120.09977.92; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Long AA, 2010, J CELL SCI, V123, P3303, DOI 10.1242/jcs.069468; Losman J, 1999, COLD SPRING HARB SYM, V64, P405, DOI 10.1101/sqb.1999.64.405; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; McAlinden A, 2008, HUM MUTAT, V29, P83, DOI 10.1002/humu.20603; Merkel Anna Lena, 2012, Expert Opin Investig Drugs, V21, P425, DOI 10.1517/13543784.2012.668527; Ozawa Y, 2007, DEV BIOL, V303, P591, DOI 10.1016/j.ydbio.2006.11.032; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rajan P, 1996, J NEUROSCI RES, V43, P403, DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-J; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Rhee KD, 2003, MOL VIS, V9, P715; Saszik S, 1999, VISUAL NEUROSCI, V16, P881, DOI 10.1017/S0952523899165076; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-50; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	72	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52177	10.1371/journal.pone.0052177	http://dx.doi.org/10.1371/journal.pone.0052177			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300608	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800052
J	Zou, SL; Ren, PP; Nguyen, M; Coselli, JS; Shen, YH; LeMaire, SA				Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.			Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; ENDOTHELIAL PROGENITOR CELLS; FACTOR-BETA; DEPENDENT PATHWAY; STEM-CELLS; IN-VITRO; DIFFERENTIATION; ACTIVATION; PHENOTYPE; DISEASE	Background: Descending thoracic aortic aneurysm and dissection (DTAAD) is characterized by progressive medial degeneration, which may result from excessive tissue destruction and insufficient repair. Resistance to tissue destruction and aortic self-repair are critical in preventing medial degeneration. The signaling pathways that control these processes in DTAAD are poorly understood. Because Notch signaling is a critical pathway for cell survival, proliferation, and tissue repair, we examined its activation in DTAAD. Methods: We studied descending thoracic aortic tissue from patients with sporadic thoracic aortic aneurysm (TAA; n = 14) or chronic thoracic aortic dissection (TAD; n = 16) and from age-matched organ donors (n = 12). Using western blot, real-time RT-PCR, and immunofluorescence staining, we examined aortic tissue samples for the Notch ligands Delta-like 1, Delta-like 4 (DLL1/4), and Jagged1; the Notch receptor 1 (Notch1); the Notch1 intracellular domain (NICD); and Hes1, a downstream target of Notch signaling. Results: Western blots and RT-PCR showed higher levels of the Notch1 protein and mRNA and the NICD and Hes1 proteins in both TAA and TAD tissues than in control tissue. However, immunofluorescence staining showed a complex pattern of Notch signaling in the diseased tissue. The ligand DLL1/4 and Notch1 were significantly decreased and NICD and Hes1 were rarely detected in medial vascular smooth muscle cells (VSMCs) in both TAA and TAD tissues, indicating downregulation of Notch signaling in aortic VSMCs. Interestingly Jagged1, NICD, and Hes1 were highly present in CD34+ stem cells and Stro-1+ stem cells in aortas from TAA and TAD patients. NICD and Hes1 were also detected in most fibroblasts and macrophages that accumulated in the aortic wall of DTAAD patients. Conclusions: Notch signaling exhibits a complex pattern in DTAAD. The Notch pathway is impaired in medial VSMCs but activated in stem cells, fibroblasts, and macrophages.	[Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA; [Zou, Sili; Ren, Pingping; Nguyen, Mary; Coselli, Joseph S.; Shen, Ying H.; LeMaire, Scott A.] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Surg, Houston, TX USA; [Zou, Sili] Second Mil Med Univ, Changhai Hosp, Dept Vasc Surg, Shanghai, Peoples R China	Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute; Naval Medical University	Shen, YH (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA.	hyshen@bcm.edu; slemaire@bcm.edu	shen, ying/HHS-5635-2022	LeMaire, Scott/0000-0002-8736-4266	Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections [NIH P50 HL083794];  [R01 HL085341]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085341, P50HL083794] Funding Source: NIH RePORTER	Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grant R01 HL085341 (to S.A.L.). The Thoracic Aortic Disease Tissue Bank at Baylor College of Medicine was supported in part through the Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections (NIH P50 HL083794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Barbour JR, 2007, J SURG RES, V139, P292, DOI 10.1016/j.jss.2006.09.020; Biros E, 2012, ATHEROSCLEROSIS, V221, P383, DOI 10.1016/j.atherosclerosis.2012.01.004; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Collins MJ, 2008, J CLIN PATHOL, V61, P519, DOI 10.1136/jcp.2006.046250; Dawson J, 2006, ANN NY ACAD SCI, V1085, P327, DOI 10.1196/annals.1383.011; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Kiparissides A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014668; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lawson ND, 2001, DEVELOPMENT, V128, P3675; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Parietti E, 2011, EUR J CARDIO-THORAC, V40, pE6, DOI 10.1016/j.ejcts.2011.02.065; Piggott K, 2011, CIRCULATION, V123, P309, DOI 10.1161/CIRCULATIONAHA.110.936203; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sciacca S., 2012, HEART VESSELS; Shen YH, 2012, ANN THORAC SURG, V93, P1524, DOI 10.1016/j.athoracsur.2012.01.063; Sho E, 2004, ARTERIOSCL THROM VAS, V24, P1916, DOI 10.1161/01.ATV.0000142805.20398.74; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stewart KS, 2011, BLOOD, V117, P719, DOI 10.1182/blood-2010-05-284869; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yamanouchi D, 2010, ARTERIOSCL THROM VAS, V30, P702, DOI 10.1161/ATVBAHA.109.200527; Yang K, 2011, J BIOL CHEM, V286, P13741, DOI 10.1074/jbc.M110.181842	46	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52833	10.1371/journal.pone.0052833	http://dx.doi.org/10.1371/journal.pone.0052833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300792	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800157
J	Rocha, MR; Vasseur, DA; Gaedke, U				Rocha, Marcia R.; Vasseur, David A.; Gaedke, Ursula			Seasonal Variations Alter the Impact of Functional Traits on Plankton Dynamics	PLOS ONE			English	Article							COMPENSATORY DYNAMICS; CLEAR-WATER; PHYTOPLANKTON; PATTERNS; LIGHT; TEMPERATURE; SIMILARITY; DIVERSITY	Gaining understanding of food-web processes often requires a simplified representation of natural diversity. One such simplification can be based on functional traits, as functionally similar species may provide a similar contribution to ecosystem level-processes. However, understanding how similarity in functional traits actually translates into similar contributions to ecosystem-level properties remains a challenge due to the complex ways in which traits can influence species' dynamics. Moreover, in many communities, seasonality alters the abiotic and biotic forcing regime, causing ongoing changes to patterns of species' dominance; groups of species do not stay intact but are rather continuously subjected to changes throughout the year. Using long-term high frequency measurements of phytoplankton in Lake Constance, we investigated the effect of seasonal changes on the relationship between functional similarity and temporal dynamics similarity of 36 morphotypes, and the relative contribution of different functional traits during the different parts of the year. Our results revealed seasonal differences in the overall degree of synchronization of morphotypes' temporal dynamics and how combinations of functional traits influence the relationship between functional trait similarity and temporal dynamics similarity, showing that different forcing regimes change how species cope with their environment based on their functional traits. Moreover, we show that the individual functional traits matter at different periods of the year indicating that species which are dynamically similar at certain parts of the year may not be at others. The differential strength of the overall and individual impact of functional traits on species' temporal dynamics makes the cohesion of a pair of functionally similar species dependent on the different forcing. Hence, simplifying food webs based solely on functional traits may not provide consistent estimates of functional groups over all seasons.	[Rocha, Marcia R.; Gaedke, Ursula] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of Potsdam; Yale University	Gaedke, U (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	gaedke@uni-potsdam.de		Vasseur, David/0000-0003-1706-9613	Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG)	Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	M.R. was partly funded by the Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE. D.A.V. was supported by a fellowship from the Alexander von Humboldt Foundation. Data acquisition was performed by a large team of scientists within the Special Collaborative Program (SFB) 248 "Cycling of Matter in Lake Constance'' supported by Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-de-Souza C, 2008, J PLANKTON RES, V30, P1233, DOI 10.1093/plankt/fbn079; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247; Gaedke U., 1998, ARCH HYDROBIOL SPEC, V53, P119; Gaedke Ursula, 1998, Advances in Limnology, V53, P565; GASOL JM, 1995, J PLANKTON RES, V17, P1879, DOI 10.1093/plankt/17.10.1879; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hase C., 1998, ARCH HYDROBIOL SPEC, V53, P159; HAWES I, 1990, J PLANKTON RES, V12, P513, DOI 10.1093/plankt/12.3.513; Hendriks AJ, 2007, ECOL MODEL, V205, P196, DOI 10.1016/j.ecolmodel.2007.02.029; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huber V, 2006, OIKOS, V114, P265, DOI 10.1111/j.2006.0030-1299.14753.x; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.2307/176991; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LAMPERT W, 1978, ARCH HYDROBIOL, V82, P364; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lee RE, 1999, PHYCOLOGY; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Luczkovich JJ, 2003, J THEOR BIOL, V220, P303, DOI 10.1006/jtbi.2003.3147; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; R Development Core Team, 2007, R LANG ENV STAT COMP; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; Rocha MR, 2011, J ECOL, V99, P1453, DOI 10.1111/j.1365-2745.2011.01893.x; Rocha MR, 2011, OIKOS, V120, P17, DOI 10.1111/j.1600-0706.2010.18786.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stuber K, 1998, THESIS U KONSTANZ GE; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; Tirok K, 2006, J PLANKTON RES, V28, P361, DOI 10.1093/plankt/fbi121; Vasseur DA, 2005, OIKOS, V110, P507, DOI 10.1111/j.0030-1299.2005.14006.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Weithoff G, 2003, FRESHWATER BIOL, V48, P1669, DOI 10.1046/j.1365-2427.2003.01116.x; Yodzis P, 1999, OIKOS, V87, P327, DOI 10.2307/3546748	35	9	9	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51257	10.1371/journal.pone.0051257	http://dx.doi.org/10.1371/journal.pone.0051257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23300539	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200077
J	Moison, C; Senamaud-Beaufort, C; Fourriere, L; Champion, C; Ceccaldi, A; Lacomme, S; Daunay, A; Tost, J; Arimondo, PB; Guieysse-Peugeot, AL				Moison, Celine; Senamaud-Beaufort, Catherine; Fourriere, Lou; Champion, Christine; Ceccaldi, Alexandre; Lacomme, Stephanie; Daunay, Antoine; Tost, Joerg; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure			DNA methylation associated with polycomb repression in retinoic acid receptor beta silencing	FASEB JOURNAL			English	Article						prostate cancer; epigenetic silencing; tumor supressor gene; DNA hypermethylation; EZH2	BREAST-CANCER CELLS; GROUP PROTEIN EZH2; PROSTATE-CANCER; TARGET GENES; CARCINOMA-CELLS; GROWTH ARREST; EXPRESSION; CHROMATIN; ISOFORM; HYPERMETHYLATION	Retinoic acid receptor beta 2 (RAR beta 2) is a tumor suppressor gene whose loss of expression is recurrent in prostate cancers. Here we studied the epigenetic mechanisms leading to its stable silencing. First, we characterized all RAR beta isoforms in 6 human tumor cell lines (prostate DU145, LNCaP, PC3, lung A549, breast Hs578T, and colon HCT116) by RT-PCR and Western blot. We excluded loss of heterozygosity (2D-FISH) and loss of RARa expression, an upstream regulator, as origin of RAR beta 2 silencing. All data concluded to an epigenetic silencing. In agreement, a DNA methylation inhibitor restored its expression. Second RAR beta 2 loss of expression was found associated with different epigenetic profiles in LNCaP and DU145 cells. According to bisulfite sequencing and ChIP analysis, we observed heavy methylation (97%) of the RAR beta 2 promoter with repressive histone mark H3K9me3 in LNCaP. While DNA methylation and polycomb repression are described to be mutually exclusive at CpG-rich promoters, we observed that in DU145, moderate DNA methylation (36%) and H3K9me3 mark were present concomitantly with H3K27me3, a signature of polycomb repression. In summary, we provide new insights on how the RAR beta 2 promoter is silenced, reveal the existence of two distinct repressive chromatin profiles at the same locus, and support a polycomb-mediated epigenetic repression process in prostate cancer.-Moison, C., Senamaud-Beaufort, C., Fourriere, L., Champion, C., Ceccaldi, A., Lacomme, S., Daunay, A., Tost, J. Arimondo, P. B., Guieysse-Peugeot, A.-L. DNA methylation associated with polycomb repression in retinoic acid receptor beta silencing. FASEB J. 27, 1468-1478 (2013). www.fasebj.org	[Moison, Celine; Arimondo, Paola B.] CRDPF, CNRS Pierre Fabre, USR ETaC 3388, F-31100 Toulouse, France; [Moison, Celine; Senamaud-Beaufort, Catherine; Fourriere, Lou; Champion, Christine; Ceccaldi, Alexandre; Guieysse-Peugeot, Anne-Laure] Museum Natl Hist Nat, CNRS, UMR7196, Paris, France; [Moison, Celine; Senamaud-Beaufort, Catherine; Fourriere, Lou; Champion, Christine; Ceccaldi, Alexandre; Guieysse-Peugeot, Anne-Laure] INSERM, U565, Paris, France; [Moison, Celine; Fourriere, Lou; Champion, Christine; Ceccaldi, Alexandre] Univ Paris 06, Paris, France; [Lacomme, Stephanie] Hop Cent, Ctr Ressources Biol, Serv Anat & Cytol Pathol, Nancy, France; [Daunay, Antoine; Tost, Joerg] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, Lab Funct Genom, F-75010 Paris, France; [Tost, Joerg] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet, Evry, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Nancy; Foundation Jean Dausset-CEPH; CEA; UDICE-French Research Universities; Universite Paris Saclay	Arimondo, PB (corresponding author), CRDPF, CNRS Pierre Fabre, USR ETaC 3388, 3 Ave Hubert Curien, F-31100 Toulouse, France.	paola.arimondo@etac.cnrs.fr; guieysse@mnhn.fr	Arimondo, Paola B/R-9095-2017; Tost, Joerg/H-7129-2019	Arimondo, Paola B/0000-0001-5175-4396; Tost, Joerg/0000-0002-2683-0817	Agence Nationale de la Recherche [ANR-06 JCJCJ-0080]; Ministry of Education, Research, and Technology; Institut National de la Sante et de la Recherche Medicale-Centre National de la Recherche Scientifique Bourse de Doctorat pour Ingenieurs; ARC	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministry of Education, Research, and Technology; Institut National de la Sante et de la Recherche Medicale-Centre National de la Recherche Scientifique Bourse de Doctorat pour Ingenieurs; ARC(Australian Research Council)	The authors acknowledge the Service d'Anatomie et Cytologie Pathologiques des Hopitaux de Toulouse for the tumor samples. The authors thank Helene Gondelle and Jean Ollion for technical help in FISH experiments and Laurent Lacroix, Christophe Escude, Loic Ponger, and Pierre-Antoine Defossez for helpful discussions. This work was supported by Agence Nationale de la Recherche (ANR-06 JCJCJ-0080) and Region Midi-Pyrenees. C. M. was the recipient of a Ministry of Education, Research, and Technology fellowship, C. C. of an Institut National de la Sante et de la Recherche Medicale-Centre National de la Recherche Scientifique Bourse de Doctorat pour Ingenieurs, and A.C. of an ARC fellowship. The authors declare no conflicts of interest.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; Berezovska OP, 2006, CELL CYCLE, V5, P1886; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Bovenzi V, 1999, ANTI-CANCER DRUG, V10, P471, DOI 10.1097/00001813-199906000-00007; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen LI, 2002, J BIOL CHEM, V277, P35411, DOI 10.1074/jbc.M202717200; Cote S, 1997, ANTI-CANCER DRUG, V8, P56; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; HOULE B, 1994, CANCER RES, V54, P365; HOULE B, 1993, P NATL ACAD SCI USA, V90, P985, DOI 10.1073/pnas.90.3.985; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Karamouzis MV, 2007, CELL ONCOL, V29, P183; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; LaTulippe E, 2002, CANCER RES, V62, P4499; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu Y, 1996, MOL CELL BIOL, V16, P1138; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; NAGPAL S, 1992, P NATL ACAD SCI USA, V89, P2718, DOI 10.1073/pnas.89.7.2718; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peng XJ, 2004, CANCER RES, V64, P8911, DOI 10.1158/0008-5472.CAN-04-1810; Petty WJ, 2005, J NATL CANCER I, V97, P1645, DOI 10.1093/jnci/dji371; Poulain S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-423; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456; Sun J., 2010, MED ONCOL, P1311; Swift ME, 2006, J CELL PHYSIOL, V209, P718, DOI 10.1002/jcp.20788; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Toulouse A, 1996, BBA-GENE STRUCT EXPR, V1309, P1, DOI 10.1016/S0167-4781(96)00126-1; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Youssef EM, 2004, CANCER BIOL THER, V3, P82, DOI 10.4161/cbt.3.1.591; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	61	28	30	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1468	1478		10.1096/fj.12-210971	http://dx.doi.org/10.1096/fj.12-210971			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23299856	Bronze			2022-12-25	WOS:000316940800019
J	Aizer, A; Kafri, P; Kalo, A; Shav-Tal, Y				Aizer, Adva; Kafri, Pinhas; Kalo, Alon; Shav-Tal, Yaron			The P Body Protein Dcp1a Is Hyper-phosphorylated during Mitosis	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; DECAPPING ENZYME; PROCESSING BODIES; CYTOPLASMIC FOCI; BINDING-PROTEIN; CELL-CYCLE; GW BODIES; DECAY; STABILITY; TRANSPORT	Processing bodies (PBs) are non-membranous cytoplasmic structures found in all eukaryotes. Many of their components such as the Dcp1 and Dcp2 proteins are highly conserved. Using live-cell imaging we found that PB structures disassembled as cells prepared for cell division, and then began to reassemble during the late stages of cytokinesis. During the cell cycle and as cells passed through S phase, PB numbers increased. However, there was no memory of PB numbers between mother and daughter cells. Examination of hDcp1a and hDcp1b proteins by electrophoresis in mitotic cell extracts showed a pronounced slower migrating band, which was caused by hyper-phosphorylation of the protein. We found that hDcp1a is a phospho-protein during interphase that becomes hyper-phosphorylated in mitotic cells. Using truncations of hDcp1a we localized the region important for hyper-phosphorylation to the center of the protein. Mutational analysis demonstrated the importance of serine 315 in the hyper-phosphorylation process, while other serine residues tested had a minor affect. Live-cell imaging demonstrated that serine mutations in other regions of the protein affected the dynamics of hDcp1a association with the PB structure. Our work demonstrates the control of PB dynamics during the cell cycle via phosphorylation.	[Shav-Tal, Yaron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; Bar Ilan Univ, Inst Nanotechnol, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Shav-Tal, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	Yaron.Shav-Tal@biu.ac.il	Aizer, Adva/AAR-3385-2020	Shav-Tal, Yaron/0000-0002-8017-948X	Israel Science Foundation [250/06]; Alon Fellowship	Israel Science Foundation(Israel Science Foundation); Alon Fellowship	This work was supported by grants to YST by the Israel Science Foundation (grant 250/06) and the Alon Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2008, PRION, V2, P131, DOI 10.4161/pri.2.4.7773; ALTUS MS, 1991, J BIOL CHEM, V266, P21190; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Blumenthal J, 2009, FEBS LETT, V583, P197, DOI 10.1016/j.febslet.2008.12.002; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Izaurralde E, 2009, NAT REV MOL CELL BIO, V10, DOI 10.1038/nrm2697; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LAIRDOFFRINGA IA, 1990, MOL CELL BIOL, V10, P6132, DOI 10.1128/MCB.10.12.6132; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Ross J, 1997, BIOESSAYS, V19, P527, DOI 10.1002/bies.950190612; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; She MP, 2004, NAT STRUCT MOL BIOL, V11, P249, DOI 10.1038/nsmb730; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; TABER R, 1971, J VIROL, V8, P395, DOI 10.1128/JVI.8.4.395-401.1971; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	35	40	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e49783	10.1371/journal.pone.0049783	http://dx.doi.org/10.1371/journal.pone.0049783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300942	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900002
J	Bonito, G; Smith, ME; Nowak, M; Healy, RA; Guevara, G; Cazares, E; Kinoshita, A; Nouhra, ER; Dominguez, LS; Tedersoo, L; Murat, C; Wang, Y; Moreno, BA; Pfister, DH; Nara, K; Zambonelli, A; Trappe, JM; Vilgalys, R				Bonito, Gregory; Smith, Matthew E.; Nowak, Michael; Healy, Rosanne A.; Guevara, Gonzalo; Cazares, Efren; Kinoshita, Akihiko; Nouhra, Eduardo R.; Dominguez, Laura S.; Tedersoo, Leho; Murat, Claude; Wang, Yun; Arroyo Moreno, Baldomero; Pfister, Donald H.; Nara, Kazuhide; Zambonelli, Alessandra; Trappe, James M.; Vilgalys, Rytas			Historical Biogeography and Diversification of Truffles in the Tuberaceae and Their Newly Identified Southern Hemisphere Sister Lineage	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; ECTOMYCORRHIZAL FUNGI; GENUS TUBER; TRUE; DIVERSITY; CLADES; ESTABLISHMENT; ASSOCIATIONS; DISPERSAL; EVOLUTION	Truffles have evolved from epigeous (aboveground) ancestors in nearly every major lineage of fleshy fungi. Because accelerated rates of morphological evolution accompany the transition to the truffle form, closely related epigeous ancestors remain unknown for most truffle lineages. This is the case for the quintessential truffle genus Tuber, which includes species with socio-economic importance and esteemed culinary attributes. Ecologically, Tuber spp. form obligate mycorrhizal symbioses with diverse species of plant hosts including pines, oaks, poplars, orchids, and commercially important trees such as hazelnut and pecan. Unfortunately, limited geographic sampling and inconclusive phylogenetic relationships have obscured our understanding of their origin, biogeography, and diversification. To address this problem, we present a global sampling of Tuberaceae based on DNA sequence data from four loci for phylogenetic inference and molecular dating. Our well-resolved Tuberaceae phylogeny shows high levels of regional and continental endemism. We also identify a previously unknown epigeous member of the Tuberaceae - the South American cup-fungus Nothojafnea thaxteri (E.K. Cash) Gamundi. Phylogenetic resolution was further improved through the inclusion of a previously unrecognized Southern hemisphere sister group of the Tuberaceae. This morphologically diverse assemblage of species includes truffle (e.g. Gymnohydnotrya spp.) and non-truffle forms that are endemic to Australia and South America. Southern hemisphere taxa appear to have diverged more recently than the Northern hemisphere lineages. Our analysis of the Tuberaceae suggests that Tuber evolved from an epigeous ancestor. Molecular dating estimates Tuberaceae divergence in the late Jurassic (similar to 156 million years ago), with subsequent radiations in the Cretaceous and Paleogene. Intra-continental diversification, limited long-distance dispersal, and ecological adaptations help to explain patterns of truffle evolution and biodiversity.	[Bonito, Gregory; Vilgalys, Rytas] Duke Univ, Deparment Biol, Durham, NC 27710 USA; [Healy, Rosanne A.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Cazares, Efren; Trappe, James M.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Nouhra, Eduardo R.; Dominguez, Laura S.] Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Tedersoo, Leho] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Tedersoo, Leho] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Murat, Claude] INRA, Champenoux, France; [Murat, Claude] Nancy Univ, Champenoux, France; [Wang, Yun] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Arroyo Moreno, Baldomero] Univ Cordoba, Dept Plant Biol, Cordoba, Spain; [Pfister, Donald H.] Harvard Univ, Farlow Herbarium, Cambridge, MA 02138 USA; [Nara, Kazuhide] Univ Tokyo, Dept Nat Environm Studies, Grad Sch Frontier Sci, Chiba, Japan; [Zambonelli, Alessandra] Univ Bologna, Dipartimento Sci Agr, Bologna, Italy; [Nowak, Michael] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	Duke University; University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; INRAE; Universite de Lorraine; New Zealand Institute for Plant & Food Research Ltd; Universidad de Cordoba; Harvard University; University of Tokyo; University of Bologna; University of Zurich; State University System of Florida; University of Florida	Bonito, G (corresponding author), Duke Univ, Deparment Biol, Durham, NC 27710 USA.	gregory.bonito@duke.edu	Zambonelli, Alessandra/AAF-3581-2019; Guevara, Gonzalo/CAF-2010-2022; Smith, Matthew E./ABC-3015-2020; Tedersoo, Leho/H-3541-2012; Tedersoo, Leho/ABE-7452-2020; Nara, Kazuhide/H-6246-2016; Guevara, Gonzalo/ABG-4765-2021; Guevara, Gonzalo/C-4674-2015; Nowak, Michael/M-3747-2017; Smith, Matthew E/A-8115-2012; Murat, Claude/AAA-5226-2020	Smith, Matthew E./0000-0002-0878-0932; Nara, Kazuhide/0000-0002-3705-231X; Guevara, Gonzalo/0000-0002-2707-4531; Nowak, Michael/0000-0001-8924-6506; Smith, Matthew E/0000-0002-0878-0932; Murat, Claude/0000-0003-0685-7307; Vilgalys, Rytas/0000-0001-8299-3605	NSF [0641297]; Friends of the Farlow; Harvard University Herbaria; David Rockefeller Center for Latin American Studies at Harvard University; Iowa Science Foundation	NSF(National Science Foundation (NSF)); Friends of the Farlow; Harvard University Herbaria; David Rockefeller Center for Latin American Studies at Harvard University; Iowa Science Foundation	This research was supported through NSF award #0641297, REVSYS: Phylogenetic and Revisionary Systematics of North American Truffles (Tuber). Support was also provided by the Friends of the Farlow, which enabled the senior author to conduct research at the Farlow Herbarium. M.E.S. participated via a postdoctoral fellowship from Harvard University Herbaria. D.H.P. received funding from the David Rockefeller Center for Latin American Studies at Harvard University that supported field work in collaboration with M.E.S. Collections and microscopy were enabled by a grant from the Iowa Science Foundation to R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado P, 2012, MYCOLOGIA, V104, P894, DOI 10.3852/11-254; ALVAREZ IF, 1992, MYCOLOGIA, V84, P926, DOI 10.2307/3760294; BEATON G, 1977, T BRIT MYCOL SOC, V69, P243, DOI 10.1016/S0007-1536(77)80044-2; BEATON G, 1986, T BRIT MYCOL SOC, V86, P503, DOI 10.1016/S0007-1536(86)80201-7; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bonito G, 2010, MYCOLOGIA, V102, P1042, DOI 10.3852/09-213; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; BRUNS TD, 1989, NATURE, V339, P140, DOI 10.1038/339140a0; Bulman SR, 2010, MYCOL PROG, V9, P205, DOI 10.1007/s11557-009-0626-0; Castellano MA, 1989, KEY SPORES GENERA HY; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Claridge A., 2005, FUNGAL COMMUNITY ITS, V20050554, P599, DOI [10.1201/9781420027891.ch29, DOI 10.1201/9781420027891.CH29]; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Comandini O, 2006, MYCORRHIZA, V16, P381, DOI 10.1007/s00572-006-0047-8; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frank JL, 2009, BOTANY, V87, P821, DOI 10.1139/B09-044; GAMUNDI I J, 1971, Boletin de la Sociedad Argentina de Botanica, V13, P260; GAMUNDI I J, 1971, Darwiniana (San Isidro), V16, P461; Guevara G, MYCOLOGIA IN PRESS; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Jeandroz S, 2008, J BIOGEOGR, V35, P815, DOI 10.1111/j.1365-2699.2007.01851.x; Kinoshita A, 2011, MYCOLOGIA, V103, P779, DOI 10.3852/10-138; Kutorga Ernestas, 2008, Acta Mycologica, V43, P133, DOI 10.5586/am.2008.016; Laessoe T, 2007, MYCOL RES, V111, P1075, DOI 10.1016/j.mycres.2007.08.004; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Maddison, 2019, MESQUITE MODULAR SYS; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Marjanovic Z, 2010, SYDOWIA, V62, P67; Martin MP, 1999, MYCOL RES, V103, P203, DOI 10.1017/S0953756298007035; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Mindell RA, 2007, AM J BOT, V94, P351, DOI 10.3732/ajb.94.3.351; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Moreno G, 2012, MYCOL PROG, V11, P463, DOI 10.1007/s11557-011-0762-1; Newsholme C, 1992, WILLOWS GENUS SALIX; O'Donnell K, 2011, FUNGAL GENET BIOL, V48, P252, DOI 10.1016/j.fgb.2010.09.006; ODonnell K, 1997, MYCOLOGIA, V89, P48, DOI 10.2307/3761172; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Perez F, 2007, MYCORRHIZA, V17, P627, DOI 10.1007/s00572-007-0140-7; Rambaut A, 2014, TRACER V1 6; Ramirez JL, 2000, INT J PLANT SCI, V161, P521, DOI 10.1086/314260; Rifai MA, 1968, VERH K NED AKAD WET, V57, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; Sims HJ, 1999, REV PALAEOBOT PALYNO, V106, P131, DOI 10.1016/S0034-6667(99)00008-1; Singer R, 1987, MUSHROOMS TRUFFLES B; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Spegazzini, 1887, ANALES SOC CI ARGENT, P10; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Trappe J. M., 2009, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Trappe JM, 2008, ECON BOT, V62, P497, DOI 10.1007/s12231-008-9041-8; TRAPPE JM, 1979, MYCOTAXON, V9, P297; WARCUP JH, 1990, MYCOL RES, V94, P173, DOI 10.1016/S0953-7562(09)80609-6; WARCUP JH, 1990, MYCOL RES, V94, P1065, DOI 10.1016/S0953-7562(09)81334-8; Weden C., 2009, ACTA BOT YUNNANICA, V31, P94; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; YAN Y, 2011, RASP RECONSTRUCT ANC; ZHANG BC, 1989, MYCOL RES, V92, P192, DOI 10.1016/S0953-7562(89)80011-5	68	149	165	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52765	10.1371/journal.pone.0052765	http://dx.doi.org/10.1371/journal.pone.0052765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300990	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000313320900037
J	Bujanda, L; Sarasqueta, C; Cosme, A; Hijona, E; Enriquez-Navascues, JM; Placer, C; Villarreal, E; Herreros-Villanueva, M; Giraldez, MD; Gironella, M; Balaguer, F; Castells, A				Bujanda, Luis; Sarasqueta, Cristina; Cosme, Angel; Hijona, Elizabeth; Enriquez-Navascues, Jose M.; Placer, Carlos; Villarreal, Eloisa; Herreros-Villanueva, Marta; Giraldez, Maria D.; Gironella, Meritxell; Balaguer, Francesc; Castells, Antoni			Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; SERUM TETRANECTIN; GASTRIC-JUICE; BLOOD; PREDICTS; MARKER; CELLS; STAGE; SUPAR	Background: Colorectal cancer (CRC) is the second most common cause of death from cancer in both men and women in the majority of developed countries. Molecular tests of blood could potentially provide this ideal screening tool. Aim: Our objective was to assess the usefulness of serum markers and mRNA expression levels in the diagnosis of CRC. Methods: In a prospective study, we measured mRNA expression levels of 13 markers (carbonic anhydrase, guanylyl cyclase C, plasminogen activator inhibitor, matrix metalloproteinase 7 (MMP7), urokinase-type plasminogen activator receptor (uPAR), urokinase-type plasminogen activator, survivin, tetranectin, vascular endothelial growth factor (VEGF), cytokeratin 20, thymidylate synthase, cyclooxygenase 2 (COX-2), and CD44) and three proteins in serum (alpha 1 antitrypsin, carcinoembryonic antigen (CEA) and activated C3 in 42 patients with CRC and 33 with normal colonoscopy results. Results: Alpha 1-antitrypsin was the serum marker that was most useful for CRC diagnosis (1.79 +/- 0.25 in the CRC group vs 1.27 +/- 0.25 in the control group, P < 0.0005). The area under the ROC curve for alpha 1-antitrypsin was 0.88 (0.79-0.96). The mRNA expression levels of five markers were statistically different between CRC cases and controls: those for which the ROC area was over 75% were MMP7 (0.81) and tetranectin (0.80), COX-2 (0.78), uPAR (0.78) and carbonic anhydrase (0.77). The markers which identified early stage CRC (Stages I and II) were alpha 1-antitrypsin, uPAR, COX-2 and MMP7. Conclusions: Serum alpha 1-antitrypsin and the levels of mRNA expression of MMP7, COX-2 and uPAR have good diagnostic accuracy for CRC, even in the early stages.	[Bujanda, Luis; Cosme, Angel; Hijona, Elizabeth; Herreros-Villanueva, Marta] Univ Basque Country UPV EHU, Ctr Invest Biomed Enfermedades Hepat & Digest CIB, Dept Gastroenterol, Biodonostia Inst,Donostia Hosp, San Sebastian, Spain; [Sarasqueta, Cristina] Donostia Hosp, CIBERESP, Dept Epidemiol, San Sebastian, Spain; [Enriquez-Navascues, Jose M.; Placer, Carlos; Villarreal, Eloisa] Donostia Hosp, Dept Surg, San Sebastian, Spain; [Giraldez, Maria D.; Gironella, Meritxell; Balaguer, Francesc; Castells, Antoni] IDIBAPS, CIBERehd, Clin Hosp, Dept Gastroenterol, Barcelona, Spain	Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bujanda, L (corresponding author), Univ Basque Country UPV EHU, Ctr Invest Biomed Enfermedades Hepat & Digest CIB, Dept Gastroenterol, Biodonostia Inst,Donostia Hosp, San Sebastian, Spain.	medik@telefonica.net	Bujanda, Luis/AAB-2485-2021; BALAGUER, FRANCESC/G-2389-2016; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Giraldez, Maria D/E-7395-2018; , Herreros-Villanueva/M-5702-2016; Enriquez-Navascues, Jose M/AAG-8632-2020	Bujanda, Luis/0000-0002-4353-9968; Castells, Antoni/0000-0001-8431-2033; Giraldez, Maria D/0000-0001-6829-7603; , Herreros-Villanueva/0000-0002-6905-0693; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Gironella, Meritxell/0000-0003-4437-5181; Balaguer, Francesc/0000-0002-0206-0539	Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Centro de Investigacion Biomedica en Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; American Joint Committee on Cancer, 1997, MAN STAG CANC; [Anonymous], 2005, SIT CANC ESP; Arvanitis DL, 2002, HISTOL HISTOPATHOL, V17, P471, DOI 10.14670/HH-17.471; Begum FD, 2009, GYNECOL ONCOL, V113, P221, DOI 10.1016/j.ygyno.2009.01.020; Begum FD, 2004, ANTICANCER RES, V24, P1981; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; BERNACKA K, 1988, CANCER, V62, P1188, DOI 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Bujanda L, 2010, WORLD J GASTROENTERO, V16, P862, DOI 10.3748/wjg.v16.i7.862; Bustin Stephen A., 2006, Molecular Aspects of Medicine, V27, P192, DOI 10.1016/j.mam.2005.12.002; Grabarczyk Ewa, 2007, Med Wieku Rozwoj, V11, P41; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Habermann JK, 2006, GASTROENTEROLOGY, V131, P1020, DOI 10.1053/j.gastro.2006.07.011; Hogdall CK, 2002, APMIS, V110, P630, DOI 10.1034/j.1600-0463.2002.1100906.x; Hsu PI, 2007, CLIN CANCER RES, V13, P876, DOI 10.1158/1078-0432.CCR-06-1404; Hurst NG, 2007, BRIT J CANCER, V97, P971, DOI 10.1038/sj.bjc.6603958; Ishigami S, 2008, J SURG RES, V148, P205, DOI 10.1016/j.jss.2007.08.013; Kapsoritakis A, 2003, INT J COLORECTAL DIS, V18, P418, DOI 10.1007/s00384-003-0495-y; Kobayashi H, 2009, INT J ONCOL, V34, P1147, DOI 10.3892/ijo_00000243; Kobayashi H, 2008, INT J ONCOL, V33, P1257, DOI 10.3892/ijo_00000116; Lee K, 2004, PROTEOMICS, V4, P3343, DOI 10.1002/pmic.200400960; Mollnes TE, 1998, CLIN EXP IMMUNOL, V123, P484; PYKE C, 1991, AM J PATHOL, V138, P1059; Sadahiro S, 2007, ANN SURG ONCOL, V14, P1092, DOI 10.1245/s10434-006-9289-0; Setoyama T, 2006, CLIN CANCER RES, V12, P5972, DOI 10.1158/1078-0432.CCR-06-0637; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; Stephens RW, 2010, JNCI, V91, P869; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188	29	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51810	10.1371/journal.pone.0051810	http://dx.doi.org/10.1371/journal.pone.0051810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300952	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900010
J	Sane, E; Isla, E; Barcena, MA; DeMaster, DJ				Sane, Elisabet; Isla, Enrique; Angeles Barcena, Maria; DeMaster, David J.			A Shift in the Biogenic Silica of Sediment in the Larsen B Continental Shelf, Off the Eastern Antarctic Peninsula, Resulting from Climate Change	PLOS ONE			English	Article							SOUTHERN-OCEAN; WEDDELL SEA; SURFACE SEDIMENTS; WESTERN BRANSFIELD; SPONGE SPICULES; ICE SHELF; COMMUNITIES; ACCUMULATION; ASSEMBLAGES; SAMPLES	In 2002, section B of the Larsen ice shelf, off of the Eastern Antarctic Peninsula, collapsed and created the opportunity to study whether the changes at the sea surface left evidence in the sedimentary record. Biogenic silica is major constituent of Antarctic marine sediment, and its presence in the sediment column is associated with diatom production in the euphotic zone. The abundance of diatom valves and the number of sponge spicules in the biogenic silica was analyzed to determine how the origin of the biogenic silica in the upper layers of the sediment column responded to recent environmental changes. Diatom valves were present only in the upper 2 cm of sediment, which roughly corresponds to the period after the collapse of the ice shelf. In contrast, sponge spicules, a more robust form of biogenic silica, were also found below the upper 2 cm layer of the sediment column. Our results indicate that in this region most of the biogenic silica in the sedimentary record originated from sponge spicules rather than diatoms during the time when the sea surface was covered by the Larsen ice shelf. Since the collapse of the ice shelf, the development of phytoplankton blooms and the consequent influx of diatom debris to the seabed have shifted the biogenic silica record to one dominated by diatom debris, as occurs in most of the Antarctic marine sediment. This shift provides further evidence of the anthropogenic changes to the benthic habitats of the Antarctic and will improve the interpretation of the sedimentary record in Polar Regions where these events occur.	[Sane, Elisabet; Isla, Enrique] Inst Marine Sci ICM CSIC, Dept Marine Geol, Barcelona, Spain; [Angeles Barcena, Maria] Univ Salamanca, Dept Geol & Paleontol, E-37008 Salamanca, Spain; [DeMaster, David J.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Salamanca; University of North Carolina; North Carolina State University	Sane, E (corresponding author), Inst Marine Sci ICM CSIC, Dept Marine Geol, Barcelona, Spain.	sane@icm.csic.es	Barcena, María Angeles/D-5839-2011; sane, elisabet/AAT-4775-2020	Barcena, María Angeles/0000-0001-8261-2286; , elisabet/0000-0001-5719-5468; Isla, Enrique/0000-0003-4959-6936	Spanish Ministry of Science and Innovation, through the project CLIMANT [POL2006-06399]; FPU [AP 2005-5060]	Spanish Ministry of Science and Innovation, through the project CLIMANT(Ministry of Science and Innovation, Spain (MICINN)); FPU(Spanish Government)	This study was supported by the Spanish Ministry of Science and Innovation, through the project CLIMANT (POL2006-06399) and the graduate program fellowship FPU AP 2005-5060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELMANN A, 1991, MAR CHEM, V35, P503, DOI 10.1016/S0304-4203(09)90040-8; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barcena MA, 2002, DEEP-SEA RES PT II, V49, P935, DOI 10.1016/S0967-0645(01)00132-1; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; BARTHEL D, 1991, MAR ECOL PROG SER, V69, P303, DOI 10.3354/meps069303; BARTHEL D, 1992, ANTARCT SCI, V4, P137, DOI 10.1017/S0954102092000221; Bavestrello G, 1996, MAR ECOL-P S Z N I, V17, P41, DOI 10.1111/j.1439-0485.1996.tb00488.x; Brey T, 1997, ANTARCT SCI, V9, P266, DOI 10.1017/S0954102097000357; Buffen A, 2007, MAR MICROPALEONTOL, V62, P7, DOI 10.1016/j.marmicro.2006.07.002; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cortese G, 2007, EARTH PLANET SC LETT, V257, P526, DOI 10.1016/j.epsl.2007.03.021; Crosta X, 2009, DEEP-SEA RES PT I, V56, P1983, DOI 10.1016/j.dsr.2009.06.009; DeMaster DJ, 1996, CONT SHELF RES, V16, P617, DOI 10.1016/0278-4343(95)00048-8; DEMASTER DJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1715, DOI 10.1016/0016-7037(81)90006-5; DeMaster DJ, 2002, DEEP-SEA RES PT II, V49, P3155, DOI 10.1016/S0967-0645(02)00076-0; DeMaster DJ, 2003, ORGANIC CARBON CALCI, DOI [10.1594/PANGAEA.124976, DOI 10.1594/PANGAEA.124976]; Diekmann B, 1999, MAR GEOL, V158, P209, DOI 10.1016/S0025-3227(98)00165-0; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; DUNBAR RB, 1989, MAR GEOL, V85, P155, DOI 10.1016/0025-3227(89)90152-7; GERDES D, 1992, POLAR BIOL, V12, P291; Gerdes D, 2003, POLAR BIOL, V26, P295, DOI 10.1007/s00300-003-0484-1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Isla E, 2004, MAR GEOL, V209, P265, DOI 10.1016/j.margeo.2004.06.003; Bertolin ML, 2009, POLAR BIOL, V32, P1435, DOI 10.1007/s00300-009-0638-x; Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; Post AL, 2007, MAR ECOL PROG SER, V344, P29, DOI 10.3354/meps06966; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; RUTZLER K, 1978, MAR BIOL, V49, P147, DOI 10.1007/BF00387114; Sane E, 2012, CONT SHELF RES, V35, P53, DOI 10.1016/j.csr.2011.12.008; Sane E, 2011, CONT SHELF RES, V31, P1161, DOI 10.1016/j.csr.2011.04.002; Sane E, 2011, J SEA RES, V65, P94, DOI 10.1016/j.seares.2010.07.005; Schluter M, 1998, DEEP-SEA RES PT I, V45, P1085, DOI 10.1016/S0967-0637(98)00006-5; Schrader H.-J., 1978, Utrecht Micropaleontological Bulletins, P129; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tsoy IB, 2009, MAR GEOL, V49, P141; Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Wright SW, 2000, DEEP-SEA RES PT II, V47, P2363, DOI 10.1016/S0967-0645(00)00029-1	43	13	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52632	10.1371/journal.pone.0052632	http://dx.doi.org/10.1371/journal.pone.0052632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300983	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900035
J	Seidel, C; Reinhardt, K				Seidel, Conrad; Reinhardt, Klaus			Bugging Forecast: Unknown, Disliked, Occasionally Intimate. Bed Bugs in Germany Meet Unprepared People	PLOS ONE			English	Article							CIMEX-LECTULARIUS L.; FARMERS PERCEPTIONS; BITES; CIMICIDAE; ANIMALS; DISEASE; FEAR	Bed bugs appear to be feared more than vector insects and other household pests. The reasons for this exaggerated fear are not fully understood. One hypothesis is that the folk knowledge on recognising and controlling bed bugs decreased as bed bugs became rarer in the 1960s and led to irrational perceptions. Here, we examine people's ability to recognise a bed bug and their response what to do in case of an infestation. We found that 13% of a sample of 391 people in four large German cities recognised a bed bug; 15% of all respondents would call a pest controller in case of bed bug infestation. This results in the pessimistic estimate that 97% of all early-stage infestations could go untreated. We discuss additional scenarios. The effectiveness of efforts to educate people about the presence of bed bugs has never been tested, but our sample is useful to guide future studies. We found three sources of information were associated with increased recognition rates of bed bugs: a) previous contacts with bed bugs (60% recognition), b) knowledge from friends or relatives (25%) and school or education courses (15%). By contrast, people who heard of bed bugs from television, print media or the Internet showed reduced recognition rates. We propose that the former factors be tested for educational interventions. In Germany, the bed bug is an estranged creature to many people, a fact that seems to hinder rational approaches to their control.	[Seidel, Conrad; Reinhardt, Klaus] Univ Tubingen, Tubingen, Germany; [Reinhardt, Klaus] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Eberhard Karls University of Tubingen; University of Sheffield	Reinhardt, K (corresponding author), Univ Tubingen, Tubingen, Germany.	k.reinhardt@uni-tuebingen.de						Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; DOGGETT SL, 2008, P 6 INT C URB PESTS, P407; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Harlan HJ, 2008, PUBLIC HLTH SIGNIFIC, P131; King F, 1990, NEW SCI, V1701, P35; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; Majekodunmi A, 2002, J ENV HLTH RES, V1; Malotki E, 1997, BEDBUGS NIGHT DANCE; Nagaraju N, 2002, INT J PEST MANAGE, V48, P333, DOI 10.1080/09670870210153164; Osborne P. J., 1971, BRITANNIA, V2, P156; Palis FG, 1998, CROP PROT, V17, P599, DOI 10.1016/S0261-2194(98)00058-1; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Potter Michael F., 2011, American Entomologist, V57, P14; Prokop P, 2010, ECOL PSYCHOL, V22, P222, DOI 10.1080/10407413.2010.496676; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Reinhardt K, 2010, MED VET ENTOMOL, V24, P46, DOI 10.1111/j.1365-2915.2009.00847.x; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K., 2012, 2012 MCGRAW HILL YB; Reinhardt K, 2008, J MED ENTOMOL, V45, P956, DOI 10.1603/0022-2585(2008)45[956:WKTBBK]2.0.CO;2; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Richards L, 2009, J ENV HLTH RES, V9, P17; Seidel C, 2011, POPULATION ANAL CIME; Soukand R, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14110; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230	26	13	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51083	10.1371/journal.pone.0051083	http://dx.doi.org/10.1371/journal.pone.0051083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300947	gold, Green Submitted, Green Published			2022-12-25	WOS:000313320900006
J	de la Pena, E; Malkia, A; Vara, H; Caires, R; Ballesta, JJ; Belmonte, C; Viana, F				de la Pena, Elvira; Maelkiae, Annika; Vara, Hugo; Caires, Rebeca; Ballesta, Juan J.; Belmonte, Carlos; Viana, Felix			The Influence of Cold Temperature on Cellular Excitability of Hippocampal Networks	PLOS ONE			English	Article							DOMAIN POTASSIUM-CHANNEL; NEUROPROTECTIVE AGENT RILUZOLE; POLYUNSATURATED FATTY-ACIDS; BRAIN TEMPERATURE; K+ CHANNELS; SYNAPTIC-TRANSMISSION; MEMBRANE-PROPERTIES; CAPSAICIN-RECEPTOR; PYRAMIDAL NEURONS; TRPM8 CHANNELS	The hippocampus plays an important role in short term memory, learning and spatial navigation. A characteristic feature of the hippocampal region is its expression of different electrical population rhythms and activities during different brain states. Physiological fluctuations in brain temperature affect the activity patterns in hippocampus, but the underlying cellular mechanisms are poorly understood. In this work, we investigated the thermal modulation of hippocampal activity at the cellular network level. Primary cell cultures of mouse E17 hippocampus displayed robust network activation upon light cooling of the extracellular solution from baseline physiological temperatures. The activity generated was dependent on action potential firing and excitatory glutamatergic synaptic transmission. Involvement of thermosensitive channels from the transient receptor potential (TRP) family in network activation by temperature changes was ruled out, whereas pharmacological and immunochemical experiments strongly pointed towards the involvement of temperature-sensitive two-pore-domain potassium channels (K-2P), TREK/TRAAK family. In hippocampal slices we could show an increase in evoked and spontaneous synaptic activity produced by mild cooling in the physiological range that was prevented by chloroform, a K-2P channel opener. We propose that cold-induced closure of background TREK/TRAAK family channels increases the excitability of some hippocampal neurons, acting as a temperature-sensitive gate of network activation. Our findings in the hippocampus open the possibility that small temperature variations in the brain in vivo, associated with metabolism or blood flow oscillations, act as a switch mechanism of neuronal activity and determination of firing patterns through regulation of thermosensitive background potassium channel activity.	[de la Pena, Elvira; Maelkiae, Annika; Vara, Hugo; Caires, Rebeca; Ballesta, Juan J.; Belmonte, Carlos; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	de la Pena, E (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain.	elvirap@umh.es; felix.viana@umh.es	Viana, Felix/U-8533-2017; Elvira, De la Pena/O-7380-2015; Vara Rivera, Hugo/L-4480-2018	Viana, Felix/0000-0003-1439-949X; Elvira, De la Pena/0000-0001-5961-5067; Vara Rivera, Hugo/0000-0002-7287-815X; Caires, Rebeca/0000-0002-5202-6080	Academy of Finland [107866]; Juan de la Cierva fellowship from the Spanish Ministry of Education and Science; Generalitat Valenciana [GVPRE/2008/205, GVAP/007/10, GRISOLIA/2010/020]; Spanish Ministry of Science and Innovation [SAF2010-14990, BFU2008-04425, CSD2007-00023]	Academy of Finland(Academy of Finland); Juan de la Cierva fellowship from the Spanish Ministry of Education and Science; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	During the course of this work, AM was supported by the Academy of Finland (#107866) and a Juan de la Cierva fellowship from the Spanish Ministry of Education and Science. The work was also supported by funds from the Generalitat Valenciana: GVPRE/2008/205 to AM, GVAP/007/10 to EP and GRISOLIA/2010/020 to RC; the Spanish Ministry of Science and Innovation: projects SAF2010-14990 to FV and BFU2008-04425 and CONSOLIDER-INGENIO 2010 CSD2007-00023 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS R, 1964, AM J PHYSIOL, V206, P641, DOI 10.1152/ajplegacy.1964.206.3.641; Aihara H, 2001, BRAIN RES, V893, P36, DOI 10.1016/S0006-8993(00)03285-6; Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Andersen P, 1995, HIPPOCAMPUS, V5, P491, DOI 10.1002/hipo.450050602; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Cadaveira-Mosquera A, 2011, J NEUROSCI, V31, P1375, DOI 10.1523/JNEUROSCI.2791-10.2011; CAIN DP, 1994, BRAIN RES, V658, P135, DOI 10.1016/S0006-8993(09)90019-1; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Danthi S, 2003, J MEMBRANE BIOL, V195, P147, DOI 10.1007/s00232-003-0616-0; de la Pena E, 2005, J PHYSIOL-LONDON, V567, P415, DOI 10.1113/jphysiol.2005.086546; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; DUNCAN WC, 1995, NEUROPSYCHOPHARMACOL, V12, P17, DOI 10.1016/0893-133X(94)00055-5; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; GAO B, 1992, PSYCHOPHARMACOLOGY, V106, P321, DOI 10.1007/BF02245412; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Guler AD, 2002, J NEUROSCI, V22, P6408; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Karnup S, 2001, J PHYSIOL-LONDON, V532, P713, DOI 10.1111/j.1469-7793.2001.0713e.x; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Leinekugel X, 2003, J PHYSIOL-PARIS, V97, P27, DOI 10.1016/j.jphysparis.2003.10.004; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Liu HY, 2007, J PHARMACOL EXP THER, V323, P39, DOI 10.1124/jpet.107.125245; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MORRIS M, 1990, SLEEP, V13, P1; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OBAL F, 1985, PFLUG ARCH EUR J PHY, V404, P73, DOI 10.1007/BF00581494; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reig R, 2010, J NEUROPHYSIOL, V103, P1253, DOI 10.1152/jn.00890.2009; Salerian AJ, 2008, MED HYPOTHESES, V70, P497, DOI 10.1016/j.mehy.2007.06.032; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takigawa T, 2003, J NEUROPHYSIOL, V89, P2238, DOI 10.1152/jn.00957.2002; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; TANCREDI V, 1992, EPILEPSIA, V33, P228, DOI 10.1111/j.1528-1157.1992.tb02311.x; THOMPSON SM, 1985, J NEUROSCI, V5, P817; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, 2000, NEUROSCIENCE, V98, P9, DOI 10.1016/S0306-4522(00)00109-3; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; WEIGHT FF, 1976, NATURE, V261, P720, DOI 10.1038/261720a0; Wu J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-18; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386	96	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52475	10.1371/journal.pone.0052475	http://dx.doi.org/10.1371/journal.pone.0052475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300680	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600016
J	Essig, S; Skinner, R; von der Weid, NX; Kuehni, CE; Michel, G				Essig, Stefan; Skinner, Roderick; von der Weid, Nicolas X.; Kuehni, Claudia E.; Michel, Gisela			Follow-Up Programs for Childhood Cancer Survivors in Europe: A Questionnaire Survey	PLOS ONE			English	Article							LONG-TERM SURVIVORS; ADULT SURVIVORS; CARE; DIAGNOSIS; OUTCOMES; CHILDREN	Background: For many childhood cancer survivors follow-up care is important long after treatment completion. We aimed to describe the availability and characteristics of long-term follow-up programs (LTFU) across Europe, their content and aims, their problems, and to assess opinions on different models of LTFU. Methodology/Principal Findings: We asked 179 pediatric oncology institutions in 20 European countries to complete an online survey on LTFU available at their institution. Of 110 respondents (62% response), 66% reported having LTFU for pediatric survivors, 38% for adult survivors of childhood cancer. Availability varied widely across European regions, from 9% of institutions in Northern Europe reporting LTFU for adult survivors to 83% of institution on the British Isles reporting LTFU for pediatric survivors. Pediatric and adult LTFU were usually located in pediatric hospitals and run by pediatric oncologists. Content of follow-up included screening for adverse outcomes and health education. Important problems included lack of time, personnel and funding. Most institutions without LTFU reported that they would like to offer a program (86%). Conclusion/Significance: Despite general agreement on the need of follow-up care, there is still a lack of well-organized LTFU for survivors of childhood cancer across Europe.	[Essig, Stefan; Kuehni, Claudia E.; Michel, Gisela] Univ Bern, ISPM, Bern, Switzerland; [Skinner, Roderick] Great N Childrens Hosp, Dept Pediat & Adolescent Hematol Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Skinner, Roderick] Great N Childrens Hosp, Childrens BMT Unit, Newcastle Upon Tyne, Tyne & Wear, England; [von der Weid, Nicolas X.] Univ Childrens Hosp Basel UKBB, Basel, Switzerland	University of Bern; University of Basel	Michel, G (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	michel@ispm.unibe.ch	Michel, Gisela/G-1081-2018	Michel, Gisela/0000-0002-9589-0928; Essig, Stefan/0000-0003-3228-7010; Kuehni, Claudia E./0000-0001-8957-2002	Swiss National Science Foundation [PZ00P3-121682, PZ00P3-141722, 323630-133897]; Cancer Research Switzerland [KFS 02606-06-2010]; Swiss Cancer League [KFS 02631-08-2010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Switzerland; Swiss Cancer League	Funding came from Swiss National Science Foundation (PZ00P3-121682, PZ00P3-141722, 323630-133897) http://www.snf.ch/, Cancer Research Switzerland (KFS 02606-06-2010) http://www.krebsforschung.ch/, and the Swiss Cancer League (KFS 02631-08-2010) http://www.krebsliga.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absolom K, 2009, BRIT J CANCER, V101, P561, DOI 10.1038/sj.bjc.6605213; Aziz NM, 2006, CANCER, V107, P841, DOI 10.1002/cncr.22096; Children's Oncology Group (COG), 2008, LONG TERM FOLL UP GU; Economic and Social Research Council, 2010, EC SOC RES COUNC RES; EISER C, 1994, PSYCHO-ONCOL, V3, P197, DOI 10.1002/pon.2960030306; Eshelman-Kent D, 2011, J CANCER SURVIV, V5, P345, DOI 10.1007/s11764-011-0192-8; Ethics Committee University of Zurich, 2012, CHECKL SELBSTB STUD; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Guilcher GMT, 2009, PEDIATR BLOOD CANCER, V52, P113, DOI 10.1002/pbc.21701; Henderson TO, 2010, J CLIN ONCOL, V28, P878, DOI 10.1200/JCO.2009.25.6107; Hess SL, 2011, ACTA ONCOL, V50, P653, DOI 10.3109/0284186X.2010.550934; Jenney M, 2008, BMJ-BRIT MED J, V336, P732, DOI 10.1136/bmj.39490.692627.80; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Landier W, 2006, PEDIATR BLOOD CANCER, V46, P149, DOI 10.1002/pbc.20612; Michel G, 2009, EUR J CANCER, V45, P1616, DOI 10.1016/j.ejca.2009.02.026; Michel G, 2011, PSYCHO-ONCOLOGY, V20, P1034, DOI 10.1002/pon.1823; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; National Health System (NHS), 2011, MOD CAR ACH BETT OUT; Oeffinger KC, 1998, J CLIN ONCOL, V16, P2864, DOI 10.1200/JCO.1998.16.8.2864; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Rebholz CE, 2011, EUR J CANCER, V47, P221, DOI 10.1016/j.ejca.2010.09.017; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Richards M, 2011, BRIT J CANCER, V105, pS1, DOI 10.1038/bjc.2011.416; Ristovski-Slijepcevic S, 2009, PAED CHILD HEALT-CAN, V14, P375, DOI 10.1093/pch/14.6.375; Scottish Intercollegiate Guidelines Network (SIGN), 2004, LONG TERM FOLL UP SU; SKINNER R, 2005, THERAPY BASED LONG T; Skinner R, 2007, ARCH DIS CHILD, V92, P257, DOI 10.1136/adc.2006.095513; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; Stichting Kinderoncologie Nederland (SKION), 2010, RICHTL FOLL UP KIND; Tabone MD, 2006, ARCH PEDIATRIE, V13, P607, DOI 10.1016/j.arcped.2006.03.035; Tabone MD, 2006, SUIVI LONG TERME ENQ; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; United Nations Statistics Division, 2011, COMP MACR CONT REG G; von der Weid N, 2003, EUR J CANCER, V39, P1150, DOI 10.1016/S0959-8049(02)00874-2; Wallace WHB, 2001, BRIT MED J, V323, P271, DOI 10.1136/bmj.323.7307.271	37	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53201	10.1371/journal.pone.0053201	http://dx.doi.org/10.1371/journal.pone.0053201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300889	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000313872600068
J	Kollmorgen, G; Bossenmaier, B; Niederfellner, G; Haring, HU; Lammers, R				Kollmorgen, Gwendlyn; Bossenmaier, Birgit; Niederfellner, Gerhard; Haering, Hans-Ulrich; Lammers, Reiner			Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; FAMILY KINASES; PKC-DELTA; C-SRC; ACTIVATION; EXPRESSION; RECEPTOR; IDENTIFICATION; ADHESION; PALMITOYLATION	Cub domain containing protein 1 (CDCP1) is strongly expressed in tumors derived from lung, colon, ovary, or kidney. It is a membrane protein that is phosphorylated and then bound by Src family kinases. Although expression and phosphorylation of CDCP1 have been investigated in many tumor cell lines, the CDCP1 features responsible for transformation have not been fully evaluated. This is in part due to the lack of an experimental system in which cellular transformation depends on expression of exogenous CDCP1 and Src. Here we use retrovirus mediated co-overexpression of c-Src and CDCP1 to induce focus formation of NIH3T3 cells. Employing different mutants of CDCP1 we show that for a full transformation capacity, the intact amino-and carboxy-termini of CDCP1 are essential. Mutation of any of the core intracellular tyrosine residues (Y734, Y743, or Y762) abolished transformation, and mutation of a palmitoylation motif (C689,690G) strongly reduced it. Src kinase binding to CDCP1 was not required since Src with a defective SH2 domain generated even more CDCP1 dependent foci whereas Src myristoylation was necessary. Taken together, the focus formation assay allowed us to define structural requirements of CDCP1/Src dependent transformation and to characterize the interaction of CDCP1 and Src.	[Kollmorgen, Gwendlyn; Bossenmaier, Birgit; Niederfellner, Gerhard] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Haering, Hans-Ulrich; Lammers, Reiner] Univ Tubingen, Dept Internal Med 4, Tubingen, Germany	Roche Holding; Eberhard Karls University of Tubingen	Lammers, R (corresponding author), Univ Tubingen, Dept Internal Med 4, Tubingen, Germany.	reiner.lammers@med.uni-tuebingen.de	Bossenmaier, Birgit/AAN-7075-2020		Roche Diagnostics	Roche Diagnostics	Roche Diagnostics supported the study by a grant to R. Lammers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Orsulic S, 2000, J CELL SCI, V113, P1793; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Spassov DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019154; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zheng CX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006841	42	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53050	10.1371/journal.pone.0053050	http://dx.doi.org/10.1371/journal.pone.0053050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300860	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872600054
J	Terziyska, N; Alves, CC; Groiss, V; Schneider, K; Farkasova, K; Ogris, M; Wagner, E; Ehrhardt, H; Brentjens, RJ; zur Stadt, U; Horstmann, M; Quintanilla-Martinez, L; Jeremias, I				Terziyska, Nadia; Alves, Catarina Castro; Groiss, Volker; Schneider, Katja; Farkasova, Katarina; Ogris, Manfred; Wagner, Ernst; Ehrhardt, Harald; Brentjens, Renier J.; zur Stadt, Udo; Horstmann, Martin; Quintanilla-Martinez, Leticia; Jeremias, Irmela			In Vivo Imaging Enables High Resolution Preclinical Trials on Patients' Leukemia Cells Growing in Mice	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MOUSE MODELS; STEM-CELL; CANCER; EVOLUTION; XENOGRAFTS; LUCIFERASE; THERAPY; IMPACT	Background: Xenograft mouse models represent helpful tools for preclinical studies on human tumors. For modeling the complexity of the human disease, primary tumor cells are by far superior to established cell lines. As qualified exemplary model, patients' acute lymphoblastic leukemia cells reliably engraft in mice inducing orthotopic disseminated leukemia closely resembling the disease in men. Unfortunately, disease monitoring of acute lymphoblastic leukemia in mice is hampered by lack of a suitable readout parameter. Design and Methods: Patients' acute lymphoblastic leukemia cells were lentivirally transduced to express the membrane-bound form of Gaussia luciferase. In vivo imaging was established in individual patients' leukemias and extensively validated. Results: Bioluminescence in vivo imaging enabled reliable and continuous follow-up of individual mice. Light emission strictly correlated to post mortem quantification of leukemic burden and revealed a logarithmic, time and cell number dependent growth pattern. Imaging conveniently quantified frequencies of leukemia initiating cells in limiting dilution transplantation assays. Upon detecting a single leukemia cell within more than 10,000 bone marrow cells, imaging enabled monitoring minimal residual disease, time to tumor re-growth and relapse. Imaging quantified therapy effects precisely and with low variances, discriminating treatment failure from partial and complete responses. Conclusions: For the first time, we characterized in detail how in vivo imaging reforms preclinical studies on patient-derived tumors upon increasing monitoring resolution. In the future, in vivo imaging will enable performing precise preclinical studies on a broad range of highly demanding clinical challenges, such as treatment failure, resistance in leukemia initiating cells, minimal residual disease and relapse.	[Terziyska, Nadia; Alves, Catarina Castro; Groiss, Volker; Schneider, Katja; Ehrhardt, Harald; Jeremias, Irmela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany; [Farkasova, Katarina; Ogris, Manfred; Wagner, Ernst] Univ Munich, Dept Pharm, Ctr System Based Drug Res, Munich, Germany; [Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [zur Stadt, Udo; Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Res Inst Childrens Canc Ctr, Hamburg Eppendorf, Germany; [zur Stadt, Udo; Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost, Hamburg Eppendorf, Germany; [Quintanilla-Martinez, Leticia] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Quintanilla-Martinez, Leticia] Univ Tubingen Hosp, Ctr Comprehens Canc, Tubingen, Germany; [Jeremias, Irmela] Univ Munich, Dept Oncol, Dr von Haunersches Kinderspital, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Jeremias, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany.	irmela.jeremias@helmholtz-muenchen.de	Wagner, Ernst/A-7435-2012; Ehrhardt, Harald/L-9007-2018; Wagner, Ernst/ABB-5976-2020; Jeremias, Irmela/C-6090-2015; Jeremias, Irmela/Q-5934-2019	Wagner, Ernst/0000-0001-8413-0934; Ehrhardt, Harald/0000-0003-4587-1734; Wagner, Ernst/0000-0001-8413-0934; Jeremias, Irmela/0000-0003-1773-7677; Ogris, Manfred/0000-0002-4576-6961	Deutsche Forschungsgemeinschaft (DFG) [SFB684, TP22]; Deutsche Jose Carreras Leukamie Stiftung [R10/26]; Bettina Brau Stiftung; DFG Cluster of Excellence NIM; Dr. Helmut Legerlotz Stiftung; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie Stiftung; Bettina Brau Stiftung; DFG Cluster of Excellence NIM; Dr. Helmut Legerlotz Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by Deutsche Forschungsgemeinschaft (DFG) (SFB684, TP22; http://www.dfg.de/en/index.jsp), Deutsche Jose Carreras Leukamie Stiftung (R10/26; www.carreras-stiftung.de/), Bettina Brau Stiftung (http://www.bettina-braeu-stiftung.de/) and Dr. Helmut Legerlotz Stiftung (all to IJ) and DFG Cluster of Excellence NIM (to EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett DM, 2011, BLOOD, V118, pE112, DOI 10.1182/blood-2011-04-346528; Bottcher S, 2011, BLOOD REV, V25, P91, DOI 10.1016/j.blre.2011.01.001; Castro A.C., 2012, BLOOD, V119, P4224; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Dy GK, 2008, CANCER-AM CANCER SOC, V113, P1857, DOI 10.1002/cncr.23651; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Ehrhardt H, 2011, BLOOD, V118, P6123, DOI 10.1182/blood-2010-02-269811; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Francia G, 2009, CLIN CANCER RES, V15, P6358, DOI 10.1158/1078-0432.CCR-09-0931; Inoue Y, 2011, MOL IMAGING, V10, P377, DOI 10.2310/7290.2010.00057; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lyons SK, 2005, J PATHOL, V205, P194, DOI 10.1002/path.1697; Macor P, 2008, CURR PHARM DESIGN, V14, P2023, DOI 10.2174/138161208785294591; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; McCormick F, 2011, CURR OPIN GENET DEV, V21, P29, DOI 10.1016/j.gde.2010.12.002; Meyer LH, 2011, CANCER CELL, V19, P206, DOI 10.1016/j.ccr.2010.11.014; Misaghian N, 2009, LEUKEMIA, V23, P25, DOI 10.1038/leu.2008.246; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Schmitz M, 2011, BLOOD, V118, P1854, DOI 10.1182/blood-2010-11-320309; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688	34	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52798	10.1371/journal.pone.0052798	http://dx.doi.org/10.1371/journal.pone.0052798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300782	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600026
J	Ulrich, A; Andersen, KR; Schwartz, TU				Ulrich, Alexander; Andersen, Kasper R.; Schwartz, Thomas U.			Exponential Megapriming PCR (EMP) Cloning-Seamless DNA Insertion into Any Target Plasmid without Sequence Constraints	PLOS ONE			English	Article							IN-VITRO; RESTRICTION-ENDONUCLEASE; ENZYMATIC AMPLIFICATION; RF CLONING; RECOMBINATION; MUTAGENESIS; FIDELITY; CONSTRUCTION; CLEAVAGE	We present a fast, reliable and inexpensive restriction-free cloning method for seamless DNA insertion into any plasmid without sequence limitation. Exponential megapriming PCR (EMP) cloning requires two consecutive PCR steps and can be carried out in one day. We show that EMP cloning has a higher efficiency than restriction-free (RF) cloning, especially for long inserts above 2.5 kb. EMP further enables simultaneous cloning of multiple inserts.	[Ulrich, Alexander; Andersen, Kasper R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ulrich, Alexander] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Massachusetts Institute of Technology (MIT); Free University of Berlin	Schwartz, TU (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Ulrich, Alexander Konstantin Christian/0000-0003-4255-4856	National Institutes of Health [GM077537]; German Academic Exchange Service (DAAD); Lundbeck Foundation; Sapere Aude DFF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Lundbeck Foundation(Lundbeckfonden); Sapere Aude DFF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM077537 to TUS. AU acknowledges a predoctoral fellowship from the German Academic Exchange Service (DAAD). KRA was funded by the Lundbeck Foundation and a Sapere Aude DFF postdoc grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte Arun, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip65; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barik S, 1997, Methods Mol Biol, V67, P173; BAUER JC, 1998, Patent No. 5789166; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Chen R, 2008, MOL BIOTECHNOL, V40, P224, DOI 10.1007/s12033-008-9078-z; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Eckert K A, 1991, PCR Methods Appl, V1, P17; FARMER AA, 2002, Patent No. 6410317; Frey B, 1995, BIOCHEMICA, V2, P34; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hansen LL, 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot4093, DOI 10.1101/PDB.PROT4093]; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HE QS, 1994, BIOTECHNIQUES, V17, P82; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mamedov TG, 2008, COMPUT BIOL CHEM, V32, P452, DOI 10.1016/j.compbiolchem.2008.07.021; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MCPHERSON MJ, 2000, PCR BASICS BACKGROUN; MERTZ JE, 1972, P NATL ACAD SCI USA, V69, P3370, DOI 10.1073/pnas.69.11.3370; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Radstrom Peter, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.top20; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SGARAMEL.V, 1970, P NATL ACAD SCI USA, V67, P1468, DOI 10.1073/pnas.67.3.1468; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	39	54	59	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53360	10.1371/journal.pone.0053360	http://dx.doi.org/10.1371/journal.pone.0053360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300917	Green Published, gold			2022-12-25	WOS:000313872600088
J	Ying, Z; Feng, C; Agrawal, R; Zhuang, YM; Gomez-Pinilla, F				Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando			Dietary Omega-3 Deficiency from Gestation Increases Spinal Cord Vulnerability to Traumatic Brain Injury-Induced Damage	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; MEMBRANE HOMEOSTASIS; PHOSPHOLIPASE A(2); RAT; SUPPLEMENTATION	Although traumatic brain injury (TBI) is often associated with gait deficits, the effects of TBI on spinal cord centers are poorly understood. We seek to determine the influence of TBI on the spinal cord and the potential of dietary omega-3 (n-3) fatty acids to counteract these effects. Male rodents exposed to diets containing adequate or deficient levels of n-3 since gestation received a moderate fluid percussion injury when becoming 14 weeks old. TBI reduced levels of molecular systems important for synaptic plasticity (BDNF, TrkB, and CREB) and plasma membrane homeostasis (4-HNE, iPLA2, syntaxin-3) in the lumbar spinal cord. These effects of TBI were more dramatic in the animals exposed to the n-3 deficient diet. Results emphasize the comprehensive action of TBI across the neuroaxis, and the critical role of dietary n-3 as a means to build resistance against the effects of TBI.	[Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724	NINDS NIH HHS [R01 NS050465, R01 NS056413] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; FITZPATRICK JS, 1994, DEV BRAIN RES, V78, P81, DOI 10.1016/0165-3806(94)90012-4; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706	23	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52998	10.1371/journal.pone.0052998	http://dx.doi.org/10.1371/journal.pone.0052998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300842	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500099
J	Cabezon, R; Ricart, E; Espana, C; Panes, J; Benitez-Ribas, D				Cabezon, Raquel; Ricart, Elena; Espana, Carolina; Panes, Julian; Benitez-Ribas, Daniel			Gram-Negative Enterobacteria Induce Tolerogenic Maturation in Dexamethasone Conditioned Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; UP-REGULATION; IN-VITRO; ACTIVATION; DIFFERENTIATION; GENERATION; IMMATURE; SERUM; HYPORESPONSIVENESS	Dendritic cells have been investigated in clinical trials, predominantly with the aim of stimulating immune responses against tumours or infectious diseases. Thus far, however, no clinical studies have taken advantage of their specific immunosuppressive potential. Tolerogenic DCs may represent a new therapeutic strategy for human immune-based diseases, such as Crohn's disease, where the perturbations of the finely tuned balance between the immune system and the microflora result in disease. In the present report, we describe the generation of tolerogenic DCs from healthy donors and Crohn's disease patients using clinical-grade reagents in combination with dexamethasone as immunosuppressive agent and characterize their response to maturation stimuli. Interestingly, we found out that dexamethasone-conditioned DCs keep their tolerogenic properties to Gram-negative bacteria. Other findings included in this study demonstrate that the combination of dexamethasone with a specific cytokine cocktail yielded clinical-grade DCs with the following characteristics: a semi-mature phenotype, a pronounced shift towards anti-inflammatory versus inflammatory cytokine production and low T-cell stimulatory properties. Importantly, in regard to their clinical application, the tolerogenic phenotype of DCs remained stable after the elimination of dexamethasone and after a second stimulation with LPS or bacteria. All these properties make this cell product suitable to be tested in clinical trials of inflammatory conditions including Crohn's disease.	[Ricart, Elena; Panes, Julian; Benitez-Ribas, Daniel] CIBERehd, Barcelona, Spain; [Ricart, Elena; Panes, Julian; Benitez-Ribas, Daniel] Ctr Esther Koplowitz, Barcelona, Spain; [Cabezon, Raquel; Ricart, Elena; Espana, Carolina; Panes, Julian] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Benitez-Ribas, D (corresponding author), CIBERehd, Barcelona, Spain.	daniel.benitez@ciberehd.org	Cabezón, Raquel/F-4208-2016; Panes, Julian/H-5991-2015	Panes, Julian/0000-0002-4971-6902	Ministerio de Ciencia e Innovacion [SAF 2009-07272]; Ministerio de Sanidad y Politica Social [TRA-097]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); CIBERehd; Instituto de Salud Carlos III; FI fellowship from the Generalitat de Catalunya	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Politica Social(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); CIBERehd; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FI fellowship from the Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grant SAF 2009-07272 from the Ministerio de Ciencia e Innovacion, grant TRA-097 from the Ministerio de Sanidad y Politica Social, and by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd). DB-R is supported by CIBERehd and by the Instituto de Salud Carlos III, RC is funded by a FI fellowship from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744; Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Berger TG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006645; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bros M, 2007, BLOOD, V109, P3820, DOI 10.1182/blood-2006-07-035576; Chamorro S, 2009, J IMMUNOL, V183, P2984, DOI 10.4049/jimmunol.0801155; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; de Vries IJM, 2002, J IMMUNOTHER, V25, P429, DOI 10.1097/00002371-200209000-00007; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Duperrier K, 2000, J IMMUNOL METHODS, V238, P119, DOI 10.1016/S0022-1759(00)00147-2; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Fazekasova H, 2009, TRANSPLANTATION, V87, P1617, DOI 10.1097/TP.0b013e3181a5504c; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Harry RA, 2010, ANN RHEUM DIS, V69, P2042, DOI 10.1136/ard.2009.126383; Jin CJ, 2009, LEUKEMIA RES, V34, P513; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kim Chang H, 2005, Curr Opin Hematol, V12, P298, DOI 10.1097/01.moh.0000166496.18773.e3; Kuwana M, 2001, EUR J IMMUNOL, V31, P2547, DOI 10.1002/1521-4141(200109)31:9<2547::AID-IMMU2547>3.0.CO;2-J; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Lagaraine C, 2008, J LEUKOCYTE BIOL, V84, P1057, DOI 10.1189/jlb.1007716; Larange A, 2012, J LEUKOCYTE BIOL, V91, P105, DOI 10.1189/jlb.1110615; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moreau A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00218; Napoletano C, 2007, J IMMUNOTHER, V30, P567, DOI 10.1097/CJI.0b013e318046f396; Naranjo-Gomez M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-89; Pedersen AE, 2009, IMMUNOLOGY, V127, P354, DOI 10.1111/j.1365-2567.2008.02996.x; Peng JC, 2005, J IMMUNOTHER, V28, P599, DOI 10.1097/01.cji.0000175491.21099.04; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 1999, J IMMUNOL, V162, P6473; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Raich-Regue D, 2012, EUR J IMMUNOL, V42, P771, DOI 10.1002/eji.201141835; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Schreibelt G, 2010, BLOOD, V116, P564, DOI 10.1182/blood-2009-11-251884; Shale M, 2009, GUT, V58, P1291, DOI 10.1136/gut.2006.098475; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N	48	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52456	10.1371/journal.pone.0052456	http://dx.doi.org/10.1371/journal.pone.0052456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300676	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100051
J	Manohar, A; Flint, RD; Knudsen, E; Moxon, KA				Manohar, Anitha; Flint, Robert D.; Knudsen, Eric; Moxon, Karen A.			Decoding Hindlimb Movement for a Brain Machine Interface after a Complete Spinal Transection	PLOS ONE			English	Article							PYRAMIDAL TRACT ACTIVITY; MOTOR CORTEX; ENSEMBLE ACTIVITY; MUSCULAR-ACTIVITY; CORTICAL-NEURONS; NEURAL ACTIVITY; PLASTICITY; LOCOMOTION; RESTORATION; RESPONSES	Stereotypical locomotor movements can be made without input from the brain after a complete spinal transection. However, the restoration of functional gait requires descending modulation of spinal circuits to independently control the movement of each limb. To evaluate whether a brain-machine interface (BMI) could be used to regain conscious control over the hindlimb, rats were trained to press a pedal and the encoding of hindlimb movement was assessed using a BMI paradigm. Off-line, information encoded by neurons in the hindlimb sensorimotor cortex was assessed. Next neural population functions, or weighted representations of the neuronal activity, were used to replace the hindlimb movement as a trigger for reward in real-time (on-line decoding) in three conditions: while the animal could still press the pedal, after the pedal was removed and after a complete spinal transection. A novel representation of the motor program was learned when the animals used neural control to achieve water reward (e.g. more information was conveyed faster). After complete spinal transection, the ability of these neurons to convey information was reduced by more than 40%. However, this BMI representation was relearned over time despite a persistent reduction in the neuronal firing rate during the task. Therefore, neural control is a general feature of the motor cortex, not restricted to forelimb movements, and can be regained after spinal injury.	[Manohar, Anitha; Flint, Robert D.; Knudsen, Eric; Moxon, Karen A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Moxon, Karen A.] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Moxon, KA (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	km57@drexel.edu	Moxon, Karen/K-7407-2012; Manohar, Anitha/AAU-4257-2020	Moxon, Karen/0000-0002-5790-097X; Manohar, Anitha/0000-0002-3011-2623	National Institutes of Health [NS057419]; Shriners Hospital for Children [89500]; Internationale Stiftung fur Forschung in Paraplegie [P113]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; Internationale Stiftung fur Forschung in Paraplegie	This work was supported by grant NS057419 from the National Institutes of Health, grant 89500 from Shriners Hospital for Children, and grant P113 from the Internationale Stiftung fur Forschung in Paraplegie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Belanger M, 1996, J NEUROPHYSIOL, V76, P471, DOI 10.1152/jn.1996.76.1.471; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Drew T, 1996, EXP BRAIN RES, V111, P153; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 2008, J PHYSIOL-LONDON, V586, P1239, DOI 10.1113/jphysiol.2007.146605; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Francis JT, 2006, IEEE T NEUR SYS REH, V14, P172, DOI 10.1109/TNSRE.2006.875553; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Hermer-Vazquez L, 2004, BEHAV BRAIN RES, V150, P93, DOI 10.1016/S0166-4328(03)00226-2; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jones TA, 1999, J NEUROSCI, V19, P10153; Kao TSJ, 2011, J NEUROPHYSIOLOGY; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Laubach M, 1999, J NEUROSCI METH, V94, P141, DOI 10.1016/S0165-0270(99)00131-4; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Song WG, 2011, J NEUROSCI, V31, P3110, DOI 10.1523/JNEUROSCI.2335-10.2011; Song WG, 2009, IEEE T BIO-MED ENG, V56, P2712, DOI 10.1109/TBME.2009.2026284; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070, DOI 10.1152/jn.1994.72.5.2070; Zacksenhouse M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000619; Zhang H, 2010, IEEE ENG MED BIO, P4124, DOI 10.1109/IEMBS.2010.5627320	56	24	24	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52173	10.1371/journal.pone.0052173	http://dx.doi.org/10.1371/journal.pone.0052173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300606	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100026
J	Mathot, L; Falk-Sorqvist, E; Moens, L; Allen, M; Sjoblom, T; Nilsson, M				Mathot, Lucy; Falk-Sorqvist, Elin; Moens, Lotte; Allen, Marie; Sjoblom, Tobias; Nilsson, Mats			Automated Genotyping of Biobank Samples by Multiplex Amplification of Insertion/Deletion Polymorphisms	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; DNA FRAGMENTS; ANEUPLOIDY; MARKERS; CANCER; MLGA	The genomic revolution in oncology will entail mutational analyses of vast numbers of patient-matched tumor and normal tissue samples. This has meant an increased risk of patient sample mix up due to manual handling. Therefore, scalable genotyping and sample identification procedures are essential to pathology biobanks. We have developed an efficient alternative to traditional genotyping methods suited for automated analysis. By targeting 53 prevalent deletions and insertions found in human populations with fluorescent multiplex ligation dependent genome amplification, followed by separation in a capillary sequencer, a peak spectrum is obtained that can be automatically analyzed. 24 tumor-normal patient samples were successfully matched using this method. The potential use of the developed assay for forensic applications is discussed.	[Mathot, Lucy; Falk-Sorqvist, Elin; Moens, Lotte; Allen, Marie; Sjoblom, Tobias; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden	Uppsala University; Stockholm University	Nilsson, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	mats.nilsson@scilifelab.se	Mathot, Lucy/AAF-1463-2020		Swedish research council, VINNOVA; Innovative Medicines Initiative Joint Undertaking [115234]; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations)	Swedish research council, VINNOVA(Swedish Research CouncilVinnova); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations)	This work has been supported by grants from the Swedish research council, VINNOVA and the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115234 (OncoTrack), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA (European Federation of Pharmaceutical Industries and Associations) companies in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckleton J, 2005, FORENSIC SCI INT, V152, P115, DOI 10.1016/j.forsciint.2004.07.020; CHAKRABORTY R, 1988, GENETICS, V118, P527; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Fondevila M, 2012, INT J LEGAL MED, V126, P725, DOI 10.1007/s00414-012-0721-7; Friis SL, 2012, FORENSIC SCI INT-GEN, V6, pE72, DOI 10.1016/j.fsigen.2011.08.002; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Isaksson M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm651; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Mathot L, 2011, CHEM COMMUN, V47, P547, DOI 10.1039/c0cc02248a; Nei M., 1987, MOL EVOLUTIONARY GEN; Pereira R, 2009, ELECTROPHORESIS, V30, P3682, DOI 10.1002/elps.200900274; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Stenberg J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni071; Stenberg J, 2009, BIOINFORMATICS, V25, P666, DOI 10.1093/bioinformatics/btp001; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wyatt AW, 2009, MOL VIS, V15, P1445	22	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52750	10.1371/journal.pone.0052750	http://dx.doi.org/10.1371/journal.pone.0052750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300761	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100077
J	Traynham, CJ; Roof, SR; Wang, HL; Prosak, RA; Tang, LF; Viatchenko-Karpinski, S; Ho, HT; Racoma, IO; Catalano, DJ; Huang, X; Han, YB; Kim, SU; Gyorke, S; Billman, GE; Villamena, FA; Ziolo, MT				Traynham, Christopher J.; Roof, Steve R.; Wang, Honglan; Prosak, Robert A.; Tang, Lifei; Viatchenko-Karpinski, Serge; Ho, Hsiang-Ting; Racoma, Ira O.; Catalano, Dominic J.; Huang, Xin; Han, Yongbin; Kim, Shang-U; Gyorke, Sandor; Billman, George E.; Villamena, Frederick A.; Ziolo, Mark T.			Diesterified Nitrone Rescues Nitroso-Redox Levels and Increases Myocyte Contraction Via Increased SR Ca2+ Handling	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RADICAL-ANION ADDUCT; MITOCHONDRIAL ELECTRON-TRANSPORT; SUDDEN CARDIAC DEATH; OXYGEN-FREE RADICALS; HEART-FAILURE; XANTHINE-OXIDASE; VENTRICULAR MYOCYTES; PHOSPHOLAMBAN PHOSPHORYLATION; UNIMOLECULAR DECOMPOSITION	Nitric oxide (NO) and superoxide (O-2(-)) are important cardiac signaling molecules that regulate myocyte contraction. For appropriate regulation, NO and O-2(center dot-) must exist at defined levels. Unfortunately, the NO and O-2(center dot-) levels are altered in many cardiomyopathies (heart failure, ischemia, hypertrophy, etc.) leading to contractile dysfunction and adverse remodeling. Hence, rescuing the nitroso-redox levels is a potential therapeutic strategy. Nitrone spin traps have been shown to scavenge O-2(center dot-) while releasing NO as a reaction byproduct; and we synthesized a novel, cell permeable nitrone, 2-2-3,4-dihydro-2H-pyrrole 1-oxide (EMEPO). We hypothesized that EMEPO would improve contractile function in myocytes with altered nitroso-redox levels. Ventricular myocytes were isolated from wildtype (C57Bl/6) and NOS1 knockout (NOS1(-/-)) mice, a known model of NO/O-2(center dot-) imbalance, and incubated with EMEPO. EMEPO significantly reduced O-2(center dot-) (lucigenin-enhanced chemiluminescence) and elevated NO (DAF-FM diacetate) levels in NOS1(-/-) myocytes. Furthermore, EMEPO increased NOS1(-/-) myocyte basal contraction (Ca2+ transients, Fluo-4AM; shortening, video-edge detection), the force-frequency response and the contractile response to beta-adrenergic stimulation. EMEPO had no effect in wildtype myocytes. EMEPO also increased ryanodine receptor activity (sarcoplasmic reticulum Ca2+ leak/load relationship) and phospholamban Serine16 phosphorylation (Western blot). We also repeated our functional experiments in a canine post-myocardial infarction model and observed similar results to those seen in NOS1(-/-) myocytes. In conclusion, EMEPO improved contractile function in myocytes experiencing an imbalance of their nitroso-redox levels. The concurrent restoration of NO and O-2(center dot-) levels may have therapeutic potential in the treatment of various cardiomyopathies.	[Traynham, Christopher J.; Roof, Steve R.; Wang, Honglan; Tang, Lifei; Viatchenko-Karpinski, Serge; Catalano, Dominic J.; Huang, Xin; Gyorke, Sandor; Billman, George E.; Ziolo, Mark T.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Prosak, Robert A.; Ho, Hsiang-Ting; Racoma, Ira O.; Han, Yongbin; Kim, Shang-U; Villamena, Frederick A.] Ohio State Univ, Dept Pharmacol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziolo, MT (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	ziolo.1@osu.edu	Ziolo, Mark/E-4371-2011; Villamena, Frederick/E-4248-2011; Billman, George E/E-2758-2011	Villamena, Frederick/0000-0002-7330-8431; Catalano, Dominic/0000-0002-5736-7888	National Institutes of Health [R01-HL079283, K02-HL094692, R01-HL81248, F31 HL096435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079283, F31HL096435, K02HL094692, R01HL081248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (R01-HL079283, K02-HL094692, MTZ; R01-HL81248, FAV; F31 HL096435 CJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Floyd RA, 2000, ANN NY ACAD SCI, V899, P222; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hare JM, 2008, J AM COLL CARDIOL, V51, P2301, DOI 10.1016/j.jacc.2008.01.068; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; INANAMI O, 1995, FREE RADICAL RES, V23, P33, DOI 10.3109/10715769509064017; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Kogler H, 2003, CARDIOVASC RES, V59, P582, DOI 10.1016/S0008-6363(03)00512-1; Kohr Mark J, 2010, Front Biosci (Elite Ed), V2, P614, DOI 10.2741/e118; Kohr MJ, 2010, J MOL CELL CARDIOL, V48, P645, DOI 10.1016/j.yjmcc.2010.01.007; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Liu Y, 2010, MOL CELL BIOCHEM, V343, P143, DOI 10.1007/s11010-010-0508-4; Locigno EJ, 2005, ORG BIOMOL CHEM, V3, P3220, DOI 10.1039/b507530k; Nediani C, 2011, ANTIOXID REDOX SIGN, V14, P289, DOI 10.1089/ars.2010.3198; Roof SR, 2012, NITRIC OXID IN PRESS; Roof SR, 2011, AM J PHYSIOL-HEART C, V301, pH1570, DOI 10.1152/ajpheart.00402.2011; Saavedra WF, 2002, CIRC RES, V90, P297, DOI 10.1161/hh0302.104531; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Villamena FA, 2005, J PHYS CHEM A, V109, P1662, DOI 10.1021/jp0451492; Villamena FA, 2010, J PHYS CHEM A, V114, P1153, DOI 10.1021/jp909614u; Villamena FA, 2009, J PHYS CHEM A, V113, P6398, DOI 10.1021/jp902269t; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wildhirt SM, 1999, CARDIOVASC RES, V43, P698, DOI 10.1016/S0008-6363(99)00080-2; Xie H, 2006, BIOPHYS J, V91, P2882, DOI 10.1529/biophysj.106.087338; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2009, BBA-BIOENERGETICS, V1787, P811, DOI 10.1016/j.bbabio.2009.03.020; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Ziolo MT, 2004, CIRCULATION, V109, P1886, DOI 10.1161/01.CIR.0000124231.98250.A8; Zuo L, 2009, J PHARMACOL EXP THER, V329, P515, DOI 10.1124/jpet.108.143479	50	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52005	10.1371/journal.pone.0052005	http://dx.doi.org/10.1371/journal.pone.0052005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300588	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100017
J	Nojima, T; Konno, H; Kodera, N; Seio, K; Taguchi, H; Yoshida, M				Nojima, Tatsuya; Konno, Hiroki; Kodera, Noriyuki; Seio, Kohji; Taguchi, Hideki; Yoshida, Masasuke			Nano-Scale Alignment of Proteins on a Flexible DNA Backbone	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ATOMIC-FORCE MICROSCOPY; NANOSTRUCTURES; VARIANT; FRET	Nano-scale alignment of several proteins with freedom of motion is equivalent to an enormous increase in effective local concentration of proteins and will enable otherwise impossible weak and/or cooperative associations between them or with their ligands. For this purpose, a DNA backbone made of six oligodeoxynucleotide (ODN) chains is designed in which five double-stranded segments are connected by four single-stranded flexible linkers. A desired protein with an introduced cysteine is connected covalently to the 5'-end of azido-ODN by catalyst-free click chemistry. Then, six protein-ODN conjugates are assembled with their complementary nucleotide sequences into a single multi-protein-DNA complex, and six proteins are aligned along the DNA backbone. Flexible alignment of proteins is directly observed by high-speed AFM imaging, and association of proteins with weak interaction is demonstrated by fluorescence resonance energy transfer between aligned proteins.	[Nojima, Tatsuya; Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 603, Japan; [Konno, Hiroki; Kodera, Noriyuki] Kanazawa Univ, Inst Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa, Japan; [Seio, Kohji] Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 227, Japan; [Taguchi, Hideki] Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 227, Japan	Kyoto Sangyo University; Kanazawa University; Tokyo Institute of Technology; Tokyo Institute of Technology	Nojima, T (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan.	nojima.t.aa@m.titech.ac.jp	Kodera, Noriyuki/AAJ-1797-2020; Seio, Kohji/Y-8597-2018; Taguchi, Hideki/B-6946-2009; Nojima, Tatsuya/S-4325-2019; Kodera, Noriyuki/E-6569-2015; Nojima, Tatsuya/E-9741-2017	Seio, Kohji/0000-0001-5258-4763; Taguchi, Hideki/0000-0002-6612-9339; Nojima, Tatsuya/0000-0002-0422-0225; Kodera, Noriyuki/0000-0003-4880-8423; Nojima, Tatsuya/0000-0002-0422-0225	Ministry of Education, Culture, Sports, Science and Technology, Japan [19058004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (No. 19058004 to M. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Erkelenz M, 2011, J AM CHEM SOC, V133, P16111, DOI 10.1021/ja204993s; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Kukolka F, 2004, ORG BIOMOL CHEM, V2, P2203, DOI 10.1039/b406492e; Liu Z, 2005, J MICROSC-OXFORD, V218, P233, DOI 10.1111/j.1365-2818.2005.01482.x; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Muller J, 2008, BIOCHEM BIOPH RES CO, V377, P62, DOI 10.1016/j.bbrc.2008.09.078; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakata E, 2012, ANGEW CHEM INT EDIT, V51, P2421, DOI 10.1002/anie.201108199; Niemeyer CM, 1998, ANGEW CHEM INT EDIT, V37, P2265, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2265::AID-ANIE2265>3.0.CO;2-F; Numajiri K, 2010, J AM CHEM SOC, V132, P9937, DOI 10.1021/ja104702q; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Tepper AWJW, 2010, J AM CHEM SOC, V132, P6550, DOI 10.1021/ja101515y; Vinkenborg JL, 2007, CHEMBIOCHEM, V8, P1119, DOI 10.1002/cbic.200700109; Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/NNANO.2009.50, 10.1038/nnano.2009.50]; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	21	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52534	10.1371/journal.pone.0052534	http://dx.doi.org/10.1371/journal.pone.0052534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300700	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800102
J	Zeng, WB; Chen, YC; Bai, Y; Trang, P; Vu, GP; Lu, SW; Wu, JG; Liu, FY				Zeng, Wenbo; Chen, Yuan-Chuan; Bai, Yong; Phong Trang; Gia-Phong Vu; Lu, Sangwei; Wu, Jianguo; Liu, Fenyong			Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme	PLOS ONE			English	Article							EXTERNAL GUIDE SEQUENCES; IN-VITRO SELECTION; HIV-1 REPLICATION; ESCHERICHIA-COLI; MESSENGER-RNA; CATALYTIC SUBUNIT; CURRENT PROGRESS; GENE-EXPRESSION; RIBONUCLEASE-P; ENZYME	Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that efficiently cleave an mRNA sequence in vitro. In this study, a variant was used to target the HIV RNA sequence in the tat region. The variant cleaved the tat RNA sequence in vitro about 20 times more efficiently than the wild type ribozyme. Our results provide the first direct evidence that combined mutations at nucleotide 83 and 340 of RNase P catalytic RNA from Escherichia coli (G(83) - > U-83 and G(340) -> A(340)) increase the overall efficiency of the ribozyme in cleaving an HIV RNA sequence. Moreover, the variant is more effective in reducing HIV-1 p24 expression and intracellular viral RNA level in cells than the wild type ribozyme. A reduction of about 90% in viral RNA level and a reduction of 150 fold in viral growth were observed in cells that expressed the variant, while a reduction of less than 10% was observed in cells that either did not express the ribozyme or produced a catalytically inactive ribozyme mutant. Thus, engineered ribozyme variants are effective in inhibiting HIV infection. These results also demonstrate the potential of engineering RNase P ribozymes for anti-HIV application.	[Zeng, Wenbo; Wu, Jianguo; Liu, Fenyong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Chen, Yuan-Chuan; Gia-Phong Vu; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Bai, Yong; Phong Trang; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lu, SW (corresponding author), Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA.	sangwei@berkeley.edu; jwu@whu.edu.cn; liu_fy@berkeley.edu	Vu, Gia-Phong/HCH-7906-2022; Zeng, Wen/GPS-8058-2022	Wu, Jianguo/0000-0002-8326-2895	Block Grant Predoctoral Fellowship (UC-Berkeley); National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 81171525]; National Mega Project on Major Infectious Disease Prevention of China [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development of China [2011ZX09401-302]; NIH [AI041927, AI091536, DE014842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927, R56AI091536, R01AI091536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	Block Grant Predoctoral Fellowship (UC-Berkeley); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention of China; National Mega Project on Major Drug Development of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Y. C. and G. V. were partially supported by a Block Grant Predoctoral Fellowship (UC-Berkeley). This research has been supported by grants from National Basic Research Program of China (973 Program, No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, and 81171525), National Mega Project on Major Infectious Disease Prevention of China (2012ZX10002006-003 and 2012ZX10004-207), National Mega Project on Major Drug Development of China (2011ZX09401-302), and NIH (AI041927, AI091536, and DE014842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Altman S., 1999, RNA WORLD, P351; Anderson J, 2003, AIDS RES HUM RETROV, V19, P699, DOI 10.1089/088922203322280928; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bertrand E, 1997, RNA, V3, P75; BERZALHERRANZ A, 1992, GENE DEV, V6, P129, DOI 10.1101/gad.6.1.129; Chung J, 2011, FUTURE VIROL, V6, P1319, DOI 10.2217/FVL.11.113; Cobaleda C, 2000, BLOOD, V95, P731, DOI 10.1182/blood.V95.3.731.003k28_731_737; Daftarian PM, 1996, J IMMUNOL, V157, P12; Ditzler MA, 2011, NUCLEIC ACIDS RES, V39, P8237, DOI 10.1093/nar/gkr381; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; FRANK DN, 1994, BIOCHEMISTRY-US, V33, P10800, DOI 10.1021/bi00201a030; Freed E., 2007, FIELDS VIROLOGY, P2108; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; GOPALAN V, 2006, RNA WORLD; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Held DM, 2006, FRONT BIOSCI-LANDMRK, V11, P89, DOI 10.2741/1782; Ikeda M, 2006, NUCLEOS NUCLEOT NUCL, V25, P427, DOI 10.1080/01457630600684120; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kilani AF, 2000, J BIOL CHEM, V275, P10611, DOI 10.1074/jbc.275.14.10611; Kim JJ, 1997, RNA, V3, P613; Kraus G, 2002, P NATL ACAD SCI USA, V99, P3406, DOI 10.1073/pnas.052651199; Kurtizkes D., 2007, FIELDS VIROLOGY, P2188; Lan N, 1998, SCIENCE, V280, P1593, DOI 10.1126/science.280.5369.1593; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Tang J, 1997, RNA, V3, P914; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trang P, 2000, J MOL BIOL, V301, P817, DOI 10.1006/jmbi.2000.4022; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Wiebusch L, 2004, J GEN VIROL, V85, P179, DOI 10.1099/vir.0.19453-0; Wong-Staal F, 1998, HUM GENE THER, V9, P2407, DOI 10.1089/hum.1998.9.16-2407; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; YU M, 1993, P NATL ACAD SCI USA, V90, P6340, DOI 10.1073/pnas.90.13.6340; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; ZHOU C, 1994, GENE, V149, P33; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149	52	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51855	10.1371/journal.pone.0051855	http://dx.doi.org/10.1371/journal.pone.0051855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300569	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800031
J	Stockdale, SR; Mahony, J; Courtin, P; Chapot-Chartier, MP; van Pijkeren, JP; Britton, RA; Neve, H; Heller, KJ; Aideh, B; Vogensen, FK; van Sinderen, D				Stockdale, Stephen R.; Mahony, Jennifer; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; van Pijkeren, Jan-Peter; Britton, Robert A.; Neve, Horst; Heller, Knut J.; Aideh, Bashir; Vogensen, Finn K.; van Sinderen, Douwe			The Lactococcal Phages Tuc2009 and TP901-1 Incorporate Two Alternate Forms of Their Tail Fiber into Their Virions for Infection Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; CONTROLLED GENE-EXPRESSION; BACILLUS-SUBTILIS; ELECTRON-MICROSCOPY; MEMBRANE-RECEPTOR; PEPTIDOGLYCAN STRUCTURE; ESCHERICHIA-COLI; LAMBDA-RECEPTOR; TAPE MEASURE; PROTEIN-GPJ	Lactococcal phages Tuc2009 and TP901-1 possess a conserved tail fiber called a tail-associated lysin (referred to as Tal(2009) for Tuc2009, and Tal(901-1) for TP901-1), suspended from their tail tips that projects a peptidoglycan hydrolase domain toward a potential host bacterium. Tal(2009) and Tal(901-1) can undergo proteolytic processing mid-protein at the glycine-rich sequence GG(S/N)SGGG, removing their C-terminal structural lysin. In this study, we show that the peptidoglycan hydrolase of these Tal proteins is an M23 peptidase that exhibits D-Ala-D-Asp endopeptidase activity and that this activity is required for efficient infection of stationary phase cells. Interestingly, the observed proteolytic processing of Tal(2009) and Tal(901-1) facilitates increased host adsorption efficiencies of the resulting phages. This represents, to the best of our knowledge, the first example of tail fiber proteolytic processing that results in a heterogeneous population of two phage types. Phages that possess a full-length tail fiber, or a truncated derivative, are better adapted to efficiently infect cells with an extensively cross-linked cell wall or infect with increased host-adsorption efficiencies, respectively.	[Stockdale, Stephen R.; Mahony, Jennifer; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, UMR1319 Micalis, Jouy En Josas, France; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [van Pijkeren, Jan-Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Neve, Horst; Heller, Knut J.] Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany; [Aideh, Bashir; Vogensen, Finn K.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark	University College Cork; University College Cork; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Michigan State University; University of Copenhagen	van Sinderen, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	d.vansinderen@ucc.ie	mahony, jennifer/AAG-8357-2020; Van Sinderen, Douwe/A-6778-2015; van Pijkeren, Jan-Peter/H-5333-2019; Vogensen, Finn/E-1245-2015	mahony, jennifer/0000-0001-5846-6303; Van Sinderen, Douwe/0000-0003-1823-7957; Vogensen, Finn/0000-0003-2151-7802; Stockdale, Stephen/0000-0002-0044-3878; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); Region Ile de France; Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages); Science Foundation Ireland Principal Investigatorship award [08/IN.1/B1909]	Institut National de la Recherche Agronomique (INRA); Region Ile de France(Region Ile-de-France); Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages)(French National Research Agency (ANR)); Science Foundation Ireland Principal Investigatorship award(Science Foundation Ireland)	This work was supported by Institut National de la Recherche Agronomique (INRA), Region Ile de France, and Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages).; A recipient of a Science Foundation Ireland Principal Investigatorship award (Ref. No. 08/IN.1/B1909). To whom correspondence should be addressed: Dept. of Microbiology and Alimentary Pharmabiotic Centre, University College Cork, Ireland. Tel.: 353-21-4901365; E-mail: d.vansinderen@ucc.ie.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; ARENDT EK, 1994, APPL ENVIRON MICROB, V60, P1875, DOI 10.1128/AEM.60.6.1875-1883.1994; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Bebeacua C, 2013, J VIROL, V87, P1061, DOI 10.1128/JVI.02836-12; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Berkane E, 2006, BIOCHEMISTRY-US, V45, P2708, DOI 10.1021/bi051800v; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; BRAUN V, 1989, J GEN MICROBIOL, V135, P2551; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; CHRISTIANSEN B, 1994, J BACTERIOL, V176, P1069, DOI 10.1128/JB.176.4.1069-1076.1994; Costello V., 1988, THESIS NATL U IRELAN; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; Gurnev PA, 2006, J MOL BIOL, V359, P1447, DOI 10.1016/j.jmb.2006.04.034; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Jakutyte L, 2012, VIROLOGY, V422, P425, DOI 10.1016/j.virol.2011.11.010; JOHNSEN MG, 1995, VIROLOGY, V212, P595, DOI 10.1006/viro.1995.1517; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Mahony J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00335; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P208, DOI 10.1128/AEM.59.1.208-212.1993; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rodriguez-Rubio L, 2012, CRIT REV MICROBIOL; ROESSNER CA, 1986, J BIOL CHEM, V261, P386; ROESSNER CA, 1984, J BACTERIOL, V157, P165, DOI 10.1128/JB.157.1.165-170.1984; ROESSNER CA, 1983, J BACTERIOL, V153, P1528, DOI 10.1128/JB.153.3.1528-1534.1983; SANDERS ME, 1980, APPL ENVIRON MICROB, V40, P500, DOI 10.1128/AEM.40.3.500-506.1980; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Seegers JFML, 2004, VIROLOGY, V329, P40, DOI 10.1016/j.virol.2004.07.003; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sudiarta IP, 2010, J BIOL CHEM, V285, P41232, DOI 10.1074/jbc.M110.156273; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	62	67	68	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5581	5590		10.1074/jbc.M112.444901	http://dx.doi.org/10.1074/jbc.M112.444901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300085	Green Published, hybrid			2022-12-25	WOS:000315342500032
J	Funakoshi-Tago, M; Sumi, K; Kasahara, T; Tago, K				Funakoshi-Tago, Megumi; Sumi, Kazuya; Kasahara, Tadashi; Tago, Kenji			Critical Roles of Myc-ODC Axis in the Cellular Transformation Induced by Myeloproliferative Neoplasm-Associated JAK2 V617F Mutant	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; C-MYC; ORNITHINE-DECARBOXYLASE; POLYCYTHEMIA-VERA; NUDE-MICE; ESSENTIAL THROMBOCYTHEMIA; LEUKEMIA CELLS; CYCLE ARREST; FERM DOMAIN; PROTEIN	The acquired mutation (V617F) of Janus kinase 2 (JAK2) is observed in the majority of patients with myeloproliferative neoplasms (MPNs). In the screening of genes whose expression was induced by JAK2 (V617F), we found the significant induction of c-Myc mRNA expression mediated by STAT5 activation. Interestingly, GSK-3 beta was inactivated in transformed Ba/F3 cells by JAK2 (V617F), and this enhanced the protein expression of c-Myc. The enforced expression of c-Myc accelerated cell proliferation but failed to inhibit apoptotic cell death caused by growth factor deprivation; however, the inhibition of GSK-3 beta completely inhibited the apoptosis of cells expressing c-Myc. Strikingly, c-Myc T58A mutant exhibited higher proliferative activity in a growth-factor-independent manner; however, this mutant failed to induce apoptosis. In addition, knockdown of c-Myc significantly inhibited the proliferation of transformed cells by JAK2 (V617F), suggesting that c-Myc plays an important role in oncogenic activity of JAK2 (V617F). Furthermore, JAK2 (V617F) induced the expression of a target gene of c-Myc, ornithine decarboxylase (ODC), known as the rate-limiting enzyme in polyamine biosynthesis. An ODC inhibitor, difluoromethylornithine (DFMO), prevented the proliferation of transformed cells by JAK2 (V617F). Importantly, administration of DFMO effectively delayed tumor formation in nude mice inoculated with transformed cells by JAK2 (V617F), resulting in prolonged survival; therefore, ODC expression through c-Myc is a critical step for JAK2 (V617F)-induced transformation and DFMO could be used as effective therapy for MPNs.	[Funakoshi-Tago, Megumi; Sumi, Kazuya; Kasahara, Tadashi] Keio Univ, Fac Pharmacol, Dept Biochem, Tokyo, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, Shimotsuke Shi, Japan	Keio University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharmacol, Dept Biochem, Tokyo, Japan.	tago-mg@pha.keio.ac.jp; ktago@jichi.ac.jp			MEXT [21790090]; Takeda Science Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants (21790090) from MEXT and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Auvinen M, 1997, CANCER RES, V57, P3016; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Choi SH, 2000, LEUKEMIA RES, V24, P119, DOI 10.1016/S0145-2126(99)00161-7; Cohen S.S., 1997, GUIDE POLYAMINES; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DESSER H, 1975, CLIN CHIM ACTA, V63, P243, DOI 10.1016/0009-8981(75)90044-3; Fozard J. R, 1980, EUR J PHARMACOL, V65, P79; FOZARD JR, 1980, SCIENCE, V208, P505; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Furuhata A, 2009, BIOCHEM BIOPH RES CO, V383, P411, DOI 10.1016/j.bbrc.2009.04.015; Ho Kevin, 2010, J Assoc Genet Technol, V36, P107; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamishimoto J, 2011, CELL SIGNAL, V23, P849, DOI 10.1016/j.cellsig.2011.01.009; Karlsson H, 1999, MOL CELL ENDOCRINOL, V154, P37, DOI 10.1016/S0303-7207(99)00101-X; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Ravanko K, 2000, CANCER RES, V60, P5244; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Theophile K, 2008, ANN HEMATOL, V87, P263, DOI 10.1007/s00277-007-0424-1; Wallace HM, 2009, ESSAYS BIOCHEM, V46, P1, DOI [10.1042/BSE0460001, 10.1042/bse0460001]; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108	50	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52844	10.1371/journal.pone.0052844	http://dx.doi.org/10.1371/journal.pone.0052844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300995	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000017
J	Bleckley, S; Stone, JW; Schroeder, SJ				Bleckley, Samuel; Stone, Jonathan W.; Schroeder, Susan J.			Crumple: A Method for Complete Enumeration of All Possible Pseudoknot-Free RNA Secondary Structures	PLOS ONE			English	Article							DYNAMIC-PROGRAMMING ALGORITHM; TOBACCO-MOSAIC-VIRUS; STRUCTURE PREDICTION; INCLUDING PSEUDOKNOTS; WEB SERVER; THERMODYNAMIC STABILITIES; TRYPANOSOMA-BRUCEI; PARTITION-FUNCTION; COAT PROTEIN; HELICAL RNA	The diverse landscape of RNA conformational space includes many canyons and crevices that are distant from the lowest minimum free energy valley and remain unexplored by traditional RNA structure prediction methods. A complete description of the entire RNA folding landscape can facilitate identification of biologically important conformations. The Crumple algorithm rapidly enumerates all possible non-pseudoknotted structures for an RNA sequence without consideration of thermodynamics while filtering the output with experimental data. The Crumple algorithm provides an alternative approach to traditional free energy minimization programs for RNA secondary structure prediction. A complete computation of all non-pseudoknotted secondary structures can reveal structures that would not be predicted by methods that sample the RNA folding landscape based on thermodynamic predictions. The free energy minimization approach is often successful but is limited by not considering RNA tertiary and protein interactions and the possibility that kinetics rather than thermodynamics determines the functional RNA fold. Efficient parallel computing and filters based on experimental data make practical the complete enumeration of all non-pseudoknotted structures. Efficient parallel computing for Crumple is implemented in a ring graph approach. Filters for experimental data include constraints from chemical probing of solvent accessibility, enzymatic cleavage of paired or unpaired nucleotides, phylogenetic covariation, and the minimum number and lengths of helices determined from crystallography or cryo-electron microscopy. The minimum number and length of helices has a significant effect on reducing conformational space. Pairing constraints reduce conformational space more than single nucleotide constraints. Examples with Alfalfa Mosaic Virus RNA and Trypanosome brucei guide RNA demonstrate the importance of evaluating all possible structures when pseduoknots, RNA-protein interactions, and metastable structures are important for biological function. Crumple software is freely available at http://adenosine.chem.ou.edu/software.html.	[Bleckley, Samuel; Stone, Jonathan W.; Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	susan.schroeder@ou.edu		Schroeder, Susan/0000-0003-4755-2294	National Science Foundation CAREER Award [0844913]; Div Of Molecular and Cellular Bioscience [0844913] Funding Source: National Science Foundation	National Science Foundation CAREER Award(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation CAREER Award # 0844913, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Bloomfield V, 2000, CHEM ENZYMATIC METHO, P45; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Byun Y, 2009, BIOINFORMATICS, V25, P1435, DOI 10.1093/bioinformatics/btp252; DIJKSTRA EW, 1980, INFORM PROCESS LETT, V11, P1, DOI 10.1016/0020-0190(80)90021-6; Dinan J, 2007, DYNAMIC LOAD BALANCI; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Forum M, 1994, MPI MESS PASS INT ST; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guogas LM, 2004, SCIENCE, V306, P2108, DOI 10.1126/science.1103399; Gupta A, 2012, RNA BIOL, V9, DOI [10.4161/rna.18386, 10.4161/rna.9.2.18386]; HE L, 1991, BIOCHEMISTRY-US, V30, P11124, DOI 10.1021/bi00110a015; Hofacker IL, 2010, RNA, V16, P1308, DOI 10.1261/rna.2093310; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; LARSON SB, 1993, NATURE, V361, P179, DOI 10.1038/361179a0; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003665; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McDowell JA, 1997, BIOCHEMISTRY-US, V36, P8030, DOI 10.1021/bi970122c; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Nguyen MT, 2010, BIOCHEMISTRY-US, V49, P10574, DOI 10.1021/bi101521p; PIPAS JM, 1975, P NATL ACAD SCI USA, V72, P2017, DOI 10.1073/pnas.72.6.2017; QUIGLEY GJ, 1984, NUCLEIC ACIDS RES, V12, P347, DOI 10.1093/nar/12.1Part1.347; Rastegari B, 2007, J COMPUT BIOL, V14, P16, DOI 10.1089/cmb.2006.0108; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Ruan JH, 2004, NUCLEIC ACIDS RES, V32, pW146, DOI 10.1093/nar/gkh444; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Schroeder SJ, 2009, J VIROL, V83, P6326, DOI 10.1128/JVI.00251-09; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52414	10.1371/journal.pone.0052414	http://dx.doi.org/10.1371/journal.pone.0052414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300665	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100047
J	Daud-Gallotti, RM; Costa, SF; Guimaraes, T; Padilha, KG; Inoue, EN; Vasconcelos, TN; Rodrigues, FDC; Barbosa, EV; Figueiredo, WB; Levin, AS				Daud-Gallotti, Renata M.; Costa, Silvia F.; Guimaraes, Thais; Padilha, Katia Grillo; Inoue, Evelize Naomi; Vasconcelos, Tiago Nery; Cunha Rodrigues, Fernanda da Silva; Barbosa, Edizangela Vasconcelos; Figueiredo, Walquiria Barcelos; Levin, Anna S.			Nursing Workload as a Risk Factor for Healthcare Associated Infections in ICU: A Prospective Study	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SCORE; MANAGEMENT; OUTCOMES; ERROR	Introduction: Nurse understaffing is frequently hypothesized as a potential risk factor for healthcare-associated infections (HAI). This study aimed to evaluate the role of nursing workload in the occurrence of HAI, using Nursing Activities Score (NAS). Methods: This prospective cohort study enrolled all patients admitted to 3 Medical ICUs and one step-down unit during 3 months (2009). Patients were followed-up until HAI, discharge or death. Information was obtained from direct daily observation of medical and nursing rounds, chart review and monitoring of laboratory system. Nursing workload was determined using NAS. Non-compliance to the nurses' patient care plans (NPC) was identified. Demographic data, clinical severity, invasive procedures, hospital interventions, and the occurrence of other adverse events were also recorded. Patients who developed HAI were compared with those who did not. Results: 195 patients were included and 43 (22%) developed HAI: 16 pneumonia, 12 urinary-tract, 8 bloodstream, 2 surgical site, 2 other respiratory infections and 3 other. Average NAS and average proportion of non compliance with NPC were significantly higher in HAI patients. They were also more likely to suffer other adverse events. Only excessive nursing workload (OR: 11.41; p: 0.019) and severity of patient's clinical condition (OR: 1.13; p: 0.015) remained as risk factors to HAI. Conclusions: Excessive nursing workload was the main risk factor for HAI, when evaluated together with other invasive devices except mechanical ventilation. To our knowledge, this study is the first to evaluate prospectively the nursing workload as a potential risk factor for HAI, using NAS.	[Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Fac Med, LIM 54, Sao Paulo, Brazil; [Daud-Gallotti, Renata M.] Univ Nove Julho, Fac Med, Sao Paulo, Brazil; [Daud-Gallotti, Renata M.] Univ Sao Paulo, Humanizat Tech Div, Hosp Clin, Sao Paulo, Brazil; [Guimaraes, Thais; Levin, Anna S.] Univ Sao Paulo, Dept Infect Control, Hosp Clin, Fac Med, Sao Paulo, Brazil; [Padilha, Katia Grillo] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Barbosa, Edizangela Vasconcelos; Figueiredo, Walquiria Barcelos] Univ Sao Paulo, Nursing Div, Fac Med, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Levin, AS (corresponding author), Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.	gcih.adm@hc.fm.usp.br	Costa, Silvia F/K-4768-2012; Levin, Anna S./AAJ-1712-2021; Figueiredo Costa, silvia/ABC-7704-2021; Guimarães, Thais/C-7134-2014; Padilha, Katia/J-6798-2012; Levin, Anna S/C-8831-2012	Costa, Silvia F/0000-0003-1087-752X; Levin, Anna S./0000-0003-2427-8368; Figueiredo Costa, silvia/0000-0003-1087-752X; Guimarães, Thais/0000-0002-7282-5453; Padilha, Katia/0000-0002-6440-4667; Levin, Anna S/0000-0003-2427-8368; Reis Barbosa, Egberto/0000-0002-6996-9130	Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/00955-2]	Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	This study was funded by the Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)-grant number 2008/00955-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Shoana, 2012, Morbidity and Mortality Weekly Report, V61, P501; [Anonymous], 2008, SUMM EV PAT SAF IMPL; Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Blatnik J, 2006, J HOSP INFECT, V63, P162, DOI 10.1016/j.jhin.2005.11.013; Centers for Disease Control and Prevention, PROT PAT PREV HARM I; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cimiotti JP, 2012, AM J INFECT CONTROL, V40, P486, DOI 10.1016/j.ajic.2012.02.029; Coffin SE, 2008, INFECT CONT HOSP EP, V29, pS31, DOI 10.1086/591062; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Daud-Gallotti R, 2005, EUR J EMERG MED, V12, P63, DOI 10.1097/00063110-200504000-00005; HIATT HH, 1989, NEW ENGL J MED, V321, P480, DOI 10.1056/NEJM198908173210725; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; KHON LT, 1999, ERR HUMAN BUILDING S; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lewin DI, 2005, ADV PATIENT SAFETY R, V2; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Lobo RD, 2010, AM J INFECT CONTROL, V38, P440, DOI 10.1016/j.ajic.2009.09.013; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P425; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Miranda DR, 2003, CRIT CARE MED, V31, P374, DOI 10.1097/01.CCM.0000045567.78801.CC; Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Stone PW, 2008, CLIN INFECT DIS, V47, P937, DOI 10.1086/591696; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; World Health Organization, 2008, 2 GLOB PAT SAF CHALL; World Health Organization, 2009, CONCEPTUAL FRAMEWORK	29	68	74	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52342	10.1371/journal.pone.0052342	http://dx.doi.org/10.1371/journal.pone.0052342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300645	Green Published, gold			2022-12-25	WOS:000312829100042
J	Di, Z; Herpers, B; Fredriksson, L; Yan, K; van de Water, B; Verbeek, FJ; Meerman, JHN				Di, Zi; Herpers, Bram; Fredriksson, Lisa; Yan, Kuan; van de Water, Bob; Verbeek, Fons J.; Meerman, John H. N.			Automated Analysis of NF-kappa B Nuclear Translocation Kinetics in High-Throughput Screening	PLOS ONE			English	Article							ACTIVATION; DYNAMICS; ALPHA; DETERMINES; PATHWAYS; P65	Nuclear entry and exit of the NF-kappa B family of dimeric transcription factors plays an essential role in regulating cellular responses to inflammatory stress. The dynamics of this nuclear translocation can vary significantly within a cell population and may dramatically change e.g. upon drug exposure. Furthermore, there is significant heterogeneity in individual cell response upon stress signaling. In order to systematically determine factors that define NF-kappa B translocation dynamics, high-throughput screens that enable the analysis of dynamic NF-kappa B responses in individual cells in real time are essential. Thus far, only NF-kappa B downstream signaling responses of whole cell populations at the transcriptional level are in high-throughput mode. In this study, we developed a fully automated image analysis method to determine the time-course of NF-kappa B translocation in individual cells, suitable for high-throughput screenings in the context of compound screening and functional genomics. Two novel segmentation methods were used for defining the individual nuclear and cytoplasmic regions: watershed masked clustering (WMC) and best-fit ellipse of Voronoi cell (BEVC). The dynamic NF kappa B oscillatory response at the single cell and population level was coupled to automated extraction of 26 analogue translocation parameters including number of peaks, time to reach each peak, and amplitude of each peak. Our automated image analysis method was validated through a series of statistical tests demonstrating computational efficient and accurate NF-kappa B translocation dynamics quantification of our algorithm. Both pharmacological inhibition of NF-kappa B and short interfering RNAs targeting the inhibitor of NF kappa B, I kappa B alpha, demonstrated the ability of our method to identify compounds and genetic players that interfere with the nuclear transition of NF-kappa B.	[Di, Zi; Herpers, Bram; Fredriksson, Lisa; van de Water, Bob; Meerman, John H. N.] Leiden Univ, Div Toxicol, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands; [Yan, Kuan; Verbeek, Fons J.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Meerman, JHN (corresponding author), Leiden Univ, Div Toxicol, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands.	meerman@lacdr.leidenuniv.nl	Herpers, Bram/P-1272-2014	Yan, Kuan/0000-0003-4143-3569	Netherlands Toxicogenomics Centre; TI Pharma [D3-201]	Netherlands Toxicogenomics Centre; TI Pharma	This work was supported by grants of the Netherlands Toxicogenomics Centre (http://toxicogenomics.nl) and TI Pharma http://www.tipharma.com), Project no. D3-201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fredriksson L, 2011, HEPATOLOGY, V53, P2027, DOI 10.1002/hep.24314; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; HADDAD RA, 1991, IEEE T SIGNAL PROCES, V39, P723, DOI 10.1109/78.80892; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kuan Yan, 2012, Leveraging Applications of Formal Methods, Verification and Validation. Applications and Case Studies. Proceedings of the 5th International Symposium, ISoLA 2012, P25, DOI 10.1007/978-3-642-34032-1_4; Kummel A, 2010, J BIOMOL SCREEN, V15, P95, DOI 10.1177/1087057109351311; Le Devedec SE, 2010, CELL MOL LIFE SCI, V67, P3219, DOI 10.1007/s00018-010-0419-2; Lee TK, 2010, CURR OPIN GENET DEV, V20, P677, DOI 10.1016/j.gde.2010.08.005; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mount E, 2005, SCI TECH NEWS, V59, P53; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang C, 2005, P WORKSH DIG IM COMP, P61; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Verbeek F. J., 2003, Proceedings of the SPIE - The International Society for Optical Engineering, V5304, P13, DOI 10.1117/12.527049; Verbeek FJ, 1995, THESIS DELFT U TECHN; Verbeek FJ, 2000, IMAGE PROCESSING PRA, P153; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52337	10.1371/journal.pone.0052337	http://dx.doi.org/10.1371/journal.pone.0052337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300644	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100041
J	Grothusen, C; Schuett, H; Hillmer, A; Lumpe, S; Grote, K; Ballmaier, M; Bleich, A; Glage, S; Tietge, UJF; Luchtefeld, M; Schieffer, B				Grothusen, Christina; Schuett, Harald; Hillmer, Anja; Lumpe, Stefan; Grote, Karsten; Ballmaier, Matthias; Bleich, Andre; Glage, Silke; Tietge, Uwe J. F.; Luchtefeld, Maren; Schieffer, Bernhard			Role of Suppressor of Cytokine Signaling-1 In Murine Atherosclerosis	PLOS ONE			English	Article							DEFICIENCY; MONOCYTES; SOCS1; HYPERLIPIDEMIA; LIPOPROTEINS; MACROPHAGES; EXPRESSION; MICE	Background: While the impact of inflammation as the substantial driving force of atherosclerosis has been investigated in detail throughout the years, the influence of negative regulators of pro-atherogenic pathways on plaque development has remained largely unknown. Suppressor of cytokine signaling (SOCS)-1 potently restricts transduction of various inflammatory signals and, thereby modulates T-cell development, macrophage activation and dendritic cell maturation. Its role in atherogenesis, however has not been elucidated so far. Methods and Results: Loss of SOCS-1 in the low-density lipoprotein receptor deficient murine model of atherosclerosis resulted in a complex, systemic and ultimately lethal inflammation with increased generation of Ly-6C(hi) monocytes and activated macrophages. Even short-term exposure of these mice to high-cholesterol dieting caused enhanced atherosclerotic plaque development with accumulation of M1 macrophages, Ly-6C positive cells and neutrophils. Conclusion: Our data not only imply that SOCS-1 is athero-protective but also emphasize the fundamental, regulatory importance of SOCS-1 in inflammation-prone organisms.	[Grothusen, Christina; Schuett, Harald; Hillmer, Anja; Lumpe, Stefan; Grote, Karsten; Luchtefeld, Maren; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Ballmaier, Matthias] Hannover Med Sch, Dept Pediat Haematol & Oncol, D-3000 Hannover, Germany; [Bleich, Andre; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9700 AB Groningen, Netherlands	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Groningen	Schieffer, B (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	Schieffer.Bernhard@mh-hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995; Grote, Karsten/0000-0001-7914-3159	German Heart Research Foundation [F23/2004]; german research foundation [SFB566]	German Heart Research Foundation; german research foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Heart Research Foundation (F23/2004) and the german research foundation grant (SFB566/project B9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Drevets DA, 2010, J IMMUNOL, V185, P2432, DOI 10.4049/jimmunol.1000486; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez-Leon MC, 2006, J ENDOTOXIN RES, V12, P296, DOI 10.1179/096805106X118843; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sachithanandan N, 2011, DIABETES, V60, P2023, DOI 10.2337/db11-0259; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang Y, 2011, J IMMUNOL, V186, P3093, DOI 10.4049/jimmunol.1002006	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51608	10.1371/journal.pone.0051608	http://dx.doi.org/10.1371/journal.pone.0051608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300554	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100010
J	Jang, HB; Kim, YK; del Castillo, CS; Nho, SW; Cha, IS; Park, SB; Ha, MA; Hikima, J; Hong, SJ; Aoki, T; Jung, TS				Jang, Ho Bin; Kim, Young Kyu; del Castillo, Carmelo S.; Nho, Seong Won; Cha, In Seok; Park, Seong Bin; Ha, Mi Ae; Hikima, Jun-ichi; Hong, Sung Jong; Aoki, Takashi; Jung, Tae Sung			RNA-Seq-Based Metatranscriptomic and Microscopic Investigation Reveals Novel Metalloproteases of Neobodo sp as Potential Virulence Factors for Soft Tunic Syndrome in Halocynthia roretzi	PLOS ONE			English	Article							EVOLUTIONARY FAMILIES; GEN.-NOV; SEQUENCE; SURFACE; KINETOPLASTIDS; LEISHMANIA; MORPHOLOGY; ENCYSTMENT; EUGLENOZOA; DIVERSITY	Bodonids and trypanosomatids are derived from a common ancestor with the bodonids being a more primitive lineage. The Neobodonida, one of the three clades of bodonids, can be free-living, commensal or parasitic. Despite the ecological and evolutionary significance of these organisms, however, many of their biological and pathological features are currently unknown. Here, we employed metatranscriptomics using RNA-seq technology combined with field-emission microscopy to reveal the virulence factors of a recently described genus of Neobodonida that is considered to be responsible for ascidian soft tunic syndrome (AsSTS), but whose pathogenesis is unclear. Our microscopic observation of infected tunic tissues suggested putative virulence factors, enabling us to extract novel candidate transcripts; these included cysteine proteases of the families C1 and C2, serine proteases of S51 and S9 families, and metalloproteases grouped into families M1, M3, M8, M14, M16, M17, M24, M41, and M49. Protease activity/inhibition assays and the estimation of expression levels within gene clusters allowed us to identify metalloprotease-like enzymes as potential virulence attributes for AsSTS. Furthermore, a multimarker-based phylogenetic analysis using 1,184 concatenated amino acid sequences clarified the order Neobodo sp. In sum, we herein used metatranscriptomics to elucidate the in situ expression profiles of uncharacterized putative transcripts of Neobodo sp., combined these results with microscopic observation to select candidate genes relevant to pathogenesis, and used empirical screening to define important virulence factors.	[Jang, Ho Bin; Kim, Young Kyu; del Castillo, Carmelo S.; Nho, Seong Won; Cha, In Seok; Park, Seong Bin; Ha, Mi Ae; Hikima, Jun-ichi; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Coll Vet Med, Aquat Biotechnol Ctr, WCU Project, Jinju, South Korea; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo, Japan; [Hong, Sung Jong] Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea	Gyeongsang National University; Waseda University; Chung Ang University; Chung Ang University Hospital	Jung, TS (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Aquat Biotechnol Ctr, WCU Project, Jinju, South Korea.	jungts@gnu.ac.kr	Hikima, Jun-ichi/AAI-6983-2020; Del Castillo, Carmelo/CAH-7345-2022; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946; del Castillo, Carmelo/0000-0001-6786-4004; Jang, Ho Bin/0000-0003-1316-316X	World Class University (WCU) Project [R32-10253]	World Class University (WCU) Project	This work was supported by World Class University (WCU) Project Grant R32-10253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2011, TRENDS PARASITOL, V27, P450, DOI 10.1016/j.pt.2011.06.003; Arner E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-391; Azumi K, 2007, ZOOL SCI, V24, P1231, DOI 10.2108/zsj.24.1231; Azumi K, 2007, FISHERIES SCI, V73, P263, DOI 10.1111/j.1444-2906.2007.01332.x; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BROOKER BE, 1972, PROTOPLASMA, V74, P397, DOI 10.1007/BF01281958; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Cha IS, 2011, DEV COMP IMMUNOL, V35, P809, DOI 10.1016/j.dci.2011.01.011; CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Choi DL, 2006, DIS AQUAT ORGAN, V72, P65, DOI 10.3354/dao072065; Cotrin SS, 2004, ANAL BIOCHEM, V335, P244, DOI 10.1016/j.ab.2004.09.012; Cubillos-Ruiz A, 2006, METAGENOMICS INTEGRA, P1; D'Avila-Levy CM, 2009, J EUKARYOT MICROBIOL, V56, P454, DOI 10.1111/j.1550-7408.2009.00424.x; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; DANSOHKAWA M, 1995, ZOOL SCI, V12, P289, DOI 10.2108/zsj.12.289; de Souza W, 2008, MICRON, V39, P77, DOI 10.1016/j.micron.2006.11.003; Deschamps P, 2011, MOL BIOL EVOL, V28, P53, DOI 10.1093/molbev/msq289; Drummond AJ, 2009, FIGTREE V 1 3 1, V1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elias CGR, 2006, PARASITOLOGY, V132, P37, DOI 10.1017/S0031182005008802; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FUKE M, 1993, ACTA ZOOL-STOCKHOLM, V74, P61, DOI 10.1111/j.1463-6395.1993.tb01221.x; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hirose E, 2009, J FISH DIS, V32, P433, DOI 10.1111/j.1365-2761.2009.01034.x; Hirose E, 2012, DIS AQUAT ORGAN, V97, P227, DOI 10.3354/dao02422; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson AP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-594; Jang HB, 2011, ANAL CHEM, V83, P1717, DOI 10.1021/ac102846q; Jung SJ, 2001, BIOLOGY OF ASCIDIANS, P436; Kitamura SI, 2010, J FISH DIS, V33, P153, DOI 10.1111/j.1365-2761.2009.01103.x; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Kumagai A, 2009, ANN REPORT JAPAN FIS, P3; Kumagai A, 2011, DIS AQUAT ORGAN, V95, P153, DOI 10.3354/dao02372; Kumagai A, 2010, DIS AQUAT ORGAN, V90, P223, DOI 10.3354/dao02228; Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Moran M. A., 2009, MICROBE, V4, P329, DOI DOI 10.1128/microbe.4.329.1; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2000, NUCLEIC ACIDS RES, V28, P323, DOI 10.1093/nar/28.1.323; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Stoeck T, 2005, INT J SYST EVOL MICR, V55, P2623, DOI 10.1099/ijs.0.63769-0; Suenaga H, 2012, ENVIRON MICROBIOL, V14, P13, DOI 10.1111/j.1462-2920.2011.02438.x; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; VANDAELE Y, 1992, BIOL CELL, V76, P87, DOI 10.1016/0248-4900(92)90198-A; Vermelho Alane Beatriz, 2010, Open Parasitology Journal, V4, P5; Vickerman K., 1990, P215; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnecke F, 2009, J BIOTECHNOL, V142, P91, DOI 10.1016/j.jbiotec.2009.03.022; Weatherby K, 2011, PROTIST, V162, P142, DOI 10.1016/j.protis.2010.02.003; Yao CQ, 2010, INFECT IMMUN, V78, P22, DOI 10.1128/IAI.00776-09; Zarlenga DS, 2004, VET PARASITOL, V126, P195, DOI 10.1016/j.vetpar.2004.09.001	73	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52379	10.1371/journal.pone.0052379	http://dx.doi.org/10.1371/journal.pone.0052379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300657	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100046
J	Koutsoudakis, G; Dragun, J; Perez-del-Pulgar, S; Coto-Llerena, M; Mensa, L; Crespo, G; Gonzalez, P; Navasa, M; Forns, X				Koutsoudakis, George; Dragun, Jakub; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Mensa, Laura; Crespo, Gonzalo; Gonzalez, Patricia; Navasa, Miquel; Forns, Xavier			Interplay between Basic Residues of Hepatitis C Virus Glycoprotein E2 with Viral Receptors, Neutralizing Antibodies and Lipoproteins	PLOS ONE			English	Article							B TYPE-I; ENVELOPE PROTEIN; CELL ENTRY; HEPARAN-SULFATE; BINDING-SITES; LOW-DENSITY; INFECTION; DOMAINS; IDENTIFICATION; CONSTRUCTION	Positively-charged amino acids are located at specific positions in the envelope glycoprotein E2 of the hepatitis C virus (HCV): two histidines (H) and four arginines (R) in two conserved WHY and one RGERCDLEDRDR motifs, respectively. Additionally, the E2 hypervariable region 1 (HVR1) is rich in basic amino acids. To investigate the role(s) of these residues in HCV entry, we subjected to comparative infection and sedimentation analysis cell culture-produced (HCVcc, genotype 2a) wild type virus, a panel of alanine single-site mutants and a HVR1-deletion variant. Initially, we analyzed the effects of these mutations on E2-heparan sulfate (HS) interactions. The positive milieu of the HVR1, formulated by its basic amino acids (key residues the conserved H-386 and R-408), and the two highly conserved basic residues H-488 and R-648 contributed to E2-HS interactions. Mutations in these residues did not alter the HCVcc-CD81 entry, but they modified the HCVcc-scavenger receptor class B type I (SR-BI) dependent entry and the neutralization by anti-E2 or patients IgG. Finally, separation by density gradients revealed that mutant viruses abolished partially or completely the infectivity of low density particles, which are believed to be associated with lipoproteins. This study shows that there exists a complex interplay between the basic amino acids located in HVR1 and other conserved E2 motifs with the HS, the SR-BI, and neutralizing antibodies and suggests that HCV-associated lipoproteins are implicated in these interactions.	[Koutsoudakis, George; Dragun, Jakub; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Mensa, Laura; Crespo, Gonzalo; Gonzalez, Patricia; Navasa, Miquel; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Koutsoudakis, G (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	gkoutsou@clinic.ub.es	Mensa, Laura/ABC-3124-2021; Navasa, Miquel/G-7958-2016; Coto Llerena, Mairene/H-4168-2014	Navasa, Miquel/0000-0002-3130-9604; Forns, Xavier/0000-0002-8188-1764; Mensa, Laura/0000-0003-2009-3550; Perez-del-Pulgar, Sofia/0000-0002-9890-300X; Crespo, Gonzalo/0000-0002-1178-4897	Instituto de Salud Carlos III Ministerio de Economia y Competitividad [PI11/01907, PI10/01551]; Fondo Europeo de Desarrollo Regional; Union Europea; Una manera de hacer Europa; EIHCV Marie Curie Research Training Network [MRTN-CT-2006-035599, MRTNCT-2006-035599]; Roche Organ Transplantation Research Foundation (ROTRF) [CI: 442035057]; Ministerio de Economia y Competitividad	Instituto de Salud Carlos III Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Union Europea; Una manera de hacer Europa; EIHCV Marie Curie Research Training Network; Roche Organ Transplantation Research Foundation (ROTRF); Ministerio de Economia y Competitividad(Spanish Government)	XF and MN received support, in part, by grants from Instituto de Salud Carlos III Ministerio de Economia y Competitividad (PI11/01907 and PI10/01551, respectively), cofunded by Fondo Europeo de Desarrollo Regional, Union Europea, Una manera de hacer Europa, and the EIHCV Marie Curie Research Training Network (MRTN-CT-2006-035599). XF also received a grant by the Roche Organ Transplantation Research Foundation (ROTRF, Cover Letter CI: 442035057). The other authors were supported by grants from the following institutions: GK and JD from the EIHCV Marie Curie Research Training Network (MRTNCT-2006-035599), LM from the Ministerio de Economia y Competitividad, and MCL the Roche Organ Transplantation Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; CARDIN AD, 1989, ANN NY ACAD SCI, V556, P186; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Dragun J, 2011, AM J TRANSPLANT, V11, P767, DOI 10.1111/j.1600-6143.2011.03440.x; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Lacek K, 2012, J HEPATOL; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Olenina LV, 2005, J VIRAL HEPATITIS, V12, P584, DOI 10.1111/j.1365-2893.2005.00647.x; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52651	10.1371/journal.pone.0052651	http://dx.doi.org/10.1371/journal.pone.0052651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300734	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100070
J	Meulenberg, CJW; Todorovic, V; Cemazar, M				Meulenberg, Cecil J. W.; Todorovic, Vesna; Cemazar, Maja			Differential Cellular Effects of Electroporation and Electrochemotherapy in Monolayers of Human Microvascular Endothelial Cells	PLOS ONE			English	Article							ACTIN CYTOSKELETON; ELECTRIC PULSES; BLOOD-FLOW; IN-VIVO; TUMORS; TRANSFECTION; BLEOMYCIN; MOLECULES; MECHANISM; MEMBRANE	In vivo electroporation of tumours shows disruption of blood flow and creates a vascular effect with an initial rapid and transient vasoconstriction phase and a much longer lasting phase with changed microvascular endothelium. These changes are not well understood but are presumed to involve the cytoskeleton. The paper presents for the first time differential in vitro effects describing cytoskeleton changes and monolayer integrity changes by both electroporation and electrochemotherapy of monolayers of human microvascular endothelial cells (HMEC-1). After the application of electric field pulses, the morphology of cells, and both the F-actin and Beta-tubulin cytoskeleton proteins were affected. During both electroporation and electrochemotherapy, the initial phase of cellular damage was noticed at 10 min as swollen cells and honeycomb-like actin bundles. The electroporation-induced cellular effects, observed from electric pulses >150 V, were voltage-dependent and within 24 hrs partly recoverable. The electrochemotherapy-induced cellular effects developed at 2 hrs in spindle-like cells, and more densely packed F-actin and Beta-tubulin were observed, which were dependent on the amount of bleomycin and the voltages applied (>50 V). In addition, for electrochemotherapy with electric pulses >150 V cellular changes were not recoverable within 24 hrs. The effects on monolayer integrity were reflected in the enhanced monolayer permeability, with the electrochemotherapy showing an earlier onset and synergy. We conclude that electrochemotherapy as compared to electroporation leads within 24 hrs to a quicker and more pronounced monolayer integrity damage and endothelial cell death, which together provide further insight into the cellular changes of the vascular disruption of electrochemotherapy.	[Meulenberg, Cecil J. W.; Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Todorovic, Vesna; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia	University of Primorska; Institute of Oncology - Slovenia	Meulenberg, CJW (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.	cecil.meulenberg@fvz.upr.si	Cemazar, Maja/K-6182-2013; Todorovic, Vesna/L-7966-2014	Cemazar, Maja/0000-0002-1418-1928; Todorovic, Vesna/0000-0002-9943-1673; Meulenberg, Cecil/0000-0001-8778-3316	Slovenian Research Agency [P3-0003, J3-4259]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (program no. P3-0003, project no. J3-4259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANGERO C, 1989, BIOCHIM BIOPHYS ACTA, V981, P295, DOI 10.1016/0005-2736(89)90040-0; Cemazar M, 2006, CURR PHARM DESIGN, V12, P3817, DOI 10.2174/138161206778559740; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Gehl J, 2000, MELANOMA RES, V10, P585, DOI 10.1097/00008390-200012000-00011; Harkin DG, 1996, CELL MOTIL CYTOSKEL, V35, P345, DOI 10.1002/(SICI)1097-0169(1996)35:4<345::AID-CM6>3.0.CO;2-5; Heller R, 1996, CANCER-AM CANCER SOC, V77, P964, DOI 10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Kotnik T, 2010, J MEMBRANE BIOL, V236, P3, DOI 10.1007/s00232-010-9279-9; Markelc B, 2012, J MEMBRANE BIOL, V245, P545, DOI 10.1007/s00232-012-9435-5; MIR LM, 1995, J IMMUNOTHER, V17, P30, DOI 10.1097/00002371-199501000-00004; OSBORN M, 1984, EXP CELL RES, V150, P408, DOI 10.1016/0014-4827(84)90584-6; Pavlin M, 2002, IEEE T BIO-MED ENG, V49, P605, DOI 10.1109/TBME.2002.1001975; Pehlivanova VN, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-9; Phez E, 2005, BBA-GEN SUBJECTS, V1724, P248, DOI 10.1016/j.bbagen.2005.04.005; Pron G, 1999, BIOCHEM PHARMACOL, V57, P45, DOI 10.1016/S0006-2952(98)00282-2; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Pucihar G, 2007, EUR BIOPHYS J BIOPHY, V36, P173, DOI 10.1007/s00249-006-0115-1; Rosazza C, 2011, MOL THER, V19, P913, DOI 10.1038/mt.2010.303; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Sersa G, 1999, EUR J CANCER, V35, P672, DOI 10.1016/S0959-8049(98)00426-2; Sersa G, 2002, BRIT J CANCER, V87, P1047, DOI 10.1038/sj.bjc.6600606; Snoj M, 2009, TUMORI J, V95, P398; Stacey M, 2011, BIOELECTROCHEMISTRY, V82, P131, DOI 10.1016/j.bioelechem.2011.06.002; Sugar IP, 2003, J PHYS CHEM B, V107, P3862, DOI 10.1021/jp022343k; Susil R, 1998, ELECTRO MAGNETOBIOL, V17, P391, DOI 10.3109/15368379809030739; Towhidi L, 2012, RADIOL ONCOL, V46, P119, DOI 10.2478/v10019-012-0014-2; Valic B, 2003, EUR BIOPHYS J BIOPHY, V32, P519, DOI 10.1007/s00249-003-0296-9; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Xiao DY, 2011, CELL BIOL INT, V35, P99, DOI 10.1042/CBI20100464	33	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52713	10.1371/journal.pone.0052713	http://dx.doi.org/10.1371/journal.pone.0052713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300747	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100074
J	Zhao, JJ; Eisenberg, JE; Spicknall, IH; Li, S; Koopman, JS				Zhao, Jijun; Eisenberg, Joseph E.; Spicknall, Ian H.; Li, Sheng; Koopman, James S.			Model Analysis of Fomite Mediated Influenza Transmission	PLOS ONE			English	Article							INFECTION RISK; A VIRUS; ENVIRONMENT; DYNAMICS; SURFACES; AEROSOL; HAND	Fomites involved in influenza transmission are either hand- or droplet-contaminated. We evaluated the interactions of fomite characteristics and human behaviors affecting these routes using an Environmental Infection Transmission System (EITS) model by comparing the basic reproduction numbers (R-0) for different fomite mediated transmission pathways. Fomites classified as large versus small surface sizes (reflecting high versus low droplet contamination levels) and high versus low touching frequency have important differences. For example, 1) the highly touched large surface fomite (public tables) has the highest transmission potential and generally strongest control measure effects; 2) transmission from droplet-contaminated routes exceed those from hand-contaminated routes except for highly touched small surface fomites such as door knob handles; and 3) covering a cough using the upper arm or using tissues effectively removes virus from the system and thus decreases total fomite transmission. Because covering a cough by hands diverts pathogens from the droplet-fomite route to the hand-fomite route, this has the potential to increase total fomite transmission for highly touched small surface fomites. An improved understanding and more refined data related to fomite mediated transmission routes will help inform intervention strategies for influenza and other pathogens that are mediated through the environment.	[Zhao, Jijun] Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China; [Zhao, Jijun; Eisenberg, Joseph E.; Spicknall, Ian H.; Li, Sheng; Koopman, James S.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Eisenberg, Joseph E.; Li, Sheng; Koopman, James S.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA	Qingdao University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhao, JJ (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China.	jjzhao@umich.edu			US Environmental Protection Agency Science to Achieve Results (STAR) Program; US Department of Homeland Security University Programs [R83236201]	US Environmental Protection Agency Science to Achieve Results (STAR) Program(United States Environmental Protection Agency); US Department of Homeland Security University Programs(United States Department of Homeland Security (DHS))	This work was funded by the US Environmental Protection Agency Science to Achieve Results (STAR) Program and by US Department of Homeland Security University Programs grant R83236201 to JK and JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Li S, 2009, AM J EPIDEMIOL, V170, P257, DOI 10.1093/aje/kwp116; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Nicas M, 2008, J OCCUP ENVIRON HYG, V5, P347, DOI 10.1080/15459620802003896; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; Nicas M, 2009, RISK ANAL, V29, P1292, DOI 10.1111/j.1539-6924.2009.01253.x; Noakes CJ, 2006, EPIDEMIOL INFECT, V134, P1082, DOI 10.1017/S0950268806005875; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Snider DE, 2010, M SUMM WORKSH HELD N; Spicknall IH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000969; Stilianakis NI, 2010, J R SOC INTERFACE, V7, P1355, DOI 10.1098/rsif.2010.0026; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426	20	29	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51984	10.1371/journal.pone.0051984	http://dx.doi.org/10.1371/journal.pone.0051984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300585	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100016
J	Kumari, P; Sahal, D; Jain, SK; Chauhan, VS				Kumari, Pinky; Sahal, Dinkar; Jain, S. K.; Chauhan, Virander S.			Bioactivity Guided Fractionation of Leaves Extract of Nyctanthes arbor tristis (Harshringar) against P falciparum	PLOS ONE			English	Article							ANTIMALARIAL ACTIVITY; MEDICINAL-PLANTS; IN-VITRO	Background: Nyctanthes arbor-tristis (Harshringar, Night Jasmine) has been traditionally used in Ayurveda, Unani and other systems of medicine in India. The juice of its leaves has been used by various tribal populations of India in treatment of fevers resembling malaria. Aim of the study: This work reports the antiplasmodial activity guided fractionation of Harshringar leaves extract. Methodology: Crude ethanolic Harshringar leaves extract and its RPHPLC purified fractions were studied for antiplasmodial potency against 3D7 (CQ sensitive) and Dd2 (CQ resistant) strains of P. falciparum and subsequently subjected to bioassay guided fractionation using reverse phase chromatography to pursue the isolation of active fractions. Principal Findings: Harshringar crude leaves extract and some of its RPHPLC purified fractions exhibited promising antiplasmodial potency against 3D7 and Dd2 strains of P. falciparum. Conclusions: The present study has provided scientific validity to the traditional use of leaves extract of Harshringar against malaria leading to the conclusion that this plant holds promise with respect to antimalarial phytotherapy. This is the first scientific report of antiplasmodial activity of RPHPLC fractions of Harshringar leaves extract against P. falciparum strains.	[Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, New Delhi, India; [Jain, S. K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jamia Hamdard University	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, Aruna Asaf Ali Marg, New Delhi, India.	virander@icgeb.res.in	SAHAL, DINKAR/GYD-7570-2022; Chauhan, Virander S./K-5276-2019		Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship" [10-2(5)/2005(i)-E.U.II]	Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship"	This study was supported by Malaria Core Fund, ICGEB, New Delhi. All studies were conducted at ICGEB, New Delhi. Pinky Kumari got financial assistance from University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship, Award No - F.No. 10-2(5)/2005(i)-E.U.II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asase A, 2005, J ETHNOPHARMACOL, V99, P273, DOI 10.1016/j.jep.2005.02.020; BADAM L, 1988, INDIAN J MED RES, V87, P379; Bhattacharya S, 2009, INT J AESTHETIC ANTI, p[2, 1]; Bombardelli E, 1989, FITOTERAPIA, V60, P1; Charak S, 1949, SHRI GULABKUNVERBA A, VV, P23; CHITRAVANSHI V C, 1992, International Journal of Pharmacognosy, V30, P71; Chopra RN., 1958, INDIGENOUS DRUGS IND, P408; Eberle C, 2011, CHEMMEDCHEM, V6, P292, DOI 10.1002/cmdc.201000420; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Ginsburg H, 2011, MALARIA J, V10; Jonville MC, 2008, J ETHNOPHARMACOL, V120, P382, DOI 10.1016/j.jep.2008.09.005; Karnik SR, 2008, INDIAN J TRADIT KNOW, V7, P330; Kirtikar K. R., 1935, INDIAN MED PLANT, V2nd, P1526; LAL J, 1976, Indian Journal of Physiology and Pharmacology, V20, P64; Lusakibanza M, 2010, J ETHNOPHARMACOL, V129, P398, DOI 10.1016/j.jep.2010.04.007; MISRA P, 1991, International Journal of Pharmacognosy, V29, P19; Nadkarni K. M., 1976, INDIAN MAT MED, V1, P857; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Ramalhete C, 2008, WORKSHOP PLANTAS MED; RATHORE A, 1990, PHYTOCHEMISTRY, V29, P1917, DOI 10.1016/0031-9422(90)85040-M; Saxena RS, 2002, J ETHNOPHARMACOL, V81, P321, DOI 10.1016/S0378-8741(02)00088-0; SAXENA RS, 1987, J ETHNOPHARMACOL, V19, P193, DOI 10.1016/0378-8741(87)90041-9; Shandhar HK., 2011, J INT PHARMACEUTICA, V1, P77; Shukla AK, 2011, J ETHNOPHARMACOL, V134, P996, DOI 10.1016/j.jep.2011.01.044; Singha U. K., 1992, International Journal of Pharmacognosy, V30, P289; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; TANDON JS, 1991, J NAT PROD, V54, P1102, DOI 10.1021/np50076a030; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Willcox ML, 2000, PARASITOL TODAY, V16, P220, DOI 10.1016/S0169-4758(00)01678-1	31	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51714	10.1371/journal.pone.0051714	http://dx.doi.org/10.1371/journal.pone.0051714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300557	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800023
J	Ohta, K; Kawano, R; Ito, N				Ohta, Kunimasa; Kawano, Rie; Ito, Naofumi			Lactic Acid Bacteria Convert Human Fibroblasts to Multipotent Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NANOG; HOST	The human gastrointestinal tract is colonized by a vast community of symbionts and commensals. Lactic acid bacteria (LAB) form a group of related, low-GC-content, gram-positive bacteria that are considered to offer a number of probiotic benefits to general health. While the role of LAB in gastrointestinal microecology has been the subject of extensive study, little is known about how commensal prokaryotic organisms directly influence eukaryotic cells. Here, we demonstrate the generation of multipotential cells from adult human dermal fibroblast cells by incorporating LAB. LAB-incorporated cell clusters are similar to embryoid bodies derived from embryonic stem cells and can differentiate into endodermal, mesodermal, and ectodermal cells in vivo and in vitro. LAB-incorporated cell clusters express a set of genes associated with multipotency, and microarray analysis indicates a remarkable increase of NANOG, a multipotency marker, and a notable decrease in HOX gene expression in LAB-incorporated cells. During the cell culture, the LAB-incorporated cell clusters stop cell division and start to express early senescence markers without cell death. Thus, LAB-incorporated cell clusters have potentially wide-ranging implications for cell generation, reprogramming, and cell-based therapy.	[Ohta, Kunimasa; Kawano, Rie; Ito, Naofumi] Kumamoto Univ, Grad Sch Life Sci, Dept Dev Neurobiol, Kumamoto, Japan	Kumamoto University	Ohta, K (corresponding author), Kumamoto Univ, Grad Sch Life Sci, Dept Dev Neurobiol, Kumamoto, Japan.	ohta9203@gpo.kumamoto-u.ac.jp	Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757; Ito, Naofumi/0000-0002-2334-0513	Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency; Ministry of Education Culture, Sports, Science, and Technology of Japan	Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency; Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research on Molecular Brain Science from the Ministry of Education Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2000, METH MOL B, V125, P57; ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Forstner Janet F., 1994, P1255; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; MARGULIS I, 1970, J THEOR BIOL, V26, P337, DOI 10.1016/S0022-5193(70)80023-6; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Mennigen R, 2009, ANN NY ACAD SCI, V1165, P183, DOI 10.1111/j.1749-6632.2009.04059.x; METCHNIKOFF II, 1907, PROLONGATION LIFE; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51866	10.1371/journal.pone.0051866	http://dx.doi.org/10.1371/journal.pone.0051866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300571	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800032
J	Rygula, R; Pluta, H; Popik, P				Rygula, Rafal; Pluta, Helena; Popik, Piotr			Laughing Rats Are Optimistic	PLOS ONE			English	Article							FREQUENCY ULTRASONIC VOCALIZATIONS; ORBITOFRONTAL CORTEX; COGNITIVE BIAS; DEPRESSION; BEHAVIOR; REWARD; NEUROBIOLOGY; ANTICIPATION; LAUGHTER; EXHIBIT	Emotions can bias human decisions-for example depressed or anxious people tend to make pessimistic judgements while those in positive affective states are often more optimistic. Several studies have reported that affect contingent judgement biases can also be produced in animals. The animals, however, cannot self-report; therefore, the valence of their emotions, to date, could only be assumed. Here we present the results of an experiment where the affect-contingent judgement bias has been produced by objectively measured positive emotions. We trained rats in operant Skinner boxes to press one lever in response to one tone to receive a food reward and to press another lever in response to a different tone to avoid punishment by electric foot shock. After attaining a stable level of discrimination performance, the animals were subjected to either handling or playful, experimenter-administered manual stimulation - tickling. This procedure has been confirmed to induce a positive affective state in rats, and the 50-kHz ultrasonic vocalisations (rat laughter) emitted by animals in response to tickling have been postulated to index positive emotions akin to human joy. During the tickling and handling sessions, the numbers of emitted high-frequency 50-kHz calls were scored. Immediately after tickling or handling, the animals were tested for their responses to a tone of intermediate frequency, and the pattern of their responses to this ambiguous cue was taken as an indicator of the animals' optimism. Our findings indicate that tickling induced positive emotions which are directly indexed in rats by laughter, can make animals more optimistic. We demonstrate for the first time a link between the directly measured positive affective state and decision making under uncertainty in an animal model. We also introduce innovative tandem-approach for studying emotional-cognitive interplay in animals, which may be of great value for understanding the emotional-cognitive changes associated with mood disorders.	[Rygula, Rafal; Pluta, Helena; Popik, Piotr] Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland; [Popik, Piotr] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Krakow, Poland	Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Rygula, R (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.	rygula@gmail.com	Popik, Piotr/R-5383-2016; Rygula, Rafal/AAI-4914-2020	Popik, Piotr/0000-0003-0722-1263; Rygula, Rafal/0000-0002-3662-5833	Foundation for Polish Science "Homing Plus" Programme; European Regional Development Fund (Innovative Economy Operational Programme); Iuventus Plus Programme of the Polish Ministry of Science and Higher Education [IP2011047271]; statutory funds of the Institute of Pharmacology Polish Academy of Sciences	Foundation for Polish Science "Homing Plus" Programme; European Regional Development Fund (Innovative Economy Operational Programme); Iuventus Plus Programme of the Polish Ministry of Science and Higher Education; statutory funds of the Institute of Pharmacology Polish Academy of Sciences	This work was supported by the Foundation for Polish Science "Homing Plus" Programme co-financed by the European Regional Development Fund (Innovative Economy Operational Programme 2007-2013), by the Iuventus Plus Programme of the Polish Ministry of Science and Higher Education (grant IP2011047271 to RR) and the statutory funds of the Institute of Pharmacology Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2009, J NEUROSCI, V29, P1648, DOI 10.1523/JNEUROSCI.4578-08.2009; BARFIELD RJ, 1986, ANN NY ACAD SCI, V474, P33, DOI 10.1111/j.1749-6632.1986.tb27996.x; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2001, PSYCHOPHARMACOLOGY, V155, P35, DOI 10.1007/s002130100685; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Darwin C., 1872, P374; Doyle RE, 2011, PHYSIOL BEHAV, V102, P503, DOI 10.1016/j.physbeh.2011.01.001; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Mallo T, 2007, BEHAV BRAIN RES, V184, P57, DOI 10.1016/j.bbr.2007.06.015; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nygren TE, 1996, ORGAN BEHAV HUM DEC, V66, P59, DOI 10.1006/obhd.1996.0038; Panksepp J, 2005, SCIENCE, V308, P62, DOI 10.1126/science.1112066; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Popik P, 2012, BEHAV BRAIN RES, V234, P223, DOI 10.1016/j.bbr.2012.06.028; Provine R, 2001, LAUGHTER SCI INVESTI; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407	36	96	96	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51959	10.1371/journal.pone.0051959	http://dx.doi.org/10.1371/journal.pone.0051959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300582	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800040
J	Zhou, LC; Yang, H; Lin, XH; Okoro, EU; Guo, ZM				Zhou, Lichun; Yang, Hong; Lin, Xinghua; Okoro, Emmanuel U.; Guo, Zhongmao			Cholecystokinin Elevates Mouse Plasma Lipids	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION; DIETARY-CHOLESTEROL; LDL RECEPTOR; MICE; CHYLOMICRONS; SUSCEPTIBILITY; GALLBLADDER; PROTEIN; RISK; CCK	Cholecystokinin (CCK) is a peptide hormone that induces bile release into the intestinal lumen which in turn aids in fat digestion and absorption in the intestine. While excretion of bile acids and cholesterol into the feces eliminates cholesterol from the body, this report examined the effect of CCK on increasing plasma cholesterol and triglycerides in mice. Our data demonstrated that intravenous injection of [Thr28, Nle31]-CCK at a dose of 50 ng/kg significantly increased plasma triglyceride and cholesterol levels by 22 and 31%, respectively, in fasting low-density lipoprotein receptor knockout (LDLR-/-) mice. The same dose of [Thr28, Nle31]-CCK induced 6 and 13% increases in plasma triglyceride and cholesterol, respectively, in wild-type mice. However, these particular before and after CCK treatment values did not achieve statistical significance. Oral feeding of olive oil further elevated plasma triglycerides, but did not alter plasma cholesterol levels in CCK-treated mice. The increased plasma cholesterol in CCK-treated mice was distributed in very-low, low and high density lipoproteins (VLDL, LDL and HDL) with less of an increase in HDL. Correspondingly, the plasma apolipoprotein (apo) B48, B100, apoE and apoAI levels were significantly higher in the CCK-treated mice than in untreated control mice. Ligation of the bile duct, blocking CCK receptors with proglumide or inhibition of Niemann-Pick C1 Like 1 transporter with ezetimibe reduced the hypercholesterolemic effect of [Thr28, Nle31]-CCK in LDLR-/- mice. These findings suggest that CCK-increased plasma cholesterol and triglycerides as a result of the reabsorption of biliary lipids from the intestine.	[Zhou, Lichun; Yang, Hong; Lin, Xinghua; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Guo, ZM (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	zguo@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants R01ES014471 and R01HL089382 (ZG), and SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, J LIPID RES; AHO HJ, 1989, INT J PANCREATOL, V5, P123; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Cartwright IJ, 2000, J LIPID RES, V41, P1728; Flint A, 2002, NEUROPSYCHOPHARMACOL, V27, P663; GARDINER BN, 1976, GASTROENTEROLOGY, V70, P403; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; JAZRAWI RP, 1986, GUT, V27, P355, DOI 10.1136/gut.27.4.355; KAPLITA PV, 1984, ARCH INT PHARMACOD T, V269, P271; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; MacIntosh CG, 2001, J CLIN ENDOCR METAB, V86, P5830, DOI 10.1210/jc.86.12.5830; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Miyasaka K, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-14; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Tomkin GH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/784536; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Wang DQH, 2004, J CLIN INVEST, V114, P521, DOI 10.1172/JCI200416801; Wang DQH, 2002, J LIPID RES, V43, P1950, DOI 10.1194/jlr.M200078-JLR200; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200	31	5	5	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51011	10.1371/journal.pone.0051011	http://dx.doi.org/10.1371/journal.pone.0051011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300532	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800006
J	Han, SH; Kim, SU; Kim, CO; Jeong, SJ; Park, JY; Choi, JY; Kim, DY; Ahn, SH; Song, YG; Han, KH; Kim, JM				Han, Sang Hoon; Kim, Seung Up; Kim, Chang Oh; Jeong, Su Jin; Park, Jun Yong; Choi, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Song, Young Goo; Han, Kwang-Hyub; Kim, June Myung			Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan (R)) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; METABOLIC SYNDROME; HEPATOTOXICITY; FIBROSIS; PREVALENCE; THERAPY; INDIVIDUALS; DISEASE; RISK	Background and Aims: Liver stiffness measurement (LSM) using transient elastography (Fibroscan (R)) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection. Methods: We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal. Results: Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (beta = -0.234, P = 0.023 and beta = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and gamma-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023). Conclusion: The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and gamma-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively.	[Han, Sang Hoon; Kim, Seung Up; Kim, Chang Oh; Jeong, Su Jin; Park, Jun Yong; Choi, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Song, Young Goo; Han, Kwang-Hyub; Kim, June Myung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Han, Sang Hoon; Kim, Chang Oh; Jeong, Su Jin; Choi, Jun Yong; Song, Young Goo; Kim, June Myung] Yonsei Univ, Coll Med, AIDS Res Inst, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, JM (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	jmkim@yuhs.ac	Park, Jun Yong/H-7127-2019; Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156; Choi, Jun Yong/0000-0002-2775-3315; Kim, Chang Oh/0000-0002-0773-5443; Han, Sang Hoon/0000-0002-4278-5198; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Jeong, Su Jin/0000-0003-4025-4542; Park, Jun Yong/0000-0001-6324-2224; Kim, Seung Up/0000-0002-9658-8050	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A050021]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Good Health R & D Project, part of the Ministry of Health, Welfare and Family Affairs, Republic of Korea (A050021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Battegay M, 2009, SWISS MED WKLY, V139, P564, DOI smw-12662; Bonfanti P, 2005, AIDS, V19, P1433, DOI 10.1097/01.aids.0000180791.85003.3b; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Cooper CL, 2002, CLIN INFECT DIS, V34, P1259, DOI 10.1086/339867; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim SU, 2010, WORLD J GASTROENTERO, V16, P5173, DOI 10.3748/wjg.v16.i41.5173; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Palella F, 2011, CURR OPIN HIV AIDS; Pineda JA, 2010, J VIRAL HEPATITIS, V17, P714, DOI 10.1111/j.1365-2893.2009.01229.x; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Vecchi VL, 2010, WORLD J GASTROENTERO, V16, P5225, DOI 10.3748/wjg.v16.i41.5225; Vogel M, 2007, CURR OPIN HIV AIDS, V2, P306, DOI 10.1097/COH.0b013e3281ca6fd2; World Health Organization, 2006, INT STAT CLASS DIS R; Worm SW, 2009, CIRCULATION, V119, P805, DOI 10.1161/CIRCULATIONAHA.108.790857; Zucchetto A, 2010, CLIN INFECT DIS, V51, P1099, DOI 10.1086/656629	27	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52720	10.1371/journal.pone.0052720	http://dx.doi.org/10.1371/journal.pone.0052720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300987	Green Published, gold, Green Submitted			2022-12-25	WOS:000313480000015
J	Mercapide, J; Anzanello, F; Rappa, G; Lorico, A				Mercapide, Javier; Anzanello, Fabio; Rappa, Germana; Lorico, Aurelio			Relationship between Tumor Cell Invasiveness and Polyploidization	PLOS ONE			English	Article							BREAST-CANCER; FUSION; METASTASIS; CONSEQUENCES; ANEUPLOIDY; MIGRATION; MECHANISM	A number of studies have shown that tumor cells fuse with other tumor and non-tumor cells. In the present study on tumor cell lines derived from glioblastoma, breast cancer, and melanoma, we estimated the frequency of fusion between tumor cells by establishing the fraction of cells with whole tumor-genome duplication in each cell line. Together with this, the capacity of the tumor cell lines to spread through a basement membrane scaffold was assessed, in order to test the hypothesis that pericellular proteolysis by enzymatic release in the spaces of intercellular contact could account for differences in the fusogenicity of tumor cells. The difference in invasiveness between the cell lines accounted for their specific amount of cells with tumor-genome duplication, which, depending on the cell line analyzed, ranged from 2% to 25% of the total cells. These results support the hypothesis that cell-to-cell invasion eliciting membrane fusion causes polyploidization in tumor cells.	[Mercapide, Javier; Anzanello, Fabio; Rappa, Germana; Lorico, Aurelio] Roseman Univ Hlth Sci, Canc Res Ctr, Las Vegas, NV USA		Lorico, A (corresponding author), Roseman Univ Hlth Sci, Canc Res Ctr, Las Vegas, NV USA.	alorico@roseman.edu	Lorico, Aurelio/AAG-8095-2021	Lorico, Aurelio/0000-0003-0644-7375	United States National Institutes of Health [R01CA133797]; NATIONAL CANCER INSTITUTE [R01CA133797] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health R01CA133797 (GR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duesberg P, 2000, CANCER GENET CYTOGEN, V119, P83, DOI 10.1016/S0165-4608(99)00236-8; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; FODSTAD O, 1988, CANCER RES, V48, P4382; GOLDENBERG D M, 1968, European Journal of Cancer, V4, P547, DOI 10.1016/0014-2964(68)90011-X; LARIZZA L, 1984, CANCER METAST REV, V3, P193, DOI 10.1007/BF00048385; Mercapide J, 2012, INT J CANCER, V131, P334, DOI 10.1002/ijc.26361; MILLER FR, 1989, CANCER RES, V49, P4316; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35	20	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53364	10.1371/journal.pone.0053364	http://dx.doi.org/10.1371/journal.pone.0053364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300919	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600090
J	Wang, H; Chen, SS; Zhang, J; Rothenbacher, FP; Jiang, TT; Kan, BA; Zhong, ZT; Zhu, J				Wang, Hui; Chen, Shusu; Zhang, Juan; Rothenbacher, Francesca P.; Jiang, Tiantian; Kan, Biao; Zhong, Zengtao; Zhu, Jun			Catalases Promote Resistance of Oxidative Stress in Vibrio Cholerae	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; OXYR; GENE; REGULATOR; COLONIZATION; EXPRESSION; PROTECTION; MUTANT; OXYGEN	Oxidative stress is a major challenge faced by bacteria. Many bacteria control oxidative stress resistance pathways through the transcriptional regulator OxyR. The human pathogen Vibrio cholerae is a Gram-negative bacterium that is the causative agent of cholera. V. cholerae lives in both aquatic environments and human small intestines, two environments in which it encounters reactive oxygen species (ROS). To study how V. cholerae responds to oxidative stress, we constructed an inframe oxyR deletion mutant. We found that this mutant was not only sensitive to H2O2, but also displayed a growth defect when diluted in rich medium. Further study showed that two catalases, KatG and KatB, either when expressed in living cells, present in culture supernatants, or added as purified recombinant proteins, could rescue the oxyR growth defect. Furthermore, although it could colonize infant mouse intestines similar to that of wildtype, the oxyR mutant was defective in zebrafish intestinal colonization. Alternatively, co-infection with wildtype, but not katG-katB deletion mutants, greatly enhanced oxyR mutant colonization. Our study suggests that OxyR in V. cholerae is critical for antioxidant defense and that the organism is capable of scavenging environmental ROS to facilitate population growth.	[Wang, Hui; Chen, Shusu; Zhang, Juan; Jiang, Tiantian; Zhong, Zengtao; Zhu, Jun] Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Rothenbacher, Francesca P.; Zhu, Jun] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kan, Biao] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Nanjing Agricultural University; University of Pennsylvania; Pennsylvania Medicine; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhong, ZT (corresponding author), Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.	mol_microb@njau.edu.cn; junzhu@mail.med.upenn.edu	Zhong, Zengtao/E-2533-2016; Zhu, Jun/A-1324-2007		United States National Institutes of Health/NIAID [R01 (AI072479)]; Natural Sciences Foundation of China [30830008, 30900036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072479] Funding Source: NIH RePORTER	United States National Institutes of Health/NIAID; Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by the United States National Institutes of Health/NIAID R01 (AI072479), an Natural Sciences Foundation of China key project (30830008) (to B. K.), and an Natural Sciences Foundation of China Young Scientist award (30900036) (to H. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaoui A, 2009, TRENDS MOL MED, V15, P571, DOI 10.1016/j.molmed.2009.10.003; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; CROSS CE, 1984, LANCET, V1, P1328; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Faruque SM, 2002, MICROBIOL IMMUNOL, V46, P59, DOI 10.1111/j.1348-0421.2002.tb02659.x; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GRISHAM MB, 1987, AM J PHYSIOL, V253, pG93, DOI 10.1152/ajpgi.1987.253.1.G93; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Helmann JD., 2002, SCI STKE, V2002, pe46; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Lizarraga-Partida ML, 2009, ENVIRON MICROBIOL, V11, P201, DOI 10.1111/j.1462-2920.2008.01753.x; Maciver I, 1996, INFECT IMMUN, V64, P4618, DOI 10.1128/IAI.64.11.4618-4629.1996; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mongkolsuk S, 1998, J BACTERIOL, V180, P3988, DOI 10.1128/JB.180.15.3988-3991.1998; O'Toole R, 2004, MICROB PATHOGENESIS, V37, P41, DOI 10.1016/j.micpath.2004.03.001; Pradel E, 2004, ANNU REV GENET, V38, P347, DOI 10.1146/annurev.genet.38.072902.092528; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Stern AM, 2012, MBIO, V3, DOI 10.1128/mBio.00013-12; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	38	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53383	10.1371/journal.pone.0053383	http://dx.doi.org/10.1371/journal.pone.0053383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300923	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600094
J	Binder, NK; Hannan, NJ; Gardner, DK				Binder, Natalie K.; Hannan, Natalie J.; Gardner, David K.			Paternal Diet-Induced Obesity Retards Early Mouse Embryo Development, Mitochondrial Activity and Pregnancy Health	PLOS ONE			English	Article							BODY-MASS INDEX; SEMEN QUALITY; REPRODUCTIVE HORMONES; PYRUVATE; PLACENTA; FAT; DYSFUNCTION; ASSOCIATION; BLASTOCYSTS; OOCYTES	Worldwide, 48% of adult males are overweight or obese. An association between infertility and excessive body weight is now accepted, although focus remains primarily on females. It has been shown that parental obesity results in compromised embryo development, disproportionate changes in embryo metabolism and reduced blastocyst cell number. The aim of this study was to determine whether paternal obesity has negative effects on the resultant embryo. Specifically, using in vitro fertilisation (IVF), we wanted to isolate the functional effects of obesity on sperm by examining the subsequent embryo both pre- and post-implantation. Epididymal sperm was collected from age matched normal and obese C57BL/6 mice and cryopreserved for subsequent IVF with oocytes collected from Swiss females (normal diet/weight). Obesity was induced in male mice by feeding a high fat diet of 22% fat for 10 weeks. Resultant embryos were cultured individually and development monitored using time-lapse microscopy. Paternal obesity resulted in a significant delay in preimplantation embryo development as early as syngamy (P<0.05). Metabolic parameters were measured across key developmental stages, demonstrating significant reduction in mitochondrial membrane potential (P<0.01). Blastocysts were stained to determine trophectoderm (TE) and inner cell mass (ICM) cell numbers, revealing significant differences in the ratio of cell allocation to TE and ICM lineages (P<0.01). Functional studies examining blastocyst attachment, growth and implantation demonstrated that blastocysts derived from sperm of obese males displayed significantly reduced outgrowth on fibronectin in vitro (P<0.05) and retarded fetal development in vivo following embryo transfer (P<0.05). Taken together, these data clearly demonstrate that paternal obesity has significant negative effects on the embryo at a variety of key early developmental stages, resulting in delayed development, reduced placental size and smaller offspring.	[Binder, Natalie K.; Hannan, Natalie J.; Gardner, David K.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Melbourne	Gardner, DK (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	david.gardner@unimelb.edu.au		Hannan, Natalie/0000-0001-8446-2250; Binder, Natalie K/0000-0002-8943-2269; Gardner, David/0000-0003-3138-8274	Australian Postgraduate Award; NHMRC [628927]	Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	NKB was supported by an Australian Postgraduate Award, and NJH was supported by NHMRC post-doctoral training fellowship # 628927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; ANDRAE U, 1985, TOXICOL LETT, V28, P93, DOI 10.1016/0378-4274(85)90015-3; ANSELL JD, 1975, J EMBRYOL EXP MORPH, V33, P177; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Binder NK, 2012, REPROD FERT DEVELOP, V24, P804, DOI 10.1071/RD11256; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Fariello RM, 2012, BJU INT, V110, P863, DOI 10.1111/j.1464-410X.2011.10813.x; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gardner DK, 2004, LAB GUIDE MAMMALIAN, P41; Giraud MN, 2000, HUM REPROD, V15, P2160, DOI 10.1093/humrep/15.10.2160; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hammoud AO, 2012, ASIAN J ANDROL, V14, P77, DOI 10.1038/aja.2011.64; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; HARDY K, 1989, DEVELOPMENT, V107, P597; Herz H, 1997, FREE RADICAL RES, V26, P19, DOI 10.3109/10715769709097781; International Federation of Red Cross and Red Crescent Societies, 2011, WORLD DIS REP 2011 F; JANSSON T, 1986, BIOL NEONATE, V49, P172; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; LANE M, 1994, J REPROD FERTIL, V102, P305, DOI 10.1530/jrf.0.1020305; Lane M, 1996, HUM REPROD, V11, P1975; Lane M, 2004, LAB GUIDE MAMMALIAN, P24; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Lyle R, 1997, J ENDOCRINOL, V155, P1, DOI 10.1677/joe.0.1550001; Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; O'Fallon J. V., 1995, Theriogenology, V43, P288, DOI 10.1016/0093-691X(95)92442-C; ono t, 2005, WHO GLOBAL COMPARABL; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Rulicke T, 2006, REPROD FERT DEVELOP, V18, P885, DOI 10.1071/RD06054; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; WAHLSTEN D, 1977, J EMBRYOL EXP MORPH, V42, P79; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wale PL, 2010, REPROD BIOMED ONLINE, V21, P402, DOI 10.1016/j.rbmo.2010.04.028	58	96	98	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52304	10.1371/journal.pone.0052304	http://dx.doi.org/10.1371/journal.pone.0052304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300638	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100039
J	Durkin, K; Conti-Ramsden, G				Durkin, Kevin; Conti-Ramsden, Gina			Frequency of Educational Computer Use as a Longitudinal Predictor of Educational Outcome in Young People with Specific Language Impairment	PLOS ONE			English	Article							SELF-EFFICACY; FOLLOW-UP; ACADEMIC-PERFORMANCE; VIDEO GAMES; SCHOOL; HOME; INTERNET; ADOLESCENTS; STUDENTS; CHILDRENS	Computer use draws on linguistic abilities. Using this medium thus presents challenges for young people with Specific Language Impairment (SLI) and raises questions of whether computer-based tasks are appropriate for them. We consider theoretical arguments predicting impaired performance and negative outcomes relative to peers without SLI versus the possibility of positive gains. We examine the relationship between frequency of computer use (for leisure and educational purposes) and educational achievement; in particular examination performance at the end of compulsory education and level of educational progress two years later. Participants were 49 young people with SLI and 56 typically developing (TD) young people. At around age 17, the two groups did not differ in frequency of educational computer use or leisure computer use. There were no associations between computer use and educational outcomes in the TD group. In the SLI group, after PIQ was controlled for, educational computer use at around 17 years of age contributed substantially to the prediction of educational progress at 19 years. The findings suggest that educational uses of computers are conducive to educational progress in young people with SLI.	[Durkin, Kevin] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Strathclyde; University of Manchester	Durkin, K (corresponding author), Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland.	kevin.durkin@strath.ac.uk			Economic and Social Research Council [RES-062-23-2745]; Nuffield Foundation [EDU/8366]; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; ESRC [ES/I00064X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Nuffield Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The sources of funding that have supported the work are the Economic and Social Research Council (http://www.esrc.ac.uk) grant no. RES-062-23-2745 and the Nuffield Foundation (http://www.nuffieldfoundation.org) grant no. EDU/8366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M. D., 2003, COMPUTERS ENTERTAINM, V1, P10, DOI DOI 10.1145/950566.950583; Aslanidou S, 2008, COMPUT EDUC, V51, P1375, DOI 10.1016/j.compedu.2007.12.003; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; BISHOP DVM, 1997, UNCOMMON UNDERSTANDI; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Brinton B., 2002, BLACKWELL HDB CHILDH, P588; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G., 2000, SPEECH LANGUAGE IMPA, P211; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); Conti-Ramsden G, 2011, CHILD PSYCHOLOGY AND PSYCHIATRY: FRAMEWORKS FOR PRACTICE, 2ND EDITION, P180; Conti-Ramsden G, 2010, COMPUT EDUC, V54, P136, DOI 10.1016/j.compedu.2009.07.015; Conti-Ramsden G, 2009, INT J LANG COMM DIS, V44, P15, DOI 10.1080/13682820801921601; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Dockrell J., 2007, RAISING ACHIEVEMENTS; Durkin K, 2011, J COMPUT ASSIST LEAR, V27, P49, DOI 10.1111/j.1365-2729.2010.00397.x; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Durkin K, 2010, COMPUT HUM BEHAV, V26, P176, DOI 10.1016/j.chb.2009.10.007; Durkin K, 2009, INT J LANG COMM DIS, V44, P36, DOI 10.1080/13682820801921510; Durkin K, 2009, BRIT J DEV PSYCHOL, V27, P197, DOI 10.1348/026151008X383553; Durndell A, 2002, COMPUT HUM BEHAV, V18, P521, DOI 10.1016/S0747-5632(02)00006-7; Ferguson CJ, 2010, REV GEN PSYCHOL, V14, P68, DOI 10.1037/a0018941; Hetzroni OE, 2004, J LEARN DISABIL-US, V37, P143, DOI 10.1177/00222194040370020501; Hofferth SL, 2012, J RES ADOLESCENCE, V22, P215, DOI 10.1111/j.1532-7795.2011.00770.x; Igbaria M, 1995, OMEGA-INT J MANAGE S, V23, P587, DOI 10.1016/0305-0483(95)00035-6; Jackson LA, 2006, DEV PSYCHOL, V42, P429, DOI 10.1037/0012-1649.42.3.429; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Kay RH, 2008, COMPUT EDUC, V50, P1269, DOI 10.1016/j.compedu.2006.12.002; Keates A, 2002, DYSLEXIA INFORM COMM; Keates Simeon, 2007, Universal Access in the Information Society, V5, P329, DOI 10.1007/s10209-006-0058-4; Kemp N, 2011, J COMPUT ASSIST LEAR, V27, P18, DOI 10.1111/j.1365-2729.2010.00400.x; Kent N, 2004, J COMPUT ASSIST LEAR, V20, P440, DOI 10.1111/j.1365-2729.2004.00102.x; Kirkorian H. L., 2009, HDB CHILDREN MEDIA D, P188, DOI DOI 10.1002/9781444302752.CH9; Kuhlemeier H, 2007, COMPUT EDUC, V49, P460, DOI 10.1016/j.compedu.2005.10.004; Leitao S, 2004, INT J LANG COMM DIS, V39, P245, DOI 10.1080/13682820310001619478; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Macgill A.R., 2008, WRITING TECHNOLOGY T; Miller CA, 2006, J SPEECH LANG HEAR R, V49, P712, DOI 10.1044/1092-4388(2006/052); Naevdal F, 2007, COMPUT EDUC, V49, P1112, DOI 10.1016/j.compedu.2006.01.003; Nippold MA, 2009, AM J SPEECH-LANG PAT, V18, P241, DOI 10.1044/1058-0360(2008/08-0022); Ohannessian CM, 2009, J CHILD FAM STUD, V18, P582, DOI 10.1007/s10826-009-9261-2; Olson CK, 2010, REV GEN PSYCHOL, V14, P180, DOI 10.1037/a0018984; Plester B, 2009, BRIT J DEV PSYCHOL, V27, P145, DOI 10.1348/026151008X320507; Roschelle JM, 2000, FUTURE CHILD, V10, P76, DOI 10.2307/1602690; Saade RG, 2009, J INF TECHNOL EDUC-R, V8, P177; Schmidt ME, 2008, FUTURE CHILD, V18, P63; Selwyn N, 2000, COMPUT EDUC, V34, P93, DOI 10.1016/S0360-1315(00)00006-3; Selwyn N, 1998, COMPUT EDUC, V31, P211, DOI 10.1016/S0360-1315(98)00033-5; Semel E.M., 2003, CLIN EVALUATION LANG, V4th ed; Simkin Z., 2006, CHILD LANG TEACH THE, V22, P315, DOI DOI 10.1191/0265659006CT310XX; Snowling MJ, 2001, INT J LANG COMM DIS, V36, P173, DOI 10.1080/13682820010019892; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; St Clair MC, 2010, BRIT J DEV PSYCHOL, V28, P109, DOI 10.1348/026151009X480158; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tsai MJ, 2003, INNOV EDUC TEACH INT, V40, P43, DOI 10.1080/1355800032000038822; Turow J., 1999, ANN PUBL POL CTR C F; Valentine G, 2005, 672 BMRB U LEEDS; Wechsler D., 1999, WECHSLER ABBREVIATED; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P489, DOI 10.1080/13682820802708080; Wittwer J, 2008, COMPUT EDUC, V50, P1558, DOI 10.1016/j.compedu.2007.03.001; Zhu YQ, 2011, COMPUT EDUC, V57, P2476, DOI 10.1016/j.compedu.2011.07.006; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.2307/1163261	65	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52194	10.1371/journal.pone.0052194	http://dx.doi.org/10.1371/journal.pone.0052194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300610	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100027
J	Eckert, JJ; Porter, R; Watkins, AJ; Burt, E; Brooks, S; Leese, HJ; Humpherson, PG; Cameron, IT; Fleming, TP				Eckert, Judith J.; Porter, Richard; Watkins, Adam J.; Burt, Elizabeth; Brooks, Suzanne; Leese, Henry J.; Humpherson, Peter G.; Cameron, Iain T.; Fleming, Tom P.			Metabolic Induction and Early Responses of Mouse Blastocyst Developmental Programming following Maternal Low Protein Diet Affecting Life-Long Health	PLOS ONE			English	Article							IN-VITRO CULTURE; FEMALE REPRODUCTIVE-TRACT; SYSTOLIC BLOOD-PRESSURE; MTOR COMPLEX 1; AMINO-ACIDS; LONG-TERM; PREIMPLANTATION EMBRYO; FETAL-GROWTH; EARLY-PREGNANCY; DISEASE	Previously, we have shown that a maternal low protein diet, fed exclusively during the preimplantation period of mouse development (Emb-LPD), is sufficient to induce by the blastocyst stage a compensatory growth phenotype in late gestation and postnatally, correlating with increased risk of adult onset cardiovascular disease and behavioural dysfunction. Here, we examine mechanisms of induction of maternal Emb-LPD programming and early compensatory responses by the embryo. Emb-LPD induced changes in maternal serum metabolites at the time of blastocyst formation (E3.5), notably reduced insulin and increased glucose, together with reduced levels of free amino acids (AAs) including branched chain AAs leucine, isoleucine and valine. Emb-LPD also caused reduction in the branched chain AAs within uterine fluid at the blastocyst stage. These maternal changes coincided with an altered content of blastocyst AAs and reduced mTORC1 signalling within blastocysts evident in reduced phosphorylation of effector S6 ribosomal protein and its ratio to total S6 protein but no change in effector 4E-BP1 phosphorylated and total pools. These changes were accompanied by increased proliferation of blastocyst trophectoderm and total cells and subsequent increased spreading of trophoblast cells in blastocyst outgrowths. We propose that induction of metabolic programming following Emb-LPD is achieved through mTORC1signalling which acts as a sensor for preimplantation embryos to detect maternal nutrient levels via branched chain AAs and/or insulin availability. Moreover, this induction step associates with changes in extra-embryonic trophectoderm behaviour occurring as early compensatory responses leading to later nutrient recovery.	[Eckert, Judith J.; Porter, Richard; Watkins, Adam J.; Burt, Elizabeth; Brooks, Suzanne; Fleming, Tom P.] Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England; [Eckert, Judith J.; Cameron, Iain T.] Univ Southampton, Fac Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Leese, Henry J.] Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Humpherson, Peter G.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Southampton; University of Southampton; University of Hull; University of York - UK; University of York - UK	Fleming, TP (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England.	tpf@soton.ac.uk	Watkins, Adam J/J-4839-2013; Watkins, Adam/AAH-9401-2021	Watkins, Adam J/0000-0002-0842-1251; Watkins, Adam/0000-0002-0842-1251; Burt, Elizabeth/0000-0003-3801-0151	BBSRC [BB/F007450/1, BB/I001840/1]; Biotechnology and Biological Sciences Research Council [BB/I001840/1, BB/F007450/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for BBSRC funding (BB/F007450/1, BB/I001840/1) to TPF and JJE in support of this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Banrezes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029388; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Basatemur E, 2008, PLACENTA, V29, pS135, DOI 10.1016/j.placenta.2008.08.013; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; CHISHOLM JC, 1985, J EMBRYOL EXP MORPH, V86, P311; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Douglas AJ, 2011, PROG NEURO-PSYCHOPH, V35, P1167, DOI 10.1016/j.pnpbp.2010.07.024; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dumoulin JC, 2010, HUM REPROD, V25, P605, DOI 10.1093/humrep/dep456; DUNGLISON GF, 1995, J REPROD FERTIL, V105, P115, DOI 10.1530/jrf.0.1050115; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2007, MOL REPROD DEV, V74, P1149, DOI 10.1002/mrd.20746; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gardner DS, 2004, HYPERTENSION, V43, P1290, DOI 10.1161/01.HYP.0000126991.67203.7b; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; Groebner AE, 2011, REPRODUCTION, V141, P685, DOI 10.1530/REP-10-0533; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hernandez CE, 2010, PHYSIOL BEHAV, V101, P588, DOI 10.1016/j.physbeh.2010.08.020; Heyner S, 1997, Early Pregnancy, V3, P153; Hong J, 2007, THERIOGENOLOGY, V68, P728, DOI 10.1016/j.theriogenology.2007.06.002; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kaye Peter L., 1995, Progress in Growth Factor Research, V6, P1, DOI 10.1016/0955-2235(95)00001-1; Kaye PL, 1999, HUM REPROD, V14, P3052, DOI 10.1093/humrep/14.12.3052; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Koga K, 2008, REPROD SCI, V15, P231, DOI 10.1177/1933719108316391; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LAMB VK, 1994, J REPROD FERTIL, V102, P169, DOI 10.1530/jrf.0.1020169; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Mahsoudi B, 2007, BIOL REPROD, V77, P889, DOI 10.1095/biolreprod.106.057885; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Pampfer S, 2000, J REPROD FERTIL, P129; Partridge RJ, 1996, REPROD FERT DEVELOP, V8, P945, DOI 10.1071/RD9960945; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Petrie L, 2002, BRIT J NUTR, V88, P471, DOI 10.1079/BJN2002695; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Richards T, 2010, BIOL REPROD, V82, P769, DOI 10.1095/biolreprod.109.081646; Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008; Satterfield MC, 2010, BIOL REPROD, V82, P224, DOI 10.1095/biolreprod.109.076729; SCHULTZ GA, 1981, J REPROD FERTIL, V61, P387, DOI 10.1530/jrf.0.0610387; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sinclair KD, 2007, THERIOGENOLOGY, V67, P43, DOI 10.1016/j.theriogenology.2006.09.017; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; SPINDLE A, 1995, THERIOGENOLOGY, V44, P761, DOI 10.1016/0093-691X(95)00275-D; Suzuki C, 2007, ZYGOTE, V15, P317, DOI 10.1017/S0967199407004273; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Thompson JG, 2007, REPROD FERT DEVELOP, V19, P43, DOI 10.1071/RD06129; Torrens C, 2009, EXP PHYSIOL, V94, P1024, DOI 10.1113/expphysiol.2009.047340; Van Winkle LJ, 2006, HUM REPROD UPDATE, V12, P145, DOI 10.1093/humupd/dmi044; VANWINKLE LJ, 1995, BIOL REPROD, V52, P96, DOI 10.1095/biolreprod52.1.96; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Watkins AJ, 2008, SEMIN REPROD MED, V26, P175, DOI 10.1055/s-2008-1042956; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783; Zhao XM, 2000, DEVELOPMENT, V127, P2643	78	81	83	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52791	10.1371/journal.pone.0052791	http://dx.doi.org/10.1371/journal.pone.0052791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300778	Green Published, Green Accepted, gold			2022-12-25	WOS:000312829100083
J	Gorostidi, A; Bergareche, A; Ruiz-Martinez, J; Marti-Masso, JF; Cruz, M; Varghese, S; Qureshi, MM; Alzahmi, F; Al-Hayani, A; de Munain, AL; El-Agnaf, OMA				Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Varghese, Shiji; Qureshi, Mohamed M.; Alzahmi, Fatimah; Al-Hayani, Abdulmonem; Lopez de Munain, Adolfo; El-Agnaf, Omar M. A.			alpha-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; CEREBROSPINAL-FLUID; SOLUBLE OLIGOMERS; SPANISH PATIENTS; ELEVATED LEVELS; DISEASE; BIOMARKER; G2019S; COMMON; NEUROPATHOLOGY	The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of permitting the preclinical detection of PD is critically needed. alpha-Synuclein is a key protein in PD, with missense and multiplication mutations in the gene encoding alpha-synuclein (SNCA) having been reported in familial cases of PD, and accumulation of the protein identified in Lewy bodies (LBs) and Lewy neurites (LNs) in affected brain regions. With the objective of validating the use of alpha-synuclein as a clinical or progressive biomarker in an accessible tissue, we used an enzyme-linked immunosorbent assay (ELISA) to measure alpha-synuclein levels in the peripheral blood plasma of idiopathic PD and LRRK2 mutation carrier patients and compared our findings with healthy control subjects. Compared to healthy controls, we found a significant decrease in plasma total alpha-synuclein levels in idiopathic PD (iPD) patients (n = 134, p = 0.010). However, the reduction was less significant in patients who were LRRK2 mutation carriers (n = 32, p = 0.133). This lack of significance could be due to the small number of individuals employed in this group. No predictive value of total alpha-synuclein in the diagnosis of PD was found in a receiver operating characteristic (ROC) curve analysis. Although this is a pilot study requiring corroboration on a larger cohort of patients, our results highlight the possible use of plasma alpha-synuclein as a biomarker for PD.	[Varghese, Shiji; Qureshi, Mohamed M.; Alzahmi, Fatimah; El-Agnaf, Omar M. A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Al-Hayani, Abdulmonem] King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia; [Cruz, Maria] Ikerbasque Basque Fdn Sci, Bilbao, Bizkaia, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Carlos III Hlth Inst, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Hosp Donostia, Dept Neurol, Movement Disorders Unit, Donostia San Sebastian, Gipuzkoa, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Biodonostia Res Inst, Neurosci Area, Donostia San Sebastian, Gipuzkoa, Spain	United Arab Emirates University; King Abdulaziz University; Basque Foundation for Science; CIBERNED; University Hospital Donostia	El-Agnaf, OMA (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	o.elagnaf@uaeu.ac.ae	Rodriguez-Oroz, Maria Cruz/D-1490-2018; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Rodriguez-Oroz, Maria Cruz/0000-0001-5962-772X; Bergareche, Alberto/0000-0002-3904-7821; /0000-0002-9509-4032; Gorostidi, Ana/0000-0002-5494-4512	Michael J. Fox Foundation for Parkinson's Research (NY)	Michael J. Fox Foundation for Parkinson's Research (NY)	This work was supported by a grant from Michael J. Fox Foundation for Parkinson's Research (NY) to O.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer DAM, 2006, EXP BRAIN RES, V173, P223, DOI 10.1007/s00221-006-0539-y; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2003, LANCET NEUROL, V2, P461, DOI 10.1016/S1474-4422(03)00481-2; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gaig C, 2007, J NEUROL NEUROSUR PS, V78, P626, DOI 10.1136/jnnp.2006.107904; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Gonzalez-Fernandez MC, 2007, PARKINSONISM RELAT D, V13, P509, DOI 10.1016/j.parkreldis.2007.04.003; Gorostidi A, 2009, NEUROGENETICS, V10, P157, DOI 10.1007/s10048-008-0162-0; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Infante J, 2006, NEUROSCI LETT, V395, P224, DOI 10.1016/j.neulet.2005.10.083; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Schlossmacher MG, 2010, BIOMARK MED, V4, P647, DOI 10.2217/BMM.10.93; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sierks MR, 2011, INTEGR BIOL-UK, V3, P1188, DOI 10.1039/c1ib00018g; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52312	10.1371/journal.pone.0052312	http://dx.doi.org/10.1371/journal.pone.0052312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300640	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100040
J	Barbone, D; Cheung, P; Battula, S; Busacca, S; Gray, SG; Longley, DB; Bueno, R; Sugarbaker, DJ; Fennell, DA; Broaddus, VC				Barbone, Dario; Cheung, Priscilla; Battula, Sailaja; Busacca, Sara; Gray, Steven G.; Longley, Daniel B.; Bueno, Raphael; Sugarbaker, David J.; Fennell, Dean A.; Broaddus, V. Courtney			Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; HISTONE DEACETYLASE INHIBITORS; APOPTOTIC RESISTANCE; MELANOMA-CELLS; LUNG-CANCER; PHASE-II; BCL-2; MODULATION; BORTEZOMIB; CONTRIBUTE	When grown in 3D cultures as spheroids, mesothelioma cells acquire a multicellular resistance to apoptosis that resembles that of solid tumors. We have previously found that resistance to the proteasome inhibitor bortezomib in 3D can be explained by a lack of upregulation of Noxa, the pro-apoptotic BH3 sensitizer that acts via displacement of the Bak/Bax-activator BH3-only protein, Bim. We hypothesized that the histone deacetylase inhibitor vorinostat might reverse this block to Noxa upregulation in 3D. Indeed, we found that vorinostat effectively restored upregulation of Noxa protein and message and abolished multicellular resistance to bortezomib in the 3D spheroids. The ability of vorinostat to reverse resistance was ablated by knockdown of Noxa or Bim, confirming the essential role of the Noxa/Bim axis in the response to vorinostat. Addition of vorinostat similarly increased the apoptotic response to bortezomib in another 3D model, the tumor fragment spheroid, which is grown from human mesothelioma ex vivo. In addition to its benefit when used with bortezomib, vorinostat also enhanced the response to cisplatin plus pemetrexed, as shown in both 3D models. Our results using clinically relevant 3D models show that the manipulation of the core apoptotic repertoire may improve the chemosensitivity of mesothelioma. Whereas neither vorinostat nor bortezomib alone has been clinically effective in mesothelioma, vorinostat may undermine chemoresistance to bortezomib and to other therapies thereby providing a rationale for combinatorial strategies.	[Barbone, Dario; Cheung, Priscilla; Battula, Sailaja; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA; [Busacca, Sara; Fennell, Dean A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Gray, Steven G.] St James Hosp, Dept Cardiothorac Surg, Dublin, Ireland; [Longley, Daniel B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Bueno, Raphael; Sugarbaker, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Thorac Surg, Boston, MA 02115 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Leicester; Trinity College Dublin; Queens University Belfast; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA.	dario.barbone@ucsf.edu	Gray, Steven G./I-3081-2019	Gray, Steven G./0000-0002-5850-6392; Cheung, Priscilla/0000-0002-8677-9304	TRDRP fellowship [18FT-0120]; Department of Defense Mesothelioma Program [PR080717]; Simmons Mesothelioma Foundation	TRDRP fellowship; Department of Defense Mesothelioma Program; Simmons Mesothelioma Foundation	This work was supported by a TRDRP fellowship to DB (18FT-0120), a Department of Defense Mesothelioma Program grant to VCB (PR080717) and by the Simmons Mesothelioma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; Facchetti F, 2004, APOPTOSIS, V9, P573, DOI 10.1023/B:APPT.0000038036.31271.50; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hurwitz JL, 2012, EUR J CANCER, V48, P1096, DOI 10.1016/j.ejca.2011.11.009; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; METCALF RA, 1992, CANCER RES, V52, P2610; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Paik PK, 2010, J THORAC ONCOL, V5, P275, DOI 10.1097/JTO.0b013e3181c5e366; Perego P, 2012, BIOCHEM PHARMACOL, V83, P987, DOI 10.1016/j.bcp.2011.11.010; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Scherpereel A, 2011, EUR RESPIR J, V37, P129, DOI 10.1183/09031936.00037310; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Wilson SM, 2008, AM J RESP CELL MOL, V39, P576, DOI 10.1165/rcmb.2007-0460OC; Xargay-Torrent S, 2011, CLIN CANCER RES, V17, P3956, DOI 10.1158/1078-0432.CCR-10-3412; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC	29	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52753	10.1371/journal.pone.0052753	http://dx.doi.org/10.1371/journal.pone.0052753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300762	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800138
J	Bender, TJ; Wise, ME; Utah, O; Moorman, AC; Sharapov, U; Drobeniuc, J; Khudyakov, Y; Fricchione, M; White-Comstock, MB; Thompson, ND; Patel, PR				Bender, Thomas John; Wise, Matthew E.; Utah, Okey; Moorman, Anne C.; Sharapov, Umid; Drobeniuc, Jan; Khudyakov, Yury; Fricchione, Marielle; White-Comstock, Mary Beth; Thompson, Nicola D.; Patel, Priti R.			Outbreak of Hepatitis B Virus Infections Associated with Assisted Monitoring of Blood Glucose in an Assisted Living Facility-Virginia, 2010	PLOS ONE			English	Article							VIRAL-HEPATITIS; UNITED-STATES; TRANSMISSION; RECOMMENDATIONS	Introduction: In January 2010, the Virginia Department of Health received reports of 2 hepatitis B virus (HBV) infections (1 acute, 1 chronic) among residents of a single assisted living facility (ALF). Both infected residents had diabetes and received assisted monitoring of blood glucose (AMBG) at the facility. An investigation was initiated in response. Objective: To determine the extent and mechanism of HBV transmission among ALF residents. Design: Retrospective cohort study. Setting: An ALF that primarily housed residents with neuropsychiatric disorders in 2 adjacent buildings in Virginia. Participants: Residents of the facility as of March 2010. Measurements: HBV serologic testing, relevant medical history, and HBV genome sequences. Risk ratios (RR) and 95% confidence intervals (CIs) were used to identify risk factors for HBV infection. Results: HBV serologic status was determined for 126 (91%) of 139 residents. Among 88 susceptible residents, 14 became acutely infected (attack rate, 16%), and 74 remained uninfected. Acute HBV infection developed among 12 (92%) of 13 residents who received AMBG, compared with 2 (3%) of 75 residents who did not (RR = 35; 95% CI, 8.7, 137). Identified infection control breaches during AMBG included shared use of fingerstick devices for multiple residents. HBV genome sequencing demonstrated 2 building-specific phylogenetic infection clusters, each having 99.8-100% sequence identity. Limitations: Transfer of residents out of the facility prior to our investigation might have contributed to an underestimate of cases. Resident interviews provided insufficient information to fully assess behavioral risk factors for HBV infection. Conclusions: Failure to adhere to safe practices during AMBG resulted in a large HBV outbreak. Protection of a growing and vulnerable ALF population requires improved training of staff and routine facility licensing inspections that scrutinize infection control practices.	[Bender, Thomas John; Utah, Okey; White-Comstock, Mary Beth] Virginia Dept Hlth, Richmond, VA USA; [Bender, Thomas John; Wise, Matthew E.] CDC, Epidem Intelligence Serv Program, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA; [Wise, Matthew E.; Thompson, Nicola D.; Patel, Priti R.] CDC, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Moorman, Anne C.; Sharapov, Umid; Drobeniuc, Jan; Khudyakov, Yury] CDC, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Fricchione, Marielle] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Drexel University	Bender, TJ (corresponding author), Virginia Dept Hlth, Richmond, VA USA.	thomas.john.bender@dm.duke.edu		Moorman, Anne/0000-0003-2411-2798				[Anonymous], 2009, WECT NEWS 6, V6; BOND WW, 1981, LANCET, V1, P550; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Carder PC, 2002, J AGING STUD, V16, P1, DOI 10.1016/S0890-4065(01)00031-7; Centers for Disease Control and Prevention, 2002, INT HEP B SER TEST R; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2011, INF PREV BLOOD GLUC; Centers for Disease Control and Prevention, 2012, HEALTHC ASS HEP B C; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P217; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1709; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P182; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P610; Centers for Medicaid and Medicare Services, 2010, POINT CAR DEV INF CO; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Counard CA, 2010, J AM GERIATR SOC, V58, P306, DOI 10.1111/j.1532-5415.2009.02669.x; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Eckert J.K., 2009, INSIDE ASSISTED LIVI; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Food and Drug Administration, 1990, SAF AL HEP B TRANSM; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Klonoff David C, 2010, J Diabetes Sci Technol, V4, P1027; Louie RF, 2005, POINT CARE, V4, P158, DOI 10.1097/01.poc.0000189933.35225.77; McIntosh Yeatoe G., 2012, Morbidity and Mortality Weekly Report, V61, P339; Park NS, 2006, GERONTOLOGIST, V46, P238, DOI 10.1093/geront/46.2.238; Patel AS, 2009, INFECT CONT HOSP EP, V30, P209, DOI 10.1086/595693; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; POLISH LB, 1992, NEW ENGL J MED, V326, P721, DOI 10.1056/NEJM199203123261101; Quale JM, 1998, AM J MED, V105, P296, DOI 10.1016/S0002-9343(98)00256-3; Ramachandran S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025232; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer MK, 2010, JAMA-J AM MED ASSOC, V303, P2273, DOI 10.1001/jama.2010.744; Schaffzin JK, 2012, AM J INFECT CONTROL, V40, P726, DOI 10.1016/j.ajic.2011.11.002; Sikorska-Simmons E, 2005, GERONTOLOGIST, V45, P196, DOI 10.1093/geront/45.2.196; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson ND, 2010, J AM GERIATR SOC, V58, P914, DOI 10.1111/j.1532-5415.2010.02802.x; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; U.S. Census Bureau, 2001, POP PROJ US AG SEX R; Webb R., 2005, Morbidity and Mortality Weekly Report, V54, P220; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935	41	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50012	10.1371/journal.pone.0050012	http://dx.doi.org/10.1371/journal.pone.0050012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300520	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800005
J	Feng, Q; Zou, X; Lu, L; Li, Y; Liu, YZ; Zhou, JF; Duan, CM				Feng, Qiang; Zou, Xia; Lu, Ling; Li, Yun; Liu, Yunzhang; Zhou, Jianfeng; Duan, Cunming			The Stress-Response Gene redd1 Regulates Dorsoventral Patterning by Antagonizing Wnt/beta-catenin Activity in Zebrafish	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; HOMEOBOX GENE; IGF BINDING; ORGANIZER FORMATION; MAMMALIAN TARGET; SKELETAL-MUSCLE; AXIS FORMATION; ENERGY STRESS; EXPRESSION	REDD1/redd1 is a stress-response gene that is induced under various stressful conditions such as hypoxia, DNA damage, and energy stress. The increased REDD1 inhibits mTOR signaling and cell growth. Here we report an unexpected role of Redd1 in regulating dorsoventral patterning in zebrafish embryos and the underlying mechanisms. Zebrafish redd1 mRNA is maternally deposited. Although it is ubiquitously detected in many adult tissues, its expression is highly tissue-specific and dynamic during early development. Hypoxia and heat shock strongly induce redd1 expression in zebrafish embryos. Knockdown of Redd1 using two independent morpholinos results in dorsalized embryos and this effect can be rescued by injecting redd1 mRNA. Forced expression of Redd1 ventralizes embryos. Co-expression of Redd1 with Wnt3a or a constitutively active form of beta-catenin suggests that Redd1 alters dorsoventral patterning by antagonizing the Wnt/beta-catenin signaling pathway. These findings have unraveled a novel role of Redd1 in early development by antagonizing Wnt/beta-catenin signaling.	[Feng, Qiang; Zou, Xia; Lu, Ling; Li, Yun; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Ocean University of China; University of Michigan System; University of Michigan	Zhou, JF (corresponding author), Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China.	jfzhou@ouc.edu.cn; cduan@umich.edu			National Science Foundation of China [30972238, 40876064, 30970357, 30928021]; Program for New Century Excellent Talents in University [NCET-10-0723]; Major Science Programs of China [2011CB943800]; US NSF [IOS-1051034]; Direct For Biological Sciences [1051034] Funding Source: National Science Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Major Science Programs of China; US NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation of China (Grant #30972238, #40876064, #30970357 and #30928021), Program for New Century Excellent Talents in University (NCET-10-0723) and Major Science Programs of China (#2011CB943800). C. D. was supported by US NSF Research Grant IOS-1051034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KD, 2010, DEV DYNAM, V239, P2828, DOI 10.1002/dvdy.22419; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai W, 2010, FASEB J, V24, P2020, DOI 10.1096/fj.09-149435; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Erter CE, 2001, DEVELOPMENT, V128, P3571; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Horndasch M, 2006, ONCOGENE, V25, P3397, DOI 10.1038/sj.onc.1209380; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang XL, 2009, AM J PHYSIOL-REG I, V296, pR1348, DOI 10.1152/ajpregu.90969.2008; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhong YB, 2011, J CELL SCI, V124, P1925, DOI 10.1242/jcs.082644	57	23	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52674	10.1371/journal.pone.0052674	http://dx.doi.org/10.1371/journal.pone.0052674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300740	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800125
J	Johnstone, DB; Shegokar, V; Nihalani, D; Rathore, YS; Mallik, L; Ashish; Zare, V; Ikizler, HO; Powar, R; Holzman, LB				Johnstone, Duncan B.; Shegokar, Vijay; Nihalani, Deepak; Rathore, Yogendra Singh; Mallik, Leena; Ashish; Zare, Vasant; Ikizler, H. Omer; Powar, Rajaram; Holzman, Lawrence B.			APOL1 Null Alleles from a Rural Village in India Do Not Correlate with Glomerulosclerosis	PLOS ONE			English	Article							APOLIPOPROTEIN-L-I; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE KIDNEY-DISEASE; AFRICAN-AMERICANS; TRYPANOSOMA-EVANSI; HISPANIC AMERICANS; ALLOGRAFT SURVIVAL; FECHTNER SYNDROMES; RENAL-DISEASE; HUMAN SERUM	Background: Among African-Americans, genome wide association revealed a strong correlation between the G1 and G2 alleles of APOL1 (apolipoproteinL1, also called trypanolytic factor) and kidney diseases including focal and segmental glomerulosclerosis, HIV-associated nephropathy and hypertensive nephrosclerosis. In the prevailing hypothesis, heterozygous APOL1 G1 and G2 alleles increase resistance against Trypanosoma that cause African sleeping sickness, resulting in positive selection of these alleles, but when homozygous the G1 and G2 alleles predispose to glomerulosclerosis. While efforts are underway to screen patients for G1 and G2 alleles and to better understand "APOL1 glomerulopathy," no data prove that these APOL1 sequence variants cause glomerulosclerosis. G1 and G2 correlate best with glomerulosclerosis as recessive alleles, which suggests a loss of function mutation for which proof of causality is commonly tested with homozygous null alleles. This test cannot be performed in rodents as the APOL gene cluster evolved only in primates. However, there is a homozygous APOL1 null human being who lives in a village in rural India. This individual and his family offer a unique opportunity to test causality between APOL1 null alleles and glomerulosclerosis. Methods and Findings: We obtained clinical data, blood and urine from this APOL1 null patient and 50 related villagers. Based on measurements of blood pressure, BUN, creatinine, albuminuria, genotyping and immunoblotting, this APOL1 null individual does not have glomerulosclerosis, nor do his relatives who carry APOL1 null alleles. Conclusions: This small study cannot provide definitive conclusions but the absence of glomerulosclerosis in this unique population is consistent with the possibility that African-American glomerulosclerosis is caused, not by loss of APOL1 function, but by other mechanisms including a subtle gain of function or by the "genetic hitchhiking" of deleterious mutations in a gene linked to APOL1 G1 and G2.	[Johnstone, Duncan B.; Nihalani, Deepak; Ikizler, H. Omer] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Shegokar, Vijay; Powar, Rajaram; Holzman, Lawrence B.] Govt Med Hosp, Dept Microbiol, Nagpur, Maharashtra, India; [Rathore, Yogendra Singh; Mallik, Leena; Ashish] CSIR Inst Microbial Technol, Chandigarh, India; [Zare, Vasant] Publ Hlth Inst Nagpur, Nagpur, Maharashtra, India	University of Pennsylvania; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Johnstone, DB (corresponding author), Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19122 USA.	Duncan.Johnstone@tuhs.temple.edu	nihalani, deepak/AAK-9453-2020; Mallik, Leena/AAM-4619-2020	Holzman, Lawrence/0000-0002-8961-234X	NIH/NIDDK [K08-DK081626]; CSIR/UGC India; NIH [RO1 1R01DK087956];  [OLP-0056]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSIR/UGC India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by NIH/NIDDK (K08-DK081626) to DBJ. YSR and LM were supported by a Senior Research Fellowship from CSIR/UGC India. Work at CSIR-IMTECH was supported by funds from OLP-0056 to A. DN was supported by NIH RO1 1R01DK087956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 2003, GENETICS, V165, P127; Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bostrom MA, 2010, NEPHROL DIAL TRANSPL, V25, P3348, DOI 10.1093/ndt/gfq214; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Cohen DM, 2011, TRANSPLANTATION, V92, P722, DOI 10.1097/TP.0b013e31822eec39; Duchateau PN, 2001, J LIPID RES, V42, P620; Freedman BI, 2012, NEPHROL DIAL TRANSPL, V27, P1288, DOI 10.1093/ndt/gfr812; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; GREENWALD IS, 1982, GENETICS, V101, P211; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Johnstone DB, 2011, AM J TRANSPLANT, V11, P2258, DOI 10.1111/j.1600-6143.2011.03673.x; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; National Institutes of Health NIoDaDaKD Bethesda MD, 2011, U S RENAL DATA SYSTE; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Poelvoorde P, 2004, MOL BIOCHEM PARASIT, V134, P155, DOI 10.1016/j.molbiopara.2003.11.006; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Tzur S, 2012, NEPHROL DIAL TRANSPL, V27, P1498, DOI 10.1093/ndt/gfr796; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Weigel D, 2008, CSH PROTOCOLS, V2008; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89	52	58	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51546	10.1371/journal.pone.0051546	http://dx.doi.org/10.1371/journal.pone.0051546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300552	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800020
J	Malla, B; Stucki, D; Borrell, S; Feldmann, J; Maharjan, B; Shrestha, B; Fenner, L; Gagneux, S				Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Maharjan, Bhagwan; Shrestha, Bhawana; Fenner, Lukas; Gagneux, Sebastien			First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; BEIJING GENOTYPE; DRUG-RESISTANCE; NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; SEX-DIFFERENCES; STRAINS; EPIDEMIOLOGY; ASSOCIATION; EVOLUTION	Background: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown. Methods and Findings: We analyzed 261 M. tuberculosis isolates recovered from pulmonary TB patients recruited between August 2009 and August 2010 in Nepal. M. tuberculosis lineages were determined by single nucleotide polymorphisms (SNP) typing and spoligotyping. Drug resistance was determined by sequencing the hot spot regions of the relevant target genes. Overall, 164 (62.8%) TB patients were new, and 97 (37.2%) were previously treated. Any drug resistance was detected in 50 (19.2%) isolates, and 16 (6.1%) were multidrug-resistant. The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). Based on spoligotyping, we found 45 different spoligotyping patterns that were previously described. The Beijing (83 isolates, 31.8%) and CAS spoligotype (52, 19.9%) were the dominant spoligotypes. A total of 36 (13.8%) isolates could not be assigned to any known spoligotyping pattern. Lineage 2 was associated with female sex (adjusted odds ratio [aOR] 2.58, 95% confidence interval [95% CI] 1.42-4.67, p = 0.002), and any drug resistance (aOR 2.79; 95% CI 1.43-5.45; p = 0.002). We found no evidence for an association of Lineage 2 with age or BCG vaccination status. Conclusions: We found a large genetic diversity of M. tuberculosis in Nepal with representation of all four major lineages. Lineages 3 and 2 were dominating. Lineage 2 was associated with clinical characteristics. This study fills an important gap on the map of the M. tuberculosis genetic diversity in the Asian region.	[Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Maharjan, Bhagwan; Shrestha, Bhawana] German Nepal TB Project, Kathmandu, Nepal; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	lfenner@ispm.unibe.ch; Sebastien.Gagneux@unibas.ch	Gagneux, Sebastien/ABE-7909-2020	Stucki, David/0000-0003-0131-9980; Fenner, Lukas/0000-0003-3309-4835; Gagneux, Sebastien/0000-0001-7783-9048	Swiss National Science Foundation [PP0033-119205]; National Institutes of Health [AI090928, HHSN266200700022C, U01 AI069924-06]; "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI090928] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (grant number PP0033-119205), and the National Institutes of Health (grant no. AI090928 and HHSN266200700022C). BIM was supported by the "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland, and LF by the National Institutes of Health (U01 AI069924-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2009, EMERG INFECT DIS, V15, P1570, DOI 10.3201/eid1510.090170; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Tho DQ, 2012, ANTIMICROB AGENTS CH, V56, P3074, DOI 10.1128/AAC.00319-12; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski FA, 2005, EUR RESPIR J, V26, P298, DOI 10.1183/09031936.05.00136004; Fenner L, 2012, ANTIMICROB AGENTS CH, V56, P3047, DOI 10.1128/AAC.06460-11; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Guo YL, 2011, INT J TUBERC LUNG D, V15, P789, DOI 10.5588/ijtld.10.0403; Gutacker MM, 2002, GENETICS, V162, P1533; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hu Yi, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P576; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Liu Rui-xi, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P593; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; National Tuberculosis Program, 2010, NTP ANN REP 2009 201; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Rajapaksa US, 2011, INDIAN J MICROBIOL, V51, P410, DOI 10.1007/s12088-011-0150-1; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Staden R, 2000, Methods Mol Biol, V132, P115; Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253; Sun JR, 2011, APMIS, V119, P581, DOI 10.1111/j.1600-0463.2011.02790.x; Sun YJ, 2006, EPIDEMIOL INFECT, V134, P329, DOI 10.1017/S095026880500525X; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Uwizeye CB, 2011, INT J TUBERC LUNG D, V15, P776, DOI 10.5588/ijtld.10.0454; Victor T. C., 1999, Tubercle and Lung Disease, V79, P343, DOI 10.1054/tuld.1999.0222; WHO, 2009, WHOHTMTB2009422; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, NAT IMM PROGR; World Health Organization, 2010, GLOBALPLAN STOP TB 2; World Health Organization, 2010, 2010 GLOB REP SURV R	67	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52297	10.1371/journal.pone.0052297	http://dx.doi.org/10.1371/journal.pone.0052297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300635	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800066
J	Chahad-Ehlers, S; Gentile, C; Lima, JBP; Peixoto, AA; Bruno, RV				Chahad-Ehlers, Samira; Gentile, Carla; Pereira Lima, Jose Bento; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira			Analysis of cycle Gene Expression in Aedes aegypti Brains by In Situ Hybridization	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; TRANSCRIPTIONAL REPRESSOR; DROSOPHILA; MOSQUITO; NEURONS; INSECT; ORANGE; LIGHT; PATTERNS; TIMELESS	Even though the blood-sucking mosquito Aedes aegypti is one of the most important disease vectors, relatively little is known about the molecular mechanisms underlying processes involved in the temporal pattern of its activity and host seeking behavior. In this study, we analyzed the expression of the cycle (cyc) gene, one of the core components of the circadian clock, in Ae. aegypti brains by in situ hybridization at two different time points in light-dark conditions and compared the results with those obtained using a quantitative PCR assay (qPCR). Within the brain, differential labeling was detected according to distinct areas empirically pre-defined. Six out of seven of these areas showed significantly higher staining at ZT3 (three hours after light-on) compared to ZT11 (one before light-off), which is consistent with the qPCR data. Predominant staining was observed in three of those areas which correspond to positions of the optical and antennal lobes, as well as the region where the neurons controlling activity rhythms are presumably localized.	[Chahad-Ehlers, Samira; Gentile, Carla; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento] Inst Biol Exercito, Lab Entomol, Rio De Janeiro, Brazil; [Pereira Lima, Jose Bento; Peixoto, Alexandre Afranio; Bruno, Rafaela Vieira] CNPq, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bruno, RV (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	rafaelav@ioc.fiocruz.br	Bruno, Rafaela/AAQ-7611-2020; Chahad-Ehlers, Samira/H-8024-2015	Chahad-Ehlers, Samira/0000-0003-2321-4389; Bruno, Rafaela/0000-0002-7082-9768	Howard Hughes Medical Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj); Fundacao Oswaldo Cruz (FIOCRUZ)	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by grants from the Howard Hughes Medical Institute, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj), and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2004, GENETICS, V168, P2025, DOI 10.1534/genetics.104.028399; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chang DC, 2003, J BIOL CHEM, V278, P38149, DOI 10.1074/jbc.M306937200; Clements AN., 1999, SENSORY RECEPTION BE; Cortes T, 2010, INSECT MOL BIOL, V19, P123, DOI 10.1111/j.1365-2583.2009.00931.x; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; KASAI M, 1987, PHYSIOL ENTOMOL, V12, P59, DOI 10.1111/j.1365-3032.1987.tb00724.x; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Malpel S, 2002, DEVELOPMENT, V129, P1443; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Meireles ACA, 2006, FEBS LETT, V580, P2, DOI 10.1016/j.febslet.2005.11.031; Meireles-Filho AC, 2006, BMC MOL BIOL, V27, P7; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NYHOF JM, 1989, INT J INSECT MORPHOL, V18, P13, DOI 10.1016/0020-7322(89)90033-0; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sambrook J, 2001, MOL CLONING LAB MANU; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Saunders DS, 2002, INSECT CLOCKS; Schiemenz H, 1957, DTSCH ENTOMOL Z, V4, P64; Shao QM, 2008, CELL TISSUE RES, V331, P435, DOI 10.1007/s00441-007-0534-z; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zucker RM, 2006, CYTOM PART A, V69A, P1143, DOI 10.1002/cyto.a.20343	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52559	10.1371/journal.pone.0052559	http://dx.doi.org/10.1371/journal.pone.0052559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300979	Green Published, gold			2022-12-25	WOS:000313320900031
J	Grietens, KP; Ribera, JM; Soto, V; Tenorio, A; Hoibak, S; Aguirre, AR; Toomer, E; Rodriguez, H; Cuentas, AL; D'Alessandro, U; Gamboa, D; Erhart, A				Grietens, Koen Peeters; Muela Ribera, Joan; Soto, Veronica; Tenorio, Alex; Hoibak, Sarah; Rosas Aguirre, Angel; Toomer, Elizabeth; Rodriguez, Hugo; Llanos Cuentas, Alejandro; D'Alessandro, Umberto; Gamboa, Dionicia; Erhart, Annette			Traditional Nets Interfere with the Uptake of Long-Lasting Insecticidal Nets in the Peruvian Amazon: The Relevance of Net Preference for Achieving High Coverage and Use	PLOS ONE			English	Article							TREATED BED NETS; ANOPHELES-DARLINGI; PLASMODIUM-VIVAX; MOSQUITO NETS; MALARIA; AREA; ACCEPTABILITY; OWNERSHIP; CURTAINS; VECTOR	Background: While coverage of long-lasting insecticide-treated nets (LLIN) has steadily increased, a growing number of studies report gaps between net ownership and use. We conducted a mixed-methods social science study assessing the importance of net preference and use after Olyset (R) LLINs were distributed through a mass campaign in rural communities surrounding Iquitos, the capital city of the Amazonian region of Peru. Methods: The study was conducted in the catchment area of the Paujil and Cahuide Health Centres (San Juan district) between July 2007 and November 2008. During a first qualitative phase, participant observation and in-depth interviews collected information on key determinants for net preference and use. In a second quantitative phase, a survey among recently confirmed malaria patients evaluated the acceptability and use of both LLINs and traditional nets, and a case control study assessed the association between net preference/use and housing structure (open vs. closed houses). Results: A total of 10 communities were selected for the anthropological fieldwork and 228 households participated in the quantitative studies. In the study area, bed nets are considered part of the housing structure and are therefore required to fulfil specific architectural and social functions, such as providing privacy and shelter, which the newly distributed Olyset (R) LLINs ultimately did not. The LLINs' failure to meet these criteria could mainly be attributed to their large mesh size, transparency and perceived ineffectiveness to protect against mosquitoes and other insects, resulting in 63.3% of households not using any of the distributed LLINs. Notably, LLIN usage was significantly lower in houses with no interior or exterior walls (35.2%) than in those with walls (73.8%) (OR = 5.2, 95CI [2.2; 12.3], p<0.001). Conclusion: Net preference can interfere with optimal LLIN use. In order to improve the number of effective days of LLIN protection per dollar spent, appropriate quantitative and qualitative methods for collecting information on net preference should be developed before any LLIN procurement decision is made.	[Grietens, Koen Peeters; D'Alessandro, Umberto; Erhart, Annette] Prince Leopold Inst Trop Med, Antwerp, Belgium; [Grietens, Koen Peeters; Muela Ribera, Joan; Toomer, Elizabeth] PASS Int, Partners Appl Social Sci, Tessenderlo, Belgium; [Soto, Veronica; Rosas Aguirre, Angel; Llanos Cuentas, Alejandro; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Tenorio, Alex; Rosas Aguirre, Angel; Rodriguez, Hugo] Proyecto PAMAFRO, Organismo Andino Salud Convenio Hipolito Unanue, Lima, Peru; [Hoibak, Sarah] MENTOR Initiat, Crawley, England; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Grietens, KP (corresponding author), Prince Leopold Inst Trop Med, Antwerp, Belgium.	kpeeters@itg.be	Aguirre, Angel Rosas/A-5054-2016; D'Alessandro, Umberto/D-3457-2015; Peeters Grietens, Koen/G-7028-2019; Gamboa, Dionicia/CAF-2097-2022; Ribera, JM/B-8181-2009	Aguirre, Angel Rosas/0000-0002-3271-7028; D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Gamboa, Dionicia/0000-0002-1420-7729; Ribera, JM/0000-0003-1042-6024; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; muela ribera, joan/0000-0003-2111-6275	Belgian Cooperation [95502]; National Institute of Health [U19 SI089681]	Belgian Cooperation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study received financial support from the Belgian Cooperation within the Framework Agreement III consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), Antwerp- Belgium, and the ITM Alexander von Humboldt (ITM-AvH), Universidad Peruana Cayetano Heredia in Lima, Peru, Project 95502. DG is also supported by a National Institute of Health grant (U19 SI089681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agypeong I, 1999, J BIOSOC SCI, V31, P79; AIKINS MK, 1994, J TROP MED HYG, V97, P81; Alliance for Malaria Prevention Toolkit 2.0, 2011, ALL MAL PREV TOOLK 2; American Anthropological Association, 2018, AM ANTHR ASS STAT ET; American Anthropological Association, 1998, ANTHR NEWS; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], QUICK FACTS PROC LON; [Anonymous], REF UPD GMAP OBJ TAR; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-298; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Bean J, 2001, INSECTICIDE TR UNPUB; Brieger W, 1994, HLTH ED RES, V11, P133; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Fernando SD, 2008, T R SOC TROP MED HYG, V22, P222; Gamble C, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003755.pub2, 10.1002/14651858.CD001031.pub2]; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Global Fund to Fight Aids Tuberculosis and Malaria, 2011, COUNTR COORD MECH; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Gunasekaran K, 2009, ACTA TROP, V112, P149, DOI 10.1016/j.actatropica.2009.07.013; Harvey SA, 2000, INSECTICIDE IM UNPUB; Harvey SA, 2008, AM J TROP MED HYG, V79, P834, DOI 10.4269/ajtmh.2008.79.834; Helman CG, 2007, CULTURE HLTH ILLNESS; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Koenker H, 2011, PUBLIC HLTH BAYER CR; Llanos-Zavalaga Fernando, 2005, Rev Med Hered, V16, P97; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Oficina General de Epidemiologia DIRESA Loreto, 2008, AN SIT SAL REG LOR A; OGEP, 2006, WEEKL EP B; Organismo Andino de Salud-Convenio Hipolito Unanue, PROYECT PAMA FRO; PAMAFRO, 2011, REP RES; Peeters Grietens K, 2010, MALARIA J, V9, P1; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; R4D, 2012, EXP ACC LLIN GLOB MA; RBM, 2001, FIN REP INS TREAT BE; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Schoeler GB, 2003, J AM MOSQUITO CONTR, V19, P286; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; Teddlie C., 2008, FDN MIXED METHODS RE; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; WHO, 2009, 12 WHOPES WORK GROUP; WHO, 2011, VECT CONTR; WHO, 2011, SYST IMPR VAL MON LL; WHO, 2011, GUIDELINES MONITORIN; WHO, 2011, INC M PIL STUD PROJ; WHOPES, 2011, LONG LAST INS MOSQ N; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	53	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50294	10.1371/journal.pone.0050294	http://dx.doi.org/10.1371/journal.pone.0050294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300943	Green Published, gold			2022-12-25	WOS:000313320900003
J	Guo, Q; Koirala, S; Perkins, EM; McCaffery, JM; Shaw, JM				Guo, Qian; Koirala, Sajjan; Perkins, Edward M.; McCaffery, J. Michael; Shaw, Janet M.			The Mitochondrial Fission Adaptors Caf4 and Mdv1 Are Not Functionally Equivalent	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; WD REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; DNM1P; YEAST; DIVISION; FIS1P; DUPLICATION; RECRUITMENT; MORPHOLOGY	Mitochondrial fission in eukaryotes is mediated by protein complexes that encircle and divide mitochondrial tubules. In budding yeast, fission requires the membrane-anchored protein Fis1 and the dynamin-related GTPase Dnm1. Dnm1 is recruited to mitochondria via interactions with the adaptor proteins Caf4 and Mdv1, which bind directly to Fis1. Unlike Mdv1, a function for Caf4 in mitochondrial membrane scission has not been established. In this study, we demonstrate that Caf4 is a bona fide fission adaptor that assembles at sites of mitochondrial division. We also show that fission complexes may contain Caf4 alone or both Caf4 and Mdv1 without compromising fission function. Although there is a correspondence between Caf4 and Mdv1 expression levels and their contribution to fission, the two adaptor proteins are not equivalent. Rather, our functional and phylogenetic analyses indicate that Caf4 mitochondrial fission activity has diverged from that of Mdv1.	[Guo, Qian; Koirala, Sajjan; Shaw, Janet M.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Perkins, Edward M.; McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	Utah System of Higher Education; University of Utah; Johns Hopkins University	Shaw, JM (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	shaw@biochem.utah.edu	Koirala, Sajjan/AAI-4424-2020	Perkins, Edward/0000-0002-3077-7422	National Institutes of Health [GM53466, GM84970]; NCRR [SRR022588A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053466, R01GM084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1 grants GM53466 and GM84970 to JMS and NCRR SRR022588A to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Maniatis T., 1982, MOL CLONING LAB MANU; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Musso G, 2007, TRENDS GENET, V23, P266, DOI 10.1016/j.tig.2007.03.012; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhang Y, 2012, J BIOL CHEM, V287, P9855, DOI 10.1074/jbc.M111.329359	32	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53523	10.1371/journal.pone.0053523	http://dx.doi.org/10.1371/journal.pone.0053523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300936	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600106
J	Marklein, D; Graab, U; Naumann, I; Yan, TD; Ridzewski, R; Nitzki, F; Rosenberger, A; Dittmann, K; Wienands, J; Wojnowski, L; Fulda, S; Hahn, H				Marklein, Diana; Graab, Ulrike; Naumann, Ivonne; Yan, Tiandong; Ridzewski, Rosalie; Nitzki, Frauke; Rosenberger, Albert; Dittmann, Kai; Wienands, Juergen; Wojnowski, Leszek; Fulda, Simone; Hahn, Heidi			PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells	PLOS ONE			English	Article							TOPOISOMERASE-II INHIBITORS; FLOW-CYTOMETRIC ANALYSIS; CYTOCHROME-C RELEASE; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; INTERGROUP RHABDOMYOSARCOMA; MTOR INHIBITION; PHASE-II; PROTEIN-1 EXPRESSION	We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy of DOX in several sarcoma cell lines and interacts with DOX in the induction of apoptosis. PI103 decreased the expression of MDR1 and MRP1, which resulted in DOX accumulation. However, the enhancement of DOX-induced apoptosis was unrelated to DOX accumulation. Neither did it involve inhibition of mTOR. Instead, the combination treatment of DOX plus PI103 activated Bax, the mitochondrial apoptosis pathway, and caspase 3. Caspase 3 activation was also observed in xenografts of sarcoma cells in nude mice upon combination of DOX with the specific PI3K inhibitor GDC-0941. Although the increase in apoptosis did not further impact on tumor growth when compared to the efficient growth inhibition by GDC-0941 alone, these findings suggest that inhibition of PI3K may improve DOX-induced proapoptotic effects in sarcoma. Taken together with similar recent studies of neuroblastoma- and glioblastoma-derived cells, PI3K inhibition seems to be a more general option to sensitize tumor cells to anthracyclines.	[Marklein, Diana; Ridzewski, Rosalie; Nitzki, Frauke; Hahn, Heidi] Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Graab, Ulrike; Naumann, Ivonne; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany; [Yan, Tiandong; Wojnowski, Leszek] Univ Med Ctr, Dept Pharmacol, Mainz, Germany; [Rosenberger, Albert] Univ Med Ctr, Dept Genet Epidemiol, Gottingen, Germany; [Dittmann, Kai; Wienands, Juergen] Univ Med Ctr, Dept Cellular & Mol Immunol, Gottingen, Germany	University of Gottingen; Goethe University Frankfurt; Johannes Gutenberg University of Mainz; University of Gottingen; University of Gottingen	Hahn, H (corresponding author), Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	hhahn@gwdg.de		Fulda, Simone/0000-0002-0459-6417	DFG [GRK 1034, WO505/3-1]; Deutsche Krebshilfe [109837 (KoSAR)]	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was supported by the DFG GRK 1034 (to H. H.), by the grant 109837 (KoSAR) from the Deutsche Krebshilfe (to H. H. and S. F.) and by the DFG grant WO505/3-1 (to L. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Beck WT, 1999, DRUG RESIST UPDATE, V2, P382, DOI 10.1054/drup.1999.0110; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Bergeron C, 2008, EUR J CANCER, V44, P427, DOI 10.1016/j.ejca.2007.12.007; Biehn SE, 2007, ANN HEMATOL, V86, P211, DOI 10.1007/s00277-006-0220-3; Blay JY, 2011, ANN ONCOL, V22, P280, DOI 10.1093/annonc/mdq307; BONADONNA G, 1970, CANCER RES, V30, P2572; Congdon LM, 2008, BIOCHEM PHARMACOL, V75, P883, DOI 10.1016/j.bcp.2007.10.026; Cortes F, 2003, MUTAGENESIS, V18, P105, DOI 10.1093/mutage/18.2.105; CRIST W, 1995, J CLIN ONCOL, V13, P610, DOI 10.1200/JCO.1995.13.3.610; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; Gatta G, 2003, EUR J CANCER, V39, P2600, DOI 10.1016/j.ejca.2003.09.004; Giantris A, 1998, CRIT REV ONCOL HEMAT, V27, P53, DOI 10.1016/S1040-8428(97)10007-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gortzak E, 2001, EUR J CANCER, V37, P1096, DOI 10.1016/S0959-8049(01)00083-1; GREENE RF, 1983, CANCER RES, V43, P3417; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Han Z, 2007, J EXP CLIN CANC RES, V26, P261; Hideshima T, 2001, CANCER RES, V61, P3071; Kanbe E, 2003, EXP HEMATOL, V31, P300, DOI 10.1016/S0301-472X(03)00003-1; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Liu F, 2010, ONCOL REP, V23, P1469, DOI 10.3892/or_00000786; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; MAURER HM, 1993, CANCER-AM CANCER SOC, V71, P1904, DOI 10.1002/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X; MAURER HM, 1988, CANCER-AM CANCER SOC, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mohr A, 2004, CELL DEATH DIFFER, V11, P1153, DOI 10.1038/sj.cdd.4401480; Murphy KM, 2000, J BIOL CHEM, V275, P17225, DOI 10.1074/jbc.C900590199; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO;2-X; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Rabbani A, 2005, BIOESSAYS, V27, P50, DOI 10.1002/bies.20160; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Simbre Valeriano C, 2005, Paediatr Drugs, V7, P187, DOI 10.2165/00148581-200507030-00005; Stahnke K, 2004, APOPTOSIS, V9, P457, DOI 10.1023/B:APPT.0000031454.62937.fa; STILLER CA, 1994, PAEDIATR PERINAT EP, V8, P107, DOI 10.1111/j.1365-3016.1994.tb00439.x; Takahashi-Hyodo SA, 1999, MUTAT RES-FUND MOL M, V431, P13, DOI 10.1016/S0027-5107(99)00151-7; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; TAN C, 1973, CANCER-AM CANCER SOC, V32, P9, DOI 10.1002/1097-0142(197307)32:1<9::AID-CNCR2820320102>3.0.CO;2-6; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Zhang LL, 2002, CANCER RES, V62, P2034	51	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52898	10.1371/journal.pone.0052898	http://dx.doi.org/10.1371/journal.pone.0052898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300809	Green Published, gold			2022-12-25	WOS:000313872600033
J	Chapman, NM; Yoder, AN; Houtman, JCD				Chapman, Nicole M.; Yoder, Ashley N.; Houtman, Jon C. D.			Non-Catalytic Functions of Pyk2 and Fyn Regulate Late Stage Adhesion in Human T Cells	PLOS ONE			English	Article							TYROSINE KINASE PYK2; ACTIN CYTOSKELETON; ANTIGEN RECEPTOR; ACTIVATION; PHOSPHORYLATION; COMPLEX; NCK; AUTOIMMUNE; INTEGRINS; SYNAPSE	T cell activation drives the protective immune response against pathogens, but is also critical for the development of pathological diseases in humans. Cytoskeletal changes are required for downstream functions in T cells, including proliferation, cytokine production, migration, spreading, and adhesion. Therefore, investigating the molecular mechanism of cytoskeletal changes is crucial for understanding the induction of T cell-driven immune responses and for developing therapies to treat immune disorders related to aberrant T cell activation. In this study, we used a plate-bound adhesion assay that incorporated near-infrared imaging technology to address how TCR signaling drives human T cell adhesion. Interestingly, we observed that T cells have weak adhesion early after TCR activation and that binding to the plate was significantly enhanced 30-60 minutes after receptor activation. This late stage of adhesion was mediated by actin polymerization but was surprisingly not dependent upon Src family kinase activity. By contrast, the non-catalytic functions of the kinases Fyn and Pyk2 were required for late stage human T cell adhesion. These data reveal a novel TCR-induced signaling pathway that controls cellular adhesion independent of the canonical TCR signaling cascade driven by tyrosine kinase activity.	[Chapman, Nicole M.; Houtman, Jon C. D.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Yoder, Ashley N.; Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Houtman, JCD (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854	American Heart Association Pre-doctoral fellowship [11PRE7390070]; National Institutes of Health (NIH) Predoctoral Training Grant in Immunology [T32 AI007485]; American Heart Association undergraduate fellowship [12UFEL12060651]; Scientist Development Grant from the American Heart Association [0830244N]; National Institutes of Health [R01 CA136729]; NATIONAL CANCER INSTITUTE [R01CA136729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	American Heart Association Pre-doctoral fellowship(American Heart Association); National Institutes of Health (NIH) Predoctoral Training Grant in Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association undergraduate fellowship(American Heart Association); Scientist Development Grant from the American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by an American Heart Association Pre-doctoral fellowship (11PRE7390070) and the National Institutes of Health (NIH) Predoctoral Training Grant in Immunology (T32 AI007485) to NMC, an American Heart Association undergraduate fellowship to ANY (12UFEL12060651), and a Scientist Development Grant 0830244N from the American Heart Association and R01 CA136729 from the National Institutes of Health to JCDH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Berg NN, 1997, J IMMUNOL, V159, P1753; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cleland SY, 2011, FEBS LETT, V585, P3710, DOI 10.1016/j.febslet.2011.10.031; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Fukai I, 2000, EUR J IMMUNOL, V30, P3507, DOI 10.1002/1521-4141(2000012)30:12<3507::AID-IMMU3507>3.0.CO;2-O; Gao CL, 2009, BIOCHEM J, V420, P49, DOI 10.1042/BJ20090037; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Keck K, 2009, MOL THER, V17, P538, DOI 10.1038/mt.2008.273; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lasserre R, 2010, FEBS LETT, V584, P4845, DOI 10.1016/j.febslet.2010.09.001; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Pauker MH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002423; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Reicher B, 2010, FEBS LETT, V584, P4858, DOI 10.1016/j.febslet.2010.09.002; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Sancho D, 2002, J IMMUNOL, V169, P292, DOI 10.4049/jimmunol.169.1.292; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen A, 2005, IMMUNOLOGY, V116, P276, DOI 10.1111/j.1365-2567.2005.02222.x; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; St-Pierre J, 2011, CELL SIGNAL, V23, P718, DOI 10.1016/j.cellsig.2010.12.006; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53011	10.1371/journal.pone.0053011	http://dx.doi.org/10.1371/journal.pone.0053011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300847	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100108
J	Dai, FJ; Chen, YH; Song, YJ; Huang, L; Zhai, D; Dong, YM; Lai, L; Zhang, T; Li, DL; Pang, XF; Liu, MY; Yi, ZF				Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang			A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells	PLOS ONE			English	Article							P53-MDM2 INTERACTION; DNA-DAMAGE; APOPTOSIS; PROTEIN; VEGF; PHOSPHORYLATION; RESTORATION; REPRESSION; EXPRESSION; COMPOUND	Activation of p53 effectively inhibits tumor angiogenesis that is necessary for tumor growth and metastasis. Reactivation of the p53 by small molecules has emerged as a promising new strategy for cancer therapy. Several classes of small-molecules that activate the p53 pathway have been discovered using various approaches. Here, we identified harmine (beta-carboline alkaloid) as a novel activator of p53 signaling involved in inhibition of angiogenesis and tumor growth. Harmine induced p53 phosphorylation and disrupted the p53-MDM2 interaction. Harmine also prevented p53 degradation in the presence of cycloheximide and activated nuclear accumulation of p53 followed by increasing its transcriptional activity in endothelial cells. Moreover, harmine not only induced endothelial cell cycle arrest and apoptosis, but also suppressed endothelial cell migration and tube formation as well as induction of neovascularity in a mouse corneal micropocket assay. Finally, harmine inhibited tumor growth by reducing tumor angiogenesis, as demonstrated by a xenograft tumor model. Our results suggested a novel mechanism and bioactivity of harmine, which inhibited tumor growth by activating the p53 signaling pathway and blocking angiogenesis in endothelial cells.	[Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX USA; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chen, YH (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	yhchen79@gmail.com; ibms.ecnu@gmail.com; yizhengfang@gmail.com	Chen, Yihua/O-2743-2019; Chen, Yihua/A-4323-2013	Chen, Yihua/0000-0003-1733-7980; Chen, Yihua/0000-0003-1733-7980; Liu, Mingyao/0000-0001-7339-5048	Major State Basic Research Development Program of China [2012CB910400, 2009CB918402]; National Natural Science Foundation of China [30930055, 30971523, 81071807]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially sponsored by the Major State Basic Research Development Program of China (2012CB910400) (http://www.most.gov.cn), (2009CB918402) (http://www.973.gov.cn), National Natural Science Foundation of China (30930055, 30971523 and 81071807) (http://www.nsfc.gov.cn) and the Science and Technology Commission of Shanghai Municipality (11DZ2260300) (http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cao MR, 2011, HEPATOB PANCREAT DIS, V10, P599, DOI 10.1016/S1499-3872(11)60102-1; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Duda DG, 2002, BRIT J CANCER, V86, P490, DOI 10.1038/sj.bjc.6600067; Frost D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019264; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Hamsa TP, 2010, EUR J PHARMACOL, V649, P64, DOI 10.1016/j.ejphar.2010.09.010; Hamsa TP, 2010, EUR J PHARM; Ho TC, 2008, J BIOL CHEM, V283, P30273, DOI 10.1074/jbc.M804196200; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HUDSON JB, 1986, PHOTOCHEM PHOTOBIOL, V43, P21, DOI 10.1111/j.1751-1097.1986.tb05586.x; Jiang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034283; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumari SR, 1998, CANCER RES, V58, P5075; Lai L, 2012, BRIT J PHARMACOL, V165, P1084, DOI 10.1111/j.1476-5381.2011.01532.x; Lala S, 2004, J DRUG TARGET, V12, P165, DOI 10.1080/10611860410001712696; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19409; Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955; Moll UM, 2003, MOL CANCER RES, V1, P1001; Montero E, 2008, J CANCER RES CLIN, V134, P193, DOI 10.1007/s00432-007-0270-5; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sionov RV, 2001, MOL CELL BIOL, V21, P5869; Song SY, 2000, NEOPLASIA, V2, P261, DOI 10.1038/sj.neo.7900088; Song Y, ANGIOGENESIS, V15, P421; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065; Zhang L, 2009, ANTI-CANCER DRUG, V20, P416, DOI 10.1097/CAD.0b013e32832aa7b0; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909	49	63	69	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52162	10.1371/journal.pone.0052162	http://dx.doi.org/10.1371/journal.pone.0052162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300602	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100024
J	Han, Y; Huang, H; Xiao, Z; Zhang, W; Cao, YF; Qu, LK; Shou, CC				Han, Yong; Huang, Hao; Xiao, Zhen; Zhang, Wei; Cao, Yanfei; Qu, Like; Shou, Chengchao			Integrated Analysis of Gene Expression Profiles Associated with Response of Platinum/Paclitaxel-Based Treatment in Epithelial Ovarian Cancer	PLOS ONE			English	Article							DNA METHYLATION; AKT INHIBITORS; COLON-CANCER; CELLS; PACLITAXEL; CHEMOTHERAPY; RESISTANCE; SIGNATURES; CISPLATIN; BETA	Purpose: This study aims to explore gene expression signatures and serum biomarkers to predict intrinsic chemoresistance in epithelial ovarian cancer (EOC). Patients and Methods: Gene expression profiling data of 322 high-grade EOC cases between 2009 and 2010 in The Cancer Genome Atlas project (TCGA) were used to develop and validate gene expression signatures that could discriminate different responses to first-line platinum/paclitaxel-based treatments. A gene regulation network was then built to further identify hub genes responsible for differential gene expression between the complete response (CR) group and the progressive disease (PD) group. Further, to find more robust serum biomarkers for clinical application, we integrated our gene signatures and gene signatures reported previously to identify secretory protein-encoding genes by searching the DAVID database. In the end, gene-drug interaction network was constructed by searching Comparative Toxicogenomics Database (CTD) and literature. Results: A 349-gene predictive model and an 18-gene model independent of key clinical features with high accuracy were developed for prediction of chemoresistance in EOC. Among them, ten important hub genes and six critical signaling pathways were identified to have important implications in chemotherapeutic response. Further, ten potential serum biomarkers were identified for predicting chemoresistance in EOC. Finally, we suggested some drugs for individualized treatment. Conclusion: We have developed the predictive models and serum biomarkers for platinum/paclitaxel response and established the new approach to discover potential serum biomarkers from gene expression profiles. The potential drugs that target hub genes are also suggested.	[Han, Yong; Huang, Hao; Cao, Yanfei; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Xiao, Zhen; Zhang, Wei] Wuhan Univ, Renmin Hosp, Dept Gynecol, Wuhan 430072, Hubei, Peoples R China; [Cao, Yanfei] Changzhi Med Coll, Changzhi, Shanxi, Peoples R China	Peking University; Wuhan University; Changzhi Medical College	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	scc@bjcancer.org		Han, Yong/0000-0001-9935-2978	National 973 Program of China [2009CB521805]	National 973 Program of China(National Basic Research Program of China)	This study was funded by the National 973 Program of China (2009CB521805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; [Anonymous], 2011, GENE EXPRESSION PROF; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Davies S, 2011, ONCOL REP, V25, P855, DOI 10.3892/or.2011.1147; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gamarra-Luques CD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-200; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Kim YJ, 2012, ANTICANCER RES, V32, P799; Kim YM, 2002, J BIOL CHEM, V277, P6799, DOI 10.1074/jbc.M109434200; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; L'Esperance S, 2006, INT J ONCOL, V29, P5; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lu ZH, 2006, EXP CELL RES, V312, P1865, DOI 10.1016/j.yexcr.2006.02.017; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Mehnert JM, 2011, MOL CANCER THER, V10, P1509, DOI 10.1158/1535-7163.MCT-10-0944; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Sabatier R, 2011, BRIT J CANCER, V105, P304, DOI 10.1038/bjc.2011.219; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Si HP, 2012, INT J ONCOL, V40, P1291, DOI 10.3892/ijo.2011.1303; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Su JL, 2011, CANCER RES, V71, P6878, DOI 10.1158/0008-5472.CAN-11-0295; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Xu R, 2009, ANTICANCER RES, V29, P261; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang CY, 2011, MOL CANCER THER, V10, P1137, DOI 10.1158/1535-7163.MCT-10-1028	58	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52745	10.1371/journal.pone.0052745	http://dx.doi.org/10.1371/journal.pone.0052745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300757	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100076
J	Ludwig, SKJ; Smits, NGE; van der Veer, G; Bremer, MGEG; Nielen, MWF				Ludwig, Susann K. J.; Smits, Nathalie G. E.; van der Veer, Grishja; Bremer, Maria G. E. G.; Nielen, Michel W. F.			Multiple Protein Biomarker Assessment for Recombinant Bovine Somatotropin (rbST) Abuse in Cattle	PLOS ONE			English	Article							IGF BINDING-PROTEINS; HUMAN GROWTH-HORMONE; GH ABUSE; PROTEOMIC APPROACH; ANTIBODY-FORMATION; COLLAGEN TURNOVER; I CONCENTRATIONS; SERUM; MARKERS; COWS	Biomarker profiling, as a rapid screening approach for detection of hormone abuse, requires well selected candidate biomarkers and a thorough in vivo biomarker evaluation as previously done for detection of growth hormone doping in athletes. The bovine equivalent of growth hormone, called recombinant bovine somatotropin (rbST) is (il)legally administered to enhance milk production in dairy cows. In this study, first a generic sample pre-treatment and 4-plex flow cytometric immunoassay (FCIA) were developed for simultaneous measurement of four candidate biomarkers selected from literature: insulin-like growth factor 1 (IGF-1), its binding protein 2 (IGFBP2), osteocalcin and endogenously produced antibodies against rbST. Next, bovine serum samples from two extensive controlled rbST animal treatment studies were used for in vivo validation and biomarker evaluation. Finally, advanced statistic tools were tested for the assessment of biomarker combination quality aiming to correctly identify rbST-treated animals. The statistical prediction tool k-nearest neighbours using a combination of the biomarkers osteocalcin and endogenously produced antibodies against rbST proved to be very reliable and correctly predicted 95% of the treated samples starting from the second rbST injection until the end of the treatment period and even thereafter. With the same biomarker combination, only 12% of untreated animals appeared false-positive. This reliability meets the requirements of Commission Decision 2002/657/EC for screening methods in veterinary control. From the results of this multidisciplinary study, it is concluded that the osteocalcin - anti-rbST-antibodies combination represent fit-for-purpose biomarkers for screening of rbST abuse in dairy cattle and can be reliably measured in both the developed 4-plex FCIA as well as in a cost-effective 2-plex microsphere-based binding assay. This screening method can be incorporated in routine veterinary monitoring programmes: in the European Union for detection of rbST abuse and in the control of rbST-free dairy farms in the United States of America and other countries.	[Ludwig, Susann K. J.; Smits, Nathalie G. E.; van der Veer, Grishja; Bremer, Maria G. E. G.; Nielen, Michel W. F.] Wageningen UR, RIKILT Inst Food Safety, Wageningen, Netherlands; [Nielen, Michel W. F.] Wageningen Univ, Organ Chem Lab, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ludwig, SKJ (corresponding author), Wageningen UR, RIKILT Inst Food Safety, Wageningen, Netherlands.	susann.ludwig@wur.nl	Ludwig, Susann KJ/I-5844-2014	Ludwig, Susann KJ/0000-0002-7614-0558	Dutch Ministry of Economic Affairs, Agriculture and Innovation [72029.01]	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This project was financially supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (http://www.rijksoverheid.nl/ministeries/eleni project 72029.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, FED REGISTER, V58, P59; [Anonymous], 1999, OFF J EUR COMM, VL 331, P71; ARMSTRONG JD, 1993, DOMEST ANIM ENDOCRIN, V10, P315, DOI 10.1016/0739-7240(93)90035-A; BLUM WF, 1993, GROWTH REGULAT, V3, P100; Boateng J, 2009, PROTEOM CLIN APPL, V3, P912, DOI 10.1002/prca.200800190; Bremer MGEG, 2010, ANALYST, V135, P1147, DOI 10.1039/b925372f; Cacciatore G, 2009, ANAL CHIM ACTA, V637, P351, DOI 10.1016/j.aca.2008.11.027; Castigliego L, 2009, RES VET SCI, V87, P29, DOI 10.1016/j.rvsc.2008.10.012; Castigliego L, 2007, J DAIRY RES, V74, P79, DOI 10.1017/S0022029906002159; Chung L, 2009, GROWTH HORM IGF RES, V19, P383, DOI 10.1016/j.ghir.2009.04.019; Chung LP, 2006, J CLIN ENDOCR METAB, V91, P671, DOI 10.1210/jc.2005-1137; Dall R, 2000, J CLIN ENDOCR METAB, V85, P4193, DOI 10.1210/jc.85.11.4193; Di Luigi L, 2009, EUR J ENDOCRINOL, V160, P753, DOI 10.1530/EJE-08-0884; Dimitriadou E, 2011, E1071 MISC FUNCTIONS; Ding J, 2011, PROTEOMICS, V11, P3565, DOI 10.1002/pmic.201100077; Ding J, 2009, GROWTH HORM IGF RES, V19, P399, DOI 10.1016/j.ghir.2009.04.018; Draisci R, 2007, PROTEOMICS, V7, P3184, DOI 10.1002/pmic.200601039; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EPPARD PJ, 1992, J DAIRY SCI, V75, P2959, DOI 10.3168/jds.S0022-0302(92)78059-X; Erotokritou-Mulligan I, 2010, CLIN ENDOCRINOL, V72, P520, DOI 10.1111/j.1365-2265.2009.03668.x; European Commission, 2002, OFFICIAL J, V221, P8; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; Healy ML, 2005, J CLIN ENDOCR METAB, V90, P641, DOI 10.1210/jc.2004-0386; KERR DE, 1991, CAN J ANIM SCI, V71, P695, DOI 10.4141/cjas91-085; Kicman AT, 1997, CLIN ENDOCRINOL, V47, P43, DOI 10.1046/j.1365-2265.1997.2111036.x; Kniess A, 2003, ANAL BIOANAL CHEM, V376, P696, DOI 10.1007/s00216-003-1926-x; Le Breton MH, 2010, J AGR FOOD CHEM, V58, P729, DOI 10.1021/jf903032q; Le Breton MH, 2009, ANAL CHIM ACTA, V637, P121, DOI 10.1016/j.aca.2008.09.003; Lee AJ, 2000, ANN CLIN BIOCHEM, V37, P432, DOI 10.1258/0004563001899573; Longobardi S, 2000, J CLIN ENDOCR METAB, V85, P1505, DOI 10.1210/jc.85.4.1505; LUCY MC, 1994, BIOL REPROD, V50, P1136, DOI 10.1095/biolreprod50.5.1136; Ludwig SKJ, 2012, FOOD CONTROL, V26, P68, DOI 10.1016/j.foodcont.2011.12.011; MCGUIRE MA, 1992, J ANIM SCI, V70, P2901, DOI 10.2527/1992.7092901x; Mooney MH, 2008, BIOMARKERS, V13, P246, DOI [10.1080/13547500701838593, 10.1080/13547500701838593 ]; Nelson AE, 2011, ENDOCR UPDAT, P139, DOI 10.1007/978-1-4419-7014-5_15; Powrie JK, 2007, GROWTH HORM IGF RES, V17, P220, DOI 10.1016/j.ghir.2007.01.011; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rochereau-Roulet S, 2011, ANAL CHIM ACTA, V700, P189, DOI 10.1016/j.aca.2011.01.035; Sartorio A, 2006, J ENDOCRINOL INVEST, V29, P237, DOI 10.1007/BF03345546; Sato R, 2011, RES VET SCI, V91, P196, DOI 10.1016/j.rvsc.2010.12.007; SHARMA BK, 1994, J DAIRY SCI, V77, P2232, DOI 10.3168/jds.S0022-0302(94)77166-6; Smits NGE, 2012, DRUG TEST ANAL, V4, P362, DOI 10.1002/dta.336; Smits NGE, 2012, ANALYST, DOI [10.1039/c1032an35226e, DOI 10.1039/C1032AN35226E]; Teale P, 2009, BIOANALYSIS, V1, P1103, DOI [10.4155/bio.09.87, 10.4155/BIO.09.87]; Wallace JD, 2000, J CLIN ENDOCR METAB, V85, P124, DOI 10.1210/jc.85.1.124; ZHAO X, 1994, DOMEST ANIM ENDOCRIN, V11, P209, DOI 10.1016/0739-7240(94)90028-0; ZWICKL CM, 1990, J DAIRY SCI, V73, P2888, DOI 10.3168/jds.S0022-0302(90)78976-X	47	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52917	10.1371/journal.pone.0052917	http://dx.doi.org/10.1371/journal.pone.0052917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300820	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100097
J	Ntusi, NBA; Badri, M; Khalfey, H; Whitelaw, A; Oliver, S; Piercy, J; Raine, R; Joubert, I; Dheda, K				Ntusi, Ntobeko B. A.; Badri, Motasim; Khalfey, Hoosain; Whitelaw, Andrew; Oliver, Stephen; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan			ICU-Associated Acinetobacter baumannii Colonisation/Infection in a High HIV-Prevalence Resource-Poor Setting	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; RISK-FACTORS; GLOBAL EPIDEMIOLOGY; RESISTANT; PATHOGENS; HOSPITALS	Background: There are hardly any data about the incidence, risk factors and outcomes of ICU-associated A. baumannii colonisation/infection in HIV-infected and uninfected persons from resource-poor settings like Africa. Methods: We reviewed the case records of patients with A. baumannii colonisation/infection admitted into the adult respiratory and surgical ICUs in Cape Town, South Africa, from January 1 to December 31 2008. In contrast to colonisation, infection was defined as isolation of A. baumannii from any biological site in conjunction with a compatible clinical picture warranting treatment with antibiotics effective against A. baumannii. Results: The incidence of A. baumannii colonisation/infection in 268 patients was 15 per 100 person-years, with an in-ICU mortality of 26.5 per 100 person-years. The average length of stay in ICU was 15 days (range 1-150). A. baumannii was most commonly isolated from the respiratory tract followed by the bloodstream. Independent predictors of mortality included older age (p = 0.02), low CD4 count if HIV-infected (p = 0.038), surgical intervention (p = 0.047), co-morbid Gram-negative sepsis (p = 0.01), high APACHE-II score (p = 0.001), multi-organ dysfunction syndrome (p = 0.012), and a positive blood culture for A. baumannii (p = 0.017). Of 21 A. baumannii colonised/infected HIV-positive persons those with clinical AIDS (CD4<200 cells/mm(3)) had significantly higher in-ICU mortality and were more likely to have a positive blood culture. Conclusion In this resource-poor setting A. baumannii infection in critically ill patients is common and associated with high mortality. HIV co-infected patients with advanced immunosuppression are at higher risk of death.	[Badri, Motasim; Khalfey, Hoosain; Dheda, Keertan] Groote Schuur Hosp, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Khalfey, Hoosain; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan] Groote Schuur Hosp, Dept Crit Care, ZA-7925 Cape Town, South Africa; [Ntusi, Ntobeko B. A.] Groote Schuur Hosp, Cardiac Clin, Dept Med, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Oliver, Stephen] Groote Schuur Hosp, Dept Microbiol, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Oliver, Stephen] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Ntusi, Ntobeko B. A.; Badri, Motasim; Khalfey, Hoosain; Whitelaw, Andrew; Oliver, Stephen; Piercy, Jenna; Raine, Richard; Joubert, Ivan; Dheda, Keertan] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Ntusi, Ntobeko/AAA-1152-2020; Badri, Motasim/E-1141-2013	Badri, Motasim/0000-0002-5268-6492; Ntusi, Ntobeko A. B./0000-0003-2347-7883; Whitelaw, Andrew/0000-0001-9070-5247	SA MRC (South African Medical Research Council); Discovery Academic Foundation; SA DST (Deptartment of Science and Technology) (SARChI); EU; EDCTP (European-Developing Countries Clinical Trial Partnership)	SA MRC (South African Medical Research Council); Discovery Academic Foundation; SA DST (Deptartment of Science and Technology) (SARChI); EU(European Commission); EDCTP (European-Developing Countries Clinical Trial Partnership)	NN receives funding from the SA MRC (South African Medical Research Council) and the Discovery Academic Foundation. KD is supported by the SA DST (Deptartment of Science and Technology) (SARChI), SA MRC, EU (FP7) and the EDCTP (European-Developing Countries Clinical Trial Partnership). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, J INFECTION, V53, P98, DOI 10.1016/j.jinf.2005.10.021; Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Chen CH, 2003, INFECTION, V31, P331, DOI 10.1007/s15010-003-3223-1; Daniels TL, 2008, INFECT CONT HOSP EP, V29, P1080, DOI 10.1086/591456; Diekema DJ, 2000, INT J ANTIMICROB AG, V13, P257, DOI 10.1016/S0924-8579(99)00131-4; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P117, DOI 10.1111/j.1469-0691.2006.01596.x; Falagas ME, 2006, CRIT CARE, V10, P793; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gounden R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-26; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; Manfredi R, 2001, CHEMOTHERAPY, V47, P19, DOI 10.1159/000048497; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Paul M, 2005, J HOSP INFECT, V60, P256, DOI 10.1016/j.jhin.2005.01.007; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; POTGIETER PD, 1987, CRIT CARE MED, V15, P495, DOI 10.1097/00003246-198705000-00008; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x; Trottier Vincent, 2007, Surg Infect (Larchmt), V8, P437, DOI 10.1089/sur.2006.029; UNAIDS/WHO, 2009, REP GLOB HIV AIDS EP; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Webster CA, 1999, EUR J CLIN MICROBIOL, V18, P595, DOI 10.1007/s100960050354; Zapor MJ, 2005, CURR OPIN INFECT DIS, V18, P395, DOI 10.1097/01.qco.0000182102.50430.2c	25	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52452	10.1371/journal.pone.0052452	http://dx.doi.org/10.1371/journal.pone.0052452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300673	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100050
J	Salker, MS; Nautiyal, J; Steel, JH; Webster, Z; Sucurovic, S; Nicou, M; Singh, Y; Lucas, ES; Murakami, K; Chan, YW; James, S; Abdallah, Y; Christian, M; Croy, BA; Mulac-Jericevic, B; Quenby, S; Brosens, JJ				Salker, Madhuri S.; Nautiyal, Jaya; Steel, Jennifer H.; Webster, Zoe; Sucurovic, Sandra; Nicou, Marilena; Singh, Yogesh; Lucas, Emma S.; Murakami, Keisuke; Chan, Yi-Wah; James, Sean; Abdallah, Yazan; Christian, Mark; Croy, B. Anne; Mulac-Jericevic, Biserka; Quenby, Siobhan; Brosens, Jan J.			Disordered IL-33/ST2 Activation in Decidualizing Stromal Cells Prolongs Uterine Receptivity in Women with Recurrent Pregnancy Loss	PLOS ONE			English	Article							SOLUBLE ST2; ENDOMETRIAL RECEPTIVITY; INDIAN HEDGEHOG; CROSS-TALK; PROGESTERONE; RECEPTOR; IMPLANTATION; INTERLEUKIN-33; EMBRYO; GENE	Decidualization renders the endometrium transiently receptive to an implanting blastocyst although the underlying mechanisms remain incompletely understood. Here we show that human endometrial stromal cells (HESCs) rapidly release IL-33, a key regulator of innate immune responses, upon decidualization. In parallel, differentiating HESCs upregulate the IL-33 transmembrane receptor ST2L and other pro-inflammatory mediators before mounting a profound anti-inflammatory response that includes downregulation of ST2L and increased expression of the soluble decoy receptor sST2. We demonstrate that HESCs secrete factors permissive of embryo implantation in mice only during the pro-inflammatory phase of the decidual process. IL-33 knockdown in undifferentiated HESCs was sufficient to abrogate this pro-inflammatory decidual response. Further, sequential activation of the IL-33/ST2L/sST2 axis was disordered in decidualizing HESCs from women with recurrent pregnancy loss. Signals from these cultures prolonged the implantation window but also caused subsequent pregnancy failure in mice. Thus, Il-33/ST2 activation in HESCS drives an autoinflammatory response that controls the temporal expression of receptivity genes. Failure to constrain this response predisposes to miscarriage by allowing out-of-phase implantation in an unsupportive uterine environment.	[Salker, Madhuri S.; Sucurovic, Sandra; Lucas, Emma S.; Murakami, Keisuke; Chan, Yi-Wah; James, Sean; Abdallah, Yazan; Quenby, Siobhan; Brosens, Jan J.] Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Div Reprod Hlth, Coventry, W Midlands, England; [Salker, Madhuri S.; Nautiyal, Jaya; Steel, Jennifer H.; Nicou, Marilena; Christian, Mark] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Webster, Zoe] Univ London Imperial Coll Sci Technol & Med, Embryon Stem Cell Facil, MRC, Ctr Clin Sci, London, England; [Sucurovic, Sandra; Mulac-Jericevic, Biserka] Univ Rijeka, Dept Physiol & Immunol, Sch Med, Rijeka, Croatia; [Singh, Yogesh] Univ London Royal Vet Coll, Dept Infect & Immun, London, England; [Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	University of Warwick; Imperial College London; Imperial College London; University of Rijeka; University of London; University of London Royal Veterinary College; Queens University - Canada	Brosens, JJ (corresponding author), Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Div Reprod Hlth, Coventry, W Midlands, England.	J.J.Brosens@warwick.ac.uk	Murakami, Keisuke/Q-1257-2019; Singh, Yogesh/T-8230-2017; Mulac-Jericevic, Biserka/S-6034-2018; Šućurović, Sandra/P-7405-2018; Steel, Jennifer/B-4737-2013; Lucas, Emma S/I-2719-2013	Singh, Yogesh/0000-0001-6919-6273; Mulac-Jericevic, Biserka/0000-0001-8418-0712; Šućurović, Sandra/0000-0002-1509-3452; Steel, Jennifer/0000-0003-4439-0090; Lucas, Emma S/0000-0002-8571-8921; Quenby, Siobhan/0000-0003-3221-5471; Brosens, Jan/0000-0003-0116-9329; Salker, Madhuri Sonal/0000-0002-7939-289X; Christian, Mark/0000-0002-1616-4179	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Genesis Research Trust	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Genesis Research Trust	This work was supported the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire National Health Service Trust and Warwick Medical School, and the Genesis Research Trust (MSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aghajanova L, 2008, SEMIN CELL DEV BIOL, V19, P204, DOI 10.1016/j.semcdb.2007.10.008; Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chaouat G, 1997, AM J REPROD IMMUNOL, V37, P427; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Granne I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024463; Grimaldi G, 2012, MOL HUMAN REPROD; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; HARPER MJK, 1992, BAILLIERE CLIN OB GY, V6, P351, DOI 10.1016/S0950-3552(05)80092-6; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koot YE, 2012, BIOCH BIOPHYSICA ACT; Kunes P, 2010, THORAC CARDIOV SURG, V58, P443, DOI 10.1055/s-0030-1250436; Laskarin G, 2005, CHEM IMMUNOL ALLERGY, V89, P10, DOI 10.1159/000087906; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mok MY, 2010, RHEUMATOLOGY, V49, P520, DOI 10.1093/rheumatology/kep402; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Quenby S, 2002, HUM REPROD, V17, P1959, DOI 10.1093/humrep/17.8.1959; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2011, NATURE MED; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wilczynski JR, 2005, EUR J OBSTET GYN R B, V122, P136, DOI 10.1016/j.ejogrb.2005.03.008; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	60	132	139	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52252	10.1371/journal.pone.0052252	http://dx.doi.org/10.1371/journal.pone.0052252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300625	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100035
J	Tollenaere, C; Susi, H; Nokso-Koivisto, J; Koskinen, P; Tack, A; Auvinen, P; Paulin, L; Frilander, MJ; Lehtonen, R; Laine, AL				Tollenaere, Charlotte; Susi, Hanna; Nokso-Koivisto, Jussi; Koskinen, Patrik; Tack, Ayco; Auvinen, Petri; Paulin, Lars; Frilander, Mikko J.; Lehtonen, Rainer; Laine, Anna-Liisa			SNP Design from 454 Sequencing of Podosphaera plantaginis Transcriptome Reveals a Genetically Diverse Pathogen Metapopulation with High Levels of Mixed-Genotype Infection	PLOS ONE			English	Article							POWDERY MILDEW FUNGI; PLANT-PATHOGEN; LOCAL ADAPTATION; EVOLUTION; VIRULENCE; DYNAMICS; ECOLOGY; SCALE; HOST; MICROSATELLITE	Background: Molecular tools may greatly improve our understanding of pathogen evolution and epidemiology but technical constraints have hindered the development of genetic resources for parasites compared to free-living organisms. This study aims at developing molecular tools for Podosphaera plantaginis, an obligate fungal pathogen of Plantago lanceolata. This interaction has been intensively studied in the A land archipelago of Finland with epidemiological data collected from over 4,000 host populations annually since year 2001. Principal Findings: A cDNA library of a pooled sample of fungal conidia was sequenced on the 454 GS-FLX platform. Over 549,411 reads were obtained and annotated into 45,245 contigs. Annotation data was acquired for 65.2% of the assembled sequences. The transcriptome assembly was screened for SNP loci, as well as for functionally important genes (mating-type genes and potential effector proteins). A genotyping assay of 27 SNP loci was designed and tested on 380 infected leaf samples from 80 populations within the A land archipelago. With this panel we identified 85 multilocus genotypes (MLG) with uneven frequencies across the pathogen metapopulation. Approximately half of the sampled populations contain polymorphism. Our genotyping protocol revealed mixed-genotype infection within a single host leaf to be common. Mixed infection has been proposed as one of the main drivers of pathogen evolution, and hence may be an important process in this pathosystem. Significance: The developed SNP panel offers exciting research perspectives for future studies in this well-characterized pathosystem. Also, the transcriptome provides an invaluable novel genomic resource for powdery mildews, which cause significant yield losses on commercially important crops annually. Furthermore, the features that render genetic studies in this system a challenge are shared with the majority of obligate parasitic species, and hence our results provide methodological insights from SNP calling to field sampling protocols for a wide range of biological systems. A	[Tollenaere, Charlotte; Susi, Hanna; Nokso-Koivisto, Jussi; Koskinen, Patrik; Tack, Ayco; Lehtonen, Rainer; Laine, Anna-Liisa] Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland; [Koskinen, Patrik; Auvinen, Petri; Paulin, Lars; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki	Laine, AL (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Laine, Anna-Liisa/B-1398-2016; Tack, Ayco/B-7120-2017; Frilander, Mikko J/B-6660-2009; Tollenaere, Charlotte/ABB-6175-2020	Auvinen, Petri/0000-0002-3947-4778; Laine, Anna-Liisa/0000-0002-0703-5850; Tack, Ayco/0000-0002-3550-1070; Frilander, Mikko J/0000-0002-1732-4808; Tollenaere, Charlotte/0000-0003-2045-2824; Koskinen, Patrik/0000-0003-1485-4990; Lehtonen, Rainer Juhani/0000-0002-8343-0318	Academy of Finland [250444, 136393, 133499]; European Research Council [PATHEVOL 281517]	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This work has been funded by the Academy of Finland (www.aka.fi/; Grant Nos 250444, 136393, 133499) and European Research Council (http://erc.europa.eu/; PATHEVOL 281517) grants to ALL. These funding sourced have covered the salary of ALL, CT, HS and AT as well as all laboratory costs and sampling costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Alizon S, 2008, AM NAT, V172, pE150, DOI 10.1086/590958; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Brewer MT, 2011, FUNGAL GENET BIOL, V48, P704, DOI 10.1016/j.fgb.2011.04.004; Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Giraud T, 2008, PARASITE, V15, P449, DOI 10.1051/parasite/2008153449; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Laine AL, 2008, ECOL LETT, V11, P327, DOI 10.1111/j.1461-0248.2007.01146.x; Linde CC, 2002, PHYTOPATHOLOGY, V92, P946, DOI 10.1094/PHYTO.2002.92.9.946; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mideo N, 2009, TRENDS PARASITOL, V25, P261, DOI 10.1016/j.pt.2009.03.001; Mori Y, 2000, MYCOLOGIA, V92, P74, DOI 10.2307/3761452; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Perez G, 2010, MOL ECOL, V19, P1801, DOI 10.1111/j.1365-294X.2010.04584.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; Salvaudon L, 2008, CURR OPIN PLANT BIOL, V11, P135, DOI 10.1016/j.pbi.2008.02.002; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Shama LNS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-278; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Tokarska M, 2009, HEREDITY, V103, P326, DOI 10.1038/hdy.2009.73; VANBAALEN M, 1995, TRENDS MICROBIOL, V3, P414, DOI 10.1016/S0966-842X(00)88991-X; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Webling R, 2012, FUNGAL GENETICS BIOL; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]	61	46	46	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52492	10.1371/journal.pone.0052492	http://dx.doi.org/10.1371/journal.pone.0052492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300684	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100053
J	Xu, QL; Shi, YL; Dadhwal, P; Liang, FT				Xu, Qilong; Shi, Yanlin; Dadhwal, Poonam; Liang, Fang Ting			RpoS Regulates Essential Virulence Factors Remaining to Be Identified in Borrelia burgdorferi	PLOS ONE			English	Article							SURFACE PROTEIN-C; BINDING-PROTEIN; INFECTIVITY; EXPRESSION; BBK32; OSPC	Background: Since the RpoN-RpoS regulatory network was revealed in the Lyme disease spirochete Borrelia burgdorferi a decade ago, both upstream and downstream of the pathway have been intensively investigated. While significant progress has been made into understanding of how the network is regulated, most notably, discovering a relationship of the network with Rrp2 and BosR, only three crucial virulence factors, including outer surface protein C (OspC) and decorin-binding proteins (Dbps) A and B, are associated with the pathway. Moreover, for more than 10 years no single RpoS-controlled gene has been found to be critical for infection, raising a question about whether additional RpoS-dependent virulence factors remain to be identified. Methodology/Principal Findings: The rpoS gene was deleted in B. burgdorferi; resulting mutants were modified to constitutively express all the known virulence factors, OspC, DbpA and DbpB. This genetic modification was unable to restore the rpoS mutant with infectivity. Conclusions/Significance: The inability to restore the rpoS mutant with infectivity by simultaneously over-expressing all the three virulence factors allows us to conclude RpoS also regulates essential genes that remain to be identified in B. burgdorferi.	[Xu, Qilong; Shi, Yanlin; Dadhwal, Poonam; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Liang, FT (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [RO1 AI077733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by RO1 AI077733 from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Banik S, 2011, INFECT IMMUN, V79, P1208, DOI 10.1128/IAI.01156-10; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Gautam A, 2008, MICROBIOL-SGM, V154, P275, DOI 10.1099/mic.0.2007/011676-0; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Samuels DS, 2009, MOL MICROBIOL, V74, P1295, DOI 10.1111/j.1365-2958.2009.06971.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shi YL, 2006, INFECT IMMUN, V74, P6509, DOI 10.1128/IAI.00740-06; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Xu H, INFECT IMMUN, V78, P2910; Xu H, PLOS PATHOG, V6; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100	30	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53212	10.1371/journal.pone.0053212	http://dx.doi.org/10.1371/journal.pone.0053212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300893	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100128
J	Jiao, S; Hsu, L; Berndt, S; Bezieau, S; Brenner, H; Buchanan, D; Caan, BJ; Campbell, PT; Carlson, CS; Casey, G; Chan, AT; Chang-Claude, J; Chanock, S; Conti, DV; Curtis, KR; Duggan, D; Gallinger, S; Gruber, SB; Harrison, TA; Hayes, RB; Henderson, BE; Hoffmeister, M; Hopper, JL; Hudson, TJ; Hutter, CM; Jackson, RD; Jenkins, MA; Kantor, ED; Kolonel, LN; Kury, S; Le Marchand, L; Lemire, M; Newcomb, PA; Potter, JD; Qu, CH; Rosse, SA; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Ulrich, CM; Zanke, BW; Peters, U				Jiao, Shuo; Hsu, Li; Berndt, Sonja; Bezieau, Stephane; Brenner, Hermann; Buchanan, Daniel; Caan, Bette J.; Campbell, Peter T.; Carlson, Christopher S.; Casey, Graham; Chan, Andrew T.; Chang-Claude, Jenny; Chanock, Stephen; Conti, David V.; Curtis, Keith R.; Duggan, David; Gallinger, Steven; Gruber, Stephen B.; Harrison, Tabitha A.; Hayes, Richard B.; Henderson, Brian E.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Hutter, Carolyn M.; Jackson, Rebecca D.; Jenkins, Mark A.; Kantor, Elizabeth D.; Kolonel, Laurence N.; Kuery, Sebastien; Le Marchand, Loic; Lemire, Mathieu; Newcomb, Polly A.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Schoen, Robert E.; Schumacher, Fred R.; Seminara, Daniela; Slattery, Martha L.; Ulrich, Cornelia M.; Zanke, Brent W.; Peters, Ulrike			Genome-Wide Search for Gene-Gene Interactions in Colorectal Cancer	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; ASSOCIATION SCAN; ENVIRONMENT INTERACTIONS; RANDOM FORESTS; HUMAN-DISEASES; VARIANTS; RISK; METAANALYSIS; EPISTASIS; SEROTONIN	Genome-wide association studies (GWAS) have successfully identified a number of single-nucleotide polymorphisms (SNPs) associated with colorectal cancer (CRC) risk. However, these susceptibility loci known today explain only a small fraction of the genetic risk. Gene-gene interaction (GxG) is considered to be one source of the missing heritability. To address this, we performed a genome-wide search for pair-wise GxG associated with CRC risk using 8,380 cases and 10,558 controls in the discovery phase and 2,527 cases and 2,658 controls in the replication phase. We developed a simple, but powerful method for testing interaction, which we term the Average Risk Due to Interaction (ARDI). With this method, we conducted a genome-wide search to identify SNPs showing evidence for GxG with previously identified CRC susceptibility loci from 14 independent regions. We also conducted a genome-wide search for GxG using the marginal association screening and examining interaction among SNPs that pass the screening threshold (p < 10(-4)). For the known locus rs10795668 (10p14), we found an interacting SNP rs367615 (5q21) with replication p = 0.01 and combined p = 4.19x10(-8). Among the top marginal SNPs after LD pruning (n = 163), we identified an interaction between rs1571218 (20p12.3) and rs10879357 (12q21.1) (nominal combined p = 2.51x10(-6); Bonferroni adjusted p = 0.03). Our study represents the first comprehensive search for GxG in CRC, and our results may provide new insight into the genetic etiology of CRC.	[Jiao, Shuo; Hsu, Li; Carlson, Christopher S.; Curtis, Keith R.; Harrison, Tabitha A.; Hutter, Carolyn M.; Kantor, Elizabeth D.; Newcomb, Polly A.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Ulrich, Cornelia M.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Berndt, Sonja; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bezieau, Stephane; Kuery, Sebastien] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Bezieau, Stephane; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Buchanan, Daniel] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Caan, Bette J.] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; [Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Carlson, Christopher S.; Newcomb, Polly A.; Potter, John D.; Ulrich, Cornelia M.; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Casey, Graham; Conti, David V.; Gruber, Stephen B.; Henderson, Brian E.; Schumacher, Fred R.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Gallinger, Steven] Toronto Gen Hosp, Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Hayes, Richard B.] NYU, Sch Med, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Ulrich, Cornelia M.] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Zanke, Brent W.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); QIMR Berghofer Medical Research Institute; Kaiser Permanente; American Cancer Society; University of Washington; University of Washington Seattle; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; New York University; University of Melbourne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University System of Ohio; Ohio State University; Cancer Research Center of Hawaii; University of Hawaii System; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Ottawa; Ottawa Hospital Research Institute	Jiao, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	sjiao@fhcrc.org	KÜRY, Sébastien/G-5971-2015; Brenner, Hermann/B-4627-2017; Gallinger, Steven/E-4575-2013; Chan, Andrew T/P-8293-2014; Brenner, Hermann/ABE-6383-2020; Schumacher, Fredrick/R-6043-2019; Jenkins, Mark/P-7803-2015; Berndt, Sonja I/J-8423-2016; Hoffmeister, Michael/B-5745-2012; Bézieau, stéphane/G-5621-2015; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022	KÜRY, Sébastien/0000-0001-5497-0465; Brenner, Hermann/0000-0002-6129-1572; Chan, Andrew T/0000-0001-7284-6767; Brenner, Hermann/0000-0002-6129-1572; Schumacher, Fredrick/0000-0002-3073-7463; Jenkins, Mark/0000-0002-8964-6160; Hoffmeister, Michael/0000-0002-8307-3197; Bézieau, stéphane/0000-0003-0095-1319; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Potter, John/0000-0001-5439-1500; Kantor, Elizabeth/0000-0002-9124-5323; Buchanan, Daniel/0000-0003-2225-6675; Caan, Bette/0000-0002-5803-310X; Harrison, Tabitha/0000-0002-4173-7530	Hospital Clinical Research Program (PHRC); Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health [U01 CA074783, U01 CA122839]; Ontario Research Fund [GL2]; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; National Cancer Institute [R01 CA60987]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Australasian Colorectal Cancer Family Registry [U01 CA097735]; Seattle Colorectal Cancer Family Registry [U01 CA074794]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [R01 CA48998, U01 CA137088, R01 CA059045]; National Institutes of Health [P01 CA 055075, R01 137178, P50 CA 127003, P01 CA 087969, CA42182, R01 CA076366]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; Intramural Research Program of the National Cancer Institute; National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI] [Z01 CP 010200]; National Cancer Institute; Gene Environment Association Studies, GENEVA Coordinating Center [U01 HG004446]; NIH GEI [U01 HG 004438]; National Institutes of Health from the National Cancer Institute and Office of Dietary Supplements [K05 CA154337]; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, 268200764316C];  [R37 CA54281];  [P01 CA033619];  [R01 CA63464]; NATIONAL CANCER INSTITUTE [R01CA060987, U01CA097735, R37CA054281, U01CA137088, P01CA033619, K05CA154337, R01CA059045, K22CA095011, R01CA048998, P50CA127003, U19CA148107, P01CA055075, U01CA074794, R01CA076366, R01CA042182, R01CA063464, P30CA015704, P01CA087969, U01CA122839, U01CA074783, Z01CP010200] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014358] Funding Source: NIH RePORTER	Hospital Clinical Research Program (PHRC); Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australasian Colorectal Cancer Family Registry; Seattle Colorectal Cancer Family Registry; Ontario Registry for Studies of Familial Colorectal Cancer; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI]; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gene Environment Association Studies, GENEVA Coordinating Center; NIH GEI; National Institutes of Health from the National Cancer Institute and Office of Dietary Supplements; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ASTERISK was funded by a Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). ARCTIC is partly supported by the National Cancer Institute, National Institutes of Health through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section below. ARCTIC is also supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. TJH and BWZ are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Economic Development and Innovation. COLO2&3 is supported by the National Cancer Institute (R01 CA60987). CCFR is supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011 and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. This genome wide scan was supported by the National Cancer Institute, National Institutes of Health by U01 CA122839. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government or the CFR. The following Colon CFR centers contributed data to this manuscript and were supported by the following sources: Australasian Colorectal Cancer Family Registry (U01 CA097735), Seattle Colorectal Cancer Family Registry (U01 CA074794) and Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783). DACHS was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS was supported by the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (R01 CA48998 to MLS). GECCO is supported by National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088). Funding for the genome-wide scan of DALS, PLCO, and WHI was provided by the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (R01 CA059045). HPFS, NHS, PHS: The National Institutes of Health supported HPFS (P01 CA 055075, R01 137178, P50 CA 127003), NHS (R01 137178, P50 CA 127003, P01 CA 087969), and PHS (CA42182). MEC is supported by R37 CA54281, P01 CA033619, and R01 CA63464. PLCO was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer scan, supported by the Intramural Research Program of the National Cancer Institute. The datasets used in this analysis were accessed with appropriate approval through the dbGaP online resource (http://www.cgems.cancer.gov/data_acess.html) through dbGaP accession number 000207v.1p1.c1.; (National Cancer Institute (2009) Cancer Genetic Markers of Susceptibility (CGEMS) data website, http://cgems.cancer.gov/data_access.html; Yeager et al. 2007). Control samples were also genotyped as part of the GWAS of Lung Cancer and Smoking (Landi et al. 2009). Funding for this work was provided through the National Institutes of Health, Genes, Environment and Health Initiative [NIH GEI] (Z01 CP 010200). The human subjects participating in the GWAS are derived from the Prostate, Lung, Colon and Ovarian Screening Trial and the study is supported by intramural resources of the National Cancer Institute. Assistance with genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies, GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01 HG 004438). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000093. PMH was supported by the National Institutes of Health (R01 CA076366 to PAN). VITAL was supported, in part, by the National Institutes of Health (K05 CA154337) from the National Cancer Institute and Office of Dietary Supplements. WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, and 268200764316C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee S, 2010, CGEN R PACKAGE ANAL; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; CATTANEO MG, 1993, CANCER RES, V53, P5566; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Gogele M, 2012, AM J EPIDEMIOL, V175, P739, DOI 10.1093/aje/kwr385; Hambek M, ANTICANCER RES, V26, P1091; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hsu L, 2012, GENET EPIDEMIOL, V36, P183, DOI 10.1002/gepi.21610; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lignitto L, 2011, NAT CELL BIOL, V13, P412, DOI 10.1038/ncb2209; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Prentice RL, 2011, J NATL CANCER I, V103, P1209, DOI 10.1093/jnci/djr279; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Siddiqui EJ, 2006, BJU INT, V97, P634, DOI 10.1111/j.1464-410X.2006.06056.x; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tao S, 2012, HUM GENET, V131, P1225, DOI 10.1007/s00439-012-1148-4; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; VanderWeele TJ, 2011, ANN HUM GENET, V75, P146, DOI 10.1111/j.1469-1809.2010.00600.x; VanderWeele TJ, 2010, GENET EPIDEMIOL, V34, P327, DOI 10.1002/gepi.20484; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	64	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52535	10.1371/journal.pone.0052535	http://dx.doi.org/10.1371/journal.pone.0052535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300701	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800103
J	Lindner, R; Friedel, CC				Lindner, Robert; Friedel, Caroline C.			A Comprehensive Evaluation of Alignment Algorithms in the Context of RNA-Seq	PLOS ONE			English	Article							SPLICE JUNCTIONS; READ ALIGNMENT; TOOL; ULTRAFAST	Transcriptome sequencing (RNA-Seq) overcomes limitations of previously used RNA quantification methods and provides one experimental framework for both high-throughput characterization and quantification of transcripts at the nucleotide level. The first step and a major challenge in the analysis of such experiments is the mapping of sequencing reads to a transcriptomic origin including the identification of splicing events. In recent years, a large number of such mapping algorithms have been developed, all of which have in common that they require algorithms for aligning a vast number of reads to genomic or transcriptomic sequences. Although the FM-index based aligner Bowtie has become a de facto standard within mapping pipelines, a much larger number of possible alignment algorithms have been developed also including other variants of FM-index based aligners. Accordingly, developers and users of RNA-seq mapping pipelines have the choice among a large number of available alignment algorithms. To provide guidance in the choice of alignment algorithms for these purposes, we evaluated the performance of 14 widely used alignment programs from three different algorithmic classes: algorithms using either hashing of the reference transcriptome, hashing of reads, or a compressed FM-index representation of the genome. Here, special emphasis was placed on both precision and recall and the performance for different read lengths and numbers of mismatches and indels in a read. Our results clearly showed the significant reduction in memory footprint and runtime provided by FM-index based aligners at a precision and recall comparable to the best hash table based aligners. Furthermore, the recently developed Bowtie 2 alignment algorithm shows a remarkable tolerance to both sequencing errors and indels, thus, essentially making hash-based aligners obsolete.	[Lindner, Robert] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Friedel, Caroline C.] Univ Munich, Inst Informat, D-80539 Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich	Friedel, CC (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	caroline.friedel@lmu.de	Friedel, Caroline/AAG-5017-2019	Friedel, Caroline/0000-0003-3569-4877	DFG [FR2938/1-1]	DFG(German Research Foundation (DFG))	The study was partially supported by DFG (www.dfg.de/) grant FR2938/1-1 to CCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bonfert T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S9; Burrows M, 1994, BLOCK SORTING LOSSLE; Chen LY, 2011, NUCL ACIDS RES; Clement NL, 2010, BIOINFORMATICS, V26, P38, DOI 10.1093/bioinformatics/btp614; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	21	48	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52403	10.1371/journal.pone.0052403	http://dx.doi.org/10.1371/journal.pone.0052403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300661	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800080
J	Pai, S; Aliyu, SH; Enoch, DA; Karas, JA				Pai, Sumita; Aliyu, Sani Hussaini; Enoch, David Andrew; Karas, Johannis Andreas			Five Years Experience of Clostridium difficile Infection in Children at a UK Tertiary Hospital: Proposed Criteria for Diagnosis and Management	PLOS ONE			English	Article							ONCOLOGY PATIENTS; DISEASE; DIARRHEA; GASTROENTERITIS; ENTEROCOLITIS; COLONIZATION; SURVEILLANCE; COHORT; TOXIN; UNIT	Background: Clostridium difficile infection (CDI) is associated with significant morbidity and mortality in adults. There is increasing evidence of the pathogenic role of C. difficile in the paediatric population. We sought to ascertain the clinical presentation and severity of CDI in children at our institution and develop criteria to aid management. Methods: Clinical data was retrospectively collected from all children (0-16 yrs) with a positive C. difficile toxin result over a 5-year period. National adult guidelines were used to assess the severity and management of CDI. Results: Seventy-five patients were included with a mean age of 2.97 years. Forty-nine were hospital onset, 22 community onset and 4 healthcare-associated. The most common co-morbidity among the hospital onset infections was malignancy. Gastrointestinal conditions were most common among community onset infections. Fifty-five cases (73.3%) had received antibiotics in the preceding month, 7 (9.3%) had cow's milk intolerance and 9 (12%) had co-infection with another gut pathogen. According to national adult guidelines 57 cases (76%) were categorised as severe. Thirty cases received oral metronidazole, two patients required intensive care and one patient had a sub-total colectomy for pseudomembranous colitis. No mortality was observed. Discussion: We confirm the association of paediatric CDI with co-morbidities such as haematological and solid organ malignancies, recent antibiotic use and hospitalisation. We observed an association between cows milk protein intolerance and C. difficile. The use of adult criteria overestimated severity of disease in this cohort, as most cases experienced a mild course of illness with low morbidity and no mortality. This indicates that adult scoring criteria are not useful in guiding management and we propose specific criteria for children.	[Pai, Sumita; Aliyu, Sani Hussaini; Karas, Johannis Andreas] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge, England; [Enoch, David Andrew] Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Peterborough, Cambs, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge	Karas, JA (corresponding author), Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge, England.	karasja@gmail.com			Cambridge University Hospitals NHS Foundation Trust	Cambridge University Hospitals NHS Foundation Trust	This work was part of an official hospital audit and was supported by Cambridge University Hospitals NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNETTO AL, 1988, ARCH DIS CHILD, V63, P979, DOI 10.1136/adc.63.8.979; BURGNER DP, 1993, ARCH DIS CHILD, V69, P239, DOI 10.1136/adc.69.2.239; Castagnola E, 2009, SUPPORT CARE CANCER, V17, P321, DOI 10.1007/s00520-008-0507-0; [Department of Health Health Protection Agency], 2008, CLOSTR DIFF DEAL PRO; El-Mahallawy HA, 2004, PEDIATR BLOOD CANCER, V42, P338, DOI 10.1002/pbc.10394; ELLIS ME, 1984, BRIT MED J, V288, P524, DOI 10.1136/bmj.288.6416.524; Enoch DA, 2011, J INFECTION, V63, P105, DOI 10.1016/j.jinf.2011.05.016; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kim J, 2008, PEDIATRICS, V122, P1266, DOI 10.1542/peds.2008-0469; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lukkarinen H, 2009, PEDIATR INFECT DIS J, V28, P847, DOI 10.1097/INF.0b013e31819d1cd9; Morinville V, 2005, CAN J GASTROENTEROL, V19, P497, DOI 10.1155/2005/326296; MURRELL WG, 1993, J MED MICROBIOL, V39, P114, DOI 10.1099/00222615-39-2-114; Oguz F, 2001, SCAND J INFECT DIS, V33, P731, DOI 10.1080/003655401317074509; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SCHULLER I, 1995, ARCH DIS CHILD, V72, P219, DOI 10.1136/adc.72.3.219; Simon A, 2000, INFECT CONT HOSP EP, V21, P592, DOI 10.1086/501809; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-70; Spivack JG, 2003, CLIN PEDIATR, V42, P347, DOI 10.1177/000992280304200407; THOMAS DFM, 1986, J PEDIATR SURG, V21, P22, DOI 10.1016/S0022-3468(86)80644-3; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; WOLFHAGEN MJHM, 1994, GUT, V35, P1608, DOI 10.1136/gut.35.11.1608; Wultanska D, 2010, EUR J CLIN MICROBIOL, V29, P1265, DOI 10.1007/s10096-010-0997-9; ZWIENER RJ, 1989, PEDIATR INFECT DIS J, V8, P876, DOI 10.1097/00006454-198912000-00010	27	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51728	10.1371/journal.pone.0051728	http://dx.doi.org/10.1371/journal.pone.0051728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300561	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800025
J	Roy, JS; O'Connor, D; Green, DM				Roy, Jean-Sebastien; O'Connor, David; Green, David M.			Oscillation of an Anuran Hybrid Zone: Morphological Evidence Spanning 50 Years	PLOS ONE			English	Article							TOADS BUFO-AMERICANUS; ALLOZYME VARIATION; GENETIC-STRUCTURE; PRESERVATION; MORPHOMETRICS; MAINTENANCE; MOVEMENT; MODELS	Background: The hybrid zone between the primarily forest-dwelling American toad, Anaxyrus americanus, and the prairie-adapted Canadian toad, A. hemiophrys, in southeastern Manitoba is known to have shifted its position during the past 50 years. Hybrid zones are areas of interbreeding between species and their movement across a landscape should reflect their underlying dynamics and environmental change. However, empirical demonstrations of hybrid zone movements over long periods of time are rare. This hybrid zone is dominated by individuals of intermediate morphology and genetic composition. We sought to determine if it had continued to move and if that movement was associated with shifts in habitat, as predicted. Methodology/Principle Findings: We used variation in the toads' most diagnostic morphological feature, the separation between their interorbital cranial crests, to determine the geographic position of the hybrid zone center at four times between 1960 and 2009 using maximum likelihood methods. The hybrid zone center moved west by 38 km over 19 years and then east again by 10 km over the succeeding 29 years. The position of the hybrid zone did not track either the direction or the magnitude of movement of the forest-prairie habitat transition over the same time period. Conclusions/Significance: This is the first reported evidence of oscillation in the position of a hybrid zone. The back and forth movement indicates that neither species maintains a selective advantage over the other in the long term. However, the movement of the hybrid zone was not bounded by the breadth of the habitat transition. Its oscillation suggests that the hybrid zone is better described as being elastically tethered to the habitat transition.	[Roy, Jean-Sebastien; O'Connor, David; Green, David M.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	McGill University	Green, DM (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	david.m.green@mcgill.ca			NSERC Canada Discovery Grant	NSERC Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by an NSERC Canada Discovery Grant to DMG. (http://www.nserc-crsng.gc.ca/Index_eng.asp.) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 1998, ANAL 1 3 APPL ANAL H; BERT TM, 1995, EVOLUTION, V49, P276, DOI 10.1111/j.1558-5646.1995.tb02240.x; Blum MJ, 2002, EVOLUTION, V56, P1992, DOI 10.1111/j.0014-3820.2002.tb00125.x; Bronson CL, 2003, EVOLUTION, V57, P630; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Buggs RJA, 2006, CURR BIOL, V16, P996, DOI 10.1016/j.cub.2006.03.093; Charpentier MJE, 2012, MOL ECOL, V21, P715, DOI 10.1111/j.1365-294X.2011.05302.x; Cook FR, 1983, NATL MUS CANADA PUBL, V3, P1; Dasmahapatra KK, 2002, EVOLUTION, V56, P741, DOI 10.1111/j.0014-3820.2002.tb01385.x; Endler J.A., 1977, Monographs in Population Biology, pi; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Good TP, 2000, EVOLUTION, V54, P1774; Goodisman MAD, 1998, EVOLUTION, V52, P1423, DOI 10.1111/j.1558-5646.1998.tb02024.x; GREEN DM, 1983, HERPETOLOGICA, V39, P28; Green DM, 1997, HERPETOLOGICA, V53, P218; Harrison RG, 1993, HYBRID ZONES EVOLUTI; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HENRICH T W, 1968, Herpetologica, V24, P1; Krosby M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014164; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; LEE JC, 1982, SYST ZOOL, V31, P266, DOI 10.2307/2413232; Lee JH, 2012, ICHTHYOL RES, V59, P49, DOI 10.1007/s10228-011-0255-x; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; McLachlan G., 1992, WILEY SERIES PROBABI, DOI DOI 10.1002/0471725293; Melo MT, 2010, ZOOLOGIA-CURITIBA, V27, P892, DOI 10.1590/S1984-46702010000600009; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOORE WS, 1977, Q REV BIOL, V52, P263, DOI 10.1086/409995; MOORE WS, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P196; Phillips BL, 2004, EVOLUTION, V58, P1536; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Reudink MW, 2007, AUK, V124, P463, DOI 10.1642/0004-8038(2007)124[463:SADOTH]2.0.CO;2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; Toews DPL, 2011, J AVIAN BIOL, V42, P434, DOI 10.1111/j.1600-048X.2011.05360.x; Vervust B, 2009, AMPHIBIA-REPTILIA, V30, P321, DOI 10.1163/156853809788795209; Weisstein EW, 2009, GNOMONIC PROJECTION; Wilcox CD, 2002, UTHSCSA IMAGETOOL WI	41	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52819	10.1371/journal.pone.0052819	http://dx.doi.org/10.1371/journal.pone.0052819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300785	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800152
J	Sano, H; Kunwar, PS; Renault, AD; Barbosa, V; Clark, IBN; Ishihara, S; Sugimura, K; Lehmann, R				Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Clark, Ivan B. N.; Ishihara, Shuji; Sugimura, Kaoru; Lehmann, Ruth			The Drosophila Actin Regulator ENABLED Regulates Cell Shape and Orientation during Gonad Morphogenesis	PLOS ONE			English	Article							ENA/VASP PROTEINS; TYROSINE KINASE; AXON GUIDANCE; E-CADHERIN; FIBROBLAST MOTILITY; EMBRYONIC GONAD; GENE-EXPRESSION; ROBO RECEPTORS; BARBED END; FAT-BODY	Organs develop distinctive morphologies to fulfill their unique functions. We used Drosophila embryonic gonads as a model to study how two different cell lineages, primordial germ cells (PGCs) and somatic gonadal precursors (SGPs), combine to form one organ. We developed a membrane GFP marker to image SGP behaviors live. These studies show that a combination of SGP cell shape changes and inward movement of anterior and posterior SGPs leads to the compaction of the spherical gonad. This process is disrupted in mutants of the actin regulator, enabled (ena). We show that Ena coordinates these cell shape changes and the inward movement of the SGPs, and Ena affects the intracellular localization of DE-cadherin (DE-cad). Mathematical simulation based on these observations suggests that changes in DE-cad localization can generate the forces needed to compact an elongated structure into a sphere. We propose that Ena regulates force balance in the SGPs by sequestering DE-cad, leading to the morphogenetic movement required for gonad compaction.	[Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Lehmann, Ruth] NYU Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, HHMI, New York, NY 10016 USA; [Sano, Hiroko; Kunwar, Prabhat S.; Renault, Andrew D.; Barbosa, Vitor; Lehmann, Ruth] NYU Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, Dev Genet Program, New York, NY 10016 USA; [Clark, Ivan B. N.] Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland; [Ishihara, Shuji] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Ishihara, Shuji] PRESTO JST, Saitama, Japan; [Sugimura, Kaoru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Sugimura, Kaoru] RIKEN Brain Sci Inst, Saitama, Japan	Howard Hughes Medical Institute; New York University; New York University; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; RIKEN	Sano, H (corresponding author), Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 830, Japan.	sano_hiroko@kurume-u.ac.jp		Renault, Andrew/0000-0003-4313-9726; Sugimura, Kaoru/0000-0002-3076-7347; Lehmann, Ruth/0000-0002-8454-5651; Sano, Hiroko/0000-0001-9834-647X	JSPS; MEXT; PRESTO from JSPS; NHI [HD3407064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900, R37HD041900] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from JSPS; NHI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Program for Researchers to Promote Creative and Independent Research from JSPS (H. S.), a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (H. S. and K. S.), PRESTO from JSPS (S. I.), and a NHI grant HD3407064 (R. L.). R. L. is an HHMI investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 1998, DEVELOPMENT, V125, P655; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Clark IBN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-52; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kirby RJ, 2001, CURR BIOL, V11, P1044, DOI 10.1016/S0960-9822(01)00319-0; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Moore LA, 1998, DEVELOPMENT, V125, P837; Moore LA, 1998, DEVELOPMENT, V125, P667; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Riechmann V, 1998, DEVELOPMENT, V125, P713; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Sonnenblick BP, 1941, P NATL ACAD SCI USA, V27, P484, DOI 10.1073/pnas.27.10.484; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tucker PK, 2011, DIS MODEL MECH, V4, P126, DOI 10.1242/dmm.005694; Van Doren M, 1998, CURR BIOL, V8, P243; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; ZHAO DB, 1988, EMBO J, V7, P1115, DOI 10.1002/j.1460-2075.1988.tb02920.x	57	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52649	10.1371/journal.pone.0052649	http://dx.doi.org/10.1371/journal.pone.0052649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300733	Green Published, gold			2022-12-25	WOS:000313618800120
J	Setati, ME; Jacobson, D; Andong, UC; Bauer, F				Setati, Mathabatha Evodia; Jacobson, Daniel; Andong, Ursula-Claire; Bauer, Florian			The Vineyard Yeast Microbiome, a Mixed Model Microbial Map	PLOS ONE			English	Article							ASCOMYCETOUS YEAST; GRAPE; IDENTIFICATION; POPULATIONS; DIVERSITY; ECOLOGY; FUNGUS; SOIL	Vineyards harbour a wide variety of microorganisms that play a pivotal role in pre- and post-harvest grape quality and will contribute significantly to the final aromatic properties of wine. The aim of the current study was to investigate the spatial distribution of microbial communities within and between individual vineyard management units. For the first time in such a study, we applied the Theory of Sampling (TOS) to sample gapes from adjacent and well established commercial vineyards within the same terroir unit and from several sampling points within each individual vineyard. Cultivation-based and molecular data sets were generated to capture the spatial heterogeneity in microbial populations within and between vineyards and analysed with novel mixed-model networks, which combine sample correlations and microbial community distribution probabilities. The data demonstrate that farming systems have a significant impact on fungal diversity but more importantly that there is significant species heterogeneity between samples in the same vineyard. Cultivation-based methods confirmed that while the same oxidative yeast species dominated in all vineyards, the least treated vineyard displayed significantly higher species richness, including many yeasts with biocontrol potential. The cultivatable yeast population was not fully representative of the more complex populations seen with molecular methods, and only the molecular data allowed discrimination amongst farming practices with multivariate and network analysis methods. Importantly, yeast species distribution is subject to significant intra-vineyard spatial fluctuations and the frequently reported heterogeneity of tank samples of grapes harvested from single vineyards at the same stage of ripeness might therefore, at least in part, be due to the differing microbiota in different sections of the vineyard.	[Setati, Mathabatha Evodia; Jacobson, Daniel; Andong, Ursula-Claire; Bauer, Florian] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University	Setati, ME (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa.	setati@sun.ac.za	Bauer, Florian/A-1078-2013	Bauer, Florian/0000-0001-5764-4542; Jacobson, Daniel/0000-0002-9822-8251; Setati, Mathabatha/0000-0002-5450-009X	Stellenbosch University (Subcom- B fund); WineTech; National Research Foundation (THRIP programme)	Stellenbosch University (Subcom- B fund); WineTech; National Research Foundation (THRIP programme)	This work was supported by Stellenbosch University (Subcom- B fund), WineTech and the National Research Foundation (THRIP programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, STAT DAT AN SOFTW SY; Barata A, 2008, J APPL MICROBIOL, V104, P1182, DOI 10.1111/j.1365-2672.2007.03631.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barata A, 2008, FEMS YEAST RES, V8, P1008, DOI 10.1111/j.1567-1364.2008.00399.x; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Barata A, 2012, INT J FOOD MICROBIOL, V154, P152, DOI 10.1016/j.ijfoodmicro.2011.12.029; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Combina M, 2005, J APPL MICROBIOL, V98, P1055, DOI 10.1111/j.1365-2672.2005.02540.x; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; Demeter, 2010, DEM PROD STAND US DE; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Esbensen K.H., 2004, CHEMOMETR INTELL LAB, V74, P236; Esbensen KH, 2010, PROCESS ANAL TECHNOL; Esbensen KH, 2007, CHEMOMETR INTELL LAB, V88, P41, DOI 10.1016/j.chemolab.2006.09.011; Esbensen KH, 2012, TRAC-TREND ANAL CHEM, V32, P154, DOI 10.1016/j.trac.2011.09.008; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Gerhards D, 2011, 9 INT S OEN BORD, P263; Gy P.M., 1998, SAMPLING ANAL PURPOS; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hoffman S, 2003, CURRENT PROTOCOLS MO; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Infruitec-Nietvoorbij Agricultural Research Council, 2010, INT PROD WIN GUID FA; Lamine C, 2011, J RURAL STUD, V27, P209, DOI 10.1016/j.jrurstud.2011.02.001; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Nisiotou AA, 2008, INT J SYST EVOL MICR, V58, P1263, DOI 10.1099/ijs.0.65649-0; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Paz Z, 2007, J APPL MICROBIOL, V103, P2570, DOI 10.1111/j.1365-2672.2007.03512.x; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pitard F.F., 1993, PIERRE GYS SAMPLING, Vsecond; Prakitchaiwattana CJ, 2004, FEMS YEAST RES, V4, P865, DOI 10.1016/j.femsyr.2004.05.004; Probst B, 2008, BIOL FERT SOILS, V44, P443, DOI 10.1007/s00374-007-0225-7; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Reeve JR, 2010, BIORESOURCE TECHNOL, V101, P5658, DOI 10.1016/j.biortech.2010.01.144; Reeve JR, 2005, AM J ENOL VITICULT, V56, P367; REGUEIRO LA, 1993, AM J ENOL VITICULT, V44, P405; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; Sabate J, 2002, MICROBIOL RES, V157, P267, DOI 10.1078/0944-5013-00163; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Schwartz A., 1993, South African Journal for Enology and Viticulture, V14, P16; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slabbert E, 2010, S AFR J SCI, V106, P52, DOI 10.4102/sajs.v106i7/8.329; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Sztejnberg A, 2004, CROP PROT, V23, P1125, DOI 10.1016/j.cropro.2004.04.004; Tofalo R, 2011, ANN MICROBIOL, V61, P57, DOI 10.1007/s13213-010-0102-8	46	119	120	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52609	10.1371/journal.pone.0052609	http://dx.doi.org/10.1371/journal.pone.0052609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300721	Green Published, gold			2022-12-25	WOS:000313618800112
J	Yu, B; Sun, HB; Ma, HW; Peng, M; Kong, FX; Meng, FX; Liu, N; Guo, QY				Yu, Bing; Sun, Hongbin; Ma, Hongwei; Peng, Miao; Kong, Fanxing; Meng, Fanxing; Liu, Na; Guo, Qiyong			Aberrant Whole-Brain Functional Connectivity and Intelligence Structure in Children with Primary Nocturnal Enuresis	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MOTOR CORTEX; CORTICAL HUBS; MRI; DISCONNECTIVITY; SINGLE; MEMORY	Aim: To assess the potential relationship between intelligence structure abnormalities and whole-brain functional connectivity in children with primary nocturnal enuresis (PNE) with resting-state functional magnetic resonance imaging (fMRI) to provide insights into the association between these two seemingly unrelated conditions. Methods: Intelligence testing and fMRI data were obtained from 133 right-handed children, including 67 PNE children (M/F, 39:28; age, 10.5 +/- 1.2 y) and 66 age-matched healthy controls (M/F, 37:29; age, 10.1 +/- 1.1 y). All intelligence tests were performed using the China-Wechsler Intelligence Scale for Children (C-WISC). Each subject's full intelligence quotient (FIQ), verbal IQ (VIQ), performance IQ (PIQ), and memory/caution (M/C) factor was measured and recorded. Resting state fMRI scans were performed on a 3.0-T MR scanner and post-processed using REST software. Comparisons of z-score correlation coefficients between distinct cerebral regions were used to identify altered functional connectivity in PNE children. Results: The PNE group had normal FIQ, VIQ, and PIQ values, indicating no significant variation from the control group. However, the M/C factor was significantly lower in the PNE group. Compared to the control group, PNE children exhibited overall lower levels of functional connectivity that were most apparent in the cerebello-thalamo-frontal pathway. The M/C factor significantly correlated with z-scores representing connectivity between Cerebellum_Crus1_L and Frontal_Mid_R. Conclusion: PNE children exhibit intelligence structure imbalance and attention deficits. Our findings suggest that cerebello-thalamo-frontal circuit abnormalities are likely to be involved in the onset and progression of attention impairment in PNE children.	[Yu, Bing; Kong, Fanxing; Meng, Fanxing; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China; [Sun, Hongbin] China Med Univ, Hosp 4, Dept Radiol, Shenyang, Peoples R China; [Ma, Hongwei] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Peoples R China; [Peng, Miao] China Med Univ, Shengjing Hosp, Psychol Outpatient Serv, Shenyang, Peoples R China; [Liu, Na] Peoples Hosp Liaoning Prov, Dept Radiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China.	guoqy@vip.sina.com		Yu, Bing/0000-0003-0237-7824; Sun, Hongbin/0000-0002-5571-5658	National Natural Science Foundation of China [30571985, 30370520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30571985, and 30370520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baeyens D, 2005, ACTA PAEDIATR, V94, P1619, DOI 10.1080/08035250510041240; Baeyens D, 2005, EUR J PEDIATR, V164, P665, DOI 10.1007/s00431-005-1712-1; Baeyens D, 2006, J UROLOGY, V176, P744, DOI 10.1016/S0022-5347(06)00295-3; Beckel JM, 2009, HDB EXP PHARM, P149; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dai Xiao-Mei, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P607; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Gong YX, 1993, MANUAL CHINESE REVIS; Jan JE, 2009, J PINEAL RES, V46, P1, DOI 10.1111/j.1600-079X.2008.00628.x; Jissendi P, 2008, J NEURORADIOLOGY, V35, P42, DOI 10.1016/j.neurad.2007.11.001; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Lei D, 2011, HUM BRAIN MAPP; Lei D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031023; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Muller D, 2001, J UROLOGY, V166, P2432, DOI 10.1016/S0022-5347(05)65609-1; ORNITZ EM, 1992, PSYCHOPHYSIOLOGY, V29, P437, DOI 10.1111/j.1469-8986.1992.tb01717.x; Peltier SJ, 2005, BRAIN RES, V1057, P10, DOI 10.1016/j.brainres.2005.06.078; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Sheridan MA, 2007, J AM ACAD CHILD PSY, V46, P1357, DOI 10.1097/chi.0b013e31812eecf7; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yu B, 2012, EUR J RADIOL; Yu B, 2011, J PAEDIATR CHILD H, V47, P429, DOI 10.1111/j.1440-1754.2010.02000.x	32	18	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51924	10.1371/journal.pone.0051924	http://dx.doi.org/10.1371/journal.pone.0051924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300958	Green Submitted, Green Published, gold			2022-12-25	WOS:000313320900014
J	Kristof, A; Husti, Z; Koncz, I; Kohajda, Z; Szel, T; Juhasz, V; Biliczki, P; Jost, N; Baczko, I; Papp, JG; Varro, A; Virag, L				Kristof, Attila; Husti, Zoltan; Koncz, Istvan; Kohajda, Zsofia; Szel, Tamas; Juhasz, Viktor; Biliczki, Peter; Jost, Norbert; Baczko, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo			Diclofenac Prolongs Repolarization in Ventricular Muscle with Impaired Repolarization Reserve	PLOS ONE			English	Article							TORSADES-DE-POINTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IN-VIVO; CARDIOVASCULAR SAFETY; PHARMACOLOGICAL BLOCK; CARDIAC-HYPERTROPHY; INHIBITION; DOG; KS; PHARMACOKINETICS	Background: The aim of the present work was to characterize the electrophysiological effects of the non-steroidal antiinflammatory drug diclofenac and to study the possible proarrhythmic potency of the drug in ventricular muscle. Methods: Ion currents were recorded using voltage clamp technique in canine single ventricular cells and action potentials were obtained from canine ventricular preparations using microelectrodes. The proarrhythmic potency of the drug was investigated in an anaesthetized rabbit proarrhythmia model. Results: Action potentials were slightly lengthened in ventricular muscle but were shortened in Purkinje fibers by diclofenac (20 mu M). The maximum upstroke velocity was decreased in both preparations. Larger repolarization prolongation was observed when repolarization reserve was impaired by previous BaCl2 application. Diclofenac (3 mg/kg) did not prolong while dofetilide (25 mu g/kg) significantly lengthened the QT(c) interval in anaesthetized rabbits. The addition of diclofenac following reduction of repolarization reserve by dofetilide further prolonged QTc. Diclofenac alone did not induce Torsades de Pointes ventricular tachycardia (TdP) while TdP incidence following dofetilide was 20%. However, the combination of diclofenac and dofetilide significantly increased TdP incidence (62%). In single ventricular cells diclofenac (30 mM) decreased the amplitude of rapid (I-Kr) and slow (I-Ks) delayed rectifier currents thereby attenuating repolarization reserve. L-type calcium current (I-Ca) was slightly diminished, but the transient outward (I-to) and inward rectifier (I-K1) potassium currents were not influenced. Conclusions: Diclofenac at therapeutic concentrations and even at high dose does not prolong repolarization markedly and does not increase the risk of arrhythmia in normal heart. However, high dose diclofenac treatment may lengthen repolarization and enhance proarrhythmic risk in hearts with reduced repolarization reserve.	[Husti, Zoltan; Koncz, Istvan; Szel, Tamas; Juhasz, Viktor; Biliczki, Peter; Baczko, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Kristof, Attila; Kohajda, Zsofia; Jost, Norbert; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Hungarian Academy of Sciences	Varro, A (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary.	varro.andras@med.u-szeged.hu	Varro, Andras/M-2647-2016; Baczko, István/I-7752-2019	Baczko, István/0000-0002-9588-0797; Husti, Zoltan/0000-0002-3956-8213	Hungarian Scientific Research Fund [OTKA CNK-77855, K-82079, NK-104331]; Hungarian National Office for Research and Technology, Anyos Jedlik Programme [TECH_08_A1_CARDIO08]; Hungarian National Development Agency; European Regional Fund [TAMOP-4.2.2./B-10/1-2010-0012, TAMOP-4.2.1/B-09/1/KONV-2010-0005]; HU-RO Cross-Border Cooperation Programmes [HURO/0802/011_AF-HURO_CARDIOPOL]; Hungarian Academy of Sciences; Janos Bolyai Research Scholarship	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office for Research and Technology, Anyos Jedlik Programme; Hungarian National Development Agency; European Regional Fund; HU-RO Cross-Border Cooperation Programmes; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Janos Bolyai Research Scholarship(Hungarian Academy of Sciences)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA CNK-77855, K-82079 and NK-104331); the Hungarian National Office for Research and Technology, Anyos Jedlik Programme (TECH_08_A1_CARDIO08), and the Hungarian National Development Agency, and co-financed by the European Regional Fund (TAMOP-4.2.2./B-10/1-2010-0012, TAMOP-4.2.1/B-09/1/KONV-2010-0005); the HU-RO Cross-Border Cooperation Programmes (HURO/0802/011_AF-HURO_CARDIOPOL); the Hungarian Academy of Sciences and the Janos Bolyai Research Scholarship (I. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jenoobi Fahad I, 2010, Sci Pharm, V78, P465, DOI 10.3797/scipharm.1003-10; Batey AJ, 2002, BRIT J PHARMACOL, V135, P1003, DOI 10.1038/sj.bjp.0704550; BIRD HA, 1986, AGENTS ACTIONS, V18, P447, DOI 10.1007/BF01965010; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bort R, 1999, BIOCHEM PHARMACOL, V58, P787, DOI 10.1016/S0006-2952(99)00167-7; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; CARLSSON L, 1990, J CARDIOVASC PHARM, V16, P276, DOI 10.1097/00005344-199008000-00014; Christ T, 2005, N-S ARCH PHARMACOL, V371, P393, DOI 10.1007/s00210-005-1063-5; CORABOEUF E, 1979, AM J PHYSIOL, V236, pH561, DOI 10.1152/ajpheart.1979.236.4.H561; Corrado D, 2007, CARDIOL CLIN, V25, P391, DOI 10.1016/j.ccl.2007.07.008; DUNCAN JJ, 1988, AM J SPORT MED, V16, P656, DOI 10.1177/036354658801600618; Farkas Andras, 2004, Journal of Pharmacological and Toxicological Methods, V50, P175, DOI 10.1016/j.vascn.2004.05.002; Fei XW, 2006, BIOCHEM BIOPH RES CO, V346, P1275, DOI 10.1016/j.bbrc.2006.06.034; Fosbol EL, 2010, EXPERT OPIN DRUG SAF, V9, P893, DOI 10.1517/14740338.2010.501331; Gillon D, 2006, HERALD SCOTLAND 0922; Girennavar B, 2007, J FOOD SCI, V72, pC417, DOI 10.1111/j.1750-3841.2007.00483.x; Hart G, 2003, EXP PHYSIOL, V88, P639, DOI 10.1113/eph8802619; Hidaka M, 2008, BIOSCI BIOTECH BIOCH, V72, P406, DOI 10.1271/bbb.70511; Huang WF, 2006, CLIN THER, V28, P1827, DOI 10.1016/j.clinthera.2006.11.009; Huang WF, 2006, DRUG SAFETY, V29, P261, DOI 10.2165/00002018-200629030-00009; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Lawrence Chris L., 2005, Journal of Pharmacological and Toxicological Methods, V52, P46, DOI 10.1016/j.vascn.2005.04.011; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Lengyel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018751; LIN JH, 1987, CLIN PHARMACOKINET, V12, P402, DOI 10.2165/00003088-198712060-00002; Liu LY, 2005, NEUROPHARMACOLOGY, V48, P918, DOI 10.1016/j.neuropharm.2004.12.020; Lu Y, 2004, DRUG CHEM TOXICOL, V27, P269, DOI 10.1081/DCT-120037748; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Niemi M, 2001, CLIN PHARMACOL THER, V69, P194, DOI 10.1067/mcp.2001.114229; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; SCHEIDEL B, 1993, ARZNEIMITTEL-FORSCH, V43-2, P1211; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Varkevisser R, 2012, HEART RHYTHM, V9, P1718, DOI 10.1016/j.hrthm.2012.05.016; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Virag L, 2009, BRIT J PHARMACOL, V156, P1076, DOI 10.1111/j.1476-5381.2009.00116.x; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; vonMoltke LL, 1996, J CLIN PSYCHOPHARM, V16, P104, DOI 10.1097/00004714-199604000-00002; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Yarishkin OV, 2009, KOREAN J PHYSIOL PHA, V13, P437, DOI 10.4196/kjpp.2009.13.6.437	45	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53255	10.1371/journal.pone.0053255	http://dx.doi.org/10.1371/journal.pone.0053255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300901	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600076
J	Chen, XS; Yin, YP; Shen, C; Liu, GG; Zhu, ZJ; Wei, WH; Wang, HC; Huang, SJ; Li, J; Tucker, JD; Mabey, DC; Peeling, RW				Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Liu, Guo-Gu; Zhu, Zheng-Jun; Wei, Wan-Hui; Wang, Hong-Chun; Huang, Shui-Jie; Li, Jing; Tucker, Joseph D.; Mabey, David C.; Peeling, Rosanna W.			Rapid Syphilis Testing Uptake for Female Sex Workers at Sex Venues in Southern China: Implications for Expanding Syphilis Screening	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PARTNER NOTIFICATION; RISK; PREVALENCE; HIV	Background: Accessibility of syphilis testing services is critical in syphilis control programs for female sex workers (FSWs), but few FSWs attend public STI clinics or other testing sites. Introduction of free rapid syphilis testing (RST) into outreach programs for FSWs will help improve test uptake. Methods: Commercial sex venues were identified in two cities in South China. In cooperation with health advocacy organizations, health outreach teams from local public health or medical facilities approached all types of sex venues in study areas to offer free RST. Acceptability and uptake of RST among FSWs were evaluated. Results: A total of 2812 FSWs were offered RST and 2670 (95.0%) accepted syphilis testing. 182 (6.8%) FSWs had a positive RST result among whom 136 (74.7%) were willing to attend an STD clinic for confirmatory testing and treatment. More than half (89, 66.4%) of those with syphilis were not willing to notify their sex partners. Multivariate logistic analysis showed that syphilis test uptake was associated with residing in Jiangmen (AOR, 1.78; 95% CI, 1.15-2.77), older age (AOR, 2.11, 95% CI, 1.17-3.79 for age of 31 years or above), and not working at a service venue (AOR, 1.60; 95% CI, 1.10-2.34). Conclusions: RST at sex venues is well accepted by FSWs when it is integrated into ongoing outreach services. Such programs provide excellent opportunities for expanding syphilis screening efforts among specific subgroups of FSW who are difficult to reach through clinic-based programs.	[Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Wei, Wan-Hui; Wang, Hong-Chun; Li, Jing] Natl Ctr Sexually Translated Dis STD Control, Nanjing, Jiangsu, Peoples R China; [Chen, Xiang-Sheng; Yin, Yue-Ping; Shen, Crystal; Wei, Wan-Hui; Wang, Hong-Chun; Li, Jing] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Shen, Crystal] Mayo Clin & Mayo Grad Sch Med, Rochester, NY USA; [Liu, Guo-Gu] Hlth Bur Liuzhou City, Liuzhou, Peoples R China; [Zhu, Zheng-Jun; Huang, Shui-Jie] Jiangmen Ctr STD Control, Jiangmen, Peoples R China; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Mabey, David C.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London WC1, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine	Chen, XS (corresponding author), Natl Ctr Sexually Translated Dis STD Control, Nanjing, Jiangsu, Peoples R China.	chenxs@ncstdlc.org		Tucker, Joseph/0000-0003-2804-1181; Mabey, David/0000-0002-0031-8276	Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases through the Bill and Melinda Gates Foundation) [A70577]; UNC Fogarty AIDS International Research and Training Program [NIH FIC D43 TW01039]; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER [D43TW001039, K01TW008200] Funding Source: NIH RePORTER	Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases through the Bill and Melinda Gates Foundation); UNC Fogarty AIDS International Research and Training Program; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a grant to principal investigator XS Chen from the Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases A70577 through a grant from the Bill and Melinda Gates Foundation), the UNC Fogarty AIDS International Research and Training Program (NIH FIC D43 TW01039), and the UNC Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-19; Campos PE, 2006, SEX TRANSM INFECT, V82, pV22, DOI 10.1136/sti.2006.023325; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Chang H, 2010, NIH FOG INT CLIN SCH; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Chen XS, 2012, SEX TRANSM DIS, V39, P1; China Ministry of Health, 2010, CHIN 2010 UNGASS COU; China's Action Plan to Prevent and Control HIV/AIDS, 2010, CHIN ACT PLAN PREV C, P2011; Gupte S, 2011, SEX TRANSM DIS, V38, P499, DOI 10.1097/OLQ.0b013e318205e45d; Han ZG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-148; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; Sabido M, 2009, EMERG INFECT DIS, V15, P647, DOI 10.3201/eid1504.081293; Sano P, 2004, SEX TRANSM DIS, V31, P713, DOI 10.1097/01.olq.0000145848.79694.7b; Tucker J, 2010, SOC SCI MED, V70, P121, DOI 10.1016/j.socscimed.2009.10.010; Tucker JD, 2011, JAIDS-J ACQ IMM DEF, V57, pE106, DOI 10.1097/QAI.0b013e31821d3694; Wang AL, 2012, SEX TRANSM INFECT, V88, P386, DOI 10.1136/sextrans-2011-050275; Wang Y, 2011, AIDS BEHAV, V15, P702, DOI 10.1007/s10461-010-9703-2; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Weeks MR, 2010, AIDS EDUC PREV, V22, P252, DOI 10.1521/aeap.2010.22.3.252; Yin YP, 2012, CLIN J INFECT	27	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52579	10.1371/journal.pone.0052579	http://dx.doi.org/10.1371/journal.pone.0052579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300709	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100064
J	Gallardo, JE				Gallardo, Jose E.			A Multilevel Probabilistic Beam Search Algorithm for the Shortest Common Supersequence Problem	PLOS ONE			English	Article							OLIGONUCLEOTIDE MICROARRAYS; COMPLEXITY; SUBSEQUENCE	The shortest common supersequence problem is a classical problem with many applications in different fields such as planning, Artificial Intelligence and especially in Bioinformatics. Due to its NP-hardness, we can not expect to efficiently solve this problem using conventional exact techniques. This paper presents a heuristic to tackle this problem based on the use at different levels of a probabilistic variant of a classical heuristic known as Beam Search. The proposed algorithm is empirically analysed and compared to current approaches in the literature. Experiments show that it provides better quality solutions in a reasonable time for medium and large instances of the problem. For very large instances, our heuristic also provides better solutions, but required execution times may increase considerably.	Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain	Universidad de Malaga	Gallardo, JE (corresponding author), Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain.	pepeg@lcc.uma.es			Spanish Ministerio de Ciencia e Innovacion [TIN2011-28627-C04-01]; Junta de Andalucia [TIC-6083]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This work is partially supported by Spanish Ministerio de Ciencia e Innovacion under project ANYSELF (TIN2011-28627-C04-01), and by Junta de Andalucia under project DNEMESIS (TIC-6083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J.E., P INT C GEN ALG THEI, P101; Barr A, 1981, HDB ARTIFICIAL INTEL; Blum C, 2007, LECT NOTES COMPUT SC, V4446, P36; Branke J., 1996, Proceedings of the Second Nordic Workshop on Genetic Algorithms and Their Applications (2NWGA), P105; Branke J, 1998, OR SPEKTRUM, V20, P39, DOI 10.1007/BF01545528; Cotta C, 2005, LECT NOTES COMPUT SC, V3562, P84; Cotta C, 2005, LECT NOTES COMPUT SC, V3512, P50; FOULSER DE, 1992, ARTIF INTELL, V57, P143, DOI 10.1016/0004-3702(92)90016-Q; Fraser C.B., 1995, THESIS U GLASGOW GLA; Gallardo JE, 2007, IEEE T SYST MAN CY B, V37, P77, DOI 10.1109/TSMCB.2006.883266; Hallet MT, 1998, THESIS U VICTORIA VI; Jeong Seop Sim, 2003, Journal of Discrete Algorithms, V1, P111, DOI 10.1016/S1570-8667(03)00011-X; JIANG T, 1995, SIAM J COMPUT, V24, P1122, DOI 10.1137/S009753979223842X; Kasif S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf105; Kubalik J, 2010, P 12 ANN C GEN EV CO, P249; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; MAIER D, 1978, J ACM, V25, P322, DOI 10.1145/322063.322075; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Michel R, 1999, NEW IDEAS OPTIMIZATI, P51; MIDDENDORF M, 1994, THEOR COMPUT SCI, V125, P205, DOI 10.1016/0304-3975(92)00074-2; Mousavi SR, 2012, ENG APPL ARTIF INTEL, V25, P457, DOI 10.1016/j.engappai.2011.08.006; Neri F, 2012, STUD COMPUT INTELL, V379, P1, DOI 10.1007/978-3-642-23247-3; Ning K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni147; Ning K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S12; Pietrzak K, 2003, J COMPUT SYST SCI, V67, P757, DOI 10.1016/S0022-0000(03)00078-3; Rahmann S, 2003, BIOINFORMATICS, V19, pII156, DOI 10.1093/bioinformatics/btg1073; TIMKOVSKII VG, 1989, CYBERNETICS+, V25, P565, DOI 10.1007/BF01075212; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winston P. H., 1984, ARTIFICIAL INTELLIGE	31	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52427	10.1371/journal.pone.0052427	http://dx.doi.org/10.1371/journal.pone.0052427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300667	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100048
J	Hardoim, CCP; Esteves, AIS; Pires, FR; Goncalves, JMS; Cox, CJ; Xavier, JR; Costa, R				Hardoim, Cristiane C. P.; Esteves, Ana I. S.; Pires, Francisco R.; Goncalves, Jorge M. S.; Cox, Cymon J.; Xavier, Joana R.; Costa, Rodrigo			Phylogenetically and Spatially Close Marine Sponges Harbour Divergent Bacterial Communities	PLOS ONE			English	Article							VERTICAL TRANSMISSION; MICROBIAL COMMUNITY; SP-NOV; HOST-SPECIFICITY; RIBOSOMAL-RNA; DNA TAXONOMY; FERROUS IRON; DIVERSITY; SYMBIONTS; AMPLIFICATION	Recent studies have unravelled the diversity of sponge-associated bacteria that may play essential roles in sponge health and metabolism. Nevertheless, our understanding of this microbiota remains limited to a few host species found in restricted geographical localities, and the extent to which the sponge host determines the composition of its own microbiome remains a matter of debate. We address bacterial abundance and diversity of two temperate marine sponges belonging to the Irciniidae family - Sarcotragus spinosulus and Ircinia variabilis - in the Northeast Atlantic. Epifluorescence microscopy revealed that S. spinosulus hosted significantly more prokaryotic cells than I. variabilis and that prokaryotic abundance in both species was about 4 orders of magnitude higher than in seawater. Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) profiles of S. spinosulus and I. variabilis differed markedly from each other - with higher number of ribotypes observed in S. spinosulus - and from those of seawater. Four PCR-DGGE bands, two specific to S. spinosulus, one specific to I. variabilis, and one present in both sponge species, affiliated with an uncultured sponge-specific phylogenetic cluster in the order Acidimicrobiales (Actinobacteria). Two PCR-DGGE bands present exclusively in S. spinosulus fingerprints affiliated with one sponge-specific phylogenetic cluster in the phylum Chloroflexi and with sponge-derived sequences in the order Chromatiales (Gammaproteobacteria), respectively. One Alphaproteobacteria band specific to S. spinosulus was placed in an uncultured sponge-specific phylogenetic cluster with a close relationship to the genus Rhodovulum. Our results confirm the hypothesized host-specific composition of bacterial communities between phylogenetically and spatially close sponge species in the Irciniidae family, with S. spinosulus displaying higher bacterial community diversity and distinctiveness than I. variabilis. These findings suggest a pivotal host-driven effect on the shape of the marine sponge microbiome, bearing implications to our current understanding of the distribution of microbial genetic resources in the marine realm.	[Hardoim, Cristiane C. P.; Esteves, Ana I. S.; Costa, Rodrigo] Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal; [Pires, Francisco R.; Xavier, Joana R.] Univ Acores, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, Dept Biol, Ponta Delgada, Acores, Portugal; [Goncalves, Jorge M. S.] Univ Algarve, Fisheries Biodivers & Conservat Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal; [Xavier, Joana R.] Ctr Adv Studies Blanes, Girona, Spain	Universidade do Algarve; Universidade dos Acores; Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Costa, R (corresponding author), Univ Algarve, Microbial Ecol & Evolut Res Grp, Ctr Marine Sci, Faro, Algarve, Portugal.	rscosta@ualg.pt	da Silva Costa, Rodrigo/N-7274-2013; Cox, Cymon/D-1303-2012; Hardoim, Cristiane C.P./D-4544-2015; Gonçalves, Jorge MS/G-5206-2011; Xavier, Joana/J-8387-2012	da Silva Costa, Rodrigo/0000-0002-5932-4101; Cox, Cymon/0000-0002-4927-979X; Hardoim, Cristiane C.P./0000-0003-4650-0177; Gonçalves, Jorge MS/0000-0001-7704-8190; Xavier, Joana/0000-0003-1386-4492; Esteves, Ana/0000-0002-9614-0635	Portuguese Foundation for Science and Technology (FCT) [PTDC/MAR/101431/2008]; FCT [SFRH/BD/60873/2009, SFRH/BPD/62946/2009]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financed by the Portuguese Foundation for Science and Technology (FCT - http://www.fct.pt) through the research project PTDC/MAR/101431/2008. CCPH has a PhD fellowship granted by FCT (Grant No. SFRH/BD/60873/2009). JRX's research is funded by a FCT postdoctoral fellowship (grant no. SFRH/BPD/62946/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Cardenas P, 2009, ZOOTAXA, P1; Cichewicz RH, 2004, ORG LETT, V6, P1951, DOI 10.1021/ol049503q; Clark DA, 1996, MICROBIOL-UK, V142, P785, DOI 10.1099/00221287-142-4-785; Clum A, 2009, STAND GENOMIC SCI, V1, P38, DOI 10.4056/sigs.1463; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Davis-Belmar CS, 2009, ADV MATER RES-SWITZ, V71-73, P271, DOI 10.4028/www.scientific.net/AMR.71-73.271; De Rosa S, 2003, BIOMOL ENG, V20, P311, DOI 10.1016/S1389-0344(03)00038-8; Emura C, 2006, TETRAHEDRON, V62, P5682, DOI 10.1016/j.tet.2006.03.087; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1563, DOI 10.1017/S0025315407058195; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Friedrich AB, 1999, MAR BIOL, V134, P461, DOI 10.1007/s002270050562; Garrity, 2006, BERGEYS MANUAL SYS C, V2, P161; Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; Hardoim CCP, 2012, BRAZ J MICR IN PRESS; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HIRAISHI A, 1995, INT J SYST BACTERIOL, V45, P319, DOI 10.1099/00207713-45-2-319; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imhoff JF, 2005, BERGEYS MANUAL SYS C, V2, P205; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; Liu YH, 2006, NAT PROD REP, V23, P630, DOI 10.1039/b604586c; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MCLACHLAN J, 1964, CAN J MICROBIOL, V10, P769, DOI 10.1139/m64-098; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mitova M, 2003, Z NATURFORSCH C, V58, P740; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P4133, DOI 10.1128/AEM.00454-08; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Orhan I, 2010, MAR DRUGS, V8, P47, DOI 10.3390/md8010047; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Proctor LM, 1997, AQUAT MICROB ECOL, V12, P105, DOI 10.3354/ame012105; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RADEMAKER JLW, 2004, MOL MICROBIAL ECOLOG, P1397; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Siegl A, 2010, ENV MICROBIOL REP, V2, P507, DOI 10.1111/j.1758-2229.2009.00057.x; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Srinivas TNR, 2007, INT J SYST EVOL MICR, V57, P228, DOI 10.1099/ijs.0.64470-0; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Usher KM, 2006, EUR J PHYCOL, V41, P179, DOI 10.1080/09670260600631352; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; VICENTE VP, 1990, CORAL REEFS, V8, P199, DOI 10.1007/BF00265011; Watjen W, 2009, J PHARM PHARMACOL, V61, P919, DOI 10.1211/jpp/61.07.0011; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xu SH, 2008, STEROIDS, V73, P568, DOI 10.1016/j.steroids.2008.01.009; Yang JK, 2011, AQUAT MICROB ECOL, V62, P231, DOI 10.3354/ame01473; [No title captured]	89	34	35	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53029	10.1371/journal.pone.0053029	http://dx.doi.org/10.1371/journal.pone.0053029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300853	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100110
J	Kawabe, T; Kawabe, K; Sapru, HN				Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.			Effect of Barodenervation on Cardiovascular Responses Elicited from the Hypothalamic Arcuate Nucleus of the Rat	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE RAT; MEDULLARY PRESSOR AREA; OBESE ZUCKER RATS; PARAVENTRICULAR NUCLEUS; SPINAL-CORD; CONTAINING NEURONS; ARTERIAL-PRESSURE; NEUROPEPTIDE-Y; BLOOD-PRESSURE; GLUTAMATE	We have previously reported that chemical stimulation of the hypothalamic arcuate nucleus (ARCN) in the rat elicited increases as well as decreases in blood pressure (BP) and sympathetic nerve activity (SNA). The type of response elicited from the ARCN (i.e., increase or decrease in BP and SNA) depended on the level of baroreceptor activity which, in turn, was determined by baseline BP in rats with intact baroreceptors. Based on this information, it was hypothesized that baroreceptor unloading may play a role in the type of response elicited from the ARCN. Therefore, the effect of barodenervation on the ARCN-induced cardiovascular and sympathetic responses and the neurotransmitters in the hypothalamic paraventricular nucleus (PVN) mediating the excitatory responses elicited from the ARCN were investigated in urethane-anesthetized adult male Wistar rats. Bilateral barodenervation converted decreases in mean arterial pressure (MAP) and greater splanchnic nerve activity (GSNA) elicited by chemical stimulation of the ARCN with microinjections of Nmethyl-D-aspartic acid to increases in MAP and GSNA and exaggerated the increases in heart rate (HR). Combined microinjections of NBQX and D-AP7 (ionotropic glutamate receptor antagonists) into the PVN in barodenervated rats converted increases in MAP and GSNA elicited by the ARCN stimulation to decreases in MAP and GSNA and attenuated increases in HR. Microinjections of SHU9119 (a melanocortin 3/4 receptor antagonist) into the PVN in barodenervated rats attenuated increases in MAP, GSNA and HR elicited by the ARCN stimulation. ARCN neurons projecting to the PVN were immunoreactive for proopiomelanocortin, alpha-melanocyte stimulating hormone (alpha-MSH) and adrenocorticotropic hormone (ACTH). It was concluded that increases in MAP and GSNA and exaggeration of tachycardia elicited by the ARCN stimulation in barodenervated rats may be mediated via release of alpha-MSH and/or ACTH and glutamate from the ARCN neurons projecting to the PVN.	[Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sapru, HN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	sapru@umdnj.edu			National Institutes of Health [HL024347, HL076248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076248, R01HL024347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this research was provided by National Institutes of Health grants HL024347 and HL076248 awarded to HNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO G, 1988, BRAIN RES, V453, P191, DOI 10.1016/0006-8993(88)90158-8; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; Dampney RAL, 2003, ACTA PHYSIOL SCAND, V177, P209, DOI 10.1046/j.1365-201X.2003.01070.x; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Dun SL, 2006, PEPTIDES, V27, P1949, DOI 10.1016/j.peptides.2005.10.027; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; GONZALEZ ER, 1983, HYPERTENSION, V5, P346, DOI 10.1161/01.HYP.5.3.346; Grassi G, 2000, HYPERTENSION, V36, P538, DOI 10.1161/01.HYP.36.4.538; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Herman JP, 2000, J COMP NEUROL, V422, P352; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huber DA, 2010, J PHYSIOL-LONDON, V588, P1515, DOI 10.1113/jphysiol.2009.186387; Hwang LL, 2004, NEUROPEPTIDES, V38, P69, DOI 10.1016/j.npep.2004.02.001; IBATA Y, 1985, BRAIN RES, V341, P233, DOI 10.1016/0006-8993(85)91062-5; Kasamatsu K, 2004, AM J PHYSIOL-REG I, V287, pR715, DOI 10.1152/ajpregu.00642.2003; Kawabe T, 2008, NEUROSCIENCE, V153, P605, DOI 10.1016/j.neuroscience.2008.02.076; Kawabe T, 2006, BRAIN RES, V1102, P117, DOI 10.1016/j.brainres.2006.05.002; Kawabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045180; Kawabe T, 2009, BRAIN RES, V1248, P115, DOI 10.1016/j.brainres.2008.10.059; Kiss J, 2005, EUR J NEUROSCI, V21, P2111, DOI 10.1111/j.1460-9568.2005.04012.x; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Li SG, 1997, J AUTONOM NERV SYST, V62, P147, DOI 10.1016/S0165-1838(96)00119-1; Liu J, 2007, ENDOCRINOLOGY, V148, P5531, DOI 10.1210/en.2007-0745; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Nakamura T, 2009, HYPERTENSION, V54, P1369, DOI 10.1161/HYPERTENSIONAHA.109.140715; OSBORN JW, 1990, AM J PHYSIOL, V259, pR1172, DOI 10.1152/ajpregu.1990.259.6.R1172; Ovesjo ML, 2001, J NEUROENDOCRINOL, V13, P505, DOI 10.1046/j.1365-2826.2001.00662.x; Palkovits M, 2008, ANN NY ACAD SCI, V1148, P57, DOI 10.1196/annals.1410.062; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pilowsky PM, 2002, J HYPERTENS, V20, P1675, DOI 10.1097/00004872-200209000-00002; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Pyner S, 1999, NEUROSCIENCE, V88, P949, DOI 10.1016/S0306-4522(98)00255-3; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sapru HN, 2002, CLIN EXP PHARMACOL P, V29, P491, DOI 10.1046/j.1440-1681.2002.03661.x; SAPRU HN, 1976, AM J PHYSIOL, V230, P664, DOI 10.1152/ajplegacy.1976.230.3.664; SAPRU HN, 1979, AM J PHYSIOL, V236, pH174, DOI 10.1152/ajpheart.1979.236.1.H174; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Steiner F A, 1970, Prog Brain Res, V32, P102, DOI 10.1016/S0079-6123(08)61525-3; STEINER FA, 1969, BRAIN RES, V12, P74, DOI 10.1016/0006-8993(69)90056-0; SUNDARAM K, 1991, BRAIN RES, V544, P33, DOI 10.1016/0006-8993(91)90882-V; Tabara Y, 2008, HYPERTENS RES, V31, P1219, DOI 10.1291/hypres.31.1219; VANDENPOL AN, 1991, J NEUROSCI, V11, P2087; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; Yang Z, 1998, J PHYSIOL-LONDON, V513, P521, DOI 10.1111/j.1469-7793.1998.521bb.x; Yang Z, 2002, EXP PHYSIOL, V87, P663, DOI 10.1113/eph8702439; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001; ZIEGLGANSBERGER W, 1973, EXP BRAIN RES, V17, P35	53	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53111	10.1371/journal.pone.0053111	http://dx.doi.org/10.1371/journal.pone.0053111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300873	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100120
J	Kuo, SH; Tang, GM; Ma, KR; Babij, R; Cortes, E; Vonsattel, JPG; Faust, PL; Sulzer, D; Louis, ED				Kuo, Sheng-Han; Tang, Guomei; Ma, Karen; Babij, Rachel; Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.; Sulzer, David; Louis, Elan D.			Macroautophagy Abnormality in Essential Tremor	PLOS ONE			English	Article							AUTOPHAGY INDUCTION; MUTANT HUNTINGTIN; PURKINJE-CELLS; DISEASE; NEURODEGENERATION; PATHOLOGY; ACCUMULATION; PARKINSONS; CLEARANCE; ATAXIN-3	Macroautophagy is a cellular mechanism for the clearance of protein aggregates and damaged organelles. Impaired macroautophagy has been observed in neurodegenerative disorders. We investigated the macroautophagy pathway in essential tremor (ET) cases compared to age-matched controls. We analyzed microtubule-associated protein light chain 3-II (LC3-II), S6K, phosphorylated S6K, beclin-1, and mitochondrial membrane proteins levels by Western blot in the postmortem cerebellum of 10 ET cases and 11 controls. We also performed immunohistochemistry in 12 ET cases and 13 controls to quantify LC3 clustering in Purkinje cells (PCs). LC3-II protein levels were significantly lower in ET cases vs. controls on Western blot (0.84 +/- 0.14 vs. 1.00 +/- 0.14, p = 0.02), and LC3-II clustering in PCs by immunohistochemistry was significantly lower in ET cases vs. controls (2.03 +/- 3.45 vs. 8.80 +/- 9.81, p = 0.03). In ET cases, disease duration was inversely correlated with LC3-II protein level (r = -0.64, p = 0.046). We found that mitochondrial membrane proteins were accumulated in ET (TIM23: 1.36 +/- 0.11 in ET cases vs. 1.00 +/- 0.08 in controls, p = 0.02; TOMM20: 1.63 +/- 0.87 in ET cases vs. 1.00 +/- 0.14 in controls, p = 0.03). Beclin-1, which is involved in macroautophagy, was strikingly deficient in ET (0.42 +/- 0.13 vs. 1.00 +/- 0.35, p<0.001). Decreased macroautophagy was observed in the ET cerebellum, and this could be due to a decrease in beclin-1 levels, which subsequently lead to mitochondrial accumulation as a result of autophagic failure. This provides a possible means by which perturbed macroautophagy could contribute to PC pathology in ET.	[Kuo, Sheng-Han; Tang, Guomei; Sulzer, David; Louis, Elan D.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA; [Ma, Karen; Babij, Rachel; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, GH Sergievsky Ctr, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Louis, Elan D.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Cortes, Etty; Vonsattel, Jean-Paul G.; Faust, Phyllis L.] New York Presbyterian Hosp, New York, NY USA; [Louis, Elan D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Louis, ED (corresponding author), Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA.	EDL2@columbia.edu		Kuo, Sheng-Han/0000-0002-9412-931X	National Institutes of Health (Bethesda, MD) [R01 NS42859]; Udall Center for Parkinson's Disease Research (Columbia University); Parkinson's Disease Foundation; JPB Foundation; American Academy of Neurology Clinical Research Training Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042859] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Center for Parkinson's Disease Research (Columbia University); Parkinson's Disease Foundation; JPB Foundation; American Academy of Neurology Clinical Research Training Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 NS42859 from the National Institutes of Health (Bethesda, MD), Udall Center for Parkinson's Disease Research (Columbia University), Parkinson's Disease Foundation, JPB Foundation, and American Academy of Neurology Clinical Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373; Erickson-Davis CR, 2010, J NEUROPATH EXP NEUR, V69, P262, DOI 10.1097/NEN.0b013e3181d1ad04; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Higashi S, 2011, J NEUROPATH EXP NEUR, V70, P264, DOI 10.1097/NEN.0b013e318211c86a; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuo SH, 2011, J NEUROL NEUROSUR PS, V82, P1038, DOI 10.1136/jnnp.2010.213330; Kuo SH, 2011, ACTA NEUROPATHOL, V121, P287, DOI 10.1007/s00401-010-0776-9; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Louis ED, 2006, NEUROLOGY, V66, P1756, DOI 10.1212/01.wnl.0000218162.80315.b9; Louis ED, 2005, MOVEMENT DISORD, V20, P1361, DOI 10.1002/mds.20583; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Louis ED, 2009, ARCH NEUROL-CHICAGO, V66, P1202, DOI 10.1001/archneurol.2009.217; Louis ED, 2009, NEUROSCI LETT, V450, P287, DOI 10.1016/j.neulet.2008.11.043; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Sosunov AA, 2008, EPILEPSIA, V49, P53, DOI 10.1111/j.1528-1167.2008.01493.x; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	40	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53040	10.1371/journal.pone.0053040	http://dx.doi.org/10.1371/journal.pone.0053040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300858	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100112
J	Nepelska, M; Cultrone, A; Beguet-Crespel, F; Le Roux, K; Dore, J; Arulampalam, V; Blottiere, HM				Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Arulampalam, Vermulugesan; Blottiere, Herve M.			Butyrate Produced by Commensal Bacteria Potentiates Phorbol Esters Induced AP-1 Response in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; HISTONE DEACETYLASE INHIBITORS; COLON-CANCER-CELLS; CHAIN FATTY-ACIDS; BILE-ACIDS; SODIUM-BUTYRATE; GENE-EXPRESSION; COLORECTAL-CANCER; IN-VITRO; JUN	The human intestine is a balanced ecosystem well suited for bacterial survival, colonization and growth, which has evolved to be beneficial both for the host and the commensal bacteria. Here, we investigated the effect of bacterial metabolites produced by commensal bacteria on AP-1 signaling pathway, which has a plethora of effects on host physiology. Using intestinal epithelial cell lines, HT-29 and Caco-2, stably transfected with AP-1-dependent luciferase reporter gene, we tested the effect of culture supernatant from 49 commensal strains. We observed that several bacteria were able to activate the AP-1 pathway and this was correlated to the amount of short chain fatty acids (SCFAs) produced. Besides being a major source of energy for epithelial cells, SCFAs have been shown to regulate several signaling pathways in these cells. We show that propionate and butyrate are potent activators of the AP-1 pathway, butyrate being the more efficient of the two. We also observed a strong synergistic activation of AP-1 pathway when using butyrate with PMA, a PKC activator. Moreover, butyrate enhanced the PMA-induced expression of c-fos and ERK1/2 phosphorylation, but not p38 and JNK. In conclusion, we showed that SCFAs especially butyrate regulate the AP-1 signaling pathway, a feature that may contribute to the physiological impact of the gut microbiota on the host. Our results provide support for the involvement of butyrate in modulating the action of PKC in colon cancer cells.	[Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Blottiere, Herve M.] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Nepelska, Malgorzata; Cultrone, Antonietta; Beguet-Crespel, Fabienne; Le Roux, Karine; Dore, Joel; Blottiere, Herve M.] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Arulampalam, Vermulugesan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet	Blottiere, HM (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020	BLOTTIERE, Hervé M/0000-0002-8390-0607; 	European Community's Seventh Framework Programme (FP7), MetaHIT [HEALTH-F4-2007-201052]; European Marie-Curie Initial Training Network Cross-Talk [215553]	European Community's Seventh Framework Programme (FP7), MetaHIT; European Marie-Curie Initial Training Network Cross-Talk	This work was financed by grants from the European Community's Seventh Framework Programme (FP7/2007-2013), MetaHIT, grant agreement HEALTH-F4-2007-201052. M.N. has been supported by the European Marie-Curie Initial Training Network Cross-Talk (grant agreement # 215553). J.D., V. A., and H. B. are partners of the European Marie-Curie Initial Training Network Cross-Talk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1980, NATURE, V283, P781, DOI 10.1038/283781a0; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Blottiere HM, 2003, P NUTR SOC, V62, P101, DOI 10.1079/PNS2002215; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHAUHAN D, 1994, BLOOD, V84, P2243; Chen-Deutsch XW, 2009, LEUKEMIA RES, V33, P1372, DOI 10.1016/j.leukres.2009.03.003; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; CUMMINGS JH, 1984, P NUTR SOC, V43, P35, DOI 10.1079/PNS19840025; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; FITZER CJ, 1987, CARCINOGENESIS, V8, P217, DOI 10.1093/carcin/8.2.217; Gaschott T, 2001, BIOCHEM BIOPH RES CO, V283, P80, DOI 10.1006/bbrc.2001.4756; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; KIM YS, 1980, CANCER-AM CANCER SOC, V45, P1185, DOI 10.1002/1097-0142(19800315)45:5+<1185::AID-CNCR2820451324>3.0.CO;2-W; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; Le Blay G, 1999, BRIT J NUTR, V82, P419, DOI 10.1017/S000711459900166X; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Maier S, 2009, J CELL PHYSIOL, V218, P638, DOI 10.1002/jcp.21642; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; MOROTOMI M, 1990, CANCER RES, V50, P3595; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rickard KL, 1999, CARCINOGENESIS, V20, P977, DOI 10.1093/carcin/20.6.977; Rivero JA, 1998, BIOCHEM BIOPH RES CO, V248, P664, DOI 10.1006/bbrc.1998.9041; Saunders N, 1999, CANCER RES, V59, P399; Siavoshian S, 2000, GUT, V46, P507, DOI 10.1136/gut.46.4.507; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; WEISBURGER JH, 1983, ENVIRON HEALTH PERSP, V50, P101, DOI 10.2307/3429539; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Young DA, 2005, FEBS J, V272, P1912, DOI 10.1111/j.1742-4658.2005.04622.x	58	53	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52869	10.1371/journal.pone.0052869	http://dx.doi.org/10.1371/journal.pone.0052869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300800	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100087
J	Ishteiwy, RA; Ward, TM; Dykxhoorn, DM; Burnstein, KL				Ishteiwy, Reema A.; Ward, Toby M.; Dykxhoorn, Derek M.; Burnstein, Kerry L.			The microRNA-23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells	PLOS ONE			English	Article							E-CADHERIN REPRESSORS; MICRORNA EXPRESSION; RHO-GTPASES; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC RELEVANCE; PROGRESSION; MIR-27B; ACTIVATION; PROTEIN; GROWTH	MicroRNAs (miRs) are small, endogenous, non-coding RNAs that regulate the stability and/or translation of complementary mRNA targets. MiRs have emerged not only as critical modulators of normal physiologic processes, but their deregulation may significantly impact prostate and other cancers. The expression of miR-23b and miR-27b, which are encoded by the same miR cluster (miR-23b/-27b), are downregulated in metastatic, castration-resistant tumors compared to primary prostate cancer and benign tissue; however, their possible role in prostate cancer progression is unknown. We found that ectopic expression of miR-23b/-27b in two independent castration-resistant prostate cancer cell lines resulted in suppression of invasion and migration, as well as reduced survival in soft agar (a measure of anoikis). However, there was no effect of miR-23b/-27b on cell proliferation suggesting that these miRs function as metastasis (but not growth) suppressors in prostate cancer. Conversely, inhibition of miR-23b/-27b in the less aggressive androgen-dependent LNCaP prostate cancer cell line resulted in enhanced invasion and migration also without affecting proliferation. Mechanistically, we found that introduction of miR-23b/-27b in metastatic, castration-resistant prostate cancer cell lines resulted in a significant attenuation of Rac1 activity without affecting total Rac1 levels and caused increased levels of the tumor suppressor E-cadherin. Inhibition of these miRs had the opposite effect in androgen-dependent LNCaP cells. These results suggest that miR-23b/-27b are metastasis suppressors that might serve as novel biomarkers and therapeutic agents for castration-resistant disease.	[Ishteiwy, Reema A.; Ward, Toby M.; Burnstein, Kerry L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Dykxhoorn, Derek M.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom,Dept Human Genet, John T Macdonald Fdn,Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami; University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kburnstein@med.miami.edu	Dykxhoorn, Derek M/D-1357-2015		National Institutes of Health Grant [CA132200]; DOD Pre-doctoral training grant [w81xwh-11-1-0314]; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Pre-doctoral training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA132200 (to KLB) and DOD Pre-doctoral training grant w81xwh-11-1-0314 (to RAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Chen LC, 2011, ONCOL REP, V26, P1617, DOI 10.3892/or.2011.1458; Chunthapong J, 2004, J CELL BIOCHEM, V91, P649, DOI 10.1002/jcb.20032; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Frisch SM, 2001, ADV CANCER RES, V80, P39, DOI 10.1016/S0065-230X(01)80011-7; Fuse M, 2012, J HUMAN GENETICS; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; Luo Jan, 1997, Pathol Oncol Res, V3, P264; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Saito T, 2000, UROL INT, V65, P140, DOI 10.1159/000064859; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; UMBAS R, 1994, CANCER RES, V54, P3929; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	49	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52106	10.1371/journal.pone.0052106	http://dx.doi.org/10.1371/journal.pone.0052106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300597	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800048
J	Kanitz, E; Otten, W; Tuchscherer, M; Grabner, M; Brussow, KP; Rehfeldt, C; Metges, CC				Kanitz, Ellen; Otten, Winfried; Tuchscherer, Margret; Graebner, Maria; Bruessow, Klaus-Peter; Rehfeldt, Charlotte; Metges, Cornelia C.			High and Low Protein: Carbohydrate Dietary Ratios during Gestation Alter Maternal-Fetal Cortisol Regulation in Pigs	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; MESSENGER-RNA EXPRESSION; TYPE-2 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; PLACENTAL METABOLISM; RIBONUCLEIC-ACID; PLASMA-CORTISOL; BIRTH-WEIGHT; PREGNANCY	Imbalanced maternal nutrition during gestation can cause alterations of the hypothalamic-pituitary-adrenal (HPA) system in offspring. The present study investigated the effects of maternal low-and high-protein diets during gestation in pigs on the maternal-fetal HPA regulation and expression of the glucocorticoid receptor (GR), mineralocorticoid receptor (MR), 11 beta-hydroxysteroid dehydrogenase 1 and 2 (11 beta-HSD1 and 11 beta-HSD2) and c-fos mRNAs in the placenta and fetal brain. Twenty-seven German Landrace sows were fed diets with high (HP, 30%), low (LP, 6.5%) or adequate (AP, 12.1%) protein levels made isoenergetic by varying the carbohydrate levels. On gestational day 94, fetuses were recovered under general anesthesia for the collection of blood, brain and placenta samples. The LP diet in sows increased salivary cortisol levels during gestation compared to the HP and AP sows and caused an increase of placental GR and c-fos mRNA expression. However, the diurnal rhythm of plasma cortisol was disturbed in both LP and HP sows. Total plasma cortisol concentrations in the umbilical cord vessels were elevated in fetuses from HP sows, whereas corticosteroid-binding globulin levels were decreased in LP fetuses. In the hypothalamus, LP fetuses displayed an enhanced mRNA expression of 11b-HSD1 and a reduced expression of c-fos. Additionally, the 11b-HSD2 mRNA expression was decreased in both LP and HP fetuses. The present results suggest that both low and high protein: carbohydrate dietary ratios during gestation may alter the expression of genes encoding key determinants of glucocorticoid hormone action in the fetus with potential long-lasting consequences for stress adaptation and health.	[Kanitz, Ellen; Otten, Winfried; Tuchscherer, Margret; Graebner, Maria] Leibniz Inst Farm Anim Biol, Res Unit Behav Physiol, Dummerstorf, Germany; [Bruessow, Klaus-Peter] Leibniz Inst Farm Anim Biol, Res Unit Reprod Biol, Dummerstorf, Germany; [Rehfeldt, Charlotte] Leibniz Inst Farm Anim Biol, Res Unit Muscle Biol & Growth, Dummerstorf, Germany; [Metges, Cornelia C.] Leibniz Inst Farm Anim Biol, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Kanitz, E (corresponding author), Leibniz Inst Farm Anim Biol, Res Unit Behav Physiol, Dummerstorf, Germany.	ekanitz@fbn-dummerstorf.de	Otten, Winfried/V-8376-2019	Otten, Winfried/0000-0002-5613-5356	German Research Foundation, Bonn [PAK 24: OT 137/3-1, ME 1420/8-1]	German Research Foundation, Bonn(German Research Foundation (DFG))	The study was supported by grants from the German Research Foundation, Bonn (PAK 24: OT 137/3-1; ME 1420/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Belda X, 2005, PHARMACOL BIOCHEM BE, V81, P41, DOI 10.1016/j.pbb.2005.02.009; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; BRIGHT GM, 1995, J CLIN ENDOCR METAB, V80, P770, DOI 10.1210/jc.80.3.770; BURTON PJ, 1994, J ENDOCRINOL, V143, P505, DOI 10.1677/joe.0.1430505; Clarke KA, 2002, J ENDOCRINOL, V172, P527, DOI 10.1677/joe.0.1720527; Daenzer M, 2002, J NUTR, V132, P142, DOI 10.1093/jn/132.2.142; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Felix B, 1999, STEREOTAXIC ATLAS PI; Galler JR, 1993, TXB PEDIAT NUTR, P173; Galler JR, 1997, NUTR PEDIAT 2, P196; GfE, 2006, EMPFEHLUNGEN ENERGIE; Gnanalingham MG, 2007, REPRODUCTION, V134, P615, DOI 10.1530/REP-06-0369; GOLD PW, 1986, NEW ENGL J MED, V314, P1335, DOI 10.1056/NEJM198605223142102; GOMEZSANCHEZ EP, 1992, AM J PHYSIOL, V263, pE1125; GOMEZSANCHEZ EP, 1986, ENDOCRINOLOGY, V118, P819, DOI 10.1210/endo-118-2-819; Heo J, 2005, J ANIM SCI, V83, P208; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herrick K, 2003, J CLIN ENDOCR METAB, V88, P3554, DOI 10.1210/jc.2003-030287; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Jacobson L, 1997, ENDOCRINOLOGY, V138, P1048, DOI 10.1210/en.138.3.1048; Kanitz E, 2002, BIOL NEONATE, V81, P203, DOI 10.1159/000051535; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Kattesh HG, 1997, BIOL NEONATE, V72, P192, DOI 10.1159/000244484; Klemcke HG, 2003, BIOL REPROD, V69, P1945, DOI 10.1095/biolreprod.103.018150; KLEMCKE HG, 1995, BIOL REPROD, V53, P1293, DOI 10.1095/biolreprod53.6.1293; Klemcke HG, 2000, LIFE SCI, V66, P1045, DOI 10.1016/S0024-3205(99)00669-4; Klemcke HG, 1996, BIOL REPROD, V55, P217, DOI 10.1095/biolreprod55.1.217; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lesage J, 2006, STRESS, V9, P183, DOI 10.1080/10253890601056192; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lohrke B, 2005, J MOL ENDOCRINOL, V35, P531, DOI 10.1677/jme.1.01852; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; Metzler-Zebeli BU, 2012, BRIT J NUTR, V108, P2176, DOI 10.1017/S0007114512000414; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Phillips DI, 1998, J CLIN ENDOCR METAB, V83, P747; POND WG, 1992, GROWTH DEVELOP AGING, V56, P115; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; SAS INSTITUTE INC, 2009, SAS STAT 9 2 US GUID; SCHOKNECHT PA, 1994, THERIOGENOLOGY, V42, P217, DOI 10.1016/0093-691X(94)90265-8; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 1995, J STEROID BIOCHEM, V55, P447, DOI 10.1016/0960-0760(95)00193-X; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; Stimson RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008779; Sun K, 2002, BIOL REPROD, V67, P1450, DOI 10.1095/biolreprod.102.005892; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Umemoto S, 1997, NEUROSCIENCE, V80, P763, DOI 10.1016/S0306-4522(97)00050-X; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; WALKER CD, 1990, ENDOCRINOLOGY, V127, P832, DOI 10.1210/endo-127-2-832; Wan SL, 2005, NEUROSCI LETT, V382, P96, DOI 10.1016/j.neulet.2005.02.066; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854	68	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52748	10.1371/journal.pone.0052748	http://dx.doi.org/10.1371/journal.pone.0052748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300759	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800137
J	Donofrio, G; Franceschi, V; Lovero, A; Capocefalo, A; Camero, M; Losurdo, M; Cavirani, S; Marinaro, M; Grandolfo, E; Buonavoglia, C; Tempesta, M				Donofrio, Gaetano; Franceschi, Valentina; Lovero, Angela; Capocefalo, Antonio; Camero, Michele; Losurdo, Michele; Cavirani, Sandro; Marinaro, Mariarosaria; Grandolfo, Erika; Buonavoglia, Canio; Tempesta, Maria			Clinical Protection of Goats against CpHV-1 Induced Genital Disease with a BoHV-4-Based Vector Expressing CpHV-1 gD	PLOS ONE			English	Article							CAPRINE HERPESVIRUS-1 INFECTION; BOVINE HERPESVIRUS-1; GLYCOPROTEIN-D; CIDOFOVIR; VACCINE; BOVINE-HERPESVIRUS-4; IMMUNIZATION; VIRUS; CELLS; PCR	Caprine herpesvirus type 1 (CpHV-1) is an alphaherpesvirus causing genital disease leading to abortion in adult pregnant goats and a systemic disease with high morbility and mortality in kids. Further, Caprine herpesvirus 1 infection represents a valuable large animal model for human herpesvirus induced genital disease, exploitable for pathogenic studies, new vaccines and antiviral molecules testing. Here, the bovine herpesvirus 4 (BoHV-4) based vector derived from an apathogenic isolate of BoHV-4 and expressing the immunodominant CpHV-1 glycoprotein D (BoHV-4-A-gD(cp)gD(106 Delta)TK) was constructed and its ability to protect goats against CpHV-1 induced genital disease evaluated. The subcutaneous route of recombinant BoHV-4 administration was first tested in vivo/ex vivo by in vivo image analysis and in vitro by goat skin primary cultures preparation and transduction. Next, an exploratory immunization and safety study in goats was performed with two recombinant BoHV4, BoHV-4-A-gD(cp)gD(106)Delta TK or BoHV-4-CMV-IgK-gE2gD-TM. In both cases no clinical signs were evident but a good titer of serum neutralizing antibodies was produced in all inoculated animals. When a challenge experiment was performed in a new group of animals using a highly pathogenic dose of CpHV-1, all the vaccinated goats with BoHV-4-AgD(cp)gD(106)Delta TK were protected toward CpHV-1 induced genital disease respect to the unvaccinated control which showed typical vaginal lesions with a high grade of clinical score as well as a long lasting viral shedding. In summary, the data acquired in the present study validate BoHV-4-based vector as a safe and effective viral vector for goat vaccination against CpHV-1 induced genital disease and pave the way for further applications.	[Donofrio, Gaetano; Franceschi, Valentina; Capocefalo, Antonio; Cavirani, Sandro; Grandolfo, Erika] Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy; [Lovero, Angela; Camero, Michele; Losurdo, Michele; Buonavoglia, Canio; Tempesta, Maria] Univ Bari, Dept Vet Publ Hlth, Valenzano, Italy; [Marinaro, Mariarosaria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	University of Parma; Universita degli Studi di Bari Aldo Moro; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Donofrio, G (corresponding author), Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	Capocefalo, Antonio/O-3027-2017; tempesta, maria/AAE-5332-2021; franceschi, valentina/AAR-5566-2020	Capocefalo, Antonio/0000-0002-4215-4265; Cavirani, Sandro/0000-0002-1014-2307; franceschi, valentina/0000-0003-3945-2285; Donofrio, Gaetano/0000-0002-8984-0377; Camero, Michele/0000-0003-0026-8325; TEMPESTA, MARIA/0000-0003-4300-8822	Ministry of Education, University and Research (PRIN) [2008WCSTJM]	Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Ministry of Education, University and Research (PRIN 2008, project 2008WCSTJM "Activity of antiviral drugs and vaccines against herpesvirus infection in goats: an animal model for the study of genital herpesvirus infection in man''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonavoglia C, 1996, COMP IMMUNOL MICROB, V19, P275, DOI 10.1016/0147-9571(96)00014-8; Camero M, 2007, VACCINE, V25, P1658, DOI 10.1016/j.vaccine.2006.11.002; Camero M, 2010, ANTIVIR THER, V15, P785, DOI 10.3851/IMP1611; Capocefalo A, 2010, J VIROL METHODS, V169, P420, DOI 10.1016/j.jviromet.2010.08.002; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Donofrio G, 2008, VACCINE, V26, P6031, DOI 10.1016/j.vaccine.2008.09.023; Donofrio G, 2002, J VIROL METHODS, V101, P49, DOI 10.1016/S0166-0934(01)00419-0; Donofrio G, 2007, REPRODUCTION, V134, P183, DOI 10.1530/REP-07-0065; Donofrio G, 2006, CLIN VACCINE IMMUNOL, V13, P1246, DOI 10.1128/CVI.00200-06; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Donofrio G, 2011, VACCINE, V29, P867, DOI 10.1016/j.vaccine.2010.11.048; Donofrio G, 2009, CLIN VACCINE IMMUNOL, V16, P1675, DOI 10.1128/CVI.00224-09; Donofrio G, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-65; Donofrio G, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-68; Elia G, 2008, J VIROL METHODS, V148, P155, DOI 10.1016/j.jviromet.2007.10.021; ENGELS M, 1987, J GEN VIROL, V68, P2019, DOI 10.1099/0022-1317-68-7-2019; Gillet L, 2009, VET RES, V40, DOI 10.1051/vetres/2009034; GREWAL AS, 1986, AUST VET J, V63, P79, DOI 10.1111/j.1751-0813.1986.tb02935.x; Keuser V, 2002, VET RES COMMUN, V26, P221, DOI 10.1023/A:1015205705149; Keuser W, 2006, VIRUS RES, V115, P112, DOI 10.1016/j.virusres.2005.07.009; Manoj S, 2003, VIROLOGY, V313, P296, DOI 10.1016/S0042-6822(03)00325-8; Marinaro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034913; McGeoch DJ, 2005, J GEN VIROL, V86, P307, DOI 10.1099/vir.0.80588-0; OSORIO FA, 1983, AM J VET RES, V44, P975; Redaelli M, 2012, NEURO-ONCOLOGY, V14, P288, DOI 10.1093/neuonc/nor219; Redaelli M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-298; Reddy PS, 2000, VET IMMUNOL IMMUNOP, V76, P257, DOI 10.1016/S0165-2427(00)00217-8; Singh M, 2011, IN VITRO CELL DEV-AN, V47, P83, DOI 10.1007/s11626-010-9373-4; Six A, 2001, ARCH VIROL, V146, P1325, DOI 10.1007/s007050170094; TARIGAN S, 1987, AUST VET J, V64, P321, DOI 10.1111/j.1751-0813.1987.tb07345.x; Tempesta M, 2008, ANTIMICROB AGENTS CH, V52, P4064, DOI 10.1128/AAC.00725-08; Tempesta M, 2007, VACCINE, V25, P7927, DOI 10.1016/j.vaccine.2007.09.004; Tempesta M, 1999, J CLIN MICROBIOL, V37, P1598, DOI 10.1128/JCM.37.5.1598-1599.1999; Tempesta M, 2000, J VET MED B, V47, P197, DOI 10.1046/j.1439-0450.2000.00334.x; Tempesta M, 2004, COMP IMMUNOL MICROB, V27, P25, DOI 10.1016/S0147-9571(03)00012-2; Tempesta M, 1999, COMP IMMUNOL MICROB, V22, P137, DOI 10.1016/S0147-9571(98)00029-0; Tempesta M, 2001, VACCINE, V19, P3860, DOI 10.1016/S0264-410X(01)00136-0; Tempesta M, 2007, ANTIVIR THER, V12, P977; Tempesta M, 2007, ANTIVIR RES, V74, P138, DOI 10.1016/j.antiviral.2006.11.001; Thiry J, 2006, VET MICROBIOL, V113, P303, DOI 10.1016/j.vetmic.2005.11.001; Thiry Julien, 2007, BMC Vet Res, V3, P33, DOI 10.1186/1746-6148-3-33; Uzal FA, 2004, J VET DIAGN INVEST, V16, P478, DOI 10.1177/104063870401600523; VANDERLUGT JJ, 1993, J S AFR VET ASSOC, V64, P169	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52758	10.1371/journal.pone.0052758	http://dx.doi.org/10.1371/journal.pone.0052758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300989	Green Submitted, Green Published, gold			2022-12-25	WOS:000313480000016
J	Chen, ZZ; Lessey, E; Berginski, ME; Cao, L; Li, J; Trepat, X; Itano, M; Gomez, SM; Kapustina, M; Huang, C; Burridge, K; Truskey, G; Jacobson, K				Chen, Zaozao; Lessey, Elizabeth; Berginski, Matthew E.; Cao, Li; Li, Jonathan; Trepat, Xavier; Itano, Michelle; Gomez, Shawn M.; Kapustina, Maryna; Huang, Cai; Burridge, Keith; Truskey, George; Jacobson, Ken			Gleevec, an Abl Family Inhibitor, Produces a Profound Change in Cell Shape and Migration	PLOS ONE			English	Article							TYROSINE KINASE; EXTRACELLULAR-MATRIX; NEONATAL LETHALITY; MICE DEFICIENT; GROWTH-FACTOR; ADHESION; ACTIN; RAT; LAMELLIPODIA; PAXILLIN	The issue of how contractility and adhesion are related to cell shape and migration pattern remains largely unresolved. In this paper we report that Gleevec (Imatinib), an Abl family kinase inhibitor, produces a profound change in the shape and migration of rat bladder tumor cells (NBTII) plated on collagen-coated substrates. Cells treated with Gleevec adopt a highly spread D-shape and migrate more rapidly with greater persistence. Accompanying this more spread state is an increase in integrin-mediated adhesion coupled with increases in the size and number of discrete adhesions. In addition, both total internal reflection fluorescence microscopy (TIRFM) and interference reflection microscopy (IRM) revealed a band of small punctate adhesions with rapid turnover near the cell leading margin. These changes led to an increase in global cell-substrate adhesion strength, as assessed by laminar flow experiments. Gleevec-treated cells have greater RhoA activity which, via myosin activation, led to an increase in the magnitude of total traction force applied to the substrate. These chemical and physical alterations upon Gleevec treatment produce the dramatic change in morphology and migration that is observed.	[Chen, Zaozao; Lessey, Elizabeth; Itano, Michelle; Kapustina, Maryna; Burridge, Keith; Jacobson, Ken] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Chen, Zaozao; Itano, Michelle; Kapustina, Maryna; Burridge, Keith; Jacobson, Ken] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Chen, Zaozao; Jacobson, Ken] Univ N Carolina, Sch Med, Program Mol & Cellular Biophys, Chapel Hill, NC USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Cao, Li; Li, Jonathan; Truskey, George] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Trepat, Xavier] Univ Barcelona, Inst Bioengn Catalonia, Barcelona, Spain; [Trepat, Xavier] Ciber Enfermedades Respiratorias, Barcelona, Spain; [Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Huang, Cai] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA; [Gomez, Shawn M.] Univ N Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Kentucky; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jacobson, K (corresponding author), Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	frap@med.unc.edu	Truskey, George/AAB-7793-2021; Chen, Zaozao/AAS-6111-2021; Truskey, George A/B-2215-2012; Kapustina, Maryna/B-8929-2014; , UNC Flow Cytometry Core/AGU-9839-2022; Itano, Michelle/AAU-4367-2020; Trepat, Xavier/I-3912-2015	Truskey, George/0000-0002-6885-4489; Truskey, George A/0000-0002-6885-4489; Itano, Michelle/0000-0001-6853-1228; Trepat, Xavier/0000-0002-7621-5214; Gomez, Shawn/0000-0002-8251-4552	National Institutes of Health Cell Migration Consortium National Institutes of Health [GM 64346]; National Institutes of Health [GM029860]; Chinese government fellowship (China Scholarship Council (CSC)); National Institutes of Health Cell Migration Consortium [NIH GM 64346]; Molecular and Cellular Biophysics Program [NIH T32GM008570]; IVB Training Program [NIH T32HL069768]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, T32GM008570, U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese government fellowship (China Scholarship Council (CSC)); National Institutes of Health Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular and Cellular Biophysics Program; IVB Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Cell Migration Consortium National Institutes of Health GM 64346 (KJ) and National Institutes of Health GM029860 (KB). ZC was supported by Chinese government fellowship (China Scholarship Council (CSC)), the National Institutes of Health Cell Migration Consortium (NIH GM 64346), and Molecular and Cellular Biophysics Program (NIH T32GM008570). EL was supported by the IVB Training Program (NIH T32HL069768). URL of funder's website: NIH: http://grants.nih.gov/grants/guide/ CSC: http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Bellone G, 2004, CANCER BIOL THER, V3, P385, DOI 10.4161/cbt.3.4.727; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chan BP, 2004, BIOTECHNOL PROGR, V20, P566, DOI 10.1021/bp034215z; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hubbard SR, 2002, CURR OPIN STRUC BIOL, V12, P735, DOI 10.1016/S0959-440X(02)00383-4; IZZARD CS, 1976, J CELL SCI, V21, P129; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Krieger SM, 2004, MOL CELL BIOL; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1997, J CELL SCI, V110, P2833; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MEININGER CJ, 1992, BLOOD, V79, P958; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanz-Moreno V, 2009, CELL CYCLE, V8, P1484, DOI 10.4161/cc.8.10.8490; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Schweizer A, 1999, J BIOL CHEM, V274, P20450, DOI 10.1074/jbc.274.29.20450; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; TOYOSHIMA K, 1971, JNCI-J NATL CANCER I, V47, P979; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H; TUCKER GC, 1991, J CELL SCI, V100, P371; TUCKER GC, 1990, CANCER RES, V50, P129; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VALLES AM, 1990, P NATL ACAD SCI USA, V87, P1124, DOI 10.1073/pnas.87.3.1124; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	60	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52233	10.1371/journal.pone.0052233	http://dx.doi.org/10.1371/journal.pone.0052233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300967	Green Published, gold, Green Submitted			2022-12-25	WOS:000313320900022
J	Forestier, A; Sarrazy, F; Caillat, S; Vandenbrouck, Y; Sauvaigo, S				Forestier, Anne; Sarrazy, Fanny; Caillat, Sylvain; Vandenbrouck, Yves; Sauvaigo, Sylvie			Functional DNA Repair Signature of Cancer Cell Lines Exposed to a Set of Cytotoxic Anticancer Drugs Using a Multiplexed Enzymatic Repair Assay on Biochip	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DAMAGE RESPONSE; MISMATCH REPAIR; ADJUVANT CHEMOTHERAPY; CROSS-LINKS; PROTEIN; 5-FLUOROURACIL; RECOMBINATION; IMPROVEMENT; MECHANISMS	The development of resistances to conventional anticancer drugs compromises the efficacy of cancer treatments. In the case of DNA-targeting chemotherapeutic agents, cancer cells may display tolerance to the drug-induced DNA lesions and/or enhanced DNA repair. However, the role of DNA damage response (DDR) and DNA repair in this chemoresistance has yet to be defined. To provide insights in this challenging area, we analyzed the DNA repair signature of 7 cancer cell lines treated by 5 cytotoxic drugs using a recently developed multiplexed functional DNA repair assay. This comprehensive approach considered the complexity and redundancy of the different DNA repair pathways. Data was analyzed using clustering methods and statistical tests. This DNA repair profiling method defined relevant groups based on similarities between different drugs, thus providing information relating to their dominant mechanism of action at the DNA level. Similarly, similarities between different cell lines presumably identified identical functional DDR despite a high level of genetic heterogeneity between cell lines. Our strategy has shed new light on the contribution of specific repair sub-pathways to drug-induced cytotoxicity. Although further molecular characterisations are needed to fully unravel the mechanisms underlying our findings, our approach proved to be very promising to interrogate the complexity of the DNA repair response. Indeed, it could be used to predict the efficacy of a given drug and the chemosensitivity of individual patients, and thus to choose the right treatment for individualised cancer care.	[Forestier, Anne; Sarrazy, Fanny; Caillat, Sylvain; Sauvaigo, Sylvie] UJF Grenoble 1, Lab Lesions Acides Nucl, CEA, DSM,INAC,SCIB,UMR E3, Grenoble, France; [Vandenbrouck, Yves] UJF Grenoble 1, Lab Biol Grande Echelle, CEA, DSV,IRTSV,U1038,INSERM, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Sauvaigo, S (corresponding author), UJF Grenoble 1, Lab Lesions Acides Nucl, CEA, DSM,INAC,SCIB,UMR E3, Grenoble, France.	sylvie.sauvaigo@cea.fr	VANDENBROUCK, Yves/Q-2675-2017	VANDENBROUCK, Yves/0000-0002-1292-373X	transversal CEA program Technologies for Health; GRAVIT; European Commission [LSHB-CT-2006-037575]	transversal CEA program Technologies for Health; GRAVIT; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank the transversal CEA program Technologies for Health for support as well as GRAVIT for its financial accompaniment. This work was also partially supported by the European Commission (Contract LSHB-CT-2006-037575) - project 'Comet assay and cell array for fast and efficient genotoxicity testing' (COMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bohanes P, 2011, CLIN COLORECTAL CANC, V10, P157, DOI 10.1016/j.clcc.2011.03.024; Branham WS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-8; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; Darzynkiewicz Z, 2009, EUR J PHARMACOL, V625, P143, DOI 10.1016/j.ejphar.2009.05.032; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Fojo T, 2001, J NATL CANCER I, V93, P1434, DOI 10.1093/jnci/93.19.1434; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Johnson SW, 1997, CANCER RES, V57, P850; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Li LS, 2009, BRIT J PHARMACOL, V158, P679, DOI 10.1111/j.1476-5381.2009.00423.x; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Ljungman M, 2009, CHEM REV, V109, P2929, DOI 10.1021/cr900047g; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Middleton MR, 2003, LANCET ONCOL, V4, P37, DOI 10.1016/S1470-2045(03)00959-8; Millau JF, 2008, LAB CHIP, V8, P1713, DOI 10.1039/b806634e; Mohammed MZ, 2011, BRIT J CANCER, V104, P653, DOI 10.1038/sj.bjc.6606058; Morris JR, 2010, CANCER RES, V70, P3861, DOI 10.1158/0008-5472.CAN-10-0468; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pons B, 2010, MECH AGEING DEV, V131, P661, DOI 10.1016/j.mad.2010.09.002; Prunier C, 2012, MUTAT RES-FUND MOL M, V736, P48, DOI 10.1016/j.mrfmmm.2011.05.005; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Robert J, 2004, CRIT REV ONCOL HEMAT, V51, P205, DOI 10.1016/S1040-8428(04)00111-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sander M, 2006, DNA REPAIR, V5, P523, DOI 10.1016/j.dnarep.2005.11.003; Sauvaigo S, 2010, J INVEST DERMATOL, V130, P1739, DOI 10.1038/jid.2010.10; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Swanton C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2159; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Vekris A, 2004, CANCER RES, V64, P356, DOI 10.1158/0008-5472.CAN-03-2258; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Zheng HY, 2006, DNA REPAIR, V5, P566, DOI 10.1016/j.dnarep.2006.01.010; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	51	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51754	10.1371/journal.pone.0051754	http://dx.doi.org/10.1371/journal.pone.0051754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300565	Green Published, gold			2022-12-25	WOS:000313872600007
J	Lee, YC; Tzeng, WF; Chiou, TJ; Chu, ST				Lee, Ying Chu; Tzeng, Woan-Fang; Chiou, Tzeon-Jye; Chu, Sin Tak			MicroRNA-138 Suppresses Neutrophil Gelatinase-Associated Lipocalin Expression and Inhibits Tumorigenicity	PLOS ONE			English	Article							NGAL; CANCER; PROTEIN	The expression of neutrophil gelatinase-associated lipocalin (NGAL) is up-regulated in some cancers; therefore NGAL has potential as a tumor biomarker. Although the regulation mechanism for this is unknown, one study has shown that it is likely to involve a microRNA (miRNA). Here, we investigate the relation between miRNA expression and NGAL expression, and the role of NGAL in tumorigenesis. Using miRNA target-detecting software, we analyze the mRNA sequence of NGAL and identify a target site for microRNA-138 (miR-138) in nucleotides 25-53 of the 3' UTR. We then analyze NGAL and miR-138 expression in three cancer cell lines originating from breast, endometrial and pancreatic carcinomas (the MCF-7, RL95-2 and AsPC-1 cell lines), respectively, using quantitative (real-time) PCR and western blot analysis. Metastasis is a critical event in cancer progression, in which malignant cell proliferation, migration and invasion increase. To determine whether miR-138-regulated NGAL expression is associated with metastasis, the proliferation and migration of the cell line are examined after miR-138 transfection. Using nude mice, we examine both the tumorigenicity of these cell lines and of miR-138-transfected cancer cells in vivo, as well as the effect of treating tumors with an antibody against NGAL. Our results show that these cancer cell lines down-regulate NGAL when miR-138 is highly expressed. Ectopic transfection of miR-138 suppresses NGAL expression and cell migration in RL95-2 and AsPC-1 cells, demonstrating that miR-138-regulated NGAL expression is associated with cell migration. Additionally, injection of the NGAL antibody diminishes NGAL-mediated tumorigenesis in nude mice, and miR-138 transfection of cancer cells reduces tumor formation. As the cell proliferation data showed that the tumor size should be regulated by NGAL-related cell growth. Taken together, our results indicate that NGAL may be a good target for cancer therapy and suggest that miR-138 acts as a tumor suppressor and may prevent metastasis.	[Lee, Ying Chu; Chu, Sin Tak] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Tzeng, Woan-Fang] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Dept Med, Div Transfus Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chu, Sin Tak] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Fu Jen Catholic University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Chu, ST (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	stc316@gate.sinica.edu.tw			National Science Council of Taiwan [NSC 98-2314-B-075-022-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council of Taiwan (grant number NSC 98-2314-B-075-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin HH, 2007, TOXICOLOGY, V234, P203, DOI 10.1016/j.tox.2007.02.017; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Rodriguez Luis G., 2004, V294, P23; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	21	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52979	10.1371/journal.pone.0052979	http://dx.doi.org/10.1371/journal.pone.0052979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300839	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600043
J	Tian, JX; Du, QZ; Chang, MQ; Zhang, DQ				Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang			Allelic Variation in PtGA20Ox Associates with Growth and Wood Properties in Populus spp	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; GIBBERELLIN BIOSYNTHESIS; NATURAL-POPULATIONS; CANDIDATE GENES; COMPLEX TRAITS; MESSENGER-RNA; GENETICS; POLYMORPHISMS; METABOLISM	Populus tomentosa is an economically important tree crop that produces wood for lumber, pulp, paper, and biofuels. Wood quality traits are likely to be strongly affected by the plant hormone gibberellic acid (GA), which regulates growth. GA20Ox encodes one of the major regulatory enzymes of GA biosynthesis and may therefore play a large role in growth and wood quality. Here, linkage disequilibrium (LD) studies were used to identify significant associations between single nucleotide polymorphisms (SNPs) within PtGA20Ox and growth and wood-quality traits of P. tomentosa. We isolated a full-length GA20Ox cDNA from Populus tomentosa by reverse transcription (RT)-PCR; this 1401 bp cDNA clone had an open reading frame of 1158 bp and encoded a protein of 385 amino acids. PtGA20Ox transcripts were maximally expressed in the mature xylem of vascular tissues, suggesting that PtGA20Ox is highly expressed and specifically associated with secondary xylem formation. Resequencing the PtGA20Ox locus of 36 individuals identified 55 SNPs, and the frequency of SNPs was 1/31 bp. The 29 most common SNPs (frequency >0.1) were genotyped in an association population (426 individuals) that was also phenotyped for key growth and wood quality traits. LD did not extend over the entire gene (r(2)<0.1, within 500 bp), demonstrating that a candidate-gene-based LD approach may the best way to understand the molecular basis underlying quantitative variation in this species. SNP-and haplotype-based association analyses indicated that four SNPs (false discovery rate Q<0.05) and 14 haplotypes (P<0.05) were significantly associated with growth and wood properties. The phenotypic variance explained by each SNP ranged from 3.44% to 14.47%. The SNP markers identified in this study can be applied to breeding programs for the improvement of growth and wood-property traits by marker-assisted selection.	[Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China; [Tian, Jiaxing; Du, Qingzhang; Chang, Mengqi; Zhang, Deqiang] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn			State Key Basic Research Program of China [2012CB114506]; Projects of the National Natural Science Foundation of China [31170622, 30872042]	State Key Basic Research Program of China(National Basic Research Program of China); Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Program of China (No. 2012CB114506) and as the Projects of the National Natural Science Foundation of China (Nos. 31170622, 30872042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, INT J PLANT GENOMICS, V2008, P1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Daykin A, 1997, PLANTA, V203, P526, DOI 10.1007/s004250050222; Deng Wei, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P1095; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fang XT, 2010, GENES GENOM, V32, P29, DOI 10.1007/s13258-010-0762-6; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HEDRICK PW, 1987, GENETICS, V117, P331; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang Z., 1992, J BEIJING FOR U, V14, P26, DOI DOI 10.13332/J.1000-1522.1992.S3.00; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Ismail M, 2012, J MOL EVOL, V74, P257, DOI 10.1007/s00239-012-9504-5; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Koshkin AA, 1998, TETRAHEDRON LETT, V39, P4381, DOI 10.1016/S0040-4039(98)00706-0; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; LEWONTIN RC, 1964, GENETICS, V49, P49; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Niki T, 2001, PLANT PHYSIOL, V126, P965, DOI 10.1104/pp.126.3.965; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pritchard JK, 2000, GENETICS, V155, P945; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Ridoutt BG, 1996, PHYSIOL PLANTARUM, V96, P559, DOI 10.1111/j.1399-3054.1996.tb00227.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sari-Gorla M, 1999, THEOR APPL GENET, V99, P289, DOI 10.1007/s001220051234; SAUTER M, 1992, PLANTA, V188, P362, DOI 10.1007/BF00192803; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sexton TR, 2010, AUST FORESTRY, V73, P254, DOI 10.1080/00049158.2010.10676336; Shao YF, 2011, THEOR APPL GENET, V122, P1005, DOI 10.1007/s00122-010-1505-4; Shen HuiJuan, 1996, Scientia Silvae Sinicae, V32, P165; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Sokal R. R, 1981, BIOMETRY; Southerton SG, 2010, AUST FORESTRY, V73, P259, DOI 10.1080/00049158.2010.10676337; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Weir BS., 1996, GENETIC DATA ANAL; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7; Zhang DeQiang, 2005, Forestry Studies in China, V7, P1, DOI 10.1007/s11632-005-0024-x	70	37	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53116	10.1371/journal.pone.0053116	http://dx.doi.org/10.1371/journal.pone.0053116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300875	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600061
J	Ho, CSJ; Rydstrom, A; Manimekalai, MSS; Svanborg, C; Gruber, G				Ho, James C. S.; Rydstrom, Anna; Manimekalai, Malathy Sony Subramanian; Svanborg, Catharina; Grueber, Gerhard			Low Resolution Solution Structure of HAMLET and the Importance of Its Alpha-Domains in Tumoricidal Activity	PLOS ONE			English	Article							APOPTOSIS-LIKE MECHANISM; KILLS TUMOR-CELLS; OLEIC-ACID; MOONLIGHTING PROTEINS; APO-BOVINE; LACTALBUMIN; LETHAL; COMPLEX; HOLOGRAPHY; CONVERSION	HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) is the first member in a new family of protein-lipid complexes with broad tumoricidal activity. Elucidating the molecular structure and the domains crucial for HAMLET formation is fundamental for understanding its tumoricidal function. Here we present the low-resolution solution structure of the complex of oleic acid bound HAMLET, derived from small angle X-ray scattering data. HAMLET shows a two-domain conformation with a large globular domain and an extended part of about 2.22 nm in length and 1.29 nm width. The structure has been superimposed into the related crystallographic structure of human alpha-lactalbumin, revealing that the major part of alpha-lactalbumin accommodates well in the shape of HAMLET. However, the C-terminal residues from L105 to L123 of the crystal structure of the human alpha-lactalbumin do not fit well into the HAMLET structure, resulting in an extended conformation in HAMLET, proposed to be required to form the tumoricidal active HAMLET complex with oleic acid. Consistent with this low resolution structure, we identified biologically active peptide epitopes in the globular as well as the extended domains of HAMLET. Peptides covering the alpha1 and alpha2 domains of the protein triggered rapid ion fluxes in the presence of sodium oleate and were internalized by tumor cells, causing rapid and sustained changes in cell morphology. The alpha peptide-oleate bound forms also triggered tumor cell death with comparable efficiency as HAMLET. In addition, shorter peptides corresponding to those domains are biologically active. These findings provide novel insights into the structural prerequisites for the dramatic effects of HAMLET on tumor cells.	[Ho, James C. S.; Rydstrom, Anna; Svanborg, Catharina] Lund Univ, Dept Microbiol Immunol & Glycobiol MIG, Inst Lab Med, Lund, Sweden; [Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Lund University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Svanborg, C (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol MIG, Inst Lab Med, Lund, Sweden.	catharina.svanborg@med.lu.se; ggrueber@ntu.edu.sg	Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Rydstrom, Anna/0000-0002-3404-7195	Sharon D. Lund foundation grant; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Ministry of Education (MOE), Singapore (AcRF) [Tier 1, RG 45/10]	Sharon D. Lund foundation grant; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Ministry of Education (MOE), Singapore (AcRF)	This research was supported by the Sharon D. Lund foundation grant and the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society to C. Svanborg and by the Ministry of Education (MOE), Singapore (AcRF, Tier 1; RG 45/10) to G. Gruber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA KR, 1989, J MOL BIOL, V208, P99, DOI 10.1016/0022-2836(89)90091-0; Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; ALEXANDRESCU AT, 1992, EUR J BIOCHEM, V210, P699, DOI 10.1111/j.1432-1033.1992.tb17471.x; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BREW K, 1967, J BIOL CHEM, V242, P3747; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; BRODBECK U, 1966, J BIOL CHEM, V241, P762; CAMPBELL J, 1964, BIOCHEM J, V93, P183, DOI 10.1042/bj0930183; Chrysina ED, 2000, J BIOL CHEM, V275, P37021, DOI 10.1074/jbc.M004752200; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Dymkowska D, 2006, BBA-MOL CELL RES, V1763, P152, DOI 10.1016/j.bbamcr.2005.12.009; Dymkowska D, 2004, TOXICOL MECH METHOD, V14, P73, DOI 10.1080/15376520490257518; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; FITZGERALD LA, 1984, J CELL SCI, V67, P1; Guinier A, 1955, SMALL ANGLE SCTTERIN; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; Harata K, 1999, J MOL BIOL, V287, P347, DOI 10.1006/jmbi.1999.2598; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KOGA K, 1985, BIOCHEMISTRY-US, V24, P7257, DOI 10.1021/bi00346a035; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Pettersson J, 2006, BIOCHEM BIOPH RES CO, V345, P260, DOI 10.1016/j.bbrc.2006.04.081; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schnars U., 2005, DIGITAL HOLOGRAPHY D; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Svensson M, 2002, ADV EXP MED BIOL, V503, P125; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Trulsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017179; Wijesinha-Bettoni R, 2001, J MOL BIOL, V307, P885, DOI 10.1006/jmbi.2001.4530; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Wu LC, 1997, P NATL ACAD SCI USA, V94, P14314, DOI 10.1073/pnas.94.26.14314; Yu FR, 2008, J PHARM PHARMACOL, V60, P253, DOI 10.1211/jpp.60.2.0015; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003	52	22	23	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53051	10.1371/journal.pone.0053051	http://dx.doi.org/10.1371/journal.pone.0053051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300861	Green Published, gold			2022-12-25	WOS:000312829100114
J	Krakstad, C; Birkeland, E; Seidel, D; Kusonmano, K; Petersen, K; Mjos, S; Hoivik, EA; Wik, E; Halle, MK; Oyan, AM; Kalland, KH; Werner, HMJ; Trovik, J; Salvesen, H				Krakstad, Camilla; Birkeland, Even; Seidel, Danila; Kusonmano, Kanthida; Petersen, Kjell; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Oyan, Anne M.; Kalland, Karl-Henning; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga			High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated	PLOS ONE			English	Article							LUNG ADENOCARCINOMA; COLORECTAL CANCERS; SOMATIC MUTATIONS; CARCINOMA; BRAF; INHIBITION; PTEN; VEMURAFENIB; ACTIVATION; GENOME	Background: Despite being the most common pelvic gynecologic malignancy in industrialized countries, no targeted therapies are available for patients with metastatic endometrial carcinoma. In order to improve treatment, underlying molecular characteristics of primary and metastatic disease must be explored. Methodology/Principal Findings: We utilized the mass spectrometric-based mutation detection technology OncoMap to define the types and frequency of point somatic mutations in endometrial cancer. 67 primary tumors, 15 metastases corresponding to 7 of the included primary tumors and 11 endometrial cancer cell lines were screened for point mutations in 28 known oncogenes. We found that 27 (40.3%) of 67 primary tumors harbored one or more mutations with no increase in metastatic lesions. FGFR2, KRAS and PIK3CA were consistently the most frequently mutated genes in primary tumors, metastatic lesions and cell lines. Conclusions/Significance: Our results emphasize the potential for targeting FGFR2, KRAS and PIK3CA mutations in endometrial cancer for development of novel therapeutic strategies.	[Krakstad, Camilla; Birkeland, Even; Kusonmano, Kanthida; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga] Univ Bergen, Dept Clin Med, Bergen, Norway; [Krakstad, Camilla; Birkeland, Even; Kusonmano, Kanthida; Mjos, Siv; Hoivik, Erling A.; Wik, Elisabeth; Halle, Mari Kylleso; Werner, Henrica Maria Johanna; Trovik, Jone; Salvesen, Helga] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Seidel, Danila] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Seidel, Danila] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Seidel, Danila] Univ Cologne, Lab Translat Canc Genom, Ctr Integrated Oncol Koln Bonn, D-50931 Cologne, Germany; [Kusonmano, Kanthida; Petersen, Kjell] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Oyan, Anne M.; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Oyan, Anne M.; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Cologne; Max Planck Society; University of Cologne; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Krakstad, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	camilla.krakstad@med.uib.no	salvesen, Helga B/C-1187-2017; Kalland, Karl-Henning/B-9445-2017; Krakstad, Camilla/AAB-5138-2020; Kusonmano, Kanthida/AAQ-2802-2020; Seidel, Danila/Y-6795-2018; Werner, henrica/ABG-1235-2021; Halle, Mari K/AAT-4856-2020; Wik, E./AAA-9105-2020	salvesen, Helga B/0000-0002-4438-8831; Kalland, Karl-Henning/0000-0003-4486-2334; Krakstad, Camilla/0000-0002-0174-8139; Seidel, Danila/0000-0003-4388-3117; Werner, henrica/0000-0001-5186-8369; Halle, Mari K/0000-0002-2660-8271	Western Norway Regional Health Authority [911351, 911624]; Norwegian Research Council [193373, 205404]; Norwegian Cancer Society [628837]	Western Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	The Western Norway Regional Health Authority (grant number: 911351 and 911624), Norwegian Research Council (grant number: 193373 and 205404), and The Norwegian Cancer Society (grant number: 628837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Birkeland E, 2012, BR J CANC; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Fujimoto T, 2009, GYNECOL ONCOL, V112, P342, DOI 10.1016/j.ygyno.2008.10.019; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; Mutter GL, 1999, J CLIN PATHOL-MOL PA, V52, P257, DOI 10.1136/mp.52.5.257; Peterson LM, 2012, INT J GYNECOL PATHOL, V31, P195, DOI 10.1097/PGP.0b013e318231fc51; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2005, INT J CANCER, V115, P930, DOI 10.1002/ijc.20702; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Semczuk A, 1998, J CANCER RES CLIN, V124, P695, DOI 10.1007/s004320050234; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532	35	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52795	10.1371/journal.pone.0052795	http://dx.doi.org/10.1371/journal.pone.0052795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300780	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100084
J	Gongora-Castillo, E; Childs, KL; Fedewa, G; Hamilton, JP; Liscombe, DK; Magallanes-Lundback, M; Mandadi, KK; Nims, E; Runguphan, W; Vaillancourt, B; Varbanova-Herde, M; DellaPenna, D; McKnight, TD; O'Connor, S; Buell, CR				Gongora-Castillo, Elsa; Childs, Kevin L.; Fedewa, Greg; Hamilton, John P.; Liscombe, David K.; Magallanes-Lundback, Maria; Mandadi, Kranthi K.; Nims, Ezekiel; Runguphan, Weerawat; Vaillancourt, Brieanne; Varbanova-Herde, Marina; DellaPenna, Dean; McKnight, Thomas D.; O'Connor, Sarah; Buell, C. Robin			Development of Transcriptomic Resources for Interrogating the Biosynthesis of Monoterpene Indole Alkaloids in Medicinal Plant Species	PLOS ONE			English	Article							GENOME; HYDROXYLATION	The natural diversity of plant metabolism has long been a source for human medicines. One group of plant-derived compounds, the monoterpene indole alkaloids (MIAs), includes well-documented therapeutic agents used in the treatment of cancer (vinblastine, vincristine, camptothecin), hypertension (reserpine, ajmalicine), malaria (quinine), and as analgesics (7-hydroxymitragynine). Our understanding of the biochemical pathways that synthesize these commercially relevant compounds is incomplete due in part to a lack of molecular, genetic, and genomic resources for the identification of the genes involved in these specialized metabolic pathways. To address these limitations, we generated large-scale transcriptome sequence and expression profiles for three species of Asterids that produce medicinally important MIAs: Camptotheca acuminata, Catharanthus roseus, and Rauvolfia serpentina. Using next generation sequencing technology, we sampled the transcriptomes of these species across a diverse set of developmental tissues, and in the case of C. roseus, in cultured cells and roots following elicitor treatment. Through an iterative assembly process, we generated robust transcriptome assemblies for all three species with a substantial number of the assembled transcripts being full or near-full length. The majority of transcripts had a related sequence in either UniRef100, the Arabidopsis thaliana predicted proteome, or the Pfam protein domain database; however, we also identified transcripts that lacked similarity with entries in either database and thereby lack a known function. Representation of known genes within the MIA biosynthetic pathway was robust. As a diverse set of tissues and treatments were surveyed, expression abundances of transcripts in the three species could be estimated to reveal transcripts associated with development and response to elicitor treatment. Together, these transcriptomes and expression abundance matrices provide a rich resource for understanding plant specialized metabolism, and promotes realization of innovative production systems for plant-derived pharmaceuticals.	[Gongora-Castillo, Elsa; Childs, Kevin L.; Hamilton, John P.; Vaillancourt, Brieanne; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Fedewa, Greg; Magallanes-Lundback, Maria; Varbanova-Herde, Marina; DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Liscombe, David K.; Nims, Ezekiel; Runguphan, Weerawat] MIT, Dept Chem, Cambridge, MA 02139 USA; [Mandadi, Kranthi K.; McKnight, Thomas D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [O'Connor, Sarah] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [O'Connor, Sarah] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	Michigan State University; Michigan State University; Massachusetts Institute of Technology (MIT); Texas A&M University System; Texas A&M University College Station; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Mandadi, Kranthi/I-4033-2019; Hamilton, John P/G-1379-2016; O'Connor, Sarah Ellen/X-2893-2019; Góngora-Castillo, Elsa B/R-8854-2016; Runguphan, Weerawat/GSM-9179-2022; Childs, Kevin/C-9513-2014; O'Connor, Sarah/O-5850-2016	Mandadi, Kranthi/0000-0003-2986-4016; Hamilton, John P/0000-0002-8682-5526; Góngora-Castillo, Elsa B/0000-0001-6327-6993; Fedewa, Greg/0000-0002-3448-3819; Vaillancourt, Brieanne/0000-0002-6795-5173; Runguphan, Weerawat/0000-0001-5707-3516; Childs, Kevin/0000-0002-3680-062X; O'Connor, Sarah/0000-0003-0356-6213; Buell, C Robin/0000-0002-6727-4677	National Institute of General Medical Sciences [1RC2GM092521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0654] Funding Source: researchfish; BBSRC [BBS/E/J/000C0654] Funding Source: UKRI	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for medicinal plant transcriptome work was provided by a grant to CRB, DD, TDM, and SO from the National Institute of General Medical Sciences (1RC2GM092521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARORA RB, 1956, J PHARMACOL EXP THER, V117, P62; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENSCH KG, 1969, SCIENCE, V165, P495, DOI 10.1126/science.165.3892.495; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; CORDELL GA, 1974, LLOYDIA, V37, P219; GEORGE P, 1965, JNCI-J NATL CANCER I, V35, P355; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kinghorn AD, 2011, J NAT PROD, V74, P1539, DOI 10.1021/np200391c; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; LopezMeyer M, 1997, PLANT J, V11, P1167, DOI 10.1046/j.1365-313X.1997.11061167.x; Lorence A, 2004, PHYTOCHEMISTRY, V65, P2735, DOI 10.1016/j.phytochem.2004.09.001; Mccoy E, 2006, J AM CHEM SOC, V128, P14276, DOI 10.1021/ja066787w; MCFARLANE J, 1975, BIOCHEM BIOPH RES CO, V66, P1263, DOI 10.1016/0006-291X(75)90495-7; MEEHAN TD, 1973, BIOCHEM BIOPH RES CO, V53, P1043, DOI 10.1016/0006-291X(73)90570-6; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; R Core Team, 2021, R LANG ENV STAT COMP; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shamon SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007655.pub2; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szabo LF, 2008, MOLECULES, V13, P1875, DOI 10.3390/molecules13081875; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vazquez-Flota FA, 1998, PHYTOCHEMISTRY, V49, P395, DOI 10.1016/S0031-9422(98)00176-9; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	107	109	3	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52506	10.1371/journal.pone.0052506	http://dx.doi.org/10.1371/journal.pone.0052506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300689	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800096
J	Hill, DL; Eriksson, EM; Carmagnac, AB; Wilson, DW; Cowman, AF; Hansen, DS; Schofield, L				Hill, Danika L.; Eriksson, Emily M.; Carmagnac, Amandine B.; Wilson, Danny W.; Cowman, Alan F.; Hansen, Diana S.; Schofield, Louis			Efficient Measurement of Opsonising Antibodies to Plasmodium falciparum Merozoites	PLOS ONE			English	Article							INVASION-INHIBITORY ANTIBODIES; GROWTH IN-VITRO; FC-GAMMA-RII; INFECTED ERYTHROCYTES; SURFACE PROTEIN-1; PARASITE GROWTH; IMMUNE-RESPONSES; MALARIAL PIGMENT; BLOOD MONOCYTES; FLOW-CYTOMETRY	Background: Antibodies targeting merozoites are important in protection from malaria. Therefore, merozoite surface proteins are attractive vaccine candidates. There is a need for robust functional assays to investigate mechanisms of acquired immunity and vaccine efficacy. To date, the study of merozoite phagocytosis has been confounded by the complexity and variability of in vitro assays. Methodology/Principal findings: We have developed a new flow cytometry-based merozoite phagocytosis assay. An optimized merozoite preparation technique produced high yields of merozoites separated from haemozoin. Phagocytosis by the undifferentiated THP-1 monocytic cell line was mediated only by Fc Receptors, and was therefore ideal for studying opsonising antibody responses. The assay showed robust phagocytosis with highly diluted immune sera and strong inter-assay correlation. The assay effectively measured differences in opsonisation-dependent phagocytosis among individuals. Conclusions/Significance: This highly reproducible assay has potential applications in assessing the role of opsonic phagocytosis in naturally acquired immunity and vaccine trials.	[Hill, Danika L.; Eriksson, Emily M.; Carmagnac, Amandine B.; Wilson, Danny W.; Cowman, Alan F.; Hansen, Diana S.; Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Hill, Danika L.; Eriksson, Emily M.; Wilson, Danny W.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Schofield, L (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	schofield@wehi.edu.au	Cowman, Alan F/C-7642-2013; Wilson, Danny W/E-6186-2019; Hill, Danika/ADA-4249-2022	Cowman, Alan F/0000-0001-5145-9004; Wilson, Danny W/0000-0002-5073-1405; Hill, Danika/0000-0001-6284-7061; Eriksson, Emily/0000-0002-7851-973X	Australian National Health and Medical Research Council [1031212]; United States National Institutes of Health [AI089686]; NHMRC [APP1035715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. This work was supported by Australian National Health and Medical Research Council grant 1031212 and United States National Institutes of Health AI089686. AFC and LS are fellows of the NHMRC. DWW is supported by a Peter Doherty Australian Biomedical Fellowship from the NHMRC (APP1035715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Ataide R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022491; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Bang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028165; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; CALLE JMC, 1992, J IMMUNOL, V149, P2695; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Healey G, 2007, J IMMUNOL METHODS, V322, P50, DOI 10.1016/j.jim.2007.01.024; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; KHUSMITH S, 1983, B SOC PATHOL EXOT, V76, P137; KHUSMITH S, 1983, PARASITE IMMUNOL, V5, P357, DOI 10.1111/j.1365-3024.1983.tb00751.x; KHUSMITH S, 1982, INFECT IMMUN, V35, P874, DOI 10.1128/IAI.35.3.874-879.1982; Kumaratilake LM, 2000, CLIN DIAGN LAB IMMUN, V7, P9, DOI 10.1128/CDLI.7.1.9-13.2000; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MENDIS KN, 1990, INT J PARASITOL, V20, P497, DOI 10.1016/0020-7519(90)90197-U; Millington OR, 2006, J BIOL-LONDON, V5, P5; Mlambo G, 2007, EXP PARASITOL, V115, P211, DOI 10.1016/j.exppara.2006.08.003; Mosiman VL, 1997, CYTOMETRY, V30, P151; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Nuutila J, 2005, CYTOM PART A, V65A, P93, DOI 10.1002/cyto.a.20139; OEUVRAY C, 1994, BLOOD, V84, P1594; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rono J, 2012, INFECT IMMUN, V80, P1900, DOI 10.1128/IAI.06190-11; RZEPCZYK CM, 1988, INT J PARASITOL, V18, P401, DOI 10.1016/0020-7519(88)90151-8; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schofield L, 1996, IMMUNOL CELL BIOL, V74, P555, DOI 10.1038/icb.1996.89; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Strom TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026657; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	67	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51692	10.1371/journal.pone.0051692	http://dx.doi.org/10.1371/journal.pone.0051692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300556	Green Published, Green Accepted, gold			2022-12-25	WOS:000313618800022
J	Ni, ZH; Tao, K; Chen, G; Chen, QG; Tang, JM; Luo, XM; Yin, PH; Tang, JH; Wang, XBA				Ni, Zhenhua; Tao, Kun; Chen, Guo; Chen, Qingge; Tang, Jianmin; Luo, Xuming; Yin, Peihao; Tang, Jihong; Wang, Xiongbiao			CLPTM1L Is Overexpressed in Lung Cancer and Associated with Apoptosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TERT-CLPTM1L LOCUS; SUSCEPTIBILITY; VARIANTS; EXPRESSION; CELLS; GENE	CLPTM1L is believed to be associated with lung cancer. However, there is little information regarding its expression and function. Here using immunohistochemistry, we found that CLPTM1L expression was markedly increased in lung cancer tissues relative to normal tissues, especially in lung adenocarcinoma. CLPTM1L expression was not found to be associated with stages, smoking status, lymph node metastasis, or T lymphocyte infiltration but with differentiation stage. We found CLPTM1L to be enriched in the mitochondrial compared with plasma membrane protein extracts. CLPTM1L-EGFP transfection showed that the molecule product was expressed in cytoplasm and indicated the mitochondrial localization stained with mitochondrial marker MitoTracker. CLPTM1L transferred lung cancer cell line 95-D showed no growth inhibition or cell apoptosis, but it did show inhibited sensitivity to cis-diamminedichloroplatinum(II) (cisplatin, CDDP). Knockdown of CLPTM1L by RNAi did not interfere with cell proliferation but it did increase cell sensitivity to CDDP and activation of caspase-9 and caspase-3/7. These data indicate CLPTM1L is a mitochondria protein and that it may be associated with anti-apoptotic mechanism which affects drug-resistance in turn.	[Ni, Zhenhua; Chen, Guo; Chen, Qingge; Tang, Jianmin; Luo, Xuming; Yin, Peihao; Tang, Jihong; Wang, Xiongbiao] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China; [Tao, Kun] Shanghai Changning Cent Hosp, Dept Pathol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, XBA (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China.	xiongbiao6@yahoo.com			Shanghai Science and Technology Committee [09JC1412900, 10411969100]; Shanghai Educational Committee [10YZ54]; Shanghai Putuo District Science and Technology Committee; Innovation Program of Shanghai Municipal Education commission [13ZZ096]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Educational Committee; Shanghai Putuo District Science and Technology Committee; Innovation Program of Shanghai Municipal Education commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the Shanghai Science and Technology Committee (No. 09JC1412900, No. 10411969100), the Shanghai Educational Committee (No. 10YZ54), the Shanghai Putuo District Science and Technology Committee (2010), and the Innovation Program of Shanghai Municipal Education commission (13ZZ096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2005, ONCOL REP, V14, P601; Batra J, 2011, AM J EPIDEMIOL, V174, P1391, DOI 10.1093/aje/kwr271; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kratz CP, 2011, J MED GENET, V48, P473, DOI 10.1136/jmedgenet-2011-100001; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Ribatti D, 2011, ADV EXP MED BIOL, V716, P270, DOI 10.1007/978-1-4419-9533-9_14; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Wang SM, 2012, MOL CARCINOGEN, V51, pE118, DOI 10.1002/mc.21872; Wauters E, 2011, EUR RESPIR J, V38, P924, DOI 10.1183/09031936.00187110; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	25	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52598	10.1371/journal.pone.0052598	http://dx.doi.org/10.1371/journal.pone.0052598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300716	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800109
J	Wachstein, J; Tischer, S; Figueiredo, C; Limbourg, A; Falk, C; Immenschuh, S; Blasczyk, R; Eiz-Vesper, B				Wachstein, Julian; Tischer, Sabine; Figueiredo, Constanca; Limbourg, Anne; Falk, Christine; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta			HSP70 Enhances Immunosuppressive Function of CD4(+)CD25(+)FoxP3(+) T Regulatory Cells and Cytotoxicity in CD4(+)CD25(-) T Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IMMUNOLOGICAL-TOLERANCE; MEDIATED SUPPRESSION; MOLECULAR CHAPERONES; ADAPTIVE IMMUNITY; PERIPHERAL-BLOOD; GRANZYME-B; IN-VIVO; ACTIVATION; INNATE	Human CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs) control effector T cells and play a central role in peripheral tolerance and immune homeostasis. Heat shock protein 70 (HSP70) is a major immunomodulatory molecule, but its effect on the functions of Tregs is not well understood. To investigate target-dependent and -independent Treg functions, we studied cytokine expression, regulation of proliferation and cytotoxicity after exposure of Tregs to HSP70. HSP70-treated Tregs significantly inhibited proliferation of CD4(+)CD25(-) target cells and downregulated the secretion of the proinflammatory cytokines IFN-gamma and TNF-alpha. By contrast, HSP70 increased the secretion of Treg suppressor cytokines IL-10 and TGF-beta. Treatment with HSP70 enhanced the cytotoxic properties of Tregs only to a minor extent (4-fold), but led to stronger responses in CD4(+)CD25(-) cells (42-fold). HSP70-induced modulation of T-cell responses was further enhanced by combined treatment with HSP70 plus IL-2. Treatment of Tregs with HSP70 led to phosphorylation of PI3K/AKT and the MAPKs JNK and p38, but not that of ERK1/2. Exposure of Tregs to specific inhibitors of PI3K/AKT and the MAPKs JNK and p38 reduced the immunosuppressive function of HSP70-treated Tregs as indicated by the modified secretion of specific target cell (IFN-gamma, TNF-alpha) and suppressor cytokines (IL-10, TGF-beta). Taken together, the data show that HSP70 enhances the suppressive capacity of Tregs to neutralize target immune cells. Thus HSP70-enhanced suppression of Tregs may prevent exaggerated immune responses and may play a major role in maintaining immune homeostasis.	[Wachstein, Julian; Tischer, Sabine; Figueiredo, Constanca; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Figueiredo, Constanca; Limbourg, Anne; Falk, Christine; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Integrated Res & Treatment Ctr IFB Tx, Hannover, Germany; [Limbourg, Anne] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Falk, Christine] Hannover Med Sch, Inst Transplant Immunol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Eiz-Vesper, B (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	eiz-vesper.britta@mh-hannover.de	Falk, Christine/Q-4143-2016; Immenschuh, Stephan/AAM-9181-2020	Falk, Christine/0000-0003-1376-7318; Immenschuh, Stephan/0000-0003-3722-5791; Blasczyk, Rainer/0000-0003-3875-3190	German Federal Ministry of Education and Research [01EO0802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported in part by the German Federal Ministry of Education and Research (reference number: 01EO0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bajor A, 2011, CLIN EXP IMMUNOL; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Borges TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014264; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chen TY, 2010, EUR J IMMUNOL, V40, P1541, DOI 10.1002/eji.201040616; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dai J, 2009, INT IMMUNOPHARMACOL, V9, P528, DOI 10.1016/j.intimp.2009.01.027; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; GERDES J, 1984, J IMMUNOL, V133, P1710; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Mahajan Supriya D., 2003, Biological Procedures Online, V5, P182, DOI 10.1251/bpo60; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nikolova M, 2009, BLOOD, V113, P4556, DOI 10.1182/blood-2008-04-151407; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schorr N, 2011, HANDCHIR MIKROCHIR P, V43, P325, DOI 10.1055/s-0030-1267966; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	59	60	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51747	10.1371/journal.pone.0051747	http://dx.doi.org/10.1371/journal.pone.0051747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300563	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800027
J	You, YY; Gupta, VK; Graham, SL; Klistorner, A				You, Yuyi; Gupta, Vivek K.; Graham, Stuart L.; Klistorner, Alexander			Anterograde Degeneration along the Visual Pathway after Optic Nerve Injury	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; TRANSNEURONAL RETROGRADE DEGENERATION; LATERAL GENICULATE-NUCLEUS; TRANSSYNAPTIC DEGENERATION; SIGNALING PATHWAYS; DISEASE PATHOLOGY; INSULIN-RECEPTOR; BRAIN-DAMAGE; NEURONS; MODEL	Purpose: To investigate anterograde degenerative changes along the visual pathway in a rat model of optic nerve axotomy. Methods: Optic nerve transection was performed in adult Sprague-Dawley rats. Animals were sacrificed at regular time intervals and tissues harvested. Immunoblotting followed by densitometric analysis was used to determine the phosphorylation profile of Akt in the dorsal lateral geniculate nucleus (dLGN) and the primary visual cortex (V1). The neuronal cell size and cell density were measured in the dLGN and the V1 using Nissl staining. The prevalence of apoptosis was characterized by terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labelling (TUNEL) histochemistry. Caspase-3 antibodies were also used to identify apoptotic cells. Neurons and astrocytes were detected using NeuN and glial fibrillary acidic protein (GFAP), respectively. Results: An early and sustained loss of Akt phosphorylation was observed after optic nerve transection in both dLGN and V1. At week one, a decrease in the neuronal cell size (50.5 +/- 4.9 vs 60.3 +/- 5.0 mu m(2), P = 0.042) and an increase of TUNEL positive cells (7.9 +/- 0.6 vs 1.4 +/- 0.56 x 10(2) cells/mm(2), P<0.001) were evident in the dLGN but not in V1. A significant decline in neuronal cell number (14.5 +/- 0.1 vs 17.4 +/- 1.3 x 10(2) cells/mm(2), P = 0.048), cell size (42.5 +/- 4.3 vs 62.1 +/- 4.7 mu m(2), P = 0.001) and an increase in apoptotic cells (5.6 +/- 0.5 vs 2.0 +/- 0.4 x 10(2) cells/mm(2), P<0.001) appeared in V1 initially at one month post-transection. The changes in the visual pathway continued through two months. Both neuronal cells and GFAP-positive glial cells were affected in this anterograde degeneration along the visual pathway. Conclusions: Anterograde degeneration along the visual pathway takes place in target relay (LGN) and visual cortex following the optic nerve injury. Apoptosis was observed in both neural and adjacent glial cells. Reduction of Akt phosphorylation preceded cellular and apoptotic changes.	[You, Yuyi; Gupta, Vivek K.; Graham, Stuart L.; Klistorner, Alexander] Macquarie Univ, Australian Sch Adv Med, Dept Ophthalmol, Sydney, NSW 2109, Australia; [Graham, Stuart L.; Klistorner, Alexander] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia	Macquarie University; University of Sydney	Gupta, VK (corresponding author), Macquarie Univ, Australian Sch Adv Med, Dept Ophthalmol, Sydney, NSW 2109, Australia.	vivek.gupta@mq.edu.au	Gupta, Vivek Kumar/AAB-8940-2022	Klistorner, Alexander/0000-0003-0361-6399; , Yuyi/0000-0002-0175-3018; Gupta, Vivek/0000-0002-0202-7843; Graham, Stuart/0000-0001-7519-969X	Ophthalmic Research Institute Australia (ORIA); National Multiple Sclerosis Society (NMSS); Multiple Sclerosis Research Australia (MSRA Incubator Grant) [10-057]; Macquarie University New Staff (MQNS) Grant; Sydney Foundation for Medical Research; Allergan Australia; Novartis Pharmaceuticals Australia	Ophthalmic Research Institute Australia (ORIA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Multiple Sclerosis Research Australia (MSRA Incubator Grant); Macquarie University New Staff (MQNS) Grant; Sydney Foundation for Medical Research; Allergan Australia(AbbVieAllergan); Novartis Pharmaceuticals Australia	Supported by Ophthalmic Research Institute Australia (ORIA), National Multiple Sclerosis Society (NMSS), Multiple Sclerosis Research Australia (MSRA Incubator Grant, 10-057), and Macquarie University New Staff (MQNS) Grant. AK was supported by the Sydney Foundation for Medical Research. VG was supported by an educational grant from Allergan Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by research funding from Allergan Australia and Novartis Pharmaceuticals Australia (competing interests: Allergan Australia, Novartis Pharmaceuticals Australia). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Bridge H, 2011, INVEST OPHTH VIS SCI, V52, P382, DOI 10.1167/iovs.10-5708; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Canudas AM, 2005, MOL BRAIN RES, V134, P147, DOI 10.1016/j.molbrainres.2004.11.012; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Conti AC, 1998, J NEUROSCI, V18, P5663; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; EIDELBERG E, 1989, BRAIN RES BULL, V22, P39, DOI 10.1016/0361-9230(89)90125-1; Flammer J, 2007, SURV OPHTHALMOL, V52, pS162, DOI 10.1016/j.survophthal.2007.08.012; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; GOBEL S, 1984, J NEUROSCI, V4, P2281; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104; Gupta VK, 2012, BBA-MOL BASIS DIS, V1822, P1643, DOI 10.1016/j.bbadis.2012.07.016; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; HASELTINE EC, 1979, BRAIN RES, V176, P153, DOI 10.1016/0006-8993(79)90878-3; Ito Y, 2010, CNS NEUROSCI THER, V16, pe169, DOI 10.1111/j.1755-5949.2010.00176.x; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Lam DY, 2003, INVEST OPHTH VIS SCI, V44, P2573, DOI 10.1167/iovs.02-0779; Lau C, 2011, NEUROIMAGE, V58, P878, DOI 10.1016/j.neuroimage.2011.06.055; Leamey CA, 2008, EYE RETINA VISUAL SY, P35; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Ly T, 2011, VISION RES, V51, P243, DOI 10.1016/j.visres.2010.08.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramu J, 2008, EXP NEUROL, V212, P100, DOI 10.1016/j.expneurol.2008.03.018; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Su JH, 1997, NEUROBIOL DIS, V4, P365, DOI 10.1006/nbdi.1997.0164; Theoret H, 1997, BRAIN RES, V775, P203, DOI 10.1016/S0006-8993(97)00949-9; Vickers JC, 1997, AUST NZ J OPHTHALMOL, V25, P239, DOI 10.1111/j.1442-9071.1997.tb01400.x; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	49	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52061	10.1371/journal.pone.0052061	http://dx.doi.org/10.1371/journal.pone.0052061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300590	Green Published, Green Submitted			2022-12-25	WOS:000313618800044
J	Ramos-Moreno, T; Lendinez, JG; Pino-Barrio, MJ; del Arco, A; Martinez-Serrano, A				Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; del Arco, Araceli; Martinez-Serrano, Alberto			Clonal Human Fetal Ventral Mesencephalic Dopaminergic Neuron Precursors for Cell Therapy Research	PLOS ONE			English	Article							STEM-CELLS; PARKINSONS-DISEASE; LONG-TERM; IN-VITRO; PROGENITOR CELLS; RAT MODEL; TRANSPLANTATION; GENERATION; DIFFERENTIATE; BEHAVIOR	A major challenge for further development of drug screening procedures, cell replacement therapies and developmental studies is the identification of expandable human stem cells able to generate the cell types needed. We have previously reported the generation of an immortalized polyclonal neural stem cell (NSC) line derived from the human fetal ventral mesencephalon (hVM1). This line has been biochemically, genetically, immunocytochemically and electrophysiologically characterized to document its usefulness as a model system for the generation of A9 dopaminergic neurons (DAn). Long-term in vivo transplantation studies in parkinsonian rats showed that the grafts do not mature evenly. We reasoned that diverse clones in the hVM1 line might have different abilities to differentiate. In the present study, we have analyzed 9 hVM1 clones selected on the basis of their TH generation potential and, based on the number of v-myc copies, v-myc down-regulation after in vitro differentiation, in vivo cell cycle exit, TH+ neuron generation and expression of a neuronal mature marker (hNSE), we selected two clones for further in vivo PD cell replacement studies. The conclusion is that homogeneity and clonality of characterized NSCs allow transplantation of cells with controlled properties, which should help in the design of long-term in vivo experiments.	[Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Dept Mol Biol UAM, Madrid, Spain; [Ramos-Moreno, Tania; Lendinez, Javier G.; Jose Pino-Barrio, Maria; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Ctr Mol Biol Severo Ochoa UAM CSIC, Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Fac Ciencias Ambientales & Bioquim, CRIB, Area Bioquim, Toledo, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Castilla-La Mancha	Ramos-Moreno, T (corresponding author), Univ Autonoma Madrid, Dept Mol Biol UAM, Nicolas Cabrera 1,Campus Cantoblanco, Madrid, Spain.	tramos@cbm.uam.es	Martínez-Serrano, Alberto/J-8146-2014; del Arco, Araceli/R-5653-2019	Martinez Serrano, Alberto/0000-0003-3927-6699; del Arco, Araceli/0000-0002-6839-542X; Ramos-Moreno, Tania/0000-0001-5269-6351	Spanish Ministry of Economy and Competitiveness [PLE2009-0101, SAF2010-17167]; Comunidad Autonoma Madrid [S2011-BMD-2336]; Instituto Salud Carlos III (RETICS TerCel) [RD06/0010/0009]; European Union (Excell) [NMP4-SL-2008-214706]; Foundation Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad Autonoma Madrid(Comunidad de Madrid); Instituto Salud Carlos III (RETICS TerCel)(Instituto de Salud Carlos III); European Union (Excell); Foundation Ramon Areces	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (formerly Science and Innovation; PLE2009-0101, SAF2010-17167), Comunidad Autonoma Madrid (S2011-BMD-2336), Instituto Salud Carlos III (RETICS TerCel, RD06/0010/0009) and European Union (Excell, NMP4-SL-2008-214706). This work was also supported by an institutional grant from Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Baizabal JM, 2012, STEM CELLS DEV, V21, P1047, DOI 10.1089/scd.2011.0241; Blakemore C, 2012, NEURON, V75, P948, DOI 10.1016/j.neuron.2012.09.001; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; Cacci E, 2007, EXP CELL RES, V313, P588, DOI 10.1016/j.yexcr.2006.11.001; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Courtois ET, 2010, J BIOL CHEM, V285, P9881, DOI 10.1074/jbc.M109.054312; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gaillard A, 2011, TRENDS NEUROSCI, V34, P124, DOI 10.1016/j.tins.2011.01.003; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hebsgaard JB, 2009, GLIA, V57, P1648, DOI 10.1002/glia.20877; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Lepski G, 2011, MOL CELL NEUROSCI, V47, P36, DOI 10.1016/j.mcn.2011.02.011; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Martinez-Serrano A, 2011, VITAM HORM, V87, P175, DOI 10.1016/B978-0-12-386015-6.00029-9; Martinez-Serrano A, 2010, FUTUR NEUROL, V5, P161, DOI 10.2217/FNL.10.6; Miljan EA, 2009, STEM CELLS DEV, V18, P307, DOI 10.1089/scd.2008.0078; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Politis M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-1; Ramos-Moreno T, 2012, BEHAV BRAIN RES, V232, P225, DOI 10.1016/j.bbr.2012.04.020; Ribeiro D, 2013, NEUROBIOL DIS, V49, P118, DOI 10.1016/j.nbd.2012.08.006; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Sanchez-Pernaute R, 2001, J NEUROSCI RES, V65, P284, DOI 10.1002/jnr.1152; Seiz EG, 2012, EXP CELL RES, V318, P2446, DOI 10.1016/j.yexcr.2012.07.018; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Wakeman DR, 2011, MT SINAI J MED, V78, P126, DOI 10.1002/msj.20233; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yan J, 2001, J NEUROCHEM, V76, P307, DOI 10.1046/j.1471-4159.2001.00073.x	36	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52714	10.1371/journal.pone.0052714	http://dx.doi.org/10.1371/journal.pone.0052714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300748	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600023
J	Sharpe, SC; Koester, JA; Loebl, M; Cockshutt, AM; Campbell, DA; Irwin, AJ; Finkel, ZV				Sharpe, Susan C.; Koester, Julie A.; Loebl, Martina; Cockshutt, Amanda M.; Campbell, Douglas A.; Irwin, Andrew J.; Finkel, Zoe V.			Influence of Cell Size and DNA Content on Growth Rate and Photosystem II Function in Cryptic Species of Ditylum brightwellii	PLOS ONE			English	Article							MARINE DIATOMS; METABOLIC-RATE; GENOME SIZE; SEXUAL REPRODUCTION; LIGHT-ABSORPTION; GENE-EXPRESSION; NUCLEAR VOLUME; LIFE-CYCLE; PHYTOPLANKTON; ALLOMETRY	DNA content and cell volume have both been hypothesized as controls on metabolic rate and other physiological traits. We use cultures of two cryptic species of Ditylum brightwellii (West) Grunow with an approximately two-fold difference in genome size and a small and large culture of each clone obtained by isolating small and large cells to compare the physiological consequences of size changes due to differences in DNA content and reduction in cell size following many generations of asexual reproduction. We quantified the growth rate, the functional absorption cross-section of photosystem II (PSII), susceptibility of PSII to photoinactivation, PSII repair capacity, and PSII reaction center proteins D1 (PsbA) and D2 (PsbD) for each culture at a range of irradiances. The species with the smaller genome has a higher growth rate and, when acclimated to growth-limiting irradiance, has higher PSII repair rate capacity, PSII functional optical absorption cross-section, and PsbA per unit protein, relative to the species with the larger genome. By contrast, cell division rates vary little within clonal cultures of the same species despite significant differences in average cell volume. Given the similarity in cell division rates within species, larger cells within species have a higher demand for biosynthetic reductant. As a consequence, larger cells within species have higher numbers of PSII per unit protein (PsbA), since PSII photochemically generates the reductant to support biosynthesis. These results suggest that DNA content, as opposed to cell volume, has a key role in setting the differences in maximum growth rate across diatom species of different size while PSII content and related photophysiological traits are influenced by both growth rate and cell size.	[Koester, Julie A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Loebl, Martina] Univ Bremen, Ctr Marine Environm Sci MARUM, Bremen Int Grad Sch Marine Sci GLOMAR, D-28359 Bremen, Germany; [Koester, Julie A.; Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada	University of Washington; University of Washington Seattle; University of Bremen; Mount Allison University	Finkel, ZV (corresponding author), Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada.	zfinkel@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe/B-9626-2008	Campbell, Douglas A./0000-0001-8996-5463; Koester, Julie A/0000-0003-2014-0310; Irwin, Andrew/0000-0001-7784-2319; Finkel, Zoe/0000-0003-4212-3917	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery; Undergraduate Student Research Awards (Canada) (USRA) program; MtA's RTM Allan Summer Research Fellowship; NBIF; IRAP; CFI	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Undergraduate Student Research Awards (Canada) (USRA) program; MtA's RTM Allan Summer Research Fellowship; NBIF; IRAP; CFI(Canada Foundation for Innovation)	Funding was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (ZF, DC, AI) and Undergraduate Student Research Awards (Canada) (USRA) program (SC), MtA's RTM Allan Summer Research Fellowship (SC), NBIF (ZF), IRAP (ZF, AC), and CFI (ZF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUSTI S, 1991, CAN J FISH AQUAT SCI, V48, P763, DOI 10.1139/f91-091; Agutter PS, 2011, J EXP BIOL, V214, P1055, DOI 10.1242/jeb.054502; Amato A, 2005, J PHYCOL, V41, P542, DOI 10.1111/j.1529-8817.2005.00080.x; Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; BANSE K, 1976, J PHYCOL, V12, P135; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; Brown J. H., 1995, MACROECOLOGY; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Connolly JA, 2008, J PHYCOL, V44, P124, DOI 10.1111/j.1529-8817.2007.00452.x; COSTELLO J C, 1981, Journal of Plankton Research, V3, P415, DOI 10.1093/plankt/3.3.415; Cyr H, 2004, ECOLOGY, V85, P1802, DOI 10.1890/03-0695; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DUYSENS LNM, 1956, BIOCHIM BIOPHYS ACTA, V19, P1; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Finkel ZV, 2004, MAR ECOL PROG SER, V273, P269, DOI 10.3354/meps273269; Francis D, 2008, ANN BOT-LONDON, V101, P747, DOI 10.1093/aob/mcn038; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Glazier DS, 2008, P ROY SOC B-BIOL SCI, V275, P1405, DOI 10.1098/rspb.2008.0118; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRIS M, 1971, EXP CELL RES, V66, P329, DOI 10.1016/0014-4827(71)90685-9; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; HEMMINGSEN AM, 1960, REP STENO MEM HOSP, V9, P15; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; KARENTZ D, 1991, J PHYCOL, V27, P326, DOI 10.1111/j.0022-3646.1991.00326.x; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; KIDD AD, 1992, GENOME, V35, P126, DOI 10.1139/g92-021; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KOCIOLEK J P, 1989, Diatom Research, V4, P47; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; LAWS EA, 1975, ECOLOGY, V56, P419, DOI 10.2307/1934972; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 2002, MAR ECOL PROG SER, V242, P95, DOI 10.3354/meps242095; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; MacDonald JD, 1869, MAG NAT HIST, V4, P1; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Mei ZP, 2011, MAR ECOL PROG SER, V434, P29, DOI 10.3354/meps09149; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mulo P, 2003, FUNCT PLANT BIOL, V30, P1097, DOI 10.1071/FP03149; Nurse P., 1985, P185; Paasche E, 1973, NORW J BOT, V20, P151; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Pfitzer E, 1869, SITZUNGSBER NIEDERRH, V26, P86; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Raven JA, 2005, VIE MILIEU, V55, P209; RAVEN JA, 1991, J PHOTOCH PHOTOBIO B, V9, P239, DOI 10.1016/1011-1344(91)80158-E; Rynearson TA, 2000, LIMNOL OCEANOGR, V45, P1329, DOI 10.4319/lo.2000.45.6.1329; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; SCHLESINGER DA, 1981, CAN J FISH AQUAT SCI, V38, P1052, DOI 10.1139/f81-145; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TAGUCHI S, 1976, J PHYCOL, V12, P185, DOI 10.1111/j.1529-8817.1976.tb00499.x; TANG EPY, 1995, J PLANKTON RES, V17, P303, DOI 10.1093/plankt/17.2.303; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Ukeles R., 1973, HDB PHYCOLOGICAL MET, P233; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; von Dassow P, 2008, J PHYCOL, V44, P335, DOI 10.1111/j.1529-8817.2008.00476.x; von Stosch HA, 1964, HELGOL WISS MEERESUN, V11, P1; WERNER D, 1971, ARCH MIKROBIOL, V80, P115, DOI 10.1007/BF00411877; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; White CR, 2010, NATURE, V464, P691, DOI 10.1038/464691a; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772	85	10	10	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52916	10.1371/journal.pone.0052916	http://dx.doi.org/10.1371/journal.pone.0052916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300819	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600037
J	Wang, Q; Huang, JS; Ma, KS; Li, TJ; Chen, M; Wang, SG; Bie, P; He, ZP				Wang, Qi; Huang, Jiansheng; Ma, Kuansheng; Li, Tingjun; Chen, Ming; Wang, Shugang; Bie, Ping; He, Zhenping			Evaluation of Ghost Cell Survival in the Area of Radiofrequency Ablation	PLOS ONE			English	Article							RADIO-FREQUENCY ABLATION; HEPATIC-TUMORS; HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; IN-VIVO; DESTRUCTION; EXPERIENCE	Background and Aim: Researchers have demonstrated dead cells in radiofrequency ablation (RFA) lesions that have morphological similarities to viable tumor cells and are thus referred to as ghost cells. However, studies on how long ghost cells persist have not been systematically performed. Methods: A tumor model was established by implanting VX2 tumor tissue into the livers of 48 New Zealand rabbits. Two weeks later, these tumors were eliminated with RFA. The lesions were resected at 0 weeks, 1 week, 2 weeks, 4 weeks, 8 weeks, or 12 weeks after treatment, and samples were stained either with hematoxylin and eosin (HE) or nicotinamide adenine dinucleotide (NADH). The presence of the cells and the morphological changes that they underwent were examined by light microscopy. Results: Four weeks after RFA, there were no obvious morphological changes observed in HE-stained ghost cells, and NADH staining revealed no viable cells. Eight weeks after RFA, the cell structure became indistinct. Twelve weeks after RFA, ghost cells were no longer present. Conclusions: The morphological characteristics of ghost cells are maintained for at least 4 weeks, during which time HE staining cannot be used to differentiate ghost cells from residual tumor cells. NADH staining for cell viability is necessary to differentiate residual tumor cells from ghost cells. This evidence adds to our understanding of the mechanisms of RFA when used on solid tumors.	[Wang, Qi; Huang, Jiansheng; Ma, Kuansheng; Li, Tingjun; Chen, Ming; Wang, Shugang; Bie, Ping; He, Zhenping] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Ma, KS (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China.	makuansheng@vip.sina.com			Natural Science Foundation from Chongqing City in China (CSTC) [2008BB5028]	Natural Science Foundation from Chongqing City in China (CSTC)	This study was supported by a grant from the Natural Science Foundation from Chongqing City in China (CSTC, 2008BB5028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 1984, CANCER, V53, P1397; Dobbins C, 2008, J SURG RES, V148, P251, DOI 10.1016/j.jss.2007.09.008; Glantzounis GK, 2004, BRIT J SURG, V91, P1330, DOI 10.1002/bjs.4694; Gnant MFX, 1999, SURGERY, V126, P890, DOI 10.1067/msy.2099.100668; Hennings L, 2009, INT J HYPERTHER, V25, P355, DOI 10.1080/02656730902964357; Isbert C, 2001, SURG ENDOSC, V15, P1320, DOI 10.1007/s00464-001-0006-6; Kim SK, 2004, KOREAN J RADIOL, V5, P240, DOI 10.3348/kjr.2004.5.4.240; Kotoh K, 2005, LIVER INT, V25, P1217, DOI 10.1111/j.1478-3231.2005.01167.x; Llovet JM, 2001, HEPATOLOGY, V33, P1124, DOI 10.1053/jhep.2001.24233; Mazzaglia PJ, 2007, SURGERY, V142, P10, DOI 10.1016/j.surg.2007.01.036; Miao Y, 2000, EUR RADIOL, V10, P188, DOI 10.1007/s003300050031; Mostafa EM, 2008, J VASC INTERV RADIOL, V19, P1740, DOI 10.1016/j.jvir.2008.08.028; Mutsaerts ELAR, 2003, EUR J SURG ONCOL, V29, P731, DOI 10.1016/S0748-7983(03)00146-X; Ng KK, 2006, BRIT J SURG, V93, P440, DOI 10.1002/bjs.5267; Nikfarjam M, 2005, J SURG RES, V127, P208, DOI 10.1016/j.jss.2005.02.009; Raman JD, 2008, J UROLOGY, V179, P2142, DOI 10.1016/j.juro.2008.01.119; Rhim H, 2008, J GASTROEN HEPATOL, V23, P1492, DOI 10.1111/j.1440-1746.2008.05550.x; Sato K, 2008, J GASTROEN HEPATOL, V23, P1105, DOI 10.1111/j.1440-1746.2008.05328.x; Shen P, 2007, J GASTROINTEST SURG, V11, P603, DOI 10.1007/s11605-006-0046-2; Ypsilantis P, 2008, J SURG RES, V150, P60, DOI 10.1016/j.jss.2007.09.019	20	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53158	10.1371/journal.pone.0053158	http://dx.doi.org/10.1371/journal.pone.0053158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300883	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600065
J	Bodelon, C; Pfeiffer, RM; Bollati, V; Debbache, J; Calista, D; Ghiorzo, P; Fargnoli, MC; Bianchi-Scarra, G; Peris, K; Hoxha, M; Hutchinson, A; Burdette, L; Burke, L; Fang, SY; Tucker, MA; Goldstein, AM; Lee, JE; Wei, QY; Savage, SA; Yang, XHR; Amos, C; Landi, MT				Bodelon, Clara; Pfeiffer, Ruth M.; Bollati, Valentina; Debbache, Julien; Calista, Donato; Ghiorzo, Paola; Fargnoli, Maria Concetta; Bianchi-Scarra, Giovanna; Peris, Ketty; Hoxha, Mirjam; Hutchinson, Amy; Burdette, Laurie; Burke, Laura; Fang, Shenying; Tucker, Margaret A.; Goldstein, Alisa M.; Lee, Jeffrey E.; Wei, Qingyi; Savage, Sharon A.; Yang, Xiaohong R.; Amos, Christopher; Landi, Maria Teresa			On the Interplay of Telomeres, Nevi and the Risk of Melanoma	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; GENOME-WIDE ASSOCIATION; MEDITERRANEAN POPULATION; FAMILIAL MELANOMA; DYSPLASTIC NEVUS; DNA-REPAIR; SUSCEPTIBILITY; MC1R; VARIANTS; DISEASE	The relationship between telomeres, nevi and melanoma is complex. Shorter telomeres have been found to be associated with many cancers and with number of nevi, a known risk factor for melanoma. However, shorter telomeres have also been found to decrease melanoma risk. We performed a systematic analysis of telomere-related genes and tagSNPs within these genes, in relation to the risk of melanoma, dysplastic nevi, and nevus count combining data from four studies conducted in Italy. In addition, we examined whether telomere length measured in peripheral blood leukocytes is related to the risk of melanoma, dysplastic nevi, number of nevi, or telomere-related SNPs. A total of 796 cases and 770 controls were genotyped for 517 SNPs in 39 telomere-related genes genotyped with a custom-made array. Replication of the top SNPs was conducted in two American populations consisting of 488 subjects from 53 melanoma-prone families and 1,086 cases and 1,024 controls from a case-control study. We estimated odds ratios for associations with SNPs and combined SNP P-values to compute gene region-specific, functional group-specific, and overall P-value using an adaptive rank-truncated product algorithm. In the Mediterranean population, we found suggestive evidence that RECQL4, a gene involved in genome stability, RTEL1, a gene regulating telomere elongation, and TERF2, a gene implicated in the protection of telomeres, were associated with melanoma, the presence of dysplastic nevi and number of nevi, respectively. However, these associations were not found in the American samples, suggesting variable melanoma susceptibility for these genes across populations or chance findings in our discovery sample. Larger studies across different populations are necessary to clarify these associations.	[Bodelon, Clara; Pfeiffer, Ruth M.; Debbache, Julien; Hutchinson, Amy; Burdette, Laurie; Burke, Laura; Tucker, Margaret A.; Goldstein, Alisa M.; Savage, Sharon A.; Yang, Xiaohong R.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bollati, Valentina; Hoxha, Mirjam] Univ Milan, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Bollati, Valentina; Hoxha, Mirjam] IRCCS Osped Maggiore Policlin, Fdn Ca Granda, Milan, Italy; [Debbache, Julien] Univ Zurich, Div Cell & Dev Biol, Zurich, Switzerland; [Calista, Donato] Osped Gen Provinciale M Bufalini, Dept Dermatol, Cesena, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] IRCCS AOU San Martino IST, Lab Genet Rare Hereditary Canc, Genoa, Italy; [Fargnoli, Maria Concetta; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy; [Fang, Shenying; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Amos, Christopher] Dartmouth Coll, Ctr Genom Med, Dept Community & Family Med, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Zurich; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of L'Aquila; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Landi, MT (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Scarrà, Giovanna Bianchi/G-8933-2014; Savage, Sharon/AAB-5160-2019; Ghiorzo, Paola/CAG-0673-2022; Tucker, Margaret A/B-4297-2015; Calista, Donato/AAM-1567-2020; Savage, Sharon A/B-9747-2015	Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Savage, Sharon/0000-0001-6006-0740; Ghiorzo, Paola/0000-0002-3651-8173; Savage, Sharon A/0000-0001-6006-0740; Bollati, Valentina/0000-0002-0370-9598; Fargnoli, Maria Concetta/0000-0002-7249-2556; Fang, Shenying/0000-0002-0604-793X; Peris, Ketty/0000-0002-5237-0463	United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH [CA 5558 - 01A2, 2P50CA093459]; Marit Peterson Fund for Melanoma Research; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marit Peterson Fund for Melanoma Research; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of United States National Institutes of Health (NIH), National Cancer Institute, Division of Cancer Epidemiology and Genetics and by the RO1 Grant (CA 5558 - 01A2) from the NIH to M. T. Landi. The MD Anderson Cancer Center study was supported by the NIH grant 2P50CA093459 (SF, JEL, QW, CA), and the Marit Peterson Fund for Melanoma Research (SF, JEL). Telomere length quantification was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) (MFAG 10361) To V. Bollati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Fargnoli MC, 2006, J NATL CANCER I, V98, P144, DOI 10.1093/jnci/djj025; Ghiorzo P, 2012, EXPT DERMAT IN PRESS; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Landi MT, 2001, BRIT J CANCER, V85, P1304, DOI 10.1054/bjoc.2001.2029; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Mirabello L, 2011, INT J MOL EPIDEMIOL, V2, P19; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Simon T, 2010, AM J MED GENET A, V152A, P1575, DOI 10.1002/ajmg.a.33427; Tucker MA, 2002, CANCER, V94, P3192, DOI 10.1002/cncr.10605; Tucker MA, 2003, ONCOGENE, V22, P3042, DOI 10.1038/sj.onc.1206444; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Wheeler W., 2011, INT J CANC; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	30	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52466	10.1371/journal.pone.0052466	http://dx.doi.org/10.1371/journal.pone.0052466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300679	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100052
J	Epperlein, HH; Khattak, S; Knapp, D; Tanaka, EM; Malashichev, YB				Epperlein, Hans-Henning; Khattak, Shahryar; Knapp, Dunja; Tanaka, Elly M.; Malashichev, Yegor B.			Neural Crest Does Not Contribute to the Neck and Shoulder in the Axolotl (Ambystoma mexicanum)	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CELL-MIGRATION; PLASTRON BONES; AVIAN SCAPULA; DUAL ORIGIN; EVOLUTION; REGENERATION; POPULATION; HOMOLOGIES; GIRDLE	Background: A major step during the evolution of tetrapods was their transition from water to land. This process involved the reduction or complete loss of the dermal bones that made up connections to the skull and a concomitant enlargement of the endochondral shoulder girdle. In the mouse the latter is derived from three separate embryonic sources: lateral plate mesoderm, somites, and neural crest. The neural crest was suggested to sustain the muscle attachments. How this complex composition of the endochondral shoulder girdle arose during evolution and whether it is shared by all tetrapods is unknown. Salamanders that lack dermal bone within their shoulder girdle were of special interest for a possible contribution of the neural crest to the endochondral elements and muscle attachment sites, and we therefore studied them in this context. Results: We grafted neural crest from GFP+ fluorescent transgenic axolotl (Ambystoma mexicanum) donor embryos into white (d/d) axolotl hosts and followed the presence of neural crest cells within the cartilage of the shoulder girdle and the connective tissue of muscle attachment sites of the neck-shoulder region. Strikingly, neural crest cells did not contribute to any part of the endochondral shoulder girdle or to the connective tissue at muscle attachment sites in axolotl. Conclusions: Our results in axolotl suggest that neural crest does not serve a general function in vertebrate shoulder muscle attachment sites as predicted by the "muscle scaffold theory," and that it is not necessary to maintain connectivity of the endochondral shoulder girdle to the skull. Our data support the possibility that the contribution of the neural crest to the endochondral shoulder girdle, which is observed in the mouse, arose de novo in mammals as a developmental basis for their skeletal synapomorphies. This further supports the hypothesis of an increased neural crest diversification during vertebrate evolution.	[Malashichev, Yegor B.] St Petersburg State Univ, Dept Embryol, Fac Biol & Soil Sci, St Petersburg, Russia; [Malashichev, Yegor B.] St Petersburg State Univ, Dept Vertebrate Zool, Fac Biol & Soil Sci, St Petersburg, Russia; [Epperlein, Hans-Henning; Khattak, Shahryar; Knapp, Dunja; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, Dresden, Germany; [Epperlein, Hans-Henning] Tech Univ Dresden, Dept Anat, Dresden, Germany	Saint Petersburg State University; Saint Petersburg State University; Technische Universitat Dresden; Technische Universitat Dresden	Malashichev, YB (corresponding author), St Petersburg State Univ, Dept Embryol, Fac Biol & Soil Sci, St Petersburg, Russia.	malashichev@embryo.pu.ru	Malashichev, Yegor/D-3511-2013; Knapp, Dunja/N-2180-2017; Tanaka, Elly M/F-8572-2010	Malashichev, Yegor/0000-0003-3813-5712; Knapp, Dunja/0000-0002-7533-2208; Tanaka, Elly/0000-0003-4240-2158	A. von Humboldt Foundation [3.4-8151/07074]; Russian Foundation of Basic Research [10-04-01202-a]; Herbert Quandt Memorial Fund; Deutscher Akademischer Austausch Dienst	A. von Humboldt Foundation(Alexander von Humboldt Foundation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Herbert Quandt Memorial Fund; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	Supported by A. von Humboldt Foundation through equipment donation grant 3.4-8151/07074, Russian Foundation of Basic Research through grant 10-04-01202-a, and by Herbert Quandt Memorial Fund and Deutscher Akademischer Austausch Dienst through travel grants to YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2006, EVOL DEV, V8, P116, DOI 10.1111/j.1525-142X.2006.00082.x; Baleeva NV, 2009, AMPHIBIAN PECTORAL G; Bordzilovskaya N. P., 1989, DEV BIOL AXOLOTL, P201; Cebra-Thomas JA, 2007, EVOL DEV, V9, P267, DOI 10.1111/j.1525-142X.2007.00159.x; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V42, P275; Clark K, 2001, GENESIS, V31, P111, DOI 10.1002/gene.10012; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; ERICKSON CA, 1995, DEVELOPMENT, V121, P915; Francis ETB, 1934, ANATOMY SALAMANDER; Grassme K, 2009, MECH DEVELOP, V126, pS292, DOI 10.1016/j.mod.2009.06.793; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Hall BK, 2001, J EXP ZOOL, V289, P153, DOI 10.1002/1097-010X(20010215)289:3<153::AID-JEZ1>3.0.CO;2-O; Hall BK, 1999, NEURAL CREST DEV EVO; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Huang RJ, 1999, ANAT EMBRYOL, V200, P137, DOI 10.1007/s004290050268; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LOFBERG J, 1989, DEV BIOL, V131, P168, DOI 10.1016/S0012-1606(89)80048-X; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McGonnell IM, 2001, J ANAT, V199, P189, DOI 10.1046/j.1469-7580.2001.19910189.x; McGonnell IM, 2001, DEV BIOL, V236, P354, DOI 10.1006/dbio.2001.0330; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Qiang J, 1999, NATURE, V398, P326, DOI [10.1038/18665, DOI 10.1038/18665]; Romer A.S, 1956, OSTEOLOGY REPTILIA; Sanchez-Villagra MR, 2006, EVOL DEV, V8, P113, DOI 10.1111/j.1525-142X.2006.00081.x; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Steinberg M, 1957, CARNEGIE I WASHINGTO, V56, P347; STOCUM DL, 1982, J EMBRYOL EXP MORPH, V69, P7; Valasek P, 2010, J ANAT, V216, P482, DOI 10.1111/j.1469-7580.2009.01200.x; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; WALMSLEY ME, 1991, J CELL BIOL, V114, P9, DOI 10.1083/jcb.114.1.9	32	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52244	10.1371/journal.pone.0052244	http://dx.doi.org/10.1371/journal.pone.0052244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300623	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100033
J	Kobayashi, Y; Okada, Y; Itakura, G; Iwai, H; Nishimura, S; Yasuda, A; Nori, S; Hikishima, K; Konomi, T; Fujiyoshi, K; Tsuji, O; Toyama, Y; Yamanaka, S; Nakamura, M; Okano, H				Kobayashi, Yoshiomi; Okada, Yohei; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Yasuda, Akimasa; Nori, Satoshi; Hikishima, Keigo; Konomi, Tsunehiko; Fujiyoshi, Kanehiro; Tsuji, Osahiko; Toyama, Yoshiaki; Yamanaka, Shinya; Nakamura, Masaya; Okano, Hideyuki			Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; EXPRESSION PROFILE; GENE-EXPRESSION; GROWTH-FACTOR; FETAL-BRAIN; MOUSE MODEL; TRANSPLANTATION; PLURIPOTENCY; GENERATION; FIBERS	Murine and human iPSC-NS/PCs (induced pluripotent stem cell-derived neural stem/progenitor cells) promote functional recovery following transplantation into the injured spinal cord in rodents. However, for clinical applicability, it is critical to obtain proof of the concept regarding the efficacy of grafted human iPSC-NS/PCs (hiPSC-NS/PCs) for the repair of spinal cord injury (SCI) in a non-human primate model. This study used a pre-evaluated "safe" hiPSC-NS/PC clone and an adult common marmoset (Callithrix jacchus) model of contusive SCI. SCI was induced at the fifth cervical level (C5), followed by transplantation of hiPSC-NS/PCs at 9 days after injury. Behavioral analyses were performed from the time of the initial injury until 12 weeks after SCI. Grafted hiPSC-NS/PCs survived and differentiated into all three neural lineages. Furthermore, transplantation of hiPSC-NS/PCs enhanced axonal sparing/regrowth and angiogenesis, and prevented the demyelination after SCI compared with that in vehicle control animals. Notably, no tumor formation occurred for at least 12 weeks after transplantation. Quantitative RT-PCR showed that mRNA expression levels of human neurotrophic factors were significantly higher in cultured hiPSC-NS/PCs than in human dermal fibroblasts (hDFs). Finally, behavioral tests showed that hiPSC-NS/PCs promoted functional recovery after SCI in the common marmoset. Taken together, these results indicate that pre-evaluated safe hiPSC-NS/PCs are a potential source of cells for the treatment of SCI in the clinic.	[Kobayashi, Yoshiomi; Okada, Yohei; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Yasuda, Akimasa; Nori, Satoshi; Konomi, Tsunehiko; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Kobayashi, Yoshiomi; Itakura, Go; Iwai, Hiroki; Nishimura, Soraya; Hikishima, Keigo; Konomi, Tsunehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kanagawa, Japan; [Fujiyoshi, Kanehiro] Natl Hosp Org, Murayama Med Ctr, Dept Orthoped Surg, Tokyo, Japan; [Tsuji, Osahiko] Saitama Social Insurance Hosp, Dept Orthoped Surg, Saitama, Japan; [Yamanaka, Shinya] Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Keio University; Keio University	Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan.	masa@a8.keio.jp; hidokano@a2.keio.jp	Nakamura, Masaya/K-4111-2013; Kobayashi, Yoshiomi/W-5573-2019; Konomi, Tsunehiko/ABB-1765-2020; Okano, Hideyuki/I-7584-2019; Toyama, Yoshiaki/K-5743-2013; Hikishima, Keigo/L-1202-2013; Tsuji, Osahiko/AHB-2622-2022; Hikishima, Keigo/AAP-9586-2020; Okada, Yohei/L-1662-2013; Nori, Satoshi/K-3260-2019; Konomi, Tsunehiko/AAY-6082-2020	Konomi, Tsunehiko/0000-0001-6704-7573; Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297; Iwai, Hiroki/0000-0002-5722-8706	Japan Society for the Promotion of Science (SPS); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Project for Realization of Regenerative Medicine; MEXT; Japan Science and Technology-California Institute for Regenerative Medicine; Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program); Keio University; JSPS; Keio Gijuku Academic Development Funds; Ministry of Education, Science, Sports and Culture of Japan	Japan Society for the Promotion of Science (SPS); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology-California Institute for Regenerative Medicine; Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development Funds; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (SPS) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Project for Realization of Regenerative Medicine; and Support for Core Institutes for iPS Cell Research from the MEXT; Japan Science and Technology-California Institute for Regenerative Medicine collaborative program; "Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program); the Kanrinmaru project from Keio University; Research Fellowships for Young Scientists from JSPS; Keio Gijuku Academic Development Funds; by a Grant-in-Aid for the Global COE program from MEXT to Keio University; and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Net-work) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Fujiyoshi K, 2011, 41 ANN M NEUR 2011 W; Fujiyoshi K, 2009, 39 ANN M NEUR 2009 C; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kitamura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027706; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Krenz NR, 1998, NEUROSCIENCE, V85, P443, DOI 10.1016/S0306-4522(97)00622-2; Krenz NR, 1999, J NEUROSCI, V19, P7405, DOI 10.1523/JNEUROSCI.19-17-07405.1999; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Ohta K, 1999, SPINAL CORD, V37, P580, DOI 10.1038/sj.sc.3100881; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Okano H, 2012, CIRCULATION IN PRESS; Okano Hideyuki, 2002, Keio Journal of Medicine, V51, P115; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rhee Y-H, 2011, J CLIN INVEST, P1; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Scivoletto G, 2009, BRAIN RES BULL, V78, P43, DOI 10.1016/j.brainresbull.2008.06.002; Shang AJ, 2011, BRAIN RES, V1391, P102, DOI 10.1016/j.brainres.2011.03.019; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sundberg M, 2010, STEM CELL RES, V5, P91, DOI 10.1016/j.scr.2010.04.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Van Middendorp JJ, 2011, LANCET; Wang W., 2011, P IEEE GLOBECOM, P1, DOI DOI 10.1080/01431161.2010.489073; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Yamane J, 2010, J NEUROSCI RES, V88, P1394, DOI 10.1002/jnr.22322; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	71	186	194	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52787	10.1371/journal.pone.0052787	http://dx.doi.org/10.1371/journal.pone.0052787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300777	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100082
J	Olausson, P; Gerdle, B; Ghafouri, N; Larsson, B; Ghafouri, B				Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar			Identification of Proteins from Interstitium of Trapezius Muscle in Women with Chronic Myalgia Using Microdialysis in Combination with Proteomics	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; 2-DIMENSIONAL GEL-ELECTROPHORESIS; CEREBROSPINAL-FLUID PROTEOME; VASTUS LATERALIS MUSCLE; SKELETAL-MUSCLE; HIGH-RESOLUTION; LARGE MOLECULES; WORK; PAIN; FIBROMYALGIA	Background: Microdialysis (MD) of the trapezius muscle has been an attractive technique to investigating small molecules and metabolites in chronic musculoskeletal pain in human. Large biomolecules such as proteins also cross the dialysis membrane of the catheters. In this study we have applied in vivo MD in combination with two dimensional gel electrophoresis (2-DE) and mass spectrometry to identify proteins in the extracellular fluid of the trapezius muscle. Materials and Methods: Dialysate from women with chronic trapezius myalgia (TM; n = 37), women with chronic wide spread pain (CWP; n = 18) and healthy controls (CON; n = 22) was collected from the trapezius muscle using a catheter with a cut-off point of 100 kDa. Proteins were separated by two-dimensional gel electrophoresis and visualized by silver staining. Detected proteins were identified by nano liquid chromatography in combination with tandem mass spectrometry. Results: Ninety-seven protein spots were identified from the interstitial fluid of the trapezius muscle; 48 proteins in TM and 30 proteins in CWP had concentrations at least two-fold higher or lower than in CON. The identified proteins pertain to several functional classes, e. g., proteins involved in inflammatory responses. Several of the identified proteins are known to be involved in processes of pain such as: creatine kinase, nerve growth factor, carbonic anhydrase, myoglobin, fatty acid binding protein and actin aortic smooth muscle. Conclusions: In this study, by using in vivo microdialysis in combination with proteomics a large number of proteins in muscle interstitium have been identified. Several of the identified proteins were at least two-fold higher or lower in chronic pain patients. The applied techniques open up for the possibility of investigating protein changes associated with nociceptive processes of chronic myalgia.	[Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Olausson, Patrik; Gerdle, Bjorn; Ghafouri, Nazdar; Larsson, Britt; Ghafouri, Bijar] Cty Council, Pain & Rehabil Ctr, Linkoping, Sweden; [Ghafouri, Nazdar] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Ghafouri, Bijar] Cty Council, Ctr Occupat & Environm Med, Linkoping, Sweden	Linkoping University; Umea University; Linkoping University	Ghafouri, B (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden.	bijar.ghafouri@liu.se	Ghafouri, Bijar/H-8257-2014	Gerdle, Bjorn/0000-0002-4316-1264; Olausson, Patrik/0000-0002-3689-788X	Swedish Research Council [K2011-69X-21874-01-6]; Swedish Council for Working Life and Social Research [2010-0913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Swedish Research Council (K2011-69X-21874-01-6) and the Swedish Council for Working Life and Social Research 2010-0913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afinowi R, 2009, J NEUROSCI METH, V181, P95, DOI 10.1016/j.jneumeth.2009.02.021; Bailey DM, 2001, AVIAT SPACE ENVIR MD, V72, P513; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Bernard BP, 1997, MUSCULOSCELETAL DISO; Blanco I, 2004, J RHEUMATOL, V31, P2082; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Darde VM, 2010, J PROTEOME RES, V9, P4420, DOI 10.1021/pr1002017; Ferrero S, 2008, EXPERT REV PROTEOMIC, V5, P705, DOI 10.1586/14789450.5.5.705; Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Fulle S, 2000, FREE RADICAL BIO MED, V29, P1252, DOI 10.1016/S0891-5849(00)00419-6; Gerdle B, 2012, POTENTIAL MUSCLE BIO; Gerdle B, 2008, PAIN, V139, P578, DOI 10.1016/j.pain.2008.06.012; Gerdle B, 2008, EUR J PAIN, V12, P82, DOI 10.1016/j.ejpain.2007.03.009; Gerdle B, 2010, J REHABIL MED, V42, P679, DOI 10.2340/16501977-0581; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Ghafouri B, 2007, ANAL BIOCHEM, V371, P121, DOI 10.1016/j.ab.2007.07.002; Ghafouri B, 2010, SCAND J CLIN LAB INV, V70, P478, DOI 10.3109/00365513.2010.511257; Ghafouri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027257; Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; HAGBERG M, 1982, INT ARCH OCC ENV HEA, V50, P377, DOI 10.1007/BF00377834; Hermens H., 1997, SENIAM STATE ART SEN; Hody S, 2011, MED SCI SPORT EXER, V43, P2281, DOI 10.1249/MSS.0b013e318222edf3; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Hung PH, 2011, MOL BIOSYST, V7, P1990, DOI 10.1039/c1mb05055a; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kunz S, 2005, NEUROSCI LETT, V381, P289, DOI 10.1016/j.neulet.2005.02.022; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Larsson B, 2005, J MUSCULOSKELET PAIN, V13, P5, DOI 10.1300/J094v13n04_03; Larsson B, 2008, PAIN, V140, P479, DOI 10.1016/j.pain.2008.10.001; Liu XD, 2006, PROTEOMICS, V6, P1019, DOI 10.1002/pmic.200500247; Marchi A, 2009, CLIN DRUG INVEST, V29, P41, DOI 10.2165/0044011-200929001-00006; Mense S, 2009, EXP BRAIN RES, V196, P89, DOI 10.1007/s00221-008-1674-4; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; Niederberger E, 2008, ANESTHESIOLOGY, V108, P314, DOI 10.1097/01.anes.0000299838.13368.6e; Oki G, 2012, PAIN, V153, P532, DOI 10.1016/j.pain.2011.11.008; Olausson P, 2012, SCANDINAVIAN J CLIN, V0, P1; Packer NH, 1998, ELECTROPHORESIS, V19, P981, DOI 10.1002/elps.1150190613; Paulo JA, 2011, ELECTROPHORESIS, V32, P1939, DOI 10.1002/elps.201100203; Robinson PA, 2003, AM J PHYSIOL-CELL PH, V284, pC681, DOI 10.1152/ajpcell.00370.2002; Rosendal L, 2005, PAIN, V119, P201, DOI 10.1016/j.pain.2005.09.026; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; Ruiz-Romero C, 2010, OSTEOARTHR CARTILAGE, V18, P500, DOI 10.1016/j.joca.2009.11.012; Schumechel DE, 2012, NEUROTOXICOLOGY; Seeber B, 2010, FERTIL STERIL, V93, P2137, DOI 10.1016/j.fertnstert.2008.12.121; Sluiter JK, 2001, SCAND J WORK ENV HEA, V27, P1; Sorichter S, 1998, BRIT J SPORT MED, V32, P121, DOI 10.1136/bjsm.32.2.121; SWAIN M, 1995, ELECTROPHORESIS, V16, P948, DOI 10.1002/elps.11501601159; Takeda S, 2011, NEUROSCIENCE, V186, P110, DOI 10.1016/j.neuroscience.2011.04.035; Tumblin A, 2010, HAEMATOL-HEMATOL J, V95, P1467, DOI 10.3324/haematol.2009.018044; Waling K, 2002, SPINE, V27, P789, DOI 10.1097/00007632-200204150-00002; Wilson R, 2009, MATRIX BIOL, V28, P121, DOI 10.1016/j.matbio.2009.01.004; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P171, DOI 10.1007/s00418-002-0427-x; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhu Y, 2011, J ORTHOP RES, V29, P1896, DOI 10.1002/jor.21466	67	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52560	10.1371/journal.pone.0052560	http://dx.doi.org/10.1371/journal.pone.0052560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300707	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100063
J	Stander, BA; Joubert, F; Tu, CK; Sippel, KH; McKenna, R; Joubert, AM				Stander, Barend Andre; Joubert, Fourie; Tu, Chingkuang; Sippel, Katherine H.; McKenna, Robert; Joubert, Annie Margaretha			In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity	PLOS ONE			English	Article							GENE LISTS; 2-METHOXYESTRADIOL; CONSEQUENCES; CHECKPOINT; DOCKING; CELLS; IX	Antimitotic compounds are still one of the most widely used chemotherapeutic anticancer drugs in the clinic today. Given their effectiveness against cancer it is beneficial to continue enhancing these drugs. One way is to improve the bioavailability and efficacy by synthesizing derivatives that reversibly bind to carbonic anhydrase II (CAII) in red blood cells followed by a slow release into the blood circulation system. In the present study we describe the in vitro biological activity of a reduced derivative of 2-ethyl-3-O-sulphamoyl-estradiol (2EE), 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10),15-tetraen-17-ol (ESE-15-ol). ESE-15-ol is capable of inhibiting carbonic anhydrase activity in the nanomolar range and is selective towards a mimic of carbonic anhydrase IX when compared to the CAII isoform. Docking studies using Autodock Vina suggest that the dehydration of the D-ring plays a role towards the selectivity of ESE-15-ol to CAIX and that the binding mode of ESE-15-ol is substantially different when compared to 2EE. ESE-15-ol is able to reduce cell growth to 50% after 48 h at 50-75 nM in MCF-7, MDA-MB-231, and MCF-12A cells. The compound is the least potent against the non-tumorigenic MCF-12A cells. In vitro mechanistic studies demonstrate that the newly synthesized compound induces mitochondrial membrane depolarization, abrogates the phosphorylation status of Bcl-2 and affects gene expression of genes associated with cell death and mitosis.	[Stander, Barend Andre; Joubert, Annie Margaretha] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa; [Joubert, Fourie] Univ Pretoria, Dept Biochem, Bioinformat & Computat Biol Unit, ZA-0002 Pretoria, Gauteng, South Africa; [Tu, Chingkuang] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Sippel, Katherine H.] Baylor Coll Med, Houston, TX 77030 USA; [McKenna, Robert] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Pretoria; University of Pretoria; State University System of Florida; University of Florida; Baylor College of Medicine; State University System of Florida; University of Florida	Stander, BA (corresponding author), Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa.	standerandre@gmail.com	Joubert, Annie/AAU-4562-2021	Joubert, Annie/0000-0002-6931-7554; Joubert, Fourie/0000-0003-4998-7531	Medical Research Council of South Africa [AG374, AK076]; Cancer Association of South Africa [AK246]; National Research Foundation (NRF) [AL239]; Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa [AJ038, AN074]	Medical Research Council of South Africa(South African Medical Research Council); Cancer Association of South Africa; National Research Foundation (NRF); Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa	This research was supported by grants from the Medical Research Council of South Africa (AG374, AK076), the Cancer Association of South Africa (AK246), National Research Foundation (NRF) (AL239), the Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria, and the Struwig-Germeshuysen Cancer Research Trust of South Africa (AJ038, AN074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola R, 2009, CURR CANCER DRUG TAR, V9, P118, DOI 10.2174/156800909787580935; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry JM, 1996, CYTOTECHNOLOGY, V21, P73, DOI 10.1007/BF00364838; Elger W, 1995, J STEROID BIOCHEM, V55, P395, DOI 10.1016/0960-0760(95)00214-6; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Genis C, 2009, BIOCHEMISTRY-US, V48, P1322, DOI 10.1021/bi802035f; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GREVER MR, 1992, SEMIN ONCOL, V19, P622; Guthrie H. David, 2008, V477, P89, DOI 10.1007/978-1-60327-517-0_8; Ho YT, 2003, BIOCHEM BIOPH RES CO, V305, P909, DOI 10.1016/S0006-291X(03)00865-9; Hughes RA, 2002, MOL PHARMACOL, V61, P1053, DOI 10.1124/mol.61.5.1053; Jourdan F, 2010, J MED CHEM, V53, P2942, DOI 10.1021/jm9018806; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kutuk O, 2008, CURR MOL MED, V8, P102; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; Luo J, 2009, MOL CELL BIOL, V30, P537; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pastorekova S, 2008, BJU INT, V101, P8, DOI 10.1111/j.1464-410X.2008.07642.x; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rao PN, 2002, STEROIDS, V67, P1079, DOI 10.1016/S0039-128X(02)00066-1; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Segel IH, 1975, ENZYME KINETICS BEHA; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sippel KH, 2011, LETT DRUG DES DISCOV, V8, P678; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Stander BA, 2010, J STEROID BIOCHEM, V119, P149, DOI 10.1016/j.jsbmb.2010.02.019; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Tinley TL, 2003, CANCER RES, V63, P1538; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang YL, 2006, J BIOCHEM, V139, P17, DOI 10.1093/jb/mvj021; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Winum JY, 2005, MED RES REV, V25, P186, DOI 10.1002/med.20021; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yao YX, 2012, FRONT BIOSCI-LANDMRK, V17, P976, DOI 10.2741/3968; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	44	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52205	10.1371/journal.pone.0052205	http://dx.doi.org/10.1371/journal.pone.0052205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300615	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100028
J	Alkhateeb, AA; Leitzel, K; Ali, SM; Campbell-Baird, C; Evans, M; Fuchs, EM; Kostler, WJ; Lipton, A; Connor, J				Alkhateeb, Ahmed A.; Leitzel, Kim; Ali, Suhail M.; Campbell-Baird, Cynthia; Evans, Matthew; Fuchs, Eva-Maria; Koestler, Wolfgang J.; Lipton, Allan; Connor, James			Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METASTATIC BREAST-CANCER; ANTIINFLAMMATORY DRUG-USE; FERRITIN; IRON; ASSOCIATION; MACROPHAGES; SURVIVAL; CELLS; SECRETION	Approximately half of all HER2/neu-overexpressing breast cancer patients do not respond to trastuzumab-containing therapy. Therefore, there remains an urgent and unmet clinical need for the development of predictive biomarkers for trastuzumab response. Recently, several lines of evidence have demonstrated that the inflammatory tumor microenvironment is a major contributor to therapy resistance in breast cancer. In order to explore the predictive value of inflammation in breast cancer patients, we measured the inflammatory biomarkers serum ferritin and C-reactive protein (CRP) in 66 patients immediately before undergoing trastuzumab-containing therapy and evaluated their progression-free and overall survival. The elevation in pre-treatment serum ferritin (> 250 ng/ml) or CRP (> 7.25 mg/l) was a significant predictor of reduced progression-free survival and shorter overall survival. When patients were stratified based on their serum ferritin and CRP levels, patients with elevation in both inflammatory biomarkers had a markedly poorer response to trastuzumab-containing therapy. Therefore, the elevation in inflammatory serum biomarkers may reflect a pathological state that decreases the clinical efficacy of this therapy. Anti-inflammatory drugs and life-style changes to decrease inflammation in cancer patients should be explored as possible strategies to sensitize patients to anti-cancer therapeutics.	[Alkhateeb, Ahmed A.; Connor, James] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Leitzel, Kim; Ali, Suhail M.; Campbell-Baird, Cynthia; Evans, Matthew; Lipton, Allan] Penn State Univ, Milton S Hershey Med Ctr, Div Hematol Med Oncol, Hershey, PA 17033 USA; [Ali, Suhail M.] Lebanon VA Med Ctr, Dept Med, Lebanon, PA USA; [Fuchs, Eva-Maria; Koestler, Wolfgang J.] Med Univ Vienna, Dept Med, Vienna, Austria	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of Vienna	Connor, J (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	jconnor@hmc.psu.edu						Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; BROXMEYER HE, 1989, BLOOD, V73, P74; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cotterchio M, 2001, CANCER EPIDEM BIOMAR, V10, P1213; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ferring-Appel D, 2009, BLOOD, V113, P679, DOI 10.1182/blood-2008-05-155093; Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; JACOBS A, 1976, BRIT J CANCER, V34, P286, DOI 10.1038/bjc.1976.164; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Johnson TW, 2002, CANCER EPIDEM BIOMAR, V11, P1586; JONES BM, 1980, CLIN CHIM ACTA, V106, P203, DOI 10.1016/0009-8981(80)90173-4; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kostler WJ, 2004, CLIN CANCER RES, V10, P1618, DOI 10.1158/1078-0432.CCR-0385-3; Liu JM, 2003, AM J CLIN NUTR, V78, P1160, DOI 10.1093/ajcn/78.6.1160; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; O'Meara A, 2011, TRANSFUSION, V51, P2183, DOI 10.1111/j.1537-2995.2011.03148.x; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; ROBERTSON JFR, 1991, CANCER IMMUNOL IMMUN, V33, P403, DOI 10.1007/BF01741602; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Streetz KL, 2001, CELL MOL BIOL, V47, P661; Tchernof A, 2002, CIRCULATION, V105, P564, DOI 10.1161/hc0502.103331; Todorich B, 2011, GLIA, V59, P927, DOI 10.1002/glia.21164; Tran TN, 1997, BLOOD, V90, P4979, DOI 10.1182/blood.V90.12.4979.4979_4979_4986; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; ZHANG DX, 1995, BIOCHEM J, V310, P143, DOI 10.1042/bj3100143; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	37	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51379	10.1371/journal.pone.0051379	http://dx.doi.org/10.1371/journal.pone.0051379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300545	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800017
J	Chotibut, T; Apple, DM; Jefferis, R; Salvatore, MF				Chotibut, Tanya; Apple, Deana M.; Jefferis, Rebecca; Salvatore, Michael F.			Dopamine Transporter Loss in 6-OHDA Parkinson's Model Is Unmet by Parallel Reduction in Dopamine Uptake	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER-3; MEDIAL PREFRONTAL CORTEX; EXTRACELLULAR DOPAMINE; IN-VIVO; SUBSTANTIA-NIGRA; NOREPINEPHRINE TRANSPORTER; MONOAMINE TRANSPORTER; NORADRENALINE CARRIER; CULTURED RAT; STRIATUM	The dopamine transporter (DAT) regulates synaptic dopamine (DA) in striatum and modulation of DAT can affect locomotor activity. Thus, in Parkinson's disease (PD), DAT loss could affect DA clearance and locomotor activity. The locomotor benefits of L-DOPA may be mediated by transport through monoamine transporters and conversion to DA. However, its impact upon DA reuptake is unknown and may modulate synaptic DA. Using the unilateral 6-OHDA rat PD model, we examined [H-3] DA uptake dynamics in relation to striatal DAT and tyrosine hydroxylase (TH) protein loss compared with contralateral intact striatum. Despite > 70% striatal DAT loss, DA uptake decreased only similar to 25% and increased as DAT loss approached 99%. As other monoamine transporters can transport DA, we determined if norepinephrine (NE) and serotonin (5-HT) differentially modulated DA uptake in lesioned striatum. Unlabeled DA, NE, and 5-HT were used, at a concentration that differentially inhibited DA uptake in intact striatum, to compete against [H-3]DA uptake. In 6-OHDA lesioned striatum, DA was less effective, whereas NE was more effective, at inhibiting [H-3]DA uptake. Furthermore, norepinephrine transporter (NET) protein levels increased and desipramine was, two-fold more effective at inhibiting NE uptake. Serotonin inhibited [H-3]DA uptake, but without significant difference between lesioned and contralateral striatum. L-DOPA inhibited [H-3]DA uptake two-fold more in lesioned striatum and inhibited NE uptake similar to five-fold more than DA uptake in naive striatum. Consequently, DA uptake may be mediated by NET when DAT loss is at PD levels. Increased inhibition of DA uptake by L-DOPA and its preferential inhibition of NE over DA uptake, indicates that NET-mediated DA uptake may be modulated by L-DOPA when DAT loss exceeds 70%. These results indicate a novel mechanism for DA uptake during PD progression and provide new insight into how L-DOPA affects DA uptake, revealing possible mechanisms of its therapeutic and side effect potential.	[Chotibut, Tanya; Apple, Deana M.; Jefferis, Rebecca; Salvatore, Michael F.] Louisiana State Univ, Dept Pharmacol Toxicol & Neurosci, Hlth Sci Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Salvatore, MF (corresponding author), Louisiana State Univ, Dept Pharmacol Toxicol & Neurosci, Hlth Sci Ctr, Shreveport, LA 71105 USA.	msalva@lsuhsc.edu	Salvatore, Michael/ABC-8926-2021		Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport; Biomedical Research Foundation of Northwest Louisiana; Parkinson's Disease Resource of NW Louisiana	Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport; Biomedical Research Foundation of Northwest Louisiana; Parkinson's Disease Resource of NW Louisiana	This work was funded in part by intramural grant awards to MFS from the Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport, The Biomedical Research Foundation of Northwest Louisiana, and the Parkinson's Disease Resource of NW Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Albin RL, 2008, J CEREBR BLOOD F MET, V28, P441, DOI 10.1038/sj.jcbfm.9600599; Arai A, 2008, SYNAPSE, V62, P632, DOI 10.1002/syn.20535; Bergstrom BP, 2011, NEUROSCIENCE, V193, P310, DOI 10.1016/j.neuroscience.2011.07.029; Bergstrom BP, 2003, J NEUROCHEM, V87, P1224, DOI 10.1046/j.1471-4159.2003.02104.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Buck K, 2009, NEUROSCIENCE, V159, P16, DOI 10.1016/j.neuroscience.2008.12.026; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Carta M, 2006, J NEUROCHEM, V96, P1718, DOI 10.1111/j.1471-4159.2006.03696.x; CASS WA, 1995, J NEUROCHEM, V65, P201; Cenci MA, 2007, TRENDS NEUROSCI, V30, P236, DOI 10.1016/j.tins.2007.03.005; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 2000, J NEUROSCI, V20, P8209; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; DICHIARA G, 1992, NEUROCHEM INT, V20, pS231; Engel K, 2005, MOL PHARMACOL, V68, P1397, DOI 10.1124/mol.105.016832; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Fisone G, 2011, INT REV NEUROBIOL, V98, P95, DOI 10.1016/B978-0-12-381328-2.00004-3; Garris PA, 1997, BRAIN RES, V753, P225, DOI 10.1016/S0006-8993(97)00003-6; Gasser PJ, 2006, J NEUROSCI, V26, P8758, DOI 10.1523/JNEUROSCI.0570-06.2006; GIROS B, 1994, J BIOL CHEM, V269, P15985; Goldberg NRS, 2012, NEUROBIOL DIS, V45, P1051, DOI 10.1016/j.nbd.2011.12.024; GRESCH PJ, 1995, J NEUROCHEM, V65, P111; Grundemann D, 1998, J BIOL CHEM, V273, P30915, DOI 10.1074/jbc.273.47.30915; GU H, 1994, J BIOL CHEM, V269, P7124; Hashimoto W, 2005, LIFE SCI, V76, P1603, DOI 10.1016/j.lfs.2004.08.029; Hebert MA, 1998, BRAIN RES, V797, P42, DOI 10.1016/S0006-8993(98)00370-9; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Inazu M, 2003, J NEUROCHEM, V84, P136, DOI 10.1046/j.1471-4159.2003.01514.x; Iravani MM, 2005, EUR J NEUROSCI, V21, P841, DOI 10.1111/j.1460-9568.2005.03915.x; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JUORIO AV, 1993, BRAIN RES, V626, P306, DOI 10.1016/0006-8993(93)90592-B; Kannari K, 2006, NEUROSCI LETT, V402, P62, DOI 10.1016/j.neulet.2006.03.059; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Khakimova G. R., 2010, Doklady Akademii Nauk, V435, P272; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Leng A, 2004, BEHAV BRAIN RES, V154, P375, DOI 10.1016/j.bbr.2004.03.004; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Madras BK, 2006, J PHARMACOL EXP THER, V319, P570, DOI 10.1124/jpet.106.105312; Miller DW, 1999, J NEUROCHEM, V72, P1516, DOI 10.1046/j.1471-4159.1999.721516.x; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mura A, 1995, BRAIN RES, V704, P51, DOI 10.1016/0006-8993(95)01104-8; Navailles S, 2010, NEUROBIOL DIS, V38, P136, DOI 10.1016/j.nbd.2010.01.012; Nutt JG, 2004, ANN NEUROL, V55, P766, DOI 10.1002/ana.20089; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Sabeti J, 2002, J PHARMACOL EXP THER, V302, P1201, DOI 10.1124/jpet.102.035816; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Salvatore MF, 2003, NEUROBIOL AGING, V24, P1147, DOI 10.1016/S0197-4580(03)00129-5; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; SANDLER M, 1971, LANCET, V1, P784; Sarre S, 2004, J NEUROCHEM, V90, P29, DOI 10.1111/j.1471-4159.2004.02471.x; SNYDER GL, 1990, J PHARMACOL EXP THER, V253, P867; SNYDER SH, 1969, J PHARMACOL EXP THER, V165, P78; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Sossi V, 2009, J NEUROCHEM, V109, P85, DOI 10.1111/j.1471-4159.2009.05904.x; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Takeda H, 2002, N-S ARCH PHARMACOL, V366, P620, DOI 10.1007/s00210-002-0640-0; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Tanda G, 1997, EUR J NEUROSCI, V9, P2077, DOI 10.1111/j.1460-9568.1997.tb01375.x; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tsai MJ, 1996, J NEUROSCI RES, V43, P490, DOI 10.1002/(SICI)1097-4547(19960215)43:4<490::AID-JNR10>3.3.CO;2-K; Vizi ES, 2004, J NEUROSCI, V24, P7888, DOI 10.1523/JNEUROSCI.1506-04.2004; Wayment HK, 2001, J NEUROSCI, V21, P35, DOI 10.1523/JNEUROSCI.21-01-00035.2001; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhou MY, 2007, BIOCHEM PHARMACOL, V73, P147, DOI 10.1016/j.bcp.2006.09.008	80	45	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52322	10.1371/journal.pone.0052322	http://dx.doi.org/10.1371/journal.pone.0052322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300642	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800069
J	Pante, E; Rohfritsch, A; Becquet, V; Belkhir, K; Bierne, N; Garcia, P				Pante, Eric; Rohfritsch, Audrey; Becquet, Vanessa; Belkhir, Khalid; Bierne, Nicolas; Garcia, Pascale			SNP Detection from De Novo Transcriptome Sequencing in the Bivalve Macoma balthica: Marker Development for Evolutionary Studies	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; MITOCHONDRIAL GENOME; NEXT-GENERATION; NUCLEOTIDE POLYMORPHISM; INTERTIDAL ECOSYSTEMS; NATURAL-POPULATION; SUMMER MORTALITY; LOCAL ADAPTATION; CLIMATE-CHANGE; HYBRID ZONES	Hybrid zones are noteworthy systems for the study of environmental adaptation to fast-changing environments, as they constitute reservoirs of polymorphism and are key to the maintenance of biodiversity. They can move in relation to climate fluctuations, as temperature can affect both selection and migration, or remain trapped by environmental and physical barriers. There is therefore a very strong incentive to study the dynamics of hybrid zones subjected to climate variations. The infaunal bivalve Macoma balthica emerges as a noteworthy model species, as divergent lineages hybridize, and its native NE Atlantic range is currently contracting to the North. To investigate the dynamics and functioning of hybrid zones in M. balthica, we developed new molecular markers by sequencing the collective transcriptome of 30 individuals. Ten individuals were pooled for each of the three populations sampled at the margins of two hybrid zones. A single 454 run generated 277 Mb from which 17K SNPs were detected. SNP density averaged 1 polymorphic site every 14 to 19 bases, for mitochondrial and nuclear loci, respectively. An FST scan detected high genetic divergence among several hundred SNPs, some of them involved in energetic metabolism, cellular respiration and physiological stress. The high population differentiation, recorded for nuclear-encoded ATP synthase and NADH dehydrogenase as well as most mitochondrial loci, suggests cytonuclear genetic incompatibilities. Results from this study will help pave the way to a high-resolution study of hybrid zone dynamics in M. balthica, and the relative importance of endogenous and exogenous barriers to gene flow in this system.	[Pante, Eric; Rohfritsch, Audrey; Becquet, Vanessa; Garcia, Pascale] Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, Ctr Natl Rech Sci, La Rochelle, France; [Belkhir, Khalid] Univ Montpellier 2, Joint Res Unit 5554, Inst Sci Entreprise & Management, Montpellier, France; [Bierne, Nicolas] Univ Montpellier 2, Joint Res Unit 5554A, Inst Sci Entreprise & Management, Stn Mediterraneenne Environm Littoral, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Universite de Montpellier; Universite de Montpellier	Pante, E (corresponding author), Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, Ctr Natl Rech Sci, La Rochelle, France.	pante.eric@gmail.com	Pante, Eric/C-4230-2011	Pante, Eric/0000-0001-7680-2112; Garcia, Pascale/0000-0001-8488-6061; Bierne, Nicolas/0000-0003-1856-3197	European Union [31031-2008]; Agence Nationale de la Recherche (Hi-Flo project) [ANR-08-BLAN-0334-01]	European Union(European Commission); Agence Nationale de la Recherche (Hi-Flo project)(French National Research Agency (ANR))	The University of La Rochelle computing infrastructure \YMIR'' was partly funded by the European Union (contract 31031-2008, European Regional Development Fund). This work was funded by the Agence Nationale de la Recherche (Hi-Flo project ANR-08-BLAN-0334-01); salaries for AR and EP were covered by a grant to the Poitou-Charente region (Contrat de Projet Etat-Region 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; ASMUSSEN MA, 1987, GENETICS, V115, P755; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Becquet V, 2012, J EXP MAR BIOL ECOL, V432, P73, DOI 10.1016/j.jembe.2012.07.008; Becquet V, 2009, CONSERV GENET RESOUR, V1, P265, DOI 10.1007/s12686-009-9065-0; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boutet I, 2004, GENE, V329, P147, DOI 10.1016/j.gene.2003.12.027; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Bultelle F, 2002, MAR ENVIRON RES, V54, P385, DOI 10.1016/S0141-1136(02)00159-9; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; DeJong RJ, 2004, J PARASITOL, V90, P991, DOI 10.1645/GE-284R; EJDUNG G, 1992, MAR ECOL PROG SER, V88, P207, DOI 10.3354/meps088207; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Faure E, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-56; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Gagnaire PA, 2012, MOL BIOL EVOL, V29, P2909, DOI 10.1093/molbev/mss076; Galindo, 2010, J EVOLUTION BIOL, V23, P2768, DOI 10.1111/j.1420-9101.2010.02173.x; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Goikoetxea N, 2009, CONT SHELF RES, V29, P1060, DOI 10.1016/j.csr.2008.11.014; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hilbish TJ, 2012, J BIOGEOGR, V39, P676, DOI 10.1111/j.1365-2699.2011.02633.x; Hilbish TJ, 2010, J BIOGEOGR, V37, P423, DOI 10.1111/j.1365-2699.2009.02218.x; Hummel H, 2000, J EXP MAR BIOL ECOL, V251, P85, DOI 10.1016/S0022-0981(00)00208-2; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Jansen JM, 2007, J EXP MAR BIOL ECOL, V344, P161, DOI 10.1016/j.jembe.2006.12.014; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Jolly MT, 2006, MOL ECOL, V15, P1841, DOI 10.1111/j.1365-294X.2006.02910.x; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Latta RG, 2001, GENETICS, V158, P843; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Luttikhuizen PC, 2003, J EVOLUTION BIOL, V16, P260, DOI 10.1046/j.1420-9101.2003.00510.x; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Luttikhuizen PC, 2012, MOL ECOL, V21, P30; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattila J, 1998, J EXP MAR BIOL ECOL, V227, P221, DOI 10.1016/S0022-0981(97)00272-4; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NCBI, 2012, SEQ READ ARCH SRA; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Orsini L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-309; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2004, TECHNICAL REPORT; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; PIERSMA T, 1993, NETH J SEA RES, V31, P299, DOI 10.1016/0077-7579(93)90047-V; Ponstingl H, 2012, SMALT; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; R Development Core Team, 2012, R LANG ENV STAT COMP; Riginos C, 2007, MOL ECOL, V16, P3971, DOI 10.1111/j.1365-294X.2007.03505.x; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; SeqClean, 2012, DFCI GEN IND SOFTW T; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Strelkov P, 2007, MOL ECOL, V16, P4110, DOI 10.1111/j.1365-294X.2007.03463.x; Tatusov T, 2012, ORF FINDER OPEN READ; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; VAINOLA R, 1989, OLSEN INT S, P309; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	102	16	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52302	10.1371/journal.pone.0052302	http://dx.doi.org/10.1371/journal.pone.0052302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300636	Green Published, gold			2022-12-25	WOS:000313618800067
J	Cai, WB; Zhang, Y; Cheng, R; Wang, Z; Fang, SH; Xu, ZM; Yang, X; Yang, ZH; Ma, JX; Shao, CK; Gao, GQ				Cai, Wei-Bin; Zhang, Yang; Cheng, Rui; Wang, Zheng; Fang, Shu-Huan; Xu, Zu-Min; Yang, Xia; Yang, Zhong-Han; Ma, Jian-Xing; Shao, Chun-Kui; Gao, Guo-Quan			Dual Inhibition of Plasminogen Kringle 5 on Angiogenesis and Chemotaxis Suppresses Tumor Metastasis by Targeting HIF-1 alpha Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; EPITHELIUM-DERIVED FACTOR; CXC CHEMOKINE RECEPTOR-4; FACTOR-I HIF-1; RETINAL NEOVASCULARIZATION; SIGNALING PATHWAY; GENE-EXPRESSION; CANCER CELLS; PROGRESSION	We had demonstrated that plasminogen kringle 5 (K5), a potent angiogenic inhibitor, inhibited retinal neovascularization and hepatocellular carcinoma growth by anti-angiogenesis. The current study investigated the effects and the underlying mechanisms of K5 on both tumor growth and spontaneous pulmonary metastasis in Lewis lung carcinoma (LLC) implanted mouse model. Similarly, K5 could decrease expression of VEGF in LLC cells and grafted tissues and suppress tumor angiogenesis and growth. K5 had no direct effect on proliferation and apoptosis of LLC. However, K5 could significantly inhibit SDF-1 alpha-induced chemotaxis movement of LLC cells and resulted in a great reduction of surface metastatic nodules and micrometastases in the lungs of LLC tumor-bearing mice. K5 also decreased expression of chemokine (C-X-C motif) receptor 4 (CXCR4) in LLC cells and grafted tissues. Furthermore, K5 down-regulated SDF-1 alpha expression in metastatic lung tissues of LLC-bearing mice. Therefore, K5 may suppress tumor pulmonary metastasis through inhibiting SDF-1 alpha-CXCR4 chemotaxis movement and down-regulation of VEGF. Moreover, the role of hypoxia inducible factor-1 alpha (HIF-1 alpha), a crucial transcriptional factor for both VEGF and CXCR4 expression, was evaluated. The siRNA of HIF-1 alpha attenuated expression of VEGF and CXCR4 and inhibited LLC migration. K5 decreased HIF-1 alpha protein level and impaired nuclear HIF-1 alpha accumulation. These results showed for the first time that K5 inhibits LLC growth and metastasis via the dual effects of anti-angiogenesis and suppression of tumor cell motility by targeting the pivotal molecule, HIF-1 alpha.	[Cai, Wei-Bin; Zhang, Yang; Cheng, Rui; Wang, Zheng; Fang, Shu-Huan; Xu, Zu-Min; Yang, Xia; Yang, Zhong-Han; Gao, Guo-Quan] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Shu-Huan] Guangzhou Univ Chinese Med, DME Ctr, Clin Pharmacol Inst, Guangzhou, Guangdong, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Key Lab Funct Mol Marine Microorganisms, Dept Educ Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Shao, Chun-Kui] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, China Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University; Sun Yat Sen University	Shao, CK (corresponding author), Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	chunkuishao2011@163.com; gaogq@mail.sysu.edu.cn			National Nature Science Foundation of China [30700120, 30971208, 30973449, 81070746, 81071893, 81172163, 81272515, 81272338, 81272553]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102-053]; Program for Doctoral Station in University [20070558215, 108104, 20100171110049]; Guandong natural science foundation [10151008901000007, S2012020010898, 10251008901000009]; Fundamental Research Funds for the Central Universities of China [09YKPY73, 10YKPY28]; Changjiang Scholars and Innovative Research Team in University [PCSIRT 0947]; Guangzhou Science and Technology Project [2011J4100106, 2011Y1-00017-8]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University; Guandong natural science foundation; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangzhou Science and Technology Project	This work was supported by National Nature Science Foundation of China (30700120, 30971208, 30973449, 81070746, 81071893, 81172163, 81272515, 81272338 and 81272553), National Key Sci-Tech Special Project of China (2009ZX09103-642 and 2013ZX09102-053), Program for Doctoral Station in University (20070558215, 108104, 20100171110049), Guandong natural science foundation (10151008901000007, S2012020010898 and Key Project 10251008901000009), Fundamental Research Funds for the Central Universities of China (Youth Program 09YKPY73, 10YKPY28), Changjiang Scholars and Innovative Research Team in University (985 project PCSIRT 0947), and Guangzhou Science and Technology Project (2011J4100106, 2011Y1-00017-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cai WB, 2005, J CELL BIOCHEM, V96, P1254, DOI 10.1002/jcb.20601; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Cheng ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023752; Chilov D, 1999, J CELL SCI, V112, P1203; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Jiang WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037132; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Reddy K, 2008, INT J CANCER, V123, P831, DOI 10.1002/ijc.23582; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Weidner N, 1991, NEW ENGL J MED, V32, P1, DOI DOI 10.1056/NEJM19910103; Yang X, 2010, J CELL MOL MED, V14, P2519, DOI 10.1111/j.1582-4934.2009.01004.x; Yang Y, 2006, CANCER BIOL THER, V5, P399; Zhang D, 2001, DIABETOLOGIA, V44, P757, DOI 10.1007/s001250051685; Zhang SX, 2004, DIABETOLOGIA, V47, P124, DOI 10.1007/s00125-003-1276-4; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; Zhu BH, 2007, MOL CANCER THER, V6, P3297, DOI 10.1158/1535-7163.MCT-06-0798; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	47	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53152	10.1371/journal.pone.0053152	http://dx.doi.org/10.1371/journal.pone.0053152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300882	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600063
J	Carey, JC; Fulweiler, RW				Carey, Joanna C.; Fulweiler, Robinson W.			The Terrestrial Silica Pump	PLOS ONE			English	Article							BIOGENIC SILICA; CARBON; CYCLE; BIOGEOCHEMISTRY; VEGETATION	Silicon (Si) cycling controls atmospheric CO2 concentrations and thus, the global climate, through three well-recognized means: chemical weathering of mineral silicates, occlusion of carbon (C) to soil phytoliths, and the oceanic biological Si pump. In the latter, oceanic diatoms directly sequester 25.8 Gton C yr(-1), accounting for 43% of the total oceanic net primary production (NPP). However, another important link between C and Si cycling remains largely ignored, specifically the role of Si in terrestrial NPP. Here we show that 55% of terrestrial NPP (33 Gton C yr(-1)) is due to active Si-accumulating vegetation, on par with the amount of C sequestered annually via marine diatoms. Our results suggest that similar to oceanic diatoms, the biological Si cycle of land plants also controls atmospheric CO2 levels. In addition, we provide the first estimates of Si fixed in terrestrial vegetation by major global biome type, highlighting the ecosystems of most dynamic Si fixation. Projected global land use change will convert forests to agricultural lands, increasing the fixation of Si by land plants, and the magnitude of the terrestrial Si pump.	[Carey, Joanna C.; Fulweiler, Robinson W.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Fulweiler, Robinson W.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University; Boston University	Carey, JC (corresponding author), Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA.	jocarey@bu.edu	Fulweiler, Robinson W./A-3806-2010	Fulweiler, Robinson W./0000-0003-0871-4246	STAR Fellowship [FP917238]; U.S. Environmental Protection Agency (EPA); Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration; Department of Earth Sciences at Boston University	STAR Fellowship; U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Department of Earth Sciences at Boston University	This research was partially developed under STAR Fellowship Assistance Agreement no. FP917238 awarded by the U.S. Environmental Protection Agency (EPA) to J.C. Carey. It has not been formally reviewed by EPA. The views expressed in this paper are solely those of J.C. Carey and R. W. Fulweiler, and EPA does not endorse any products or commercial services mentioned in this publication. In addition, this research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration to J.C. Carey. The authors would also like to thank the Department of Earth Sciences at Boston University for partial funding support of J.C Carey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMIRAAL W, 1990, BIOGEOCHEMISTRY, V9, P175, DOI 10.1007/BF00692170; Amos GL, 1952, SILICA TIMBERS; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Carey JC, 2013, BIOGEOCHEMISTRY, V113, P525, DOI 10.1007/s10533-012-9784-2; Carey JC, 2012, BIOGEOCHEMISTRY, V111, P125, DOI 10.1007/s10533-011-9671-2; Clymans W, 2011, BIOGEOSCIENCE DISCUS, V8, P4391; CONLEY DJ, 1993, MAR ECOL PROG SER, V101, P179, DOI 10.3354/meps101179; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Cornelis J.-T., 2010, BIOGEOSCI DISCUSS, V7, P5873, DOI DOI 10.5194/BGD-7-5873-2010; Danielsson A, 2008, J MARINE SYST, V73, P263, DOI 10.1016/j.jmarsys.2007.10.015; Derry LA, 2005, NATURE, V433, P728, DOI 10.1038/nature03299; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Epstein E, 2009, ANN APPL BIOL, V155, P155, DOI 10.1111/j.1744-7348.2009.00343.x; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Fulweiler RW, 2005, BIOGEOCHEMISTRY, V74, P115, DOI 10.1007/s10533-004-2947-z; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Hou LJ, 2010, J ENVIRON SCI, V22, P374, DOI 10.1016/S1001-0742(09)60118-2; Houghton R. A., 1990, EARTH TRANSFORMED HU; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Ittekkot V, 2000, BIOSCIENCE, V50, P776, DOI 10.1641/0006-3568(2000)050[0776:HAAMBA]2.0.CO;2; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Koeppen RC, 1978, SOME ANATOMICAL CHAR, P15; Laruelle GG, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003267; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Ma J.F, 2001, SILICON AGR, V8, P17, DOI 10.1016/S0928-3420(01)80006-9; OFFICER CB, 1980, MAR ECOL PROG SER, V3, P83, DOI 10.3354/meps003083; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sferratore A, 2006, ENVIRON SCI TECHNOL, V40, P6630, DOI 10.1021/es060710q; Street-Perrott FA, 2008, EARTH SURF PROC LAND, V33, P1436, DOI 10.1002/esp.1712; Struyf E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1128; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Turner RE, 1998, P NATL ACAD SCI USA, V95, P13048, DOI 10.1073/pnas.95.22.13048; Vandevenne F, 2012, FRONT ECOL ENVIRON, V10, P243, DOI 10.1890/110046	35	88	89	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52932	10.1371/journal.pone.0052932	http://dx.doi.org/10.1371/journal.pone.0052932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300825	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600038
J	Cherry, JD; Liu, B; Frost, JL; Lemere, CA; Williams, JP; Olschowka, JA; O'Banion, MK				Cherry, Jonathan D.; Liu, Bin; Frost, Jeffrey L.; Lemere, Cynthia A.; Williams, Jacqueline P.; Olschowka, John A.; O'Banion, M. Kerry			Galactic Cosmic Radiation Leads to Cognitive Impairment and Increased A beta Plaque Accumulation in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							HIPPOCAMPAL IL-1-BETA OVEREXPRESSION; AMYLOID-BETA; DEPOSITION; CLEARANCE; EXPOSURE; DEFICITS; DAMAGE; NEUROINFLAMMATION; INFLAMMATION; NEUROGENESIS	Galactic Cosmic Radiation consisting of high-energy, high-charged (HZE) particles poses a significant threat to future astronauts in deep space. Aside from cancer, concerns have been raised about late degenerative risks, including effects on the brain. In this study we examined the effects of Fe-56 particle irradiation in an APP/PS1 mouse model of Alzheimer's disease (AD). We demonstrated 6 months after exposure to 10 and 100 cGy Fe-56 radiation at 1 GeV/mu, that APP/PS1 mice show decreased cognitive abilities measured by contextual fear conditioning and novel object recognition tests. Furthermore, in male mice we saw acceleration of A beta plaque pathology using Congo red and 6E10 staining, which was further confirmed by ELISA measures of A beta isoforms. Increases were not due to higher levels of amyloid precursor protein (APP) or increased cleavage as measured by levels of the beta C-terminal fragment of APP. Additionally, we saw no change in microglial activation levels judging by CD68 and Iba-1 immunoreactivities in and around A beta plaques or insulin degrading enzyme, which has been shown to degrade A beta. However, immunohistochemical analysis of ICAM-1 showed evidence of endothelial activation after 100 cGy irradiation in male mice, suggesting possible alterations in A beta trafficking through the blood brain barrier as a possible cause of plaque increase. Overall, our results show for the first time that HZE particle radiation can increase A beta plaque pathology in an APP/PS1 mouse model of AD.	[Cherry, Jonathan D.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Liu, Bin; Frost, Jeffrey L.; Lemere, Cynthia A.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA; [Williams, Jacqueline P.] Univ Rochester, Sch Med & Dent, Dept Radiat Oncol, Rochester, NY USA; [Olschowka, John A.; O'Banion, M. Kerry] Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Rochester; University of Rochester	O'Banion, MK (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA.	Kerry_Obanion@urmc.rochester.edu	Cherry, Jonathan/D-5394-2015	O'Banion, M. Kerry/0000-0003-1246-3363	NASA Space Radiobiology Research Program [NNX08BA09G]; University of Rochester Behavioral Science Facility Core [P30 ES01247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NASA Space Radiobiology Research Program; University of Rochester Behavioral Science Facility Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NASA Space Radiobiology Research Program, Grant NNX08BA09G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; The authors thank Peter Guida, Adam Rusek, and their teams at Brookhaven National Laboratories for support during mouse irradiations. Jack Walter, Mallory Olschowka, and Lee Trojanczyk assisted with irradiations, animal management, contextual fear conditioning, and tissue collection and processing. We thank Katherine Bachmann in the University of Rochester Behavioral Science Facility Core (supported in part by P30 ES01247) for running the novel object recognition test.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chakrabarty P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-16; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; Clark RE, 2000, J NEUROSCI, V20, P8853; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Encinas JM, 2008, EXP NEUROL, V210, P274, DOI 10.1016/j.expneurol.2007.10.021; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hein AM, 2012, J NEUROIMMUNE PHARM, V7, P145, DOI 10.1007/s11481-011-9294-3; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kahn MS, 2012, BEHAV BRAIN RES, V229, P176, DOI 10.1016/j.bbr.2012.01.010; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Kyrkanides S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-112; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mizumatsu S, 2003, CANCER RES, V63, P4021; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Nelson Gregory A, 2003, Gravit Space Biol Bull, V16, P29; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rydberg B, 1996, RADIAT RES, V145, P200, DOI 10.2307/3579175; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Villasana L, 2010, HIPPOCAMPUS, V20, P19, DOI 10.1002/hipo.20659; Vlkolinsky R, 2010, RADIAT RES, V173, P342, DOI 10.1667/RR1825.1; Vlkolinsky R, 2008, RADIAT RES, V169, P523, DOI 10.1667/RR1228.1; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	51	133	138	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53275	10.1371/journal.pone.0053275	http://dx.doi.org/10.1371/journal.pone.0053275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300905	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600078
J	Yoshikawa, N; Shimizu, N; Maruyama, T; Sano, M; Matsuhashi, T; Fukuda, K; Kataoka, M; Satoh, T; Ojima, H; Sawai, T; Morimoto, C; Kuribara, A; Hosono, O; Tanaka, H				Yoshikawa, Noritada; Shimizu, Noriaki; Maruyama, Takako; Sano, Motoaki; Matsuhashi, Tomohiro; Fukuda, Keiichi; Kataoka, Masaharu; Satoh, Toru; Ojima, Hidenori; Sawai, Takashi; Morimoto, Chikao; Kuribara, Akiko; Hosono, Osamu; Tanaka, Hirotoshi			Cardiomyocyte-Specific Overexpression of HEXIM1 Prevents Right Ventricular Hypertrophy in Hypoxia-Induced Pulmonary Hypertension in Mice	PLOS ONE			English	Article							CARDIAC LINEAGE PROTEIN-1; SMOOTH-MUSCLE-CELLS; ELONGATION-FACTOR-B; ENDOTHELIAL GROWTH-FACTOR; ARTERIAL-HYPERTENSION; GLUCOCORTICOID-RECEPTOR; PRESSURE-OVERLOAD; GENE-EXPRESSION; DOWN-REGULATION; P-TEFB	Right ventricular hypertrophy (RVH) and right ventricular (RV) contractile dysfunction are major determinants of prognosis in pulmonary arterial hypertension (PAH) and PAH remains a severe disease. Recently, direct interruption of left ventricular hypertrophy has been suggested to decrease the risk of left-sided heart failure. Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is a negative regulator of positive transcription elongation factor b (P-TEFb), which activates RNA polymerase II (RNAPII)-dependent transcription and whose activation is strongly associated with left ventricular hypertrophy. We hypothesized that during the progression of PAH, increased P-TEFb activity might also play a role in RVH, and that HEXIM1 might have a preventive role against such process. We revealed that, in the mouse heart, HEXIM1 is highly expressed in the early postnatal period and its expression is gradually decreased, and that prostaglandin I-2, a therapeutic drug for PAH, increases HEXIM1 levels in cardiomyocytes. These results suggest that HEXIM1 might possess negative effect on cardiomyocyte growth and take part in cardiomyocyte regulation in RV. Using adenovirus-mediated gene delivery to cultured rat cardiomyocytes, we revealed that overexpression of HEXIM1 prevents endothelin-1-induced phosphorylation of RNAPII, cardiomyocyte hypertrophy, and mRNA expression of hypertrophic genes, whereas a HEXIM1 mutant lacking central basic region, which diminishes P-TEFb-suppressing activity, could not. Moreover, we created cardiomyocyte-specific HEXIM1 transgenic mice and revealed that HEXIM1 ameliorates RVH and prevents RV dilatation in hypoxia-induced PAH model. Taken together, these findings indicate that cardiomyocyte-specific overexpression of HEXIM1 inhibits progression to RVH under chronic hypoxia, most possibly via inhibition of P-TEFb-mediated enlargement of cardiomyocytes. We conclude that P-TEFb/HEXIM1-dependent transcriptional regulation may play a pathophysiological role in RVH and be a novel therapeutic target for mitigating RVH in PAH.	[Yoshikawa, Noritada; Shimizu, Noriaki; Maruyama, Takako; Kuribara, Akiko; Hosono, Osamu; Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, Dept Rheumatol & Allergy, IMSUT Hosp, Tokyo, Japan; [Sano, Motoaki; Matsuhashi, Tomohiro; Fukuda, Keiichi; Kataoka, Masaharu] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kataoka, Masaharu; Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Mitaka, Tokyo 181, Japan; [Ojima, Hidenori] Natl Canc Ctr, Res Inst, Div Pathol, Tokyo 104, Japan; [Sawai, Takashi] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate, Japan; [Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders, Tokyo, Japan; [Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Tokyo, Japan	University of Tokyo; Keio University; Kyorin University; National Cancer Center - Japan; Iwate Medical University; Juntendo University; Juntendo University	Tanaka, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Rheumatol & Allergy, IMSUT Hosp, Tokyo, Japan.	hirotnk@ims.u-tokyo.ac.jp	Fukuda, Keiichi/L-3777-2013; Sano, Motoaki/L-3405-2013	Yoshikawa, Noritada/0000-0002-7530-0791	Ministry of Health, Labour, and Welfare [24390236, 22790693, 23791050, 24930026]; Takeda Science Foundation; Suzuken Memorial Foundation; Actelion Academia Prize (Actelion Pharmaceuticals); Actelion Pharmaceuticals; Grants-in-Aid for Scientific Research [22390200, 23791050, 24390236] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Actelion Academia Prize (Actelion Pharmaceuticals); Actelion Pharmaceuticals; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (B) to HT (24390236), for Young Scientists (B) to NY (22790693) and NS (23791050), and for Encouragement of Scientists to TM (24930026), grants from the Ministry of Health, Labour, and Welfare to HT, grants from Takeda Science Foundation and Suzuken Memorial Foundation to NS, and grant from Actelion Academia Prize (Actelion Pharmaceuticals) to NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With respect to funding from Actelion Pharmaceuticals, the authors do not have any other relevant declarations such as employment, consultancy, patents, products in development or marketed products, and their funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Endo J, 2007, CIRCULATION, V116, P1176, DOI 10.1161/CIRCULATIONAHA.106.650903; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Espinoza-Derout J, 2009, CIRC RES, V104, P1347, DOI 10.1161/CIRCRESAHA.108.191726; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; FILEP JG, 1995, CIRCULATION, V92, P2969, DOI 10.1161/01.CIR.92.10.2969; Gardin JM, 2004, JAMA-J AM MED ASSOC, V292, P2396, DOI 10.1001/jama.292.19.2396; GRAINGER DJ, 1992, BIOCHEM J, V283, P403, DOI 10.1042/bj2830403; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Huang F, 2004, MECH DEVELOP, V121, P559, DOI 10.1016/j.mod.2004.04.012; Huang FC, 2002, GENE, V292, P245, DOI 10.1016/S0378-1119(02)00596-6; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Mascareno E, 2012, J BIOL CHEM, V287, P13084, DOI 10.1074/jbc.M111.288944; Mascareno E, 2009, J CELL MOL MED, V13, P2744, DOI 10.1111/j.1582-4934.2008.00404.x; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Ogba N, 2010, ONCOGENE, V29, P3639, DOI 10.1038/onc.2010.110; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Park AM, 2010, HYPERTENSION, V56, P1145, DOI 10.1161/HYPERTENSIONAHA.110.160515; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ritchie RH, 2004, AM J PHYSIOL-HEART C, V287, pH1179, DOI 10.1152/ajpheart.00725.2003; Roeleveld RJ, 2004, CHEST, V125, P572, DOI 10.1378/chest.125.2.572; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shimizu N, 2008, MOL ENDOCRINOL, V22, P2609, DOI 10.1210/me.2008-0101; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Turano M, 2006, J CELL PHYSIOL, V206, P603, DOI 10.1002/jcp.20502; UNVERFERTH DV, 1986, AM J CARDIOL, V57, P816, DOI 10.1016/0002-9149(86)90620-X; Uzuki M, 2001, CLIN SCI, V100, P577, DOI 10.1042/CS20000242; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wilkins MR, 2005, AM J RESP CRIT CARE, V171, P1292, DOI 10.1164/rccm.200410-1411OC; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yokoyama C, 2002, CIRCULATION, V106, P2397, DOI 10.1161/01.CIR.0000034733.93020.BC; Yoshikawa N, 2008, BIOCHEM BIOPH RES CO, V371, P44, DOI 10.1016/j.bbrc.2008.03.155; Yoshikawa N, 2009, AM J PHYSIOL-ENDOC M, V296, pE1363, DOI 10.1152/ajpendo.90767.2008	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52522	10.1371/journal.pone.0052522	http://dx.doi.org/10.1371/journal.pone.0052522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300697	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600018
J	Biswal, BK; Beyrouthy, MJ; Hever-Jardine, MP; Armstrong, D; Tomlinson, CR; Christensen, BC; Marsit, CJ; Spinella, MJ				Biswal, Bijesh K.; Beyrouthy, Maroun J.; Hever-Jardine, Mary P.; Armstrong, David; Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.			Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation	PLOS ONE			English	Article							GERM-CELL TUMORS; STEM-CELLS; DOWN-REGULATION; METHYLATION; DNMT3B; GENES; CISPLATIN; DIFFERENTIATION; LINKING; COMPLEX	Human embryonal carcinoma (EC) cells are the stem cells of nonseminoma testicular germ cells tumors (TGCTs) and share remarkable similarities to human embryonic stem (ES) cells. In prior work we found that EC cells are hypersensitive to low nanomolar doses of 5-aza deoxycytidine (5-aza) and that this hypersensitivity partially depended on unusually high levels of the DNA methyltransferase, DNMT3B. We show here that low-dose 5-aza treatment results in DNA damage and induction of p53 in NT2/D1 cells. In addition, low-dose 5-aza results in global and gene specific promoter DNA hypomethylation. Low-dose 5-aza induces a p53 transcriptional signature distinct from that induced with cisplatin in NT2/D1 cells and also uniquely downregulates genes associated with pluripotency including NANOG, SOX2, GDF3 and Myc target genes. Changes in the p53 and pluripotency signatures with 5-aza were to a large extent dependent on high levels of DNMT3B. In contrast to the majority of p53 target genes upregulated by 5-aza that did not show DNA hypomethylation, several other genes induced with 5-aza had corresponding decreases in promoter methylation. These genes include RIN1, SOX15, GPER, and TLR4 and are novel candidate tumors suppressors in TGCTs. Our studies suggest that the hypersensitivity of NT2/D1 cells to low-dose 5-aza is multifactorial and involves the combined activation of p53 targets, repression of pluripotency genes, and activation of genes repressed by DNA methylation. Low-dose 5-aza therapy may be a general strategy to treat those tumors that are sustained by cells with embryonic stem-like properties. GEO number for the microarray data: GSE42647.	[Biswal, Bijesh K.; Beyrouthy, Maroun J.; Hever-Jardine, Mary P.; Armstrong, David; Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Tomlinson, Craig R.; Christensen, Brock C.; Marsit, Carmen J.; Spinella, Michael J.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Hanover, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Spinella, MJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	michael.spinella@dartmouth.edu	Tomlinson, Craig/F-1319-2017; Spinella, Michael/B-7210-2014	Biswal, Bijesh Kumar/0000-0002-5609-7660; Tomlinson, Craig/0000-0003-0923-1449; Marsit, Carmen/0000-0003-4566-150X	United States Department of Defense Investigator-Initiated Research Award [PR093629]; Prouty developmental award from the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	United States Department of Defense Investigator-Initiated Research Award(United States Department of Defense); Prouty developmental award from the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Department of Defense Investigator-Initiated Research Award PR093629 (MJS) and a Prouty developmental award from the Norris Cotton Cancer Center (MJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Baylin SB, 2005, COLD SH Q B, V70, P427, DOI 10.1101/sqb.2005.70.010; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Efstathiou Eleni, 2006, J Natl Compr Canc Netw, V4, P1059; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Giuliano CJ, 2005, BBA-GENE STRUCT EXPR, V1731, P48, DOI 10.1016/j.bbaexp.2005.08.006; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kashiwagi K, 2011, NUCLEIC ACIDS RES, V39, P874, DOI 10.1093/nar/gkq870; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Koychev D, 2011, INT J ANDROL, V34, pE266, DOI 10.1111/j.1365-2605.2011.01145.x; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Maslov AY, 2012, ONCOGENE, DOI [10.1038/onc.2012.9, DOI 10.1038/0NC.2012.9]; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okamoto K, 2012, INT J UROL, V19, P504, DOI 10.1111/j.1442-2042.2012.02986.x; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	56	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53003	10.1371/journal.pone.0053003	http://dx.doi.org/10.1371/journal.pone.0053003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300844	Green Submitted, gold, Green Published			2022-12-25	WOS:000312829100106
J	Chen, DF; Li, Y; Zhou, ZY; Xing, YG; Zhong, Y; Zou, XN; Tian, W; Zhang, C				Chen, Dafu; Li, Yang; Zhou, Zhiyu; Xing, Yonggang; Zhong, Yu; Zou, Xuenong; Tian, Wei; Zhang, Chi			Synergistic Inhibition of Wnt Pathway by HIF-1 alpha and Osteoblast-Specific Transcription Factor Osterix (Osx) in Osteoblasts	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; RECEPTOR-RELATED PROTEIN-5; GROWTH-FACTOR VEGF; BONE-FORMATION; SKELETAL DEVELOPMENT; DIFFERENTIATION; ANGIOGENESIS; CHONDROCYTES; HEDGEHOG; PROLIFERATION	Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation. Inhibition of Wnt pathway by Osx highlights the potential for feedback control mechanisms involved in bone formation. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of hypoxia. HIF-1 alpha has been reported to couple angiogenesis to osteogenesis. Our recent study has demonstrated that Osx and HIF-1 alpha cooperatively regulate VEGF expression in osteoblasts. Effects of hypoxia/HIF-1 alpha on osteoblast proliferation and related mechanisms are not well understood. In this study, osteoblast growth under hypoxia was examined. We observed that osteoblast growth was inhibited under hypoxia. To explore possible mechanisms for hypoxia/HIF-1 alpha to inhibit osteoblast proliferation, we tested the effect of hypoxia/HIF-1 alpha on Wnt pathway. Quantitative RT-PCR results revealed that Wnt target genes such as cyclin D1 and c-Myc were downregulated under hypoxia while HIF-1 alpha was upregulated. Treatment of desferrioxamine, a HIF-1 alpha activator, led to further downregulation of expressions of cyclin D1 and c-Myc in osteoblasts. On the contrary, the inhibition of HIF-1 alpha by siRNA in osteoblasts led to the expression increase of cyclin D1 and c-Myc. These data suggest that HIF-1 alpha inhibits Wnt pathway in osteoblasts. To examine the effect of HIF-1 alpha on Wnt pathway, HIF-1 alpha was cotransfected with beta-catenin along with Topflash reporter in transient transfection assay. Our results showed that HIF-1 alpha inhibited beta-catenin-induced Topflash reporter activity. Interestingly, a synergistic interplay was observed between Osx and HIF-1 alpha in the inhibition of beta-catenin-induced Topflash expression. Our findings indicate that Osx and HIF-1 alpha cooperatively inhibit Wnt pathway. This study revealed additional new information of the cooperation between HIF-1 alpha and Osx in osteoblasts.	[Chen, Dafu; Xing, Yonggang; Tian, Wei] Beijing JiShuiTan Hosp, Lab Bone Tissue Engn, Beijing Res Inst Traumatol & Orthopaed, Beijing, Peoples R China; [Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, Dallas, TX 75390 USA; [Li, Yang; Zhong, Yu; Zou, Xuenong] Sun Yat Sen Univ, Dept Spine, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University	Tian, W (corresponding author), Beijing JiShuiTan Hosp, Lab Bone Tissue Engn, Beijing Res Inst Traumatol & Orthopaed, Beijing, Peoples R China.	tianweijst@yahoo.com.cn; Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012; ZHOU, ZHIYU/AAU-5036-2021	ZHOU, ZHIYU/0000-0002-8101-2083	Arthritis Foundation; National Basic Research Program of China (973 Program) [2012CB619105]; National Natural Science Foundation of China [81171682]	Arthritis Foundation; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Bone Research Laboratory is supported by a Research Grant from the Arthritis Foundation (http://www.arthritis.org). This work is also supported by the National Basic Research Program of China (973 Program, No. 2012CB619105) and is in part supported by the National Natural Science Foundation of China (Grant Number 81171682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Chen DF, 2012, BIOCHEM BIOPH RES CO, V424, P176, DOI 10.1016/j.bbrc.2012.06.104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maxwell PH, 2002, CLIN MED, V2, P356, DOI 10.7861/clinmedicine.2-4-356; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; Ratcliffe PJ, 2000, NAT MED, V6, P1315, DOI 10.1038/82113; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	32	38	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52948	10.1371/journal.pone.0052948	http://dx.doi.org/10.1371/journal.pone.0052948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300831	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100103
J	Hassenklover, T; Pallesen, LP; Schild, D; Manzini, I				Hassenkloever, Thomas; Pallesen, Lars P.; Schild, Detlev; Manzini, Ivan			Amino Acid- vs. Peptide-Odorants: Responses of Individual Olfactory Receptor Neurons in an Aquatic Species	PLOS ONE			English	Article							XENOPUS-LAEVIS TADPOLES; MULTIDRUG-RESISTANCE TRANSPORTERS; CHANNEL CATFISH; N-ACETYLASPARTYLGLUTAMATE; ICTALURUS-PUNCTATUS; FEEDING-BEHAVIOR; FISH OLFACTION; DISSOLVED FREE; RAINBOW-TROUT; STREAM WATER	Amino acids are widely used waterborne olfactory stimuli proposed to serve as cues in the search for food. In natural waters the main source of amino acids is the decomposition of proteins. But this process also produces a variety of small peptides as intermediate cleavage products. In the present study we tested whether amino acids actually are the natural and adequate stimuli for the olfactory receptors they bind to. Alternatively, these olfactory receptors could be peptide receptors which also bind amino acids though at lower affinity. Employing calcium imaging in acute slices of the main olfactory epithelium of the fully aquatic larvae of Xenopus laevis we show that amino acids, and not peptides, are more effective waterborne odorants.	[Hassenkloever, Thomas; Pallesen, Lars P.; Schild, Detlev; Manzini, Ivan] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany; [Hassenkloever, Thomas; Schild, Detlev; Manzini, Ivan] Univ Gottingen, Cluster Excellence Nanoscale Microscopy & Mol Phy, Gottingen, Germany	University of Gottingen; University of Gottingen	Manzini, I (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany.	imanzin@gwdg.de	Manzini, Ivan/V-4545-2019; Manzini, Ivan/F-8927-2015	Manzini, Ivan/0000-0002-3575-9637; Manzini, Ivan/0000-0002-3575-9637; Hassenklover, Thomas/0000-0002-9895-1263	DFG Schwerpunktprogramm [1392]; Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB)	DFG Schwerpunktprogramm(German Research Foundation (DFG)); Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB)	This work was supported by DFG Schwerpunktprogramm 1392 (http://cms.uni-konstanz.de/spp) to IM, and Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain'' (CNMPB, http://www.cmpb.de) to IM and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Bischofberger J, 1996, J NEUROPHYSIOL, V76, P2089, DOI 10.1152/jn.1996.76.3.2089; Braubach OR, 2009, BEHAV BRAIN RES, V198, P190, DOI 10.1016/j.bbr.2008.10.044; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; CARR WES, 1986, J CHEM ECOL, V12, P989, DOI 10.1007/BF01638992; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; COFFIN RB, 1989, LIMNOL OCEANOGR, V34, P531, DOI 10.4319/lo.1989.34.3.0531; Delay RJ, 2002, CHEM SENSES, V27, P673, DOI 10.1093/chemse/27.8.673; Dittmar T., 2009, PRACTICAL GUIDELINES, P67; Doolin RE, 2005, CHEM SENSES, V30, P105, DOI 10.1093/chemse/bji005; Doolin RE, 2005, CHEM SENSES, V30, P127, DOI 10.1093/chemse/bji008; DUCHAMPVIRET P, 1989, J NEUROPHYSIOL, V61, P1085, DOI 10.1152/jn.1989.61.5.1085; DUCHAMPVIRET P, 1990, BRAIN RES, V517, P256, DOI 10.1016/0006-8993(90)91035-F; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Hansen A, 2003, J NEUROSCI, V23, P9328; HARA TJ, 1994, REV FISH BIOL FISHER, V4, P1, DOI 10.1007/BF00043259; HARA TJ, 1977, COMP BIOCHEM PHYS A, V56, P559, DOI 10.1016/0300-9629(77)90285-7; HARA TJ, 1992, FISH CHEMORECEPTION, P150; Hassenklover T, 2008, GLIA, V56, P1614, DOI 10.1002/glia.20714; Hubbard PC, 2011, J COMP PHYSIOL A, V197, P839, DOI 10.1007/s00359-011-0646-5; Ishizawa S, 2010, FISHERIES SCI, V76, P669, DOI 10.1007/s12562-010-0246-2; Janecka A, 2004, CURR TOP MED CHEM, V4, P1, DOI 10.2174/1568026043451618; JORGENSEN NOG, 1986, FRESHWATER BIOL, V16, P255, DOI 10.1111/j.1365-2427.1986.tb00969.x; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; KANG JS, 1991, J GEN PHYSIOL, V98, P699, DOI 10.1085/jgp.98.4.699; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEE C, 1977, LIMNOL OCEANOGR, V22, P502, DOI 10.4319/lo.1977.22.3.0502; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Manzini I, 2002, J NEUROSCI METH, V121, P159, DOI 10.1016/S0165-0270(02)00248-0; Manzini I, 2002, J PHYSIOL-LONDON, V545, P475, DOI 10.1113/jphysiol.2002.031914; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; Mezler M, 2001, J EXP BIOL, V204, P2987; Michel WC, 2003, J EXP BIOL, V206, P1697, DOI 10.1242/jeb.00339; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Mobley AS, 2008, ANAT REC, V291, P763, DOI 10.1002/ar.20704; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Nikonov AA, 2007, J NEUROPHYSIOL, V98, P1909, DOI 10.1152/jn.00548.2007; Pantoja S, 1999, MAR CHEM, V63, P273, DOI 10.1016/S0304-4203(98)00067-X; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Schmachtenberg O, 2004, EUR J NEUROSCI, V20, P3378, DOI 10.1111/j.1460-9568.2004.03825.x; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; SORENSEN PW, 1998, PHYSL FISHES, P251; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; TRANVIK LJ, 1995, BIOGEOCHEMISTRY, V30, P77; Valentincic T, 2000, J EXP BIOL, V203, P3307; Valentincic T, 1997, CHEM SENSES, V22, P375, DOI 10.1093/chemse/22.4.375; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x	59	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53097	10.1371/journal.pone.0053097	http://dx.doi.org/10.1371/journal.pone.0053097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300867	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100118
J	Nolan-Stevaux, O; Zhong, WD; Culp, S; Shaffer, K; Hoover, J; Wickramasinghe, D; Ruefli-Brasse, A				Nolan-Stevaux, Olivier; Zhong, Wendy; Culp, Stacey; Shaffer, Kathy; Hoover, Joseph; Wickramasinghe, Dineli; Ruefli-Brasse, Astrid			Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-LIKE KINASE-1; SMAD1/5 PHOSPHORYLATION; TUMOR-GROWTH; 1 ALK1; ANGIOGENESIS; EXPRESSION; VEGF; PROLIFERATION; PHASE	Endoglin (ENG), a co-receptor for several TGF beta-family cytokines, is expressed in dividing endothelial cells alongside ALK1, the ACVRL1 gene product. ENG and ACVRL1 are both required for angiogenesis and mutations in either gene are associated with Hereditary Hemorrhagic Telangectasia, a rare genetic vascular disorder. ENG and ALK1 function in the same genetic pathway but the relative contribution of TGF beta and BMP9 to SMAD1/5/8 activation and the requirement of ENG as a co-mediator of SMAD phosphorylation in endothelial cells remain debated. Here, we show that BMP9 and TGF beta 1 induce distinct SMAD phosphorylation responses in primary human endothelial cells and that, unlike BMP9, TGF beta only induces SMAD1/5/8 phosphorylation in a subset of immortalized mouse endothelial cell lines, but not in primary human endothelial cells. We also demonstrate, using siRNA depletion of ENG and novel anti-ENG antibodies, that ENG is required for BMP9/pSMAD1 signaling in all human and mouse endothelial cells tested. Finally, anti-ENG antibodies that interfere with BMP9/pSMAD1 signaling, but not with TGF beta 1/pSMAD3 signaling, also decrease in vitro HUVEC endothelial tube formation and inhibit BMP9 binding to recombinant ENG in vitro. Our data demonstrate that BMP9 signaling inhibition is a key and previously unreported mechanism of action of TRC105, an anti-angiogenic anti-Endoglin antibody currently evaluated in clinical trials.	[Nolan-Stevaux, Olivier; Zhong, Wendy; Wickramasinghe, Dineli; Ruefli-Brasse, Astrid] Amgen Inc, Oncol Res, San Francisco, CA USA; [Culp, Stacey; Shaffer, Kathy; Hoover, Joseph] Amgen Inc, Therapeut Discovery, Seattle, WA USA	Amgen; Amgen	Nolan-Stevaux, O (corresponding author), Amgen Inc, Oncol Res, San Francisco, CA USA.	oliviern@amgen.com		Nolan-Stevaux, Olivier/0000-0002-5934-4786	Amgen	Amgen(Amgen)	This work was performed at Amgen, solely supported by Amgen, and all authors are employed by Amgen. Monoclonal Rat anti-Human ENG Ab and monoclonal Rat anti-mouse Eng Ab (both developed at Amgen) were used in this study. The authors thank Dyke McEwen for running the first sets of HUVEC tube formation assays at Essen Bioscience. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Bailly S, 2008, BLOOD, V111, P478, DOI 10.1182/blood-2007-10-118042; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gazit-Bornstein G, 2010, ANTIBODIES DIRECTED; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lebrin F, 2008, TRENDS CARDIOVAS MED, V18, P25, DOI 10.1016/j.tcm.2007.11.003; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Nolan-Stevaux O, 2012, TUMOR ANGIOGENESIS, P85; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; She X, 2003, THESIS STATE U NEW Y; Sorensen LK, 2003, DEV BIOL, V261, P235, DOI 10.1016/S0012-1606(03)00158-1; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; van Meeteren LA, 2011, CELL TISSUE RES; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995	53	71	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e50920	10.1371/journal.pone.0050920	http://dx.doi.org/10.1371/journal.pone.0050920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300529	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100005
J	Wang, F; Shi, Y; Lu, L; Liu, L; Cai, YL; Zheng, HR; Liu, X; Yan, F; Zou, C; Sun, CY; Shi, J; Lu, SK; Chen, Y				Wang, Feng; Shi, Yu; Lu, Lin; Liu, Li; Cai, Youli; Zheng, Hairong; Liu, Xin; Yan, Fei; Zou, Chao; Sun, Chengyu; Shi, Jie; Lu, Shukun; Chen, Yun			Targeted Delivery of GDNF through the Blood-Brain Barrier by MRI-Guided Focused Ultrasound	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; P-SELECTIN; RAT-BRAIN; DRUG; MICROBUBBLES; DISRUPTION; ADDICTION; MOUSE	Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), are promising therapeutic agents for neurodegenerative diseases. However, the application of GDNF to treat these diseases effectively is limited because the blood-brain barrier (BBB) prevents the local delivery of macromolecular therapeutic agents from entering the central nervous system (CNS). Focused ultrasound combined with microbubbles (MBs) using appropriate parameters has been previously demonstrated to be able to open the BBB locally and noninvasively. This study investigated the targeted delivery of GDNF MBs through the BBB by magnetic resonance imaging (MRI)-guided focused ultrasound. Evans Blue extravasation and histological examination were used to determine the optimum focused ultrasound parameters. Enzyme-linked immunosorbent assay was performed to verify the effects of GDNF bound on MBs using a biotin-avidin bridging chemistry method to promote GDNF delivery into the brain. The results showed that GDNF can be delivered locally and noninvasively into the CNS through the BBB using MRI-guided focused ultrasound combined with MBs under optimum parameters. MBs that bind GDNF combined with MRI-guided focused ultrasound may be an effective way of delivering neurotrophic factors directly into the CNS. The method described herein provides a potential means of treating patients with CNS diseases.	[Wang, Feng; Shi, Yu; Liu, Li; Cai, Youli; Lu, Shukun; Chen, Yun] Peking Univ, Dept Ultrasound, Shenzhen Hosp, Biomed Res Inst,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Lu, Lin; Sun, Chengyu; Shi, Jie] Peking Univ, Natl Inst Drug Dependence, Shenzhen, Peoples R China; [Zheng, Hairong; Liu, Xin; Yan, Fei; Zou, Chao] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wang, Feng] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China; [Liu, Xin; Zou, Chao] Shenzhen Key Lab MRI, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Xinxiang Medical University	Chen, Y (corresponding author), Peking Univ, Dept Ultrasound, Shenzhen Hosp, Biomed Res Inst,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China.	cyun126@126.com	SHI, JIE/GXG-3394-2022		National Natural Science Foundation [30970833, 81101048, U1204810]; National 973 basic research program [2011CB707903]; National Postdoctoral Science Foundation [2011M501111]; Shenzhen Basic Research Program [JC201005280495A]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 basic research program(National Basic Research Program of China); National Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shenzhen Basic Research Program	This work was supported by grants from the National Natural Science Foundation (No. 30970833), National 973 basic research program (No. 2011CB707903), the National Natural Science Foundation (No. 81101048 and No. U1204810), National Postdoctoral Science Foundation (No. 2011M501111), and Shenzhen Basic Research Program (No. JC201005280495A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carnicella S, 2009, PHARMACOL THERAPEUT, V122, P9, DOI 10.1016/j.pharmthera.2008.12.001; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; Deng CX, 2010, THER DELIV, V1, P819, DOI 10.4155/TDE.10.66; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Garbayo E, 2007, INT J PHARMACEUT, V344, P9, DOI 10.1016/j.ijpharm.2007.04.003; Gearhart DA, 2006, J NEUROSCI METH, V150, P159, DOI 10.1016/j.jneumeth.2005.06.009; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kaufmann BA, 2007, EUR HEART J, V28, P2011, DOI 10.1093/eurheartj/ehm176; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Mcdannold N, 2008, ULTRASOUND MED BIOL, V34, P930, DOI 10.1016/j.ultrasmedbio.2007.11.009; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nevalainen N, 2010, NEUROSCIENCE, V171, P1357, DOI 10.1016/j.neuroscience.2010.10.010; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takalkar AM, 2004, J CONTROL RELEASE, V96, P473, DOI 10.1016/j.jconrel.2004.03.002; Tempany CMC, 2003, RADIOLOGY, V226, P897, DOI 10.1148/radiol.2271020395; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang F, 2009, J ULTRAS MED, V28, P1501, DOI 10.7863/jum.2009.28.11.1501; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038	30	41	48	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52925	10.1371/journal.pone.0052925	http://dx.doi.org/10.1371/journal.pone.0052925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300823	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100100
J	Zhang, N; Pan, XM; Ge, M				Zhang, Nan; Pan, Xian-Ming; Ge, Meng			Without Salt, the 'Thermophilic' Protein Mth10b Is Just Mesophilic	PLOS ONE			English	Article							DNA-BINDING PROTEIN; CRYSTAL-STRUCTURE; METHANOPYRUS-KANDLERI; ION-PAIRS; HYPERTHERMOPHILIC ARCHAEON; GUANIDINE-HYDROCHLORIDE; THERMOTOGA-MARITIMA; THERMOSTABILITY; STABILITY; ENZYMES	Most proteins from thermophiles or hyperthermophiles are intrinsically thermostable. However, though Methanobacterium thermoautotrophicum Delta H is a thermophilic archaeon with an optimal growth temperature of 65 degrees C, Mth10b, an atypical member the Sac10b protein family from M. thermoautotrophicum DH, seems not intrinsically thermostable. In this work, to clarify the molecular mechanism of Mth10b remaining stable under its physiological conditions, the thermodynamic properties of Mth10b were studied through equilibrium unfolding experiments performed at pH 7.0 monitored by circular dichroism (CD) spectra in detail. Our work demonstrated that Mth10b is not intrinsically thermostable and that due to the masking effect upon the large numbers of destabilizing electrostatic repulsions resulting from the extremely uneven distribution of charged residues over the surface of Mth10b, salt can contribute to the thermostability of Mth10b greatly. Considering that the intracellular salt concentration is high to 0.7 M, we concluded that salt is the key extrinsic factor to Mth10b remaining stable under its physiological conditions. In other word, without salt, 'thermophilic' protein Mth10b is just a mesophilic one.	[Zhang, Nan; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ge, Meng] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Pan, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn; gemeng@big.ac.cn			Natural Science Foundation of China [30870475]; Ministry of Science and Technology of China [2009CB918801]; China Postdoctoral Science Foundation [201104166, 20100470567]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants 30870475 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm), 2009CB918801 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), and 201104166 and 20100470567 from the China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Ermler U, 1997, STRUCTURE, V5, P635, DOI 10.1016/S0969-2126(97)00219-0; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Freire E, 1995, METHOD ENZYMOL, V259, P144; Gaseidnes S, 2003, PROTEIN ENG, V16, P841, DOI 10.1093/protein/gzg105; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Ge M, 2009, EXTREMOPHILES, V13, P481, DOI 10.1007/s00792-009-0233-7; Ge M, 2009, EXTREMOPHILES, V13, P131, DOI 10.1007/s00792-008-0204-4; Goihberg E, 2007, PROTEINS, V66, P196, DOI 10.1002/prot.21170; Grabarse W, 1999, STRUCTURE, V7, P1257, DOI 10.1016/S0969-2126(00)80059-3; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Liu YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034986; Liu YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019977; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pace C N, 1986, Methods Enzymol, V131, P266; Privalov PL, 1979, ADV PROCHEM SIOPHYS, V210, P455; Rahman RNZA, 1998, BIOCHEM BIOPH RES CO, V248, P920, DOI 10.1006/bbrc.1998.8933; Ramos A, 1997, APPL ENVIRON MICROB, V63, P4020, DOI 10.1128/AEM.63.10.4020-4025.1997; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Shima S, 1998, ARCH MICROBIOL, V170, P469, DOI 10.1007/s002030050669; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Suvd D, 2001, J BIOCHEM, V129, P461, DOI 10.1093/oxfordjournals.jbchem.a002878; SUZUKI Y, 1989, P JPN ACAD B-PHYS, V65, P146, DOI 10.2183/pjab.65.146; SUZUKI Y, 1987, APPL MICROBIOL BIOT, V26, P546, DOI 10.1007/BF00253030; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Wilquet V, 1998, EUR J BIOCHEM, V255, P628, DOI 10.1046/j.1432-1327.1998.2550628.x; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250	51	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53125	10.1371/journal.pone.0053125	http://dx.doi.org/10.1371/journal.pone.0053125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300880	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100124
J	Russo, RR; Dasa, V; Duarte, R; Beakley, B; Mishra, M; Thompson, H				Russo, Russell R.; Dasa, Vinod; Duarte, Robert; Beakley, Burton; Mishra, Manish; Thompson, Hilary			Post-Operative Hypertension after Total Knee Arthroplasty and the Effects on Transfusion Rates	PLOS ONE			English	Article							BLOOD-TRANSFUSION; TOTAL HIP	Transfusions are a cause of significant patient morbidity as well as expense. Anesthesia literature has examined controlled intraoperative hypotension as a means for reducing blood loss and transfusions. Our hypothesis is that inversely increased blood pressure post-operatively would then lead to increased blood loss and transfusions. We examined 105 consecutive patients who underwent TKA. We found a significant odds ratio of 1.123 for pre-operative hematocrit. For post-operative blood pressure, we calculated an insignificant odds ratio of 1.007, proving no relationship between post-operative blood pressure and transfusions. This is the first study to examine increased post-operative blood pressure's contribution to transfusion rates. Although we confirmed that low pre-operative hematocrit contributes to increased transfusions, we did not find a relationship between post-operative blood pressure and transfusions.	[Russo, Russell R.; Dasa, Vinod; Duarte, Robert] Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA; [Beakley, Burton] Louisiana State Univ, Sch Med, Hlth Sci Ctr, Shreveport, LA USA; [Mishra, Manish] Tulane Sch Med, New Orleans, LA USA; [Thompson, Hilary] Louisiana State Univ, Hlth Sci Ctr, Dept Biostat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Russo, RR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA.	rrusso@lsuhsc.edu		dasa, vinod/0000-0001-5282-4026; Russo, Russell/0000-0002-6465-4746				Bong MR, 2004, J ARTHROPLASTY, V19, P281, DOI 10.1016/j.arth.2003.10.013; ETCHASON J, 1995, NEW ENGL J MED, V332, P719, DOI 10.1056/NEJM199503163321106; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Juelsgaard P, 2001, REGIONAL ANESTHESIA, V26, P2; Kourtzis N, 2004, AM J SURG, V187, P261, DOI 10.1016/j.amjsurg.2003.11.022; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Lee GC, 2005, CLIN ORTHOP RELAT R, P170, DOI 10.1097/01.blo.0000187338.25250.6a; Levy O, 1999, J BONE JOINT SURG AM, V81A, P1580, DOI 10.2106/00004623-199911000-00010; Mesa-Ramos F, 2008, ACTA ORTHOP BELG, V74, P83; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; SooHoo NF, 2006, J BONE JOINT SURG AM, V88A, P480, DOI 10.2106/JBJS.E.00629; THOMPSON GE, 1978, ANESTHESIOLOGY, V48, P91, DOI 10.1097/00000542-197802000-00003	12	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50967	10.1371/journal.pone.0050967	http://dx.doi.org/10.1371/journal.pone.0050967			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300531	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800009
J	Baczyk, D; Kibschull, M; Mellstrom, B; Levytska, K; Rivas, M; Drewlo, S; Lye, SJ; Naranjo, JR; Kingdom, JCP				Baczyk, Dora; Kibschull, Mark; Mellstrom, Britt; Levytska, Khrystyna; Rivas, Marcos; Drewlo, Sascha; Lye, Stephen J.; Naranjo, Jose R.; Kingdom, John C. P.			DREAM Mediated Regulation of GCM1 in the Human Placental Trophoblast	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSOR; PROTEIN; CELLS; CALSENILIN; SYNCYTIN; TERM; DIFFERENTIATION; APOPTOSIS; INTERACTS	The trophoblast transcription factor glial cell missing-1 (GCM1) regulates differentiation of placental cytotrophoblasts into the syncytiotrophoblast layer in contact with maternal blood. Reduced placental expression of GCM1 and abnormal syncytiotrophoblast structure are features of hypertensive disorder of pregnancy - preeclampsia. In-silico techniques identified the calcium-regulated transcriptional repressor - DREAM (Downstream Regulatory Element Antagonist Modulator) - as a candidate for GCM1 gene expression. Our objective was to determine if DREAM represses GCM1 regulated syncytiotrophoblast formation. EMSA and ChIP assays revealed a direct interaction between DREAM and the GCM1 promoter. siRNA-mediated DREAM silencing in cell culture and placental explant models significantly up-regulated GCM1 expression and reduced cytotrophoblast proliferation. DREAM calcium dependency was verified using ionomycin. Furthermore, the increased DREAM protein expression in preeclamptic placental villi was predominantly nuclear, coinciding with an overall increase in sumolylated DREAM and correlating inversely with GCM1 levels. In conclusion, our data reveal a calcium-regulated pathway whereby GCM1-directed villous trophoblast differentiation is repressed by DREAM. This pathway may be relevant to disease prevention via calcium-supplementation.	[Baczyk, Dora; Kibschull, Mark; Levytska, Khrystyna; Drewlo, Sascha; Lye, Stephen J.; Kingdom, John C. P.] Univ Toronto, Mt Sinai Hosp, Res Ctr Womens & Infants Hlth, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mellstrom, Britt; Rivas, Marcos; Naranjo, Jose R.] CSIC, Natl Biotechnol Ctr, Dept Mol & Cellular Biol, Madrid, Spain; [Lye, Stephen J.; Kingdom, John C. P.] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Baczyk, D (corresponding author), Univ Toronto, Mt Sinai Hosp, Res Ctr Womens & Infants Hlth, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	baczyk@lunenfeld.ca	Drewlo, Sascha/AAS-9890-2020; NARANJO, Jose R/K-1950-2014; Kingdom, John/A-3247-2013; Kingdom, John/AAF-2145-2020; Lye, Stephen J/E-7269-2013	NARANJO, Jose R/0000-0002-0270-3469; Lye, Stephen J/0000-0002-3305-4406	Canadian Institute of Health Research [64302]; Department of Obstetrics Gynecology; Rose Torno Chair at MSH; Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health; Molly Towell Perinatal Research Foundation Fellowship; Spanish Science Agency-DGICYT [SAF2010-21784, SAF2008-03469]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Obstetrics Gynecology; Rose Torno Chair at MSH; Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health(Canadian Institutes of Health Research (CIHR)); Molly Towell Perinatal Research Foundation Fellowship; Spanish Science Agency-DGICYT	This research is supported by Canadian Institute of Health Research (Grant no. 64302) to JK, Department of Obstetrics & Gynecology and Rose Torno Chair at MSH as well as by the Canadian Institutes of Health Research Interface Training Program, Applying Genomics to Human Health & Molly Towell Perinatal Research Foundation Fellowship to SD, and Spanish Science Agency-DGICYT (grants SAF2010-21784; SAF2008-03469) to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Baczyk D, 2004, PLACENTA, V25, P553, DOI 10.1016/j.placenta.2003.12.004; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baczyk D, 2011, CELL CALCIUM, V49, P350, DOI 10.1016/j.ceca.2010.12.003; Benirschke K., 2005, PATHOLOGY HUMAN PLAC; Bieche I, 1999, CANCER RES, V59, P2759; Burton GJ, 2009, TAIWAN J OBSTET GYNE, V48, P28, DOI 10.1016/S1028-4559(09)60032-2; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cali T., 2012, J BIOL CHEM; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Ellery PM, 2009, PLACENTA, V30, P329, DOI 10.1016/j.placenta.2009.01.002; Fitzgerald B, 2011, PLACENTA, V32, P339, DOI 10.1016/j.placenta.2011.01.018; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Huppertz B, 2010, PLACENTA, V31, pS75, DOI 10.1016/j.placenta.2009.12.001; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Matsuda M, 2006, ENDOCRINOLOGY, V147, P4608, DOI 10.1210/en.2006-0254; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Moreau R, 2002, BIOL REPROD, V67, P1473, DOI 10.1095/biolreprod.102.005397; Palczewska M, 2011, BBA-MOL CELL RES, V1813, P1050, DOI 10.1016/j.bbamcr.2010.11.001; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rivas M, 2011, ANTIOXID REDOX SIGNA; Robson SC, 2002, AM J OBSTET GYNECOL, V187, P1349, DOI 10.1067/mob.2002.126866; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; SIMPSON RA, 1992, PLACENTA, V13, P501, DOI 10.1016/0143-4004(92)90055-X; Walker MG, 2012, PLACENTA; Wu LJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-3; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	43	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e51837	10.1371/journal.pone.0051837	http://dx.doi.org/10.1371/journal.pone.0051837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300953	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000004
J	Schuldt, BM; Guhr, A; Lenz, M; Kobold, S; MacArthur, BD; Schuppert, A; Loser, P; Muller, FJ				Schuldt, Bernhard M.; Guhr, Anke; Lenz, Michael; Kobold, Sabine; MacArthur, Ben D.; Schuppert, Andreas; Loeser, Peter; Mueller, Franz-Josef			Power-Laws and the Use of Pluripotent Stem Cell Lines	PLOS ONE			English	Article							DERIVATION; GENERATION; ADVANTAGE; EMBRYOS; POLICY; STATE; CALL	It is widely accepted that the (now reversed) Bush administration's decision to restrict federal funding for human embryonic stem cell (hESC) research to a few "eligible" hESC lines is responsible for the sustained preferential use of a small subset of hESC lines (principally the H1 and H9 lines) in basic and preclinical research. Yet, international hESC usage patterns, in both permissive and restrictive political environments, do not correlate with a specific type of stem cell policy. Here we conducted a descriptive analysis of hESC line usage and compared the ability of policy-driven processes and collaborative processes inherent to biomedical research to recapitulate global hESC usage patterns. We find that current global hESC usage can be modelled as a cumulative advantage process, independent of restrictive or permissive policy influence, suggesting a primarily innovation-driven (rather than policy-driven) mechanism underlying human pluripotent stem cell usage in preclinical research.	[Schuldt, Bernhard M.; Lenz, Michael; Schuppert, Andreas] Rhein Westfal TH Aachen, Graduiertenschule Aachen Inst Adv Study Computat, D-52062 Aachen, Germany; [Guhr, Anke; Kobold, Sabine; Loeser, Peter] Robert Koch Inst, Berlin, Germany; [MacArthur, Ben D.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton, Hants, England; [MacArthur, Ben D.] Univ Southampton, Sch Math, Southampton, Hants, England; [MacArthur, Ben D.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany	RWTH Aachen University; Robert Koch Institute; University of Southampton; University of Southampton; University of Southampton	Loser, P (corresponding author), Robert Koch Inst, Berlin, Germany.	loeserp@rki.de; fj.mueller@zip-kiel.de	Lenz, Michael/J-4401-2016; Müller, Franz-Josef/E-3336-2010	Lenz, Michael/0000-0002-6319-6480; Müller, Franz-Josef/0000-0001-9478-8430; MacArthur, Ben/0000-0002-5396-9750; Schuppert, Andreas/0000-0003-3783-6605	Bayer Technologies Services; Else Kroner Fresenius Stiftung	Bayer Technologies Services; Else Kroner Fresenius Stiftung	The authors would like to formally state that the work leading to the manuscript has been funded in part by Bayer Technologies Services by providing salary to Bernhard Schuldt and Andreas Schuppert. Also, the work has been funded in part by a fellowship to Franz-Josef Muller by the Else Kroner Fresenius Stiftung. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials and there are no commercial or other interests (such as patents, products in development, consultancy etc.) tied to the manuscript. The funding sources had no influence on or took part in the interpretation of the scientific data presented or conclusions drawn.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aldhous P, 2005, NATURE, V434, P694, DOI 10.1038/434694a; [Anonymous], 2009, GER REC FDA CLEAR BE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Csardi N., 2006, INT J COMP SYST, V1695, P1; Fletcher J, 2006, TLS-TIMES LIT SUPPL, P8; Fraga AM, 2011, CELL TRANSPLANT, V20, P431, DOI 10.3727/096368910X522261; GENTLEMAN RCV, 2005, BIOINFORMATICS COMPU, V19; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Holden C, 2009, SCIENCE, V323, P1552, DOI 10.1126/science.323.5921.1552a; Isasi RM, 2009, STEM CELL RES, V3, P96, DOI 10.1016/j.scr.2009.05.003; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Levine AD, 2011, NAT BIOTECHNOL, V29, P1079, DOI 10.1038/nbt.2029; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; McCormick JB, 2009, CELL STEM CELL, V4, P107, DOI 10.1016/j.stem.2009.01.002; Miller G, 2010, SCIENCE, V330, P1742, DOI 10.1126/science.330.6012.1742; Morris SA, 2005, 10 INT C INT SOC SCI; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; O'Rourke PP, 2008, CELL STEM CELL, V2, P307, DOI 10.1016/j.stem.2008.03.018; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel R, 2011, J STEM CELL RES THER, V1, P107, DOI DOI 10.4172/2157-7633.1000107; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Peura TT, 2007, THERIOGENOLOGY, V67, P32, DOI 10.1016/j.theriogenology.2006.09.031; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Russo E, 2005, PLOS BIOL, V3, P1167, DOI 10.1371/journal.pbio.0030234; Schlaeger TM, 2007, DRUG DISCOV TODAY, V12, P269, DOI 10.1016/j.drudis.2007.02.011; Scott CT, 2011, CELL, V145, P820, DOI 10.1016/j.cell.2011.05.032; Scott CT, 2010, NAT METHODS, V7, P866, DOI 10.1038/nmeth1110-866; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Scott CT, 2009, NATURE, V460, P33, DOI 10.1038/460033b; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon C, 2005, FERTIL STERIL, V83, P246, DOI 10.1016/j.fertnstert.2004.09.004; SIMON HA, 1955, BIOMETRIKA, V42, P425; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vogel G, 2001, SCIENCE, V293, P1242, DOI 10.1126/science.293.5533.1242; Vogel G, 2008, SCIENCE, V322, P1766, DOI 10.1126/science.322.5909.1766; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	57	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52068	10.1371/journal.pone.0052068	http://dx.doi.org/10.1371/journal.pone.0052068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300961	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900017
J	Clark, CM; Flynn, DFB; Butterfield, BJ; Reich, PB				Clark, Christopher M.; Flynn, Dan F. B.; Butterfield, Bradley J.; Reich, Peter B.			Testing the Link between Functional Diversity and Ecosystem Functioning in a Minnesota Grassland Experiment	PLOS ONE			English	Article							COMMUNITY ASSEMBLY RULES; PLANT DIVERSITY; SPECIES RICHNESS; UNIFIED APPROACH; TRAIT DIVERSITY; MULTIPLE TRAITS; BIODIVERSITY; INDEXES; PRODUCTIVITY; DISSIMILARITY	The functional diversity of a community can influence ecosystem functioning and reflects assembly processes. The large number of disparate metrics used to quantify functional diversity reflects the range of attributes underlying this concept, generally summarized as functional richness, functional evenness, and functional divergence. However, in practice, we know very little about which attributes drive which ecosystem functions, due to a lack of field-based tests. Here we test the association between eight leading functional diversity metrics (Rao's Q, FD, FDis, FEve, FDiv, convex hull volume, and species and functional group richness) that emphasize different attributes of functional diversity, plus 11 extensions of these existing metrics that incorporate heterogeneous species abundances and trait variation. We assess the relationships among these metrics and compare their performances for predicting three key ecosystem functions (above-and belowground biomass and light capture) within a long-term grassland biodiversity experiment. Many metrics were highly correlated, although unique information was captured in FEve, FDiv, and dendrogram-based measures (FD) that were adjusted by abundance. FD adjusted by abundance outperformed all other metrics in predicting both above-and belowground biomass, although several others also performed well (e. g. Rao's Q, FDis, FDiv). More generally, trait-based richness metrics and hybrid metrics incorporating multiple diversity attributes outperformed evenness metrics and single-attribute metrics, results that were not changed when combinations of metrics were explored. For light capture, species richness alone was the best predictor, suggesting that traits for canopy architecture would be necessary to improve predictions. Our study provides a comprehensive test linking different attributes of functional diversity with ecosystem function for a grassland system.	[Clark, Christopher M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Clark, Christopher M.] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Flynn, Dan F. B.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Butterfield, Bradley J.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Butterfield, Bradley J.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Columbia University; Northern Arizona University; Northern Arizona University; University of Minnesota System; University of Minnesota Twin Cities	Clark, CM (corresponding author), US EPA, Global Change Res Program, Off Res & Dev, Washington, DC 20460 USA.	clark.christopher@epa.gov	Flynn, Dan/AAT-7028-2020; Flynn, Dan/A-4200-2008	Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Reich, Peter/0000-0003-4424-662X	U.S. Department of Energy; National Institute for Climate Change Research; NSF; Direct For Biological Sciences [1242531] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute for Climate Change Research; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding from U.S. Department of Energy, National Institute for Climate Change Research; and the NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Burnham KaDA, 2002, MODEL SELECTION MULT; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lin BB, 2011, J APPL ECOL, V48, P609, DOI 10.1111/j.1365-2664.2010.01944.x; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S., 2009, BIODIVERSITY ECOSYST; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Petchey O.L., 2009, BIODIVERSITY ECOSYST, P49; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; USDA National Plant Data Team, 2012, PLANTS DAT; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	54	62	63	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52821	10.1371/journal.pone.0052821	http://dx.doi.org/10.1371/journal.pone.0052821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300787	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000313872600027
J	Guenther, S; Aschenbrenner, K; Stamm, I; Bethe, A; Semmler, T; Stubbe, A; Stubbe, M; Batsajkhan, N; Glupczynski, Y; Wieler, LH; Ewers, C				Guenther, Sebastian; Aschenbrenner, Katja; Stamm, Ivonne; Bethe, Astrid; Semmler, Torsten; Stubbe, Annegret; Stubbe, Michael; Batsajkhan, Nyamsuren; Glupczynski, Youri; Wieler, Lothar H.; Ewers, Christa			Comparable High Rates of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in Birds of Prey from Germany and Mongolia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; CTX-M; COMPANION ANIMALS; FECAL SAMPLES; BACTERIA; ENTEROBACTERIACEAE; EMERGENCE; LIVESTOCK; STRAINS; GENES	Frequent contact with human waste and liquid manure from intensive livestock breeding, and the increased loads of antibiotic-resistant bacteria that result, are believed to be responsible for the high carriage rates of ESBL-producing E. coli found in birds of prey (raptors) in Central Europe. To test this hypothesis against the influence of avian migration, we initiated a comparative analysis of faecal samples from wild birds found in Saxony-Anhalt in Germany and the Gobi-Desert in Mongolia, regions of dissimilar human and livestock population characteristics and agricultural practices. We sampled a total of 281 wild birds, mostly raptors with primarily north-to-south migration routes. We determined antimicrobial resistance, focusing on ESBL production, and unravelled the phylogenetic and clonal relatedness of identified ESBL-producing E. coli isolates using multi-locus sequence typing (MLST) and macrorestriction analyses. Surprisingly, the overall carriage rates (approximately 5%) and the proportion of ESBL-producers among E. coli (Germany: 13.8%, Mongolia: 10.8%) were similar in both regions. Whereas bla(CTX-M-1) predominated among German isolates (100%), bla(CTX-M-9) was the most prevalent in Mongolian isolates (75%). We identified sequence types (STs) that are well known in human and veterinary clinical ESBL-producing E. coli (ST12, ST117, ST167, ST648) and observed clonal relatedness between a Mongolian avian ESBL-E. coli (ST167) and a clinical isolate of the same ST that originated in a hospitalised patient in Europe. Our data suggest the influence of avian migratory species in the transmission of ESBL-producing E. coli and challenge the prevailing assumption that reducing human influence alone invariably leads to lower rates of antimicrobial resistance.	[Guenther, Sebastian; Aschenbrenner, Katja; Bethe, Astrid; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Stamm, Ivonne] Vet Med Labor GmbH, Ludwigsburg, Germany; [Stubbe, Annegret; Stubbe, Michael] Univ Halle Wittenberg, Inst Biol, Dept Zool, D-06108 Halle, Germany; [Batsajkhan, Nyamsuren] Natl Univ Mongolia, Dept Zool, Ulaanbaatar, Mongolia; [Glupczynski, Youri] Catholic Univ Louvain, CHU Mont Godinne, Natl Reference Lab Antimicrobial Resistance Gram, Yvoir, Belgium; [Ewers, Christa] Univ Giessen, Fac Vet, Inst Hyg & Infect Dis Anim, D-35390 Giessen, Germany	Free University of Berlin; Vet Med Labor GmbH; Martin Luther University Halle Wittenberg; National University of Mongolia; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Justus Liebig University Giessen	Guenther, S (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	guenther.sebastian@fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Ewers, Christa/AAL-9186-2020; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Ewers, Christa/0000-0001-6167-1340; Wieler, Lothar H./0000-0003-4365-3717; Guenther, Sebastian/0000-0003-0173-7314	Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo) [01KI1012A]; German Research Foundation (DFG); Indo-German Research Training Group [GRK1673]	Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Indo-German Research Training Group	This work was supported by the Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo, Grant no. 01KI1012A) and the German Research Foundation (DFG) funded Indo-German Research Training Group (Grant GRK1673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Berthold P, 2001, OXFORD ORNITHOLOGICA; Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Bloom DE, 2011, SCIENCE, V333, P562, DOI 10.1126/science.1209290; Bonnedahl J., 2011, ANTIBIOTIC RESISTANC; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; Grimm V, 2004, J CLIN MICROBIOL, V42, P3766, DOI 10.1128/JCM.42.8.3766-3774.2004; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; Hernandez J, 2010, ENV MICROBIOL REP, V2, P329, DOI 10.1111/j.1758-2229.2010.00142.x; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Maguire AJ, 2001, ANTIMICROB AGENTS CH, V45, P1022, DOI 10.1128/AAC.45.4.1022-1029.2001; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Naseer U, 2009, APMIS, V117, P526, DOI 10.1111/j.1600-0463.2009.02465.x; Nelson M, 2008, DIS AQUAT ORGAN, V81, P53, DOI 10.3354/dao01937; Nemoy LL, 2005, J CLIN MICROBIOL, V43, P1776, DOI 10.1128/JCM.43.4.1776-1781.2005; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Park YJ, 2007, J ANTIMICROB CHEMOTH, V60, P868, DOI 10.1093/jac/dkm266; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pinto L, 2010, APPL ENVIRON MICROB, V76, P4118, DOI 10.1128/AEM.02761-09; Radhouani H, 2010, J ANTIMICROB CHEMOTH, V65, P171, DOI 10.1093/jac/dkp403; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Steinfeld H., 2010, LIVESTOCK CHANGING L; Stubbe M., 2010, Erforschung Biologischer Ressourcen der Mongolei, V11, P23; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Williams NJ, 2011, J APPL MICROBIOL, V110, P962, DOI 10.1111/j.1365-2672.2011.04952.x; Wint W., 2007, GRIDDED LIVESTOCK WO; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	49	93	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53039	10.1371/journal.pone.0053039	http://dx.doi.org/10.1371/journal.pone.0053039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300857	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600053
J	Komine, Y; Takao, K; Miyakawa, T; Yamamori, T				Komine, Yuriko; Takao, Keizo; Miyakawa, Tsuyoshi; Yamamori, Tetsuo			Behavioral Abnormalities Observed in Zfhx2-Deficient Mice	PLOS ONE			English	Article							KNOCKOUT MICE; FACTOR ATBF1; TESTS; SCHIZOPHRENIA; HYPERACTIVITY; DISORDERS; ANXIETY; BRAIN; MODEL	Zfhx2 (also known as zfh-5) encodes a transcription factor containing three homeobox domains and 18 Zn-finger motifs. We have reported that Zfhx2 mRNA is expressed mainly in differentiating neurons in the mouse brain and its expression level is negatively regulated by the antisense transcripts of Zfhx2. Although the expression profile of Zfhx2 suggests that ZFHX2 might have a role in a particular step of neuronal differentiation, the specific function of the gene has not been determined. We generated a Zfhx2-deficient mouse line and performed a comprehensive battery of behavioral tests to elucidate the function of ZFHX2. Homozygous Zfhx2-deficient mice showed several behavioral abnormalities, namely, hyperactivity, enhanced depression-like behaviors, and an aberrantly altered anxiety-like phenotype. These behavioral phenotypes suggest that ZFHX2 might play roles in controlling emotional aspects through the function of monoaminergic neurons where ZFHX2 is expressed. Moreover, considering their phenotypes, the Zfhx2-deficient mice may provide a novel model of human psychiatric disorders.	[Komine, Yuriko; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Genet Engn & Funct Genom Grp, Frontier Technol Ctr, Grad Sch Med, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Fujita Health University; Japan Science & Technology Agency (JST)	Yamamori, T (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Miyakawa, Tsuyoshi/A-7741-2008; Yamamori, Tetsuo/N-6536-2015; Takao, Keizo/B-9527-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Yamamori, Tetsuo/0000-0001-5016-0078; Takao, Keizo/0000-0002-4734-3583; KOMINE, Yuriko/0000-0002-0097-8813	Ministry of Education, Culture, Sports, Science and Technology of Japan [170245, 22123009]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) (170245 to TY and YK), a Grant-in-Aid for Scientific Research on Innovative Areas (Neocortical Organization) (22123009 to TY), a Grant-in-Aid for Exploratory Research and Integrative Brain Research (IBR-shien), and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Komine Y, 2006, MOL CELL NEUROSCI, V31, P273, DOI 10.1016/j.mcn.2005.09.017; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Takao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009460; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	21	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53114	10.1371/journal.pone.0053114	http://dx.doi.org/10.1371/journal.pone.0053114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300874	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600060
J	Reineke, EL; York, B; Stashi, E; Chen, X; Tsimelzon, A; Xu, JM; Newgard, CB; Taffet, GE; Taegtmeyer, H; Entman, ML; O'Malley, BW				Reineke, Erin L.; York, Brian; Stashi, Erin; Chen, Xian; Tsimelzon, Anna; Xu, Jianming; Newgard, Christopher B.; Taffet, George E.; Taegtmeyer, Heinrich; Entman, Mark L.; O'Malley, Bert W.			SRC-2 Coactivator Deficiency Decreases Functional Reserve in Response to Pressure Overload of Mouse Heart	PLOS ONE			English	Article							FETAL GENE PROGRAM; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; DILATED CARDIOMYOPATHY; INSULIN-RESISTANCE; ENERGY-METABOLISM; SKELETAL-MUSCLES; IN-VIVO; EXPRESSION; SIGNATURE	A major component of the cardiac stress response is the simultaneous activation of several gene regulatory networks. Interestingly, the transcriptional regulator steroid receptor coactivator-2, SRC-2 is often decreased during cardiac failure in humans. We postulated that SRC-2 suppression plays a mechanistic role in the stress response and that SRC-2 activity is an important regulator of the adult heart gene expression profile. Genome-wide microarray analysis, confirmed with targeted gene expression analyses revealed that genetic ablation of SRC-2 activates the "fetal gene program'' in adult mice as manifested by shifts in expression of a) metabolic and b) sarcomeric genes, as well as associated modulating transcription factors. While these gene expression changes were not accompanied by changes in left ventricular weight or cardiac function, imposition of transverse aortic constriction (TAC) predisposed SRC-2 knockout (KO) mice to stress-induced cardiac dysfunction. In addition, SRC-2 KO mice lacked the normal ventricular hypertrophic response as indicated through heart weight, left ventricular wall thickness, and blunted molecular signaling known to activate hypertrophy. Our results indicate that SRC-2 is involved in maintenance of the steady-state adult heart transcriptional profile, with its ablation inducing transcriptional changes that mimic a stressed heart. These results further suggest that SRC-2 deletion interferes with the timing and integration needed to respond efficiently to stress through disruption of metabolic and sarcomeric gene expression and hypertrophic signaling, the three key stress responsive pathways.	[Reineke, Erin L.; York, Brian; Stashi, Erin; Chen, Xian; Xu, Jianming; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tsimelzon, Anna] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Newgard, Christopher B.] Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Taegtmeyer, Heinrich] Univ Texas Med Sch Houston, Dept Internal Med, Div Cardiol, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Duke University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.tmc.edu			Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U19 DK62434-08]; National Institute of Child Health and Human Development (NICHD) [HD08818-37]; Curtis & Doris K. Hankamer Foundation; Medallion Foundation; National Institutes of Health (NIH) [R01 HL-089792, 5 T32 HD07165]; NHLBI [R01 HL061483];  [CA125123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD007857, P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089792, R01HL022512, R01HL061483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Curtis & Doris K. Hankamer Foundation; Medallion Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by Nuclear Receptor Signaling Axis (NURSA)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) U19 DK62434-08, National Institute of Child Health and Human Development (NICHD) HD08818-37 to B. W. O'Malley, and in part to M. L. Entman (the Curtis & Doris K. Hankamer Foundation, the Medallion Foundation, and National Institutes of Health (NIH) R01 HL-089792), H. Taegtmeyer (NHLBI R01 HL061483), and A. Tsimelzon (CA125123). Erin Reineke is supported by NIH Training Grant 5 T32 HD07165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Duteil D, 2010, CELL METAB, V12, P496, DOI 10.1016/j.cmet.2010.09.016; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2011, ANN REV PHARM TOXICO; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pandya K, 2011, CIRC RES, V109, P609, DOI 10.1161/CIRCRESAHA.111.252619; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53395	10.1371/journal.pone.0053395	http://dx.doi.org/10.1371/journal.pone.0053395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300926	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600097
J	Wilson, JR; Kay, MC; Colgate, J; Qi, R; Lenihan, HS				Wilson, Jono R.; Kay, Matthew C.; Colgate, John; Qi, Roy; Lenihan, Hunter S.			Small-Scale Spatial Variation in Population Dynamics and Fishermen Response in a Coastal Marine Fishery	PLOS ONE			English	Article							LIFE-HISTORY; MANAGEMENT; CALIFORNIA; PATTERNS; REPRODUCTION; ROCKFISH; HABITAT; GROWTH	A major challenge for small-scale fisheries management is high spatial variability in the demography and life history characteristics of target species. Implementation of local management actions that can reduce overfishing and maximize yields requires quantifying ecological heterogeneity at small spatial scales and is therefore limited by available resources and data. Collaborative fisheries research (CFR) is an effective means to collect essential fishery information at local scales, and to develop the social, technical, and logistical framework for fisheries management innovation. We used a CFR approach with fishing partners to collect and analyze geographically precise demographic information for grass rockfish (Sebastes rastrelliger), a sedentary, nearshore species harvested in the live fish fishery on the West Coast of the USA. Data were used to estimate geographically distinct growth rates, ages, mortality, and length frequency distributions in two environmental subregions of the Santa Barbara Channel, CA, USA. Results indicated the existence of two subpopulations; one located in the relatively cold, high productivity western Channel, and another in the relatively warm, low productivity eastern Channel. We parameterized yield per recruit models, the results of which suggested nearly twice as much yield per recruit in the high productivity subregion relative to the low productivity subregion. The spatial distribution of fishing in the two environmental subregions demonstrated a similar pattern to the yield per recruit outputs with greater landings, effort, and catch per unit effort in the high productivity subregion relative to the low productivity subregion. Understanding how spatial variability in stock dynamics translates to variability in fishery yield and distribution of effort is important to developing management plans that maximize fishing opportunities and conservation benefits at local scales.	[Wilson, Jono R.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Kay, Matthew C.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Colgate, John] Commercial Fishermen Santa Barbara, Santa Barbara, CA USA; [Qi, Roy] Univ Calif Santa Barbara, Coll Creat Studies, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wilson, JR (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	jonowilson@bren.ucsb.edu			California Ocean Protection Council/California Coastal Conservancy research award [07-021]; California Sea Grant award [NA10OAR4170060]; Coastal Environmental Quality Initiative Fellowship	California Ocean Protection Council/California Coastal Conservancy research award; California Sea Grant award; Coastal Environmental Quality Initiative Fellowship	Funding for this work was provided by the California Ocean Protection Council/California Coastal Conservancy research award 07-021 to MCK, JRW and HSL, California Sea Grant award (# NA10OAR4170060) to HSL, JRW, and MCK and Coastal Environmental Quality Initiative Fellowship to JRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Berkes F., 2001, MANAGING SMALL SCALE; Beverton R.J., 1957, FISHERY INVESTIGAT 2, VXIX; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; Buonaccorsi VP, 2004, MAR BIOL, V145, P779, DOI 10.1007/s00227-004-1362-2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cailliet GML, 1986, FISHES FIELD LAB MAN; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Caselle JE, 2010, B MAR SCI, V86, P355; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Choat J. Howard, 2002, P57; Davis NA, 2008, MAR POLICY, V32, P867, DOI 10.1016/j.marpol.2008.01.001; Fujita RM, 2010, B MAR SCI, V86, P251; Gunderson DR, 2008, FISHERIES, V33, P172, DOI 10.1577/1548-8446-33.4.172; GUNDERSON DR, 1977, FISH B-NOAA, V75, P369; Hamilton SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024580; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hanan Doyle A., 2012, Open Fish Science Journal, V5, P30; Harms S, 1998, J GEOPHYS RES-OCEANS, V103, P3041, DOI 10.1029/97JC02393; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hill B. J., 1990, LEGAL SIZE THEIR USE, P9; HOENIG JM, 1983, FISH B US, V82, P898, DOI DOI 10.1890/04-0594; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Jentoft S, 1998, MAR POLICY, V22, P423, DOI 10.1016/S0308-597X(97)00040-7; Kay MC, 2012, ECOL APPL, V22, P322, DOI 10.1890/11-0155.1; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; LOVE MS, 1981, FISH B-NOAA, V79, P533; Miller D., 1972, CALIFORNIA DEP FISH; Phipps K, 2010, P MAN DAT POOR FISH; Prince J, 2010, B MAR SCI, V86, P197; Prince Jeremy, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P187; Punt A.E., 2005, USING INFORM DATA RI; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Stephenson RL, 1999, FISH RES, V43, P247, DOI 10.1016/S0165-7836(99)00076-4; Stewart J, 2008, FISHERIES MANAG ECOL, V15, P291, DOI 10.1111/j.1365-2400.2008.00614.x; WESTRHEIM SJ, 1975, J FISH RES BOARD CAN, V32, P2399, DOI 10.1139/f75-277; White JW, 2008, ECOLOGY, V89, P1323, DOI 10.1890/07-0840.1; YOSHIYAMA RM, 1986, ENVIRON BIOL FISH, V17, P23, DOI 10.1007/BF00000398; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	14	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52837	10.1371/journal.pone.0052837	http://dx.doi.org/10.1371/journal.pone.0052837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300793	Green Published, gold			2022-12-25	WOS:000313872600028
J	Bogdanowicz, W; Piksa, K; Tereba, A				Bogdanowicz, Wieslaw; Piksa, Krzysztof; Tereba, Anna			Hybridization Hotspots at Bat Swarming Sites	PLOS ONE			English	Article							SPECIES MYOTIS-MYOTIS; POPULATION-STRUCTURE; CRYPTIC DIVERSITY; GENETIC-STRUCTURE; GENUS MYOTIS; VESPERTILIONIDAE; CHIROPTERA; ALCATHOE; HYBRIDS; INTROGRESSION	During late summer and early autumn in temperate zones of the Northern Hemisphere, thousands of bats gather at caves, mainly for the purpose of mating. We demonstrated that this swarming behavior most probably leads not only to breeding among bats of the same species but also interbreeding between different species. Using 14 nuclear microsatellites and three different methods (the Bayesian assignment approaches of STRUCTURE and NEWHYBRIDS and a principal coordinate analysis of pairwise genetic distances), we analyzed 375 individuals belonging to three species of whiskered bats (genus Myotis) at swarming sites across their sympatric range in southern Poland. The overall hybridization rate varied from 3.2 to 7.2%. At the species level, depending on the method used, these values ranged from 2.1-4.6% in M. mystacinus and 3.0-3.7% in M. brandtii to 6.5-30.4% in M. alcathoe. Hybrids occurred in about half of the caves we studied. In all three species, the sex ratio of hybrids was biased towards males but the observed differences did not differ statistically from those noted at the population level. In our opinion, factors leading to the formation of these admixed individuals and their relatively high frequency are: i) swarming behaviour at swarming sites, where high numbers of bats belonging to several species meet; ii) male-biased sex ratio during the swarming period; iii) the fact that all these bats are generally polygynous. The highly different population sizes of different species at swarming sites may also play some role. Swarming sites may represent unique hybrid hotspots, which, as there are at least 2,000 caves in the Polish Carpathians alone, may occur on a massive scale not previously observed for any group of mammal species in the wild. Evidently, these sites should be treated as focal points for the conservation of biodiversity and evolutionary processes.	[Bogdanowicz, Wieslaw; Tereba, Anna] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Piksa, Krzysztof] Cracow Pedag Univ, Inst Biol, Krakow, Poland	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Pedagogical University of Cracow	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland.	wieslawb@miiz.waw.pl		Piksa, Krzysztof/0000-0001-5057-895X; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education in Poland [N N304 081 435]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	Funding was provided by the Ministry of Science and Higher Education in Poland (Grant No. N N304 081 435). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLEN I., 2010, FAUNA FLORA, V108, P8; Anderson EC, 2002, GENETICS, V160, P1217; Artyushin IV, 2009, ZOOTAXA, P40; Bachanek J, 2010, ACTA CHIROPTEROL, V12, P439, DOI 10.3161/150811010X538007; Bashta AT, 2011, FOLIA ZOOL, V60, P1; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P279, DOI 10.3161/150811012X661611; Bogdanowicz W, 2012, J MAMMAL, V93, P799, DOI 10.1644/11-MAMM-A-180.3; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Castella V, 2000, MOL ECOL, V9, P1000, DOI 10.1046/j.1365-294x.2000.00939-6.x; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davies N, 1996, TRENDS ECOL EVOL, V11, P508, DOI 10.1016/0169-5347(96)88900-2; Dietz C., 2007, FLEDERMAUSE EUROPAS; Dietz C, 2004, ILLUSTRATED IDENTI 2; Fenton MB, 2012, P NATL ACAD SCI USA, V109, P6794, DOI 10.1073/pnas.1204793109; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HOOD G, 2005, POPTOOLS VERSION 2 6; Hosken DJ, 1998, J ZOOL, V245, P261, DOI 10.1111/j.1469-7998.1998.tb00100.x; HUFF DR, 1993, THEOR APPL GENET, V86, P927, DOI 10.1007/BF00211043; Hulva P, 2010, MOL ECOL, V19, P5417, DOI 10.1111/j.1365-294X.2010.04899.x; Hutson AM, 2008, MYOTIS MYSTACINUS IU; Hutson AM, 2008, MYOTIS BRANDTII ICUN; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Jan CMI, 2010, ACTA CHIROPTEROL, V12, P471, DOI 10.3161/150811010X538043; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lucan RK, 2009, ACTA CHIROPTEROL, V11, P61, DOI 10.3161/150811009X465695; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Niermann N, 2007, ACTA CHIROPTEROL, V9, P361; Papadatou E, 2008, J MAMMAL, V89, P503, DOI 10.1644/07-MAMM-A-163R1.1; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R., 2007, GENALEX 6 1 APPENDIX; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard JK, 2000, GENETICS, V155, P945; Racey P. A., 2000, REPROD BIOL BATS, P314; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Shriver MD, 1997, AM J HUM GENET, V60, P957; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Sztencel-Jablonka A, 2012, CAN J ZOOL, V90, P1251, DOI 10.1139/Z2012-092; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Dyke F., 2008, CONSERVATION BIOL FD; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; von Helversen O, 2001, NATURWISSENSCHAFTEN, V88, P217, DOI 10.1007/s001140100225; WATT EM, 1995, MOL ECOL, V4, P261, DOI 10.1111/j.1365-294X.1995.tb00217.x; Webb N. J., 1995, Australian Mammalogy, V18, P19	62	26	26	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53334	10.1371/journal.pone.0053334	http://dx.doi.org/10.1371/journal.pone.0053334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300912	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500139
J	Ahmed, A; Al Tamimi, DM; Isab, AA; Alkhawajah, AMM; Shawarby, MA				Ahmed, Ayesha; Al Tamimi, Dalal M.; Isab, Anvarhusein A.; Alkhawajah, Abdulaziz M. Mansour; Shawarby, Mohamed A.			Histological Changes in Kidney and Liver of Rats Due to Gold (III) Compound [Au(en)Cl-2]Cl	PLOS ONE			English	Article							CISPLATIN NEPHROTOXICITY; COMPLEXES; DRUG; ETHYLENEDIAMINE; APOPTOSIS; NECROSIS	Introduction: Development of novel metallodrugs with enhanced anti-proliferative potential and reduced toxicity has become the prime focus of the evolving medicinal chemistry. In this regards, gold (III) complexes with various ligands are being extensively investigated. In the current study renal and hepatic toxicity of a newly developed gold (III) compound [Au(en)Cl-2]Cl was assessed by histopathological evaluation of liver and kidney specimens of rats exposed to the compound. Methods: Male rats (n = 42) weighing 200-250 gram were injected single, varying doses of gold (III) compound [(dichlorido(ethylenediamine) aurate((III)] chloride [Au(en)Cl-2]Cl in the acute toxicity component of the study. In the subacute toxicity part, a dose of 32.2 mg/kg (equivalent to 1/10 of LD50) was administered intraperitoneally for 14 consecutive days before sacrificing the animals. After autopsy, the renal and hepatic tissues were preserved in buffered formalin. Processing of the samples was followed by histopathological evaluation. The results were compared with the normal controls (n = 11). Results: A dose of 32.2 mg/kg (1/10 of LD50) revealed no renal tubular necrosis. The predominant histopathological finding was mild pyelitis, a prominence of eosinophils and mild congestion. The hepatic lesions comprised varying extents of ballooning degeneration with accompanying congestion and focal portal inflammation. Conclusion: Gold (III) compound [Au(en)Cl-2]Cl causes minimal histological changes in kidney and liver of rats, reflecting its relative safety as compared to other clinically established antineoplastic drugs.	[Ahmed, Ayesha; Al Tamimi, Dalal M.; Shawarby, Mohamed A.] Univ Dammam, Coll Med, Dept Pathol, Al Khobar, Saudi Arabia; [Ahmed, Ayesha; Al Tamimi, Dalal M.; Shawarby, Mohamed A.] Univ Al Khobar, King Fahd Hosp, Al Khobar, Saudi Arabia; [Isab, Anvarhusein A.] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia; [Alkhawajah, Abdulaziz M. Mansour] Univ Dammam, Coll Med, Dept Pharmacol, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; King Fahd University of Petroleum & Minerals; Imam Abdulrahman Bin Faisal University	Ahmed, A (corresponding author), Univ Dammam, Coll Med, Dept Pathol, Al Khobar, Saudi Arabia.	ayesash@hotmail.com; aisab@kfupm.edu.sa	Ahmed, Ayesha/A-5195-2015	Ahmed, Ayesha/0000-0002-2036-7067	King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum Minerals [08-BIO94-4]	King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum Minerals	The funding agency is King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum & Minerals through project No. 08-BIO94-4 as part of the National Science, Technology and Innovation Plan (Kingdom of Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maythalony BA, 2009, INORG CHIM ACTA, V362, P3109, DOI 10.1016/j.ica.2009.02.009; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Atasayar S, 2009, EXP TOXICOL PATHOL, V61, P23, DOI 10.1016/j.etp.2008.04.016; Avci A, 2008, TURK J MED SCI, V38, P117; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026; BROCK PR, 1991, J PEDIATR-US, V118, P531, DOI 10.1016/S0022-3476(05)83372-4; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Chao SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-23; Chow KHM, 2010, CANCER RES, V70, P329, DOI 10.1158/0008-5472.CAN-09-3324; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; El-Sayyad HI, 2009, INT J BIOL SCI, V5, P466; FELSON DT, 1990, ARTHRITIS RHEUM, V33, P1449, DOI 10.1002/art.1780331001; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gronroos M, 2006, PEDIATR BLOOD CANCER, V46, P624, DOI 10.1002/pbc.20471; Hanigan MH, 2001, AM J PATHOL, V159, P1889, DOI 10.1016/S0002-9440(10)63035-0; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; HOKE GD, 1989, TOXICOL APPL PHARM, V100, P293, DOI 10.1016/0041-008X(89)90315-3; Isab AA, 2011, SPECTROCHIM ACTA A, V79, P1196, DOI 10.1016/j.saa.2011.04.042; Kart A, 2010, EXP TOXICOL PATHOL, V62, P45, DOI 10.1016/j.etp.2009.02.066; Kean W F, 1987, Singapore Med J, V28, P117; KEAN WF, 1985, SEMIN ARTHRITIS RHEU, V14, P180, DOI 10.1016/0049-0172(85)90037-X; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Liu J, 1998, TOXICOL APPL PHARM, V149, P24, DOI 10.1006/taap.1997.8325; Magherini F, 2010, J BIOL INORG CHEM, V15, P573, DOI 10.1007/s00775-010-0624-3; MAHDIHASSAN S, 1985, AM J CHINESE MED, V13, P93, DOI 10.1142/S0192415X85000149; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; MEIJER S, 1982, CANCER CHEMOTH PHARM, V8, P27, DOI 10.1007/BF00292867; Milacic V, 2008, HISTOL HISTOPATHOL, V23, P101, DOI 10.14670/HH-23.101; Miller LC, 1944, P SOC EXP BIOL MED, V57, P261; Milovanovic M, 2010, J INORG BIOCHEM, V104, P944, DOI 10.1016/j.jinorgbio.2010.04.014; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Pacheco E. A., 2009, GOLD, P217; Panyala NR, 2009, J APPL BIOMED, V7, P75, DOI 10.32725/jab.2009.008; Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248; Ravindra P, 2010, J CELL ANIMAL BIOL, V4, P108; Rollino Cristiana, 2010, G Ital Nefrol, V27 Suppl 50, pS70; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Schmidbauer H, 1999, GOLD PROGR CHEM BIOC; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Tiekink ERT, 2002, CRIT REV ONCOL HEMAT, V42, P225, DOI 10.1016/S1040-8428(01)00216-5; Underwood JCE, 1985, HISTOCHEMISTRY THEOR, V2; Wu ML, 2001, J TOXICOL-CLIN TOXIC, V39, P739, DOI 10.1081/CLT-100108516; Yamashita T, 2010, OTOLARYNGOL HEAD NEC, V143, P54; Yan JJ, 2010, CHEM COMMUN, V46, P3893, DOI 10.1039/c001216e; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang J, 2008, TOXICOL PATHOL, V36, P397, DOI 10.1177/0192623308315832; Zhu SR, 2006, INORG CHEM, V45, P2688, DOI 10.1021/ic051411p	52	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51889	10.1371/journal.pone.0051889	http://dx.doi.org/10.1371/journal.pone.0051889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300573	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100013
J	Bottger, A; Doxey, AC; Hess, MW; Pfaller, K; Salvenmoser, W; Deutzmann, R; Geissner, A; Pauly, B; Altstatter, J; Munder, S; Heim, A; Gabius, HJ; McConkey, BJ; David, CN				Boettger, Angelika; Doxey, Andrew C.; Hess, Michael W.; Pfaller, Kristian; Salvenmoser, Willi; Deutzmann, Rainer; Geissner, Andreas; Pauly, Barbara; Altstaetter, Johannes; Muender, Sandra; Heim, Astrid; Gabius, Hans-Joachim; McConkey, Brendan J.; David, Charles N.			Horizontal Gene Transfer Contributed to the Evolution of Extracellular Surface Structures: The Freshwater Polyp Hydra Is Covered by a Complex Fibrous Cuticle Containing Glycosaminoglycans and Proteins of the PPOD and SWT (Sweet Tooth) Families	PLOS ONE			English	Article							EPITHELIUM CORYNE TUBULOSA; FIBROBLAST GROWTH-FACTORS; CYSTEINE-RICH DOMAIN; ELECTRON-MICROSCOPY; MANNOSE RECEPTOR; BINDING; LECTIN; CELL; CHONDROITIN; SULFATE	The single-cell layered ectoderm of the fresh water polyp Hydra fulfills the function of an epidermis by protecting the animals from the surrounding medium. Its outer surface is covered by a fibrous structure termed the cuticle layer, with similarity to the extracellular surface coats of mammalian epithelia. In this paper we have identified molecular components of the cuticle. We show that its outermost layer contains glycoproteins and glycosaminoglycans and we have identified chondroitin and chondroitin-6-sulfate chains. In a search for proteins that could be involved in organising this structure we found PPOD proteins and several members of a protein family containing only SWT (sweet tooth) domains. Structural analyses indicate that PPODs consist of two tandem beta-trefoil domains with similarity to carbohydrate-binding sites found in lectins. Experimental evidence confirmed that PPODs can bind sulfated glycans and are secreted into the cuticle layer from granules localized under the apical surface of the ectodermal epithelial cells. PPODs are taxon-specific proteins which appear to have entered the Hydra genome by horizontal gene transfer from bacteria. Their acquisition at the time Hydra evolved from a marine ancestor may have been critical for the transition to the freshwater environment.	[Boettger, Angelika; Pauly, Barbara; Altstaetter, Johannes; Muender, Sandra; Heim, Astrid; David, Charles N.] Univ Munich, Dept Biol 2, Munich, Germany; [Doxey, Andrew C.; McConkey, Brendan J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Hess, Michael W.; Pfaller, Kristian] Innsbruck Med Univ, Div Histol & Embryol, Innsbruck, Austria; [Salvenmoser, Willi] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Salvenmoser, Willi] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Deutzmann, Rainer; Geissner, Andreas] Univ Regensburg, Dept Biol, Regensburg, Germany; [Gabius, Hans-Joachim] Univ Munich, Fac Vet, Inst Physiol Chem, Munich, Germany	University of Munich; University of Waterloo; Medical University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Regensburg; University of Munich	Bottger, A (corresponding author), Univ Munich, Dept Biol 2, Munich, Germany.	boettger@zi.biologie.uni-muenchen.de	Geissner, Andreas/C-5834-2014; Hess, Michael/AAE-1985-2019	Geissner, Andreas/0000-0002-6996-4671; Hess, Michael/0000-0002-5154-3553; Bottger, Angelika/0000-0003-3273-9558; Doxey, Andrew/0000-0003-2015-099X; Gabius, Hans-Joachim/0000-0003-3467-3900	German Research Foundation; FWF Austrian Science Foundation	German Research Foundation(German Research Foundation (DFG)); FWF Austrian Science Foundation(Austrian Science Fund (FWF))	Funding provided by the German Research Foundation (http://www.dfg.de/index.jsp) and the FWF Austrian Science Foundation (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottger A, 2006, EUR J CELL BIOL, V85, P1107, DOI 10.1016/j.ejcb.2006.05.007; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; DEANGELIS PL, 1990, BIOCHIM BIOPHYS ACTA, V1037, P100, DOI 10.1016/0167-4838(90)90107-Q; DEANGELIS PL, 1987, J BIOL CHEM, V262, P13946; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fraune S, 2010, P NATL ACAD SCI USA, V107, P18067, DOI 10.1073/pnas.1008573107; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; GABIUS HJ, 1984, J NATL CANCER I, V73, P1349; GABIUS HJ, 2009, SUGAR CODE FUNDAMENT, P317; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HESS MW, 1995, HISTOCHEM CELL BIOL, V104, P443, DOI 10.1007/BF01464334; Hoffmeister-Ullerich SAH, 2002, EUR J BIOCHEM, V269, P4597, DOI 10.1046/j.1432-1033.2002.03159.x; Holstein TW, 2010, METHOD CELL BIOL, V96, P285, DOI 10.1016/S0091-679X(10)96013-5; Holtman M, 2001, J COMP NEUROL, V432, P550; Holtmann M, 2001, J COMP NEUROL, V432, P537, DOI 10.1002/cne.1118; Hroudova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036420; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOHNKEGODT B, 1989, BIOCHEMISTRY-US, V28, P6531, DOI 10.1021/bi00442a001; Kuznetsov SG, 2002, J EXP BIOL, V205, P3809; LENHOFF H M, 1970, Laboratory Animals (London), V4, P139, DOI 10.1258/002367770781036463; LENTZ T, 1966, CELL BIOL HYDRA; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; McConkey BJ, 2002, BIOINFORMATICS, V18, P1365, DOI 10.1093/bioinformatics/18.10.1365; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Moran Y, 2012, MOL BIOL EVOL; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Sarras MP, 2001, BIOESSAYS, V23, P716, DOI 10.1002/bies.1101; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; SHIGENAKA Y, 1971, J CELL SCI, V8, P127; THIERY JP, 1967, J MICROSC-PARIS, V6, P987; THOMAS MB, 1995, INVERTEBR BIOL, V114, P107, DOI 10.2307/3226883; Thomsen S, 2006, DEV GENES EVOL, V216, P57, DOI 10.1007/s00427-005-0032-9; Viola M, 2008, CONNECT TISSUE RES, V49, P111, DOI 10.1080/03008200802148405; Westheide W., 1996, SPECIAL ZOOLOGY 1; WINEERA JS, 1974, J MORPHOL, V144, P131, DOI 10.1002/jmor.1051440202; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051	53	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52278	10.1371/journal.pone.0052278	http://dx.doi.org/10.1371/journal.pone.0052278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300632	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100037
J	Li, GQ; Wang, KY; Li, DH; Wang, N; Liu, DH				Li, GangQiang; Wang, Kevin Yueju; Li, DaHui; Wang, Nan; Liu, DeHu			Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein	PLOS ONE			English	Article							FIBRINOLYTIC ENZYME; PLASMINOGEN-ACTIVATOR; LUMBROKINASE; PROTEASES	A lumbrokinase gene encoding a blood-clot dissolving protein was cloned from earthworm (Eisenia fetida) by RT-PCR amplification. The gene designated as CST1 (GenBank No. AY840996) was sequence analyzed. The cDNA consists of 888 bp with an open reading frame of 729 bp, which encodes 242 amino acid residues. Multiple sequence alignments revealed that CST1 shares similarities and conserved amino acids with other reported lumbrokinases. The amino acid sequence of CST1 exhibits structural features similar to those found in other serine proteases, including human tissue-type (tPA), urokinase (uPA), and vampire bat (DSPA alpha 1) plasminogen activators. CST1 has a conserved catalytic triad, found in the active sites of protease enzymes, which are important residues involved in polypeptide catalysis. CST1 was expressed as inclusion bodies in Escherichia coli BL21(DE3). The molecular mass of recombinant CST1 (rCST) was 25 kDa as estimated by SDS-PAGE, and further confirmed by Western Blot analysis. His-tagged rCST1 was purified and renatured using nickel-chelating resin with a recovery rate of 50% and a purity of 95%. The purified, renatured rCST1 showed fibrinolytic activity evaluated by both a fibrin plate and a blood clot lysis assay. rCST1 degraded fibrin on the fibrin plate. A significant percentage (65.7%) of blood clot lysis was observed when blood clot was treated with 80 mg/mL of rCST1 in vitro. The antithrombotic activity of rCST1 was 912 units/mg calculated by comparison with the activity of a lumbrokinase standard. These findings indicate that rCST1 has potential as a potent blood-clot treatment. Therefore, the expression and purification of a single lumbrokinase represents an important improvement in the use of lumbrokinases.	[Li, GangQiang; Wang, Nan; Liu, DeHu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Wang, Kevin Yueju] NE State Univ, Dept Nat Sci, Broken Arrow, OK USA; [Li, DaHui] Peking Univ, Pharmaceut Sch, Beijing 100871, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Peking University	Liu, DH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	liudehu2006@126.com			National High-tech Research & Development Program of China (863 Program) [2007AA02Z111]; National Technology for the 11th Five-year Plan of China [2006BAD31B01-04]; National Biotechnology Development Plan [2008ZX08005-004, 2009ZX08005-004B]; Researcher Foundation of the Chinese Academy of Agricultural Sciences	National High-tech Research & Development Program of China (863 Program); National Technology for the 11th Five-year Plan of China; National Biotechnology Development Plan; Researcher Foundation of the Chinese Academy of Agricultural Sciences	This work was supported by the National High-tech Research & Development Program of China (863 Program: 2007AA02Z111), National Technology for the 11th Five-year Plan of China (2006BAD31B01-04), National Biotechnology Development Plan (2008ZX08005-004), (2009ZX08005-004B) and the Researcher Foundation of the Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode W, 1997, CURR OPIN STRUC BIOL, V7, P865, DOI 10.1016/S0959-440X(97)80159-5; Cooper E., 2009, FOCUS, P1; Cooper EL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164152; Cooper EL, 2010, DRUG DISCOV TODAY, V15, P966, DOI 10.1016/j.drudis.2010.09.004; Cooper EL, 2004, ADV EXP MED BIOL, V546, P359; Dafer Rima M, 2007, Expert Rev Neurother, V7, P333, DOI 10.1586/14737175.7.4.333; DEOGNY L, 1975, CLIN CHIM ACTA, V60, P85, DOI 10.1016/0009-8981(75)90183-7; Dong GQ, 2004, ACTA BIOCH BIOPH SIN, V36, P303, DOI 10.1093/abbs/36.4.303; Gao Y, 1999, J CAP U MED SCI, V20, P264; Ge T, 2005, PROTEIN EXPRES PURIF, V42, P20, DOI 10.1016/j.pep.2005.04.005; Hraenjak T, 1998, COMP BIOCH PHYSL B, V119, P825; Hu RL, 2004, PROTEIN EXPRES PURIF, V37, P83, DOI 10.1016/j.pep.2004.05.018; Hu Y, 2005, PROTEIN EXPRES PURIF, V43, P18, DOI 10.1016/j.pep.2005.05.003; Ji HR, 2008, EUR J PHARMACOL, V590, P281, DOI 10.1016/j.ejphar.2008.05.037; Jin LR, 2000, CLIN HEMORHEOL MICRO, V23, P213; Kim YS, 1998, ARCH PHARM RES, V21, P374, DOI 10.1007/BF02974629; Labat-Robert J, 2012, PATHOL BIOL, V60, P66, DOI 10.1016/j.patbio.2011.11.010; Li DH, 2008, WORLD J MICROB BIOT, V24, P613, DOI 10.1007/s11274-007-9515-3; Li Yu-hua, 2006, Yaoxue Xuebao, V41, P939; MIHARA H, 1983, THROMB HAEMOSTASIS, V50, P258; MIHARA H, 1991, JPN J PHYSIOL, V41, P461, DOI 10.2170/jjphysiol.41.461; Pan R., 2010, APPL ENV SOIL SCI, DOI [10.1155/2010/294258, DOI 10.1155/2010/294258]; Prasad S, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-14; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; SUMI H, 1993, COMP BIOCHEM PHYS B, V106, P763, DOI 10.1016/0305-0491(93)90160-7; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Wang F, 2005, J MOL BIOL, V348, P671, DOI 10.1016/j.jmb.2005.02.055; Wei ZR, 2008, PROTEIN EXPRES PURIF, V57, P27, DOI 10.1016/j.pep.2007.09.001; Wu JX, 2007, INT J BIOL MACROMOL, V40, P399, DOI 10.1016/j.ijbiomac.2006.10.001; Xu JM, 2000, CHIN J NEW DRUGS CLI, V5, P406; Xu ZR, 2010, PROTEIN EXPRES PURIF, V69, P198, DOI 10.1016/j.pep.2009.08.013; Zhao J, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/97654	32	14	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53110	10.1371/journal.pone.0053110	http://dx.doi.org/10.1371/journal.pone.0053110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300872	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100119
J	Liu, J; Wei, XL; Huang, WH; Chen, CF; Bai, JW; Zhang, GJ				Liu, Jing; Wei, Xiao-Long; Huang, Wen-He; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun			Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas	PLOS ONE			English	Article							CANCER; P27; PHOSPHORYLATION; LOCALIZATION; UBIQUITINATION; MODULATION; IMPACT	Background: S-phase kinase protein 2 (Skp2), an oncogenic protein, is a key regulator in different cellular and molecular processes, through ubiquitin-proteasome degradation pathway. Increased levels of Skp2 are observed in various types of cancer and associated with poor prognosis. However, in human breast carcinomas, the underlying mechanism and prognostic significance of cytoplasmic Skp2 is still undefined. Methods: To investigate the role of cytoplasmic Skp2 expression in human breast carcinomas, we immnohistochemically assessed cytoplasmic Skp2, p-Akt1, and p27 expression in 251 patients with invasive ductal carcinomas of the breast. Association of cytoplasmic Skp2 expression with p-Akt1 and p27 was analyzed as well as correspondence with other clinicopathological parameters. Disease-free survival and overall survival were determined based on the Kaplan-Meier method and Cox regression models. Results: Cytoplasmic of Skp2 was detected in 165 out of 251 (65.7%) patients. Cytoplasmic Skp2 expression was associated with larger tumor size, more advanced histological grade, and positive HER2 expression. Increased cytoplasmic Skp2 expression correlated with p-Akt1 expression, with 54.2% (51/94) of low p-Akt1-expressing breast carcinomas, but 72.6% (114/157) of high p-Akt1-expressing breast carcinomas exhibiting cytoplasmic Skp2 expression. Elevated cytoplasmic Skp2 expression with low p-Akt1 expression was associated with poor disease-free and overall survival (DFS and OS), and Cox regression models demonstrated that cytoplasmic Skp2 expression was an independent prognostic marker for invasive breast carcinomas. Conclusion: Cytoplasmic Skp2 expression is associated with aggressive prognostic factors, such as larger tumor size, and advanced histological grade of the breast cancers. Results demonstrate that combined cytoplasmic Skp2 and p-Akt1 expression may be prognostic for patients with invasive breast carcinomas, and cytoplasmic Skp2 may serve as a potential therapeutic target.	[Liu, Jing; Wei, Xiao-Long; Huang, Wen-He; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Affiliated Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China; [Liu, Jing; Wei, Xiao-Long; Chen, Chun-Fa; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China.	guoj_zhang@yahoo.com	Chen, Chunfa/V-7357-2019; Zhang, Guo-Jun/H-3890-2015; Bai, Jingwen/AAG-3794-2019	Chen, Chunfa/0000-0002-1128-485X; Zhang, Guo-Jun/0000-0001-5182-5887; bai, jingwen/0000-0002-2107-2746	State Key Development Program for Basic Research of China [2011CB707705]; National Natural Science Foundation of China [30973377]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by State Key Development Program for Basic Research of China (No. 2011CB707705, http://www.973.gov.cn/Default_3.aspx), and by National Natural Science Foundation of China (No. 30973377, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2012, APPL IMMUNOHISTO M M, V20, P47, DOI 10.1097/PAI.0b013e318219a19f; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chander H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022456; Chen GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017578; Ganiatsas S, 2001, ONCOGENE, V20, P3641, DOI 10.1038/sj.onc.1204501; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Genestie C, 1998, ANTICANCER RES, V18, P571; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu SG, 2011, MOL CANCER RES, V9, P390, DOI 10.1158/1541-7786.MCR-10-0359; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Masuda T, 2002, CANCER RES, V62, P3819; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Traub F, 2006, BREAST CANCER RES TR, V99, P185, DOI 10.1007/s10549-006-9202-3; Yang G, 2002, CLIN CANCER RES, V8, P3419; Zheng WQ, 2005, STEROIDS, V70, P770, DOI 10.1016/j.steroids.2005.04.012	23	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52675	10.1371/journal.pone.0052675	http://dx.doi.org/10.1371/journal.pone.0052675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300741	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100072
J	Moenke, G; Falcke, M; Thurley, K				Moenke, Gregor; Falcke, Martin; Thurley, Keven			Hierarchic Stochastic Modelling Applied to Intracellular Ca2+ Signals	PLOS ONE			English	Article							WAITING TIME DISTRIBUTIONS; GENE-EXPRESSION; CALCIUM; PUFFS; OSCILLATIONS; ROBUSTNESS; TRANSDUCTION; VARIABILITY; RECEPTORS; CLUSTERS	Important biological processes like cell signalling and gene expression have noisy components and are very complex at the same time. Mathematical analysis of such systems has often been limited to the study of isolated subsystems, or approximations are used that are difficult to justify. Here we extend a recently published method (Thurley and Falcke, PNAS 2011) which is formulated in observable system configurations instead of molecular transitions. This reduces the number of system states by several orders of magnitude and avoids fitting of kinetic parameters. The method is applied to Ca2+ signalling. Ca2+ is a ubiquitous second messenger transmitting information by stochastic sequences of concentration spikes, which arise by coupling of subcellular Ca2+ release events (puffs). We derive analytical expressions for a mechanistic Ca2+ model, based on recent data from live cell imaging, and calculate Ca2+ spike statistics in dependence on cellular parameters like stimulus strength or number of Ca2+ channels. The new approach substantiates a generic Ca2+ model, which is a very convenient way to simulate Ca2+ spike sequences with correct spiking statistics.	[Moenke, Gregor; Falcke, Martin; Thurley, Keven] Max Delbruck Ctr Mol Med, Berlin, Germany; [Thurley, Keven] Charite, Inst Theoret Biol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thurley, K (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	kevin.thurley@mdc-berlin.de	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114; Monke, Gregor/0000-0002-3521-715X	German Research Foundation [GRK 1772]	German Research Foundation(German Research Foundation (DFG))	GM was supported by the German Research Foundation funded graduate school GRK 1772: http://www2.hu-berlin.de/biologie/theorybp/index.php?goto = PhD%20program%20CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bel G, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016003; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Blochl F, 2011, B MATH BIOL, V73, P706, DOI 10.1007/s11538-010-9604-6; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [10.1063/1.1750549, DOI 10.1063/1.1750549]; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dickinson GD, 2012, BIOPHYS J, V102, P1826, DOI 10.1016/j.bpj.2012.03.029; Dupont G, 2000, BBA-MOL CELL RES, V1498, P134, DOI 10.1016/S0167-4889(00)00090-2; Dupont G, 2008, BIOPHYS J, V95, P2193, DOI 10.1529/biophysj.108.133777; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gupta RD, 2007, J STAT PLANN INFEREN, P137; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Higgins ER, 2009, J THEOR BIOL, V259, P338, DOI 10.1016/j.jtbi.2009.03.018; Josic K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002264; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Lu T, 2006, P NATL ACAD SCI USA, V103, P16752, DOI 10.1073/pnas.0607698103; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Penzlin H, 2009, NATURWISSENSCHAFTEN, V96, P1, DOI 10.1007/s00114-008-0422-8; Prager T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011118; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Skupin A, 2007, GENOME INFORM SER, V18, P44; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Skupin A, 2012, ADV EXP MED BIOL, V740, P531, DOI 10.1007/978-94-007-2888-2_24; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; Skupin A, 2009, CHAOS, V19, DOI 10.1063/1.3184537; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Sneyd J, 2005, PROG BIOPHYS MOL BIO, V89, P207, DOI 10.1016/j.pbiomolbio.2004.11.001; Sneyd J, 2004, PROG BIOPHYS MOL BIO, V85, P121, DOI 10.1016/j.pbiomolbio.2004.01.013; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tanase-Nicola S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000125; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Thul R, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/38003; Thul R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188103; Thurley K, 2012, BBA-GEN SUBJECTS, V1820, P1185, DOI 10.1016/j.bbagen.2011.10.007; Thurley K, 2011, BIOPHYS J, V101, P2638, DOI 10.1016/j.bpj.2011.10.030; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Ueda M, 2007, BIOPHYS J, V93, P11, DOI 10.1529/biophysj.106.100263; VANKAMPEN NG, 2002, STOCHASTIC PROCESSES; Zhou CS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098101	60	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51178	10.1371/journal.pone.0051178	http://dx.doi.org/10.1371/journal.pone.0051178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300536	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312829100006
J	Schlegel, P; Havenhand, JN; Gillings, MR; Williamson, JE				Schlegel, Peter; Havenhand, Jon N.; Gillings, Michael R.; Williamson, Jane E.			Individual Variability in Reproductive Success Determines Winners and Losers under Ocean Acidification: A Case Study with Sea Urchins	PLOS ONE			English	Article							INFLUENCE FERTILIZATION SUCCESS; SPAWNING MARINE-INVERTEBRATES; NEAR-FUTURE LEVELS; CLIMATE-CHANGE; STRONGYLOCENTROTUS-FRANCISCANUS; INTRACELLULAR-PH; SPERM LIMITATION; GAMETE TRAITS; SEXUAL SELECTION; INTERNAL PH	Background: Climate change will lead to intense selection on many organisms, particularly during susceptible early life stages. To date, most studies on the likely biotic effects of climate change have focused on the mean responses of pooled groups of animals. Consequently, the extent to which inter-individual variation mediates different selection responses has not been tested. Investigating this variation is important, since some individuals may be preadapted to future climate scenarios. Methodology/Principal Findings: We examined the effect of CO2-induced pH changes ("ocean acidification'') in sperm swimming behaviour on the fertilization success of the Australasian sea urchin Heliocidaris erythrogramma, focusing on the responses of separate individuals and pairs. Acidification significantly decreased the proportion of motile sperm but had no effect on sperm swimming speed. Subsequent fertilization experiments showed strong inter-individual variation in responses to ocean acidification, ranging from a 44% decrease to a 14% increase in fertilization success. This was partly explained by the significant relationship between decreases in percent sperm motility and fertilization success at Delta pH = 0.3, but not at Delta pH = 0.5. Conclusions and Significance: The effects of ocean acidification on reproductive success varied markedly between individuals. Our results suggest that some individuals will exhibit enhanced fertilization success in acidified oceans, supporting the concept of 'winners' and 'losers' of climate change at an individual level. If these differences are heritable it is likely that ocean acidification will lead to selection against susceptible phenotypes as well as to rapid fixation of alleles that allow reproduction under more acidic conditions. This selection may ameliorate the biotic effects of climate change if taxa have sufficient extant genetic variation upon which selection can act.	[Schlegel, Peter; Gillings, Michael R.; Williamson, Jane E.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Havenhand, Jon N.] Univ Gothenburg, Dept Biol & Environm Sci, Tjarno Marine Biol Lab, Stromstad, Sweden	Macquarie University; University of Gothenburg	Schlegel, P (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	peter.schlegel@mq.edu.au	Havenhand, Jon N/F-5435-2013; Gillings, Michael/AAF-5772-2020; Gillings, Michael R/C-6553-2008; Williamson, Jane E/G-9871-2011	Havenhand, Jon N/0000-0003-0253-3428; Gillings, Michael/0000-0002-4043-4351; Gillings, Michael R/0000-0002-4043-4351; Williamson, Jane E/0000-0003-3627-4508; Havenhand, Jonathan/0000-0001-6721-7763	Australian Research Council; Linnaeus-grant from the Swedish Research Council VR-Review; Linnaeus-grant Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Australian Research Council(Australian Research Council); Linnaeus-grant from the Swedish Research Council VR-Review(Swedish Research Council); Linnaeus-grant Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	This work was funded by the Australian Research Council and a Linnaeus-grant from the Swedish Research Councils VR-Review and Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(www.cemeb.gu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Chan KYK, 2011, J EXP BIOL, V214, P3857, DOI 10.1242/jeb.054809; CHRISTEN R, 1983, EXP CELL RES, V149, P289, DOI 10.1016/0014-4827(83)90400-7; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Doo SS, 2012, ICES J MAR SCI, V69, P460, DOI 10.1093/icesjms/fsr123; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Evans JP, 2005, EVOLUTION, V59, P106; Frankham R, 2005, HEREDITY, V95, P183, DOI 10.1038/sj.hdy.6800706; Glantz MH, 1995, STUD ENVIRON SCI, V65, P41, DOI 10.1016/S0166-1116(06)80193-7; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; LEE HC, 1983, DEV BIOL, V95, P31, DOI 10.1016/0012-1606(83)90004-0; Levitan DR, 2008, EVOLUTION, V62, P1305, DOI 10.1111/j.1558-5646.2008.00378.x; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; LEVITAN DR, 1995, J EXP MAR BIOL ECOL, V190, P221, DOI 10.1016/0022-0981(95)00039-T; Levitan DR, 1996, NATURE, V382, P153, DOI 10.1038/382153a0; LEWIS E, 1998, ORNLCDIAC105 US DOE; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Styan CA, 1998, AM NAT, V152, P290, DOI 10.1086/286168; Styan CA, 2005, MAR BIOL, V147, P235, DOI 10.1007/s00227-005-1554-4; Styan CA, 2000, MAR BIOL, V137, P943, DOI 10.1007/s002270000401; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; VOGEL H, 1982, MATH BIOSCI, V58, P189, DOI 10.1016/0025-5564(82)90073-6; Wright JT, 2005, MAR ECOL PROG SER, V298, P143, DOI 10.3354/meps298143; Wright JT, 2001, ECOLOGY, V82, P2200, DOI 10.1890/0012-9658(2001)082[2200:EOVRAP]2.0.CO;2	59	69	70	3	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53118	10.1371/journal.pone.0053118	http://dx.doi.org/10.1371/journal.pone.0053118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300876	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100121
J	Xu, X; Fu, WW; Wu, WY				Xu, Xin; Fu, Wen-Wen; Wu, Wen-Yu			Serum 25-Hydroxyvitamin D Deficiency in Chinese Patients with Vitiligo: A Case-Control Study	PLOS ONE			English	Article							VITAMIN-D; RISK	Background: Low vitamin D levels have been noted in patients with a variety of autoimmune diseases. A recent study showed that low vitamin D levels may be associated with vitiligo. Objectives: To assess 25-hydroxyvitamin D (25(OH)D) status in Chinese patients with vitiligo in comparison of normal controls and explore possible affecting factors. Methods: We performed a case-control study including 171 patients, 50 controls in 25(OH)D lowest months and 30 patients, 20 controls in 25(OH)D highest months. Demographic and clinical variables of patients were analyzed to determine the correlation with 25(OH) D levels. Results: 25(OH)D mean value of patients was highest in September and October, lowest in March. None of the patients and normal controls had 'sufficient' 25(OH)D (> = 75 nmol/L). No significant difference was found in either 25(OH)D mean values or insufficiency/deficiency ratio between patients and controls in 25(OH)D highest and lowest periods. Female patients were at a higher risk of 25(OH)D deficiency than male patients(P = 0.019). For non-segmental type, patients with 25(OH)D deficiency were more likely to have autoimmune thyroid disease than those with insufficiency (P = 0.016). Sex (P = 0.035), thyroid conditions (p = 0.034), testing month (p = 0.049) were independent factors affecting 25(OH)D level in multivariate analysis. Conclusion: Chinese population lack 25(OH)D universally. 25(OH)D level shows no correlation with onset of vitiligo in Chinese. However deficient 25(OH)D level may be linked to autoimmune disorders in patients.	[Xu, Xin; Fu, Wen-Wen; Wu, Wen-Yu] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China	Fudan University	Wu, WY (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.	wuwydr@gmail.com			Shanghai Medical College of Fudan University	Shanghai Medical College of Fudan University	The funder of the article was Shanghai Medical College of Fudan University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutillas-Marco E, 2010, LUPUS, V19, P810, DOI 10.1177/0961203309360807; Cutolo M, 2007, ARTHRITIS RHEUM, V56, P1719, DOI 10.1002/art.22569; De Souza HN, 2008, ARQ BRAS ENDOCRINOL, V52, P684, DOI 10.1590/S0004-27302008000400015; Ersoy-Evans S, 2010, J AM ACAD DERMATOL, V62, P942, DOI 10.1016/j.jaad.2010.02.009; Gallagher JC, 2010, J CLIN ENDOCR METAB, V95, P2630, DOI 10.1210/jc.2010-0918; Gannage-Yared MH, 2009, EUR J ENDOCRINOL, V160, P965, DOI 10.1530/EJE-08-0952; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Orgaz-Molina J, 2012, J AM ACAD DERMATOL; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Silverberg JI, 2010, J AM ACAD DERMATOL, V62, P937, DOI 10.1016/j.jaad.2009.11.024; Word AP, 2012, BRIT J DERMATOL, V166, P372, DOI 10.1111/j.1365-2133.2011.10667.x	11	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52778	10.1371/journal.pone.0052778	http://dx.doi.org/10.1371/journal.pone.0052778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300773	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100080
J	Bergmann, HC; Rijpkema, M; Fernandez, G; Kessels, RPC				Bergmann, Heiko C.; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.			The Effects of Valence and Arousal on Associative Working Memory and Long-Term Memory	PLOS ONE			English	Article							ATTENTION-GRABBING POWER; AUTOMATIC VIGILANCE; EMOTIONAL AROUSAL; NEGATIVE WORDS; PERCEPTION; ACTIVATION; ENHANCEMENT; SPECIFICITY; RETENTION; DECISION	Background: Emotion can either facilitate or impair memory, depending on what, when and how memory is tested and whether the paradigm at hand is administered as a working memory (WM) or a long-term memory (LTM) task. Whereas emotionally arousing single stimuli are more likely to be remembered, memory for the relationship between two or more component parts (i.e., relational memory) appears to be worse in the presence of emotional stimuli, at least in some relational memory tasks. The current study investigated the effects of both valence (neutral vs. positive vs. negative) and arousal (low vs. high) in an inter-item WM binding and LTM task. Methodology/Principal Findings: A five-pair delayed-match-to-sample (WM) task was administered. In each trial, study pairs consisted of one neutral picture and a second picture of which the emotional qualities (valence and arousal levels) were manipulated. These pairs had to be remembered across a delay interval of 10 seconds. This was followed by a probe phase in which five pairs were tested. After completion of this task, an unexpected single item LTM task as well as an LTM task for the pairs was assessed. As expected, emotional arousal impaired WM processing. This was reflected in lower accuracy for pairs consisting of high-arousal pictures compared to pairs with low-arousal pictures. A similar effect was found for the associative LTM task. However, the arousal effect was modulated by affective valence for the WM but not the LTM task; pairs with low-arousal negative pictures were not processed as well in the WM task. No significant differences were found for the single-item LTM task. Conclusions/Significance: The present study provides additional evidence that processes during initial perception/encoding and post-encoding processes, the time interval between study and test and the interaction between valence and arousal might modulate the effects of "emotion" on associative memory.	[Bergmann, Heiko C.; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bergmann, HC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	h.bergmann@donders.ru.nl	Fernandez, Guillen/B-3771-2009; Rijpkema, Mark/D-1974-2010; Kessels, Roy P.C./D-1902-2010	Fernandez, Guillen/0000-0002-5522-0604; Rijpkema, Mark/0000-0002-8495-4703; Kessels, Roy P.C./0000-0001-9500-9793	Netherlands Organisation for Scientific Research (NWO) [452-08-005]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a VIDI innovational grant from the Netherlands Organisation for Scientific Research (NWO, no. 452-08-005), awarded to RPCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; BARGH JA, 1992, J PERS SOC PSYCHOL, V62, P893, DOI 10.1037/0022-3514.62.6.893; Bergmann HC, 2012, NEUROIMAGE, V63, P989, DOI 10.1016/j.neuroimage.2012.03.047; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CONTINI L, 1992, PERCEPT MOTOR SKILL, V75, P427, DOI 10.2466/PMS.75.5.427-431; D'Argembeau A, 2004, EMOTION, V4, P173, DOI 10.1037/1528-3542.4.2.173; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Ecker UKH, 2007, BRAIN RES, V1185, P221, DOI 10.1016/j.brainres.2007.09.047; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; Guillet R, 2009, MEM COGNITION, V37, P866, DOI 10.3758/MC.37.6.866; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Horstmann G, 2006, PSYCHON B REV, V13, P1067, DOI 10.3758/BF03213927; Huijbers M.J, 2011, J AGING RES; Jacobs WJ, 1998, PSYCHOL PUBLIC POL L, V4, P1110; Jang Y, 2009, J EXP PSYCHOL GEN, V138, P291, DOI 10.1037/a0015525; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2005, PSYCHOL AGING, V20, P241, DOI 10.1037/0882-7974.20.2.241; Kensinger EA, 2007, J GERONTOL B-PSYCHOL, V62, pP208, DOI 10.1093/geronb/62.4.P208; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Kensinger EA, 2007, J MEM LANG, V56, P575, DOI 10.1016/j.jml.2006.05.004; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kindt M, 1999, J PSYCHOPATHOL BEHAV, V21, P207, DOI 10.1023/A:1022873331067; Kohler T, 2005, Z KLIN PSYCH PSYCHIA, V53, P205; Kohler T, 2002, Z KLIN PSYCHOL PSYCH, V50, P328; Lang PJ, 2008, INT AFFECTIVE PICTUR; Levine LJ, 2009, COGNITION EMOTION, V23, P833, DOI 10.1080/02699930902738863; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; MacKay DG, 2005, PSYCHOL SCI, V16, P25, DOI 10.1111/j.0956-7976.2005.00776.x; Madan CR, 2012, J MEM LANG, V66, P695, DOI 10.1016/j.jml.2012.04.001; Mather M, 2006, J COGNITIVE NEUROSCI, V18, P614, DOI 10.1162/jocn.2006.18.4.614; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Mather M, 2007, PERSPECT PSYCHOL SCI, V2, P33, DOI 10.1111/j.1745-6916.2007.00028.x; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Mitchell KJ, 2006, NEUROREPORT, V17, P1543, DOI 10.1097/01.wnr.0000234743.50442.e5; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Murray BD, 2012, MEM COGNITION, V40, P1056, DOI 10.3758/s13421-012-0215-3; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pierce BH, 2011, EMOTION, V11, P139, DOI 10.1037/a0021287; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Schmidt SR, 2002, J EXP PSYCHOL LEARN, V28, P353, DOI 10.1037//0278-7393.28.2.353; Stanny CJ, 2000, AM J PSYCHOL, V113, P359, DOI 10.2307/1423364; STEBLAY NM, 1992, LAW HUMAN BEHAV, V16, P413, DOI 10.1007/BF02352267; Tabert MH, 2001, NEUROPSYCHOLOGIA, V39, P556, DOI 10.1016/S0028-3932(00)00157-3; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Zimmer H.D., 2012, HDB BINDING MEMORY P, P3, DOI [DOI 10.1093/ACPROF:OSO/9780198529675.003.0001, 10.1093/acprof:oso/9780198529675.003.0001]; Zimmerman CA, 2010, J MEM LANG, V62, P240, DOI 10.1016/j.jml.2009.11.004	60	14	15	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52616	10.1371/journal.pone.0052616	http://dx.doi.org/10.1371/journal.pone.0052616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300724	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800114
J	Heyes, DJ; Khara, B; Sakuma, M; Hardman, SJO; O'Cualain, R; Rigby, SEJ; Scrutton, NS				Heyes, Derren J.; Khara, Basile; Sakuma, Michiyo; Hardman, Samantha J. O.; O'Cualain, Ronan; Rigby, Stephen E. J.; Scrutton, Nigel S.			Ultrafast Red Light Activation of Synechocystis Phytochrome Cph1 Triggers Major Structural Change to Form the Pfr Signalling-Competent State	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; MIDINFRARED SPECTROSCOPY; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PROTEIN MOTIONS; DRIVEN ENZYME; GROUND-STATE; SOLVENT	Phytochromes are dimeric photoreceptors that regulate a range of responses in plants and microorganisms through interconversion of red light-absorbing (Pr) and far-red light-absorbing (Pfr) states. Photoconversion between these states is initiated by light-driven isomerization of a bilin cofactor, which triggers protein structural change. The extent of this change, and how light-driven structural changes in the N-terminal photosensory region are transmitted to the C-terminal regulatory domain to initiate the signalling cascade, is unknown. We have used pulsed electron-electron double resonance (PELDOR) spectroscopy to identify multiple structural transitions in a phytochrome from Synechocystis sp. PCC6803 (Cph1) by measuring distances between nitroxide labels introduced into the protein. We show that monomers in the Cph1 dimer are aligned in a parallel 'head-to-head' arrangement and that photoconversion between the Pr and Pfr forms involves conformational change in both the N- and C-terminal domains of the protein. Cryo-trapping and kinetic measurements were used to probe the extent and temporal properties of protein motions for individual steps during photoconversion of Cph1. Formation of the primary photoproduct Lumi-R is not affected by changes in solvent viscosity and dielectric constant. Lumi-R formation occurs at cryogenic temperatures, consistent with their being no major structural reorganization of Cph1 during primary photoproduct formation. All remaining steps in the formation of the Pfr state are affected by solvent viscosity and dielectric constant and occur only at elevated temperatures, implying involvement of a series of long-range solvent-coupled conformational changes in Cph1. We show that signalling is achieved through ultrafast photoisomerization where localized structural change in the GAF domain is transmitted and amplified to cause larger-scale and slower conformational change in the PHY and histidine kinase domains. This hierarchy of timescales and extent of structural change orientates the histidine kinase domain to elicit the desired light-activated biological response.	[Heyes, Derren J.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; Univ Manchester, Fac Life Sci, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk		Hardman, Samantha/0000-0002-8310-4758; Heyes, Derren/0000-0002-7453-1571; O'Cualain, Ronan/0000-0002-4767-6142	Engineering and Physical Sciences Research Council; Royal Society; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish; EPSRC [EP/J020192/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (Established Career Fellowship to NSS) and the Royal Society (Wolfson Merit Award to NSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Frauenfelder H, 2002, BIOPHYS CHEM, V98, P35, DOI 10.1016/S0301-4622(02)00083-2; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Schweiger A, 2001, PRINCIPLES PULSE ELE, P444; SCHWEIGER A, 2001, PRINCIPLES PULSE ELE, P183; Schweiger A, 2001, PRINCIPLES PULSE ELE, P420; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	46	15	15	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52418	10.1371/journal.pone.0052418	http://dx.doi.org/10.1371/journal.pone.0052418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300666	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800084
J	Qu, F; Wu, CS; Hou, JF; Jin, Y; Zhang, JL				Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan			Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; QUANTITATIVE-ANALYSIS; INDUCED APOPTOSIS; IN-VITRO; KAPPA-B; CELLS; TRIPTERYGIUM; INJURY; RATS; MICE	Background: Hypersensitivity diseases are associated with many severe human illnesses, including leprosy and tuberculosis. Emerging evidence suggests that the pathogenesis and pathological mechanisms of treating these diseases may be attributable to sphingolipid metabolism. Methods: High performance liquid chromatography-tandem mass spectrometry was employed to target and measure 43 core sphingolipids in the plasma, kidneys, livers and spleens of BALB/c mice from four experimental groups: control, delayed-type hypersensitivity (DTH) model, DTH+triptolide, and control+triptolide. Orthogonal partial least squares discriminant analysis (OPLS-DA) was used to identify potential biomarkers associated with variance between groups. Relationships between the identified biomarkers and disease markers were evaluated by Spearman correlation. Results: As a treatment to hypersensitivity disease, triptolide significantly inhibit the ear swelling and recover the reduction of splenic index caused by DTH. The sphingolipidomic result revealed marked alterations in sphingolipid levels between groups that were associated with the effects of the disease and triptolide treatment. Based on this data, 23 potential biomarkers were identified by OPLS-DA, and seven of these biomarkers correlated markedly with the disease markers (p<0.05) by Spearman correlation. Conclusions: These data indicate that differences in sphingolipid levels in plasma and tissues are related to DTH and treatment with triptolide. Restoration of proper sphingolipid levels may attribute to the therapeutic effect of triptolide treatment. Furthermore, these findings demonstrate that targeted sphingolipidomic analysis followed by multivariate analysis presents a novel strategy for the identification of biomarkers in biological samples.	[Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan] Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100021, Peoples R China; [Qu, Feng; Wu, Cai-Sheng; Hou, Jin-Feng; Jin, Ying; Zhang, Jin-Lan] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhang, JL (corresponding author), Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100021, Peoples R China.	zhjl@imm.ac.cn	Qu, Feng/L-6355-2013; Wu, Caisheng/AAT-2701-2021	Qu, Feng/0000-0002-3812-0732; 	Ministry of Science and Technology of People's Republic of China [2012ZX09301002-006]; Natural Science Foundation of China [81273484]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by Ministry of Science and Technology of People's Republic of China (2012ZX09301002-006) and the Natural Science Foundation of China (No. 81273484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2011, BRIT J CLIN PHARMACO, V71, P701, DOI 10.1111/j.1365-2125.2010.03764.x; Aoyagi Y, 2008, BIOORG MED CHEM LETT, V18, P2459, DOI 10.1016/j.bmcl.2008.02.039; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bucci M, 2011, NAT CHEM BIOL, V7, P577; [Committee BC Services USDoHaH Administration FaD Research CfDEa Medicine CfV], 2001, GUID IND BIOAN METH; Dan H, 2008, J BIOCHEM MOL TOXIC, V22, P422, DOI 10.1002/jbt.20261; de Grauw JC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3427; Dyatlovitskaya EV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P347, DOI 10.1134/S0006297906040018; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Ge HL, 2011, ANGIOLOGY, V62, P265, DOI 10.1177/0003319710385337; GU WZ, 1995, INT J IMMUNOPHARMACO, V17, P351; Hawthorne KM, 2011, SEMIN OPHTHALMOL, V26, P246, DOI 10.3109/08820538.2011.588659; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Jia W., 2009, MED METABONOMICS; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lalazar G, 2006, MINI-REV MED CHEM, V6, P1249, DOI 10.2174/138955706778742722; Leuenroth SJ, 2008, J AM SOC NEPHROL, V19, P1659, DOI 10.1681/ASN.2008030259; Liang M, 2008, CANCER LETT, V270, P337, DOI 10.1016/j.canlet.2008.05.025; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Liou JT, 2008, EUR J PHARMACOL, V589, P288, DOI 10.1016/j.ejphar.2008.04.056; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Mouritsen OG, 2011, PHYS CHEM CHEM PHYS; Napolitano G, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3141pe34; Organization TWH, 2009, HDB GOOD LAB PRACT; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Steenholdt C, 2012, J CROHNS COLITIS, V6, P108, DOI 10.1016/j.crohns.2011.08.001; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tao R, 2011, EXP MOL PATHOL, V90, P137, DOI 10.1016/j.yexmp.2010.12.001; Tao X, 2008, ARTHRITIS RHEUM-US, V58, P1774, DOI 10.1002/art.23513; Ullrich SE, 1999, TOXICOL SCI, V52, P61, DOI 10.1093/toxsci/52.1.61; van Eden W, 2009, J NEUROIMMUNOL, V217, P10, DOI 10.1016/j.jneuroim.2009.09.008; Wang T, 2009, PHARMACOL REP, V61, P697, DOI 10.1016/S1734-1140(09)70122-7; Wang ZP, 2009, INT J TOXICOL, V28, P177, DOI 10.1177/1091581809337418; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; Yang F, 2011, EXP TOXICOL PATHOL; Yang F, 2011, J HUAZHONG U SCI-MED, V31, P335, DOI 10.1007/s11596-011-0377-4; Ye XC, 2010, TOXICOL LETT, V192, P212, DOI 10.1016/j.toxlet.2009.10.028; Yu C, 2011, FITOTERAPIA, V82, P709, DOI 10.1016/j.fitote.2011.02.011; Zeng R, 2011, J HUAZHONG U SCI-MED, V31, P446, DOI 10.1007/s11596-011-0471-7; Zhang GT, 2009, J ETHNOPHARMACOL, V125, P41, DOI 10.1016/j.jep.2009.06.020; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	47	23	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52454	10.1371/journal.pone.0052454	http://dx.doi.org/10.1371/journal.pone.0052454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300675	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800090
J	Song, AAL; Abdullah, JO; Abdullah, MP; Shafee, N; Othman, R; Tan, EF; Noor, NM; Raha, AR				Song, Adelene Ai-Lian; Abdullah, Janna Ong; Abdullah, Mohd Puad; Shafee, Norazizah; Othman, Roohaida; Tan, Ee-Fun; Noor, Normah Mohd; Raha, Abdul Rahim			Overexpressing 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGR) in the Lactococcal Mevalonate Pathway for Heterologous Plant Sesquiterpene Production	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COA REDUCTASE; ESSENTIAL OIL; EXPRESSION; SYNTHASE; GENES; BIOSYNTHESIS; ESSENTIALITY; CLONING	Isoprenoids are a large and diverse group of metabolites with interesting properties such as flavour, fragrance and therapeutic properties. They are produced via two pathways, the mevalonate pathway or the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway. While plants are the richest source of isoprenoids, they are not the most efficient producers. Escherichia coli and yeasts have been extensively studied as heterologous hosts for plant isoprenoids production. In the current study, we describe the usage of the food grade Lactococcus lactis as a potential heterologous host for the production of sesquiterpenes from a local herbaceous Malaysian plant, Persicaria minor (synonym Polygonum minus). A sesquiterpene synthase gene from P. minor was successfully cloned and expressed in L. lactis. The expressed protein was identified to be a beta-sesquiphellandrene synthase as it was demonstrated to be functional in producing beta-sesquiphellandrene at 85.4% of the total sesquiterpenes produced based on in vitro enzymatic assays. The recombinant L. lactis strain developed in this study was also capable of producing beta-sesquiphellandrene in vivo without exogenous substrates supplementation. In addition, overexpression of the strain's endogenous 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMGR), an established rate-limiting enzyme in the eukaryotic mevalonate pathway, increased the production level of beta-sesquiphellandrene by 1.25-1.60 fold. The highest amount achieved was 33 nM at 2 h post-induction.	[Song, Adelene Ai-Lian; Abdullah, Mohd Puad; Raha, Abdul Rahim] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia; [Abdullah, Janna Ong; Shafee, Norazizah] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia; [Raha, Abdul Rahim] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor Darul, Malaysia; [Othman, Roohaida; Noor, Normah Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor Darul, Malaysia; [Tan, Ee-Fun] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Raha, AR (corresponding author), Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor Darul, Malaysia.	raha@biotech.upm.edu.my	Noor, Normah Mohd/X-1754-2019; BIOTECH, JANNA ONG BINTI ABDULLAH //AAF-9573-2020	BIOTECH, JANNA ONG BINTI ABDULLAH //0000-0002-8280-5923	The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI) [07-05-MGI-GMB 004]	The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI)	This work was supported by "The Genomics and Molecular Biology Initiative of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation, Malaysia (MOSTI) (07-05-MGI-GMB 004)" and National Science Fellowship, MOSTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha K, 2010, J APPL MICROBIOL, V109, P1632, DOI 10.1111/j.1365-2672.2010.04789.x; Baharum SN, 2010, MOLECULES, V15, P7006, DOI 10.3390/molecules15107006; Balibar CJ, 2009, J BACTERIOL, V191, P851, DOI 10.1128/JB.01357-08; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; de Vos WM, 2004, TRENDS BIOTECHNOL, V22, P72, DOI 10.1016/j.tibtech.2003.11.011; Deligeorgopoulou A, 2003, BIOCHEMISTRY-US, V42, P7741, DOI 10.1021/bi034410m; DENYER CV, 1994, J NAT PROD, V57, P658, DOI 10.1021/np50107a017; El-Baroty G. S., 2010, Advances in Food Sciences, V32, P142; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Hernandez I, 2007, APPL ENVIRON MICROB, V73, P1544, DOI 10.1128/AEM.01870-06; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KH, 2011, J FOOD SCI, V76, pH226, DOI 10.1111/j.1750-3841.2011.02427.x; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; Ohto C, 2009, APPL MICROBIOL BIOT, V82, P837, DOI 10.1007/s00253-008-1807-5; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Song AAL, 2012, INT J MOL SCI, V13, P1582, DOI 10.3390/ijms13021582; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1	35	25	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52444	10.1371/journal.pone.0052444	http://dx.doi.org/10.1371/journal.pone.0052444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300671	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800087
J	Wang, XY; Jensen-Taubman, SM; Keefe, KM; Yang, DL; Linnoila, RI				Wang, Xiao-Yang; Jensen-Taubman, Sandra M.; Keefe, Kathleen M.; Yang, Danlei; Linnoila, R. Ilona			Achaete-Scute Complex Homolog-1 Promotes DNA Repair in the Lung Carcinogenesis through Matrix Metalloproteinase-7 and O(6)-Methylguanine-DNA Methyltransferase	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; NEUROENDOCRINE DIFFERENTIATION; HISTONE H2AX; CANCER; GENE; CELL; TUMORIGENESIS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; HYPERMETHYLATION; PROLIFERATION	Lung cancer is the leading cause of cancer-related deaths in the world. Achaete-scute complex homolog-1 (Ascl1) is a member of the basic helix-loop-helix (bHLH) transcription factor family that has multiple functions in the normal and neoplastic lung such as the regulation of neuroendocrine differentiation, prevention of apoptosis and promotion of tumor-initiating cells. We now show that Ascl1 directly regulates matrix metalloproteinase-7 (MMP-7) and O(6)-methylguanine-DNA methyltransferase (MGMT). Loss- and gain-of-function experiments in human bronchial epithelial and lung carcinoma cell lines revealed that Ascl1, MMP-7 and MGMT are able to protect cells from the tobacco-specific nitrosamine NNK-induced DNA damage and the alkylating agent cisplatin-induced apoptosis. We also examined the role of Ascl1 in NNK-induced lung tumorigenesis in vivo. Using transgenic mice which constitutively expressed human Ascl1 in airway lining cells, we found that there was a delay in lung tumorigenesis. We conclude that Ascl1 potentially enhances DNA repair through activation of MMP-7 and MGMT which may impact lung carcinogenesis and chemoresistance. The study has uncovered a novel and unexpected function of Ascl1 which will contribute to better understanding of lung carcinogenesis and the broad implications of transcription factors in tobacco-related carcinogenesis.	[Wang, Xiao-Yang; Jensen-Taubman, Sandra M.; Keefe, Kathleen M.; Yang, Danlei; Linnoila, R. Ilona] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XY (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	xiaoyangwang@gmail.com; linnoila@mail.nih.gov			Intramural Research Program of the National Cancer Institute at National Institutes of Health	Intramural Research Program of the National Cancer Institute at National Institutes of Health	This study was supported by the Intramural Research Program of the National Cancer Institute at National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan G, 2006, INT J ONCOL, V29, P745; Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; BELINSKY SA, 1992, CANCER RES, V52, P3164; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Biswas T, 1999, ONCOGENE, V18, P525, DOI 10.1038/sj.onc.1202320; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Brown PJ, 2008, CANCER LETT, V260, P48, DOI 10.1016/j.canlet.2007.10.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Demelash A, 2012, MOL BIOL CELL, V23, P2856, DOI 10.1091/mbc.E10-12-1010; Esteller M, 1999, CANCER RES, V59, P793; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Hang B, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/709521; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen-Taubman S, 2010, TOXICOL SCI, V117, P238, DOI 10.1093/toxsci/kfq177; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Kondo N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/543531; LINNOILA RI, 1988, AM J CLIN PATHOL, V90, P641, DOI 10.1093/ajcp/90.6.641; Linnoila RI, 2000, CANCER RES, V60, P4005; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu LL, 1999, CARCINOGENESIS, V20, P279, DOI 10.1093/carcin/20.2.279; Miki M, 2012, LUNG CANCER, V75, P58, DOI 10.1016/j.lungcan.2011.05.019; Mitsiades N, 2001, CANCER RES, V61, P577; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pulling LC, 2003, CANCER RES, V63, P4842; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakumi K, 1997, CANCER RES, V57, P2415; Shopland DR, 1995, ENVIRON HEALTH PERSP, V103, P131, DOI 10.2307/3432300; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Verbeek B, 2008, BRIT MED BULL, V85, P17, DOI 10.1093/bmb/ldm036; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2007, LAB INVEST, V87, P527, DOI 10.1038/labinvest.3700552; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675	38	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52832	10.1371/journal.pone.0052832	http://dx.doi.org/10.1371/journal.pone.0052832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300791	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800156
J	Zhou, H; Gao, J; Zou, DW; Wu, WB; Li, ZS				Zhou, Hui; Gao, Jun; Zou, Duowu; Wu, Wenbin; Li, Zhaoshen			Effect of Octreotide on Enteric Motor Neurons in Experimental Acute Necrotizing Pancreatitis	PLOS ONE			English	Article							SMALL-BOWEL MOTILITY; INTERSTITIAL-CELLS; BACTERIAL OVERGROWTH; INFLAMMATORY RESPONSE; NERVOUS-SYSTEM; SOMATOSTATIN; RATS; DYSMOTILITY; MOUSE; MODEL	Background/Aims: Amelioration of intestinal dysmotility and stasis during the early period of acute necrotizing pancreatitis (ANP) appears to be important to reduce the risks of secondary pancreatic infection. We aimed to characterize the association between the neuropathy of the enteric nervous system and gut dysfunction and to examine the effect of octreotide on motor innervation in the early stage of ANP. Methodology/Principal Findings: The rats were randomly divided into eight groups: control+saline; control+octreotide; ANP+saline and ANP+octreotide (24 h, 48 h, 72 h). The spontaneous activity of ileal segments and the response to ACh, L-NNA were recorded. The alterations of myenteric neuronal nitric oxide synthase (nNOS), choline acetyltransferase (CHAT), PGP9.5 and somatostatin receptor 2 (SSTR2) immunoreactive cells were evaluated by immunofluorescence and the protein expression of nNOS and CHAT were evaluated by western blot. We found the amplitude of spontaneous contractions at 48 h and the response to ACh at 24 h declined in the ANP+saline rats. A higher contractile response to both ACh and to L-NNA was observed in the ANP+octreotide group, compared with the ANP+saline rats at 24 h. A significant reduction in the nNOS and cholinergic neurons was observed in ANP+saline rats at the three time points. However, this reduction was greatly ameliorated in the presence of octreotide at 24 h and 48 h. The protein expression of CHAT neurons at 24 h and the nNOS neurons at 48 h in the ANP+octreotide rats was much higher than the ANP+saline rats. Conclusion: The pathogenesis of ileus in the early stage of ANP may be related to the neuropathy of the enteric nervous system. Octreotide may reduce the severity of ileus by lessening the damage to enteric motor innervation.	[Zhou, Hui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Zhou, Hui] Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Div Gastroenterol, Shanghai, Peoples R China; [Wu, Wenbin] Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Lab Stress Res, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Naval Medical University	Li, ZS (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Div Gastroenterol, Shanghai, Peoples R China.	zhsli@96590.net	Gao, Jun/C-1686-2008	Gao, Jun/0000-0003-4637-1918	National Nature Science Funds, China [81100257]	National Nature Science Funds, China	This work was supported by grants from the National Nature Science Funds, serial numbers: (81100257) to Zhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; BEGER HG, 1986, GASTROENTEROLOGY, V91, P433, DOI 10.1016/0016-5085(86)90579-2; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Cescato R, 2006, J NUCL MED, V47, P502; Chandrasekharan B, 2007, NEUROGASTROENT MOTIL, V19, P951, DOI 10.1111/j.1365-2982.2007.01023.x; Chen Chun-Chia, 1999, Proceedings of the National Science Council Republic of China Part B Life Sciences, V23, P1; Corleto VD, 2006, NEUROGASTROENT MOTIL, V18, P217, DOI 10.1111/j.1365-2982.2005.00752.x; Corleto VD, 2010, CURR OPIN ENDOCRINOL, V17, P63, DOI 10.1097/MED.0b013e32833463ed; De Man JG, 2002, INT J PARASITOL, V32, P1309, DOI 10.1016/S0020-7519(02)00128-5; Demedts I, 2006, NEUROGASTROENT MOTIL, V18, P1102, DOI 10.1111/j.1365-2982.2006.00857.x; Dugernier T, 2005, PANCREAS, V31, P168, DOI 10.1097/01.mpa.0000170681.89652.95; FAUSSONEPELLEGRINI MS, 1985, ANAT EMBRYOL, V171, P163, DOI 10.1007/BF00341410; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Fritz S, 2008, CRIT CARE, V12, DOI 10.1186/cc7118; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HARUMA K, 1994, GUT, V35, P1064, DOI 10.1136/gut.35.8.1064; JOHANSSON C, 1978, SCAND J GASTROENTERO, V13, P481, DOI 10.3109/00365527809181925; Li J, 2011, CURR PHARM DESIGN, V17, P1594, DOI 10.2174/138161211796196936; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; MILENOV K, 1993, COMP BIOCHEM PHYS C, V106, P337, DOI 10.1016/0742-8413(93)90143-9; Nieuwenhuijs VB, 1998, ANN SURG, V228, P188, DOI 10.1097/00000658-199808000-00007; ODONNELL LJD, 1990, ALIMENT PHARM THERAP, V4, P177; Pawlikowski M., 2007, SOMATOSTATIN ANALOGS, DOI [10.1201/9781498713528, DOI 10.1201/9781498713528]; Rakonczay Z, 2008, CRIT CARE MED, V36, P2117, DOI 10.1097/CCM.0b013e31817d7f5c; Rickenbacher A, 2008, SURGERY, V143, P94, DOI 10.1016/j.surg.2007.06.034; RUNKEL NSF, 1991, J SURG RES, V51, P18, DOI 10.1016/0022-4804(91)90064-S; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Shimojima N, 2006, J SURG RES, V135, P255, DOI 10.1016/j.jss.2006.04.022; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; Tang WF, 2007, J DIGEST DIS, V8, P96, DOI 10.1111/j.1443-9573.2007.00293.x; Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Wang XP, 2003, J GASTROEN HEPATOL, V18, P57, DOI 10.1046/j.1440-1746.2003.02898.x; Weber CK, 2001, PANCREATOLOGY, V1, P356, DOI 10.1159/000055834; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P85; Zhang XP, 2009, TURK J GASTROENTEROL, V20, P108; Zhou H, 2011, PANCREAS, V40, P1226, DOI 10.1097/MPA.0b013e318220afab; Zhou H, 2011, SURGERY, V149, P262, DOI 10.1016/j.surg.2010.04.023; Zhou MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037347	42	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52163	10.1371/journal.pone.0052163	http://dx.doi.org/10.1371/journal.pone.0052163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300603	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800050
J	Bock, J; Mochmann, LH; Schlee, C; Farhadi-Sartangi, N; Gollner, S; Muller-Tidow, C; Baldus, CD				Bock, Juliane; Mochmann, Liliana H.; Schlee, Cornelia; Farhadi-Sartangi, Nasrin; Goellner, Stefanie; Mueller-Tidow, Carsten; Baldus, Claudia D.			ERG Transcriptional Networks in Primary Acute Leukemia Cells Implicate a Role for ERG in Deregulated Kinase Signaling	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER; LYMPHOBLASTIC-LEUKEMIA; NORMAL KARYOTYPE; SCREEN REVEALS; PHASE I/II; EXPRESSION; GENE; PREDICTS; TARGET	High expression of the E26 transforming sequence related gene ( ERG) is associated with poor prognosis in a subgroup of leukemia patients with acute myeloid (AML) and acute T-lymphoblastic leukemia (T-ALL). In a previous study we proposed that ERG overexpression may deregulate several signaling cascades in acute leukemia. Herein, we further expand those studies by identifying a consensus of biological targets in primary blasts of newly diagnosed acute leukemia patients. Our findings of chromatin immunoprecipitation-on-chip of primary samples revealed 48 significantly enriched single genes including DAAM1 and NUMB. Significantly enriched signaling pathways included WNT/beta-catenin, p53, and PI3K/AKT with ERG overexpression inducing dephosphorylation of AKT(Ser473) relative to non ERG expressing K562 cells. Cell based ERG overexpression studies also revealed drug resistance to multi-kinase inhibitor, BAY 43-9006 (Sorafenib) and to the tyrosine kinase inhibitor TKI258. Thus in primary leukemic cells, ERG may contribute to the dysregulation of kinase signaling, which results in resistance to kinase inhibitors.	[Bock, Juliane; Mochmann, Liliana H.; Schlee, Cornelia; Farhadi-Sartangi, Nasrin; Baldus, Claudia D.] Univ Hosp Berlin, Charite, Dept Hematol & Oncol, Berlin, Germany; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol Oncol & Pneumol, D-48149 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster	Baldus, CD (corresponding author), Univ Hosp Berlin, Charite, Dept Hematol & Oncol, Campus Benjamin Franklin, Berlin, Germany.	claudia.baldus@charite.de	Müller-Tidow, Carsten CMT/B-5257-2014; Göllner, Stefanie/AAX-3901-2020; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by research funding from the Deutsche Krebshilfe to CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Ciarlo M, 2012, INT J CANCER, V131, P582, DOI 10.1002/ijc.26402; Eid MA, 2010, INT J LAB HEMATOL, V32, P197, DOI 10.1111/j.1751-553X.2009.01168.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fortson WS, 2011, INT J ONCOL, V39, P111, DOI 10.3892/ijo.2011.1014; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hart AH, 2000, ONCOGENE, V19, P6400, DOI 10.1038/sj.onc.1204040; Hoemme C, 2008, BLOOD, V111, P2887, DOI 10.1182/blood-2007-03-079921; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim KB, 2011, CLIN CANCER RES, V17, P7451, DOI 10.1158/1078-0432.CCR-11-1747; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong XT, 1997, BLOOD, V90, P1192; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Metzeler KH, 2009, J CLIN ONCOL, V27, P5031, DOI 10.1200/JCO.2008.20.5328; Mochmann LH, 2011, ONCOGENE, V30, P2044, DOI 10.1038/onc.2010.582; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Pereira JKN, 2012, LEUKEMIA RES, V36, P1300, DOI 10.1016/j.leukres.2012.06.010; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsuzuki S, 2012, BLOOD, V117, P7079; Vu C, 2010, CLIN CANCER RES, V16, P5374, DOI 10.1158/1078-0432.CCR-10-0480; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhu XP, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-17; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	39	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52872	10.1371/journal.pone.0052872	http://dx.doi.org/10.1371/journal.pone.0052872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300998	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000019
J	Vacchi-Suzzi, C; Hahne, F; Scheubel, P; Marcellin, M; Dubost, V; Westphal, M; Boeglen, C; Buchmann-Moller, S; Cheung, MS; Cordier, A; De Benedetto, C; Deurinck, M; Frei, M; Moulin, P; Oakeley, E; Grenet, O; Grevot, A; Stull, R; Theil, D; Moggs, JG; Marrer, E; Couttet, P				Vacchi-Suzzi, Caterina; Hahne, Florian; Scheubel, Philippe; Marcellin, Magali; Dubost, Valerie; Westphal, Magdalena; Boeglen, Catherine; Buechmann-Moller, Stine; Cheung, Ming Sin; Cordier, Andre; De Benedetto, Christopher; Deurinck, Mark; Frei, Moritz; Moulin, Pierre; Oakeley, Edward; Grenet, Olivier; Grevot, Armelle; Stull, Robert; Theil, Diethilde; Moggs, Jonathan G.; Marrer, Estelle; Couttet, Philippe			Heart Structure-Specific Transcriptomic Atlas Reveals Conserved microRNA-mRNA Interactions	PLOS ONE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; RAT-LIVER; PROLIFERATION; ACTIVATION; BIOMARKERS; MOUSE; HYPERTROPHY	MicroRNAs are short non-coding RNAs that regulate gene expression at the post-transcriptional level and play key roles in heart development and cardiovascular diseases. Here, we have characterized the expression and distribution of microRNAs across eight cardiac structures (left and right ventricles, apex, papillary muscle, septum, left and right atrium and valves) in rat, Beagle dog and cynomolgus monkey using microRNA sequencing. Conserved microRNA signatures enriched in specific heart structures across these species were identified for cardiac valve (miR-let-7c, miR-125b, miR-127, miR-199a-3p, miR-204, miR-320, miR-99b, miR-328 and miR-744) and myocardium (miR-1, miR-133b, miR-133a, miR-208b, miR-30e, miR-499-5p, miR-30e*). The relative abundance of myocardium-enriched (miR-1) and valve-enriched (miR-125b-5p and miR-204) microRNAs was confirmed using in situ hybridization. MicroRNA-mRNA interactions potentially relevant for cardiac functions were explored using anti-correlation expression analysis and microRNA target prediction algorithms. Interactions between miR-1/Timp3, miR-125b/Rbm24, miR-204/Tgfbr2 and miR-208b/Csnk2a2 were identified and experimentally investigated in human pulmonary smooth muscle cells and luciferase reporter assays. In conclusion, we have generated a high-resolution heart structure-specific mRNA/microRNA expression atlas for three mammalian species that provides a novel resource for investigating novel microRNA regulatory circuits involved in cardiac molecular physiopathology.	[Vacchi-Suzzi, Caterina; Hahne, Florian; Scheubel, Philippe; Marcellin, Magali; Dubost, Valerie; Westphal, Magdalena; Boeglen, Catherine; Buechmann-Moller, Stine; Cheung, Ming Sin; Cordier, Andre; Deurinck, Mark; Frei, Moritz; Moulin, Pierre; Oakeley, Edward; Grenet, Olivier; Grevot, Armelle; Theil, Diethilde; Moggs, Jonathan G.; Marrer, Estelle; Couttet, Philippe] Novartis Inst Biomed Res, Basel, Switzerland; [De Benedetto, Christopher; Stull, Robert] Novartis Inst Biomed Res, E Hanover, NJ USA	Novartis; Novartis	Couttet, P (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	philippe.couttet@novartis.com	Couttet, Philippe/AAH-5489-2019	Couttet, Philippe/0000-0002-5255-6647				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukushima Tamio, 2007, Journal of Toxicological Sciences, V32, P401, DOI 10.2131/jts.32.401; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lema C, 2010, TOXICOL LETT, V198, P100, DOI 10.1016/j.toxlet.2010.06.019; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; Van Hummelen P, 2010, MUTAT RES-REV MUTAT, V705, P165, DOI 10.1016/j.mrrev.2010.04.007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang RR, 2011, INTERNAL MED, V50, P1789, DOI 10.2169/internalmedicine.50.5129; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	67	57	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52442	10.1371/journal.pone.0052442	http://dx.doi.org/10.1371/journal.pone.0052442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300973	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900025
J	Vorsino, AE; King, CB; Haines, WP; Rubinoff, D				Vorsino, Adam E.; King, Cynthia B.; Haines, William P.; Rubinoff, Daniel			Modeling the Habitat Retreat of the Rediscovered Endemic Hawaiian Moth Omiodes continuatalis Wallengren (Lepidoptera: Crambidae)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOLOGICAL-CONTROL; LEAFROLLER MOTH; THRESHOLD CRITERIA; ECOLOGICAL NICHES; PRESENCE-ABSENCE; CLIMATE MODELS; DISTRIBUTIONS; IMPACTS; RARE	Survey data over the last 100 years indicate that populations of the endemic Hawaiian leafroller moth, Omiodes continuatalis (Wallengren) (Lepidoptera: Crambidae), have declined, and the species is extirpated from large portions of its original range. Declines have been attributed largely to the invasion of non-native parasitoid species into Hawaiian ecosystems. To quantify changes in O. continuatalis distribution, we applied the maximum entropy modeling approach using MAXENT. The model referenced historical (1892-1967) and current (2004-2008) survey data, to create predictive habitat suitability maps which illustrate the probability of occurrence of O. continuatalis based on historical data as contrasted with recent survey results. Probability of occurrence is predicted based on the association of biotic (vegetation) and abiotic (proxy of precipitation, proxy of temperature, elevation) environmental factors with 141 recent and historic survey locations, 38 of which O. continuatalis were collected from. Models built from the historical and recent surveys suggest habitat suitable for O. continuatalis has changed significantly over time, decreasing both in quantity and quality. We reference these data to examine the potential effects of non-native parasitoids as a factor in changing habitat suitability and range contraction for O. continuatalis. Synthesis and applications: Our results suggest that the range of O. continuatalis, an endemic Hawaiian species of conservation concern, has shrunk as its environment has degraded. Although few range shifts have been previously demonstrated in insects, such contractions caused by pressure from introduced species may be important factors in insect extinctions.	[Vorsino, Adam E.; King, Cynthia B.; Haines, William P.; Rubinoff, Daniel] Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu	Vorsino, Adam/H-3435-2013		USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award) [2004-34135-14998]; USDA-NIFA Agreement [58-5320-9-430]; Hatch projects [HAW00942-H, HAW00956-H]; University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant) [DGE02-32016]; NSF Graduate Research Fellowship Program	USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award); USDA-NIFA Agreement; Hatch projects(United States Department of Agriculture (USDA)); University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant); NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	This research was funded by a USDA Cooperative State Research, Education and Extension (CSREES) Special Research Grant Tropical and Subtropical Agricultural Research (USDA CSREES Award #2004-34135-14998), as well as USDA-NIFA Agreement No. 58-5320-9-430, and Hatch projects HAW00942-H and HAW00956-H, administered by the College of Tropical Agriculture and Human Resources. Additional funding was provided by the University of Hawaii Manoa Ecology, Evolution and Conservation Biology program (NSF grant #DGE02-32016), and the NSF Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bartel RA, 2009, ECOGRAPHY, V32, P888, DOI 10.1111/j.1600-0587.2009.05797.x; Benson J, 2003, BIOL CONTROL, V28, P197, DOI 10.1016/S1049-9644(03)00058-6; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Chu PS, 2010, J CLIMATE, V23, P4881, DOI 10.1175/2010JCLI3484.1; CLOUT MN, 1995, IBIS, V137, pS181, DOI 10.1111/j.1474-919X.1995.tb08440.x; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 10; Follett Peter A., 2000, American Entomologist, V46, P82; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; Gagne W.C., 1985, P105; Gagne W. C, 1982, P 3 C EUR LEP CAMBR; Gagne W. C., 1982, P 4 C NAT SCI HAW VO, P63; Gagne WC, 1981, ISLAND ECOSYSTEMS BI; Gagne WC, 1980, P 3 HAW VOLC NAT PAR, P115; Giambelluca TW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034377; Haines William P., 2004, Bishop Museum Occasional Papers, V79, P45; HAWKINS BA, 1993, SCIENCE, V262, P1429, DOI 10.1126/science.262.5138.1429; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howarth F.G., 1985, P149; HOWARTH F G, 1983, Proceedings of the Hawaiian Entomological Society, V24, P239; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Irving DB, 2011, CLIM RES, V49, P169, DOI 10.3354/cr01028; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Johnson MT, 2005, OECOLOGIA, V142, P529, DOI 10.1007/s00442-004-1754-5; King C, 2008, PAC SCI, V62, P147, DOI 10.2984/1534-6188(2008)62[147:FROFBI]2.0.CO;2; King C, 2009, J LEPID SOC, V63, P11; King Cynthia B. A., 2008, Proceedings of the Hawaiian Entomological Society, V40, P11; King CBA, 2010, J APPL ECOL, V47, P299, DOI 10.1111/j.1365-2664.2010.01780.x; Krushelnycky Paul D., 2005, Proceedings of the Hawaiian Entomological Society, V37, P1; Krushelnycky PD, 2012, ANTWEB ANTS HAWAII; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; LEVINS RICHARD, 1968; Lippitt CD, 2008, ECOL MODEL, V210, P339, DOI 10.1016/j.ecolmodel.2007.08.005; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Menuz DR, 2011, THESIS; Messing RH, 2006, FRONT ECOL ENVIRON, V4, P132, DOI 10.1890/1540-9295(2006)004[0132:BCOISS]2.0.CO;2; [National Oceanic and Atmospheric Institute (NOAA) National Ocean Services (NOS)], 2007, 10 M DIG EL MOD HAW; NISHIDA G. M., 2002, HAWAIIAN TERRESTRIAL; Oboyski PT, 2004, J INSECT CONSERV, V8, P229, DOI 10.1023/B:JICO.0000045821.71118.54; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peck RW, 2008, BIOL INVASIONS, V10, P1441, DOI 10.1007/s10530-008-9218-1; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; REIMER NJ, 1994, WESTV STUD, P11; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; ROLLINS M.G., 2007, DEV LANDFIRE FIRE RE; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Rubinoff D, 2002, FREMONTIA, V30, P62; Samways M.J., 2005, INSECT DIVERSITY CON; Schultz CB, 1999, OECOLOGIA, V119, P231, DOI 10.1007/s004420050781; Speight MR, 1999, ECOLOGY INSECTS CONC; Timm OE, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014923; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Zimmerman E.C., 1958, INSECTS HAWAII LEPID	77	6	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51885	10.1371/journal.pone.0051885	http://dx.doi.org/10.1371/journal.pone.0051885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300954	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900011
J	Bailey, JR; Bland, PW; Tarlton, JF; Peters, I; Moorghen, M; Sylvester, PA; Probert, CSJ; Whiting, CV				Bailey, Jennifer R.; Bland, Paul W.; Tarlton, John F.; Peters, Iain; Moorghen, Moganaden; Sylvester, Paul A.; Probert, Christopher S. J.; Whiting, Christine V.			IL-13 Promotes Collagen Accumulation in Crohn's Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells?	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; GENE-EXPRESSION; LIVER FIBROSIS; INTERLEUKIN-13; PATHOGENESIS; INFLAMMATION; ACTIVATION; RECEPTORS; INDUCTION	Background: Fibrosis is a serious consequence of Crohn's disease (CD), often necessitating surgical resection. We examined the hypothesis that IL-13 may promote collagen accumulation within the CD muscle microenvironment. Methods: Factors potentially modulating collagen deposition were examined in intestinal tissue samples from fibrotic (f) CD and compared with cancer control (C), ulcerative colitis (UC) and uninvolved (u) CD. Mechanisms attributable to IL-13 were analysed using cell lines derived from uninvolved muscle tissue and tissue explants. Results: In fCD muscle extracts, collagen synthesis was significantly increased compared to other groups, but MMP-2 was not co-ordinately increased. IL-13 transcripts were highest in fCD muscle compared to muscle from other groups. IL-13 receptor (R) alpha 1 was expressed by intestinal muscle smooth muscle, nerve and KIR+ cells. Fibroblasts from intestinal muscle expressed R alpha 1, phosphorylated STAT6 in response to IL-13, and subsequently down-regulated MMP-2 and TNF-alpha-induced MMP-1 and MMP-9 synthesis. Cells with the phenotype KIR(+)CD45(+)CD56(+/-)CD3(-) were significantly increased in fCD muscle compared to all other groups, expressed Ra1 and membrane IL-13, and transcribed high levels of IL-13. In explanted CD muscle, these cells did not phosphorylate STAT6 in response to exogenous IL-13. Conclusions: The data indicate that in fibrotic intestinal muscle of Crohn's patients, the IL-13 pathway is stimulated, involving a novel population of infiltrating IL-13R alpha 1(+), KIR+ innate lymphoid cells, producing IL-13 which inhibits fibroblast MMP synthesis. Consequently, matrix degradation is down-regulated and this leads to excessive collagen deposition.	[Bailey, Jennifer R.; Bland, Paul W.; Tarlton, John F.; Whiting, Christine V.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Bland, Paul W.] Univ Gothenburg, Dept Microbiol & Immunol, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Sweden; [Peters, Iain] Univ Exeter, Innovat Ctr, Exeter, Devon, England; [Moorghen, Moganaden] St Marks Hosp, Dept Histopathol, Harrow, Middx, England; [Sylvester, Paul A.] Univ Bristol, Bristol Royal Infirm, Dept Surg, Bristol BS2 8HW, Avon, England; [Probert, Christopher S. J.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Bristol; University of Gothenburg; University of Exeter; Imperial College London; Bristol Royal Infirmary; University of Bristol; University of Liverpool	Tarlton, JF (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	John.Tarlton@bris.ac.uk	Bailey, Jennifer/H-5856-2013	Tarlton, John/0000-0002-4886-6634; Probert, Christopher/0000-0003-4550-0239	Action Medical Research [SP4260]; National Association for Colitis and Crohn's disease [M/07/5]; Swedish Fund for Strategic Research; Edith Lidiard Private Bequest	Action Medical Research; National Association for Colitis and Crohn's disease; Swedish Fund for Strategic Research(Swedish Foundation for Strategic Research); Edith Lidiard Private Bequest	This work was supported by Action Medical Research, SP4260 (http://www.action.org.uk); National Association for Colitis and Crohn's disease, M/07/5 (http://www.nacc.org.uk); Swedish Fund for Strategic Research (http://www.stratresearch.se/en/), and Edith Lidiard Private Bequest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Bishop JE, 1998, MOL MED TODAY, V4, P69, DOI 10.1016/S1357-4310(97)01193-3; Bosse Y, 2008, INT ARCH ALLERGY IMM, V146, P138, DOI 10.1159/000113517; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Goffin L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2991; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Kadivar K, 2004, INFLAMM BOWEL DIS, V10, P593, DOI 10.1097/00054725-200409000-00014; Kawashima R, 2006, GASTROENTEROLOGY, V131, P130, DOI 10.1053/j.gastro.2006.04.022; Kim ES, 2007, CANCER LETT, V252, P147, DOI 10.1016/j.canlet.2006.12.016; Koukoulis G, 2001, ARCH PATHOL LAB MED, V125, P1331; Krantz SB, 2011, MOL CANCER RES, V9, P1294, DOI 10.1158/1541-7786.MCR-11-0023; Lee PJ, 2006, J CLIN INVEST, V116, P163, DOI 10.1172/JCI25711; Leonardi A, 2003, INVEST OPHTH VIS SCI, V44, P183, DOI 10.1167/iovs.02-0420; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Mourelle M, 1998, GASTROENTEROLOGY, V114, P519, DOI 10.1016/S0016-5085(98)70535-9; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Oriente A, 2000, J PHARMACOL EXP THER, V292, P988; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; Rozen S, 2000, Methods Mol Biol, V132, P365; Scharl M, 2012, GUT; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Straub RH, 2008, GUT, V57, P911, DOI 10.1136/gut.2007.125401; Tarlton JF, 2000, AM J PATHOL, V157, P1927, DOI 10.1016/S0002-9440(10)64831-6; Vainer B, 2000, CYTOKINE, V12, P1531, DOI 10.1006/cyto.2000.0744; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Whiting CV, 2001, J HISTOCHEM CYTOCHEM, V49, P727, DOI 10.1177/002215540104900606; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zhou XX, 2007, J ALLERGY CLIN IMMUN, V119, P1388, DOI 10.1016/j.jaci.2007.02.011; Zhou XX, 2005, AM J PHYSIOL-CELL PH, V288, pC435, DOI 10.1152/ajpcell.00035.2004	40	86	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52332	10.1371/journal.pone.0052332	http://dx.doi.org/10.1371/journal.pone.0052332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300643	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600014
J	Nasu, M; Takata, N; Danjo, T; Sakaguchi, H; Kadoshima, T; Futaki, S; Sekiguchi, K; Eiraku, M; Sasai, Y				Nasu, Makoto; Takata, Nozomu; Danjo, Teruko; Sakaguchi, Hideya; Kadoshima, Taisuke; Futaki, Sugiko; Sekiguchi, Kiyotoshi; Eiraku, Mototsugu; Sasai, Yoshiki			Robust Formation and Maintenance of Continuous Stratified Cortical Neuroepithelium by Laminin-Containing Matrix in Mouse ES Cell Culture	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIRECTED DIFFERENTIATION; CAJAL-RETZIUS; RADIAL GLIA; NEURONS; GENES; PAX6; SPECIFICATION; EXPRESSION; GENERATION	In the mammalian cortex, the dorsal telencephalon exhibits a characteristic stratified structure. We previously reported that three-dimensional (3D) culture of mouse ES cells (mESCs) can efficiently generate cortical neuroepithelium (NE) and layer-specific cortical neurons. However, the cortical NE generated in this mESC culture was structurally unstable and broke into small neural rosettes by culture day 7, suggesting that some factors for reinforcing the structural integrity were missing. Here we report substantial supporting effects of the extracellular matrix (ECM) protein laminin on the continuous formation of properly polarized cortical NE in floating aggregate culture of mESCs. The addition of purified laminin and entactin (a laminin-associated protein), even at low concentrations, stabilized the formation of continuous cortical NE as well as the maintenance of basement membrane and prevented rosette formation. Treatment with the neutralizing beta 1-integrin antibody impaired the continuous NE formation. The stabilized cortical NE exhibited typical interkinetic nuclear migration of cortical progenitors, as seen in the embryonic cortex. The laminin-treated cortical NE maintained a continuous structure even on culture days 12 and 15, and contained ventricular, basal-progenitor, cortical-plate and Cajal-Retzius cell layers. The cortical NE in this culture was flanked by cortical hem-like tissue. Furthermore, when Shh was added, ventral telencephalic structures such as lateral ganglionic eminence-like tissue formed in the region adjacent to the cortical NE. Thus, our results indicate that laminin-entactin ECM promotes the formation of structurally stable telencephalic tissues in 3D ESC culture, and supports the morphogenetic recapitulation of cortical development.	[Nasu, Makoto; Takata, Nozomu; Danjo, Teruko; Sakaguchi, Hideya; Kadoshima, Taisuke; Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Kadoshima, Taisuke; Eiraku, Mototsugu; Sasai, Yoshiki] RIKEN, Dimens Tissue Anal Unit 4, Ctr Dev Biol, Kobe, Hyogo, Japan; [Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 565, Japan	RIKEN; RIKEN; Osaka University	Sasai, Y (corresponding author), RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan.	yoshikisasai@cdb.riken.jp	Takata, Nozomu/AAI-9801-2020; Nasu, Makoto/ABB-9555-2021	Nasu, Makoto/0000-0003-1361-7598; Eiraku, Mototsugu/0000-0002-9433-9085; Takata, Nozomu/0000-0003-0171-6994	MEXT; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [24680037] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from MEXT (YS, ME, KS), and the Leading Project for Realization of Regenerative Medicine (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; CHAMSON A, 1989, ARCH DERMATOL RES, V281, P267, DOI 10.1007/BF00431061; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021; FLEISCHMAJER R, 1993, J HISTOCHEM CYTOCHEM, V41, P1359, DOI 10.1177/41.9.7689083; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; OJAKIAN GK, 1994, J CELL SCI, V107, P561; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	46	59	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53024	10.1371/journal.pone.0053024	http://dx.doi.org/10.1371/journal.pone.0053024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300850	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872600048
J	Renner, SC; Baur, S; Possler, A; Winkler, J; Kalko, EKV; Bates, PJJ; Mello, MAR				Renner, Swen C.; Baur, Sofia; Possler, Astrid; Winkler, Julia; Kalko, Elisabeth K. V.; Bates, Paul J. J.; Mello, Marco A. R.			Food Preferences of Winter Bird Communities in Different Forest Types	PLOS ONE			English	Article							HABITAT QUALITY; FORAGING BEHAVIOR; BREEDING HABITAT; WEIGHT CYCLE; LIDAR; RISK; TEMPERATURE; PREDATION; ABUNDANCE; FITNESS	Food availability for forest birds is a function of habitat type, forest management regime, and season. In winter, it is also impacted by variations in the weather. In the current study we assessed the food preferences of wild bird populations in two types of forest (spruce and beech) during the months of November 2010 to April 2011 in the Schwabische Alb Biodiversity Exploratory, south-western Germany. Our aim was to investigate whether local bird communities preferred fat-rich, carbohydrate-rich or wild fruits and to determine how forest structure, seasonality and local weather conditions affected food preferences. We found higher bird activity in beech forests for the eleven resident species. We observed a clear preference for fat-rich food for all birds in both forest types. Snow cover affected activity at food stations but did not affect food preferences. Periods of extreme low temperatures increased activity.	[Renner, Swen C.; Baur, Sofia; Possler, Astrid; Winkler, Julia; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Bates, Paul J. J.] Harrison Inst, Sevenoaks, Kent, England; [Mello, Marco A. R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol, Belo Horizonte, MG, Brazil	Ulm University; Universidade Federal de Minas Gerais	Renner, SC (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	swen.renner@uni-ulm.de	Bates, Paul/HDO-0192-2022; Mello, Marco A. R./B-1095-2008	Mello, Marco A. R./0000-0002-9098-9427; /0000-0002-6893-4219	DFG Priority Program [1374]	DFG Priority Program(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; [Anonymous], 2010, R LANG ENV STAT COMP; Antczak M, 2010, ORNIS FENNICA, V87, P99; Barboza PS, 2009, INTEGRATIVE WILDLIFE, P209; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brotons L, 1997, ARDEA, V85, P249; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Diggs NE, 2011, CONDOR, V113, P646, DOI 10.1525/cond.2011.090201; Doligez B, 2008, ECOLOGY, V89, P1436, DOI 10.1890/07-0113.1; ELGAR MA, 1986, BEHAV ECOL SOCIOBIOL, V19, P433, DOI 10.1007/BF00300546; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Glutz von Blotzheim U. N., 1988, HDB VOGEL MITTELEURO, V11; Glutz von Blotzheim U. N., 1997, HDB VOGEL MITTELEURO, V14, P2; Glutz von Blotzheim U. N., 1993, HDB VOGEL MITTELEURO, V13/I; Glutz Von Blotzheim U.N., 1980, HDB VOGEL MITTELEURO, V9; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; GRODZINSKI W, 1970, OIKOS, V21, P52, DOI 10.2307/3543838; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; HAFTORN S, 1992, ORNIS SCAND, V23, P435, DOI 10.2307/3676674; Hewson CM, 2011, FOREST ECOL MANAG, V261, P1224, DOI 10.1016/j.foreco.2011.01.001; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; Hinsley SA, 1999, J AVIAN BIOL, V30, P271, DOI 10.2307/3677353; Hinsley SA, 2002, FUNCT ECOL, V16, P851, DOI 10.1046/j.1365-2435.2002.00697.x; Holzinger J., 1997, VOGEL BADEN WURTTEMB; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Kohler A, 2010, FUNCT ECOL, V24, P1241, DOI 10.1111/j.1365-2435.2010.01728.x; Lahti K, 1998, ECOLOGY, V79, P2904, DOI 10.1890/0012-9658(1998)079[2904:TAFDIW]2.0.CO;2; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; LEHIKOINEN E, 1987, ORNIS SCAND, V18, P216, DOI 10.2307/3676769; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; LWF Bayern, 2004, VOG STAATSW WAS STEC; MACCARONE AD, 1987, WILSON BULL, V99, P94; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Muller J, 2009, BASIC APPL ECOL, V10, P671, DOI 10.1016/j.baae.2009.03.004; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Nakamura M, 2001, ECOL RES, V16, P301, DOI 10.1046/j.1440-1703.2001.00397.x; Nikolov SC, 2009, FOREST ECOL MANAG, V257, P580, DOI 10.1016/j.foreco.2008.09.030; Nutrition values, 2012, NAHRW ERN; Renner SC, 2006, BIODIVERS CONSERV, V15, P1545, DOI 10.1007/s10531-005-2930-6; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; ROGERS CM, 1990, ORNIS SCAND, V21, P105, DOI 10.2307/3676805; Sjoberg K, 2000, ECOLOGY, V81, P329, DOI 10.2307/177430; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; Turcotte Y, 2005, ECOGRAPHY, V28, P129, DOI 10.1111/j.0906-7590.2005.04047.x; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Wells K, 2011, BASIC APPL ECOL, V12, P97, DOI 10.1016/j.baae.2011.01.002	52	20	23	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53121	10.1371/journal.pone.0053121	http://dx.doi.org/10.1371/journal.pone.0053121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300878	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600062
J	Sawiak, SJ; Wood, NI; Carpenter, TA; Morton, AJ				Sawiak, Stephen J.; Wood, Nigel I.; Carpenter, T. Adrian; Morton, A. Jennifer			Huntington's Disease Mouse Models Online: High-Resolution MRI Images with Stereotaxic Templates for Computational Neuroanatomy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EXPANDED CAG REPEAT; MUTANT HUNTINGTIN; TRANSGENIC MOUSE; MATTER ATROPHY; EARLY MOTOR; MICE; LENGTH; MUTATION; BRAIN	Magnetic resonance imaging (MRI) has proved to be an ideal modality for non-destructive and highly detailed assessment of structural morphology in biological tissues. Here we used MRI to make a dataset of ex vivo brains from two different rodent models of Huntington's disease (HD), the R6/2 line and the YAC 128 mouse. We are making the whole dataset (399 transgenic HD and wildtype (WT) brains, from mice aged 9-80 weeks) publicly available. These data will be useful, not only to investigators interested in the study of HD, but also to researchers of computational neuroanatomy who may not have access to such large datasets from mouse models. Here we demonstrate a number of uses of such data, for example to produce maps of grey and white matter and cortical thickness. As an example of how the library might provide insights in mouse models of HD, we calculated whole brain grey matter volumes across different age groups with different numbers of cytosine-adenine-guanine (CAG) repeats in a fragment of the gene responsible for HD in humans. (The R6/2 dataset was obtained from an allelic series of R6/2 mice carrying a range of CAG repeat lengths between 109 and 464.) This analysis revealed different trajectories for each fragment length. In particular there was a gradient of decreasing pathology with longer CAG repeat lengths, reflecting our previous findings with behavioural and histological studies. There will be no constraints placed on the use of the datasets included here. The original data will be easily and permanently accessible via the University of Cambridge data repository (http://www.dspace.cam.ac.uk/handle/1810/243361).	[Sawiak, Stephen J.; Carpenter, T. Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Sawiak, Stephen J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Wood, Nigel I.; Morton, A. Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge; University of Cambridge; University of Cambridge	Sawiak, SJ (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England.	sjs80@wbic.cam.ac.uk	Sawiak, Stephen J/I-8944-2012; Morton, Jenny/AAT-8642-2020	Sawiak, Stephen J/0000-0003-4210-9816; Morton, Jenny/0000-0003-0181-6346	CHDI, Inc.	CHDI, Inc.	This study was supported by a grant from CHDI, Inc. to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Carroll JB, 2011, NEUROBIOL DIS, V43, P257, DOI 10.1016/j.nbd.2011.03.018; Carter RJ, 1999, J NEUROSCI, V19, P3248; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Glynn D, 2007, NEUROBIOL DIS, V25, P483, DOI 10.1016/j.nbd.2006.10.011; Gomez-Anson B, 2009, PARKINSONISM RELAT D, V15, P213, DOI 10.1016/j.parkreldis.2008.05.010; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hobbs NZ, 2010, J NEUROL NEUROSUR PS, V81, P756, DOI 10.1136/jnnp.2009.190702; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Jech R, 2007, MOVEMENT DISORD, V22, P1783, DOI 10.1002/mds.21620; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kielar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032636; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; OLIVA D, 1993, ARCH NEUROL-CHICAGO, V50, P17, DOI 10.1001/archneur.1993.00540010013010; Paxinos G, 2004, MOUSE BRAIN STEREOTA, V1; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Shan ZYY, 2006, LECT NOTES COMPUT SC, V4191, P332; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tang B, 2011, NEUROBIOL DIS, V42, P459, DOI 10.1016/j.nbd.2011.02.008; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1	41	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53361	10.1371/journal.pone.0053361	http://dx.doi.org/10.1371/journal.pone.0053361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300918	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600089
J	Yasuda, T; Loenneke, JP; Thiebaud, RS; Abe, T				Yasuda, Tomohiro; Loenneke, Jeremy P.; Thiebaud, Robert S.; Abe, Takashi			Effects of Blood Flow Restricted Low-Intensity Concentric or Eccentric Training on Muscle Size and Strength	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; HORMONAL RESPONSES; CONTRACTIONS; EXERCISE; ACTIVATION; HYDRATION; HYPERTROPHY; GLUCOSE	We investigated the acute and chronic effects of low-intensity concentric or eccentric resistance training with blood flow restriction (BFR) on muscle size and strength. Ten young men performed 30% of concentric one repetition maximal dumbbell curl exercise (four sets, total 75 reps) 3 days/week for 6 weeks. One arm was randomly chosen for concentric BFR (CON-BFR) exercise only and the other arm performed eccentric BFR (ECC-BFR) exercise only at the same exercise load. During the exercise session, iEMG for biceps brachii muscles increased progressively during CON-BFR, which was greater (p<0.05) than that of the ECC-BFR. Immediately after the exercise, muscle thickness (MTH) of the elbow flexors acutely increased (p<0.01) with both CON-BFR and ECC-BFR, but was greater with CON-BFR (11.7%) (p<0.01) than ECC-BFR (3.9%) at 10-cm above the elbow joint. Following 6-weeks of training, MRI-measured muscle cross-sectional area (CSA) at 10-cm position and mid-upper arm (12.0% and 10.6%, respectively) as well as muscle volume (12.5%) of the elbow flexors were increased (p<0.01) with CON-BFR. Increases in muscle CSA and volume were lower in ECC-BFR (5.1%, 0.8% and 2.9%, respectively) than in the CON-BFR and only muscle CSA at 10-cm position increased significantly (p<0.05) after the training. Maximal voluntary isometric strength of elbow flexors was increased (p<0.05) in CON-BFR (8.6%), but not in ECC (3.8%). These results suggest that CON-BFR training leads to pronounced acute changes in muscle size, an index of muscle cell swelling, the response to which may be an important factor for promoting muscle hypertrophy with BFR resistance training.	[Yasuda, Tomohiro] Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan; [Loenneke, Jeremy P.; Thiebaud, Robert S.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA; [Abe, Takashi] Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, Oxford, MS USA	University of Tokyo; University of Oklahoma System; University of Oklahoma - Norman; University of Mississippi	Yasuda, T (corresponding author), Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan.	yasuda-tomohiro@umin.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology [23700713]	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by Grant-in-aid (#23700713 to TY) from the Japan Ministry of Education, Culture, Sports, Science, and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, INT J KAATSU TRAININ, V1, P6, DOI DOI 10.3806/IJKTR.1.6; Abe T, 2012, CLIN PHYSIOL FUNCT I, V32, P247, DOI 10.1111/j.1475-097X.2012.01126.x; Berneis K, 1999, AM J PHYSIOL-ENDOC M, V276, pE188, DOI 10.1152/ajpendo.1999.276.1.E188; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DALTON PA, 1991, EUR J APPL PHYSIOL O, V63, P412, DOI 10.1007/BF00868071; Durand RJ, 2003, MED SCI SPORT EXER, V35, P937, DOI 10.1249/01.MSS.0000069522.38141.0B; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farthing JP, 2003, EUR J APPL PHYSIOL, V89, P578, DOI 10.1007/s00421-003-0842-2; Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Grant ACG, 2000, BBA-GEN SUBJECTS, V1475, P39, DOI 10.1016/S0304-4165(00)00045-3; Gundermann DM, 2012, J APPL PHYSIOL, V112, P1520, DOI 10.1152/japplphysiol.01267.2011; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173, DOI 10.1152/jappl.1996.81.5.2173; Karabulut M, 2010, EUR J APPL PHYSIOL, V108, P147, DOI 10.1007/s00421-009-1204-5; Keller U, 2003, EUR J CLIN NUTR, V57, pS69, DOI 10.1038/sj.ejcn.1601904; Kraemer RR, 2006, EUR J APPL PHYSIOL, V96, P551, DOI 10.1007/s00421-005-0094-4; Loenneke JP, 2012, MED HYPOTHESES, V78, P151, DOI 10.1016/j.mehy.2011.10.014; Loenneke JP, 2010, INT J SPORTS MED, V31, P1, DOI 10.1055/s-0029-1239499; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P2903, DOI 10.1007/s00421-011-2266-8; Manini TM, 2011, ACTA PHYSIOL, V201, P255, DOI 10.1111/j.1748-1716.2010.02172.x; Manini TM, 2009, EXERC SPORT SCI REV, V37, P78, DOI 10.1097/JES.0b013e31819c2e5c; Millar ID, 1997, BIOCHEM BIOPH RES CO, V230, P351, DOI 10.1006/bbrc.1996.5959; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179, DOI 10.1152/jappl.1986.60.4.1179; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Ogawa M., 2012, J PHYS ED SPORTS MAN, V3, P14; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Seger JY, 1988, EUR J APPL PHYSL OCC, V79, P49; Takarada Y, 2000, J APPL PHYSIOL, V88, P2097, DOI 10.1152/jappl.2000.88.6.2097; Umbel JD, 2009, EUR J APPL PHYSIOL, V107, P687, DOI 10.1007/s00421-009-1175-6; Yasuda T, 2012, SCAND J MED IN PRESS; Yasuda T, 2011, EUR J APPL PHYSIOL, V111, P2525, DOI 10.1007/s00421-011-1873-8; Yasuda T, 2010, METABOLISM, V59, P1510, DOI 10.1016/j.metabol.2010.01.016; Yasuda T, 2010, CLIN PHYSIOL FUNCT I, V30, P338, DOI 10.1111/j.1475-097X.2010.00949.x; Yasuda T, 2008, J SPORT SCI MED, V7, P467; Yasuda T, 2009, J SPORT SCI, V27, P479, DOI 10.1080/02640410802626567	38	109	111	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52843	10.1371/journal.pone.0052843	http://dx.doi.org/10.1371/journal.pone.0052843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300795	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600029
J	Castellino, FJ; Liang, Z; Davis, PK; Balsara, RD; Musunuru, H; Donahue, DL; Smith, DL; Sandoval-Cooper, MJ; Ploplis, VA; Walsh, M				Castellino, Francis J.; Liang, Zhong; Davis, Patrick K.; Balsara, Rashna D.; Musunuru, Harsha; Donahue, Deborah L.; Smith, Denise L.; Sandoval-Cooper, Mayra J.; Ploplis, Victoria A.; Walsh, Mark			Abnormal Whole Blood Thrombi in Humans with Inherited Platelet Receptor Defects	PLOS ONE			English	Article							GLYCOPROTEIN-IB-ALPHA; BERNARD-SOULIER-SYNDROME; CARDIOPULMONARY BYPASS; DINUCLEOTIDE DELETION; POLYMORPHISM; AGGREGATION; ACTIVATION; COLLAGEN; DOMAIN; THROMBELASTOGRAPHY	To delineate the critical features of platelets required for formation and stability of thrombi, thromboelastography and platelet aggregation measurements were employed on whole blood of normal patients and of those with Bernard-Soulier Syndrome (BSS) and Glanzmann's Thrombasthenia (GT). We found that separation of platelet activation, as assessed by platelet aggregation, from that needed to form viscoelastic stable whole blood thrombi, occurred. In normal human blood, ristocetin and collagen aggregated platelets, but did not induce strong viscoelastic thrombi. However, ADP, arachidonic acid, thrombin, and protease-activated-receptor-1 and -4 agonists, stimulated both processes. During this study, we identified the genetic basis of a very rare double heterozygous GP1b deficiency in a BSS patient, along with a new homozygous GP1b inactivating mutation in another BSS patient. In BSS whole blood, ADP responsiveness, as measured by thrombus strength, was diminished, while ADP-induced platelet aggregation was normal. Further, the platelets of 3 additional GT patients showed very weak whole blood platelet aggregation toward the above agonists and provided whole blood thrombi of very low viscoelastic strength. These results indicate that measurements of platelet counts and platelet aggregability do not necessarily correlate with generation of stable thrombi, a potentially significant feature in patient clinical outcomes.	[Castellino, Francis J.; Liang, Zhong; Davis, Patrick K.; Balsara, Rashna D.; Musunuru, Harsha; Donahue, Deborah L.; Smith, Denise L.; Sandoval-Cooper, Mayra J.; Ploplis, Victoria A.; Walsh, Mark] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Walsh, Mark] Mem Hosp S Bend, Dept Emergency Med, South Bend, IN USA	University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Walsh, Mark/0000-0002-5795-1144	Memorial Hospital of South Bend	Memorial Hospital of South Bend	This work was supported by a grant from Memorial Hospital of South Bend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfsharKharghan V, 1997, BLOOD, V90, P2634, DOI 10.1182/blood.V90.7.2634.2634_2634_2643; Ballotta A, 2007, J THORAC CARDIOV SUR, V134, P132, DOI 10.1016/j.jtcvs.2007.01.055; Basani RB, 1999, METH MOLEC MED, V31, P313, DOI 10.1385/1-59259-248-1:313; Basani RB, 1996, BLOOD, V88, P167; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Bunescu A, 2002, CLIN SCI, V102, P279, DOI 10.1042/CS20010118; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cammerer U, 2003, ANESTH ANALG, V96, P51, DOI 10.1097/00000539-200301000-00011; CARR ME, 1986, BIOCHEM J, V239, P513, DOI 10.1042/bj2390513; Castellino FJ, 2011, BLOOD, V117, P283, DOI 10.1182/blood-2010-07-299057; Cheng H, 2009, AM J PHYSIOL-HEART C, V297, pH2128, DOI 10.1152/ajpheart.00107.2009; Davis PK, 2012, NEUROCRIT CARE; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Ezumi Y, 2000, BIOCHEM BIOPH RES CO, V277, P27, DOI 10.1006/bbrc.2000.3624; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; JENKINS CSP, 1976, J CLIN INVEST, V57, P112, DOI 10.1172/JCI108251; Johansson PI, 2012, CURR OPIN ANESTHESIO, V25, P235, DOI 10.1097/ACO.0b013e32834fab76; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kaski S, 1996, IMMUNOGENETICS, V44, P170, DOI 10.1007/s002510050108; Kenny D, 1997, BLOOD, V90, P2626, DOI 10.1182/blood.V90.7.2626.2626_2626_2633; Kenny D, 1998, BLOOD, V92, P175, DOI 10.1182/blood.V92.1.175.413a36_175_183; KUIJPERS RWAM, 1992, J CLIN INVEST, V89, P381, DOI 10.1172/JCI115596; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Maquelin KN, 1998, J THORAC CARDIOV SUR, V115, P1160, DOI 10.1016/S0022-5223(98)70416-7; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Preisman S, 2010, EUR J CARDIO-THORAC, V37, P1367, DOI 10.1016/j.ejcts.2009.12.044; RINDER CS, 1994, J THORAC CARDIOV SUR, V107, P280; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; SUGIYAMA T, 1987, BLOOD, V69, P1712; Walsh Mark, 2011, J Extra Corpor Technol, V43, P162; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wolberg AS, 2005, BRIT J HAEMATOL, V131, P645, DOI 10.1111/j.1365-2141.2005.05820.x; Wolberg AS, 2003, BLOOD, V101, P3008, DOI 10.1182/blood-2002-08-2527	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52878	10.1371/journal.pone.0052878	http://dx.doi.org/10.1371/journal.pone.0052878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300803	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500076
J	Chan, T; Shimizu, Y; Pospisil, P; Nijo, N; Fujiwara, A; Taninaka, Y; Ishikawa, T; Hori, H; Nanba, D; Imai, A; Morita, N; Yoshioka-Nishimura, M; Izumi, Y; Yamamoto, Y; Kobayashi, H; Mizusawa, N; Wada, H; Yamamoto, Y				Chan, Tiffanie; Shimizu, Yurika; Pospisil, Pavel; Nijo, Nobuyoshi; Fujiwara, Anna; Taninaka, Yoshito; Ishikawa, Tomomi; Hori, Haruka; Nanba, Daisuke; Imai, Aya; Morita, Noriko; Yoshioka-Nishimura, Miho; Izumi, Yohei; Yamamoto, Yoko; Kobayashi, Hideki; Mizusawa, Naoki; Wada, Hajime; Yamamoto, Yasusi			Quality Control of Photosystem II: Lipid Peroxidation Accelerates Photoinhibition under Excessive Illumination	PLOS ONE			English	Article							SINGLET OXYGEN PRODUCTION; D1 PROTEIN; SIDE PHOTOINHIBITION; LIGHT; TURNOVER; THYLAKOIDS; STRESS; PLANTS; PHOTOPRODUCTION; MALONDIALDEHYDE	Environmental stresses lower the efficiency of photosynthesis and sometimes cause irreversible damage to plant functions. When spinach thylakoids and Photosystem II membranes were illuminated with excessive visible light (100- 1,000 mmol photons m(-1) s(-1)) for 10 min at either 20 degrees C or 30 degrees C, the optimum quantum yield of Photosystem II decreased as the light intensity and temperature increased. Reactive oxygen species and endogenous cationic radicals produced through a photochemical reaction at and/or near the reaction center have been implicated in the damage to the D1 protein. Here we present evidence that lipid peroxidation induced by the illumination is involved in the damage to the D1 protein and the subunits of the light-harvesting complex of Photosystem II. This is reasoned from the results that considerable lipid peroxidation occurred in the thylakoids in the light, and that lipoxygenase externally added in the dark induced inhibition of Photosystem II activity in the thylakoids, production of singlet oxygen, which was monitored by electron paramagnetic resonance spin trapping, and damage to the D1 protein, in parallel with lipid peroxidation. Modification of the subunits of the light-harvesting complex of Photosystem II by malondialdehyde as well as oxidation of the subunits was also observed. We suggest that mainly singlet oxygen formed through lipid peroxidation under light stress participates in damaging the Photosystem II subunits.	[Chan, Tiffanie; Shimizu, Yurika; Nijo, Nobuyoshi; Fujiwara, Anna; Taninaka, Yoshito; Ishikawa, Tomomi; Hori, Haruka; Nanba, Daisuke; Imai, Aya; Morita, Noriko; Yoshioka-Nishimura, Miho; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic; [Izumi, Yohei; Yamamoto, Yoko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama, Japan; [Mizusawa, Naoki; Wada, Hajime] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	Okayama University; Palacky University Olomouc; Okayama University; Okayama University; University of Tokyo	Yamamoto, Y (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015	POSPÍŠIL, Pavel/0000-0001-9126-2011; Ishikawa, Tomomi/0000-0002-7262-4870	Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039]; Ministry of Education Youth and Sports, Czech Republic [ED0007/01/01, CZ.1.07/2.3.00/20.0057]; Grants-in-Aid for Scientific Research [22780046, 24570160] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y. Y.) and by the grants no. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research and no. CZ.1.07/2.3.00/20.0057 Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic (P. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BLUBAUGH DJ, 1991, BIOCHEMISTRY-US, V30, P7586, DOI 10.1021/bi00244a030; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; DORNE AJ, 1990, P NATL ACAD SCI USA, V87, P71, DOI 10.1073/pnas.87.1.71; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Halliwell B., 2007, FREE RADICALS BIOL M; Havaux M, 2003, TRENDS PLANT SCI, V8, P409, DOI 10.1016/S1360-1385(03)00185-7; Henmi T, 2003, PLANT CELL PHYSIOL, V44, P451, DOI 10.1093/pcp/pcg049; HIDEG E, 1994, PHOTOSYNTH RES, V39, P191, DOI 10.1007/BF00029386; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; JEGERSCHOLD C, 1990, BIOCHEMISTRY-US, V29, P6179, DOI 10.1021/bi00478a010; KANERVO E, 1995, FEBS LETT, V364, P239, DOI 10.1016/0014-5793(95)00404-W; Khorobrykh SA, 2002, PHOTOSYNTH RES, V71, P209, DOI 10.1023/A:1015583502345; Khorobrykh SA, BIOCHEMISTRY, V50; KLIMOV V, 1993, PHOTOSYNTH RES, V38, P409, DOI 10.1007/BF00046768; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; MARNETT LJ, 1979, ANAL BIOCHEM, V99, P458, DOI 10.1016/S0003-2697(79)80033-0; McGinley CM, 2003, CHEM COMMUN, P2843, DOI 10.1039/b311008g; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SOMERVILLE C, 2000, LIPIDS BIOCH MOL BIO, P456; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; TELFER A, 1994, J BIOL CHEM, V269, P13244; Vass I, 2008, PHOTOINHIBITION PHOT; Wada H., 2010, LIPIDS PHOTOSYNTHESI; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; [No title captured]	49	40	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52100	10.1371/journal.pone.0052100	http://dx.doi.org/10.1371/journal.pone.0052100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300595	Green Submitted, gold, Green Published			2022-12-25	WOS:000312829100019
J	Gawthorne, JA; Reddick, LE; Akpunarlieva, SN; Beckham, KSH; Christie, JM; Alto, NM; Gabrielsen, M; Roe, AJ				Gawthorne, Jayde A.; Reddick, L. Evan; Akpunarlieva, Snezhana N.; Beckham, Katherine S. H.; Christie, John M.; Alto, Neal M.; Gabrielsen, Mads; Roe, Andrew J.			Express Your LOV: An Engineered Flavoprotein as a Reporter for Protein Expression and Purification	PLOS ONE			English	Article							INNER MEMBRANE-PROTEINS; ESCHERICHIA-COLI; CRYSTALLIZATION; OVEREXPRESSION; OPTIMIZATION; ILOV; GFP	In this work, we describe the utility of Light, Oxygen, or Voltage-sensing (LOV) flavoprotein domains from plant phototropins as a reporter for protein expression and function. Specifically, we used iLOV, an enhanced and more photostable variant of LOV. A pET-based plasmid for protein expression was constructed, encoding a C terminal iLOV-octahistidine (His8)-tag and a HRV 3C protease cleavage recognition site. Ten different proteins, with various sub-cellular locations, were cloned into the plasmid, creating iLOV-His8 tag fusions. To test protein expression and how iLOV could be used as a reporter, the proteins were expressed in three different cell lines, in four different culture media, at two different temperatures. To establish whether the presence of the iLOV tag could have an impact on the functionality, one of the proteins, EspG, was over-expressed and purified. EspG is an "effector" protein normally produced by enterohemorrhagic E. coli strains and "injected" into host cells via the T3SS. We tested functionality of EspG-iLOV fusion by performing functional studies of EspG in mammalian host cells. When EspG-iLOV was microinjected into the host cell, the Golgi apparatus was completely disrupted as had previously been observed for EspG.	[Gabrielsen, Mads] Beatson Inst, Glasgow, Lanark, Scotland; [Christie, John M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gawthorne, Jayde A.; Akpunarlieva, Snezhana N.; Beckham, Katherine S. H.; Roe, Andrew J.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Reddick, L. Evan; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Mol Microbiol, Dallas, TX 75390 USA	Beatson Institute; University of Glasgow; University of Glasgow; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gabrielsen, M (corresponding author), Beatson Inst, Glasgow, Lanark, Scotland.	mgabr@chem.gla.ac.uk; Andrew.Roe@Glasgow.ac.uk		Beckham, Kate/0000-0002-4929-6119; Gabrielsen, Mads/0000-0002-9848-2276; Christie, John/0000-0002-9976-0055; roe, andrew/0000-0003-3698-6134	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G011389/1, BB/H023518/1]; Biotechnology and Biological Sciences Research Council [BB/G011389/1, BB/H023518/1] Funding Source: researchfish; BBSRC [BB/H023518/1, BB/G011389/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to AJR and MG (BB/G011389/1) and a BBSRC Tools and Development Fund (BB/H023518/1) to AJR and JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Dortay H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018900; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Gabrielsen M, 2011, MOL MEMBR BIOL, V28, P445, DOI 10.3109/09687688.2011.628954; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; McLuskey K, 2008, MOL MEMBR BIOL, V25, P599, DOI 10.1080/09687680802510289; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Reddick LE, 2012, JOVE-J VIS EXP, DOI 10.3791/3650; Selyunin Andrey S, 2011, Small GTPases, V2, P217; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vizcaino-Caston I, 2012, BIOTECHNOL LETT, V34, P175, DOI 10.1007/s10529-011-0767-5	22	22	22	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52962	10.1371/journal.pone.0052962	http://dx.doi.org/10.1371/journal.pone.0052962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300834	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000312829100105
J	Pan, QC; Ali, F; Yang, XH; Li, JS; Yan, JB				Pan, Qingchun; Ali, Farhan; Yang, Xiaohong; Li, Jiansheng; Yan, Jianbing			Exploring the Genetic Characteristics of Two Recombinant Inbred Line Populations via High-Density SNP Markers in Maize	PLOS ONE			English	Article							SEGREGATION DISTORTION; CONFIDENCE-INTERVALS; MOLECULAR MARKERS; LOCI; DIVERSITY; QTL; MAP	Understanding genetic characteristics can reveal the genetic diversity in maize and be used to explore evolutionary mechanisms and gene cloning. A high-density linkage map was constructed to determine recombination rates (RRs), segregation distortion regions (SDRs), and recombinant blocks (RBs) in two recombinant inbred line populations (RILs) (B73/By804 and Zong3/87-1) generated by the single seed descent method. Population B73/By804 containing 174 lines were genotyped with 198 simple sequence repeats (SSRs) markers while population Zong3/87-1 comprised of 175 lines, were genotyped with 210 SSR markers along with 1536 single nucleotide polymorphism (SNP) markers for each population, spanning 1526.7 cM and 1996.2 cM in the B73/By804 and Zong3/87-1 populations, respectively. The total variance of the RR in the whole genome was nearly 100 fold, and the maximum average was 10.43-11.50 cM/Mb while the minimum was 0.08-0.10 cM/Mb in the two populations. The average number of RB was 44 and 37 in the Zong3/87-1 and B73/By804 populations, respectively, whereas 28 SDRs were observed in both populations. We investigated 11 traits in Zong3/87-1 and 10 traits in B73/By804. Quantitative trait locus (QTLs) mapping of SNP+SSR with SNP and SSR marker sets were compared to showed the impact of different density markers on QTL mapping and resolution. The confidence interval of QTL Pa19 (FatB gene controlling palmitic acid content) was reduced from 3.5 Mb to 1.72 Mb, and the QTL Oil6 (DGAT1-2 gene controlling oil concentration) was significantly reduced from 10.8 Mb to 1.62 Mb. Thus, the use of high-density markers considerably improved QTL mapping resolution. The genetic information resulting from this study will support forthcoming efforts to understand recombination events, SDRs, and variations among different germplasm. Furthermore, this study will facilitate gene cloning and understanding of the fundamental sources of total variation and RR in maize, which is the most widely cultivated cereal crop.	[Ali, Farhan; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Pan, Qingchun; Yang, Xiaohong; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Ali, Farhan] Cereal Crops Res Inst CCRI Nowshera, Kyber Pukhtunkhwa, Pakistan	Huazhong Agricultural University; China Agricultural University	Yan, JB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yjianbing@mail.hzau.edu.cn	Ali, Farhan/AAA-6193-2019	Ali, Farhan/0000-0003-4519-7903	National Hi-Tech Research and Development Program of China [2012AA10A307]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Hi-Tech Research and Development Program of China (2012AA10A307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2006, GENOME RES, V16, P115, DOI [10.1101/gr.4249906, 10.1101/gr4249906]; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Bennewitz J, 2002, GENETICS, V160, P1673; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Davis GL, 1999, GENETICS, V152, P1137; Esch E, 2007, GENETICS, V177, P1851, DOI 10.1534/genetics.107.080622; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HENDERSON CR, 1984, J DAIRY SCI, V67, P1581, DOI 10.3168/jds.S0022-0302(84)81480-0; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lawrence CJ, 2007, PLANT CELL, V19, P2091, DOI 10.1105/tpc.107.053660; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024699; Li Lin, 2009, Scientia Agricultura Sinica, V42, P2262; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Liu XianJun, 2011, Journal of Agricultural Science (Toronto), V3, P172; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Visscher PM, 1996, GENETICS, V143, P1013; Wang G, 2012, GENET MOL RES, V11, P693, DOI 10.4238/2012.March.19.3; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yan Jian-Bing, 2003, Acta Genetica Sinica, V30, P913; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Zak M, 2007, GENETICS, V176, P1845, DOI 10.1534/genetics.106.068031; Zhang H, 2011, THEOR APPL GENET, V124, P459; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	44	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52777	10.1371/journal.pone.0052777	http://dx.doi.org/10.1371/journal.pone.0052777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300772	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100079
J	Dobrovolska, O; Shumilina, E; Gladyshev, VN; Dikiy, A				Dobrovolska, Olena; Shumilina, Elena; Gladyshev, Vadim N.; Dikiy, Alexander			Structural Analysis of Glutaredoxin Domain of Mus musculus Thioredoxin Glutathione Reductase	PLOS ONE			English	Article							CATALYTIC MECHANISM; TARGETING SEQUENCES; ESCHERICHIA-COLI; CDNA CLONING; RAT-LIVER; SELENOCYSTEINE; SELENOPROTEIN; PURIFICATION; EXPRESSION; PROTEINS	Thioredoxin glutathione reductase (TGR) is a member of the mammalian thioredoxin reductase family that has a monothiol glutaredoxin (Grx) domain attached to the thioredoxin reductase module. Here, we report a structure of the Grx domain of mouse TGR, determined through high resolution NMR spectroscopy to the final backbone RMSD value of 0.48 +/- 0.10 angstrom. The structure represents a sandwich-like molecule composed of a four stranded beta-sheet flanked by five alpha-helixes, with the CxxS active motif located on the catalytic loop. We structurally characterized the glutathione-binding site in the protein and describe sequence and structural relationships of the domain with glutaredoxins. The structure illuminates a key functional center that evolved in mammalian TGRs to act in thiol-disulfide reactions. Our study allows us to hypothesize that Cys105 might be functionally relevant for TGR catalysis. In addition, the data suggest that the N-terminus of Grx acts as a possible regulatory signal also protecting the protein active site from unwanted interactions in cellular cytosol.	[Dobrovolska, Olena; Shumilina, Elena; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	Norwegian University of Science & Technology (NTNU); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; Shumilina, Elena/AFJ-4014-2022; Shumilina, Elena/AAF-4604-2022	Shumilina, Elena/0000-0002-6798-2374; Shumilina, Elena/0000-0002-6798-2374; Gladyshev, Vadim/0000-0002-0372-7016; Dobrovolska, Olena/0000-0002-0881-4960	NT Faculty, NTNU; United States National Institutes of Health [GM065204]; BioStruct; Norwegian national graduate school in Structural biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	NT Faculty, NTNU; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioStruct; Norwegian national graduate school in Structural biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AD acknowledges the support from NT Faculty, NTNU. ES acknowledges the NT Faculty, NTNU, for financial support through a post-doctoral fellowship. OD acknowledges the NT Faculty, NTNU, for financial support through PhD fellowship. This work was also supported by United States National Institutes of Health GM065204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge support from BioStruct, the Norwegian national graduate school in Structural biology.	Aachmann FL, 2010, J BIOL CHEM, V285, P33315, DOI 10.1074/jbc.M110.132308; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; Aslund F, 1996, J BIOL CHEM, V271, P6736, DOI 10.1074/jbc.271.12.6736; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gasdaska PY, 1999, FEBS LETT, V442, P105, DOI 10.1016/S0014-5793(98)01638-X; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Ge Y, 2009, INT J BIOCHEM CELL B, V41, P900, DOI 10.1016/j.biocel.2008.08.032; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Goncharuk SA, 2011, ACTA NATURAE, V3, P77, DOI 10.32607/20758251-2011-3-3-77-84; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang HH, 2011, BIOCHEMISTRY-US, V50, P5870, DOI 10.1021/bi200107n; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krueger-Koplin RD, 2004, J BIOMOL NMR, V28, P43, DOI 10.1023/B:JNMR.0000012875.80898.8f; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Miranda-Vizuete A, 1999, BBA-GENE STRUCT EXPR, V1447, P113, DOI 10.1016/S0167-4781(99)00129-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Shumilina E, 2012, BIOMOL NMR ASSIGN, V6, P103, DOI 10.1007/s12104-011-9335-0; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Sutovsky P, 1997, MOL REPROD DEV, V47, P79, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;79::AID-MRD11&gt;3.0.CO;2-V; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Watabe S, 1999, EUR J BIOCHEM, V264, P74, DOI 10.1046/j.1432-1327.1999.00578.x; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52914	10.1371/journal.pone.0052914	http://dx.doi.org/10.1371/journal.pone.0052914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300818	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800161
J	Hatcher, AM; Tsai, AC; Kumbakumba, E; Dworkin, SL; Hunt, PW; Martin, JN; Clark, G; Bangsberg, DR; Weiser, SD				Hatcher, Abigail M.; Tsai, Alexander C.; Kumbakumba, Elias; Dworkin, Shari L.; Hunt, Peter W.; Martin, Jeffrey N.; Clark, Gina; Bangsberg, David R.; Weiser, Sheri D.			Sexual Relationship Power and Depression among HIV-Infected Women in Rural Uganda	PLOS ONE			English	Article							LEARNED HELPLESSNESS MODEL; INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH-SERVICES; QUALITY-OF-LIFE; CD4 CELL COUNT; MEDICAL OUTCOMES; ANTIRETROVIRAL THERAPY; POSTTRAUMATIC-STRESS; GENDER-DIFFERENCES; DOMESTIC VIOLENCE	Background: Depression is associated with increased HIV transmission risk, increased morbidity, and higher risk of HIV-related death among HIV-infected women. Low sexual relationship power also contributes to HIV risk, but there is limited understanding of how it relates to mental health among HIV-infected women. Methods: Participants were 270 HIV-infected women from the Uganda AIDS Rural Treatment Outcomes study, a prospective cohort of individuals initiating antiretroviral therapy (ART) in Mbarara, Uganda. Our primary predictor was baseline sexual relationship power as measured by the Sexual Relationship Power Scale (SRPS). The primary outcome was depression severity, measured with the Hopkins Symptom Checklist (HSCL), and a secondary outcome was a functional scale for mental health status (MHS). Adjusted models controlled for socio-demographic factors, CD4 count, alcohol and tobacco use, baseline WHO stage 4 disease, social support, and duration of ART. Results: The mean HSCL score was 1.34 and 23.7% of participants had HSCL scores consistent with probable depression (HSCL > 1.75). Compared to participants with low SRPS scores, individuals with both moderate (coefficient b = -0.21; 95% CI, -0.36 to -0.07) and high power (b = -0.21; 95% CI, -0.36 to -0.06) reported decreased depressive symptomology. High SRPS scores halved the likelihood of women meeting criteria for probable depression (adjusted odds ratio = 0.44; 95% CI, 0.20 to 0.93). In lagged models, low SRPS predicted subsequent depression severity, but depression did not predict subsequent changes in SPRS. Results were similar for MHS, with lagged models showing SRPS predicts subsequent mental health, but not visa versa. Both Decision-Making Dominance and Relationship Control subscales of SRPS were associated with depression symptom severity. Conclusions: HIV-infected women with high sexual relationship power had lower depression and higher mental health status than women with low power. Interventions to improve equity in decision-making and control within dyadic partnerships are critical to prevent HIV transmission and to optimize mental health of HIV-infected women.	[Hatcher, Abigail M.; Hunt, Peter W.; Weiser, Sheri D.] Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco, CA 94143 USA; [Hatcher, Abigail M.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Tsai, Alexander C.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kumbakumba, Elias; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Dworkin, Shari L.] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Clark, Gina] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco; University of Witwatersrand; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hatcher, AM (corresponding author), Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco, CA 94143 USA.	hatchera@globalhealth.ucsf.edu	Tsai, Alexander C./F-4247-2015; Hatcher, Abigail M/G-9128-2011; Hunt, Peter W./P-2976-2017	Tsai, Alexander C./0000-0001-6397-7917; Hatcher, Abigail M/0000-0002-4150-1405; Hunt, Peter W./0000-0002-4571-4870	NIH [K23 MH-079713, MH-79713-03S1, R01 MH-54907, P30 AI27763, K24 MH-87227, K23 MH-096620]; Tim and Jane Meyer Family Foundation; Burke Family Foundation; Paiko Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH096620, R25MH060482, K24MH087227, R01MH054907, K23MH079713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tim and Jane Meyer Family Foundation; Burke Family Foundation; Paiko Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by NIH K23 MH-079713, MH-79713-03S1, NIH R01 MH-54907, NIH P30 AI27763, and the Tim and Jane Meyer Family Foundation. The authors acknowledge the following additional sources of salary support: the Burke Family Foundation, NIH K24 MH-87227, K23 MH-096620, and the Paiko Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Bougarel L, 2011, PSYCHOPHARMACOLOGY, V215, P595, DOI 10.1007/s00213-011-2218-3; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; BUCHWALD AM, 1978, J ABNORM PSYCHOL, V87, P180; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CAMPBELL R, 1995, PSYCHOL WOMEN QUART, V19, P237, DOI 10.1111/j.1471-6402.1995.tb00290.x; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chonody JM, 2008, AFFILIA J WOM SOC WO, V23, P338, DOI 10.1177/0886109908323971; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cohen MH, 2009, J WOMENS HEALTH, V18, P1783, DOI 10.1089/jwh.2009.1367; CONNELL RW, 1985, SOCIOLOGY, V19, P260, DOI 10.1177/0038038585019002008; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Eller L S, 2001, Clin Nurs Res, V10, P401; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Epino HM, 2012, AIDS CARE; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Farmer P, 1996, COMMON COURAGE PR; Filson J, 2010, J INTERPERS VIOLENCE, V25, P400, DOI 10.1177/0886260509334401; Gagnon AJ, 2010, HEALTH PLACE, V16, P10, DOI 10.1016/j.healthplace.2009.06.009; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639; GRANT RL, 1978, AM J PSYCHIAT, V135, P625; Hahm HC, 2011, AIDS BEHAV; Hahm HC, 2012, AIDS BEHAV, V16, P179, DOI 10.1007/s10461-011-9885-2; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; James John S, 2004, AIDS Treat News, P2; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Ketchen B, 2009, WOMEN HEALTH, V49, P197, DOI 10.1080/03630240902963648; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P13, DOI 10.1097/00006842-198701000-00002; Kim HK, 2002, J FAM ISSUES, V23, P885, DOI 10.1177/019251302237296; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; Landstedt E, 2009, SOCIOL HEALTH ILL, V31, P962, DOI 10.1111/j.1467-9566.2009.01170.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P295; Lundberg P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-125; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x; Mello VA, 2010, ARCH WOMEN MENT HLTH, V13, P193, DOI 10.1007/s00737-009-0094-1; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; Millikin CP, 2003, J CLIN EXP NEUROPSYC, V25, P201, DOI 10.1076/jcen.25.2.201.13644; Mirowsky J, 2017, SOCIAL CAUSES PSYCHO; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Ovuga E, 2005, SOC PSYCH PSYCH EPID, V40, P439, DOI 10.1007/s00127-005-0915-0; Palar K, 2012, AIDS; Bermudez MP, 2010, CURR HIV RES, V8, P172, DOI 10.2174/157016210790442669; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Petty F, 1997, ANN NY ACAD SCI, V821, P529, DOI 10.1111/j.1749-6632.1997.tb48322.x; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Prachakul W, 2007, J ASSOC NURSE AIDS C, V18, P67, DOI 10.1016/j.jana.2007.08.002; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Rabkin JG, 2000, PSYCHOSOM MED, V62, P413, DOI 10.1097/00006842-200005000-00015; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Seligman M. E., 1974, DEPRESSION LEARNED H; Shahriar Jim, 2003, Health Qual Life Outcomes, V1, P25, DOI 10.1186/1477-7525-1-25; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Siedner MJ, 2012, AIDS BEHAV; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Stein MD, 1997, J WOMENS HEALTH, V6, P569, DOI 10.1089/jwh.1997.6.569; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2010, ARCH GEN PSYCHIAT, V67, P1282, DOI 10.1001/archgenpsychiatry.2010.160; Valente Sharon M, 2003, J Assoc Nurses AIDS Care, V14, P41, DOI 10.1177/1055329002250993; Valverde EE, 2007, JAIDS-J ACQ IMM DEF, V46, pS96, DOI 10.1097/QAI.0b013e318157683b; Weeks MR, 2010, AIDS PATIENT CARE ST, V24, P297, DOI 10.1089/apc.2009.0312; Weiser SD, 2010, 17 C RETR OPP INF SA; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; World Vision, 2017, INT LIV ASS TARG REF; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011; Wu DY, 2008, JAIDS-J ACQ IMM DEF, V48, P500, DOI 10.1097/QAI.0b013e31817dc3e9; Yang XS, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.525620	89	40	41	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e49821	10.1371/journal.pone.0049821	http://dx.doi.org/10.1371/journal.pone.0049821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300519	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800004
J	Ibison, F; Olotu, A; Muema, DM; Mwacharo, J; Ohuma, E; Kimani, D; Marsh, K; Bejon, P; Ndungu, FM				Ibison, Frances; Olotu, Ally; Muema, Daniel M.; Mwacharo, Jedida; Ohuma, Eric; Kimani, Domtila; Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.			Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; CLINICAL MALARIA; MICE; TRANSMISSION; INFECTION; CHABAUDI; PERSISTENCE; MECHANISMS; PROTECTION; PATTERNS	Background: Although antibodies are critical for immunity to malaria, their functional attributes that determine protection remain unclear. We tested for associations between antibody avidities to Plasmodium falciparum (Pf) antigens and age, asymptomatic parasitaemia, malaria exposure index (a distance weighted local malaria prevalence) and immunity to febrile malaria during 10-months of prospective follow up. Methods: Cross-sectional antibody levels and avidities to Apical Membrane Antigen 1 (AMA1), Merozoite Surface Protein 142 (MSP1) and Merozoite Surface Protein 3 (MSP3) were measured by Enzyme Linked Immunosorbent Assay in 275 children, who had experienced at least one episode of clinical malaria by the time of this study, as determined by active weekly surveillance. Results: Antibody levels to AMA1, MSP1 and MSP3 increased with age. Anti-AMA1 and MSP1 antibody avidities were (respectively) positively and negatively associated with age, while anti-MSP3 antibody avidities did not change. Antibody levels to all three antigens were elevated in the presence of asymptomatic parasitaemia, but their associated avidities were not. Unlike antibody levels, antibody avidities to the three-merozoite antigens did not increase with exposure to Pf malaria. There were no consistent prospective associations between antibody avidities and malaria episodes. Conclusion: We found no evidence that antibody avidities to Pf-merozoite antigens are associated with either exposure or immunity to malaria.	[Ibison, Frances; Olotu, Ally; Muema, Daniel M.; Mwacharo, Jedida; Ohuma, Eric; Kimani, Domtila; Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Ibison, Frances] Univ Birmingham, Sch Med, Birmingham, W Midlands, England; [Marsh, Kevin; Bejon, Philip; Ndungu, Francis M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of Birmingham; University of Oxford	Ndungu, FM (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.	FNdungu@kemri-wellcome.org	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030	Wellcome Trust [B9RTIR0]; European and Developing Countries Clinical Trials Partnership (EDCTP); MRC Medical Research Council (UK); MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European and Developing Countries Clinical Trials Partnership (EDCTP); MRC Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (grant number B9RTIR0). FMN is a post-doctoral fellow under the Malaria Vectored Vaccines Consortium (MVVC), funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). PB is funded by the MRC Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Ferreira MU, 1996, AM J TROP MED HYG, V55, P315, DOI 10.4269/ajtmh.1996.55.315; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736; Leoratti FMS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-186; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; Moormann AM, 2009, PARASITE IMMUNOL, V31, P547, DOI 10.1111/j.1365-3024.2009.01137.x; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; O'Meara WP, 2009, TROP MED INT HEALTH, V14, P29, DOI 10.1111/j.1365-3156.2008.02194.x; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; STEVENSON MM, 1989, EXP MOL PATHOL, V51, P80, DOI 10.1016/0014-4800(89)90009-9; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Tutterrow Yeung Lo, 2012, PLoS One, V7, pe40049, DOI 10.1371/journal.pone.0040049; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; WEISS L, 1989, AM J TROP MED HYG, V41, P144, DOI 10.4269/ajtmh.1989.41.144; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52939	10.1371/journal.pone.0052939	http://dx.doi.org/10.1371/journal.pone.0052939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300828	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800162
J	Meng, ZF; Xin, RL; Zhong, P; Zhang, CY; Abubakar, YF; Li, JY; Liu, W; Zhang, XY; Xu, JQ				Meng, Zhefeng; Xin, Ruolei; Zhong, Ping; Zhang, Chiyu; Abubakar, Yassir F.; Li, Jingyun; Liu, Wei; Zhang, Xiaoyan; Xu, Jianqing			A New Migration Map of HIV-1 CRF07_BC in China: Analysis of Sequences from 12 Provinces over a Decade	PLOS ONE			English	Article							INJECTION-DRUG USERS; HEPATITIS-C VIRUS; CIRCULATING RECOMBINANT; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; INFECTION; SUBTYPES; STRAINS; HISTORY; RATES	Background: As one of prevalence HIV-1 strains in IDUs in Asia, the origination and full transmission map of CRF07_BC is of great interested and remains unclear. In the study, we collected 769 CRF07_BC derived sequences (including 45 sequences generated in our laboratory) from 12 provinces in China for reconstructing transmission map. Meanwhile, ample historic epidemic evidences were also reviewed to assist sequences analysis. Methodology/Principal Findings: In the study, we collected 769 CRF07_BC derived sequences and identified 138 independent sequences from 12 provinces in China for subsequent phylogeographic tree analysis, Bayes Factor test and the estimation of state tMRCA. The analyses demonstrated that CRF07_BC was originated in 1993 in IDU in Yunnan province and then initially spread to Guangxi (eastern neighbor to Yunnan) in 1994, to Xinjiang (northwest) in 1995 and to Sichuan (northern neighbor to Yunnan) in 1996. The subsequent transmissions occurred from Yunnan to Liaoning (northeast) in 1997 and to Jiangsu in 1998. Interestingly, after the early introduction of CRF07_BC into Guangxi, Xinjiang and Sichuan, these three regions served as secondary epicenters for further spreading into Gansu, Ningxia, Qinghai, Beijing and Hunan during 1999-2001. These analyzed results are in accordance with early epidemic investigations. Conclusions/Significance: Our data not just reconstructed the migration map of CRF07_BC, but also firstly revealed the active roles of these secondary epicenters in the dynamic migration of CRF07_BC in China.	[Meng, Zhefeng; Abubakar, Yassir F.; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Meng, Zhefeng; Abubakar, Yassir F.; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xin, Ruolei] Beijing Ctr Dis Control & Prevent, Dept AIDS STD, Beijing, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS STD, Shanghai, Peoples R China; [Zhang, Chiyu] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Jingyun] Acad Mil Med Sci, Inst Microbiol Epidemiol, Beijing, Peoples R China; [Liu, Wei] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhang, XY (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhang_xycn2002@yahoo.com.cn; jianqingxu2008@gmail.com		Zhang, Chiyu/0000-0001-8735-9857; meng, zhefeng/0000-0001-9396-0673	NSFC [30901257]; National Grand Program on Key Infectious Disease Control [2008ZX10001-004, 2012ZX10001-006, 2012ZX10001-008]; China Ministry of Health; China Ministry of Science and Technology	NSFC(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease Control; China Ministry of Health; China Ministry of Science and Technology(Ministry of Science and Technology, China)	The researches were supported by NSFC Grant 30901257 and National Grand Program on Key Infectious Disease Control (Grant# 2008ZX10001-004, 2012ZX10001-006 and 2012ZX10001-008), China Ministry of Health & China Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Chen J, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P74; Chen X, 2000, J CHINA AIDS STD PRE, V6, P141; Chu Tian-xin, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P281; Department of Control Minister of Health China, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P7; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jia C, 2003, JIANGSU HLTH CARE, V5, P6; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin YT, 2007, J INFECT DIS, V195, P1283, DOI 10.1086/513437; Liu J, 2011, PLOS ONE, V8; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; Liu W, 2003, PRAC PREV MED, V10, P644; Liu W, 2001, GUANGXI YU FANG ZHI, V7, P257; Ma F, 2004, MED ANIM PREV CONT, V20, P250; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2011, CHINESE MED J-PEKING, V124, P304, DOI 10.3760/cma.j.issn.0366-6999.2011.02.028; Meng ZF, 2007, AIDS RES HUM RETROV, V23, P1049, DOI 10.1089/aid.2007.0058; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; National HIV Sentinel Surveillance Collaborative Group, 2000, J CHINA AIDS STD PRE, V4, P242; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Qin G, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P39; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shao Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P109; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sun X, 1999, J CHIN AIDS STD PREV, V5, P97; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Wolf H, 1996, CHINESE J VIROL, V12, P9; Wu H, 2000, CHIN J MICROBIOL IMM, V20, P462; Xin Ruo-lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P876; Xing S, 2002, J CHINA AIDS STD PRE, V8, P21; Yan YanSheng (et al. ), 2000, Chinese Journal of Zoonoses, V16, P91; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang G, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P15; Zhang T, 2001, J CHINA AIDS STD PRE, V7, P28	50	32	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52373	10.1371/journal.pone.0052373	http://dx.doi.org/10.1371/journal.pone.0052373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300654	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800075
J	Riedel, SS; Mottok, A; Brede, C; Bauerlein, CA; Garrote, ALJ; Ritz, M; Mattenheimer, K; Rosenwald, A; Einsele, H; Bogen, B; Beilhack, A				Riedel, Simone S.; Mottok, Anja; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Ritz, Miriam; Mattenheimer, Katharina; Rosenwald, Andreas; Einsele, Hermann; Bogen, Bjarne; Beilhack, Andreas			Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma	PLOS ONE			English	Article							T-CELLS; MELPHALAN; MARROW; GROWTH; MICE; PLASMACYTOMA; CHEMOKINES; CLEARANCE; MIGRATION; PROTEINS	Background: Multiple myeloma (MM) is a B-cell malignancy, where malignant plasma cells clonally expand in the bone marrow of older people, causing significant morbidity and mortality. Typical clinical symptoms include increased serum calcium levels, renal insufficiency, anemia, and bone lesions. With standard therapies, MM remains incurable; therefore, the development of new drugs or immune cell-based therapies is desirable. To advance the goal of finding a more effective treatment for MM, we aimed to develop a reliable preclinical MM mouse model applying sensitive and reproducible methods for monitoring of tumor growth and metastasis in response to therapy. Material and Methods: A mouse model was created by intravenously injecting bone marrow-homing mouse myeloma cells (MOPC-315.BM) that expressed luciferase into BALB/c wild type mice. The luciferase in the myeloma cells allowed in vivo tracking before and after melphalan treatment with bioluminescence imaging (BLI). Homing of MOPC-315.BM luciferase+ myeloma cells to specific tissues was examined by flow cytometry. Idiotype-specific myeloma protein serum levels were measured by ELISA. In vivo measurements were validated with histopathology. Results: Strong bone marrow tropism and subsequent dissemination of MOPC-315.BM luciferase+ cells in vivo closely mimicked the human disease. In vivo BLI and later histopathological analysis revealed that 12 days of melphalan treatment slowed tumor progression and reduced MM dissemination compared to untreated controls. MOPC-315.BM luciferase+ cells expressed CXCR4 and high levels of CD44 and alpha 4 beta 1 in vitro which could explain the strong bone marrow tropism. The results showed that MOPC-315.BM cells dynamically regulated homing receptor expression and depended on interactions with surrounding cells. Conclusions: This study described a novel MM mouse model that facilitated convenient, reliable, and sensitive tracking of myeloma cells with whole body BLI in living animals. This model is highly suitable for monitoring the effects of different treatment regimens.	[Riedel, Simone S.; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Ritz, Miriam; Mattenheimer, Katharina; Einsele, Hermann; Beilhack, Andreas] Wurzburg Univ Clin, Dept Med 2, Wurzburg, Germany; [Riedel, Simone S.; Brede, Christian; Baeuerlein, Carina A.; Garrote, Ana-Laura Jordan; Beilhack, Andreas] GK Immunomodulat, Grad Sch Life Sci, Wurzburg, Germany; [Mottok, Anja; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Beilhack, Andreas] Univ Wurzburg, Interdisciplinary Ctr Clin Res IZKF, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Oslo; University of Oslo; National Hospital Norway; University of Wurzburg	Bogen, B (corresponding author), Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway.	bjarne.bogen@medisin.uio.no; beilhack_a@medizin.uni-wuerzburg.de	Mottok, Anja/AAO-1801-2021	Mottok, Anja/0000-0003-3125-0494	German Research Foundation (DFG) [CRU 216 TP4]; Multiple Myeloma Research Foundation; Interdisciplinary Center for Clinical Research at Wurzburg University; Norwegian Cancer Society; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Multiple Myeloma Research Foundation; Interdisciplinary Center for Clinical Research at Wurzburg University; Norwegian Cancer Society(Norwegian Cancer Society); University of Wuerzburg	This work was supported by grants to AB from the German Research Foundation (DFG CRU 216 TP4)(www.dfg.de), the Multiple Myeloma Research Foundation (www.themmrf.org) and the Interdisciplinary Center for Clinical Research (IZKF) at Wurzburg University (www.izkf.uni-wuerzburg.de). BB is supported by grants from the Norwegian Cancer Society (www.kreftforeningen.no) and Multiple Myeloma Research Foundation (www.themmrf.org). This publication was funded by the German Research Foundation (DFG) (www.dfg.de) and the University of Wuerzburg in the funding programme Open Access Publishing (http://openaccess.uni-wuerzburg.de/open_access_zeitschriften). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Chesi M., 2012, BLOOD; Deleu S, 2009, LEUKEMIA, V23, P1894, DOI 10.1038/leu.2009.121; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Fowler JA, 2009, DIS MODEL MECH, V2, P604, DOI 10.1242/dmm.003160; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; HOOGSTRATEN B, 1967, BLOOD-J HEMATOL, V30, P74, DOI 10.1182/blood.V30.1.74.74; Howlander N, 2012, SEER CANCER STATISTI; Jodal HC, 2011, SCAND J IMMUNOL, V73, P388; Jovasevic VM, 2004, J IMMUNOL, V172, P1449, DOI 10.4049/jimmunol.172.3.1449; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kueh, 2008, WHO CLASSIFICATION T; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Laubach JP, 2010, MED ONCOL, V27, P1, DOI 10.1007/s12032-010-9442-2; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; MILLAR JL, 1978, BRIT J CANCER, V38, P137, DOI 10.1038/bjc.1978.173; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; Mokyr MB, 2006, CANCER IMMUNOL IMMUN, V55, P459, DOI 10.1007/s00262-005-0029-2; MORELL A, 1973, CLIN EXP IMMUNOL, V13, P521; OGAWA M, 1971, CANCER RES, V31, P2116; Okada T, 1999, CLIN EXP METASTAS, V17, P623, DOI 10.1023/A:1006715504719; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Parmo-Cabanas M, 2004, EXP CELL RES, V294, P571, DOI 10.1016/j.yexcr.2003.12.003; Pellegrino A, 2004, CANCER LETT, V207, P221, DOI 10.1016/j.canlet.2003.10.036; Poeschinger T, 2013, MOL IMAGING BIOL, V15, P28, DOI 10.1007/s11307-012-0559-x; RIFAI A, 1983, J IMMUNOL, V130, P1826; ROHRER JW, 1979, J IMMUNOL, V123, P1083; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; Sahota SS, 1997, BLOOD, V89, P219, DOI 10.1182/blood.V89.1.219.219_219_226; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; VALERIOTE F, 1981, JNCI-J NATL CANCER I, V66, P1083, DOI 10.1093/jnci/66.6.1083; van Driel M, 1998, LEUKEMIA, V12, P1821, DOI 10.1038/sj.leu.2401179; Van Riet I, 1998, MED ONCOL, V15, P154, DOI 10.1007/BF02821934; Vanderkerken Karin, 2005, V113, P191, DOI 10.1385/1-59259-916-8:191; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52398	10.1371/journal.pone.0052398	http://dx.doi.org/10.1371/journal.pone.0052398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300660	Green Submitted, gold, Green Published			2022-12-25	WOS:000313618800079
J	Tsai, WY; Hsieh, SC; Lai, CY; Lin, HE; Nerurkar, VR; Wang, WK				Tsai, Wen-Yang; Hsieh, Szu-Chia; Lai, Chih-Yun; Lin, Hong-En; Nerurkar, Vivek R.; Wang, Wei-Kung			C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; TRUNCATED DENGUE-2; PRECURSOR MEMBRANE; PARTIAL PROTECTION; GLYCOPROTEINS; EPITOPES; IMMUNOGENICITY; PREMEMBRANE	Background: The envelope (E) protein of dengue virus (DENV) is the major immunogen for dengue vaccine development. At the C-erminus are two alpha-helices (EH1 and EH2) and two transmembrane domains (ET1 and ET2). After synthesis, E protein forms a heterodimer with the precursor membrane (prM) protein, which has been shown as a chaperone for E protein and could prevent premature fusion of E protein during maturation. Recent reports of enhancement of DENV infectivity by anti-prM monoclonal antibodies (mAbs) suggest the presence of prM protein in dengue vaccine is potentially harmful. A better understanding of prM-E interaction and its effect on recognition of E and prM proteins by different antibodies would provide important information for future design of safe and effective subunit dengue vaccines. Methodology/Principal Findings: In this study, we examined a series of C-terminal truncation constructs of DENV4 prME, E and prM. In the absence of E protein, prM protein expressed poorly. In the presence of E protein, the expression of prM protein increased in a dose-dependent manner. Radioimmunoprecipitation, sucrose gradient sedimentation and pulse-chase experiments revealed ET1 and EH2 were involved in prM-E interaction and EH2 in maintaining the stability of prM protein. Dot blot assay revealed E protein affected the recognition of prM protein by an anti-prM mAb; truncation of EH2 or EH1 affected the recognition of E protein by several anti-E mAbs, which was further verified by capture ELISA. The E protein ectodomain alone can be recognized well by all anti-E mAbs tested. Conclusions/Significance: A C-terminal domain (EH2) of DENV E protein can affect the expression and stability of its chaperone prM protein. These findings not only add to our understanding of the interaction between prM and E proteins, but also suggest the ectodomain of E protein alone could be a potential subunit immunogen without inducing anti-prM response.	[Tsai, Wen-Yang; Hsieh, Szu-Chia; Lai, Chih-Yun; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Hsieh, Szu-Chia; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA; [Lin, Hong-En] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10764, Taiwan	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Taiwan University	Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	wangwk@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine; National Institute of General Medical Sciences, National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Cooperative Research Agreement by International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from John A. Burns School of Medicine and Award Number P20GM103516 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 1999, J IMMUNOL, V163, P6756; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bonafe N, 2009, VACCINE, V27, P213, DOI 10.1016/j.vaccine.2008.10.046; BRAY M, 1991, VIROLOGY, V185, P505, DOI 10.1016/0042-6822(91)90809-P; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DELENDA C, 1994, J GEN VIROL, V75, P1569, DOI 10.1099/0022-1317-75-7-1569; Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; Hu HP, 2007, VIROLOGY, V368, P376, DOI 10.1016/j.virol.2007.06.026; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175; Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WHO, 2009, DENG HEM FEV DIAGN T; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990	48	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52600	10.1371/journal.pone.0052600	http://dx.doi.org/10.1371/journal.pone.0052600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300717	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800110
J	Chen, BJ; Jiao, YQ; Zhang, P; Sun, AY; Pitt, GS; Deoliveira, D; Drago, N; Ye, T; Liu, C; Chao, NJ				Chen, Benny J.; Jiao, Yiqun; Zhang, Ping; Sun, Albert Y.; Pitt, Geoffrey S.; Deoliveira, Divino; Drago, Nicholas; Ye, Tong; Liu, Chen; Chao, Nelson J.			Long-Term In Vivo Imaging of Multiple Organs at the Single Cell Level	PLOS ONE			English	Article							BONE-MARROW; TRANSPLANTATION; MOTILITY	Two-photon microscopy has enabled the study of individual cell behavior in live animals. Many organs and tissues cannot be studied, especially longitudinally, because they are located too deep, behind bony structures or too close to the lung and heart. Here we report a novel mouse model that allows long-term single cell imaging of many organs. A wide variety of live tissues were successfully engrafted in the pinna of the mouse ear. Many of these engrafted tissues maintained the normal tissue histology. Using the heart and thymus as models, we further demonstrated that the engrafted tissues functioned as would be expected. Combining two-photon microscopy with fluorescent tracers, we successfully visualized the engrafted tissues at the single cell level in live mice over several months. Four dimensional (three-dimensional (3D) plus time) information of individual cells was obtained from this imaging. This model makes long-term high resolution 4D imaging of multiple organs possible.	[Chen, Benny J.; Jiao, Yiqun; Zhang, Ping; Sun, Albert Y.; Pitt, Geoffrey S.; Deoliveira, Divino; Drago, Nicholas; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Chao, Nelson J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Chen, Benny J.; Chao, Nelson J.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Ye, Tong] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Duke University; Duke University; Duke University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Chen, BJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	chen0032@mc.duke.edu	Ye, Tong/A-8251-2010; Pitt, Geoffrey/L-4927-2019; Ye, Tong/ABG-8560-2021	Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969; Pitt, Geoffrey/0000-0003-2246-0289	NIH [U19AI067798, R33-AI080525, P01-CA047741]; NATIONAL CANCER INSTITUTE [P01CA047741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101, R01HL071165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, R33AI080525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partly supported by NIH grants U19AI067798, R33-AI080525, and P01-CA047741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhakta NR, 2005, SEMIN IMMUNOL, V17, P411, DOI 10.1016/j.smim.2005.09.004; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2002, TRANSPLANTATION, V73, P115, DOI 10.1097/00007890-200201150-00022; Chen BJ, 2002, BLOOD, V99, P364, DOI 10.1182/blood.V99.1.364; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; FULMER RI, 1963, AM J ANAT, V113, P273, DOI 10.1002/aja.1001130206; Hajdu SI, 2002, ANN CLIN LAB SCI, V32, P309; Markees TG, 1997, TRANSPLANTATION, V64, P329, DOI 10.1097/00007890-199707270-00026; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Zhang JF, 2012, BLOOD, V119, P6344, DOI 10.1182/blood-2011-03-342055	16	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52087	10.1371/journal.pone.0052087	http://dx.doi.org/10.1371/journal.pone.0052087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300962	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900018
J	Mangner, N; Linke, A; Oberbach, A; Kullnick, Y; Gielen, S; Sandri, M; Hoellriegel, R; Matsumoto, Y; Schuler, G; Adams, V				Mangner, Norman; Linke, Axel; Oberbach, Andreas; Kullnick, Yvonne; Gielen, Stephan; Sandri, Marcus; Hoellriegel, Robert; Matsumoto, Yasuharu; Schuler, Gerhard; Adams, Volker			Exercise Training Prevents TNF-alpha Induced Loss of Force in the Diaphragm of Mice	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ANTIINFLAMMATORY CYTOKINES; PHYSICAL-EXERCISE; CREATINE-KINASE; EXPRESSION; DYSFUNCTION; PROTEINS; CONTRACTILITY	Rationale: Inflammatory cytokines like tumor necrosis factor alpha (TNF-alpha) are elevated in congestive heart failure and are known to induce the production of reactive oxygen species as well as to deteriorate respiratory muscle function. Objectives: Given the antioxidative effects of exercise training, the aim of the present study was to investigate if exercise training is capable of preventing a TNF-alpha induced loss of diaphragmatic force in mice and, if so, to elucidate the potential underlying mechanisms. Methods: Prior to intraperitoneal injection of TNF-alpha or saline, C57Bl6 mice were assigned to four weeks of exercise training or sedentary behavior. Diaphragmatic force and power generation were determined in vitro. Expression/activity of radical scavenger enzymes, enzymes producing reactive oxygen species and marker of oxidative stress were measured in the diaphragm. Main Results: In sedentary animals, TNF-alpha reduced specific force development by 42% concomitant with a 2.6-fold increase in the amount of carbonylated alpha-actin and creatine kinase. Furthermore, TNF-alpha led to an increased NAD(P) H oxidase activity in both sedentary and exercised mice whereas xanthine oxidase activity and intramitochondrial ROS production was only enhanced in sedentary animals by TNF-alpha. Exercise training prevented the TNF-alpha induced force reduction and led to an enhanced mRNA expression and activity of glutathione peroxidase. Carbonylation of proteins, in particular of alpha-actin and creatine kinase, was diminished by exercise training. Conclusion: TNF-alpha reduces the force development in the diaphragm of mice. This effect is almost abolished by exercise training. This may be a result of reduced carbonylation of proteins due to the antioxidative properties of exercise training.	[Mangner, Norman; Linke, Axel; Sandri, Marcus; Hoellriegel, Robert; Schuler, Gerhard; Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany; [Oberbach, Andreas; Kullnick, Yvonne] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany; [Gielen, Stephan] Univ Halle Wittenberg, Univ Hosp, D-06108 Halle, Germany; [Matsumoto, Yasuharu] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan	Heart Center Leipzig GMBH; Leipzig University; Leipzig University; Martin Luther University Halle Wittenberg; Tohoku University	Mangner, N (corresponding author), Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany.	norman.mangner@med.uni-leipzig.de	Mangner, Norman/AAN-4673-2020	Mangner, Norman/0000-0003-0793-7923				Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; Adams V, 2008, EUR J CARDIOV PREV R, V15, P293, DOI 10.1097/HJR.0b013e3282f3ec43; Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Alloatti G, 2000, AM J PHYSIOL-REG I, V279, pR2156, DOI 10.1152/ajpregu.2000.279.6.R2156; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Barreiro E, 2005, AM J RESP CELL MOL, V33, P636, DOI 10.1165/rcmb.2005-0114OC; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Eikermann M, 2006, INTENS CARE MED, V32, P251, DOI 10.1007/s00134-005-0029-x; Filippatos GS, 2005, CURR OPIN CLIN NUTR, V8, P249, DOI 10.1097/01.mco.0000165002.08955.5b; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; HATCH MD, 1978, ANAL BIOCHEM, V85, P271, DOI 10.1016/0003-2697(78)90299-3; Hollriegel R., 2012, INT J CARDIOL; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; KOTTKE M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P215, DOI 10.1016/0005-2736(91)90287-I; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Li X, 2000, CIRCULATION, V102, P1690, DOI 10.1161/01.CIR.102.14.1690; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5; MANCINI DM, 1992, CIRCULATION, V86, P909, DOI 10.1161/01.CIR.86.3.909; Matsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224; Meyer FJ, 2001, CIRCULATION, V103, P2153; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Powell SR, 2012, PROG MOL BIOL TRANSL, V109, P295, DOI 10.1016/B978-0-12-397863-9.00009-2; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Smart Neil A, 2011, Congest Heart Fail, V17, P110, DOI 10.1111/j.1751-7133.2011.00217.x; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Supinski GS, 2009, AM J PHYSIOL-LUNG C, V296, pL994, DOI 10.1152/ajplung.90404.2008; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Wilcox P, 1996, AM J RESP CRIT CARE, V153, P1611, DOI 10.1164/ajrccm.153.5.8630610; WILCOX PG, 1994, AM J RESP CRIT CARE, V150, P1368, DOI 10.1164/ajrccm.150.5.7952566; Yan LJ, 2011, J CHROMATOGR B, V879, P1308, DOI 10.1016/j.jchromb.2010.08.004; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007; Zheng JZ, 2010, J NEUROCHEM, V115, P1556, DOI 10.1111/j.1471-4159.2010.07062.x	51	33	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52274	10.1371/journal.pone.0052274	http://dx.doi.org/10.1371/journal.pone.0052274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300968	gold, Green Published, Green Submitted			2022-12-25	WOS:000313320900023
J	Steiner, WW; Steiner, EM				Steiner, Walter W.; Steiner, Estelle M.			Fission Yeast Hotspot Sequence Motifs Are Also Active in Budding Yeast	PLOS ONE			English	Article							RECOMBINATION HOT-SPOT; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; GENE; HUMANS; BREAKS	In most organisms, including humans, meiotic recombination occurs preferentially at a limited number of sites in the genome known as hotspots. There has been substantial progress recently in elucidating the factors determining the location of meiotic recombination hotspots, and it is becoming clear that simple sequence motifs play a significant role. In S. pombe, there are at least five unique sequence motifs that have been shown to produce hotspots of recombination, and it is likely that there are more. In S. cerevisiae, simple sequence motifs have also been shown to produce hotspots or show significant correlations with hotspots. Some of the hotspot motifs in both yeasts are known or suspected to bind transcription factors (TFs), which are required for the activity of those hotspots. Here we show that four of the five hotspot motifs identified in S. pombe also create hotspots in the distantly related budding yeast S. cerevisiae. For one of these hotspots, M26 (also called CRE), we identify TFs, Cst6 and Sko1, that activate and inhibit the hotspot, respectively. In addition, two of the hotspot motifs show significant correlations with naturally occurring hotspots. The conservation of these hotspots between the distantly related fission and budding yeasts suggests that these sequence motifs, and others yet to be discovered, may function widely as hotspots in many diverse organisms.	[Steiner, Walter W.] Niagara Univ, Dept Biol, Lewiston, NY 14109 USA; [Steiner, Estelle M.] Niagara Cty Community Coll, Div Sci & Technol, Sanborn, NY USA	State University of New York (SUNY) System; SUNY Community College	Steiner, WW (corresponding author), Niagara Univ, Dept Biol, Lewiston, NY 14109 USA.	wsteiner@niagara.edu			National Institutes of Health [R15GM078065-01A1]; Niagara University Academic Center for Integrated Sciences (ACIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM078065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Niagara University Academic Center for Integrated Sciences (ACIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health, R15GM078065-01A1, to WWS and the Niagara University Academic Center for Integrated Sciences (ACIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de Castro E, 2012, EMBO J, V31, P124, DOI 10.1038/emboj.2011.350; Fox ME, 2000, GENETICS, V156, P59; Garcia-Gimeno MA, 2000, MOL CELL BIOL, V20, P4340, DOI 10.1128/MCB.20.12.4340-4349.2000; GEDVILAITE A, 1994, CURR GENET, V25, P475, DOI 10.1007/BF00351665; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GUTZ H, 1971, GENETICS, V69, P331; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; JUDD SR, 1988, GENETICS, V118, P401; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Loprieno N, 1974, HDB GENETICS, P395; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NEHLIN JO, 1992, NUCLEIC ACIDS RES, V20, P5271, DOI 10.1093/nar/20.20.5271; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; Sipiczki M, 2000, GENOME BIOL, V1, P10111011; STAPLETON A, 1991, GENETICS, V127, P39; Steiner WW, 2011, GENETICS, V187, P385, DOI 10.1534/genetics.110.124636; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; TRECO D, 1985, MOL CELL BIOL, V5, P2029, DOI 10.1128/MCB.5.8.2029; Wahls WP, 2011, GENETICS, V189, P685, DOI 10.1534/genetics.111.134130; Wahls WP, 2010, TRENDS GENET, V26, P202, DOI 10.1016/j.tig.2010.02.003; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53090	10.1371/journal.pone.0053090	http://dx.doi.org/10.1371/journal.pone.0053090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300865	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600055
J	Caidi, H; Harcourt, JL; Tripp, RA; Anderson, LJ; Haynes, LM				Caidi, Hayat; Harcourt, Jennifer L.; Tripp, Ralph A.; Anderson, Larry J.; Haynes, Lia M.			Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice	PLOS ONE			English	Article							SUBSTANCE-P; F-GLYCOPROTEIN; CX3C MOTIF; INFECTION; BRONCHIOLITIS; INFLAMMATION; NEUTRALIZATION; PATHOGENESIS; VACCINATION; EXPRESSION	Therapeutic options to control respiratory syncytial virus (RSV) are limited, thus development of new therapeutics is high priority. Previous studies with a monoclonal antibody (mAb) reactive to an epitope proximal to the central conserved region (CCR) of RSV G protein (mAb 131-2G) showed therapeutic efficacy for reducing pulmonary inflammation RSV infection in BALB/c mice. Here, we show a protective effect in RSV-infected mice therapeutically treated with a mAb (130-6D) reactive to an epitope within the CCR of G protein, while treatment with a mAb specific for a carboxyl G protein epitope had no effect. Combined treatment with mAbs 130-6D and 131-2G significantly decreased RSV-associated pulmonary inflammation compared to either antibody alone. The results suggest that anti-RSV G protein mAbs that react at or near the CCR and can block RSV G protein-mediated activities are effective at preventing RSV disease and may be an effective strategy for RSV therapeutic treatment.	[Caidi, Hayat; Harcourt, Jennifer L.; Haynes, Lia M.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA; [Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Anderson, Larry J.] Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Haynes, LM (corresponding author), Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA.	loh5@cdc.gov		Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [5RO1AI06275-03]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (5RO1AI06275-03) and through the Georgia Research Alliance to R. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatidou V, 2006, PEDIATR INFECT DIS J, V25, P410, DOI 10.1097/01.inf.0000214998.16248.b7; ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; ANDERSON LJ, 1986, J CLIN MICROBIOL, V23, P475, DOI 10.1128/JCM.23.3.475-480.1986; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Andersson C, 2000, FEMS IMMUNOL MED MIC, V29, P247, DOI 10.1111/j.1574-695X.2000.tb01530.x; Coffman S, 2009, MCN-AM J MATERN-CHIL, V34, P378, DOI 10.1097/01.NMC.0000363687.27939.e4; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Haynes LM, 2002, J VIROL, V76, P6873, DOI 10.1128/JVI.76.14.6873-6881.2002; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Kauvar LM, 2010, IMMUNOTHERAPY-UK, V2, P655, DOI [10.2217/imt.10.53, 10.2217/IMT.10.53]; Krilov LR, 2011, EXPERT REV ANTI-INFE, V9, P27, DOI 10.1586/ERI.10.140; Langeduk JP, 1997, J VIROL, V71, P4065; Mejias A, 2004, ANTIMICROB AGENTS CH, V48, P1811, DOI 10.1128/AAC.48.5.1811-1822.2004; Miao C, 2009, J GEN VIROL, V200, P1119; Murata Y, 2009, CLIN LAB MED, V29, P725, DOI 10.1016/j.cll.2009.07.004; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; Radu GU, 2010, J VIROL, V84, P9632, DOI 10.1128/JVI.00451-10; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; SULLENDER W, 1995, VIROLOGY, V209, P70, DOI 10.1006/viro.1995.1231; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 2000, J VIROL, V74, P6227, DOI 10.1128/JVI.74.13.6227-6229.2000; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Walsh EE, 1998, J GEN VIROL, V79, P479, DOI 10.1099/0022-1317-79-3-479; WIN N, 1992, CLIN LAB HAEMATOL, V14, P29	32	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51485	10.1371/journal.pone.0051485	http://dx.doi.org/10.1371/journal.pone.0051485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300550	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100009
J	Wang, S; Wei, W; Zheng, YD; Hou, JL; Dou, YX; Zhang, SH; Luo, XN; Cai, XP				Wang, Shuai; Wei, Wei; Zheng, Yadong; Hou, Junling; Dou, Yongxi; Zhang, Shaohua; Luo, Xuenong; Cai, Xuepeng			The Role of Insulin C-Peptide in the Coevolution Analyses of the Insulin Signaling Pathway: A Hint for Its Functions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EVOLUTIONARY ANALYSIS; PROTEIN-INTERACTION; HUMAN PROINSULIN; DIABETIC-RATS; TUBULAR CELLS; PREDICTION; RECEPTOR; INCREASES; RESIDUES	As the linker between the A chain and B chain of proinsulin, C-peptide displays high variability in length and amino acid composition, and has been considered as an inert byproduct of insulin synthesis and processing for many years. Recent studies have suggested that C-peptide can act as a bioactive hormone, exerting various biological effects on the pathophysiology and treatment of diabetes. In this study, we analyzed the coevolution of insulin molecules among vertebrates, aiming at exploring the evolutionary characteristics of insulin molecule, especially the C-peptide. We also calculated the correlations of evolutionary rates between the insulin and the insulin receptor (IR) sequences as well as the domain-domain pairs of the ligand and receptor by the mirrortree method. The results revealed distinctive features of C-peptide in insulin intramolecular coevolution and correlated residue substitutions, which partly supported the idea that C-peptide can act as a bioactive hormone, with significant sequence features, as well as a linker assisting the formation of mature insulin during synthesis. Interestingly, the evolution of C-peptide exerted the highest correlation with that of the insulin receptor and its ligand binding domain (LBD), implying a potential relationship with the insulin signaling pathway.	[Wang, Shuai; Wei, Wei; Zheng, Yadong; Hou, Junling; Dou, Yongxi; Zhang, Shaohua; Luo, Xuenong; Cai, Xuepeng] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Zoonoses CAAS, Key Lab Vet Parasitol Gansu Prov,Lanzhou Vet Res, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Luo, XN (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Zoonoses CAAS, Key Lab Vet Parasitol Gansu Prov,Lanzhou Vet Res, Lanzhou, Gansu, Peoples R China.	xuenongluo@yahoo.com.cn; wslanzhou@126.com	YD, Zh/HGA-5541-2022; Sánchez-Margalet, Victor/AAB-9986-2021; Wang, Shuai/ABE-4447-2022; WEI, Wei/AAK-9139-2021	YD, Zh/0000-0001-6795-9978; Sánchez-Margalet, Victor/0000-0001-8638-8680; Wang, Shuai/0000-0001-7028-8503; WEI, Wei/0000-0002-6478-5973	"863" High Technology Project [2006AA10A207]; National Key Project of Scientific and Technical Supporting program [2007BAD40B03]; Ministry of Science and Technology, China	"863" High Technology Project(National High Technology Research and Development Program of China); National Key Project of Scientific and Technical Supporting program; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was supported by "863" High Technology Project (NO. 2006AA10A207) and a National Key Project of Scientific and Technical Supporting program (No. 2007BAD40B03), the Ministry of Science and Technology, China, funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; BENNER SA, 1994, J MOL BIOL, V235, P926, DOI 10.1006/jmbi.1994.1049; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; Chen LM, 2002, J BIOCHEM, V131, P855, DOI 10.1093/oxfordjournals.jbchem.a003175; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dou TH, 2006, FRONT BIOSCI-LANDMRK, V11, P380, DOI 10.2741/1805; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Felsenstein, 2002, SCIENCES; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Grunberger G, 2001, DIABETOLOGIA, V44, P1247, DOI 10.1007/s001250100632; Hills CE, 2008, EXP DIABETES RES, DOI 10.1155/2008/635158; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; Johansson J, 2002, BIOCHEM BIOPH RES CO, V295, P1035, DOI 10.1016/S0006-291X(02)00721-0; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kitamura T, 2001, BIOCHEM J, V355, P123, DOI 10.1042/0264-6021:3550123; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lindahl E, 2007, CELL MOL LIFE SCI, V64, P479, DOI 10.1007/s00018-007-6467-6; Livingstone CD, 1996, METHOD ENZYMOL, V266, P497; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Maestroni A, 2005, EUR J ENDOCRINOL, V152, P135, DOI 10.1530/eje.1.01823; Min CY, 2004, EUR J BIOCHEM, V271, P1737, DOI 10.1111/j.1432-1033.2004.04079.x; Munte CE, 2005, FEBS J, V272, P4284, DOI 10.1111/j.1742-4658.2005.04843.x; Nordquist L, 2009, AM J PHYSIOL-RENAL, V297, pF1265, DOI 10.1152/ajprenal.00228.2009; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Samnegard B, 2005, NEPHROL DIAL TRANSPL, V20, P532, DOI 10.1093/ndt/gfh683; Shafqat J, 2002, CELL MOL LIFE SCI, V59, P1185, DOI 10.1007/s00018-002-8496-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Stevens MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE497, DOI 10.1152/ajpendo.00048.2004; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; VINGRON M, 1989, COMPUT APPL BIOSCI, V5, P115; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200	52	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52847	10.1371/journal.pone.0052847	http://dx.doi.org/10.1371/journal.pone.0052847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300796	Green Submitted, gold, Green Published			2022-12-25	WOS:000312829100086
J	Collu, F; Ceccarelli, M; Ruggerone, P				Collu, Francesca; Ceccarelli, Matteo; Ruggerone, Paolo			Exploring Binding Properties of Agonists Interacting with a delta-Opioid Receptor	PLOS ONE			English	Article							CONFORMATIONALLY SAMPLED PHARMACOPHORE; PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS; N-DESMETHYLCLOZAPINE; SIMULATIONS REVEAL; CRYSTAL-STRUCTURE; LIGAND-BINDING; COMPLEX; RHODOPSIN; HYDRATION	Ligand-receptor interactions are at the basis of the mediation of our physiological responses to a large variety of ligands, such as hormones, neurotransmitters and environmental stimulants, and their tuning represents the goal of a large variety of therapies. Several molecular details of these interactions are still largely unknown. In an effort to shed some light on this important issue, we performed a computational study on the interaction of two related compounds differing by a single methyl group (clozapine and desmethylclozapine) with a delta-opioid receptor. According to experiments, desmethylclozapine is more active than clozapine, providing a system well suited for a comparative study. We investigated stable configurations of the two drugs inside the receptor by simulating their escape routes by molecular dynamics simulations. Our results point out that the action of the compounds might be related to the spatial and temporal distribution of the affinity sites they visit during their permanency. Moreover, no particularly pronounced structural perturbations of the receptor were detected during the simulations, reinforcing the idea of a strong dynamical character of the interaction process, with an important role played by the solvent in addition.	[Collu, Francesca] Univ Cagliari, CNR IOM SLACS, Monserrato, Italy; [Collu, Francesca; Ceccarelli, Matteo; Ruggerone, Paolo] Univ Cagliari, Dipartimento Fis, Monserrato, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Cagliari; University of Cagliari	Ruggerone, P (corresponding author), Univ Cagliari, Dipartimento Fis, Monserrato, Italy.	paolo.ruggerone@dsf.unica.it	Ceccarelli, Matteo/C-8557-2018; Ruggerone, Paolo/AAN-6032-2021	Ceccarelli, Matteo/0000-0003-4272-902X; Ruggerone, Paolo/0000-0003-0825-0824	COSMOLAB; Cybersar	COSMOLAB; Cybersar	The authors have read the journal's policy and have the following conflicts. Funding for this study was received from COSMOLAB and Cybersar. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Alkorta I, 1996, PROTEIN ENG, V9, P573, DOI 10.1093/protein/9.7.573; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Aparasu R, 1999, J PAIN SYMPTOM MANAG, V18, P280, DOI 10.1016/S0885-3924(99)00085-8; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baron Riccardo, 2006, Trends in Physical Chemistry, V11, P87; Baron R, 2009, J CHEM THEORY COMPUT, V5, P3150, DOI 10.1021/ct900373z; Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Bernard D, 2005, J MED CHEM, V48, P7773, DOI 10.1021/jm050785p; Bernard D, 2003, J AM CHEM SOC, V125, P3101, DOI 10.1021/ja027644m; Biarnes X, 2011, J COMPUT AID MOL DES, V25, P395, DOI 10.1007/s10822-011-9415-3; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chakrabarti S, 1998, MOL PHARMACOL, V54, P949, DOI 10.1124/mol.54.6.949; Chang CE, 2005, J CHEM THEORY COMPUT, V1, P1017, DOI 10.1021/ct0500904; Chaturvedi K, 2000, BIOPOLYMERS, V55, P334, DOI 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dolenc J, 2011, J COMPUT AID MOL DES, V25, P709, DOI 10.1007/s10822-011-9453-x; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Ensing B, 2006, ACCOUNTS CHEM RES, V39, P73, DOI 10.1021/ar040198i; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; FILLERS JP, 1982, ACTA CRYSTALLOGR B, V38, P1750, DOI 10.1107/S0567740882007109; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010; Hajjar E, 2010, J MOL MODEL, V16, P1701, DOI 10.1007/s00894-010-0698-4; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; HUBER T, 1994, J COMPUT AID MOL DES, V8, P695, DOI 10.1007/BF00124016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Iannuzzi M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238302; Jardon-Valadez E, 2010, BIOPHYS J, V99, P2200, DOI 10.1016/j.bpj.2010.06.067; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kane BE, 2006, AAPS J, V8, pE126, DOI 10.1208/aapsj080115; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lameh J, 2007, PHARMACOL THERAPEUT, V115, P223, DOI 10.1016/j.pharmthera.2007.05.004; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LIPKOWSKI AW, 1986, J MED CHEM, V29, P1222, DOI 10.1021/jm00157a018; Mancini I, 1998, SUPPORT CARE CANCER, V6, P356, DOI 10.1007/s005200050177; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marchi M, 1998, J CHEM PHYS, V109, P5194, DOI 10.1063/1.477136; Masetti M, 2009, J PHYS CHEM B, V113, P4807, DOI 10.1021/jp803936q; Mendoza MC, 2009, CLIN NEUROPHARMACOL, V32, P154, DOI 10.1097/WNF.0b013e31818d46f5; Meng F, 2000, J BIOL CHEM, V275, P21939, DOI 10.1074/jbc.M002864200; Mezei M, 2006, J COMPUT AID MOL DES, V20, P97, DOI 10.1007/s10822-006-9039-1; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Nguyen PH, 2012, PHYS CHEM CHEM PHYS, V14, P877, DOI 10.1039/c1cp21779h; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Olianas MC, 2009, EUR J PHARMACOL, V607, P96, DOI 10.1016/j.ejphar.2009.02.025; Onali P, 2007, NEUROPSYCHOPHARMACOL, V32, P773, DOI 10.1038/sj.npp.1301152; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pizzitutti F, 2007, J PHYS CHEM B, V111, P7584, DOI 10.1021/jp0717185; Pogozheva ID, 2005, AAPS J, V7; Procacci P, 1997, J COMPUT CHEM, V18, P1848, DOI 10.1002/(SICI)1096-987X(19971130)18:15<1848::AID-JCC2>3.0.CO;2-O; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Provasi D, 2010, BIOPHYS J, V98, P2347, DOI 10.1016/j.bpj.2010.01.047; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Quock RM, 1999, PHARMACOL REV, V51, P503; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith A, 2003, LIFE SCI, V73; Sterpone F, 2001, J MOL BIOL, V311, P409, DOI 10.1006/jmbi.2001.4860; STRAATSMA TP, 2004, NWCHEM COMPUTATIONAL; Sugihara M, 2011, J PHYS CHEM B, V115, P6172, DOI 10.1021/jp1101785; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Vargiu AV, 2008, NUCLEIC ACIDS RES, V36, P5910, DOI 10.1093/nar/gkn561; Venken T, 2011, PROTEINS, V79, P3221, DOI 10.1002/prot.23158; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	98	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52633	10.1371/journal.pone.0052633	http://dx.doi.org/10.1371/journal.pone.0052633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300729	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800117
J	Hammond, E; Brandt, R; Dredge, K				Hammond, Edward; Brandt, Ralf; Dredge, Keith			PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANTIANGIOGENIC THERAPY; CANCER METASTASIS; DISEASE PROGRESSION; LUNG-CANCER; TUMOR; ANGIOGENESIS; INHIBITOR; IMPACT; TARGET	PG545 is a clinically relevant heparan sulfate (HS) mimetic which, in addition to possessing anti-angiogenic properties, also acts as a heparanase inhibitor which may differentiate its mechanism(s) of action from approved angiogenesis inhibitors. The degradation of HS by heparanase has been strongly implicated in cell dissemination and the metastatic process. Thus, the anti-metastatic activity of PG545 has been linked to the enzymatic function of heparanase - the only endoglycosidase known to cleave HS, an important component of the extracellular matrix (ECM) which represents a potential avenue for therapeutic intervention for certain metastatic cancer indications. Recent concerns raised about the paucity of overall survival as an endpoint in mouse models of clinically relevant metastasis led us to examine the effect of PG545 on the progression of both primary tumor growth and the spontaneously metastasizing disease in the 4T1 syngeneic breast carcinoma model in a non-surgical and surgical (mastectomy) setting. PG545 significantly inhibited primary tumor growth but importantly also inhibited lung metastasis in treated mice, an effect not observed with the tyrosine kinase inhibitor sorafenib. Importantly, PG545 significantly enhanced overall survival compared to vehicle control and the sorafenib group, suggesting PG545's inhibitory effect on heparanase is indeed a critical attribute to induce anti-metastatic activity. In addition to blocking a common angiogenic signalling pathway in tumor cells, the expression of heparanase in the primary tumor and lung was also significantly reduced by PG545 treatment. These results support the ongoing development of PG545 and highlight the potential utility in metastatic disease settings.	[Hammond, Edward; Dredge, Keith] Progen Pharmaceut, Res & Dev, Darra, Qld, Australia; [Brandt, Ralf] vivoPharm, Bundoora, Vic, Australia	Progen Pharmaceuticals - Australia	Hammond, E (corresponding author), Progen Pharmaceut, Res & Dev, Darra, Qld, Australia.	edwardh@progen-pharma.com						Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Borsig L, 2011, NEOPLASIA, V13, P445, DOI 10.1593/neo.101734; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Gandhi NS, 2010, DRUG DISCOV TODAY, V15, P1058, DOI 10.1016/j.drudis.2010.10.009; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hammond E., 2006, NEW DEV THERAPEUTIC, P251; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hortobagyi G, 2010, CANC MED, P1449; Imada T, 2006, INT J MOL MED, V17, P221; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Li QN, 2009, ACTA PHARMACOL SIN, V30, P1033, DOI 10.1038/aps.2009.97; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Luan Q, 2011, CANCER LETT, V308, P100, DOI 10.1016/j.canlet.2011.04.019; Maxhimer JB, 2005, J AM COLL SURGEONS, V200, P328, DOI 10.1016/j.jamcollsurg.2004.10.034; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Raman Karthik, 2010, Curr Chem Biol, V4, P20; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Sargent DJ, 2008, J CLIN ONCOL, V26, P1922, DOI 10.1200/JCO.2007.14.8064; Sasaki M, 2001, MEDIAT INFLAMM, V10, P259, DOI 10.1080/09629350120093731; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Steeg PS, 2009, CLIN CANCER RES, V15, P4529, DOI 10.1158/1078-0432.CCR-09-1363; Theodoro TR, 2007, NEOPLASIA, V9, P504, DOI 10.1593/neo.07241; Utsugi T, 1996, CANCER RES, V56, P2809; Verma S, 2011, ONCOLOGIST, V16, P25, DOI 10.1634/theoncologist.2010-0278; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021106	50	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52175	10.1371/journal.pone.0052175	http://dx.doi.org/10.1371/journal.pone.0052175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300607	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800051
J	Seiler, S; Schmidt, H; Lechner, A; Benke, T; Sanin, G; Ransmayr, G; Lehner, R; Dal-Bianco, P; Santer, P; Linortner, P; Eggers, C; Haider, B; Uranues, M; Marksteiner, J; Leblhuber, F; Kapeller, P; Bancher, C; Schmidt, R				Seiler, Stephan; Schmidt, Helena; Lechner, Anita; Benke, Thomas; Sanin, Guenter; Ransmayr, Gerhard; Lehner, Riccarda; Dal-Bianco, Peter; Santer, Peter; Linortner, Patricia; Eggers, Christian; Haider, Bernhard; Uranues, Margarete; Marksteiner, Josef; Leblhuber, Friedrich; Kapeller, Peter; Bancher, Christian; Schmidt, Reinhold		PRODEM Study Grp	Driving Cessation and Dementia: Results of the Prospective Registry on Dementia in Austria (PRODEM)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER DRIVERS; PATHOLOGICAL DIAGNOSIS; PERFORMANCE; RISK; PREDICTORS; CONSORTIUM; GUIDELINES; CRASHES; ABILITY	Objective: To assess the influence of cognitive, functional and behavioral factors, co-morbidities as well as caregiver characteristics on driving cessation in dementia patients. Methods: The study cohort consists of those 240 dementia cases of the ongoing prospective registry on dementia in Austria (PRODEM) who were former or current car-drivers (mean age 74.2 (+/- 8.8) years, 39.6% females, 80.8% Alzheimer's disease). Reasons for driving cessation were assessed with the patients' caregivers. Standardized questionnaires were used to evaluate patient-and caregiver characteristics. Cognitive functioning was determined by Mini-Mental State Examination (MMSE), the CERAD neuropsychological test battery and Clinical Dementia Rating (CDR), activities of daily living (ADL) by the Disability Assessment for Dementia, behavior by the Neuropsychiatric Inventory (NPI) and caregiver burden by the Zarit burden scale. Results: Among subjects who had ceased driving, 136 (93.8%) did so because of "Unacceptable risk'' according to caregiver's judgment. Car accidents and revocation of the driving license were responsible in 8 (5.5%) and 1(0.7%) participant, respectively. Female gender (OR 5.057; 95% CI 1.803-14.180; p = 0.002), constructional abilities (OR 0.611; 95% CI 0.445-0.839; p = 0.002) and impairment in Activities of Daily Living (OR 0.941; 95% CI 0.911-0.973; p<0.001) were the only significant and independent associates of driving cessation. In multivariate analysis none of the currently proposed screening tools for assessment of fitness to drive in elderly subjects including the MMSE and CDR were significantly associated with driving cessation. Conclusion: The risk-estimate of caregivers, but not car accidents or revocation of the driving license determines if dementia patients cease driving. Female gender and increasing impairment in constructional abilities and ADL raise the probability for driving cessation. If any of these factors also relates to undesired traffic situations needs to be determined before recommendations for their inclusion into practice parameters for the assessment of driving abilities in the elderly can be derived from our data.	[Seiler, Stephan; Schmidt, Helena; Lechner, Anita; Linortner, Patricia; Schmidt, Reinhold] Med Univ Graz, Div Neurogeriatr, Dept Neurol, Graz, Austria; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Graz, Austria; [Benke, Thomas; Sanin, Guenter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Ransmayr, Gerhard; Lehner, Riccarda] Gen Hosp Linz, Dept Neurol, Linz, Austria; [Dal-Bianco, Peter; Santer, Peter] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Eggers, Christian; Haider, Bernhard] Konventhosp Barmherzigen Bruder Linz, Dept Neurol, Linz, Austria; [Uranues, Margarete] Landesnervenklin Sigmund Freud Graz, Dept Geriatr Psychiat, Graz, Austria; [Marksteiner, Josef] Reg Hosp Hall Tirol, Dept Psychiat & Psychotherapy, Hall In Tirol, Austria; [Leblhuber, Friedrich] Nervenklin Wagner Jauregg Linz, Dept Neurol & Geriatr Psychiat, Linz, Austria; [Kapeller, Peter] Reg Hosp Villach, Dept Neurol & Psychosomat Med, Villach, Austria; [Bancher, Christian] Reg Hosp Horn, Dept Neurol, Horn, Austria	Medical University of Graz; Medical University of Graz; Medical University of Innsbruck; Kepler University Hospital; Medical University of Vienna; Konventhospital Der Barmherzigen Bruder; Kepler University Hospital	Schmidt, R (corresponding author), Med Univ Graz, Div Neurogeriatr, Dept Neurol, Graz, Austria.	reinhold.schmidt@medunigraz.at	Schmidt, Reinhold/E-1137-2014; bancher, christian/AAX-8974-2020	Delazer, Margarete/0000-0001-6482-4445; Sen, Abhijit/0000-0001-9560-4226; Berger-Sieczkowski, Evelyn/0000-0001-7570-0499	Austrian Alzheimer Society; Jubilaumsfonds of the Austrian National Bank [13240]	Austrian Alzheimer Society; Jubilaumsfonds of the Austrian National Bank	The research presented in this paper was supported by the Austrian Alzheimer Society (http://alzheimer.mcw-portal.com) and the Jubilaumsfonds of the Austrian National Bank, grant 13240 (http://www.oenb.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2003, ALZ DIS ASSOC DIS, V17, P68, DOI 10.1097/00002093-200304000-00003; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auracher-Jaeger B, 2006, LEITLINIEN FUER GESU; Berry C, 2011, OLDER DRIVERS BEHAV; Brown LB, 2004, J GERIATR PSYCH NEUR, V17, P232, DOI 10.1177/0891988704269825; Canadian Medical Association, 2000, DET MED FITN DRIV GU, P56; Carr DB, 2000, J AM GERIATR SOC, V48, P18, DOI 10.1111/j.1532-5415.2000.tb03023.x; Chipman ML, 1998, ACCIDENT ANAL PREV, V30, P299, DOI 10.1016/S0001-4575(97)00107-3; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; De Raedt R, 2000, AGE AGEING, V29, P517, DOI 10.1093/ageing/29.6.517; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Foley DJ, 2000, J AM GERIATR SOC, V48, P928, DOI 10.1111/j.1532-5415.2000.tb06889.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frittelli C, 2009, INT J GERIATR PSYCH, V24, P232, DOI 10.1002/gps.2095; Fuller R, 2005, ACCIDENT ANAL PREV, V37, P461, DOI 10.1016/j.aap.2004.11.003; Gallo JJ, 1999, J AM GERIATR SOC, V47, P335, DOI 10.1111/j.1532-5415.1999.tb02998.x; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Grabowski DC, 2004, JAMA-J AM MED ASSOC, V291, P2840, DOI 10.1001/jama.291.23.2840; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; Herrmann N, 2006, CAN MED ASSOC J, V175, P591, DOI 10.1503/cmaj.051707; Langford J, 2004, ACCIDENT ANAL PREV, V36, P993, DOI 10.1016/j.aap.2003.11.003; Lincoln NB, 2010, INT J GERIATR PSYCH, V25, P489, DOI 10.1002/gps.2367; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKENNA FP, 1991, ACCIDENT ANAL PREV, V23, P45, DOI 10.1016/0001-4575(91)90034-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Memory Clinic NPZ, 2005, CONSTR EST REG ALZH; Mitchell CGB, 2008, TRAFFIC INJ PREV, V9, P360, DOI 10.1080/15389580801895160; Molnar LJ, 2005, PUBLIC POLICY AGING, V15, P13; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; ONeill D., 2004, TRANSPORTATION AGING, V27, P56; Patterson C, 2001, T CAN J NEUROL SC S1, V28, P3; Redberg RF, 2009, J AM COLL CARDIOL, V54, P1364, DOI 10.1016/j.jacc.2009.08.005; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; Siren A, 2012, ACCIDENT ANAL PREV, V45, P634, DOI 10.1016/j.aap.2011.09.032; Stapleton T, 2012, AUST OCCUP THER J, V59, P63, DOI 10.1111/j.1440-1630.2011.00980.x; Talbot A, 2005, AGE AGEING, V34, P363, DOI 10.1093/ageing/afi090; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	48	73	73	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52710	10.1371/journal.pone.0052710	http://dx.doi.org/10.1371/journal.pone.0052710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300746	Green Published, gold			2022-12-25	WOS:000313618800128
J	Xiong, JJ; Che, XX; Li, XQ; Yu, H; Gong, Z; Li, WD				Xiong, Jianjun; Che, Xiangxin; Li, Xueqin; Yu, Huan; Gong, Zhen; Li, Weidong			Cloning and Characterization of the Human USP22 Gene Promoter	PLOS ONE			English	Article							CELL-CYCLE; SP1 PHOSPHORYLATION; CANCER-CELLS; TRANSCRIPTION; EXPRESSION; DEATH; OVEREXPRESSION	Ubiquitin-specific processing enzyme 22 (USP22) plays a direct role in regulating cell cycle, and its overexpression has been reported to be involved in tumor progression. However, little is known about the regulation of USP22 transcription. In this study, we cloned and characterized the human USP22 promoter. Using 5' RACE (rapid amplification of cDNA ends) analysis, the transcriptional initiation site was identified. Promoter deletion analysis showed that the sequence between -210 and -7 contains the basal promoter for USP22 in human fibroblast and tumor cells. Surprisingly, mutations in a putative Sp1 binding site immediately upstream of the USP22 transcriptional start site (-13 to -7) resulted in a significant induction of promoter activity. Further study revealed that Sp1 binds to this site in human normal fibroblast cells, and treatment with the Sp1 inhibitor mithramycin A led to a marked increase in USP22 transcript levels. Forced expression of exogenous Sp1 repressed the USP22 promoter activity in HeLa cells. In contrast, knockdown of Sp1 enhanced USP22 promoter activity and mRNA levels. These data suggest that Sp1 is a crucial regulator of USP22 transcription.	[Xiong, Jianjun; Che, Xiangxin; Li, Xueqin; Yu, Huan; Gong, Zhen] Jiujiang Univ, Coll Basic Med Sci, Jiujiang, Peoples R China; [Xiong, Jianjun; Che, Xiangxin; Li, Weidong] Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China	Jiujiang University	Li, WD (corresponding author), Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China.	lwd62518@yahoo.com.cn			National Natural Sciences Foundation of China [31000581]; Natural Science Foundation of Jiangxi, China [2010GQY0199]; Jiangxi Provincial Department of Education, China [GJJ11619];  [2010BSA14000]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province); Jiangxi Provincial Department of Education, China; 	This work was supported by the National Natural Sciences Foundation of China (31000581); Natural Science Foundation of Jiangxi, China (2010GQY0199); Jiangxi Science and Technology Support Programmer, China (2010BSA14000); and Science Programmer of Jiangxi Provincial Department of Education, China (GJJ11619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Guo LL, 2010, J NEUROSCI RES, V88, P3233, DOI 10.1002/jnr.22486; Hsu TI, 2011, ONCOGENE, V568, P1; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Li F, 2012, GENE, V503, P200, DOI 10.1016/j.gene.2012.04.088; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Vij N, 2006, AM J RESP CELL MOL, V34, P754, DOI 10.1165/rcmb.2005-0442OC; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	28	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52716	10.1371/journal.pone.0052716	http://dx.doi.org/10.1371/journal.pone.0052716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300749	gold, Green Submitted, Green Published			2022-12-25	WOS:000313618800129
J	Qiu, XJ; Ding, SS; Shi, TL				Qiu, Xiaojie; Ding, Shanshan; Shi, Tieliu			From Understanding the Development Landscape of the Canonical Fate-Switch Pair to Constructing a Dynamic Landscape for Two-Step Neural Differentiation	PLOS ONE			English	Article							POTENTIAL LANDSCAPE; IPS CELLS; FIBROBLASTS; IDENTIFICATION; TRANSCRIPTOME; EXPRESSION; EXISTENCE; EVOLUTION; GENES; NOISE	Recent progress in stem cell biology, notably cell fate conversion, calls for novel theoretical understanding for cell differentiation. The existing qualitative concept of Waddington's "epigenetic landscape" has attracted particular attention because it captures subsequent fate decision points, thus manifesting the hierarchical ("tree-like") nature of cell fate diversification. Here, we generalized a recent work and explored such a developmental landscape for a two-gene fate decision circuit by integrating the underlying probability landscapes with different parameters (corresponding to distinct developmental stages). The change of entropy production rate along the parameter changes indicates which parameter changes can represent a normal developmental process while other parameters' change can not. The transdifferentiation paths over the landscape under certain conditions reveal the possibility of a direct and reversible phenotypic conversion. As the intensity of noise increases, we found that the landscape becomes flatter and the dominant paths more straight, implying the importance of biological noise processing mechanism in development and reprogramming. We further extended the landscape of the one-step fate decision to that for two-step decisions in central nervous system (CNS) differentiation. A minimal network and dynamic model for CNS differentiation was firstly constructed where two three-gene motifs are coupled. We then implemented the SDEs (Stochastic Differentiation Equations) simulation for the validity of the network and model. By integrating the two landscapes for the two switch gene pairs, we constructed the two-step development landscape for CNS differentiation. Our work provides new insights into cellular differentiation and important clues for better reprogramming strategies.	[Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Sch Life Sci, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Shi, TL (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Sch Life Sci, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com			National 973 Key Basic Research Program [2010CB945401, 2012CB910400]; National Natural Science Foundation of China [31171264, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National 973 Key Basic Research Program (2010CB945401, 2012CB910400); the National Natural Science Foundation of China (31171264, 31071162, 31000590); and the Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrecut M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019358; Ao P, 2005, PHYS LIFE REV, V2, P117, DOI 10.1016/j.plrev.2005.03.002; Ao P, 2004, J PHYS A-MATH GEN, V37, pL25, DOI 10.1088/0305-4470/37/3/L01; Ao P, 2007, COMPLEXITY, V12, P19, DOI 10.1002/cplx.20171; Ao P, 2009, J GENET GENOMICS, V36, P63, DOI 10.1016/S1673-8527(08)60093-4; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Huang S, 2011, BIOESSAYS; Huang S, 2011, SEMINARS CANC BIOL; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kwon C, 2005, P NATL ACAD SCI USA, V102, P13029, DOI 10.1073/pnas.0506347102; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Qiang M, 2011, SCI CHINA LIFE SCI, V54, P1156, DOI 10.1007/s11427-011-4261-z; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Sanosaka T, 2008, NEUROSCIENCE, V155, P780, DOI 10.1016/j.neuroscience.2008.06.039; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SWENSON R, 1991, Ecological Psychology, V3, P317, DOI 10.1207/s15326969eco0304_2; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thom R, 1954, COMMENT MATH HELV, V28, P17, DOI DOI 10.1007/BF02566923; VanOoyen A, 2003, DEV COGN NEUROSCI, P1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang Jin, 2008, PMC Biophys, V1, P7, DOI 10.1186/1757-5036-1-7; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478547; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xing JH, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/37/375003; Yin L, 2006, J PHYS A-MATH GEN, V39, P8593, DOI 10.1088/0305-4470/39/27/003; Zhou J, 2010, TRENDS GENETICS; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	51	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49271	10.1371/journal.pone.0049271	http://dx.doi.org/10.1371/journal.pone.0049271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23300518	Green Published			2022-12-25	WOS:000312108500004
J	Wuttke, A; Idevall-Hagren, O; Tengholm, A				Wuttke, Anne; Idevall-Hagren, Olof; Tengholm, Anders			P2Y(1) receptor-dependent diacylglycerol signaling microdomains in beta cells promote insulin secretion	FASEB JOURNAL			English	Article						ATP; pancreatic islets; protein kinase C; oscillations; pulsatile insulin release	PROTEIN-KINASE-C; PANCREATIC-ISLETS; PHOSPHOLIPASE-C; INOSITOL 1,4,5-TRISPHOSPHATE; ADENINE-NUCLEOTIDES; GLUCOSE; RELEASE; ACTIVATION; EXOCYTOSIS; CA2+	Diacylglycerol (DAG) controls numerous cell functions by regulating the localization of C1-domain-containing proteins, including protein kinase C (PKC), but little is known about the spatiotemporal dynamics of the lipid. Here, we explored plasma membrane DAG dynamics in pancreatic beta cells and determined whether DAG signaling is involved in secretagogue-induced pulsatile release of insulin. Single MIN6 cells, primary mouse beta cells, and human beta cells within intact islets were transfected with translocation biosensors for DAG, PKC activity, or insulin secretion and imaged with total internal reflection fluorescence microscopy. Muscarinic receptor stimulation triggered stable, homogenous DAG elevations, whereas glucose induced short-lived (7.1 +/- 0.4 s) but high-amplitude elevations (up to 109 +/- 10% fluorescence increase) in spatially confined membrane regions. The spiking was mimicked by membrane depolarization and suppressed after inhibition of exocytosis or of purinergic P2Y(1), but not P2X receptors, reflecting involvement of autocrine purinoceptor activation after exocytotic release of ATP. Each DAG spike caused local PKC activation with resulting dissociation of its substrate protein MARCKS from the plasma membrane. Inhibition of spiking reduced glucose-induced pulsatile insulin secretion. Thus, stimulus-specific DAG signaling patterns appear in the plasma membrane, including distinct microdomains, which have implications for the kinetic control of exocytosis and other membrane-associated processes.-Wuttke, A., Idevall-Hagren, O., Tengholm, A. P2Y(1) receptor-dependent diacylglycerol signaling microdomains in beta cells promote insulin secretion. FASEB J. 27, 1610-1620 (2013). www.fasebj.org	[Wuttke, Anne; Idevall-Hagren, Olof; Tengholm, Anders] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, SE-75123 Uppsala, Sweden	Uppsala University	Tengholm, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.	anders.tengholm@mcb.uu.se		Idevall Hagren, Olof/0000-0002-0241-6304	Swedish Research Council; EFSD/MSD; Novo Nordisk Foundation; Swedish Diabetes Foundation; Family Ernfors Foundation; Swedish national strategic research initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); EFSD/MSD; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; Family Ernfors Foundation; Swedish national strategic research initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors thank Dr. Tobias Meyer (Stanford University, Palo Alto, CA, USA) and Dr. Naoaki Saito (Kobe University, Hyogo, Japan) for generously providing expression plasmids; H. Dansk, H. Emanuelsson, and I. Morsare for technical assistance; and Drs. S. Barg, E. Gylfe, and B. Hellman for helpful discussions. This study was supported by grants from the Swedish Research Council, EFSD/MSD, the Novo Nordisk Foundation, the Swedish Diabetes Foundation, and the Family Ernfors Foundation. Human pancreatic islets were obtained from the Nordic network for clinical islet transplantation, supported by the Swedish national strategic research initiative Exodiab (Excellence of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation. A. W. and A. T. designed the study, analyzed data, and wrote the article; A. W. acquired the DAG data; O.I-H. acquired the PIP<INF>3</INF> data.	ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BERTRAND G, 1989, BRIT J PHARMACOL, V98, P998, DOI 10.1111/j.1476-5381.1989.tb14631.x; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHAPAL J, 1981, EUR J PHARMACOL, V74, P127, DOI 10.1016/0014-2999(81)90522-7; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Grapengiesser E, 2004, BIOCHEM PHARMACOL, V68, P667, DOI 10.1016/j.bcp.2004.04.018; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Hellman B, 2004, AM J PHYSIOL-ENDOC M, V286, pE759, DOI 10.1152/ajpendo.00452.2003; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Idevall-Hagren O, 2006, J BIOL CHEM, V281, P39121; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kittel A, 2002, J HISTOCHEM CYTOCHEM, V50, P549, DOI 10.1177/002215540205000412; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; LEITNER JW, 1975, ENDOCRINOLOGY, V96, P662; Leon Catherine, 2005, Purinergic Signal, V1, P145, DOI 10.1007/s11302-005-6209-x; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; PETIT P, 1989, BRIT J PHARMACOL, V98, P875, DOI 10.1111/j.1476-5381.1989.tb14616.x; Petit P, 2009, EUR J PHARM SCI, V37, P67, DOI 10.1016/j.ejps.2009.01.007; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Poulsen CR, 1999, DIABETES, V48, P2171, DOI 10.2337/diabetes.48.11.2171; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Salehi A, 2005, DIABETES, V54, P2126, DOI 10.2337/diabetes.54.7.2126; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Verspohl EJ, 2002, CAN J PHYSIOL PHARM, V80, P562, DOI 10.1139/Y02-079; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; WOLF BA, 1989, BIOCHEMISTRY-US, V28, P4291, DOI 10.1021/bi00436a026; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zawalich WS, 1996, AM J PHYSIOL-ENDOC M, V271, pE409, DOI 10.1152/ajpendo.1996.271.3.E409; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241	63	37	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1610	1620		10.1096/fj.12-221499	http://dx.doi.org/10.1096/fj.12-221499			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23299857				2022-12-25	WOS:000316940800031
J	Akama, KT; Thompson, LI; Milner, TA; McEwen, BS				Akama, Keith T.; Thompson, Louisa I.; Milner, Teresa A.; McEwen, Bruce S.			Post-synaptic Density-95 (PSD-95) Binding Capacity of G-protein-coupled Receptor 30 (GPR30), an Estrogen Receptor That Can Be Identified in Hippocampal Dendritic Spines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM PDZ DOMAINS; PLASMA-MEMBRANE; ULTRASTRUCTURAL-LOCALIZATION; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; SEX-DIFFERENCES; BREAST-CANCER; AGING BRAIN; RAT-BRAIN; TRAFFICKING	The estrogen 17 beta-estradiol (E2) modulates dendritic spine plasticity in the cornu ammonis 1 (CA1) region of the hippocampus, and GPR30 (G-protein coupled estrogen receptor 1 (GPER1)) is an estrogen-sensitive G-protein-coupled receptor (GPCR) that is expressed in the mammalian brain and in specific subregions that are responsive to E2, including the hippocampus. The subcellular localization of hippocampal GPR30, however, remains unclear. Here, we demonstrate that GPR30 immunoreactivity is detected in dendritic spines of rat CA1 hippocampal neurons in vivo and that GPR30 protein can be found in rat brain synaptosomes. GPR30 immunoreactivity is identified at the post-synaptic density (PSD) and in the adjacent peri-synaptic zone, and GPR30 can associate with the spine scaffolding protein PSD-95 both in vitro and in vivo. This PSD-95 binding capacity of GPR30 is specific and determined by the receptor C-terminal tail that is both necessary and sufficient for PSD-95 interaction. The interaction with PSD-95 functions to increase GPR30 protein levels residing at the plasma membrane surface. GPR30 associates with the N-terminal tandem pair of PDZ domains in PSD-95, suggesting that PSD-95 may be involved in clustering GPR30 with other receptors in the hippocampus. We demonstrate that GPR30 has the potential to associate with additional post-synaptic GPCRs, including the membrane progestin receptor, the corticotropin releasing hormone receptor, and the 5HT1a serotonin receptor. These data demonstrate that GPR30 is well positioned in the dendritic spine compartment to integrate E2 sensitivity directly onto multiple inputs on synaptic activity and might begin to provide a molecular explanation as to how E2 modulates dendritic spine plasticity.	[Akama, Keith T.; Milner, Teresa A.; McEwen, Bruce S.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA; [Thompson, Louisa I.; Milner, Teresa A.] Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY 10065 USA	Rockefeller University; Cornell University	McEwen, BS (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave,Box 165, New York, NY 10065 USA.	mcewen@rockefeller.edu	McEwen, Bruce/Z-1630-2019		National Institutes of Health [AG016765, NS007080, DA08259, HL098351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG016765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG016765 and NS007080 (to B. S. Mc) and DA08259 and HL098351 (to T. A. M.).	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bonini JA, 1997, BIOCHEM BIOPH RES CO, V234, P190, DOI 10.1006/bbrc.1997.6591; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai ZL, 2005, ENDOCRINOLOGY, V146, P5522, DOI 10.1210/en.2005-0759; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dumitriu D, 2010, ANN NY ACAD SCI, V1204, P104, DOI 10.1111/j.1749-6632.2010.05529.x; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Foy MR, 2010, VITAM HORM, V82, P219, DOI 10.1016/S0083-6729(10)82012-6; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gee SH, 2000, BIOCHEMISTRY-US, V39, P14638, DOI 10.1021/bi001633t; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Hammond R, 2011, BRAIN RES, V1379, P53, DOI 10.1016/j.brainres.2010.11.098; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Haucke V, 2006, CELL, V127, P35, DOI 10.1016/j.cell.2006.09.012; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim KM, 2008, BIOCHEM BIOPH RES CO, V366, P42, DOI 10.1016/j.bbrc.2007.11.055; Kramar Eniko A, 2009, Mol Cell Pharmacol, V1, P258; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Le Saux M, 2005, J PSYCHIATR NEUROSCI, V30, P110; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Luttrell Louis M., 2006, V332, P3; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McEwen BS, 2007, BRAIN RES REV, V55, P343, DOI 10.1016/j.brainresrev.2007.02.006; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Mizukami Y, 2010, ENDOCR J, V57, P101, DOI 10.1507/endocrj.K09E-332; Morrison JH, 2006, J NEUROSCI, V26, P10332, DOI 10.1523/JNEUROSCI.3369-06.2006; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Peters A., 1991, FINE STRUCTURE NERVO; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Piroli GG, 2002, J COMP NEUROL, V452, P103, DOI 10.1002/cne.10368; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Pula G, 2004, J NEUROCHEM, V89, P1009, DOI 10.1111/j.1471-4159.2004.02387.x; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Roepke TA, 2011, FRONT BIOSCI-LANDMRK, V16, P1560, DOI 10.2741/3805; Romeo RD, 2005, NEUROENDOCRINOLOGY, V81, P391, DOI 10.1159/000089557; Rossi DV, 2010, PSYCHONEUROENDOCRINO, V35, P1023, DOI 10.1016/j.psyneuen.2010.01.003; Rybaczyk Leszek A, 2005, BMC Womens Health, V5, P12, DOI 10.1186/1472-6874-5-12; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Williams TJ, 2011, EXP NEUROL, V230, P186, DOI 10.1016/j.expneurol.2011.04.012; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xu ZQD, 2007, ACTA PHYSIOL, V190, P39, DOI 10.1111/j.1365-201X.2007.01695.x; YAMAMURA HI, 1973, J NEUROCHEM, V21, P1355, DOI 10.1111/j.1471-4159.1973.tb06022.x; Young SF, 2007, CELL MOL NEUROBIOL, V27, P439, DOI 10.1007/s10571-006-9135-8; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	98	102	111	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6438	6450		10.1074/jbc.M112.412478	http://dx.doi.org/10.1074/jbc.M112.412478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300088	Green Published, hybrid			2022-12-25	WOS:000315820700038
J	Cao, W; Ribeiro, RD; Liu, DA; Saintigny, P; Xia, RH; Xue, YW; Lin, RX; Mao, L; Ren, HN				Cao, Wei; Ribeiro, Rachel de Oliveira; Liu, Diane; Saintigny, Pierre; Xia, Ronghui; Xue, Yuwen; Lin, Ruxian; Mao, Li; Ren, Hening			EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POLYCOMB GROUP GENE; ZESTE HOMOLOG 2; AGGRESSIVE BREAST-CANCER; GROUP PROTEINS BMI1; DNA METHYLATION; PROSTATE-CANCER; CLINICAL-IMPLICATIONS; INCREASED EXPRESSION; HISTONE DEACETYLASE; DOWN-REGULATION	Background: Epigenetic silencing is a common mechanism to inactivate tumor suppressor genes during carcinogenesis. Enhancer of Zeste 2 (EZH2) is the histone methyltransferase subunit in polycomb repressive complex 2 which mediates transcriptional repression through histone methylation. EZH2 overexpression has been linked to aggressive phenotypes of certain cancers. However, the mechanism that EZH2 played in promoting malignancy in non-small cell lung cancer (NSCLC) remains unclear. In addition, the correlation of EZH2 overexpression and the prognosis of NSCLC patients in non-Asian cohort need to be determined. Methodology/Principal Findings: Up-regulation of EZH2 was found in NSCLC cells compared with normal human bronchial epithelial cells by western blot assay. Upon EZH2 knockdown using small interfering RNA (siRNA), the proliferation, anchorage-independent growth and invasion of NSCLC cells were remarkably suppressed with profound induction of G1 arrest. Furthermore, the expression of cyclin D1 was notably reduced whereas p15(INK4B), p21(Waf1/Cip1) and p27(Kip1) were increased in NSCLC cells after EZH2-siRNA delivery. To determine whether EZH2 expression contributes to disease progression in patients with NSCLC, Taqman quantitative real-time RT-PCR was used to measure the expression of EZH2 in paired tumor and normal samples. Univariate analysis revealed that patients with NSCLC whose tumors had a higher EZH2 expression had significantly inferior overall, disease-specific, and disease-free survivals compared to those whose tumors expressed lower EZH2 (P = 0.005, P = 0.001 and P = 0.003, respectively). In multivariate analysis, EZH2 expression was an independent predictor of disease-free survival (hazard ratio = 0.450, 95% CI: 0.270 to 0.750, P = 0.002). Conclusions/Significance: Our results demonstrate that EZH2 overexpression is critical for NSCLC progression. EZH2 mRNA levels may serve as a prognostic predictor for patients with NSCLC.	[Cao, Wei; Xia, Ronghui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Maxillofacial Head & Neck Oncol,Hosp 9, Shanghai 200030, Peoples R China; [Cao, Wei; Xia, Ronghui; Lin, Ruxian; Mao, Li; Ren, Hening] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Ribeiro, Rachel de Oliveira; Saintigny, Pierre; Xue, Yuwen; Mao, Li; Ren, Hening] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center	Ren, HN (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	Hren@umaryland.edu	Cao, Wei/ABE-1035-2021; Mao, Li/C-7570-2011	Cao, Wei/0000-0003-2184-9380; Mao, Li/0000-0001-7263-3358; Saintigny, Pierre/0000-0002-8090-9323	NIH [R01 CA126818, R01 CA136635]; National Natural Science Foundation of China [81202130]; NATIONAL CANCER INSTITUTE [R01CA126818, P30CA016672, R01CA136635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by NIH grants R01 CA126818 and R01 CA136635. WC is supported in part by the National Natural Science Foundation of China (Grant No. 81202130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Custodio AB, 2009, J THORAC ONCOL, V4, P891, DOI 10.1097/JTO.0b013e3181a4b8fb; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Cao W, 2011, CANCER PREV RES, V4, P1816, DOI 10.1158/1940-6207.CAPR-11-0130; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Choi JH, 2010, APMIS, V118, P196, DOI 10.1111/j.1600-0463.2009.02579.x; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Hinz S, 2009, J UROLOGY, V182, P2920, DOI 10.1016/j.juro.2009.08.014; Huqun, 2012, CANCER-AM CANCER SOC, V118, P1599, DOI 10.1002/cncr.26441; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kikuchi J, 2010, CANCER-AM CANCER SOC, V116, P3015, DOI 10.1002/cncr.25128; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Mao L, 2001, LUNG CANCER, V34, pS27, DOI 10.1016/S0169-5002(01)00341-5; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mok Tony, 2009, Discov Med, V8, P227; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Toll AD, 2010, HUM PATHOL, V41, P1205, DOI 10.1016/j.humpath.2010.03.004; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang J, 2007, CANCER RES, V67, P10647, DOI 10.1158/0008-5472.CAN-07-1337; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; Zhang J, 2006, CANCER RES, V66, P18, DOI 10.1158/0008-5472.CAN-04-3905	47	56	61	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52984	10.1371/journal.pone.0052984	http://dx.doi.org/10.1371/journal.pone.0052984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300840	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600044
J	Emde, S; Rueckert, S; Palm, HW; Klimpel, S				Emde, Sebastian; Rueckert, Sonja; Palm, Harry W.; Klimpel, Sven			Invasive Ponto-Caspian Amphipods and Fish Increase the Distribution Range of the Acanthocephalan Pomphorhynchus tereticollis in the River Rhine	PLOS ONE			English	Article							NEOGOBIUS-MELANOSTOMUS PALLAS; GOBY APOLLONIA-MELANOSTOMA; ROUND GOBY; MACROINVERTEBRATE COMMUNITY; METAZOAN PARASITES; GREAT-LAKES; LAEVIS; PREDATION; GOBIIDAE; HOST	Non-indigenous species that become invasive are one of the main drivers of biodiversity loss worldwide. In various freshwater systems in Europe, populations of native amphipods and fish are progressively displaced by highly adaptive non-indigenous species that can perform explosive range extensions. A total of 40 Ponto-Caspian round gobies Neogobius melanostomus from the Rhine River near Dusseldorf, North Rhine-Westphalia, Germany, were examined for metazoan parasites and feeding ecology. Three metazoan parasite species were found: two Nematoda and one Acanthocephala. The two Nematoda, Raphidascaris acus and Paracuaria adunca, had a low prevalence of 2.5%. The Acanthocephala, Pomphorhynchus tereticollis, was the predominant parasite species, reaching a level of 90.0% prevalence in the larval stage, correlated with fish size. In addition, four invasive amphipod species, Corophium curvispinum (435 specimens), Dikerogammarus villosus (5,454), Echinogammarus trichiatus (2,695) and Orchestia cavimana (1,448) were trapped at the sampling site. Only D. villosus was infected with P. tereticollis at a prevalence of 0.04%. The invasive goby N. melanostomus mainly preys on these non-indigenous amphipods, and may have replaced native amphipods in the transmission of P. tereticollis into the vertebrate paratenic host. This study gives insight into a potential parasite-host system that consists mainly of invasive species, such as the Ponto-Caspian fish and amphipods in the Rhine. We discuss prospective distribution and migration pathways of non-indigenous vertebrate (round goby) and invertebrates (amphipods) under special consideration of parasite dispersal.	[Emde, Sebastian; Klimpel, Sven] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, SGN, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Rueckert, Sonja] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Palm, Harry W.] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Edinburgh Napier University; University of Rostock	Klimpel, S (corresponding author), Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, SGN, Inst Ecol Evolut & Divers, Frankfurt, Germany.	sven.klimpel@senckenberg.de	Rueckert, Sonja/E-4695-2011		Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council DFG [PA 664/4-2, 6-1]	Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council DFG(German Research Foundation (DFG))	The present study was financially supported by the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts as well as the German Research Council DFG PA 664/4-2 and 6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin OM, 2003, SYST PARASITOL, V54, P229, DOI 10.1023/A:1022654921523; Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; [Anonymous], 2000, NEMATODE PARASITES V; [Anonymous], 1994, PARASITIC NEMATODES; Baldauf SA, 2007, INT J PARASITOL, V37, P61, DOI 10.1016/j.ijpara.2006.09.003; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Bernauer Dietmar, 2006, Aquatic Invasions, V1, P55, DOI 10.3391/ai.2006.1.2.2; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Bombarova M, 2007, GENETICA, V131, P141, DOI 10.1007/s10709-006-9124-3; Busch Markus Wilhelm, 2012, P329; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Dezfuli BS, 2011, PARASITE IMMUNOL, V33, P116, DOI 10.1111/j.1365-3024.2010.01266.x; DICK JTA, 1995, BEHAV ECOL SOCIOBIOL, V37, P393, DOI 10.1007/s002650050206; Dunn AM, 1998, ECOGRAPHY, V21, P593, DOI 10.1111/j.1600-0587.1998.tb00551.x; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Eggers Thomas Ols, 2004, Lauterbornia, V50, P1; Emde S, 2010, THESIS HEINRICH HEIN; Francova K, 2011, J APPL ICHTHYOL, V27, P879, DOI 10.1111/j.1439-0426.2010.01582.x; Freyhof J, 2003, BERICHTE IGB, V17, P51; Galil Bella S., 2007, V193, P59; Go Nan YJ, 1969, MEMOIRES MUSEUM NA A, V57; Gollasch Stephan, 2006, Aquatic Invasions, V1, P245, DOI 10.3391/ai.2006.1.4.8; HINE PM, 1974, J FISH BIOL, V6, P521, DOI 10.1111/j.1095-8649.1974.tb04569.x; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson CJ, 1997, CAN J FISH AQUAT SCI, V54, P815, DOI 10.1139/cjfas-54-4-815; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kopp K, 2007, OIKOS, V116, P295, DOI [10.1111/j.2006.0030-1299.15290.x, 10.1111/j.0030-1299.2007.15290.x]; Kvach Y, 2008, J GREAT LAKES RES, V34, P23, DOI 10.3394/0380-1330(2008)34[23:MPOIRA]2.0.CO;2; Kvach Yuriy, 2005, Acta Ichthyologica et Piscatoria, V35, P103; Kvach Y, 2007, PARASITOL RES, V100, P767, DOI 10.1007/s00436-006-0311-z; Kvach Y, 2011, PARASITOL RES, V109, P769, DOI 10.1007/s00436-011-2321-8; Lederer AM, 2008, J GREAT LAKES RES, V34, P690, DOI 10.3394/0380-1330-34.4.690; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Machkevsky V.K., 1990, EKOL MORYA, V36, P69; MacNeil C, 2003, FRESHWATER BIOL, V48, P2085, DOI 10.1046/j.1365-2427.2003.01145.x; Molnar K, 2006, J APPL ICHTHYOL, V22, P395, DOI 10.1111/j.1439-0426.2006.00742.x; Muhlegger JM, 2008, THESIS U WIEN; Nachev M, 2010, IMPACT INVASIVE GOBI, V2010; Ondrackova M, 2005, J APPL ICHTHYOL, V21, P345, DOI 10.1111/j.1439-0426.2005.00682.x; Palm HW, 2008, ZOOMORPHOLOGY, V127, P249, DOI 10.1007/s00435-008-0068-2; Panov Vadim E., 2009, Integrated Environmental Assessment and Management, V5, P110, DOI 10.1897/IEAM_2008-034.1; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Paterson RA, 2011, J ANIM ECOL, V80, P990, DOI 10.1111/j.1365-2656.2011.01834.x; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Perrot-Minnot MJ, 2004, INT J PARASITOL, V34, P45, DOI 10.1016/j.ijpara.2003.10.005; Pinkas L., 1971, CALIF FISH GAME FISH, V152, P1, DOI DOI 10.1201/B18714-2; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pronin NM, 1997, FOLIA PARASIT, V44, P1; QUIGLEY MA, 1989, HYDROBIOLOGIA, V171, P255, DOI 10.1007/BF00008147; Rakauskas Vytautas, 2008, Acta Zoologica Lituanica, V18, P180, DOI 10.2478/v10043-008-0030-z; Riemann F., 1988, P293; Sapota MR, 2006, NOBANIS INVASIVE ALI; Scholl F, 2007, MAKROZOOBENTHOS RHEI; Spakulova M, 2011, HELMINTHOLOGIA, V48, P268, DOI 10.2478/s11687-011-0038-y; Staas S, 2009, FISCHE RHEINS ANGELF; STOREY AW, 1991, HYDROBIOLOGIA, V211, P111, DOI 10.1007/BF00037367; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Thomas F, 2002, BEHAV ECOL SOCIOBIOL, V51, P296, DOI [10.1007/s00265-001-0442-2, 10.1007/S00265-001-0442-2]; Thunken T, 2010, HYDROBIOLOGIA, V654, P137, DOI 10.1007/s10750-010-0377-6; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; van der Velde G, 2007, AQUAT INVASIONS, V2, P261, DOI 10.3391/ai.2007.2.3.11	67	39	40	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53218	10.1371/journal.pone.0053218	http://dx.doi.org/10.1371/journal.pone.0053218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300895	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600072
J	Maletzki, C; Stier, S; Gruenert, U; Gock, M; Ostwald, C; Prall, F; Linnebacher, M				Maletzki, Claudia; Stier, Saskia; Gruenert, Ulrike; Gock, Michael; Ostwald, Christiane; Prall, Friedrich; Linnebacher, Michael			Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; CANCER XENOGRAFTS; MOLECULAR-BIOLOGY; BRAF MUTATION; MODEL; PROLIFERATION; HETEROGENEITY; IMPACT; TUMORS	Background: Colorectal cancer (CRC) represents a morphologic and molecular heterogenic disease. This heterogeneity substantially impairs drug effectiveness and prognosis. The subtype of mismatch repair deficient (MMR-D) CRCs, accounting for about 15% of all cases, shows particular differential responses up to resistance towards currently approved cytostatic drugs. Pre-clinical in vitro models representing molecular features of MMR-D tumors are thus mandatory for identifying biomarkers that finally help to predict responses towards new cytostatic drugs. Here, we describe the successful establishment and characterization of three patient-derived MMR-D cell lines (HROC24, HROC87, and HROC113) along with their corresponding xenografts. Methodology: MMR-D cell lines (HROC24, HROC87, and HROC113) were established from a total of ten clinicopathological well-defined MMR-D cases (120 CRC cases in total). Cells were comprehensively characterized by phenotype, morphology, growth kinetics, invasiveness, and molecular profile. Additionally, response to clinically relevant chemotherapeutics was examined in vitro and in vivo. Principal Findings: Two MMR-D lines showing CIMP-H derived from sporadic CRC (HROC24: K-ras(wt), B-raf(mut), HROC87: K-ras(wt), B-raf(mut)), whereas the HROC113 cell line (K-ras(mut), B-raf(wt)) was HNPCC-associated. A diploid DNA-status could be verified by flow cytometry and SNP Array analysis. All cell lines were characterized as epithelial (EpCAM(+)) tumor cells, showing surface tumor marker expression (CEACAM(+)). MHC-class II was inducible by Interferon-gamma stimulation. Growth kinetics as well as invasive potential was quite heterogeneous between individual lines. Besides, MMR-D cell lines exhibited distinct responsiveness towards chemotherapeutics, even when comparing in vitro and in vivo sensitivity. Conclusions: These newly established and well-characterized, low-passage MMR-D cell lines provide a useful tool for future investigations on the biological characteristics of MMR-D CRCs, both of sporadic and hereditary origin. Additionally, matched patient-derived immune cells allow for comparative genetic studies.	[Maletzki, Claudia; Stier, Saskia; Gruenert, Ulrike; Linnebacher, Michael] Univ Rostock, Div Mol Oncol & Immunotherapy, D-18055 Rostock, Germany; [Gock, Michael] Univ Rostock, Dept Gen Thorac Vasc & Transplantat Surg, D-18055 Rostock, Germany; [Ostwald, Christiane; Prall, Friedrich] Univ Rostock, Inst Pathol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Linnebacher, M (corresponding author), Univ Rostock, Div Mol Oncol & Immunotherapy, D-18055 Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402	Else-Kroner Fresenius Stiftung [2006/A29]; Deutsche Krebshilfe [108919]	Else-Kroner Fresenius Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was substantially supported by grant number 2006/A29 from the Else-Kroner Fresenius Stiftung to ML and by grant number 108919 from the Deutsche Krebshilfe (http://www.northgermantumorbank-crc.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JM, 2011, VIRCHOWS ARCH, V459, P55, DOI 10.1007/s00428-011-1080-3; Baguley BC, 1999, ONCOL RES, V11, P115; Bass A, 2011, J CLIN ONCOL, V29, P2728, DOI 10.1200/JCO.2011.36.1816; Bocsi J, 1999, J CANCER RES CLIN, V125, P9, DOI 10.1007/s004320050236; Castellanos E, 2011, CURR ONCOL REP, V13, P195, DOI 10.1007/s11912-011-0164-1; Correale P, 2012, INT J CANCER, V130, P1577, DOI 10.1002/ijc.26181; DANES BS, 1988, SCAND J GASTROENTERO, V23, P840, DOI 10.3109/00365528809090770; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; El-Osta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025806; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Gagos S, 1996, CANCER GENET CYTOGEN, V90, P157, DOI 10.1016/S0165-4608(96)00049-0; Harrison S, 2011, SURG-J R COLL SURG E, V9, P200, DOI 10.1016/j.surge.2011.01.011; Hector S, 2012, GUT, V61, P725, DOI 10.1136/gutjnl-2011-300433; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hewitt RE, 2000, J PATHOL, V192, P446; Jaster R, 2005, J CELL MOL MED, V9, P670, DOI 10.1111/j.1582-4934.2005.tb00497.x; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kang GH, 2011, ARCH PATHOL LAB MED, V135, P698, DOI 10.1043/2010-0523-RA.1; Kim ST, 2010, CANCER CHEMOTH PHARM, V66, P659, DOI 10.1007/s00280-009-1206-3; KIRKLAND SC, 1986, BRIT J CANCER, V53, P779, DOI 10.1038/bjc.1986.132; Klier U, 2010, LANGENBECK ARCH SURG, V395, P365, DOI 10.1007/s00423-010-0598-1; Ku JL, 2010, CARCINOGENESIS, V31, P1003, DOI 10.1093/carcin/bgq043; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Madajewicz S, 2012, INVEST NEW DRUG, V30, P772, DOI 10.1007/s10637-010-9598-9; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; POUPON MF, 1993, J NATL CANCER I, V85, P2023, DOI 10.1093/jnci/85.24.2023; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Saif MW, 2011, ANTICANCER RES, V31, P2971; Swanton C, 2009, BRIT J CANCER, V100, P1517, DOI 10.1038/sj.bjc.6605031; Tognon M, 1996, CANCER GENET CYTOGEN, V90, P17, DOI 10.1016/0165-4608(96)00067-2; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227	37	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52485	10.1371/journal.pone.0052485	http://dx.doi.org/10.1371/journal.pone.0052485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300683	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600017
J	Calaminus, SDJ; Guitart, A; Sinclair, A; Schachtner, H; Watson, SP; Holyoake, TL; Kranc, KR; Machesky, LM				Calaminus, Simon D. J.; Guitart, Amelie; Sinclair, Amy; Schachtner, Hannah; Watson, Steve P.; Holyoake, Tessa L.; Kranc, Kamil R.; Machesky, Laura M.			Lineage Tracing of Pf4-Cre Marks Hematopoietic Stem Cells and Their Progeny	PLOS ONE			English	Article							PLATELET-FUNCTION; TRANSGENIC MICE; CRE; MEGAKARYOPOIESIS; MEGAKARYOCYTE; ACTIVATION; EXPRESSION; REGULATOR; KNOCKOUTS; TISSUES	The development of a megakaryocyte lineage specific Cre deleter, using the Pf4 (CXCL4) promoter (Pf4-Cre), was a significant step forward in the specific analysis of platelet and megakaryocyte cell biology. However, in the present study we have employed a sensitive reporter-based approach to demonstrate that Pf4-Cre also recombines in a significant proportion of both fetal liver and bone marrow hematopoietic stem cells (HSCs), including the most primitive fraction containing the long-term repopulating HSCs. Consequently, we demonstrate that Pf4-Cre activity is not megakaryocyte lineage-specific but extends to other myeloid and lymphoid lineages at significant levels between 15-60%. Finally, we show for the first time that Pf4 transcripts are present in adult HSCs and primitive hematopoietic progenitor cells. These results have fundamental implications for the use of the Pf4-Cre mouse model and for our understanding of a possible role for Pf4 in the development of the hematopoietic lineage.	[Guitart, Amelie; Sinclair, Amy; Holyoake, Tessa L.; Kranc, Kamil R.] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland; [Calaminus, Simon D. J.; Schachtner, Hannah; Machesky, Laura M.] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Birmingham, W Midlands, England	University of Glasgow; Beatson Institute; University of Glasgow; University of Birmingham	Kranc, KR (corresponding author), Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland.	kamil.kranc@glasgow.ac.uk; l.machesky@beatson.gla.ac.uk	Holyoake, Tessa/M-3668-2015; Machesky, Laura/Z-4554-2019; Watson, Stephen P/Q-6292-2016	Holyoake, Tessa/0000-0002-0608-6066; Machesky, Laura/0000-0002-7592-9856; Watson, Stephen P/0000-0002-7846-7423; Guitart, Amelie/0000-0002-1451-8789	Leukemia & Lymphoma Research; Kay Kendal Leukemia Fund; Royal Society; Tenovus Scotland; Cancer Research UK; Biotechnology and Biological Sciences Research Council; BHF; British Heart Foundation [FS/09/034/27756] Funding Source: researchfish; Cancer Research UK [15673] Funding Source: researchfish	Leukemia & Lymphoma Research; Kay Kendal Leukemia Fund; Royal Society(Royal Society of London); Tenovus Scotland; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	The authors' laboratories are supported by grants from Leukemia & Lymphoma Research (K. R. K), Kay Kendal Leukemia Fund (K. R. K, A. G.), The Royal Society (K. R. K), Tenovus Scotland (K. R. K), and the Cancer Research UK (L. M, K. R. K and T. L. H). K. R. K is a Cancer Research UK Senior Cancer Research Fellow. S. P. W is a BHF chair. A. S is supported by a PhD Studentship from the Biotechnology and Biological Sciences Research Council. H. S. is supported by a Ph.D. studentship from the BHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Chagraoui H, 2011, BLOOD, V118, P723, DOI 10.1182/blood-2011-01-328765; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Halene S, 2010, BLOOD, V116, P1942, DOI 10.1182/blood-2010-01-261743; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; Mazharian A, 2011, BLOOD, V117, P5198, DOI 10.1182/blood-2010-12-326850; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Pearce AC, 2007, BIOCHEM J, V401, P753, DOI 10.1042/BJ20061508; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Schaffner A, 2005, J LEUKOCYTE BIOL, V78, P202, DOI 10.1189/jlb.0105024; Speck NA, 2009, BLOOD CELL MOL DIS, V43, P6, DOI 10.1016/j.bcmd.2009.01.010; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242	21	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51361	10.1371/journal.pone.0051361	http://dx.doi.org/10.1371/journal.pone.0051361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300543	Green Published, gold, Green Accepted			2022-12-25	WOS:000312829100007
J	Nassour, M; Idoux-Gillet, Y; Selmi, A; Come, C; Faraldo, MLM; Deugnier, MA; Savagner, P				Nassour, Mayssa; Idoux-Gillet, Ysia; Selmi, Abdelkader; Come, Christophe; Faraldo, Maria-Luisa M.; Deugnier, Marie-Ange; Savagner, Pierre			Slug Controls Stem/Progenitor Cell Growth Dynamics during Mammary Gland Morphogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMAD-INTERACTING PROTEIN-1; CANCER STEM-CELLS; BREAST-CANCER; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NEURAL CREST; SELF-RENEWAL; SNAIL; CARCINOMA	Background: Morphogenesis results from the coordination of distinct cell signaling pathways controlling migration, differentiation, apoptosis, and proliferation, along stem/progenitor cell dynamics. To decipher this puzzle, we focused on epithelial-mesenchymal transition (EMT) "master genes''. EMT has emerged as a unifying concept, involving cell-cell adhesion, migration and apoptotic pathways. EMT also appears to mingle with stemness. However, very little is known on the physiological role and relevance of EMT master-genes. We addressed this question during mammary morphogenesis. Recently, a link between Slug/Snai2 and stemness has been described in mammary epithelial cells, but EMT master genes actual localization, role and targets during mammary gland morphogenesis are not known and we focused on this basic question. Methodology/Principal Findings: Using a Slug-lacZ transgenic model and immunolocalization, we located Slug in a distinct subpopulation covering about 10-20% basal cap and duct cells, mostly cycling cells, coexpressed with basal markers P-cadherin, CK5 and CD49f. During puberty, Slug-deficient mammary epithelium exhibited a delayed development after transplantation, contained less cycling cells, and overexpressed CK8/18, ER, GATA3 and BMI1 genes, linked to luminal lineage. Other EMT master genes were overexpressed, suggesting compensation mechanisms. Gain/loss-of-function in vitro experiments confirmed Slug control of mammary epithelial cell luminal differentiation and proliferation. In addition, they showed that Slug enhances specifically clonal mammosphere emergence and growth, cell motility, and represses apoptosis. Strikingly, Slug-deprived mammary epithelial cells lost their potential to generate secondary clonal mammospheres. Conclusions/Significance: We conclude that Slug pathway controls the growth dynamics of a subpopulation of cycling progenitor basal cells during mammary morphogenesis. Overall, our data better define a key mechanism coordinating cell lineage dynamics and morphogenesis, and provide physiological relevance to broadening EMT pathways.	[Nassour, Mayssa; Idoux-Gillet, Ysia; Selmi, Abdelkader; Come, Christophe; Savagner, Pierre] Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, Ctr Reg Lutte Canc Val dAurelle Paul Lamarque,U89, F-34059 Montpellier, France; [Faraldo, Maria-Luisa M.; Deugnier, Marie-Ange] Inst Curie, CNRS, UMR144, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Savagner, P (corresponding author), Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, Ctr Reg Lutte Canc Val dAurelle Paul Lamarque,U89, F-34059 Montpellier, France.	psavagner@unicancer.montpellier.fr	Deugnier, Marie-Ange/M-7556-2018; Savagner, Pierre/AAD-9357-2020; Martin-Faraldo, Maria-Luisa/M-5811-2018; Côme, Christophe/E-8395-2016; Deugnier, Marie-Ange/AAF-5877-2021	Côme, Christophe/0000-0001-5229-4440; Deugnier, Marie-Ange/0000-0002-2199-1099; Faraldo, Marisa/0000-0001-9497-1171; Savagner, Pierre/0000-0002-8287-2229; Selmi, Abdelkader/0000-0001-5760-0507; Idoux-Gillet, Ysia/0000-0002-0436-1968	Fondation de France; Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon); Ligue Regionale contre le Cancer; ARC (Association pour la Recherche sur le Cancer); Ligue Regionale contre le Cancer (Languedoc-Roussillon)	Fondation de France(Fondation de France); Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon); Ligue Regionale contre le Cancer(Ligue nationale contre le cancer); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale contre le Cancer (Languedoc-Roussillon)	Financial support was provided by the Fondation de France, the Ligue Regionale contre le Cancer (Languedoc-Roussillon) and Groupement des Entreprises Francaises dans la lutte contre le Cancer (Languedoc-Roussillon). In addition, the authors gratefully acknowledge support from the Ligue Regionale contre le Cancer for C. Come and Y. Idoux-Gillet and ARC (Association pour la Recherche sur le Cancer) for M. Nassour and V. Arnoux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DEOME KB, 1959, CANCER RES, V19, P515; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MAYOR R, 1995, DEVELOPMENT, V121, P767; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Perez-Losada J, 2010, CELL CYCLE, V9, P2706; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Romano LA, 1999, DEV BIOL, V212, P243, DOI 10.1006/dbio.1999.9339; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shi J, 2011, DEVELOPMENT; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Sun Y, 2010, BLOOD, V115, P1709, DOI 10.1182/blood-2009-07-232934; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, COLD SPRING HARBOR P, V3; Wegwitz F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012103; YOUNG LJT, 1984, CANCER RES, V44, P4333	42	73	76	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53498	10.1371/journal.pone.0053498	http://dx.doi.org/10.1371/journal.pone.0053498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300933	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100133
J	Cure, C; Antunes, R; Samarra, F; Alves, AC; Visser, F; Kvadsheim, PH; Miller, PJO				Cure, Charlotte; Antunes, Ricardo; Samarra, Filipa; Alves, Ana Catarina; Visser, Fleur; Kvadsheim, Petter H.; Miller, Patrick J. O.			Pilot Whales Attracted to Killer Whale Sounds: Acoustically-Mediated Interspecific Interactions in Cetaceans	PLOS ONE			English	Article							ORCINUS-ORCA; MEGAPTERA-NOVAEANGLIAE; HUMPBACK WHALES; PLAYBACK; BEHAVIOR; ECOLOGY; NORTH; WILD	In cetaceans' communities, interactions between individuals of different species are often observed in the wild. Yet, due to methodological and technical challenges very little is known about the mediation of these interactions and their effect on cetaceans' behavior. Killer whales (Orcinus orca) are a highly vocal species and can be both food competitors and potential predators of many other cetaceans. Thus, the interception of their vocalizations by unintended cetacean receivers may be particularly important in mediating interspecific interactions. To address this hypothesis, we conducted playbacks of killer whale vocalizations recorded during herring-feeding activity to free-ranging long-finned pilot whales (Globicephala melas). Using a multi-sensor tag, we were able to track the whales and to monitor changes of their movements and social behavior in response to the playbacks. We demonstrated that the playback of killer whale sounds to pilot whales induced a clear increase in group size and a strong attraction of the animals towards the sound source. These findings provide the first experimental evidence that the interception of heterospecific vocalizations can mediate interactions between different cetacean species in previously unrecognized ways.	[Cure, Charlotte; Antunes, Ricardo; Samarra, Filipa; Alves, Ana Catarina; Miller, Patrick J. O.] Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews, Fife, Scotland; [Visser, Fleur] Netherlands Org Appl Sci Res TNO, The Hague, Netherlands; [Visser, Fleur] Kelp Marine Res, Hoorn, Netherlands; [Kvadsheim, Petter H.] Norwegian Def Res Estab FFI, Horten, Norway	University of St Andrews; Netherlands Organization Applied Science Research; Norwegian Defence Research Establishment	Cure, C (corresponding author), Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews, Fife, Scotland.	cc201@st-andrews.ac.uk		Visser, Fleur/0000-0003-1024-3244; Samarra, Filipa/0000-0002-9909-0565; Antunes, Ricardo/0000-0001-6783-3523	US Office of Naval Research; Norwegian Ministry of Defense; Netherlands Ministry of Defense; WWF-Norway; TOTAL Foundation; Foundation Bleustein-Blanchet	US Office of Naval Research(Office of Naval Research); Norwegian Ministry of Defense; Netherlands Ministry of Defense; WWF-Norway; TOTAL Foundation(Total SA); Foundation Bleustein-Blanchet	This study was mainly funded by three naval organisations: the US Office of Naval Research, the Norwegian Ministry of Defense and the Netherlands Ministry of Defense. In addition, WWF-Norway, TOTAL Foundation and the Foundation Bleustein-Blanchet also contributed financially. Authors are employed by government (Norwegian Defense Research Establishment), independent no-profit (Netherlands Organization for Applied Scientific Research and Kelp Marine Research), or academic (University of St. Andrews) research organisations. No authors are employed by naval organisations. The funders had no role in study design, data analysis, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Bisther A, 2001, CULTURE MARINE ANIMA; Blanchet S, 2010, ANN NY ACAD SCI, V1195, P149, DOI 10.1111/j.1749-6632.2010.05477.x; CLARK CW, 1980, SCIENCE, V207, P663, DOI 10.1126/science.207.4431.663; CUMMINGS WC, 1971, FISH BULL NATL OC AT, V69, P525; de Stephanis R, 2005, 19 ANN C EUR CET SOC; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Deecke Volker B., 2006, Aquatic Mammals, V32, P461, DOI 10.1578/AM.32.4.2006.461; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Eskesen IG, 2011, J ACOUST SOC AM, V130, P9, DOI 10.1121/1.3583499; FISH JF, 1971, FISH BULL NATL OC AT, V69, P531; Foote AD, 2008, J ACOUST SOC AM, V123, P1747, DOI 10.1121/1.2836752; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Golubski AJ, 2011, J ANIM ECOL, V80, P1097, DOI 10.1111/j.1365-2656.2011.01852.x; Hardin J., 2003, GEN ESTIMATING EQUAT; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Miller PJO, 2006, J COMP PHYSIOL A, V192, P449, DOI 10.1007/s00359-005-0085-2; MOBLEY JR, 1988, BEHAV ECOL SOCIOBIOL, V23, P211, DOI 10.1007/BF00302944; Pacini AF, 2010, J EXP BIOL, V213, P3138, DOI 10.1242/jeb.044636; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Peake Tom M., 2006, P13; Selling J, 2011, 25 ANN C EUR CET SOC; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Simon M, 2007, ACTA ETHOL, V10, P47, DOI 10.1007/s10211-007-0029-7; STENERSEN J., 2004, NORWEGIAN KILLER WHA; TYACK P, 1983, BEHAV ECOL SOCIOBIOL, V13, P49, DOI 10.1007/BF00295075; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Visser F, 2011, 201101289 FFI	33	37	38	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52201	10.1371/journal.pone.0052201	http://dx.doi.org/10.1371/journal.pone.0052201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300613	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800056
J	Jiang, N; Yang, YP; Janbon, G; Pan, J; Zhu, XD				Jiang, Nan; Yang, Yaping; Janbon, Guilhem; Pan, Jiao; Zhu, Xudong			Identification and Functional Demonstration of miRNAs in the Fungus Cryptococcus neoformans	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; RNA INTERFERENCE; MICRORNAS; GENE; LACCASE; BIOGENESIS; MECHANISMS; EXPRESSION; VIRULENCE; PATHWAYS	microRNAs (miRNAs), endogenous posttranscriptional repressors by base-pairing of their cognate mRNAs in plants and animals, have mostly been thought lost in the kingdom of fungi. Here, we report the identification of miRNAs from the fungus Cryptococcus neoformans. With bioinformatics and Northern blotting approaches, we found that these miRNAs and their hairpin precursors were present in this fungus. The size of miR1 and miR2 is 22 nt and 18 nt, respectively. The precursors are about similar to 70 nt in length that is close to mammalian pre-miRNAs. Characteristic features of miRNAs are also found in miR1/2. We demonstrated that the identified miRNAs, miR1 and miR2, caused transgene silencing via the canonical RNAi pathway. Bioinformantics analysis helps to reveal a number of identical sequences of the miR1/2 in transposable elements (TEs) and pseudogenes, prompting us to think that fungal miRNAs might be involved in the regulation of the activity of transposons and the expression of pseudogenes. This study identified functional miRNAs in C. neoformans, and sheds light on the diversity and evolutionary origin of eukaryotic miRNAs.	[Jiang, Nan; Yang, Yaping; Pan, Jiao; Zhu, Xudong] Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China; [Jiang, Nan] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Janbon, Guilhem] Inst Pasteur, Dept Mol Mycol, Paris, France	Nankai University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zhu, XD (corresponding author), Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China.	Xudong82@nankai.edu.cn	yang, yaping/AAQ-8228-2020; Janbon, Guilhem/AAW-7398-2021; Janbon, Guilhem/AAL-6607-2021; JIANG, NAN/AHB-1945-2022	Janbon, Guilhem/0000-0002-4788-1154; 	Natural Science Foundation of China (NSFC) [30770043]; National Basic Research Program ("973'' Program) [2007CB707801]; National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI47087]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI047087] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program ("973'' Program)(National Basic Research Program of China); National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported, in part, by Natural Science Foundation of China (NSFC Grant #30770043), and a National Basic Research Program ("973'' Program #2007CB707801). The authors also acknowledge use of the C. neoformans Genome Project, Stanford Genome Technology Center (http://www-sequence.standford.edu), funded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health under cooperative agreement AI47087. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benfey PN, 2003, SCIENCE, V425, P244; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Drivinya Antra, 2004, Nihon Ishinkin Gakkai Zasshi, V45, P1, DOI 10.3314/jjmm.45.1; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Janbon G, 2010, FUNGAL GENET BIOL, V47, P1070, DOI 10.1016/j.fgb.2010.10.005; Jiang N, 2009, APPL ENVIRON MICROB, V75, P6777, DOI 10.1128/AEM.00708-09; Jiang N, 2009, FEMS MICROBIOL LETT, V296, P84, DOI 10.1111/j.1574-6968.2009.01619.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Liu H, 2002, GENETICS, V160, P463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Swami M, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2834; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wickes B.L., 1994, MOL BIOL PATHOGENIC, P309; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Yu SW, 2010, PLANT MOL BIOL REP, V28, P502, DOI 10.1007/s11105-009-0175-3; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004; Zhu XD, 2003, MOL MICROBIOL, V50, P1271, DOI 10.1046/j.1365-2958.2003.03752.x	44	52	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52734	10.1371/journal.pone.0052734	http://dx.doi.org/10.1371/journal.pone.0052734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300755	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800135
J	Ng, TP; Niti, M; Yap, KB; Tan, WC				Ng, Tze Pin; Niti, Mathew; Yap, Keng Bee; Tan, Wan Cheng			Curcumins-Rich Curry Diet and Pulmonary Function in Asian Older Adults	PLOS ONE			English	Article							FRESH FRUIT CONSUMPTION; LUNG-FUNCTION DECLINE; 3RD NATIONAL-HEALTH; VITAMIN-E; VENTILATORY FUNCTION; SERUM CAROTENOIDS; NUTRITION; ANTIOXIDANTS; PHARMACOLOGY; SMOKING	Background: Research on the effects of dietary nutrients on respiratory health in human populations have not investigated curcumin, a potent anti-oxidant and anti-inflammatory compound present principally in turmeric used in large amounts in Asian curry meals. Objectives: To examine the association of curry intake with pulmonary function among smokers and non-smokers. Design: The frequency of curry intake, respiratory risk factors and spirometry were measured in a population-based study of 2,478 Chinese older adults aged 55 and above in the Singapore Longitudinal Ageing Studies. Results: Curry intake (at least once monthly) was significantly associated with better FEV1 (b = 0.045 +/- 0.018, p = 0.011) and FEV1/FVC (b = 1.14 +/- 0.52, p = 0.029) in multivariate analyses that controlled simultaneously for gender, age, height, height-squared, smoking, occupational exposure and asthma/COPD history and other dietary or supplementary intakes. Increasing levels of curry intake ('never or rarely', 'occasional', 'often', 'very often') were associated with higher mean adjusted FEV1 (p for linear trend = 0.001) and FEV1/FVC% (p for linear trend = 0.048). Significant effect modifications were observed for FEV1 (curry*smoking interaction, p = 0.028) and FEV1/FVC% (curry* smoking interaction, p = 0.05). There were significantly larger differences in FEV1 and FEV1/FVC% between curry intake and non-curry intake especially among current and past smokers. The mean adjusted FEV1 associated with curry intake was 9.2% higher among current smokers, 10.3% higher among past smokers, and 1.5% higher among non-smokers. Conclusion: The possible role of curcumins in protecting the pulmonary function of smokers should be investigated in further clinical studies.	[Ng, Tze Pin; Niti, Mathew; Yap, Keng Bee; Tan, Wan Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Gerontol Res Programme, Singapore 117595, Singapore; [Ng, Tze Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore; [Niti, Mathew] Minist Hlth, Singapore, Singapore; [Yap, Keng Bee] Alexandra Hosp, Singapore, Singapore; [Tan, Wan Cheng] Univ British Columbia, James Hogg Res Ctr, Heart Lung Inst, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	National University of Singapore; National University of Singapore; Ministry of Health-Singapore; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ng, TP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Gerontol Res Programme, Singapore 117595, Singapore.	pcmngtp@nus.edu.sg			Biomedical Research Council, Agency for Science, Technology and Research in Singapore [03/1/21/17/214, 08/1/21/19/567]	Biomedical Research Council, Agency for Science, Technology and Research in Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by research grants (No. 03/1/21/17/214 and No. 08/1/21/19/567) from the Biomedical Research Council, Agency for Science, Technology and Research in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; AMMON HPT, 1993, J ETHNOPHARMACOL, V38, P113, DOI 10.1016/0378-8741(93)90005-P; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; BRITTON JR, 1995, AM J RESP CRIT CARE, V151, P1383, DOI 10.1164/ajrccm.151.5.7735589; Butland BK, 2000, THORAX, V55, P102, DOI 10.1136/thorax.55.2.102; Carey IM, 1998, AM J RESP CRIT CARE, V158, P728, DOI 10.1164/ajrccm.158.3.9712065; Cook DG, 1997, THORAX, V52, P628, DOI 10.1136/thx.52.7.628; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Grievink L, 2000, AM J RESP CRIT CARE, V161, P790, DOI 10.1164/ajrccm.161.3.9904040; Grievink L, 1998, THORAX, V53, P166, DOI 10.1136/thx.53.3.166; Guenegou A, 2006, THORAX, V61, P320, DOI 10.1136/thx.2005.047373; Hu GZ, 2000, AM J EPIDEMIOL, V151, P975, DOI 10.1093/oxfordjournals.aje.a010141; Kelly Y, 2003, EUR RESPIR J, V21, P664, DOI 10.1183/09031936.03.00055702; Koli K, 2000, CELL GROWTH DIFFER, V11, P221; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Pearson P, 2005, EUR J CLIN NUTR, V59, P1043, DOI 10.1038/sj.ejcn.1602209; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Romieu I, 2001, EPIDEMIOL REV, V23, P268, DOI 10.1093/oxfordjournals.epirev.a000806; Schunemann HJ, 2001, EPIDEMIOL REV, V23, P248, DOI 10.1093/oxfordjournals.epirev.a000805; Schunemann HJ, 2001, AM J RESP CRIT CARE, V163, P1246, DOI 10.1164/ajrccm.163.5.2007135; SCHWARTZ J, 1994, EUR RESPIR J, V7, P1821, DOI 10.1183/09031936.94.07101821; SHAHAR E, 1994, NEW ENGL J MED, V331, P228, DOI 10.1056/NEJM199407283310403; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; SHARP DS, 1994, AM J RESP CRIT CARE, V150, P983, DOI 10.1164/ajrccm.150.4.7921474; SREEJAYAN, 1994, J PHARM PHARMACOL, V46, P1013, DOI 10.1111/j.2042-7158.1994.tb03258.x; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; STRACHAN DP, 1991, THORAX, V46, P624, DOI 10.1136/thx.46.9.624; Suzuki M, 2009, AM J PHYSIOL-LUNG C, V296, pL614, DOI 10.1152/ajplung.90443.2008; Tabak C, 1999, THORAX, V54, P1021, DOI 10.1136/thx.54.11.1021; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49	35	16	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51753	10.1371/journal.pone.0051753	http://dx.doi.org/10.1371/journal.pone.0051753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300564	gold, Green Published			2022-12-25	WOS:000313618800028
J	Ritz, T; Enlow, MB; Schulz, SM; Kitts, R; Staudenmayer, J; Wright, RJ				Ritz, Thomas; Enlow, Michelle Bosquet; Schulz, Stefan M.; Kitts, Robert; Staudenmayer, John; Wright, Rosalind J.			Respiratory Sinus Arrhythmia as an Index of Vagal Activity during Stress in Infants: Respiratory Influences and Their Control	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PULMONARY GAS-EXCHANGE; PERIOD VARIABILITY; PRETERM INFANTS; STILL-FACE; REACTIVITY; ATTENTION; RESPONSES; STABILITY; ADOLESCENTS	Respiratory sinus arrhythmia (RSA) is related to cardiac vagal outflow and the respiratory pattern. Prior infant studies have not systematically examined respiration rate and tidal volume influences on infant RSA or the extent to which infants' breathing is too fast to extract a valid RSA. We therefore monitored cardiac activity, respiration, and physical activity in 23 six-month old infants during a standardized laboratory stressor protocol. On average, 12.6% (range 0-58.2%) of analyzed breaths were too short for RSA extraction. Higher respiration rate was associated with lower RSA amplitude in most infants, and lower tidal volume was associated with lower RSA amplitude in some infants. RSA amplitude corrected for respiration rate and tidal volume influences showed theoretically expected strong reductions during stress, whereas performance of uncorrected RSA was less consistent. We conclude that stress-induced changes of peak-valley RSA and effects of variations in breathing patterns on RSA can be determined for a representative percentage of infant breaths. As expected, breathing substantially affects infant RSA and needs to be considered in studies of infant psychophysiology.	[Ritz, Thomas] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Enlow, Michelle Bosquet; Kitts, Robert] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Enlow, Michelle Bosquet; Kitts, Robert] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schulz, Stefan M.] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany; [Schulz, Stefan M.] Univ Wurzburg, CHFC, D-97070 Wurzburg, Germany; [Staudenmayer, John] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Wright, Rosalind J.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Dept Med,Med Sch, Boston, MA 02115 USA; [Wright, Rosalind J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Southern Methodist University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wurzburg; University of Wurzburg; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ritz, T (corresponding author), So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA.	tritz@smu.edu; michelle.bosquet@childrens.harvard.edu	Ghiami, Zeinab/G-5492-2016; Schulz, Stefan M/E-8737-2010	Schulz, Stefan M/0000-0003-0550-2440; Bosquet Enlow, Michelle/0000-0003-2598-3894	BMBF [01EO1004, R01 HL080674]; Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital;  [R01 HL089761];  [K08MH074588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089761, R01HL080674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH074588] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	During preparation of this manuscript, the authors were supported by R01 HL089761 (TR), K08MH074588 (MBE), BMBF project 01EO1004 (SMS), R01 HL080674 (RJW), and the Program for Behavioral Science, Department of Psychiatry, Boston Children's Hospital (MBE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkon A, 2006, DEV PSYCHOBIOL, V48, P197, DOI 10.1002/dev.20129; Balding DJ, 2004, APPL LONGITUDINAL AN; BALDZER K, 1989, PEDIATR RES, V26, P188, DOI 10.1203/00006450-198909000-00004; Bar-Haim Y, 2000, DEV PSYCHOBIOL, V37, P44, DOI 10.1002/1098-2302(200007)37:1<44::AID-DEV6>3.0.CO;2-7; Bazhenova OV, 2007, INT J PSYCHOPHYSIOL, V63, P64, DOI 10.1016/j.ijpsycho.2006.08.008; Bazhenova OV, 2001, CHILD DEV, V72, P1314, DOI 10.1111/1467-8624.00350; Beauchaine TP, 2001, J ABNORM PSYCHOL, V110, P610, DOI 10.1037//0021-843X.110.4.610; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; BIGGER JT, 1993, J AM COLL CARDIOL, V21, P729, DOI 10.1016/0735-1097(93)90106-B; Brown TE, 2003, J APPL PHYSIOL, V75, P2310; Carroll JL, 2003, J APPL PHYSIOL, V94, P375, DOI 10.1152/japplphysiol.00809.2002; Castro Mario, 2009, Proc Am Thorac Soc, V6, P1, DOI 10.1513/pats.200810-116CB; Chen CL, 2004, J APPL PHYSIOL, V96, P2226, DOI 10.1152/japplphysiol.01037.2003; Cyranowski JM, 2011, PSYCHOSOM MED, V73, P336, DOI 10.1097/PSY.0b013e318213925d; De Geus EJC, 2007, PSYCHOSOM MED, V69, P356, DOI 10.1097/PSY.0b013e318049cc2d; DITTO B, 1990, PSYCHOSOM MED, V52, P610, DOI 10.1097/00006842-199011000-00002; Dubreuil E, 2003, PSYCHOPHYSIOLOGY, V40, P849, DOI 10.1111/1469-8986.00103; DYKES FD, 1986, PEDIATR RES, V20, P301, DOI 10.1203/00006450-198604000-00005; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961, DOI 10.1152/jappl.1983.54.4.961; Eckberg DL, 2009, J APPL PHYSIOL, V106, P1740, DOI 10.1152/japplphysiol.91107.2008; El-Sheikh M, 2005, DEV PSYCHOBIOL, V46, P66, DOI 10.1002/dev.20036; Enlow MB, 2009, PSYCHOSOM MED, V71, P607, DOI 10.1097/PSY.0b013e3181ad1c8b; FOX NA, 1983, PSYCHOPHYSIOLOGY, V20, P481, DOI 10.1111/j.1469-8986.1983.tb03000.x; Gerlach AL, 2006, PSYCHOSOM MED, V68, P331, DOI 10.1097/01.psy.0000203284.53066.4b; Giardino ND, 2003, AM J PHYSIOL-HEART C, V284, pH1585, DOI 10.1152/ajpheart.00893.2002; GIDDENS DP, 1985, J THEOR BIOL, V113, P759, DOI 10.1016/S0022-5193(85)80192-2; Gorman J M, 2000, Am Heart J, V140, P77, DOI 10.1067/mhj.2000.109981; Grossman P, 2004, AM J PHYSIOL-HEART C, V287, pH728, DOI 10.1152/ajpheart.00825.2003; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P702, DOI 10.1111/j.1469-8986.1990.tb03198.x; GROSSMAN P, 1991, PSYCHOPHYSIOLOGY, V28, P201, DOI 10.1111/j.1469-8986.1991.tb00412.x; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Haley DW, 2003, CHILD DEV, V74, P1534, DOI 10.1111/1467-8624.00621; HARPER RM, 1978, SLEEP, V1, P33, DOI 10.1093/sleep/1.1.33; Hayano J, 1996, CIRCULATION, V94, P842, DOI 10.1161/01.CIR.94.4.842; Hill-Soderlund AL, 2008, DEV PSYCHOBIOL, V50, P361, DOI 10.1002/dev.20302; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Holditch-Davis Diane, 2004, J Perinatol, V24, P631, DOI 10.1038/sj.jp.7211150; INUI K, 1993, J NEUROPHYSIOL, V70, P2205, DOI 10.1152/jn.1993.70.6.2205; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Karemaker JM, 2009, J APPL PHYSIOL, V106, P1742, DOI 10.1152/japplphysiol.91107.2008a; KITNEY R I, 1984, Automedica (London), V5, P289; KOIZUMI K, 1981, J AUTONOM NERV SYST, V3, P483, DOI 10.1016/0165-1838(81)90082-5; Longin E, 2005, EARLY HUM DEV, V81, P663, DOI 10.1016/j.earlhumdev.2005.03.015; LOPES OU, 1976, NATURE, V264, P454, DOI 10.1038/264454a0; Lucini D, 2005, HYPERTENSION, V46, P1201, DOI 10.1161/01.HYP.0000185147.32385.4b; Marsh P, 2008, PSYCHOPHYSIOLOGY, V45, P100, DOI 10.1111/j.1469-8986.2007.00603.x; Moore GA, 2004, DEV PSYCHOL, V40, P1068, DOI 10.1037/0012-1649.40.6.1068; Moore GA, 2009, J CHILD PSYCHOL PSYC, V50, P1392, DOI 10.1111/j.1469-7610.2009.02171.x; Oberlander TF, 2010, ALCOHOL CLIN EXP RES, V34, P681, DOI 10.1111/j.1530-0277.2009.01137.x; Overbeek TJM, 2012, BIOL PSYCHOL, V91, P128, DOI 10.1016/j.biopsycho.2012.05.011; Patzak A, 1996, AM J PHYSIOL-REG I, V271, pR1025, DOI 10.1152/ajpregu.1996.271.4.R1025; PEREYRA PM, 1992, J NEUROL SCI, V110, P107, DOI 10.1016/0022-510X(92)90016-E; Porges SW, 1999, PSYCHOPHYSIOLOGY, V36, P14, DOI 10.1017/S004857729997035X; PORGES SW, 1991, ANN NY ACAD SCI, V618, P57, DOI 10.1111/j.1749-6632.1991.tb27237.x; RICHARDS JE, 1994, PSYCHOPHYSIOLOGY, V31, P235, DOI 10.1111/j.1469-8986.1994.tb02212.x; RICHARDS JE, 1991, PSYCHOPHYSIOLOGY, V28, P43, DOI 10.1111/j.1469-8986.1991.tb03385.x; RICHARDS JE, 1989, PSYCHOPHYSIOLOGY, V26, P422, DOI 10.1111/j.1469-8986.1989.tb01944.x; Ritz T, 2005, PSYCHOPHYSIOLOGY, V42, P568, DOI 10.1111/j.1469-8986.2005.00312.x; Ritz T, 2002, PSYCHOPHYSIOLOGY, V39, P546, DOI 10.1017/S0048577202010715; Ritz T, 2001, PSYCHOPHYSIOLOGY, V38, P858, DOI 10.1017/S0048577201000701; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Ritz T, 2009, BIOL PSYCHOL, V80, P158, DOI 10.1016/j.biopsycho.2008.08.003; ROTHER M, 1989, EARLY HUM DEV, V20, P1, DOI 10.1016/0378-3782(89)90068-6; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; Schulz SM, 2009, BEHAV RES METHODS, V41, P1121, DOI 10.3758/BRM.41.4.1121; SLEIGHT P, 1978, CLIN SCI MOL MED, V55, pS381, DOI 10.1042/cs055381s; SNIDMAN N, 1995, PSYCHOPHYSIOLOGY, V32, P199, DOI 10.1111/j.1469-8986.1995.tb02949.x; SPYER KM, 1988, ANN NY ACAD SCI, V533, P350, DOI 10.1111/j.1749-6632.1988.tb37263.x; Steptoe A, 1996, J Cardiovasc Risk, V3, P83, DOI 10.1097/00043798-199602000-00012; STEVENSON M, 1978, DEV PSYCHOBIOL, V11, P393, DOI 10.1002/dev.420110503; THOMPSON CR, 1993, EARLY HUM DEV, V31, P217, DOI 10.1016/0378-3782(93)90197-3; Weinberg MK, 1996, CHILD DEV, V67, P905, DOI 10.2307/1131869; Wilhelm FH, 2004, TECH PAPERS ISA, V449, P317; WITTE H, 1988, PFLUG ARCH EUR J PHY, V412, P442, DOI 10.1007/BF01907565; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2010, BIOL PSYCHOL, V84, P46, DOI 10.1016/j.biopsycho.2010.01.007; Yeragani VK, 2002, BIOL PSYCHIAT, V52, P418, DOI 10.1016/S0006-3223(02)01394-X	81	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52729	10.1371/journal.pone.0052729	http://dx.doi.org/10.1371/journal.pone.0052729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300753	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800133
J	Rokitta, SD; John, U; Rost, B				Rokitta, Sebastian D.; John, Uwe; Rost, Bjoern			Ocean Acidification Affects Redox-Balance and Ion-Homeostasis in the Life-Cycle Stages of Emiliania huxleyi	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; INORGANIC CARBON; ELEVATED CO2; LIGHT; TEMPERATURE; TRANSCRIPTOMICS; PHOTOSYNTHESIS; CALCIFICATION; METABOLISM; PROTEOMICS	Ocean Acidification (OA) has been shown to affect photosynthesis and calcification in the coccolithophore Emiliania huxleyi, a cosmopolitan calcifier that significantly contributes to the regulation of the biological carbon pumps. Its non-calcifying, haploid life-cycle stage was found to be relatively unaffected by OA with respect to biomass production. Deeper insights into physiological key processes and their dependence on environmental factors are lacking, but are required to understand and possibly estimate the dynamics of carbon cycling in present and future oceans. Therefore, calcifying diploid and non-calcifying haploid cells were acclimated to present and future CO2 partial pressures (pCO(2); 38.5 Pa vs. 101.3 Pa CO2) under low and high light (50 vs. 300 mu mol photons m(-2) s(-1)). Comparative microarray-based transcriptome profiling was used to screen for the underlying cellular processes and allowed to follow up interpretations derived from physiological data. In the diplont, the observed increases in biomass production under OA are likely caused by stimulated production of glycoconjugates and lipids. The observed lowered calcification under OA can be attributed to impaired signal-transduction and ion-transport. The haplont utilizes distinct genes and metabolic pathways, reflecting the stage-specific usage of certain portions of the genome. With respect to functionality and energy-dependence, however, the transcriptomic OA-responses resemble those of the diplont. In both life-cycle stages, OA affects the cellular redox-state as a master regulator and thereby causes a metabolic shift from oxidative towards reductive pathways, which involves a reconstellation of carbon flux networks within and across compartments. Whereas signal transduction and ion-homeostasis appear equally OA-sensitive under both light intensities, the effects on carbon metabolism and light physiology are clearly modulated by light availability. These interactive effects can be attributed to the influence of OA and light on the redox equilibria of NAD and NADP, which function as major sensors for energization and stress. This generic mode of action of OA may therefore provoke similar cell-physiological responses in other protists.	[Rokitta, Sebastian D.; John, Uwe; Rost, Bjoern] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Rokitta, SD (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Sebastian.Rokitta@awi.de	john, uwe/S-3009-2016; Rokitta, Sebastian/ABC-6832-2020; Rost, Bjoern/B-4447-2015	john, uwe/0000-0002-1297-4086; Rokitta, Sebastian/0000-0002-7540-9033; Rost, Bjoern/0000-0001-5452-5505	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7) [205150]; European Project on Ocean Acidification (EPOCA) [211384]	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7)(European Research Council (ERC)); European Project on Ocean Acidification (EPOCA)	The work was funded by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7 / 2007 - 2013), grant agreement #205150, and contributes to the European Project on Ocean Acidification (EPOCA), grant agreement 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann A, 2007, CELL RES, V17, P483, DOI 10.1038/cr.2007.49; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Baginsky S, 2010, PLANT PHYSIOL, V152, P402, DOI 10.1104/pp.109.150433; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borchard C, 2011, J EXP MAR BIOL ECOL, V410, P61, DOI 10.1016/j.jembe.2011.10.004; Bustos DM, 2002, FEBS LETT, V530, P169, DOI 10.1016/S0014-5793(02)03455-5; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui LQ, 2010, J APPL PHYCOL, V22, P563, DOI 10.1007/s10811-009-9494-x; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1981, DEEP-SEA RES, V28, P609, DOI 10.1016/0198-0149(81)90121-7; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Eastmond PJ, 2003, CURR OPIN PLANT BIOL, V6, P231, DOI 10.1016/S1369-5266(03)00037-2; Eicks M, 2002, PLANT PHYSIOL, V128, P512, DOI 10.1104/pp.010576; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Fernie AR, 2001, PLANTA, V212, P250, DOI 10.1007/s004250000386; Fiorini S, 2011, AQUAT MICROB ECOL, V64, P221, DOI 10.3354/ame01520; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hanning I, 1999, PLANT PHYSIOL, V119, P1025, DOI 10.1104/pp.119.3.1025; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lam PJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003868; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Mackinder L, 2011, ENV MICROBIOL, P16; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Riebesell U., 2000, NATURE, V407, P634, DOI DOI 10.1038/35030078; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Staats N, 2000, MAR ECOL PROG SER, V193, P261, DOI 10.3354/meps193261; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; Tamoi M, 2011, PHOTOSYNTH RES, V108, P15, DOI 10.1007/s11120-011-9645-1; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Trimborn S, 2007, LIMNOL OCEANOGR, V52, P2285, DOI 10.4319/lo.2007.52.5.2285; Tsuji Y, 2012, PLANT CELL PHYSIOL, V53, P1043, DOI 10.1093/pcp/pcs045; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wallace D, 2006, MS EXCEL PROGRAM DEV; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Xiong YQ, 2009, PLANT CELL PHYSIOL, V50, P1277, DOI 10.1093/pcp/pcp070; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	66	57	59	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52212	10.1371/journal.pone.0052212	http://dx.doi.org/10.1371/journal.pone.0052212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300616	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800058
J	Netto-Ferreira, AL; Birindelli, JLO; de Sousa, LM; Mariguela, TC; Oliveira, C				Netto-Ferreira, Andre Luiz; Olivan Birindelli, Jose Luis; de Sousa, Leandro Melo; Mariguela, Tatiane Casagrande; Oliveira, Claudio			A New Miniature Characid (Ostariophysi: Characiformes: Characidae), with Phylogenetic Position Inferred from Morphological and Molecular Data	PLOS ONE			English	Article							TELEOSTEI CHARACIFORMES; FISHES TELEOSTEI; RESOLUTION	Erythrocharax altipinnis is described from the Serra do Cachimbo, Para, Brazil. The new taxon is distinguished from all of the Characidae genera by having the pelvic bones firmly attached through the isquiatic processes; a nearly triangular hiatus in the musculature covering the anterior chamber of the swim bladder between the first and second pleural ribs (pseudotympanum); the pedunculate, notably expanded and distally compressed teeth in both jaws; circumorbital series represented by antorbital and four infraorbital bones with laterosensory canals not enclosed; a single tooth row in the premaxillary with the teeth perfectly aligned and similar in shape and cusp number; the first three branched dorsal-fin rays distinctly elongate in males; a bright red adipose and caudal fins in life; a conspicuous dark midlateral stripe extending from the opercle to the tip of the median caudal-fin rays; and by the absence of a humeral spot. The phylogenetic position of the new taxon is discussed using morphological and molecular datasets, with conflicting results of both approaches discussed. Additionally, a summarized discussion on the current problems in the Characidae taxonomy is presented and the principal biases in the morphological dataset are also discussed.	[Netto-Ferreira, Andre Luiz; Olivan Birindelli, Jose Luis] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [de Sousa, Leandro Melo] Fed Univ Para, Fac Ciencias Biol, Zool Lab, Altamira, Para, Brazil; [Mariguela, Tatiane Casagrande; Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Para; Universidade de Sao Paulo; Universidade Estadual Paulista	Netto-Ferreira, AL (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	alnferreira@gmail.com	Fapesp, Biota/F-8655-2017; Birindelli, José L.O./AAS-7096-2020; Netto-Ferreira, André/F-7018-2015; de Sousa, Leandro Melo/I-6108-2012; Birindelli, Jose LO/F-4991-2015; Oliveira, Claudio/D-7713-2012	Fapesp, Biota/0000-0002-9887-8449; Birindelli, José L.O./0000-0001-9646-9636; Netto-Ferreira, André/0000-0002-3096-0411; de Sousa, Leandro Melo/0000-0002-0793-9737; Oliveira, Claudio/0000-0002-7010-8880	FAPESP [2010/19088-7, 2010/51250-9, 2010/17999-2, 2010/17009-2]; CNPQ [303854/2009-0]; South American Characiformes Inventory (FAPESP) [2011/50282-7]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); South American Characiformes Inventory (FAPESP)	Authors are financially supported by FAPESP (ALN-F - 2010/19088-7; JLB - 2010/51250-9; TCM - 2010/17999-2; CO - 2010/17009-2), and CNPQ (CO 303854/2009-0). The present contribution was also supported by the South American Characiformes Inventory (FAPESP 2011/50282-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Carvalho MR, 2011, ZOOTAXA, P2946; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Eschmeyer W. N., 2012, SPECIES FAMILY SUBFA; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Langeani F, 2010, NEOTROP ICHTHYOL, V8, P727, DOI 10.1590/S1679-62252010000400004; Lima F. C. T., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Malabarba LR, 1999, P BIOL SOC WASH, V112, P410; Malabarba LR, 2012, ZOOTAXA, P47; Malabarba Luiz R., 1998, P193; Malabarba LR, 2012, COPEIA, P243, DOI 10.1643/CI-11-143; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2011, ZOOTAXA, P1; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mariguela TC, 2012, MOL PHYLOGE IN PRESS; Mattox GMT, 2012, ZOOL J LINN SOC-LOND, V165, P809, DOI 10.1111/j.1096-3642.2012.00830.x; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Nelson JS, 1984, FISHES WORLD; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Orti G, 1996, MOL BIOL EVOL, V13, P556, DOI 10.1093/oxfordjournals.molbev.a025616; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Tagliacollo VA, 2012, MOL PHYLOGENET EVOL, V64, P297, DOI 10.1016/j.ympev.2012.04.007; TAYLOR W R, 1985, Cybium, V9, P107; Weiss FE, 2012, J SYST PALAEONTOL, V10, P73, DOI 10.1080/14772019.2011.565082; WEITZMAN SH, 1988, P BIOL SOC WASH, V101, P444	28	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52098	10.1371/journal.pone.0052098	http://dx.doi.org/10.1371/journal.pone.0052098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300963	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900019
J	Bernal, A; Fernandez, M; Perez, LM; Martin, NS; Galvez, BG				Bernal, Aurora; Fernandez, Maria; Perez, Laura M.; San Martin, Nuria; Galvez, Beatriz G.			Method for Obtaining Committed Adult Mesenchymal Precursors from Skin and Lung Tissue	PLOS ONE			English	Article							STEM-CELLS; ADIPOSE-TISSUE; MULTIPOTENT; BONE; DIFFERENTIATION; IDENTIFICATION; POPULATION; MOUSE; BLOOD; MICE	Aims: The present study reports an easy and efficient method for obtaining adult mesenchymal precursors from different adult mouse tissues. Materials and Methods: We describe the isolation and expansion of mesenchymal precursors from skin and lung by a non-enzymatic method. Skin and lung mesenchymal precursors isolated by a modified explant technique were characterized in vitro by defined morphology and by a specific gene expression profile and surface markers. Results and Conclusions: Our results show that these precursors express stem cell and mesenchymal surface markers as well as epithelial markers. However, they are negative for markers of endothelium, cardiac and skeletal muscle or adipose tissue, indicating that they have initiated commitment to the tissues from which were isolated. These precursors can migrate without any stimulus and in response to stimuli as SDF1, MCP1 and TNF alpha and can be differentiated into epithelial lineages. Based on the properties of these precursors from adult tissues, we propose their use as tools for regenerative biomedicine.	[Bernal, Aurora; Fernandez, Maria; Perez, Laura M.; San Martin, Nuria; Galvez, Beatriz G.] CNIC, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Galvez, BG (corresponding author), CNIC, Madrid, Spain.	bgonzalez@cnic.es	Gálvez, Beatriz G./H-1644-2015; Pérez, Laura M./E-7818-2016; Bernal, Aurora/AAG-1926-2019	Gálvez, Beatriz G./0000-0002-8082-9323; Pérez, Laura M./0000-0003-0649-7778; Bernal, Aurora/0000-0002-5741-7865	Spanish Ministry of Science and Innovation [SAF 2010-15239]; "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation [RYC2009-04669]; Spanish Ministry of Economy and Competition; Pro-CNIC Foundation; FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competition(Spanish Government); Pro-CNIC Foundation; FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry	This study was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2010-15239) to BGG. BGG acknowledges support from the "Ramon y Cajal" tenure track program of the Spanish Ministry of Science and Innovation (RYC2009-04669). The CNIC (Centro Nacional de Investigaciones Cardiovasculares) is supported by the Spanish Ministry of Economy and Competition and the Pro-CNIC Foundation. LMP and AB are supported by FPI (Formacion de Personal Investigador) fellowships from the Spanish Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barrandon Y, 2012, SEMIN CELL DEV BIOL; Bernal A, 2012, CELL DEATH DIFFER, V19, P345, DOI 10.1038/cdd.2011.110; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2010, HUM GENE THER, V21, P1057, DOI 10.1089/hum.2010.136; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carmeliet P, 1997, AM J PHYSIOL-HEART C, V273, pH2091, DOI 10.1152/ajpheart.1997.273.5.H2091; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hegab AE, 2010, STEM CELLS DEV, V19, P523, DOI 10.1089/scd.2009.0287; Hunt DPJ, 2009, CURR OPIN BIOTECH, V20, P522, DOI 10.1016/j.copbio.2009.10.004; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Minasi MG, 2002, DEVELOPMENT, V129, P2773; NAKAHARA H, 1991, EXP CELL RES, V195, P492, DOI 10.1016/0014-4827(91)90401-F; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sellheyer K, 2010, J AM ACAD DERMATOL, V63, P93, DOI 10.1016/j.jaad.2009.07.013; Snippert HJ, 2010, SCIENCE; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	41	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53215	10.1371/journal.pone.0053215	http://dx.doi.org/10.1371/journal.pone.0053215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300894	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600071
J	Bhattacharjee, RB; Bag, J				Bhattacharjee, Rumpa Biswas; Bag, Jnanankur			Depletion of Nuclear Poly(A) Binding Protein PABPN1 Produces a Compensatory Response by Cytoplasmic PABP4 and PABP5 in Cultured Human Cells	PLOS ONE			English	Article							POLY(A)-BINDING PROTEIN; MESSENGER-RNA; TAIL LENGTH; APOPTOSIS; P53; PHOSPHORYLATION; TRANSCRIPTION; ACETYLATION; POLYMERASE; CLEAVAGE	Background: In vertebrates, poly(A) binding protein (PABP) is known to exist in five different isoforms. PABPs are primarily cytosolic with the exception of the nuclear PABP (PABPN1), which is located in the nucleus. Within the nucleus, PABPN1 is believed to bind to the poly(A) tail of nascent mRNA and along with cleavage and polyadenylation specificity factor (CPSF) define the length of the newly synthesized poly(A) tail. Methodology/Principal Findings: The cellular role of PABP1 has been extensively studied over the years; however, the function of other PABPs remains poorly defined. In order to understand the role of PABPN1 in cellular mRNA metabolism and it's interrelation with other PABPs, we depleted PABPN1 using RNAi in HeLa and HEK293 cells. Our results show that PABPN1 depletion did not have any effect on the poly(A) tail length, nuclear export of mRNA, mRNA translation, and transcription. Rather, PABPN1 depletion resulted in a compensatory response as observed by increased level of PABP5 and nuclear accumulation of PABP4. In addition, PABP4 was associated with the poly(A) tract of pre-mRNA and CPSF in PABPN1 depleted cells. Nevertheless, PABPN1 depletion significantly affected cell survival as evidenced by an increase in apoptosis markers: phosphorylated p53 and PUMA and as judged by the expression of ER stress marker GRP78. Conclusion: Our results suggest that although function of PABPN1 may be compensated by nuclear translocation of PABP4 and perhaps by increase in the cytoplasmic abundance of PABP5, these were not sufficient to prevent apoptosis of cells. Thus PABPN1 may have a novel anti apoptotic role in mammalian cells.	[Bhattacharjee, Rumpa Biswas; Bag, Jnanankur] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Bag, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jbag@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study has been funded by The Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bhattacharjee RB, 2012, CELL BIOL INT, V36, P697, DOI 10.1042/CBI20110348; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Burgess H, 2004, J CELL SCI, V124, P3344; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lemay JF, 2010, MOL CELL, V37, P447, DOI 10.1016/j.molcel.2010.01.029; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Salles FJ, 1999, METH MOL B, V118, P441; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V409, P171, DOI 10.1016/j.bbrc.2011.04.094; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V408, P375, DOI 10.1016/j.bbrc.2011.04.003	37	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53036	10.1371/journal.pone.0053036	http://dx.doi.org/10.1371/journal.pone.0053036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300856	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872600052
J	Fuchs, JE; Huber, RG; Von Grafenstein, S; Wallnoefer, HG; Spitzer, GM; Fuchs, D; Liedl, KR				Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Fuchs, Dietmar; Liedl, Klaus R.			Dynamic Regulation of Phenylalanine Hydroxylase by Simulated Redox Manipulation	PLOS ONE			English	Article							RESOLUTION CRYSTAL-STRUCTURES; CATALYTIC DOMAIN; SERUM PHENYLALANINE; MOLECULAR MOTIONS; OXIDATIVE STRESS; STRUCTURAL BASIS; ACTIVATION; TETRAHYDROBIOPTERIN; PHENYLKETONURIA; ACID	Recent clinical studies revealed increased phenylalanine levels and phenylalanine to tyrosine ratios in patients suffering from infection, inflammation and general immune activity. These data implicated down-regulation of activity of phenylalanine hydroxylase by oxidative stress upon in vivo immune activation. Though the structural damage of oxidative stress is expected to be comparably small, a structural rationale for this experimental finding was lacking. Hence, we investigated the impact of side chain oxidation at two vicinal cysteine residues on local conformational flexibility in the protein by comparative molecular dynamics simulations. Analysis of backbone dynamics revealed a highly flexible loop region (Tyr138-loop) in proximity to the active center of phenylalanine hydroxylase. We observed elevated loop dynamics in connection with a loop movement towards the active site in the oxidized state, thereby partially blocking access for the substrate phenylalanine. These findings were confirmed by extensive replica exchange molecular dynamics simulations and serve as a first structural explanation for decreased enzyme turnover in situations of oxidative stress.	[Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; [Fuchs, Julian E.; Huber, Roland G.; Von Grafenstein, Susanne; Wallnoefer, Hannes G.; Spitzer, Gudrun M.; Liedl, Klaus R.] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Medical University of Innsbruck	Liedl, KR (corresponding author), Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria.	Klaus.Liedl@uibk.ac.at	Liedl, Klaus/ABB-4725-2021; Fuchs, Dietmar/AAL-8011-2021; Huber, Roland G/AAG-6353-2019; Liedl, Klaus R/F-3099-2015	Liedl, Klaus/0000-0002-0985-2299; Fuchs, Dietmar/0000-0003-1627-9563; Huber, Roland G/0000-0001-5093-5988; Liedl, Klaus R/0000-0002-0985-2299	Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase" [P23051]; DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck; Austrian Science Fund (FWF) [P 23051] Funding Source: researchfish	Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase"(Austrian Science Fund (FWF)); DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research of the manuscript was supported by funding of the Austrian Science Fund FWF: project "Targeting Influenza Neuraminidase" (P23051). Julian E. Fuchs is a recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Institute of General, Inorganic and Theoretical Chemistry at University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABITA JP, 1976, J BIOL CHEM, V251, P5310; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; Andersen OA, 2001, J MOL BIOL, V314, P279, DOI 10.1006/jmbi.2001.5061; [Anonymous], 2008, AMBER 10; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Cerreto M, 2011, BBA-MOL BASIS DIS, V1812, P1435, DOI 10.1016/j.bbadis.2011.07.012; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Eisensmith RC, 1996, PEDIATRICS, V97, P512; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 2003, PEDIATRICS, V112, P1557; Erlandsen H, 2002, J MOL BIOL, V320, P645, DOI 10.1016/S0022-2836(02)00496-5; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Folling A., 1934, Z PHYSL CHEM, V227, P169; Frisch M., 2016, GAUSSIAN 16 REVISION; Fuchs J E, 2011, PTERIDINES, V22, P31; Fuchs JE, 2012, PTERIDINES, V23, P57; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAUFMAN S, 1975, NEW ENGL J MED, V293, P785, DOI 10.1056/NEJM197510162931601; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kirchmair J, 2008, J MED CHEM, V51, P7021, DOI 10.1021/jm8005977; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; KOIZUMI S, 1987, BIOCHEMISTRY-US, V26, P6461, DOI 10.1021/bi00394a025; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Miranda FF, 2004, PROTEIN SCI, V13, P1219, DOI 10.1110/ps.03595904; Miranda FF, 2002, J BIOL CHEM, V277, P40937, DOI 10.1074/jbc.M112197200; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Murr C, 1999, INCREASED NEOPTERIN; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Neurauter G, 2008, CANCER LETT, V272, P141, DOI 10.1016/j.canlet.2008.07.002; Olsson E, 2011, EUR J INORG CHEM, P2720, DOI 10.1002/ejic.201001218; Olsson E, 2011, CHEM-EUR J, V17, P3746, DOI 10.1002/chem.201002910; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; Ribas GS, 2011, CELL MOL NEUROBIOL, V31, P653, DOI 10.1007/s10571-011-9693-2; Ronau JA, 2012, CRYSTALLOGR IN PRESS; ROSENBLATT D, 1968, NATURE, V218, P677, DOI 10.1038/218677a0; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; SHIMAN R, 1982, J BIOL CHEM, V257, P1213; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Sura GR, 2006, BIOCHEMISTRY-US, V45, P9632, DOI 10.1021/bi060754b; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Teigen K, 2003, J BIOMOL STRUCT DYN, V20, P733, DOI 10.1080/07391102.2003.10506889; Teigen K, 2007, CURR MED CHEM, V14, P455, DOI 10.2174/092986707779941023; Van Gool AR, 2004, ANTI-CANCER DRUG, V15, P587, DOI 10.1097/01.cad.0000132230.51759.8d; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	73	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53005	10.1371/journal.pone.0053005	http://dx.doi.org/10.1371/journal.pone.0053005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300845	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600046
J	Hwang, I; Scott, JM; Kakarla, T; Duriancik, DM; Choi, S; Cho, C; Lee, T; Park, H; French, AR; Beli, E; Gardner, E; Kim, S				Hwang, Ilwoong; Scott, Jeannine M.; Kakarla, Tejaswi; Duriancik, David M.; Choi, Seohyun; Cho, Chunghwan; Lee, Taehyung; Park, Hyojin; French, Anthony R.; Beli, Eleni; Gardner, Elizabeth; Kim, Sungjin			Activation Mechanisms of Natural Killer Cells during Influenza Virus Infection	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; HUMAN NK CELLS; DENDRITIC CELLS; CUTTING EDGE; STAT4 ACTIVATION; IMMUNE-RESPONSES; MEDIATED CYTOTOXICITY; ANTIVIRAL DEFENSE; DISTINCT ROLES; ALPHA-BETA	During early viral infection, activation of natural killer (NK) cells elicits the effector functions of target cell lysis and cytokine production. However, the cellular and molecular mechanisms leading to NK cell activation during viral infections are incompletely understood. In this study, using a model of acute viral infection, we investigated the mechanisms controlling cytotoxic activity and cytokine production in response to influenza (flu) virus. Analysis of cytokine receptor deficient mice demonstrated that type I interferons (IFNs), but not IL-12 or IL-18, were critical for the NK cell expression of both IFN-gamma and granzyme B in response to flu infection. Further, adoptive transfer experiments revealed that NK cell activation was mediated by type I IFNs acting directly on NK cells. Analysis of signal transduction molecules showed that during flu infection, STAT1 activation in NK cells was completely dependent on direct type I IFN signaling, whereas STAT4 activation was only partially dependent. In addition, granzyme B induction in NK cells was mediated by signaling primarily through STAT1, but not STAT4, while IFN-gamma production was mediated by signaling through STAT4, but not STAT1. Therefore, our findings demonstrate the importance of direct action of type I IFNs on NK cells to mount effective NK cell responses in the context of flu infection and delineate NK cell signaling pathways responsible for controlling cytotoxic activity and cytokine production.	[Hwang, Ilwoong; Scott, Jeannine M.; Kakarla, Tejaswi; Choi, Seohyun; Cho, Chunghwan; Lee, Taehyung; Park, Hyojin; Kim, Sungjin] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Duriancik, David M.; Beli, Eleni; Gardner, Elizabeth] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [French, Anthony R.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Rheumatol, St Louis, MO 63110 USA	Michigan State University; Michigan State University; Washington University (WUSTL)	Kim, S (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	kimsj@msu.edu	Beli, Eleni/AAL-7433-2020	Beli, Eleni/0000-0003-1889-640X	National Institute on Aging [5R01AG034949]; Korea Research Council of Fundamental Science & Technology in Republic of Korea; NATIONAL INSTITUTE ON AGING [R01AG034949] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Korea Research Council of Fundamental Science & Technology in Republic of Korea; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging, 5R01AG034949 to EG and National Agenda Project grant from the Korea Research Council of Fundamental Science & Technology in Republic of Korea to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barr DP, 2007, EUR J IMMUNOL, V37, P1334, DOI 10.1002/eji.200636362; Beli E, 2011, MECH AGEING DEV, V132, P503, DOI 10.1016/j.mad.2011.08.005; Bertoletti A, 2011, GUT; Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; BLOOMFIELD SE, 1980, OPHTHALMOLOGY, V87, P1226; BRUTKIEWICZ RR, 1992, NAT IMMUN, V11, P203; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chen Y, 2005, J VIRAL HEPATITIS, V12, P38, DOI 10.1111/j.1365-2893.2005.00543.x; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Farrell HE, 1999, IMMUNOL REV, V168, P187, DOI 10.1111/j.1600-065X.1999.tb01293.x; Fawaz LM, 1999, J IMMUNOL, V163, P4473; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geurs TL, 2009, J IMMUNOL, V183, P5830, DOI 10.4049/jimmunol.0901520; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hansen ML, 2011, MOL IMMUNOL, V48, P2087, DOI 10.1016/j.molimm.2011.07.008; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kida K, 2000, PEDIATR INT, V42, P631, DOI 10.1046/j.1442-200x.2000.01315.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; KUNDER SC, 1993, ANN NY ACAD SCI, V685, P618, DOI 10.1111/j.1749-6632.1993.tb35926.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Lesinski GB, 2003, J CLIN INVEST, V112, P170, DOI 10.1172/JCI200316603; Liang SJ, 2003, CYTOKINE, V23, P190, DOI 10.1016/S1043-4666(03)00226-6; Liu BX, 2003, MICROB PATHOGENESIS, V34, P161, DOI 10.1016/S0882-4010(02)00191-2; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mack EA, 2011, MBIO, V2, DOI 10.1128/mBio.00169-11; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Miyagi T, 2010, METHODS MOL BIOL, V612, P159, DOI 10.1007/978-1-60761-362-6_11; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Reading PC, 2007, J IMMUNOL, V179, P3214, DOI 10.4049/jimmunol.179.5.3214; SANTOLI D, 1978, J IMMUNOL, V121, P532; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1978, J IMMUNOL, V120, P1849; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang KS, 1999, J IMMUNOL, V162, P299; Zhang C, 2008, CYTOKINE, V42, P128, DOI 10.1016/j.cyto.2008.01.003; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015	80	45	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51858	10.1371/journal.pone.0051858	http://dx.doi.org/10.1371/journal.pone.0051858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300570	gold, Green Submitted, Green Published			2022-12-25	WOS:000313872600009
J	Ji, GY; Zhang, YP; Yang, QH; Cheng, SB; Hao, J; Zhao, XH; Jiang, ZQ				Ji, Guiyuan; Zhang, Yupei; Yang, Qinhe; Cheng, Shaobin; Hao, Jing; Zhao, Xihong; Jiang, Zhuoqin			Genistein Suppresses LPS-Induced Inflammatory Response through Inhibiting NF-kappa B following AMP Kinase Activation in RAW 264.7 Macrophages	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; PROSTATE-CANCER CELLS; PROTEIN-KINASE; INSULIN-RESISTANCE; SIGNALING PATHWAY; SOY ISOFLAVONES; METABOLISM; APOPTOSIS; STRESS; PLASMA	Genistein, the major isoflavone in soybean, was recently reported to exert beneficial effects in metabolic disorders and inflammatory diseases. In the present study, we investigated the effects and mechanisms of a dietary concentration of genistein on the inflammatory response in lipopolysaccharide (LPS)-treated RAW 264.7 macrophages. Our results demonstrated that genistein effectively inhibited the LPS-induced overproduction of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6), as well as LPS-induced nuclear factor kappa B (NF-kappa B) activation. In addition, the data also showed that genistein prevented LPS-induced decrease in adenosine monophosphate-activated protein kinase (AMPK) phosphorylation. These effects were obviously attenuated by an AMPK inhibitor. Taken together, our results suggest that the dietary concentration of genistein is able to attenuate inflammatory responses via inhibition of NF-kappa B activation following AMPK stimulation. The data provide direct evidence for the potential application of low concentrations of genistein in the prevention and treatment of inflammatory diseases.	[Ji, Guiyuan] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ji, Guiyuan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhang, Yupei; Yang, Qinhe; Cheng, Shaobin] Jinan Univ, Dept Tradit Chinese Med, Coll Med, Guangzhou, Guangdong, Peoples R China; [Hao, Jing] Guangxi Bot Garden Med Plant, Nanning, Peoples R China; [Zhao, Xihong] Wuhan Inst Technol, Key Lab Green Chem Proc, Minist Educ, Sch Chem Engn & Pharm, Wuhan, Peoples R China; [Ji, Guiyuan; Jiang, Zhuoqin] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Jinan University; Wuhan Institute of Technology; Sun Yat Sen University	Jiang, ZQ (corresponding author), Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	jiangzhq@mail.sysu.edu.cn			Guangdong Natural Science Foundation [10151008901000063]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The study was supported by Guangdong Natural Science Foundation (10151008901000063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu PVA, 2012, J NUTR, V142, P724, DOI 10.3945/jn.111.152322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cederroth CR, 2008, DIABETES, V57, P1176, DOI 10.2337/db07-0630; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Choi C, 2003, BIOSCI BIOTECH BIOCH, V67, P1916, DOI 10.1271/bbb.67.1916; Dalmas E, 2012, ADIPOSE TISSUE BIOL, P167; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Hsu MH, 2011, J PHARMACOL EXP THER, V337, P125, DOI 10.1124/jpet.110.175851; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Ji G, 2011, INT IMMUNOPHARMACOLO; Kang JL, 2001, AM J RESP CRIT CARE, V164, P2206, DOI 10.1164/ajrccm.164.12.2104017; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; King RA, 1998, AM J CLIN NUTR, V67, P867, DOI 10.1093/ajcn/67.5.867; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lahti Aleksi, 2006, BMC Pharmacology, V6, P5, DOI 10.1186/1471-2210-6-5; Li YW, 2002, CLIN CANCER RES, V8, P2369; Misra P, 2008, AMP ACTIVATED PROTEI; Park CE, 2010, J MED FOOD, V13, P815, DOI 10.1089/jmf.2009.1359; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, P1; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sheu F, 2001, J AGR FOOD CHEM, V49, P1767, DOI 10.1021/jf001198+; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Squadrito F, 2002, ATHEROSCLEROSIS, V163, P339, DOI 10.1016/S0021-9150(02)00013-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu X, 1995, BIOAVAILABILITY SOYB, P2307; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	40	99	104	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53101	10.1371/journal.pone.0053101	http://dx.doi.org/10.1371/journal.pone.0053101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300870	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872600058
J	Oyanagi, J; Ogawa, T; Sato, H; Higashi, S; Miyazaki, K				Oyanagi, Jun; Ogawa, Takashi; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru			Epithelial-Mesenchymal Transition Stimulates Human Cancer Cells to Extend Microtubule-based Invasive Protrusions and Suppresses Cell Growth in Collagen Gel	PLOS ONE			English	Article							TGF-BETA; E-CADHERIN; K-RAS; PROTEIN; EXPRESSION; TAU; INVADOPODIA; PLASTICITY; TGF-BETA-1; PODOSOMES	Epithelial-mesenchymal transition (EMT) is a crucial event in tumor invasion and metastasis. However, most of past EMT studies have been conducted in the conventional two-dimensional (2D) monolayer culture. Therefore, it remains unclear what invasive phenotypes are acquired by EMT-induced cancer cells. To address this point, we attempted to characterize EMT cells in more physiological, three-dimensional (3D) collagen gel culture. EMT was induced by treating three human carcinoma cell lines (A549, Panc-1 and MKN-1) with TGF-beta. The TGF-beta treatment stimulated these cells to overexpress the invasion markers laminin gamma 2 and MT1-MMP in 2D culture, in addition to the induction of well-known morphological change and EMT marker expression. EMT induction enhanced cell motility and adhesiveness to fibronectin and collagen in 2D culture. Although EMT cells showed comparable cell growth to control cells in 2D culture, their growth rates were extremely suppressed in soft agar and collagen gel cultures. Most characteristically, EMT-induced cancer cells commonly and markedly extended invasive protrusions in collagen gel. These protrusions were mainly supported by microtubules rather than actin cytoskeleton. Snail-introduced, stable EMT cells showed similar protrusions in 3D conditions without TGF-beta. Moreover, these protrusions were suppressed by colchicine or inhibitors of heat shock protein 90 (HSP-90) and protein phosphatase 2A. However, MMP inhibitors did not suppress the protrusion formation. These data suggest that EMT enhances tumor cell infiltration into interstitial stroma by extending microtubule-based protrusions and suppressing cell growth. The elevated cell adhesion to fibronectin and collagen and high cell motility also seem important for the tumor invasion.	[Oyanagi, Jun; Ogawa, Takashi; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan; [Oyanagi, Jun; Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Universi, Div Cell Biol, Kihara Inst Biol Res, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University	Miyazaki, K (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23112517, 23300351]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (23112517 and 23300351) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/english/e-grants/index.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; ANZANO MA, 1983, P NATL ACAD SCI-BIOL, V80, P6264, DOI 10.1073/pnas.80.20.6264; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bakin AV, 2002, J CELL SCI, V115, P3193; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; HOWE PH, 1993, J BIOL CHEM, V268, P21448; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; ITO M, 1992, JPN J CANCER RES, V83, P86, DOI 10.1111/j.1349-7006.1992.tb02356.x; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kikuchi K, 2008, CANCER SCI, V99, P2252, DOI 10.1111/j.1349-7006.2008.00927.x; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matrone MA, 2010, ONCOGENE, V29, P3217, DOI 10.1038/onc.2010.68; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsubota Y, 2010, INT J CANCER, V127, P2031, DOI 10.1002/ijc.25231; VALVERIUS EM, 1989, CANCER RES, V49, P6269; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Whipple RA, 2007, EXP CELL RES, V313, P1326, DOI 10.1016/j.yexcr.2007.02.001; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279	48	51	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53209	10.1371/journal.pone.0053209	http://dx.doi.org/10.1371/journal.pone.0053209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300891	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600069
J	Clark, KB; Noisakran, S; Onlamoon, N; Hsiao, HM; Roback, J; Villinger, F; Ansari, AA; Perng, GC				Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Roback, John; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen			Multiploid CD61+Cells Are the Pre-Dominant Cell Lineage Infected during Acute Dengue Virus Infection in Bone Marrow	PLOS ONE			English	Article							IN-VITRO; MONONUCLEAR PHAGOCYTES; HUMAN MEGAKARYOCYTES; HEMORRHAGIC-FEVER; GUINEA-PIGS; BLOOD; EXPRESSION; PLATELETS; DIFFERENTIATION; THROMBOPOIETIN	Depression of the peripheral blood platelet count during acute infection is a hallmark of dengue. This thrombocytopenia has been attributed, in part, to an insufficient level of platelet production by megakaryocytes that reside in the bone marrow (BM). Interestingly, it was observed that dengue patients experience BM suppression at the onset of fever. However, few studies focus on the interaction between dengue virus (DENV) and megakaryocytes and how this interaction can lead to a reduction in platelets. In the studies reported herein, BM cells from normal healthy rhesus monkeys (RM) and humans were utilized to identify the cell lineage(s) that were capable of supporting virus infection and replication. A number of techniques were employed in efforts to address this issue. These included the use of viral RNA quantification, nonstructural protein and infectivity assays, phenotypic studies utilizing immunohistochemical staining, anti-differentiation DEAB treatment, and electron microscopy. Cumulative results from these studies revealed that cells in the BM were indeed highly permissive for DENV infection, with human BM having higher levels of viral production compared to RM. DENV-like particles were predominantly observed in multi-nucleated cells that expressed CD61+. These data suggest that megakaryocytes are likely the predominant cell type infected by DENV in BM, which provides one explanation for the thrombocytopenia and the dysfunctional platelets characteristic of dengue virus infection.	[Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Clark, Kristina B.; Noisakran, Sansanee; Onlamoon, Nattawat; Hsiao, Hui-Mien; Villinger, Francois; Ansari, Aftab A.; Perng, Guey Chuen] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Onlamoon, Nattawat] Mahidol Univ, Off Res & Dev, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Roback, John] Emory Univ, Ctr Emory Bone Marrow Transplant Ctr, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Perng, Guey Chuen] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	Emory University; Emory University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Emory University; Emory University; National Cheng Kung University	Perng, GC (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	gperng@emory.edu	Noisakran, Sansanee/H-5186-2011; Onlamoon, Nattawat/AAR-8390-2020; Clark, Kristina/G-2821-2016	Noisakran, Sansanee/0000-0002-9336-3331; Clark, Kristina/0000-0002-8829-9793; Onlamoon, Nattawat/0000-0002-8784-3005; Perng, Oscar/0000-0001-7510-4486	U19 Pilot Project Funds [U19 AI057266, RFA-AI-02-042]; National Institutes of Health/SERCEB; Emory URC grants; HHMI Grad-into-Med program fund; NCRR [DRR000165]; National Science Council [NSC99-2321-B006-008]; Center of Infectious Disease and Signaling Research, NCKU, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	U19 Pilot Project Funds; National Institutes of Health/SERCEB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory URC grants; HHMI Grad-into-Med program fund; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Council(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, NCKU, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported in part by the U19 Pilot Project Funds U19 AI057266 (RFA-AI-02-042), National Institutes of Health/SERCEB, Emory URC grants, HHMI Grad-into-Med program fund, the NCRR p51 support to the Yerkes National Primate Research Center DRR000165, and the National Science Council (NSC99-2321-B006-008) with the Center of Infectious Disease and Signaling Research, NCKU, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P46, DOI 10.1111/j.1574-695X.2008.00399.x; BESSMAN JD, 1984, AM J HEMATOL, V16, P161, DOI 10.1002/ajh.2830160208; BIERMAN HR, 1965, ANN INTERN MED, V62, P867, DOI 10.7326/0003-4819-62-5-867; Boukour S, 2006, J THROMB HAEMOST, V4, P426, DOI 10.1111/j.1538-7836.2006.01749.x; Butthep P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P246; CARBALLAL G, 1977, J INFECT DIS, V135, P367, DOI 10.1093/infdis/135.3.367; CARBALLAL G, 1981, J INFECT DIS, V143, P7, DOI 10.1093/infdis/143.1.7; CASSEL DL, 1993, MOL IMMUNOL, V30, P451, DOI 10.1016/0161-5890(93)90113-P; DALTON AJ, 1961, J NATL CANCER I, V27, P747; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Gubler DJ, 1997, DENGUE DENGUE HEMORR; HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hathirat P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P80; Institute of Laboratory Animal Research CoLS National Research Council, 1996, GUID CAR US LAB AN; JACOBS MG, 1991, BRIT MED J, V302, P828, DOI 10.1136/bmj.302.6780.828; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Kho L K, 1972, Paediatr Indones, V12, P31; Kim JA, 2002, STEM CELLS, V20, P402, DOI 10.1634/stemcells.20-5-402; LARRAMENDY ML, 1994, BRIT J HAEMATOL, V86, P203, DOI 10.1111/j.1365-2141.1994.tb03279.x; LEVINE RF, 1980, BRIT J HAEMATOL, V45, P487, DOI 10.1111/j.1365-2141.1980.tb07168.x; MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23; Marianneau P, 1998, CLIN DIAGN VIROL, V10, P113, DOI 10.1016/S0928-0197(98)00031-2; Mosquera JA, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-26; Murgue B, 1997, J INFECT DIS, V175, P1497, DOI 10.1086/516486; NAKAO S, 1989, BLOOD, V74, P1235; NANAKORN S, 1966, B WORLD HEALTH ORGAN, V35, P54; NELSON ER, 1964, JAMA-J AM MED ASSOC, V190, P99; Noisakran S, 2012, EXP HEMATOL, V40, P250, DOI 10.1016/j.exphem.2011.11.011; Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253; Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990; Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67; Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503; RUSSELL PK, 1967, J IMMUNOL, V99, P285; STENBERG PE, 1989, BLOOD CELLS, V15, P23; Tsai JJ, 2012, THER ADV HEMATOL, V3, P59, DOI 10.1177/2040620711417660; Tsai JJ, 2011, J INNATE IMMUN, V3, P530, DOI 10.1159/000322904; WONG KF, 1991, AM J HEMATOL, V38, P339, DOI 10.1002/ajh.2830380420; Wu ZH, 1996, THROMB HAEMOSTASIS, V75, P661; ZUCKERFRANKLIN D, 1989, P NATL ACAD SCI USA, V86, P5595, DOI 10.1073/pnas.86.14.5595	42	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52902	10.1371/journal.pone.0052902	http://dx.doi.org/10.1371/journal.pone.0052902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300812	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100093
J	Tang, XM; Han, FT; Zhao, K; Xu, Y; Wu, X; Wang, JB; Jiang, LX; Shi, W				Tang, Xueming; Han, Fangting; Zhao, Kai; Xu, Yan; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi; Shi, Wei			A 90-Day Dietary Toxicity Study of Genetically Modified Rice T1C-1 Expressing Cry1C Protein in Sprague Dawley Rats	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; SAFETY; PLANTS; RESISTANCE; BORER; GENE; MOTH; CORN	In a 90-day study, Sprague Dawley rats were fed transgenic T1C-1 rice expressing Cry1C protein and were compared with rats fed non-transgenic parental rice Minghui 63 and rats fed a basal diet. No adverse effects on animal behavior or weight gain were observed during the study. Blood samples were collected and analyzed, and standard hematological and biochemical parameters were compared. A few of these parameters were found to be significantly different, but were within the normal reference intervals for rats of this breed and age, and were thus not considered to be treatment-related. Following sacrifice, a large number of organs were weighed, and macroscopic and histopathological examinations were performed with no changes reported. The aim of this study was to use a known animal model to determine the safety of the genetically modified (GM) rice T1C-1. The results showed no adverse or toxic effects due to T1C-1 rice when tested in this 90-day study.	[Tang, Xueming; Zhao, Kai; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Tang, Xueming; Zhao, Kai; Wu, Xiao; Wang, Jinbin; Jiang, Lingxi] Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China; [Han, Fangting; Xu, Yan; Shi, Wei] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences; Shanghai Normal University	Zhao, K (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China.	kzhao118@163.com		wang, jinbin/0000-0001-7080-4264	Shanghai Agricultural Science Committee Key Foundation of China [6-4 (2009), 1-8 (2011)]; Shanghai Agricultural Science Key Research Foundation [1-8 (2011)]; Public Research Platform Foundation of SSTC [10DZ2294103]; National Science & Technology Support Programme [2010BAK69B18]; Shanghai Academy of Agricultural Sciences [2012 (9)]	Shanghai Agricultural Science Committee Key Foundation of China; Shanghai Agricultural Science Key Research Foundation; Public Research Platform Foundation of SSTC; National Science & Technology Support Programme; Shanghai Academy of Agricultural Sciences	This work was financially supported by Shanghai Agricultural Science Committee Key Foundation of China, grant no. 6-4 (2009) & 1-8 (2011), Shanghai Agricultural Science Key Research Foundation, grant no. 1-8 (2011), The Public Research Platform Foundation of SSTC, grant no. 10DZ2294103, the National Science & Technology Support Programme, grant no. 2010BAK69B18, and the Shanghai Academy of Agricultural Sciences, grant no. 2012 (9). The authors also thank Experimental Animal Centre of Fudan University and Shanghai Agrobiological Gene Center, especially Dr. Weiwei Qiao, Dr. Xianzhe Zhao, and Dr. Guolan Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Brake DG, 2004, J AGR FOOD CHEM, V52, P2097, DOI 10.1021/jf0347362; Cao J, 1999, MOL BREEDING, V5, P131, DOI 10.1023/A:1009619924620; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Cheng XY, 1998, P NATL ACAD SCI USA, V95, P2767, DOI 10.1073/pnas.95.6.2767; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; FAO, 1996, 61 FAO UN; FAO/WHO, 2000, SAF ASP GEN MOD FOOD; Gatehouse AMR, 1997, MOL BREEDING, V3, P49, DOI 10.1023/A:1009600321838; Guo Xing, 2010, Journal of Agricultural Biotechnology, V18, P346; High SM, 2004, TRENDS PLANT SCI, V9, P286, DOI 10.1016/j.tplants.2004.04.002; HOFTE H, 1989, MICROBIOL REV, V53, P242; *ILSI, 1996, SAF ASS NOV FOOD GUI; James C., 2004, GLOBAL STATUS COMMER; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; MONETTE R, 1994, J INSECT PHYSIOL, V40, P273, DOI 10.1016/0022-1910(94)90067-1; Oecd, 1993, SAFETY EVALUATION FO; OECD, 1996, FOOD SAF EV; *OECD, 1997, OECD WORKSH TOX NUTR; Papst C, 2005, AGRON J, V97, P219; Poulsen M, 2007, FOOD CHEM TOXICOL, V45, P364, DOI 10.1016/j.fct.2006.09.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SCHARDEIN JL, 1968, PATHOL VET, V5, P238, DOI 10.1177/030098586800500305; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Wang ZH, 2002, J SCI FOOD AGR, V82, P738, DOI 10.1002/jsfa.1105; WHO, 1995, WHO WORKSH; WHO, 1991, STRAT ASS SAF FOODS; Xue JL, 2005, LETT APPL MICROBIOL, V40, P460, DOI 10.1111/j.1472-765X.2005.01712.x; Yuan YF, 2011, J SCI FOOD AGR, V91, P2066, DOI 10.1002/jsfa.4421; 宋立江, 2003, [卫生毒理学杂志, Journal of Health Toxicology], V17, P193	33	14	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52507	10.1371/journal.pone.0052507	http://dx.doi.org/10.1371/journal.pone.0052507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300690	Green Submitted, Green Published, gold			2022-12-25	WOS:000312829100057
J	Urushihara, H; Taketsuna, M; Liu, Y; Oda, E; Nakamura, M; Nishiuma, S; Maeda, R				Urushihara, Hisashi; Taketsuna, Masanori; Liu, Ying; Oda, Eisei; Nakamura, Masaki; Nishiuma, Shinichi; Maeda, Rei			Increased Risk of Acute Pancreatitis in Patients with Type 2 Diabetes: An Observational Study Using a Japanese Hospital Database	PLOS ONE			English	Article							POPULATION-BASED COHORT; ANTIDIABETIC DRUGS; EXENATIDE; EPIDEMIOLOGY; ASSOCIATION; SITAGLIPTIN; MANAGEMENT; GLYBURIDE; THERAPIES; MELLITUS	Background: Increased risks of acute pancreatitis in patients with type 2 diabetes mellitus have been reported recently in several countries. We aimed to estimate the risks of acute pancreatitis in Japanese patients with diabetes mellitus. Methods/Findings: We examined a large-scale hospital administrative database consisting of one million patients in 16 secondary medical care hospitals, from 2003 to 2010. The incidence rates of acute pancreatitis were estimated with cohort design; the odds ratios associated with diabetes mellitus and other comorbid risk factors were estimated with separate case-control analyses. In cohort analysis, the incidence of acute pancreatitis was higher in 14,707 diabetic patients than in 186,032 non-diabetic patients (4.75 vs. 1.65 per 1,000 patient-years) and increased in male patients and as age advanced. The adjusted odds ratio of acute pancreatitis in patients with diabetes mellitus was 1.86 (P<0.001) compared with non-diabetic patients in case-control analysis from 1,372 cases and 5,469 matched controls, which is consistent with the ones reported in previous studies. Alcoholism and gallstones were associated with a large increase in the risk of acute pancreatitis (adjusted odds ratio 13.40 and 14.29, respectively, P<0.001), although dyslipidemia was associated with significant risk reduction (adjusted odds ratio 0.62, P<0.001). Conclusions: This observational study ascertained the elevated incidence rates and risk of acute pancreatitis in Japanese patients with diabetes. The risk estimates in Japanese patients with diabetes were in agreement with the ones reported in previous studies, and the elevated risk of acute pancreatitis in patients with diabetes would be generalized in different locations/populations.	[Urushihara, Hisashi] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan; [Taketsuna, Masanori] Eli Lilly Japan KK, Asia Pacific Stat Sci, Kobe, Hyogo, Japan; [Liu, Ying; Nishiuma, Shinichi; Maeda, Rei] Eli Lilly Japan KK, Global Patient Safety Japan, Kobe, Hyogo, Japan; [Oda, Eisei] Med TOUKEI Corp, Shinjuku Ku, Tokyo, Japan; [Nakamura, Masaki] Med Data Vis Co Ltd, Business Dev Dept, Chiyoda Ku, Tokyo, Japan	Kyoto University; Eli Lilly; Eli Lilly	Urushihara, H (corresponding author), Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan.	urushihara.hisashi.2s@kyoto-u.ac.jp		Urushihara, Hisashi/0000-0001-6913-9930	Pfizer Health Research Foundation [10-8-043]; Eli Lilly Japan	Pfizer Health Research Foundation; Eli Lilly Japan(Eli Lilly)	This study was sponsored by Eli Lilly Japan. HU was supported by the 2011 research grant of Pfizer Health Research Foundation (10-8-043) (http://www.pfizer-zaidan.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2010, ANN PHARMACOTHER, V44, P904, DOI 10.1345/aph.1M676; [Anonymous], 2010, 2010 GUID AC PANCR; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Blomgren KB, 2002, DIABETES CARE, V25, P298, DOI 10.2337/diacare.25.2.298; Dore DD, 2011, DIABETES OBES METAB, V13, P559, DOI 10.1111/j.1463-1326.2011.01376.x; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Eland IA, 2000, SCAND J GASTROENTERO, V35, P1110; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; Floyd A, 2002, SCAND J GASTROENTERO, V37, P1461, DOI 10.1080/003655202762671369; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; Hashikata Hirokuni, 2011, Environmental Health and Preventive Medicine, V16, P313, DOI 10.1007/s12199-010-0201-y; JENSEN E, 1988, EUR J CLIN INVEST, V18, P226, DOI 10.1111/j.1365-2362.1988.tb01250.x; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kingsnorth A, 2006, BMJ-BRIT MED J, V332, P1072, DOI 10.1136/bmj.332.7549.1072; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; Lee Phillip H, 2011, Ann Pharmacother, V45, pe22, DOI 10.1345/aph.1P714; MOREAU JA, 1988, MAYO CLIN PROC, V63, P466, DOI 10.1016/S0025-6196(12)65644-4; Murata A, 2011, PANCREAS, V40, P1018, DOI 10.1097/MPA.0b013e31821bd233; National Statistics Center Statistics Bureau, PORT SIT OFF STAT JA; Nitsche CJ, 2010, BEST PRACT RES CL GA, V24, P143, DOI 10.1016/j.bpg.2010.02.002; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Seino Y, 1995, MED FRONTLINE, V50, P639; Sekimoto M, 2006, J HEPATO-BILIARY-PAN, V13, P10, DOI 10.1007/s00534-005-1047-3; Spranger J, 2011, GASTROENTEROLOGY, V141, P20, DOI 10.1053/j.gastro.2011.05.019; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	31	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53224	10.1371/journal.pone.0053224	http://dx.doi.org/10.1371/journal.pone.0053224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300896	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100129
J	Chou, MF; Prisic, S; Lubner, JM; Church, GM; Husson, RN; Schwartz, D				Chou, Michael F.; Prisic, Sladjana; Lubner, Joshua M.; Church, George M.; Husson, Robert N.; Schwartz, Daniel			Using Bacteria to Determine Protein Kinase Specificity and Predict Target Substrates	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; CASEIN KINASE; MASS-SPECTROMETRY; IN-VITRO; PHOSPHORYLATED INVITRO; ESCHERICHIA-COLI; MOTIFS; IDENTIFICATION; CHANNEL; PHOSPHOPROTEOME	The identification of protein kinase targets remains a significant bottleneck for our understanding of signal transduction in normal and diseased cellular states. Kinases recognize their substrates in part through sequence motifs on substrate proteins, which, to date, have most effectively been elucidated using combinatorial peptide library approaches. Here, we present and demonstrate the ProPeL method for easy and accurate discovery of kinase specificity motifs through the use of native bacterial proteomes that serve as in vivo libraries for thousands of simultaneous phosphorylation reactions. Using recombinant kinases expressed in E. coli followed by mass spectrometry, the approach accurately recapitulated the well-established motif preferences of human basophilic (Protein Kinase A) and acidophilic (Casein Kinase II) kinases. These motifs, derived for PKA and CK II using only bacterial sequence data, were then further validated by utilizing them in conjunction with the scan-x software program to computationally predict known human phosphorylation sites with high confidence.	[Chou, Michael F.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Prisic, Sladjana; Husson, Robert N.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Lubner, Joshua M.; Schwartz, Daniel] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Connecticut	Schwartz, D (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	daniel.schwartz@uconn.edu	Husson, Robert/Y-7288-2019	Lubner, Joshua/0000-0003-1506-0949; Prisic, Sladjana/0000-0003-3137-4358; church, george/0000-0001-6232-9969	University of Connecticut Research Foundation; Genomes to Life grant from US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI051707, R01AI059702, R01AI099204] Funding Source: NIH RePORTER	University of Connecticut Research Foundation; Genomes to Life grant from US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by grants from the University of Connecticut Research Foundation (http://uconn.edu/)(DS) and the Genomes to Life grant from US Department of Energy (http://genomicscience.energy.gov/)(GMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Chambers SP, 2004, PROTEIN EXPRES PURIF, V36, P40, DOI 10.1016/j.pep.2004.03.003; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Kettenbach AN, 2012, CHEM BIOL, V19, P608, DOI 10.1016/j.chembiol.2012.04.011; Knight JDR, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-5; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; O'Donnell M RM, 2011, FASEB J; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saad FA, 2005, BIOCHEM BIOPH RES CO, V333, P443, DOI 10.1016/j.bbrc.2005.05.124; Sarno S, 1996, J BIOL CHEM, V271, P10595, DOI 10.1074/jbc.271.18.10595; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SUGIMOTO K, 1992, BIOSCI BIOTECH BIOCH, V56, P1174, DOI 10.1271/bbb.56.1174; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	49	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52747	10.1371/journal.pone.0052747	http://dx.doi.org/10.1371/journal.pone.0052747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300758	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800136
J	Kim, J; Gao, L; Tan, K				Kim, Jongkwang; Gao, Long; Tan, Kai			Multi-Analyte Network Markers for Tumor Prognosis	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DNA METHYLATION; GLIOBLASTOMA; CLASSIFICATION; GLIOMAS; HYPERMETHYLATION; EPIGENETICS; INTERACTOME; MODULARITY	Deregulation of gene expression, a hallmark of cancer, is caused by both genetic and epigenetic mechanisms. The rapid accumulation of epigenome maps of various cancers suggests a new avenue of research, namely integrating epigenomic data with other types of omic data for cancer diagnosis, prognosis, and biomarker discovery. We introduce the MAPIT algorithm (Multi Analyte Pathway Inference Tool), to enable principled integration of epigenomic, transcriptomic, and protein interactome data. As a proof-of-principle, we apply MAPIT to glioblastoma multiforme (GBM), the most common and aggressive form of brain tumor. Few predictive markers were reported for the prognosis of GBM patients. By integrating mRNA transcriptome, promoter DNA methylome and protein-protein physical interactome, we find ten expression-and three methylation-based network markers, involving 118 genes. When tested on additional GBM patient samples, the prognostic accuracy of the multi-analyte network markers (73.5%) is 9.7% and 8.6% higher than previous prognostic signatures built on gene expression or DNA methylation alone. Our results highlight the critical role of two novel pathways in the prognosis of GBM patients, small GTPase-mediated protein trafficking and ubiquitination-dependent protein degradation. A better understanding of these two pathways could lead to personalized therapies for subgroups of GBM patients. Our study demonstrates that integrating epigenomic, transcriptomic, and interactomic data can improve the accuracy network-based prognosis markers and lead to novel mechanistic understanding of cancer.	[Kim, Jongkwang; Tan, Kai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Gao, Long; Tan, Kai] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Tan, K (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	kai-tan@uiowa.edu		Kim, Jong K./0000-0001-9290-0820; Tan, Kai/0000-0002-9104-5567; Gao, Long/0000-0002-2631-6914	American Brain Tumor Association Discovery grant; National Institutes of Health [HG006130, HL110349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110349] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006130] Funding Source: NIH RePORTER	American Brain Tumor Association Discovery grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an American Brain Tumor Association Discovery grant and the National Institutes of Health grants HG006130 and HL110349 (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Buonerba C., 2010, CRIT REV ONCOL HEMAT; Castaldi PJ, 2011, BRIEF BIOINFORM, V12, P189, DOI 10.1093/bib/bbq073; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Guillaud M, 2008, CANCER RES, V68, P3099, DOI 10.1158/0008-5472.CAN-07-2113; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; IARC, 2007, WHO CLASSIFICATION T; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-521; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu HQ, 2005, BIOINFORMATICS, V21, P3377, DOI 10.1093/bioinformatics/bti544; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Nutt CL, 2003, CANCER RES, V63, P1602; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unterkircher T, 2011, CLIN CANCER RES, V17, P4019, DOI 10.1158/1078-0432.CCR-11-0075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen Z, 2012, J AM MED INFORM ASS; Wu WKK, 2010, CANCER LETT, V293, P15, DOI 10.1016/j.canlet.2009.12.002; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52973	10.1371/journal.pone.0052973	http://dx.doi.org/10.1371/journal.pone.0052973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300836	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800164
J	Peralta Quesada, PC; Schausberger, P				Peralta Quesada, Paulo C.; Schausberger, Peter			Prenatal Chemosensory Learning by the Predatory Mite Neoseiulus californicus	PLOS ONE			English	Article							BEHAVIOR; MEMORY; EXPOSURE; PREY; CANNIBALISM; PREFERENCES; EXPERIENCE; LARVAE; ACARI	Background: Prenatal or embryonic learning, behavioral change following experience made prior to birth, may have significant consequences for postnatal foraging behavior in a wide variety of animals, including mammals, birds, fish, amphibians, and molluscs. However, prenatal learning has not been previously shown in arthropods such as insects, spiders and mites. Methodology/Principal Findings: We examined prenatal chemosensory learning in the plant-inhabiting predatory mite Neoseiulus californicus. We exposed these predators in the embryonic stage to two flavors (vanillin or anisaldehyde) or no flavor (neutral) by feeding their mothers on spider mite prey enriched with these flavors or not enriched with any flavor (neutral). After the predators reached the protonymphal stage, we assessed their prey choice through residence and feeding preferences in experiments, in which they were offered spider mites matching the maternal diet (neutral, vanillin or anisaldehyde spider mites) and non-matching spider mites. Predator protonymphs preferentially resided in the vicinity of spider mites matching the maternal diet irrespective of the type of maternal diet and choice situation. Across treatments, the protonymphs preferentially fed on spider mites matching the maternal diet. Prey and predator sizes did not differ among neutral, vanillin and anisaldehyde treatments, excluding the hypothesis that size-assortative predation influenced the outcome of the experiments. Conclusions/Significance: Our study reports the first example of prenatal learning in arthropods.	[Peralta Quesada, Paulo C.; Schausberger, Peter] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Vienna, Austria.	peter.schausberger@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198				Becques A, 2010, CHEM SENSES, V35, P41, DOI 10.1093/chemse/bjp080; Bertin A, 2010, ETHOLOGY, V116, P1027, DOI 10.1111/j.1439-0310.2010.01820.x; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Brodsgaard H.F., 1990, Bulletin SROP, V13, P36; Castagnoli Marisa, 2003, Redia, V86, P153; CAUBET Y, 1992, Q J EXP PSYCHOL-B, V44B, P165; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Croft BA, 1999, EXP APPL ACAROL, V23, P599, DOI 10.1023/A:1006236310613; Darmaillacq AS, 2008, ANIM BEHAV, V76, P131, DOI 10.1016/j.anbehav.2008.02.006; Davis CP, 2010, BEHAV BRAIN RES, V212, P27, DOI 10.1016/j.bbr.2010.03.022; Desage M, 1996, J CHROMATOGR B, V678, P205, DOI 10.1016/0378-4347(95)00527-7; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Ferrari MCO, 2010, BEHAV ECOL SOCIOBIOL, V64, P549, DOI 10.1007/s00265-009-0870-y; Gandolfi M, 2003, P ROY SOC B-BIOL SCI, V270, P2623, DOI 10.1098/rspb.2003.2541; Gottlieb G., 1971, DEV SPECIES IDENTIFI; Gruest N, 2004, DEV PSYCHOBIOL, V44, P189, DOI 10.1002/dev.20004; Harshaw C, 2011, DEV PSYCHOBIOL, V53, P291, DOI 10.1002/dev.20521; Helle W, 1985, SPIDER MITES BIOL B, V1B; Hepper PG, 1996, ACTA PAEDIATR, V85, P16, DOI 10.1111/j.1651-2227.1996.tb14272.x; HEPPER PG, 1992, Q J EXP PSYCHOL-B, V44B, P179; Hoy MA, 2011, AGRICULTURAL ACAROLOGY: INTRODUCTION TO INTEGRATED MITE MANAGEMENT, P1, DOI 10.1201/b10909; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Minelli A, 2006, DEV GENES EVOL, V216, P373, DOI 10.1007/s00427-006-0075-6; Oostindjer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025318; Oostindjer M, 2009, CHEM SENSES, V34, P775, DOI 10.1093/chemse/bjp063; Palma AD, 2001, EXP APPL ACAROL, V25, P525, DOI 10.1023/A:1014741808835; Pearse JM, 2008, ANIMAL LEARNING COGN; PEDERSEN PE, 1982, DEV PSYCHOBIOL, V15, P349, DOI 10.1002/dev.420150407; Rahmani H, 2009, BEHAV ECOL, V20, P946, DOI 10.1093/beheco/arp081; Ray WS, 1932, CHILD DEV, V3, P175, DOI 10.2307/1125392; Sabelis M.W., 1985, P141; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2008, J ANIM ECOL, V77, P1109, DOI 10.1111/j.1365-2656.2008.01440.x; Schausberger P, 1999, ENVIRON ENTOMOL, V28, P322, DOI 10.1093/ee/28.2.322; Schausberger P, 2010, BEHAVIOUR, V147, P883, DOI 10.1163/000579510X495799; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Shimoda T, 2005, J CHEM ECOL, V31, P2019, DOI 10.1007/s10886-005-6075-6; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; SPELT DK, 1948, J EXP PSYCHOL, V38, P338, DOI 10.1037/h0059632; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Walter DE, 2009, MANUAL ACAROLOGY, P83; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Walzer A, 2007, BIOL CONTROL, V41, P42, DOI 10.1016/j.biocontrol.2006.11.012; Wells DL, 2006, ANIM BEHAV, V72, P681, DOI 10.1016/j.anbehav.2005.12.008; YASTREBTSOV A, 1992, International Journal of Acarology, V18, P121; Zhukovskaya NA, 2009, CHEM NAT COMPD+, V45, P148, DOI 10.1007/s10600-009-9264-7	51	21	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e53229	10.1371/journal.pone.0053229	http://dx.doi.org/10.1371/journal.pone.0053229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300897	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800167
J	Saba, GK; Schofield, O; Torres, JJ; Ombres, EH; Steinberg, DK				Saba, Grace K.; Schofield, Oscar; Torres, Joseph J.; Ombres, Erica H.; Steinberg, Deborah K.			Increased Feeding and Nutrient Excretion of Adult Antarctic Krill, Euphausia superba, Exposed to Enhanced Carbon Dioxide (CO2)	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; COPEPOD ACARTIA-TONSA; OCEAN ACIDIFICATION; SOUTHERN-OCEAN; AUSTRAL SUMMER; ELEMENTAL COMPOSITION; HYPERCAPNIC ACIDOSIS; NITROGEN-EXCRETION; METABOLIC-ACTIVITY; ATLANTIC SECTOR	Ocean acidification has a wide-ranging potential for impacting the physiology and metabolism of zooplankton. Sufficiently elevated CO2 concentrations can alter internal acid-base balance, compromising homeostatic regulation and disrupting internal systems ranging from oxygen transport to ion balance. We assessed feeding and nutrient excretion rates in natural populations of the keystone species Euphausia superba (Antarctic krill) by conducting a CO2 perturbation experiment at ambient and elevated atmospheric CO2 levels in January 2011 along the West Antarctic Peninsula (WAP). Under elevated CO2 conditions (similar to 672 ppm), ingestion rates of krill averaged 78 mu g C individual(-1) d(-1) and were 3.5 times higher than krill ingestion rates at ambient, present day CO2 concentrations. Additionally, rates of ammonium, phosphate, and dissolved organic carbon (DOC) excretion by krill were 1.5, 1.5, and 3.0 times higher, respectively, in the high CO2 treatment than at ambient CO2 concentrations. Excretion of urea, however, was similar to 17% lower in the high CO2 treatment, suggesting differences in catabolic processes of krill between treatments. Activities of key metabolic enzymes, malate dehydrogenase (MDH) and lactate dehydrogenase (LDH), were consistently higher in the high CO2 treatment. The observed shifts in metabolism are consistent with increased physiological costs associated with regulating internal acid-base equilibria. This represents an additional stress that may hamper growth and reproduction, which would negatively impact an already declining krill population along the WAP.	[Saba, Grace K.; Schofield, Oscar] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Torres, Joseph J.; Ombres, Erica H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Steinberg, Deborah K.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA	Rutgers State University New Brunswick; State University System of Florida; University of South Florida; William & Mary; Virginia Institute of Marine Science	Saba, GK (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	saba@marine.rutgers.edu	Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131	LTER Program of the U. S. National Science Foundation [ANT-0823101]; Moore Foundation grant [1859]	LTER Program of the U. S. National Science Foundation(National Science Foundation (NSF)); Moore Foundation grant	The research was supported by the LTER Program of the U. S. National Science Foundation (ANT-0823101) and Moore Foundation grant #1859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albessard E, 2001, COMP BIOCHEM PHYS A, V129, P373, DOI 10.1016/S1095-6433(00)00355-X; Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barry J, 2011, GUIDE BEST PRACTICES, P53; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Boyd CM, 1984, CRUST BIOL, V4; Brewer PG, 2009, P NATL ACAD SCI USA, V106, P12213, DOI 10.1073/pnas.0906815106; Bridges C., 1983, LIFE CHEM REP S, V1, P353; Burleson ML, 2000, COMP BIOCHEM PHYS A, V125, P403, DOI 10.1016/S1095-6433(00)00167-7; Christian J. R., 2007, PICES SPEC PUBL, V3, P1; CLARKE A, 1983, POLAR BIOL, V2, P69, DOI 10.1007/BF00303172; Conover R. J., 1956, Bulletin of the Bingham Oceanographic Collection, V15, P156; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P345, DOI 10.1017/S0025315400018968; Cullen M, 2003, DEEP-SEA RES PT II, V50, P1787, DOI 10.1016/S0967-0645(03)00088-2; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donnelly J, 2004, DEEP-SEA RES PT II, V51, P2225, DOI 10.1016/j.dsr2.2004.07.003; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Everson I, 2000, KRILL BIOL ECOLOGY F; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Froneman PW, 2000, DEEP-SEA RES PT I, V47, P1687, DOI 10.1016/S0967-0637(99)00121-1; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geiger SP, 2001, HYDROBIOLOGIA, V453, P79, DOI 10.1023/A:1013107715862; Godlewska Malgorzata, 1996, Polskie Archiwum Hydrobiologii, V43, P9; Grasshoff K, 1999, METHODS SEAWATER ANA; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Haberman KL, 2003, J EXP MAR BIOL ECOL, V283, P97, DOI 10.1016/S0022-0981(02)00467-7; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; Hauton C, 2009, BIOGEOSCIENCES, V6, P1479, DOI 10.5194/bg-6-1479-2009; Hedges JI, 1984, LIMNOL OCEANOGR, V29, P20; HOLMHANSEN O, 1984, J CRUSTACEAN BIOL, V4, P156; HOPKINS TL, 1985, MAR BIOL, V89, P197, DOI 10.1007/BF00392890; Hosie GW, 2000, DEEP-SEA RES PT II, V47, P2437, DOI 10.1016/S0967-0645(00)00031-X; Houghton J. T., 1996, CLIMATE CHANGE SCI C; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; HUNTLEY ME, 1994, MAR ECOL PROG SER, V107, P23, DOI 10.3354/meps107023; IKEDA T, 1982, MAR BIOL, V71, P283, DOI 10.1007/BF00397045; IKEDA T, 1981, AUST J MAR FRESH RES, V32, P921; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; ISHII H, 1987, POLAR BIOL, V7, P379, DOI 10.1007/BF00293228; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kato M, 1982, T TOKYO U FISH, V5, P167; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kim HC, 2006, LIMNOL OCEANOGR, V51, P331, DOI 10.4319/lo.2006.51.1.0331; Kim HC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040271; King R, 2003, MAR FRESHW BEHAV PHY, V36, P271, DOI 10.1080/10236240310001614457; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Koeve W, 2012, BIOGEOSCIENCES, V9, P3787, DOI 10.5194/bg-9-3787-2012; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; LAWS RM, 1985, AM SCI, V73, P26; Lehninger A L, 1982, PRINCIPLES BIOCH; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; McKendry JE, 2001, J EXP BIOL, V204, P1519; McKenzie DJ, 2002, J COMP PHYSIOL B, V172, P339, DOI 10.1007/s00360-002-0260-5; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; MEYER MA, 1983, POLAR BIOL, V1, P193, DOI 10.1007/BF00443187; Michaelidis B, 2007, MAR BIOL, V150, P1417, DOI 10.1007/s00227-006-0436-8; Miller CA, 1998, J PLANKTON RES, V20, P1767, DOI 10.1093/plankt/20.9.1767; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; MORRIS DJ, 1984, J CRUSTACEAN BIOL, V4, P185, DOI 10.1163/1937240X84X00589; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pakhomov EA, 2004, DEEP-SEA RES PT II, V51, P2617, DOI 10.1016/j.dsr2.2000.11.002; Pakhomov EA, 1997, J PLANKTON RES, V19, P399, DOI 10.1093/plankt/19.4.399; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peltzer ET, 1996, MAR CHEM, V54, P85, DOI 10.1016/0304-4203(96)00023-0; Perissinotto R, 1997, MAR ECOL PROG SER, V160, P77, DOI 10.3354/meps160077; Perissinotto R, 2000, MAR BIOL, V136, P129, DOI 10.1007/s002270050015; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; PORTNER HO, 1990, J EXP BIOL, V150, P407; PRICE HJ, 1988, MAR BIOL, V97, P67, DOI 10.1007/BF00391246; PRICE NM, 1987, MAR BIOL, V94, P307, DOI 10.1007/BF00392945; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Quetin L.B., 1985, P372; QUETIN LB, 1991, AM ZOOL, V31, P49; Quetin LB, 1987, EOS, V68, P109; Raven J, 2005, 1205 ROYAL SCI; REGNAULT M, 1987, BIOL REV, V62, P1, DOI 10.1111/j.1469-185X.1987.tb00623.x; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Roger C., 1982, Oceanographie Tropicale, V17, P177; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; ROSS RM, 1982, MAR BIOL, V68, P1, DOI 10.1007/BF00393135; Ruiz-Halpern S, 2011, LIMNOL OCEANOGR, V56, P521, DOI 10.4319/lo.2011.56.2.0521; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Saba GK, 2011, J EXP MAR BIOL ECOL, V404, P47, DOI 10.1016/j.jembe.2011.04.013; Saba GK, 2009, MAR ECOL PROG SER, V386, P147, DOI 10.3354/meps08070; Sabine CL, 2007, GREENHOUSE GAS SINKS, P31, DOI 10.1079/9781845931896.0031; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, J EXP BIOL, V206, P641, DOI 10.1242/jeb.00141; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Sharp JH, 2002, MAR CHEM, V77, P239, DOI 10.1016/S0304-4203(02)00002-6; Siegel V., 1988, P219; Skvarca P, 1999, ANN GLACIOL-SER, V29, P255, DOI 10.3189/172756499781821283; Smetacek V, 2004, ANTARCT SCI, V16, P541, DOI 10.1017/S0954102004002317; Somero G.N., 1985, P454; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Steinberg DK, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1135, DOI 10.1016/B978-0-12-372522-6.00026-8; Strickland J.D.H., 1968, B FISHERIES RES BOAR, V167; Tovar-Sanchez A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029096; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; WALSH PJ, 1989, B MAR SCI, V45, P68; Watanabe Y, 2006, J OCEANOGR, V62, P185, DOI 10.1007/s10872-006-0043-9; WEBER LH, 1985, ANTARCTIC NUTR CYCLE, P283; Whitehouse MJ, 2011, DEEP-SEA RES PT I, V58, P725, DOI 10.1016/j.dsr.2011.03.006; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Yen J, 2003, MAR FRESHW BEHAV PHY, V36, P307, DOI 10.1080/10236240310001614439	124	54	55	0	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52224	10.1371/journal.pone.0052224	http://dx.doi.org/10.1371/journal.pone.0052224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300621	Green Published, gold			2022-12-25	WOS:000313618800060
J	Hardikar, S; Onstad, L; Blount, PL; Odze, RD; Reid, BJ; Vaughan, TL				Hardikar, Sheetal; Onstad, Lynn; Blount, Patricia L.; Odze, Robert D.; Reid, Brian J.; Vaughan, Thomas L.			The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: A Prospective Study of Barrett's Esophagus	PLOS ONE			English	Article							BODY-MASS INDEX; GASTROESOPHAGEAL-REFLUX DISEASE; SQUAMOUS-CELL CARCINOMA; HIGH-GRADE DYSPLASIA; GASTRIC CARDIA; CANCER-RISK; CIGARETTE-SMOKING; HELICOBACTER-PYLORI; ABDOMINAL OBESITY; INTESTINAL METAPLASIA	Background: Esophageal adenocarcinoma (EA) incidence in many developed countries has increased dramatically over four decades, while survival remains poor. Persons with Barrett's esophagus (BE), who experience substantially elevated EA risk, are typically followed in surveillance involving periodic endoscopy with biopsies, although few progress to EA. No medical, surgical or lifestyle interventions have been proven to safely lower EA risk. Design: We investigated whether smoking, obesity or alcohol could predict progression to EA in a prospective cohort of 411 BE patients. Data were collected during personal interview. Adjusted hazard ratios (HR) were estimated using Cox regression. Results: 39% had body mass index (BMI) over 30 and 64% had smoked cigarettes. Main analyses focused on those with at least 5 months of follow-up (33,635 person-months), in whom 45 developed EA. Risk increased by 3% per year of age (trend p-value 0.02), with approximate doubling of risk among males. EA risk increased with smoking pack-years (trend p-value 0.04) and duration (p-value 0.05). Compared to never-smokers, the HR for those in the highest pack-year tertile was 2.29 (95%CI 1.04-5.07). No association was found with alcohol or BMI, whereas a suggestion of increased risk was observed in those with higher waist-hip ratio, especially among males. Conclusion: EA risk significantly increased with increasing age and cigarette exposure. Abdominal obesity, but not BMI, was associated with a modest increased risk. Continued follow-up of this and other cohorts is needed to precisely define these relationships so as to inform risk stratification and preventive interventions.	[Hardikar, Sheetal; Onstad, Lynn; Blount, Patricia L.; Reid, Brian J.; Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hardikar, Sheetal; Vaughan, Thomas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Blount, Patricia L.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA USA; [Odze, Robert D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Odze, Robert D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle	Vaughan, TL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	tvaughan@u.washington.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	United States National Institutes of Health [P01CA091955, K05CA124911]; NATIONAL CANCER INSTITUTE [K05CA124911, P01CA091955] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported through the United States National Institutes of Health grants P01CA091955 and K05CA124911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2008, EUR J CANCER, V44, P465, DOI 10.1016/j.ejca.2007.12.009; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Chow WH, 1998, CANCER RES, V58, P588; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Coleman HG, 2012, GASTROENTEROLOGY, V142, P233, DOI 10.1053/j.gastro.2011.10.034; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Cook MB, 2012, GASTROENTEROLOGY, V142, P744, DOI 10.1053/j.gastro.2011.12.049; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2008, CANCER EPIDEM BIOMAR, V17, P352, DOI 10.1158/1055-9965.EPI-07-0748; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; de Jonge PJF, 2010, GUT, V59, P1030, DOI 10.1136/gut.2009.176701; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Dong LM, 2008, NUTR CANCER, V60, P39, DOI 10.1080/01635580701586762; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Ertan A, 2000, DIGEST DIS SCI, V45, P1670, DOI 10.1023/A:1005545918399; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; Fouad YM, 2009, WORLD J GASTROENTERO, V15, P3511, DOI 10.3748/wjg.15.3511; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Freedman ND, 2011, GUT, V60, P1029, DOI 10.1136/gut.2010.233866; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Jung KW, 2011, AM J GASTROENTEROL, V106, P1447, DOI 10.1038/ajg.2011.130; Kendall BJ, 2008, GUT, V57, P448, DOI 10.1136/gut.2007.131243; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Kubo A, 2009, CANCER CAUSE CONTROL, V20, P303, DOI 10.1007/s10552-008-9244-4; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Loffeld RJLF, 2005, NETH J MED, V63, P344; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; Oh DS, 2010, WORLD J GASTROENTERO, V16, P3762, DOI 10.3748/wjg.v16.i30.3762; Orlando RC, 2005, MED CLIN N AM, V89, P219, DOI 10.1016/j.mcna.2004.08.006; Pandeya N, 2009, GASTROENTEROLOGY, V136, P1215, DOI 10.1053/j.gastro.2008.12.052; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Sikkema M, 2011, AM J GASTROENTEROL, V106, P1231, DOI 10.1038/ajg.2011.153; Smit CF, 2001, ANN OTO RHINOL LARYN, V110, P190, DOI 10.1177/000348940111000216; Smith KJ, 2009, CLIN GASTROENTEROL H, V7, P840, DOI 10.1016/j.cgh.2009.04.018; Solaymani-Dodaran M, 2005, AM J GASTROENTEROL, V100, P2616, DOI 10.1111/j.1572-0241.2005.00340.x; Steevens J, 2011, CANCER EPIDEM BIOMAR, V20, P345, DOI 10.1158/1055-9965.EPI-10-0636; Steffen A, 2009, CANCER EPIDEM BIOMAR, V18, P2079, DOI 10.1158/1055-9965.EPI-09-0265; Thompson OM, 2010, OBESITY, V18, P2204, DOI 10.1038/oby.2009.508; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; Vaughan TL, 2002, CANCER EPIDEM BIOMAR, V11, P745; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Vogt S, 2006, TOXICOLOGY, V222, P71, DOI 10.1016/j.tox.2006.01.025; Weston AP, 2004, AM J GASTROENTEROL, V99, P1657, DOI 10.1111/j.1572-0241.2004.30426.x; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121	64	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52192	10.1371/journal.pone.0052192	http://dx.doi.org/10.1371/journal.pone.0052192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300966	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000006
J	Lam, NT; Currie, PD; Lieschke, GJ; Rosenthal, NA; Kaye, DM				Lam, Nicholas T.; Currie, Peter D.; Lieschke, Graham J.; Rosenthal, Nadia A.; Kaye, David M.			Nerve Growth Factor Stimulates Cardiac Regeneration via Cardiomyocyte Proliferation in Experimental Heart Failure	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ZEBRAFISH; ACTIVATION; EXPRESSION; GSK3-BETA; RECEPTOR; REPAIR; END	Although the adult heart likely retains some regenerative capacity, heart failure (HF) typically remains a progressive disorder. We hypothesise that alterations in the local environment contribute to the failure of regeneration in HF. Previously we showed that nerve growth factor (NGF) is deficient in the failing heart and here we hypothesise that diminished NGF limits the cardiac regenerative response in HF. The capacity of NGF to augment cardiac regeneration was tested in a zebrafish model of HF. Cardiac injury with a HF phenotype was induced in zebrafish larvae at 72 hours post fertilization (hpf) by exposure to aristolochic acid (AA, 2.5 mu M, 72-75 hpf). By 168 hpf, AA induced HF and death in 37.5% and 20.8% of larvae respectively (p<0.001). NGF mRNA expression was reduced by 42% (p<0.05). The addition of NGF (50 ng/ml) after exposure to AA reduced the incidence of HF by 50% (p<0.01) and death by 65% (p<0.01). Mechanistically, AA mediated HF was characterised by reduced cardiomyocyte proliferation as reflected by a 6.4 fold decrease in BrdU+ cardiomyocytes (p<0.01) together with features of apoptosis and loss of cardiomyocytes. Following AA exposure, NGF increased the abundance of BrdU+ cardiomyocytes in the heart by 4.8 fold (p<0.05), and this was accompanied by a concomitant significant increase in cardiomyocyte numbers. The proliferative effect of NGF on cardiomyocytes was not associated with an anti-apoptotic effect. Taken together the study suggests that NGF stimulates a regenerative response in the failing zebrafish heart, mediated by stimulation of cardiomyocyte proliferation.	[Lam, Nicholas T.; Kaye, David M.] Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Lam, Nicholas T.; Kaye, David M.] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Lam, Nicholas T.; Currie, Peter D.; Lieschke, Graham J.; Rosenthal, Nadia A.] Monash Univ, ARMI, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Australian Regenerative Medicine Institute; Monash University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Rosenthal, Nadia/H-4012-2013; Kaye, David/AAF-1202-2021	Lieschke, Graham/0000-0003-0325-798X; Currie, Peter/0000-0001-8874-8862; Lam, Nicholas/0000-0002-9446-7378; Kaye, David/0000-0003-4058-0372	NHMRC of Australia; National Health and Medical Research Council of Australia; Victorian Government; Australian Regenerative Medicine Institute (ARMI); State Government of Victoria; Australian Government	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Australian Regenerative Medicine Institute (ARMI); State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	The project was supported by the NHMRC of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tanneale Marshall and Ouda Khammy for technical assistance; Stephen Cody, Judy Callaghan and Iska Carmichael from Monash Micro Imaging for confocal microscope training and imaging advice. We also thank Geoffrey Burns (Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School) for Tg(cmlc2:DsRed2-nuc) zebrafish and technical advice. DMK is supported by a Program Grant from the National Health and Medical Research Council of Australia and Baker IDI receives Infrastructure support from the Victorian Government. NTL was supported by an Australian Regenerative Medicine Institute (ARMI) post-graduate scholarship. ARMI is supported by grants from the State Government of Victoria and the Australian Government.	Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhat RV, 2002, J ALZHEIMERS DIS, V4, P291, DOI 10.3233/JAD-2002-4404; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Goold RG, 2003, J NEUROCHEM, V87, P935, DOI 10.1046/j.1471-4159.2003.02062.x; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Woulfe KC, 2010, CIRC RES, V106, P1635, DOI 10.1161/CIRCRESAHA.109.211482; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	33	22	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53210	10.1371/journal.pone.0053210	http://dx.doi.org/10.1371/journal.pone.0053210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300892	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600070
J	Noguchi, C; Araki, Y; Miki, D; Shimizu, N				Noguchi, Chiemi; Araki, Yoshio; Miki, Daisuke; Shimizu, Noriaki			Fusion of the Dhfr/Mtx and IR/MAR Gene Amplification Methods Produces a Rapid and Efficient Method for Stable Recombinant Protein Production	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; EXTRACHROMOSOMAL DOUBLE MINUTES; REPLICATION INITIATION REGION; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; DNA-DAMAGE; EXPRESSION; LINES; METHOTREXATE; STABILITY	Amplification of the dihydrofolate reductase gene (Dhfr) by methotrexate (Mtx) exposure is commonly used for recombinant protein expression in Chinese hamster ovary (CHO) cells. However, this method is both time-and labor-intensive, and the high-producing cells that are generated are frequently unstable in culture. Another gene amplification method is based on using a plasmid bearing a mammalian replication initiation region (IR) and a matrix attachment region (MAR), which result in the spontaneous initiation of gene amplification in transfected cells. The IR/MAR and Dhfr/Mtx methods of gene amplification are based on entirely different principles. In this study, we combine these two methods to yield a novel method, termed the IR/MAR-Dhfr fusion method, which was used to express three proteins, the Fc receptor, GFP, and recombinant antibody. The fusion method resulted in a dramatic increase in expression of all three proteins in two CHO sub-lines, DXB-11, and DG44. The IR/MAR-Dhfr fusion amplified the genes rapidly and efficiently, and produced larger amounts of antibody than the Dhfr/Mtx or IR/MAR methods alone. While the amplified structure produced by the Dhfr/Mtx method was highly unstable, and the antibody production rate rapidly decreased with the culture time of the cells, the IR/MAR-Dhfr fusion method resulted in stable amplification and generated clonal cells that produced large amounts of antibody protein over a long period of time. In summary, the novel IR/MAR-Dhfr fusion method enables isolation of stable cells that produce larger amounts of a target recombinant protein more rapidly and easily than either the Dhfr/Mtx or IR/MAR methods alone.	[Noguchi, Chiemi; Araki, Yoshio; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan; [Miki, Daisuke] Tosoh Co, Ayase, Kanagawa, Japan	Hiroshima University; Tosoh Corporation	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Science and Technology; Japan Society for the Promotion of Science [23380203]	Japan Science and Technology(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Practical Application Research from Japan Science and Technology to NS, and a Grant-in-Aid for Scientific Research (B) [grant number 23380203] from the Japan Society for the Promotion of Science to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Asaoka Y, 2012, PROTEIN EXPRES PURIF, V82, P155, DOI 10.1016/j.pep.2011.12.006; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; HAKALA MT, 1957, SCIENCE, V126, P255, DOI 10.1126/science.126.3267.255; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Jun SC, 2005, APPL MICROBIOL BIOT, V69, P162, DOI 10.1007/s00253-005-1972-8; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kim M., 2011, BIOTECHNOL BIOENG; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; LORICO A, 1988, CANCER RES, V48, P2036; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; Omasa T, 2002, J BIOSCI BIOENG, V94, P600, DOI 10.1016/S1389-1723(02)80201-8; PALLAVICINI MG, 1990, MOL CELL BIOL, V10, P401, DOI 10.1128/MCB.10.1.401; Savelyeva L, 2001, CANCER LETT, V167, P115, DOI 10.1016/S0304-3835(01)00472-4; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	35	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52990	10.1371/journal.pone.0052990	http://dx.doi.org/10.1371/journal.pone.0052990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300841	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600045
J	Pombert, JF; James, ER; Janouskovec, J; Keeling, PJ				Pombert, Jean-Francois; James, Erick R.; Janouskovec, Jan; Keeling, Patrick J.			Evidence for Transitional Stages in the Evolution of Euglenid Group II Introns and Twintrons in the Monomorphina aenigmatica Plastid Genome	PLOS ONE			English	Article							PHOTOSYNTHETIC EUGLENOIDS; CHLOROPLAST GENOME; SEQUENCE; GENE; RNA; GENERATION; ALIGNMENT; ORIGIN; TOOL	Background: Photosynthetic euglenids acquired their plastid by secondary endosymbiosis of a prasinophyte-like green alga. But unlike its prasinophyte counterparts, the plastid genome of the euglenid Euglena gracilis is riddled with introns that interrupt almost every protein-encoding gene. The atypical group II introns and twintrons (introns-within-introns) found in the E. gracilis plastid have been hypothesized to have been acquired late in the evolution of euglenids, implying that massive numbers of introns may be lacking in other taxa. This late emergence was recently corroborated by the plastid genome sequences of the two basal euglenids, Eutreptiella gymnastica and Eutreptia viridis, which were found to contain fewer introns. Methodology/Principal Findings: To gain further insights into the proliferation of introns in euglenid plastids, we have characterized the complete plastid genome sequence of Monomorphina aenigmatica, a freshwater species occupying an intermediate phylogenetic position between early and late branching euglenids. The M. aenigmatica UTEX 1284 plastid genome (74,746 bp, 70.6% A+ T, 87 genes) contains 53 intron insertion sites, of which 41 were found to be shared with other euglenids including 12 of the 15 twintron insertion sites reported in E. gracilis. Conclusions: The pattern of insertion sites suggests an ongoing but uneven process of intron gain in the lineage, with perhaps a minimum of two bursts of rapid intron proliferation. We also identified several sites that represent intermediates in the process of twintron evolution, where the external intron is in place, but not the internal one, offering a glimpse into how these convoluted molecular contraptions originate.	[Pombert, Jean-Francois; James, Erick R.; Janouskovec, Jan; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Pombert, JF (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jpombert@mail.ubc.ca; pkeeling@mail.ubc.ca	Janouškovec, Jan/ABA-2568-2021; James, Erick R/D-4725-2012	Janouškovec, Jan/0000-0001-6547-749X; Pombert, Jean-Francois/0000-0002-3449-8375; Keeling, Patrick/0000-0002-7644-0745	Natural History and Engineering Research Council of Canada [227301]	Natural History and Engineering Research Council of Canada	This work was supported by a grant from the Natural History and Engineering Research Council of Canada to PJK (227301). PJK is a Fellow of the Canadian Institute for Advanced Research (CIFAR). The authors gratefully acknowledge the Compute Canada/CLUMEQ consortium for access to their computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; COPERTINO DW, 1993, TRENDS BIOCHEM SCI, V18, P467, DOI 10.1016/0968-0004(93)90008-B; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Doetsch NA, 1998, MOL BIOL EVOL, V15, P76, DOI 10.1093/oxfordjournals.molbev.a025850; Doetsch NA, 2001, MOL GEN GENET, V264, P682, DOI 10.1007/s004380000355; DRAGER RG, 1993, NUCLEIC ACIDS RES, V21, P2389, DOI 10.1093/nar/21.10.2389; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hrda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033746; JENKINS KP, 1995, RNA, V1, P624; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim JI, 2010, J PHYCOL, V46, P1278, DOI 10.1111/j.1529-8817.2010.00910.x; Krajcovic J, 2002, CELL OR EX, V4, P185; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leander BS, 2007, BIOESSAYS, V29, P987, DOI 10.1002/bies.20645; Leander BS, 2004, TRENDS MICROBIOL, V12, P251, DOI 10.1016/j.tim.2004.04.001; Leander BS, 2001, EUR J PROTISTOL, V37, P337, DOI 10.1078/0932-4739-00842; Linton EW, 2010, PROTIST, V161, P603, DOI 10.1016/j.protis.2010.02.002; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIER UG, 1995, MOL GEN GENET, V246, P128, DOI 10.1007/BF00290141; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Nudelman MA, 2006, J PHYCOL, V42, P194, DOI 10.1111/j.1529-8817.2006.00170.x; Scamborova P, 2004, MOL CELL BIOL, V24, P1855, DOI 10.1128/MCB.24.5.1855-1869.2004; Sheveleva EV, 2002, NUCLEIC ACIDS RES, V30, P1247, DOI 10.1093/nar/30.5.1247; Thompson MD, 1995, NUCLEIC ACIDS RES, V23, P4745, DOI 10.1093/nar/23.23.4745; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Wiegert KE, 2012, PROTIST, V163, P832, DOI 10.1016/j.protis.2012.01.002; Zhang LQ, 1995, RNA, V1, P1079	37	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53433	10.1371/journal.pone.0053433	http://dx.doi.org/10.1371/journal.pone.0053433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300929	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600100
J	Sun, YR; Fukamachi, T; Saito, H; Kobayashi, H				Sun, Yirong; Fukamachi, Toshihiko; Saito, Hiromi; Kobayashi, Hiroshi			Respiration and the F(1)Fo-ATPase Enhance Survival under Acidic Conditions in Escherichia coli	PLOS ONE			English	Article							PROTON-TRANSLOCATING ATPASE; PARTIAL PURIFICATION; AGMATINE ANTIPORTER; MOTIVE FORCE; CAD OPERON; RESISTANCE; PH; EXPRESSION; INCREASES; SYNTHASE	Besides amino acid decarboxylation, the ADP biosynthetic pathway was reported to enhance survival under extremely acidic conditions in Escherichia coli (Sun et al., J. Bacteriol. 193: 3072-3077, 2011). E. coli has two pathways for ATP synthesis from ADP: glycolysis and oxidative phosphorylation. We found in this study that the deletion of the F(1)Fo-ATPase, which catalyzes the synthesis of ATP from ADP and inorganic phosphate using the electro-chemical gradient of protons generated by respiration in E. coli, decreased the survival at pH 2.5. A mutant deficient in hemA encoding the glutamyl tRNA reductase, which synthesizes glutamate 1-semialdehyde also showed the decreased survival of E. coli at pH 2.5. Glutamate 1-semialdehyde is a precursor of heme synthesis that is an essential component of the respiratory chain. The ATP content decreased rapidly at pH 2.5 in these mutants as compared with that of their parent strain. The internal pH was lowered by the deletion of these genes at pH 2.5. These results suggest that respiration and the F(1)Fo-ATPase are still working at pH 2.5 to enhance the survival under such extremely acidic conditions.	[Sun, Yirong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Fukamachi, Toshihiko] Interscience Co Ltd, Tokyo, Japan; [Saito, Hiromi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba, Japan; [Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chiba University	Sun, YR (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	sunyr1206@163.com						AVISSAR YJ, 1989, J BACTERIOL, V171, P2919, DOI 10.1128/jb.171.6.2919-2924.1989; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugelavicius A, 2006, BIOLOGIJA, V2, P89; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gensure RH, 2006, BIOCHEM J, V398, P485, DOI 10.1042/BJ20051620; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hirata S, 2008, IMMUNOL LETT, V115, P105, DOI 10.1016/j.imlet.2007.10.006; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; KINOSHITA N, 1984, J BACTERIOL, V160, P1074, DOI 10.1128/JB.160.3.1074-1077.1984; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KOBAYASHI H, 1972, J BIOCHEM, V71, P387; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; LASKO DR, 1993, BIOTECHNOL BIOENG, V42, P30, DOI 10.1002/bit.260420105; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LEYER GJ, 1995, APPL ENVIRON MICROB, V61, P3752, DOI 10.1128/AEM.61.10.3752-3755.1995; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; MENG SY, 1992, J BACTERIOL, V174, P2659, DOI 10.1128/jb.174.8.2659-2669.1992; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Sato M, 2000, APPL ENVIRON MICROB, V66, P943, DOI 10.1128/AEM.66.3.943-947.2000; Sun L, 2005, LETT APPL MICROBIOL, V40, P397, DOI 10.1111/j.1472-765X.2005.01714.x; Sun Y, 2012, J APPL MICROBIOL, V112, P775, DOI 10.1111/j.1365-2672.2012.05246.x; Sun YR, 2011, J BACTERIOL, V193, P3072, DOI 10.1128/JB.00091-11; SUZUKI T, 1988, J BIOL CHEM, V263, P11840; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Vazquez-Juarez RC, 2008, INFECT IMMUN, V76, P5072, DOI 10.1128/IAI.00677-08; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Vothknecht UC, 1996, P NATL ACAD SCI USA, V93, P9287, DOI 10.1073/pnas.93.17.9287	39	8	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52577	10.1371/journal.pone.0052577	http://dx.doi.org/10.1371/journal.pone.0052577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300708	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500036
J	Yuan, PY; Shen, XQ; Liu, J; Hou, YR; Zhu, MQ; Huang, JS; Xu, PP				Yuan, Peiyan; Shen, Xiaoqing; Liu, Jing; Hou, Yarong; Zhu, Manqun; Huang, Jiansheng; Xu, Pingping			Effects of Dentifrice Containing Hydroxyapatite on Dentinal Tubule Occlusion and Aqueous Hexavalent Chromium Cations Sorption: A Preliminary Study	PLOS ONE			English	Article							HYDRAULIC CONDUCTANCE; DESENSITIZING AGENTS; CONTAMINATED SOILS; SENSITIVE TEETH; METAL; WATER; LEAD; DESORPTION; RETENTION; INGESTION	In order to endow environmental protection features to dentifrice, hydroxyapatite (HA) was added to ordinary dentifrice. The effects on dentinal tubule occlusion and surface mineralization were compared after brushing dentine discs with dentifrice with or without HA. The two types of dentifrice were then added to 100 mu g/ml of hexavalent chromium cation (Cr6+) solution in order to evaluate their capacities of adsorbing Cr6+ from water. Our results showed that the dentifrice containing HA was significantly better than the ordinary dentifrice in occluding the dentinal tubules with a plugging rate greater than 90%. Moreover, the effect of the HA dentifrice was persistent and energy-dispersive spectrometer (EDS) revealed that the atomic percentages of calcium and phosphorus on the surface of dentine discs increased significantly. Adding HA to ordinary dentifrice significantly enhanced the ability of dentifrice to adsorb Cr6+ from water with the removal rate up to 52.36%. In addition, the sorption was stable. Our study suggests that HA can be added to ordinary dentifrice to obtain dentifrice that has both relieving dentin hypersensitivity benefits and also helps to control environmental pollution.	[Yuan, Peiyan; Liu, Jing; Hou, Yarong; Zhu, Manqun; Huang, Jiansheng; Xu, Pingping] So Med Univ, Guangdong Prov Stomatol Hosp, Lab Oral Dis, Guangzhou, Guangdong, Peoples R China; [Shen, Xiaoqing] So Med Univ, Zhujiang Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Xu, PP (corresponding author), So Med Univ, Guangdong Prov Stomatol Hosp, Lab Oral Dis, Guangzhou, Guangdong, Peoples R China.	sci8620@gmail.com			Guangdong Provincial Science and Technology Projects [2011B080701099]	Guangdong Provincial Science and Technology Projects	The study was supported by the Guangdong Provincial Science and Technology Projects (No. 2011B080701099) (http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TR, 2005, J ORAL REHABIL, V32, P589, DOI 10.1111/j.1365-2842.2005.01473.x; Arrais César Augusto Galvão, 2004, J. Appl. Oral Sci., V12, P144, DOI 10.1590/S1678-77572004000200012; Arrais UAG, 2003, J DENT, V31, P577, DOI 10.1016/S0300-5712(03)00115-5; Bradberry SM, 1999, J TOXICOL-CLIN TOXIC, V37, P195, DOI 10.1081/CLT-100102419; BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366; Cao XD, 2004, ENVIRON POLLUT, V131, P435, DOI 10.1016/j.envpol.2004.03.003; Chaturvedi PK, 2006, CHEMOSPHERE, V64, P1109, DOI 10.1016/j.chemosphere.2005.11.077; Chen JH, 2010, ENVIRON PROG SUSTAIN, V29, P233, DOI 10.1002/ep.10371; 김민수, 2008, Journal of Periodontal & Implant Science, V38, P1; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Cummins D, 2010, AM J DENT, V23, p3A; del Rio JAG, 2004, J ENVIRON MANAGE, V71, P169, DOI 10.1016/j.jenvman.2004.02.004; Driessens F C, 1982, Monogr Oral Sci, V10, P1; Felter SP, 1997, REGUL TOXICOL PHARM, V25, P43, DOI 10.1006/rtph.1996.1073; Gillam D G, 1997, Adv Dent Res, V11, P487; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; Giovanna GM, 2008, J DENT, V36, P565, DOI 10.1016/j.jdent.2008.03.012; GREENHILL JD, 1981, J DENT RES, V60, P686, DOI 10.1177/00220345810600030401; 강소진, 2009, Journal of Periodontal & Implant Science, V39, P9; Huang SB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/034104; ISO TR 10271, 1993, 10271 ISO TR; Itthagarun A, 2010, HONG KONG DENT J, V7, P61; Izzotti A, 2002, MOL CARCINOGEN, V35, P75, DOI 10.1002/mc.10077; Kim BI, 2006, KEY ENG MATER, V309-311, P541, DOI 10.4028/www.scientific.net/KEM.309-311.541; Kim Su-Hwan, 2009, Journal of Periodontal & Implant Science, V39, P87; Kodaka T, 1999, J ELECTRON MICROSC, V48, P167, DOI 10.1093/oxfordjournals.jmicro.a023663; Kodaka T, 2001, J ELECTRON MICROSC, V50, P57, DOI 10.1093/jmicro/50.1.57; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Lavender SA, 2010, AM J DENT, V23, p14A; Lee SY, 2008, J ORAL REHABIL, V35, P847, DOI 10.1111/j.1365-2842.2008.01876.x; LeGeros R Z, 1991, Monogr Oral Sci, V15, P1; Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50; MA QY, 1995, ENVIRON SCI TECHNOL, V29, P1118, DOI 10.1021/es00004a034; Markowitz K, 2008, J ORAL REHABIL, V35, P300, DOI 10.1111/j.1365-2842.2007.01798.x; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mobasherpour I, 2011, DESALINATION, V266, P142, DOI 10.1016/j.desal.2010.08.016; Mojiri A, 2012, AFR J MICROBIOL RES, V6, P643, DOI 10.5897/AJMR-11-1492; Mordan NJ, 1997, J ORAL REHABIL, V24, P148, DOI 10.1046/j.1365-2842.1997.d01-260.x; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; Pan HB, 2007, ARCH ORAL BIOL, V52, P618, DOI 10.1016/j.archoralbio.2006.12.007; Parolia Abhishek, 2011, J Calif Dent Assoc, V39, P167; Peld M, 2004, ENVIRON SCI TECHNOL, V38, P5626, DOI 10.1021/es049831l; Pereira JC, 2005, DENT MATER, V21, P129, DOI 10.1016/j.dental.2004.02.007; Phuengprasop T, 2011, J HAZARD MATER, V186, P502, DOI 10.1016/j.jhazmat.2010.11.065; Rafael AL, 2007, TOXICOL APPL PHARM, V224, P163, DOI 10.1016/j.taap.2007.07.004; Raicevic S, 2005, J HAZARD MATER, V117, P41, DOI 10.1016/j.jhazmat.2004.07.024; Sandrine B, 2007, J HAZARD MATER, V139, P443, DOI 10.1016/j.jhazmat.2006.02.039; Schiff Thomas, 2009, Am J Dent, V22 Spec No A, p8A; SENA FJ, 1990, DENT CLIN N AM, V34, P475; Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002; Vanoirbeek JAJ, 2003, J TOXICOL ENV HEAL A, V66, P393, DOI 10.1080/15287390306366; Younger PL, 2002, ENVIRON POLLUT, V5; Zeidler-Erdely PC, 2011, J TOXICOL ENV HEAL A, V74, P728, DOI 10.1080/15287394.2011.556063	54	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e45283	10.1371/journal.pone.0045283	http://dx.doi.org/10.1371/journal.pone.0045283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300511	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500001
J	Knudsen, L; Hansen, BF; Jensen, P; Pedersen, TA; Vestergaard, K; Schaffer, L; Blagoev, B; Oleksiewicz, MB; Kiselyov, VV; De Meyts, P				Knudsen, Louise; Hansen, Bo Falck; Jensen, Pia; Pedersen, Thomas Askov; Vestergaard, Kirsten; Schaffer, Lauge; Blagoev, Blagoy; Oleksiewicz, Martin B.; Kiselyov, Vladislav V.; De Meyts, Pierre			Agonism and Antagonism at the Insulin Receptor	PLOS ONE			English	Article							LIGAND-INDUCED ACTIVATION; GROWTH-FACTOR RECEPTOR; NEGATIVE COOPERATIVITY; MONOCLONAL-ANTIBODIES; SIGNALING PATHWAYS; STRUCTURAL BASIS; BINDING; HORMONE; PEPTIDE; KINASE	Insulin can trigger metabolic as well as mitogenic effects, the latter being pharmaceutically undesirable. An understanding of the structure/function relationships between insulin receptor (IR) binding and mitogenic/metabolic signalling would greatly facilitate the preclinical development of new insulin analogues. The occurrence of ligand agonism and antagonism is well described for G protein-coupled receptors (GPCRs) and other receptors but in general, with the exception of antibodies, not for receptor tyrosine kinases (RTKs). In the case of the IR, no natural ligand or insulin analogue has been shown to exhibit antagonistic properties, with the exception of a crosslinked insulin dimer (B29-B'29). However, synthetic monomeric or dimeric peptides targeting sites 1 or 2 of the IR were shown to be either agonists or antagonists. We found here that the S961 peptide, previously described to be an IR antagonist, exhibited partial agonistic effects in the 1-10 nM range, showing altogether a bell-shaped dose-response curve. Intriguingly, the agonistic effects of S961 were seen only on mitogenic endpoints (H-3-thymidine incorporation), and not on metabolic endpoints (C-14-glucose incorporation in adipocytes and muscle cells). The agonistic effects of S961 were observed in 3 independent cell lines, with complete concordance between mitogenicity (H-3-thymidine incorporation) and phosphorylation of the IR and Akt. Together with the B29-B'29 crosslinked dimer, S961 is a rare example of a mixed agonist/antagonist for the human IR. A plausible mechanistic explanation based on the bivalent crosslinking model of IR activation is proposed.	[Knudsen, Louise; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte, Denmark; [Knudsen, Louise; Schaffer, Lauge; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Dept Insulin & Incretin Biol, Gentofte, Denmark; [Hansen, Bo Falck; Jensen, Pia; Pedersen, Thomas Askov; Vestergaard, Kirsten] Novo Nordisk AS, Insulin Biol, Malov, Denmark; [Knudsen, Louise; Blagoev, Blagoy] Univ So Denmark, Odense M, Denmark; [Oleksiewicz, Martin B.] Arsanis Biosci, Vienna, Austria	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; University of Southern Denmark	Knudsen, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte, Denmark.	lsek@novonordisk.com		De Meyts, Pierre/0000-0001-6214-0824; Blagoev, Blagoy/0000-0002-3596-0066	Danish Ministry of Science, Technology and Innovation; Corporate Research Affairs (CORA) within Novo Nordisk A/S; Novo Nordisk [S661, S961]	Danish Ministry of Science, Technology and Innovation; Corporate Research Affairs (CORA) within Novo Nordisk A/S; Novo Nordisk(Novo Nordisk)	L. Knudsen is supported by an Industrial PhD scholarship from the Danish Ministry of Science, Technology and Innovation as well as by Corporate Research Affairs (CORA) within Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Thomas Askov Pedersen, Kirsten Vestergaard, Pierre De Meyts, Vladislav V. Kiselyov, Bo Falck Hansen, Pia Jensen, and Lauge Schaffer were employees of Novo Nordisk A/S. Pierre De Meyts, Bo Falck Hansen, Pia Jensen, Lauge Schaffer Louise Knudsen, Kirsten Vestergaard and Thomas Askov Pedersen own Novo Nordisk stocks. Novo Nordisk were a funder for this study and provided the S661 and S961 for the study. Martin B. Oleksiewicz was employed by Arsanis Biosciences at the time of the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blagoev B, 2002, J BIOL CHEM, V277, P42011, DOI 10.1074/jbc.M206975200; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; DIACONESCU C, 1982, H-S Z PHYSIOL CHEM, V363, P187, DOI 10.1515/bchm2.1982.363.1.187; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FIGLEWICZ DP, 1983, AM J PHYSIOL, V245, pE483, DOI 10.1152/ajpendo.1983.245.5.E483; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GU JL, 1988, BIOCHEM BIOPH RES CO, V150, P694, DOI 10.1016/0006-291X(88)90447-0; Hansen BF, 1996, BIOCHEM J, V315, P271; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; ILONDO MM, 1994, ENDOCRINOLOGY, V134, P2397, DOI 10.1210/en.134.6.2397; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Knudsen L, 2011, BIOCHEM J, V440, P397, DOI 10.1042/BJ20110550; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; Leahy DJ, 2008, CANCER CELL, V13, P291, DOI 10.1016/j.ccr.2008.03.010; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; OLEFSKY JM, 1980, J BIOL CHEM, V255, P6098; Oleksiewicz MB, 2011, J APPL TOXICOL, V31, P329, DOI 10.1002/jat.1590; PETRUZZELLI LM, 1982, P NATL ACAD SCI-BIOL, V79, P6792, DOI 10.1073/pnas.79.22.6792; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VERSPOHL EJ, 1988, J CLIN ENDOCR METAB, V67, P169, DOI 10.1210/jcem-67-1-169; Vikram A, 2011, STEROIDS, V76, P416, DOI 10.1016/j.steroids.2010.12.014; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WEILAND M, 1990, P NATL ACAD SCI USA, V87, P1154, DOI 10.1073/pnas.87.3.1154; WHITESELL RR, 1979, J BIOL CHEM, V254, P5276; WHITTAKER J, 1987, P NATL ACAD SCI USA, V84, P5237, DOI 10.1073/pnas.84.15.5237; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109	50	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51972	10.1371/journal.pone.0051972	http://dx.doi.org/10.1371/journal.pone.0051972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300584	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100015
J	Masuda, S; Iwasaki, S; Tomaru, U; Sato, J; Kawakami, A; Ichijo, K; Sogo, S; Baba, T; Katsumata, K; Kasahara, M; Ishizu, A				Masuda, Sakiko; Iwasaki, Sari; Tomaru, Utano; Sato, Juri; Kawakami, Ai; Ichijo, Kana; Sogo, Sayuri; Baba, Tomohisa; Katsumata, Kazuaki; Kasahara, Masanori; Ishizu, Akihiro			Mechanism of Fc gamma Receptor-Mediated Trogocytosis-Based False-Positive Results in Flow Cytometry	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; T-CELLS; ANTIGEN PRESENTATION; TARGET-CELLS; MONOCYTES; LYMPHOCYTES; ANTIBODIES; COMPLEXES; EXCHANGE	The whole blood erythrocyte lysis method is the most common protocol of sample preparation for flow cytometry (FCM). Although this method has many virtues, our recent study has demonstrated false-positive results when surface markers of monocytes were examined by this method due to the phenomenon called Fc gamma receptor (Fc gamma R)-mediated trogocytosis. In the present study, similar Fc gamma R-mediated trogocytosis-based false-positive results have been demonstrated when granulocytes were focused on instead of monocytes. These findings indicated that not only monocytes but also granulocytes, the largest population with Fc gamma R expression in peripheral blood, could perform Fc gamma R-mediated trogocytosis. Since the capacity of Fc gamma R-mediated trogocytosis was different among blood samples, identification of factors that could regulate the occurrence of Fc gamma R-mediated trogocytosis should be important for the quality control of FCM. Our studies have suggested that such factors are present in the serum. In order to identify the serum factors, we employed the in vitro model of Fc gamma R-mediated trogocytosis using granulocytes. Investigation with this model determined the serum factors as heat-labile molecules with molecular weight of more than 100 kDa. Complements in the classical pathway were initially assumed as candidates; however, the C1 inhibitor did not yield an obvious influence on Fc gamma R-mediated trogocytosis. On the other hand, although immunoglobulin ought to be resistant to heat inactivation, the inhibitor of human anti-mouse antibodies (HAMA) effectively blocked Fc gamma R-mediated trogocytosis. Moreover, the inhibition rates were significantly higher in HAMA(high) serum than HAMA(low) serum. The collective findings suggested the involvement of heterophilic antibodies such as HAMA in the mechanism of false-positive results in FCM due to Fc gamma R-mediated trogocytosis.	[Iwasaki, Sari; Katsumata, Kazuaki; Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Masuda, Sakiko; Kawakami, Ai] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Iwasaki, Sari; Tomaru, Utano; Baba, Tomohisa; Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Sato, Juri; Ichijo, Kana; Sogo, Sayuri] Hokkaido Univ, Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Ishizu, A (corresponding author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan.	aishizu@med.hokudai.ac.jp	Katsumata, Kazuaki/J-8277-2019; Kasahara, Masanori/G-7651-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan; Hokkaido University, Faculty of Health Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkaido University, Faculty of Health Sciences	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the grant from Hokkaido University, Faculty of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Horner H, 2007, J IMMUNOL, V179, P337, DOI 10.4049/jimmunol.179.1.337; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Iwasaki S, 2011, CYTOM PART A, V79A, P46, DOI 10.1002/cyto.a.20984; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Li YL, 2007, J IMMUNOL, V179, P4263, DOI 10.4049/jimmunol.179.6.4263; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; Xu H, 2006, J IMMUNOL, V176, P750, DOI 10.4049/jimmunol.176.2.750	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52918	10.1371/journal.pone.0052918	http://dx.doi.org/10.1371/journal.pone.0052918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300821	Green Published, gold			2022-12-25	WOS:000312829100098
J	DeSantis, LRG; Schubert, BW; Scott, JR; Ungar, PS				DeSantis, Larisa R. G.; Schubert, Blaine W.; Scott, Jessica R.; Ungar, Peter S.			Implications of Diet for the Extinction of Saber-Toothed Cats and American Lions	PLOS ONE			English	Article							RANCHO-LA-BREA; MICROWEAR TEXTURE ANALYSIS; SCANNING-ELECTRON-MICROSCOPY; DENTAL MICROWEAR; LARGE CARNIVORES; FEEDING-BEHAVIOR; SMILODON-FATALIS; PREDATORY BEHAVIOR; KILLING BEHAVIOR; LATE PLEISTOCENE	The saber-toothed cat, Smilodon fatalis, and American lion, Panthera atrox, were among the largest terrestrial carnivores that lived during the Pleistocene, going extinct along with other megafauna,12,000 years ago. Previous work suggests that times were difficult at La Brea (California) during the late Pleistocene, as nearly all carnivores have greater incidences of tooth breakage (used to infer greater carcass utilization) compared to today. As Dental Microwear Texture Analysis (DMTA) can differentiate between levels of bone consumption in extant carnivores, we use DMTA to clarify the dietary niches of extinct carnivorans from La Brea. Specifically, we test the hypothesis that times were tough at La Brea with carnivorous taxa utilizing more of the carcasses. Our results show no evidence of bone crushing by P. atrox, with DMTA attributes most similar to the extant cheetah, Acinonyx jubatus, which actively avoids bone. In contrast, S. fatalis has DMTA attributes most similar to the African lion Panthera leo, implying that S. fatalis did not avoid bone to the extent previously suggested by SEM microwear data. DMTA characters most indicative of bone consumption (i.e., complexity and textural fill volume) suggest that carcass utilization by the extinct carnivorans was not necessarily more complete during the Pleistocene at La Brea; thus, times may not have been "tougher" than the present. Additionally, minor to no significant differences in DMTA attributes from older (similar to 30-35 Ka) to younger (similar to 11.5 Ka) deposits offer little evidence that declining prey resources were a primary cause of extinction for these large cats.	[DeSantis, Larisa R. G.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Schubert, Blaine W.] E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Johnson City, TN 37614 USA; [Schubert, Blaine W.] E Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA; [Scott, Jessica R.] Univ Arkansas, Dept Sociol & Anthropol, Little Rock, AR 72204 USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Vanderbilt University; East Tennessee State University; East Tennessee State University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		DeSantis, Larisa/0000-0003-1159-9154	Vanderbilt University; East Tennessee State University; University of Arkansas	Vanderbilt University; East Tennessee State University; University of Arkansas	Funding was provided by Vanderbilt University, East Tennessee State University, and the University of Arkansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyonge W, 1996, J MAMMAL, V77, P1059, DOI 10.2307/1382786; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Behrensmeyer Anna K., 1992, P15; Binder WJ, 2010, J VERTEBR PALEONTOL, V30, P255, DOI 10.1080/02724630903413016; Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; Christiansen P, 2009, J VERTEBR PALEONTOL, V29, P934, DOI 10.1671/039.029.0314; Dunn OJ, 1964, AM SOC QUAL, V6, P241; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; Freeman PW, 2006, PAPERS NATURAL RESOU, V12; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Galbany J, 2005, SCANNING, V27, P23; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Harris, 2001, RANCHO BREA RECORD P; HAYNES G, 1982, ARCTIC, V35, P266; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Martin PS, 1984, QUATERNARY EXTINCTIO; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen JA, 2012, P NATL ACAD SCI USA, V109, P4191, DOI 10.1073/pnas.1113788109; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam JC., 1932, FELIDAE RANCHO BREA; Milhacher MC, 2012, PALAEONTOL ELECTRON, V15, P1; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Mondini M, 2008, QUATERN INT, V180, P52, DOI 10.1016/j.quaint.2007.08.013; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nigra John O., 1947, BULL SO CALIFORNIA ACAD SCI, V46, P26; O'Keefe F, 2008, J VERTEBR PALEONTOL, V28, p122A; O'Keefe RF, 2009, CONTRIB SCI, V518, P1; Plavcan JM, 2008, AM J PHYS ANTHROPOL, V136, P65, DOI 10.1002/ajpa.20779; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; PROTHERO DR, 2009, CINCINNATI MUSEUM CT, V3, P291; Schaller G. B., 1972, SERENGETI LION STUDY; Schmitt E, 2011, THESIS E TENNESSEE S; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shaw CA, 1985, CONTRIBUTIONS SCI, V359, P1; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Therrien F, 2005, J ZOOL, V267, P249, DOI 10.1017/S0952836905007430; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; Ungar PS, 2008, DENTAL MICROWEAR TEX, V53, P389; Van Valkenburgh B, 2009, BIOL LETTERS, V5, P563, DOI 10.1098/rsbl.2009.0261; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; VanValkenburgh B, 1996, J MAMMAL, V77, P240, DOI 10.2307/1382725; Watts HE, 2009, P ROY SOC B-BIOL SCI, V276, P2291, DOI 10.1098/rspb.2009.0268; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2004, ALCHERINGA, V28, P291, DOI 10.1080/03115510408619286	57	57	58	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52453	10.1371/journal.pone.0052453	http://dx.doi.org/10.1371/journal.pone.0052453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300674	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800089
J	Ganzenmuller, GC; Hiermaier, S; Steinhauser, MO				Ganzenmueller, Georg C.; Hiermaier, Stefan; Steinhauser, Martin O.			Consistent Temperature Coupling with Thermal Fluctuations of Smooth Particle Hydrodynamics and Molecular Dynamics	PLOS ONE			English	Article							VELOCITY IMPACT COMPUTATIONS; FRACTURE INSTABILITIES; ENERGY-CONSERVATION; LIPID-BILAYERS; SHOCK-WAVES; SIMULATIONS; WATER; DEFORMATION; MODEL; SPH	We propose a thermodynamically consistent and energy-conserving temperature coupling scheme between the atomistic and the continuum domain. The coupling scheme links the two domains using the DPDE (Dissipative Particle Dynamics at constant Energy) thermostat and is designed to handle strong temperature gradients across the atomistic/continuum domain interface. The fundamentally different definitions of temperature in the continuum and atomistic domain - internal energy and heat capacity versus particle velocity - are accounted for in a straightforward and conceptually intuitive way by the DPDE thermostat. We verify the here-proposed scheme using a fluid, which is simultaneously represented as a continuum using Smooth Particle Hydrodynamics, and as an atomistically resolved liquid using Molecular Dynamics. In the case of equilibrium contact between both domains, we show that the correct microscopic equilibrium properties of the atomistic fluid are obtained. As an example of a strong non-equilibrium situation, we consider the propagation of a steady shock-wave from the continuum domain into the atomistic domain, and show that the coupling scheme conserves both energy and shock-wave dynamics. To demonstrate the applicability of our scheme to real systems, we consider shock loading of a phospholipid bilayer immersed in water in a multi-scale simulation, an interesting topic of biological relevance.	[Ganzenmueller, Georg C.; Hiermaier, Stefan; Steinhauser, Martin O.] Ernst Mach Inst, Fraunhofer Inst High Speed Dynam, Freiburg, Germany	Fraunhofer Gesellschaft	Ganzenmuller, GC (corresponding author), Ernst Mach Inst, Fraunhofer Inst High Speed Dynam, Freiburg, Germany.	georg.ganzenmueller@emi.fraunhofer.de		Ganzenmueller, Georg/0000-0001-5741-8844; Steinhauser, Martin Oliver/0000-0002-8639-4252	Fraunhofer-Gesellschaft, Germany [600016]	Fraunhofer-Gesellschaft, Germany	This work was carried out with financial support from the Fraunhofer-Gesellschaft, Germany, grant number 600016 (Vintage Class). http://www.fraunhofer.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham FF, 2000, PHYS REV LETT, V84, P3113, DOI 10.1103/PhysRevLett.84.3113; Allen MP., 1989, COMPUTER SIMULATION; Avalos JB, 1997, EUROPHYS LETT, V40, P141, DOI 10.1209/epl/i1997-00436-6; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Cleary PW, 1999, J COMPUT PHYS, V148, P227, DOI 10.1006/jcph.1998.6118; COOKE CH, 1992, COMMUN APPL NUMER M, V8, P219, DOI 10.1002/cnm.1630080403; de la Rubia TD, 2000, NATURE, V406, P871, DOI 10.1038/35022544; Diestler DJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.184104; Espanol P, 1997, EUROPHYS LETT, V40, P631, DOI 10.1209/epl/i1997-00515-8; Espanol P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026705; Fago M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.100102; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Gonzalez LM, 2009, PROCEEDINGS OF THE 4; Gravouil A, 2001, INT J NUMER METH ENG, V50, P199, DOI 10.1002/1097-0207(20010110)50:1<199::AID-NME132>3.0.CO;2-A; Gu YT, 2006, MULTISCALE MODEL SIM, V5, P1128, DOI 10.1137/060654232; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Hoover WilliamGraham., 2006, SMOOTH PARTICLE APPL, DOI 10.1142/6218; JOHNSON GR, 1994, NUCL ENG DES, V150, P265, DOI 10.1016/0029-5493(94)90143-0; Johnson GR, 1996, COMPUT METHOD APPL M, V139, P347, DOI 10.1016/S0045-7825(96)01089-4; Kermode JR, 2008, NATURE, V455, P1224, DOI 10.1038/nature07297; Kodama T, 2002, BBA-MOL CELL RES, V1542, P186, DOI 10.1016/S0167-4889(01)00177-X; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Kwon Y. W., 2008, MULTISCALE MODELLING; Lu G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024108; Lucy L, 1977, ASTRON J, V82; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; REE FH, 1980, J CHEM PHYS, V73, P5401, DOI 10.1063/1.439940; Shenoy VB, 1998, PHYS REV LETT, V80, P742, DOI 10.1103/PhysRevLett.80.742; Smith GS, 2000, PHYS REV LETT, V84, P1260, DOI 10.1103/PhysRevLett.84.1260; Steinhauser M.O., 2008, COMPUTATIONAL MULTIS; Steinhauser MO, 2006, EUROPHYS LETT, V73, P62, DOI 10.1209/epl/i2005-10353-2; Stoltz G, 2006, EUROPHYS LETT, V76, P849, DOI 10.1209/epl/i2006-10350-y; Warner DH, 2006, INT J PLASTICITY, V22, P754, DOI 10.1016/j.ijplas.2005.04.014; Xiao SP, 2004, COMPUT METHOD APPL M, V193, P1645, DOI 10.1016/j.cma.2003.12.053	40	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51989	10.1371/journal.pone.0051989	http://dx.doi.org/10.1371/journal.pone.0051989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300586	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800042
J	Karimian, G; Buist-Homan, M; Mikus, B; Henning, RH; Faber, KN; Moshage, H				Karimian, Golnar; Buist-Homan, Manon; Mikus, Bojana; Henning, Robert H.; Faber, Klaas Nico; Moshage, Han			Angiotensin II Protects Primary Rat Hepatocytes against Bile Salt-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEPATIC STELLATE CELLS; ACID-INDUCED APOPTOSIS; LIVER FIBROSIS; ER STRESS; INDUCED HEPATOTOXICITY; TRIGGERS APOPTOSIS; RECEPTOR BLOCKER; OXIDATIVE STRESS; CHOP GADD153	Angiotensin II (AT-II) is a pro-fibrotic compound that acts via membrane-bound receptors (AT-1R/AT-2R) and thereby activates hepatic stellate cells (HSCs). AT-II receptor blockers (ARBs) are thus important candidates in the treatment of liver fibrosis. However, multiple case reports suggest that AT-1R blockers may induce hepatocyte injury. Therefore, we investigated the effect of AT-II and its receptor blockers on cytokine-, oxidative stress-and bile salt-induced cell death in hepatocytes. Primary rat hepatocytes were exposed to TNF-alpha/Actinomycin D, the ROS-generating agent menadione or the bile salts: glycochenodeoxycholic acid (GCDCA) and tauro-lithocholic acid-3 sulfate (TLCS), to induce apoptosis. AT-II (100 nmol/L) was added 10 minutes prior to the cell death-inducing agent. AT-1R antagonists (Sartans) and the AT-2R antagonist PD123319 were used at 1 mu mol/L. Apoptosis (caspase-3 activity, acridine orange staining) and necrosis (Sytox green staining) were quantified. Expression of CHOP (marker for ER stress) and AT-II receptor mRNAs were quantified by Q-PCR. AT-II dose-dependently reduced GCDCA-induced apoptosis of hepatocytes (-50%, p<0.05) without inducing necrosis. In addition, AT-II reduced TLCS-induced apoptosis of hepatocytes (-50%, p<0.05). However, AT-II did not suppress TNF/Act-D and menadione-induced apoptosis. Only the AT-1R antagonists abolished the protective effect of AT-II against GCDCA-induced apoptosis. AT-II increased phosphorylation of ERK and a significant reversal of the protective effect of AT-II was observed when signaling kinases, including ERK, were inhibited. Moreover, AT-II prevented the GCDCA-induced expression of CHOP (the marker of the ER-mediated apoptosis). Conclusion: Angiotensin II protects hepatocytes from bile salt-induced apoptosis through a combined activation of PI3-kinase, MAPKs, PKC pathways and inhibition of bile salt-induced ER stress. Our results suggest a mechanism for the observed hepatocyte-toxicity of Sartans (angiotensin receptor blockers, ARBs) in some patients with chronic liver injury.	[Karimian, Golnar; Buist-Homan, Manon; Mikus, Bojana; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands	University of Groningen; University of Groningen	Karimian, G (corresponding author), Univ Groningen, Sect Hepatobiliairy Surg & Liver Transplantat, Surg Res Lab, Dept Surg,Univ Med Ctr Groningen, Groningen, Netherlands.	g.karimian01@umcg.nl	Henning, Robert H/AAY-5222-2020	Henning, Robert/0000-0002-5135-4621; Moshage, Han/0000-0002-4764-0246	University of Groningen	University of Groningen	This research was funded by the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, DIGEST DIS SCI, V56, P564, DOI 10.1007/s10620-010-1507-8; Andrade RJ, 1998, ANN PHARMACOTHER, V32, P1371, DOI 10.1345/aph.18087a; Andrade RJ, 2002, EUR J GASTROEN HEPAT, V14, P887, DOI 10.1097/00042737-200208000-00014; ASBERT M, 1992, J HEPATOL, V15, P179, DOI 10.1016/0168-8278(92)90033-L; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; Basile G, 2003, J CLIN GASTROENTEROL, V36, P273, DOI 10.1097/00004836-200303000-00017; Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Beltran AE, 2009, J HYPERTENS, V27, P142, DOI 10.1097/HJH.0b013e328317a730; Bernstein H, 1999, TOXICOL LETT, V108, P37, DOI 10.1016/S0378-4274(99)00113-7; Bosch X, 1997, JAMA-J AM MED ASSOC, V278, P1572, DOI 10.1001/jama.278.19.1572; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; El-Demerdash E, 2008, CLIN EXP PHARMACOL P, V35, P159, DOI 10.1111/j.1440-1681.2007.04797.x; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Guo Jeff J, 2005, Res Social Adm Pharm, V1, P460, DOI 10.1016/j.sapharm.2005.06.005; Hariraj R, 2000, BRIT MED J, V321, P547, DOI 10.1136/bmj.321.7260.547; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hsieh YC, 2003, SHOCK, V19, P582, DOI 10.1097/01.shk.0000065705.84144.ed; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Ikura Y, 2005, HEPATOL RES, V32, P107, DOI 10.1016/j.hepres.2005.01.017; Jao HC, 2001, SHOCK, V15, P130, DOI 10.1097/00024382-200115020-00009; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Kiykim A, 2003, AM J GASTROENTEROL, V98, P507; Lee W, 2005, APOPTOSIS, V10, P407, DOI 10.1007/s10495-005-0814-6; Leung PS, 2004, CURR PROTEIN PEPT SC, V5, P267, DOI 10.2174/1389203043379693; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; MORRIS BJ, 1979, ENDOCRINOLOGY, V105, P796, DOI 10.1210/endo-105-3-796; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; Nygaard Birte, 1996, Blood Pressure, V5, P190, DOI 10.3109/08037059609062128; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Perez MJ, 2011, BRIT J PHARMACOL, V162, P1686, DOI 10.1111/j.1476-5381.2010.01174.x; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rene JM, 2001, MED CLIN-BARCELONA, V117, P637, DOI 10.1016/S0025-7753(01)72204-X; Roma MG, 2011, CLIN SCI, V121, P523, DOI 10.1042/CS20110184; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Tabak F, 2002, J CLIN GASTROENTEROL, V34, P585, DOI 10.1097/00004836-200205000-00022; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tsuchiya S, 2006, TOXICOL LETT, V166, P140, DOI 10.1016/j.toxlet.2006.06.006; Vallejo I, 2000, MED CLIN-BARCELONA, V115, P719, DOI 10.1016/S0025-7753(00)71672-1; Warner FJ, 2007, CLIN SCI, V113, P109, DOI 10.1042/CS20070026; Weng YI, 2003, ALCOHOL, V29, P83, DOI 10.1016/S0741-8329(02)00325-7; Weng YI, 2002, BBA-MOL CELL RES, V1589, P285, DOI 10.1016/S0167-4889(02)00189-1; Weng YI, 2008, ALCOHOL, V42, P397, DOI 10.1016/j.alcohol.2008.02.004; Woudenberg-Vrenken TE, 2010, LIVER INT, V30, P1511, DOI 10.1111/j.1478-3231.2010.02325.x; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshiji H, 2003, HEPATOL RES, V27, P51, DOI 10.1016/S1386-6346(03)00160-8; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017	65	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52647	10.1371/journal.pone.0052647	http://dx.doi.org/10.1371/journal.pone.0052647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300732	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800119
J	Lockyer, AE; Emery, AM; Kane, RA; Walker, AJ; Mayer, CD; Mitta, G; Coustau, C; Adema, CM; Hanelt, B; Rollinson, D; Noble, LR; Jones, CS				Lockyer, Anne E.; Emery, Aidan M.; Kane, Richard A.; Walker, Anthony J.; Mayer, Claus D.; Mitta, Guillaume; Coustau, Christine; Adema, Coen M.; Hanelt, Ben; Rollinson, David; Noble, Leslie R.; Jones, Catherine S.			Early Differential Gene Expression in Haemocytes from Resistant and Susceptible Biomphalaria glabrata Strains in Response to Schistosoma mansoni	PLOS ONE			English	Article							INTERMEDIATE SNAIL HOST; ECHINOSTOMA-PARAENSEI; DEFENSE CELLS; SUPEROXIDE-DISMUTASE; PRIMARY SPOROCYSTS; MICROARRAY DATA; INFECTION; COMPATIBILITY; DISCOVERY; SYSTEM	The outcome of infection in the host snail Biomphalaria glabrata with the digenean parasite Schistosoma mansoni is determined by the initial molecular interplay occurring between them. The mechanisms by which schistosomes evade snail immune recognition to ensure survival are not fully understood, but one possibility is that the snail internal defence system is manipulated by the schistosome enabling the parasite to establish infection. This study provides novel insights into the nature of schistosome resistance and susceptibility in B. glabrata at the transcriptomic level by simultaneously comparing gene expression in haemocytes from parasite-exposed and control groups of both schistosome-resistant and schistosome-susceptible strains, 2 h post exposure to S. mansoni miracidia, using an novel 5 K cDNA microarray. Differences in gene expression, including those for immune/stress response, signal transduction and matrix/adhesion genes were identified between the two snail strains and tests for asymmetric distributions of gene function also identified immune-related gene expression in resistant snails, but not in susceptible. Gene set enrichment analysis revealed that genes involved in mitochondrial electron transport, ubiquinone biosynthesis and electron carrier activity were consistently up-regulated in resistant snails but down-regulated in susceptible. This supports the hypothesis that schistosome-resistant snails recognize schistosomes and mount an appropriate defence response, while in schistosome-susceptible snails the parasite suppresses this defence response, early in infection.	[Lockyer, Anne E.; Emery, Aidan M.; Kane, Richard A.; Rollinson, David] Nat Hist Museum, Dept Life Sci, Wolfson Wellcome Biomed Labs, London SW7 5BD, England; [Walker, Anthony J.] Univ Kingston, Sch Life Sci, Kingston Upon Thames KT1 2EE, Surrey, England; [Mayer, Claus D.] Univ Aberdeen, Rowett Inst Nutr & Hlth, BioSS Biomath & Stat Scotland Off, Aberdeen, Scotland; [Mitta, Guillaume] Univ Perpignan, CNRS, F-66025 Perpignan, France; [Coustau, Christine] INRA CNRS UNS, Sophia Agrobiotech Inst, F-06903 Sophia Antipolis, France; [Adema, Coen M.; Hanelt, Ben] Univ New Mexico, CETI, Albuquerque, NM 87131 USA; [Noble, Leslie R.; Jones, Catherine S.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Natural History Museum London; Kingston University; James Hutton Institute; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; INRAE; University of New Mexico; University of Aberdeen	Jones, CS (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	c.s.jones@abdn.ac.uk	Rollinson, David/C-7406-2009; Lockyer, Anne/AAO-4327-2021; Mayer, Claus-Dieter/L-9353-2013	Hanelt, Ben/0000-0001-9298-7356; mitta, guillaume/0000-0003-1188-1467; Lockyer, Anne/0000-0002-3498-2423; Emery, Aidan/0000-0001-9028-8586; Noble, leslie/0000-0003-3076-0759; COUSTAU, Christine/0000-0001-7524-0947; Mayer, Claus-Dieter/0000-0001-8788-3149	Wellcome Trust [068589/Z/02/Z]; United States National Institutes of Health (NIH), USA [R01AI052363, COBRE 1P20RR018754 IdEA]; NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052363] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out with funding from the Wellcome Trust (068589/Z/02/Z). CMA and BH acknowledge support from the United States National Institutes of Health (NIH), USA R01AI052363 (CMA) and COBRE 1P20RR018754 IdEA, NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema C.M., 1997, ADV TREMATODE BIOL, P230; Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Bayne CJ, 2009, MOL BIOCHEM PARASIT, V165, P8, DOI 10.1016/j.molbiopara.2009.01.005; Bayne CJ, 2001, PARASITOLOGY, V123, pS159; Bender RC, 2007, DEV COMP IMMUNOL, V31, P874, DOI 10.1016/j.dci.2006.12.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSWELL CA, 1985, EXP PARASITOL, V60, P133, DOI 10.1016/S0014-4894(85)80030-8; Bouchut A, 2006, INT J PARASITOL, V36, P175, DOI 10.1016/j.ijpara.2005.09.009; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davids BJ, 1998, DEV COMP IMMUNOL, V22, P39, DOI 10.1016/S0145-305X(97)00039-6; Davids BJ, 1999, GENE, V228, P213, DOI 10.1016/S0378-1119(99)00008-6; Deleury E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032512; El-Ansary A, 2006, MED SCI MONITOR, V12, pRA282; Goodall CP, 2006, MOL BIOCHEM PARASIT, V147, P207, DOI 10.1016/j.molbiopara.2006.02.009; Hanelt B, 2008, J INVERTEBR PATHOL, V99, P192, DOI 10.1016/j.jip.2008.06.002; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Humphries JE, 2008, DEV COMP IMMUNOL, V32, P554, DOI 10.1016/j.dci.2007.09.001; Ittiprasert W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002677; Ittiprasert W, 2009, EXP PARASITOL, V123, P203, DOI 10.1016/j.exppara.2009.07.015; Jones CS, 2001, PARASITOLOGY, V123, pS181; Jung Y, 2005, J INVERTEBR PATHOL, V90, P59, DOI 10.1016/j.jip.2005.06.014; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; LEWIS FA, 1986, J PARASITOL, V72, P813, DOI 10.2307/3281829; LIE KJ, 1976, J PARASITOL, V62, P608, DOI 10.2307/3279428; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lockyer AE, 2000, PARASITOLOGY, V120, P399, DOI 10.1017/S0031182099005624; Lockyer AE, 2004, EXP PARASITOL, V107, P97, DOI 10.1016/j.exppara.2004.04.004; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; LOKER ES, 1992, J PARASITOL, V78, P104, DOI 10.2307/3283696; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2011, INT J PARASITOL, V41, P721, DOI 10.1016/j.ijpara.2011.01.007; Mourao MD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000550; NEWTON WL, 1953, EXP PARASITOL, V2, P242, DOI 10.1016/0014-4894(53)90036-8; Pan SCT, 1996, JPN J MED SCI BIOL, V49, P129, DOI 10.7883/yoken1952.49.129; PARAENSE W. L., 1963, REV INST MED TROP SAO PAULO, V5, P15; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Plows LD, 2005, INT J PARASITOL, V35, P293, DOI 10.1016/j.ijpara.2004.11.012; Plows LD, 2006, BBA-MOL CELL RES, V1763, P779, DOI 10.1016/j.bbamcr.2006.04.008; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Theron A, 2005, J HELMINTHOL, V79, P187, DOI 10.1079/JOH2005299; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2010, CELL TISSUE RES, V341, P131, DOI 10.1007/s00441-010-0986-4; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Webster JP, 2001, PARASITOLOGY, V123, pS41, DOI 10.1017/S0031182001008071; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Yoshino TP, 2008, GENE, V411, P46, DOI 10.1016/j.gene.2008.01.003; YOSHINO TP, 1983, PARASITE IMMUNOL, V5, P317, DOI 10.1111/j.1365-3024.1983.tb00747.x; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z; Zahoor Z, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-18; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	69	44	47	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e511020	10.1371/journal.pone.0051102	http://dx.doi.org/10.1371/journal.pone.0051102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300533	Green Published, Green Accepted, gold			2022-12-25	WOS:000313618800010
J	Mannara, F; Valente, T; Saura, J; Graus, F; Saiz, A; Moreno, B				Mannara, Francesco; Valente, Tony; Saura, Josep; Graus, Francesc; Saiz, Albert; Moreno, Beatriz			Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IMMUNOGLOBULIN-DEFICIENT RATS; T-CELLS; PROTEOLIPID PROTEIN; FINE SPECIFICITY; BASIC-PROTEIN; MICE; INDUCTION; EXPRESSION	Experimental autoimmune encephalomyelitis (EAE) is the most relevant animal model to study demyelinating diseases such as multiple sclerosis. EAE can be induced by active (active EAE) or passive (at-EAE) transfer of activated T cells in several species and strains of rodents. However, histological features of at-EAE model in C57BL/6 are poorly described. The aim of this study was to characterize the neuroinflammatory and neurodegenerative responses of at-EAE in C57BL/6 mice by histological techniques and compare them with that observed in the active EAE model. To develop the at-EAE, splenocytes from active EAE female mice were harvested and cultured in presence of MOG35-55 and IL-12, and then injected intraperitoneally in recipient female C57BL6/J mice. In both models, the development of EAE was similar except for starting before the onset of symptoms and presenting a higher EAE cumulative score in the at-EAE model. Spinal cord histological examination revealed an increased glial activation as well as more extensive demyelinating areas in the at-EAE than in the active EAE model. Although inflammatory infiltrates composed by macrophages and T lymphocytes were found in the spinal cord and brain of both models, B lymphocytes were significantly increased in the at-EAE model. The co-localization of these B cells with IgG and their predominant distribution in areas of demyelination would suggest that IgG-secreting B cells are involved in the neurodegenerative processes associated with at-EAE.	[Mannara, Francesco; Valente, Tony; Graus, Francesc; Saiz, Albert; Moreno, Beatriz] Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain; [Mannara, Francesco; Valente, Tony; Graus, Francesc; Saiz, Albert; Moreno, Beatriz] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Mannara, Francesco; Valente, Tony; Saura, Josep] Univ Barcelona, Biochem & Mol Biol Unit, Sch Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Valente, T (corresponding author), Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain.	valente@clinic.ub.es	Graus, Francesc/K-9904-2018; Saiz, Albert/K-8236-2014; Valente, Tony/M-3097-2014; Saura, Josep/I-4428-2012	Saiz, Albert/0000-0002-5793-8791; Valente, Tony/0000-0002-2697-8184; Graus, Francesc/0000-0002-8924-8322; Saura, Josep/0000-0002-5601-4466	Fundacio La Marato de TV3 [101610]	Fundacio La Marato de TV3	This work was supported by a grant from Fundacio La Marato de TV3 (101610). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Amor S, 1996, J IMMUNOL, V156, P3000; AMOR S, 1994, J IMMUNOL, V153, P4349; Batoulis H, 2011, APMIS, V119, P819, DOI 10.1111/j.1600-0463.2011.02794.x; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; LASSMANN H, 1988, ACTA NEUROPATHOL, V75, P566, DOI 10.1007/BF00686201; LININGTON C, 1988, AM J PATHOL, V130, P443; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; TUOHY VK, 1992, J NEUROIMMUNOL, V39, P67, DOI 10.1016/0165-5728(92)90175-K; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WEINBERG AD, 1993, J NEUROIMMUNOL, V48, P105, DOI 10.1016/0165-5728(93)90064-6; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; WILLENBORG DO, 1983, J NEUROIMMUNOL, V5, P99, DOI 10.1016/0165-5728(83)90001-2; WILLENBORG DO, 1986, J NEUROIMMUNOL, V11, P93, DOI 10.1016/0165-5728(86)90111-6; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52361	10.1371/journal.pone.0052361	http://dx.doi.org/10.1371/journal.pone.0052361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300649	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800070
J	Soubannier, V; Rippstein, P; Kaufman, BA; Shoubridge, EA; McBride, HM				Soubannier, Vincent; Rippstein, Peter; Kaufman, Brett A.; Shoubridge, Eric A.; McBride, Heidi M.			Reconstitution of Mitochondria Derived Vesicle Formation Demonstrates Selective Enrichment of Oxidized Cargo	PLOS ONE			English	Article							VESICULAR TRANSPORT; PROTEIN; PARKIN; MITOPHAGY; FUSION; TRANSLOCATION; DEGRADATION; PROTEASOME; MITOFUSIN; MEMBRANE	The mechanisms that ensure the removal of damaged mitochondrial proteins and lipids are critical for the health of the cell, and errors in these pathways are implicated in numerous degenerative diseases. We recently uncovered a new pathway for the selective removal of proteins mediated by mitochondrial derived vesicular carriers (MDVs) that transit to the lysosome. However, it was not determined whether these vesicles were selectively enriched for oxidized, or damaged proteins, and the extent to which the complexes of the electron transport chain and the mtDNA-containing nucloids may have been incorporated. In this study, we have developed a cell-free mitochondrial budding reaction in vitro in order to better dissect the pathway. Our data confirm that MDVs are stimulated upon various forms of mitochondrial stress, and the vesicles incorporated quantitative amounts of cargo, whose identity depended upon the nature of the stress. Under the conditions examined, MDVs did not incorporate complexes I and V, nor were any nucleoids present, demonstrating the specificity of cargo incorporation. Stress-induced MDVs are selectively enriched for oxidized proteins, suggesting that conformational changes induced by oxidation may initiate their incorporation into the vesicles. Ultrastructural analyses of MDVs isolated on sucrose flotation gradients revealed the formation of both single and double membranes vesicles of unique densities and uniform diameter. This work provides a framework for a reductionist approach towards a detailed examination of the mechanisms of MDV formation and cargo incorporation, and supports the emerging concept that MDVs are critical contributors to mitochondrial quality control.	[Soubannier, Vincent; Shoubridge, Eric A.; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rippstein, Peter] Univ Ottawa, Inst Heart, Lipoproteins & Atherosclerosis Grp, Ottawa, ON, Canada; [Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	McGill University; University of Ottawa; University of Ottawa Heart Institute; University of Pennsylvania	McBride, HM (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	heidi.mcbride@mcgill.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280	Heart and Stroke Foundation of Ontario [5769]; Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar	This study was supported by the Heart and Stroke Foundation of Ontario, Grant-In-Aid 5769; The Ernest and Margaret Ford Endowed Research Fellowship in Cardiology at the University of Ottawa; Howard Hughes International Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; ARGAN C, 1983, J BIOL CHEM, V258, P6667; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Cai Q, 2012, CURR BIOL; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Joselin AP, 2012, HUM MOL GENET; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; McBride HM, 1996, J CELL BIOL, V134, P307, DOI 10.1083/jcb.134.2.307; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	37	198	200	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52830	10.1371/journal.pone.0052830	http://dx.doi.org/10.1371/journal.pone.0052830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300790	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800155
J	Xu, GQ; Zou, W; Chen, XL; Xu, N; Liu, LM; Chen, J				Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian			Fumaric Acid Production in Saccharomyces cerevisiae by In Silico Aided Metabolic Engineering	PLOS ONE			English	Article							ESCHERICHIA-COLI; YEAST; RECONSTRUCTION; EXPRESSION; MODELS; GROWTH	Fumaric acid (FA) is a promising biomass-derived building-block chemical. Bio-based FA production from renewable feedstock is a promising and sustainable alternative to petroleum-based chemical synthesis. Here we report on FA production by direct fermentation using metabolically engineered Saccharomyces cerevisiae with the aid of in silico analysis of a genome-scale metabolic model. First, FUM1 was selected as the target gene on the basis of extensive literature mining. Flux balance analysis (FBA) revealed that FUM1 deletion can lead to FA production and slightly lower growth of S. cerevisiae. The engineered S. cerevisiae strain obtained by deleting FUM1 can produce FA up to a concentration of 610 +/- 31 mg L-1 without any apparent change in growth in fed-batch culture. FT-IR and H-1 and C-13 NMR spectra confirmed that FA was synthesized by the engineered S. cerevisiae strain. FBA identified pyruvate carboxylase as one of the factors limiting higher FA production. When the RoPYC gene was introduced, S. cerevisiae produced 1134 +/- 48 mg L-1 FA. Furthermore, the final engineered S. cerevisiae strain was able to produce 1675 +/- 52 mg L-1 FA in batch culture when the SFC1 gene encoding a succinate-fumarate transporter was introduced. These results demonstrate that the model shows great predictive capability for metabolic engineering. Moreover, FA production in S. cerevisiae can be efficiently developed with the aid of in silico metabolic engineering.	[Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Xu, Guoqiang; Zou, Wei; Liu, Liming; Chen, Jian] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	mingll@jiangnan.edu.cn; jchen@jiangnan.edu.cn	Chen, Xiulai/AAB-8395-2020; Liu, Liming/B-1972-2009	Chen, Xiulai/0000-0002-5154-3860; Liu, Liming/0000-0003-3022-936X; Xu, Nan/0000-0002-2510-3394	Key Program of National Natural Science Foundation of China [20836003]; National Outstanding Doctorate Paper Author Special Fund [200962]; Program for New Century Excellent Talents in University [NCET-10-0456]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctor Candidate Foundation of Jiangnan University [JUDCF09015]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Outstanding Doctorate Paper Author Special Fund; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctor Candidate Foundation of Jiangnan University	This work was supported by grants from the Key Program of National Natural Science Foundation of China (No. 20836003), the National Outstanding Doctorate Paper Author Special Fund (No. 200962), Program for New Century Excellent Talents in University (NCET-10-0456), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Doctor Candidate Foundation of Jiangnan University (JUDCF09015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DA, 2009, FEMS YEAST RES, V9, P1123, DOI 10.1111/j.1567-1364.2009.00537.x; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P28, DOI 10.1016/S1389-1723(99)80004-8; Bojunga N, 1998, MOL GEN GENET, V260, P453, DOI 10.1007/s004380050916; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Cao NJ, 1996, APPL ENVIRON MICROB, V62, P2926, DOI 10.1128/AEM.62.8.2926-2931.1996; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; KACLIKOVA E, 1992, FEMS MICROBIOL LETT, V91, P101; KENEALY W, 1986, APPL ENVIRON MICROB, V52, P128, DOI 10.1128/AEM.52.1.128-133.1986; Kim TY, 2011, CURR OPIN BIOTECHNOL; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Liu LM, 2010, FEBS LETT, V584, P2556, DOI 10.1016/j.febslet.2010.04.052; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2011, BIOTECHNOL ADV; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Raab AM, 2011, APPL ENVIRON MICROB, V77, P1981, DOI 10.1128/AEM.02219-10; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Redruello B, 1999, FEBS LETT, V445, P246, DOI 10.1016/S0014-5793(99)00120-9; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Tokuhiro K, 2009, APPL MICROBIOL BIOT, V82, P883, DOI 10.1007/s00253-008-1831-5; Xu GQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-24; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zelle RM, 2010, APPL ENVIRON MICROB, V76, P744, DOI 10.1128/AEM.02396-09	33	36	42	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52086	10.1371/journal.pone.0052086	http://dx.doi.org/10.1371/journal.pone.0052086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300594	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800047
J	Delhanty, PJD; Huisman, M; Baldeon-Rojas, LY; van den Berge, I; Grefhorst, A; Abribat, T; Leenen, PJM; Themmen, APN; van der Lely, AJ				Delhanty, Patric J. D.; Huisman, Martin; Baldeon-Rojas, Lucy Y.; van den Berge, Iris; Grefhorst, Aldo; Abribat, Thierry; Leenen, Pieter J. M.; Themmen, Axel P. N.; van der Lely, Aart-Jan			Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis	FASEB JOURNAL			English	Article						obesity; insulin resistance; inflammation	BROWN ADIPOSE-TISSUE; MESSENGER-RNA EXPRESSION; UNACYLATED GHRELIN; GROWTH-HORMONE; INSULIN SENSITIVITY; INDUCED OBESITY; FOOD-INTAKE; T-CELLS; MICE; THERMOGENESIS	There is clinical evidence that des-acyl ghrelin (DAG) favorably modulates glucose and lipid metabolism, although its mode of action is unknown. A murine model of prediabetes was used to assess possible mechanisms of action for DAG and a newly developed bioactive analog, AZP531. C57BL/6J mice were infused with saline, DAG, or AZP531 continuously for 4 wk, and fed either normal diet (ND) or normal diet for 2 wk followed by a high-fat diet (HFD) for 2 wk. Compared with mice in the ND group, HFD increased body and fat mass, caused glucose intolerance and insulin resistance, had proinflammatory effects in white adipose tissue, and caused lipid accumulation in brown adipose tissue. DAG and AZP531 treatment prevented HFD-induced proinflammatory effects, stimulated expression of mitochondrial function markers in brown adipose tissue, and prevented development of a prediabetic metabolic state. AZP531 also prevented a HFD-induced increase in acyl ghrelin levels. Our data indicate DAG analogs as potential treatment for the prevention of metabolic syndrome.-Delhanty, P. J. D., Huisman, M., Baldeon-Rojas, L.Y., van den Berge, I., Grefhorst, A., Abribat, T., Leenen, P. J. M., Themmen, A. P. N., van der Lely, A.-J. Des-acyl ghrelin analogs prevent high-fat diet-induced dysregulation of glucose homeostasis. FASEB J. 27, 1690-1700 (2013). www.fasebj.org	[Delhanty, Patric J. D.; Huisman, Martin; van den Berge, Iris; Grefhorst, Aldo; Themmen, Axel P. N.; van der Lely, Aart-Jan] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Baldeon-Rojas, Lucy Y.; Leenen, Pieter J. M.] Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands; [Abribat, Thierry] Alize Pharma, Ecully, France	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Delhanty, PJD (corresponding author), Erasmus MC, Dept Internal Med, Rm Ee532,POB 2040, NL-3000 CA Rotterdam, Netherlands.	p.delhanty@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013; Baldeon, Lucy/AAE-6323-2022	Leenen, Pieter JM/0000-0001-9860-2920; Baldeon, Lucy/0000-0002-0447-0136				Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94; Benso A, 2012, EUR J ENDOCRINOL, V166, P911, DOI 10.1530/EJE-11-0982; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Buysschaert M, 2011, MED CLIN N AM, V95, P289, DOI 10.1016/j.mcna.2010.11.002; Cederberg H, 2012, CLIN ENDOCRINOL, V76, P39, DOI 10.1111/j.1365-2265.2011.04135.x; Colagiuri S, 2011, MED CLIN N AM, V95, P299, DOI 10.1016/j.mcna.2010.11.003; Delhanty PJD, 2011, PEPTIDES, V32, P2309, DOI 10.1016/j.peptides.2011.03.001; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Dixit VD, 2005, EXP GERONTOL, V40, P900, DOI 10.1016/j.exger.2005.09.003; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Garcia B, 2002, AM J PHYSIOL-CELL PH, V282, pC105, DOI 10.1152/ajpcell.01396.2000; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Granata R, 2012, J MED CHEM, V55, P2585, DOI 10.1021/jm201223m; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Julien M, 2012, EUR J PHARM SCI, V47, P625, DOI 10.1016/j.ejps.2012.07.014; Kellokoski E, 2009, PEPTIDES, V30, P2292, DOI 10.1016/j.peptides.2009.09.008; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Loomans CJM, 2009, MOL MED, V15, P152, DOI 10.2119/molmed.2009.00032; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Mano-Otagiri A, 2010, REGUL PEPTIDES, V160, P81, DOI 10.1016/j.regpep.2009.11.010; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Perreault M, 2004, INT J OBESITY, V28, P879, DOI 10.1038/sj.ijo.0802640; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Souza-Moreira L, 2011, NEUROENDOCRINOLOGY, V94, P89, DOI 10.1159/000328636; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sutherland LN, 2008, AM J PHYSIOL-ENDOC M, V295, pE1076, DOI 10.1152/ajpendo.90408.2008; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; van der Lely AJ, 2007, MOL CELL ENDOCRINOL, V274, P30, DOI 10.1016/j.mce.2006.05.010; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wadden D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045748; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	62	58	59	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1690	1700		10.1096/fj.12-221143	http://dx.doi.org/10.1096/fj.12-221143			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23299855				2022-12-25	WOS:000316940800038
J	Heul, AMV; Fowler, CA; Ramaswamy, S; Piper, RC				Heul, Aaron M. Ver; Fowler, C. Andrew; Ramaswamy, S.; Piper, Robert C.			Ubiquitin Regulates Caspase Recruitment Domain-mediated Signaling by Nucleotide-binding Oligomerization Domain-containing Proteins NOD1 and NOD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; STRUCTURAL BASIS; INNATE; RECOGNITION; ACTIVATION; AUTOPHAGY; RECEPTORS; CARD; IMMUNITY; PEPTIDOGLYCAN	NOD1 and NOD2 (nucleotide-binding oligomerization domain-containing proteins) are intracellular pattern recognition receptors that activate inflammation and autophagy. These pathways rely on the caspase recruitment domains (CARDs) within the receptors, which serve as protein interaction platforms that coordinately regulate immune signaling. We show that NOD1 CARD binds ubiquitin (Ub), in addition to directly binding its downstream targets receptor-interacting protein kinase 2 (RIP2) and autophagy-related protein 16-1 (ATG16L1). NMR spectroscopy and structure-guided mutagenesis identified a small hydrophobic surface of NOD1 CARD that binds Ub. In vitro, Ub competes with RIP2 for association with NOD1 CARD. In vivo, we found that the ligand-stimulated activity of NOD1 with a mutant CARD lacking Ub binding but retaining ATG16L1 and RIP2 binding is increased relative to wild-type NOD1. Likewise, point mutations in the tandem NOD2 CARDs at positions analogous to the surface residues defining the Ub interface on NOD1 resulted in loss of Ub binding and increased ligand-stimulated NOD2 signaling. These data suggest that Ub binding provides a negative feedback loop upon NOD-dependent activation of RIP2.	[Heul, Aaron M. Ver; Piper, Robert C.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52246 USA; [Heul, Aaron M. Ver; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52246 USA; [Fowler, C. Andrew] Carver Coll Med, NMR Facil, Iowa City, IA 52246 USA; [Ramaswamy, S.] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Ramaswamy, S (corresponding author), Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India.	ramas@instem.res.in; Robert-Piper@uiowa.edu	Subramanian, Ramaswamy/Q-8671-2019	Subramanian, Ramaswamy/0000-0002-6709-190X; Fowler, Andrew/0000-0001-5646-5307; Piper, Robert/0000-0001-9995-5699; Ver Heul, Aaron/0000-0003-3386-8351	National Institutes of Health [5R01GM058202]; InStem, Bangalore; National Institutes of Health Biotechnology Training Grant through the University of Iowa Center for Biocatalysis and Bioprocessing [5T32GM008365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, R01GM058202, T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); InStem, Bangalore; National Institutes of Health Biotechnology Training Grant through the University of Iowa Center for Biocatalysis and Bioprocessing; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM058202. This work was also supported by InStem, Bangalore, intramural research grants.; Supported in part by National Institutes of Health Biotechnology Training Grant 5T32GM008365 through the University of Iowa Center for Biocatalysis and Bioprocessing.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen YR, 2004, PROTEIN SCI, V13, P2196, DOI 10.1110/ps.03521504; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goddard T. D., SPARKY3; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Johnson B. A., 2010, NMRVIEWJ VERSION 8 2; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Magalhaes JG, 2011, CURR OPIN IMMUNOL, V23, P29, DOI 10.1016/j.coi.2010.12.003; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saleh M, 2011, IMMUNOL REV, V243, P235, DOI 10.1111/j.1600-065X.2011.01045.x; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6890	6902		10.1074/jbc.M112.413781	http://dx.doi.org/10.1074/jbc.M112.413781			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23300079	Green Published, hybrid			2022-12-25	WOS:000316002400010
J	Dokter, AM; Shamoun-Baranes, J; Kemp, MU; Tijm, S; Holleman, I				Dokter, Adriaan M.; Shamoun-Baranes, Judy; Kemp, Michael U.; Tijm, Sander; Holleman, Iwan			High Altitude Bird Migration at Temperate Latitudes: A Synoptic Perspective on Wind Assistance	PLOS ONE			English	Article							NOCTURNAL PASSERINE MIGRATION; FLIGHT ALTITUDES; RADAR; AUTUMN; MIGRANTS; WEATHER; EUROPE; MODELS	At temperate latitudes the synoptic patterns of bird migration are strongly structured by the presence of cyclones and anticyclones, both in the horizontal and altitudinal dimensions. In certain synoptic conditions, birds may efficiently cross regions with opposing surface wind by choosing a higher flight altitude with more favourable wind. We observed migratory passerines at mid-latitudes that selected high altitude wind optima on particular nights, leading to the formation of structured migration layers at varying altitude up to 3 km. Using long-term vertical profiling of bird migration by C-band Doppler radar in the Netherlands, we find that such migration layers occur nearly exclusively during spring migration in the presence of a high-pressure system. A conceptual analytic framework providing insight into the synoptic patterns of wind assistance for migrants that includes the altitudinal dimension has so far been lacking. We present a simple model for a baroclinic atmosphere that relates vertical profiles of wind assistance to the pressure and temperature patterns occurring at temperate latitudes. We show how the magnitude and direction of the large scale horizontal temperature gradient affects the relative gain in wind assistance that migrants obtain through ascending. Temperature gradients typical for northerly high-pressure systems in spring are shown to cause high altitude wind optima in the easterly sectors of anticyclones, thereby explaining the frequent observations of high altitude migration in these synoptic conditions. Given the recurring synoptic arrangements of pressure systems across temperate continents, the opportunities for exploiting high altitude wind will differ between flyways, for example between easterly and westerly oceanic coasts.	[Dokter, Adriaan M.; Shamoun-Baranes, Judy; Kemp, Michael U.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Dokter, Adriaan M.; Tijm, Sander; Holleman, Iwan] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Holleman, Iwan] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Royal Netherlands Meteorological Institute; Radboud University Nijmegen	Dokter, AM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	a.m.dokter@uva.nl	Holleman, Iwan/D-6229-2013; Shamoun-Baranes, Judy/Q-1311-2019; Dokter, Adriaan/AAA-9244-2021; Shamoun-Baranes, Judy/C-6921-2013	Shamoun-Baranes, Judy/0000-0002-1652-7646; Shamoun-Baranes, Judy/0000-0002-1652-7646				ABLE KP, 1970, BIRD BANDING, V41, P282, DOI 10.2307/4511688; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Baas P, 2009, J APPL METEOROL CLIM, V48, P1627, DOI 10.1175/2009JAMC1965.1; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; BRUDERER B, 1995, IBIS, V137, P44, DOI 10.1111/j.1474-919X.1995.tb03218.x; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; BRUDERER B, 1995, ISR J ZOOL, V76, P1106; BRUDERER B, 1971, ORNITHOL BEOB, V68, P89; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Dokter AM, 2011, J R SOC INTERFACE, V8, P30, DOI 10.1098/rsif.2010.0116; Erni B, 2002, ARDEA, V90, P155; GAUTHREAUX SA, 1991, AM ZOOL, V31, P187; Gauthreaux Sidney A. Jr, 2005, P182; Green M, 2002, J THEOR BIOL, V218, P485, DOI 10.1006/jtbi.2002.3094; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Holton J., 2004, INTRO DYNAMIC METEOR; Karlsson H, 2011, IBIS, V153, P485, DOI 10.1111/j.1474-919X.2011.01130.x; Karlsson H, 2010, BEHAV ECOL SOCIOBIOL, V64, P2021, DOI 10.1007/s00265-010-1015-z; Kemp MU, 2012, J THEOR BIOL, V308, P56, DOI 10.1016/j.jtbi.2012.05.026; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Klaassen M, 2000, J AVIAN BIOL, V31, P47, DOI 10.1034/j.1600-048X.2000.310107.x; KNMI, 2011, EUR WEATH CHARTS ARC; KNMI, 2011, CLIM MONTHL DESCR KN; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Liechti F, 2000, AUK, V117, P205, DOI 10.1642/0004-8038(2000)117[0205:PMFABP]2.0.CO;2; PIERSMA T, 1990, ARDEA, V78, P315; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Richardson W.J., 1990, P78; RICHARDSON WJ, 1976, IBIS, V118, P309, DOI 10.1111/j.1474-919X.1976.tb02023.x; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Schmaljohann H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1609, DOI 10.1007/s00265-009-0758-x; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Unden P., 2002, TECHNICAL REPORT; Van Belle J, 2007, J APPL ECOL, V44, P864, DOI 10.1111/j.1365-2664.2007.01322.x; Zehnder S, 2001, J AVIAN BIOL, V32, P239, DOI 10.1111/j.0908-8857.2001.320306.x	36	50	51	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52300	10.1371/journal.pone.0052300	http://dx.doi.org/10.1371/journal.pone.0052300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300969	Green Published, Green Submitted, gold			2022-12-25	WOS:000313480000007
J	Theodoropoulou, S; Brodowska, K; Kayama, M; Morizane, Y; Miller, JW; Gragoudas, ES; Vavvas, DG				Theodoropoulou, Sofia; Brodowska, Katarzyna; Kayama, Maki; Morizane, Yuki; Miller, Joan W.; Gragoudas, Evangelos S.; Vavvas, Demetrios G.			Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; SKELETAL-MUSCLE; ENERGY STATUS; TUMOR-GROWTH; PHOSPHORYLATION SITES; SIGNALING PATHWAY; MAMMALIAN TARGET; CDK INHIBITORS; BREAST-CANCER	5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR), an analog of AMP is widely used as an activator of AMP-kinase (AMPK), a protein that regulates the responses of the cell to energy change. Recently, we showed that AICAR-induced AMPK activation inhibits the growth of retinoblastoma cells in vitro by decreasing cyclins and by inducing apoptosis and S-phase arrest. In this study, we investigated the effects of AMPK activator AICAR on the growth of retinoblastoma in vivo. Intraperitoneal injection of AICAR resulted in 48% growth inhibition of Y79 retinoblastoma cell tumors in mice. Tumors isolated from mice treated with AICAR had decreased expression of Ki67 and increased apoptotic cells (TUNEL positive) compared with the control. In addition, AICAR treatment suppressed significantly tumor vessel density and macrophage infiltration. We also showed that AICAR administration resulted in AMPK activation and mTOR pathway inhibition. Paradoxically observed down-regulation of p21, which indicates that p21 may have a novel function of an oncogene in retinoblastoma tumor. Our results indicate that AICAR treatment inhibited the growth of retinoblastoma tumor in vivo via AMPK/mTORC1 pathway and by apoptogenic, anti-proliferative, anti-angiogenesis mechanism. AICAR is a promising novel non-chemotherapeutic drug that may be effective as an adjuvant in treating Retinoblastoma.	[Theodoropoulou, Sofia; Brodowska, Katarzyna; Kayama, Maki; Morizane, Yuki; Miller, Joan W.; Gragoudas, Evangelos S.; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Retina Serv,Angiogenesis Lab, Dept Ophthalmol,Massachusetts Eye & Ear Infirmary, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Vavvas, DG (corresponding author), Harvard Univ, Sch Med, Retina Serv,Angiogenesis Lab, Dept Ophthalmol,Massachusetts Eye & Ear Infirmary, Boston, MA 02115 USA.	vavvas@meei.harvard.edu		Theodoropoulou, Sofia/0000-0003-3038-5354; Vavvas, Demetrios/0000-0002-8622-6478; Miller, Joan/0000-0003-2046-3996	National Eye Institute grant [EY014104]; Research to Prevent Blindness Unrestricted Institutional Award; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER	National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Institutional Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grant EY014104 (MEEI Core Grant) and Research to Prevent Blindness Unrestricted Institutional Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Eye Institute grant EY014104 (MEEI Core Grant) and Research to Prevent Blindness Unrestricted Institutional Award.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Apte RS, 2007, OPHTHAL RES, V39, P188, DOI 10.1159/000103578; Baumann P, 2007, EXP CELL RES, V313, P3592, DOI 10.1016/j.yexcr.2007.06.020; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Fadden P, 1997, J BIOL CHEM, V272, P10240; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Gingras AC, 2001, PROG MOLEC, V27, P143; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HEALY E, 1995, BRIT J DERMATOL, V133, P737, DOI 10.1111/j.1365-2133.1995.tb02748.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jia RB, 2007, OPHTHAL RES, V39, P108, DOI 10.1159/000099247; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp B., 2003, AMP ACTIVATED PROTEI; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Miyano-Kurosaki N, 2006, BIOL PHARM BULL, V29, P2197, DOI 10.1248/bpb.29.2197; Nakanishi C, 2004, ONCOLOGY-BASEL, V67, P476, DOI 10.1159/000082933; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishimura S, 2001, J CLIN ONCOL, V19, P4182, DOI 10.1200/JCO.2001.19.21.4182; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Petti C, 2012, MELANOMA RES, V22, P341, DOI 10.1097/CMR.0b013e3283544929; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; ROARTY JD, 1988, OPHTHALMOLOGY, V95, P1583; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P282, DOI 10.1001/archophthalmol.2008.626; Shields CL, 2003, J PEDIAT OPHTH STRAB, V40, P6; Shields CL, 2002, ARCH OPHTHALMOL-CHIC, V120, P460; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Tsuji T, 1998, BIOCHEM BIOPH RES CO, V242, P317, DOI 10.1006/bbrc.1997.7958; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	66	31	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52852	10.1371/journal.pone.0052852	http://dx.doi.org/10.1371/journal.pone.0052852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300996	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000018
J	Chen, HY; Sun, B; Zhao, YJ; Song, X; Fan, WW; Zhou, KK; Zhou, LF; Mao, Y; Lu, DR				Chen, Hongyan; Sun, Bing; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Zhou, Keke; Zhou, Liangfu; Mao, Ying; Lu, Daru			Fine Mapping of a Region of Chromosome 11q23.3 Reveals Independent Locus Associated with Risk of Glioma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CHINESE POPULATION; VARIANTS; SUSCEPTIBILITY; LL5-BETA; VESICLE; IDENTIFICATION; HAPLOTYPES; FILAMIN; COMMON	Background: A single nucleotide polymorphism (SNP) at locus 11q23.3 (rs498872) in the near 5'-UTR of the PHLDB1 gene was recently implicated as a risk factor for gliomas in a genome-wide association study, and this involvement was confirmed in three additional studies. Methodology/Principal Findings: To identify possible causal variants in the region, the authors genotyped 15 tagging SNPs in the 200 kb genomic region at 11q23.3 locus in a Chinese Han population-based case-control study with 983 cases and 1024 controls. We found evidence for an association between two independent loci (both the PHLDB1 and the ACRN1 genes) and a predisposition for gliomas. Among the multiple significant SNPs in the PHLDB1 gene region, the rs17749 SNP was the most significant [P = 1.31x10(-6) in a recessive genetic model]. Additionally, two novel SNPs (rs2236661 and rs494560) that were independent of rs17749 were significantly associated with glioma risk in a recessive genetic model [P = 1.31x10(-5) and P = 3.32x10(-5), respectively]. The second novel locus was within the ARCN1 gene, and it was associated with a significantly reduced risk for glioma. Conclusions/Significance: Our data strongly support PHLDB1 as a susceptibility gene for glioma, also shedding light on a new potentially candidate gene, ARCN1.	[Chen, Hongyan; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Lu, Daru] Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China; [Chen, Hongyan; Zhao, Yingjie; Song, Xiao; Fan, Weiwei; Lu, Daru] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Sun, Bing; Zhou, Keke; Zhou, Liangfu; Mao, Ying] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Mao, Y (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China.	maoyinghs@hotmail.com; drlu@fudan.edu.cn	Frank, Viki/GXZ-9902-2022	Mao, Ying/0000-0001-8055-115X	Shanghai Science and Technology Research Program [09JC1402200]; Natural Science Foundation of China [81001114]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry); Doctoral Fund of Ministry of Education of China	Shanghai Science and Technology Research Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was partially supported by Shanghai Science and Technology Research Program (09JC1402200), Natural Science Foundation of China (81001114), the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry) and the Doctoral Fund of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Kateb H, 2007, DIABETES, V56, P2161, DOI 10.2337/db07-0376; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Katoh M, 2003, INT J ONCOL, V23, P1477; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YH, 2008, HUM MUTAT, V29, P381, DOI 10.1002/humu.20645; Liu YH, 2007, CARCINOGENESIS, V28, P1906, DOI 10.1093/carcin/bgm073; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; National Bureau of Statistics of China, 2009, CHIN HLTH STAT YB, P254; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donnell MJ, 1997, GENET ENG NEWS, V17, P39; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schoemaker MJ, 2010, AM J EPIDEMIOL, V171, P1165, DOI 10.1093/aje/kwq075; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xu XJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000956; XUE QC, 1990, CLIN NEUROL NEUROSUR, V92, P27, DOI 10.1016/0303-8467(90)90004-O; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhou KK, 2009, INT J CANCER, V124, P2948, DOI 10.1002/ijc.24307; Zhou QOL, 2010, J BIOL CHEM, V285, P27581, DOI 10.1074/jbc.M110.146886	35	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52864	10.1371/journal.pone.0052864	http://dx.doi.org/10.1371/journal.pone.0052864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300798	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600031
J	Zhang, XL; Qiao, H; Zhao, YL; Wang, X; Sun, HM; Liu, A; Xu, LD; Sun, DL; Jin, Y; Yu, Y; Meng, XN; Bai, J; Chen, F; Fu, SB				Zhang, Xuelong; Qiao, Hong; Zhao, Yanling; Wang, Xi; Sun, Haiming; Liu, An; Xu, Lidan; Sun, Donglin; Jin, Yan; Yu, Yang; Meng, Xiangning; Bai, Jing; Chen, Feng; Fu, Songbin			Association of Single Nucleotide Polymorphisms in TCF2 with Type 2 Diabetes Susceptibility in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER RISK; COMMON VARIANTS; YOUNG GENES; HNF1-BETA; CLASSIFICATION; NEPHROGENESIS; PARTNERS; DISEASE; LINKAGE	Hepatocyte nuclear factor 1 beta (HNF1 beta), a transcription factor encoded by the transcription factor 2 gene (TCF2), plays a critical role in pancreatic cell formation and glucose homeostasis. It has been suggested that single nucleotide polymorphisms (SNPs) of TCF2 are associated with susceptibility to type 2 diabetes (T2D). However, published results are inconsistent and inclusive. To further investigate the role of these common variants, we examined the association of TCF2 polymorphisms with the risk of T2D in a Han population in northeastern China. We genotyped five SNPs in 624 T2D patients and 630 healthy controls by using a SNaPshot method, and evaluated the T2D risk conferred by individual SNPs and haplotypes. In the single-locus analysis, we found that rs752010, rs4430796 and rs7501939 showed allelic differences between T2D patients and healthy controls, with an OR of 1.26 (95% CI 1.08-1.51, P=0.003), an OR of 1.23 (95% CI 1.06-1.55, P=0.001) and an OR of 1.28 (95% CI 1.10-1.61, P=0.001), respectively. Genotype association analysis of each locus also revealed that the homozygous carriers of the at-risk allele had a significant increased T2D risk compared to homozygous carriers of the other allele (OR 1.78, 95% CI 1.20-2.64 for rs752010; OR 1.82, 95% CI 1.24-2.67 for rs4430796; OR 1.95, 95% CI 1.31-2.90 for rs7501939), even after Bonferroni correction for multiple comparisons. Besides, the haplotype-based analysis demonstrated that AGT in block rs752010-rs4430796-rs7501939 was associated with about 30% increase in T2D risk (OR 1.31, 95% CI 1.09-1.57, P=0.01). Our findings suggested that TCF2 variants may be involved in T2D risk in a Han population of northeastern China. Larger studies with ethnically diverse populations are warranted to confirm the results reported in this investigation.	[Zhang, Xuelong; Zhao, Yanling; Sun, Haiming; Liu, An; Xu, Lidan; Sun, Donglin; Jin, Yan; Yu, Yang; Meng, Xiangning; Bai, Jing; Chen, Feng; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Qiao, Hong] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Peoples R China; [Wang, Xi] Harbin Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Harbin, Peoples R China; [Fu, Songbin] Harbin Med Univ, Heilongjiang Higher Educ Inst, Key Lab Med Genet, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Fu, SB (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn			National Basic Research Program of China [2010CB534901]; National Natural Science Foundation of China [81172742]; Ministry of Education of China [NCET-08-0671, NCET-10-0149]; Public Health Department of Heilongjiang Province of China [2010-183]; post-doctoral foundation of Heilongjiang Province of China [LRB 09-293]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Public Health Department of Heilongjiang Province of China; post-doctoral foundation of Heilongjiang Province of China	This work was funded by the National Basic Research Program of China (2010CB534901), the National Natural Science Foundation of China (81172742), the New Century Support Program for the Excellent Scholar, Ministry of Education of China (NCET-08-0671 and NCET-10-0149), the Public Health Department of Heilongjiang Province (No. 2010-183) of China, and the post-doctoral foundation of Heilongjiang Province (LRB 09-293) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Edghill EL, 2008, NEPHROL DIAL TRANSPL, V23, P627, DOI 10.1093/ndt/gfm603; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Fischer E, 2008, KIDNEY INT, V74, P145, DOI 10.1038/ki.2008.250; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Holmkvist J, 2008, DIABETES, V57, P1738, DOI 10.2337/db06-1464; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wang CR, 2009, DIABETES, V58, P1023, DOI 10.2337/db08-1064; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	28	6	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52938	10.1371/journal.pone.0052938	http://dx.doi.org/10.1371/journal.pone.0052938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300827	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872600039
J	Drannik, AG; Nag, K; Yao, XD; Henrick, BM; Ball, TB; Plummer, FA; Wachihi, C; Kimani, J; Rosenthal, KL				Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Ball, T. Blake; Plummer, Francis A.; Wachihi, Charles; Kimani, Joshua; Rosenthal, Kenneth L.			Anti-HIV-1 Activity of Elafin Depends on Its Nuclear Localization and Altered Innate Immune Activation in Female Genital Epithelial Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKOCYTE PROTEASE INHIBITOR; NF-KAPPA-B; HERPES-SIMPLEX-VIRUS; TRAPPIN-2 PRE-ELAFIN; HIV-INFECTION; SEX-WORKERS; PROTEINASE-INHIBITOR; REPRODUCTIVE-TRACT; PSEUDOMONAS-AERUGINOSA	Elafin (E) and its precursor trappin-2 (Tr) are alarm antiproteases with antimicrobial and immunomodulatory activities. Tr and E (Tr/E) have been associated with HIV-1 resistance. We recently showed that Tr/E reduced IL-8 secretion and NF-kappa B activation in response to a mimic of viral dsRNA and contributed to anti-HIV activity of cervicovaginal lavage fluid (CVL) of HIV-resistant (HIV-R) commercial sex workers (CSWs). Additionally, Tr, and more so E, were found to inhibit attachment/entry and transcytosis of HIV-1 in human endometrial HEC-1A cells, acting through virus or cells. Given their immunomodulatory activity, we hypothesized that Tr/E could exert anti-HIV-1 activity at multiple levels. Here, using tagged and untagged Tr/E proteins, we comparatively evaluated their protease inhibitory, anti-HIV-1, and immunomodulatory activities, and cellular distribution. E appeared to function as an autocrine/paracrine factor in HEC-1A cells, and anti-HIV-1 activity of E depended on its unmodified N-terminus and altered cellular innate activation, but not its antiprotease activity. Specifically, exogenously added N-terminus-unmodified E was able to enter the nucleus and to reduce viral attachment/entry and transcytosis, preferentially affecting R5-HIV-1(ADA), but not X4-HIV-1(IIIB). Further, anti-HIV-1 activity of E was associated with significantly decreased HIV-1-triggered IL-8 release, attenuated NF-kappa B/p65 nuclear translocation, and significantly modulated mRNA expression of innate sensors TLR3 and RIG-I in HEC-1A cells. Most importantly, we found that elevated Tr/E in CVLs of HIV-R CSWs were associated with lower mRNA levels of TLRs 2, 3, 4 and RIG-I in the genital ECs from this cohort, suggesting a link between Tr/E, HIV-1 resistance and modulated innate viral recognition in the female genital mucosa. Collectively, our data indicate that unmodified N-terminus is critical for intranuclear localization and anti-HIV-1 activity of E. We also propose that E-mediated altered cellular innate activation most likely contributes to the HIV-R phenotype of these subjects.	[Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Rosenthal, Kenneth L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake; Plummer, Francis A.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Wachihi, Charles; Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	McMaster University; University of Manitoba; Public Health Agency of Canada; University of Nairobi	Rosenthal, KL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	Henrick, Bethany/P-7388-2016	Henrick, Bethany/0000-0003-1883-6749	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), Collaboration for AIDS Vaccine Development (CAVD); Bill and Melinda Gates Foundation; Ontario HIV Treatment Network (OHTN); OHTN	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), Collaboration for AIDS Vaccine Development (CAVD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ontario HIV Treatment Network (OHTN); OHTN	This research was supported by a grant as part of the Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD) funded by the Bill and Melinda Gates Foundation to K. L. R. A. G. D. was supported, in part, by a Studentship Award from the Ontario HIV Treatment Network (OHTN) and K. L. R. by a Career Scientist Award from the OHTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bellemare A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-253; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Broliden K, 2009, J INTERN MED, V265, P5, DOI 10.1111/j.1365-2796.2008.02053.x; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Carreno MP, 2002, CYTOKINE, V20, P289, DOI 10.1006/cyto.2002.2009; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035866; Drannik AG, 2012, J VIROL, V86, P4599, DOI 10.1128/JVI.06561-11; Drannik AG, 2011, BIOCHEM SOC T, V39, P1427, DOI 10.1042/BST0391427; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Fantuzzi L, 2008, BLOOD, V111, P3355, DOI 10.1182/blood-2007-08-104901; Flach CF, 2006, INFLAMM BOWEL DIS, V12, P837, DOI 10.1097/01.mib.0000232469.23574.11; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hayashi T, 2010, MICROBES INFECT, V12, P937, DOI 10.1016/j.micinf.2010.06.003; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Hiemstra PS, 2004, CURR PHARM DESIGN, V10, P2891, DOI 10.2174/1381612043383566; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Jain S, 2011, MUCOSAL IMMUNOL, V4, P539, DOI 10.1038/mi.2011.21; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002; MANN DM, 1994, J BIOL CHEM, V269, P23661; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nikolic DS, 2010, J INVEST DERMATOL, V130, P352, DOI 10.1038/jid.2009.227; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; Sanghavi SK, 2005, J IMMUNOL, V175, P5314, DOI 10.4049/jimmunol.175.8.5314; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; SCHALKWIJK J, 1990, BRIT J DERMATOL, V122, P631, DOI 10.1111/j.1365-2133.1990.tb07285.x; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zani ML, 2011, BIOCHEM SOC T, V39, P1441, DOI 10.1042/BST0391441; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176	73	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52738	10.1371/journal.pone.0052738	http://dx.doi.org/10.1371/journal.pone.0052738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300756	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100075
J	Henriquez, DR; Bodaleo, FJ; Montenegro-Venegas, C; Gonzalez-Billault, C				Henriquez, Daniel R.; Bodaleo, Felipe J.; Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian			The Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B) Is Responsible for Tiam1 Binding and Rac1 Activation in Neuronal Cells	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ACTIN STRESS FIBERS; AXON FORMATION; RHO-GTPASES; HIPPOCAMPAL-NEURONS; HEAVY-CHAIN; GROWTH; IDENTIFICATION; INVASION; POLARITY	Microtubule-associated protein 1B (MAP1B) is a neuronal protein involved in the stabilization of microtubules both in the axon and somatodendritic compartments. Acute, genetic inactivation of MAP1B leads to delayed axonal outgrowth, most likely due to changes in the post-translational modification of tubulin subunits, which enhances microtubule polymerization. Furthermore, MAP1B deficiency is accompanied by abnormal actin microfilament polymerization and dramatic changes in the activity of small GTPases controlling the actin cytoskeleton. In this work, we showed that MAP1B interacts with a guanine exchange factor, termed Tiam1, which specifically activates Rac1. These proteins co-segregated in neurons, and interact in both heterologous expression systems and primary neurons. We dissected the molecular domains involved in the MAP1B-Tiam1 interaction, and demonstrated that pleckstrin homology (PH) domains in Tiam1 are responsible for MAP1B binding. Interestingly, only the light chain 1 (LC1) of MAP1B was able to interact with Tiam1. Moreover, it was able to increase the activity of the small GTPase, Rac1. These results suggest that the interaction between Tiam1 and MAP1B, is produced by the binding of LC1 with PH domains in Tiam1. The formation of such a complex impacts on the activation levels of Rac1 confirming a novel function of MAP1B related with the control of small GTPases. These results also support the idea of cross-talk between cytoskeleton compartments inside neuronal cells.	[Henriquez, Daniel R.; Bodaleo, Felipe J.; Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam CENEDYN, Dept Biol, Santiago, Chile	Universidad de Chile	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam CENEDYN, Dept Biol, Santiago, Chile.	chrgonza@uchile.cl	Gonzalez-Billault, Christian/P-2393-2019		FONDECYT grant [1095089]	FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a FONDECYT grant (1095089) to CG-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Cueille N, 2007, BRAIN RES BULL, V71, P610, DOI 10.1016/j.brainresbull.2006.12.003; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DiTella MC, 1996, J CELL SCI, V109, P467; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evers EE, 2000, METHOD ENZYMOL, V325, P403; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gonzalez-Billault C, 2012, CYTOSKELETON HOBOKEN; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1993, PHILOS T ROY SOC B, V340, P267, DOI 10.1098/rstb.1993.0067; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; HAMMARBACK JA, 1991, NEURON, V7, P129, DOI 10.1016/0896-6273(91)90081-A; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mei X, 2000, J NEUROSCI RES, V62, P56, DOI 10.1002/1097-4547(20001001)62:1<56::AID-JNR6>3.0.CO;2-#; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Shepherd TR, 2011, BIOCHEMISTRY-US, V50, P1296, DOI 10.1021/bi1013613; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Takefuji M, 2007, BIOCHEM BIOPH RES CO, V355, P788, DOI 10.1016/j.bbrc.2007.02.028; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; TAKEMURA R, 1992, J CELL SCI, V103, P953; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Togel M, 1998, FEBS LETT, V423, P254, DOI 10.1016/S0014-5793(98)00104-5; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; ZAUNER W, 1992, EUR J CELL BIOL, V57, P66	53	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53123	10.1371/journal.pone.0053123	http://dx.doi.org/10.1371/journal.pone.0053123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300879	Green Published, gold, Green Submitted			2022-12-25	WOS:000312829100123
J	Luni, C; Marth, JD; Doyle, FJ				Luni, Camilla; Marth, Jamey D.; Doyle, Francis J., III			Computational Modeling of Glucose Transport in Pancreatic beta-Cells Identifies Metabolic Thresholds and Therapeutic Targets in Diabetes	PLOS ONE			English	Article							INSULIN-SECRETION; EXPRESSION; GLUT2; GLYCOSYLATION; RATS; ISOFORM; PATHWAY; 1-ALPHA; GENE	Pancreatic beta-cell dysfunction is a diagnostic criterion of Type 2 diabetes and includes defects in glucose transport and insulin secretion. In healthy individuals, beta-cells maintain plasma glucose concentrations within a narrow range in concert with insulin action among multiple tissues. Postprandial elevations in blood glucose facilitate glucose uptake into beta-cells by diffusion through glucose transporters residing at the plasma membrane. Glucose transport is essential for glycolysis and glucose-stimulated insulin secretion. In human Type 2 diabetes and in the mouse model of obesity-associated diabetes, a marked deficiency of beta-cell glucose transporters and glucose uptake occurs with the loss of glucose-stimulated insulin secretion. Recent studies have shown that the preservation of glucose transport in beta-cells maintains normal insulin secretion and blocks the development of obesity-associated diabetes. To further elucidate the underlying mechanisms, we have constructed a computational model of human beta-cell glucose transport in health and in Type 2 diabetes, and present a systems analysis based on experimental results from human and animal studies. Our findings identify a metabolic threshold or "tipping point" whereby diminished glucose transport across the plasma membrane of beta-cells limits intracellular glucose-6-phosphate production by glucokinase. This metabolic threshold is crossed in Type 2 diabetes and results in beta-cell dysfunction including the loss of glucose stimulated insulin secretion. Our model further discriminates among molecular control points in this pathway wherein maximal therapeutic intervention is achieved.	[Luni, Camilla; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Luni, Camilla; Doyle, Francis J., III] Sansum Diabet Res Inst, Santa Barbara, CA USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; William Sansum Diabetes Center; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Doyle, FJ (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	frank.doyle@icb.ucsb.edu	Luni, Camilla/ABC-6306-2020	Luni, Camilla/0000-0002-1211-9629	Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; US National Institutes of Health (NIH) grant [DK048247, GM100192]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100192] Funding Source: NIH RePORTER	Institute for Collaborative Biotechnologies from the US Army Research Office; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the US Army Research Office (CL, FJD), and by US National Institutes of Health (NIH) grant DK048247 and GM100192 (JDM). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO T, 1991, J BIOL CHEM, V266, P24632; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Cha JY, 2000, J BIOL CHEM, V275, P18358, DOI 10.1074/jbc.M909536199; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; FERRER J, 1995, DIABETES, V44, P1369, DOI 10.2337/diabetes.44.12.1369; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; ORCI L, 1990, J CLIN INVEST, V86, P1615, DOI 10.1172/JCI114883; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; PERMUTT MA, 1989, P NATL ACAD SCI USA, V86, P8688, DOI 10.1073/pnas.86.22.8688; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; THORENS B, 1993, J CELL BIOL, V123, P1687, DOI 10.1083/jcb.123.6.1687; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Velho G, 1997, DIABETES METAB, V23, P7; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	26	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e53130	10.1371/journal.pone.0053130	http://dx.doi.org/10.1371/journal.pone.0053130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300881	Green Published, Green Submitted, gold			2022-12-25	WOS:000312829100125
J	Anangi, R; Koshy, S; Huq, R; Beeton, C; Chuang, WJ; King, GF				Anangi, Raveendra; Koshy, Shyny; Huq, Redwan; Beeton, Christine; Chuang, Woei-Jer; King, Glenn F.			Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers	PLOS ONE			English	Article							MEMORY T-CELLS; GATED K+ CHANNELS; THERAPEUTIC TARGET; POTASSIUM CHANNELS; KV1.3 CHANNEL; PEPTIDE INHIBITOR; TOXINS; VENOM; PURIFICATION; LYMPHOCYTES	The K(v)1.3 voltage-gated potassium channel regulates membrane potential and calcium signaling in human effector memory T cells that are key mediators of autoimmune diseases such as multiple sclerosis, type 1 diabetes, and rheumatoid arthritis. Thus, subtype-specific K(v)1.3 blockers have potential for treatment of autoimmune diseases. Several K(v)1.3 channel blockers have been characterized from scorpion venom, all of which have an alpha/beta scaffold stabilized by 3-4 intramolecular disulfide bridges. Chemical synthesis is commonly used for producing these disulfide-rich peptides but this approach is time consuming and not cost effective for production of mutants, fusion proteins, fluorescently tagged toxins, or isotopically labelled peptides for NMR studies. Recombinant production of K(v)1.3 blockers in the cytoplasm of E. coli generally necessitates oxidative refolding of the peptides in order to form their native disulfide architecture. An alternative approach that avoids the need for refolding is expression of peptides in the periplasm of E. coli but this often produces low yields. Thus, we developed an efficient Pichia pastoris expression system for production of K(v)1.3 blockers using margatoxin (MgTx) and agitoxin-2 (AgTx2) as prototypic examples. The Pichia system enabled these toxins to be obtained in high yield (12-18 mg/L). NMR experiments revealed that the recombinant toxins adopt their native fold without the need for refolding, and electrophysiological recordings demonstrated that they are almost equipotent with the native toxins in blocking K(V)1.3 (IC50 values of 201 +/- 39 pM and 97 +/- 3 pM for recombinant AgTx2 and MgTx, respectively). Furthermore, both recombinant toxins inhibited T-lymphocyte proliferation. A MgTx mutant in which the key pharmacophore residue K28 was mutated to alanine was ineffective at blocking K(V)1.3 and it failed to inhibit T-lymphocyte proliferation. Thus, the approach described here provides an efficient method of producing toxin mutants with a view to engineering K(v)1.3 blockers with therapeutic potential.	[Anangi, Raveendra; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Koshy, Shyny; Huq, Redwan; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	University of Queensland; Baylor College of Medicine; National Cheng Kung University	Anangi, R (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	r.anangi@imb.uq.edu.au; glenn.king@imb.uq.edu.au	King, Glenn F/J-5059-2012	King, Glenn F/0000-0002-2308-2200; Beeton, Christine/0000-0002-2500-5874	Taiwan National Science Council [NSC-101-2325-B-006-006]; National Institute of Health (NIH), USA [NINDS NS073712]; Australian National Health and Medical Research Council [APP1012338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Institute of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant (NSC-101-2325-B-006-006) from the Taiwan National Science Council, and in part by grants from the National Institute of Health (NIH) (NINDS NS073712), USA, and the Australian National Health and Medical Research Council (APP1012338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anangi R, 2007, TOXIN REV, V26, P169, DOI 10.1080/15569540701209815; Anangi R, 2010, TOXICON, V56, P1388, DOI 10.1016/j.toxicon.2010.08.004; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chen CY, 2006, PROTEINS, V62, P279, DOI 10.1002/prot.20742; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Giangiacomo KM, 2004, TOXICON, V43, P877, DOI 10.1016/j.toxicon.2003.11.029; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Maggio F, 2002, TOXICON, V40, P1355, DOI 10.1016/S0041-0101(02)00154-X; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Meng E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021608; Mobli M, 2010, TOXICON, V56, P849, DOI 10.1016/j.toxicon.2010.06.018; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Nikouee A, 2012, J PHYS CHEM B, V116, P5132, DOI 10.1021/jp2102463; Pereira LE, 2007, EXP BIOL MED, V232, P1338, DOI 10.3181/0705-RM-148; Possani LD, 1999, PERSPECT DRUG DISCOV, V16, P15; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shah K, 2003, CELL IMMUNOL, V221, P100, DOI 10.1016/S0008-8749(03)00063-7; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Turkov M, 1997, PROTEIN EXPRES PURIF, V10, P123, DOI 10.1006/prep.1997.0724; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wuthrich K, 1986, NMR PROTEINS NUCL AC	50	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52965	10.1371/journal.pone.0052965	http://dx.doi.org/10.1371/journal.pone.0052965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300835	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800163
J	Buss, H; Handschick, K; Jurrmann, N; Pekkonen, P; Beuerlein, K; Muller, H; Wait, R; Saklatvala, J; Ojala, PM; Schmitz, ML; Naumann, M; Kracht, M				Buss, Holger; Handschick, Katja; Jurrmann, Nadine; Pekkonen, Pirita; Beuerlein, Knut; Mueller, Helmut; Wait, Robin; Saklatvala, Jeremy; Ojala, Paivi M.; Schmitz, M. Lienhard; Naumann, Michael; Kracht, Michael			Cyclin-Dependent Kinase 6 Phosphorylates NF-kappa B P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression	PLOS ONE			English	Article							CELL-CYCLE; TRANSACTIVATION DOMAIN; THYMOCYTE DEVELOPMENT; HERPESVIRUS CYCLIN; STATISTICAL-MODEL; VIRAL CYCLIN; IKK-EPSILON; IN-VIVO; CDK6; CANCER	Nuclear factor kappa-B (NF-kappa B) activates multiple genes with overlapping roles in cell proliferation, inflammation and cancer. Using an unbiased approach we identified human CDK6 as a novel kinase phosphorylating NF-kappa B p65 at serine 536. Purified and reconstituted CDK6/cyclin complexes phosphorylated p65 in vitro and in transfected cells. The physiological role of CDK6 for basal as well as cytokine-induced p65 phosphorylation or NF-kappa B activation was revealed upon RNAi-mediated suppression of CDK6. Inhibition of CDK6 catalytic activity by PD332991 suppressed activation of NF-kappa B and TNF-induced gene expression. In complex with a constitutively active viral cyclin CDK6 stimulated NF-kappa B p65-mediated transcription in a target gene specific manner and this effect was partially dependent on its ability to phosphorylate p65 at serine 536. Tumor formation in thymi and spleens of v-cyclin transgenic mice correlated with increased levels of p65 Ser536 phosphorylation, increased expression of CDK6 and upregulaton of the NF-kappa B target cyclin D3. These results suggest that aberrant CDK6 expression or activation that is frequently observed in human tumors can contribute through NF-kappa B to chronic inflammation and neoplasia.	[Buss, Holger] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Jurrmann, Nadine; Naumann, Michael] Otto Von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany; [Pekkonen, Pirita; Ojala, Paivi M.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Pekkonen, Pirita; Ojala, Paivi M.] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Beuerlein, Knut; Mueller, Helmut; Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35390 Giessen, Germany; [Wait, Robin; Saklatvala, Jeremy] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London, England; [Ojala, Paivi M.] Univ Helsinki, Fdn Finnish Canc Inst, Biomedicum Helsinki, Helsinki, Finland; [Schmitz, M. Lienhard] Univ Giessen, Inst Biochem, D-35390 Giessen, Germany	Hannover Medical School; Otto von Guericke University; University of Helsinki; University of Helsinki; Justus Liebig University Giessen; Imperial College London; University of Oxford; University of Helsinki; Justus Liebig University Giessen	Naumann, M (corresponding author), Otto Von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany.	Naumann@med.ovgu.de; Michael.Kracht@pharma.med.uni-giessen.de	Schmitz, M. Lienhard/D-9328-2017; Ojala, Paivi M/J-3266-2014; Naumann, Michael/B-5285-2011	Schmitz, M. Lienhard/0000-0002-6984-7192; Naumann, Michael/0000-0002-8060-2313; Kracht, Michael/0000-0002-8501-043X; Ojala, Paivi/0000-0001-9065-1832	Deutsche Forschungsgemeinschaft [Kr1143/7-1, TRR81 (B2), Na292/9-1, SFB854 (TP4)]; Cancer Foundation Finland sr [110105] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Foundation Finland sr	This work was supported by grants from the Deutsche Forschungsgemeinschaft Kr1143/7-1, TRR81 (B2), Na292/9-1, SFB854 (TP4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bockstaele L, 2009, MOL CELL BIOL, V29, P4188, DOI 10.1128/MCB.01823-08; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chang Y, 1996, NATURE, V382, P410, DOI 10.1038/382410a0; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Errico A, 2010, ADV ENZYME REGUL, V50, P375, DOI 10.1016/j.advenzreg.2009.12.001; Fry DW, 2004, MOL CANCER THER, V3, P1427; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Hu MG, 2011, BLOOD, V117, P6120, DOI 10.1182/blood-2010-08-300517; Hu MG, 2009, CANCER RES, V69, P810, DOI 10.1158/0008-5472.CAN-08-2473; Jones R, 2007, CANCER RES, V67, P9134, DOI 10.1158/0008-5472.CAN-07-1528; JUNG JU, 1994, MOL CELL BIOL, V14, P7235, DOI 10.1128/MCB.14.11.7235; Kaldis P, 2001, MOL BIOL CELL, V12, P3987, DOI 10.1091/mbc.12.12.3987; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140; Kress E, 2011, NAT CELL BIOL, V13, P638, DOI 10.1038/ncb2276; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; MEYERSON M, 1991, COLD SPRING HARB SYM, V56, P177; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Nagel S, 2008, LEUKEMIA, V22, P387, DOI 10.1038/sj.leu.2405028; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Phelps DE, 1997, METHOD ENZYMOL, V283, P194; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sarek G, 2006, BLOOD, V107, P725, DOI 10.1182/blood-2005-06-2534; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702	71	58	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51847	10.1371/journal.pone.0051847	http://dx.doi.org/10.1371/journal.pone.0051847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300567	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800029
J	Chen, CG; Diao, DK; Guo, L; Shi, M; Gao, J; Hu, MR; Yu, M; Qian, L; Guo, N				Chen, Changguo; Diao, Dekun; Guo, Liang; Shi, Ming; Gao, Jie; Hu, Meiru; Yu, Ming; Qian, Lu; Guo, Ning			All-Trans-Retinoic Acid Modulates ICAM-1 N-Glycan Composition by Influencing GnT-III Levels and Inhibits Cell Adhesion and Trans-Endothelial Migration	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN HEPATOCARCINOMA CELLS; BREAST-CANCER CELLS; INTERCELLULAR-ADHESION; ACETYLGLUCOSAMINYLTRANSFERASE-III; MOLECULE-1 ICAM-1; DOWN-REGULATION; EXPRESSION; GLYCOSYLATION; METASTASIS	Changes in the expression of glycosyltransferases directly influence the oligosaccharide structures and conformations of cell surface glycoproteins and consequently cellular phenotype transitions and biological behaviors. In the present study, we show that all-trans-retinoic acid (ATRA) modulates the N-glycan composition of intercellular adhesion molecule-1 (ICAM-1) by manipulating the expression of two N-acetylglucosaminyltransferases, GnT-III and GnT-V, via the ERK signaling pathway. Exposure of various cells to ATRA caused a remarkable gel mobility down-shift of ICAM-1. Treatment with PNGase F confirmed that the reduction of the ICAM-1 molecular mass is attributed to the decreased complexity of N-glycans. We noticed that the expression of the mRNA encoding GnT-III, which stops branching, was significantly enhanced following ATRA exposure. In contrast, the level of the mRNA encoding GnT-V, which promotes branching, was reduced following ATRA exposure. Silencing of GnT-III prevented the molecular mass shift of ICAM-1. Moreover, ATRA induction greatly inhibited the adhesion of SW480 and U937 cells to the HUVEC monolayer, whereas knock-down of GnT-III expression effectively restored cell adhesion function. Treatment with ATRA also dramatically reduced the trans-endothelial migration of U937 cells. These data indicate that the alteration of ICAM-1 N-glycan composition by ATRA-induced GnT-III activities hindered cell adhesion and cell migration functions simultaneously, pinpointing a unique regulatory role of specific glycosyltransferases in the biological behaviors of tumor cells and a novel function of ATRA in the modulation of ICAM-1 N-glycan composition.	[Chen, Changguo; Guo, Liang; Shi, Ming; Hu, Meiru; Yu, Ming; Qian, Lu; Guo, Ning] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China; [Chen, Changguo] Navy Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Diao, Dekun] Henan Univ, Sch Med, Lab Cellular & Mol Immunol, Kaifeng, Peoples R China; [Gao, Jie] Shandong Acad Med Sci, Inst Basic Med, Jinan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Sixth Medical Center of Chinese PLA General Hospital; Henan University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Qian, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China.	qianlubj@sohu.com; ningguo@nic.bmi.ac.cn		, Liang/0000-0002-8748-5770	National Basic Research Program of China (973 Program) [2010CB911904]; National Natural Science Foundation of China [30972690, 31271440, 81272232, 30800582]; Beijing National Natural Science Foundation [5103042]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing National Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by the National Basic Research Program of China (973 Program, 2010CB911904), the National Natural Science Foundation of China (No. 30972690, 31271440, 81272232 and 30800582) and Beijing National Natural Science Foundation (No. 5103042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyak MA, 2001, J BIOL CHEM, V276, P33582, DOI 10.1074/jbc.M105318200; AOUDJIT F, 1995, CELL GROWTH DIFFER, V6, P515; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Baj G, 1999, J BIOL REG HOMEOS AG, V13, P115; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carvalho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027892; Chang YJ, 2002, J BIOL CHEM, V277, P7118, DOI 10.1074/jbc.M109924200; Donadio AC, 2002, CLIN EXP METASTAS, V19, P437, DOI 10.1023/A:1016329802327; Geyer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1853, DOI 10.1016/j.bbapap.2006.10.007; Gille J, 1997, J CLIN INVEST, V99, P492, DOI 10.1172/JCI119184; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Guo HB, 2000, J CELL BIOCHEM, V79, P370, DOI 10.1002/1097-4644(20001201)79:3<370::AID-JCB30>3.0.CO;2-Z; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; ISHIBASHI K, 1989, CLIN CHIM ACTA, V185, P325, DOI 10.1016/0009-8981(89)90223-4; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Klaassen I, 2001, INT J CANCER, V92, P661, DOI 10.1002/1097-0215(20010601)92:5<661::AID-IJC1251>3.0.CO;2-O; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Maeda K, 2002, ONCOL REP, V9, P511; Maruo Y, 2002, INT J CANCER, V100, P486, DOI 10.1002/ijc.10514; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Salomon B, 1998, J IMMUNOL, V161, P5138; Santin AD, 1998, AM J OBSTET GYNECOL, V179, P1020, DOI 10.1016/S0002-9378(98)70209-1; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Soprano KJ, 2002, J NUTR, V132, p3809S, DOI 10.1093/jn/132.12.3809S; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Streb JW, PLOS ONE, V6, P4; TAKAHASHI M, 1995, CARDIOVASC RES, V29, P670; Tempia-Caliera AA, 2002, J SURG ONCOL, V79, P93, DOI 10.1002/jso.10053; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Urano F, 2000, J CELL SCI, V113, P3697; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Xu YY, 2010, J CELL BIOCHEM, V109, P468, DOI 10.1002/jcb.22423; Yamamoto H, 2000, CANCER RES, V60, P134; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	53	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52975	10.1371/journal.pone.0052975	http://dx.doi.org/10.1371/journal.pone.0052975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300837	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800165
J	Grompone, G; Martorell, P; Llopis, S; Gonzalez, N; Genoves, S; Mulet, AP; Fernandez-Calero, T; Tiscornia, I; Bollati-Fogolin, M; Chambaud, I; Foligne, B; Montserrat, A; Ramon, D				Grompone, Gianfranco; Martorell, Patricia; Llopis, Silvia; Gonzalez, Nuria; Genoves, Salvador; Paula Mulet, Ana; Fernandez-Calero, Tamara; Tiscornia, Ines; Bollati-Fogolin, Mariela; Chambaud, Isabelle; Foligne, Benoit; Montserrat, Agustin; Ramon, Daniel			Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; FREE-RADICALS; LONGEVITY; MODEL; INHIBITION; DISEASE; CONSUMPTION; ACIDOPHILUS; MODULATION; DISCOVERY	Numerous studies have shown that resistance to oxidative stress is crucial to stay healthy and to reduce the adverse effects of aging. Accordingly, nutritional interventions using antioxidant food-grade compounds or food products are currently an interesting option to help improve health and quality of life in the elderly. Live lactic acid bacteria (LAB) administered in food, such as probiotics, may be good antioxidant candidates. Nevertheless, information about LAB-induced oxidative stress protection is scarce. To identify and characterize new potential antioxidant probiotic strains, we have developed a new functional screening method using the nematode Caenorhabditis elegans as host. C. elegans were fed on different LAB strains (78 in total) and nematode viability was assessed after oxidative stress (3 mM and 5 mM H2O2). One strain, identified as Lactobacillus rhamnosus CNCM I-3690, protected worms by increasing their viability by 30% and, also, increased average worm lifespan by 20%. Moreover, transcriptomic analysis of C. elegans fed with this strain showed that increased lifespan is correlated with differential expression of the DAF-16/insulin-like pathway, which is highly conserved in humans. This strain also had a clear anti-inflammatory profile when co-cultured with HT-29 cells, stimulated by pro-inflammatory cytokines, and co-culture systems with HT-29 cells and DC in the presence of LPS. Finally, this Lactobacillus strain reduced inflammation in a murine model of colitis. This work suggests that C. elegans is a fast, predictive and convenient screening tool to identify new potential antioxidant probiotic strains for subsequent use in humans.	[Grompone, Gianfranco; Chambaud, Isabelle] Danone Res, Gut Microbiol & Probiot Platform, Palaiseau, France; [Martorell, Patricia; Llopis, Silvia; Gonzalez, Nuria; Genoves, Salvador; Ramon, Daniel] Biopolis SL, Dept Food Biotechnol, Valencia, Spain; [Fernandez-Calero, Tamara] Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay; [Tiscornia, Ines; Bollati-Fogolin, Mariela] Inst Pasteur Montevideo, Cell Biol Unit, Montevideo, Uruguay; [Foligne, Benoit] Univ Lille Nord France, CNRS UMR 8204, Ctr Infect & Immun Lille, INSERM,U1019,IPL, Lille, France; [Montserrat, Agustin] Danone Res Spain, Barcelona, Spain	Danone Nutricia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Danone Nutricia	Grompone, G (corresponding author), Danone Res, Gut Microbiol & Probiot Platform, Palaiseau, France.	gianfranco.grompone@danone.com	Mulet, Ana/AAW-5713-2021; Martorell, Patricia/ABC-8717-2021; Foligne, Benoit/B-2754-2014	Foligne, Benoit/0000-0001-9263-9706; Bollati-Fogolin, Mariela/0000-0001-6829-3135	ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY)	ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY)	Funders of this work were: ANII (Agencia Nacional de Investigacion e Innovacion, URUGUAY): PE_ALI_1_1702 and Danone Research. ANII had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Danone Research had no role in study design, data collection and analysis, but checked the manuscript before publication.	Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; Amrit Francis R G, 2010, Curr Aging Sci, V3, P166; Ashrafi Kaveh, 2007, WormBook, P1; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Butalla AC, 2012, NUTR CANCER, V64, P331, DOI 10.1080/01635581.2012.650779; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Ellinger S, 2011, PHYTOMEDICINE, V18, P903, DOI 10.1016/j.phymed.2011.06.006; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Fasseas MK, 2013, APPL MICROBIOL BIOT, V97, P2109, DOI 10.1007/s00253-012-4357-9; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano-Santini R, 2011, CELL MOL LIFE SCI, V68, P1917, DOI 10.1007/s00018-011-0670-1; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Han W, 2006, INFLAMM BOWEL DIS, V12, P1044, DOI 10.1097/01.mib.0000235101.09231.9e; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kim SO, 2006, CELL MICROBIOL, V8, P1958, DOI 10.1111/j.1462-5822.2006.00763.x; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LeBlanc JG, 2011, J BIOTECHNOL, V151, P287, DOI 10.1016/j.jbiotec.2010.11.008; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lin MY, 1999, J AGR FOOD CHEM, V47, P3661, DOI 10.1021/jf981235l; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Lin MY, 2000, DIGEST DIS SCI, V45, P1617, DOI 10.1023/A:1005577330695; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Pravda J, 2005, WORLD J GASTROENTERO, V11, P2371, DOI 10.3748/wjg.v11.i16.2371; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Richmond J, 2000, ATLA-ALTERN LAB ANIM, V28, P761, DOI 10.1177/026119290002800608; Richmond Jon, 2002, ILAR J, V43 Suppl, pS63; Rijkers GT, 2010, J NUTR, V140, p671S, DOI 10.3945/jn.109.113779; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Salminen A, 2008, CELL MOL LIFE SCI, V65, P1049, DOI 10.1007/s00018-008-7461-3; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Sanz Alberto, 2008, Curr Aging Sci, V1, P10; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; Sun J, 2010, LETT APPL MICROBIOL, V50, P264, DOI 10.1111/j.1472-765X.2009.02786.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Tomas-Barberan FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wang CY, 2011, J FOOD PROTECT, V74, P86, DOI 10.4315/0362-028X.JFP-10-155; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367; Zhou YM, 2011, BIOSCI BIOTECH BIOCH, V75, P1746, DOI 10.1271/bbb.110290	65	102	105	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52493	10.1371/journal.pone.0052493	http://dx.doi.org/10.1371/journal.pone.0052493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300685	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800095
J	Kronish, IM; Carson, AP; Davidson, KW; Muntner, P; Safford, MM				Kronish, Ian M.; Carson, April P.; Davidson, Karina W.; Muntner, Paul; Safford, Monika M.			Depressive Symptoms and Cardiovascular Health by the American Heart Association's Definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study	PLOS ONE			English	Article							DIABETES-MELLITUS; CARDIAC RISK; DISEASE; HYPERTENSION; EVENTS; CARE; PREVALENCE; BEHAVIORS; MORTALITY; ADHERENCE	Background: Depressive symptoms are associated with increased incident and recurrent cardiovascular events. In 2010, the American Heart Association published the Life's Simple 7, a metric for assessing cardiovascular health as measured by 4 health behaviors (smoking, physical activity, body mass index, diet) and 3 biological measures (cholesterol, blood pressure, glucose). The association between depressive symptoms and the Life's Simple 7 has not yet been explored. Methods: Data from 20,093 participants >= 45 years of age who enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between 2003 and 2007 and who had complete data available on Life's Simple 7 components were used for these analyses. The prevalence of ideal, intermediate, and poor health on each Life's Simple 7 component and total Life's Simple 7 scores were compared between participants with and without depressive symptoms. Depressive symptoms were measured using the 4-item Centers for Epidemiologic Studies of Depression scale. Results: Participants with depressive symptoms were more likely to have poor levels on each of the Life's Simple 7 components other than cholesterol [ adjusted prevalence ratios (95% CI): smoking 1.41 (1.29-1.55); physical activity 1.38 (1.31-1.46); body mass index 1.09 (1.04-1.15); diet 1.08 (1.06-1.10); blood pressure 1.11 (1.02-1.21); glucose 1.24 (1.09-1.41)]. There was a graded association between increasing depressive symptoms and lower total Life's Simple 7 score. Conclusion: Depressive symptoms are associated with worse cardiovascular health on the overall Life's Simple 7 and on individual components representing both health behaviors and biological factors.	[Kronish, Ian M.; Davidson, Karina W.] Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA; [Carson, April P.; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kronish, IM (corresponding author), Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA.	ik2293@columbia.edu	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kronish, Ian/0000-0003-0945-2380; Carson, April/0000-0002-7970-6756	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01 NS041588]; National Heart, Lung, and Blood Institute [K23 HL098359, R01 HL080477, HL088117, HL084034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, K24HL084034, K23HL098359, P01HL088117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. Dr. Kronish was supported by grant K23 HL098359 from the National Heart, Lung, and Blood Institute. Drs. Safford and Muntner were supported by R01 HL080477 from the National Heart, Lung, and Blood Institute. Dr. Davidson was supported by HL088117 and HL084034 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Behrens T, 2004, METHOD INFORM MED, V43, P505; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038; Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Feighner JP, 1995, J CLIN PSYCHIAT, V56, P574; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Glymour MM, 2010, NEUROLOGY, V75, P2063, DOI 10.1212/WNL.0b013e318200d70e; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; Huffman JC, 2011, CIRC-CARDIOVASC QUAL, V4, P198, DOI 10.1161/CIRCOUTCOMES.110.959379; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Katon W, 2010, CONTEMP CLIN TRIALS, V31, P312, DOI 10.1016/j.cct.2010.03.009; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Pan A, 2011, STROKE; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014; Rush AJ, 2003, BIOL PSYCHIAT, V53, P743, DOI 10.1016/S0006-3223(03)00088-X; Rutledge T, 2002, PSYCHOSOM MED, V64, P758, DOI 10.1097/01.PSY.0000031578.42041.1C; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Tedders SH, 2011, J AFFECT DISORD; Thorndike AN, 2008, ARCH INTERN MED, V168, P186, DOI 10.1001/archinternmed.2007.60; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	40	66	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52771	10.1371/journal.pone.0052771	http://dx.doi.org/10.1371/journal.pone.0052771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300767	Green Published, Green Submitted, gold			2022-12-25	WOS:000313618800142
J	Osthus, IBO; Sgura, A; Berardinelli, F; Alsnes, IV; Bronstad, E; Rehn, T; Stobakk, PK; Hatle, H; Wisloff, U; Nauman, J				Osthus, Ida Beate O.; Sgura, Antonella; Berardinelli, Francesco; Alsnes, Ingvild Vatten; Bronstad, Eivind; Rehn, Tommy; Stobakk, Per Kristian; Hatle, Havard; Wisloff, Ulrik; Nauman, Javaid			Telomere Length and Long-Term Endurance Exercise: Does Exercise Training Affect Biological Age? A Pilot Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTHY; MORTALITY; WOMEN; ASSOCIATION; RISK; DIET	Background: Telomeres are potential markers of mitotic cellular age and are associated with physical ageing process. Longterm endurance training and higher aerobic exercise capacity (VO2max) are associated with improved survival, and dynamic effects of exercise are evident with ageing. However, the association of telomere length with exercise training and VO2max has so far been inconsistent. Our aim was to assess whether muscle telomere length is associated with endurance exercise training and VO2max in younger and older people. Methods: Twenty men; 10 young (22-27 years) and 10 old (66-77 years), were studied in this cross-sectional study. Five out of 10 young adults and 5 out of 10 older were endurance athletes, while other halves were exercising at a medium level of activity. Mean telomere length was measured as telomere/single copy gene-ratio (T/S-ratio) using quantitative real time polymerase chain reaction. VO2max was measured directly running on a treadmill. Results: Older endurance trained athletes had longer telomere length compared with older people with medium activity levels (T/S ratio 1.12 +/- 0.1 vs. 0.92 +/- 0.2, p = 0.04). Telomere length of young endurance trained athletes was not different than young non-athletes (1.47 +/- 0.2 vs. 1.33 +/- 0.1, p = 0.12). Overall, there was a positive association between T/S ratio and VO2max (r = 0.70, p = 0.001). Among endurance trained athletes, we found a strong correlation between VO2max and T/S ratio (r = 0.78, p = 0.02). However, corresponding association among non-athlete participants was relatively weak (r = 0.58, p = 0.09). Conclusion: Our data suggest that VO2max is positively associated with telomere length, and we found that long-term endurance exercise training may provide a protective effect on muscle telomere length in older people.	[Osthus, Ida Beate O.; Alsnes, Ingvild Vatten; Bronstad, Eivind; Rehn, Tommy; Stobakk, Per Kristian; Hatle, Havard; Wisloff, Ulrik; Nauman, Javaid] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Sgura, Antonella; Berardinelli, Francesco] Univ Rome Roma Tre, Dept Biol, Rome, Italy; [Bronstad, Eivind] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Bronstad, Eivind; Rehn, Tommy] Norwegian Univ Sci & Technol, Ctr Sports & Phys Act Res, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Roma Tre University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Nauman, J (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	javaid.nauman@ntnu.no	Nauman, Javaid/AAF-2284-2019; Sgura, Antonella/H-3274-2019; Berardinelli, Francesco/AAP-2355-2021; Wisloff, Ulrik/K-2899-2012	Nauman, Javaid/0000-0003-1347-2448; Berardinelli, Francesco/0000-0002-3094-4139; Wisloff, Ulrik/0000-0002-7211-3587; Alsnes, Ingvild Vatten/0000-0002-2136-6664	K.G. Jebsen Foundation; Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim	K.G. Jebsen Foundation; Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim	The present study was supported by grants from the K.G. Jebsen Foundation, the Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2012, DIABETIC MED, V29, pe377, DOI 10.1111/j.1464-5491.2012.03737.x; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bronstad E, 2012, EUR RESPIR J, V40, P1130, DOI 10.1183/09031936.00193411; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Grimsmo J, 2011, SCAND J MED SCI SPOR, V21, pE351, DOI 10.1111/j.1600-0838.2011.01307.x; Grimsmo J, 2010, EUR J CARDIOV PREV R, V17, P100, DOI 10.1097/HJR.0b013e32833226be; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Kadi F, 2010, SCAND J MED SCI SPOR, V20, P39, DOI 10.1111/j.1600-0838.2009.00966.x; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Ludlow Andrew T, 2011, J Aging Res, V2011, P790378, DOI 10.4061/2011/790378; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Lund TC, 2007, MUSCLE NERVE, V36, P387, DOI 10.1002/mus.20824; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Ponsot E, 2008, MUSCLE NERVE, V37, P467, DOI 10.1002/mus.20964; Rae DE, 2010, EUR J APPL PHYSIOL, V109, P323, DOI 10.1007/s00421-010-1353-6; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Shin YA, 2008, MECH AGEING DEV, V129, P254, DOI 10.1016/j.mad.2008.01.001; Walters SJ, 2009, PHARM STAT, V8, P163, DOI 10.1002/pst.334; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Woo J, 2008, ARCH INTERN MED, V168, P2163, DOI 10.1001/archinte.168.19.2163; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	32	81	83	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52769	10.1371/journal.pone.0052769	http://dx.doi.org/10.1371/journal.pone.0052769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300766	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800141
J	Papareddy, P; Kalle, M; Sorensen, OE; Lundqvist, K; Morgelin, M; Malmsten, M; Schmidtchen, A				Papareddy, Praveen; Kalle, Martina; Sorensen, Ole E.; Lundqvist, Katarina; Morgelin, Matthias; Malmsten, Martin; Schmidtchen, Artur			Tissue Factor Pathway Inhibitor 2 Is Found in Skin and Its C-Terminal Region Encodes for Antibacterial Activity	PLOS ONE			English	Article							SERINE PROTEINASE-INHIBITORS; ANTIMICROBIAL PEPTIDES; PROTEASE INHIBITORS; IMMUNE-RESPONSES; EXPRESSION; MECHANISM; BACTERIA; BILAYERS; KININOGEN; MELITTIN	Background: Tissue factor pathway inhibitor 2 (TFPI-2) is a matrix-associated serine protease inhibitor with an enigmatic function in vivo. Here, we describe that TFPI-2 is present in fibrin of wounds and also expressed in skin, where it is up-regulated upon wounding. Methodology and Principal Findings: Neutrophil elastase cleaved TFPI-2, and a C-terminal fragment was found to bind to bacteria. Similarly, a prototypic peptide representing this C-terminal part, EDC34, bound to bacteria and bacterial lipopolysaccharide, and induced bacterial permeabilization. The peptide also induced leakage in artificial liposomes, and displayed a random coil conformation upon interactions with liposomes as well as lipopolysaccharide. EDC34 was antibacterial against both Gram-negative and Gram-positive bacteria in physiological buffer conditions. Conclusions/Significance: The results demonstrate that the C-terminus of TFPI-2 encodes for antimicrobial activity, and may be released during wounding.	[Papareddy, Praveen; Kalle, Martina; Lundqvist, Katarina; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Sorensen, Ole E.; Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden	Lund University; Lund University; Uppsala University	Papareddy, P (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	praveen.papareddy@med.lu.se	Schmidtchen, Artur/F-9507-2015	Sorensen, Ole E./0000-0001-8681-6921; Papareddy, Praveen/0000-0002-3872-478X	Swedish Research Council [2009-3378, 2009-3009]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; The Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; The Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 2009-3378 and 2009-3009), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, and Kock Foundations, XImmune AB, and The Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Hisaka T, 2004, THROMB HAEMOSTASIS, V91, P569, DOI 10.1160/TH03-06-0358; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Iino M, 1998, ARTERIOSCL THROM VAS, V18, P40, DOI 10.1161/01.ATV.18.1.40; Kong DS, 2004, BIOCHEM BIOPH RES CO, V324, P1179, DOI 10.1016/j.bbrc.2004.09.179; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V317, P311, DOI 10.1006/abbi.1995.1168; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V319, P55, DOI 10.1006/abbi.1995.1266; RAO CN, 1995, J INVEST DERMATOL, V104, P379, DOI 10.1111/1523-1747.ep12665851; Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tossi A, 2000, BIOPOLYMERS, V55, P4; Udagawa K, 1998, PLACENTA, V19, P217, DOI 10.1016/S0143-4004(98)90011-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52772	10.1371/journal.pone.0052772	http://dx.doi.org/10.1371/journal.pone.0052772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300768	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800143
J	Timmers, I; Jansma, BM; Rubio-Gozalbo, ME				Timmers, Inge; Jansma, Bernadette M.; Rubio-Gozalbo, M. Estela			From Mind to Mouth: Event Related Potentials of Sentence Production in Classic Galactosemia	PLOS ONE			English	Article							LEXICAL ACCESS; ELECTROPHYSIOLOGICAL EVIDENCE; SYNTACTIC STRUCTURE; BRAIN POTENTIALS; VERBAL DYSPRAXIA; TIME-COURSE; LANGUAGE; CHILDREN; SPEECH; COMPREHENSION	Patients with classic galactosemia, an inborn error of metabolism, have speech and language production impairments. Past research primarily focused on speech (motor) problems, but these cannot solely explain the language impairments. Which specific deficits contribute to the impairments in language production is not yet known. Deficits in semantic and syntactic planning are plausible and require further investigation. In the present study, we examined syntactic encoding while patients and matched controls overtly described scenes of moving objects using either separate words (minimal syntactic planning) or sentences (sentence-level syntactic planning). The design of the paradigm also allowed tapping into local noun phrase- and more global sentence-level syntactic planning. Simultaneously, we recorded event-related potentials (ERPs). The patients needed more time to prepare and finish the utterances and made more errors. The patient ERPs had a very similar morphology to that of healthy controls, indicating overall comparable neural processing. Most importantly, the ERPs diverged from those of controls in several functionally informative time windows, ranging from very early (90-150 ms post scene onset) to relatively late (1820-2020 ms post scene onset). These time windows can be associated with different linguistic encoding stages. The ERP results form the first neuroscientific evidence for language production impairments in patients with galactosemia in lexical and syntactic planning stages, i.e., prior to the linguistic output phase. These findings hence shed new light on the language impairments in this disease.	[Timmers, Inge; Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Timmers, Inge; Jansma, Bernadette M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Jansma, Bernadette M.] Maastricht Univ, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Lab Genet Metab Dis, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Rubio-Gozalbo, ME (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	estela.rubio@mumc.nl	Rubio-Gozalbo, M Estela/H-1833-2011	Timmers, Inge/0000-0001-7162-6623; Jansma, Bernadette M./0000-0002-2925-0244	Maastricht University Incentive; Galactosemia Research Fund	Maastricht University Incentive; Galactosemia Research Fund	This work was supported by a Maastricht University Incentive to B. M. Jansma in the context of supporting "Woman in higher positions in science" and a Galactosemia Research Fund grant to M. E. Rubio-Gozalbo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Allum PH, 2009, J EXP PSYCHOL LEARN, V35, P1240, DOI 10.1037/a0016367; Antshel KM, 2004, NEUROPSYCHOLOGY, V18, P658, DOI 10.1037/0894-4105.18.4.658; Berry GT, 2011, J INHERIT METAB DIS, V34, P345, DOI 10.1007/s10545-010-9260-x; Bles M, 2007, BRAIN RES, V1150, P143, DOI 10.1016/j.brainres.2007.02.071; Bock J. K., 1994, HDB PSYCHOLINGUISTIC, P945; BOCK JK, 1982, PSYCHOL REV, V89, P1, DOI 10.1037/0033-295X.89.1.1; Bock K., 1995, SPEECH LANGUAGE COMM, V2nd ed., P181, DOI DOI 10.1016/B978-012497770-9/50008-X; Coles M.G.H., 1995, OX PSYCH S, P1; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doyle CM, 2010, J INHERIT METAB DIS, V33, P603, DOI 10.1007/s10545-010-9154-y; Dubroff JG, 2008, J INHERIT METAB DIS, V31, P533, DOI 10.1007/s10545-008-0806-0; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Indefrey P, 2004, BRAIN LANG, V89, P312, DOI 10.1016/S0093-934X(03)00352-3; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jansma Bernadette M., 2004, MULTIDISCIPLINARY AP, P361, DOI DOI 10.1515/9783110894028; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KAUFMAN FR, 1995, EUR J PEDIATR, V154, pS2, DOI 10.1007/BF02143794; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kutas M, 2003, MIND, BRAIN, AND LANGUAGE: MULTIDISCIPLINARY PERSPECTIVES, P171; Lebea PJ, 2005, MED HYPOTHESES, V65, P1051, DOI 10.1016/j.mehy.2005.06.025; Levelt, 1993, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luck S.J., 2005, INTRO EVENT RELATED; Makeig S., 2009, OXFORD HDB EVENT REL; Marek A, 2007, APHASIOLOGY, V21, P1147, DOI 10.1080/02687030600646577; Mercier M, 2009, EUR J NEUROSCI, V29, P424, DOI 10.1111/j.1460-9568.2008.06583.x; Meyer A. S., 2004, INTERFACE LANGUAGE V, P191; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Meyers J. E., 1995, REY COMPLEX FIGURE T; Mortensen L, 2008, Q J EXP PSYCHOL, V61, P1217, DOI 10.1080/17470210701467912; NELSON CD, 1991, PEDIATRICS, V88, P346; NELSON MD, 1992, RADIOLOGY, V184, P255, DOI 10.1148/radiology.184.1.1319076; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Potter NL, 2008, J INHERIT METAB DIS, V31, P524, DOI 10.1007/s10545-008-0877-y; Potter NL, 2011, J INHERIT METAB DIS, V34, P377, DOI 10.1007/s10545-010-9213-4; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rabovsky M, 2011, J COGNITIVE NEUROSCI; Rahman RA, 2008, PSYCHON B REV, V15, P1055, DOI 10.3758/PBR.15.6.1055; Robertson A, 2000, GENET MED, V2, P142, DOI 10.1097/00125817-200003000-00005; Rogalski E, 2011, J NEUROSCI, V31, P3344, DOI 10.1523/JNEUROSCI.5544-10.2011; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schadewaldt P, 2010, PEDIATRICS, V125, pE374, DOI 10.1542/peds.2008-3325; Schmitt BM, 2000, J COGNITIVE NEUROSCI, P48; SCHWEITZER S, 1993, EUR J PEDIATR, V152, P36, DOI 10.1007/BF02072514; Shield JPH, 2000, ARCH DIS CHILD, V83, P248, DOI 10.1136/adc.83.3.248; Shriberg LD, 2010, J SPEECH LANGUAGE HE; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; van Haasen PP, 1986, WISC R WESCHLER INTE; vanTurennout M, 1997, J EXP PSYCHOL LEARN, V23, P787, DOI 10.1037/0278-7393.23.4.787; Vos PG, 1988, BOURDON VOS TEST BOU; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619; WAISBREN SE, 1983, J PEDIATR-US, V102, P75, DOI 10.1016/S0022-3476(83)80292-3; Waisbren SE, 2012, J INHERIT METAB DIS, V35, P279, DOI 10.1007/s10545-011-9372-y; Webb AL, 2003, PEDIATR RES, V53, P396, DOI 10.1203/01.PDR.0000049666.19532.1B; Widhalm K, 2002, NUTR RES, V22, P257, DOI 10.1016/S0271-5317(01)00401-8	69	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52826	10.1371/journal.pone.0052826	http://dx.doi.org/10.1371/journal.pone.0052826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300788	Green Submitted, Green Published, gold			2022-12-25	WOS:000313618800153
J	Zhou, QC; Sheng, GH				Zhou, Quancheng; Sheng, Guihua			Pyrolytic and Kinetic Characteristics of the Thermal Decomposition of Perilla frutescens Polysaccharide	PLOS ONE			English	Article							TG-FTIR; CAKE	The thermal decomposition of Perilla frutescens polysaccharide was examined by thermogravimetry, differential thermogravimetry, and differential thermal analysis. The results showed that the mass loss of the substance proceeded in three steps. The first stage can be attributed to the expulsion of the water from ambient temperature to 182 degrees C. The second stage corresponded to devolatilization from 182 degrees C to 439 degrees C. The residue slowly degraded in the third stage. The weight loss in air is faster than that in nitrogen, because the oxygen in air accelerated the pyrolytic reaction speed reaction. The heating rate significantly affected the pyrolysis of the sample. Similar activation energies of the degradation process (210-211 kJ mol(-1)) were obtained by the FWO, KAS, and Popescu techniques. According to Popescu mechanism functions, the possible kinetic model was estimated to be Avrami-Erofeev 20 g(alpha) = [-ln(1-alpha)](4).	[Zhou, Quancheng] Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Peoples R China; [Sheng, Guihua] Shandong Univ Technol, Sch Life Sci, Zibo, Peoples R China	Shandong University of Technology; Shandong University of Technology	Zhou, QC (corresponding author), Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Peoples R China.	zhouquancheng@126.com		Sheng, Guihua/0000-0003-3933-7930				Adriana V.M., 2011, BIOMA BIOEN, V35, P1121; Beis SH, 2002, RENEW ENERG, V26, P21, DOI 10.1016/S0960-1481(01)00109-4; Brebu M, 2011, CELL CHEM TECHNOL, V45, P43; Cabrales L, 2010, J THERM ANAL CALORIM, V102, P485, DOI 10.1007/s10973-010-0911-9; Feng XB, 2011, J MICROBIOL METH, V84, P359, DOI 10.1016/j.mimet.2010.12.012; Hirose S, 2002, J THERM ANAL CALORIM, V70, P853, DOI 10.1023/A:1022212421525; Karaosmanoglu F, 2001, ENERG SOURCE, V23, P377; KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045; Lerdkanchanaporn S, 1998, THERMOCHIM ACTA, V324, P25, DOI 10.1016/S0040-6031(98)00520-6; Li DM, 2011, BIOMASS BIOENERG, V35, P1765, DOI 10.1016/j.biombioe.2011.01.011; Li DM, 2010, CHEM ENG RES DES, V88, P647, DOI 10.1016/j.cherd.2009.10.011; Liang J, 2008, THERMOSETTING RESIN, V23, P11; Liu Q, 2008, J ANAL APPL PYROL, V82, P170, DOI 10.1016/j.jaap.2008.03.007; Liu Y., 2008, J CHANGSHA U TECH NA, V5, P1; Lopez FA, 2008, J THERM ANAL CALORIM, V91, P633, DOI 10.1007/s10973-007-8321-3; Orfao JJM, 1999, FUEL, V78, P349, DOI 10.1016/S0016-2361(98)00156-2; OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881; Pappa A, 2003, J ANAL APPL PYROL, V67, P221, DOI 10.1016/S0165-2370(02)00063-3; Park HY, 2010, FOOD CHEM, V119, P724, DOI 10.1016/j.foodchem.2009.07.020; Peiretti PG, 2011, LIVEST SCI, V138, P118, DOI 10.1016/j.livsci.2010.12.007; [彭云云 PENG Yunyun], 2009, [化工进展, Chemical Industry and Engineering Progress], V28, P1478; Popescu C, 1996, THERMOCHIM ACTA, V285, P309, DOI 10.1016/0040-6031(96)02916-4; Putun AE, 2002, ENERGY, V27, P703, DOI 10.1016/S0360-5442(02)00015-4; Putun E, 2006, BIORESOURCE TECHNOL, V97, P701, DOI 10.1016/j.biortech.2005.04.005; Rao TR, 1998, ENERGY, V23, P973, DOI 10.1016/S0360-5442(98)00037-1; Rychly J, 2002, POLYM DEGRAD STABIL, V78, P357, DOI 10.1016/S0141-3910(02)00187-8; Sensoz S, 2008, BIORESOURCE TECHNOL, V99, P5492, DOI 10.1016/j.biortech.2007.10.046; She ZG, 2003, CHINESE J ORG CHEM, V23, P1149; Shen DK, 2010, J ANAL APPL PYROL, V87, P199, DOI 10.1016/j.jaap.2009.12.001; Wang X., 2009, FOOD SCI, V44, P44; Xiujuan Guo, 2011, Recent Researches in Energy & Environment. 6th IASME - WSEAS International Conference on Energy and Environment (EE '11), P137; Ye NH, 2010, PLOS ONE, P126; Zhao G, 2010, NEUROCHEM INT, V56, P168, DOI 10.1016/j.neuint.2009.09.015; Zhou QC, 2012, ADV MAT RES, V518-523, P3904; Zhu JF, 2011, J ANHUI AGR SCI, V39, P266	35	2	3	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52597	10.1371/journal.pone.0052597	http://dx.doi.org/10.1371/journal.pone.0052597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300715	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800108
J	Totary-Jain, H; Sanoudou, D; Ben-Dov, IZ; Dautriche, CN; Guarnieri, P; Marx, SO; Tuschl, T; Marks, AR				Totary-Jain, Hana; Sanoudou, Despina; Ben-Dov, Iddo Z.; Dautriche, Cula N.; Guarnieri, Paolo; Marx, Steven O.; Tuschl, Thomas; Marks, Andrew R.			Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; RNA-BINDING PROTEIN; MTOR INHIBITORS; DEFECTIVE REGULATION; CANCER; MYC; PATHWAY; GROWTH; EXPRESSION; TARGET	The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized that miRNAs could play important roles in the response of tumors to mTOR inhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.	[Totary-Jain, Hana; Dautriche, Cula N.; Marks, Andrew R.] Columbia Univ, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Sanoudou, Despina] Univ Athens, Sch Med, Dept Pharmacol, Athens 11527, Greece; [Ben-Dov, Iddo Z.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Guarnieri, Paolo] Herbert Irving Comprehens Canc Ctr, Bioinformat Div, New York, NY 10032 USA; [Marx, Steven O.; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Athens Medical School; National & Kapodistrian University of Athens; Howard Hughes Medical Institute; Rockefeller University; Columbia University	Totary-Jain, H (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA.	ht2167@columbia.edu; arm42@columbia.edu	Ben-Dov, Iddo/F-3282-2010; Sanoudou, Despina/AAD-8139-2019; Totary-Jain, Hana/ABC-3469-2021; Totary-Jain, Hana/A-6387-2014	Ben-Dov, Iddo/0000-0002-9180-3604; Sanoudou, Despina/0000-0003-3704-1941; Totary-Jain, Hana/0000-0003-2203-0377; 	National Institutes of Health from the NHLBI [F32HL088815, K99HL109133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL109133, F32HL088815] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants F32HL088815 and K99HL109133 (to H.T.-J.) from the NHLBI.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Atkins MB, 2009, NAT REV DRUG DISCOV, V8, P535, DOI 10.1038/nrd2924; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Chan JA, 2009, CURR ONCOL REP, V11, P193, DOI 10.1007/s11912-009-0028-0; Chan S, 2004, BRIT J CANCER, V91, P1420, DOI 10.1038/sj.bjc.6602162; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Ellard SL, 2009, J CLIN ONCOL, V27, P4536, DOI 10.1200/JCO.2008.21.3033; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Figlin Robert A, 2008, J Natl Compr Canc Netw, V6 Suppl 5, pS1; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Havelange V, 2009, BRIT J CANCER, V101, P743, DOI 10.1038/sj.bjc.6605232; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Marx SO, 1999, MOL CELL BIOL, V19, P6041; Mavrakis KJ, 2011, CELL CYCLE, V10, P2845, DOI 10.4161/cc.10.17.16959; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mita M, 2008, EXPERT OPIN INV DRUG, V17, P1947, DOI [10.1517/13543780802556485, 10.1517/13543780802556485 ]; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Osaki M, 2008, BIOMARKERS, V13, P658, DOI 10.1080/13547500802646572 ; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Totary-Jain H, 2012, CANCER RES, V72, P1836, DOI 10.1158/0008-5472.CAN-11-2195; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wysocki PJ, 2009, EXPERT REV MOL DIAGN, V9, P231, DOI [10.1586/erm.09.8, 10.1586/ERM.09.8]; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	69	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6034	6044		10.1074/jbc.M112.416446	http://dx.doi.org/10.1074/jbc.M112.416446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300087	Green Published, hybrid			2022-12-25	WOS:000315820700001
J	Lisi, L; Camardese, G; Treglia, M; Tringali, G; Carrozza, C; Janiri, L; Dello Russo, C; Navarra, P				Lisi, Lucia; Camardese, Giovanni; Treglia, Mariangela; Tringali, Giuseppe; Carrozza, Cinzia; Janiri, Luigi; Dello Russo, Cinzia; Navarra, Pierluigi			Monocytes from Depressed Patients Display an Altered Pattern of Response to Endotoxin Challenge	PLOS ONE			English	Article							MAJOR DEPRESSION; GENE-EXPRESSION; SEROTONIN TRANSPORTER; IN-VITRO; PROSTAGLANDINS; LYMPHOCYTES; CYTOKINES	It is now well established that major depression is accompanied and characterized by altered responses of the immune-inflammatory system. In this study we investigated the pro-inflammatory activation of monocytes isolated from depressed patients as a parameter not influenced by such confounds as the time of day, the nutritional and exercise status or the age and gender of patients. Monocytes from depressed patients and from healthy controls were isolated in vitro; after 24-h incubation under basal conditions, cells were exposed for 24-h to 100 ng/ml of endotoxin (bacterial lipopolysaccharide, LPS). We found that monocytes from drug-free depressed patients and controls release the same amounts of prostaglandin E2 (PGE2) under basal conditions, whereas monocytes from patients are dramatically less reactive to LPS (8.62-fold increase vs previous 24 hrs) compared to healthy controls (123.3-fold increase vs previous 24 hrs). Such blunted prostanoid production was paralleled by a reduction in COX-2 gene expression, whereas other pro-inflammatory mediators, namely interleukin-1 beta (IL-1 beta) and -6 (IL-6) showed a trend to increased gene expression. The above changes were not associated to increased levels of circulating glucocorticoids. After 8 months of antidepressive drug treatment, the increase in PGE2 production after the endotoxin challenge was partially restored, whereas the increase in IL-1 beta and -6 levels observed at baseline was completely abolished. In conclusion, our findings show that the reactivity of monocytes from depressed patients might be considered as a marker of the immune-inflammatory disorders associated to depression, although the lack of paired healthy controls at follow-up does not allow to conclude that monocyte reactivity to endotoxin is also a marker of treatment outcome.	[Lisi, Lucia; Tringali, Giuseppe; Dello Russo, Cinzia; Navarra, Pierluigi] Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, I-00168 Rome, Italy; [Camardese, Giovanni; Treglia, Mariangela; Janiri, Luigi] Univ Cattolica Sacro Cuore, Sch Med, Inst Psychiat & Psychol, I-00168 Rome, Italy; [Carrozza, Cinzia] Univ Cattolica Sacro Cuore, Sch Med, Inst Biochem & Clin Biochem, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Navarra, P (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, I-00168 Rome, Italy.	pnavarra@rm.unicatt.it	Navarra, Pierluigi/AAL-4307-2020; Dello Russo, Cinzia/K-5283-2018; Camardese, Giovanni/AAC-1840-2022; Lisi, Lucia/AAL-1063-2020; Stevens, David/F-4683-2015	Dello Russo, Cinzia/0000-0002-2538-3832; Camardese, Giovanni/0000-0002-8139-9230; NAVARRA, Pierluigi/0000-0002-4424-650X; Lisi, Lucia/0000-0003-1397-2426; JANIRI, LUIGI/0000-0002-1633-9418				CALABRESE JR, 1986, PSYCHIAT RES, V17, P41, DOI 10.1016/0165-1781(86)90040-5; Dean B, 2011, INT J NEUROPSYCHOPH, V14, P997, DOI 10.1017/S1461145710001410; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Fazzino F, 2008, J NEUROIMMUNOL, V196, P173, DOI 10.1016/j.jneuroim.2008.03.012; Galli M, 2006, INT J MOL MED, V18, P141; Gonda X, 2008, ANN GEN PSYCHIATR, V13, P7; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Bonfiglio JJ, 2011, NEUROENDOCRINOLOGY, V94, P12, DOI 10.1159/000328226; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Krause Daniela L., 2012, Inflammopharmacology, V20, P169, DOI 10.1007/s10787-011-0112-6; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lima L, 2002, CELL MOL NEUROBIOL, V22, P797, DOI 10.1023/A:1021869310702; LINNOILA M, 1983, ARCH GEN PSYCHIAT, V40, P405; Lok A, 2012, PSYCHONEUROENDOCRINO, V37, P892, DOI 10.1016/j.psyneuen.2011.10.005; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; OHISHI K, 1988, BIOL PSYCHIAT, V23, P326, DOI 10.1016/0006-3223(88)90283-1; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SEHGAL PB, 1992, RES IMMUNOL, V143, P724, DOI 10.1016/0923-2494(92)80011-9; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029	25	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2013	8	1							e52585	10.1371/journal.pone.0052585	http://dx.doi.org/10.1371/journal.pone.0052585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070BE	23300980	gold, Green Published, Green Submitted			2022-12-25	WOS:000313480000011
J	Party, V; Hanot, C; Busser, DS; Rochat, D; Renou, M				Party, Virginie; Hanot, Christophe; Buesser, Daniela Schmidt; Rochat, Didier; Renou, Michel			Changes in Odor Background Affect the Locomotory Response to Pheromone in Moths	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; HOST-PLANT VOLATILES; SEX-PHEROMONE; EMISSION; WALKING; DISTRACTION; ATTRACTION; MORPHOLOGY; PHYSIOLOGY; LOCATION	Many animals rely on chemical cues to recognize and locate a resource, and they must extract the relevant information from a complex and changing odor environment. For example, in moths, finding a mate is mediated by a sex pheromone, which is detected in a rich environment of volatile plant compounds. Here, we investigated the effects of a volatile plant background on the walking response of male Spodoptera littoralis to the female pheromone. Males were stimulated by combining pheromone with one of three plant compounds, and their walking paths were recorded with a locomotion compensator and analyzed. We found that the addition of certain volatile plant compounds disturbed the orientation toward the sex pheromone. The effect on locomotion was correlated with the capacity of the plant compound to antagonize pheromone detection by olfactory receptor neurons, suggesting a masking effect of the background over the pheromone signal. Moths were more sensitive to changes in background compared to a constant background, suggesting that a background odor also acts as a distracting stimulus. Our experiments show that the effects of odorant background on insect responses to chemical signals are complex and cannot be explained by a single mechanism.	[Party, Virginie; Hanot, Christophe; Buesser, Daniela Schmidt; Rochat, Didier; Renou, Michel] INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Party, V (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France.	vparty@live.fr	RENOU, Michel/AAT-7340-2021	RENOU, Michel/0000-0001-6172-0210				Barrozo RB, 2004, CHEM SENSES, V29, P319, DOI 10.1093/chemse/bjh035; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Berti S, 2008, PSYCHOPHYSIOLOGY, V45, P608, DOI 10.1111/j.1469-8986.2008.00660.x; Blejec A, 2005, NEUROCOMPUTING, V65, P557, DOI 10.1016/j.neucom.2004.10.103; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Byers JA, 2004, NATURWISSENSCHAFTEN, V91, P215, DOI 10.1007/s00114-004-0520-1; Chan AAYH, 2010, ANIM BEHAV, V80, P1075, DOI 10.1016/j.anbehav.2010.09.025; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kolosova N, 2001, PLANT CELL, V13, P2333, DOI 10.1105/tpc.13.10.2333; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Light Douglas M., 1993, Chemoecology, V4, P145, DOI 10.1007/BF01256549; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; MarionPoll F, 1995, J NEUROSCI METH, V63, P197, DOI 10.1016/0165-0270(95)00110-7; Minoli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034141; MOORHOUSE JE, 1990, ANIM BEHAV, V39, P613, DOI 10.1016/S0003-3472(05)80372-0; MOORHOUSE JE, 1987, EXP BIOL, V46, P193; NEIL SJ, 1986, ETHOLOGY, V73, P225; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Parmentier FBR, 2008, COGNITION, V106, P408, DOI 10.1016/j.cognition.2007.03.008; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Raguso Robert A., 1999, Plant Species Biology, V14, P95, DOI 10.1046/j.1442-1984.1999.00014.x; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Rouyar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026443; Sakuma M, 2002, COMPUT ELECTRON AGR, V35, P243, DOI 10.1016/S0168-1699(02)00021-2; Schmidt-Busser D, 2009, J COMP PHYSIOL A, V195, P853, DOI 10.1007/s00359-009-0464-1; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Svensson GP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5901; Svensson GP, 2004, OIKOS, V104, P91, DOI 10.1111/j.0030-1299.2004.12517.x; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thorpe CM, 2002, BEHAV PROCESS, V58, P79; Willis MA, 2011, J EXP BIOL, V214, P4121, DOI 10.1242/jeb.036954	45	24	28	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e52897	10.1371/journal.pone.0052897	http://dx.doi.org/10.1371/journal.pone.0052897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301000	Green Published, gold			2022-12-25	WOS:000313320900043
J	Soga, M; Koike, S				Soga, Masashi; Koike, Shinsuke			Large Forest Patches Promote Breeding Success of a Terrestrial Mammal in Urban Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; RACCOON DOG; DECIDUOUS FORESTS; BIODIVERSITY; CONNECTIVITY; JAPAN; AREA	Despite a marked increase in the focus toward biodiversity conservation in fragmented landscapes, studies that confirm species breeding success are scarce and limited. In this paper, we asked whether local (area of forest patches) and landscape (amount of suitable habitat surrounding of focal patches) factors affect the breeding success of raccoon dogs (Nyctereutes procyonoides) in Tokyo, Central Japan. The breeding success of raccoon dogs is easy to judge as adults travel with pups during the breeding season. We selected 21 forest patches (3.3-797.8 ha) as study sites. In each forest patch, we used infrared-triggered cameras for a total of 60 camera days per site. We inspected each photo to determine whether it was of an adult or a pup. Although we found adult raccoon dogs in all 21 forest patches, pups were found only in 13 patches. To estimate probability of occurrence and detection for raccoon in 21 forest fragments, we used single season site occupancy models in PRESENCE program. Model selection based on AIC and model averaging showed that the occupancy probability of pups was positively affected by patch area. This result suggests that large forests improve breeding success of raccoon dogs. A major reason for the low habitat value of small, isolated patches may be the low availability of food sources and the high risk of being killed on the roads in such areas. Understanding the effects of local and landscape parameters on species breeding success may help us to devise and implement effective long-term conservation and management plans.	[Soga, Masashi; Koike, Shinsuke] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan	Tokyo University of Agriculture & Technology	Soga, M (corresponding author), Tokyo Univ Agr & Technol, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	soga06154053@yahoo.co.jp	Koike, Shinsuke/C-4619-2013	Koike, Shinsuke/0000-0002-2926-8196	Tokyu Foundation for Better Environment [2012-13];  [22651086]	Tokyu Foundation for Better Environment; 	This study was funded by Grant-in-Aid for Challenging Exploratory Research (22651086) and the Tokyu Foundation for Better Environment (no. 2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Davies KF, 1998, J ANIM ECOL, V67, P460, DOI 10.1046/j.1365-2656.1998.00210.x; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HARASHINA K, 1999, J JAPANESE I LANDSCA, V62, P569; Hines J. E, 2006, PRESENCE SOFTWARE ES; Hirasawa Mizuho, 2006, Mammal Study, V31, P9, DOI 10.3106/1348-6160(2006)31[9:SFHOTR]2.0.CO;2; Kauhala K, 1998, ECOGRAPHY, V21, P457, DOI 10.1111/j.1600-0587.1998.tb00436.x; Koike S, 2008, J FOREST RES-JPN, V13, P215, DOI 10.1007/s10310-008-0069-5; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Kurki S, 2000, ECOLOGY, V81, P1985, DOI 10.1890/0012-9658(2000)081[1985:LFAFCE]2.0.CO;2; Kurosawa R, 2003, CONSERV BIOL, V17, P695, DOI 10.1046/j.1523-1739.2003.01118.x; LOMOLINO MV, 1990, OIKOS, V57, P297, DOI 10.2307/3565957; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Marzluff JM, 2000, WILDLIFE SOC B, V28, P1132; Morrison M.L., 1998, WILDLIFE HABITAT REL; Mortelliti A, 2011, J APPL ECOL, V48, P153, DOI 10.1111/j.1365-2664.2010.01918.x; Newmark WD, 2011, P NATL ACAD SCI USA, V108, P11488, DOI 10.1073/pnas.1104955108; OHDACHI S. D., 2009, WILD MAMMALS JAPAN; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Saeki M, 2004, BIOL CONSERV, V118, P559, DOI 10.1016/j.biocon.2003.10.004; Soga M, J INSECT CO IN PRESS; Sonoda Y, 2002, ENV SYST RES, V30, P101; Sonoda Youichi, 2008, Ecology and Civil Engineering, V11, P41, DOI 10.3825/ece.11.41; Takatsuki S, 2008, MAMMALOGY JAPAN	28	13	14	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51802	10.1371/journal.pone.0051802	http://dx.doi.org/10.1371/journal.pone.0051802			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23300951	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900009
J	Liu, Y; Whelan, RJ; Pattnaik, BR; Ludwig, K; Subudhi, E; Rowland, H; Claussen, N; Zucker, N; Uppal, S; Kushner, DM; Felder, M; Patankar, MS; Kapur, A				Liu, Yang; Whelan, Rebecca J.; Pattnaik, Bikash R.; Ludwig, Kai; Subudhi, Enkateswar; Rowland, Helen; Claussen, Nick; Zucker, Noah; Uppal, Shitanshu; Kushner, David M.; Felder, Mildred; Patankar, Manish S.; Kapur, Arvinder			Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53	PLOS ONE			English	Article							PHASE-III TRIAL; DOXORUBICIN PLUS CISPLATIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; MOUSE SKIN; CARCINOMA; PACLITAXEL; GROWTH; FILGRASTIM; INHIBITION	Novel strategies are necessary to improve chemotherapy response in advanced and recurrent endometrial cancer. Here, we demonstrate that terpenoids present in the Steam Distilled Extract of Ginger (SDGE) are potent inhibitors of proliferation of endometrial cancer cells. SDGE, isolated from six different batches of ginger rhizomes, consistently inhibited proliferation of the endometrial cancer cell lines Ishikawa and ECC-1 at IC50 of 1.25 mu g/ml. SDGE also enhanced the anti-proliferative effect of radiation and cisplatin. Decreased proliferation of Ishikawa and ECC-1 cells was a direct result of SDGE-induced apoptosis as demonstrated by FITC-Annexin V staining and expression of cleaved caspase 3. GC/MS analysis identified a total of 22 different terpenoid compounds in SDGE, with the isomers neral and geranial constituting 30-40%. Citral, a mixture of neral and geranial inhibited the proliferation of Ishikawa and ECC-1 cells at an IC50 10 mu M (2.3 mu g/ml). Phenolic compounds such as gingerol and shogaol were not detected in SDGE and 6-gingerol was a weaker inhibitor of the proliferation of the endometrial cancer cells. SDGE was more effective in inducing cancer cell death than citral, suggesting that other terpenes present in SDGE were also contributing to endometrial cancer cell death. SDGE treatment resulted in a rapid and strong increase in intracellular calcium and a 20-40% decrease in the mitochondrial membrane potential. Ser-15 of p53 was phosphorylated after 15 min treatment of the cancer cells with SDGE. This increase in p53 was associated with 90% decrease in Bcl2 whereas no effect was observed on Bax. Inhibitor of p53, pifithrin-alpha, attenuated the anti-cancer effects of SDGE and apoptosis was also not observed in the p53(neg) SKOV-3 cells. Our studies demonstrate that terpenoids from SDGE mediate apoptosis by activating p53 and should be therefore be investigated as agents for the treatment of endometrial cancer.	[Liu, Yang] Shandong Univ, Dept Obstet & Gynecol, Qi Lu Hosp, Jinan, Peoples R China; [Liu, Yang; Ludwig, Kai; Rowland, Helen; Claussen, Nick; Zucker, Noah; Uppal, Shitanshu; Kushner, David M.; Felder, Mildred; Patankar, Manish S.; Kapur, Arvinder] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Whelan, Rebecca J.] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA; [Pattnaik, Bikash R.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Subudhi, Enkateswar] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Orissa, India	Shandong University; University of Wisconsin System; University of Wisconsin Madison; Oberlin College; University of Wisconsin System; University of Wisconsin Madison; Siksha 'O' Anusandhan University	Patankar, MS (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.	patankar@wisc.edu; akaur@wisc.edu	Uppal, Shitanshu/D-9374-2015; Whelan, Rebecca/J-7861-2019; Subudhi, Enketeswara/B-6206-2016	Uppal, Shitanshu/0000-0002-8329-6948; Whelan, Rebecca/0000-0002-9293-1528; Subudhi, Enketeswara/0000-0003-0571-6940; Ludwig, Kai/0000-0001-9867-9346; Pattnaik, Bikash/0000-0002-5385-358X	Department of Obstetrics and Gynecology; Wisconsin Ovarian Cancer Alliance; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation); University of Wisconsin Comprehensive Cancer Centers; National Institutes of Health [CA14520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Department of Obstetrics and Gynecology; Wisconsin Ovarian Cancer Alliance; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation); University of Wisconsin Comprehensive Cancer Centers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was provided by grants from the Department of Obstetrics and Gynecology to AK and MSP, a charitable donation from Jean McKenzie and research grants from the Wisconsin Ovarian Cancer Alliance to MSP and the Rebecca Meyer Brown Professorship of the UW-Eye Research Institute (Retina Research Foundation) to BRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply grateful to Dagna Sheerar and Karen Erslund (University of Wisconsin-Madison Paul P. Carbone Comprehensive Cancer Center, Flow Cytometry Facility) for their advice and help with the flow cytometry assays, to Rob McClain (Department of Chemistry) for his help with the GC-MS analysis, Dr. Randy Kimple and Molly Smith for their assistance with the irradiation of cells, and Jennifer Gubbels (Augustana College, Sioux Falls, ND) for critical reading of the manuscript. We also acknowledge the support provided by the University of Wisconsin Comprehensive Cancer Centers Flow Cytometry facility which is supported by a core grant (CA14520) from the National Institutes of Health.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Brown AC, 2009, PHYTOTHER RES, V23, P640, DOI 10.1002/ptr.2677; Chen CY, 2008, J NAT PROD, V71, P137, DOI 10.1021/np070279y; Choudhury D, 2010, FOOD CHEM TOXICOL, V48, P2872, DOI 10.1016/j.fct.2010.07.020; COHEN CJ, 1984, OBSTET GYNECOL, V63, P719; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Fleming GF, 2004, ANN ONCOL, V15, P1173, DOI 10.1093/annonc/mdh316; Gallion HH, 2003, J CLIN ONCOL, V21, P3808, DOI 10.1200/JCO.2003.10.083; Gehrig PA, 2010, GYNECOL ONCOL, V116, P187, DOI 10.1016/j.ygyno.2009.10.041; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Homesley HD, 2009, GYNECOL ONCOL, V112, P543, DOI 10.1016/j.ygyno.2008.11.014; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang HC, 2011, BIOSCI BIOTECH BIOCH, V75, P1067, DOI 10.1271/bbb.100851; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Ju SA, 2012, INT J CANCER, V130, P2618, DOI 10.1002/ijc.26316; Katiyar SK, 1996, CANCER RES, V56, P1023; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krell J, 2012, LANCET ONCOL, V13, P235, DOI 10.1016/S1470-2045(12)70097-9; Lee C, 2011, FOOD CHEM TOXICOL, V49, P1261, DOI 10.1016/j.fct.2011.03.005; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; LUNA RMD, 1995, NATURE, V378, P203; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Pan MH, 2008, MOL NUTR FOOD RES, V52, P527, DOI 10.1002/mnfr.200700157; Park EJ, 2002, CANCER METAST REV, V21, P231, DOI 10.1023/A:1021254725842; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Rhode Jennifer, 2007, BMC Complement Altern Med, V7, P44, DOI 10.1186/1472-6882-7-44; Riyazi A, 2007, PLANTA MED, V73, P355, DOI 10.1055/s-2007-967171; SATYASWAROOP PG, 1991, CANCER RES, V51, P5661; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spinner DM, 2000, METH MOLEC MED, V39, P175; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; Weng CJ, 2010, MOL NUTR FOOD RES, V54, P1618, DOI 10.1002/mnfr.201000108; Wohlmuth H, 2006, J AGR FOOD CHEM, V54, P1414, DOI 10.1021/jf0521799; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang SY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/936030	48	64	68	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e53178	10.1371/journal.pone.0053178	http://dx.doi.org/10.1371/journal.pone.0053178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300887	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600067
J	Son, DS; Kabir, SM; Dong, YL; Lee, E; Adunyah, SE				Son, Deok-Soo; Kabir, Syder M.; Dong, Yuan-Lin; Lee, Eunsook; Adunyah, Samuel E.			Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of I kappa B	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; WILD-TYPE P53; EPITHELIAL CANCER; ASCITIC FLUID; CROSS-TALK; ALPHA; GROWTH; ACTIVATION; RESISTANCE; PHOSPHORYLATION	Ovarian cancer, one of inflammation-associated cancers, is the fifth leading cause of cancer deaths among women. Inflammation in the tumor microenvironment is associated with peritoneal tumor dissemination and massive ascites, which contribute to high mortality in ovarian cancer. Tumor suppressor p53 is frequently deleted or mutated in aggressive and high-grade ovarian cancer, probably aggravating cancer progression and increasing mortality. We therefore investigated the influence of p53 on proinflammatory chemokines in ovarian cancer cells. A PCR array of the chemokine network revealed that ovarian cancer cells with low or mutated p53 expression expressed high levels of proinflammatory chemokines such as CXCL1, 2, 3 and 8. Transient transfection of p53 into p53-null ovarian cancer cells downregulated proinflammatory chemokines induced by tumor necrosis factor-alpha (TNF), a proinflammatory cytokine abundantly expressed in ovarian cancer. Furthermore, p53 restoration or stabilization blocked TNF-induced NF-kappa B promoter activity and reduced TNF-activated I kappa B. Restoration of p53 increased ubiquitination of I kappa B, resulting from concurrently reduced proteasome activity followed by stability of I kappa B. A ubiquitination PCR array on restoration of p53 did not reveal any significant change in expression except for Mdm2, indicating that the balance between p53 and Mdm2 is more important in regulating NF-kappa B signaling rather than the direct effect of p53 on ubiquitin-related genes or I kappa B kinases. In addition, nutlin-3, a specific inducer of p53 stabilization, inhibited proinflammatory chemokines by reducing TNF-activated I kappa B through p53 stabilization. Taken together, these results suggest that p53 inhibits proinflammatory chemokines in ovarian cancer cells by reducing proteasomal degradation of I kappa B. Thus, frequent loss or mutation of p53 may promote tumor progression by enhancing inflammation in the tumor microenvironment.	[Son, Deok-Soo; Kabir, Syder M.; Dong, Yuan-Lin; Adunyah, Samuel E.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Eunsook] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Son, DS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	dson@mmc.edu			National Institutes of Health NIAID [SC1AI089073]; NIGMS [SC1 089630]; NCI [U54CA163069-02]; NIMHD from the National Institutes of Health [U54MD007593-04]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI089073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089630] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMHD from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health NIAID SC1AI089073 (DS), NIGMS SC1 089630 (EL), NCI U54CA163069-02 and NIMHD U54MD007593-04 (SA) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Dreyfus DH, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-12; Duan ZF, 1999, CLIN CANCER RES, V5, P3445; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Fleming JS, 2006, MOL CELL ENDOCRINOL, V247, P4, DOI 10.1016/j.mce.2005.09.014; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hwang IY, 2010, CANCER LETT, V294, P82, DOI 10.1016/j.canlet.2010.01.025; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; Ivarsson K, 1998, GYNECOL ONCOL, V71, P420, DOI 10.1006/gyno.1998.5198; Ivarsson K, 2000, ACTA OBSTET GYN SCAN, V79, P777, DOI 10.1034/j.1600-0412.2000.079009777.x; Jin X, 2002, ANTICANCER RES, V22, P659; Kagami S, 2006, EXP DERMATOL, V15, P95, DOI 10.1111/j.1600-0625.2005.00390.x; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; Ravi R, 1998, CANCER RES, V58, P4531; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Son DS, 2007, CANCER BIOL THER, V6, P1302; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tanaka K, 2001, BIOCHIMIE, V83, P351, DOI 10.1016/S0300-9084(01)01237-8; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wilson AJ, 2011, CANCER BIOL THER, V12, P484, DOI 10.4161/cbt.12.6.15956; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Zhou MX, 2003, ONCOGENE, V22, P8137, DOI 10.1038/sj.onc.1206911	41	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51116	10.1371/journal.pone.0051116	http://dx.doi.org/10.1371/journal.pone.0051116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300534	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872600004
J	Jego, S; Salvert, D; Renouard, L; Mori, M; Goutagny, R; Luppi, PH; Fort, P				Jego, Sonia; Salvert, Denise; Renouard, Leslie; Mori, Masatomo; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice			Tuberal Hypothalamic Neurons Secreting the Satiety Molecule Nesfatin-1 Are Critically Involved in Paradoxical (REM) Sleep Homeostasis	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; C-FOS EXPRESSION; OREXIN NEURONS; GABAERGIC NEURONS; MCH NEURONS; LOCUS-COERULEUS; DEPRIVATION; EXCITABILITY; ACTIVATION; RECEPTOR	The recently discovered Nesfatin-1 plays a role in appetite regulation as a satiety factor through hypothalamic leptin-independent mechanisms. Nesfatin-1 is co-expressed with Melanin-Concentrating Hormone (MCH) in neurons from the tuberal hypothalamic area (THA) which are recruited during sleep states, especially paradoxical sleep (PS). To help decipher the contribution of this contingent of THA neurons to sleep regulatory mechanisms, we thus investigated in rats whether the co-factor Nesfatin-1 is also endowed with sleep-modulating properties. Here, we found that the disruption of the brain Nesfatin-1 signaling achieved by icv administration of Nesfatin-1 antiserum or antisense against the nucleobindin2 (NUCB2) prohormone suppressed PS with little, if any alteration of slow wave sleep (SWS). Further, the infusion of Nesfatin-1 antiserum after a selective PS deprivation, designed for elevating PS needs, severely prevented the ensuing expected PS recovery. Strengthening these pharmacological data, we finally demonstrated by using c-Fos as an index of neuronal activation that the recruitment of Nesfatin-1-immunoreactive neurons within THA is positively correlated to PS but not to SWS amounts experienced by rats prior to sacrifice. In conclusion, this work supports a functional contribution of the Nesfatin-1 signaling, operated by THA neurons, to PS regulatory mechanisms. We propose that these neurons, likely releasing MCH as a synergistic factor, constitute an appropriate lever by which the hypothalamus may integrate endogenous signals to adapt the ultradian rhythm and maintenance of PS in a manner dictated by homeostatic needs. This could be done through the inhibition of downstream targets comprised primarily of the local hypothalamic wake-active orexin-and histamine-containing neurons.	[Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] CNRS, UMR5292, Sleep Waking Neuronal Networks, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Lyon Neurosci Res Ctr CRNL, INSERM, U1028, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Univ Lyon, Lyon, France; [Jego, Sonia; Salvert, Denise; Renouard, Leslie; Goutagny, Romain; Luppi, Pierre-Herve; Fort, Patrice] Univ Lyon 1, F-69365 Lyon, France; [Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Gunma University	Fort, P (corresponding author), CNRS, UMR5292, Sleep Waking Neuronal Networks, Lyon, France.	patrice.fort@univ-lyon1.fr	Luppi, Pierre-Hervé/C-4333-2014; goutagny, romain/C-1461-2018; FORT, Patrice/G-6851-2017	Luppi, Pierre-Hervé/0000-0002-0503-423X; goutagny, romain/0000-0002-1268-533X; FORT, Patrice/0000-0003-1211-8631	CNRS; INSERM; Universite Claude Bernard - Lyon I	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Claude Bernard - Lyon I	This work was supported by CNRS, INSERM and Universite Claude Bernard - Lyon I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2009, J PHYSIOL-LONDON, V587, P33, DOI 10.1113/jphysiol.2008.164400; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Antal-Zimanyi I, 2009, J MOL NEUROSCI, V39, P86, DOI 10.1007/s12031-009-9207-6; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Cahill L, 2000, NEUROBIOL LEARN MEM, V74, P259, DOI 10.1006/nlme.1999.3950; Chen X, 2012, REGUL PEPTIDES, V177, P21, DOI 10.1016/j.regpep.2012.04.003; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Fujihara H, 2003, MOL BRAIN RES, V119, P152, DOI 10.1016/j.molbrainres.2003.09.005; Garcia-Fuster MJ, 2012, EUR NEUROPSYCHOPHARM, V22, P607, DOI 10.1016/j.euroneuro.2011.12.001; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Goebel M, 2011, PEPTIDES, V32, P36, DOI 10.1016/j.peptides.2010.09.027; Gokcek-Sarac C, 2012, BEHAV BRAIN RES, V235, P326, DOI 10.1016/j.bbr.2012.08.005; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Palasz A, 2012, NEUROPEPTIDES, V46, P105, DOI 10.1016/j.npep.2011.12.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Price CJ, 2008, J NEUROENDOCRINOL, V20, P245, DOI 10.1111/j.1365-2826.2007.01641.x; Price CJ, 2008, BRAIN RES, V1230, P99, DOI 10.1016/j.brainres.2008.06.084; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Satoh S, 2006, BEHAV BRAIN RES, V170, P277, DOI 10.1016/j.bbr.2006.03.010; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; SHIROMANI PJ, 1995, J NEUROSCI, V15, P3500; SIM LJ, 1995, BRAIN RES BULL, V36, P399, DOI 10.1016/0361-9230(94)00220-U; Stengel A, 2011, ENDOCRINOLOGY, V152, P4033, DOI 10.1210/en.2011-1500; Stengel A, 2010, REGUL PEPTIDES, V163, P18, DOI 10.1016/j.regpep.2010.05.002; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Torterolo Pablo, 2011, Front Neurol, V2, P14, DOI 10.3389/fneur.2011.00014; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Verret L, 2006, J COMP NEUR IN PRESS; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	68	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52525	10.1371/journal.pone.0052525	http://dx.doi.org/10.1371/journal.pone.0052525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300698	gold, Green Submitted, Green Published			2022-12-25	WOS:000312829100060
J	Ju, JM; Qi, ZC; Cai, XT; Cao, P; Huang, Y; Wang, SZ; Liu, N; Chen, YJ				Ju, Jianming; Qi, Zhichao; Cai, Xueting; Cao, Peng; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun			The Apoptotic Effects of Toosendanin Are Partially Mediated by Activation of Deoxycytidine Kinase in HL-60 Cells	PLOS ONE			English	Article							CHINESE TRADITIONAL MEDICINE; HUMAN CANCER-CELLS; HUMAN-LYMPHOCYTES; NUCLEOSIDE ANALOGS; DNA-SYNTHESIS; PHOSPHORYLATION; INHIBITION; CYTOTOXICITY; IRRADIATION; BINDING	Triterpenoid toosendanin (TSN) exhibits potent cytotoxic activity through inducing apoptosis in a variety of cancer cell lines. However, the target and mechanism of the apoptotic effects by TSN remain unknown. In this study, we captured a specific binding protein of TSN in HL-60 cells by serial affinity chromatography and further identified it as deoxycytidine kinase (dCK). Combination of direct activation of dCK and inhibition of TSN-induced apoptosis by a dCK inhibitor confirmed that dCK is a target for TSN partially responsible for the apoptosis in HL-60 cells. Moreover, the activation of dCK by TSN was a result of conformational change, rather than auto-phosphorylation. Our results further imply that, in addition to the dATP increase by dCK activation in tumor cells, dCK may also involve in the apoptotic regulation.	[Ju, Jianming; Qi, Zhichao; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Ju, Jianming; Qi, Zhichao; Huang, Yan; Wang, Shuzhen; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China; [Ju, Jianming; Cai, Xueting; Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Dept Pharmaceut Anal & Metabol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Nanjing University of Chinese Medicine	Liu, N (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	liunan0428@yahoo.com.cn; yjchen@cpu.edu.cn	Wang, Shuzhen/L-2895-2016; Chen, Yijun/H-3209-2019	Wang, Shuzhen/0000-0003-3869-2463; Chen, Yijun/0000-0002-4920-152X; , Peng/0000-0002-2044-3074	Ministry of Education of China; State Administration of Foreign Export Affairs of China [111-2-07]; National Natural Science Foundation of China [81001378, 81102467]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMKF201208]	Ministry of Education of China(Ministry of Education, China); State Administration of Foreign Export Affairs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Natural Medicines, China Pharmaceutical University	This work was supported by the grants from the "111'' Project from the Ministry of Education of China and the State Administration of Foreign Export Affairs of China (No. 111-2-07), the National Natural Science Foundation of China (No. 81001378 and No. 81102467) and the Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. SKLNMKF201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bierau J, 2006, CANCER CHEMOTH PHARM, V57, P105, DOI 10.1007/s00280-005-0005-8; Carpinella MC, 2003, J AGR FOOD CHEM, V51, P369, DOI 10.1021/jf025811w; Chung C.-C., 1975, ACTA CHIM SINICA, V33, P35; Csapo Z, 2003, BIOCHEM PHARMACOL, V65, P2031, DOI 10.1016/S0006-2952(03)00182-5; Csapo Z, 2001, BIOCHEM PHARMACOL, V61, P191, DOI 10.1016/S0006-2952(00)00534-7; Guo Y, 2012, J AGR FOOD CHEM, V60, P7016, DOI 10.1021/jf301734h; He YJ, 2010, PLANTA MED, V76, P1447, DOI 10.1055/s-0029-1240902; Ju JM, 2012, TOXICOL IN VITRO; Keszler G, 2005, ARCH BIOCHEM BIOPHYS, V436, P69, DOI 10.1016/j.abb.2005.01.009; Keszler G, 2004, NUCLEOS NUCLEOT NUCL, V23, P1335, DOI 10.1081/NCN-200027586; Keszler G, 2004, BIOCHEM PHARMACOL, V67, P947, DOI 10.1016/j.bcp.2003.10.019; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; LI PZ, 1982, CHIN TRADIT HERB DRU, V13, P28; Liu Qian, 2010, Journal of China Pharmaceutical University, V41, P451; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Paintsil E, 2011, ANTIMICROB AGENTS CH, V55, P895, DOI 10.1128/AAC.01303-10; PLAGEMANN PGW, 1978, CANCER RES, V38, P978; Raynal NJM, 2011, LEUKEMIA RES, V35, P110, DOI 10.1016/j.leukres.2010.04.014; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Sabini E, 2007, NUCLEIC ACIDS RES, V35, P186, DOI 10.1093/nar/gkl1038; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; Sasvari-Szekely M, 1998, BIOCHEM PHARMACOL, V56, P1175, DOI 10.1016/S0006-2952(98)00108-7; Sato S, 2011, CHEM BIOL, V18, P131, DOI 10.1016/j.chembiol.2010.10.017; Shi YL, 2007, PROG NEUROBIOL, V82, P1, DOI 10.1016/j.pneurobio.2007.02.002; Shu G.X., 1980, ACTA CHIM SINICA, V38, P196; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Smal C, 2010, NUCLEOS NUCLEOT NUCL, V29, P404, DOI 10.1080/15257771003741216; Spasokoukotskaja T, 1999, EUR J CANCER, V35, P1862, DOI 10.1016/S0959-8049(99)00223-3; Tang MZ, 2004, TOXICOLOGY, V201, P31, DOI 10.1016/j.tox.2004.03.023; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; Van den Neste E, 2003, BIOCHEM PHARMACOL, V65, P573, DOI 10.1016/S0006-2952(02)01559-9; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamamoto K, 2006, ANAL BIOCHEM, V352, P15, DOI 10.1016/j.ab.2006.02.008; Yu JCH, 2004, NEUROSIGNALS, V13, P248, DOI 10.1159/000079339; Yu XC, 2010, J BIOMOL SCREEN, V15, P72, DOI 10.1177/1087057109353604; Zhang B, 2005, INVEST NEW DRUG, V23, P547, DOI 10.1007/s10637-005-0909-5; Zhang J, 2008, ANAL CHIM ACTA, V622, P182, DOI 10.1016/j.aca.2008.05.046; Zhou JY, 2003, FEBS LETT, V555, P375, DOI 10.1016/S0014-5793(03)01291-2; ZOU J, 1985, Journal of Traditional Chinese Medicine, V5, P29	41	14	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52536	10.1371/journal.pone.0052536	http://dx.doi.org/10.1371/journal.pone.0052536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300702	gold, Green Published, Green Submitted			2022-12-25	WOS:000312829100061
J	Le Calvez-Kelm, F; Oliver, J; Damiola, F; Forey, N; Robinot, N; Durand, G; Voegele, C; Vallee, MP; Byrnes, G; Hopper, JL; Southey, MC; Andrulis, IL; John, EM; Tavtigian, SV; Lesueur, F				Le Calvez-Kelm, Florence; Oliver, Javier; Damiola, Francesca; Forey, Nathalie; Robinot, Nivonirina; Durand, Geoffroy; Voegele, Catherine; Vallee, Maxime P.; Byrnes, Graham; Hopper, John L.; Southey, Melissa C.; Andrulis, Irene L.; John, Esther M.; Tavtigian, Sean V.; Lesueur, Fabienne		Breast Canc Family Registry	RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; OVARIAN-CANCER; GERMLINE MUTATIONS; MISSENSE SUBSTITUTIONS; PENETRANCE ANALYSIS; BRCA1 CARRIERS; GENE; RISK; PALB2; RECOMBINATION	Background: Although inherited breast cancer has been associated with germline mutations in genes that are functionally involved in the DNA homologous recombination repair (HRR) pathway, including BRCA1, BRCA2, TP53, ATM, BRIP1, CHEK2 and PALB2, about 70% of breast cancer heritability remains unexplained. Because of their critical functions in maintaining genome integrity and already well-established associations with breast cancer susceptibility, it is likely that additional genes involved in the HRR pathway harbor sequence variants associated with increased risk of breast cancer. RAD51 plays a central biological function in DNA repair and despite the fact that rare, likely dysfunctional variants in three of its five paralogs, RAD51C, RAD51D, and XRCC2, have been associated with breast and/or ovarian cancer risk, no population-based case-control mutation screening data are available for the RAD51 gene. We thus postulated that RAD51 could harbor rare germline mutations that confer increased risk of breast cancer. Methodology/Principal Findings: We screened the coding exons and proximal splice junction regions of the gene for germline sequence variation in 1,330 early-onset breast cancer cases and 1,123 controls from the Breast Cancer Family Registry, using the same population-based sampling and analytical strategy that we developed for assessment of rare sequence variants in ATM and CHEK2. In total, 12 distinct very rare or private variants were characterized in RAD51, with 10 cases (0.75%) and 9 controls (0.80%) carrying such a variant. Variants were either likely neutral missense substitutions (3), silent substitutions (4) or non-coding substitutions (5) that were predicted to have little effect on efficiency of the splicing machinery. Conclusion: Altogether, our data suggest that RAD51 tolerates so little dysfunctional sequence variation that rare variants in the gene contribute little, if anything, to breast cancer susceptibility.	[Le Calvez-Kelm, Florence; Oliver, Javier; Damiola, Francesca; Forey, Nathalie; Robinot, Nivonirina; Durand, Geoffroy; Voegele, Catherine; Vallee, Maxime P.; Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Hopper, John L.] EGA Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.; Breast Canc Family Registry] Stanford Canc Inst, Stanford, CA USA; [Tavtigian, Sean V.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of Melbourne; University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Lesueur, F (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	lesueurf@iarc.fr	Andrulis, Irene L./E-7267-2013; oliver, javier/A-5338-2009; Lesueur, Fabienne/R-2178-2017	oliver, javier/0000-0002-8073-4711; Lesueur, Fabienne/0000-0001-7404-4549; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Damiola, Francesca/0000-0002-0238-1252; Vallee, Maxime/0000-0002-3616-9508; Ranoroarivony Robiniot, Nivonirina/0000-0002-2532-1455; Southey, Melissa/0000-0002-6313-9005; Byrnes, Graham/0000-0003-3893-7539	National Cancer Institute (NCI), National Institutes of Health (NIH) [R01 CA121245]; NIH [RFA-CA-06-503]; Cancer Care Ontario [U01 CA69467]; Cancer Prevention Institute of California [U01 CA69417]; University of Melbourne [U01 CA69638]; NATIONAL CANCER INSTITUTE [U01CA069467, R01CA121245, U01CA069417, U01CA069638] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Care Ontario; Cancer Prevention Institute of California; University of Melbourne(University of Melbourne); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH) grant R01 CA121245. The Breast Cancer Family Registry (BCFR) was supported by the NIH under RFA-CA-06-503 and through cooperative agreements with members of the BCFR and Principal Investigators, including Cancer Care Ontario (U01 CA69467), the Cancer Prevention Institute of California (U01 CA69417) and the University of Melbourne (U01 CA69638). The content of this manuscript does not necessarily reflect the views or policies of the NCI or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the BCFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; He XF, 2011, BREAST CANCER RES TR, V129, P649, DOI 10.1007/s10549-011-1537-8; Ishida T, 2007, BIOL PHARM BULL, V30, P1374, DOI 10.1248/bpb.30.1374; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Kadouri L, 2004, BRIT J CANCER, V90, P2002, DOI 10.1038/sj.bjc.6601837; Kato M, 2000, J HUM GENET, V45, P133, DOI 10.1007/s100380050199; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lose F, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1415; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nguyen-Dumont T, 2009, HUM MUTAT, V30, P884, DOI 10.1002/humu.20949; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Park JY, 2008, NUCLEIC ACIDS RES, V36, P3226, DOI 10.1093/nar/gkn171; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rapakko K, 2006, CANCER LETT, V236, P142, DOI 10.1016/j.canlet.2005.05.032; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Voegele C, 2007, BIOINFORMATICS, V23, P2504, DOI 10.1093/bioinformatics/btm365; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang ZW, 2010, BREAST CANCER RES TR, V124, P765, DOI 10.1007/s10549-010-0885-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yu KD, 2011, BREAST CANCER RES TR, V128, P297, DOI 10.1007/s10549-011-1402-9; Yu KD, 2011, BREAST CANCER RES TR, V126, P365, DOI 10.1007/s10549-010-0937-5; Zheng YL, 2010, BREAST CANCER RES TR, V124, P857, DOI 10.1007/s10549-010-1095-5	57	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52374	10.1371/journal.pone.0052374	http://dx.doi.org/10.1371/journal.pone.0052374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300655	gold, Green Published			2022-12-25	WOS:000312829100045
J	Abdelhadi, J; Wefstaedt, P; Nolte, I; Schilling, N				Abdelhadi, Jalal; Wefstaedt, Patrick; Nolte, Ingo; Schilling, Nadja			Fore-Aft Ground Force Adaptations to Induced Forelimb Lameness in Walking and Trotting Dogs	PLOS ONE			English	Article							TOTAL-ELBOW ARTHROPLASTY; LABRADOR RETRIEVERS; EPAXIAL MUSCLES; PLATE ANALYSES; GAIT ANALYSIS; HIND-LIMB; JOINT; TREADMILL; REDISTRIBUTION; ACCELERATION	Animals alter their locomotor mechanics to adapt to a loss of limb function. To better understand their compensatory mechanisms, this study evaluated the changes in the fore-aft ground forces to forelimb lameness and tested the hypothesis that dogs unload the affected limb by producing a nose-up pitching moment via the exertion of a net-propulsive force when the lame limb is on the ground. Seven healthy Beagles walked and trotted at steady speed on an instrumented treadmill while horizontal force data were collected before and after a moderate lameness was induced. Peak, mean and summed braking and propulsive forces as well as the duration each force was exerted and the time to reach maximum force were evaluated for both the sound and the lame condition. Compared with the sound condition, a net-propulsive force was produced by the lame diagonal limbs due to a reduced braking force in the affected forelimb and an increased propulsive force in the contralateral hindlimb when the dogs walked and trotted. To regain pitch stability and ensure steady speed for a given locomotor cycle, the dogs produced a net-braking force when the sound diagonal limbs were on the ground by exerting greater braking forces in both limbs during walking and additionally reducing the propulsive force in the hindlimb during trotting. Consistent with the proposed mechanism, dogs maximize their double support phases when walking. Likely associated with the fore-aft force adaptations to lameness are changes in muscle recruitment that potentially result in short- and long-term effects on the limb and trunk muscles.	[Abdelhadi, Jalal; Wefstaedt, Patrick; Nolte, Ingo; Schilling, Nadja] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Abdelhadi, Jalal] Univ Tripoli, Fac Vet Med, Dept Surg & Reprod, Tripoli, Libya; [Schilling, Nadja] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Schilling, N (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	nadja.schilling@tiho-hannover.de	Schilling, Nadja/F-9627-2013		Lybian government; Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP); Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt; Friedrich-Schiller-University Jena	Lybian government; Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP); Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt; Friedrich-Schiller-University Jena	This study was supported by Lybian government (scholarship to JA) and the Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP) funded by the Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt and the Friedrich-Schiller-University Jena (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, AM J VET RE IN PRESS; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Bertram JEA, 1997, VET COMP ORTHOPAED, V10, P160; Bockstahler BA, 2009, VET J, V180, P202, DOI 10.1016/j.tvjl.2007.12.025; BRYANT JD, 1987, J ZOOL, V213, P193, DOI 10.1111/j.1469-7998.1987.tb03693.x; Bubenik LJ, 2002, VET SURG, V31, P23, DOI 10.1053/jvet.2002.29460; BUDSBERG SC, 1987, AM J VET RES, V48, P915; BUDSBERG SC, 1993, AM J VET RES, V54, P1569; BUDSBERG SC, 1988, AM J VET RES, V49, P1522; Budsberg SC, 1999, VET COMP ORTHOPAED, V12, P15; Burton NJ, 2008, VET COMP ORTHOPAED, V21, P110, DOI 10.3415/VCOT-07-04-0038; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Conzemius MG, 2003, VET SURG, V32, P545, DOI 10.1111/j.1532-950X.2003.00545.x; Conzemius MG, 2001, VET SURG, V30, P11, DOI 10.1053/jvet.2001.20325; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1997, VET CLIN N AM-SMALL, V27, P825, DOI 10.1016/S0195-5616(97)50082-9; Druen S, 2010, BERL MUNCH TIERARZTL, V123, P339, DOI 10.2376/0005-9366-123-339; Fanchon L, 2006, VET COMP ORTHOPAED, V19, P81; FARLEY CT, 1993, J EXP BIOL, V185, P71; Griffin TM, 2004, J EXP BIOL, V207, P3545, DOI 10.1242/jeb.01177; GRIFFON DJ, 1994, VET COMP ORTHOPAED, V7, P154; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Kapatkin AS, 2006, JAVMA-J AM VET MED A, V228, P1350, DOI 10.2460/javma.228.9.1350; Kirpensteijn J, 2000, VET REC, V146, P155, DOI 10.1136/vr.146.6.155; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Lee DV, 1999, J EXP BIOL, V202, P3565; MCLAUGHLIN R, 1995, VET SURG, V24, P207, DOI 10.1111/j.1532-950X.1995.tb01320.x; MCLAUGHLIN R, 1995, AM J VET RES, V56, P159; Ragetly CA, 2012, AM J VET RES, V73, P1171, DOI 10.2460/ajvr.73.8.1171; Ragetly CA, 2010, VET SURG, V39, P513, DOI 10.1111/j.1532-950X.2010.00680.x; RIGGS CM, 1993, AM J VET RES, V54, P1523; RUMPH PF, 1994, AM J VET RES, V55, P756; Schilling N, 2010, J EXP BIOL, V213, P1490, DOI 10.1242/jeb.039487; Schilling N, 2009, J EXP BIOL, V212, P1053, DOI 10.1242/jeb.020248; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Theyse LFH, 2000, VET COMP ORTHOPAED, V13, P135; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; WENTINK GH, 1977, ANAT EMBRYOL, V151, P171, DOI 10.1007/BF00297479; [No title captured]	41	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52202	10.1371/journal.pone.0052202	http://dx.doi.org/10.1371/journal.pone.0052202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300614	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800057
J	Chopra, K; Chadha, VK; Ramachandra, J; Aggarwal, N				Chopra, Kamal; Chadha, Vineet K.; Ramachandra, Jitendra; Aggarwal, Nishi			Trend in Annual Risk of Tuberculous Infection in North India	PLOS ONE			English	Article								Setting: Six selected districts in Northern India. Objectives: To find out the trend in Annual risk of tuberculous infection (ARTI) in north India. Study Design: Two rounds of community level surveys were conducted during 2000-2001 and 2009-10 respectively. Representative samples of children 1-9 years of age were tuberculin tested and maximum transverse diameter of induration was recorded in mm at about 72 hours. ARTI was computed from the estimated Prevalence of infection using mirror-image technique and anti-mode method. Results: ARTI was found to decline from 1.9% (confidence interval: 1.7-2.1) at round I to 1.1% (confidence interval: 0.8-1.3) at round II at the rate of 8% per year during the intervening period. Conclusion: A significant reduction in the risk of tuberculous infection among children was observed between two rounds of surveys carried out at an interval of about 9 years.	[Chopra, Kamal] New Delhi TB Ctr, Directors Off, New Delhi, India; [Chadha, Vineet K.] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India; [Ramachandra, Jitendra] Natl TB Inst, HRD Div, Bangalore, Karnataka, India; [Aggarwal, Nishi] New Delhi TB Ctr, Dept Stat, New Delhi, India		Chopra, K (corresponding author), New Delhi TB Ctr, Directors Off, New Delhi, India.	chopra_drkk@yahoo.co.in			Ministry of Health and Family welfare, Government of India	Ministry of Health and Family welfare, Government of India	Authors are grateful to all the field staff and district health authorities for support. Funds were provided by the Ministry of Health and Family welfare, Government of India. Best regards will remain due to Dr V K Dhingra (late), the then Director of New Delhi TB Centre.	Bleiker M A, 1989, Bull Int Union Tuberc Lung Dis, V64, P7; Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India, 2010, TB INDIA 2010 REVISE; Chadha VK, 2008, INT J TUBERC LUNG D, V12, P1116; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chadha VK, 2004, INT J TUBERC LUNG D, V8, P1437; Chadha VK, 2003, B WORLD HEALTH ORGAN, V81, P573; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; Chadha VK, 2011, TEXT BOOK OF PULMONA, P489; Channabasavaiah R, 1993, INDIAN J TUBERCULOSI, V40, P137; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P345; HONG YP, 1993, TUBERCLE LUNG DIS, V74, P323, DOI 10.1016/0962-8479(93)90107-9; Indian Council of Medical Research, 1959, SPECIAL REPORT SERIE, V34; Neuenschwander BE, 2010, BAYESIAN MIXTURE ANA; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Styblo K, 1991, EPIDEMIOLOGY OF TUBE, V24	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51854	10.1371/journal.pone.0051854	http://dx.doi.org/10.1371/journal.pone.0051854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300568	Green Published, gold, Green Submitted			2022-12-25	WOS:000313618800030
J	Wall, JS; Kennel, SJ; Williams, A; Richey, T; Stuckey, A; Huang, Y; Macy, S; Donnell, R; Barbour, R; Seubert, P; Schenk, D				Wall, Jonathan S.; Kennel, Stephen J.; Williams, Angela; Richey, Tina; Stuckey, Alan; Huang, Ying; Macy, Sallie; Donnell, Robert; Barbour, Robin; Seubert, Peter; Schenk, Dale			AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils	PLOS ONE			English	Article							P-COMPONENT SCINTIGRAPHY; RENAL-DISEASE; LIGHT-CHAINS; BETA; TRANSTHYRETIN; MECHANISMS; EPRODISATE; DIAGNOSIS; PATHOLOGY; SYSTEM	The monoclonal antibody 2A4 binds an epitope derived from a cleavage site of serum amyloid protein A (sAA) containing a -Glu-Asp- amino acid pairing. In addition to its reactivity with sAA amyloid deposits, the antibody was also found to bind amyloid fibrils composed of immunoglobulin light chains. The antibody binds to synthetic fibrils and human light chain (AL) amyloid extracts with high affinity even in the presence of soluble light chain proteins. Immunohistochemistry with biotinylated 2A4 demonstrated positive reaction with AL kappa and AL lambda human amyloid deposits in various organs. Surface plasmon resonance analyses using synthetic AL fibrils as a substrate revealed that 2A4 bound with a K-D of similar to 10 nM. Binding was inhibited in the presence of the -Glu-Asp- containing immunogen peptide. Radiolabeled 2A4 specifically localized with human AL amyloid extracts implanted in mice (amyloidomas) as evidenced by single photon emission (SPECT) imaging. Furthermore, co-localization of the radiolabeled mAb with amyloid was shown in biodistribution and micro-autoradiography studies. Treatment with 2A4 expedited regression of AL kappa amyloidomas in mice, likely mediated by the action of macrophages and neutrophils, relative to animals that received a control antibody. These data indicate that the 2A4 mAb might be of interest for potential imaging and immunotherapy in patients with AL amyloidosis.	[Wall, Jonathan S.; Kennel, Stephen J.; Williams, Angela; Richey, Tina; Huang, Ying; Macy, Sallie] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA; [Wall, Jonathan S.; Kennel, Stephen J.; Stuckey, Alan] Univ Tennessee, Dept Radiol, Grad Sch Med, Knoxville, TN 37996 USA; [Donnell, Robert] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Barbour, Robin; Seubert, Peter; Schenk, Dale] Neotope Biosci, San Francisco, CA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Wall, JS (corresponding author), Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA.	jwall@utmck.edu		Donnell, Robert L./0000-0002-6778-954X; Wall, Jonathan/0000-0002-5516-8578	Elan Pharmaceuticals, South San Francisco, USA	Elan Pharmaceuticals, South San Francisco, USA	This work was supported by a collaborative research grant from Elan Pharmaceuticals, South San Francisco, USA ("funders''). The funders had no role in data collection and analysis associated with this manuscript. The decision to publish (and where) as well as certain aspects of the experimental design, were made jointly by JSW, SJK, PS, and DS.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benson MD, 2006, MUSCLE NERVE, V33, P609, DOI 10.1002/mus.20503; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Chee CE, 2010, CL LYMPH MYELOM LEUK, V10, P177, DOI 10.3816/CLML.2010.n.027; Davis DP, 1999, J IMMUNOL, V163, P3842; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Guz G, 2009, CURR OPIN INFECT DIS, V22, P309, DOI 10.1097/QCO.0b013e328329d15e; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hachulla E, 1996, AM J MED, V101, P77, DOI 10.1016/S0002-9343(94)00054-9; Hachulla E, 2002, JOINT BONE SPINE, V69, P538, DOI 10.1016/S1297-319X(02)00449-9; Haupt C, 2011, J MOL BIOL, V408, P529, DOI 10.1016/j.jmb.2011.02.032; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hazenberg BPC, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.043; Hazenberg BPC, 2004, NETH J MED, V62, P121; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Hrncic R, 1988, DISSOLUTION HUMAN AM, P166; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Koivuniemi R, 2008, AMYLOID, V15, P262, DOI 10.1080/13506120802524676; Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724; Kurosawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1012, DOI 10.1016/j.bbrc.2005.09.142; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Mekinian A, 2010, AM J MED, V123, P864, DOI 10.1016/j.amjmed.2010.03.022; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Nakamura T, 2011, CLIN EXP RHEUMATOL, V29, P850; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2005, AMYLOID AMYLOIDOSIS, P482; Phipps JE, 2010, EXP HEMATOL, V38, P1006, DOI 10.1016/j.exphem.2010.07.001; Pinney JH, 2012, ANN CLIN BIOCHEM, V49, P229, DOI 10.1258/acb.2011.011225; Pokkuluri PR, 1999, AMYLOID, V6, P165, DOI 10.3109/13506129909007322; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roy I, 2004, BIOTECHNOL APPL BIOC, V39, P165, DOI 10.1042/BA20030133; Rule AD, 2007, NAT CLIN PRACT NEPHR, V3, P592, DOI 10.1038/ncpneph0615; Rumjon A, 2012, INT J NEPHROL RENOV, V5, P37, DOI 10.2147/IJNRD.S19165; SAILE R, 1993, EUR J NUCL MED, V20, P130; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Stangou AJ, 2004, CURR OPIN NEUROL, V17, P615, DOI 10.1097/00019052-200410000-00012; Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2006, J NUCL MED, V47, P2016; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00032; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Zago W, 2012, J NEUROSCI, V32, P2696, DOI 10.1523/JNEUROSCI.1676-11.2012	48	56	59	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52686	10.1371/journal.pone.0052686	http://dx.doi.org/10.1371/journal.pone.0052686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300743	gold, Green Published, Green Submitted			2022-12-25	WOS:000313618800126
J	Li, ZM; Huang, JJ; Xia, Y; Sun, J; Huang, Y; Wang, Y; Zhu, YJ; Li, YJ; Zhao, W; Wei, WX; Lin, TY; Huang, HQ; Jiang, WQ				Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi			Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; ABSOLUTE MONOCYTE; RESPONSE CRITERIA; PROGNOSTIC-FACTOR; SURVIVAL; LYMPHOPENIA; EXPRESSION; COUNT; TUMOR; CHEMOTHERAPY	Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic significance of the immunologically relevant lymphocyte-to-monocyte ratio (LMR), in diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Methodology/Principal Findings: We analyzed retrospective data from 438 newly diagnosed DLBCL patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. We randomly selected 200 patients (training set) to generate a cutoff value for LMR by receiver operating characteristic (ROC) curve analysis. LMR was then analyzed in a testing set (n = 238) and in all patients (n = 438) for validation. The LMR cutoff value for survival analysis determined by ROC curve in the training set was 2.6. Patients with low LMR tended to have more adverse clinical characteristics. Low LMR at diagnosis was associated with worse survival in DLBCL, and could also identify high-risk patients in the low-risk IPI category. Multivariate analysis identified LMR as an independent prognostic factor of survival in the testing set and in all patients. Conclusions/Significance: Baseline LMR, a surrogate biomarker of the immune microenvironment, is an effective prognostic factor in DLBCL patients treated with R-CHOP therapy. Future prospective studies are required to confirm our findings.	[Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Ctr Canc, Dept Clin Trial Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022; Wu, William K.K./A-3277-2009	Wu, William K.K./0000-0002-5662-5240; Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (NO. 81071950), Fundamental Research Funds for the Central Universities (NO. 10ykpy36), National-Eleventh Five Technology Major Project (NO. 2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Ansell SM, 2001, J CLIN ONCOL, V19, P720, DOI 10.1200/JCO.2001.19.3.720; Bari A, 2010, ANN ONCOL, V21, P1486, DOI 10.1093/annonc/mdp531; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Borg C, 2004, CANCER-AM CANCER SOC, V101, P2675, DOI 10.1002/cncr.20688; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Huang JJ, 2011, ANN ONCOL, V22, P149, DOI 10.1093/annonc/mdq314; Huang JJ, 2011, HUM PATHOL, V42, P1459, DOI 10.1016/j.humpath.2010.12.014; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Kim YR, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-34; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Pileri SA, 2011, SEMIN DIAGN PATHOL, V28, P113, DOI 10.1053/j.semdp.2011.02.001; Porrata LF, 2007, LEUKEMIA, V21, P2554, DOI 10.1038/sj.leu.2404819; Porrata LF, 2004, CLIN EXP MED, V4, P78, DOI 10.1007/s10238-004-0041-4; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vegso G, 2011, PATHOL ONCOL RES, V17, P443, DOI 10.1007/s12253-010-9329-8; Wada N, 2012, HISTOPATHOLOGY, V60, P924, DOI 10.1111/j.1365-2559.2011.04161.x; Wada N, 2012, HISTOPATHOLOGY, V60, P313, DOI 10.1111/j.1365-2559.2011.04096.x; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Wilcox RA, 2009, BLOOD, V114, P2936, DOI 10.1182/blood-2009-05-220111	35	221	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41658	10.1371/journal.pone.0041658	http://dx.doi.org/10.1371/journal.pone.0041658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	23300886	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700134
J	Pratheeshkumar, P; Budhraja, A; Son, YO; Wang, X; Zhang, Z; Ding, SZ; Wang, L; Hitron, A; Lee, JC; Xu, M; Chen, G; Luo, J; Shi, XL				Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Xu, Mei; Chen, Gang; Luo, Jia; Shi, Xianglin			Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR-2 Regulated AKT/mTOR/P70S6K Signaling Pathways	PLOS ONE			English	Article							CANCER PREVENTION; ACTIVATION; APOPTOSIS; INVASION; BIOLOGY; CELLS; MTOR	Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.	[Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Xu, Mei; Chen, Gang; Luo, Jia] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Luo, Jia/E-4674-2012; Wang, Lei/E-3063-2012; Son, Youngok/AAB-1380-2021; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Luo, Jia/0000-0002-6968-3618; Budhraja, Amit/0000-0002-4216-8608; Son, Youngok/0000-0003-0154-4061	National Institutes of Health [1R01ES020870, 5R21ES019249]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020870, R21ES019249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants: 1R01ES020870 (Shi), and 5R21ES019249 (Shi and Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; Berger NA, 2010, POLY ADP RIBOSE CELL; Bhat TA, 2008, FOOD CHEM TOXICOL, V46, P1334, DOI 10.1016/j.fct.2007.08.032; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Fasolo A, 2008, MTOR INHIBITORS TREA; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Nicholson DW, 1995, IDENTIFICATION INHIB; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Patan S, 2004, CANC TREAT, V117, P3; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P33, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.40; Pratheeshkumar P, 2012, ANTICANCER AGENTS ME; Pratheeshkumar P, 2011, EUROPEAN J PHARM; Pratheeshkumar P, 2011, DRUG CHEM TOXICOL, V34, P261, DOI 10.3109/01480545.2010.520017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 1997, CANCER RES, V57, P765; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tie Jeanne, 2012, Critical Reviews in Oncogenesis, V17, P51; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Wang SP, 2011, BOUND VALUE PROBL, DOI 10.1155/2011/901796; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	40	186	200	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47516	10.1371/journal.pone.0047516	http://dx.doi.org/10.1371/journal.pone.0047516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23300633	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500013
J	Yang, WH; He, KL; Zhang, J; Guo, SY				Yang, Wenhui; He, Kanglai; Zhang, Jie; Guo, Shuyuan			pH-Controlled Bacillus thuringiensis Cry1Ac Protoxin Loading and Release from Polyelectrolyte Microcapsules	PLOS ONE			English	Article							CALCIUM-CARBONATE PARTICLES; LOW-MOLECULAR-WEIGHT; DELTA-ENDOTOXIN; SPODOPTERA-EXIGUA; INSECTICIDAL ACTIVITY; MULTILAYER FILMS; DOMAIN III; TOXICITY; ENCAPSULATION; FORMULATIONS	Crystal proteins synthesized by Bacillus thuringiensis (Bt) have been used as biopesticides because of their toxicity to the insect larval hosts. To protect the proteins from environmental stress to extend their activity, we have developed a new microcapsule formulation. Poly (acrylic acid) (PAH) and poly (styrene sulfonate) (PSS) were fabricated through layer-by-layer self-assembly based on a CaCO3 core. Cry1Ac protoxins were loaded into microcapsules through layer-by-layer self-assembly at low pH, and the encapsulated product was stored in water at 4 degrees C. Scanning electron microscopy (SEM) was used to observe the morphology of the capsules. To confirm the successful encapsulation, the loading results were observed with a confocal laser scattering microscope (CLSM), using fluorescein-labeled Cry1Ac protoxin (FITC-Cry1Ac). The protoxins were released from the capsule under the alkaline condition corresponding to the midgut of certain insects, a condition which seldom exists elsewhere in the environment. The following bioassay experiment demonstrated that the microcapsules with Cry1Ac protoxins displayed approximately equivalent insecticidal activity to the Asian corn borer compared with free Cry1Ac protoxins, and empty capsules proved to have no effect on insects. Further result also indicated that the formulation could keep stable under the condition of heat and desiccation. These results suggest that this formulation provides a promising methodology that protects protoxins from the environment and releases them specifically in the target insects' midgut, which has shown potential as biopesticide in the field.	[Yang, Wenhui; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, WH (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn	Yang, Wan/K-7592-2013	Yang, Wan/0000-0002-7555-9728	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Natural Science Foundation of China [31171911]; National High Technology Research and Development Program of China (863 Program) [2011AA10A203]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the grants from the Major State Basic Research Development Program of China (973 Program; No. 2009CB118902), the Natural Science Foundation of China (No. 31171911), and the National High Technology Research and Development Program of China (863 Program; No. 2011AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov A, 2003, MACROMOL RAPID COMM, V24, P274, DOI 10.1002/marc.200390041; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Cote JC, 2001, PHYTOPROTECTION, V82, P73, DOI 10.7202/706218ar; de Maagd RA, 2000, APPL ENVIRON MICROB, V66, P1559, DOI 10.1128/AEM.66.4.1559-1563.2000; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891; Donath E, 2002, CHEM-EUR J, V8, P5481, DOI 10.1002/1521-3765(20021202)8:23<5481::AID-CHEM5481>3.0.CO;2-8; Gao CY, 2002, ANGEW CHEM INT EDIT, V41, P3789, DOI 10.1002/1521-3773(20021018)41:20<3789::AID-ANIE3789>3.0.CO;2-D; Garcia-Gutierrez K, 2011, BIOPROC BIOSYST ENG, V34, P701, DOI 10.1007/s00449-011-0519-x; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850, DOI 10.1093/jee/64.4.850; IGNOFFO CM, 1992, FLA ENTOMOL, V75, P516, DOI 10.2307/3496133; Jada A, 2003, COLLOID SURFACE A, V219, P7, DOI 10.1016/S0927-7757(03)00010-4; Jada A, 2000, J MATER SCI LETT, V19, P2077, DOI 10.1023/A:1026737701570; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Lamprecht A, 2000, EUR J PHARM BIOPHARM, V49, P1, DOI 10.1016/S0939-6411(99)00063-6; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Myasnik M, 2001, CURR MICROBIOL, V43, P140, DOI 10.1007/s002840010276; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Regev A, 1996, APPL ENVIRON MICROB, V62, P3581, DOI 10.1128/AEM.62.10.3581-3586.1996; Sopena F, 2009, CIENC INVESTIG AGRAR, V36, P27; Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U; Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P219, DOI 10.1603/0022-0493-93.2.219; Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.3.CO;2-P; Tong WJ, 2006, J PHYS CHEM B, V110, P12905, DOI 10.1021/jp055258w; Tong WJ, 2005, J PHYS CHEM B, V109, P13159, DOI 10.1021/jp0511092; Wei W, 2008, ADV MATER, V20, P2292, DOI 10.1002/adma.200702663; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004	35	152	155	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45233	10.1371/journal.pone.0045233	http://dx.doi.org/10.1371/journal.pone.0045233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024810	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100068
